data_2z2d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2z2d _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 mtt-85 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 123.146 1.451 . . . . 1.2 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 52.57 0.48 Allowed 'General case' 0 C--N 1.379 1.87 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 108.179 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -168.96 -55.39 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.219 -1.355 . . . . 0.56999999999999995 109.321 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -98.62 112.13 24.28 Favored 'General case' 0 C--N 1.371 1.515 0 O-C-N 124.006 0.816 . . . . 0.56999999999999995 110.934 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.72 151.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.062 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -106.0 159.77 15.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.56999999999999995 111.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 5.7 t80 -148.59 150.51 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.92 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -142.8 132.91 24.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 1.2 110.889 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.97 140.46 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.147 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -160.88 0.02 OUTLIER 'General case' 0 C--N 1.379 1.883 0 CA-C-O 124.362 2.03 . . . . 0.56999999999999995 109.718 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.32 39.38 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 111.069 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 59.33 16.8 5.32 Favored 'General case' 0 C--N 1.386 2.161 0 O-C-N 124.362 1.039 . . . . 0.56999999999999995 110.083 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.436 HG23 ' CE1' ' A' ' 163' ' ' PHE . 0.1 OUTLIER 65.98 158.18 0.13 Allowed Pre-proline 0 C--N 1.367 1.331 0 O-C-N 128.217 3.448 . . . . 0.56999999999999995 109.793 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.44 -43.65 0.35 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 O-C-N 118.265 -1.492 . . . . 0.56999999999999995 112.145 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -63.71 1.18 Allowed 'General case' 0 C--N 1.371 1.509 0 C-N-CA 125.209 1.404 . . . . 0.91000000000000003 113.471 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.1 ttm -42.64 132.44 3.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 128.035 3.779 . . . . 0.56999999999999995 110.336 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.06 143.4 37.46 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.038 -2.289 . . . . 0.56999999999999995 107.97 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -46.59 47.06 Favored 'General case' 0 C--N 1.38 1.903 0 N-CA-C 107.03 -1.47 . . . . 1.2 107.03 -164.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -54.75 -34.78 62.99 Favored 'General case' 0 C--N 1.396 2.602 0 CA-C-N 111.428 -2.624 . . . . 0.91000000000000003 110.927 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.11 -43.71 70.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.933 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.62 -39.07 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.174 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.13 87.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.91000000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -67.32 -49.05 65.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 110.929 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.12 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 111.101 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.44 -31.94 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.17 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -67.93 -46.78 70.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CD ' ' OE1' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.56 -46.05 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.926 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.89 80.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 111.061 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 -44.11 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.56999999999999995 110.902 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.416 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.0 pt20 -63.75 -37.05 85.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.91 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -69.47 -34.01 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.13 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.433 ' O ' ' CG2' ' A' ' 145' ' ' THR . 49.6 m95 -82.97 -34.3 26.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 110.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -49.36 13.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.875 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -59.51 -12.71 6.83 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-O 121.429 0.633 . . . . 0.56999999999999995 112.352 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 23.8 m -115.63 16.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 C-N-CA 124.027 0.931 . . . . 0.56999999999999995 109.531 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 75.2 p -146.01 150.69 43.04 Favored Pre-proline 0 C--N 1.367 1.362 0 CA-C-O 124.642 2.163 . . . . 0.56999999999999995 107.474 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -80.38 -11.01 13.31 Favored 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-O 123.027 1.178 . . . . 0.56999999999999995 111.072 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.75 113.19 26.62 Favored 'General case' 0 C--N 1.371 1.529 0 N-CA-C 103.85 -2.648 . . . . 0.56999999999999995 103.85 -172.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.52 158.4 36.32 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-O 125.213 2.435 . . . . 0.56999999999999995 117.177 166.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 224' ' ' LEU . 9.6 m-85 -131.15 158.8 39.49 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.573 -1.649 . . . . 0.56999999999999995 107.439 -174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 125.57 5.96 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-O 124.29 1.995 . . . . 0.56999999999999995 106.956 -171.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 150.08 20.95 Favored 'General case' 0 C--N 1.367 1.363 0 CA-C-O 123.335 1.54 . . . . 0.56999999999999995 109.736 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 pt -144.15 -178.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.552 0 CA-C-O 123.618 1.675 . . . . 0.56999999999999995 108.919 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -155.09 54.59 0.64 Allowed 'General case' 0 C--N 1.379 1.89 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 107.949 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.4 -69.27 0.06 Allowed 'General case' 0 C--N 1.377 1.781 0 C-N-CA 119.955 -0.698 . . . . 0.56999999999999995 109.813 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -86.05 173.64 46.88 Favored Glycine 0 C--N 1.372 2.569 0 CA-C-O 124.161 1.978 . . . . 0.56999999999999995 110.38 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.2 ttt -63.66 154.4 33.07 Favored 'General case' 0 C--N 1.377 1.782 0 CA-C-N 112.331 -1.935 . . . . 0.56999999999999995 107.81 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.59 170.92 15.25 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 113.721 -1.582 . . . . 0.56999999999999995 109.636 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.67 -67.8 0.76 Allowed 'General case' 0 C--N 1.379 1.877 0 N-CA-C 102.255 -3.239 . . . . 0.91000000000000003 102.255 -168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.9 mt -92.51 109.9 22.17 Favored 'Isoleucine or valine' 0 C--N 1.402 2.871 0 O-C-N 124.544 1.153 . . . . 0.56999999999999995 111.087 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 194' ' ' ASP . 0.9 OUTLIER -105.45 132.11 52.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.918 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -109.84 117.02 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 111.143 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.61 146.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.137 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.436 ' CE1' HG23 ' A' ' 122' ' ' THR . 57.1 m-85 -103.74 118.48 36.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.833 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.25 167.59 23.12 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-O 124.109 1.909 . . . . 0.56999999999999995 109.69 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 149.29 24.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.426 -2.046 . . . . 1.2 108.524 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.78 121.05 1.83 Allowed Glycine 0 C--N 1.375 2.738 0 CA-C-N 113.349 -1.751 . . . . 0.56999999999999995 110.861 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -178.21 -57.8 0.01 OUTLIER 'General case' 0 C--N 1.379 1.878 0 CA-C-O 123.028 1.394 . . . . 0.56999999999999995 108.396 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--N 1.389 2.286 0 CA-C-O 123.266 1.507 . . . . 0.56999999999999995 109.732 -174.015 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.948 0 CA-C-O 122.616 1.198 . . . . 0.56999999999999995 111.44 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -57.44 -97.52 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 123.986 1.85 . . . . 0.56999999999999995 112.894 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.48 178.36 4.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 125.25 2.452 . . . . 0.91000000000000003 110.324 173.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -150.87 35.53 0.92 Allowed Glycine 0 C--N 1.372 2.561 0 CA-C-N 112.221 -2.263 . . . . 0.56999999999999995 112.258 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 14.55 0.14 Allowed 'General case' 0 C--N 1.376 1.76 0 CA-C-O 122.012 0.911 . . . . 0.56999999999999995 112.541 -175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.56 -143.46 10.2 Favored Glycine 0 C--N 1.364 2.097 0 CA-C-O 122.515 1.064 . . . . 0.56999999999999995 110.801 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.93 -130.99 47.61 Favored Glycine 0 C--N 1.36 1.881 0 O-C-N 119.994 -1.886 . . . . 0.56999999999999995 111.194 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 174' ' ' PHE . 1.0 OUTLIER -54.41 163.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.517 0 CA-C-N 113.065 -1.568 . . . . 0.56999999999999995 108.866 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' C ' HD13 ' A' ' 180' ' ' ILE . 11.2 mt -111.4 -40.29 4.43 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 115.527 1.677 . . . . 0.56999999999999995 115.527 169.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 197' ' ' PHE . . . -175.03 179.92 1.49 Allowed 'General case' 0 C--N 1.363 1.177 0 O-C-N 121.278 -0.889 . . . . 0.56999999999999995 111.111 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.34 159.9 39.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.852 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.57 153.06 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.56999999999999995 111.141 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -93.85 -177.82 4.47 Favored 'General case' 0 C--N 1.373 1.588 0 CA-C-O 123.052 1.406 . . . . 0.56999999999999995 109.758 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.58 -158.96 15.92 Favored Glycine 0 C--N 1.378 2.866 0 CA-C-N 114.372 -1.286 . . . . 0.56999999999999995 112.075 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.39 -139.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.443 2.762 . . . . 0.56999999999999995 112.169 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.19 -132.4 10.94 Favored Glycine 0 C--N 1.371 2.513 0 O-C-N 119.307 -2.12 . . . . 0.56999999999999995 108.968 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.66 157.13 31.25 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.817 -1.549 . . . . 0.56999999999999995 106.817 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.71 3.8 Favored Glycine 0 C--N 1.381 3.053 1 N-CA-C 102.479 -4.249 . . . . 0.56999999999999995 102.479 165.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -36.35 67.95 Favored 'Isoleucine or valine' 0 C--N 1.377 1.785 0 CA-C-O 124.534 2.111 . . . . 0.56999999999999995 109.97 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.15 132.48 28.24 Favored Glycine 0 C--N 1.38 2.996 0 N-CA-C 104.389 -3.484 . . . . 0.56999999999999995 104.389 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.46 -6.61 57.68 Favored Glycine 0 C--N 1.366 2.2 0 CA-C-O 124.085 1.936 . . . . 0.56999999999999995 110.268 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 160' ' ' LEU . 1.3 m-20 -88.24 166.67 14.18 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.073 -1.839 . . . . 0.91000000000000003 110.897 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.54 161.12 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.066 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -129.24 125.77 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.919 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 2.0 m-85 -105.41 133.0 50.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.56999999999999995 110.883 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -61.83 86.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.886 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.01 -33.05 70.0 Favored 'General case' 0 C--N 1.398 2.674 0 C-N-CA 115.823 -2.351 . . . . 0.91000000000000003 105.576 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.98 -47.72 8.62 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 123.821 0.848 . . . . 0.91000000000000003 108.774 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.02 174.37 0.06 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-O 127.562 3.553 . . . . 0.91000000000000003 111.978 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.21 110.63 22.64 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 112.365 -2.198 . . . . 0.56999999999999995 109.898 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.438 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.7 m95 -93.09 148.56 21.9 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 107.588 -1.264 . . . . 0.56999999999999995 107.588 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.1 p -127.14 125.94 42.05 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 110.007 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.06 133.74 42.11 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.452 -1.685 . . . . 0.56999999999999995 106.452 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 80.69 -43.76 0.22 Allowed 'General case' 0 C--N 1.374 1.646 0 CA-C-N 114.571 -1.195 . . . . 0.56999999999999995 109.591 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.54 153.98 0.37 Allowed 'General case' 0 C--N 1.369 1.43 0 N-CA-C 107.996 -1.112 . . . . 0.56999999999999995 107.996 -173.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 125.93 6.25 6.0 Favored Glycine 0 C--N 1.376 2.784 0 CA-C-N 114.556 -1.202 . . . . 0.56999999999999995 114.089 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 144.31 -119.75 1.33 Allowed Glycine 0 C--N 1.378 2.869 0 CA-C-O 123.752 1.751 . . . . 0.56999999999999995 112.36 -168.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 p -94.25 133.0 38.25 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-N 113.951 -1.124 . . . . 0.56999999999999995 109.331 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -98.2 150.39 21.55 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.878 1.799 . . . . 0.56999999999999995 111.713 177.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -75.54 -29.65 59.49 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 106.087 -1.82 . . . . 0.56999999999999995 106.087 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 7.8 t80 -57.45 -50.25 73.63 Favored 'General case' 0 C--N 1.373 1.623 0 CA-C-N 115.305 -0.861 . . . . 0.56999999999999995 110.909 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -51.15 68.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.56999999999999995 110.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.32 -35.5 79.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.56999999999999995 111.132 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.21 96.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 111.114 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.443 HG23 ' CE1' ' A' ' 213' ' ' PHE . 95.4 t -65.23 -48.02 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.171 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 236' ' ' MET . 6.4 t-160 -64.63 -50.21 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.815 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' HG3' ' CZ ' ' A' ' 197' ' ' PHE . 17.3 mm-40 -57.92 -42.22 84.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.91000000000000003 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -46.81 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.32 -33.53 61.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.56999999999999995 112.501 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -64.71 -38.89 92.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.56999999999999995 110.833 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.99 -53.23 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.831 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 149' ' ' PHE . 3.0 pp -93.94 -56.8 2.74 Favored 'General case' 0 C--N 1.381 1.958 0 N-CA-C 117.783 2.512 . . . . 0.56999999999999995 117.783 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 221' ' ' GLY . . . -45.08 149.89 1.1 Allowed Glycine 0 C--N 1.373 2.611 1 CA-C-O 128.049 4.139 . . . . 0.56999999999999995 110.486 177.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.16 -153.51 0.05 Allowed 'General case' 0 C--N 1.365 1.247 0 CA-C-N 109.975 -3.113 . . . . 0.56999999999999995 107.153 -171.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.0 -175.62 0.5 Allowed Glycine 0 C--N 1.379 2.923 0 CA-C-O 127.213 3.674 . . . . 0.56999999999999995 113.001 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -100.56 -174.25 2.6 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 118.997 -2.472 . . . . 0.56999999999999995 111.343 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.1 p -103.63 -34.67 8.55 Favored 'General case' 0 C--N 1.38 1.932 0 CA-C-N 113.835 -1.53 . . . . 0.56999999999999995 108.748 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.78 22.37 0.39 Allowed 'General case' 0 C--N 1.385 2.121 0 N-CA-C 114.152 1.168 . . . . 0.56999999999999995 114.152 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.74 131.99 11.05 Favored Pre-proline 0 C--N 1.378 1.838 0 N-CA-C 102.828 -3.027 . . . . 0.91000000000000003 102.828 -164.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.462 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 47.5 Cg_exo -61.73 74.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 124.9 3.733 . . . . 0.56999999999999995 114.913 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.38 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 CA-C-N 113.634 -1.621 . . . . 0.56999999999999995 111.349 -171.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.61 133.53 34.84 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 106.655 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.465 ' O ' ' CG ' ' A' ' 236' ' ' MET . 11.5 p -70.48 68.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.318 0 CA-C-N 113.028 -1.896 . . . . 0.56999999999999995 112.166 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER -175.64 -35.76 0.01 OUTLIER 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.635 -1.291 . . . . 0.56999999999999995 109.931 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.469 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.16 145.46 0.32 Allowed Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 124.948 2.309 . . . . 0.56999999999999995 111.575 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -57.93 -47.66 19.73 Favored 'Trans proline' 0 C--N 1.374 1.869 0 O-C-N 119.21 -0.995 . . . . 0.56999999999999995 111.499 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.469 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 14.1 m -49.35 124.66 9.58 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-O 124.328 2.013 . . . . 0.56999999999999995 109.921 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -94.15 140.19 30.06 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-O 123.297 1.523 . . . . 0.56999999999999995 107.997 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -155.56 109.39 2.82 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 105.635 -1.987 . . . . 0.56999999999999995 105.635 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -54.03 123.71 13.4 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-O 124.144 1.926 . . . . 0.56999999999999995 109.628 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.65 111.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 114.158 -1.383 . . . . 0.56999999999999995 107.349 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.21 142.44 51.77 Favored 'General case' 0 C--N 1.365 1.248 0 N-CA-C 103.219 -2.882 . . . . 0.91000000000000003 103.219 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.406 HG12 ' CG ' ' A' ' 213' ' ' PHE . 1.1 mp -46.05 -23.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.309 0 CA-C-N 111.248 -2.706 . . . . 0.56999999999999995 112.769 174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -51.72 -37.47 51.13 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.051 -0.977 . . . . 0.56999999999999995 109.767 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.9 p -103.88 -0.64 28.84 Favored 'General case' 0 C--N 1.386 2.171 0 N-CA-C 116.48 2.03 . . . . 0.56999999999999995 116.48 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.17 93.66 0.07 Allowed 'General case' 0 C--N 1.365 1.252 0 CA-C-O 127.039 3.304 . . . . 0.56999999999999995 107.491 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 152.57 42.33 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 112.745 -2.025 . . . . 1.2 106.371 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.15 131.31 53.89 Favored 'General case' 0 C--N 1.372 1.577 0 CA-C-O 125.634 2.635 . . . . 0.56999999999999995 104.987 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.77 136.71 58.0 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.599 -1.938 . . . . 0.56999999999999995 111.68 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.23 94.06 Favored 'General case' 0 C--N 1.383 2.05 0 N-CA-C 106.245 -1.761 . . . . 0.56999999999999995 106.245 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -41.03 85.16 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.215 -0.928 . . . . 0.91000000000000003 110.858 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -55.34 23.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.91000000000000003 110.892 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.21 -34.9 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.108 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -70.44 -30.38 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.872 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.15 -39.78 57.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.798 -0.715 . . . . 0.56999999999999995 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.19 -41.41 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.175 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -34.45 68.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.382 2.012 0 CA-C-O 122.23 1.014 . . . . 0.56999999999999995 109.489 -176.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.87 -0.789 . . . . 1.2 108.87 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 -50.94 0.01 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 122.316 1.055 . . . . 0.56999999999999995 110.4 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -69.68 -32.24 70.74 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 114.117 -1.401 . . . . 0.56999999999999995 108.482 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -109.17 109.47 20.44 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 120.129 -1.607 . . . . 0.56999999999999995 110.935 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.69 139.88 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.139 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 4.4 p -112.94 159.76 18.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.56999999999999995 111.118 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -149.08 153.37 37.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.955 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.477 ' CD ' ' C ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -142.1 122.02 13.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.939 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 119' ' ' ASN . 12.8 mm -87.65 117.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 111.14 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ILE . 1.5 t-20 -37.52 -57.72 0.92 Allowed 'General case' 0 C--N 1.37 1.473 0 C-N-CA 120.019 -0.672 . . . . 0.56999999999999995 111.382 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 24.9 t-20 -155.87 -61.14 0.11 Allowed 'General case' 0 C--N 1.378 1.812 0 CA-C-N 113.725 -1.58 . . . . 0.56999999999999995 107.995 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 120' ' ' ASN . 1.2 m-30 152.99 30.76 0.0 OUTLIER 'General case' 0 C--N 1.379 1.88 0 O-C-N 126.17 2.169 . . . . 0.56999999999999995 112.731 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 68.87 141.54 0.08 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 CA-C-O 124.38 2.038 . . . . 0.56999999999999995 107.924 172.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HG3' ' CG ' ' A' ' 199' ' ' GLU . 39.7 Cg_endo -70.47 -41.58 3.28 Favored 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 118.432 -1.404 . . . . 0.56999999999999995 112.319 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -110.74 -51.76 2.84 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 111.074 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.46 ' HE2' ' CZ3' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -43.96 143.87 1.02 Allowed 'General case' 0 C--N 1.377 1.802 0 CA-C-O 124.953 2.311 . . . . 0.56999999999999995 108.926 -174.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.402 ' HB2' ' OD2' ' A' ' 129' ' ' ASP . 62.0 m-20 -73.47 139.01 45.48 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.977 -1.92 . . . . 0.56999999999999995 109.358 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.403 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -67.59 -50.07 60.08 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 107.758 -1.201 . . . . 1.2 107.758 -170.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.96 -36.36 65.26 Favored 'General case' 0 C--N 1.38 1.894 0 CA-C-N 113.271 -1.786 . . . . 0.91000000000000003 110.891 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 126' ' ' ASN . 97.4 m-20 -70.82 -37.83 73.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.18 -49.2 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 111.137 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 16.8 m-20 -69.93 -40.62 75.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.817 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -66.02 -42.22 89.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.891 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.47 ' CB ' ' CD2' ' A' ' 212' ' ' LEU . . . -63.62 -49.01 75.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 111.136 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 15.8 pt -64.9 -31.94 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -66.89 -46.8 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.88 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -46.04 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.56999999999999995 110.913 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.98 83.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.049 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.97 -44.89 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.56999999999999995 110.893 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.471 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.4 pt20 -64.97 -35.27 80.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.918 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 1.2 t -69.53 -34.2 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.085 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 7.5 m95 -83.03 -34.2 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.56999999999999995 110.911 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -48.24 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.56999999999999995 110.853 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -61.0 -12.61 12.07 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.854 0.835 . . . . 0.56999999999999995 111.612 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 19.6 m -115.42 -10.06 12.21 Favored 'Isoleucine or valine' 0 C--N 1.375 1.687 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.533 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.414 HG22 ' CD1' ' A' ' 224' ' ' LEU . 0.5 OUTLIER -139.99 148.73 56.09 Favored Pre-proline 0 C--N 1.36 1.058 0 CA-C-O 125.092 2.377 . . . . 0.56999999999999995 110.021 -177.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -70.7 -39.67 4.5 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 118.24 -1.505 . . . . 0.56999999999999995 111.857 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mt -50.63 111.41 0.54 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 122.734 1.254 . . . . 0.56999999999999995 107.923 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -76.37 159.24 30.68 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 114.473 -1.239 . . . . 0.56999999999999995 111.176 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 6.1 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 108.756 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 m -159.85 110.96 1.96 Allowed 'General case' 0 C--N 1.386 2.183 0 CA-C-O 124.923 2.297 . . . . 0.56999999999999995 109.022 -172.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.55 133.83 37.75 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 109.645 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.03 172.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.364 1.231 0 CA-C-O 124.545 2.117 . . . . 0.56999999999999995 110.135 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -63.77 1.24 Allowed 'General case' 0 C--N 1.383 2.038 0 CA-C-N 113.31 -1.768 . . . . 0.56999999999999995 110.023 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.9 t -142.62 52.58 1.42 Allowed 'General case' 0 C--N 1.376 1.733 0 CA-C-O 124.926 2.298 . . . . 0.56999999999999995 110.154 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.94 5.5 Favored Glycine 0 C--N 1.364 2.106 0 C-N-CA 118.492 -1.813 . . . . 0.56999999999999995 112.515 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.12 95.05 0.06 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.961 2.315 . . . . 0.56999999999999995 110.264 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' CB ' ' C ' ' A' ' 116' ' ' TYR . . . -96.36 174.68 6.75 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 117.89 -1.524 . . . . 0.56999999999999995 112.49 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.16 -50.75 13.74 Favored 'General case' 0 C--N 1.375 1.694 0 N-CA-C 105.197 -2.149 . . . . 0.91000000000000003 105.197 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 1.8 pp -114.11 116.18 51.83 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 CA-C-N 115.158 -0.928 . . . . 0.56999999999999995 111.141 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.87 132.15 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.56999999999999995 110.877 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.412 ' CG1' ' CE1' ' A' ' 197' ' ' PHE . 30.6 t -101.96 117.0 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 111.1 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.02 146.01 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.132 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.465 ' CD1' HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -106.18 119.99 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.89 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.28 168.6 18.58 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 123.795 1.76 . . . . 0.56999999999999995 109.696 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -107.3 167.72 9.72 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.701 -1.25 . . . . 1.2 110.595 177.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.426 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -40.17 143.05 0.58 Allowed Glycine 0 C--N 1.38 3.027 0 CA-C-O 123.22 1.455 . . . . 0.56999999999999995 112.303 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 72.19 43.65 0.5 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-O 124.708 2.194 . . . . 0.56999999999999995 109.218 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.419 ' HB3' ' O ' ' A' ' 165' ' ' ARG . 31.2 p-80 . . . . . 0 C--N 1.373 1.607 0 CA-C-O 123.663 1.697 . . . . 0.56999999999999995 108.385 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.756 0 CA-C-O 122.026 0.917 . . . . 0.56999999999999995 109.593 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.426 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -116.73 -161.6 0.81 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 114.221 -1.354 . . . . 0.56999999999999995 111.697 175.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -99.38 -68.68 0.79 Allowed 'General case' 0 C--N 1.378 1.827 0 N-CA-C 108.758 -0.83 . . . . 0.91000000000000003 108.758 178.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.401 ' N ' ' OD2' ' A' ' 175' ' ' ASP . . . 54.69 165.16 0.02 OUTLIER Glycine 0 C--N 1.392 3.666 0 CA-C-O 125.095 2.497 . . . . 0.56999999999999995 116.813 -167.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.49 7.77 5.11 Favored 'General case' 0 C--N 1.379 1.88 0 O-C-N 120.507 -1.584 . . . . 0.56999999999999995 113.48 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.18 -140.73 11.98 Favored Glycine 0 C--N 1.363 2.072 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.02 -104.17 0.11 Allowed Glycine 0 C--N 1.362 2.026 0 CA-C-O 123.566 1.648 . . . . 0.56999999999999995 112.52 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.7 mt -62.58 169.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.494 0 CA-C-O 123.333 1.54 . . . . 0.56999999999999995 112.506 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' CD1' ' HB ' ' A' ' 210' ' ' THR . 23.5 tp -128.92 -40.31 1.53 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 118.211 -2.805 . . . . 0.56999999999999995 110.499 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 197' ' ' PHE . . . -176.5 179.94 1.11 Allowed 'General case' 0 C--N 1.379 1.854 0 CA-C-N 114.918 -1.037 . . . . 0.56999999999999995 111.081 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.438 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -155.04 145.86 22.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 110.846 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.01 151.24 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.082 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.13 -179.99 7.13 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.968 1.842 . . . . 0.56999999999999995 111.131 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.99 -162.89 24.0 Favored Glycine 0 C--N 1.38 2.985 0 CA-C-O 124.142 1.968 . . . . 0.56999999999999995 111.703 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.24 79.15 1.79 Allowed 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.099 1.866 . . . . 0.56999999999999995 112.074 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -128.31 160.76 22.1 Favored Glycine 0 C--N 1.367 2.281 0 CA-C-O 123.182 1.434 . . . . 0.56999999999999995 110.074 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -74.94 -177.61 3.4 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.428 -1.386 . . . . 0.56999999999999995 109.237 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.13 -117.22 5.9 Favored Glycine 0 C--N 1.383 3.186 0 N-CA-C 109.834 -1.306 . . . . 0.56999999999999995 109.834 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.44 -46.81 92.44 Favored 'Isoleucine or valine' 0 C--N 1.383 2.051 0 CA-C-N 112.547 -1.826 . . . . 0.56999999999999995 110.44 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.7 133.89 4.61 Favored Glycine 0 C--N 1.369 2.415 0 CA-C-O 124.486 2.159 . . . . 0.56999999999999995 109.671 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.8 -48.82 1.21 Allowed Glycine 0 C--N 1.37 2.465 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 113.129 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.29 160.06 0.17 Allowed 'General case' 0 C--N 1.376 1.724 0 CA-C-O 120.798 0.333 . . . . 0.91000000000000003 110.901 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.46 32.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.101 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -121.62 126.25 48.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 110.875 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.445 ' CD2' ' HB1' ' A' ' 182' ' ' ALA . 2.5 m-85 -108.22 150.08 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.89 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 90.41 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.91000000000000003 110.803 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.401 ' CG ' ' HG3' ' A' ' 123' ' ' PRO . 3.8 tp10 -74.65 -5.52 43.52 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 124.216 1.96 . . . . 0.91000000000000003 110.475 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -32.97 35.16 Favored 'General case' 0 C--N 1.369 1.416 0 CA-C-O 123.003 1.382 . . . . 0.91000000000000003 108.902 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.58 176.06 2.58 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-O 123.439 1.59 . . . . 0.91000000000000003 111.99 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.76 104.02 16.01 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-N 112.576 -2.102 . . . . 0.56999999999999995 112.589 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.46 ' CZ3' ' HE2' ' A' ' 125' ' ' MET . 18.2 m95 -76.7 128.52 34.83 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 114.273 -1.33 . . . . 0.56999999999999995 108.525 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.0 p -122.86 104.88 9.56 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 109.309 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.46 130.83 57.01 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 108.658 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 24.85 3.45 Favored 'General case' 0 C--N 1.389 2.318 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 111.402 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.16 -71.41 0.5 Allowed 'General case' 0 C--N 1.38 1.896 0 CA-C-N 114.241 -1.345 . . . . 0.56999999999999995 108.479 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.94 90.96 0.08 OUTLIER Glycine 0 C--N 1.389 3.487 0 C-N-CA 118.478 -1.82 . . . . 0.56999999999999995 113.09 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.5 -141.71 7.61 Favored Glycine 0 C--N 1.378 2.879 0 C-N-CA 119.55 -1.309 . . . . 0.56999999999999995 110.132 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' A' ' 181' ' ' LEU . 72.7 p -67.42 128.66 37.25 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-O 124.128 1.918 . . . . 0.56999999999999995 112.146 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -135.34 145.46 47.45 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 109.607 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' A' ' 133' ' ' ALA . 1.4 pt? -65.0 -25.37 67.83 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-O 123.911 1.815 . . . . 0.56999999999999995 108.933 -174.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.443 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 48.7 t80 -54.18 -42.65 69.92 Favored 'General case' 0 C--N 1.372 1.568 0 CA-C-N 113.734 -1.575 . . . . 0.56999999999999995 110.879 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.11 -51.11 70.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.926 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.55 -33.78 73.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 111.139 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -65.92 -46.33 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.113 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 213' ' ' PHE . 6.0 t -65.43 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.14 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.432 ' CD2' ' HG2' ' A' ' 236' ' ' MET . 6.2 t-160 -71.33 -50.04 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 110.844 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.31 -42.07 98.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.91000000000000003 110.876 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 34.5 mt -65.04 -37.94 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.56999999999999995 111.119 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.451 ' HA3' ' CZ2' ' A' ' 141' ' ' TRP . . . -68.3 -33.99 79.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 0.56999999999999995 112.49 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.448 ' CG ' ' CE ' ' A' ' 236' ' ' MET . 2.9 m-70 -67.39 -40.67 85.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.56999999999999995 110.871 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m -70.54 -41.22 72.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.882 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.48 HD11 ' CE3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -40.76 -36.97 0.69 Allowed 'General case' 0 C--N 1.358 0.97 0 CA-C-O 124.475 2.083 . . . . 0.56999999999999995 111.753 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.4 -38.92 1.13 Allowed Glycine 0 C--N 1.369 2.386 0 N-CA-C 108.392 -1.883 . . . . 0.56999999999999995 108.392 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -100.09 150.95 21.95 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-O 123.062 1.41 . . . . 0.56999999999999995 111.602 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.22 -118.92 0.27 Allowed Glycine 0 C--N 1.374 2.668 0 CA-C-O 125.063 2.479 . . . . 0.56999999999999995 111.881 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -110.55 -155.01 0.55 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 109.053 -178.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -115.56 -8.06 12.16 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 114.614 -1.175 . . . . 0.56999999999999995 111.149 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 82.54 -5.41 1.36 Allowed 'General case' 0 C--N 1.381 1.962 0 N-CA-C 113.527 0.936 . . . . 0.56999999999999995 113.527 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.56 158.84 74.23 Favored Pre-proline 0 C--N 1.372 1.577 0 N-CA-C 107.346 -1.353 . . . . 0.91000000000000003 107.346 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -55.02 -29.92 67.26 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.952 2.435 . . . . 0.56999999999999995 112.99 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.35 -25.51 1.02 Allowed 'General case' 0 C--N 1.382 2.021 0 CA-C-N 114.662 -1.154 . . . . 0.56999999999999995 113.589 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -91.13 124.62 35.49 Favored 'General case' 0 C--N 1.378 1.814 0 CA-C-O 124.656 2.169 . . . . 0.56999999999999995 110.77 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.483 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -70.41 -8.36 10.65 Favored 'Isoleucine or valine' 0 C--N 1.377 1.768 0 CA-C-N 113.016 -1.902 . . . . 0.56999999999999995 111.838 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.501 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 1.3 ttt -99.4 17.92 19.02 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.227 -0.897 . . . . 0.56999999999999995 110.689 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.456 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 9.8 t80 -55.3 141.54 61.56 Favored Pre-proline 0 C--N 1.367 1.344 0 CA-C-O 123.12 1.438 . . . . 0.56999999999999995 108.693 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 51.6 Cg_exo -51.76 -52.94 7.89 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.98 1.787 . . . . 0.56999999999999995 113.714 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.95 142.24 56.62 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 125.288 1.618 . . . . 0.56999999999999995 109.929 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 7.9 t80 -94.71 153.21 17.9 Favored 'General case' 0 C--N 1.385 2.126 0 CA-C-N 113.583 -1.644 . . . . 0.56999999999999995 109.63 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 4.2 tmtt? 177.31 104.17 0.02 OUTLIER 'General case' 0 C--N 1.389 2.292 0 CA-C-O 123.238 1.494 . . . . 0.56999999999999995 107.461 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.25 120.02 4.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 125.105 2.384 . . . . 0.56999999999999995 109.927 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.95 9.51 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 110.407 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.88 -16.31 0.5 Allowed 'General case' 0 C--N 1.367 1.342 0 O-C-N 125.631 1.832 . . . . 0.91000000000000003 111.683 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.5 mt 74.87 -48.71 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.121 0 N-CA-C 114.605 1.335 . . . . 0.56999999999999995 114.605 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -45.22 -27.06 0.57 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 114.376 1.25 . . . . 0.56999999999999995 114.376 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.3 p -106.28 -0.68 24.2 Favored 'General case' 0 C--N 1.376 1.721 0 CA-C-N 115.373 -0.83 . . . . 0.56999999999999995 110.959 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 235' ' ' VAL . 12.5 t80 -58.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.372 1.559 0 CA-C-O 124.46 2.076 . . . . 0.56999999999999995 109.054 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.403 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -109.74 152.0 26.21 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-N 113.351 -1.75 . . . . 1.2 107.22 -176.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.6 OUTLIER -121.83 134.66 54.89 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-O 124.549 2.118 . . . . 0.56999999999999995 106.246 -173.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -67.01 136.79 55.84 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 120.551 -1.343 . . . . 0.56999999999999995 110.441 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.4 94.94 Favored 'General case' 0 C--N 1.381 1.977 0 N-CA-C 107.218 -1.401 . . . . 0.56999999999999995 107.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.43 -37.51 87.78 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 119.62 -1.925 . . . . 0.91000000000000003 110.849 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.83 -55.35 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.7 pt -66.23 -35.51 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.094 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.414 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 48.7 mtm180 -70.33 -34.32 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.2 110.843 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.63 -49.56 59.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.493 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.3 pt -62.15 -45.23 99.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.56999999999999995 111.089 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.493 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -71.45 -28.06 63.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 110.878 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.362 1.111 0 CA-C-O 121.909 0.862 . . . . 0.56999999999999995 110.883 -178.896 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 122.867 1.318 . . . . 1.2 107.962 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.58 -44.13 0.09 Allowed 'General case' 0 C--N 1.372 1.549 0 CA-C-N 113.301 -1.772 . . . . 0.56999999999999995 110.185 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 2.4 p-80 -89.43 -21.65 22.92 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 113.001 -1.909 . . . . 0.56999999999999995 111.644 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -113.04 107.95 16.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 115.784 -0.644 . . . . 0.56999999999999995 110.92 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 155.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.138 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 150.55 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.137 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -150.04 160.08 43.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.502 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -141.14 129.18 21.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.849 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -94.5 129.52 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.162 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -54.36 178.78 0.02 OUTLIER 'General case' 0 C--N 1.369 1.447 0 CA-C-O 124.701 2.191 . . . . 0.56999999999999995 109.121 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.51 45.09 0.84 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.026 -1.672 . . . . 0.56999999999999995 109.926 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 7.0 m-85 53.85 -168.15 0.07 Allowed 'General case' 0 C--N 1.386 2.152 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 107.432 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.63 165.34 17.62 Favored Pre-proline 0 C--N 1.378 1.837 0 CA-C-N 113.668 -1.606 . . . . 0.56999999999999995 107.487 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 -55.62 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 120.904 1.069 . . . . 0.56999999999999995 113.467 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.78 -52.71 63.09 Favored 'General case' 0 C--N 1.375 1.701 0 CA-C-N 114.042 -1.436 . . . . 0.91000000000000003 111.985 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.538 ' CE ' ' CD1' ' A' ' 203' ' ' TRP . 2.6 ttm -77.03 126.85 31.66 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 124.565 2.126 . . . . 0.56999999999999995 110.844 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -72.05 131.36 42.78 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-N 112.78 -2.009 . . . . 0.56999999999999995 109.009 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.405 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.62 -49.95 64.59 Favored 'General case' 0 C--N 1.366 1.313 0 N-CA-C 107.737 -1.208 . . . . 1.2 107.737 -169.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -55.52 -35.38 65.57 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-N 112.221 -2.263 . . . . 0.91000000000000003 110.841 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.44 -43.35 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.91000000000000003 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.04 -49.93 82.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -59.22 -44.14 92.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.91000000000000003 110.803 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.72 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.938 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.06 73.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.062 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 134' ' ' ILE . 2.4 mm -65.28 -40.41 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.35 -46.13 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.2 110.852 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -42.7 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 110.921 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.93 89.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.11 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.544 ' CD1' HD13 ' A' ' 220' ' ' ILE . 11.8 m-85 -64.15 -36.35 83.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 110.86 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.6 tt0 -67.12 -40.05 86.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.95 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.459 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -69.5 -34.1 60.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.106 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.477 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 43.8 m95 -82.92 -34.03 26.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.56999999999999995 110.939 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 m -79.3 -50.57 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.883 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -56.77 -14.04 3.04 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.34 0.867 . . . . 0.56999999999999995 113.34 178.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 17.9 m -113.73 -7.33 12.04 Favored 'Isoleucine or valine' 0 C--N 1.377 1.788 0 CA-C-N 113.678 -1.601 . . . . 0.56999999999999995 112.628 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 259' ' ' GLN . 0.2 OUTLIER -150.58 143.18 16.18 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-O 125.068 2.366 . . . . 0.56999999999999995 109.291 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 112' ' ' HIS . 55.7 Cg_endo -82.12 49.9 3.28 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.017 1.811 . . . . 0.56999999999999995 111.362 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.457 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mt -134.02 73.79 1.52 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 106.551 -1.648 . . . . 0.56999999999999995 106.551 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.75 161.9 22.57 Favored 'General case' 0 C--N 1.369 1.456 0 CA-C-O 125.468 2.556 . . . . 0.56999999999999995 117.499 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -135.15 159.94 39.95 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.486 -2.143 . . . . 0.56999999999999995 106.237 -172.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.2 m -140.78 111.16 6.74 Favored 'General case' 0 C--N 1.379 1.885 0 CA-C-O 124.154 1.931 . . . . 0.56999999999999995 106.523 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 27.5 tttt -82.19 145.97 29.78 Favored 'General case' 0 C--N 1.369 1.446 0 CA-C-N 112.833 -1.985 . . . . 0.56999999999999995 111.934 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.0 pt -128.68 162.14 36.2 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 CA-C-N 112.928 -1.942 . . . . 0.56999999999999995 109.48 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -139.8 39.76 2.0 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-N 113.442 -1.708 . . . . 0.56999999999999995 110.684 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.62 -70.81 0.54 Allowed 'General case' 0 C--N 1.378 1.83 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 108.479 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -99.41 -130.44 6.95 Favored Glycine 0 C--N 1.382 3.108 0 N-CA-C 108.802 -1.719 . . . . 0.56999999999999995 108.802 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -122.79 134.67 54.42 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 111.885 -2.158 . . . . 0.56999999999999995 109.083 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.48 179.0 4.7 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 112.831 -1.986 . . . . 0.56999999999999995 111.527 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.24 -65.34 0.74 Allowed 'General case' 0 C--N 1.387 2.217 0 N-CA-C 103.924 -2.621 . . . . 0.91000000000000003 103.924 -166.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.84 109.84 24.96 Favored 'Isoleucine or valine' 0 C--N 1.37 1.486 0 CA-C-N 114.834 -1.075 . . . . 0.56999999999999995 111.112 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.0 130.97 51.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.927 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.467 ' CG1' ' CE1' ' A' ' 197' ' ' PHE . 83.3 t -102.09 117.02 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.094 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.1 146.02 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.105 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -99.15 116.74 32.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.857 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.08 170.04 16.51 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 124.967 2.318 . . . . 0.56999999999999995 110.923 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 168.26 9.25 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 113.753 -1.567 . . . . 1.2 111.646 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -43.41 128.12 5.75 Favored Glycine 0 C--N 1.385 3.27 0 O-C-N 126.299 2.25 . . . . 0.56999999999999995 112.569 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -179.89 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.384 2.076 0 CA-C-N 111.7 -2.25 . . . . 0.56999999999999995 110.853 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.378 1.83 0 CA-C-N 113.656 -1.611 . . . . 0.56999999999999995 108.578 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.268 0 CA-C-O 122.11 0.957 . . . . 0.56999999999999995 112.124 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -133.53 -159.88 1.0 Allowed 'General case' 0 C--N 1.368 1.408 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 110.273 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.34 175.31 6.79 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.28 -1.782 . . . . 0.91000000000000003 110.946 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.03 34.59 1.65 Allowed Glycine 0 C--N 1.389 3.516 0 CA-C-N 111.927 -2.397 . . . . 0.56999999999999995 111.697 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.45 -40.99 0.05 OUTLIER 'General case' 0 C--N 1.376 1.749 0 CA-C-N 112.79 -1.705 . . . . 0.56999999999999995 112.077 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -166.65 -122.56 0.61 Allowed Glycine 0 C--N 1.38 2.978 0 C-N-CA 117.846 -2.121 . . . . 0.56999999999999995 110.399 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.48 -122.52 26.88 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 117.316 -1.825 . . . . 0.56999999999999995 113.418 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.457 ' CG2' ' OD2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -45.75 170.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 O-C-N 127.434 2.491 . . . . 0.56999999999999995 114.077 172.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.432 ' HG ' ' CG2' ' A' ' 215' ' ' THR . 6.6 tp -123.77 -66.71 0.98 Allowed 'General case' 0 C--N 1.374 1.634 0 CA-C-O 123.151 1.453 . . . . 0.56999999999999995 113.864 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 197' ' ' PHE . . . -178.15 179.88 0.78 Allowed 'General case' 0 C--N 1.358 0.963 0 CA-C-N 112.719 -2.037 . . . . 0.56999999999999995 111.054 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.436 ' O ' ' CB ' ' A' ' 195' ' ' ALA . 2.8 p80 -158.23 177.12 11.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.854 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.75 17.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.56999999999999995 111.151 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -84.69 173.41 10.75 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 118.578 -1.249 . . . . 0.56999999999999995 108.9 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.07 -156.17 4.33 Favored Glycine 0 C--N 1.382 3.085 0 C-N-CA 118.356 -1.878 . . . . 0.56999999999999995 110.563 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.66 -87.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.063 1.175 . . . . 0.56999999999999995 110.643 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.28 -143.52 2.42 Favored Glycine 0 C--N 1.387 3.388 0 CA-C-O 123.958 1.866 . . . . 0.56999999999999995 110.233 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.88 163.99 38.06 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 111.164 -2.518 . . . . 0.56999999999999995 108.705 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.82 -108.26 2.51 Favored Glycine 0 C--N 1.386 3.308 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.64 -37.32 69.05 Favored 'Isoleucine or valine' 0 C--N 1.386 2.158 0 CA-C-O 125.513 2.578 . . . . 0.56999999999999995 109.292 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.11 138.5 49.5 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 108.922 -1.671 . . . . 0.56999999999999995 108.922 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.77 -15.78 62.09 Favored Glycine 0 C--N 1.37 2.468 0 CA-C-O 124.701 2.279 . . . . 0.56999999999999995 109.044 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -73.72 144.22 45.82 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.531 -1.334 . . . . 0.91000000000000003 110.864 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 183' ' ' HIS . . . -125.76 152.62 45.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.114 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -134.04 132.45 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.874 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.54 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -121.04 147.26 45.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.907 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.457 ' OD2' ' CG2' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.97 83.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.91000000000000003 110.881 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.4 -46.81 78.58 Favored 'General case' 0 C--N 1.375 1.682 0 N-CA-C 105.327 -2.101 . . . . 0.91000000000000003 105.327 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -44.3 -43.43 7.42 Favored 'General case' 0 C--N 1.372 1.544 0 O-C-N 126.092 2.12 . . . . 0.91000000000000003 109.706 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -49.23 173.92 0.02 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 125.53 2.586 . . . . 0.91000000000000003 113.971 172.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.4 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 16.2 m-85 -113.28 95.08 5.19 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.388 -2.187 . . . . 0.56999999999999995 112.412 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.54 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 35.5 m95 -75.63 132.39 40.58 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 106.95 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.3 p -110.86 103.26 11.75 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 124.908 2.289 . . . . 0.56999999999999995 109.038 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 69.5 p -104.13 106.88 17.54 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 114.096 -1.411 . . . . 0.56999999999999995 110.122 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 171.46 -59.46 0.01 OUTLIER 'General case' 0 C--N 1.383 2.047 0 CA-C-N 113.222 -1.808 . . . . 0.56999999999999995 107.333 177.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 158.18 58.88 0.0 OUTLIER 'General case' 0 C--N 1.391 2.372 0 O-C-N 127.772 3.17 . . . . 0.56999999999999995 110.992 -171.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.3 -88.1 0.3 Allowed Glycine 0 C--N 1.382 3.129 0 C-N-CA 117.082 -2.485 . . . . 0.56999999999999995 113.442 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.97 -108.23 3.19 Favored Glycine 0 C--N 1.383 3.14 0 CA-C-O 126.984 3.547 . . . . 0.56999999999999995 112.787 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 p -66.63 119.33 11.56 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 111.744 -2.228 . . . . 0.56999999999999995 111.512 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.17 143.34 43.37 Favored 'General case' 0 C--N 1.373 1.614 0 CA-C-N 113.758 -1.565 . . . . 0.56999999999999995 109.702 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.43 -25.12 60.38 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-N 112.728 -2.033 . . . . 0.56999999999999995 107.276 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.424 ' CE1' ' CG2' ' A' ' 217' ' ' VAL . 12.4 t80 -58.47 -49.16 78.33 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 113.926 -1.488 . . . . 0.56999999999999995 110.823 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 214' ' ' LEU . 0.9 OUTLIER -54.97 -50.96 67.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.56999999999999995 110.976 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.432 ' CG2' ' HG ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -67.22 -37.65 83.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.93 91.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.093 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.424 ' CG2' ' CE1' ' A' ' 213' ' ' PHE . 7.8 t -65.14 -40.17 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.111 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -72.08 -37.55 69.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 110.892 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -42.07 97.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 138' ' ' PHE . 64.6 mt -70.0 -38.98 76.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 111.134 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.18 93.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.56999999999999995 112.481 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.4 OUTLIER -63.97 -43.17 96.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.56999999999999995 110.844 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -38.07 72.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.886 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.11 -42.93 19.99 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 118.452 -1.299 . . . . 0.56999999999999995 111.007 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 127.25 33.46 0.62 Allowed Glycine 0 C--N 1.385 3.265 0 CA-C-N 112.33 -2.213 . . . . 0.56999999999999995 109.449 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.34 177.35 4.9 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-O 123.523 1.63 . . . . 0.56999999999999995 109.355 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -136.08 23.39 3.35 Favored Glycine 0 C--N 1.381 3.082 0 CA-C-N 112.679 -2.055 . . . . 0.56999999999999995 110.526 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.2 OUTLIER 62.68 177.07 0.14 Allowed 'General case' 0 C--N 1.395 2.546 0 CA-C-N 113.056 -1.572 . . . . 0.56999999999999995 110.041 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.5 p -103.85 -23.59 13.37 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 113.206 -1.815 . . . . 0.56999999999999995 111.17 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 81.39 21.39 0.35 Allowed 'General case' 0 C--N 1.385 2.134 0 O-C-N 125.683 1.864 . . . . 0.56999999999999995 112.627 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.9 143.68 45.39 Favored Pre-proline 0 C--N 1.392 2.419 0 N-CA-C 103.216 -2.883 . . . . 0.91000000000000003 103.216 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.82 66.49 6.71 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.444 2.763 . . . . 0.56999999999999995 111.005 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 -35.44 0.01 OUTLIER 'General case' 0 C--N 1.362 1.142 0 CA-C-N 113.537 -1.665 . . . . 0.56999999999999995 112.699 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -70.05 114.63 8.4 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 113.724 -1.58 . . . . 0.56999999999999995 112.141 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 235' ' ' VAL . 5.1 t -53.2 88.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 CA-C-N 112.907 -1.951 . . . . 0.56999999999999995 112.17 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER 159.13 -29.33 0.0 OUTLIER 'General case' 0 C--N 1.367 1.347 0 CA-C-N 115.033 -0.985 . . . . 0.56999999999999995 111.747 -174.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 9.2 p90 -45.61 143.99 2.75 Favored Pre-proline 0 C--N 1.372 1.55 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 110.65 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -59.54 -38.08 84.94 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 120.54 0.826 . . . . 0.56999999999999995 111.911 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -40.49 113.51 0.37 Allowed 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.596 1.665 . . . . 0.56999999999999995 111.383 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 179' ' ' GLY . 2.6 t80 -76.66 133.83 39.46 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 112.603 -2.09 . . . . 0.56999999999999995 105.909 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -175.53 98.24 0.07 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 124.267 1.984 . . . . 0.56999999999999995 108.815 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -61.12 127.88 33.68 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 124.1 1.905 . . . . 0.56999999999999995 110.973 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -9.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.365 1.282 0 CA-C-N 113.022 -1.899 . . . . 0.56999999999999995 112.267 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER 75.85 -3.64 2.53 Favored 'General case' 0 C--N 1.384 2.088 0 O-C-N 126.605 2.441 . . . . 0.91000000000000003 110.865 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.462 ' CB ' ' O ' ' A' ' 244' ' ' ASP . 2.4 mt 83.0 5.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.696 0 CA-C-N 114.525 -1.216 . . . . 0.56999999999999995 113.105 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -36.6 29.61 Favored 'General case' 0 C--N 1.385 2.126 0 N-CA-C 102.713 -3.069 . . . . 0.56999999999999995 102.713 -165.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.7 p -116.92 -4.68 11.52 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 113.164 -1.835 . . . . 0.56999999999999995 114.023 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.457 ' CZ ' HG11 ' A' ' 235' ' ' VAL . 30.9 t80 -56.02 91.48 0.01 OUTLIER 'General case' 0 C--N 1.373 1.594 0 CA-C-O 124.312 2.006 . . . . 0.56999999999999995 109.485 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.45 151.7 51.82 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 112.434 -2.167 . . . . 1.2 106.675 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.6 OUTLIER -124.17 127.59 47.98 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 125.082 2.372 . . . . 0.56999999999999995 104.936 -171.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 147.22 46.87 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 113.666 -1.606 . . . . 0.56999999999999995 111.896 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.37 93.07 Favored 'General case' 0 C--N 1.388 2.239 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 108.7 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -37.28 85.35 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-N 115.516 -0.765 . . . . 0.91000000000000003 110.862 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.22 -55.02 24.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.91000000000000003 110.846 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 12.9 pt -66.1 -34.78 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 111.125 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.08 -30.12 67.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.841 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.74 -41.51 49.78 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 0.56999999999999995 112.471 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.476 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 0.6 OUTLIER -68.09 -42.66 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.56999999999999995 111.089 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.476 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -71.97 -27.26 62.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.97 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.366 1.293 0 CA-C-O 124.121 1.915 . . . . 0.56999999999999995 108.784 -176.119 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.845 0 CA-C-O 121.541 0.686 . . . . 1.2 109.172 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.05 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.373 1.63 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 110.437 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -68.1 -17.3 64.33 Favored 'General case' 0 C--N 1.375 1.687 0 CA-C-N 113.929 -1.487 . . . . 0.56999999999999995 110.438 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.98 106.65 14.67 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.938 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.44 155.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.119 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.1 p -134.53 159.96 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.56999999999999995 111.143 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.668 ' CE2' ' CE2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -140.26 160.08 40.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.935 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -139.11 121.96 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 1.2 110.873 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.471 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -78.13 117.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.14 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -36.97 -60.18 0.65 Allowed 'General case' 0 C--N 1.351 0.649 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 109.972 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 157.16 33.67 0.0 OUTLIER 'General case' 0 C--N 1.37 1.478 0 O-C-N 125.938 2.024 . . . . 0.56999999999999995 111.204 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 2.4 m-30 73.54 -170.96 0.12 Allowed 'General case' 0 C--N 1.374 1.641 0 CA-C-N 114.65 -1.159 . . . . 0.56999999999999995 108.13 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.5 149.79 58.52 Favored Pre-proline 0 C--N 1.364 1.204 0 CA-C-O 122.34 1.066 . . . . 0.56999999999999995 109.068 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.58 -55.03 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.463 1.442 . . . . 0.56999999999999995 112.764 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -63.25 -48.72 77.01 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.3 1.048 . . . . 0.91000000000000003 112.573 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.406 ' HE2' ' CE3' ' A' ' 203' ' ' TRP . 3.6 ttm -83.15 142.11 31.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.484 2.087 . . . . 0.56999999999999995 111.471 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -70.68 135.89 48.65 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 120.324 -1.485 . . . . 0.56999999999999995 109.869 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.479 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.96 -51.21 57.97 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.087 -0.708 . . . . 1.2 109.087 -173.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -34.89 61.7 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-N 113.615 -1.63 . . . . 0.91000000000000003 110.917 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.02 -44.04 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.91000000000000003 110.893 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.3 t -62.33 -38.75 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.182 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.61 -43.17 81.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.866 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -47.7 76.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.905 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.97 -48.24 78.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 111.033 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.481 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.2 mm -61.85 -35.81 70.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.56999999999999995 111.146 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -64.56 -48.05 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 1.2 110.854 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 213' ' ' PHE . 0.0 OUTLIER -62.88 -38.59 91.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 110.872 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.421 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -62.46 -45.07 94.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.56999999999999995 111.064 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.668 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 15.3 m-85 -64.21 -34.12 77.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.906 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.8 tt0 -67.74 -41.13 83.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -69.7 -34.0 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.56999999999999995 111.105 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.95 -34.04 26.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.918 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.47 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 49.1 m -79.27 -48.87 13.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 110.852 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.83 -12.99 8.62 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.838 0.828 . . . . 0.56999999999999995 111.965 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 20.6 m -115.32 3.29 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.751 -1.113 . . . . 0.56999999999999995 112.127 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.91 148.86 40.56 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 124.105 1.907 . . . . 0.56999999999999995 110.418 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.18 -32.22 6.95 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 120.862 1.041 . . . . 0.56999999999999995 112.509 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.27 109.63 0.63 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 109.531 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 157.39 33.5 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.494 -1.23 . . . . 0.56999999999999995 111.77 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.529 ' CE1' HD21 ' A' ' 224' ' ' LEU . 10.8 m-85 -127.57 149.05 50.33 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-N 113.671 -1.604 . . . . 0.56999999999999995 109.19 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.39 121.19 6.02 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-O 123.605 1.669 . . . . 0.56999999999999995 109.792 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.611 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 21.0 tttp -92.52 145.89 24.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 120.674 -1.266 . . . . 0.56999999999999995 110.834 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.3 pt -128.53 129.02 68.69 Favored 'Isoleucine or valine' 0 C--N 1.372 1.544 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -73.95 -55.46 6.13 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.147 0.975 . . . . 0.56999999999999995 110.773 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.99 113.18 25.36 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 114.575 -1.193 . . . . 0.56999999999999995 110.781 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.27 164.5 19.23 Favored Glycine 0 C--N 1.37 2.466 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.123 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.9 ttt -88.28 131.75 34.66 Favored 'General case' 0 C--N 1.371 1.523 0 CA-C-O 122.192 0.996 . . . . 0.56999999999999995 111.085 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.53 175.02 6.37 Favored 'General case' 0 C--N 1.366 1.298 0 CA-C-N 114.423 -1.262 . . . . 0.56999999999999995 110.856 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.44 -46.47 89.94 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 106.432 -1.692 . . . . 0.91000000000000003 106.432 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.8 mt -113.88 109.93 30.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 114.733 -1.121 . . . . 0.56999999999999995 111.166 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.79 120.99 40.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.975 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.469 HG12 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -102.34 116.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.171 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.452 HG23 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.93 146.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.101 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.566 ' CD2' ' CD1' ' A' ' 197' ' ' PHE . 0.5 OUTLIER -98.68 122.76 42.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.56999999999999995 110.887 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 168' ' ' HIS . . . -144.97 168.45 20.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.242 1.02 . . . . 0.56999999999999995 109.929 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 166.25 10.91 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.547 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.45 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -30.62 105.37 0.01 OUTLIER Glycine 0 C--N 1.375 2.71 0 O-C-N 124.288 0.993 . . . . 0.56999999999999995 113.246 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 166' ' ' GLY . . . 80.56 93.55 0.05 OUTLIER 'General case' 0 C--N 1.391 2.402 0 CA-C-O 124.741 2.21 . . . . 0.56999999999999995 113.338 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.475 ' CG ' ' HB2' ' A' ' 164' ' ' ALA . 1.2 p-80 . . . . . 0 C--N 1.371 1.506 0 CA-C-N 113.729 -1.578 . . . . 0.56999999999999995 110.693 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 124.484 2.088 . . . . 0.56999999999999995 109.644 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -99.78 -160.36 0.8 Allowed 'General case' 0 C--N 1.362 1.145 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.027 177.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.503 ' CB ' ' CG1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -113.13 139.36 48.8 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-N 115.23 -0.895 . . . . 0.91000000000000003 110.85 176.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -100.16 92.47 1.11 Allowed Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 112.798 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER 69.95 50.07 0.48 Allowed 'General case' 0 C--N 1.377 1.779 0 CA-C-O 122.596 1.189 . . . . 0.56999999999999995 112.132 175.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 176.13 19.99 Favored Glycine 0 C--N 1.357 1.695 0 N-CA-C 108.217 -1.953 . . . . 0.56999999999999995 108.217 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 240' ' ' TYR . . . -44.46 -33.57 3.2 Favored Glycine 0 C--N 1.379 2.952 0 CA-C-O 122.198 0.888 . . . . 0.56999999999999995 112.252 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.503 ' CG1' ' CB ' ' A' ' 175' ' ' ASP . 3.1 mm -45.24 168.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 O-C-N 121.556 -0.967 . . . . 0.56999999999999995 111.722 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -148.17 -39.09 0.18 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.86 0.838 . . . . 0.56999999999999995 110.102 177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -176.63 179.94 1.07 Allowed 'General case' 0 C--N 1.363 1.176 0 CA-C-N 115.32 -0.855 . . . . 0.56999999999999995 111.042 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.426 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -153.35 141.86 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.889 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.14 152.42 33.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.142 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.725 -0.67 . . . . 0.56999999999999995 109.551 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 -151.56 7.98 Favored Glycine 0 C--N 1.367 2.255 0 CA-C-N 114.996 -1.002 . . . . 0.56999999999999995 110.905 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.33 88.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.958 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.25 118.11 1.32 Allowed Glycine 0 C--N 1.37 2.436 0 N-CA-C 109.501 -1.44 . . . . 0.56999999999999995 109.501 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -61.93 104.79 0.49 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.303 1.049 . . . . 0.56999999999999995 109.73 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.12 -101.59 1.01 Allowed Glycine 0 C--N 1.377 2.815 0 CA-C-N 114.965 -1.016 . . . . 0.56999999999999995 112.491 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.15 -37.61 77.82 Favored 'Isoleucine or valine' 0 C--N 1.375 1.691 0 CA-C-O 122.84 1.305 . . . . 0.56999999999999995 109.36 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.58 126.15 15.67 Favored Glycine 0 C--N 1.369 2.378 0 CA-C-O 122.696 1.165 . . . . 0.56999999999999995 110.579 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 106.95 -49.82 0.84 Allowed Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.844 -0.678 . . . . 0.56999999999999995 111.483 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 1.0 OUTLIER -45.45 107.61 0.1 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 120.86 0.362 . . . . 0.91000000000000003 110.88 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.31 142.17 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.063 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.452 ' CD2' HG23 ' A' ' 162' ' ' VAL . 16.3 m170 -134.87 135.83 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.827 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.566 ' CD1' ' CD2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -105.22 150.21 25.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.923 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.448 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.5 p30 -83.37 93.07 7.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.91000000000000003 110.865 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.96 80.07 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.991 -0.744 . . . . 0.91000000000000003 108.991 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -36.22 -45.07 0.43 Allowed 'General case' 0 C--N 1.363 1.194 0 CA-C-O 122.464 1.126 . . . . 0.91000000000000003 110.053 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 177' ' ' LYS . 8.5 pt-20 -56.54 -176.19 0.01 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-O 125.218 2.437 . . . . 0.91000000000000003 113.225 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -112.28 89.95 3.21 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.115 -1.616 . . . . 0.56999999999999995 111.185 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.539 ' CH2' ' CD2' ' A' ' 181' ' ' LEU . 49.1 m95 -71.93 142.84 49.45 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 109.164 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.41 ' CG2' ' HA3' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -125.73 126.56 44.81 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-O 123.047 1.403 . . . . 0.56999999999999995 109.727 -177.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.8 p -103.89 111.58 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.387 -1.279 . . . . 0.56999999999999995 108.29 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 83.46 65.36 0.02 OUTLIER 'General case' 0 C--N 1.386 2.191 0 CA-C-N 114.386 -1.279 . . . . 0.56999999999999995 108.867 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.62 124.37 0.03 OUTLIER 'General case' 0 C--N 1.383 2.052 0 CA-C-O 124.532 2.11 . . . . 0.56999999999999995 108.869 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.41 ' HA3' ' CG2' ' A' ' 204' ' ' THR . . . 149.61 -12.4 1.01 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 120.537 -1.352 . . . . 0.56999999999999995 112.611 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.83 -115.08 0.64 Allowed Glycine 0 C--N 1.375 2.734 0 CA-C-O 122.955 1.309 . . . . 0.56999999999999995 110.919 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.18 119.58 38.1 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 108.059 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.2 p30 -91.07 142.13 28.09 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-N 114.252 -1.34 . . . . 0.56999999999999995 110.39 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -27.72 69.52 Favored 'General case' 0 C--N 1.375 1.714 0 CA-C-O 124.596 2.141 . . . . 0.56999999999999995 107.695 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.531 ' CD2' HG12 ' A' ' 245' ' ' ILE . 32.8 t80 -59.67 -50.0 75.56 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.346 -1.297 . . . . 0.56999999999999995 110.886 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -62.13 -41.97 98.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.917 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 214' ' ' LEU . 94.3 m -65.11 -45.01 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 111.157 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -63.13 -36.66 84.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 111.085 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.421 HG22 ' CB ' ' A' ' 137' ' ' ALA . 59.7 t -65.87 -41.0 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.118 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -72.05 -51.08 23.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 110.861 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -62.13 -39.96 94.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.91000000000000003 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.533 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.7 mm -70.18 -47.21 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.56999999999999995 111.142 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.75 -34.26 64.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 1.1 m-70 -67.82 -36.07 79.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.56999999999999995 110.814 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -49.33 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.888 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.529 HD21 ' CE1' ' A' ' 149' ' ' PHE . 3.4 pp -97.66 -58.62 1.95 Allowed 'General case' 0 C--N 1.353 0.751 0 N-CA-C 113.96 1.096 . . . . 0.56999999999999995 113.96 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' GLY . . . -43.69 159.28 0.1 Allowed Glycine 0 C--N 1.365 2.145 0 CA-C-O 125.211 2.562 . . . . 0.56999999999999995 110.936 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -67.68 0.76 Allowed 'General case' 0 C--N 1.364 1.226 0 CA-C-N 113.195 -1.502 . . . . 0.56999999999999995 108.735 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.18 39.0 Favored Glycine 0 C--N 1.368 2.358 0 CA-C-O 123.298 1.499 . . . . 0.56999999999999995 110.595 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 1.1 m-70 -91.11 165.38 13.53 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-N 113.891 -1.154 . . . . 0.56999999999999995 110.218 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -84.04 -8.63 59.07 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 114.438 -1.255 . . . . 0.56999999999999995 110.682 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.84 1.14 2.48 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 111.97 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 145.44 57.07 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 114.542 -1.208 . . . . 0.91000000000000003 109.115 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.45 -44.97 37.59 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 121.717 1.611 . . . . 0.56999999999999995 112.072 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -32.49 0.19 Allowed 'General case' 0 C--N 1.371 1.525 0 CA-C-N 115.297 -0.865 . . . . 0.56999999999999995 113.237 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.19 136.73 48.22 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 124.383 2.039 . . . . 0.56999999999999995 114.81 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -73.76 -23.45 19.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 124.043 1.878 . . . . 0.56999999999999995 111.102 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.492 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -84.08 8.88 14.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.464 -1.698 . . . . 0.56999999999999995 111.183 -178.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 5.3 t80 -51.81 142.56 24.37 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-O 123.211 1.481 . . . . 0.56999999999999995 110.601 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 47.4 Cg_endo -78.56 -45.46 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.389 1.393 . . . . 0.56999999999999995 112.256 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.403 ' OG1' ' CE2' ' A' ' 237' ' ' PHE . 1.3 m -57.99 138.01 56.29 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.524 1.154 . . . . 0.56999999999999995 110.27 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 179' ' ' GLY . 2.5 t80 -75.42 154.14 37.28 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-N 114.052 -1.431 . . . . 0.56999999999999995 108.652 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 46.2 tttt 178.63 106.34 0.03 OUTLIER 'General case' 0 C--N 1.378 1.838 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.796 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -55.19 121.22 8.34 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 124.08 1.895 . . . . 0.56999999999999995 110.153 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.9 m -125.86 -14.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 110.804 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 1.4 p30 60.21 18.23 7.68 Favored 'General case' 0 C--N 1.369 1.453 0 O-C-N 124.31 1.006 . . . . 0.91000000000000003 111.98 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.531 HG12 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mt 79.05 -10.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.672 0 CA-C-N 114.91 -1.041 . . . . 0.56999999999999995 113.423 -175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -41.35 99.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.773 -1.566 . . . . 0.56999999999999995 106.773 -171.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -15.43 14.4 Favored 'General case' 0 C--N 1.373 1.627 0 N-CA-C 114.572 1.323 . . . . 0.56999999999999995 114.572 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.535 ' CE1' ' CG2' ' A' ' 235' ' ' VAL . 17.2 t80 -53.48 87.29 0.0 OUTLIER 'General case' 0 C--N 1.366 1.323 0 CA-C-O 123.566 1.651 . . . . 0.56999999999999995 110.563 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.434 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.49 149.2 45.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.452 -1.249 . . . . 1.2 109.172 -178.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.434 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -113.38 131.9 55.81 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-O 123.75 1.738 . . . . 0.56999999999999995 108.664 -176.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.68 134.39 52.16 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 120.413 -1.429 . . . . 0.56999999999999995 110.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 256' ' ' ARG . . . -57.64 -42.24 83.03 Favored 'General case' 0 C--N 1.373 1.605 0 CA-C-N 115.009 -0.996 . . . . 0.56999999999999995 109.507 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -41.29 97.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.954 -0.567 . . . . 0.91000000000000003 110.79 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -55.27 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.91000000000000003 110.898 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.438 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -66.24 -38.35 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.173 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.439 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 3.9 mtt180 -68.51 -29.91 68.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.869 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -69.62 -47.92 46.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.56999999999999995 112.476 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.1 pt -63.58 -43.18 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 0.56999999999999995 111.117 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.47 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.07 -34.64 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 110.906 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.351 0.644 0 CA-C-O 122.18 0.99 . . . . 0.56999999999999995 110.915 -178.722 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 122.718 1.247 . . . . 1.2 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -156.04 55.73 0.59 Allowed 'General case' 0 C--N 1.391 2.38 0 CA-C-O 123.927 1.822 . . . . 0.56999999999999995 108.671 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -166.8 -43.51 0.02 OUTLIER 'General case' 0 C--N 1.381 1.96 0 CA-C-N 113.895 -1.502 . . . . 0.56999999999999995 109.719 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 1.3 t80 -113.68 105.52 13.4 Favored 'General case' 0 C--N 1.367 1.338 0 CA-C-N 115.049 -0.978 . . . . 0.56999999999999995 110.905 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' N ' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -99.13 155.0 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.15 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.7 p -116.68 135.22 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.091 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -128.43 139.01 52.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.961 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.87 121.98 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.2 110.923 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -82.58 133.15 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.121 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -49.32 -63.0 1.23 Allowed 'General case' 0 C--N 1.372 1.575 0 N-CA-C 107.908 -1.145 . . . . 0.56999999999999995 107.908 -173.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 161.04 32.45 0.0 OUTLIER 'General case' 0 C--N 1.391 2.397 0 CA-C-N 113.6 -1.637 . . . . 0.56999999999999995 110.608 -169.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.7 m-85 63.28 -151.1 0.33 Allowed 'General case' 0 C--N 1.386 2.189 0 N-CA-C 106.926 -1.509 . . . . 0.56999999999999995 106.926 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.23 166.7 1.61 Allowed Pre-proline 0 C--N 1.38 1.894 0 CA-C-O 123.313 1.53 . . . . 0.56999999999999995 109.616 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -70.59 -42.38 2.59 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 120.865 1.043 . . . . 0.56999999999999995 112.049 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.43 -34.95 35.7 Favored 'General case' 0 C--N 1.38 1.893 0 CA-C-N 114.591 -1.186 . . . . 0.91000000000000003 112.779 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.3 ttm -93.14 111.86 23.63 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-O 125.67 2.652 . . . . 0.56999999999999995 109.068 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.26 141.74 54.31 Favored 'General case' 0 C--N 1.384 2.074 0 CA-C-N 113.272 -1.786 . . . . 0.56999999999999995 109.118 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.448 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.14 -51.41 58.1 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.446 -1.316 . . . . 1.2 107.446 -170.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -54.41 -34.76 61.95 Favored 'General case' 0 C--N 1.39 2.345 0 CA-C-N 113.06 -1.882 . . . . 0.91000000000000003 110.948 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.35 -44.01 69.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.91000000000000003 110.892 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.2 t -61.46 -43.09 96.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 111.122 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -66.45 -44.1 83.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.872 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -49.09 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.885 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.67 84.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.122 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.487 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.1 mm -67.44 -32.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.126 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -65.51 -48.1 73.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.2 110.88 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.28 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.56999999999999995 111.136 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.533 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 6.7 m-85 -67.01 -33.87 76.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.56999999999999995 110.912 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.464 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.2 tt0 -68.6 -42.08 78.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.928 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.499 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 5.2 p -69.43 -34.17 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.56999999999999995 111.172 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.503 ' O ' ' CG2' ' A' ' 145' ' ' THR . 3.7 m95 -83.02 -34.16 26.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.912 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.9 m -78.78 -50.46 11.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.883 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -57.4 -13.51 3.57 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 113.255 0.835 . . . . 0.56999999999999995 113.255 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 21.6 m -114.99 -11.11 12.14 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-N 114.517 -1.22 . . . . 0.56999999999999995 111.375 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -135.81 149.03 67.62 Favored Pre-proline 0 C--N 1.371 1.541 0 CA-C-O 125.517 2.58 . . . . 0.56999999999999995 109.057 -177.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.37 44.44 1.63 Allowed 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.611 2.208 . . . . 0.56999999999999995 112.25 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.75 89.28 2.25 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 105.649 -1.982 . . . . 0.56999999999999995 105.649 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -69.43 157.72 36.54 Favored 'General case' 0 C--N 1.38 1.921 0 CA-C-O 125.12 2.391 . . . . 0.56999999999999995 114.538 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CG ' ' CE1' ' A' ' 138' ' ' PHE . 72.7 m-85 -126.28 155.52 41.79 Favored 'General case' 0 C--N 1.387 2.222 0 CA-C-N 112.879 -1.964 . . . . 0.56999999999999995 108.903 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 124.62 7.31 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-O 125.302 2.477 . . . . 0.56999999999999995 107.101 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 33.2 tttt -82.82 145.38 29.52 Favored 'General case' 0 C--N 1.379 1.861 0 CA-C-N 113.626 -1.624 . . . . 0.56999999999999995 111.005 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.4 pt -135.78 172.37 15.76 Favored 'Isoleucine or valine' 0 C--N 1.38 1.911 0 CA-C-O 123.641 1.686 . . . . 0.56999999999999995 109.321 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -125.95 29.26 5.93 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-O 123.819 1.771 . . . . 0.56999999999999995 110.597 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 t -80.79 -170.46 2.67 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-N 114.217 -1.356 . . . . 0.56999999999999995 111.025 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -49.44 -55.24 13.6 Favored Glycine 0 C--N 1.391 3.62 0 CA-C-N 113.812 -1.54 . . . . 0.56999999999999995 110.929 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.89 138.9 9.6 Favored 'General case' 0 C--N 1.379 1.86 0 N-CA-C 107.663 -1.236 . . . . 0.56999999999999995 107.663 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -104.07 172.46 6.79 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.874 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -49.99 -65.45 0.56 Allowed 'General case' 0 C--N 1.38 1.924 0 CA-C-N 113.614 -1.63 . . . . 0.91000000000000003 106.919 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.97 110.06 24.88 Favored 'Isoleucine or valine' 0 C--N 1.371 1.527 0 O-C-N 121.802 -0.561 . . . . 0.56999999999999995 111.13 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -95.34 120.99 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 110.887 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.45 118.12 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.115 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.12 146.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.56999999999999995 111.149 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.68 120.65 42.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.9 167.26 26.19 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 123.242 1.496 . . . . 0.56999999999999995 108.214 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 169.26 8.57 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 115.06 -0.973 . . . . 1.2 109.926 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -41.79 133.68 3.72 Favored Glycine 0 C--N 1.387 3.381 0 CA-C-N 114.13 -1.396 . . . . 0.56999999999999995 109.623 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 85.32 45.14 0.02 OUTLIER 'General case' 0 C--N 1.4 2.792 0 CA-C-O 124.191 1.948 . . . . 0.56999999999999995 111.203 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 C--N 1.379 1.877 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 110.978 -179.662 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 123.433 1.587 . . . . 0.56999999999999995 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.544 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 1.4 m-85 -119.84 -173.08 2.47 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.95 -1.932 . . . . 0.56999999999999995 110.36 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.24 -178.66 3.51 Favored 'General case' 0 C--N 1.377 1.789 0 CA-C-N 113.044 -1.889 . . . . 0.91000000000000003 112.862 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.73 150.22 21.06 Favored Glycine 0 C--N 1.385 3.285 0 CA-C-N 113.47 -1.696 . . . . 0.56999999999999995 109.029 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.24 8.33 5.26 Favored 'General case' 0 C--N 1.376 1.748 0 CA-C-O 122.721 1.248 . . . . 0.56999999999999995 111.617 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 159.22 -104.53 0.25 Allowed Glycine 0 C--N 1.378 2.9 0 CA-C-O 122.869 1.261 . . . . 0.56999999999999995 110.185 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.31 -126.15 35.92 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-O 123.635 1.686 . . . . 0.56999999999999995 110.388 176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 182' ' ' ALA . 2.3 pp -79.03 -173.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.876 0 CA-C-N 113.745 -1.227 . . . . 0.56999999999999995 109.557 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.516 ' CD1' ' CZ3' ' A' ' 203' ' ' TRP . 9.4 tp -109.83 -37.1 5.73 Favored 'General case' 0 C--N 1.377 1.765 0 N-CA-C 115.763 1.764 . . . . 0.56999999999999995 115.763 170.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.46 ' N ' ' CD1' ' A' ' 180' ' ' ILE . . . -178.78 179.84 0.68 Allowed 'General case' 0 C--N 1.384 2.083 0 CA-C-N 113.787 -1.551 . . . . 0.56999999999999995 111.117 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 4.9 p80 -161.59 136.04 7.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.848 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -135.02 144.21 47.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.56999999999999995 111.108 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -79.56 175.88 10.21 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-O 123.244 1.497 . . . . 0.56999999999999995 109.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.84 -173.39 40.63 Favored Glycine 0 C--N 1.383 3.172 0 CA-C-O 123.158 1.421 . . . . 0.56999999999999995 111.312 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.52 71.83 3.79 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.56 2.173 . . . . 0.56999999999999995 111.506 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.13 -123.03 1.0 Allowed Glycine 0 C--N 1.382 3.087 0 CA-C-O 123.931 1.85 . . . . 0.56999999999999995 110.184 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.0 m -125.41 -62.89 1.18 Allowed 'General case' 0 C--N 1.392 2.417 0 CA-C-O 123.386 1.565 . . . . 0.56999999999999995 108.205 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.06 -71.3 0.7 Allowed Glycine 0 C--N 1.394 3.802 0 N-CA-C 108.861 -1.696 . . . . 0.56999999999999995 108.861 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.76 56.15 Favored 'Isoleucine or valine' 0 C--N 1.384 2.1 0 CA-C-O 125.815 2.721 . . . . 0.56999999999999995 108.885 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.3 134.94 29.12 Favored Glycine 0 C--N 1.393 3.746 0 N-CA-C 106.562 -2.615 . . . . 0.56999999999999995 106.562 -172.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.8 47.02 Favored Glycine 0 C--N 1.368 2.308 0 N-CA-C 110.172 -1.171 . . . . 0.56999999999999995 110.172 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.422 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.1 m-20 -73.96 124.86 26.99 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.993 -1.298 . . . . 0.91000000000000003 110.922 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.3 142.09 37.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.56999999999999995 111.083 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -124.69 129.39 50.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.925 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.62 150.18 27.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 110.919 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 91.25 5.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.91000000000000003 110.887 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.74 -47.51 77.96 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-N 114.977 -1.01 . . . . 0.91000000000000003 108.815 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.51 -44.9 0.06 Allowed 'General case' 0 C--N 1.374 1.633 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 203' ' ' TRP . 1.4 mp0 -62.58 -178.14 0.18 Allowed 'General case' 0 C--N 1.382 1.999 0 CA-C-O 127.219 3.39 . . . . 0.91000000000000003 106.948 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.24 78.0 1.18 Allowed 'General case' 0 C--N 1.379 1.848 0 O-C-N 118.664 -2.522 . . . . 0.56999999999999995 108.241 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.516 ' CZ3' ' CD1' ' A' ' 181' ' ' LEU . 21.4 m95 -74.0 143.16 45.7 Favored 'General case' 0 C--N 1.376 1.744 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 109.154 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 60.6 p -114.2 123.35 49.36 Favored 'General case' 0 C--N 1.377 1.8 0 CA-C-O 124.349 2.023 . . . . 0.56999999999999995 108.905 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.1 p -96.11 111.68 23.64 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-O 123.929 1.823 . . . . 0.56999999999999995 108.497 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 77.34 48.96 0.05 Allowed 'General case' 0 C--N 1.388 2.276 0 CA-C-O 124.57 2.129 . . . . 0.56999999999999995 110.626 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 t -129.09 -91.78 0.47 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 114.242 -1.345 . . . . 0.56999999999999995 109.651 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.91 -45.07 0.07 OUTLIER Glycine 0 C--N 1.387 3.381 0 C-N-CA 119.356 -1.402 . . . . 0.56999999999999995 111.985 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.51 -133.65 0.03 OUTLIER Glycine 0 C--N 1.393 3.743 0 CA-C-O 126.708 3.393 . . . . 0.56999999999999995 109.598 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 41.5 p -67.71 130.63 43.59 Favored 'General case' 0 C--N 1.37 1.473 0 O-C-N 119.582 -2.128 . . . . 0.56999999999999995 110.945 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -134.09 149.52 51.11 Favored 'General case' 0 C--N 1.38 1.923 0 CA-C-N 113.338 -1.755 . . . . 0.56999999999999995 108.476 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -71.08 -23.92 62.22 Favored 'General case' 0 C--N 1.375 1.702 0 CA-C-O 124.836 2.255 . . . . 0.56999999999999995 111.111 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 217' ' ' VAL . 23.8 t80 -54.51 -39.29 67.45 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.506 -1.679 . . . . 0.56999999999999995 110.855 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -51.13 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.895 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 181' ' ' LEU . 11.7 p -66.53 -40.41 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.131 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.79 96.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.09 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' ' 213' ' ' PHE . 24.6 t -65.31 -40.83 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.407 ' HA ' ' SD ' ' A' ' 236' ' ' MET . 24.8 t-80 -69.29 -44.97 70.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.858 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -59.64 -41.49 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.936 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.483 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 49.8 mt -66.48 -40.86 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.181 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.54 -33.7 87.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.56999999999999995 112.441 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -43.35 96.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.847 0.356 . . . . 0.56999999999999995 110.889 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -37.36 73.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.863 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.454 ' CD1' ' CE3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -45.47 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.367 1.343 0 CA-C-O 124.434 2.064 . . . . 0.56999999999999995 114.26 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -158.11 -88.74 0.07 OUTLIER Glycine 0 C--N 1.377 2.828 0 C-N-CA 118.654 -1.736 . . . . 0.56999999999999995 110.837 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.391 2.412 0 O-C-N 125.66 1.447 . . . . 0.56999999999999995 110.581 -173.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 99.07 98.28 2.14 Favored Glycine 0 C--N 1.385 3.303 0 C-N-CA 118.894 -1.622 . . . . 0.56999999999999995 110.281 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 172.75 0.16 Allowed 'General case' 0 C--N 1.395 2.556 0 CA-C-O 124.3 2.0 . . . . 0.56999999999999995 108.188 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 p -131.61 -6.42 3.67 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 117.294 -1.762 . . . . 0.56999999999999995 110.408 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.1 t 83.28 -12.25 0.87 Allowed 'General case' 0 C--N 1.391 2.397 0 CA-C-N 115.299 -0.864 . . . . 0.56999999999999995 112.049 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.68 148.17 45.49 Favored Pre-proline 0 C--N 1.385 2.129 0 N-CA-C 106.135 -1.802 . . . . 0.91000000000000003 106.135 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.33 -16.64 35.72 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.031 2.487 . . . . 0.56999999999999995 112.273 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 1.89 2.49 Favored 'General case' 0 C--N 1.38 1.91 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -111.5 143.1 42.89 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-O 124.877 2.275 . . . . 0.56999999999999995 108.687 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.516 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -72.91 -11.83 15.17 Favored 'Isoleucine or valine' 0 C--N 1.382 1.985 0 CA-C-N 112.322 -2.217 . . . . 0.56999999999999995 111.842 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.407 ' SD ' ' HA ' ' A' ' 218' ' ' HIS . 0.3 OUTLIER -108.29 26.67 10.16 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-N 114.437 -1.256 . . . . 0.56999999999999995 110.349 -178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 17.0 t80 -54.64 142.62 52.07 Favored Pre-proline 0 C--N 1.371 1.506 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 108.914 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 76.6 Cg_exo -54.92 -49.34 17.0 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.022 1.814 . . . . 0.56999999999999995 112.762 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 m -62.9 136.03 57.63 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 123.303 1.525 . . . . 0.56999999999999995 110.459 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 240' ' ' TYR . 0.7 OUTLIER -94.21 82.96 4.17 Favored 'General case' 0 C--N 1.382 2.001 0 CA-C-O 124.521 2.105 . . . . 0.56999999999999995 108.555 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -111.69 100.14 8.72 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-O 123.711 1.72 . . . . 0.56999999999999995 108.89 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -53.05 118.68 3.92 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-O 125.666 2.651 . . . . 0.56999999999999995 110.629 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.12 11.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 CA-C-N 112.499 -2.137 . . . . 0.56999999999999995 111.406 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 86.68 -16.01 0.42 Allowed 'General case' 0 C--N 1.377 1.768 0 O-C-N 125.247 1.592 . . . . 0.91000000000000003 111.918 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.6 mt 75.64 -49.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.389 2.284 0 N-CA-C 114.296 1.221 . . . . 0.56999999999999995 114.296 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -46.26 -28.86 1.4 Allowed 'General case' 0 C--N 1.368 1.383 0 N-CA-C 113.395 0.887 . . . . 0.56999999999999995 113.395 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 p -108.19 9.47 28.13 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-O 122.592 1.187 . . . . 0.56999999999999995 111.295 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 235' ' ' VAL . 9.9 t80 -68.01 86.54 0.25 Allowed 'General case' 0 C--N 1.377 1.775 0 CA-C-O 125.023 2.344 . . . . 0.56999999999999995 108.97 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.405 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -108.63 153.51 23.3 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-O 124.748 2.213 . . . . 1.2 107.204 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.4 131.82 54.07 Favored 'General case' 0 C--N 1.381 1.938 0 CA-C-O 125.874 2.75 . . . . 0.56999999999999995 105.867 -172.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 45.2 t -66.45 138.28 57.43 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.359 -2.088 . . . . 0.56999999999999995 110.26 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.21 86.13 Favored 'General case' 0 C--N 1.393 2.49 0 CA-C-N 113.612 -1.631 . . . . 0.56999999999999995 108.614 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.289 -0.882 . . . . 0.91000000000000003 110.87 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -55.08 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.91000000000000003 110.86 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 22.7 pt -66.08 -35.23 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.166 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.404 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 0.2 OUTLIER -70.35 -35.44 73.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 1.2 110.852 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.51 -49.58 64.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.56999999999999995 112.469 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.3 pt -62.32 -45.65 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.56999999999999995 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.485 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.11 -24.04 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.56999999999999995 110.92 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--N 1.367 1.354 0 CA-C-O 123.388 1.566 . . . . 0.56999999999999995 111.03 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 107.717 -1.216 . . . . 1.2 107.717 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.42 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.383 2.03 0 CA-C-N 113.692 -1.595 . . . . 0.56999999999999995 111.402 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.418 ' HA ' ' CD2' ' A' ' 147' ' ' LEU . 5.8 p-80 -53.04 -35.91 59.99 Favored 'General case' 0 C--N 1.382 2.008 0 CA-C-N 112.91 -1.95 . . . . 0.56999999999999995 109.954 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -111.11 111.59 22.79 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.493 -1.38 . . . . 0.56999999999999995 110.891 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.24 144.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.085 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -105.94 158.47 16.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.56999999999999995 111.149 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 159' ' ' ILE . 15.7 m-85 -140.6 159.59 41.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.886 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.737 HH11 ' N ' ' A' ' 156' ' ' MET . 12.3 ttm180 -150.0 129.62 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 1.2 110.854 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 134' ' ' ILE . 1.1 mm -99.09 128.92 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 111.08 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.61 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.373 1.624 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 112.682 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -179.18 24.63 0.0 OUTLIER 'General case' 0 C--N 1.378 1.822 0 CA-C-N 113.595 -1.639 . . . . 0.56999999999999995 107.767 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.459 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.3 m-85 82.87 -152.56 0.01 OUTLIER 'General case' 0 C--N 1.392 2.415 0 N-CA-C 105.504 -2.036 . . . . 0.56999999999999995 105.504 170.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.2 167.56 14.1 Favored Pre-proline 0 C--N 1.382 2.01 0 N-CA-C 108.542 -0.91 . . . . 0.56999999999999995 108.542 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -57.04 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 121.303 1.335 . . . . 0.56999999999999995 114.305 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.32 -59.05 3.1 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.837 -1.529 . . . . 0.91000000000000003 112.986 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.4 mtm -63.39 137.17 58.07 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 123.903 1.811 . . . . 0.56999999999999995 108.902 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.49 143.86 26.48 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 106.095 -1.817 . . . . 0.56999999999999995 106.095 -171.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.459 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.03 -49.67 42.47 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.728 -1.582 . . . . 1.2 106.728 -167.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.74 -34.79 62.98 Favored 'General case' 0 C--N 1.392 2.425 0 CA-C-N 112.238 -2.255 . . . . 0.91000000000000003 110.884 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -44.03 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.91000000000000003 110.877 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.5 t -65.03 -49.32 80.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.15 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -56.79 -44.07 81.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.91000000000000003 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -38.03 89.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.88 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.421 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -65.92 -40.64 91.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.086 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.459 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -66.97 -42.56 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.56999999999999995 111.178 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -62.05 -44.83 95.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 1.2 110.841 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.27 96.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.91 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.69 96.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.117 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.459 ' CE2' HG22 ' A' ' 134' ' ' ILE . 14.4 m-85 -62.53 -33.68 75.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.901 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.441 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.5 OUTLIER -68.28 -39.36 82.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.884 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.454 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -72.3 -33.87 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.189 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.414 ' O ' ' CG2' ' A' ' 145' ' ' THR . 9.8 m95 -83.16 -34.06 26.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.923 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.2 m -77.99 -49.13 14.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.56999999999999995 110.852 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.99 -13.06 9.58 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 122.049 0.928 . . . . 0.56999999999999995 112.349 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.42 HG12 ' ND2' ' A' ' 143' ' ' ASN . 17.6 m -112.87 9.45 8.12 Favored 'Isoleucine or valine' 0 C--N 1.382 2.009 0 CA-C-N 114.326 -1.306 . . . . 0.56999999999999995 112.757 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 19.3 p -149.32 151.62 34.15 Favored Pre-proline 0 C--N 1.378 1.812 0 CA-C-O 126.201 2.905 . . . . 0.56999999999999995 110.677 -171.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.57 -29.29 2.38 Favored 'Trans proline' 0 C--N 1.365 1.432 0 O-C-N 117.31 -1.995 . . . . 0.56999999999999995 110.923 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 112' ' ' HIS . 3.6 mt -73.3 111.98 8.94 Favored 'General case' 0 C--N 1.376 1.76 0 N-CA-C 106.543 -1.651 . . . . 0.56999999999999995 106.543 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -69.48 157.75 36.52 Favored 'General case' 0 C--N 1.381 1.963 0 CA-C-O 124.369 2.033 . . . . 0.56999999999999995 116.279 170.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 224' ' ' LEU . 17.0 m-85 -130.4 154.25 47.9 Favored 'General case' 0 C--N 1.387 2.213 0 CA-C-N 112.675 -2.057 . . . . 0.56999999999999995 109.141 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 m -156.15 109.13 2.65 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-O 125.442 2.544 . . . . 0.56999999999999995 108.83 -171.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.53 149.53 23.56 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.323 -1.762 . . . . 0.56999999999999995 112.394 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -160.17 -172.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.385 2.109 0 CA-C-N 113.833 -1.53 . . . . 0.56999999999999995 110.334 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -163.36 98.17 0.91 Allowed 'General case' 0 C--N 1.38 1.905 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.6 m -147.03 -81.59 0.14 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 115.288 -0.869 . . . . 0.56999999999999995 109.92 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.07 0.82 Allowed Glycine 0 C--N 1.384 3.228 0 N-CA-C 107.404 -2.278 . . . . 0.56999999999999995 107.404 -169.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.737 ' N ' HH11 ' A' ' 117' ' ' ARG . 5.0 ttm 72.19 135.98 0.04 OUTLIER 'General case' 0 C--N 1.404 2.977 0 O-C-N 126.362 1.86 . . . . 0.56999999999999995 108.274 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.22 163.67 27.23 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.27 -1.752 . . . . 0.56999999999999995 106.27 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 158' ' ' ASP 0.288 0.0 OUTLIER -18.7 -73.62 0.01 OUTLIER 'General case' 0 C--N 1.377 1.803 0 CA-C-N 112.875 -1.966 . . . . 0.91000000000000003 113.996 165.587 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 116' ' ' TYR . 2.5 mp -96.15 109.8 23.43 Favored 'Isoleucine or valine' 0 C--N 1.383 2.063 0 O-C-N 126.9 2.625 . . . . 0.56999999999999995 111.215 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 122.49 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.879 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 m -110.44 121.44 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.08 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.13 139.97 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.087 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -90.19 118.84 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.946 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.46 169.18 20.07 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 118.861 -1.135 . . . . 0.56999999999999995 109.162 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 167.3 9.88 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 115.245 -0.889 . . . . 1.2 110.398 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.11 129.02 2.78 Favored Glycine 0 C--N 1.393 3.726 0 O-C-N 125.201 1.563 . . . . 0.56999999999999995 111.699 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 82.69 104.04 0.06 Allowed 'General case' 0 C--N 1.406 3.041 0 CA-C-O 124.893 2.283 . . . . 0.56999999999999995 112.271 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 . . . . . 0 C--N 1.386 2.187 0 CA-C-N 113.823 -1.535 . . . . 0.56999999999999995 110.405 -177.117 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 125.549 2.595 . . . . 0.56999999999999995 109.023 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.499 ' CE2' ' CG2' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -64.93 178.06 0.88 Allowed 'General case' 0 C--N 1.377 1.784 0 CA-C-N 111.945 -2.389 . . . . 0.56999999999999995 112.051 177.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -58.37 -160.27 0.0 OUTLIER 'General case' 0 C--N 1.386 2.19 0 CA-C-O 124.519 2.104 . . . . 0.91000000000000003 114.479 172.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -172.63 101.39 0.16 Allowed Glycine 0 C--N 1.391 3.602 0 C-N-CA 117.261 -2.4 . . . . 0.56999999999999995 109.205 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.63 96.64 0.07 Allowed 'General case' 0 C--N 1.39 2.345 0 CA-C-O 123.472 1.605 . . . . 0.56999999999999995 113.056 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.27 -152.37 25.45 Favored Glycine 0 C--N 1.381 3.065 0 C-N-CA 119.02 -1.562 . . . . 0.56999999999999995 110.596 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.83 -132.91 40.66 Favored Glycine 0 C--N 1.376 2.784 0 N-CA-C 111.788 -0.525 . . . . 0.56999999999999995 111.788 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.499 ' CG2' ' CE2' ' A' ' 174' ' ' PHE . 0.1 OUTLIER -46.97 168.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.061 0 O-C-N 125.806 1.533 . . . . 0.56999999999999995 113.196 175.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.6 tp -121.94 -92.26 0.54 Allowed 'General case' 0 C--N 1.359 1.008 0 CA-C-O 126.781 3.181 . . . . 0.56999999999999995 112.907 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -106.22 179.73 4.18 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 112.524 -2.126 . . . . 0.56999999999999995 111.1 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 54.4 p-80 -163.12 135.84 5.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.856 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.7 166.74 21.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.072 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -71.71 0.6 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 117.491 -1.684 . . . . 0.56999999999999995 108.083 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.23 0.55 Allowed Glycine 0 C--N 1.386 3.331 0 C-N-CA 120.696 -0.764 . . . . 0.56999999999999995 112.579 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -53.16 -47.29 28.3 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 110.755 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 192' ' ' GLY . . . 98.99 -169.74 23.22 Favored Glycine 0 C--N 1.378 2.883 0 C-N-CA 118.958 -1.592 . . . . 0.56999999999999995 113.857 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 78.0 83.09 0.07 Allowed 'General case' 0 C--N 1.392 2.436 0 CA-C-O 124.137 1.922 . . . . 0.56999999999999995 107.649 173.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.63 -103.65 1.99 Allowed Glycine 0 C--N 1.394 3.781 0 N-CA-C 105.155 -3.178 . . . . 0.56999999999999995 105.155 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.88 -47.18 94.44 Favored 'Isoleucine or valine' 0 C--N 1.387 2.208 0 CA-C-O 127.102 3.334 . . . . 0.56999999999999995 110.691 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 188' ' ' GLY . . . -63.83 158.64 40.51 Favored Glycine 0 N--CA 1.404 -3.469 0 O-C-N 117.019 -3.551 . . . . 0.56999999999999995 108.827 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.29 -8.11 19.88 Favored Glycine 0 C--N 1.375 2.743 0 CA-C-N 113.782 -1.209 . . . . 0.56999999999999995 113.853 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.45 108.36 18.98 Favored 'General case' 0 C--N 1.378 1.842 0 CA-C-N 114.464 -0.868 . . . . 0.91000000000000003 110.835 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.18 151.0 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.137 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 6.7 m170 -135.28 151.21 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.56999999999999995 110.834 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -114.37 139.7 49.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.844 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.3 p-10 -66.92 82.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.836 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.15 69.78 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 106.629 -1.619 . . . . 0.91000000000000003 106.629 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -48.37 19.04 Favored 'General case' 0 C--N 1.389 2.297 0 O-C-N 125.835 1.96 . . . . 0.91000000000000003 107.548 -163.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.89 171.71 0.02 OUTLIER 'General case' 0 C--N 1.392 2.417 0 CA-C-O 127.167 3.365 . . . . 0.91000000000000003 116.356 172.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -97.06 100.51 12.01 Favored 'General case' 0 C--N 1.378 1.82 0 O-C-N 119.19 -2.194 . . . . 0.56999999999999995 111.117 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -78.54 152.89 31.69 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.869 -1.514 . . . . 0.56999999999999995 109.089 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.7 105.6 9.44 Favored 'General case' 0 C--N 1.378 1.805 0 CA-C-O 124.523 2.106 . . . . 0.56999999999999995 110.599 -175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.3 p -96.93 107.29 19.78 Favored 'General case' 0 C--N 1.365 1.25 0 CA-C-N 114.492 -1.231 . . . . 0.56999999999999995 110.064 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 53.7 46.92 24.92 Favored 'General case' 0 C--N 1.393 2.476 0 CA-C-O 125.371 2.51 . . . . 0.56999999999999995 110.846 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 t -134.26 -74.97 0.47 Allowed 'General case' 0 C--N 1.387 2.221 0 CA-C-N 112.5 -2.137 . . . . 0.56999999999999995 107.793 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.55 64.01 0.05 OUTLIER Glycine 0 C--N 1.394 3.782 0 C-N-CA 118.24 -1.933 . . . . 0.56999999999999995 111.214 -171.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.64 -142.01 6.14 Favored Glycine 0 C--N 1.387 3.372 0 CA-C-O 123.483 1.602 . . . . 0.56999999999999995 111.132 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 56.2 m -68.24 118.02 10.81 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.841 -1.18 . . . . 0.56999999999999995 110.456 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.49 145.47 24.43 Favored 'General case' 0 C--N 1.378 1.826 0 O-C-N 126.117 2.136 . . . . 0.56999999999999995 112.519 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -73.49 -32.14 64.13 Favored 'General case' 0 C--N 1.391 2.395 0 CA-C-O 124.424 2.059 . . . . 0.56999999999999995 107.508 -174.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 213' ' ' PHE . 4.3 t80 -49.57 -50.12 43.69 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-N 113.104 -1.862 . . . . 0.56999999999999995 110.891 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -42.68 81.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.933 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -45.04 80.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.095 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.77 79.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.56999999999999995 111.063 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -59.96 -41.48 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.098 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.76 -36.59 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.832 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -43.23 86.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.91000000000000003 110.807 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.2 mm -64.02 -45.28 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.94 87.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.819 -0.705 . . . . 0.56999999999999995 112.441 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.425 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -64.01 -42.61 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.56999999999999995 110.821 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 t -71.07 -55.63 7.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.872 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -78.07 -164.31 0.52 Allowed 'General case' 0 C--N 1.382 1.984 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 171.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.75 -146.03 44.5 Favored Glycine 0 C--N 1.38 2.998 0 N-CA-C 104.487 -3.445 . . . . 0.56999999999999995 104.487 169.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -82.18 0.64 Allowed 'General case' 0 C--N 1.38 1.916 0 CA-C-N 111.738 -2.231 . . . . 0.56999999999999995 110.481 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.91 -157.27 7.29 Favored Glycine 0 C--N 1.379 2.929 0 CA-C-O 123.871 1.817 . . . . 0.56999999999999995 108.843 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.7 m-70 -103.2 -171.34 1.93 Allowed 'General case' 0 C--N 1.376 1.738 0 CA-C-N 113.777 -1.212 . . . . 0.56999999999999995 111.934 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 p -116.32 -31.26 5.68 Favored 'General case' 0 C--N 1.386 2.166 0 CA-C-N 113.93 -1.487 . . . . 0.56999999999999995 108.985 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 m 82.11 23.11 0.23 Allowed 'General case' 0 C--N 1.401 2.828 0 CA-C-O 123.095 1.426 . . . . 0.56999999999999995 114.556 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -127.99 151.13 75.38 Favored Pre-proline 0 N--CA 1.418 -2.067 0 CA-C-N 113.105 -1.861 . . . . 0.91000000000000003 108.345 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 71.0 Cg_exo -58.23 -28.07 82.91 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.168 1.912 . . . . 0.56999999999999995 115.289 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -33.74 71.82 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 111.295 -2.684 . . . . 0.56999999999999995 117.884 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.3 131.23 45.09 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 113.778 -1.555 . . . . 0.56999999999999995 109.483 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -3.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 CA-C-O 125.927 2.775 . . . . 0.56999999999999995 112.366 -176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 11.2 mtp -122.82 -10.77 8.23 Favored 'General case' 0 C--N 1.374 1.668 0 CA-C-N 112.847 -1.978 . . . . 0.56999999999999995 112.153 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.514 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.66 141.82 0.55 Allowed Pre-proline 0 C--N 1.373 1.605 0 CA-C-O 125.496 2.57 . . . . 0.56999999999999995 113.638 174.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.94 -50.04 12.65 Favored 'Trans proline' 0 C--N 1.37 1.667 0 O-C-N 118.831 -1.194 . . . . 0.56999999999999995 111.122 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.514 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 39.5 m -44.23 118.71 1.58 Allowed 'General case' 0 C--N 1.366 1.288 0 CA-C-O 123.404 1.573 . . . . 0.56999999999999995 110.507 -172.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -92.92 157.56 16.28 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.555 -1.657 . . . . 0.56999999999999995 108.326 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.96 126.14 0.02 OUTLIER 'General case' 0 C--N 1.392 2.434 0 N-CA-C 105.448 -2.056 . . . . 0.56999999999999995 105.448 169.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.67 120.45 7.3 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 125.491 2.567 . . . . 0.56999999999999995 109.497 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 247' ' ' THR . 1.4 p -128.27 -16.05 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 CA-C-N 112.538 -2.119 . . . . 0.56999999999999995 110.973 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 244' ' ' ASP 0.289 0.0 OUTLIER 84.51 178.22 0.05 OUTLIER 'General case' 0 C--N 1.371 1.54 0 O-C-N 126.872 2.607 . . . . 0.91000000000000003 111.782 -174.289 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 245' ' ' ILE . 1.8 mp -93.81 -35.64 6.57 Favored 'Isoleucine or valine' 0 C--N 1.382 1.983 0 N-CA-C 118.322 2.712 . . . . 0.56999999999999995 118.322 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.77 -14.52 0.05 OUTLIER 'General case' 0 C--N 1.377 1.784 0 N-CA-C 117.224 2.305 . . . . 0.56999999999999995 117.224 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.439 ' HB ' ' CG2' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -124.59 -21.53 4.83 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.504 -175.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.29 88.67 0.02 OUTLIER 'General case' 0 C--N 1.378 1.845 0 CA-C-O 125.566 2.603 . . . . 0.56999999999999995 108.488 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.07 154.07 29.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 112.816 -1.993 . . . . 1.2 107.609 -178.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.406 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -124.42 127.84 48.13 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 125.745 2.688 . . . . 0.56999999999999995 105.393 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 143.27 58.06 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.214 -2.179 . . . . 0.56999999999999995 111.916 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.29 95.42 Favored 'General case' 0 C--N 1.392 2.43 0 CA-C-N 113.842 -1.526 . . . . 0.56999999999999995 107.996 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.71 -38.51 81.83 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 115.644 -0.707 . . . . 0.91000000000000003 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.17 -55.09 24.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.91000000000000003 110.842 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.06 -34.82 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.164 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -70.15 -32.35 70.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.882 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.81 62.41 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.655 -0.783 . . . . 0.56999999999999995 112.499 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.474 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.8 -44.59 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.176 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.474 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.17 -19.18 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.914 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.366 1.326 0 CA-C-O 122.122 0.963 . . . . 0.56999999999999995 108.667 -175.604 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 . . . . . 0 N--CA 1.435 -1.195 0 CA-C-O 122.303 1.049 . . . . 1.2 109.278 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.83 155.44 14.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 81.96 -41.72 0.14 Allowed 'General case' 0 C--N 1.377 1.777 0 CA-C-O 122.187 0.994 . . . . 0.56999999999999995 110.622 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -114.4 131.47 56.56 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.579 -1.191 . . . . 0.56999999999999995 110.868 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 148' ' ' LYS . 1.1 mm -127.45 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.12 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.0 157.81 17.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.098 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 16.7 t80 -145.29 160.02 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.914 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.598 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 3.9 tpt85 -146.49 121.97 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.841 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -95.53 125.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.122 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -61.83 -179.37 0.19 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.616 1.674 . . . . 0.56999999999999995 111.268 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.09 51.37 0.98 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 110.824 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.4 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 5.2 m-85 44.19 -150.15 0.05 Allowed 'General case' 0 C--N 1.366 1.323 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 109.045 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.425 ' CB ' ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -165.84 168.24 8.07 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-O 122.286 1.041 . . . . 0.56999999999999995 110.454 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 122' ' ' THR . 32.5 Cg_endo -68.06 -36.23 17.85 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 121.444 1.429 . . . . 0.56999999999999995 112.963 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -84.84 -45.42 12.32 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.987 1.375 . . . . 0.91000000000000003 113.134 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.498 ' CE ' ' CE2' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -77.92 110.09 12.52 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 123.68 1.705 . . . . 0.56999999999999995 109.482 -176.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.27 135.89 47.67 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.947 -1.479 . . . . 0.56999999999999995 109.192 -176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.4 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -61.61 -50.83 70.98 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 108.448 -0.945 . . . . 1.2 108.448 -170.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.56 -34.86 69.63 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 113.083 -1.871 . . . . 0.91000000000000003 110.896 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -39.71 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.91000000000000003 110.826 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.7 t -64.97 -49.74 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 111.153 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -41.61 91.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 110.896 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -42.3 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 110.863 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 212' ' ' LEU . . . -66.5 -48.88 68.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.56999999999999995 111.092 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.515 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -64.35 -31.95 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.122 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.95 -46.71 70.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 1.2 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -62.82 -37.2 85.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.5 82.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.065 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CE2' HG22 ' A' ' 134' ' ' ILE . 5.5 m-85 -67.06 -33.83 76.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.919 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.426 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.3 tp60 -70.21 -44.65 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.871 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.489 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.7 p -68.54 -33.6 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.56999999999999995 111.16 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.46 -34.31 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.854 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 138' ' ' PHE . 29.3 m -72.22 -49.45 35.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 110.863 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -60.66 -11.97 8.92 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-O 121.881 0.848 . . . . 0.56999999999999995 112.706 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -111.98 -5.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.367 1.358 0 CA-C-N 114.792 -1.094 . . . . 0.56999999999999995 112.69 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.0 p -140.63 146.38 44.43 Favored Pre-proline 0 C--N 1.365 1.261 0 CA-C-O 124.594 2.14 . . . . 0.56999999999999995 111.115 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -77.19 -25.54 8.48 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 121.218 1.278 . . . . 0.56999999999999995 111.77 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 96.09 4.77 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 122.668 1.223 . . . . 0.56999999999999995 109.518 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -77.04 160.75 28.86 Favored 'General case' 0 C--N 1.363 1.184 0 CA-C-N 115.168 -0.924 . . . . 0.56999999999999995 112.198 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -133.05 140.77 47.88 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 107.702 -1.222 . . . . 0.56999999999999995 107.702 -173.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.0 m -155.67 135.56 12.78 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 109.387 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -74.97 144.17 43.3 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 114.513 -1.222 . . . . 0.56999999999999995 109.213 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.2 pt -125.14 -179.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.364 1.213 0 CA-C-O 121.947 0.879 . . . . 0.56999999999999995 109.887 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -134.41 63.87 1.61 Allowed 'General case' 0 C--N 1.37 1.483 0 CA-C-O 122.93 1.348 . . . . 0.56999999999999995 111.299 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.76 95.83 1.57 Allowed 'General case' 0 C--N 1.373 1.624 0 CA-C-N 114.553 -1.203 . . . . 0.56999999999999995 110.357 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 45.66 -137.63 7.04 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 122.418 1.01 . . . . 0.56999999999999995 111.681 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 151.53 46.96 Favored 'General case' 0 C--N 1.366 1.307 0 CA-C-O 123.145 1.45 . . . . 0.56999999999999995 110.74 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.68 163.64 28.99 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 114.497 -1.229 . . . . 0.56999999999999995 109.814 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -46.06 -52.0 12.75 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 108.245 -1.02 . . . . 0.91000000000000003 108.245 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 41.6 mt -116.43 110.47 31.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 O-C-N 123.816 0.697 . . . . 0.56999999999999995 111.093 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 122.02 46.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.977 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.19 120.21 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 111.098 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.8 t -131.23 124.94 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 111.084 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 197' ' ' PHE . 2.4 m-85 -86.78 120.48 28.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.852 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.13 169.0 18.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 110.626 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 163.44 13.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.749 -1.219 . . . . 1.2 108.945 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 167' ' ' ALA . . . -33.03 130.89 0.3 Allowed Glycine 0 C--N 1.37 2.429 0 O-C-N 124.009 0.818 . . . . 0.56999999999999995 112.718 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 166' ' ' GLY . . . 84.28 40.28 0.03 OUTLIER 'General case' 0 C--N 1.39 2.361 0 CA-C-O 124.763 2.221 . . . . 0.56999999999999995 112.383 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--N 1.364 1.237 0 CA-C-N 114.249 -1.342 . . . . 0.56999999999999995 109.087 -178.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.142 0.496 . . . . 0.56999999999999995 110.72 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.429 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -147.6 -167.82 2.89 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 122.018 0.914 . . . . 0.56999999999999995 110.07 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -72.61 -177.74 2.38 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 124.477 1.111 . . . . 0.91000000000000003 112.252 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.27 49.13 0.21 Allowed Glycine 0 C--N 1.381 3.049 0 CA-C-O 123.411 1.562 . . . . 0.56999999999999995 113.192 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -171.72 -36.48 0.02 OUTLIER 'General case' 0 C--N 1.384 2.069 0 CA-C-O 123.425 1.583 . . . . 0.56999999999999995 112.819 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 177' ' ' LYS . . . 169.41 -103.62 0.2 Allowed Glycine 0 C--N 1.375 2.7 0 CA-C-O 122.955 1.308 . . . . 0.56999999999999995 110.457 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.541 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 36.04 -92.19 0.01 OUTLIER Glycine 0 C--N 1.367 2.267 0 O-C-N 120.309 -1.7 . . . . 0.56999999999999995 114.49 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 178' ' ' GLY . 1.9 mm -51.23 170.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.064 0 CA-C-O 121.297 0.57 . . . . 0.56999999999999995 111.593 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.427 ' O ' ' CD1' ' A' ' 197' ' ' PHE . 3.6 tp -136.09 -41.33 0.66 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.945 0.879 . . . . 0.56999999999999995 112.55 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 196' ' ' HIS . . . -176.72 179.87 1.06 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.359 -0.837 . . . . 0.56999999999999995 111.094 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -156.03 137.91 14.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.928 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.01 40.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.101 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.43 ' CB ' HG22 ' A' ' 191' ' ' ILE . 1.9 m-85 -91.93 176.59 6.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.523 1.154 . . . . 0.56999999999999995 110.964 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.37 55.07 0.1 Allowed Glycine 0 C--N 1.366 2.21 0 CA-C-N 115.501 -0.772 . . . . 0.56999999999999995 112.797 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HD2' ' CA ' ' A' ' 192' ' ' GLY . 47.0 Cg_endo -74.42 -42.98 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 120.907 1.071 . . . . 0.56999999999999995 112.008 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.41 87.32 0.17 Allowed Glycine 0 C--N 1.379 2.93 0 C-N-CA 120.137 -1.03 . . . . 0.56999999999999995 111.569 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 79.75 97.02 0.06 Allowed 'General case' 0 C--N 1.386 2.155 0 CA-C-O 123.59 1.662 . . . . 0.56999999999999995 110.073 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.65 -118.56 1.27 Allowed Glycine 0 C--N 1.381 3.047 0 N-CA-C 109.61 -1.396 . . . . 0.56999999999999995 109.61 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -72.11 -11.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 CA-C-O 124.689 2.185 . . . . 0.56999999999999995 110.36 -178.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' HD2' ' A' ' 187' ' ' PRO . . . -66.91 124.62 23.89 Favored Glycine 0 C--N 1.372 2.552 0 O-C-N 120.077 -1.639 . . . . 0.56999999999999995 109.758 -174.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 115.09 -33.12 5.45 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-O 121.737 0.631 . . . . 0.56999999999999995 112.521 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -72.91 129.37 37.99 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 122.162 -0.61 . . . . 0.91000000000000003 110.828 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -121.51 160.05 25.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.481 . . . . 0.56999999999999995 111.089 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 182' ' ' ALA . 46.0 m170 -133.74 140.07 46.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.66 139.42 38.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 110.887 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.55 78.89 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -29.61 11.36 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 118.529 -0.748 . . . . 0.91000000000000003 112.515 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -39.15 -55.94 1.55 Allowed 'General case' 0 C--N 1.352 0.713 0 CA-C-O 124.907 2.289 . . . . 0.91000000000000003 109.189 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.416 ' HB3' ' C ' ' A' ' 177' ' ' LYS . 1.6 pm0 -75.09 176.38 7.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-O 125.474 2.559 . . . . 0.91000000000000003 112.379 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.11 90.82 3.44 Favored 'General case' 0 C--N 1.369 1.431 0 O-C-N 119.282 -2.136 . . . . 0.56999999999999995 109.638 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -88.63 147.63 24.45 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 114.063 -1.426 . . . . 0.56999999999999995 111.708 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 99.6 m -123.05 121.57 36.37 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-O 124.387 2.041 . . . . 0.56999999999999995 112.429 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.35 133.47 34.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 120.865 -1.147 . . . . 0.56999999999999995 110.588 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' A' ' 207' ' ' SER . 2.2 t-80 78.89 62.79 0.03 OUTLIER 'General case' 0 C--N 1.38 1.909 0 CA-C-O 122.726 1.251 . . . . 0.56999999999999995 110.219 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.7 m 85.09 92.85 0.03 OUTLIER 'General case' 0 C--N 1.381 1.945 0 CA-C-O 123.703 1.716 . . . . 0.56999999999999995 109.057 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.42 110.21 0.5 Allowed Glycine 0 C--N 1.375 2.721 0 O-C-N 120.997 -1.064 . . . . 0.56999999999999995 111.772 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 43.57 -113.26 0.68 Allowed Glycine 0 C--N 1.375 2.73 0 CA-C-O 123.756 1.753 . . . . 0.56999999999999995 111.689 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 126.21 38.31 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 113.599 -1.3 . . . . 0.56999999999999995 112.243 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.527 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.4 OUTLIER -95.71 151.04 19.72 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.186 -1.37 . . . . 0.56999999999999995 111.885 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.446 ' C ' ' CD1' ' A' ' 212' ' ' LEU . 0.7 OUTLIER -72.75 -38.51 67.35 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 123.518 1.628 . . . . 0.56999999999999995 107.873 -175.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 1.9 t80 -51.79 -46.8 64.33 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 114.242 -1.344 . . . . 0.56999999999999995 110.867 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.76 -51.18 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.56999999999999995 110.923 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.42 HG22 ' CG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -64.18 -45.37 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.115 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.453 ' O ' ' CD1' ' A' ' 220' ' ' ILE . . . -59.14 -39.91 83.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 111.074 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 248' ' ' PHE . 1.1 t -65.25 -39.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.118 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -66.31 -49.03 68.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.827 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.9 -42.26 84.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.91000000000000003 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 216' ' ' ALA . 11.7 mt -67.0 -46.17 85.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.56999999999999995 111.16 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.94 -33.67 64.19 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.476 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.411 ' CE1' ' O ' ' A' ' 227' ' ' GLY . 1.5 m-70 -64.31 -40.65 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.56999999999999995 110.872 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.6 t -71.23 -51.04 26.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.815 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 225' ' ' GLY . 3.3 pp -72.4 -64.89 0.86 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.868 1.062 . . . . 0.56999999999999995 113.868 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.477 ' N ' ' CD1' ' A' ' 224' ' ' LEU . . . -73.13 169.98 52.5 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-O 124.871 2.373 . . . . 0.56999999999999995 111.493 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -154.73 0.01 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-O 123.727 1.727 . . . . 0.56999999999999995 108.796 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 222' ' ' HIS . . . -53.47 -99.47 0.01 OUTLIER Glycine 0 C--N 1.38 2.982 0 CA-C-O 123.849 1.805 . . . . 0.56999999999999995 111.921 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -112.67 -93.82 0.46 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 119.684 -2.068 . . . . 0.56999999999999995 112.216 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 234' ' ' ALA . 16.1 p -162.75 -43.85 0.04 OUTLIER 'General case' 0 C--N 1.372 1.563 0 CA-C-N 115.219 -0.9 . . . . 0.56999999999999995 110.666 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 83.84 28.99 0.08 Allowed 'General case' 0 C--N 1.399 2.726 0 CA-C-N 114.189 -1.368 . . . . 0.56999999999999995 114.501 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.3 128.68 2.4 Favored Pre-proline 0 C--N 1.383 2.056 0 CA-C-N 114.459 -1.246 . . . . 0.91000000000000003 108.545 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.42 64.41 7.26 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.909 2.406 . . . . 0.56999999999999995 112.12 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.7 -31.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 121.086 -1.009 . . . . 0.56999999999999995 113.276 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -69.82 120.07 15.01 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-O 123.521 1.629 . . . . 0.56999999999999995 110.41 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.544 HG13 ' CZ ' ' A' ' 248' ' ' PHE . 40.0 t -58.4 88.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.71 -1.132 . . . . 0.56999999999999995 112.849 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 158.37 -20.74 0.0 OUTLIER 'General case' 0 C--N 1.367 1.361 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 112.488 -176.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 4.0 p90 -50.02 153.03 2.48 Favored Pre-proline 0 N--CA 1.43 -1.459 0 CA-C-O 123.088 1.423 . . . . 0.56999999999999995 111.322 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.67 -47.87 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.331 1.354 . . . . 0.56999999999999995 110.591 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 m -39.6 121.25 1.2 Allowed 'General case' 0 C--N 1.353 0.719 0 CA-C-O 122.725 1.25 . . . . 0.56999999999999995 110.926 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 179' ' ' GLY . 36.2 t80 -68.18 162.52 24.7 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.355 -1.293 . . . . 0.56999999999999995 108.113 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 14.4 tttt 167.4 124.22 0.01 OUTLIER 'General case' 0 C--N 1.373 1.618 0 CA-C-O 123.064 1.411 . . . . 0.56999999999999995 108.112 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -74.77 120.11 19.87 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-O 122.898 1.332 . . . . 0.56999999999999995 111.325 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.18 115.6 12.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.239 0 CA-C-N 115.166 -0.925 . . . . 0.56999999999999995 108.891 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -41.47 142.36 0.61 Allowed 'General case' 0 C--N 1.366 1.31 0 CA-C-O 124.052 1.882 . . . . 0.91000000000000003 109.53 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.96 -22.29 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 112.209 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -17.04 61.98 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.126 0.965 . . . . 0.56999999999999995 111.387 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.7 p -112.18 8.25 19.81 Favored 'General case' 0 C--N 1.371 1.519 0 CA-C-O 122.654 1.216 . . . . 0.56999999999999995 113.376 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.544 ' CZ ' HG13 ' A' ' 235' ' ' VAL . 45.0 t80 -77.16 88.49 3.63 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-O 124.193 1.949 . . . . 0.56999999999999995 108.577 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.418 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -112.42 153.56 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 O-C-N 120.678 -1.263 . . . . 1.2 110.32 177.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -119.98 129.36 54.25 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 124.331 2.015 . . . . 0.56999999999999995 107.934 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 143.91 55.51 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 119.659 -1.901 . . . . 0.56999999999999995 112.25 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.68 89.61 Favored 'General case' 0 C--N 1.382 1.98 0 CA-C-N 114.663 -1.153 . . . . 0.56999999999999995 109.428 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.17 -40.71 94.92 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.796 -0.638 . . . . 0.91000000000000003 110.882 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.29 -54.92 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.91000000000000003 110.849 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.435 ' HA ' ' CD1' ' A' ' 258' ' ' ILE . 26.1 pt -66.1 -34.79 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.081 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 255' ' ' ILE . 37.3 mtp180 -62.84 -43.47 98.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.934 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.57 -57.52 12.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.547 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 255' ' ' ILE . 28.4 pt -46.62 -44.2 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.56999999999999995 111.224 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.415 ' N ' HG13 ' A' ' 258' ' ' ILE . 2.6 pt20 -72.02 -26.75 62.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 122.594 1.187 . . . . 0.56999999999999995 110.441 -178.037 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 123.112 1.434 . . . . 1.2 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -44.83 0.1 Allowed 'General case' 0 C--N 1.374 1.659 0 CA-C-N 113.081 -1.872 . . . . 0.56999999999999995 111.037 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -78.25 -30.86 48.89 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 113.468 -1.696 . . . . 0.56999999999999995 109.983 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -112.02 109.12 18.7 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 114.26 -1.336 . . . . 0.56999999999999995 110.903 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.447 ' CG1' ' CE1' ' A' ' 149' ' ' PHE . 1.9 mm -102.22 155.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 111.13 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 149.5 36.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 111.106 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.1 t80 -145.86 156.57 43.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -154.54 132.17 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.936 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.74 146.32 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.137 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.568 ' HB3' ' CE2' ' A' ' 163' ' ' PHE . 55.5 t30 -53.4 -60.44 3.3 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 117.651 -1.619 . . . . 0.56999999999999995 107.454 -167.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 159.21 31.08 0.0 OUTLIER 'General case' 0 C--N 1.383 2.024 0 O-C-N 126.474 2.359 . . . . 0.56999999999999995 109.567 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 77.18 92.16 0.07 Allowed 'General case' 0 C--N 1.409 3.162 0 N-CA-C 105.461 -2.052 . . . . 0.56999999999999995 105.461 164.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.433 HG21 ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -49.43 163.82 0.35 Allowed Pre-proline 0 C--N 1.383 2.041 0 CA-C-N 111.993 -2.367 . . . . 0.56999999999999995 108.548 -168.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.23 -47.92 11.1 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 115.692 -0.503 . . . . 0.56999999999999995 112.537 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -63.72 1.32 Allowed 'General case' 0 C--N 1.386 2.153 0 N-CA-C 104.32 -2.474 . . . . 0.91000000000000003 104.32 -163.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.37 154.48 3.35 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-O 125.141 2.4 . . . . 0.56999999999999995 108.219 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.54 137.74 32.07 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 112.79 -2.005 . . . . 0.56999999999999995 110.125 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -49.43 70.19 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 115.116 -0.947 . . . . 1.2 108.579 -170.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.07 -35.24 64.33 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 126.838 2.586 . . . . 0.91000000000000003 110.98 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -70.7 -42.26 70.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.91000000000000003 110.883 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.13 -47.68 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.1 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 7.7 t70 -60.12 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.91000000000000003 110.872 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.37 -41.44 97.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.927 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.08 75.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.56999999999999995 111.125 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 18.1 pt -64.76 -39.22 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.144 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -58.85 -49.11 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.813 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.479 ' N ' ' HZ1' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -62.79 -34.87 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.888 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.15 88.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.12 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m-85 -63.52 -36.85 85.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.91 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.446 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 8.2 tt0 -66.38 -39.19 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.56999999999999995 110.935 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.464 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.9 t -69.51 -34.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.152 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.446 ' CD2' ' CD1' ' A' ' 224' ' ' LEU . 4.8 m95 -82.93 -34.13 26.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.977 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.7 m -78.66 -48.11 15.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.905 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -61.02 -12.72 12.52 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 121.892 0.853 . . . . 0.56999999999999995 111.844 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 18.9 m -114.48 11.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.378 1.842 0 CA-C-N 113.892 -1.504 . . . . 0.56999999999999995 112.898 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 8.8 p -150.67 150.45 28.35 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-O 125.381 2.515 . . . . 0.56999999999999995 110.264 -173.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.81 -24.54 4.06 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 O-C-N 118.133 -1.562 . . . . 0.56999999999999995 113.054 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.94 111.48 11.35 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-O 124.534 2.112 . . . . 0.56999999999999995 107.487 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 156.8 38.79 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 114.687 172.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' CE1' HD23 ' A' ' 224' ' ' LEU . 1.1 m-85 -128.04 160.01 33.27 Favored 'General case' 0 C--N 1.376 1.723 0 CA-C-N 112.526 -2.125 . . . . 0.56999999999999995 109.441 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.0 m -157.92 114.71 2.9 Favored 'General case' 0 C--N 1.389 2.29 0 CA-C-O 124.855 2.264 . . . . 0.56999999999999995 109.344 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -95.3 129.17 42.53 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.106 -1.861 . . . . 0.56999999999999995 110.69 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.89 137.07 37.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.406 0 CA-C-O 124.681 2.182 . . . . 0.56999999999999995 111.361 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -46.29 71.27 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 110.533 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -121.41 171.92 8.43 Favored 'General case' 0 C--N 1.379 1.875 0 CA-C-N 113.361 -1.745 . . . . 0.56999999999999995 110.143 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.08 -119.91 6.68 Favored Glycine 0 C--N 1.382 3.11 0 N-CA-C 109.514 -1.434 . . . . 0.56999999999999995 109.514 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 ttt -165.46 108.72 0.82 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-O 123.389 1.566 . . . . 0.56999999999999995 109.759 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.03 143.58 33.96 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 112.722 -2.035 . . . . 0.56999999999999995 110.462 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -51.22 10.08 Favored 'General case' 0 C--N 1.374 1.665 0 CA-C-N 116.001 -0.545 . . . . 0.91000000000000003 110.356 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.6 mt -90.17 109.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.386 2.169 0 O-C-N 128.124 3.39 . . . . 0.56999999999999995 111.116 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.97 132.06 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.957 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.6 118.14 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.126 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.5 t -133.08 146.02 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 111.166 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -92.07 121.66 33.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.834 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.01 168.8 18.86 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-O 123.445 1.593 . . . . 0.56999999999999995 109.829 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.73 169.78 8.95 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 114.974 -1.012 . . . . 1.2 110.531 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.35 139.18 2.46 Favored Glycine 0 C--N 1.383 3.152 0 O-C-N 126.202 2.189 . . . . 0.56999999999999995 111.517 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.68 57.69 0.84 Allowed 'General case' 0 C--N 1.4 2.777 0 CA-C-O 125.475 2.56 . . . . 0.56999999999999995 110.585 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 . . . . . 0 C--N 1.375 1.681 0 CA-C-N 112.39 -2.187 . . . . 0.56999999999999995 110.34 -179.363 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.375 0 CA-C-O 121.85 0.833 . . . . 0.56999999999999995 111.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.444 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 9.7 m-85 -92.94 179.58 5.41 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-N 111.823 -2.444 . . . . 0.56999999999999995 111.184 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.422 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -86.7 -175.82 5.56 Favored 'General case' 0 C--N 1.382 2.014 0 CA-C-N 113.724 -1.58 . . . . 0.91000000000000003 113.009 173.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . -147.96 142.68 10.32 Favored Glycine 0 C--N 1.39 3.563 0 O-C-N 126.337 2.273 . . . . 0.56999999999999995 110.482 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.72 25.02 2.61 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 113.025 -1.587 . . . . 0.56999999999999995 113.086 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.78 -132.65 4.34 Favored Glycine 0 C--N 1.372 2.564 0 CA-C-O 116.679 -2.178 . . . . 0.56999999999999995 112.69 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.96 -109.67 1.58 Allowed Glycine 0 C--N 1.38 3.008 0 O-C-N 125.409 1.3 . . . . 0.56999999999999995 111.405 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.3 mt -73.77 166.5 2.65 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 N-CA-C 115.332 1.604 . . . . 0.56999999999999995 115.332 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.54 -41.4 2.82 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 119.962 -1.711 . . . . 0.56999999999999995 110.129 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.95 179.9 1.26 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.893 -1.503 . . . . 0.56999999999999995 111.089 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 1.2 p80 -165.78 135.85 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 110.849 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.43 162.51 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.08 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.7 -171.0 1.74 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.337 -0.945 . . . . 0.56999999999999995 111.05 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -145.66 -76.2 0.03 OUTLIER Glycine 0 C--N 1.377 2.843 0 C-N-CA 119.385 -1.388 . . . . 0.56999999999999995 110.551 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.47 75.73 4.91 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.019 1.812 . . . . 0.56999999999999995 111.465 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -148.11 13.97 1.29 Allowed Glycine 0 C--N 1.367 2.288 0 C-N-CA 118.574 -1.774 . . . . 0.56999999999999995 111.926 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 57.28 -93.19 0.04 OUTLIER 'General case' 0 C--N 1.388 2.278 0 O-C-N 125.549 1.382 . . . . 0.56999999999999995 110.424 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -62.56 -71.56 0.8 Allowed Glycine 0 C--N 1.389 3.477 0 CA-C-N 114.69 -1.141 . . . . 0.56999999999999995 112.33 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -31.65 53.79 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 CA-C-O 124.686 2.184 . . . . 0.56999999999999995 108.915 -176.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.76 140.66 43.66 Favored Glycine 0 C--N 1.376 2.787 0 N-CA-C 107.783 -2.127 . . . . 0.56999999999999995 107.783 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.42 -38.84 2.97 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-N 113.869 -1.165 . . . . 0.56999999999999995 113.883 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -48.32 150.97 1.13 Allowed 'General case' 0 C--N 1.392 2.416 0 CA-C-N 113.417 -1.391 . . . . 0.91000000000000003 110.907 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.09 145.86 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -121.68 134.48 54.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.56999999999999995 110.826 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.402 ' CE1' ' HB ' ' A' ' 215' ' ' THR . 29.0 m-85 -103.94 144.28 31.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.892 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 201' ' ' GLU . 0.4 OUTLIER -71.54 75.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -56.65 18.1 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 108.211 -1.033 . . . . 0.91000000000000003 108.211 -175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.4 -45.55 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.903 1.377 . . . . 0.91000000000000003 110.692 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -55.29 172.64 0.13 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 126.669 3.128 . . . . 0.91000000000000003 113.178 177.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.71 102.63 10.67 Favored 'General case' 0 C--N 1.376 1.756 0 CA-C-N 111.975 -2.375 . . . . 0.56999999999999995 114.119 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.433 ' CH2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -92.28 150.36 20.91 Favored 'General case' 0 C--N 1.361 1.1 0 CA-C-N 112.946 -1.934 . . . . 0.56999999999999995 108.675 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.47 122.09 42.79 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 123.751 1.739 . . . . 0.56999999999999995 109.032 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -89.41 131.87 35.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 112.169 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 78.81 -148.33 0.02 OUTLIER 'General case' 0 C--N 1.395 2.572 0 O-C-N 125.362 1.664 . . . . 0.56999999999999995 110.492 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.465 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 1.6 t -60.72 93.27 0.03 OUTLIER 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.612 2.148 . . . . 0.56999999999999995 109.281 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -174.38 -34.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.29 0 CA-C-N 112.359 -2.2 . . . . 0.56999999999999995 113.407 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 141.73 -112.97 0.79 Allowed Glycine 0 C--N 1.387 3.41 0 CA-C-O 123.378 1.543 . . . . 0.56999999999999995 111.81 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.5 p -82.11 117.68 22.47 Favored 'General case' 0 C--N 1.369 1.427 0 CA-C-N 114.27 -0.965 . . . . 0.56999999999999995 110.23 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.75 176.87 4.92 Favored 'General case' 0 C--N 1.374 1.655 0 O-C-N 126.72 2.512 . . . . 0.56999999999999995 110.75 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.55 -33.81 71.53 Favored 'General case' 0 C--N 1.382 2.006 0 CA-C-N 113.803 -1.544 . . . . 0.56999999999999995 107.629 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.452 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 27.5 t80 -57.53 -50.13 74.08 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.376 -1.453 . . . . 0.56999999999999995 110.871 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -51.41 70.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.402 ' HB ' ' CE1' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -68.78 -32.66 72.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 111.098 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.35 -46.12 70.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.56999999999999995 111.058 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 213' ' ' PHE . 20.1 t -63.33 -39.28 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.142 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.95 -46.27 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.879 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 220' ' ' ILE . 3.0 pt-20 -60.91 -44.52 97.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.91000000000000003 110.837 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 219' ' ' GLU . 10.1 pt -71.67 -32.82 46.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.235 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' ' 224' ' ' LEU . . . -65.17 -34.93 90.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.56999999999999995 112.453 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.84 -42.07 97.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.56999999999999995 110.908 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.9 m -70.95 -36.81 72.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.897 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.46 HD23 ' CE1' ' A' ' 149' ' ' PHE . 29.6 mt -40.64 -60.49 1.13 Allowed 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 123.443 1.592 . . . . 0.56999999999999995 112.296 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.48 -30.38 0.17 Allowed Glycine 0 C--N 1.392 3.654 0 C-N-CA 118.403 -1.856 . . . . 0.56999999999999995 112.404 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.81 160.24 22.28 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-N 112.396 -1.902 . . . . 0.56999999999999995 112.558 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.56 -151.93 12.36 Favored Glycine 0 C--N 1.382 3.088 0 CA-C-O 123.96 1.867 . . . . 0.56999999999999995 110.61 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -65.28 -97.81 0.0 OUTLIER 'General case' 0 C--N 1.38 1.911 0 CA-C-N 113.162 -1.519 . . . . 0.56999999999999995 113.484 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.408 ' CB ' ' CB ' ' A' ' 234' ' ' ALA . 97.0 p -174.3 -32.99 0.01 OUTLIER 'General case' 0 C--N 1.373 1.604 0 C-N-CA 118.498 -1.281 . . . . 0.56999999999999995 108.916 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.25 5.2 0.85 Allowed 'General case' 0 C--N 1.401 2.826 0 O-C-N 125.862 1.976 . . . . 0.56999999999999995 114.663 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -135.65 140.51 34.08 Favored Pre-proline 0 C--N 1.382 2.009 0 N-CA-C 104.608 -2.367 . . . . 0.91000000000000003 104.608 -169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.83 17.64 1.6 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 C-N-CA 123.568 2.845 . . . . 0.56999999999999995 113.534 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 -0.29 5.52 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 114.109 -1.405 . . . . 0.56999999999999995 113.729 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.446 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -99.3 124.14 44.16 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.709 1.719 . . . . 0.56999999999999995 112.639 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 248' ' ' PHE . 11.1 t -60.55 87.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.233 0 CA-C-N 113.927 -1.488 . . . . 0.56999999999999995 113.381 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 3.3 mmm 159.62 -23.94 0.0 OUTLIER 'General case' 0 C--N 1.368 1.411 0 O-C-N 125.045 1.466 . . . . 0.56999999999999995 111.77 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 5.3 p90 -51.86 153.87 4.09 Favored Pre-proline 0 C--N 1.369 1.432 0 CA-C-O 123.755 1.74 . . . . 0.56999999999999995 111.999 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.99 -25.22 7.67 Favored 'Trans proline' 0 C--N 1.368 1.596 0 CA-C-O 117.773 -1.011 . . . . 0.56999999999999995 112.304 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.466 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.2 m -41.06 113.67 0.41 Allowed 'General case' 0 C--N 1.368 1.391 0 CA-C-O 124.016 1.865 . . . . 0.56999999999999995 110.337 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 179' ' ' GLY . 4.7 t80 -80.47 106.25 12.34 Favored 'General case' 0 C--N 1.369 1.453 0 N-CA-C 106.241 -1.763 . . . . 0.56999999999999995 106.241 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -154.73 107.56 2.8 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 124.772 2.225 . . . . 0.56999999999999995 107.095 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -61.62 118.03 6.55 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 126.09 2.852 . . . . 0.56999999999999995 111.633 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 2.5 p -101.97 -19.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.05 -1.886 . . . . 0.56999999999999995 112.627 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.465 ' OD2' ' HA ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 72.87 4.59 5.01 Favored 'General case' 0 C--N 1.365 1.277 0 O-C-N 126.303 2.252 . . . . 0.91000000000000003 113.531 -179.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.0 mt 79.59 7.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.376 1.737 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 115.054 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -35.16 73.88 Favored 'General case' 0 C--N 1.39 2.354 0 N-CA-C 105.107 -2.182 . . . . 0.56999999999999995 105.107 -165.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.47 -22.79 8.57 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-N 112.394 -2.185 . . . . 0.56999999999999995 113.087 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.471 ' CE1' HG12 ' A' ' 235' ' ' VAL . 13.2 t80 -40.94 99.85 0.02 OUTLIER 'General case' 0 C--N 1.382 1.994 0 O-C-N 125.729 1.893 . . . . 0.56999999999999995 110.326 -175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.64 147.28 8.63 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 112.189 -2.278 . . . . 1.2 106.946 -171.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.448 ' CD1' ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.99 127.71 55.84 Favored 'General case' 0 C--N 1.372 1.563 0 CA-C-O 124.657 2.17 . . . . 0.56999999999999995 107.511 -173.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.69 158.8 35.5 Favored 'General case' 0 C--N 1.362 1.116 0 O-C-N 120.445 -1.409 . . . . 0.56999999999999995 112.014 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 255' ' ' ILE . . . -56.32 -43.64 79.18 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.289 -1.323 . . . . 0.56999999999999995 109.491 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -41.56 95.11 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.021 0.528 . . . . 0.91000000000000003 110.846 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -63.82 -55.1 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.91000000000000003 110.869 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 252' ' ' ALA . 0.5 OUTLIER -65.94 -35.93 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.134 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.411 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 18.1 mtp85 -70.19 -32.3 70.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.88 -44.83 77.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 0.56999999999999995 112.495 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.483 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.1 pt -66.16 -44.7 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.56999999999999995 111.118 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.483 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -70.77 -20.7 62.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 110.891 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--N 1.36 1.052 0 CA-C-O 123.063 1.411 . . . . 0.56999999999999995 111.35 -178.15 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.051 0 CA-C-O 124.674 2.178 . . . . 1.2 109.034 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.28 -48.75 0.03 OUTLIER 'General case' 0 C--N 1.389 2.284 0 CA-C-N 113.564 -1.653 . . . . 0.56999999999999995 110.838 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.63 -40.03 95.86 Favored 'General case' 0 C--N 1.389 2.291 0 CA-C-N 113.505 -1.68 . . . . 0.56999999999999995 108.35 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.84 103.58 11.57 Favored 'General case' 0 C--N 1.384 2.104 0 O-C-N 125.324 1.64 . . . . 0.56999999999999995 110.88 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.03 154.84 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.158 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -106.03 142.98 34.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.106 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.3 t80 -140.57 160.07 40.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 110.916 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.52 121.84 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.2 110.824 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 mm -99.4 138.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 111.146 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.57 173.59 1.22 Allowed 'General case' 0 C--N 1.363 1.187 0 CA-C-O 124.324 2.011 . . . . 0.56999999999999995 108.944 -176.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.67 73.31 6.38 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 125.166 2.412 . . . . 0.56999999999999995 109.971 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -177.53 2.13 Favored 'General case' 0 C--N 1.374 1.648 0 CA-C-N 112.357 -2.201 . . . . 0.56999999999999995 110.467 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.462 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER 160.56 -53.4 0.0 OUTLIER Pre-proline 0 C--N 1.38 1.912 0 C-N-CA 125.337 1.455 . . . . 0.56999999999999995 107.809 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 122' ' ' THR . 19.0 Cg_endo -75.36 -72.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.406 3.581 0 N-CA-C 108.022 -1.569 . . . . 0.56999999999999995 108.022 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.86 -7.68 57.02 Favored 'General case' 0 C--N 1.398 2.677 0 CA-C-N 113.131 -1.85 . . . . 0.91000000000000003 106.578 -171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 122' ' ' THR . 6.4 mtm -154.42 136.04 14.33 Favored 'General case' 0 C--N 1.386 2.191 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 109.638 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -90.98 141.63 28.63 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-O 123.182 1.468 . . . . 0.56999999999999995 109.328 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -50.11 68.76 Favored 'General case' 0 C--N 1.384 2.076 0 CA-C-N 114.324 -1.307 . . . . 1.2 109.109 -170.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.25 -35.28 69.54 Favored 'General case' 0 C--N 1.374 1.666 0 CA-C-N 111.992 -2.367 . . . . 0.91000000000000003 110.874 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.33 -43.78 69.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.91000000000000003 110.862 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.436 HG13 ' CD1' ' A' ' 212' ' ' LEU . 19.1 t -68.69 -39.74 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.179 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.35 -44.11 97.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.91000000000000003 110.873 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -40.94 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.19 66.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 111.139 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.422 HG23 ' CD1' ' A' ' 212' ' ' LEU . 25.2 pt -62.4 -36.9 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 111.167 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -63.72 -43.74 95.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.853 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -46.06 89.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 110.933 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.09 83.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.56999999999999995 111.082 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 3.7 m-85 -62.95 -44.06 97.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.821 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.461 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.2 pt20 -63.45 -36.21 82.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.971 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 16.0 t -69.64 -34.2 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.123 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.453 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 34.1 m95 -83.05 -34.06 26.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.923 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 m -78.99 -51.08 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.916 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -56.2 -13.96 2.45 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 114.103 1.149 . . . . 0.56999999999999995 114.103 178.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 20.2 m -113.34 -8.77 12.18 Favored 'Isoleucine or valine' 0 C--N 1.389 2.29 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 112.298 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.407 HG22 ' CB ' ' A' ' 259' ' ' GLN . 0.2 OUTLIER -150.47 141.93 15.16 Favored Pre-proline 0 C--N 1.383 2.055 0 CA-C-O 125.379 2.514 . . . . 0.56999999999999995 110.14 -172.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.7 71.21 7.16 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.138 1.892 . . . . 0.56999999999999995 114.593 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.415 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -169.35 83.52 0.13 Allowed 'General case' 0 C--N 1.39 2.328 0 N-CA-C 106.698 -1.593 . . . . 0.56999999999999995 106.698 -168.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -72.37 162.16 29.84 Favored 'General case' 0 C--N 1.383 2.048 0 CA-C-O 125.739 2.685 . . . . 0.56999999999999995 115.672 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' ' O ' ' A' ' 147' ' ' LEU . 2.9 m-85 -136.63 158.9 43.37 Favored 'General case' 0 C--N 1.39 2.354 0 CA-C-N 113.004 -1.907 . . . . 0.56999999999999995 106.09 -172.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -157.48 121.61 4.24 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.879 2.276 . . . . 0.56999999999999995 108.301 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 133.4 37.17 Favored 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.65 -1.613 . . . . 0.56999999999999995 110.513 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.2 pt -107.18 171.95 2.01 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-O 124.214 1.959 . . . . 0.56999999999999995 110.921 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -141.72 51.65 1.53 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 113.482 -1.69 . . . . 0.56999999999999995 110.566 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 p -117.66 -62.59 1.54 Allowed 'General case' 0 C--N 1.384 2.096 0 CA-C-N 113.479 -1.691 . . . . 0.56999999999999995 109.887 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.68 -152.87 5.73 Favored Glycine 0 C--N 1.381 3.028 0 N-CA-C 108.796 -1.722 . . . . 0.56999999999999995 108.796 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.4 ttp -72.11 110.49 6.62 Favored 'General case' 0 C--N 1.386 2.176 0 CA-C-O 123.705 1.716 . . . . 0.56999999999999995 108.246 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -98.19 177.83 5.27 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.058 -1.883 . . . . 0.56999999999999995 111.186 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.96 -59.38 4.91 Favored 'General case' 0 C--N 1.397 2.645 0 CA-C-N 112.456 -2.156 . . . . 0.91000000000000003 105.233 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.438 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 6.3 mt -95.79 111.47 26.22 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 C-N-CA 122.942 0.497 . . . . 0.56999999999999995 111.14 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 162' ' ' VAL . 0.3 OUTLIER -120.01 126.59 51.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.942 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.083 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.405 ' CG2' HD23 ' A' ' 160' ' ' LEU . 3.9 t -133.15 128.94 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 111.134 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -85.0 122.77 29.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.884 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.53 170.14 17.5 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 118.812 -1.155 . . . . 0.56999999999999995 108.636 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.91 167.8 9.72 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.69 -1.595 . . . . 1.2 108.842 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.437 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -38.1 118.91 0.72 Allowed Glycine 0 C--N 1.389 3.497 0 CA-C-N 114.135 -1.393 . . . . 0.56999999999999995 111.956 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 81.37 63.44 0.02 OUTLIER 'General case' 0 C--N 1.417 3.524 0 CA-C-O 125.469 2.557 . . . . 0.56999999999999995 114.117 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 . . . . . 0 C--N 1.386 2.19 0 CA-C-N 113.12 -1.855 . . . . 0.56999999999999995 111.966 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 123.876 1.798 . . . . 0.56999999999999995 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -83.05 -158.98 0.31 Allowed 'General case' 0 C--N 1.388 2.255 0 CA-C-N 112.961 -1.927 . . . . 0.56999999999999995 113.753 173.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.16 173.39 6.32 Favored 'General case' 0 C--N 1.388 2.251 0 CA-C-N 114.627 -1.169 . . . . 0.91000000000000003 111.686 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.51 114.69 0.89 Allowed Glycine 1 C--N 1.4 4.109 0 CA-C-N 111.566 -2.561 . . . . 0.56999999999999995 113.89 166.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.85 82.8 0.15 Allowed 'General case' 0 C--N 1.406 3.037 0 CA-C-O 124.757 2.218 . . . . 0.56999999999999995 113.533 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.51 -155.7 22.05 Favored Glycine 0 C--N 1.376 2.786 0 CA-C-N 114.259 -1.337 . . . . 0.56999999999999995 110.67 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -35.71 149.17 0.03 OUTLIER Glycine 1 C--N 1.403 4.276 0 CA-C-N 113.384 -1.408 . . . . 0.56999999999999995 110.098 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.448 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 89.28 65.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.399 2.731 0 N-CA-C 108.483 -0.932 . . . . 0.56999999999999995 108.483 175.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.461 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 4.3 mp -71.22 -37.45 72.05 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-O 123.448 1.594 . . . . 0.56999999999999995 111.78 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 197' ' ' PHE . . . -174.33 179.84 1.74 Allowed 'General case' 0 C--N 1.364 1.199 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 111.09 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -164.23 142.46 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.874 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.52 23.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 111.111 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.02 -87.1 0.05 OUTLIER 'General case' 0 C--N 1.372 1.562 0 C-N-CA 117.749 -1.58 . . . . 0.56999999999999995 108.699 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 120.12 -61.22 0.51 Allowed Glycine 0 C--N 1.397 3.956 0 C-N-CA 119.848 -1.168 . . . . 0.56999999999999995 112.836 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.91 56.13 5.22 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.142 2.561 . . . . 0.56999999999999995 111.774 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 192' ' ' GLY . . . 47.66 -154.79 1.22 Allowed Glycine 0 C--N 1.39 3.536 0 CA-C-O 123.579 1.655 . . . . 0.56999999999999995 111.265 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.76 57.61 0.01 OUTLIER 'General case' 0 C--N 1.387 2.228 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 106.524 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.79 -88.92 0.37 Allowed Glycine 0 C--N 1.398 3.996 0 O-C-N 120.692 -1.255 . . . . 0.56999999999999995 110.008 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 tp -62.2 0.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.165 0 CA-C-O 124.964 2.316 . . . . 0.56999999999999995 113.854 174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 188' ' ' GLY . . . -73.37 117.21 5.77 Favored Glycine 0 C--N 1.393 3.737 0 C-N-CA 117.384 -2.341 . . . . 0.56999999999999995 107.283 -169.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 109.35 -44.73 1.44 Allowed Glycine 0 C--N 1.373 2.584 0 O-C-N 124.871 0.983 . . . . 0.56999999999999995 114.123 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -50.68 113.4 0.89 Allowed 'General case' 0 C--N 1.385 2.123 0 CA-C-N 115.358 -0.421 . . . . 0.91000000000000003 110.841 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.68 156.82 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 111.111 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -130.17 131.9 45.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.859 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.417 ' CE2' ' CG2' ' A' ' 215' ' ' THR . 2.4 m-85 -104.04 148.51 26.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 110.944 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.0 p-10 -89.97 102.46 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.91000000000000003 110.853 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -36.55 64.42 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 116.912 -1.518 . . . . 0.91000000000000003 109.3 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.5 -40.96 9.09 Favored 'General case' 0 C--N 1.376 1.761 0 O-C-N 125.366 1.666 . . . . 0.91000000000000003 107.507 -163.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.48 -173.28 0.01 OUTLIER 'General case' 0 C--N 1.391 2.378 0 CA-C-O 128.143 3.83 . . . . 0.91000000000000003 114.439 170.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.4 77.44 1.57 Allowed 'General case' 0 C--N 1.379 1.865 0 O-C-N 118.091 -2.88 . . . . 0.56999999999999995 108.941 -172.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.461 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 52.1 m95 -72.82 115.45 12.13 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-O 122.64 1.21 . . . . 0.56999999999999995 108.317 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.3 p -123.89 128.02 48.86 Favored 'General case' 0 C--N 1.384 2.094 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 109.425 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 5.1 p -116.2 105.94 13.14 Favored 'General case' 0 C--N 1.369 1.424 0 CA-C-O 122.939 1.352 . . . . 0.56999999999999995 108.724 -176.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 172.5 -51.94 0.01 OUTLIER 'General case' 0 C--N 1.395 2.568 0 CA-C-N 112.877 -1.965 . . . . 0.56999999999999995 107.099 175.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 158.66 50.72 0.0 OUTLIER 'General case' 0 C--N 1.412 3.316 0 O-C-N 126.315 2.259 . . . . 0.56999999999999995 110.172 -171.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.16 -108.46 2.69 Favored Glycine 0 C--N 1.393 3.74 0 C-N-CA 118.16 -1.972 . . . . 0.56999999999999995 113.681 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.97 -91.49 2.21 Favored Glycine 0 C--N 1.397 3.957 0 CA-C-O 124.857 2.365 . . . . 0.56999999999999995 112.792 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 p -73.89 117.5 15.75 Favored 'General case' 0 C--N 1.384 2.088 0 CA-C-O 123.847 1.784 . . . . 0.56999999999999995 111.454 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -111.15 150.26 29.72 Favored 'General case' 0 C--N 1.388 2.279 0 CA-C-N 112.307 -2.224 . . . . 0.56999999999999995 110.13 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.436 ' CD1' HG13 ' A' ' 130' ' ' VAL . 2.6 tm? -73.45 -32.7 64.51 Favored 'General case' 0 C--N 1.394 2.505 0 CA-C-O 124.412 2.053 . . . . 0.56999999999999995 108.858 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.54 ' CD1' HG12 ' A' ' 245' ' ' ILE . 4.7 t80 -52.28 -50.08 62.84 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 112.678 -2.056 . . . . 0.56999999999999995 110.848 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -43.61 98.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.417 ' CG2' ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -61.27 -49.36 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.56999999999999995 111.19 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.2 73.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.107 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.48 -48.18 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -71.57 -43.21 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.867 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -57.91 -42.14 84.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.91000000000000003 110.877 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.453 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 57.7 mt -69.61 -39.78 78.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.56999999999999995 111.187 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.46 -33.78 85.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.465 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.44 ' N ' ' CE ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -63.85 -44.28 93.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.353 . . . . 0.56999999999999995 110.813 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' LEU . 71.1 m -71.27 -44.5 65.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 110.864 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 223' ' ' SER . 0.7 OUTLIER -36.38 -47.79 0.62 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 119.771 -0.772 . . . . 0.56999999999999995 112.557 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.13 -106.47 0.22 Allowed Glycine 1 C--N 1.398 4.026 0 O-C-N 126.699 2.499 . . . . 0.56999999999999995 112.061 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.01 172.78 0.01 OUTLIER 'General case' 0 C--N 1.395 2.559 0 CA-C-O 125.726 2.679 . . . . 0.56999999999999995 112.554 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.35 -120.91 0.02 OUTLIER Glycine 0 C--N 1.392 3.665 0 CA-C-O 126.133 3.074 . . . . 0.56999999999999995 110.677 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -123.96 -76.19 0.59 Allowed 'General case' 0 C--N 1.391 2.382 0 CA-C-N 112.258 -1.971 . . . . 0.56999999999999995 108.375 -174.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.36 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.754 -1.567 . . . . 0.56999999999999995 108.373 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.06 23.48 0.31 Allowed 'General case' 0 C--N 1.422 3.727 0 N-CA-C 118.925 2.935 . . . . 0.56999999999999995 118.925 -171.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -137.65 143.29 39.96 Favored Pre-proline 0 C--N 1.398 2.703 0 C-N-CA 116.348 -2.141 . . . . 0.91000000000000003 106.086 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.545 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 71.7 Cg_exo -54.97 -41.11 81.94 Favored 'Trans proline' 0 C--N 1.375 1.93 0 CA-C-O 124.724 1.885 . . . . 0.56999999999999995 114.09 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -41.91 86.18 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-N 111.61 -2.541 . . . . 0.56999999999999995 113.492 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -50.82 125.21 12.79 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-O 125.317 2.484 . . . . 0.56999999999999995 111.82 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -76.03 -1.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.386 2.154 0 CA-C-N 112.473 -2.149 . . . . 0.56999999999999995 112.504 -177.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.44 ' CE ' ' N ' ' A' ' 222' ' ' HIS . 0.8 OUTLIER -124.62 -5.49 7.58 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-N 114.056 -1.429 . . . . 0.56999999999999995 109.03 -177.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -40.57 148.2 0.36 Allowed Pre-proline 0 C--N 1.376 1.753 0 CA-C-O 125.22 2.438 . . . . 0.56999999999999995 113.951 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.57 -48.85 19.68 Favored 'Trans proline' 0 C--N 1.381 2.289 0 O-C-N 118.824 -1.198 . . . . 0.56999999999999995 113.7 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.485 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -51.74 135.13 29.82 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-O 125.012 2.339 . . . . 0.56999999999999995 110.959 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.66 142.57 34.09 Favored 'General case' 0 C--N 1.386 2.154 0 CA-C-O 123.106 1.431 . . . . 0.56999999999999995 107.362 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -158.28 114.56 2.77 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-O 124.515 2.102 . . . . 0.56999999999999995 108.453 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -55.25 118.57 4.5 Favored 'General case' 0 C--N 1.368 1.398 0 CA-C-O 126.433 3.016 . . . . 0.56999999999999995 108.861 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.488 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 2.6 p -125.41 -13.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 CA-C-N 112.498 -2.137 . . . . 0.56999999999999995 111.062 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.266 0.7 OUTLIER 70.53 4.36 4.92 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-O 123.153 1.454 . . . . 0.91000000000000003 112.811 176.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.0 mt 77.88 4.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.394 2.533 0 CA-C-N 113.347 -1.751 . . . . 0.56999999999999995 114.315 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.11 -33.17 69.89 Favored 'General case' 0 C--N 1.379 1.85 0 N-CA-C 104.593 -2.373 . . . . 0.56999999999999995 104.593 -163.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.7 -16.65 12.74 Favored 'General case' 0 C--N 1.39 2.365 0 CA-C-N 112.739 -2.028 . . . . 0.56999999999999995 113.107 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.443 ' CD1' HG22 ' A' ' 235' ' ' VAL . 19.2 t80 -38.86 99.46 0.02 OUTLIER 'General case' 0 C--N 1.388 2.28 0 CA-C-O 126.034 2.826 . . . . 0.56999999999999995 109.319 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -133.09 149.12 52.16 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-N 112.18 -2.282 . . . . 1.2 105.374 -175.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.441 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -118.09 130.38 56.11 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 126.7 3.143 . . . . 0.56999999999999995 107.325 -173.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.87 145.43 42.75 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 117.99 -2.944 . . . . 0.56999999999999995 110.606 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.05 86.43 Favored 'General case' 0 C--N 1.4 2.797 0 CA-C-N 113.676 -1.602 . . . . 0.56999999999999995 110.416 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -35.74 81.1 Favored 'General case' 0 C--N 1.367 1.342 0 CA-C-N 114.874 -1.057 . . . . 0.91000000000000003 110.802 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.36 -55.29 25.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.91000000000000003 110.854 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.0 pt -66.04 -36.56 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.168 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 34.7 mtt180 -70.3 -34.1 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 1.2 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.29 -47.52 79.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.56999999999999995 112.511 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.498 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.2 pt -64.35 -45.46 95.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.56999999999999995 111.163 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.498 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.3 -21.03 61.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.933 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.369 1.435 0 CA-C-O 125.154 2.407 . . . . 0.56999999999999995 110.22 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 123.712 1.72 . . . . 1.2 109.368 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.53 -49.84 0.02 OUTLIER 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.851 -1.522 . . . . 0.56999999999999995 110.646 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -98.21 -8.55 27.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 112.98 -1.918 . . . . 0.56999999999999995 111.091 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -114.56 112.76 23.45 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.169 -0.923 . . . . 0.56999999999999995 110.872 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.11 138.19 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.119 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.26 135.27 50.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.56999999999999995 111.109 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -129.81 150.9 50.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.888 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -143.52 129.88 19.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.2 110.903 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mm -99.03 130.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.169 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -118.89 131.67 56.07 Favored 'General case' 0 C--N 1.368 1.385 0 N-CA-C 107.636 -1.246 . . . . 0.56999999999999995 107.636 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.3 t30 50.41 81.13 0.07 Allowed 'General case' 0 C--N 1.391 2.401 0 O-C-N 126.527 2.392 . . . . 0.56999999999999995 109.587 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 163' ' ' PHE . 22.6 m-85 -37.73 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.391 2.395 0 O-C-N 126.721 2.513 . . . . 0.56999999999999995 109.514 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.0 135.14 0.16 Allowed Pre-proline 0 C--N 1.371 1.522 0 C-N-CA 118.285 -1.366 . . . . 0.56999999999999995 108.355 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.17 -52.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-O 122.341 0.892 . . . . 0.56999999999999995 110.938 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -77.22 -33.29 56.19 Favored 'General case' 0 C--N 1.388 2.256 0 CA-C-N 113.937 -1.483 . . . . 0.91000000000000003 114.486 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.38 134.24 37.09 Favored 'General case' 0 C--N 1.374 1.663 0 CA-C-O 125.747 2.689 . . . . 0.56999999999999995 106.002 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.53 139.7 53.83 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 110.555 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -48.63 37.6 Favored 'General case' 0 C--N 1.378 1.821 0 N-CA-C 106.918 -1.512 . . . . 1.2 106.918 -169.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -35.26 62.33 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.788 -2.005 . . . . 0.91000000000000003 110.89 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.04 -43.15 71.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.91000000000000003 110.869 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.42 -37.94 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.56999999999999995 111.082 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -40.36 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.91000000000000003 110.847 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' CE ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -65.29 -41.8 93.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.56999999999999995 110.877 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.23 -49.12 73.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 111.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.7 pt -62.55 -40.16 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -60.59 -43.39 97.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 1.2 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -62.92 -43.4 98.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.873 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.65 91.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.117 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.488 ' CE1' ' CE2' ' A' ' 116' ' ' TYR . 17.3 m-85 -67.17 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.917 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.436 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.7 OUTLIER -67.66 -40.49 84.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.56999999999999995 110.909 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 5.0 p -71.46 -33.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.16 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.464 ' O ' ' CG2' ' A' ' 145' ' ' THR . 5.1 m95 -82.59 -34.04 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 m -79.21 -49.18 12.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.56999999999999995 110.817 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.36 -13.3 7.79 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-O 121.804 0.811 . . . . 0.56999999999999995 112.564 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 19.8 m -113.91 12.77 8.19 Favored 'Isoleucine or valine' 0 C--N 1.382 2.022 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.028 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 29.5 p -148.03 146.75 24.46 Favored Pre-proline 0 N--CA 1.428 -1.544 0 CA-C-O 124.132 1.92 . . . . 0.56999999999999995 109.197 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.86 8.74 3.59 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.285 1.323 . . . . 0.56999999999999995 114.449 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.51 110.76 21.13 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 109.117 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.92 158.56 35.24 Favored 'General case' 0 C--N 1.382 1.999 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 114.778 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 15.6 m-30 -126.5 151.37 47.92 Favored 'General case' 0 C--N 1.389 2.314 0 CA-C-N 112.788 -2.005 . . . . 0.56999999999999995 108.675 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.99 110.99 2.66 Favored 'General case' 0 C--N 1.39 2.364 0 CA-C-O 124.653 2.168 . . . . 0.56999999999999995 108.302 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -95.2 133.41 39.08 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 113.776 -1.556 . . . . 0.56999999999999995 110.254 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.14 173.78 4.08 Favored 'Isoleucine or valine' 0 C--N 1.372 1.562 0 CA-C-O 124.175 1.941 . . . . 0.56999999999999995 109.957 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -127.2 -2.03 6.37 Favored 'General case' 0 C--N 1.384 2.067 0 CA-C-N 113.175 -1.83 . . . . 0.56999999999999995 112.687 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 m -136.72 89.4 2.45 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 114.583 -1.189 . . . . 0.56999999999999995 108.067 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.29 99.69 1.32 Allowed Glycine 0 C--N 1.386 3.36 0 C-N-CA 118.956 -1.592 . . . . 0.56999999999999995 110.513 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.4 ttp -42.95 118.35 1.25 Allowed 'General case' 0 C--N 1.377 1.804 0 CA-C-O 122.56 1.172 . . . . 0.56999999999999995 111.3 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.34 169.79 9.82 Favored 'General case' 0 C--N 1.381 1.957 0 CA-C-N 113.025 -1.898 . . . . 0.56999999999999995 109.517 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -54.45 23.29 Favored 'General case' 0 C--N 1.386 2.179 0 CA-C-N 113.501 -1.681 . . . . 0.91000000000000003 110.586 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.542 HD12 ' CE2' ' A' ' 116' ' ' TYR . 3.5 mt -90.64 109.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.385 2.143 0 O-C-N 127.846 3.216 . . . . 0.56999999999999995 111.127 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -107.98 129.45 55.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.856 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.98 116.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.56999999999999995 111.08 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -133.47 124.88 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.109 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -93.7 121.42 35.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.876 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -145.33 168.01 21.5 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 123.701 1.715 . . . . 0.56999999999999995 108.51 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 160.28 16.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.592 -1.262 . . . . 1.2 107.592 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -39.28 93.87 0.01 OUTLIER Glycine 0 C--N 1.385 3.26 0 O-C-N 125.894 1.997 . . . . 0.56999999999999995 117.401 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 154.31 45.57 0.0 OUTLIER 'General case' 0 C--N 1.405 2.982 0 CA-C-O 125.734 2.683 . . . . 0.56999999999999995 112.898 -165.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 . . . . . 0 C--N 1.38 1.899 0 CA-C-N 113.416 -1.72 . . . . 0.56999999999999995 109.874 178.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.211 -1.033 . . . . 0.56999999999999995 108.211 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.532 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.5 OUTLIER -50.64 168.54 0.05 OUTLIER 'General case' 0 C--N 1.388 2.277 0 O-C-N 126.7 2.5 . . . . 0.56999999999999995 107.152 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.411 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -44.57 163.21 0.02 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 117.904 -1.518 . . . . 0.91000000000000003 112.969 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.53 48.25 0.6 Allowed Glycine 0 C--N 1.388 3.458 0 C-N-CA 117.287 -2.387 . . . . 0.56999999999999995 111.815 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -168.66 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.389 2.323 0 C-N-CA 118.868 -1.133 . . . . 0.56999999999999995 111.336 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -165.3 -61.65 0.02 OUTLIER Glycine 0 C--N 1.392 3.663 0 CA-C-O 125.014 2.452 . . . . 0.56999999999999995 112.852 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -42.84 147.16 0.75 Allowed Glycine 0 C--N 1.376 2.802 0 O-C-N 118.963 -2.493 . . . . 0.56999999999999995 110.24 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.532 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 1.6 mt 84.75 49.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.951 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 9.9 tp -42.94 -41.72 3.46 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.876 2.274 . . . . 0.56999999999999995 111.345 -172.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 179.84 -174.31 0.25 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 112.415 -2.175 . . . . 0.56999999999999995 111.047 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.497 ' N ' ' HD1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -143.95 158.59 43.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.879 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.409 ' HB1' ' CB ' ' A' ' 222' ' ' HIS . . . -151.02 155.19 38.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 0.56999999999999995 111.087 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.44 -179.52 3.75 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 105.249 -2.13 . . . . 0.56999999999999995 105.249 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' O ' ' CA ' ' A' ' 192' ' ' GLY . . . -122.15 -160.11 10.85 Favored Glycine 0 C--N 1.382 3.101 0 C-N-CA 119.795 -1.193 . . . . 0.56999999999999995 111.493 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.44 -65.94 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.831 1.687 . . . . 0.56999999999999995 112.508 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.44 -104.87 0.07 OUTLIER Glycine 0 C--N 1.395 3.858 0 O-C-N 125.605 1.816 . . . . 0.56999999999999995 110.537 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.72 129.3 0.04 OUTLIER 'General case' 0 C--N 1.393 2.478 0 CA-C-N 112.794 -1.703 . . . . 0.56999999999999995 108.886 175.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -95.86 1.64 Allowed Glycine 0 C--N 1.388 3.445 0 CA-C-O 122.773 1.207 . . . . 0.56999999999999995 110.697 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.3 tp -66.85 -11.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.394 2.541 0 CA-C-O 126.845 3.212 . . . . 0.56999999999999995 110.745 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 186' ' ' GLY . . . -66.71 134.34 32.53 Favored Glycine 0 C--N 1.377 2.827 0 N-CA-C 107.12 -2.392 . . . . 0.56999999999999995 107.12 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.49 -4.68 64.35 Favored Glycine 0 C--N 1.375 2.704 0 N-CA-C 110.169 -1.172 . . . . 0.56999999999999995 110.169 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.78 141.25 39.35 Favored 'General case' 0 C--N 1.378 1.841 0 CA-C-N 114.221 -0.99 . . . . 0.91000000000000003 110.872 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.03 132.63 22.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.098 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -126.52 143.2 51.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.89 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.527 ' CD2' ' CD1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.55 148.38 26.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.685 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.8 p-10 -81.12 87.89 6.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.91000000000000003 110.854 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -74.26 5.49 4.45 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.615 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.77 -35.13 44.98 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-O 123.328 1.537 . . . . 0.91000000000000003 109.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -73.76 176.87 5.9 Favored 'General case' 0 C--N 1.382 1.998 0 CA-C-O 124.289 1.995 . . . . 0.91000000000000003 108.965 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.53 111.11 23.09 Favored 'General case' 0 C--N 1.391 2.398 0 CA-C-N 112.642 -2.072 . . . . 0.56999999999999995 112.992 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -92.62 148.0 22.42 Favored 'General case' 0 C--N 1.382 2.017 0 CA-C-N 113.144 -1.844 . . . . 0.56999999999999995 108.495 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -121.28 104.21 9.55 Favored 'General case' 0 C--N 1.384 2.069 0 CA-C-N 114.143 -1.39 . . . . 0.56999999999999995 107.806 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -103.02 106.91 17.53 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 115.499 -0.773 . . . . 0.56999999999999995 109.864 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 205' ' ' THR . 2.0 t60 169.1 -70.71 0.0 OUTLIER 'General case' 0 C--N 1.392 2.429 0 N-CA-C 106.944 -1.502 . . . . 0.56999999999999995 106.944 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.413 ' C ' ' OD2' ' A' ' 244' ' ' ASP . 4.7 p 150.75 63.19 0.0 OUTLIER 'General case' 0 C--N 1.399 2.731 0 CA-C-O 127.412 3.482 . . . . 0.56999999999999995 110.325 -166.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.18 29.58 0.11 Allowed Glycine 0 C--N 1.394 3.803 0 C-N-CA 116.964 -2.541 . . . . 0.56999999999999995 113.136 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.6 -162.32 35.81 Favored Glycine 0 C--N 1.383 3.144 0 CA-C-O 124.234 2.019 . . . . 0.56999999999999995 110.873 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 122.26 24.71 Favored 'General case' 0 C--N 1.372 1.58 0 CA-C-O 123.478 1.608 . . . . 0.56999999999999995 107.761 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -121.01 -167.77 1.55 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-N 112.84 -1.982 . . . . 0.56999999999999995 111.039 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.2 -33.54 71.83 Favored 'General case' 0 C--N 1.392 2.436 0 CA-C-N 112.901 -1.954 . . . . 0.56999999999999995 109.541 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 9.8 t80 -51.75 -50.15 61.21 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.909 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -51.02 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 110.948 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.4 m -58.95 -35.65 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.17 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.44 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -67.2 -41.53 85.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.097 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.15 -46.46 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.094 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -72.36 -49.91 30.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.762 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -57.66 -42.5 83.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.91000000000000003 110.927 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 216' ' ' ALA . 60.7 mt -70.32 -43.32 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.442 ' HA2' ' CD1' ' A' ' 224' ' ' LEU . . . -56.82 -33.93 64.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.56999999999999995 112.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.409 ' CB ' ' HB1' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -63.75 -41.09 98.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.749 0.309 . . . . 0.56999999999999995 110.823 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.26 -44.36 65.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.867 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 149' ' ' PHE . 84.3 mt -42.89 -62.54 0.99 Allowed 'General case' 0 C--N 1.365 1.248 0 CA-C-O 123.829 1.776 . . . . 0.56999999999999995 112.148 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 169.6 134.65 1.77 Allowed Glycine 0 C--N 1.374 2.694 0 N-CA-C 107.774 -2.131 . . . . 0.56999999999999995 107.774 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 78.85 -170.54 0.05 OUTLIER 'General case' 0 C--N 1.393 2.494 0 CA-C-O 124.329 2.014 . . . . 0.56999999999999995 109.524 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.21 -154.63 10.66 Favored Glycine 0 C--N 1.386 3.318 0 CA-C-O 125.728 2.849 . . . . 0.56999999999999995 112.86 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -93.95 -178.97 4.82 Favored 'General case' 0 C--N 1.376 1.722 0 CA-C-N 111.217 -2.491 . . . . 0.56999999999999995 110.717 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.2 p -72.24 -31.59 65.96 Favored 'General case' 0 C--N 1.387 2.236 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 109.187 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 82.8 23.59 0.17 Allowed 'General case' 0 C--N 1.399 2.734 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.41 151.01 35.69 Favored Pre-proline 0 C--N 1.383 2.027 0 N-CA-C 105.361 -2.089 . . . . 0.91000000000000003 105.361 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.34 75.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 124.826 3.684 . . . . 0.56999999999999995 113.871 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 178.42 -33.56 0.01 OUTLIER 'General case' 0 C--N 1.374 1.644 0 CA-C-N 113.814 -1.539 . . . . 0.56999999999999995 112.722 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.12 149.05 33.86 Favored 'General case' 0 C--N 1.382 2.02 0 CA-C-N 113.619 -1.628 . . . . 0.56999999999999995 107.854 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -0.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.099 0 CA-C-N 113.052 -1.885 . . . . 0.56999999999999995 112.959 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.442 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -160.1 28.53 0.17 Allowed 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 113.137 -1.847 . . . . 0.56999999999999995 109.885 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -48.64 147.41 4.33 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 123.866 1.793 . . . . 0.56999999999999995 113.023 176.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 72.5 Cg_exo -55.49 -50.15 13.72 Favored 'Trans proline' 0 C--N 1.373 1.824 0 O-C-N 118.875 -1.171 . . . . 0.56999999999999995 112.44 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.462 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.3 OUTLIER -50.18 125.4 12.27 Favored 'General case' 0 C--N 1.368 1.382 0 CA-C-O 123.989 1.852 . . . . 0.56999999999999995 110.553 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -81.34 144.96 31.11 Favored 'General case' 0 C--N 1.369 1.435 0 O-C-N 119.894 -1.754 . . . . 0.56999999999999995 108.232 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 242' ' ' TYR . 0.8 OUTLIER -175.29 121.3 0.2 Allowed 'General case' 0 C--N 1.388 2.27 0 CA-C-O 124.187 1.946 . . . . 0.56999999999999995 107.556 173.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 241' ' ' LYS . 25.9 p90 -68.86 132.85 47.42 Favored 'General case' 0 C--N 1.368 1.393 0 CA-C-O 125.761 2.696 . . . . 0.56999999999999995 109.704 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.75 -16.88 7.82 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 O-C-N 119.759 -1.838 . . . . 0.56999999999999995 113.353 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . 0.413 ' OD2' ' C ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 79.18 -8.15 1.66 Allowed 'General case' 0 C--N 1.376 1.736 0 O-C-N 125.077 1.486 . . . . 0.91000000000000003 114.393 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.8 mt 81.68 18.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.381 1.978 0 CA-C-N 114.028 -1.442 . . . . 0.56999999999999995 112.524 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' CB ' ' OD1' ' A' ' 244' ' ' ASP . 1.6 t-20 -84.22 -28.57 27.18 Favored 'General case' 0 C--N 1.391 2.381 0 C-N-CA 114.057 -3.057 . . . . 0.56999999999999995 103.11 -165.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.0 p -119.04 -6.84 10.45 Favored 'General case' 0 C--N 1.389 2.311 0 CA-C-N 112.603 -2.089 . . . . 0.56999999999999995 112.237 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -38.09 97.33 0.01 OUTLIER 'General case' 0 C--N 1.384 2.068 0 CA-C-O 125.059 2.362 . . . . 0.56999999999999995 110.588 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.481 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -134.58 151.72 51.28 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.665 -2.061 . . . . 1.2 105.46 -174.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.481 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -118.43 128.94 55.09 Favored 'General case' 0 C--N 1.376 1.76 0 CA-C-O 126.142 2.877 . . . . 0.56999999999999995 108.337 -172.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.6 t -73.23 136.24 44.62 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.363 -2.711 . . . . 0.56999999999999995 109.947 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.78 76.63 Favored 'General case' 0 C--N 1.388 2.244 0 CA-C-N 113.996 -1.456 . . . . 0.56999999999999995 109.094 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.07 -41.25 92.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.257 0.623 . . . . 0.91000000000000003 110.917 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.03 -55.12 24.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.838 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.12 -35.28 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.089 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.418 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 3.4 mtp85 -70.42 -34.08 72.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.2 110.86 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.18 -46.94 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.56999999999999995 112.446 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.492 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.1 pt -64.48 -44.78 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.56999999999999995 111.172 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.492 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.19 -21.0 61.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.952 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--N 1.363 1.168 0 CA-C-O 122.227 1.013 . . . . 0.56999999999999995 109.533 -178.091 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 . . . . . 0 C--O 1.237 0.417 0 N-CA-C 106.949 -1.5 . . . . 1.2 106.949 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.29 121.22 0.04 OUTLIER 'General case' 0 C--N 1.4 2.794 0 CA-C-N 114.106 -1.407 . . . . 0.56999999999999995 111.456 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 77.47 -59.57 0.46 Allowed 'General case' 0 C--N 1.391 2.4 0 CA-C-N 114.585 -1.189 . . . . 0.56999999999999995 112.325 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.14 125.34 53.68 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-N 114.64 -1.163 . . . . 0.56999999999999995 110.875 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 154.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.106 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.9 p -119.96 160.07 23.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.56999999999999995 111.103 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 3.0 t80 -147.07 152.88 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.933 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.566 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.97 122.0 14.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.852 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -98.97 126.32 52.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.097 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -174.36 0.02 OUTLIER 'General case' 0 C--N 1.366 1.307 0 CA-C-O 124.873 2.273 . . . . 0.56999999999999995 108.963 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -76.36 48.58 0.54 Allowed 'General case' 0 C--N 1.369 1.427 0 O-C-N 120.216 -1.552 . . . . 0.56999999999999995 111.676 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 48.4 -148.24 0.22 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 122.467 1.127 . . . . 0.56999999999999995 108.221 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.8 167.13 8.19 Favored Pre-proline 0 C--N 1.38 1.892 0 CA-C-N 113.703 -1.59 . . . . 0.56999999999999995 108.839 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.39 -47.07 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 CA-C-O 122.673 1.03 . . . . 0.56999999999999995 112.906 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 4.5 p-10 -71.92 -38.71 69.84 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 113.658 -1.61 . . . . 0.91000000000000003 114.249 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 110.67 21.47 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-O 125.427 2.537 . . . . 0.56999999999999995 109.751 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.88 143.53 49.35 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 112.399 -2.182 . . . . 0.56999999999999995 108.558 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -49.33 59.94 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 114.18 -1.373 . . . . 1.2 107.529 -168.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.83 -34.74 63.19 Favored 'General case' 0 C--N 1.394 2.523 0 CA-C-N 112.586 -2.097 . . . . 0.91000000000000003 110.903 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.25 -43.44 70.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.91000000000000003 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.2 t -63.39 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.56999999999999995 111.149 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.19 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.91000000000000003 110.906 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.97 -49.0 79.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.937 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.22 87.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.065 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 1.1 mm -66.77 -31.91 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.116 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -66.2 -47.85 72.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.849 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -40.35 97.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.898 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.88 94.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.082 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -67.19 -33.77 76.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.914 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.453 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -68.55 -42.12 78.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.56999999999999995 110.909 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.46 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 5.7 p -69.69 -34.25 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.112 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -82.94 -34.04 26.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 110.898 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.1 m -79.2 -49.58 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.901 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -58.68 -13.02 4.85 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 121.837 0.827 . . . . 0.56999999999999995 113.104 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 21.4 m -114.01 12.03 8.11 Favored 'Isoleucine or valine' 0 C--N 1.391 2.375 0 CA-C-N 114.118 -1.401 . . . . 0.56999999999999995 111.943 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.2 p -150.76 145.04 17.85 Favored Pre-proline 0 C--N 1.381 1.953 0 CA-C-O 125.405 2.526 . . . . 0.56999999999999995 108.619 -172.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.22 -24.27 9.6 Favored 'Trans proline' 0 C--N 1.37 1.679 0 O-C-N 118.344 -1.451 . . . . 0.56999999999999995 111.891 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.35 102.87 11.52 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 111.176 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.11 162.45 28.97 Favored 'General case' 0 C--N 1.382 1.991 0 CA-C-O 124.108 1.909 . . . . 0.56999999999999995 114.099 171.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -135.6 160.7 37.67 Favored 'General case' 0 C--N 1.392 2.433 0 CA-C-N 112.466 -2.152 . . . . 0.56999999999999995 107.007 -172.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 m -160.3 122.34 3.22 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 125.177 2.418 . . . . 0.56999999999999995 107.353 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -92.65 135.93 33.66 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.493 -1.685 . . . . 0.56999999999999995 110.364 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.35 177.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.755 0 CA-C-O 124.254 1.978 . . . . 0.56999999999999995 110.195 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -104.18 -38.76 6.77 Favored 'General case' 0 C--N 1.386 2.161 0 CA-C-N 112.581 -2.1 . . . . 0.56999999999999995 112.401 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.4 p -130.25 133.27 46.39 Favored 'General case' 0 C--N 1.379 1.852 0 CA-C-O 122.409 1.099 . . . . 0.56999999999999995 108.929 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.09 169.59 15.54 Favored Glycine 0 C--N 1.386 3.334 0 CA-C-O 123.864 1.813 . . . . 0.56999999999999995 112.389 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.1 ttt -80.72 139.15 36.27 Favored 'General case' 0 C--N 1.389 2.292 0 CA-C-N 112.114 -2.043 . . . . 0.56999999999999995 109.551 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.71 173.23 11.35 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-N 112.446 -2.161 . . . . 0.56999999999999995 111.144 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.9 -59.33 2.53 Favored 'General case' 0 C--N 1.385 2.12 0 N-CA-C 103.501 -2.778 . . . . 0.91000000000000003 103.501 -168.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 220' ' ' ILE . 5.6 mt -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 C--N 1.389 2.288 0 O-C-N 125.064 1.478 . . . . 0.56999999999999995 111.15 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 195' ' ' ALA . 0.3 OUTLIER -99.21 128.44 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.884 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.59 119.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.086 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.72 125.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.087 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.51 122.76 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.86 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 199' ' ' GLU . . . -142.66 167.94 20.9 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-O 123.258 1.504 . . . . 0.56999999999999995 107.12 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CD ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -112.48 135.63 52.95 Favored 'General case' 0 C--N 1.369 1.437 0 CA-C-N 114.097 -1.411 . . . . 1.2 109.775 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.13 -133.86 28.27 Favored Glycine 0 C--N 1.397 3.919 0 CA-C-O 124.913 2.396 . . . . 0.56999999999999995 109.562 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.39 135.18 39.69 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 111.496 -2.352 . . . . 0.56999999999999995 113.799 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 . . . . . 0 C--N 1.398 2.683 0 CA-C-N 113.533 -1.667 . . . . 0.56999999999999995 107.096 -171.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 122.931 1.348 . . . . 0.56999999999999995 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -98.97 -157.08 0.58 Allowed 'General case' 0 C--N 1.384 2.074 0 CA-C-N 112.776 -2.011 . . . . 0.56999999999999995 111.253 175.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.46 -77.52 0.1 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.475 -1.693 . . . . 0.91000000000000003 112.267 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.45 16.43 Favored Glycine 0 C--N 1.385 3.266 0 C-N-CA 120.882 -0.675 . . . . 0.56999999999999995 113.757 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 160.38 40.88 0.0 OUTLIER 'General case' 0 C--N 1.399 2.759 0 CA-C-O 124.183 1.944 . . . . 0.56999999999999995 112.341 -170.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.414 ' HA2' ' OE1' ' A' ' 201' ' ' GLU . . . 116.02 -156.79 15.42 Favored Glycine 0 C--N 1.37 2.446 0 N-CA-C 107.009 -2.436 . . . . 0.56999999999999995 107.009 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.45 -39.84 2.54 Favored Glycine 0 C--N 1.367 2.265 0 O-C-N 120.268 -1.725 . . . . 0.56999999999999995 113.989 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -152.56 167.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.86 0 N-CA-C 105.294 -2.113 . . . . 0.56999999999999995 105.294 -172.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 210' ' ' THR . 66.9 mt -118.77 -80.6 0.62 Allowed 'General case' 0 C--N 1.374 1.673 0 O-C-N 126.684 2.49 . . . . 0.56999999999999995 114.77 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -107.65 179.5 4.22 Favored 'General case' 0 C--N 1.377 1.765 0 CA-C-N 115.356 -0.838 . . . . 0.56999999999999995 111.112 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER -169.24 135.9 1.72 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.904 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.05 161.97 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.151 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -171.22 2.85 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.029 1.395 . . . . 0.56999999999999995 110.846 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.91 -159.11 35.16 Favored Glycine 0 C--N 1.385 3.275 0 CA-C-N 114.001 -1.454 . . . . 0.56999999999999995 112.838 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.42 74.28 3.74 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 110.068 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.76 -134.86 6.95 Favored Glycine 0 C--N 1.376 2.798 0 CA-C-O 124.067 1.926 . . . . 0.56999999999999995 110.155 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.26 -80.08 0.6 Allowed 'General case' 0 C--N 1.396 2.604 0 CA-C-N 112.909 -1.645 . . . . 0.56999999999999995 108.938 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.99 -54.76 2.11 Favored Glycine 1 C--N 1.398 4.006 0 N-CA-C 108.252 -1.939 . . . . 0.56999999999999995 108.252 -174.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -44.37 99.47 Favored 'Isoleucine or valine' 0 C--N 1.396 2.625 0 CA-C-N 113.38 -1.41 . . . . 0.56999999999999995 107.615 -173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.52 136.44 43.89 Favored Glycine 0 C--N 1.395 3.835 0 N-CA-C 106.89 -2.484 . . . . 0.56999999999999995 106.89 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.62 -41.54 2.11 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-N 113.33 -1.435 . . . . 0.56999999999999995 113.531 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.83 97.16 0.1 Allowed 'General case' 0 C--N 1.39 2.343 0 CA-C-N 115.096 -0.552 . . . . 0.91000000000000003 110.921 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -102.95 148.29 25.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.08 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -129.37 151.27 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.895 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.49 ' HB2' ' CH2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -123.59 150.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.897 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.577 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 2.8 p30 -79.39 83.19 5.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.91000000000000003 110.833 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 164' ' ' ALA . 11.7 tp10 -57.1 -32.52 66.39 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 117.72 -1.133 . . . . 0.91000000000000003 110.349 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -41.98 -51.41 4.44 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 125.768 1.918 . . . . 0.91000000000000003 110.429 -173.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 178' ' ' GLY . 0.7 OUTLIER -58.25 -173.87 0.01 OUTLIER 'General case' 0 C--N 1.392 2.434 0 CA-C-O 127.766 3.65 . . . . 0.91000000000000003 113.045 175.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 122.59 46.71 Favored 'General case' 0 C--N 1.382 2.019 0 O-C-N 119.125 -2.234 . . . . 0.56999999999999995 113.078 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 197' ' ' PHE . 26.1 m0 -96.39 123.85 40.18 Favored 'General case' 0 C--N 1.391 2.383 0 N-CA-C 105.262 -2.125 . . . . 0.56999999999999995 105.262 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.401 ' HG1' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -82.46 102.61 11.44 Favored 'General case' 0 C--N 1.374 1.649 0 CA-C-O 126.235 2.921 . . . . 0.56999999999999995 112.136 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.8 p -102.09 120.59 40.68 Favored 'General case' 0 C--N 1.376 1.739 0 O-C-N 119.564 -1.96 . . . . 0.56999999999999995 108.904 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 65.86 66.63 0.5 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-O 123.958 1.837 . . . . 0.56999999999999995 109.673 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.98 -72.14 0.01 OUTLIER 'General case' 0 C--N 1.397 2.661 0 CA-C-O 123.522 1.629 . . . . 0.56999999999999995 109.334 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.81 -145.92 5.2 Favored Glycine 0 C--N 1.385 3.263 0 N-CA-C 108.262 -1.935 . . . . 0.56999999999999995 108.262 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 47.06 -146.56 3.75 Favored Glycine 0 C--N 1.383 3.18 0 CA-C-O 127.134 3.63 . . . . 0.56999999999999995 110.095 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.437 ' CG2' HD21 ' A' ' 181' ' ' LEU . 8.3 p -77.77 124.34 27.84 Favored 'General case' 0 C--N 1.368 1.378 0 O-C-N 119.983 -1.892 . . . . 0.56999999999999995 112.331 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.86 155.97 28.12 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-N 114.815 -1.084 . . . . 0.56999999999999995 109.435 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.87 -32.93 74.73 Favored 'General case' 0 C--N 1.393 2.491 0 CA-C-O 124.22 1.962 . . . . 0.56999999999999995 107.641 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 245' ' ' ILE . 27.5 t80 -57.55 -50.0 74.53 Favored 'General case' 0 C--N 1.376 1.72 0 CA-C-N 113.16 -1.836 . . . . 0.56999999999999995 110.898 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.03 -51.12 67.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.937 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -63.83 -44.95 91.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.151 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.87 80.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 111.085 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.17 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.096 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.26 -49.97 62.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 110.823 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -42.11 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.91000000000000003 110.885 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.412 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 3.3 mm -67.68 -47.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.56999999999999995 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.79 -33.75 63.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.466 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.41 -38.74 88.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.56999999999999995 110.9 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.0 t -71.22 -53.53 14.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.836 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 225' ' ' GLY . 3.2 pp -72.23 -60.77 2.06 Favored 'General case' 0 C--N 1.375 1.68 0 N-CA-C 118.992 2.96 . . . . 0.56999999999999995 118.992 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.466 ' N ' ' CD1' ' A' ' 224' ' ' LEU . . . -70.42 -175.09 17.1 Favored Glycine 0 C--N 1.375 2.741 0 CA-C-O 126.157 3.087 . . . . 0.56999999999999995 110.114 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -146.33 0.16 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-N 109.628 -3.286 . . . . 0.56999999999999995 106.432 -172.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.01 -107.57 0.01 OUTLIER Glycine 0 C--N 1.394 3.794 0 CA-C-O 125.769 2.871 . . . . 0.56999999999999995 111.665 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.436 ' CE1' ' HG3' ' A' ' 238' ' ' PRO . 21.4 m170 -113.83 -96.43 0.45 Allowed 'General case' 0 C--N 1.382 1.994 0 O-C-N 119.633 -2.098 . . . . 0.56999999999999995 110.34 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.03 -42.58 0.01 OUTLIER 'General case' 0 C--N 1.391 2.413 0 N-CA-C 107.893 -1.151 . . . . 0.56999999999999995 107.893 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 81.87 24.11 0.23 Allowed 'General case' 0 C--N 1.415 3.454 0 N-CA-C 116.676 2.102 . . . . 0.56999999999999995 116.676 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -157.94 138.2 8.95 Favored Pre-proline 0 C--N 1.386 2.156 0 N-CA-C 106.539 -1.652 . . . . 0.91000000000000003 106.539 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.541 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 67.8 Cg_exo -57.29 -57.68 1.18 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.445 2.763 . . . . 0.56999999999999995 114.529 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.99 -37.75 4.25 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 112.976 -1.92 . . . . 0.56999999999999995 113.396 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 117.56 8.27 Favored 'General case' 0 C--N 1.393 2.493 0 CA-C-O 124.445 2.069 . . . . 0.56999999999999995 115.762 167.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.3 t -72.19 47.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.033 0 CA-C-O 124.693 2.187 . . . . 0.56999999999999995 115.449 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.8 mmm -144.76 -31.94 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 CA-C-N 113.575 -1.648 . . . . 0.56999999999999995 110.227 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER -39.11 144.37 0.44 Allowed Pre-proline 0 C--N 1.38 1.928 0 CA-C-O 126.283 2.944 . . . . 0.56999999999999995 114.371 173.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.436 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 54.0 Cg_exo -58.87 -48.14 15.66 Favored 'Trans proline' 0 C--N 1.383 2.371 0 O-C-N 118.294 -1.477 . . . . 0.56999999999999995 111.806 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.51 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 98.9 m -46.3 122.54 4.07 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.003 -173.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.0 OUTLIER -98.03 117.69 32.96 Favored 'General case' 0 C--N 1.386 2.164 0 CA-C-N 112.81 -1.995 . . . . 0.56999999999999995 106.602 -178.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -138.5 108.03 6.19 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 113.281 -1.781 . . . . 0.56999999999999995 106.63 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.5 120.89 5.03 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-O 124.455 2.074 . . . . 0.56999999999999995 110.796 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.24 18.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 CA-C-N 112.868 -1.969 . . . . 0.56999999999999995 110.718 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.3 t0 64.03 115.95 0.02 OUTLIER 'General case' 0 C--N 1.385 2.147 0 CA-C-O 126.937 3.256 . . . . 0.91000000000000003 106.651 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' A' ' 213' ' ' PHE . 2.6 mp -51.97 -19.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.46 0 O-C-N 119.048 -2.283 . . . . 0.56999999999999995 115.4 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -31.46 64.56 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.003 -1.453 . . . . 0.56999999999999995 111.23 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -5.62 15.42 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 123.121 0.568 . . . . 0.56999999999999995 110.914 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -65.01 93.85 0.12 Allowed 'General case' 0 C--N 1.385 2.119 0 CA-C-O 125.678 2.656 . . . . 0.56999999999999995 105.332 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -114.41 154.14 28.64 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 112.414 -2.176 . . . . 1.2 105.79 -177.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.89 132.62 53.77 Favored 'General case' 0 C--N 1.385 2.15 0 CA-C-O 125.559 2.6 . . . . 0.56999999999999995 105.768 -170.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 25.8 m -69.32 141.79 54.19 Favored 'General case' 0 C--N 1.365 1.249 0 O-C-N 120.229 -1.544 . . . . 0.56999999999999995 109.124 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.45 93.98 Favored 'General case' 0 C--N 1.396 2.609 0 CA-C-N 113.337 -1.756 . . . . 0.56999999999999995 107.412 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -41.52 89.07 Favored 'General case' 0 C--N 1.365 1.243 0 CA-C-N 115.501 -0.772 . . . . 0.91000000000000003 110.834 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.4 -54.8 27.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.91000000000000003 110.857 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.6 pt -66.08 -34.54 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 111.196 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -67.55 -31.12 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.2 110.796 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.41 19.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.56999999999999995 112.457 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 1.2 pt -59.59 -36.15 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.731 0.301 . . . . 0.56999999999999995 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.13 -44.61 68.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.896 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.374 1.673 0 CA-C-O 121.933 0.873 . . . . 0.56999999999999995 110.891 -179.765 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 122.986 1.374 . . . . 1.2 108.943 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -65.83 0.03 OUTLIER 'General case' 0 C--N 1.382 2.018 0 CA-C-N 113.886 -1.507 . . . . 0.56999999999999995 111.07 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -11.61 59.85 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 125.542 2.591 . . . . 0.56999999999999995 110.268 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -110.07 105.48 14.61 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.144 -1.598 . . . . 0.56999999999999995 110.946 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.01 135.32 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.108 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.42 159.03 18.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.181 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -150.14 158.07 43.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.56999999999999995 110.883 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.07 126.5 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.2 110.921 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.98 136.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -53.23 -53.92 43.65 Favored 'General case' 0 C--N 1.376 1.744 0 N-CA-C 107.805 -1.183 . . . . 0.56999999999999995 107.805 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 161.98 35.44 0.0 OUTLIER 'General case' 0 C--N 1.382 1.996 0 O-C-N 126.599 2.437 . . . . 0.56999999999999995 110.049 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 4.8 m-30 72.52 -172.22 0.15 Allowed 'General case' 0 C--N 1.383 2.025 0 N-CA-C 107.41 -1.33 . . . . 0.56999999999999995 107.41 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 161.51 55.98 Favored Pre-proline 0 C--N 1.373 1.614 0 CA-C-N 114.141 -1.39 . . . . 0.56999999999999995 108.619 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -50.51 1.41 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 112.584 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.16 -66.87 0.82 Allowed 'General case' 0 C--N 1.379 1.882 0 N-CA-C 104.768 -2.308 . . . . 0.91000000000000003 104.768 -165.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.7 ttm -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-O 125.694 2.664 . . . . 0.56999999999999995 110.19 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.95 139.69 41.7 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.396 -2.184 . . . . 0.56999999999999995 107.714 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.47 -47.46 67.03 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 107.736 -1.209 . . . . 1.2 107.736 -168.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -34.67 63.27 Favored 'General case' 0 C--N 1.387 2.226 0 O-C-N 126.482 2.364 . . . . 0.91000000000000003 110.898 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -44.04 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.91000000000000003 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.5 t -61.31 -44.55 98.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.84 -44.09 97.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.91000000000000003 110.869 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.61 -44.06 87.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 110.894 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.97 87.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.56999999999999995 111.13 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -65.15 -42.89 95.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.56999999999999995 111.112 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -49.05 78.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.868 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.473 ' N ' ' HZ2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -62.68 -36.55 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.91 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.06 99.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 111.132 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 134' ' ' ILE . 20.4 m-85 -65.93 -37.09 85.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 110.86 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.4 tt0 -67.16 -38.11 84.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.882 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 8.3 t -71.12 -34.07 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.122 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -83.25 -34.09 25.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.913 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m -77.55 -49.39 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.876 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.76 -12.56 7.45 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-O 122.174 0.988 . . . . 0.56999999999999995 112.737 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 25.0 m -115.98 1.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.379 1.854 0 CA-C-N 114.014 -1.448 . . . . 0.56999999999999995 111.42 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.8 150.28 45.92 Favored Pre-proline 0 C--N 1.368 1.412 0 CA-C-O 125.615 2.626 . . . . 0.56999999999999995 110.203 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.38 -34.03 6.36 Favored 'Trans proline' 0 C--N 1.361 1.224 0 O-C-N 118.114 -1.572 . . . . 0.56999999999999995 110.69 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.7 114.34 2.46 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 108.73 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 158.36 32.05 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 113.742 -1.572 . . . . 0.56999999999999995 112.507 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' CD2' ' OG ' ' A' ' 142' ' ' SER . 12.6 m-85 -130.07 139.61 50.94 Favored 'General case' 0 C--N 1.388 2.272 0 CA-C-N 112.368 -2.196 . . . . 0.56999999999999995 108.711 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.4 m -145.53 125.02 13.14 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 108.367 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 15.9 tttt -89.45 146.58 24.54 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 112.731 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.2 pt -139.11 155.97 27.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.852 0 CA-C-O 123.41 1.576 . . . . 0.56999999999999995 109.738 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 -6.23 1.48 Allowed 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.808 -1.542 . . . . 0.56999999999999995 109.951 -174.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.5 p -76.79 -62.82 1.51 Allowed 'General case' 0 C--N 1.372 1.569 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.539 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.56 -174.69 17.47 Favored Glycine 0 C--N 1.374 2.648 0 CA-C-O 123.253 1.474 . . . . 0.56999999999999995 110.861 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 ttt -57.62 124.97 20.89 Favored 'General case' 0 C--N 1.382 1.997 0 CA-C-N 113.014 -1.593 . . . . 0.56999999999999995 108.411 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.04 173.56 7.21 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.147 -1.842 . . . . 0.56999999999999995 110.582 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.43 -83.39 0.03 OUTLIER 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.989 -1.914 . . . . 0.91000000000000003 107.674 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.448 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 1.9 pp -94.69 114.57 31.54 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-N 114.665 -1.152 . . . . 0.56999999999999995 111.108 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.38 132.06 42.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.92 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.02 116.9 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.148 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.33 145.13 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.101 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.77 117.77 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.89 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.36 170.12 18.0 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 124.341 2.019 . . . . 0.56999999999999995 109.646 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 134.02 52.43 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.909 -1.744 . . . . 1.2 108.156 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 42.32 -106.02 0.07 OUTLIER Glycine 0 C--N 1.379 2.957 0 O-C-N 126.135 2.147 . . . . 0.56999999999999995 113.009 171.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 57.04 -140.03 0.86 Allowed 'General case' 0 C--N 1.384 2.097 0 O-C-N 127.111 2.301 . . . . 0.56999999999999995 107.518 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 168' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.383 2.059 0 O-C-N 124.957 1.411 . . . . 0.56999999999999995 111.36 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 124.157 1.932 . . . . 0.56999999999999995 115.185 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.529 ' CE2' HG23 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -85.89 -131.1 0.05 OUTLIER 'General case' 0 C--N 1.376 1.745 0 CA-C-N 113.224 -1.807 . . . . 0.56999999999999995 108.633 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 t70 54.0 -157.42 0.19 Allowed 'General case' 0 C--N 1.39 2.343 0 N-CA-C 105.647 -1.982 . . . . 0.91000000000000003 105.647 170.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 127.72 9.18 4.02 Favored Glycine 0 C--N 1.368 2.344 0 N-CA-C 109.067 -1.613 . . . . 0.56999999999999995 109.067 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.13 -57.14 0.01 OUTLIER 'General case' 0 C--N 1.393 2.492 0 CA-C-O 122.764 1.269 . . . . 0.56999999999999995 111.031 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -156.95 -38.25 0.02 OUTLIER Glycine 0 C--N 1.382 3.102 0 CA-C-N 114.126 -1.397 . . . . 0.56999999999999995 111.497 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -41.6 142.06 1.19 Allowed Glycine 0 C--N 1.38 3.027 0 O-C-N 120.0 -1.883 . . . . 0.56999999999999995 109.379 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.529 HG23 ' CE2' ' A' ' 174' ' ' PHE . 1.3 mp 74.04 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.62 0 O-C-N 124.153 0.561 . . . . 0.56999999999999995 112.449 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 tp -124.29 -57.81 1.56 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 122.966 1.365 . . . . 0.56999999999999995 111.882 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -177.43 179.53 0.94 Allowed 'General case' 0 C--N 1.364 1.229 0 CA-C-N 114.584 -1.189 . . . . 0.56999999999999995 111.042 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.434 ' O ' ' CB ' ' A' ' 195' ' ' ALA . 2.7 p80 -152.94 168.24 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.874 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.89 142.71 22.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.057 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.4 ' CD2' ' HA2' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -52.02 129.71 27.93 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 117.745 -1.582 . . . . 0.56999999999999995 110.143 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.26 -58.19 4.4 Favored Glycine 0 C--N 1.381 3.046 0 CA-C-N 112.859 -1.973 . . . . 0.56999999999999995 111.785 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -67.96 -83.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 121.495 1.463 . . . . 0.56999999999999995 111.342 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.32 -142.52 7.61 Favored Glycine 0 C--N 1.375 2.711 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 -176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 83.59 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.382 1.987 0 O-C-N 125.611 1.418 . . . . 0.56999999999999995 109.382 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -44.87 -65.08 1.91 Allowed Glycine 0 C--N 1.388 3.426 0 CA-C-O 125.678 2.821 . . . . 0.56999999999999995 112.549 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.97 -15.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.382 1.982 0 CA-C-N 111.306 -2.447 . . . . 0.56999999999999995 109.03 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 185' ' ' PHE . . . -44.98 148.35 1.39 Allowed Glycine 0 C--N 1.362 1.972 0 O-C-N 120.693 -1.254 . . . . 0.56999999999999995 113.676 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.38 -44.47 1.94 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 117.428 1.731 . . . . 0.56999999999999995 117.428 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -37.48 147.15 0.04 OUTLIER 'General case' 0 C--N 1.387 2.205 0 O-C-N 124.894 0.997 . . . . 0.91000000000000003 110.853 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 183' ' ' HIS . . . -143.42 152.0 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.113 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.33 126.41 37.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 110.828 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.7 OUTLIER -109.97 134.93 51.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 110.923 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 85.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.86 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -72.98 -49.24 30.27 Favored 'General case' 0 C--N 1.382 1.999 0 N-CA-C 104.209 -2.515 . . . . 0.91000000000000003 104.209 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.84 -45.75 0.1 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 123.938 0.895 . . . . 0.91000000000000003 112.151 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -53.19 174.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 126.631 3.11 . . . . 0.91000000000000003 109.77 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 2.1 t80 -97.1 107.52 20.07 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 112.74 -2.027 . . . . 0.56999999999999995 114.275 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -91.25 151.42 20.92 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 108.493 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.0 p -126.22 104.4 8.2 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 109.92 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.56 137.29 37.43 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-N 113.271 -1.786 . . . . 0.56999999999999995 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 207' ' ' SER . 1.3 t60 76.78 42.56 0.15 Allowed 'General case' 0 C--N 1.385 2.144 0 CA-C-N 113.796 -1.547 . . . . 0.56999999999999995 110.834 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.1 p 81.69 123.17 0.04 OUTLIER 'General case' 0 C--N 1.382 1.989 0 CA-C-O 124.55 2.119 . . . . 0.56999999999999995 108.849 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.37 -13.91 0.15 Allowed Glycine 0 C--N 1.382 3.135 0 C-N-CA 118.514 -1.803 . . . . 0.56999999999999995 111.752 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 153.88 -119.13 0.92 Allowed Glycine 0 C--N 1.389 3.509 0 CA-C-O 123.723 1.735 . . . . 0.56999999999999995 112.994 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.7 p -80.02 117.53 20.94 Favored 'General case' 0 C--N 1.377 1.795 0 CA-C-O 123.142 1.448 . . . . 0.56999999999999995 111.625 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -91.59 152.14 20.41 Favored 'General case' 0 C--N 1.369 1.417 0 CA-C-N 112.738 -2.028 . . . . 0.56999999999999995 111.648 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.04 -31.23 61.27 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 113.184 -1.825 . . . . 0.56999999999999995 107.338 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 217' ' ' VAL . 1.3 t80 -58.22 -46.61 85.57 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-N 113.819 -1.537 . . . . 0.56999999999999995 110.889 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -51.84 65.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.898 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -49.05 69.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.162 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.32 73.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.174 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 213' ' ' PHE . 92.5 t -65.18 -39.49 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 111.081 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 236' ' ' MET . 7.2 t-160 -70.29 -42.3 72.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.866 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 219' ' ' GLU . 1.2 mm-40 -61.1 -43.78 98.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.91000000000000003 110.869 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.09 -42.94 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 111.114 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.96 -33.76 64.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.56999999999999995 112.523 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.53 -42.02 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.7 t -71.01 -36.01 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.888 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.8 mt -43.74 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.367 1.344 0 CA-C-O 124.25 1.976 . . . . 0.56999999999999995 114.318 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.64 -161.83 35.56 Favored Glycine 0 C--N 1.369 2.408 0 N-CA-C 107.93 -2.068 . . . . 0.56999999999999995 107.93 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.65 -164.07 0.05 OUTLIER 'General case' 0 C--N 1.389 2.293 0 CA-C-N 112.633 -1.783 . . . . 0.56999999999999995 111.131 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -111.34 -162.61 17.51 Favored Glycine 0 C--N 1.373 2.624 0 CA-C-O 125.61 2.783 . . . . 0.56999999999999995 112.682 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.48 -167.06 1.74 Allowed 'General case' 0 C--N 1.39 2.328 0 CA-C-N 110.578 -2.811 . . . . 0.56999999999999995 112.032 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.24 -20.1 20.13 Favored 'General case' 0 C--N 1.385 2.125 0 CA-C-N 113.421 -1.718 . . . . 0.56999999999999995 109.944 -175.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 86.48 5.38 0.39 Allowed 'General case' 0 C--N 1.387 2.22 0 O-C-N 125.558 1.786 . . . . 0.56999999999999995 114.853 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -149.12 143.86 17.43 Favored Pre-proline 0 C--N 1.38 1.908 0 O-C-N 125.193 1.558 . . . . 0.91000000000000003 109.377 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.11 -47.18 18.56 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.589 2.192 . . . . 0.56999999999999995 112.295 -172.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -41.89 -39.35 1.8 Allowed 'General case' 0 C--N 1.38 1.909 0 CA-C-N 114.035 -1.438 . . . . 0.56999999999999995 113.032 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.48 131.56 48.56 Favored 'General case' 0 C--N 1.383 2.046 0 N-CA-C 118.955 2.946 . . . . 0.56999999999999995 118.955 167.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.453 HG23 ' CE2' ' A' ' 248' ' ' PHE . 21.9 t -73.55 70.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.9 0 CA-C-N 112.256 -2.247 . . . . 0.56999999999999995 111.435 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.459 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -179.55 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-N 113.233 -1.803 . . . . 0.56999999999999995 109.424 -178.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.469 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 3.4 t80 -52.77 140.25 39.63 Favored Pre-proline 0 C--N 1.363 1.193 0 O-C-N 120.014 -1.679 . . . . 0.56999999999999995 109.868 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.469 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 54.0 Cg_exo -54.77 -19.41 18.82 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.8 1.667 . . . . 0.56999999999999995 114.9 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.41 107.57 0.13 Allowed 'General case' 0 C--N 1.371 1.515 0 CA-C-O 123.665 1.698 . . . . 0.56999999999999995 110.677 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -81.86 134.11 35.38 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 105.869 -1.9 . . . . 0.56999999999999995 105.869 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? 174.96 113.49 0.02 OUTLIER 'General case' 0 C--N 1.383 2.048 0 N-CA-C 106.744 -1.576 . . . . 0.56999999999999995 106.744 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.59 123.26 9.55 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 113.238 -1.801 . . . . 0.56999999999999995 110.701 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.35 113.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.779 0 CA-C-N 113.806 -1.543 . . . . 0.56999999999999995 108.103 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.39 150.05 12.2 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 113.211 -1.813 . . . . 0.91000000000000003 107.086 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 248' ' ' PHE . 1.1 mp -75.86 -23.57 16.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 124.227 1.965 . . . . 0.56999999999999995 110.02 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -84.15 -7.52 59.34 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.481 -1.387 . . . . 0.56999999999999995 112.714 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 39.7 p -122.39 3.51 9.71 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-O 123.679 1.704 . . . . 0.56999999999999995 111.578 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -83.97 -156.73 0.23 Allowed 'General case' 0 C--N 1.368 1.4 0 CA-C-N 113.259 -1.791 . . . . 0.56999999999999995 110.376 178.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.4 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER 178.28 163.37 0.69 Allowed 'General case' 0 C--N 1.385 2.124 0 N-CA-C 105.637 -1.986 . . . . 1.2 105.637 168.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -117.56 141.98 47.73 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.732 2.682 . . . . 0.56999999999999995 108.262 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.3 t -64.5 134.02 53.6 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 119.846 -1.784 . . . . 0.56999999999999995 112.645 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.91 -49.91 64.08 Favored 'General case' 0 C--N 1.39 2.361 0 CA-C-N 114.072 -1.422 . . . . 0.56999999999999995 108.663 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -35.96 73.97 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 115.357 -0.838 . . . . 0.91000000000000003 110.845 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -63.94 -55.13 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.91000000000000003 110.885 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.7 pt -66.37 -35.31 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.56999999999999995 111.149 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.404 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 35.5 mtp180 -70.72 -35.52 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 1.2 110.784 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.02 -51.2 55.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.722 . . . . 0.56999999999999995 112.465 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 2.4 pt -61.17 -45.61 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.56999999999999995 111.119 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.21 -28.69 63.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.56999999999999995 110.907 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 31.3 t . . . . . 0 C--N 1.365 1.251 0 C-N-CA 119.096 -1.042 . . . . 0.56999999999999995 109.796 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.349 0 CA-C-O 125.034 2.349 . . . . 1.2 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.91 -54.32 1.31 Allowed 'General case' 0 C--N 1.379 1.868 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 107.822 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.388 2.247 0 CA-C-O 124.172 1.939 . . . . 0.56999999999999995 108.471 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.6 103.81 10.06 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-N 112.054 -2.339 . . . . 0.56999999999999995 110.929 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mm -102.11 146.91 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.112 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -105.93 156.51 18.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.473 . . . . 0.56999999999999995 111.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 20.3 t80 -138.64 160.1 40.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.929 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.528 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -145.68 121.85 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.509 . . . . 1.2 110.847 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.484 HG12 ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -93.51 132.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 111.125 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -59.48 -86.76 0.01 OUTLIER 'General case' 0 C--N 1.375 1.696 0 CA-C-N 114.739 -1.119 . . . . 0.56999999999999995 110.206 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t30 169.4 60.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.28 0 N-CA-C 104.15 -2.537 . . . . 0.56999999999999995 104.15 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -67.07 178.37 1.45 Allowed 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.065 -1.88 . . . . 0.56999999999999995 111.544 166.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 162.45 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.32 2.648 . . . . 0.56999999999999995 108.134 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.71 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-O 124.365 1.735 . . . . 0.56999999999999995 110.079 -165.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.99 3.31 12.54 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 114.309 -1.314 . . . . 0.91000000000000003 113.986 173.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.1 mmt -142.75 119.45 11.13 Favored 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.007 -1.479 . . . . 0.56999999999999995 107.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.32 139.09 31.04 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 122.617 1.199 . . . . 0.56999999999999995 108.58 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -46.66 74.22 Favored 'General case' 0 C--N 1.388 2.261 0 CA-C-O 123.871 1.796 . . . . 1.2 109.261 -166.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.24 -35.17 64.65 Favored 'General case' 0 C--N 1.364 1.208 0 CA-C-N 111.376 -2.647 . . . . 0.91000000000000003 110.979 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.61 -41.92 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.91000000000000003 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.416 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.3 t -65.54 -39.57 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 111.112 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.63 -42.1 87.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.838 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -49.02 75.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.949 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.62 -49.1 67.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.052 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.42 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.5 mm -62.22 -46.03 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.094 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -56.28 -43.64 79.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 1.2 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -38.13 89.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.878 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.57 -45.29 87.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.078 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 220' ' ' ILE . 14.9 m-85 -62.97 -34.4 77.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.916 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -40.0 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 110.934 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -34.24 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.56999999999999995 111.125 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.15 -33.62 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 110.929 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.7 m -78.94 -49.01 13.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.808 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.438 ' ND2' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -59.97 -14.84 17.86 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-O 120.969 0.414 . . . . 0.56999999999999995 111.072 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG11 ' CD1' ' A' ' 255' ' ' ILE . 19.6 m -112.51 -13.61 11.24 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 CA-C-O 117.89 -1.053 . . . . 0.56999999999999995 111.016 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.7 142.39 17.93 Favored Pre-proline 0 C--N 1.383 2.038 0 O-C-N 124.859 1.349 . . . . 0.56999999999999995 112.555 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -78.52 67.75 8.25 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.201 1.934 . . . . 0.56999999999999995 112.66 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.71 90.58 0.63 Allowed 'General case' 0 C--N 1.372 1.576 0 N-CA-C 104.516 -2.401 . . . . 0.56999999999999995 104.516 -167.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 160.53 25.73 Favored 'General case' 0 C--N 1.381 1.977 0 CA-C-N 114.432 -1.258 . . . . 0.56999999999999995 113.035 170.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -136.32 141.22 43.77 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-N 113.723 -1.58 . . . . 0.56999999999999995 106.747 -172.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -157.02 139.76 15.11 Favored 'General case' 0 C--N 1.366 1.315 0 CA-C-O 124.454 2.073 . . . . 0.56999999999999995 108.161 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.26 145.8 27.37 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 114.199 -1.364 . . . . 0.56999999999999995 109.733 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -111.27 159.48 11.23 Favored 'Isoleucine or valine' 0 C--N 1.367 1.333 0 CA-C-O 123.979 1.847 . . . . 0.56999999999999995 108.032 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -90.1 100.26 13.12 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.21 -1.814 . . . . 0.56999999999999995 107.038 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 67.67 -178.75 0.21 Allowed 'General case' 0 C--N 1.371 1.512 0 CA-C-O 122.189 0.995 . . . . 0.56999999999999995 109.44 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.09 71.35 Favored Glycine 0 C--N 1.371 2.487 0 C-N-CA 119.728 -1.225 . . . . 0.56999999999999995 113.435 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.63 113.89 0.06 Allowed 'General case' 0 C--N 1.374 1.671 0 CA-C-O 122.586 1.184 . . . . 0.56999999999999995 109.735 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -91.31 159.49 15.99 Favored 'General case' 0 C--N 1.37 1.478 0 C-N-CA 117.612 -1.635 . . . . 0.56999999999999995 109.659 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -47.13 68.61 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-N 112.28 -2.236 . . . . 0.91000000000000003 106.061 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.3 mt -103.49 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.388 2.241 0 O-C-N 127.117 2.761 . . . . 0.56999999999999995 111.159 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.41 124.4 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.921 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.9 t -108.75 123.04 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.074 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 124.94 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.156 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' C ' ' HB2' ' A' ' 199' ' ' GLU . 5.4 m-85 -89.46 116.85 27.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.864 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.8 29.7 Favored 'General case' 0 C--N 1.378 1.81 0 CA-C-O 122.89 1.328 . . . . 0.56999999999999995 108.593 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 177.11 5.05 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 114.501 -1.227 . . . . 1.2 110.892 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.93 144.19 23.51 Favored Glycine 0 C--N 1.376 2.76 0 CA-C-N 113.213 -1.812 . . . . 0.56999999999999995 111.466 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 82.54 50.83 0.02 OUTLIER 'General case' 0 C--N 1.382 1.993 0 CA-C-O 123.136 1.446 . . . . 0.56999999999999995 112.307 -175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 . . . . . 0 C--N 1.377 1.778 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 109.69 -179.475 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 107.185 -1.413 . . . . 0.56999999999999995 107.185 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.402 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -91.93 -164.51 1.19 Allowed 'General case' 0 C--N 1.369 1.44 0 CA-C-N 112.857 -1.974 . . . . 0.56999999999999995 108.715 173.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.56 142.13 35.18 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 105.061 -2.2 . . . . 0.91000000000000003 105.061 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.88 157.28 22.93 Favored Glycine 0 C--N 1.368 2.36 0 N-CA-C 107.645 -2.182 . . . . 0.56999999999999995 107.645 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.07 28.21 6.74 Favored 'General case' 0 C--N 1.369 1.425 0 N-CA-C 113.605 0.965 . . . . 0.56999999999999995 113.605 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.62 -163.99 14.9 Favored Glycine 0 C--N 1.364 2.101 0 N-CA-C 108.056 -2.017 . . . . 0.56999999999999995 108.056 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.48 -104.03 3.12 Favored Glycine 0 C--N 1.365 2.188 0 CA-C-N 114.758 -0.721 . . . . 0.56999999999999995 111.42 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.46 167.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.38 1.898 0 C-N-CA 123.526 0.73 . . . . 0.56999999999999995 109.142 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' CE2' ' A' ' 240' ' ' TYR . 5.6 tp -101.13 -42.63 6.29 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 122.087 0.946 . . . . 0.56999999999999995 110.743 173.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.89 -179.99 2.19 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 120.56 -1.337 . . . . 0.56999999999999995 111.102 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.402 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 2.3 p80 -163.87 136.1 4.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.883 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.42 163.14 40.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.56999999999999995 111.136 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -121.32 176.59 5.56 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-O 123.191 1.472 . . . . 0.56999999999999995 108.478 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.68 53.09 0.2 Allowed Glycine 0 C--N 1.376 2.763 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 112.219 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.83 -49.84 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 CA-C-O 123.695 1.456 . . . . 0.56999999999999995 110.764 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -155.91 -61.58 0.01 OUTLIER Glycine 0 C--N 1.381 3.053 0 N-CA-C 109.844 -1.303 . . . . 0.56999999999999995 109.844 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m -152.06 -179.73 7.75 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.33 -104.57 1.6 Allowed Glycine 0 C--N 1.379 2.961 0 N-CA-C 105.888 -2.885 . . . . 0.56999999999999995 105.888 171.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.2 tp -55.38 -42.77 68.73 Favored 'Isoleucine or valine' 0 C--N 1.375 1.715 0 CA-C-O 122.818 1.294 . . . . 0.56999999999999995 109.067 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.51 134.69 38.72 Favored Glycine 0 C--N 1.379 2.941 0 C-N-CA 118.37 -1.872 . . . . 0.56999999999999995 108.498 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.6 -29.16 12.36 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 124.287 0.946 . . . . 0.56999999999999995 113.29 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 123.46 26.4 Favored 'General case' 0 C--N 1.371 1.522 0 O-C-N 120.91 -1.347 . . . . 0.91000000000000003 110.885 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.23 146.39 49.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.131 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -123.81 134.47 53.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 110.81 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.3 OUTLIER -108.97 150.01 28.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.883 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 91.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.91000000000000003 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 3.7 tp10 -67.56 -44.56 77.96 Favored 'General case' 0 C--N 1.369 1.414 0 O-C-N 125.714 1.884 . . . . 0.91000000000000003 108.068 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -30.84 43.91 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-O 122.526 1.155 . . . . 0.91000000000000003 111.299 -167.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.52 172.02 0.17 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-O 125.278 2.466 . . . . 0.91000000000000003 114.906 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -120.61 83.36 2.05 Favored 'General case' 0 C--N 1.384 2.07 0 CA-C-N 113.241 -1.8 . . . . 0.56999999999999995 108.463 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -74.4 152.53 39.49 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 113.695 -1.593 . . . . 0.56999999999999995 107.498 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 126.84 35.15 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-O 124.734 2.207 . . . . 0.56999999999999995 105.488 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.8 p -106.42 123.06 47.49 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 105.344 -2.095 . . . . 0.56999999999999995 105.344 -175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 70.6 34.83 2.02 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.318 1.533 . . . . 0.56999999999999995 109.621 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -139.11 -82.06 0.29 Allowed 'General case' 0 C--N 1.375 1.703 0 N-CA-C 107.752 -1.203 . . . . 0.56999999999999995 107.752 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.73 -163.33 33.69 Favored Glycine 0 C--N 1.365 2.148 0 N-CA-C 107.851 -2.1 . . . . 0.56999999999999995 107.851 -171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.3 -142.85 47.75 Favored Glycine 0 C--N 1.373 2.588 0 C-N-CA 119.295 -1.431 . . . . 0.56999999999999995 110.724 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 p -74.62 115.45 14.19 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-O 124.684 2.183 . . . . 0.56999999999999995 113.723 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.55 147.67 26.49 Favored 'General case' 0 C--N 1.373 1.618 0 CA-C-N 112.748 -2.024 . . . . 0.56999999999999995 110.183 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -34.34 70.44 Favored 'General case' 0 C--N 1.381 1.966 0 N-CA-C 105.339 -2.097 . . . . 0.56999999999999995 105.339 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.499 ' CD1' HG12 ' A' ' 245' ' ' ILE . 3.3 t80 -53.73 -49.95 67.03 Favored 'General case' 0 C--N 1.375 1.686 0 CA-C-N 114.993 -1.003 . . . . 0.56999999999999995 110.9 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -48.28 73.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.946 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -38.2 77.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.128 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -61.55 -46.31 90.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 111.158 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.6 t -65.36 -40.01 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.089 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.12 -50.0 57.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.891 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.9 -42.12 93.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.91000000000000003 110.849 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.475 HD12 ' CE1' ' A' ' 138' ' ' PHE . 2.4 mm -68.44 -43.92 83.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.11 -33.86 76.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.438 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -39.4 89.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.779 0.323 . . . . 0.56999999999999995 110.849 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 m -71.05 -51.56 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.833 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.407 ' CD2' HG23 ' A' ' 220' ' ' ILE . 3.7 pp -69.35 -55.73 9.55 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 116.002 1.853 . . . . 0.56999999999999995 116.002 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -71.73 -148.44 0.67 Allowed Glycine 0 C--N 1.364 2.096 0 N-CA-C 107.51 -2.236 . . . . 0.56999999999999995 107.51 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.63 -21.26 4.5 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 113.19 -1.505 . . . . 0.56999999999999995 108.835 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 148.19 -172.28 28.48 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 123.172 1.429 . . . . 0.56999999999999995 112.847 -161.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 236' ' ' MET . 2.2 m170 -73.97 -162.21 0.13 Allowed 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.074 -2.063 . . . . 0.56999999999999995 109.364 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.1 p -122.15 -10.94 8.5 Favored 'General case' 0 C--N 1.374 1.639 0 C-N-CA 120.313 -0.555 . . . . 0.56999999999999995 109.869 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 85.71 -4.58 0.83 Allowed 'General case' 0 C--N 1.377 1.771 0 N-CA-C 113.834 1.05 . . . . 0.56999999999999995 113.834 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -130.03 152.0 79.26 Favored Pre-proline 0 C--N 1.375 1.708 0 N-CA-C 106.572 -1.64 . . . . 0.91000000000000003 106.572 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -63.72 -21.19 69.78 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.289 1.993 . . . . 0.56999999999999995 114.167 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 14.01 0.26 Allowed 'General case' 0 C--N 1.369 1.448 0 N-CA-C 117.33 2.345 . . . . 0.56999999999999995 117.33 168.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -94.8 132.68 39.32 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 123.074 1.416 . . . . 0.56999999999999995 108.103 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -5.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.372 1.547 0 CA-C-O 124.156 1.931 . . . . 0.56999999999999995 110.857 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.55 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 74.8 mtp -121.77 26.42 8.69 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 114.046 -1.434 . . . . 0.56999999999999995 108.726 -176.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.414 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 0.3 OUTLIER -64.8 149.49 96.04 Favored Pre-proline 0 C--N 1.371 1.505 0 C-N-CA 117.696 -1.602 . . . . 0.56999999999999995 110.231 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 39.6 Cg_endo -78.64 -15.05 13.88 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.278 1.319 . . . . 0.56999999999999995 112.711 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 130.18 45.73 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-O 122.813 1.292 . . . . 0.56999999999999995 109.411 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.508 ' CE2' HD11 ' A' ' 181' ' ' LEU . 6.3 t80 -89.53 106.75 18.66 Favored 'General case' 0 C--N 1.364 1.215 0 N-CA-C 105.822 -1.918 . . . . 0.56999999999999995 105.822 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -154.94 115.83 3.95 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 105.106 -2.183 . . . . 0.56999999999999995 105.106 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -68.6 113.71 6.35 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 110.081 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 p -95.75 -21.42 5.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 CA-C-N 114.142 -1.39 . . . . 0.56999999999999995 112.299 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.312 0.0 OUTLIER 82.32 -11.98 0.96 Allowed 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.033 0.833 . . . . 0.91000000000000003 111.282 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.499 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.6 mt 87.54 14.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.795 0 C-N-CA 124.858 1.263 . . . . 0.56999999999999995 110.766 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.61 -30.47 46.55 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-O 125.595 2.617 . . . . 0.56999999999999995 106.273 -166.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.5 p -119.31 -10.09 9.79 Favored 'General case' 0 C--N 1.386 2.185 0 CA-C-N 112.072 -2.331 . . . . 0.56999999999999995 112.613 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -48.01 103.64 0.05 OUTLIER 'General case' 0 C--N 1.374 1.668 0 CA-C-O 123.162 1.458 . . . . 0.56999999999999995 107.461 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.423 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -138.4 146.71 42.54 Favored 'General case' 0 C--N 1.363 1.188 0 N-CA-C 104.816 -2.291 . . . . 1.2 104.816 -172.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.423 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -115.8 132.02 56.76 Favored 'General case' 0 C--N 1.368 1.373 0 CA-C-N 111.704 -2.498 . . . . 0.56999999999999995 106.482 -172.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.7 t -79.51 146.05 32.88 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 119.804 -1.81 . . . . 0.56999999999999995 109.325 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.82 90.18 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 114.704 -1.134 . . . . 0.56999999999999995 109.264 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.58 -39.35 90.86 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.462 -0.79 . . . . 0.91000000000000003 110.852 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -55.0 24.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.91000000000000003 110.871 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.494 ' CD1' HG11 ' A' ' 144' ' ' VAL . 11.8 pt -65.99 -34.84 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 111.166 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -70.05 -31.45 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.927 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.53 56.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.56999999999999995 112.445 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.43 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.94 -44.28 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.56999999999999995 111.149 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.43 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.08 -19.96 61.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.913 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.391 2.406 0 CA-C-O 126.135 2.874 . . . . 0.56999999999999995 107.782 -174.707 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 123.835 1.779 . . . . 1.2 107.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -48.79 1.73 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-N 112.653 -2.067 . . . . 0.56999999999999995 109.89 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -85.11 -37.47 20.21 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-O 124.226 1.965 . . . . 0.56999999999999995 107.838 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -81.39 122.46 27.52 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.066 -1.425 . . . . 0.56999999999999995 110.882 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.94 138.67 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.163 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -131.1 157.27 43.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.139 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.601 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -137.41 159.38 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.874 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -135.08 129.4 33.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -99.08 124.72 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.145 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . 15.7 t-20 -41.81 -59.41 1.69 Allowed 'General case' 0 C--N 1.384 2.108 0 C-N-CA 117.498 -1.681 . . . . 0.56999999999999995 110.122 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 164.36 35.49 0.0 OUTLIER 'General case' 0 C--N 1.387 2.201 0 O-C-N 126.023 2.077 . . . . 0.56999999999999995 109.521 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 1.7 m-30 80.05 -173.37 0.05 Allowed 'General case' 0 C--N 1.385 2.151 0 N-CA-C 105.36 -2.089 . . . . 0.56999999999999995 105.36 170.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.69 160.72 65.04 Favored Pre-proline 0 C--N 1.369 1.45 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 108.835 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.66 -49.99 1.42 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.315 1.343 . . . . 0.56999999999999995 112.166 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.22 -65.71 0.98 Allowed 'General case' 0 C--N 1.388 2.244 0 N-CA-C 104.726 -2.324 . . . . 0.91000000000000003 104.726 -163.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.0 ttm -59.62 140.9 56.0 Favored 'General case' 0 C--N 1.38 1.912 0 CA-C-O 126.464 3.031 . . . . 0.56999999999999995 110.071 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.496 ' ND2' HH21 ' A' ' 127' ' ' ARG . 0.4 OUTLIER -72.73 139.29 47.08 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 112.698 -2.046 . . . . 0.56999999999999995 109.773 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.496 HH21 ' ND2' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -69.63 -52.13 28.71 Favored 'General case' 0 C--N 1.374 1.658 0 N-CA-C 105.414 -2.069 . . . . 1.2 105.414 -168.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.32 -34.57 57.98 Favored 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.001 -2.363 . . . . 0.91000000000000003 110.877 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.76 -44.01 71.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.91000000000000003 110.931 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.93 -41.5 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.166 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.82 -40.6 92.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.91000000000000003 110.858 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -37.98 81.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.945 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.18 71.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.091 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.3 pt -61.4 -41.47 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.135 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -43.58 97.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 213' ' ' PHE . 2.0 tppt? -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.881 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.8 98.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.092 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 18.7 m-85 -63.7 -36.53 84.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.861 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.2 tp60 -67.71 -39.83 84.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.903 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.441 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 2.3 t -68.72 -34.05 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 111.196 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -84.5 -33.38 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.919 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -73.82 -47.67 36.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.849 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -62.34 -12.05 18.88 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 118.836 -1.145 . . . . 0.56999999999999995 112.877 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.71 0.1 9.71 Favored 'Isoleucine or valine' 0 C--N 1.379 1.882 0 CA-C-N 113.844 -1.525 . . . . 0.56999999999999995 112.675 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' A' ' 146' ' ' PRO . 2.1 m -150.53 140.43 13.88 Favored Pre-proline 0 C--N 1.376 1.745 0 CA-C-O 124.234 1.969 . . . . 0.56999999999999995 110.559 -172.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.419 ' HD2' ' CG2' ' A' ' 145' ' ' THR . 45.5 Cg_endo -79.6 63.16 8.7 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.092 1.861 . . . . 0.56999999999999995 114.048 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.39 120.62 9.53 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 105.824 -1.917 . . . . 0.56999999999999995 105.824 -169.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 158.28 34.79 Favored 'General case' 0 C--N 1.382 1.982 0 CA-C-N 113.278 -1.783 . . . . 0.56999999999999995 113.416 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -129.31 136.31 49.87 Favored 'General case' 0 C--N 1.388 2.276 0 CA-C-N 112.68 -2.055 . . . . 0.56999999999999995 109.818 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.98 111.83 3.52 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 124.808 2.242 . . . . 0.56999999999999995 109.163 -175.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tttm -89.34 146.66 24.55 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 114.108 -1.405 . . . . 0.56999999999999995 111.938 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.64 163.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 109.498 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 9.04 13.4 Favored 'General case' 0 C--N 1.382 2.004 0 CA-C-N 113.06 -1.882 . . . . 0.56999999999999995 111.552 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.8 m -145.0 125.97 14.48 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.97 -130.17 10.15 Favored Glycine 0 C--N 1.376 2.785 0 N-CA-C 109.389 -1.484 . . . . 0.56999999999999995 109.389 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.5 ttp -150.66 146.95 26.81 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.986 1.375 . . . . 0.56999999999999995 107.303 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.35 177.06 6.97 Favored 'General case' 0 C--N 1.373 1.59 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 109.695 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -65.23 -68.18 0.38 Allowed 'General case' 0 C--N 1.378 1.846 0 N-CA-C 104.69 -2.337 . . . . 0.91000000000000003 104.69 -168.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.87 110.26 22.8 Favored 'Isoleucine or valine' 0 C--N 1.378 1.805 0 O-C-N 124.649 1.218 . . . . 0.56999999999999995 111.098 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 121.81 46.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.48 116.95 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.56999999999999995 111.136 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.5 m -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.152 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.13 125.71 33.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.887 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.5 169.88 17.1 Favored 'General case' 0 C--N 1.369 1.445 0 C-N-CA 117.898 -1.521 . . . . 0.56999999999999995 107.675 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 168.29 9.42 Favored 'General case' 0 C--N 1.367 1.343 0 CA-C-N 114.2 -1.363 . . . . 1.2 108.608 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -44.6 132.81 7.35 Favored Glycine 0 C--N 1.377 2.856 0 O-C-N 124.933 1.396 . . . . 0.56999999999999995 111.82 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.99 105.39 0.06 Allowed 'General case' 0 C--N 1.401 2.822 0 CA-C-O 124.668 2.175 . . . . 0.56999999999999995 112.385 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 . . . . . 0 C--N 1.387 2.206 0 CA-C-O 123.401 1.572 . . . . 0.56999999999999995 111.995 -174.489 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 CA-C-O 123.328 1.537 . . . . 0.56999999999999995 109.873 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -117.19 -165.79 1.11 Allowed 'General case' 0 C--N 1.386 2.185 0 CA-C-N 113.146 -1.843 . . . . 0.56999999999999995 111.353 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.27 159.8 16.35 Favored 'General case' 0 C--N 1.38 1.913 0 CA-C-N 114.45 -1.25 . . . . 0.91000000000000003 109.849 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -136.52 62.28 0.6 Allowed Glycine 0 C--N 1.378 2.895 0 CA-C-O 123.869 1.816 . . . . 0.56999999999999995 110.095 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -166.66 -35.53 0.03 OUTLIER 'General case' 0 C--N 1.376 1.736 0 CA-C-N 113.23 -1.485 . . . . 0.56999999999999995 112.713 169.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.48 -63.68 0.04 OUTLIER Glycine 0 C--N 1.37 2.457 0 C-N-CA 119.567 -1.301 . . . . 0.56999999999999995 113.003 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 180' ' ' ILE . . . -35.88 112.39 0.12 Allowed Glycine 0 C--N 1.375 2.729 0 N-CA-C 109.241 -1.544 . . . . 0.56999999999999995 109.241 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 88.91 52.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.889 0 O-C-N 119.217 -2.343 . . . . 0.56999999999999995 108.559 175.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.462 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 2.5 tp -43.11 -30.91 0.49 Allowed 'General case' 0 C--N 1.375 1.697 0 CA-C-O 123.797 1.76 . . . . 0.56999999999999995 112.083 -174.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -179.49 179.78 0.58 Allowed 'General case' 0 C--N 1.368 1.41 0 CA-C-N 113.229 -1.805 . . . . 0.56999999999999995 111.123 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.592 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -142.56 164.67 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.837 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.79 140.87 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -89.93 152.49 21.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 117.816 -1.554 . . . . 0.56999999999999995 109.449 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -92.54 -42.17 4.59 Favored Glycine 0 C--N 1.373 2.595 0 CA-C-N 114.417 -1.265 . . . . 0.56999999999999995 113.623 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 50.7 Cg_exo -63.53 -143.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.401 3.32 0 CA-C-O 125.953 2.397 . . . . 0.56999999999999995 111.676 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -151.47 -148.31 4.78 Favored Glycine 0 C--N 1.376 2.755 0 C-N-CA 117.493 -2.289 . . . . 0.56999999999999995 109.781 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m 77.76 52.17 0.04 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-N 112.629 -1.785 . . . . 0.56999999999999995 107.512 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.54 -72.73 2.75 Favored Glycine 0 C--N 1.376 2.761 0 N-CA-C 106.919 -2.473 . . . . 0.56999999999999995 106.919 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.12 -48.2 63.48 Favored 'Isoleucine or valine' 0 C--N 1.374 1.649 0 CA-C-O 125.85 2.738 . . . . 0.56999999999999995 105.515 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.29 153.92 53.03 Favored Glycine 0 C--N 1.378 2.91 0 C-N-CA 116.282 -2.866 . . . . 0.56999999999999995 108.351 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.23 22.46 Favored Glycine 0 C--N 1.372 2.549 0 CA-C-O 124.178 1.988 . . . . 0.56999999999999995 113.305 -173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.07 146.38 53.54 Favored 'General case' 0 C--N 1.374 1.636 0 O-C-N 120.287 -1.714 . . . . 0.91000000000000003 110.833 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 183' ' ' HIS . . . -144.04 137.36 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.56999999999999995 111.098 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 1.1 m170 -128.39 150.17 50.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.791 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.3 OUTLIER -123.11 150.19 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.48 112.62 14.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.799 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -43.5 88.54 Favored 'General case' 0 C--N 1.383 2.053 0 CA-C-O 117.436 -1.268 . . . . 0.91000000000000003 108.966 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.74 -32.85 0.65 Allowed 'General case' 0 C--N 1.38 1.9 0 O-C-N 125.646 1.841 . . . . 0.91000000000000003 108.959 -173.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.96 176.1 0.44 Allowed 'General case' 0 C--N 1.384 2.072 0 CA-C-O 126.535 3.064 . . . . 0.91000000000000003 109.216 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.91 80.5 1.33 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-N 112.615 -2.084 . . . . 0.56999999999999995 109.016 -175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.462 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 79.6 m95 -76.13 109.14 9.54 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 106.977 -1.49 . . . . 0.56999999999999995 106.977 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.57 121.88 31.75 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-O 125.149 2.404 . . . . 0.56999999999999995 109.869 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.2 p -96.99 151.27 19.87 Favored 'General case' 0 C--N 1.368 1.395 0 N-CA-C 106.198 -1.778 . . . . 0.56999999999999995 106.198 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.65 -48.55 0.23 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 114.316 -1.311 . . . . 0.56999999999999995 109.915 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.3 m -168.78 137.98 2.21 Favored 'General case' 0 C--N 1.384 2.092 0 N-CA-C 108.05 -1.093 . . . . 0.56999999999999995 108.05 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 148.2 -36.92 1.09 Allowed Glycine 0 C--N 1.382 3.122 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 111.671 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 148.82 -84.16 0.17 Allowed Glycine 0 C--N 1.386 3.344 0 CA-C-O 123.801 1.778 . . . . 0.56999999999999995 111.686 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.0 p -78.7 135.94 37.3 Favored 'General case' 0 C--N 1.383 2.025 0 CA-C-N 113.079 -1.56 . . . . 0.56999999999999995 110.964 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.71 141.39 52.14 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 113.949 -1.478 . . . . 0.56999999999999995 108.011 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.15 -26.74 63.13 Favored 'General case' 0 C--N 1.387 2.225 0 CA-C-O 125.086 2.374 . . . . 0.56999999999999995 108.576 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 3.5 t80 -57.6 -50.15 74.08 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-N 113.862 -1.517 . . . . 0.56999999999999995 110.855 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -51.22 69.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.933 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -44.41 97.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.423 ' HA ' ' OE2' ' A' ' 219' ' ' GLU . . . -57.08 -41.36 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.079 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.42 -39.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 111.096 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.458 ' CD2' ' CE ' ' A' ' 236' ' ' MET . 3.7 t-160 -70.08 -50.51 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.802 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 216' ' ' ALA . 0.7 OUTLIER -64.08 -42.02 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.91000000000000003 110.902 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.01 -34.22 62.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 111.113 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.19 -33.48 73.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.699 -0.762 . . . . 0.56999999999999995 112.444 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.59 -44.02 95.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 110.842 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.24 -49.96 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 13.48 5.02 Favored 'General case' 0 C--N 1.392 2.441 0 CA-C-O 123.595 1.664 . . . . 0.56999999999999995 115.324 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -153.12 176.93 31.02 Favored Glycine 0 C--N 1.363 2.04 0 CA-C-O 126.635 3.353 . . . . 0.56999999999999995 108.167 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -158.93 0.23 Allowed 'General case' 0 C--N 1.367 1.337 0 CA-C-O 125.873 2.749 . . . . 0.56999999999999995 109.278 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.78 -143.18 0.11 Allowed Glycine 0 C--N 1.387 3.411 0 CA-C-O 125.524 2.736 . . . . 0.56999999999999995 112.311 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 236' ' ' MET . 34.0 m170 -83.83 -175.29 5.74 Favored 'General case' 0 C--N 1.379 1.861 0 O-C-N 120.444 -1.621 . . . . 0.56999999999999995 114.609 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.11 -84.46 0.4 Allowed 'General case' 0 C--N 1.389 2.308 0 N-CA-C 106.448 -1.686 . . . . 0.56999999999999995 106.448 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 m 155.81 -30.25 0.0 OUTLIER 'General case' 0 C--N 1.389 2.29 0 O-C-N 125.842 1.964 . . . . 0.56999999999999995 113.168 -167.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.2 152.07 42.95 Favored Pre-proline 0 C--N 1.388 2.282 0 N-CA-C 108.291 -1.003 . . . . 0.91000000000000003 108.291 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -60.7 -47.83 12.48 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.687 2.258 . . . . 0.56999999999999995 111.92 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.42 22.79 Favored 'General case' 0 C--N 1.381 1.948 0 CA-C-N 113.252 -1.794 . . . . 0.56999999999999995 115.284 176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.46 120.11 16.57 Favored 'General case' 0 C--N 1.375 1.674 0 CA-C-O 125.158 2.408 . . . . 0.56999999999999995 113.0 173.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 236' ' ' MET . 68.2 t -73.93 86.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.867 0 CA-C-N 111.446 -2.615 . . . . 0.56999999999999995 108.612 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 218' ' ' HIS . 0.0 OUTLIER 162.06 -34.28 0.0 OUTLIER 'General case' 0 C--N 1.377 1.802 0 O-C-N 125.37 1.669 . . . . 0.56999999999999995 109.273 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 4.4 t80 -49.97 146.96 7.33 Favored Pre-proline 0 C--N 1.372 1.579 0 CA-C-O 122.971 1.367 . . . . 0.56999999999999995 110.223 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 74.0 Cg_exo -56.53 -36.99 98.27 Favored 'Trans proline' 0 C--N 1.393 2.904 0 C-N-CA 122.219 1.946 . . . . 0.56999999999999995 112.406 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -45.39 111.79 0.38 Allowed 'General case' 0 C--N 1.376 1.741 0 CA-C-O 123.633 1.683 . . . . 0.56999999999999995 110.642 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -83.92 94.62 8.29 Favored 'General case' 0 C--N 1.38 1.914 0 CA-C-O 124.385 2.041 . . . . 0.56999999999999995 106.431 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -110.84 119.41 39.01 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 108.124 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -55.6 120.91 7.96 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-O 126.105 2.859 . . . . 0.56999999999999995 110.991 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.79 115.23 5.88 Favored 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 105.86 -1.904 . . . . 0.56999999999999995 105.86 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -77.3 33.46 0.16 Allowed 'General case' 0 C--N 1.364 1.239 0 N-CA-C 114.885 1.439 . . . . 0.91000000000000003 114.885 170.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.472 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.5 mt 82.94 -2.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.382 1.987 0 CA-C-O 124.145 1.926 . . . . 0.56999999999999995 108.713 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -88.5 -35.48 16.96 Favored 'General case' 0 C--N 1.38 1.904 0 N-CA-C 103.016 -2.957 . . . . 0.56999999999999995 103.016 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.27 3.47 15.97 Favored 'General case' 0 C--N 1.387 2.229 0 CA-C-N 113.47 -1.695 . . . . 0.56999999999999995 109.778 -173.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 12.06 3.43 Favored 'General case' 0 C--N 1.386 2.195 0 O-C-N 125.754 1.909 . . . . 0.56999999999999995 109.86 -171.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 154.07 12.02 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 124.724 2.202 . . . . 1.2 107.778 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 126.97 52.08 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 103.676 -2.713 . . . . 0.56999999999999995 103.676 -167.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.03 140.53 48.79 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-O 124.883 2.278 . . . . 0.56999999999999995 116.323 169.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.47 86.83 Favored 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.689 -1.596 . . . . 0.56999999999999995 110.184 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.22 -33.12 74.69 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.994 -1.003 . . . . 0.91000000000000003 110.863 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -55.23 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.91000000000000003 110.901 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.144 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -70.17 -32.95 71.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.92 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.7 -48.0 58.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.56999999999999995 112.495 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.467 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.3 pt -62.42 -45.8 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.56999999999999995 111.1 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.467 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.1 pt20 -72.53 -19.11 61.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 110.954 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.377 1.775 0 CA-C-O 122.575 1.178 . . . . 0.56999999999999995 110.687 -176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.013 0 CA-C-O 122.341 1.067 . . . . 1.2 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 60.14 176.94 0.09 Allowed 'General case' 0 C--N 1.399 2.746 0 CA-C-N 113.407 -1.724 . . . . 0.56999999999999995 110.471 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.27 -84.99 0.03 OUTLIER 'General case' 0 C--N 1.387 2.224 0 CA-C-N 114.23 -1.35 . . . . 0.56999999999999995 110.323 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -117.49 107.08 13.87 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.44 1.713 . . . . 0.56999999999999995 110.933 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -103.0 147.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.149 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -109.79 134.96 51.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.145 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.507 ' CD2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -143.87 155.61 44.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.892 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -142.43 139.4 31.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.851 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.08 142.97 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.118 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 163' ' ' PHE . 22.9 t30 -54.07 -63.87 1.01 Allowed 'General case' 0 C--N 1.366 1.29 0 N-CA-C 108.433 -0.951 . . . . 0.56999999999999995 108.433 -171.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.45 -172.01 3.2 Favored 'General case' 0 C--N 1.38 1.916 0 N-CA-C 107.398 -1.334 . . . . 0.56999999999999995 107.398 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -176.96 82.57 0.02 OUTLIER 'General case' 0 C--N 1.39 2.327 0 CA-C-O 124.419 2.057 . . . . 0.56999999999999995 113.653 -172.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 125' ' ' MET . 0.5 OUTLIER -171.71 -56.28 0.0 OUTLIER Pre-proline 0 C--N 1.372 1.574 0 O-C-N 119.894 -1.753 . . . . 0.56999999999999995 110.167 -174.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.9 -55.31 0.18 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 N-CA-C 107.932 -1.603 . . . . 0.56999999999999995 107.932 -171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -129.46 -12.07 4.47 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 114.221 -1.354 . . . . 0.91000000000000003 110.921 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -114.19 128.08 56.2 Favored 'General case' 0 C--N 1.38 1.907 0 CA-C-O 124.638 2.161 . . . . 0.56999999999999995 106.798 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.02 144.56 25.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.446 -2.659 . . . . 0.56999999999999995 110.256 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -53.49 8.27 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 106.409 -1.701 . . . . 1.2 106.409 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.54 -37.69 88.42 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-N 114.222 -1.354 . . . . 0.91000000000000003 110.934 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -70.2 -44.06 69.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.91000000000000003 110.896 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.22 -46.28 77.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.095 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -56.82 -44.16 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.839 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -39.6 90.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.37 -49.07 70.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.56999999999999995 111.141 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.4 pt -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.172 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -49.32 77.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -35.66 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.88 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.41 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.133 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 149' ' ' PHE . 1.8 m-85 -67.25 -33.67 75.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.835 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.474 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.6 pt20 -68.44 -40.72 81.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.912 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.471 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 5.2 p -70.53 -34.35 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.168 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.418 ' CD1' HD22 ' A' ' 224' ' ' LEU . 4.4 m95 -83.25 -33.72 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.6 m -78.26 -50.55 11.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.898 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -56.59 -13.88 2.75 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 113.278 0.844 . . . . 0.56999999999999995 113.278 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.429 HG13 ' ND2' ' A' ' 143' ' ' ASN . 18.2 m -114.52 9.11 7.7 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 CA-C-N 114.541 -1.209 . . . . 0.56999999999999995 111.451 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.2 p -149.23 147.17 22.78 Favored Pre-proline 0 C--N 1.373 1.594 0 CA-C-O 124.599 2.142 . . . . 0.56999999999999995 108.484 -173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.85 22.07 1.0 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 121.544 1.496 . . . . 0.56999999999999995 113.056 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.91 101.03 6.15 Favored 'General case' 0 C--N 1.378 1.829 0 N-CA-C 105.619 -1.993 . . . . 0.56999999999999995 105.619 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.27 159.59 30.98 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-O 126.77 3.176 . . . . 0.56999999999999995 116.263 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . 45.6 m-85 -132.19 162.64 30.42 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.533 -2.122 . . . . 0.56999999999999995 107.396 -177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.3 m -157.67 123.33 4.62 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 125.859 2.742 . . . . 0.56999999999999995 108.394 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -95.97 141.48 29.34 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 110.972 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.93 159.55 41.85 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-O 124.276 1.988 . . . . 0.56999999999999995 108.986 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.4 -15.01 14.56 Favored 'General case' 0 C--N 1.384 2.097 0 CA-C-N 113.117 -1.856 . . . . 0.56999999999999995 107.807 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 89.3 m -60.22 -59.8 4.83 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 123.343 1.544 . . . . 0.56999999999999995 107.373 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.93 146.16 4.9 Favored Glycine 0 C--N 1.38 2.997 0 N-CA-C 110.539 -1.024 . . . . 0.56999999999999995 110.539 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.6 ttp 78.79 88.59 0.06 Allowed 'General case' 0 C--N 1.399 2.758 0 CA-C-O 124.465 2.078 . . . . 0.56999999999999995 110.075 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.9 172.16 13.18 Favored 'General case' 0 C--N 1.373 1.622 0 CA-C-N 113.158 -1.837 . . . . 0.56999999999999995 109.718 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 115' ' ' THR . 33.1 m-20 -61.15 -59.4 5.39 Favored 'General case' 0 C--N 1.37 1.469 0 N-CA-C 105.836 -1.913 . . . . 0.91000000000000003 105.836 -173.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.82 109.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.388 2.282 0 O-C-N 124.326 1.016 . . . . 0.56999999999999995 111.118 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.8 128.59 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 t -105.48 118.26 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.087 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 196' ' ' HIS . 6.8 t -131.48 132.16 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.085 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 119' ' ' ASN . 4.2 m-85 -90.61 121.32 32.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.836 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.15 166.57 24.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 107.599 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 167.62 9.76 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 114.19 -1.368 . . . . 1.2 109.888 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -39.45 121.49 1.42 Allowed Glycine 0 C--N 1.395 3.825 0 O-C-N 125.297 1.623 . . . . 0.56999999999999995 111.018 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 87.71 80.9 0.01 OUTLIER 'General case' 0 C--N 1.397 2.653 0 CA-C-O 125.214 2.435 . . . . 0.56999999999999995 109.882 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--N 1.39 2.351 0 CA-C-N 113.13 -1.85 . . . . 0.56999999999999995 110.494 -179.446 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 122.609 1.195 . . . . 0.56999999999999995 111.768 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.436 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -124.11 -161.5 1.0 Allowed 'General case' 0 C--N 1.39 2.361 0 CA-C-N 113.01 -1.904 . . . . 0.56999999999999995 111.804 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.61 -54.38 4.3 Favored 'General case' 0 C--N 1.388 2.269 0 CA-C-N 114.676 -1.147 . . . . 0.91000000000000003 111.934 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.03 105.64 0.05 OUTLIER Glycine 0 C--N 1.396 3.87 0 C-N-CA 118.591 -1.766 . . . . 0.56999999999999995 117.317 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.66 90.4 0.09 Allowed 'General case' 0 C--N 1.381 1.967 0 CA-C-O 125.28 2.467 . . . . 0.56999999999999995 112.43 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.29 -144.73 26.09 Favored Glycine 0 C--N 1.381 3.079 0 O-C-N 119.529 -1.982 . . . . 0.56999999999999995 113.453 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.72 -118.96 8.6 Favored Glycine 0 C--N 1.395 3.817 0 N-CA-C 108.39 -1.884 . . . . 0.56999999999999995 108.39 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.57 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.706 0 N-CA-C 105.94 -1.874 . . . . 0.56999999999999995 105.94 -175.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.432 ' CD2' ' CE1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -38.23 -33.94 0.11 Allowed 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.881 -175.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -178.41 179.95 0.73 Allowed 'General case' 0 C--N 1.383 2.057 0 O-C-N 125.727 1.892 . . . . 0.56999999999999995 111.081 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.456 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -151.03 151.01 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.865 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.81 140.36 31.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.063 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.1 OUTLIER -87.64 124.24 33.33 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 118.323 -1.351 . . . . 0.56999999999999995 108.715 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -124.48 50.19 0.87 Allowed Glycine 0 C--N 1.371 2.476 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 113.579 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 33.9 Cg_endo -76.49 -52.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 121.217 1.278 . . . . 0.56999999999999995 109.765 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.17 47.36 0.71 Allowed Glycine 0 C--N 1.392 3.642 0 CA-C-O 123.759 1.755 . . . . 0.56999999999999995 111.869 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -155.02 -147.79 0.22 Allowed 'General case' 0 C--N 1.384 2.065 0 O-C-N 121.074 -1.251 . . . . 0.56999999999999995 108.732 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -55.85 -79.19 0.1 OUTLIER Glycine 0 C--N 1.388 3.466 0 CA-C-O 126.105 3.058 . . . . 0.56999999999999995 112.531 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -11.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.387 2.232 0 CA-C-O 124.823 2.249 . . . . 0.56999999999999995 110.362 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.06 126.51 22.71 Favored Glycine 0 C--N 1.37 2.446 0 O-C-N 118.292 -2.755 . . . . 0.56999999999999995 111.829 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 108.93 -50.14 0.8 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 113.527 -1.336 . . . . 0.56999999999999995 111.985 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -34.92 102.7 0.02 OUTLIER 'General case' 0 C--N 1.379 1.877 0 O-C-N 124.649 0.852 . . . . 0.91000000000000003 110.901 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -116.52 150.32 38.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.068 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.438 ' CD2' ' HB ' ' A' ' 162' ' ' VAL . 19.5 m170 -135.03 139.16 44.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 110.854 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.4 OUTLIER -111.09 150.11 29.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 110.903 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.31 110.82 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.788 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.91 -20.66 52.47 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-O 126.423 3.011 . . . . 0.91000000000000003 108.555 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -12.38 60.27 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 118.3 -2.75 . . . . 0.91000000000000003 110.712 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.05 -179.63 7.47 Favored 'General case' 0 C--N 1.398 2.678 0 N-CA-C 102.651 -3.092 . . . . 0.91000000000000003 102.651 -168.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.98 82.05 1.59 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.346 -1.752 . . . . 0.56999999999999995 110.624 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 60.5 m95 -72.51 102.93 3.35 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 123.788 1.756 . . . . 0.56999999999999995 108.754 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.35 130.82 35.44 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 113.762 -1.563 . . . . 0.56999999999999995 110.953 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 p -119.02 101.24 7.88 Favored 'General case' 0 C--N 1.385 2.135 0 CA-C-N 113.034 -1.894 . . . . 0.56999999999999995 107.752 -175.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 77.6 36.73 0.26 Allowed 'General case' 0 C--N 1.403 2.9 0 CA-C-O 126.039 2.828 . . . . 0.56999999999999995 104.863 168.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 t -138.07 -92.22 0.21 Allowed 'General case' 0 C--N 1.391 2.406 0 CA-C-N 112.716 -2.038 . . . . 0.56999999999999995 109.053 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.58 156.39 24.0 Favored Glycine 0 C--N 1.38 3.022 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 110.541 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.24 -136.44 13.01 Favored Glycine 0 C--N 1.369 2.412 0 CA-C-O 124.126 1.959 . . . . 0.56999999999999995 111.242 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.9 m -69.08 117.54 10.86 Favored 'General case' 0 C--N 1.384 2.078 0 CA-C-O 123.317 1.532 . . . . 0.56999999999999995 112.517 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.92 153.91 19.74 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.311 1.529 . . . . 0.56999999999999995 111.603 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.72 -31.45 64.98 Favored 'General case' 0 C--N 1.389 2.324 0 CA-C-N 113.347 -1.752 . . . . 0.56999999999999995 106.653 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . 0.477 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 1.6 t80 -59.04 -50.46 73.99 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.086 -1.634 . . . . 0.56999999999999995 110.859 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.531 HD23 ' CE1' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -58.19 -51.83 68.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.906 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -33.96 75.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.178 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 219' ' ' GLU . . . -68.83 -39.48 79.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.56999999999999995 111.114 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 213' ' ' PHE . 41.4 t -68.1 -38.46 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 111.154 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -70.06 -50.85 37.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.56999999999999995 110.837 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -56.6 -45.19 81.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.91000000000000003 110.913 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 217' ' ' VAL . 5.5 pt -72.73 -39.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 111.075 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.03 -33.88 64.92 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.474 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.86 -44.02 94.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.56999999999999995 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -50.24 55.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.828 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 141' ' ' TRP . 3.4 pp -75.82 0.6 17.51 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.954 2.576 . . . . 0.56999999999999995 117.954 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -145.73 -158.79 7.86 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 -173.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.28 -156.73 0.76 Allowed 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 107.678 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -55.93 -167.21 0.06 OUTLIER Glycine 0 C--N 1.397 3.951 0 CA-C-O 125.717 2.843 . . . . 0.56999999999999995 112.486 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.5 m80 -100.28 -150.31 0.38 Allowed 'General case' 0 C--N 1.37 1.484 0 O-C-N 120.387 -1.654 . . . . 0.56999999999999995 110.225 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 p -122.39 -24.24 5.05 Favored 'General case' 0 C--N 1.387 2.219 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 110.493 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 83.06 16.43 0.31 Allowed 'General case' 0 C--N 1.398 2.704 0 CA-C-O 123.2 1.476 . . . . 0.56999999999999995 113.21 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -134.29 150.28 73.59 Favored Pre-proline 0 C--N 1.386 2.18 0 N-CA-C 104.818 -2.29 . . . . 0.91000000000000003 104.818 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -56.6 -20.58 34.81 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.091 2.527 . . . . 0.56999999999999995 114.036 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -40.29 85.09 Favored 'General case' 0 C--N 1.385 2.142 0 CA-C-N 113.329 -1.76 . . . . 0.56999999999999995 115.628 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.79 128.33 23.43 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 123.86 1.79 . . . . 0.56999999999999995 110.716 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -75.52 2.48 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.126 0 CA-C-O 125.38 2.514 . . . . 0.56999999999999995 111.53 -177.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.496 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 5.7 ptm -142.31 8.19 1.79 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 120.422 -1.424 . . . . 0.56999999999999995 110.188 -175.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.501 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -42.79 143.96 1.11 Allowed Pre-proline 0 C--N 1.37 1.459 0 CA-C-O 124.097 1.903 . . . . 0.56999999999999995 112.844 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.92 -50.31 14.41 Favored 'Trans proline' 0 C--N 1.371 1.728 0 O-C-N 119.481 -0.852 . . . . 0.56999999999999995 112.351 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.501 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -52.46 126.46 19.45 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-O 123.318 1.532 . . . . 0.56999999999999995 109.669 -175.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.531 ' CE1' HD23 ' A' ' 214' ' ' LEU . 78.4 t80 -99.28 166.57 11.15 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 119.959 -1.713 . . . . 0.56999999999999995 107.833 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 169.36 121.45 0.01 OUTLIER 'General case' 0 C--N 1.39 2.352 0 N-CA-C 106.058 -1.83 . . . . 0.56999999999999995 106.058 173.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.85 121.6 6.19 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.882 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.38 113.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.741 -1.572 . . . . 0.56999999999999995 107.702 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -44.65 146.0 0.81 Allowed 'General case' 0 C--N 1.383 2.044 0 CA-C-O 125.737 2.684 . . . . 0.91000000000000003 107.719 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.464 ' CG1' ' CD1' ' A' ' 213' ' ' PHE . 3.9 mp -62.03 -22.87 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-N 113.319 -1.764 . . . . 0.56999999999999995 112.603 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.66 -21.93 66.63 Favored 'General case' 0 C--N 1.372 1.585 0 CA-C-O 123.034 1.397 . . . . 0.56999999999999995 111.397 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.6 p -108.36 1.11 21.58 Favored 'General case' 0 C--N 1.385 2.134 0 N-CA-C 114.904 1.446 . . . . 0.56999999999999995 114.904 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 235' ' ' VAL . 51.3 t80 -74.47 83.84 1.99 Allowed 'General case' 0 C--N 1.376 1.725 0 CA-C-O 124.973 2.32 . . . . 0.56999999999999995 109.292 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.448 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 1.6 tmt_? -99.32 154.79 17.91 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-O 123.813 1.768 . . . . 1.2 108.913 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -121.84 136.1 54.92 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 106.246 -173.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 42.5 m -67.67 137.65 55.73 Favored 'General case' 0 C--N 1.376 1.719 0 CA-C-N 113.305 -1.771 . . . . 0.56999999999999995 111.627 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.08 -46.36 81.45 Favored 'General case' 0 C--N 1.384 2.099 0 N-CA-C 108.055 -1.091 . . . . 0.56999999999999995 108.055 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.71 -36.81 79.76 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 115.41 -0.814 . . . . 0.91000000000000003 110.845 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.46 -55.22 25.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.91000000000000003 110.846 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.3 pt -66.09 -36.38 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.116 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.419 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 4.3 mtt-85 -70.32 -33.33 71.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.828 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.86 76.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.56999999999999995 112.48 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.497 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.2 pt -64.81 -45.05 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.685 0.279 . . . . 0.56999999999999995 111.052 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.497 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.14 -23.5 61.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.981 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.366 1.302 0 CA-C-O 122.403 1.096 . . . . 0.56999999999999995 109.785 -178.064 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 CA-C-O 119.319 -0.711 . . . . 0.56999999999999995 111.612 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.82 108.39 2.64 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.316 2.677 . . . . 0.56999999999999995 108.983 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.41 122.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.545 0 CA-C-N 114.755 -1.111 . . . . 0.56999999999999995 109.057 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -166.59 72.88 0.14 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 124.397 2.046 . . . . 0.56999999999999995 109.121 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 mtt-85 -115.48 156.67 25.25 Favored 'General case' 0 C--N 1.375 1.679 0 CA-C-O 123.146 1.451 . . . . 1.2 109.468 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 52.57 0.48 Allowed 'General case' 0 C--N 1.379 1.87 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 108.179 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -168.96 -55.39 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.219 -1.355 . . . . 0.56999999999999995 109.321 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -98.62 112.13 24.28 Favored 'General case' 0 C--N 1.371 1.515 0 O-C-N 124.006 0.816 . . . . 0.56999999999999995 110.934 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.72 151.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.062 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -106.0 159.77 15.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.56999999999999995 111.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 5.7 t80 -148.59 150.51 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.92 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -142.8 132.91 24.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 1.2 110.889 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.97 140.46 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.147 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -160.88 0.02 OUTLIER 'General case' 0 C--N 1.379 1.883 0 CA-C-O 124.362 2.03 . . . . 0.56999999999999995 109.718 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.32 39.38 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 111.069 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 59.33 16.8 5.32 Favored 'General case' 0 C--N 1.386 2.161 0 O-C-N 124.362 1.039 . . . . 0.56999999999999995 110.083 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.436 HG23 ' CE1' ' A' ' 163' ' ' PHE . 0.1 OUTLIER 65.98 158.18 0.13 Allowed Pre-proline 0 C--N 1.367 1.331 0 O-C-N 128.217 3.448 . . . . 0.56999999999999995 109.793 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.44 -43.65 0.35 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 O-C-N 118.265 -1.492 . . . . 0.56999999999999995 112.145 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -63.71 1.18 Allowed 'General case' 0 C--N 1.371 1.509 0 C-N-CA 125.209 1.404 . . . . 0.91000000000000003 113.471 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.1 ttm -42.64 132.44 3.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 128.035 3.779 . . . . 0.56999999999999995 110.336 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -78.06 143.4 37.46 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.038 -2.289 . . . . 0.56999999999999995 107.97 -172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -46.59 47.06 Favored 'General case' 0 C--N 1.38 1.903 0 N-CA-C 107.03 -1.47 . . . . 1.2 107.03 -164.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -54.75 -34.78 62.99 Favored 'General case' 0 C--N 1.396 2.602 0 CA-C-N 111.428 -2.624 . . . . 0.91000000000000003 110.927 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.11 -43.71 70.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.933 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.62 -39.07 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.174 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.13 87.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.91000000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -67.32 -49.05 65.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 110.929 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.12 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 111.101 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.44 -31.94 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.17 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -67.93 -46.78 70.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CD ' ' OE1' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.56 -46.05 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.926 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.89 80.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 111.061 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 -44.11 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.56999999999999995 110.902 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.416 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.0 pt20 -63.75 -37.05 85.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.91 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -69.47 -34.01 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.13 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.433 ' O ' ' CG2' ' A' ' 145' ' ' THR . 49.6 m95 -82.97 -34.3 26.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 110.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -49.36 13.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.875 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -59.51 -12.71 6.83 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-O 121.429 0.633 . . . . 0.56999999999999995 112.352 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 23.8 m -115.63 16.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 C-N-CA 124.027 0.931 . . . . 0.56999999999999995 109.531 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 75.2 p -146.01 150.69 43.04 Favored Pre-proline 0 C--N 1.367 1.362 0 CA-C-O 124.642 2.163 . . . . 0.56999999999999995 107.474 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -80.38 -11.01 13.31 Favored 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-O 123.027 1.178 . . . . 0.56999999999999995 111.072 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.75 113.19 26.62 Favored 'General case' 0 C--N 1.371 1.529 0 N-CA-C 103.85 -2.648 . . . . 0.56999999999999995 103.85 -172.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.52 158.4 36.32 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-O 125.213 2.435 . . . . 0.56999999999999995 117.177 166.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CZ ' HD21 ' A' ' 224' ' ' LEU . 9.6 m-85 -131.15 158.8 39.49 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.573 -1.649 . . . . 0.56999999999999995 107.439 -174.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 125.57 5.96 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-O 124.29 1.995 . . . . 0.56999999999999995 106.956 -171.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 150.08 20.95 Favored 'General case' 0 C--N 1.367 1.363 0 CA-C-O 123.335 1.54 . . . . 0.56999999999999995 109.736 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 pt -144.15 -178.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.552 0 CA-C-O 123.618 1.675 . . . . 0.56999999999999995 108.919 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -155.09 54.59 0.64 Allowed 'General case' 0 C--N 1.379 1.89 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 107.949 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.4 -69.27 0.06 Allowed 'General case' 0 C--N 1.377 1.781 0 C-N-CA 119.955 -0.698 . . . . 0.56999999999999995 109.813 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -86.05 173.64 46.88 Favored Glycine 0 C--N 1.372 2.569 0 CA-C-O 124.161 1.978 . . . . 0.56999999999999995 110.38 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.2 ttt -63.66 154.4 33.07 Favored 'General case' 0 C--N 1.377 1.782 0 CA-C-N 112.331 -1.935 . . . . 0.56999999999999995 107.81 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -137.59 170.92 15.25 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 113.721 -1.582 . . . . 0.56999999999999995 109.636 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.67 -67.8 0.76 Allowed 'General case' 0 C--N 1.379 1.877 0 N-CA-C 102.255 -3.239 . . . . 0.91000000000000003 102.255 -168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.9 mt -92.51 109.9 22.17 Favored 'Isoleucine or valine' 0 C--N 1.402 2.871 0 O-C-N 124.544 1.153 . . . . 0.56999999999999995 111.087 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 194' ' ' ASP . 0.9 OUTLIER -105.45 132.11 52.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.918 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.5 t -109.84 117.02 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 111.143 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.61 146.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.137 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.436 ' CE1' HG23 ' A' ' 122' ' ' THR . 57.1 m-85 -103.74 118.48 36.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.833 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.25 167.59 23.12 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-O 124.109 1.909 . . . . 0.56999999999999995 109.69 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 149.29 24.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.426 -2.046 . . . . 1.2 108.524 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.78 121.05 1.83 Allowed Glycine 0 C--N 1.375 2.738 0 CA-C-N 113.349 -1.751 . . . . 0.56999999999999995 110.861 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -178.21 -57.8 0.01 OUTLIER 'General case' 0 C--N 1.379 1.878 0 CA-C-O 123.028 1.394 . . . . 0.56999999999999995 108.396 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -68.61 -15.56 63.57 Favored 'General case' 0 C--N 1.389 2.286 0 CA-C-O 123.266 1.507 . . . . 0.56999999999999995 109.732 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 177.32 -127.79 1.24 Allowed Glycine 0 C--N 1.377 2.83 0 N-CA-C 108.286 -1.925 . . . . 0.56999999999999995 108.286 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' A' ' 174' ' ' PHE . 3.2 m-20 67.84 26.44 7.62 Favored 'General case' 0 C--N 1.382 2.012 0 N-CA-C 105.825 -1.917 . . . . 0.91000000000000003 105.825 170.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 76.58 54.51 0.04 OUTLIER 'General case' 0 C--N 1.379 1.872 0 CA-C-N 114.67 -1.15 . . . . 0.56999999999999995 108.205 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 64.07 42.37 5.74 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 119.19 -1.004 . . . . 0.56999999999999995 111.814 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.94 95.63 0.03 OUTLIER 'General case' 0 C--N 1.368 1.395 0 CA-C-O 122.616 1.198 . . . . 0.56999999999999995 111.44 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -57.44 -97.52 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 123.986 1.85 . . . . 0.56999999999999995 112.894 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.48 178.36 4.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 125.25 2.452 . . . . 0.91000000000000003 110.324 173.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -150.87 35.53 0.92 Allowed Glycine 0 C--N 1.372 2.561 0 CA-C-N 112.221 -2.263 . . . . 0.56999999999999995 112.258 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 14.55 0.14 Allowed 'General case' 0 C--N 1.376 1.76 0 CA-C-O 122.012 0.911 . . . . 0.56999999999999995 112.541 -175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.56 -143.46 10.2 Favored Glycine 0 C--N 1.364 2.097 0 CA-C-O 122.515 1.064 . . . . 0.56999999999999995 110.801 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.93 -130.99 47.61 Favored Glycine 0 C--N 1.36 1.881 0 O-C-N 119.994 -1.886 . . . . 0.56999999999999995 111.194 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 174' ' ' PHE . 1.0 OUTLIER -54.41 163.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.517 0 CA-C-N 113.065 -1.568 . . . . 0.56999999999999995 108.866 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.433 ' HB2' ' H21' ' A' ' 269' ' ' HSI . 11.2 mt -111.4 -40.29 4.43 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 115.527 1.677 . . . . 0.56999999999999995 115.527 169.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 197' ' ' PHE . . . -175.03 179.92 1.49 Allowed 'General case' 0 C--N 1.363 1.177 0 O-C-N 121.278 -0.889 . . . . 0.56999999999999995 111.111 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.34 159.9 39.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.852 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.57 153.06 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.56999999999999995 111.141 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -93.85 -177.82 4.47 Favored 'General case' 0 C--N 1.373 1.588 0 CA-C-O 123.052 1.406 . . . . 0.56999999999999995 109.758 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.58 -158.96 15.92 Favored Glycine 0 C--N 1.378 2.866 0 CA-C-N 114.372 -1.286 . . . . 0.56999999999999995 112.075 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.39 -139.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.443 2.762 . . . . 0.56999999999999995 112.169 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.19 -132.4 10.94 Favored Glycine 0 C--N 1.371 2.513 0 O-C-N 119.307 -2.12 . . . . 0.56999999999999995 108.968 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.66 157.13 31.25 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.817 -1.549 . . . . 0.56999999999999995 106.817 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.71 3.8 Favored Glycine 0 C--N 1.381 3.053 1 N-CA-C 102.479 -4.249 . . . . 0.56999999999999995 102.479 165.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -36.35 67.95 Favored 'Isoleucine or valine' 0 C--N 1.377 1.785 0 CA-C-O 124.534 2.111 . . . . 0.56999999999999995 109.97 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.15 132.48 28.24 Favored Glycine 0 C--N 1.38 2.996 0 N-CA-C 104.389 -3.484 . . . . 0.56999999999999995 104.389 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.46 -6.61 57.68 Favored Glycine 0 C--N 1.366 2.2 0 CA-C-O 124.085 1.936 . . . . 0.56999999999999995 110.268 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 160' ' ' LEU . 1.3 m-20 -88.24 166.67 14.18 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.073 -1.839 . . . . 0.91000000000000003 110.897 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.54 161.12 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.066 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -129.24 125.77 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.919 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 2.0 m-85 -105.41 133.0 50.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.56999999999999995 110.883 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -61.83 86.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.886 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.01 -33.05 70.0 Favored 'General case' 0 C--N 1.398 2.674 0 C-N-CA 115.823 -2.351 . . . . 0.91000000000000003 105.576 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.98 -47.72 8.62 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 123.821 0.848 . . . . 0.91000000000000003 108.774 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.02 174.37 0.06 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-O 127.562 3.553 . . . . 0.91000000000000003 111.978 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.21 110.63 22.64 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 112.365 -2.198 . . . . 0.56999999999999995 109.898 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.438 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.7 m95 -93.09 148.56 21.9 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 107.588 -1.264 . . . . 0.56999999999999995 107.588 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.1 p -127.14 125.94 42.05 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 110.007 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.06 133.74 42.11 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.452 -1.685 . . . . 0.56999999999999995 106.452 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 80.69 -43.76 0.22 Allowed 'General case' 0 C--N 1.374 1.646 0 CA-C-N 114.571 -1.195 . . . . 0.56999999999999995 109.591 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.54 153.98 0.37 Allowed 'General case' 0 C--N 1.369 1.43 0 N-CA-C 107.996 -1.112 . . . . 0.56999999999999995 107.996 -173.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 125.93 6.25 6.0 Favored Glycine 0 C--N 1.376 2.784 0 CA-C-N 114.556 -1.202 . . . . 0.56999999999999995 114.089 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 144.31 -119.75 1.33 Allowed Glycine 0 C--N 1.378 2.869 0 CA-C-O 123.752 1.751 . . . . 0.56999999999999995 112.36 -168.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.6 p -94.25 133.0 38.25 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-N 113.951 -1.124 . . . . 0.56999999999999995 109.331 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -98.2 150.39 21.55 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.878 1.799 . . . . 0.56999999999999995 111.713 177.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -75.54 -29.65 59.49 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 106.087 -1.82 . . . . 0.56999999999999995 106.087 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 7.8 t80 -57.45 -50.25 73.63 Favored 'General case' 0 C--N 1.373 1.623 0 CA-C-N 115.305 -0.861 . . . . 0.56999999999999995 110.909 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.425 HD13 ' C26' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -55.55 -51.15 68.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.56999999999999995 110.952 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.32 -35.5 79.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.56999999999999995 111.132 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.21 96.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 111.114 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.443 HG23 ' CE1' ' A' ' 213' ' ' PHE . 95.4 t -65.23 -48.02 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.171 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 236' ' ' MET . 6.4 t-160 -64.63 -50.21 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.815 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' HG3' ' CZ ' ' A' ' 197' ' ' PHE . 17.3 mm-40 -57.92 -42.22 84.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.91000000000000003 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.56 -46.81 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.32 -33.53 61.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.56999999999999995 112.501 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -64.71 -38.89 92.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.56999999999999995 110.833 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.99 -53.23 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.831 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 149' ' ' PHE . 3.0 pp -93.94 -56.8 2.74 Favored 'General case' 0 C--N 1.381 1.958 0 N-CA-C 117.783 2.512 . . . . 0.56999999999999995 117.783 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 221' ' ' GLY . . . -45.08 149.89 1.1 Allowed Glycine 0 C--N 1.373 2.611 1 CA-C-O 128.049 4.139 . . . . 0.56999999999999995 110.486 177.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.16 -153.51 0.05 Allowed 'General case' 0 C--N 1.365 1.247 0 CA-C-N 109.975 -3.113 . . . . 0.56999999999999995 107.153 -171.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.0 -175.62 0.5 Allowed Glycine 0 C--N 1.379 2.923 0 CA-C-O 127.213 3.674 . . . . 0.56999999999999995 113.001 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -100.56 -174.25 2.6 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 118.997 -2.472 . . . . 0.56999999999999995 111.343 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.1 p -103.63 -34.67 8.55 Favored 'General case' 0 C--N 1.38 1.932 0 CA-C-N 113.835 -1.53 . . . . 0.56999999999999995 108.748 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.78 22.37 0.39 Allowed 'General case' 0 C--N 1.385 2.121 0 N-CA-C 114.152 1.168 . . . . 0.56999999999999995 114.152 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.74 131.99 11.05 Favored Pre-proline 0 C--N 1.378 1.838 0 N-CA-C 102.828 -3.027 . . . . 0.91000000000000003 102.828 -164.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.462 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 47.5 Cg_exo -61.73 74.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 124.9 3.733 . . . . 0.56999999999999995 114.913 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.38 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 CA-C-N 113.634 -1.621 . . . . 0.56999999999999995 111.349 -171.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.61 133.53 34.84 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 106.655 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.465 ' O ' ' CG ' ' A' ' 236' ' ' MET . 11.5 p -70.48 68.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.318 0 CA-C-N 113.028 -1.896 . . . . 0.56999999999999995 112.166 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER -175.64 -35.76 0.01 OUTLIER 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.635 -1.291 . . . . 0.56999999999999995 109.931 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.469 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.16 145.46 0.32 Allowed Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 124.948 2.309 . . . . 0.56999999999999995 111.575 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.551 ' HB3' H521 ' A' ' 269' ' ' HSI . 89.2 Cg_exo -57.93 -47.66 19.73 Favored 'Trans proline' 0 C--N 1.374 1.869 0 O-C-N 119.21 -0.995 . . . . 0.56999999999999995 111.499 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.469 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 14.1 m -49.35 124.66 9.58 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-O 124.328 2.013 . . . . 0.56999999999999995 109.921 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -94.15 140.19 30.06 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-O 123.297 1.523 . . . . 0.56999999999999995 107.997 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.506 ' HD2' ' H33' ' A' ' 269' ' ' HSI . 4.9 tmtt? -155.56 109.39 2.82 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 105.635 -1.987 . . . . 0.56999999999999995 105.635 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -54.03 123.71 13.4 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-O 124.144 1.926 . . . . 0.56999999999999995 109.628 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.561 HG11 ' C33' ' A' ' 269' ' ' HSI . 9.6 p -154.65 111.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 114.158 -1.383 . . . . 0.56999999999999995 107.349 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.21 142.44 51.77 Favored 'General case' 0 C--N 1.365 1.248 0 N-CA-C 103.219 -2.882 . . . . 0.91000000000000003 103.219 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.406 HG12 ' CG ' ' A' ' 213' ' ' PHE . 1.1 mp -46.05 -23.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.309 0 CA-C-N 111.248 -2.706 . . . . 0.56999999999999995 112.769 174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -51.72 -37.47 51.13 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.051 -0.977 . . . . 0.56999999999999995 109.767 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.9 p -103.88 -0.64 28.84 Favored 'General case' 0 C--N 1.386 2.171 0 N-CA-C 116.48 2.03 . . . . 0.56999999999999995 116.48 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.17 93.66 0.07 Allowed 'General case' 0 C--N 1.365 1.252 0 CA-C-O 127.039 3.304 . . . . 0.56999999999999995 107.491 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 152.57 42.33 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 112.745 -2.025 . . . . 1.2 106.371 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.15 131.31 53.89 Favored 'General case' 0 C--N 1.372 1.577 0 CA-C-O 125.634 2.635 . . . . 0.56999999999999995 104.987 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.77 136.71 58.0 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.599 -1.938 . . . . 0.56999999999999995 111.68 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.23 94.06 Favored 'General case' 0 C--N 1.383 2.05 0 N-CA-C 106.245 -1.761 . . . . 0.56999999999999995 106.245 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -41.03 85.16 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.215 -0.928 . . . . 0.91000000000000003 110.858 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -55.34 23.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.91000000000000003 110.892 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.21 -34.9 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.108 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -70.44 -30.38 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.872 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.15 -39.78 57.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.798 -0.715 . . . . 0.56999999999999995 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.19 -41.41 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.175 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -34.45 68.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t -76.77 -24.0 52.93 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-O 122.23 1.014 . . . . 0.56999999999999995 109.489 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.897 1.808 . . . . 0.56999999999999995 109.945 -174.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.32 18.52 8.21 Favored 'General case' 0 C--N 1.369 1.447 0 CA-C-N 113.979 -1.464 . . . . 0.56999999999999995 114.824 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 2.296 0 N-CA-C 117.764 1.866 . . . . 0.91000000000000003 117.764 174.831 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.561 ' C33' HG11 ' A' ' 243' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 111.093 -0.803 . . . . 0.56999999999999995 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.89 93.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.589 2.193 . . . . 0.56999999999999995 112.945 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.56 132.98 56.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 CA-C-N 113.935 -1.484 . . . . 0.56999999999999995 108.565 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -162.95 59.18 0.2 Allowed 'General case' 0 C--N 1.383 2.043 0 CA-C-O 125.671 2.653 . . . . 0.56999999999999995 108.663 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.59 146.52 26.59 Favored 'General case' 0 C--N 1.374 1.635 0 O-C-N 119.944 -1.722 . . . . 1.2 108.87 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 -50.94 0.01 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 122.316 1.055 . . . . 0.56999999999999995 110.4 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -69.68 -32.24 70.74 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 114.117 -1.401 . . . . 0.56999999999999995 108.482 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -109.17 109.47 20.44 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 120.129 -1.607 . . . . 0.56999999999999995 110.935 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.69 139.88 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.139 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 4.4 p -112.94 159.76 18.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.56999999999999995 111.118 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -149.08 153.37 37.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.955 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.477 ' CD ' ' C ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -142.1 122.02 13.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.939 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 119' ' ' ASN . 12.8 mm -87.65 117.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 111.14 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ILE . 1.5 t-20 -37.52 -57.72 0.92 Allowed 'General case' 0 C--N 1.37 1.473 0 C-N-CA 120.019 -0.672 . . . . 0.56999999999999995 111.382 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 24.9 t-20 -155.87 -61.14 0.11 Allowed 'General case' 0 C--N 1.378 1.812 0 CA-C-N 113.725 -1.58 . . . . 0.56999999999999995 107.995 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 120' ' ' ASN . 1.2 m-30 152.99 30.76 0.0 OUTLIER 'General case' 0 C--N 1.379 1.88 0 O-C-N 126.17 2.169 . . . . 0.56999999999999995 112.731 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 68.87 141.54 0.08 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 CA-C-O 124.38 2.038 . . . . 0.56999999999999995 107.924 172.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HG3' ' CG ' ' A' ' 199' ' ' GLU . 39.7 Cg_endo -70.47 -41.58 3.28 Favored 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 118.432 -1.404 . . . . 0.56999999999999995 112.319 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -110.74 -51.76 2.84 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 111.074 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.46 ' HE2' ' CZ3' ' A' ' 203' ' ' TRP . 0.1 OUTLIER -43.96 143.87 1.02 Allowed 'General case' 0 C--N 1.377 1.802 0 CA-C-O 124.953 2.311 . . . . 0.56999999999999995 108.926 -174.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' HB2' ' OD2' ' A' ' 129' ' ' ASP . 62.0 m-20 -73.47 139.01 45.48 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.977 -1.92 . . . . 0.56999999999999995 109.358 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.403 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -67.59 -50.07 60.08 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 107.758 -1.201 . . . . 1.2 107.758 -170.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.96 -36.36 65.26 Favored 'General case' 0 C--N 1.38 1.894 0 CA-C-N 113.271 -1.786 . . . . 0.91000000000000003 110.891 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 126' ' ' ASN . 97.4 m-20 -70.82 -37.83 73.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.18 -49.2 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 111.137 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 16.8 m-20 -69.93 -40.62 75.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.817 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -66.02 -42.22 89.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.891 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' CB ' ' CD2' ' A' ' 212' ' ' LEU . . . -63.62 -49.01 75.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 111.136 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 15.8 pt -64.9 -31.94 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -66.89 -46.8 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.88 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -46.04 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.56999999999999995 110.913 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.98 83.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.049 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.97 -44.89 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.56999999999999995 110.893 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.471 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.4 pt20 -64.97 -35.27 80.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.918 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 1.2 t -69.53 -34.2 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.085 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 7.5 m95 -83.03 -34.2 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.56999999999999995 110.911 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -48.24 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.56999999999999995 110.853 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -61.0 -12.61 12.07 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.854 0.835 . . . . 0.56999999999999995 111.612 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 19.6 m -115.42 -10.06 12.21 Favored 'Isoleucine or valine' 0 C--N 1.375 1.687 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.533 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 HG22 ' CD1' ' A' ' 224' ' ' LEU . 0.5 OUTLIER -139.99 148.73 56.09 Favored Pre-proline 0 C--N 1.36 1.058 0 CA-C-O 125.092 2.377 . . . . 0.56999999999999995 110.021 -177.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -70.7 -39.67 4.5 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 118.24 -1.505 . . . . 0.56999999999999995 111.857 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mt -50.63 111.41 0.54 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 122.734 1.254 . . . . 0.56999999999999995 107.923 -174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -76.37 159.24 30.68 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 114.473 -1.239 . . . . 0.56999999999999995 111.176 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 6.1 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 108.756 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 m -159.85 110.96 1.96 Allowed 'General case' 0 C--N 1.386 2.183 0 CA-C-O 124.923 2.297 . . . . 0.56999999999999995 109.022 -172.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.55 133.83 37.75 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 109.645 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.03 172.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.364 1.231 0 CA-C-O 124.545 2.117 . . . . 0.56999999999999995 110.135 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -63.77 1.24 Allowed 'General case' 0 C--N 1.383 2.038 0 CA-C-N 113.31 -1.768 . . . . 0.56999999999999995 110.023 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.9 t -142.62 52.58 1.42 Allowed 'General case' 0 C--N 1.376 1.733 0 CA-C-O 124.926 2.298 . . . . 0.56999999999999995 110.154 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -127.9 21.94 5.5 Favored Glycine 0 C--N 1.364 2.106 0 C-N-CA 118.492 -1.813 . . . . 0.56999999999999995 112.515 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.12 95.05 0.06 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.961 2.315 . . . . 0.56999999999999995 110.264 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' CB ' ' C ' ' A' ' 116' ' ' TYR . . . -96.36 174.68 6.75 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 117.89 -1.524 . . . . 0.56999999999999995 112.49 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.16 -50.75 13.74 Favored 'General case' 0 C--N 1.375 1.694 0 N-CA-C 105.197 -2.149 . . . . 0.91000000000000003 105.197 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 1.8 pp -114.11 116.18 51.83 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 CA-C-N 115.158 -0.928 . . . . 0.56999999999999995 111.141 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.87 132.15 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.56999999999999995 110.877 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.412 ' CG1' ' CE1' ' A' ' 197' ' ' PHE . 30.6 t -101.96 117.0 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 111.1 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.02 146.01 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.132 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.465 ' CD1' HG22 ' A' ' 122' ' ' THR . 0.3 OUTLIER -106.18 119.99 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.89 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.28 168.6 18.58 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 123.795 1.76 . . . . 0.56999999999999995 109.696 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -107.3 167.72 9.72 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.701 -1.25 . . . . 1.2 110.595 177.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.426 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -40.17 143.05 0.58 Allowed Glycine 0 C--N 1.38 3.027 0 CA-C-O 123.22 1.455 . . . . 0.56999999999999995 112.303 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 72.19 43.65 0.5 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-O 124.708 2.194 . . . . 0.56999999999999995 109.218 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.419 ' HB3' ' O ' ' A' ' 165' ' ' ARG . 31.2 p-80 -99.27 -54.3 3.0 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 123.663 1.697 . . . . 0.56999999999999995 108.385 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.2 -169.99 42.92 Favored Glycine 0 C--N 1.372 2.548 0 N-CA-C 109.156 -1.578 . . . . 0.56999999999999995 109.156 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.63 18.57 8.56 Favored 'General case' 0 C--N 1.391 2.41 0 CA-C-N 112.8 -1.7 . . . . 0.91000000000000003 109.182 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 159.9 -32.88 0.0 OUTLIER 'General case' 0 C--N 1.372 1.563 0 O-C-N 125.063 1.477 . . . . 0.56999999999999995 111.377 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.1 t60 82.85 34.48 0.06 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 123.62 1.676 . . . . 0.56999999999999995 111.565 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 167.54 121.13 0.01 OUTLIER 'General case' 0 C--N 1.385 2.129 0 O-C-N 120.894 -1.129 . . . . 0.56999999999999995 109.593 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.426 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -116.73 -161.6 0.81 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 114.221 -1.354 . . . . 0.56999999999999995 111.697 175.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -99.38 -68.68 0.79 Allowed 'General case' 0 C--N 1.378 1.827 0 N-CA-C 108.758 -0.83 . . . . 0.91000000000000003 108.758 178.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.401 ' N ' ' OD2' ' A' ' 175' ' ' ASP . . . 54.69 165.16 0.02 OUTLIER Glycine 0 C--N 1.392 3.666 0 CA-C-O 125.095 2.497 . . . . 0.56999999999999995 116.813 -167.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.49 7.77 5.11 Favored 'General case' 0 C--N 1.379 1.88 0 O-C-N 120.507 -1.584 . . . . 0.56999999999999995 113.48 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.18 -140.73 11.98 Favored Glycine 0 C--N 1.363 2.072 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.02 -104.17 0.11 Allowed Glycine 0 C--N 1.362 2.026 0 CA-C-O 123.566 1.648 . . . . 0.56999999999999995 112.52 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.7 mt -62.58 169.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.494 0 CA-C-O 123.333 1.54 . . . . 0.56999999999999995 112.506 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' CD1' ' HB ' ' A' ' 210' ' ' THR . 23.5 tp -128.92 -40.31 1.53 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 118.211 -2.805 . . . . 0.56999999999999995 110.499 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 197' ' ' PHE . . . -176.5 179.94 1.11 Allowed 'General case' 0 C--N 1.379 1.854 0 CA-C-N 114.918 -1.037 . . . . 0.56999999999999995 111.081 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.438 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -155.04 145.86 22.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 110.846 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.01 151.24 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.082 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.13 -179.99 7.13 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.968 1.842 . . . . 0.56999999999999995 111.131 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.99 -162.89 24.0 Favored Glycine 0 C--N 1.38 2.985 0 CA-C-O 124.142 1.968 . . . . 0.56999999999999995 111.703 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.24 79.15 1.79 Allowed 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.099 1.866 . . . . 0.56999999999999995 112.074 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -128.31 160.76 22.1 Favored Glycine 0 C--N 1.367 2.281 0 CA-C-O 123.182 1.434 . . . . 0.56999999999999995 110.074 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -74.94 -177.61 3.4 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.428 -1.386 . . . . 0.56999999999999995 109.237 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.13 -117.22 5.9 Favored Glycine 0 C--N 1.383 3.186 0 N-CA-C 109.834 -1.306 . . . . 0.56999999999999995 109.834 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.44 -46.81 92.44 Favored 'Isoleucine or valine' 0 C--N 1.383 2.051 0 CA-C-N 112.547 -1.826 . . . . 0.56999999999999995 110.44 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.7 133.89 4.61 Favored Glycine 0 C--N 1.369 2.415 0 CA-C-O 124.486 2.159 . . . . 0.56999999999999995 109.671 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.8 -48.82 1.21 Allowed Glycine 0 C--N 1.37 2.465 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 113.129 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.29 160.06 0.17 Allowed 'General case' 0 C--N 1.376 1.724 0 CA-C-O 120.798 0.333 . . . . 0.91000000000000003 110.901 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.46 32.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.101 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -121.62 126.25 48.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 110.875 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.445 ' CD2' ' HB1' ' A' ' 182' ' ' ALA . 2.5 m-85 -108.22 150.08 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.89 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 90.41 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.91000000000000003 110.803 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.401 ' CG ' ' HG3' ' A' ' 123' ' ' PRO . 3.8 tp10 -74.65 -5.52 43.52 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 124.216 1.96 . . . . 0.91000000000000003 110.475 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -32.97 35.16 Favored 'General case' 0 C--N 1.369 1.416 0 CA-C-O 123.003 1.382 . . . . 0.91000000000000003 108.902 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.58 176.06 2.58 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-O 123.439 1.59 . . . . 0.91000000000000003 111.99 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.76 104.02 16.01 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-N 112.576 -2.102 . . . . 0.56999999999999995 112.589 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.46 ' CZ3' ' HE2' ' A' ' 125' ' ' MET . 18.2 m95 -76.7 128.52 34.83 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 114.273 -1.33 . . . . 0.56999999999999995 108.525 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.0 p -122.86 104.88 9.56 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 109.309 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.46 130.83 57.01 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 108.658 -177.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 24.85 3.45 Favored 'General case' 0 C--N 1.389 2.318 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 111.402 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.16 -71.41 0.5 Allowed 'General case' 0 C--N 1.38 1.896 0 CA-C-N 114.241 -1.345 . . . . 0.56999999999999995 108.479 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.94 90.96 0.08 OUTLIER Glycine 0 C--N 1.389 3.487 0 C-N-CA 118.478 -1.82 . . . . 0.56999999999999995 113.09 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.5 -141.71 7.61 Favored Glycine 0 C--N 1.378 2.879 0 C-N-CA 119.55 -1.309 . . . . 0.56999999999999995 110.132 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' A' ' 181' ' ' LEU . 72.7 p -67.42 128.66 37.25 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-O 124.128 1.918 . . . . 0.56999999999999995 112.146 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -135.34 145.46 47.45 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 109.607 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' A' ' 133' ' ' ALA . 1.4 pt? -65.0 -25.37 67.83 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-O 123.911 1.815 . . . . 0.56999999999999995 108.933 -174.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.443 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 48.7 t80 -54.18 -42.65 69.92 Favored 'General case' 0 C--N 1.372 1.568 0 CA-C-N 113.734 -1.575 . . . . 0.56999999999999995 110.879 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.11 -51.11 70.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.926 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.55 -33.78 73.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 111.139 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -65.92 -46.33 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.113 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 213' ' ' PHE . 6.0 t -65.43 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.14 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.432 ' CD2' ' HG2' ' A' ' 236' ' ' MET . 6.2 t-160 -71.33 -50.04 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 110.844 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.31 -42.07 98.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.91000000000000003 110.876 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 34.5 mt -65.04 -37.94 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.56999999999999995 111.119 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.451 ' HA3' ' CZ2' ' A' ' 141' ' ' TRP . . . -68.3 -33.99 79.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 0.56999999999999995 112.49 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.448 ' CG ' ' CE ' ' A' ' 236' ' ' MET . 2.9 m-70 -67.39 -40.67 85.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.56999999999999995 110.871 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m -70.54 -41.22 72.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.882 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.48 HD11 ' CE3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -40.76 -36.97 0.69 Allowed 'General case' 0 C--N 1.358 0.97 0 CA-C-O 124.475 2.083 . . . . 0.56999999999999995 111.753 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.4 -38.92 1.13 Allowed Glycine 0 C--N 1.369 2.386 0 N-CA-C 108.392 -1.883 . . . . 0.56999999999999995 108.392 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -100.09 150.95 21.95 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-O 123.062 1.41 . . . . 0.56999999999999995 111.602 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.22 -118.92 0.27 Allowed Glycine 0 C--N 1.374 2.668 0 CA-C-O 125.063 2.479 . . . . 0.56999999999999995 111.881 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -110.55 -155.01 0.55 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 109.053 -178.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -115.56 -8.06 12.16 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 114.614 -1.175 . . . . 0.56999999999999995 111.149 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 82.54 -5.41 1.36 Allowed 'General case' 0 C--N 1.381 1.962 0 N-CA-C 113.527 0.936 . . . . 0.56999999999999995 113.527 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.56 158.84 74.23 Favored Pre-proline 0 C--N 1.372 1.577 0 N-CA-C 107.346 -1.353 . . . . 0.91000000000000003 107.346 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -55.02 -29.92 67.26 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.952 2.435 . . . . 0.56999999999999995 112.99 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.35 -25.51 1.02 Allowed 'General case' 0 C--N 1.382 2.021 0 CA-C-N 114.662 -1.154 . . . . 0.56999999999999995 113.589 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -91.13 124.62 35.49 Favored 'General case' 0 C--N 1.378 1.814 0 CA-C-O 124.656 2.169 . . . . 0.56999999999999995 110.77 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.483 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -70.41 -8.36 10.65 Favored 'Isoleucine or valine' 0 C--N 1.377 1.768 0 CA-C-N 113.016 -1.902 . . . . 0.56999999999999995 111.838 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.501 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 1.3 ttt -99.4 17.92 19.02 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.227 -0.897 . . . . 0.56999999999999995 110.689 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.456 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 9.8 t80 -55.3 141.54 61.56 Favored Pre-proline 0 C--N 1.367 1.344 0 CA-C-O 123.12 1.438 . . . . 0.56999999999999995 108.693 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 51.6 Cg_exo -51.76 -52.94 7.89 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.98 1.787 . . . . 0.56999999999999995 113.714 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.95 142.24 56.62 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 125.288 1.618 . . . . 0.56999999999999995 109.929 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.557 ' HA ' ' C25' ' A' ' 269' ' ' HSI . 7.9 t80 -94.71 153.21 17.9 Favored 'General case' 0 C--N 1.385 2.126 0 CA-C-N 113.583 -1.644 . . . . 0.56999999999999995 109.63 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 4.2 tmtt? 177.31 104.17 0.02 OUTLIER 'General case' 0 C--N 1.389 2.292 0 CA-C-O 123.238 1.494 . . . . 0.56999999999999995 107.461 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.25 120.02 4.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 125.105 2.384 . . . . 0.56999999999999995 109.927 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.95 9.51 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 110.407 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.88 -16.31 0.5 Allowed 'General case' 0 C--N 1.367 1.342 0 O-C-N 125.631 1.832 . . . . 0.91000000000000003 111.683 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.5 mt 74.87 -48.71 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.121 0 N-CA-C 114.605 1.335 . . . . 0.56999999999999995 114.605 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -45.22 -27.06 0.57 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 114.376 1.25 . . . . 0.56999999999999995 114.376 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.3 p -106.28 -0.68 24.2 Favored 'General case' 0 C--N 1.376 1.721 0 CA-C-N 115.373 -0.83 . . . . 0.56999999999999995 110.959 -176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 235' ' ' VAL . 12.5 t80 -58.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.372 1.559 0 CA-C-O 124.46 2.076 . . . . 0.56999999999999995 109.054 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.403 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -109.74 152.0 26.21 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-N 113.351 -1.75 . . . . 1.2 107.22 -176.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.6 OUTLIER -121.83 134.66 54.89 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-O 124.549 2.118 . . . . 0.56999999999999995 106.246 -173.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -67.01 136.79 55.84 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 120.551 -1.343 . . . . 0.56999999999999995 110.441 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.4 94.94 Favored 'General case' 0 C--N 1.381 1.977 0 N-CA-C 107.218 -1.401 . . . . 0.56999999999999995 107.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.43 -37.51 87.78 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 119.62 -1.925 . . . . 0.91000000000000003 110.849 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.83 -55.35 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 11.7 pt -66.23 -35.51 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.094 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.414 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 48.7 mtm180 -70.33 -34.32 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.2 110.843 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.63 -49.56 59.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.493 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.3 pt -62.15 -45.23 99.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.56999999999999995 111.089 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.493 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -71.45 -28.06 63.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 110.878 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.7 t -75.25 -21.11 58.81 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-O 121.909 0.862 . . . . 0.56999999999999995 110.883 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -81.71 0.04 OUTLIER 'General case' 0 C--N 1.375 1.675 0 CA-C-O 123.531 1.634 . . . . 0.56999999999999995 109.903 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 58.8 1.67 Allowed 'General case' 0 C--N 1.37 1.462 0 CA-C-N 114.818 -1.083 . . . . 0.56999999999999995 110.589 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.366 2.229 0 CA-C-O 115.843 -2.643 . . . . 0.91000000000000003 115.151 176.522 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.557 ' C25' ' HA ' ' A' ' 240' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.455 0 CA-C-O 118.655 -1.08 . . . . 0.56999999999999995 111.305 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.21 131.71 47.93 Favored 'Trans proline' 0 C--N 1.367 1.539 0 O-C-N 125.673 2.407 . . . . 0.56999999999999995 110.89 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.34 117.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-N 112.268 -2.242 . . . . 0.56999999999999995 109.2 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -153.82 105.38 2.77 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 113.166 -1.834 . . . . 0.56999999999999995 108.986 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.01 151.69 18.24 Favored 'General case' 0 C--N 1.381 1.935 0 CA-C-N 112.835 -1.984 . . . . 1.2 107.962 -172.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.58 -44.13 0.09 Allowed 'General case' 0 C--N 1.372 1.549 0 CA-C-N 113.301 -1.772 . . . . 0.56999999999999995 110.185 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.436 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 2.4 p-80 -89.43 -21.65 22.92 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 113.001 -1.909 . . . . 0.56999999999999995 111.644 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -113.04 107.95 16.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 115.784 -0.644 . . . . 0.56999999999999995 110.92 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 155.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.138 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 150.55 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.137 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -150.04 160.08 43.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.502 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -141.14 129.18 21.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.849 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -94.5 129.52 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.162 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -54.36 178.78 0.02 OUTLIER 'General case' 0 C--N 1.369 1.447 0 CA-C-O 124.701 2.191 . . . . 0.56999999999999995 109.121 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.51 45.09 0.84 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.026 -1.672 . . . . 0.56999999999999995 109.926 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 7.0 m-85 53.85 -168.15 0.07 Allowed 'General case' 0 C--N 1.386 2.152 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 107.432 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.63 165.34 17.62 Favored Pre-proline 0 C--N 1.378 1.837 0 CA-C-N 113.668 -1.606 . . . . 0.56999999999999995 107.487 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 -55.62 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 120.904 1.069 . . . . 0.56999999999999995 113.467 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.78 -52.71 63.09 Favored 'General case' 0 C--N 1.375 1.701 0 CA-C-N 114.042 -1.436 . . . . 0.91000000000000003 111.985 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.538 ' CE ' ' CD1' ' A' ' 203' ' ' TRP . 2.6 ttm -77.03 126.85 31.66 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 124.565 2.126 . . . . 0.56999999999999995 110.844 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -72.05 131.36 42.78 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-N 112.78 -2.009 . . . . 0.56999999999999995 109.009 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.405 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.62 -49.95 64.59 Favored 'General case' 0 C--N 1.366 1.313 0 N-CA-C 107.737 -1.208 . . . . 1.2 107.737 -169.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -55.52 -35.38 65.57 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-N 112.221 -2.263 . . . . 0.91000000000000003 110.841 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.44 -43.35 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.91000000000000003 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.04 -49.93 82.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -59.22 -44.14 92.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.91000000000000003 110.803 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.72 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.938 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.06 73.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.062 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 134' ' ' ILE . 2.4 mm -65.28 -40.41 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.35 -46.13 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.2 110.852 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -42.7 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 110.921 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.45 -44.93 89.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.11 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.544 ' CD1' HD13 ' A' ' 220' ' ' ILE . 11.8 m-85 -64.15 -36.35 83.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 110.86 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.6 tt0 -67.12 -40.05 86.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.95 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.459 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -69.5 -34.1 60.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.106 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.477 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 43.8 m95 -82.92 -34.03 26.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.56999999999999995 110.939 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 m -79.3 -50.57 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.883 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -56.77 -14.04 3.04 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.34 0.867 . . . . 0.56999999999999995 113.34 178.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 17.9 m -113.73 -7.33 12.04 Favored 'Isoleucine or valine' 0 C--N 1.377 1.788 0 CA-C-N 113.678 -1.601 . . . . 0.56999999999999995 112.628 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.429 HG23 ' CB ' ' A' ' 259' ' ' GLN . 0.2 OUTLIER -150.58 143.18 16.18 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-O 125.068 2.366 . . . . 0.56999999999999995 109.291 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 112' ' ' HIS . 55.7 Cg_endo -82.12 49.9 3.28 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.017 1.811 . . . . 0.56999999999999995 111.362 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.457 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mt -134.02 73.79 1.52 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 106.551 -1.648 . . . . 0.56999999999999995 106.551 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.75 161.9 22.57 Favored 'General case' 0 C--N 1.369 1.456 0 CA-C-O 125.468 2.556 . . . . 0.56999999999999995 117.499 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -135.15 159.94 39.95 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.486 -2.143 . . . . 0.56999999999999995 106.237 -172.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.2 m -140.78 111.16 6.74 Favored 'General case' 0 C--N 1.379 1.885 0 CA-C-O 124.154 1.931 . . . . 0.56999999999999995 106.523 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 27.5 tttt -82.19 145.97 29.78 Favored 'General case' 0 C--N 1.369 1.446 0 CA-C-N 112.833 -1.985 . . . . 0.56999999999999995 111.934 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.0 pt -128.68 162.14 36.2 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 CA-C-N 112.928 -1.942 . . . . 0.56999999999999995 109.48 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -139.8 39.76 2.0 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-N 113.442 -1.708 . . . . 0.56999999999999995 110.684 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.62 -70.81 0.54 Allowed 'General case' 0 C--N 1.378 1.83 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 108.479 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -99.41 -130.44 6.95 Favored Glycine 0 C--N 1.382 3.108 0 N-CA-C 108.802 -1.719 . . . . 0.56999999999999995 108.802 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -122.79 134.67 54.42 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 111.885 -2.158 . . . . 0.56999999999999995 109.083 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.48 179.0 4.7 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 112.831 -1.986 . . . . 0.56999999999999995 111.527 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.24 -65.34 0.74 Allowed 'General case' 0 C--N 1.387 2.217 0 N-CA-C 103.924 -2.621 . . . . 0.91000000000000003 103.924 -166.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.84 109.84 24.96 Favored 'Isoleucine or valine' 0 C--N 1.37 1.486 0 CA-C-N 114.834 -1.075 . . . . 0.56999999999999995 111.112 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.0 130.97 51.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.927 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.467 ' CG1' ' CE1' ' A' ' 197' ' ' PHE . 83.3 t -102.09 117.02 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.094 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.1 146.02 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.105 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -99.15 116.74 32.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.857 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.08 170.04 16.51 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 124.967 2.318 . . . . 0.56999999999999995 110.923 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 168.26 9.25 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 113.753 -1.567 . . . . 1.2 111.646 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -43.41 128.12 5.75 Favored Glycine 0 C--N 1.385 3.27 0 O-C-N 126.299 2.25 . . . . 0.56999999999999995 112.569 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -179.89 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.384 2.076 0 CA-C-N 111.7 -2.25 . . . . 0.56999999999999995 110.853 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.34 142.98 48.65 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.656 -1.611 . . . . 0.56999999999999995 108.578 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 37.59 -138.28 0.6 Allowed Glycine 0 C--N 1.377 2.854 0 O-C-N 125.629 1.83 . . . . 0.56999999999999995 112.637 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 11.8 m-20 64.74 38.47 6.86 Favored 'General case' 0 C--N 1.401 2.808 0 CA-C-O 125.632 2.634 . . . . 0.91000000000000003 106.276 169.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 63.99 -97.43 0.06 Allowed 'General case' 0 C--N 1.381 1.977 0 CA-C-N 113.431 -1.713 . . . . 0.56999999999999995 110.747 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 51.9 t60 -115.58 63.97 0.69 Allowed 'General case' 0 C--N 1.379 1.886 0 CA-C-N 114.357 -1.292 . . . . 0.56999999999999995 110.846 174.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 172' ' ' HIS . . . 73.97 -159.29 0.08 Allowed 'General case' 0 C--N 1.376 1.746 0 C-N-CA 117.969 -1.492 . . . . 0.56999999999999995 112.124 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -133.53 -159.88 1.0 Allowed 'General case' 0 C--N 1.368 1.408 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 110.273 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.34 175.31 6.79 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.28 -1.782 . . . . 0.91000000000000003 110.946 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.03 34.59 1.65 Allowed Glycine 0 C--N 1.389 3.516 0 CA-C-N 111.927 -2.397 . . . . 0.56999999999999995 111.697 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.45 -40.99 0.05 OUTLIER 'General case' 0 C--N 1.376 1.749 0 CA-C-N 112.79 -1.705 . . . . 0.56999999999999995 112.077 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -166.65 -122.56 0.61 Allowed Glycine 0 C--N 1.38 2.978 0 C-N-CA 117.846 -2.121 . . . . 0.56999999999999995 110.399 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.48 -122.52 26.88 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 117.316 -1.825 . . . . 0.56999999999999995 113.418 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.565 HG13 ' H52' ' A' ' 269' ' ' HSI . 0.3 OUTLIER -45.75 170.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 O-C-N 127.434 2.491 . . . . 0.56999999999999995 114.077 172.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.432 ' HG ' ' CG2' ' A' ' 215' ' ' THR . 6.6 tp -123.77 -66.71 0.98 Allowed 'General case' 0 C--N 1.374 1.634 0 CA-C-O 123.151 1.453 . . . . 0.56999999999999995 113.864 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 197' ' ' PHE . . . -178.15 179.88 0.78 Allowed 'General case' 0 C--N 1.358 0.963 0 CA-C-N 112.719 -2.037 . . . . 0.56999999999999995 111.054 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.436 ' O ' ' CB ' ' A' ' 195' ' ' ALA . 2.8 p80 -158.23 177.12 11.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.854 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.75 17.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.56999999999999995 111.151 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -84.69 173.41 10.75 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 118.578 -1.249 . . . . 0.56999999999999995 108.9 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.07 -156.17 4.33 Favored Glycine 0 C--N 1.382 3.085 0 C-N-CA 118.356 -1.878 . . . . 0.56999999999999995 110.563 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.66 -87.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.063 1.175 . . . . 0.56999999999999995 110.643 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.28 -143.52 2.42 Favored Glycine 0 C--N 1.387 3.388 0 CA-C-O 123.958 1.866 . . . . 0.56999999999999995 110.233 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.88 163.99 38.06 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 111.164 -2.518 . . . . 0.56999999999999995 108.705 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.82 -108.26 2.51 Favored Glycine 0 C--N 1.386 3.308 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.64 -37.32 69.05 Favored 'Isoleucine or valine' 0 C--N 1.386 2.158 0 CA-C-O 125.513 2.578 . . . . 0.56999999999999995 109.292 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.11 138.5 49.5 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 108.922 -1.671 . . . . 0.56999999999999995 108.922 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.77 -15.78 62.09 Favored Glycine 0 C--N 1.37 2.468 0 CA-C-O 124.701 2.279 . . . . 0.56999999999999995 109.044 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -73.72 144.22 45.82 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.531 -1.334 . . . . 0.91000000000000003 110.864 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 183' ' ' HIS . . . -125.76 152.62 45.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.114 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -134.04 132.45 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.874 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.54 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 0.7 OUTLIER -121.04 147.26 45.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.907 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.457 ' OD2' ' CG2' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.97 83.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.91000000000000003 110.881 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.4 -46.81 78.58 Favored 'General case' 0 C--N 1.375 1.682 0 N-CA-C 105.327 -2.101 . . . . 0.91000000000000003 105.327 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -44.3 -43.43 7.42 Favored 'General case' 0 C--N 1.372 1.544 0 O-C-N 126.092 2.12 . . . . 0.91000000000000003 109.706 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -49.23 173.92 0.02 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 125.53 2.586 . . . . 0.91000000000000003 113.971 172.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.4 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 16.2 m-85 -113.28 95.08 5.19 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.388 -2.187 . . . . 0.56999999999999995 112.412 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.54 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 35.5 m95 -75.63 132.39 40.58 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 106.95 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.3 p -110.86 103.26 11.75 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 124.908 2.289 . . . . 0.56999999999999995 109.038 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 69.5 p -104.13 106.88 17.54 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 114.096 -1.411 . . . . 0.56999999999999995 110.122 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 171.46 -59.46 0.01 OUTLIER 'General case' 0 C--N 1.383 2.047 0 CA-C-N 113.222 -1.808 . . . . 0.56999999999999995 107.333 177.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 158.18 58.88 0.0 OUTLIER 'General case' 0 C--N 1.391 2.372 0 O-C-N 127.772 3.17 . . . . 0.56999999999999995 110.992 -171.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.3 -88.1 0.3 Allowed Glycine 0 C--N 1.382 3.129 0 C-N-CA 117.082 -2.485 . . . . 0.56999999999999995 113.442 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.97 -108.23 3.19 Favored Glycine 0 C--N 1.383 3.14 0 CA-C-O 126.984 3.547 . . . . 0.56999999999999995 112.787 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 p -66.63 119.33 11.56 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 111.744 -2.228 . . . . 0.56999999999999995 111.512 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.17 143.34 43.37 Favored 'General case' 0 C--N 1.373 1.614 0 CA-C-N 113.758 -1.565 . . . . 0.56999999999999995 109.702 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.43 -25.12 60.38 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-N 112.728 -2.033 . . . . 0.56999999999999995 107.276 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.424 ' CE1' ' CG2' ' A' ' 217' ' ' VAL . 12.4 t80 -58.47 -49.16 78.33 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 113.926 -1.488 . . . . 0.56999999999999995 110.823 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.721 HD13 ' C26' ' A' ' 269' ' ' HSI . 0.9 OUTLIER -54.97 -50.96 67.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.56999999999999995 110.976 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.432 ' CG2' ' HG ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -67.22 -37.65 83.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.93 91.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.093 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.424 ' CG2' ' CE1' ' A' ' 213' ' ' PHE . 7.8 t -65.14 -40.17 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.111 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -72.08 -37.55 69.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 110.892 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -42.07 97.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 138' ' ' PHE . 64.6 mt -70.0 -38.98 76.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 111.134 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.18 93.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.56999999999999995 112.481 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.4 OUTLIER -63.97 -43.17 96.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.56999999999999995 110.844 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -38.07 72.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.886 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.11 -42.93 19.99 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 118.452 -1.299 . . . . 0.56999999999999995 111.007 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 127.25 33.46 0.62 Allowed Glycine 0 C--N 1.385 3.265 0 CA-C-N 112.33 -2.213 . . . . 0.56999999999999995 109.449 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.34 177.35 4.9 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-O 123.523 1.63 . . . . 0.56999999999999995 109.355 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -136.08 23.39 3.35 Favored Glycine 0 C--N 1.381 3.082 0 CA-C-N 112.679 -2.055 . . . . 0.56999999999999995 110.526 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.2 OUTLIER 62.68 177.07 0.14 Allowed 'General case' 0 C--N 1.395 2.546 0 CA-C-N 113.056 -1.572 . . . . 0.56999999999999995 110.041 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.5 p -103.85 -23.59 13.37 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 113.206 -1.815 . . . . 0.56999999999999995 111.17 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 81.39 21.39 0.35 Allowed 'General case' 0 C--N 1.385 2.134 0 O-C-N 125.683 1.864 . . . . 0.56999999999999995 112.627 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.9 143.68 45.39 Favored Pre-proline 0 C--N 1.392 2.419 0 N-CA-C 103.216 -2.883 . . . . 0.91000000000000003 103.216 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.82 66.49 6.71 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.444 2.763 . . . . 0.56999999999999995 111.005 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 -35.44 0.01 OUTLIER 'General case' 0 C--N 1.362 1.142 0 CA-C-N 113.537 -1.665 . . . . 0.56999999999999995 112.699 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -70.05 114.63 8.4 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 113.724 -1.58 . . . . 0.56999999999999995 112.141 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 235' ' ' VAL . 5.1 t -53.2 88.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 CA-C-N 112.907 -1.951 . . . . 0.56999999999999995 112.17 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER 159.13 -29.33 0.0 OUTLIER 'General case' 0 C--N 1.367 1.347 0 CA-C-N 115.033 -0.985 . . . . 0.56999999999999995 111.747 -174.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 9.2 p90 -45.61 143.99 2.75 Favored Pre-proline 0 C--N 1.372 1.55 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 110.65 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.43 ' O ' ' H14' ' A' ' 269' ' ' HSI . 55.9 Cg_exo -59.54 -38.08 84.94 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 120.54 0.826 . . . . 0.56999999999999995 111.911 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -40.49 113.51 0.37 Allowed 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.596 1.665 . . . . 0.56999999999999995 111.383 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 179' ' ' GLY . 2.6 t80 -76.66 133.83 39.46 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 112.603 -2.09 . . . . 0.56999999999999995 105.909 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.704 ' O ' ' H35' ' A' ' 269' ' ' HSI . 1.2 tmtt? -175.53 98.24 0.07 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 124.267 1.984 . . . . 0.56999999999999995 108.815 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -61.12 127.88 33.68 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 124.1 1.905 . . . . 0.56999999999999995 110.973 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.421 HG11 ' H33' ' A' ' 269' ' ' HSI . 0.0 OUTLIER -104.04 -9.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.365 1.282 0 CA-C-N 113.022 -1.899 . . . . 0.56999999999999995 112.267 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER 75.85 -3.64 2.53 Favored 'General case' 0 C--N 1.384 2.088 0 O-C-N 126.605 2.441 . . . . 0.91000000000000003 110.865 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.462 ' CB ' ' O ' ' A' ' 244' ' ' ASP . 2.4 mt 83.0 5.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.696 0 CA-C-N 114.525 -1.216 . . . . 0.56999999999999995 113.105 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -36.6 29.61 Favored 'General case' 0 C--N 1.385 2.126 0 N-CA-C 102.713 -3.069 . . . . 0.56999999999999995 102.713 -165.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.7 p -116.92 -4.68 11.52 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 113.164 -1.835 . . . . 0.56999999999999995 114.023 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.457 ' CZ ' HG11 ' A' ' 235' ' ' VAL . 30.9 t80 -56.02 91.48 0.01 OUTLIER 'General case' 0 C--N 1.373 1.594 0 CA-C-O 124.312 2.006 . . . . 0.56999999999999995 109.485 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.45 151.7 51.82 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 112.434 -2.167 . . . . 1.2 106.675 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.6 OUTLIER -124.17 127.59 47.98 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 125.082 2.372 . . . . 0.56999999999999995 104.936 -171.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 147.22 46.87 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 113.666 -1.606 . . . . 0.56999999999999995 111.896 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.37 93.07 Favored 'General case' 0 C--N 1.388 2.239 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 108.7 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -37.28 85.35 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-N 115.516 -0.765 . . . . 0.91000000000000003 110.862 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -64.22 -55.02 24.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.91000000000000003 110.846 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 12.9 pt -66.1 -34.78 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 111.125 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.08 -30.12 67.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.841 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.74 -41.51 49.78 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 0.56999999999999995 112.471 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.476 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 0.6 OUTLIER -68.09 -42.66 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.56999999999999995 111.089 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.476 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -71.97 -27.26 62.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.97 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 t -66.71 -32.85 74.43 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 124.121 1.915 . . . . 0.56999999999999995 108.784 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt -48.3 -67.32 0.28 Allowed 'General case' 0 C--N 1.384 2.088 0 CA-C-O 124.045 1.879 . . . . 0.56999999999999995 110.686 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 74.44 1.11 Allowed 'General case' 0 C--N 1.367 1.335 0 CA-C-N 113.164 -1.835 . . . . 0.56999999999999995 112.9 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 3.471 0 CA-C-O 114.973 -3.126 . . . . 0.91000000000000003 117.919 -172.696 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.721 ' C26' HD13 ' A' ' 214' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.605 0 CA-C-O 121.367 0.426 . . . . 0.56999999999999995 112.063 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 96.03 0.9 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.734 1.623 . . . . 0.56999999999999995 112.187 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 p -117.19 134.65 60.09 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 CA-C-O 122.743 1.259 . . . . 0.56999999999999995 110.143 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.11 162.67 13.42 Favored 'General case' 0 C--N 1.366 1.296 0 CA-C-O 123.244 1.497 . . . . 0.56999999999999995 111.387 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.08 143.94 12.69 Favored 'General case' 0 C--N 1.369 1.447 0 CA-C-N 114.726 -1.125 . . . . 1.2 109.172 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.05 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.373 1.63 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 110.437 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -68.1 -17.3 64.33 Favored 'General case' 0 C--N 1.375 1.687 0 CA-C-N 113.929 -1.487 . . . . 0.56999999999999995 110.438 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.98 106.65 14.67 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.938 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.44 155.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.119 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.1 p -134.53 159.96 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.56999999999999995 111.143 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.668 ' CE2' ' CE2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -140.26 160.08 40.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.935 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -139.11 121.96 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 1.2 110.873 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.471 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -78.13 117.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.14 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -36.97 -60.18 0.65 Allowed 'General case' 0 C--N 1.351 0.649 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 109.972 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 157.16 33.67 0.0 OUTLIER 'General case' 0 C--N 1.37 1.478 0 O-C-N 125.938 2.024 . . . . 0.56999999999999995 111.204 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 2.4 m-30 73.54 -170.96 0.12 Allowed 'General case' 0 C--N 1.374 1.641 0 CA-C-N 114.65 -1.159 . . . . 0.56999999999999995 108.13 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.5 149.79 58.52 Favored Pre-proline 0 C--N 1.364 1.204 0 CA-C-O 122.34 1.066 . . . . 0.56999999999999995 109.068 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.58 -55.03 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.463 1.442 . . . . 0.56999999999999995 112.764 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -63.25 -48.72 77.01 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.3 1.048 . . . . 0.91000000000000003 112.573 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.406 ' HE2' ' CE3' ' A' ' 203' ' ' TRP . 3.6 ttm -83.15 142.11 31.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.484 2.087 . . . . 0.56999999999999995 111.471 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -70.68 135.89 48.65 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 120.324 -1.485 . . . . 0.56999999999999995 109.869 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.479 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.96 -51.21 57.97 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.087 -0.708 . . . . 1.2 109.087 -173.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -34.89 61.7 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-N 113.615 -1.63 . . . . 0.91000000000000003 110.917 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.02 -44.04 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.91000000000000003 110.893 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.3 t -62.33 -38.75 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.182 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.61 -43.17 81.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.866 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -47.7 76.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.905 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.97 -48.24 78.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 111.033 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.481 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.2 mm -61.85 -35.81 70.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.56999999999999995 111.146 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -64.56 -48.05 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 1.2 110.854 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 213' ' ' PHE . 0.0 OUTLIER -62.88 -38.59 91.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 110.872 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -62.46 -45.07 94.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.56999999999999995 111.064 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.668 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 15.3 m-85 -64.21 -34.12 77.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.906 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.8 tt0 -67.74 -41.13 83.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 0.4 OUTLIER -69.7 -34.0 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.56999999999999995 111.105 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.95 -34.04 26.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.918 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.47 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 49.1 m -79.27 -48.87 13.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 110.852 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.83 -12.99 8.62 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.838 0.828 . . . . 0.56999999999999995 111.965 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 20.6 m -115.32 3.29 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.751 -1.113 . . . . 0.56999999999999995 112.127 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.91 148.86 40.56 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 124.105 1.907 . . . . 0.56999999999999995 110.418 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.18 -32.22 6.95 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 120.862 1.041 . . . . 0.56999999999999995 112.509 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.27 109.63 0.63 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 109.531 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 157.39 33.5 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.494 -1.23 . . . . 0.56999999999999995 111.77 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.529 ' CE1' HD21 ' A' ' 224' ' ' LEU . 10.8 m-85 -127.57 149.05 50.33 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-N 113.671 -1.604 . . . . 0.56999999999999995 109.19 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.39 121.19 6.02 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-O 123.605 1.669 . . . . 0.56999999999999995 109.792 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.611 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 21.0 tttp -92.52 145.89 24.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 120.674 -1.266 . . . . 0.56999999999999995 110.834 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.3 pt -128.53 129.02 68.69 Favored 'Isoleucine or valine' 0 C--N 1.372 1.544 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -73.95 -55.46 6.13 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.147 0.975 . . . . 0.56999999999999995 110.773 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.99 113.18 25.36 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 114.575 -1.193 . . . . 0.56999999999999995 110.781 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.27 164.5 19.23 Favored Glycine 0 C--N 1.37 2.466 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.123 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.9 ttt -88.28 131.75 34.66 Favored 'General case' 0 C--N 1.371 1.523 0 CA-C-O 122.192 0.996 . . . . 0.56999999999999995 111.085 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.53 175.02 6.37 Favored 'General case' 0 C--N 1.366 1.298 0 CA-C-N 114.423 -1.262 . . . . 0.56999999999999995 110.856 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.44 -46.47 89.94 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 106.432 -1.692 . . . . 0.91000000000000003 106.432 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.8 mt -113.88 109.93 30.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 114.733 -1.121 . . . . 0.56999999999999995 111.166 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.79 120.99 40.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.975 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.469 HG12 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -102.34 116.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.171 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.452 HG23 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.93 146.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.101 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.566 ' CD2' ' CD1' ' A' ' 197' ' ' PHE . 0.5 OUTLIER -98.68 122.76 42.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.56999999999999995 110.887 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 168' ' ' HIS . . . -144.97 168.45 20.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.242 1.02 . . . . 0.56999999999999995 109.929 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 166.25 10.91 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.547 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.45 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -30.62 105.37 0.01 OUTLIER Glycine 0 C--N 1.375 2.71 0 O-C-N 124.288 0.993 . . . . 0.56999999999999995 113.246 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 166' ' ' GLY . . . 80.56 93.55 0.05 OUTLIER 'General case' 0 C--N 1.391 2.402 0 CA-C-O 124.741 2.21 . . . . 0.56999999999999995 113.338 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.475 ' CG ' ' HB2' ' A' ' 164' ' ' ALA . 1.2 p-80 -126.51 -95.08 0.45 Allowed 'General case' 0 C--N 1.371 1.506 0 CA-C-N 113.729 -1.578 . . . . 0.56999999999999995 110.693 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.31 -76.34 1.22 Allowed Glycine 0 C--N 1.375 2.716 0 N-CA-C 111.485 -0.646 . . . . 0.56999999999999995 111.485 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -40.07 -41.21 1.2 Allowed 'General case' 0 C--N 1.361 1.072 0 CA-C-N 114.874 -0.663 . . . . 0.91000000000000003 110.558 -177.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.7 t80 81.53 68.73 0.02 OUTLIER 'General case' 0 C--N 1.385 2.136 0 CA-C-O 124.878 2.275 . . . . 0.56999999999999995 105.545 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -142.34 11.5 1.93 Allowed 'General case' 0 C--N 1.37 1.462 0 CA-C-N 113.596 -1.638 . . . . 0.56999999999999995 110.862 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.8 113.37 0.02 OUTLIER 'General case' 0 C--N 1.383 2.023 0 CA-C-O 124.484 2.088 . . . . 0.56999999999999995 109.644 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -99.78 -160.36 0.8 Allowed 'General case' 0 C--N 1.362 1.145 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.027 177.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.503 ' CB ' ' CG1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -113.13 139.36 48.8 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-N 115.23 -0.895 . . . . 0.91000000000000003 110.85 176.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -100.16 92.47 1.11 Allowed Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 112.798 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER 69.95 50.07 0.48 Allowed 'General case' 0 C--N 1.377 1.779 0 CA-C-O 122.596 1.189 . . . . 0.56999999999999995 112.132 175.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 176.13 19.99 Favored Glycine 0 C--N 1.357 1.695 0 N-CA-C 108.217 -1.953 . . . . 0.56999999999999995 108.217 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 240' ' ' TYR . . . -44.46 -33.57 3.2 Favored Glycine 0 C--N 1.379 2.952 0 CA-C-O 122.198 0.888 . . . . 0.56999999999999995 112.252 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.503 ' CG1' ' CB ' ' A' ' 175' ' ' ASP . 3.1 mm -45.24 168.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 O-C-N 121.556 -0.967 . . . . 0.56999999999999995 111.722 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -148.17 -39.09 0.18 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.86 0.838 . . . . 0.56999999999999995 110.102 177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' H401 ' A' ' 269' ' ' HSI . . . -176.63 179.94 1.07 Allowed 'General case' 0 C--N 1.363 1.176 0 CA-C-N 115.32 -0.855 . . . . 0.56999999999999995 111.042 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.426 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -153.35 141.86 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.889 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.14 152.42 33.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.142 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.725 -0.67 . . . . 0.56999999999999995 109.551 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 -151.56 7.98 Favored Glycine 0 C--N 1.367 2.255 0 CA-C-N 114.996 -1.002 . . . . 0.56999999999999995 110.905 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.33 88.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.958 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.25 118.11 1.32 Allowed Glycine 0 C--N 1.37 2.436 0 N-CA-C 109.501 -1.44 . . . . 0.56999999999999995 109.501 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -61.93 104.79 0.49 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.303 1.049 . . . . 0.56999999999999995 109.73 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.12 -101.59 1.01 Allowed Glycine 0 C--N 1.377 2.815 0 CA-C-N 114.965 -1.016 . . . . 0.56999999999999995 112.491 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.15 -37.61 77.82 Favored 'Isoleucine or valine' 0 C--N 1.375 1.691 0 CA-C-O 122.84 1.305 . . . . 0.56999999999999995 109.36 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.58 126.15 15.67 Favored Glycine 0 C--N 1.369 2.378 0 CA-C-O 122.696 1.165 . . . . 0.56999999999999995 110.579 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 106.95 -49.82 0.84 Allowed Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.844 -0.678 . . . . 0.56999999999999995 111.483 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 1.0 OUTLIER -45.45 107.61 0.1 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 120.86 0.362 . . . . 0.91000000000000003 110.88 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.31 142.17 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.063 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.452 ' CD2' HG23 ' A' ' 162' ' ' VAL . 16.3 m170 -134.87 135.83 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.827 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.566 ' CD1' ' CD2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -105.22 150.21 25.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.923 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.448 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.5 p30 -83.37 93.07 7.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.91000000000000003 110.865 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.96 80.07 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.991 -0.744 . . . . 0.91000000000000003 108.991 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -36.22 -45.07 0.43 Allowed 'General case' 0 C--N 1.363 1.194 0 CA-C-O 122.464 1.126 . . . . 0.91000000000000003 110.053 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 177' ' ' LYS . 8.5 pt-20 -56.54 -176.19 0.01 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-O 125.218 2.437 . . . . 0.91000000000000003 113.225 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -112.28 89.95 3.21 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.115 -1.616 . . . . 0.56999999999999995 111.185 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.539 ' CH2' ' CD2' ' A' ' 181' ' ' LEU . 49.1 m95 -71.93 142.84 49.45 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 109.164 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.41 ' CG2' ' HA3' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -125.73 126.56 44.81 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-O 123.047 1.403 . . . . 0.56999999999999995 109.727 -177.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.8 p -103.89 111.58 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.387 -1.279 . . . . 0.56999999999999995 108.29 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 83.46 65.36 0.02 OUTLIER 'General case' 0 C--N 1.386 2.191 0 CA-C-N 114.386 -1.279 . . . . 0.56999999999999995 108.867 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.62 124.37 0.03 OUTLIER 'General case' 0 C--N 1.383 2.052 0 CA-C-O 124.532 2.11 . . . . 0.56999999999999995 108.869 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.41 ' HA3' ' CG2' ' A' ' 204' ' ' THR . . . 149.61 -12.4 1.01 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 120.537 -1.352 . . . . 0.56999999999999995 112.611 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.83 -115.08 0.64 Allowed Glycine 0 C--N 1.375 2.734 0 CA-C-O 122.955 1.309 . . . . 0.56999999999999995 110.919 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.18 119.58 38.1 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 108.059 -175.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.2 p30 -91.07 142.13 28.09 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-N 114.252 -1.34 . . . . 0.56999999999999995 110.39 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -27.72 69.52 Favored 'General case' 0 C--N 1.375 1.714 0 CA-C-O 124.596 2.141 . . . . 0.56999999999999995 107.695 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.531 ' CD2' HG12 ' A' ' 245' ' ' ILE . 32.8 t80 -59.67 -50.0 75.56 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.346 -1.297 . . . . 0.56999999999999995 110.886 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -62.13 -41.97 98.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.917 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 214' ' ' LEU . 94.3 m -65.11 -45.01 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 111.157 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -63.13 -36.66 84.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 111.085 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.421 HG22 ' CB ' ' A' ' 137' ' ' ALA . 59.7 t -65.87 -41.0 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.118 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -72.05 -51.08 23.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 110.861 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -62.13 -39.96 94.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.91000000000000003 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.533 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.7 mm -70.18 -47.21 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.56999999999999995 111.142 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.75 -34.26 64.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 1.1 m-70 -67.82 -36.07 79.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.56999999999999995 110.814 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -49.33 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.888 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.529 HD21 ' CE1' ' A' ' 149' ' ' PHE . 3.4 pp -97.66 -58.62 1.95 Allowed 'General case' 0 C--N 1.353 0.751 0 N-CA-C 113.96 1.096 . . . . 0.56999999999999995 113.96 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' GLY . . . -43.69 159.28 0.1 Allowed Glycine 0 C--N 1.365 2.145 0 CA-C-O 125.211 2.562 . . . . 0.56999999999999995 110.936 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -67.68 0.76 Allowed 'General case' 0 C--N 1.364 1.226 0 CA-C-N 113.195 -1.502 . . . . 0.56999999999999995 108.735 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.18 39.0 Favored Glycine 0 C--N 1.368 2.358 0 CA-C-O 123.298 1.499 . . . . 0.56999999999999995 110.595 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 1.1 m-70 -91.11 165.38 13.53 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-N 113.891 -1.154 . . . . 0.56999999999999995 110.218 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -84.04 -8.63 59.07 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 114.438 -1.255 . . . . 0.56999999999999995 110.682 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.84 1.14 2.48 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 111.97 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 145.44 57.07 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 114.542 -1.208 . . . . 0.91000000000000003 109.115 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.45 -44.97 37.59 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 121.717 1.611 . . . . 0.56999999999999995 112.072 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -32.49 0.19 Allowed 'General case' 0 C--N 1.371 1.525 0 CA-C-N 115.297 -0.865 . . . . 0.56999999999999995 113.237 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.19 136.73 48.22 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 124.383 2.039 . . . . 0.56999999999999995 114.81 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -73.76 -23.45 19.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 124.043 1.878 . . . . 0.56999999999999995 111.102 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.492 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -84.08 8.88 14.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.464 -1.698 . . . . 0.56999999999999995 111.183 -178.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 5.3 t80 -51.81 142.56 24.37 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-O 123.211 1.481 . . . . 0.56999999999999995 110.601 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 47.4 Cg_endo -78.56 -45.46 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.389 1.393 . . . . 0.56999999999999995 112.256 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.403 ' OG1' ' CE2' ' A' ' 237' ' ' PHE . 1.3 m -57.99 138.01 56.29 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.524 1.154 . . . . 0.56999999999999995 110.27 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 179' ' ' GLY . 2.5 t80 -75.42 154.14 37.28 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-N 114.052 -1.431 . . . . 0.56999999999999995 108.652 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 46.2 tttt 178.63 106.34 0.03 OUTLIER 'General case' 0 C--N 1.378 1.838 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.796 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -55.19 121.22 8.34 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 124.08 1.895 . . . . 0.56999999999999995 110.153 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.9 m -125.86 -14.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 110.804 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 1.4 p30 60.21 18.23 7.68 Favored 'General case' 0 C--N 1.369 1.453 0 O-C-N 124.31 1.006 . . . . 0.91000000000000003 111.98 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.531 HG12 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mt 79.05 -10.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.672 0 CA-C-N 114.91 -1.041 . . . . 0.56999999999999995 113.423 -175.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -41.35 99.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.773 -1.566 . . . . 0.56999999999999995 106.773 -171.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -15.43 14.4 Favored 'General case' 0 C--N 1.373 1.627 0 N-CA-C 114.572 1.323 . . . . 0.56999999999999995 114.572 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.535 ' CE1' ' CG2' ' A' ' 235' ' ' VAL . 17.2 t80 -53.48 87.29 0.0 OUTLIER 'General case' 0 C--N 1.366 1.323 0 CA-C-O 123.566 1.651 . . . . 0.56999999999999995 110.563 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.434 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.49 149.2 45.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.452 -1.249 . . . . 1.2 109.172 -178.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.434 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -113.38 131.9 55.81 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-O 123.75 1.738 . . . . 0.56999999999999995 108.664 -176.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.68 134.39 52.16 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 120.413 -1.429 . . . . 0.56999999999999995 110.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 256' ' ' ARG . . . -57.64 -42.24 83.03 Favored 'General case' 0 C--N 1.373 1.605 0 CA-C-N 115.009 -0.996 . . . . 0.56999999999999995 109.507 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -41.29 97.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.954 -0.567 . . . . 0.91000000000000003 110.79 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -55.27 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.91000000000000003 110.898 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.438 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -66.24 -38.35 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.173 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.439 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 3.9 mtt180 -68.51 -29.91 68.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.869 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -69.62 -47.92 46.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.56999999999999995 112.476 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.1 pt -63.58 -43.18 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 0.56999999999999995 111.117 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.47 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.07 -34.64 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 110.906 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.5 t -74.44 -15.68 60.9 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 122.18 0.99 . . . . 0.56999999999999995 110.915 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.24 -87.38 0.02 OUTLIER 'General case' 0 C--N 1.37 1.494 0 CA-C-O 123.676 1.703 . . . . 0.56999999999999995 110.903 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.02 0.79 49.3 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-N 114.607 -1.178 . . . . 0.56999999999999995 112.776 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 2.131 0 N-CA-C 117.778 1.871 . . . . 0.91000000000000003 117.778 173.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.459 H401 ' O ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.708 0 N-CA-C 111.737 -0.545 . . . . 0.56999999999999995 111.737 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.44 158.05 1.88 Allowed 'Trans proline' 0 C--N 1.391 2.773 0 O-C-N 123.681 1.359 . . . . 0.56999999999999995 112.122 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.74 132.99 68.46 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.56999999999999995 108.673 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -177.52 118.87 0.1 Allowed 'General case' 0 C--N 1.38 1.904 0 CA-C-O 123.364 1.554 . . . . 0.56999999999999995 108.392 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -134.81 158.03 45.25 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-N 114.107 -1.406 . . . . 1.2 109.579 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -156.04 55.73 0.59 Allowed 'General case' 0 C--N 1.391 2.38 0 CA-C-O 123.927 1.822 . . . . 0.56999999999999995 108.671 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -166.8 -43.51 0.02 OUTLIER 'General case' 0 C--N 1.381 1.96 0 CA-C-N 113.895 -1.502 . . . . 0.56999999999999995 109.719 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 1.3 t80 -113.68 105.52 13.4 Favored 'General case' 0 C--N 1.367 1.338 0 CA-C-N 115.049 -0.978 . . . . 0.56999999999999995 110.905 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' N ' ' CD1' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -99.13 155.0 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.15 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.7 p -116.68 135.22 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.091 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -128.43 139.01 52.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.961 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -122.87 121.98 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.2 110.923 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -82.58 133.15 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.121 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -49.32 -63.0 1.23 Allowed 'General case' 0 C--N 1.372 1.575 0 N-CA-C 107.908 -1.145 . . . . 0.56999999999999995 107.908 -173.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 161.04 32.45 0.0 OUTLIER 'General case' 0 C--N 1.391 2.397 0 CA-C-N 113.6 -1.637 . . . . 0.56999999999999995 110.608 -169.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.7 m-85 63.28 -151.1 0.33 Allowed 'General case' 0 C--N 1.386 2.189 0 N-CA-C 106.926 -1.509 . . . . 0.56999999999999995 106.926 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.23 166.7 1.61 Allowed Pre-proline 0 C--N 1.38 1.894 0 CA-C-O 123.313 1.53 . . . . 0.56999999999999995 109.616 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -70.59 -42.38 2.59 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 120.865 1.043 . . . . 0.56999999999999995 112.049 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.43 -34.95 35.7 Favored 'General case' 0 C--N 1.38 1.893 0 CA-C-N 114.591 -1.186 . . . . 0.91000000000000003 112.779 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.3 ttm -93.14 111.86 23.63 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-O 125.67 2.652 . . . . 0.56999999999999995 109.068 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.26 141.74 54.31 Favored 'General case' 0 C--N 1.384 2.074 0 CA-C-N 113.272 -1.786 . . . . 0.56999999999999995 109.118 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.448 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.14 -51.41 58.1 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.446 -1.316 . . . . 1.2 107.446 -170.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -54.41 -34.76 61.95 Favored 'General case' 0 C--N 1.39 2.345 0 CA-C-N 113.06 -1.882 . . . . 0.91000000000000003 110.948 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.35 -44.01 69.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.91000000000000003 110.892 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.2 t -61.46 -43.09 96.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 111.122 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -66.45 -44.1 83.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.872 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -49.09 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.885 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.67 84.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.122 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.487 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.1 mm -67.44 -32.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.126 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -65.51 -48.1 73.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.2 110.88 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.28 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.56999999999999995 111.136 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.533 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 6.7 m-85 -67.01 -33.87 76.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.56999999999999995 110.912 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.464 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.2 tt0 -68.6 -42.08 78.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.928 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.499 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 5.2 p -69.43 -34.17 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.56999999999999995 111.172 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.503 ' O ' ' CG2' ' A' ' 145' ' ' THR . 3.7 m95 -83.02 -34.16 26.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.912 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.9 m -78.78 -50.46 11.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.883 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -57.4 -13.51 3.57 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 113.255 0.835 . . . . 0.56999999999999995 113.255 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 21.6 m -114.99 -11.11 12.14 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-N 114.517 -1.22 . . . . 0.56999999999999995 111.375 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -135.81 149.03 67.62 Favored Pre-proline 0 C--N 1.371 1.541 0 CA-C-O 125.517 2.58 . . . . 0.56999999999999995 109.057 -177.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.37 44.44 1.63 Allowed 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.611 2.208 . . . . 0.56999999999999995 112.25 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.75 89.28 2.25 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 105.649 -1.982 . . . . 0.56999999999999995 105.649 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -69.43 157.72 36.54 Favored 'General case' 0 C--N 1.38 1.921 0 CA-C-O 125.12 2.391 . . . . 0.56999999999999995 114.538 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CG ' ' CE1' ' A' ' 138' ' ' PHE . 72.7 m-85 -126.28 155.52 41.79 Favored 'General case' 0 C--N 1.387 2.222 0 CA-C-N 112.879 -1.964 . . . . 0.56999999999999995 108.903 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 124.62 7.31 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-O 125.302 2.477 . . . . 0.56999999999999995 107.101 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 33.2 tttt -82.82 145.38 29.52 Favored 'General case' 0 C--N 1.379 1.861 0 CA-C-N 113.626 -1.624 . . . . 0.56999999999999995 111.005 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.4 pt -135.78 172.37 15.76 Favored 'Isoleucine or valine' 0 C--N 1.38 1.911 0 CA-C-O 123.641 1.686 . . . . 0.56999999999999995 109.321 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -125.95 29.26 5.93 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-O 123.819 1.771 . . . . 0.56999999999999995 110.597 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 t -80.79 -170.46 2.67 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-N 114.217 -1.356 . . . . 0.56999999999999995 111.025 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -49.44 -55.24 13.6 Favored Glycine 0 C--N 1.391 3.62 0 CA-C-N 113.812 -1.54 . . . . 0.56999999999999995 110.929 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.89 138.9 9.6 Favored 'General case' 0 C--N 1.379 1.86 0 N-CA-C 107.663 -1.236 . . . . 0.56999999999999995 107.663 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -104.07 172.46 6.79 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.874 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -49.99 -65.45 0.56 Allowed 'General case' 0 C--N 1.38 1.924 0 CA-C-N 113.614 -1.63 . . . . 0.91000000000000003 106.919 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.9 mt -97.97 110.06 24.88 Favored 'Isoleucine or valine' 0 C--N 1.371 1.527 0 O-C-N 121.802 -0.561 . . . . 0.56999999999999995 111.13 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -95.34 120.99 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 110.887 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.45 118.12 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.115 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -133.12 146.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.56999999999999995 111.149 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.68 120.65 42.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.9 167.26 26.19 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 123.242 1.496 . . . . 0.56999999999999995 108.214 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 169.26 8.57 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 115.06 -0.973 . . . . 1.2 109.926 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -41.79 133.68 3.72 Favored Glycine 0 C--N 1.387 3.381 0 CA-C-N 114.13 -1.396 . . . . 0.56999999999999995 109.623 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 85.32 45.14 0.02 OUTLIER 'General case' 0 C--N 1.4 2.792 0 CA-C-O 124.191 1.948 . . . . 0.56999999999999995 111.203 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -104.41 -57.2 2.07 Favored 'General case' 0 C--N 1.379 1.877 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 110.978 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.82 -165.7 32.7 Favored Glycine 0 C--N 1.376 2.788 0 N-CA-C 108.925 -1.67 . . . . 0.56999999999999995 108.925 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.92 93.89 0.06 Allowed 'General case' 0 C--N 1.4 2.767 0 CA-C-O 123.906 1.812 . . . . 0.91000000000000003 107.701 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 69.19 -97.11 0.03 OUTLIER 'General case' 0 C--N 1.376 1.734 0 CA-C-N 114.095 -1.411 . . . . 0.56999999999999995 110.138 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -122.46 -132.7 0.28 Allowed 'General case' 0 C--N 1.383 2.047 0 CA-C-O 124.252 1.977 . . . . 0.56999999999999995 109.482 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.82 179.2 4.34 Favored 'General case' 0 C--N 1.381 1.971 0 CA-C-O 123.433 1.587 . . . . 0.56999999999999995 110.211 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.544 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 1.4 m-85 -119.84 -173.08 2.47 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.95 -1.932 . . . . 0.56999999999999995 110.36 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.24 -178.66 3.51 Favored 'General case' 0 C--N 1.377 1.789 0 CA-C-N 113.044 -1.889 . . . . 0.91000000000000003 112.862 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.73 150.22 21.06 Favored Glycine 0 C--N 1.385 3.285 0 CA-C-N 113.47 -1.696 . . . . 0.56999999999999995 109.029 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.24 8.33 5.26 Favored 'General case' 0 C--N 1.376 1.748 0 CA-C-O 122.721 1.248 . . . . 0.56999999999999995 111.617 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 159.22 -104.53 0.25 Allowed Glycine 0 C--N 1.378 2.9 0 CA-C-O 122.869 1.261 . . . . 0.56999999999999995 110.185 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.31 -126.15 35.92 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-O 123.635 1.686 . . . . 0.56999999999999995 110.388 176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 182' ' ' ALA . 2.3 pp -79.03 -173.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.876 0 CA-C-N 113.745 -1.227 . . . . 0.56999999999999995 109.557 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.516 ' CD1' ' CZ3' ' A' ' 203' ' ' TRP . 9.4 tp -109.83 -37.1 5.73 Favored 'General case' 0 C--N 1.377 1.765 0 N-CA-C 115.763 1.764 . . . . 0.56999999999999995 115.763 170.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.46 ' N ' ' CD1' ' A' ' 180' ' ' ILE . . . -178.78 179.84 0.68 Allowed 'General case' 0 C--N 1.384 2.083 0 CA-C-N 113.787 -1.551 . . . . 0.56999999999999995 111.117 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 4.9 p80 -161.59 136.04 7.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.848 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -135.02 144.21 47.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.56999999999999995 111.108 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -79.56 175.88 10.21 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-O 123.244 1.497 . . . . 0.56999999999999995 109.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.84 -173.39 40.63 Favored Glycine 0 C--N 1.383 3.172 0 CA-C-O 123.158 1.421 . . . . 0.56999999999999995 111.312 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.52 71.83 3.79 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.56 2.173 . . . . 0.56999999999999995 111.506 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.13 -123.03 1.0 Allowed Glycine 0 C--N 1.382 3.087 0 CA-C-O 123.931 1.85 . . . . 0.56999999999999995 110.184 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.0 m -125.41 -62.89 1.18 Allowed 'General case' 0 C--N 1.392 2.417 0 CA-C-O 123.386 1.565 . . . . 0.56999999999999995 108.205 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.06 -71.3 0.7 Allowed Glycine 0 C--N 1.394 3.802 0 N-CA-C 108.861 -1.696 . . . . 0.56999999999999995 108.861 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.76 56.15 Favored 'Isoleucine or valine' 0 C--N 1.384 2.1 0 CA-C-O 125.815 2.721 . . . . 0.56999999999999995 108.885 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.3 134.94 29.12 Favored Glycine 0 C--N 1.393 3.746 0 N-CA-C 106.562 -2.615 . . . . 0.56999999999999995 106.562 -172.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.37 -19.8 47.02 Favored Glycine 0 C--N 1.368 2.308 0 N-CA-C 110.172 -1.171 . . . . 0.56999999999999995 110.172 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.422 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.1 m-20 -73.96 124.86 26.99 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.993 -1.298 . . . . 0.91000000000000003 110.922 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -107.3 142.09 37.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.56999999999999995 111.083 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -124.69 129.39 50.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.925 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.62 150.18 27.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 110.919 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 91.25 5.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.91000000000000003 110.887 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.74 -47.51 77.96 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-N 114.977 -1.01 . . . . 0.91000000000000003 108.815 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.51 -44.9 0.06 Allowed 'General case' 0 C--N 1.374 1.633 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.44 ' HB2' ' CZ2' ' A' ' 203' ' ' TRP . 1.4 mp0 -62.58 -178.14 0.18 Allowed 'General case' 0 C--N 1.382 1.999 0 CA-C-O 127.219 3.39 . . . . 0.91000000000000003 106.948 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.24 78.0 1.18 Allowed 'General case' 0 C--N 1.379 1.848 0 O-C-N 118.664 -2.522 . . . . 0.56999999999999995 108.241 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.516 ' CZ3' ' CD1' ' A' ' 181' ' ' LEU . 21.4 m95 -74.0 143.16 45.7 Favored 'General case' 0 C--N 1.376 1.744 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 109.154 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 60.6 p -114.2 123.35 49.36 Favored 'General case' 0 C--N 1.377 1.8 0 CA-C-O 124.349 2.023 . . . . 0.56999999999999995 108.905 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.1 p -96.11 111.68 23.64 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-O 123.929 1.823 . . . . 0.56999999999999995 108.497 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 77.34 48.96 0.05 Allowed 'General case' 0 C--N 1.388 2.276 0 CA-C-O 124.57 2.129 . . . . 0.56999999999999995 110.626 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 t -129.09 -91.78 0.47 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 114.242 -1.345 . . . . 0.56999999999999995 109.651 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.91 -45.07 0.07 OUTLIER Glycine 0 C--N 1.387 3.381 0 C-N-CA 119.356 -1.402 . . . . 0.56999999999999995 111.985 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.51 -133.65 0.03 OUTLIER Glycine 0 C--N 1.393 3.743 0 CA-C-O 126.708 3.393 . . . . 0.56999999999999995 109.598 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 41.5 p -67.71 130.63 43.59 Favored 'General case' 0 C--N 1.37 1.473 0 O-C-N 119.582 -2.128 . . . . 0.56999999999999995 110.945 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -134.09 149.52 51.11 Favored 'General case' 0 C--N 1.38 1.923 0 CA-C-N 113.338 -1.755 . . . . 0.56999999999999995 108.476 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -71.08 -23.92 62.22 Favored 'General case' 0 C--N 1.375 1.702 0 CA-C-O 124.836 2.255 . . . . 0.56999999999999995 111.111 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 217' ' ' VAL . 23.8 t80 -54.51 -39.29 67.45 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.506 -1.679 . . . . 0.56999999999999995 110.855 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.443 ' CD1' ' C26' ' A' ' 269' ' ' HSI . 0.3 OUTLIER -55.0 -51.13 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.895 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 181' ' ' LEU . 11.7 p -66.53 -40.41 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.131 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.79 96.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.09 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' ' 213' ' ' PHE . 24.6 t -65.31 -40.83 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.407 ' HA ' ' SD ' ' A' ' 236' ' ' MET . 24.8 t-80 -69.29 -44.97 70.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.858 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -59.64 -41.49 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.936 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.483 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 49.8 mt -66.48 -40.86 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.181 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.54 -33.7 87.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.56999999999999995 112.441 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -43.35 96.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.847 0.356 . . . . 0.56999999999999995 110.889 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -37.36 73.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.863 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.454 ' CD1' ' CE3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -45.47 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.367 1.343 0 CA-C-O 124.434 2.064 . . . . 0.56999999999999995 114.26 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -158.11 -88.74 0.07 OUTLIER Glycine 0 C--N 1.377 2.828 0 C-N-CA 118.654 -1.736 . . . . 0.56999999999999995 110.837 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.391 2.412 0 O-C-N 125.66 1.447 . . . . 0.56999999999999995 110.581 -173.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 99.07 98.28 2.14 Favored Glycine 0 C--N 1.385 3.303 0 C-N-CA 118.894 -1.622 . . . . 0.56999999999999995 110.281 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 172.75 0.16 Allowed 'General case' 0 C--N 1.395 2.556 0 CA-C-O 124.3 2.0 . . . . 0.56999999999999995 108.188 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 p -131.61 -6.42 3.67 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 117.294 -1.762 . . . . 0.56999999999999995 110.408 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.1 t 83.28 -12.25 0.87 Allowed 'General case' 0 C--N 1.391 2.397 0 CA-C-N 115.299 -0.864 . . . . 0.56999999999999995 112.049 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.68 148.17 45.49 Favored Pre-proline 0 C--N 1.385 2.129 0 N-CA-C 106.135 -1.802 . . . . 0.91000000000000003 106.135 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.33 -16.64 35.72 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.031 2.487 . . . . 0.56999999999999995 112.273 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 1.89 2.49 Favored 'General case' 0 C--N 1.38 1.91 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -111.5 143.1 42.89 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-O 124.877 2.275 . . . . 0.56999999999999995 108.687 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.875 ' O ' ' H28' ' A' ' 269' ' ' HSI . 0.5 OUTLIER -72.91 -11.83 15.17 Favored 'Isoleucine or valine' 0 C--N 1.382 1.985 0 CA-C-N 112.322 -2.217 . . . . 0.56999999999999995 111.842 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.407 ' SD ' ' HA ' ' A' ' 218' ' ' HIS . 0.3 OUTLIER -108.29 26.67 10.16 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-N 114.437 -1.256 . . . . 0.56999999999999995 110.349 -178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 17.0 t80 -54.64 142.62 52.07 Favored Pre-proline 0 C--N 1.371 1.506 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 108.914 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 76.6 Cg_exo -54.92 -49.34 17.0 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.022 1.814 . . . . 0.56999999999999995 112.762 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 m -62.9 136.03 57.63 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 123.303 1.525 . . . . 0.56999999999999995 110.459 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 240' ' ' TYR . 0.7 OUTLIER -94.21 82.96 4.17 Favored 'General case' 0 C--N 1.382 2.001 0 CA-C-O 124.521 2.105 . . . . 0.56999999999999995 108.555 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -111.69 100.14 8.72 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-O 123.711 1.72 . . . . 0.56999999999999995 108.89 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -53.05 118.68 3.92 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-O 125.666 2.651 . . . . 0.56999999999999995 110.629 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.12 11.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 CA-C-N 112.499 -2.137 . . . . 0.56999999999999995 111.406 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 86.68 -16.01 0.42 Allowed 'General case' 0 C--N 1.377 1.768 0 O-C-N 125.247 1.592 . . . . 0.91000000000000003 111.918 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.6 mt 75.64 -49.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.389 2.284 0 N-CA-C 114.296 1.221 . . . . 0.56999999999999995 114.296 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -46.26 -28.86 1.4 Allowed 'General case' 0 C--N 1.368 1.383 0 N-CA-C 113.395 0.887 . . . . 0.56999999999999995 113.395 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 p -108.19 9.47 28.13 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-O 122.592 1.187 . . . . 0.56999999999999995 111.295 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 235' ' ' VAL . 9.9 t80 -68.01 86.54 0.25 Allowed 'General case' 0 C--N 1.377 1.775 0 CA-C-O 125.023 2.344 . . . . 0.56999999999999995 108.97 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.405 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -108.63 153.51 23.3 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-O 124.748 2.213 . . . . 1.2 107.204 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.4 131.82 54.07 Favored 'General case' 0 C--N 1.381 1.938 0 CA-C-O 125.874 2.75 . . . . 0.56999999999999995 105.867 -172.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 45.2 t -66.45 138.28 57.43 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.359 -2.088 . . . . 0.56999999999999995 110.26 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.21 86.13 Favored 'General case' 0 C--N 1.393 2.49 0 CA-C-N 113.612 -1.631 . . . . 0.56999999999999995 108.614 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.289 -0.882 . . . . 0.91000000000000003 110.87 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.06 -55.08 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.91000000000000003 110.86 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 22.7 pt -66.08 -35.23 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.166 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.404 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 0.2 OUTLIER -70.35 -35.44 73.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 1.2 110.852 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.51 -49.58 64.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.56999999999999995 112.469 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.3 pt -62.32 -45.65 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.56999999999999995 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.485 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.11 -24.04 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.56999999999999995 110.92 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.7 t -76.03 -16.84 59.88 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 123.388 1.566 . . . . 0.56999999999999995 111.03 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -93.98 0.05 Allowed 'General case' 0 C--N 1.386 2.179 0 CA-C-O 123.965 1.84 . . . . 0.56999999999999995 112.444 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.47 14.51 8.03 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 114.315 -1.311 . . . . 0.56999999999999995 113.531 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.375 2.73 0 N-CA-C 118.382 2.113 . . . . 0.91000000000000003 118.382 172.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.875 ' H28' ' O ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 3.865 0 CA-C-O 119.247 -0.751 . . . . 0.56999999999999995 111.935 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.5 103.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 122.171 1.914 . . . . 0.56999999999999995 112.5 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 t -111.44 134.95 52.16 Favored 'Isoleucine or valine' 0 C--N 1.374 1.661 0 CA-C-N 112.909 -1.95 . . . . 0.56999999999999995 109.125 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -122.01 -89.8 0.59 Allowed 'General case' 0 C--N 1.387 2.203 0 CA-C-N 112.918 -1.946 . . . . 0.56999999999999995 109.429 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.47 156.63 36.9 Favored 'General case' 0 C--N 1.378 1.824 0 N-CA-C 107.717 -1.216 . . . . 1.2 107.717 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.42 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.383 2.03 0 CA-C-N 113.692 -1.595 . . . . 0.56999999999999995 111.402 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.418 ' HA ' ' CD2' ' A' ' 147' ' ' LEU . 5.8 p-80 -53.04 -35.91 59.99 Favored 'General case' 0 C--N 1.382 2.008 0 CA-C-N 112.91 -1.95 . . . . 0.56999999999999995 109.954 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -111.11 111.59 22.79 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.493 -1.38 . . . . 0.56999999999999995 110.891 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.24 144.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.085 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -105.94 158.47 16.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.56999999999999995 111.149 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 159' ' ' ILE . 15.7 m-85 -140.6 159.59 41.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.886 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.737 HH11 ' N ' ' A' ' 156' ' ' MET . 12.3 ttm180 -150.0 129.62 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 1.2 110.854 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.448 HD12 ' CD1' ' A' ' 134' ' ' ILE . 1.1 mm -99.09 128.92 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 111.08 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.61 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.373 1.624 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 112.682 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -179.18 24.63 0.0 OUTLIER 'General case' 0 C--N 1.378 1.822 0 CA-C-N 113.595 -1.639 . . . . 0.56999999999999995 107.767 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.459 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.3 m-85 82.87 -152.56 0.01 OUTLIER 'General case' 0 C--N 1.392 2.415 0 N-CA-C 105.504 -2.036 . . . . 0.56999999999999995 105.504 170.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.2 167.56 14.1 Favored Pre-proline 0 C--N 1.382 2.01 0 N-CA-C 108.542 -0.91 . . . . 0.56999999999999995 108.542 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -57.04 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 121.303 1.335 . . . . 0.56999999999999995 114.305 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.32 -59.05 3.1 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.837 -1.529 . . . . 0.91000000000000003 112.986 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.4 mtm -63.39 137.17 58.07 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 123.903 1.811 . . . . 0.56999999999999995 108.902 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.49 143.86 26.48 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 106.095 -1.817 . . . . 0.56999999999999995 106.095 -171.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.459 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.03 -49.67 42.47 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.728 -1.582 . . . . 1.2 106.728 -167.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.74 -34.79 62.98 Favored 'General case' 0 C--N 1.392 2.425 0 CA-C-N 112.238 -2.255 . . . . 0.91000000000000003 110.884 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -44.03 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.91000000000000003 110.877 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.5 t -65.03 -49.32 80.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.15 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -56.79 -44.07 81.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.91000000000000003 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -38.03 89.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.88 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.421 ' CB ' HD12 ' A' ' 212' ' ' LEU . . . -65.92 -40.64 91.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.086 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.459 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -66.97 -42.56 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.56999999999999995 111.178 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -62.05 -44.83 95.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 1.2 110.841 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.27 96.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.91 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.69 96.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.117 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' CE2' HG22 ' A' ' 134' ' ' ILE . 14.4 m-85 -62.53 -33.68 75.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.901 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.441 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.5 OUTLIER -68.28 -39.36 82.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.884 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.454 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.3 OUTLIER -72.3 -33.87 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.189 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.414 ' O ' ' CG2' ' A' ' 145' ' ' THR . 9.8 m95 -83.16 -34.06 26.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.923 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.2 m -77.99 -49.13 14.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.56999999999999995 110.852 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.99 -13.06 9.58 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 122.049 0.928 . . . . 0.56999999999999995 112.349 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.42 HG12 ' ND2' ' A' ' 143' ' ' ASN . 17.6 m -112.87 9.45 8.12 Favored 'Isoleucine or valine' 0 C--N 1.382 2.009 0 CA-C-N 114.326 -1.306 . . . . 0.56999999999999995 112.757 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 19.3 p -149.32 151.62 34.15 Favored Pre-proline 0 C--N 1.378 1.812 0 CA-C-O 126.201 2.905 . . . . 0.56999999999999995 110.677 -171.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.57 -29.29 2.38 Favored 'Trans proline' 0 C--N 1.365 1.432 0 O-C-N 117.31 -1.995 . . . . 0.56999999999999995 110.923 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 112' ' ' HIS . 3.6 mt -73.3 111.98 8.94 Favored 'General case' 0 C--N 1.376 1.76 0 N-CA-C 106.543 -1.651 . . . . 0.56999999999999995 106.543 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -69.48 157.75 36.52 Favored 'General case' 0 C--N 1.381 1.963 0 CA-C-O 124.369 2.033 . . . . 0.56999999999999995 116.279 170.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 224' ' ' LEU . 17.0 m-85 -130.4 154.25 47.9 Favored 'General case' 0 C--N 1.387 2.213 0 CA-C-N 112.675 -2.057 . . . . 0.56999999999999995 109.141 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 m -156.15 109.13 2.65 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-O 125.442 2.544 . . . . 0.56999999999999995 108.83 -171.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.53 149.53 23.56 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.323 -1.762 . . . . 0.56999999999999995 112.394 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -160.17 -172.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.385 2.109 0 CA-C-N 113.833 -1.53 . . . . 0.56999999999999995 110.334 -176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -163.36 98.17 0.91 Allowed 'General case' 0 C--N 1.38 1.905 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.6 m -147.03 -81.59 0.14 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 115.288 -0.869 . . . . 0.56999999999999995 109.92 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.07 0.82 Allowed Glycine 0 C--N 1.384 3.228 0 N-CA-C 107.404 -2.278 . . . . 0.56999999999999995 107.404 -169.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.737 ' N ' HH11 ' A' ' 117' ' ' ARG . 5.0 ttm 72.19 135.98 0.04 OUTLIER 'General case' 0 C--N 1.404 2.977 0 O-C-N 126.362 1.86 . . . . 0.56999999999999995 108.274 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.22 163.67 27.23 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.27 -1.752 . . . . 0.56999999999999995 106.27 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 158' ' ' ASP 0.288 0.0 OUTLIER -18.7 -73.62 0.01 OUTLIER 'General case' 0 C--N 1.377 1.803 0 CA-C-N 112.875 -1.966 . . . . 0.91000000000000003 113.996 165.587 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 116' ' ' TYR . 2.5 mp -96.15 109.8 23.43 Favored 'Isoleucine or valine' 0 C--N 1.383 2.063 0 O-C-N 126.9 2.625 . . . . 0.56999999999999995 111.215 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 122.49 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.879 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.4 m -110.44 121.44 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.08 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.13 139.97 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.087 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -90.19 118.84 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.946 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.46 169.18 20.07 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 118.861 -1.135 . . . . 0.56999999999999995 109.162 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 167.3 9.88 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 115.245 -0.889 . . . . 1.2 110.398 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.11 129.02 2.78 Favored Glycine 0 C--N 1.393 3.726 0 O-C-N 125.201 1.563 . . . . 0.56999999999999995 111.699 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 82.69 104.04 0.06 Allowed 'General case' 0 C--N 1.406 3.041 0 CA-C-O 124.893 2.283 . . . . 0.56999999999999995 112.271 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -171.18 -59.37 0.02 OUTLIER 'General case' 0 C--N 1.386 2.187 0 CA-C-N 113.823 -1.535 . . . . 0.56999999999999995 110.405 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -155.82 -125.12 0.9 Allowed Glycine 0 C--N 1.381 3.032 0 CA-C-N 115.048 -0.978 . . . . 0.56999999999999995 110.799 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 41.1 p-10 -33.78 147.68 0.02 OUTLIER 'General case' 0 C--N 1.388 2.245 0 O-C-N 127.331 2.43 . . . . 0.91000000000000003 113.532 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.492 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.5 t80 78.15 -151.19 0.02 OUTLIER 'General case' 0 C--N 1.394 2.534 0 CA-C-N 113.12 -1.855 . . . . 0.56999999999999995 111.986 -172.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -167.51 97.27 0.48 Allowed 'General case' 0 C--N 1.382 2.006 0 N-CA-C 108.254 -1.017 . . . . 0.56999999999999995 108.254 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.74 77.94 0.31 Allowed 'General case' 0 C--N 1.398 2.681 0 CA-C-O 125.549 2.595 . . . . 0.56999999999999995 109.023 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.499 ' CE2' ' CG2' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -64.93 178.06 0.88 Allowed 'General case' 0 C--N 1.377 1.784 0 CA-C-N 111.945 -2.389 . . . . 0.56999999999999995 112.051 177.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -58.37 -160.27 0.0 OUTLIER 'General case' 0 C--N 1.386 2.19 0 CA-C-O 124.519 2.104 . . . . 0.91000000000000003 114.479 172.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -172.63 101.39 0.16 Allowed Glycine 0 C--N 1.391 3.602 0 C-N-CA 117.261 -2.4 . . . . 0.56999999999999995 109.205 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.63 96.64 0.07 Allowed 'General case' 0 C--N 1.39 2.345 0 CA-C-O 123.472 1.605 . . . . 0.56999999999999995 113.056 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.27 -152.37 25.45 Favored Glycine 0 C--N 1.381 3.065 0 C-N-CA 119.02 -1.562 . . . . 0.56999999999999995 110.596 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.83 -132.91 40.66 Favored Glycine 0 C--N 1.376 2.784 0 N-CA-C 111.788 -0.525 . . . . 0.56999999999999995 111.788 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.499 ' CG2' ' CE2' ' A' ' 174' ' ' PHE . 0.1 OUTLIER -46.97 168.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.061 0 O-C-N 125.806 1.533 . . . . 0.56999999999999995 113.196 175.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.6 tp -121.94 -92.26 0.54 Allowed 'General case' 0 C--N 1.359 1.008 0 CA-C-O 126.781 3.181 . . . . 0.56999999999999995 112.907 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -106.22 179.73 4.18 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 112.524 -2.126 . . . . 0.56999999999999995 111.1 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 54.4 p-80 -163.12 135.84 5.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.856 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.7 166.74 21.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.072 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -71.71 0.6 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 117.491 -1.684 . . . . 0.56999999999999995 108.083 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.23 0.55 Allowed Glycine 0 C--N 1.386 3.331 0 C-N-CA 120.696 -0.764 . . . . 0.56999999999999995 112.579 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -53.16 -47.29 28.3 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 110.755 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 192' ' ' GLY . . . 98.99 -169.74 23.22 Favored Glycine 0 C--N 1.378 2.883 0 C-N-CA 118.958 -1.592 . . . . 0.56999999999999995 113.857 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 78.0 83.09 0.07 Allowed 'General case' 0 C--N 1.392 2.436 0 CA-C-O 124.137 1.922 . . . . 0.56999999999999995 107.649 173.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.63 -103.65 1.99 Allowed Glycine 0 C--N 1.394 3.781 0 N-CA-C 105.155 -3.178 . . . . 0.56999999999999995 105.155 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -61.88 -47.18 94.44 Favored 'Isoleucine or valine' 0 C--N 1.387 2.208 0 CA-C-O 127.102 3.334 . . . . 0.56999999999999995 110.691 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 188' ' ' GLY . . . -63.83 158.64 40.51 Favored Glycine 0 N--CA 1.404 -3.469 0 O-C-N 117.019 -3.551 . . . . 0.56999999999999995 108.827 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.29 -8.11 19.88 Favored Glycine 0 C--N 1.375 2.743 0 CA-C-N 113.782 -1.209 . . . . 0.56999999999999995 113.853 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.45 108.36 18.98 Favored 'General case' 0 C--N 1.378 1.842 0 CA-C-N 114.464 -0.868 . . . . 0.91000000000000003 110.835 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.18 151.0 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.137 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 6.7 m170 -135.28 151.21 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.56999999999999995 110.834 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -114.37 139.7 49.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.844 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.3 p-10 -66.92 82.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.836 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.15 69.78 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 106.629 -1.619 . . . . 0.91000000000000003 106.629 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -48.37 19.04 Favored 'General case' 0 C--N 1.389 2.297 0 O-C-N 125.835 1.96 . . . . 0.91000000000000003 107.548 -163.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.89 171.71 0.02 OUTLIER 'General case' 0 C--N 1.392 2.417 0 CA-C-O 127.167 3.365 . . . . 0.91000000000000003 116.356 172.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -97.06 100.51 12.01 Favored 'General case' 0 C--N 1.378 1.82 0 O-C-N 119.19 -2.194 . . . . 0.56999999999999995 111.117 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -78.54 152.89 31.69 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.869 -1.514 . . . . 0.56999999999999995 109.089 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.7 105.6 9.44 Favored 'General case' 0 C--N 1.378 1.805 0 CA-C-O 124.523 2.106 . . . . 0.56999999999999995 110.599 -175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.3 p -96.93 107.29 19.78 Favored 'General case' 0 C--N 1.365 1.25 0 CA-C-N 114.492 -1.231 . . . . 0.56999999999999995 110.064 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 53.7 46.92 24.92 Favored 'General case' 0 C--N 1.393 2.476 0 CA-C-O 125.371 2.51 . . . . 0.56999999999999995 110.846 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 t -134.26 -74.97 0.47 Allowed 'General case' 0 C--N 1.387 2.221 0 CA-C-N 112.5 -2.137 . . . . 0.56999999999999995 107.793 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.55 64.01 0.05 OUTLIER Glycine 0 C--N 1.394 3.782 0 C-N-CA 118.24 -1.933 . . . . 0.56999999999999995 111.214 -171.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.64 -142.01 6.14 Favored Glycine 0 C--N 1.387 3.372 0 CA-C-O 123.483 1.602 . . . . 0.56999999999999995 111.132 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 56.2 m -68.24 118.02 10.81 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.841 -1.18 . . . . 0.56999999999999995 110.456 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -92.49 145.47 24.43 Favored 'General case' 0 C--N 1.378 1.826 0 O-C-N 126.117 2.136 . . . . 0.56999999999999995 112.519 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -73.49 -32.14 64.13 Favored 'General case' 0 C--N 1.391 2.395 0 CA-C-O 124.424 2.059 . . . . 0.56999999999999995 107.508 -174.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 213' ' ' PHE . 4.3 t80 -49.57 -50.12 43.69 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-N 113.104 -1.862 . . . . 0.56999999999999995 110.891 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -42.68 81.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.933 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -45.04 80.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.095 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.77 79.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.56999999999999995 111.063 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 2.8 t -59.96 -41.48 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.098 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.531 ' HD1' ' C19' ' A' ' 269' ' ' HSI . 2.8 t-160 -62.76 -36.59 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.832 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -43.23 86.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.91000000000000003 110.807 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.2 mm -64.02 -45.28 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.94 87.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.819 -0.705 . . . . 0.56999999999999995 112.441 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.425 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -64.01 -42.61 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.56999999999999995 110.821 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 t -71.07 -55.63 7.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.872 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -78.07 -164.31 0.52 Allowed 'General case' 0 C--N 1.382 1.984 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 171.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.439 ' N ' ' OH ' ' A' ' 262' ' ' TYR . . . 68.75 -146.03 44.5 Favored Glycine 0 C--N 1.38 2.998 0 N-CA-C 104.487 -3.445 . . . . 0.56999999999999995 104.487 169.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -124.1 -82.18 0.64 Allowed 'General case' 0 C--N 1.38 1.916 0 CA-C-N 111.738 -2.231 . . . . 0.56999999999999995 110.481 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.91 -157.27 7.29 Favored Glycine 0 C--N 1.379 2.929 0 CA-C-O 123.871 1.817 . . . . 0.56999999999999995 108.843 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.7 m-70 -103.2 -171.34 1.93 Allowed 'General case' 0 C--N 1.376 1.738 0 CA-C-N 113.777 -1.212 . . . . 0.56999999999999995 111.934 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 p -116.32 -31.26 5.68 Favored 'General case' 0 C--N 1.386 2.166 0 CA-C-N 113.93 -1.487 . . . . 0.56999999999999995 108.985 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 m 82.11 23.11 0.23 Allowed 'General case' 0 C--N 1.401 2.828 0 CA-C-O 123.095 1.426 . . . . 0.56999999999999995 114.556 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -127.99 151.13 75.38 Favored Pre-proline 0 N--CA 1.418 -2.067 0 CA-C-N 113.105 -1.861 . . . . 0.91000000000000003 108.345 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 71.0 Cg_exo -58.23 -28.07 82.91 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.168 1.912 . . . . 0.56999999999999995 115.289 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -33.74 71.82 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 111.295 -2.684 . . . . 0.56999999999999995 117.884 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.3 131.23 45.09 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 113.778 -1.555 . . . . 0.56999999999999995 109.483 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.32 -3.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 CA-C-O 125.927 2.775 . . . . 0.56999999999999995 112.366 -176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 11.2 mtp -122.82 -10.77 8.23 Favored 'General case' 0 C--N 1.374 1.668 0 CA-C-N 112.847 -1.978 . . . . 0.56999999999999995 112.153 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.514 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.66 141.82 0.55 Allowed Pre-proline 0 C--N 1.373 1.605 0 CA-C-O 125.496 2.57 . . . . 0.56999999999999995 113.638 174.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.476 ' CA ' H442 ' A' ' 269' ' ' HSI . 75.2 Cg_exo -56.94 -50.04 12.65 Favored 'Trans proline' 0 C--N 1.37 1.667 0 O-C-N 118.831 -1.194 . . . . 0.56999999999999995 111.122 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.514 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 39.5 m -44.23 118.71 1.58 Allowed 'General case' 0 C--N 1.366 1.288 0 CA-C-O 123.404 1.573 . . . . 0.56999999999999995 110.507 -172.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -92.92 157.56 16.28 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.555 -1.657 . . . . 0.56999999999999995 108.326 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.96 126.14 0.02 OUTLIER 'General case' 0 C--N 1.392 2.434 0 N-CA-C 105.448 -2.056 . . . . 0.56999999999999995 105.448 169.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.67 120.45 7.3 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 125.491 2.567 . . . . 0.56999999999999995 109.497 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.565 ' CG1' ' C33' ' A' ' 269' ' ' HSI . 1.4 p -128.27 -16.05 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 CA-C-N 112.538 -2.119 . . . . 0.56999999999999995 110.973 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 244' ' ' ASP 0.289 0.0 OUTLIER 84.51 178.22 0.05 OUTLIER 'General case' 0 C--N 1.371 1.54 0 O-C-N 126.872 2.607 . . . . 0.91000000000000003 111.782 -174.289 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 245' ' ' ILE . 1.8 mp -93.81 -35.64 6.57 Favored 'Isoleucine or valine' 0 C--N 1.382 1.983 0 N-CA-C 118.322 2.712 . . . . 0.56999999999999995 118.322 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.77 -14.52 0.05 OUTLIER 'General case' 0 C--N 1.377 1.784 0 N-CA-C 117.224 2.305 . . . . 0.56999999999999995 117.224 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.439 ' HB ' ' CG2' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -124.59 -21.53 4.83 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.504 -175.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.29 88.67 0.02 OUTLIER 'General case' 0 C--N 1.378 1.845 0 CA-C-O 125.566 2.603 . . . . 0.56999999999999995 108.488 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.07 154.07 29.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 112.816 -1.993 . . . . 1.2 107.609 -178.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.406 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -124.42 127.84 48.13 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 125.745 2.688 . . . . 0.56999999999999995 105.393 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 143.27 58.06 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.214 -2.179 . . . . 0.56999999999999995 111.916 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.29 95.42 Favored 'General case' 0 C--N 1.392 2.43 0 CA-C-N 113.842 -1.526 . . . . 0.56999999999999995 107.996 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.71 -38.51 81.83 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 115.644 -0.707 . . . . 0.91000000000000003 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -64.17 -55.09 24.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.91000000000000003 110.842 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 pt -66.06 -34.82 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.164 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -70.15 -32.35 70.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.882 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.81 62.41 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.655 -0.783 . . . . 0.56999999999999995 112.499 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.474 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.8 -44.59 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.176 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.474 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.17 -19.18 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.914 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.5 t -67.14 -31.7 72.32 Favored 'General case' 0 C--N 1.366 1.326 0 CA-C-O 122.122 0.963 . . . . 0.56999999999999995 108.667 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.422 ' CD1' HD23 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -51.15 -69.85 0.1 Allowed 'General case' 0 C--N 1.388 2.239 0 CA-C-O 124.859 2.266 . . . . 0.56999999999999995 111.226 -175.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.439 ' OH ' ' N ' ' A' ' 225' ' ' GLY . 0.1 OUTLIER -96.23 142.25 28.61 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 112.729 -2.032 . . . . 0.56999999999999995 111.903 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.576 3.865 0 N-CA-C 120.24 2.856 . . . . 0.91000000000000003 120.24 -168.687 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.565 ' C33' ' CG1' ' A' ' 243' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.325 -0.708 . . . . 0.56999999999999995 111.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.48 179.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 O-C-N 125.101 2.106 . . . . 0.56999999999999995 111.619 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.62 126.4 71.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.113 0 CA-C-O 123.242 1.496 . . . . 0.56999999999999995 111.053 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.5 -170.05 3.42 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 114.68 -1.146 . . . . 0.56999999999999995 108.428 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 -129.45 162.32 28.37 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 122.303 1.049 . . . . 1.2 109.278 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.83 155.44 14.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 81.96 -41.72 0.14 Allowed 'General case' 0 C--N 1.377 1.777 0 CA-C-O 122.187 0.994 . . . . 0.56999999999999995 110.622 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -114.4 131.47 56.56 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.579 -1.191 . . . . 0.56999999999999995 110.868 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 148' ' ' LYS . 1.1 mm -127.45 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.12 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.0 157.81 17.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.098 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 16.7 t80 -145.29 160.02 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.914 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.598 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 3.9 tpt85 -146.49 121.97 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.841 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -95.53 125.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.122 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -61.83 -179.37 0.19 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.616 1.674 . . . . 0.56999999999999995 111.268 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.09 51.37 0.98 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 110.824 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.4 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 5.2 m-85 44.19 -150.15 0.05 Allowed 'General case' 0 C--N 1.366 1.323 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 109.045 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.425 ' CB ' ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -165.84 168.24 8.07 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-O 122.286 1.041 . . . . 0.56999999999999995 110.454 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 122' ' ' THR . 32.5 Cg_endo -68.06 -36.23 17.85 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 121.444 1.429 . . . . 0.56999999999999995 112.963 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -84.84 -45.42 12.32 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.987 1.375 . . . . 0.91000000000000003 113.134 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.498 ' CE ' ' CE2' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -77.92 110.09 12.52 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 123.68 1.705 . . . . 0.56999999999999995 109.482 -176.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.27 135.89 47.67 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.947 -1.479 . . . . 0.56999999999999995 109.192 -176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.4 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -61.61 -50.83 70.98 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 108.448 -0.945 . . . . 1.2 108.448 -170.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.56 -34.86 69.63 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 113.083 -1.871 . . . . 0.91000000000000003 110.896 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -39.71 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.91000000000000003 110.826 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.7 t -64.97 -49.74 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 111.153 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -41.61 91.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 110.896 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -42.3 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 110.863 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 212' ' ' LEU . . . -66.5 -48.88 68.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.56999999999999995 111.092 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.515 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -64.35 -31.95 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.122 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.95 -46.71 70.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 1.2 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -62.82 -37.2 85.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.5 82.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.065 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CE2' HG22 ' A' ' 134' ' ' ILE . 5.5 m-85 -67.06 -33.83 76.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.919 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.426 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.3 tp60 -70.21 -44.65 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.871 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.489 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.7 p -68.54 -33.6 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.56999999999999995 111.16 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.46 -34.31 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.854 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 138' ' ' PHE . 29.3 m -72.22 -49.45 35.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 110.863 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -60.66 -11.97 8.92 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-O 121.881 0.848 . . . . 0.56999999999999995 112.706 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -111.98 -5.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.367 1.358 0 CA-C-N 114.792 -1.094 . . . . 0.56999999999999995 112.69 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.0 p -140.63 146.38 44.43 Favored Pre-proline 0 C--N 1.365 1.261 0 CA-C-O 124.594 2.14 . . . . 0.56999999999999995 111.115 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -77.19 -25.54 8.48 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 121.218 1.278 . . . . 0.56999999999999995 111.77 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.68 96.09 4.77 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 122.668 1.223 . . . . 0.56999999999999995 109.518 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -77.04 160.75 28.86 Favored 'General case' 0 C--N 1.363 1.184 0 CA-C-N 115.168 -0.924 . . . . 0.56999999999999995 112.198 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -133.05 140.77 47.88 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 107.702 -1.222 . . . . 0.56999999999999995 107.702 -173.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.0 m -155.67 135.56 12.78 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 109.387 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -74.97 144.17 43.3 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 114.513 -1.222 . . . . 0.56999999999999995 109.213 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.2 pt -125.14 -179.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.364 1.213 0 CA-C-O 121.947 0.879 . . . . 0.56999999999999995 109.887 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -134.41 63.87 1.61 Allowed 'General case' 0 C--N 1.37 1.483 0 CA-C-O 122.93 1.348 . . . . 0.56999999999999995 111.299 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.76 95.83 1.57 Allowed 'General case' 0 C--N 1.373 1.624 0 CA-C-N 114.553 -1.203 . . . . 0.56999999999999995 110.357 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 45.66 -137.63 7.04 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 122.418 1.01 . . . . 0.56999999999999995 111.681 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 151.53 46.96 Favored 'General case' 0 C--N 1.366 1.307 0 CA-C-O 123.145 1.45 . . . . 0.56999999999999995 110.74 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.68 163.64 28.99 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 114.497 -1.229 . . . . 0.56999999999999995 109.814 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -46.06 -52.0 12.75 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 108.245 -1.02 . . . . 0.91000000000000003 108.245 -173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 41.6 mt -116.43 110.47 31.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 O-C-N 123.816 0.697 . . . . 0.56999999999999995 111.093 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 122.02 46.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.977 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.19 120.21 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 111.098 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.8 t -131.23 124.94 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 111.084 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 197' ' ' PHE . 2.4 m-85 -86.78 120.48 28.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.852 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.13 169.0 18.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 110.626 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 163.44 13.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.749 -1.219 . . . . 1.2 108.945 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 167' ' ' ALA . . . -33.03 130.89 0.3 Allowed Glycine 0 C--N 1.37 2.429 0 O-C-N 124.009 0.818 . . . . 0.56999999999999995 112.718 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 166' ' ' GLY . . . 84.28 40.28 0.03 OUTLIER 'General case' 0 C--N 1.39 2.361 0 CA-C-O 124.763 2.221 . . . . 0.56999999999999995 112.383 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -107.0 155.6 19.63 Favored 'General case' 0 C--N 1.364 1.237 0 CA-C-N 114.249 -1.342 . . . . 0.56999999999999995 109.087 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.79 168.77 1.32 Allowed Glycine 0 C--N 1.378 2.865 0 N-CA-C 110.104 -1.198 . . . . 0.56999999999999995 110.104 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.77 8.03 5.66 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-O 122.402 1.096 . . . . 0.91000000000000003 113.367 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.41 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -165.76 -77.65 0.03 OUTLIER 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.085 -0.961 . . . . 0.56999999999999995 111.152 -171.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER 83.2 43.78 0.02 OUTLIER 'General case' 0 C--N 1.373 1.608 0 CA-C-O 123.034 1.397 . . . . 0.56999999999999995 110.239 175.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 172' ' ' HIS . . . 159.88 114.17 0.0 OUTLIER 'General case' 0 C--N 1.382 2.012 0 CA-C-N 114.999 -1.001 . . . . 0.56999999999999995 110.72 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.429 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -147.6 -167.82 2.89 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 122.018 0.914 . . . . 0.56999999999999995 110.07 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 175' ' ' ASP . 0.4 OUTLIER -72.61 -177.74 2.38 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 124.477 1.111 . . . . 0.91000000000000003 112.252 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.27 49.13 0.21 Allowed Glycine 0 C--N 1.381 3.049 0 CA-C-O 123.411 1.562 . . . . 0.56999999999999995 113.192 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -171.72 -36.48 0.02 OUTLIER 'General case' 0 C--N 1.384 2.069 0 CA-C-O 123.425 1.583 . . . . 0.56999999999999995 112.819 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 177' ' ' LYS . . . 169.41 -103.62 0.2 Allowed Glycine 0 C--N 1.375 2.7 0 CA-C-O 122.955 1.308 . . . . 0.56999999999999995 110.457 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.541 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 36.04 -92.19 0.01 OUTLIER Glycine 0 C--N 1.367 2.267 0 O-C-N 120.309 -1.7 . . . . 0.56999999999999995 114.49 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.537 HG21 H402 ' A' ' 269' ' ' HSI . 1.9 mm -51.23 170.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.064 0 CA-C-O 121.297 0.57 . . . . 0.56999999999999995 111.593 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.427 ' O ' ' CD1' ' A' ' 197' ' ' PHE . 3.6 tp -136.09 -41.33 0.66 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.945 0.879 . . . . 0.56999999999999995 112.55 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 196' ' ' HIS . . . -176.72 179.87 1.06 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.359 -0.837 . . . . 0.56999999999999995 111.094 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -156.03 137.91 14.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.928 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.01 40.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.101 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.43 ' CB ' HG22 ' A' ' 191' ' ' ILE . 1.9 m-85 -91.93 176.59 6.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.523 1.154 . . . . 0.56999999999999995 110.964 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.37 55.07 0.1 Allowed Glycine 0 C--N 1.366 2.21 0 CA-C-N 115.501 -0.772 . . . . 0.56999999999999995 112.797 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.432 ' HD2' ' CA ' ' A' ' 192' ' ' GLY . 47.0 Cg_endo -74.42 -42.98 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 120.907 1.071 . . . . 0.56999999999999995 112.008 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.41 87.32 0.17 Allowed Glycine 0 C--N 1.379 2.93 0 C-N-CA 120.137 -1.03 . . . . 0.56999999999999995 111.569 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 79.75 97.02 0.06 Allowed 'General case' 0 C--N 1.386 2.155 0 CA-C-O 123.59 1.662 . . . . 0.56999999999999995 110.073 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.65 -118.56 1.27 Allowed Glycine 0 C--N 1.381 3.047 0 N-CA-C 109.61 -1.396 . . . . 0.56999999999999995 109.61 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -72.11 -11.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 CA-C-O 124.689 2.185 . . . . 0.56999999999999995 110.36 -178.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' HD2' ' A' ' 187' ' ' PRO . . . -66.91 124.62 23.89 Favored Glycine 0 C--N 1.372 2.552 0 O-C-N 120.077 -1.639 . . . . 0.56999999999999995 109.758 -174.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 115.09 -33.12 5.45 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-O 121.737 0.631 . . . . 0.56999999999999995 112.521 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -72.91 129.37 37.99 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 122.162 -0.61 . . . . 0.91000000000000003 110.828 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -121.51 160.05 25.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.481 . . . . 0.56999999999999995 111.089 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 182' ' ' ALA . 46.0 m170 -133.74 140.07 46.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.66 139.42 38.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 110.887 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.55 78.89 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -29.61 11.36 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 118.529 -0.748 . . . . 0.91000000000000003 112.515 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -39.15 -55.94 1.55 Allowed 'General case' 0 C--N 1.352 0.713 0 CA-C-O 124.907 2.289 . . . . 0.91000000000000003 109.189 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.416 ' HB3' ' C ' ' A' ' 177' ' ' LYS . 1.6 pm0 -75.09 176.38 7.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-O 125.474 2.559 . . . . 0.91000000000000003 112.379 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.11 90.82 3.44 Favored 'General case' 0 C--N 1.369 1.431 0 O-C-N 119.282 -2.136 . . . . 0.56999999999999995 109.638 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -88.63 147.63 24.45 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 114.063 -1.426 . . . . 0.56999999999999995 111.708 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 99.6 m -123.05 121.57 36.37 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-O 124.387 2.041 . . . . 0.56999999999999995 112.429 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.35 133.47 34.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 120.865 -1.147 . . . . 0.56999999999999995 110.588 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' A' ' 207' ' ' SER . 2.2 t-80 78.89 62.79 0.03 OUTLIER 'General case' 0 C--N 1.38 1.909 0 CA-C-O 122.726 1.251 . . . . 0.56999999999999995 110.219 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.7 m 85.09 92.85 0.03 OUTLIER 'General case' 0 C--N 1.381 1.945 0 CA-C-O 123.703 1.716 . . . . 0.56999999999999995 109.057 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.42 110.21 0.5 Allowed Glycine 0 C--N 1.375 2.721 0 O-C-N 120.997 -1.064 . . . . 0.56999999999999995 111.772 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 43.57 -113.26 0.68 Allowed Glycine 0 C--N 1.375 2.73 0 CA-C-O 123.756 1.753 . . . . 0.56999999999999995 111.689 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 126.21 38.31 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 113.599 -1.3 . . . . 0.56999999999999995 112.243 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.527 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.4 OUTLIER -95.71 151.04 19.72 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.186 -1.37 . . . . 0.56999999999999995 111.885 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.446 ' C ' ' CD1' ' A' ' 212' ' ' LEU . 0.7 OUTLIER -72.75 -38.51 67.35 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 123.518 1.628 . . . . 0.56999999999999995 107.873 -175.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 1.9 t80 -51.79 -46.8 64.33 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 114.242 -1.344 . . . . 0.56999999999999995 110.867 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.427 HD13 ' C25' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -54.76 -51.18 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.56999999999999995 110.923 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.42 HG22 ' CG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -64.18 -45.37 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.115 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.453 ' O ' ' CD1' ' A' ' 220' ' ' ILE . . . -59.14 -39.91 83.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 111.074 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 248' ' ' PHE . 1.1 t -65.25 -39.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.118 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.458 ' HD1' ' C19' ' A' ' 269' ' ' HSI . 3.5 t-160 -66.31 -49.03 68.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.827 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.9 -42.26 84.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.91000000000000003 110.904 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 216' ' ' ALA . 11.7 mt -67.0 -46.17 85.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.56999999999999995 111.16 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.94 -33.67 64.19 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.476 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.411 ' CE1' ' O ' ' A' ' 227' ' ' GLY . 1.5 m-70 -64.31 -40.65 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.56999999999999995 110.872 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.6 t -71.23 -51.04 26.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.815 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 225' ' ' GLY . 3.3 pp -72.4 -64.89 0.86 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.868 1.062 . . . . 0.56999999999999995 113.868 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.477 ' N ' ' CD1' ' A' ' 224' ' ' LEU . . . -73.13 169.98 52.5 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-O 124.871 2.373 . . . . 0.56999999999999995 111.493 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -154.73 0.01 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-O 123.727 1.727 . . . . 0.56999999999999995 108.796 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 222' ' ' HIS . . . -53.47 -99.47 0.01 OUTLIER Glycine 0 C--N 1.38 2.982 0 CA-C-O 123.849 1.805 . . . . 0.56999999999999995 111.921 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -112.67 -93.82 0.46 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 119.684 -2.068 . . . . 0.56999999999999995 112.216 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 234' ' ' ALA . 16.1 p -162.75 -43.85 0.04 OUTLIER 'General case' 0 C--N 1.372 1.563 0 CA-C-N 115.219 -0.9 . . . . 0.56999999999999995 110.666 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 83.84 28.99 0.08 Allowed 'General case' 0 C--N 1.399 2.726 0 CA-C-N 114.189 -1.368 . . . . 0.56999999999999995 114.501 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.3 128.68 2.4 Favored Pre-proline 0 C--N 1.383 2.056 0 CA-C-N 114.459 -1.246 . . . . 0.91000000000000003 108.545 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.42 64.41 7.26 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.909 2.406 . . . . 0.56999999999999995 112.12 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.7 -31.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 121.086 -1.009 . . . . 0.56999999999999995 113.276 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -69.82 120.07 15.01 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-O 123.521 1.629 . . . . 0.56999999999999995 110.41 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.544 HG13 ' CZ ' ' A' ' 248' ' ' PHE . 40.0 t -58.4 88.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.71 -1.132 . . . . 0.56999999999999995 112.849 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 158.37 -20.74 0.0 OUTLIER 'General case' 0 C--N 1.367 1.361 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 112.488 -176.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 4.0 p90 -50.02 153.03 2.48 Favored Pre-proline 0 N--CA 1.43 -1.459 0 CA-C-O 123.088 1.423 . . . . 0.56999999999999995 111.322 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.67 -47.87 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.331 1.354 . . . . 0.56999999999999995 110.591 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 m -39.6 121.25 1.2 Allowed 'General case' 0 C--N 1.353 0.719 0 CA-C-O 122.725 1.25 . . . . 0.56999999999999995 110.926 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 179' ' ' GLY . 36.2 t80 -68.18 162.52 24.7 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.355 -1.293 . . . . 0.56999999999999995 108.113 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 14.4 tttt 167.4 124.22 0.01 OUTLIER 'General case' 0 C--N 1.373 1.618 0 CA-C-O 123.064 1.411 . . . . 0.56999999999999995 108.112 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -74.77 120.11 19.87 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-O 122.898 1.332 . . . . 0.56999999999999995 111.325 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.18 115.6 12.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.239 0 CA-C-N 115.166 -0.925 . . . . 0.56999999999999995 108.891 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -41.47 142.36 0.61 Allowed 'General case' 0 C--N 1.366 1.31 0 CA-C-O 124.052 1.882 . . . . 0.91000000000000003 109.53 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.4 mt -65.96 -22.29 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 112.209 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -17.04 61.98 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.126 0.965 . . . . 0.56999999999999995 111.387 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.7 p -112.18 8.25 19.81 Favored 'General case' 0 C--N 1.371 1.519 0 CA-C-O 122.654 1.216 . . . . 0.56999999999999995 113.376 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.544 ' CZ ' HG13 ' A' ' 235' ' ' VAL . 45.0 t80 -77.16 88.49 3.63 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-O 124.193 1.949 . . . . 0.56999999999999995 108.577 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.418 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -112.42 153.56 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 O-C-N 120.678 -1.263 . . . . 1.2 110.32 177.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -119.98 129.36 54.25 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 124.331 2.015 . . . . 0.56999999999999995 107.934 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 143.91 55.51 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 119.659 -1.901 . . . . 0.56999999999999995 112.25 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.68 89.61 Favored 'General case' 0 C--N 1.382 1.98 0 CA-C-N 114.663 -1.153 . . . . 0.56999999999999995 109.428 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.17 -40.71 94.92 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.796 -0.638 . . . . 0.91000000000000003 110.882 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.29 -54.92 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.91000000000000003 110.849 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.435 ' HA ' ' CD1' ' A' ' 258' ' ' ILE . 26.1 pt -66.1 -34.79 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.081 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 255' ' ' ILE . 37.3 mtp180 -62.84 -43.47 98.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.934 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.57 -57.52 12.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.547 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 255' ' ' ILE . 28.4 pt -46.62 -44.2 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.56999999999999995 111.224 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.415 ' N ' HG13 ' A' ' 258' ' ' ILE . 2.6 pt20 -72.02 -26.75 62.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.594 1.187 . . . . 0.56999999999999995 110.441 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.3 mp -50.95 -56.87 10.27 Favored 'General case' 0 C--N 1.377 1.802 0 CA-C-O 123.101 1.429 . . . . 0.56999999999999995 110.92 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.424 ' CZ ' ' O ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -92.52 -73.68 0.54 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-N 114.367 -1.288 . . . . 0.56999999999999995 113.054 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.268 2.225 0 CA-C-O 117.09 -1.95 . . . . 0.91000000000000003 115.094 173.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.537 H402 HG21 ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.573 0 CA-C-O 119.256 -0.747 . . . . 0.56999999999999995 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.5 -30.58 28.12 Favored 'Trans proline' 0 C--N 1.377 2.049 0 O-C-N 124.336 1.703 . . . . 0.56999999999999995 113.377 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 t -111.46 124.09 67.9 Favored 'Isoleucine or valine' 0 C--N 1.382 1.981 0 CA-C-N 113.951 -1.477 . . . . 0.56999999999999995 108.847 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 11.3 m0 70.67 -158.9 0.14 Allowed 'General case' 0 C--N 1.386 2.175 0 CA-C-N 112.623 -2.08 . . . . 0.56999999999999995 106.925 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.86 149.15 31.75 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-O 123.112 1.434 . . . . 1.2 109.382 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -44.83 0.1 Allowed 'General case' 0 C--N 1.374 1.659 0 CA-C-N 113.081 -1.872 . . . . 0.56999999999999995 111.037 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -78.25 -30.86 48.89 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 113.468 -1.696 . . . . 0.56999999999999995 109.983 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -112.02 109.12 18.7 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 114.26 -1.336 . . . . 0.56999999999999995 110.903 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.447 ' CG1' ' CE1' ' A' ' 149' ' ' PHE . 1.9 mm -102.22 155.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 111.13 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 149.5 36.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 111.106 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.1 t80 -145.86 156.57 43.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -154.54 132.17 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.936 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.74 146.32 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.137 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.568 ' HB3' ' CE2' ' A' ' 163' ' ' PHE . 55.5 t30 -53.4 -60.44 3.3 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 117.651 -1.619 . . . . 0.56999999999999995 107.454 -167.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 159.21 31.08 0.0 OUTLIER 'General case' 0 C--N 1.383 2.024 0 O-C-N 126.474 2.359 . . . . 0.56999999999999995 109.567 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 77.18 92.16 0.07 Allowed 'General case' 0 C--N 1.409 3.162 0 N-CA-C 105.461 -2.052 . . . . 0.56999999999999995 105.461 164.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.433 HG21 ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -49.43 163.82 0.35 Allowed Pre-proline 0 C--N 1.383 2.041 0 CA-C-N 111.993 -2.367 . . . . 0.56999999999999995 108.548 -168.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.23 -47.92 11.1 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 115.692 -0.503 . . . . 0.56999999999999995 112.537 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -63.72 1.32 Allowed 'General case' 0 C--N 1.386 2.153 0 N-CA-C 104.32 -2.474 . . . . 0.91000000000000003 104.32 -163.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.0 ttm -53.37 154.48 3.35 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-O 125.141 2.4 . . . . 0.56999999999999995 108.219 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.54 137.74 32.07 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 112.79 -2.005 . . . . 0.56999999999999995 110.125 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -49.43 70.19 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 115.116 -0.947 . . . . 1.2 108.579 -170.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.07 -35.24 64.33 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 126.838 2.586 . . . . 0.91000000000000003 110.98 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -70.7 -42.26 70.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.91000000000000003 110.883 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.13 -47.68 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.1 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 7.7 t70 -60.12 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.91000000000000003 110.872 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.37 -41.44 97.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.927 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.08 75.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.56999999999999995 111.125 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 18.1 pt -64.76 -39.22 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.144 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -58.85 -49.11 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.813 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.479 ' N ' ' HZ1' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -62.79 -34.87 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.888 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.15 88.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.12 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m-85 -63.52 -36.85 85.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.91 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 8.2 tt0 -66.38 -39.19 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.56999999999999995 110.935 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.464 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.9 t -69.51 -34.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.152 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.446 ' CD2' ' CD1' ' A' ' 224' ' ' LEU . 4.8 m95 -82.93 -34.13 26.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.977 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.7 m -78.66 -48.11 15.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.905 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -61.02 -12.72 12.52 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 121.892 0.853 . . . . 0.56999999999999995 111.844 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 18.9 m -114.48 11.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.378 1.842 0 CA-C-N 113.892 -1.504 . . . . 0.56999999999999995 112.898 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 8.8 p -150.67 150.45 28.35 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-O 125.381 2.515 . . . . 0.56999999999999995 110.264 -173.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.81 -24.54 4.06 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 O-C-N 118.133 -1.562 . . . . 0.56999999999999995 113.054 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.94 111.48 11.35 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-O 124.534 2.112 . . . . 0.56999999999999995 107.487 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 156.8 38.79 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 114.687 172.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' CE1' HD23 ' A' ' 224' ' ' LEU . 1.1 m-85 -128.04 160.01 33.27 Favored 'General case' 0 C--N 1.376 1.723 0 CA-C-N 112.526 -2.125 . . . . 0.56999999999999995 109.441 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.0 m -157.92 114.71 2.9 Favored 'General case' 0 C--N 1.389 2.29 0 CA-C-O 124.855 2.264 . . . . 0.56999999999999995 109.344 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -95.3 129.17 42.53 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.106 -1.861 . . . . 0.56999999999999995 110.69 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.89 137.07 37.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.406 0 CA-C-O 124.681 2.182 . . . . 0.56999999999999995 111.361 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -46.29 71.27 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 110.533 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -121.41 171.92 8.43 Favored 'General case' 0 C--N 1.379 1.875 0 CA-C-N 113.361 -1.745 . . . . 0.56999999999999995 110.143 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.08 -119.91 6.68 Favored Glycine 0 C--N 1.382 3.11 0 N-CA-C 109.514 -1.434 . . . . 0.56999999999999995 109.514 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 ttt -165.46 108.72 0.82 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-O 123.389 1.566 . . . . 0.56999999999999995 109.759 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.03 143.58 33.96 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 112.722 -2.035 . . . . 0.56999999999999995 110.462 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -44.98 -51.22 10.08 Favored 'General case' 0 C--N 1.374 1.665 0 CA-C-N 116.001 -0.545 . . . . 0.91000000000000003 110.356 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.6 mt -90.17 109.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.386 2.169 0 O-C-N 128.124 3.39 . . . . 0.56999999999999995 111.116 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.97 132.06 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.957 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.6 118.14 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.126 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.5 t -133.08 146.02 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 111.166 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -92.07 121.66 33.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.834 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.01 168.8 18.86 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-O 123.445 1.593 . . . . 0.56999999999999995 109.829 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.73 169.78 8.95 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 114.974 -1.012 . . . . 1.2 110.531 177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.35 139.18 2.46 Favored Glycine 0 C--N 1.383 3.152 0 O-C-N 126.202 2.189 . . . . 0.56999999999999995 111.517 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.68 57.69 0.84 Allowed 'General case' 0 C--N 1.4 2.777 0 CA-C-O 125.475 2.56 . . . . 0.56999999999999995 110.585 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -108.5 -50.31 3.05 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 112.39 -2.187 . . . . 0.56999999999999995 110.34 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -171.77 -121.54 0.6 Allowed Glycine 0 C--N 1.377 2.823 0 CA-C-N 114.395 -1.275 . . . . 0.56999999999999995 111.857 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 41.7 p-10 -36.22 147.38 0.03 OUTLIER 'General case' 0 C--N 1.387 2.221 0 O-C-N 127.138 2.317 . . . . 0.91000000000000003 112.494 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.3 OUTLIER 75.72 -155.11 0.04 OUTLIER 'General case' 0 C--N 1.391 2.392 0 CA-C-N 112.501 -2.136 . . . . 0.56999999999999995 112.181 -172.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -112.57 -133.74 0.34 Allowed 'General case' 0 C--N 1.38 1.913 0 CA-C-O 123.452 1.596 . . . . 0.56999999999999995 107.463 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.51 128.31 54.0 Favored 'General case' 0 C--N 1.38 1.92 0 CA-C-N 114.959 -1.019 . . . . 0.56999999999999995 111.129 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.444 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 9.7 m-85 -92.94 179.58 5.41 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-N 111.823 -2.444 . . . . 0.56999999999999995 111.184 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.422 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -86.7 -175.82 5.56 Favored 'General case' 0 C--N 1.382 2.014 0 CA-C-N 113.724 -1.58 . . . . 0.91000000000000003 113.009 173.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . -147.96 142.68 10.32 Favored Glycine 0 C--N 1.39 3.563 0 O-C-N 126.337 2.273 . . . . 0.56999999999999995 110.482 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.72 25.02 2.61 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 113.025 -1.587 . . . . 0.56999999999999995 113.086 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.78 -132.65 4.34 Favored Glycine 0 C--N 1.372 2.564 0 CA-C-O 116.679 -2.178 . . . . 0.56999999999999995 112.69 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.96 -109.67 1.58 Allowed Glycine 0 C--N 1.38 3.008 0 O-C-N 125.409 1.3 . . . . 0.56999999999999995 111.405 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.3 mt -73.77 166.5 2.65 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 N-CA-C 115.332 1.604 . . . . 0.56999999999999995 115.332 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.54 -41.4 2.82 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 119.962 -1.711 . . . . 0.56999999999999995 110.129 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -175.95 179.9 1.26 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.893 -1.503 . . . . 0.56999999999999995 111.089 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 1.2 p80 -165.78 135.85 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 110.849 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.43 162.51 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.08 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.7 -171.0 1.74 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.337 -0.945 . . . . 0.56999999999999995 111.05 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -145.66 -76.2 0.03 OUTLIER Glycine 0 C--N 1.377 2.843 0 C-N-CA 119.385 -1.388 . . . . 0.56999999999999995 110.551 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.47 75.73 4.91 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.019 1.812 . . . . 0.56999999999999995 111.465 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -148.11 13.97 1.29 Allowed Glycine 0 C--N 1.367 2.288 0 C-N-CA 118.574 -1.774 . . . . 0.56999999999999995 111.926 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 57.28 -93.19 0.04 OUTLIER 'General case' 0 C--N 1.388 2.278 0 O-C-N 125.549 1.382 . . . . 0.56999999999999995 110.424 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -62.56 -71.56 0.8 Allowed Glycine 0 C--N 1.389 3.477 0 CA-C-N 114.69 -1.141 . . . . 0.56999999999999995 112.33 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -31.65 53.79 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 CA-C-O 124.686 2.184 . . . . 0.56999999999999995 108.915 -176.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.76 140.66 43.66 Favored Glycine 0 C--N 1.376 2.787 0 N-CA-C 107.783 -2.127 . . . . 0.56999999999999995 107.783 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.42 -38.84 2.97 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-N 113.869 -1.165 . . . . 0.56999999999999995 113.883 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -48.32 150.97 1.13 Allowed 'General case' 0 C--N 1.392 2.416 0 CA-C-N 113.417 -1.391 . . . . 0.91000000000000003 110.907 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.09 145.86 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -121.68 134.48 54.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.56999999999999995 110.826 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.402 ' CE1' ' HB ' ' A' ' 215' ' ' THR . 29.0 m-85 -103.94 144.28 31.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.892 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 201' ' ' GLU . 0.4 OUTLIER -71.54 75.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.808 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -56.65 18.1 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 108.211 -1.033 . . . . 0.91000000000000003 108.211 -175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.4 -45.55 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.903 1.377 . . . . 0.91000000000000003 110.692 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -55.29 172.64 0.13 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 126.669 3.128 . . . . 0.91000000000000003 113.178 177.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.71 102.63 10.67 Favored 'General case' 0 C--N 1.376 1.756 0 CA-C-N 111.975 -2.375 . . . . 0.56999999999999995 114.119 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.433 ' CH2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -92.28 150.36 20.91 Favored 'General case' 0 C--N 1.361 1.1 0 CA-C-N 112.946 -1.934 . . . . 0.56999999999999995 108.675 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.47 122.09 42.79 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 123.751 1.739 . . . . 0.56999999999999995 109.032 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -89.41 131.87 35.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 112.169 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 78.81 -148.33 0.02 OUTLIER 'General case' 0 C--N 1.395 2.572 0 O-C-N 125.362 1.664 . . . . 0.56999999999999995 110.492 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.465 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 1.6 t -60.72 93.27 0.03 OUTLIER 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.612 2.148 . . . . 0.56999999999999995 109.281 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -174.38 -34.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.29 0 CA-C-N 112.359 -2.2 . . . . 0.56999999999999995 113.407 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 141.73 -112.97 0.79 Allowed Glycine 0 C--N 1.387 3.41 0 CA-C-O 123.378 1.543 . . . . 0.56999999999999995 111.81 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.5 p -82.11 117.68 22.47 Favored 'General case' 0 C--N 1.369 1.427 0 CA-C-N 114.27 -0.965 . . . . 0.56999999999999995 110.23 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.75 176.87 4.92 Favored 'General case' 0 C--N 1.374 1.655 0 O-C-N 126.72 2.512 . . . . 0.56999999999999995 110.75 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.55 -33.81 71.53 Favored 'General case' 0 C--N 1.382 2.006 0 CA-C-N 113.803 -1.544 . . . . 0.56999999999999995 107.629 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.452 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 27.5 t80 -57.53 -50.13 74.08 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.376 -1.453 . . . . 0.56999999999999995 110.871 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -51.41 70.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.402 ' HB ' ' CE1' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -68.78 -32.66 72.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 111.098 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.35 -46.12 70.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.56999999999999995 111.058 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 213' ' ' PHE . 20.1 t -63.33 -39.28 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.142 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.95 -46.27 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.879 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 220' ' ' ILE . 3.0 pt-20 -60.91 -44.52 97.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.91000000000000003 110.837 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.431 ' N ' ' CG ' ' A' ' 219' ' ' GLU . 10.1 pt -71.67 -32.82 46.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.235 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.41 ' HA2' ' CD1' ' A' ' 224' ' ' LEU . . . -65.17 -34.93 90.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.56999999999999995 112.453 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.84 -42.07 97.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.56999999999999995 110.908 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.9 m -70.95 -36.81 72.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.897 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.46 HD23 ' CE1' ' A' ' 149' ' ' PHE . 29.6 mt -40.64 -60.49 1.13 Allowed 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 123.443 1.592 . . . . 0.56999999999999995 112.296 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.48 -30.38 0.17 Allowed Glycine 0 C--N 1.392 3.654 0 C-N-CA 118.403 -1.856 . . . . 0.56999999999999995 112.404 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.81 160.24 22.28 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-N 112.396 -1.902 . . . . 0.56999999999999995 112.558 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.56 -151.93 12.36 Favored Glycine 0 C--N 1.382 3.088 0 CA-C-O 123.96 1.867 . . . . 0.56999999999999995 110.61 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -65.28 -97.81 0.0 OUTLIER 'General case' 0 C--N 1.38 1.911 0 CA-C-N 113.162 -1.519 . . . . 0.56999999999999995 113.484 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.408 ' CB ' ' CB ' ' A' ' 234' ' ' ALA . 97.0 p -174.3 -32.99 0.01 OUTLIER 'General case' 0 C--N 1.373 1.604 0 C-N-CA 118.498 -1.281 . . . . 0.56999999999999995 108.916 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.25 5.2 0.85 Allowed 'General case' 0 C--N 1.401 2.826 0 O-C-N 125.862 1.976 . . . . 0.56999999999999995 114.663 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -135.65 140.51 34.08 Favored Pre-proline 0 C--N 1.382 2.009 0 N-CA-C 104.608 -2.367 . . . . 0.91000000000000003 104.608 -169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.83 17.64 1.6 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 C-N-CA 123.568 2.845 . . . . 0.56999999999999995 113.534 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 -0.29 5.52 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 114.109 -1.405 . . . . 0.56999999999999995 113.729 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.446 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -99.3 124.14 44.16 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.709 1.719 . . . . 0.56999999999999995 112.639 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.674 ' HA ' ' H30' ' A' ' 269' ' ' HSI . 11.1 t -60.55 87.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.233 0 CA-C-N 113.927 -1.488 . . . . 0.56999999999999995 113.381 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 3.3 mmm 159.62 -23.94 0.0 OUTLIER 'General case' 0 C--N 1.368 1.411 0 O-C-N 125.045 1.466 . . . . 0.56999999999999995 111.77 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 5.3 p90 -51.86 153.87 4.09 Favored Pre-proline 0 C--N 1.369 1.432 0 CA-C-O 123.755 1.74 . . . . 0.56999999999999995 111.999 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.99 -25.22 7.67 Favored 'Trans proline' 0 C--N 1.368 1.596 0 CA-C-O 117.773 -1.011 . . . . 0.56999999999999995 112.304 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.466 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.2 m -41.06 113.67 0.41 Allowed 'General case' 0 C--N 1.368 1.391 0 CA-C-O 124.016 1.865 . . . . 0.56999999999999995 110.337 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.508 ' CE2' ' O ' ' A' ' 179' ' ' GLY . 4.7 t80 -80.47 106.25 12.34 Favored 'General case' 0 C--N 1.369 1.453 0 N-CA-C 106.241 -1.763 . . . . 0.56999999999999995 106.241 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -154.73 107.56 2.8 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 124.772 2.225 . . . . 0.56999999999999995 107.095 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -61.62 118.03 6.55 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 126.09 2.852 . . . . 0.56999999999999995 111.633 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 2.5 p -101.97 -19.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.05 -1.886 . . . . 0.56999999999999995 112.627 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.465 ' OD2' ' HA ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 72.87 4.59 5.01 Favored 'General case' 0 C--N 1.365 1.277 0 O-C-N 126.303 2.252 . . . . 0.91000000000000003 113.531 -179.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.0 mt 79.59 7.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.376 1.737 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 115.054 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -35.16 73.88 Favored 'General case' 0 C--N 1.39 2.354 0 N-CA-C 105.107 -2.182 . . . . 0.56999999999999995 105.107 -165.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.47 -22.79 8.57 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-N 112.394 -2.185 . . . . 0.56999999999999995 113.087 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.499 ' HA ' 'CL1 ' ' A' ' 269' ' ' HSI . 13.2 t80 -40.94 99.85 0.02 OUTLIER 'General case' 0 C--N 1.382 1.994 0 O-C-N 125.729 1.893 . . . . 0.56999999999999995 110.326 -175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.64 147.28 8.63 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 112.189 -2.278 . . . . 1.2 106.946 -171.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.448 ' CD1' ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.99 127.71 55.84 Favored 'General case' 0 C--N 1.372 1.563 0 CA-C-O 124.657 2.17 . . . . 0.56999999999999995 107.511 -173.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.69 158.8 35.5 Favored 'General case' 0 C--N 1.362 1.116 0 O-C-N 120.445 -1.409 . . . . 0.56999999999999995 112.014 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 255' ' ' ILE . . . -56.32 -43.64 79.18 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.289 -1.323 . . . . 0.56999999999999995 109.491 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -41.56 95.11 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.021 0.528 . . . . 0.91000000000000003 110.846 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -63.82 -55.1 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.91000000000000003 110.869 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 252' ' ' ALA . 0.5 OUTLIER -65.94 -35.93 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.134 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.411 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 18.1 mtp85 -70.19 -32.3 70.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.88 -44.83 77.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 0.56999999999999995 112.495 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.483 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.1 pt -66.16 -44.7 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.56999999999999995 111.118 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.534 ' HA ' ' CE1' ' A' ' 262' ' ' TYR . 1.0 OUTLIER -70.77 -20.7 62.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 110.891 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.3 t -64.27 -15.07 59.43 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.063 1.411 . . . . 0.56999999999999995 111.35 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.75 -85.99 0.07 Allowed 'General case' 0 C--N 1.385 2.117 0 CA-C-O 123.653 1.692 . . . . 0.56999999999999995 115.348 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.31 -178.14 0.34 Allowed 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.932 -1.94 . . . . 0.56999999999999995 112.85 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.38 2.976 0 CA-C-O 114.202 -3.555 . . . . 0.91000000000000003 114.722 175.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.674 ' H30' ' HA ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.059 0 N-CA-C 111.626 -0.59 . . . . 0.56999999999999995 111.626 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.41 -86.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.36 1.374 . . . . 0.56999999999999995 111.087 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.72 117.27 26.22 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 N-CA-C 106.245 -1.761 . . . . 0.56999999999999995 106.245 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -142.6 148.78 38.05 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-N 112.636 -2.074 . . . . 0.56999999999999995 108.673 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.52 158.16 45.09 Favored 'General case' 0 C--N 1.385 2.122 0 CA-C-O 124.674 2.178 . . . . 1.2 109.034 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.28 -48.75 0.03 OUTLIER 'General case' 0 C--N 1.389 2.284 0 CA-C-N 113.564 -1.653 . . . . 0.56999999999999995 110.838 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.63 -40.03 95.86 Favored 'General case' 0 C--N 1.389 2.291 0 CA-C-N 113.505 -1.68 . . . . 0.56999999999999995 108.35 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.84 103.58 11.57 Favored 'General case' 0 C--N 1.384 2.104 0 O-C-N 125.324 1.64 . . . . 0.56999999999999995 110.88 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.03 154.84 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.158 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -106.03 142.98 34.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.106 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.3 t80 -140.57 160.07 40.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 110.916 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.52 121.84 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.2 110.824 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 mm -99.4 138.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 111.146 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.57 173.59 1.22 Allowed 'General case' 0 C--N 1.363 1.187 0 CA-C-O 124.324 2.011 . . . . 0.56999999999999995 108.944 -176.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.67 73.31 6.38 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 125.166 2.412 . . . . 0.56999999999999995 109.971 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -177.53 2.13 Favored 'General case' 0 C--N 1.374 1.648 0 CA-C-N 112.357 -2.201 . . . . 0.56999999999999995 110.467 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.462 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER 160.56 -53.4 0.0 OUTLIER Pre-proline 0 C--N 1.38 1.912 0 C-N-CA 125.337 1.455 . . . . 0.56999999999999995 107.809 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 122' ' ' THR . 19.0 Cg_endo -75.36 -72.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.406 3.581 0 N-CA-C 108.022 -1.569 . . . . 0.56999999999999995 108.022 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.86 -7.68 57.02 Favored 'General case' 0 C--N 1.398 2.677 0 CA-C-N 113.131 -1.85 . . . . 0.91000000000000003 106.578 -171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 122' ' ' THR . 6.4 mtm -154.42 136.04 14.33 Favored 'General case' 0 C--N 1.386 2.191 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 109.638 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -90.98 141.63 28.63 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-O 123.182 1.468 . . . . 0.56999999999999995 109.328 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -50.11 68.76 Favored 'General case' 0 C--N 1.384 2.076 0 CA-C-N 114.324 -1.307 . . . . 1.2 109.109 -170.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.25 -35.28 69.54 Favored 'General case' 0 C--N 1.374 1.666 0 CA-C-N 111.992 -2.367 . . . . 0.91000000000000003 110.874 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.33 -43.78 69.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.91000000000000003 110.862 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.436 HG13 ' CD1' ' A' ' 212' ' ' LEU . 19.1 t -68.69 -39.74 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.179 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.35 -44.11 97.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.91000000000000003 110.873 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -40.94 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.19 66.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 111.139 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.422 HG23 ' CD1' ' A' ' 212' ' ' LEU . 25.2 pt -62.4 -36.9 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 111.167 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -63.72 -43.74 95.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.853 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -46.06 89.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 110.933 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.09 83.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.56999999999999995 111.082 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 3.7 m-85 -62.95 -44.06 97.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.821 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.461 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.2 pt20 -63.45 -36.21 82.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.971 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 16.0 t -69.64 -34.2 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.123 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.453 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 34.1 m95 -83.05 -34.06 26.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.923 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 m -78.99 -51.08 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.916 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -56.2 -13.96 2.45 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 114.103 1.149 . . . . 0.56999999999999995 114.103 178.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 20.2 m -113.34 -8.77 12.18 Favored 'Isoleucine or valine' 0 C--N 1.389 2.29 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 112.298 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.407 HG22 ' CB ' ' A' ' 259' ' ' GLN . 0.2 OUTLIER -150.47 141.93 15.16 Favored Pre-proline 0 C--N 1.383 2.055 0 CA-C-O 125.379 2.514 . . . . 0.56999999999999995 110.14 -172.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -79.7 71.21 7.16 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.138 1.892 . . . . 0.56999999999999995 114.593 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -169.35 83.52 0.13 Allowed 'General case' 0 C--N 1.39 2.328 0 N-CA-C 106.698 -1.593 . . . . 0.56999999999999995 106.698 -168.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -72.37 162.16 29.84 Favored 'General case' 0 C--N 1.383 2.048 0 CA-C-O 125.739 2.685 . . . . 0.56999999999999995 115.672 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' ' O ' ' A' ' 147' ' ' LEU . 2.9 m-85 -136.63 158.9 43.37 Favored 'General case' 0 C--N 1.39 2.354 0 CA-C-N 113.004 -1.907 . . . . 0.56999999999999995 106.09 -172.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -157.48 121.61 4.24 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.879 2.276 . . . . 0.56999999999999995 108.301 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 133.4 37.17 Favored 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.65 -1.613 . . . . 0.56999999999999995 110.513 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.2 pt -107.18 171.95 2.01 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-O 124.214 1.959 . . . . 0.56999999999999995 110.921 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -141.72 51.65 1.53 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 113.482 -1.69 . . . . 0.56999999999999995 110.566 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 p -117.66 -62.59 1.54 Allowed 'General case' 0 C--N 1.384 2.096 0 CA-C-N 113.479 -1.691 . . . . 0.56999999999999995 109.887 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.68 -152.87 5.73 Favored Glycine 0 C--N 1.381 3.028 0 N-CA-C 108.796 -1.722 . . . . 0.56999999999999995 108.796 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.4 ttp -72.11 110.49 6.62 Favored 'General case' 0 C--N 1.386 2.176 0 CA-C-O 123.705 1.716 . . . . 0.56999999999999995 108.246 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -98.19 177.83 5.27 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.058 -1.883 . . . . 0.56999999999999995 111.186 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.96 -59.38 4.91 Favored 'General case' 0 C--N 1.397 2.645 0 CA-C-N 112.456 -2.156 . . . . 0.91000000000000003 105.233 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.438 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 6.3 mt -95.79 111.47 26.22 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 C-N-CA 122.942 0.497 . . . . 0.56999999999999995 111.14 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.405 HD23 ' CG2' ' A' ' 162' ' ' VAL . 0.3 OUTLIER -120.01 126.59 51.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.942 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.083 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.405 ' CG2' HD23 ' A' ' 160' ' ' LEU . 3.9 t -133.15 128.94 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 111.134 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -85.0 122.77 29.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.884 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.53 170.14 17.5 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 118.812 -1.155 . . . . 0.56999999999999995 108.636 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.91 167.8 9.72 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.69 -1.595 . . . . 1.2 108.842 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.437 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -38.1 118.91 0.72 Allowed Glycine 0 C--N 1.389 3.497 0 CA-C-N 114.135 -1.393 . . . . 0.56999999999999995 111.956 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 81.37 63.44 0.02 OUTLIER 'General case' 0 C--N 1.417 3.524 0 CA-C-O 125.469 2.557 . . . . 0.56999999999999995 114.117 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -105.38 -61.45 1.48 Allowed 'General case' 0 C--N 1.386 2.19 0 CA-C-N 113.12 -1.855 . . . . 0.56999999999999995 111.966 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.06 -115.85 0.85 Allowed Glycine 0 C--N 1.389 3.486 0 C-N-CA 119.188 -1.482 . . . . 0.56999999999999995 110.077 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -37.62 -34.73 0.11 Allowed 'General case' 0 C--N 1.388 2.24 0 N-CA-C 115.904 1.816 . . . . 0.91000000000000003 115.904 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.72 87.94 2.62 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-O 124.884 2.278 . . . . 0.56999999999999995 113.364 171.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -80.68 49.39 1.18 Allowed 'General case' 0 C--N 1.377 1.783 0 CA-C-N 113.871 -1.513 . . . . 0.56999999999999995 110.502 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 160.03 69.2 0.0 OUTLIER 'General case' 0 C--N 1.395 2.579 0 CA-C-O 123.876 1.798 . . . . 0.56999999999999995 110.263 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -83.05 -158.98 0.31 Allowed 'General case' 0 C--N 1.388 2.255 0 CA-C-N 112.961 -1.927 . . . . 0.56999999999999995 113.753 173.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.16 173.39 6.32 Favored 'General case' 0 C--N 1.388 2.251 0 CA-C-N 114.627 -1.169 . . . . 0.91000000000000003 111.686 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.51 114.69 0.89 Allowed Glycine 1 C--N 1.4 4.109 0 CA-C-N 111.566 -2.561 . . . . 0.56999999999999995 113.89 166.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.85 82.8 0.15 Allowed 'General case' 0 C--N 1.406 3.037 0 CA-C-O 124.757 2.218 . . . . 0.56999999999999995 113.533 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.51 -155.7 22.05 Favored Glycine 0 C--N 1.376 2.786 0 CA-C-N 114.259 -1.337 . . . . 0.56999999999999995 110.67 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -35.71 149.17 0.03 OUTLIER Glycine 1 C--N 1.403 4.276 0 CA-C-N 113.384 -1.408 . . . . 0.56999999999999995 110.098 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.448 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 89.28 65.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.399 2.731 0 N-CA-C 108.483 -0.932 . . . . 0.56999999999999995 108.483 175.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.461 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 4.3 mp -71.22 -37.45 72.05 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-O 123.448 1.594 . . . . 0.56999999999999995 111.78 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 197' ' ' PHE . . . -174.33 179.84 1.74 Allowed 'General case' 0 C--N 1.364 1.199 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 111.09 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -164.23 142.46 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.874 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.94 167.52 23.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 111.111 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -77.02 -87.1 0.05 OUTLIER 'General case' 0 C--N 1.372 1.562 0 C-N-CA 117.749 -1.58 . . . . 0.56999999999999995 108.699 -177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 120.12 -61.22 0.51 Allowed Glycine 0 C--N 1.397 3.956 0 C-N-CA 119.848 -1.168 . . . . 0.56999999999999995 112.836 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.91 56.13 5.22 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.142 2.561 . . . . 0.56999999999999995 111.774 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 192' ' ' GLY . . . 47.66 -154.79 1.22 Allowed Glycine 0 C--N 1.39 3.536 0 CA-C-O 123.579 1.655 . . . . 0.56999999999999995 111.265 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.76 57.61 0.01 OUTLIER 'General case' 0 C--N 1.387 2.228 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 106.524 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.79 -88.92 0.37 Allowed Glycine 0 C--N 1.398 3.996 0 O-C-N 120.692 -1.255 . . . . 0.56999999999999995 110.008 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 tp -62.2 0.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.165 0 CA-C-O 124.964 2.316 . . . . 0.56999999999999995 113.854 174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 188' ' ' GLY . . . -73.37 117.21 5.77 Favored Glycine 0 C--N 1.393 3.737 0 C-N-CA 117.384 -2.341 . . . . 0.56999999999999995 107.283 -169.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 109.35 -44.73 1.44 Allowed Glycine 0 C--N 1.373 2.584 0 O-C-N 124.871 0.983 . . . . 0.56999999999999995 114.123 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -50.68 113.4 0.89 Allowed 'General case' 0 C--N 1.385 2.123 0 CA-C-N 115.358 -0.421 . . . . 0.91000000000000003 110.841 -178.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.68 156.82 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 111.111 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -130.17 131.9 45.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.859 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.417 ' CE2' ' CG2' ' A' ' 215' ' ' THR . 2.4 m-85 -104.04 148.51 26.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 110.944 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.0 p-10 -89.97 102.46 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.91000000000000003 110.853 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -36.55 64.42 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 116.912 -1.518 . . . . 0.91000000000000003 109.3 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.5 -40.96 9.09 Favored 'General case' 0 C--N 1.376 1.761 0 O-C-N 125.366 1.666 . . . . 0.91000000000000003 107.507 -163.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.48 -173.28 0.01 OUTLIER 'General case' 0 C--N 1.391 2.378 0 CA-C-O 128.143 3.83 . . . . 0.91000000000000003 114.439 170.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.4 77.44 1.57 Allowed 'General case' 0 C--N 1.379 1.865 0 O-C-N 118.091 -2.88 . . . . 0.56999999999999995 108.941 -172.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.461 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 52.1 m95 -72.82 115.45 12.13 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-O 122.64 1.21 . . . . 0.56999999999999995 108.317 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.3 p -123.89 128.02 48.86 Favored 'General case' 0 C--N 1.384 2.094 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 109.425 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 5.1 p -116.2 105.94 13.14 Favored 'General case' 0 C--N 1.369 1.424 0 CA-C-O 122.939 1.352 . . . . 0.56999999999999995 108.724 -176.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 172.5 -51.94 0.01 OUTLIER 'General case' 0 C--N 1.395 2.568 0 CA-C-N 112.877 -1.965 . . . . 0.56999999999999995 107.099 175.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 158.66 50.72 0.0 OUTLIER 'General case' 0 C--N 1.412 3.316 0 O-C-N 126.315 2.259 . . . . 0.56999999999999995 110.172 -171.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.16 -108.46 2.69 Favored Glycine 0 C--N 1.393 3.74 0 C-N-CA 118.16 -1.972 . . . . 0.56999999999999995 113.681 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.97 -91.49 2.21 Favored Glycine 0 C--N 1.397 3.957 0 CA-C-O 124.857 2.365 . . . . 0.56999999999999995 112.792 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 p -73.89 117.5 15.75 Favored 'General case' 0 C--N 1.384 2.088 0 CA-C-O 123.847 1.784 . . . . 0.56999999999999995 111.454 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -111.15 150.26 29.72 Favored 'General case' 0 C--N 1.388 2.279 0 CA-C-N 112.307 -2.224 . . . . 0.56999999999999995 110.13 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.436 ' CD1' HG13 ' A' ' 130' ' ' VAL . 2.6 tm? -73.45 -32.7 64.51 Favored 'General case' 0 C--N 1.394 2.505 0 CA-C-O 124.412 2.053 . . . . 0.56999999999999995 108.858 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.54 ' CD1' HG12 ' A' ' 245' ' ' ILE . 4.7 t80 -52.28 -50.08 62.84 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 112.678 -2.056 . . . . 0.56999999999999995 110.848 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -43.61 98.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.417 ' CG2' ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -61.27 -49.36 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.56999999999999995 111.19 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.2 73.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.107 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.48 -48.18 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -71.57 -43.21 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.867 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -57.91 -42.14 84.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.91000000000000003 110.877 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.453 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 57.7 mt -69.61 -39.78 78.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.56999999999999995 111.187 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.46 -33.78 85.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.465 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.44 ' N ' ' CE ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -63.85 -44.28 93.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.353 . . . . 0.56999999999999995 110.813 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' LEU . 71.1 m -71.27 -44.5 65.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 110.864 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 223' ' ' SER . 0.7 OUTLIER -36.38 -47.79 0.62 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 119.771 -0.772 . . . . 0.56999999999999995 112.557 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.13 -106.47 0.22 Allowed Glycine 1 C--N 1.398 4.026 0 O-C-N 126.699 2.499 . . . . 0.56999999999999995 112.061 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.01 172.78 0.01 OUTLIER 'General case' 0 C--N 1.395 2.559 0 CA-C-O 125.726 2.679 . . . . 0.56999999999999995 112.554 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.35 -120.91 0.02 OUTLIER Glycine 0 C--N 1.392 3.665 0 CA-C-O 126.133 3.074 . . . . 0.56999999999999995 110.677 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -123.96 -76.19 0.59 Allowed 'General case' 0 C--N 1.391 2.382 0 CA-C-N 112.258 -1.971 . . . . 0.56999999999999995 108.375 -174.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.36 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.754 -1.567 . . . . 0.56999999999999995 108.373 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.06 23.48 0.31 Allowed 'General case' 0 C--N 1.422 3.727 0 N-CA-C 118.925 2.935 . . . . 0.56999999999999995 118.925 -171.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -137.65 143.29 39.96 Favored Pre-proline 0 C--N 1.398 2.703 0 C-N-CA 116.348 -2.141 . . . . 0.91000000000000003 106.086 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.545 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 71.7 Cg_exo -54.97 -41.11 81.94 Favored 'Trans proline' 0 C--N 1.375 1.93 0 CA-C-O 124.724 1.885 . . . . 0.56999999999999995 114.09 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -41.91 86.18 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-N 111.61 -2.541 . . . . 0.56999999999999995 113.492 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -50.82 125.21 12.79 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-O 125.317 2.484 . . . . 0.56999999999999995 111.82 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.591 HG22 ' H30' ' A' ' 269' ' ' HSI . 0.4 OUTLIER -76.03 -1.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.386 2.154 0 CA-C-N 112.473 -2.149 . . . . 0.56999999999999995 112.504 -177.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.44 ' CE ' ' N ' ' A' ' 222' ' ' HIS . 0.8 OUTLIER -124.62 -5.49 7.58 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-N 114.056 -1.429 . . . . 0.56999999999999995 109.03 -177.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 0.1 OUTLIER -40.57 148.2 0.36 Allowed Pre-proline 0 C--N 1.376 1.753 0 CA-C-O 125.22 2.438 . . . . 0.56999999999999995 113.951 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.445 ' O ' ' H14' ' A' ' 269' ' ' HSI . 76.2 Cg_exo -53.57 -48.85 19.68 Favored 'Trans proline' 0 C--N 1.381 2.289 0 O-C-N 118.824 -1.198 . . . . 0.56999999999999995 113.7 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.485 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -51.74 135.13 29.82 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-O 125.012 2.339 . . . . 0.56999999999999995 110.959 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.66 142.57 34.09 Favored 'General case' 0 C--N 1.386 2.154 0 CA-C-O 123.106 1.431 . . . . 0.56999999999999995 107.362 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -158.28 114.56 2.77 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-O 124.515 2.102 . . . . 0.56999999999999995 108.453 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -55.25 118.57 4.5 Favored 'General case' 0 C--N 1.368 1.398 0 CA-C-O 126.433 3.016 . . . . 0.56999999999999995 108.861 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.488 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 2.6 p -125.41 -13.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 CA-C-N 112.498 -2.137 . . . . 0.56999999999999995 111.062 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.266 0.7 OUTLIER 70.53 4.36 4.92 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-O 123.153 1.454 . . . . 0.91000000000000003 112.811 176.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.0 mt 77.88 4.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.394 2.533 0 CA-C-N 113.347 -1.751 . . . . 0.56999999999999995 114.315 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.11 -33.17 69.89 Favored 'General case' 0 C--N 1.379 1.85 0 N-CA-C 104.593 -2.373 . . . . 0.56999999999999995 104.593 -163.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.7 -16.65 12.74 Favored 'General case' 0 C--N 1.39 2.365 0 CA-C-N 112.739 -2.028 . . . . 0.56999999999999995 113.107 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.443 ' CD1' HG22 ' A' ' 235' ' ' VAL . 19.2 t80 -38.86 99.46 0.02 OUTLIER 'General case' 0 C--N 1.388 2.28 0 CA-C-O 126.034 2.826 . . . . 0.56999999999999995 109.319 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -133.09 149.12 52.16 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-N 112.18 -2.282 . . . . 1.2 105.374 -175.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.441 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -118.09 130.38 56.11 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 126.7 3.143 . . . . 0.56999999999999995 107.325 -173.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.87 145.43 42.75 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 117.99 -2.944 . . . . 0.56999999999999995 110.606 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.05 86.43 Favored 'General case' 0 C--N 1.4 2.797 0 CA-C-N 113.676 -1.602 . . . . 0.56999999999999995 110.416 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -35.74 81.1 Favored 'General case' 0 C--N 1.367 1.342 0 CA-C-N 114.874 -1.057 . . . . 0.91000000000000003 110.802 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.36 -55.29 25.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.91000000000000003 110.854 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.0 pt -66.04 -36.56 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.168 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 34.7 mtt180 -70.3 -34.1 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 1.2 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.29 -47.52 79.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.56999999999999995 112.511 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.498 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.2 pt -64.35 -45.46 95.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.56999999999999995 111.163 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.498 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.3 -21.03 61.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.933 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.44 -28.33 66.03 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-O 125.154 2.407 . . . . 0.56999999999999995 110.22 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -64.79 0.83 Allowed 'General case' 0 C--N 1.4 2.798 0 CA-C-O 124.55 2.119 . . . . 0.56999999999999995 109.63 -175.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.56 80.53 3.13 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 113.372 -1.74 . . . . 0.56999999999999995 113.279 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.39 3.577 0 N-CA-C 120.488 2.955 . . . . 0.91000000000000003 120.488 -170.593 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.591 ' H30' HG22 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.254 0 CA-C-O 119.597 -0.557 . . . . 0.56999999999999995 113.181 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.07 168.92 1.06 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 O-C-N 124.58 1.832 . . . . 0.56999999999999995 111.043 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.11 144.86 29.96 Favored 'Isoleucine or valine' 0 C--N 1.373 1.625 0 CA-C-N 112.992 -1.913 . . . . 0.56999999999999995 109.866 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.45 102.59 0.42 Allowed 'General case' 0 C--N 1.389 2.31 0 CA-C-O 124.095 1.902 . . . . 0.56999999999999995 109.625 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.47 151.1 50.46 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-O 123.712 1.72 . . . . 1.2 109.368 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.53 -49.84 0.02 OUTLIER 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.851 -1.522 . . . . 0.56999999999999995 110.646 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -98.21 -8.55 27.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 112.98 -1.918 . . . . 0.56999999999999995 111.091 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -114.56 112.76 23.45 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.169 -0.923 . . . . 0.56999999999999995 110.872 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.11 138.19 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.119 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.26 135.27 50.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.56999999999999995 111.109 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -129.81 150.9 50.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.888 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -143.52 129.88 19.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.2 110.903 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mm -99.03 130.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.169 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -118.89 131.67 56.07 Favored 'General case' 0 C--N 1.368 1.385 0 N-CA-C 107.636 -1.246 . . . . 0.56999999999999995 107.636 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.3 t30 50.41 81.13 0.07 Allowed 'General case' 0 C--N 1.391 2.401 0 O-C-N 126.527 2.392 . . . . 0.56999999999999995 109.587 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 163' ' ' PHE . 22.6 m-85 -37.73 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.391 2.395 0 O-C-N 126.721 2.513 . . . . 0.56999999999999995 109.514 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.0 135.14 0.16 Allowed Pre-proline 0 C--N 1.371 1.522 0 C-N-CA 118.285 -1.366 . . . . 0.56999999999999995 108.355 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.17 -52.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-O 122.341 0.892 . . . . 0.56999999999999995 110.938 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -77.22 -33.29 56.19 Favored 'General case' 0 C--N 1.388 2.256 0 CA-C-N 113.937 -1.483 . . . . 0.91000000000000003 114.486 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.38 134.24 37.09 Favored 'General case' 0 C--N 1.374 1.663 0 CA-C-O 125.747 2.689 . . . . 0.56999999999999995 106.002 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.53 139.7 53.83 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 110.555 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -48.63 37.6 Favored 'General case' 0 C--N 1.378 1.821 0 N-CA-C 106.918 -1.512 . . . . 1.2 106.918 -169.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -35.26 62.33 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.788 -2.005 . . . . 0.91000000000000003 110.89 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.04 -43.15 71.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.91000000000000003 110.869 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.42 -37.94 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.56999999999999995 111.082 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -40.36 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.91000000000000003 110.847 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' CE ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -65.29 -41.8 93.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.56999999999999995 110.877 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.23 -49.12 73.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 111.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.7 pt -62.55 -40.16 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -60.59 -43.39 97.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 1.2 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -62.92 -43.4 98.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.873 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.65 91.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.117 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.488 ' CE1' ' CE2' ' A' ' 116' ' ' TYR . 17.3 m-85 -67.17 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.917 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.436 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.7 OUTLIER -67.66 -40.49 84.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.56999999999999995 110.909 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 5.0 p -71.46 -33.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.16 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.464 ' O ' ' CG2' ' A' ' 145' ' ' THR . 5.1 m95 -82.59 -34.04 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 m -79.21 -49.18 12.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.56999999999999995 110.817 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.36 -13.3 7.79 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-O 121.804 0.811 . . . . 0.56999999999999995 112.564 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 19.8 m -113.91 12.77 8.19 Favored 'Isoleucine or valine' 0 C--N 1.382 2.022 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.028 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 141' ' ' TRP . 29.5 p -148.03 146.75 24.46 Favored Pre-proline 0 N--CA 1.428 -1.544 0 CA-C-O 124.132 1.92 . . . . 0.56999999999999995 109.197 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.86 8.74 3.59 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.285 1.323 . . . . 0.56999999999999995 114.449 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.51 110.76 21.13 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 109.117 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.92 158.56 35.24 Favored 'General case' 0 C--N 1.382 1.999 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 114.778 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.499 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 15.6 m-30 -126.5 151.37 47.92 Favored 'General case' 0 C--N 1.389 2.314 0 CA-C-N 112.788 -2.005 . . . . 0.56999999999999995 108.675 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.99 110.99 2.66 Favored 'General case' 0 C--N 1.39 2.364 0 CA-C-O 124.653 2.168 . . . . 0.56999999999999995 108.302 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -95.2 133.41 39.08 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 113.776 -1.556 . . . . 0.56999999999999995 110.254 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.9 pt -117.14 173.78 4.08 Favored 'Isoleucine or valine' 0 C--N 1.372 1.562 0 CA-C-O 124.175 1.941 . . . . 0.56999999999999995 109.957 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -127.2 -2.03 6.37 Favored 'General case' 0 C--N 1.384 2.067 0 CA-C-N 113.175 -1.83 . . . . 0.56999999999999995 112.687 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 m -136.72 89.4 2.45 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 114.583 -1.189 . . . . 0.56999999999999995 108.067 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 124.29 99.69 1.32 Allowed Glycine 0 C--N 1.386 3.36 0 C-N-CA 118.956 -1.592 . . . . 0.56999999999999995 110.513 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.4 ttp -42.95 118.35 1.25 Allowed 'General case' 0 C--N 1.377 1.804 0 CA-C-O 122.56 1.172 . . . . 0.56999999999999995 111.3 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.34 169.79 9.82 Favored 'General case' 0 C--N 1.381 1.957 0 CA-C-N 113.025 -1.898 . . . . 0.56999999999999995 109.517 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -54.45 23.29 Favored 'General case' 0 C--N 1.386 2.179 0 CA-C-N 113.501 -1.681 . . . . 0.91000000000000003 110.586 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.542 HD12 ' CE2' ' A' ' 116' ' ' TYR . 3.5 mt -90.64 109.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.385 2.143 0 O-C-N 127.846 3.216 . . . . 0.56999999999999995 111.127 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.41 ' CD1' HG12 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -107.98 129.45 55.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.856 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.98 116.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.56999999999999995 111.08 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.473 HG13 ' CD2' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -133.47 124.88 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.109 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -93.7 121.42 35.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.876 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -145.33 168.01 21.5 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 123.701 1.715 . . . . 0.56999999999999995 108.51 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.71 160.28 16.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.592 -1.262 . . . . 1.2 107.592 -177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -39.28 93.87 0.01 OUTLIER Glycine 0 C--N 1.385 3.26 0 O-C-N 125.894 1.997 . . . . 0.56999999999999995 117.401 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 154.31 45.57 0.0 OUTLIER 'General case' 0 C--N 1.405 2.982 0 CA-C-O 125.734 2.683 . . . . 0.56999999999999995 112.898 -165.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -159.85 -155.78 0.47 Allowed 'General case' 0 C--N 1.38 1.899 0 CA-C-N 113.416 -1.72 . . . . 0.56999999999999995 109.874 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.91 -175.37 2.07 Favored Glycine 0 C--N 1.39 3.577 0 CA-C-O 122.499 1.055 . . . . 0.56999999999999995 113.504 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER 59.83 77.47 0.31 Allowed 'General case' 0 C--N 1.416 3.457 0 CA-C-O 124.688 2.185 . . . . 0.91000000000000003 107.399 167.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 78.94 -154.27 0.02 OUTLIER 'General case' 0 C--N 1.381 1.937 0 CA-C-N 112.388 -2.187 . . . . 0.56999999999999995 111.791 -174.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -115.4 -127.17 0.29 Allowed 'General case' 0 C--N 1.386 2.163 0 CA-C-O 122.694 1.235 . . . . 0.56999999999999995 109.052 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.92 85.43 0.22 Allowed 'General case' 0 C--N 1.387 2.219 0 N-CA-C 108.211 -1.033 . . . . 0.56999999999999995 108.211 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.532 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.5 OUTLIER -50.64 168.54 0.05 OUTLIER 'General case' 0 C--N 1.388 2.277 0 O-C-N 126.7 2.5 . . . . 0.56999999999999995 107.152 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.411 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -44.57 163.21 0.02 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 117.904 -1.518 . . . . 0.91000000000000003 112.969 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.53 48.25 0.6 Allowed Glycine 0 C--N 1.388 3.458 0 C-N-CA 117.287 -2.387 . . . . 0.56999999999999995 111.815 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -168.66 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.389 2.323 0 C-N-CA 118.868 -1.133 . . . . 0.56999999999999995 111.336 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -165.3 -61.65 0.02 OUTLIER Glycine 0 C--N 1.392 3.663 0 CA-C-O 125.014 2.452 . . . . 0.56999999999999995 112.852 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -42.84 147.16 0.75 Allowed Glycine 0 C--N 1.376 2.802 0 O-C-N 118.963 -2.493 . . . . 0.56999999999999995 110.24 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.532 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 1.6 mt 84.75 49.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.951 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 9.9 tp -42.94 -41.72 3.46 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.876 2.274 . . . . 0.56999999999999995 111.345 -172.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 179.84 -174.31 0.25 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 112.415 -2.175 . . . . 0.56999999999999995 111.047 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.497 ' N ' ' HD1' ' A' ' 183' ' ' HIS . 0.8 OUTLIER -143.95 158.59 43.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.879 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.409 ' HB1' ' CB ' ' A' ' 222' ' ' HIS . . . -151.02 155.19 38.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 0.56999999999999995 111.087 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -117.44 -179.52 3.75 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 105.249 -2.13 . . . . 0.56999999999999995 105.249 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' O ' ' CA ' ' A' ' 192' ' ' GLY . . . -122.15 -160.11 10.85 Favored Glycine 0 C--N 1.382 3.101 0 C-N-CA 119.795 -1.193 . . . . 0.56999999999999995 111.493 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.44 -65.94 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.831 1.687 . . . . 0.56999999999999995 112.508 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.44 -104.87 0.07 OUTLIER Glycine 0 C--N 1.395 3.858 0 O-C-N 125.605 1.816 . . . . 0.56999999999999995 110.537 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.72 129.3 0.04 OUTLIER 'General case' 0 C--N 1.393 2.478 0 CA-C-N 112.794 -1.703 . . . . 0.56999999999999995 108.886 175.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -95.86 1.64 Allowed Glycine 0 C--N 1.388 3.445 0 CA-C-O 122.773 1.207 . . . . 0.56999999999999995 110.697 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.3 tp -66.85 -11.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.394 2.541 0 CA-C-O 126.845 3.212 . . . . 0.56999999999999995 110.745 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 186' ' ' GLY . . . -66.71 134.34 32.53 Favored Glycine 0 C--N 1.377 2.827 0 N-CA-C 107.12 -2.392 . . . . 0.56999999999999995 107.12 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.49 -4.68 64.35 Favored Glycine 0 C--N 1.375 2.704 0 N-CA-C 110.169 -1.172 . . . . 0.56999999999999995 110.169 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.78 141.25 39.35 Favored 'General case' 0 C--N 1.378 1.841 0 CA-C-N 114.221 -0.99 . . . . 0.91000000000000003 110.872 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.03 132.63 22.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.098 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -126.52 143.2 51.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.89 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.527 ' CD2' ' CD1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.55 148.38 26.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.685 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.8 p-10 -81.12 87.89 6.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.91000000000000003 110.854 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -74.26 5.49 4.45 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.615 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.77 -35.13 44.98 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-O 123.328 1.537 . . . . 0.91000000000000003 109.92 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -73.76 176.87 5.9 Favored 'General case' 0 C--N 1.382 1.998 0 CA-C-O 124.289 1.995 . . . . 0.91000000000000003 108.965 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.53 111.11 23.09 Favored 'General case' 0 C--N 1.391 2.398 0 CA-C-N 112.642 -2.072 . . . . 0.56999999999999995 112.992 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 36.4 m95 -92.62 148.0 22.42 Favored 'General case' 0 C--N 1.382 2.017 0 CA-C-N 113.144 -1.844 . . . . 0.56999999999999995 108.495 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -121.28 104.21 9.55 Favored 'General case' 0 C--N 1.384 2.069 0 CA-C-N 114.143 -1.39 . . . . 0.56999999999999995 107.806 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -103.02 106.91 17.53 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 115.499 -0.773 . . . . 0.56999999999999995 109.864 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 205' ' ' THR . 2.0 t60 169.1 -70.71 0.0 OUTLIER 'General case' 0 C--N 1.392 2.429 0 N-CA-C 106.944 -1.502 . . . . 0.56999999999999995 106.944 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.413 ' C ' ' OD2' ' A' ' 244' ' ' ASP . 4.7 p 150.75 63.19 0.0 OUTLIER 'General case' 0 C--N 1.399 2.731 0 CA-C-O 127.412 3.482 . . . . 0.56999999999999995 110.325 -166.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.18 29.58 0.11 Allowed Glycine 0 C--N 1.394 3.803 0 C-N-CA 116.964 -2.541 . . . . 0.56999999999999995 113.136 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.6 -162.32 35.81 Favored Glycine 0 C--N 1.383 3.144 0 CA-C-O 124.234 2.019 . . . . 0.56999999999999995 110.873 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.08 122.26 24.71 Favored 'General case' 0 C--N 1.372 1.58 0 CA-C-O 123.478 1.608 . . . . 0.56999999999999995 107.761 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -121.01 -167.77 1.55 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-N 112.84 -1.982 . . . . 0.56999999999999995 111.039 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.2 -33.54 71.83 Favored 'General case' 0 C--N 1.392 2.436 0 CA-C-N 112.901 -1.954 . . . . 0.56999999999999995 109.541 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 9.8 t80 -51.75 -50.15 61.21 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.909 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.437 HD12 ' H19' ' A' ' 269' ' ' HSI . 0.2 OUTLIER -62.86 -51.02 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 110.948 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.4 m -58.95 -35.65 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.17 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.44 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -67.2 -41.53 85.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.097 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.15 -46.46 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.094 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -72.36 -49.91 30.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.762 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -57.66 -42.5 83.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.91000000000000003 110.927 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 216' ' ' ALA . 60.7 mt -70.32 -43.32 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.442 ' HA2' ' CD1' ' A' ' 224' ' ' LEU . . . -56.82 -33.93 64.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.56999999999999995 112.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.409 ' CB ' ' HB1' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -63.75 -41.09 98.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.749 0.309 . . . . 0.56999999999999995 110.823 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.26 -44.36 65.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.867 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 149' ' ' PHE . 84.3 mt -42.89 -62.54 0.99 Allowed 'General case' 0 C--N 1.365 1.248 0 CA-C-O 123.829 1.776 . . . . 0.56999999999999995 112.148 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 169.6 134.65 1.77 Allowed Glycine 0 C--N 1.374 2.694 0 N-CA-C 107.774 -2.131 . . . . 0.56999999999999995 107.774 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 78.85 -170.54 0.05 OUTLIER 'General case' 0 C--N 1.393 2.494 0 CA-C-O 124.329 2.014 . . . . 0.56999999999999995 109.524 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.21 -154.63 10.66 Favored Glycine 0 C--N 1.386 3.318 0 CA-C-O 125.728 2.849 . . . . 0.56999999999999995 112.86 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -93.95 -178.97 4.82 Favored 'General case' 0 C--N 1.376 1.722 0 CA-C-N 111.217 -2.491 . . . . 0.56999999999999995 110.717 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.2 p -72.24 -31.59 65.96 Favored 'General case' 0 C--N 1.387 2.236 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 109.187 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 82.8 23.59 0.17 Allowed 'General case' 0 C--N 1.399 2.734 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.41 151.01 35.69 Favored Pre-proline 0 C--N 1.383 2.027 0 N-CA-C 105.361 -2.089 . . . . 0.91000000000000003 105.361 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.34 75.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 124.826 3.684 . . . . 0.56999999999999995 113.871 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 178.42 -33.56 0.01 OUTLIER 'General case' 0 C--N 1.374 1.644 0 CA-C-N 113.814 -1.539 . . . . 0.56999999999999995 112.722 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.12 149.05 33.86 Favored 'General case' 0 C--N 1.382 2.02 0 CA-C-N 113.619 -1.628 . . . . 0.56999999999999995 107.854 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -0.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.099 0 CA-C-N 113.052 -1.885 . . . . 0.56999999999999995 112.959 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.442 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -160.1 28.53 0.17 Allowed 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 113.137 -1.847 . . . . 0.56999999999999995 109.885 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.67 ' HE1' ' C26' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -48.64 147.41 4.33 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 123.866 1.793 . . . . 0.56999999999999995 113.023 176.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.583 ' O ' ' H14' ' A' ' 269' ' ' HSI . 72.5 Cg_exo -55.49 -50.15 13.72 Favored 'Trans proline' 0 C--N 1.373 1.824 0 O-C-N 118.875 -1.171 . . . . 0.56999999999999995 112.44 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.583 ' O ' ' H16' ' A' ' 269' ' ' HSI . 0.3 OUTLIER -50.18 125.4 12.27 Favored 'General case' 0 C--N 1.368 1.382 0 CA-C-O 123.989 1.852 . . . . 0.56999999999999995 110.553 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -81.34 144.96 31.11 Favored 'General case' 0 C--N 1.369 1.435 0 O-C-N 119.894 -1.754 . . . . 0.56999999999999995 108.232 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 242' ' ' TYR . 0.8 OUTLIER -175.29 121.3 0.2 Allowed 'General case' 0 C--N 1.388 2.27 0 CA-C-O 124.187 1.946 . . . . 0.56999999999999995 107.556 173.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 241' ' ' LYS . 25.9 p90 -68.86 132.85 47.42 Favored 'General case' 0 C--N 1.368 1.393 0 CA-C-O 125.761 2.696 . . . . 0.56999999999999995 109.704 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.75 -16.88 7.82 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 O-C-N 119.759 -1.838 . . . . 0.56999999999999995 113.353 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.413 ' OD2' ' C ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 79.18 -8.15 1.66 Allowed 'General case' 0 C--N 1.376 1.736 0 O-C-N 125.077 1.486 . . . . 0.91000000000000003 114.393 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.8 mt 81.68 18.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.381 1.978 0 CA-C-N 114.028 -1.442 . . . . 0.56999999999999995 112.524 -174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' CB ' ' OD1' ' A' ' 244' ' ' ASP . 1.6 t-20 -84.22 -28.57 27.18 Favored 'General case' 0 C--N 1.391 2.381 0 C-N-CA 114.057 -3.057 . . . . 0.56999999999999995 103.11 -165.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.0 p -119.04 -6.84 10.45 Favored 'General case' 0 C--N 1.389 2.311 0 CA-C-N 112.603 -2.089 . . . . 0.56999999999999995 112.237 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -38.09 97.33 0.01 OUTLIER 'General case' 0 C--N 1.384 2.068 0 CA-C-O 125.059 2.362 . . . . 0.56999999999999995 110.588 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.481 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -134.58 151.72 51.28 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.665 -2.061 . . . . 1.2 105.46 -174.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.481 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -118.43 128.94 55.09 Favored 'General case' 0 C--N 1.376 1.76 0 CA-C-O 126.142 2.877 . . . . 0.56999999999999995 108.337 -172.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.6 t -73.23 136.24 44.62 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.363 -2.711 . . . . 0.56999999999999995 109.947 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.44 -44.78 76.63 Favored 'General case' 0 C--N 1.388 2.244 0 CA-C-N 113.996 -1.456 . . . . 0.56999999999999995 109.094 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.07 -41.25 92.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.257 0.623 . . . . 0.91000000000000003 110.917 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.03 -55.12 24.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.838 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.5 pt -66.12 -35.28 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.089 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.418 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 3.4 mtp85 -70.42 -34.08 72.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.2 110.86 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.18 -46.94 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.56999999999999995 112.446 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.492 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.1 pt -64.48 -44.78 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.56999999999999995 111.172 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.492 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.19 -21.0 61.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.952 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.1 t -74.07 -34.8 64.15 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 122.227 1.013 . . . . 0.56999999999999995 109.533 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.37 -63.84 0.98 Allowed 'General case' 0 C--N 1.388 2.251 0 CA-C-O 124.325 2.012 . . . . 0.56999999999999995 110.273 -173.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 79.15 2.93 Favored 'General case' 0 C--N 1.377 1.794 0 CA-C-N 113.114 -1.857 . . . . 0.56999999999999995 112.617 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.374 2.69 0 CA-C-O 115.267 -2.963 . . . . 0.91000000000000003 115.79 -175.235 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.67 ' C26' ' HE1' ' A' ' 237' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 CA-C-O 119.073 -0.848 . . . . 0.56999999999999995 111.278 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.91 162.06 2.0 Favored 'Trans proline' 0 C--N 1.382 2.319 0 O-C-N 125.589 2.363 . . . . 0.56999999999999995 111.919 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.53 118.98 59.76 Favored 'Isoleucine or valine' 0 C--N 1.385 2.119 0 CA-C-N 112.975 -1.92 . . . . 0.56999999999999995 107.326 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -76.23 121.78 23.42 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.872 -1.967 . . . . 0.56999999999999995 109.453 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -145.33 170.32 16.54 Favored 'General case' 0 C--N 1.39 2.329 0 CA-C-N 113.776 -1.556 . . . . 1.2 106.949 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.29 121.22 0.04 OUTLIER 'General case' 0 C--N 1.4 2.794 0 CA-C-N 114.106 -1.407 . . . . 0.56999999999999995 111.456 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 77.47 -59.57 0.46 Allowed 'General case' 0 C--N 1.391 2.4 0 CA-C-N 114.585 -1.189 . . . . 0.56999999999999995 112.325 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.14 125.34 53.68 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-N 114.64 -1.163 . . . . 0.56999999999999995 110.875 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.85 154.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.106 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.9 p -119.96 160.07 23.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.56999999999999995 111.103 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 3.0 t80 -147.07 152.88 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.933 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.566 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.97 122.0 14.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.852 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -98.97 126.32 52.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.097 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -174.36 0.02 OUTLIER 'General case' 0 C--N 1.366 1.307 0 CA-C-O 124.873 2.273 . . . . 0.56999999999999995 108.963 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -76.36 48.58 0.54 Allowed 'General case' 0 C--N 1.369 1.427 0 O-C-N 120.216 -1.552 . . . . 0.56999999999999995 111.676 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 48.4 -148.24 0.22 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 122.467 1.127 . . . . 0.56999999999999995 108.221 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.8 167.13 8.19 Favored Pre-proline 0 C--N 1.38 1.892 0 CA-C-N 113.703 -1.59 . . . . 0.56999999999999995 108.839 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.39 -47.07 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 CA-C-O 122.673 1.03 . . . . 0.56999999999999995 112.906 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 4.5 p-10 -71.92 -38.71 69.84 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 113.658 -1.61 . . . . 0.91000000000000003 114.249 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 110.67 21.47 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-O 125.427 2.537 . . . . 0.56999999999999995 109.751 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.88 143.53 49.35 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 112.399 -2.182 . . . . 0.56999999999999995 108.558 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -49.33 59.94 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 114.18 -1.373 . . . . 1.2 107.529 -168.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.83 -34.74 63.19 Favored 'General case' 0 C--N 1.394 2.523 0 CA-C-N 112.586 -2.097 . . . . 0.91000000000000003 110.903 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.25 -43.44 70.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.91000000000000003 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.2 t -63.39 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.56999999999999995 111.149 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.19 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.91000000000000003 110.906 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.97 -49.0 79.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.937 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.22 87.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.065 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 1.1 mm -66.77 -31.91 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.116 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -66.2 -47.85 72.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.849 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -40.35 97.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.898 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.88 94.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.082 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 149' ' ' PHE . 1.0 OUTLIER -67.19 -33.77 76.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.914 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.453 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -68.55 -42.12 78.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.56999999999999995 110.909 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.46 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 5.7 p -69.69 -34.25 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.112 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -82.94 -34.04 26.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 110.898 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.1 m -79.2 -49.58 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.901 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -58.68 -13.02 4.85 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 121.837 0.827 . . . . 0.56999999999999995 113.104 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 21.4 m -114.01 12.03 8.11 Favored 'Isoleucine or valine' 0 C--N 1.391 2.375 0 CA-C-N 114.118 -1.401 . . . . 0.56999999999999995 111.943 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.2 p -150.76 145.04 17.85 Favored Pre-proline 0 C--N 1.381 1.953 0 CA-C-O 125.405 2.526 . . . . 0.56999999999999995 108.619 -172.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.22 -24.27 9.6 Favored 'Trans proline' 0 C--N 1.37 1.679 0 O-C-N 118.344 -1.451 . . . . 0.56999999999999995 111.891 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.482 ' CD2' ' CZ ' ' A' ' 262' ' ' TYR . 0.7 OUTLIER -82.35 102.87 11.52 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 111.176 178.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.11 162.45 28.97 Favored 'General case' 0 C--N 1.382 1.991 0 CA-C-O 124.108 1.909 . . . . 0.56999999999999995 114.099 171.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -135.6 160.7 37.67 Favored 'General case' 0 C--N 1.392 2.433 0 CA-C-N 112.466 -2.152 . . . . 0.56999999999999995 107.007 -172.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 m -160.3 122.34 3.22 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 125.177 2.418 . . . . 0.56999999999999995 107.353 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -92.65 135.93 33.66 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.493 -1.685 . . . . 0.56999999999999995 110.364 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.35 177.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.755 0 CA-C-O 124.254 1.978 . . . . 0.56999999999999995 110.195 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -104.18 -38.76 6.77 Favored 'General case' 0 C--N 1.386 2.161 0 CA-C-N 112.581 -2.1 . . . . 0.56999999999999995 112.401 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.4 p -130.25 133.27 46.39 Favored 'General case' 0 C--N 1.379 1.852 0 CA-C-O 122.409 1.099 . . . . 0.56999999999999995 108.929 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.09 169.59 15.54 Favored Glycine 0 C--N 1.386 3.334 0 CA-C-O 123.864 1.813 . . . . 0.56999999999999995 112.389 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.1 ttt -80.72 139.15 36.27 Favored 'General case' 0 C--N 1.389 2.292 0 CA-C-N 112.114 -2.043 . . . . 0.56999999999999995 109.551 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.71 173.23 11.35 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-N 112.446 -2.161 . . . . 0.56999999999999995 111.144 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.9 -59.33 2.53 Favored 'General case' 0 C--N 1.385 2.12 0 N-CA-C 103.501 -2.778 . . . . 0.91000000000000003 103.501 -168.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 220' ' ' ILE . 5.6 mt -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 C--N 1.389 2.288 0 O-C-N 125.064 1.478 . . . . 0.56999999999999995 111.15 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 195' ' ' ALA . 0.3 OUTLIER -99.21 128.44 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.884 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.59 119.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.086 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.72 125.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.087 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.51 122.76 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.86 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 199' ' ' GLU . . . -142.66 167.94 20.9 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-O 123.258 1.504 . . . . 0.56999999999999995 107.12 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CD ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -112.48 135.63 52.95 Favored 'General case' 0 C--N 1.369 1.437 0 CA-C-N 114.097 -1.411 . . . . 1.2 109.775 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.13 -133.86 28.27 Favored Glycine 0 C--N 1.397 3.919 0 CA-C-O 124.913 2.396 . . . . 0.56999999999999995 109.562 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.39 135.18 39.69 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 111.496 -2.352 . . . . 0.56999999999999995 113.799 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 179.64 119.8 0.05 Allowed 'General case' 0 C--N 1.398 2.683 0 CA-C-N 113.533 -1.667 . . . . 0.56999999999999995 107.096 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 40.65 -125.82 2.84 Favored Glycine 0 C--N 1.384 3.228 0 CA-C-O 123.804 1.78 . . . . 0.56999999999999995 114.288 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -50.52 106.33 0.12 Allowed 'General case' 0 C--N 1.397 2.65 0 CA-C-N 110.772 -2.714 . . . . 0.91000000000000003 112.853 165.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 83.58 75.63 0.02 OUTLIER 'General case' 0 C--N 1.409 3.185 0 CA-C-O 126.687 3.137 . . . . 0.56999999999999995 107.786 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -69.93 59.89 0.17 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 112.665 -2.062 . . . . 0.56999999999999995 113.533 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 162.56 91.14 0.0 OUTLIER 'General case' 0 C--N 1.39 2.359 0 CA-C-O 122.931 1.348 . . . . 0.56999999999999995 109.094 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -98.97 -157.08 0.58 Allowed 'General case' 0 C--N 1.384 2.074 0 CA-C-N 112.776 -2.011 . . . . 0.56999999999999995 111.253 175.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.46 -77.52 0.1 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.475 -1.693 . . . . 0.91000000000000003 112.267 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.45 16.43 Favored Glycine 0 C--N 1.385 3.266 0 C-N-CA 120.882 -0.675 . . . . 0.56999999999999995 113.757 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 160.38 40.88 0.0 OUTLIER 'General case' 0 C--N 1.399 2.759 0 CA-C-O 124.183 1.944 . . . . 0.56999999999999995 112.341 -170.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.414 ' HA2' ' OE1' ' A' ' 201' ' ' GLU . . . 116.02 -156.79 15.42 Favored Glycine 0 C--N 1.37 2.446 0 N-CA-C 107.009 -2.436 . . . . 0.56999999999999995 107.009 174.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.45 -39.84 2.54 Favored Glycine 0 C--N 1.367 2.265 0 O-C-N 120.268 -1.725 . . . . 0.56999999999999995 113.989 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -152.56 167.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.86 0 N-CA-C 105.294 -2.113 . . . . 0.56999999999999995 105.294 -172.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 210' ' ' THR . 66.9 mt -118.77 -80.6 0.62 Allowed 'General case' 0 C--N 1.374 1.673 0 O-C-N 126.684 2.49 . . . . 0.56999999999999995 114.77 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -107.65 179.5 4.22 Favored 'General case' 0 C--N 1.377 1.765 0 CA-C-N 115.356 -0.838 . . . . 0.56999999999999995 111.112 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER -169.24 135.9 1.72 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.904 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.05 161.97 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.151 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -171.22 2.85 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.029 1.395 . . . . 0.56999999999999995 110.846 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.91 -159.11 35.16 Favored Glycine 0 C--N 1.385 3.275 0 CA-C-N 114.001 -1.454 . . . . 0.56999999999999995 112.838 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.42 74.28 3.74 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 110.068 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.76 -134.86 6.95 Favored Glycine 0 C--N 1.376 2.798 0 CA-C-O 124.067 1.926 . . . . 0.56999999999999995 110.155 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.26 -80.08 0.6 Allowed 'General case' 0 C--N 1.396 2.604 0 CA-C-N 112.909 -1.645 . . . . 0.56999999999999995 108.938 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.99 -54.76 2.11 Favored Glycine 1 C--N 1.398 4.006 0 N-CA-C 108.252 -1.939 . . . . 0.56999999999999995 108.252 -174.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -44.37 99.47 Favored 'Isoleucine or valine' 0 C--N 1.396 2.625 0 CA-C-N 113.38 -1.41 . . . . 0.56999999999999995 107.615 -173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.52 136.44 43.89 Favored Glycine 0 C--N 1.395 3.835 0 N-CA-C 106.89 -2.484 . . . . 0.56999999999999995 106.89 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.62 -41.54 2.11 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-N 113.33 -1.435 . . . . 0.56999999999999995 113.531 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.83 97.16 0.1 Allowed 'General case' 0 C--N 1.39 2.343 0 CA-C-N 115.096 -0.552 . . . . 0.91000000000000003 110.921 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 160' ' ' LEU . . . -102.95 148.29 25.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.08 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -129.37 151.27 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.895 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.49 ' HB2' ' CH2' ' A' ' 203' ' ' TRP . 0.0 OUTLIER -123.59 150.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.897 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.577 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 2.8 p30 -79.39 83.19 5.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.91000000000000003 110.833 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 164' ' ' ALA . 11.7 tp10 -57.1 -32.52 66.39 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 117.72 -1.133 . . . . 0.91000000000000003 110.349 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -41.98 -51.41 4.44 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 125.768 1.918 . . . . 0.91000000000000003 110.429 -173.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 178' ' ' GLY . 0.7 OUTLIER -58.25 -173.87 0.01 OUTLIER 'General case' 0 C--N 1.392 2.434 0 CA-C-O 127.766 3.65 . . . . 0.91000000000000003 113.045 175.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 122.59 46.71 Favored 'General case' 0 C--N 1.382 2.019 0 O-C-N 119.125 -2.234 . . . . 0.56999999999999995 113.078 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 197' ' ' PHE . 26.1 m0 -96.39 123.85 40.18 Favored 'General case' 0 C--N 1.391 2.383 0 N-CA-C 105.262 -2.125 . . . . 0.56999999999999995 105.262 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.401 ' HG1' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -82.46 102.61 11.44 Favored 'General case' 0 C--N 1.374 1.649 0 CA-C-O 126.235 2.921 . . . . 0.56999999999999995 112.136 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.8 p -102.09 120.59 40.68 Favored 'General case' 0 C--N 1.376 1.739 0 O-C-N 119.564 -1.96 . . . . 0.56999999999999995 108.904 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 65.86 66.63 0.5 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-O 123.958 1.837 . . . . 0.56999999999999995 109.673 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.98 -72.14 0.01 OUTLIER 'General case' 0 C--N 1.397 2.661 0 CA-C-O 123.522 1.629 . . . . 0.56999999999999995 109.334 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.81 -145.92 5.2 Favored Glycine 0 C--N 1.385 3.263 0 N-CA-C 108.262 -1.935 . . . . 0.56999999999999995 108.262 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 47.06 -146.56 3.75 Favored Glycine 0 C--N 1.383 3.18 0 CA-C-O 127.134 3.63 . . . . 0.56999999999999995 110.095 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.437 ' CG2' HD21 ' A' ' 181' ' ' LEU . 8.3 p -77.77 124.34 27.84 Favored 'General case' 0 C--N 1.368 1.378 0 O-C-N 119.983 -1.892 . . . . 0.56999999999999995 112.331 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.86 155.97 28.12 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-N 114.815 -1.084 . . . . 0.56999999999999995 109.435 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.87 -32.93 74.73 Favored 'General case' 0 C--N 1.393 2.491 0 CA-C-O 124.22 1.962 . . . . 0.56999999999999995 107.641 -173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 245' ' ' ILE . 27.5 t80 -57.55 -50.0 74.53 Favored 'General case' 0 C--N 1.376 1.72 0 CA-C-N 113.16 -1.836 . . . . 0.56999999999999995 110.898 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.414 ' CD1' ' C26' ' A' ' 269' ' ' HSI . 1.0 OUTLIER -55.03 -51.12 67.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.937 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -63.83 -44.95 91.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.151 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.93 -42.87 80.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 111.085 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.17 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.096 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.26 -49.97 62.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 110.823 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -42.11 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.91000000000000003 110.885 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.412 ' HA ' ' CD1' ' A' ' 159' ' ' ILE . 3.3 mm -67.68 -47.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.56999999999999995 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.79 -33.75 63.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.466 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.41 -38.74 88.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.56999999999999995 110.9 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.0 t -71.22 -53.53 14.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.836 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 225' ' ' GLY . 3.2 pp -72.23 -60.77 2.06 Favored 'General case' 0 C--N 1.375 1.68 0 N-CA-C 118.992 2.96 . . . . 0.56999999999999995 118.992 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.466 ' N ' ' CD1' ' A' ' 224' ' ' LEU . . . -70.42 -175.09 17.1 Favored Glycine 0 C--N 1.375 2.741 0 CA-C-O 126.157 3.087 . . . . 0.56999999999999995 110.114 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 263' ' ' GLY . 0.2 OUTLIER -89.01 -146.33 0.16 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-N 109.628 -3.286 . . . . 0.56999999999999995 106.432 -172.02 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.01 -107.57 0.01 OUTLIER Glycine 0 C--N 1.394 3.794 0 CA-C-O 125.769 2.871 . . . . 0.56999999999999995 111.665 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.436 ' CE1' ' HG3' ' A' ' 238' ' ' PRO . 21.4 m170 -113.83 -96.43 0.45 Allowed 'General case' 0 C--N 1.382 1.994 0 O-C-N 119.633 -2.098 . . . . 0.56999999999999995 110.34 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.03 -42.58 0.01 OUTLIER 'General case' 0 C--N 1.391 2.413 0 N-CA-C 107.893 -1.151 . . . . 0.56999999999999995 107.893 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 81.87 24.11 0.23 Allowed 'General case' 0 C--N 1.415 3.454 0 N-CA-C 116.676 2.102 . . . . 0.56999999999999995 116.676 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -157.94 138.2 8.95 Favored Pre-proline 0 C--N 1.386 2.156 0 N-CA-C 106.539 -1.652 . . . . 0.91000000000000003 106.539 -171.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.541 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 67.8 Cg_exo -57.29 -57.68 1.18 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.445 2.763 . . . . 0.56999999999999995 114.529 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.99 -37.75 4.25 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 112.976 -1.92 . . . . 0.56999999999999995 113.396 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 117.56 8.27 Favored 'General case' 0 C--N 1.393 2.493 0 CA-C-O 124.445 2.069 . . . . 0.56999999999999995 115.762 167.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.3 t -72.19 47.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.033 0 CA-C-O 124.693 2.187 . . . . 0.56999999999999995 115.449 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.8 mmm -144.76 -31.94 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 CA-C-N 113.575 -1.648 . . . . 0.56999999999999995 110.227 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 232' ' ' PRO . 0.0 OUTLIER -39.11 144.37 0.44 Allowed Pre-proline 0 C--N 1.38 1.928 0 CA-C-O 126.283 2.944 . . . . 0.56999999999999995 114.371 173.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.436 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 54.0 Cg_exo -58.87 -48.14 15.66 Favored 'Trans proline' 0 C--N 1.383 2.371 0 O-C-N 118.294 -1.477 . . . . 0.56999999999999995 111.806 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.51 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 98.9 m -46.3 122.54 4.07 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.003 -173.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.0 OUTLIER -98.03 117.69 32.96 Favored 'General case' 0 C--N 1.386 2.164 0 CA-C-N 112.81 -1.995 . . . . 0.56999999999999995 106.602 -178.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -138.5 108.03 6.19 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 113.281 -1.781 . . . . 0.56999999999999995 106.63 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.5 120.89 5.03 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-O 124.455 2.074 . . . . 0.56999999999999995 110.796 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.24 18.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 CA-C-N 112.868 -1.969 . . . . 0.56999999999999995 110.718 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.3 t0 64.03 115.95 0.02 OUTLIER 'General case' 0 C--N 1.385 2.147 0 CA-C-O 126.937 3.256 . . . . 0.91000000000000003 106.651 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' A' ' 213' ' ' PHE . 2.6 mp -51.97 -19.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.46 0 O-C-N 119.048 -2.283 . . . . 0.56999999999999995 115.4 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -31.46 64.56 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.003 -1.453 . . . . 0.56999999999999995 111.23 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -5.62 15.42 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 123.121 0.568 . . . . 0.56999999999999995 110.914 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -65.01 93.85 0.12 Allowed 'General case' 0 C--N 1.385 2.119 0 CA-C-O 125.678 2.656 . . . . 0.56999999999999995 105.332 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.41 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -114.41 154.14 28.64 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 112.414 -2.176 . . . . 1.2 105.79 -177.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.89 132.62 53.77 Favored 'General case' 0 C--N 1.385 2.15 0 CA-C-O 125.559 2.6 . . . . 0.56999999999999995 105.768 -170.552 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 25.8 m -69.32 141.79 54.19 Favored 'General case' 0 C--N 1.365 1.249 0 O-C-N 120.229 -1.544 . . . . 0.56999999999999995 109.124 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.45 93.98 Favored 'General case' 0 C--N 1.396 2.609 0 CA-C-N 113.337 -1.756 . . . . 0.56999999999999995 107.412 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -41.52 89.07 Favored 'General case' 0 C--N 1.365 1.243 0 CA-C-N 115.501 -0.772 . . . . 0.91000000000000003 110.834 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.4 -54.8 27.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.91000000000000003 110.857 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.6 pt -66.08 -34.54 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 111.196 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -67.55 -31.12 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.2 110.796 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.41 19.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.56999999999999995 112.457 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.435 ' O ' ' CD1' ' A' ' 262' ' ' TYR . 1.2 pt -59.59 -36.15 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.731 0.301 . . . . 0.56999999999999995 111.077 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -70.13 -44.61 68.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.896 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 t -64.99 -42.56 94.4 Favored 'General case' 0 C--N 1.374 1.673 0 CA-C-O 121.933 0.873 . . . . 0.56999999999999995 110.891 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.29 126.83 26.94 Favored 'General case' 0 C--N 1.38 1.933 0 CA-C-O 125.48 2.562 . . . . 0.56999999999999995 107.66 -176.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 147' ' ' LEU . 32.0 m-85 -105.37 9.58 33.7 Favored 'General case' 0 C--N 1.379 1.85 0 CA-C-N 112.716 -2.038 . . . . 0.56999999999999995 110.778 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 226' ' ' LEU . . . . . . . . 1 C--N 1.4 4.118 0 CA-C-O 114.625 -3.32 . . . . 0.91000000000000003 119.716 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.537 ' O4 ' ' C11' ' A' ' 269' ' ' HSI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 CA-C-O 118.414 -1.214 . . . . 0.56999999999999995 111.315 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.11 121.27 9.35 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.249 2.633 . . . . 0.56999999999999995 111.077 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -123.71 132.87 70.65 Favored 'Isoleucine or valine' 0 C--N 1.374 1.667 0 CA-C-N 113.414 -1.721 . . . . 0.56999999999999995 109.26 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.92 114.66 4.94 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.857 -1.519 . . . . 0.56999999999999995 107.81 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -118.09 150.36 39.46 Favored 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.851 -1.522 . . . . 1.2 108.943 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -65.83 0.03 OUTLIER 'General case' 0 C--N 1.382 2.018 0 CA-C-N 113.886 -1.507 . . . . 0.56999999999999995 111.07 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -11.61 59.85 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 125.542 2.591 . . . . 0.56999999999999995 110.268 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -110.07 105.48 14.61 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.144 -1.598 . . . . 0.56999999999999995 110.946 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.01 135.32 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.108 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.42 159.03 18.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.181 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -150.14 158.07 43.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.56999999999999995 110.883 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.07 126.5 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.2 110.921 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.98 136.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.114 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -53.23 -53.92 43.65 Favored 'General case' 0 C--N 1.376 1.744 0 N-CA-C 107.805 -1.183 . . . . 0.56999999999999995 107.805 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 161.98 35.44 0.0 OUTLIER 'General case' 0 C--N 1.382 1.996 0 O-C-N 126.599 2.437 . . . . 0.56999999999999995 110.049 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 4.8 m-30 72.52 -172.22 0.15 Allowed 'General case' 0 C--N 1.383 2.025 0 N-CA-C 107.41 -1.33 . . . . 0.56999999999999995 107.41 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 161.51 55.98 Favored Pre-proline 0 C--N 1.373 1.614 0 CA-C-N 114.141 -1.39 . . . . 0.56999999999999995 108.619 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -50.51 1.41 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 112.584 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.16 -66.87 0.82 Allowed 'General case' 0 C--N 1.379 1.882 0 N-CA-C 104.768 -2.308 . . . . 0.91000000000000003 104.768 -165.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.7 ttm -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-O 125.694 2.664 . . . . 0.56999999999999995 110.19 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -75.95 139.69 41.7 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.396 -2.184 . . . . 0.56999999999999995 107.714 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.47 -47.46 67.03 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 107.736 -1.209 . . . . 1.2 107.736 -168.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -34.67 63.27 Favored 'General case' 0 C--N 1.387 2.226 0 O-C-N 126.482 2.364 . . . . 0.91000000000000003 110.898 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -44.04 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.91000000000000003 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.5 t -61.31 -44.55 98.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.84 -44.09 97.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.91000000000000003 110.869 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.61 -44.06 87.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 110.894 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.97 87.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.56999999999999995 111.13 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -65.15 -42.89 95.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.56999999999999995 111.112 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -49.05 78.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.868 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' N ' ' HZ2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -62.68 -36.55 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.91 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.06 99.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 111.132 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 134' ' ' ILE . 20.4 m-85 -65.93 -37.09 85.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 110.86 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.4 tt0 -67.16 -38.11 84.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.882 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.496 ' O ' ' CG2' ' A' ' 144' ' ' VAL . 8.3 t -71.12 -34.07 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.122 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -83.25 -34.09 25.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.913 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m -77.55 -49.39 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.876 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -59.76 -12.56 7.45 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-O 122.174 0.988 . . . . 0.56999999999999995 112.737 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 140' ' ' VAL . 25.0 m -115.98 1.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.379 1.854 0 CA-C-N 114.014 -1.448 . . . . 0.56999999999999995 111.42 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.8 150.28 45.92 Favored Pre-proline 0 C--N 1.368 1.412 0 CA-C-O 125.615 2.626 . . . . 0.56999999999999995 110.203 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 262' ' ' TYR . 33.8 Cg_endo -73.38 -34.03 6.36 Favored 'Trans proline' 0 C--N 1.361 1.224 0 O-C-N 118.114 -1.572 . . . . 0.56999999999999995 110.69 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.7 114.34 2.46 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 108.73 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 158.36 32.05 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 113.742 -1.572 . . . . 0.56999999999999995 112.507 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' CD2' ' OG ' ' A' ' 142' ' ' SER . 12.6 m-85 -130.07 139.61 50.94 Favored 'General case' 0 C--N 1.388 2.272 0 CA-C-N 112.368 -2.196 . . . . 0.56999999999999995 108.711 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.4 m -145.53 125.02 13.14 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 108.367 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 15.9 tttt -89.45 146.58 24.54 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 112.731 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 8.2 pt -139.11 155.97 27.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.852 0 CA-C-O 123.41 1.576 . . . . 0.56999999999999995 109.738 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 -6.23 1.48 Allowed 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.808 -1.542 . . . . 0.56999999999999995 109.951 -174.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.5 p -76.79 -62.82 1.51 Allowed 'General case' 0 C--N 1.372 1.569 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.539 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.56 -174.69 17.47 Favored Glycine 0 C--N 1.374 2.648 0 CA-C-O 123.253 1.474 . . . . 0.56999999999999995 110.861 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 ttt -57.62 124.97 20.89 Favored 'General case' 0 C--N 1.382 1.997 0 CA-C-N 113.014 -1.593 . . . . 0.56999999999999995 108.411 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.04 173.56 7.21 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.147 -1.842 . . . . 0.56999999999999995 110.582 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.43 -83.39 0.03 OUTLIER 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.989 -1.914 . . . . 0.91000000000000003 107.674 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.448 ' O ' ' CD1' ' A' ' 159' ' ' ILE . 1.9 pp -94.69 114.57 31.54 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-N 114.665 -1.152 . . . . 0.56999999999999995 111.108 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.38 132.06 42.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.92 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.02 116.9 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.148 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.33 145.13 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.101 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.77 117.77 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.89 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.36 170.12 18.0 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 124.341 2.019 . . . . 0.56999999999999995 109.646 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 134.02 52.43 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.909 -1.744 . . . . 1.2 108.156 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 42.32 -106.02 0.07 OUTLIER Glycine 0 C--N 1.379 2.957 0 O-C-N 126.135 2.147 . . . . 0.56999999999999995 113.009 171.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 57.04 -140.03 0.86 Allowed 'General case' 0 C--N 1.384 2.097 0 O-C-N 127.111 2.301 . . . . 0.56999999999999995 107.518 170.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -40.31 145.78 0.16 Allowed 'General case' 0 C--N 1.383 2.059 0 O-C-N 124.957 1.411 . . . . 0.56999999999999995 111.36 177.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.9 -145.86 0.68 Allowed Glycine 0 C--N 1.376 2.761 0 C-N-CA 116.874 -2.584 . . . . 0.56999999999999995 114.256 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.84 23.98 13.95 Favored 'General case' 0 C--N 1.395 2.57 0 CA-C-N 112.59 -1.805 . . . . 0.91000000000000003 108.341 167.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.0 t80 60.48 76.69 0.35 Allowed 'General case' 0 C--N 1.383 2.031 0 CA-C-N 114.063 -1.426 . . . . 0.56999999999999995 112.616 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.84 42.76 6.39 Favored 'General case' 0 C--N 1.384 2.099 0 CA-C-N 114.842 -1.072 . . . . 0.56999999999999995 112.936 177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 65.16 101.92 0.04 OUTLIER 'General case' 0 C--N 1.377 1.769 0 CA-C-O 124.157 1.932 . . . . 0.56999999999999995 115.185 -173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.529 ' CE2' HG23 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -85.89 -131.1 0.05 OUTLIER 'General case' 0 C--N 1.376 1.745 0 CA-C-N 113.224 -1.807 . . . . 0.56999999999999995 108.633 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 t70 54.0 -157.42 0.19 Allowed 'General case' 0 C--N 1.39 2.343 0 N-CA-C 105.647 -1.982 . . . . 0.91000000000000003 105.647 170.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 127.72 9.18 4.02 Favored Glycine 0 C--N 1.368 2.344 0 N-CA-C 109.067 -1.613 . . . . 0.56999999999999995 109.067 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.13 -57.14 0.01 OUTLIER 'General case' 0 C--N 1.393 2.492 0 CA-C-O 122.764 1.269 . . . . 0.56999999999999995 111.031 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -156.95 -38.25 0.02 OUTLIER Glycine 0 C--N 1.382 3.102 0 CA-C-N 114.126 -1.397 . . . . 0.56999999999999995 111.497 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.495 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -41.6 142.06 1.19 Allowed Glycine 0 C--N 1.38 3.027 0 O-C-N 120.0 -1.883 . . . . 0.56999999999999995 109.379 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.529 HG23 ' CE2' ' A' ' 174' ' ' PHE . 1.3 mp 74.04 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.62 0 O-C-N 124.153 0.561 . . . . 0.56999999999999995 112.449 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 tp -124.29 -57.81 1.56 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 122.966 1.365 . . . . 0.56999999999999995 111.882 172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -177.43 179.53 0.94 Allowed 'General case' 0 C--N 1.364 1.229 0 CA-C-N 114.584 -1.189 . . . . 0.56999999999999995 111.042 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.434 ' O ' ' CB ' ' A' ' 195' ' ' ALA . 2.7 p80 -152.94 168.24 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.874 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.89 142.71 22.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.057 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.4 ' CD2' ' HA2' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -52.02 129.71 27.93 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 117.745 -1.582 . . . . 0.56999999999999995 110.143 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.26 -58.19 4.4 Favored Glycine 0 C--N 1.381 3.046 0 CA-C-N 112.859 -1.973 . . . . 0.56999999999999995 111.785 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -67.96 -83.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 121.495 1.463 . . . . 0.56999999999999995 111.342 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.32 -142.52 7.61 Favored Glycine 0 C--N 1.375 2.711 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 -176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 83.59 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.382 1.987 0 O-C-N 125.611 1.418 . . . . 0.56999999999999995 109.382 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -44.87 -65.08 1.91 Allowed Glycine 0 C--N 1.388 3.426 0 CA-C-O 125.678 2.821 . . . . 0.56999999999999995 112.549 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.97 -15.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.382 1.982 0 CA-C-N 111.306 -2.447 . . . . 0.56999999999999995 109.03 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 185' ' ' PHE . . . -44.98 148.35 1.39 Allowed Glycine 0 C--N 1.362 1.972 0 O-C-N 120.693 -1.254 . . . . 0.56999999999999995 113.676 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.38 -44.47 1.94 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 117.428 1.731 . . . . 0.56999999999999995 117.428 -171.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -37.48 147.15 0.04 OUTLIER 'General case' 0 C--N 1.387 2.205 0 O-C-N 124.894 0.997 . . . . 0.91000000000000003 110.853 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 183' ' ' HIS . . . -143.42 152.0 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.113 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.33 126.41 37.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 110.828 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.7 OUTLIER -109.97 134.93 51.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 110.923 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 85.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.86 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -72.98 -49.24 30.27 Favored 'General case' 0 C--N 1.382 1.999 0 N-CA-C 104.209 -2.515 . . . . 0.91000000000000003 104.209 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.84 -45.75 0.1 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 123.938 0.895 . . . . 0.91000000000000003 112.151 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -53.19 174.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 126.631 3.11 . . . . 0.91000000000000003 109.77 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 2.1 t80 -97.1 107.52 20.07 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 112.74 -2.027 . . . . 0.56999999999999995 114.275 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -91.25 151.42 20.92 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 108.493 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.0 p -126.22 104.4 8.2 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 109.92 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.56 137.29 37.43 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-N 113.271 -1.786 . . . . 0.56999999999999995 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 207' ' ' SER . 1.3 t60 76.78 42.56 0.15 Allowed 'General case' 0 C--N 1.385 2.144 0 CA-C-N 113.796 -1.547 . . . . 0.56999999999999995 110.834 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.1 p 81.69 123.17 0.04 OUTLIER 'General case' 0 C--N 1.382 1.989 0 CA-C-O 124.55 2.119 . . . . 0.56999999999999995 108.849 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.37 -13.91 0.15 Allowed Glycine 0 C--N 1.382 3.135 0 C-N-CA 118.514 -1.803 . . . . 0.56999999999999995 111.752 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 153.88 -119.13 0.92 Allowed Glycine 0 C--N 1.389 3.509 0 CA-C-O 123.723 1.735 . . . . 0.56999999999999995 112.994 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.7 p -80.02 117.53 20.94 Favored 'General case' 0 C--N 1.377 1.795 0 CA-C-O 123.142 1.448 . . . . 0.56999999999999995 111.625 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -91.59 152.14 20.41 Favored 'General case' 0 C--N 1.369 1.417 0 CA-C-N 112.738 -2.028 . . . . 0.56999999999999995 111.648 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.04 -31.23 61.27 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 113.184 -1.825 . . . . 0.56999999999999995 107.338 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 217' ' ' VAL . 1.3 t80 -58.22 -46.61 85.57 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-N 113.819 -1.537 . . . . 0.56999999999999995 110.889 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.428 HD12 ' C25' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -55.68 -51.84 65.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.898 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -49.05 69.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.162 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.32 73.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.174 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 213' ' ' PHE . 92.5 t -65.18 -39.49 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 111.081 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 236' ' ' MET . 7.2 t-160 -70.29 -42.3 72.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.866 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 219' ' ' GLU . 1.2 mm-40 -61.1 -43.78 98.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.91000000000000003 110.869 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 12.5 pt -71.09 -42.94 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 111.114 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.96 -33.76 64.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.56999999999999995 112.523 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.53 -42.02 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.7 t -71.01 -36.01 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.888 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.8 mt -43.74 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.367 1.344 0 CA-C-O 124.25 1.976 . . . . 0.56999999999999995 114.318 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.64 -161.83 35.56 Favored Glycine 0 C--N 1.369 2.408 0 N-CA-C 107.93 -2.068 . . . . 0.56999999999999995 107.93 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.65 -164.07 0.05 OUTLIER 'General case' 0 C--N 1.389 2.293 0 CA-C-N 112.633 -1.783 . . . . 0.56999999999999995 111.131 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -111.34 -162.61 17.51 Favored Glycine 0 C--N 1.373 2.624 0 CA-C-O 125.61 2.783 . . . . 0.56999999999999995 112.682 171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.48 -167.06 1.74 Allowed 'General case' 0 C--N 1.39 2.328 0 CA-C-N 110.578 -2.811 . . . . 0.56999999999999995 112.032 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.24 -20.1 20.13 Favored 'General case' 0 C--N 1.385 2.125 0 CA-C-N 113.421 -1.718 . . . . 0.56999999999999995 109.944 -175.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 86.48 5.38 0.39 Allowed 'General case' 0 C--N 1.387 2.22 0 O-C-N 125.558 1.786 . . . . 0.56999999999999995 114.853 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -149.12 143.86 17.43 Favored Pre-proline 0 C--N 1.38 1.908 0 O-C-N 125.193 1.558 . . . . 0.91000000000000003 109.377 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.11 -47.18 18.56 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.589 2.192 . . . . 0.56999999999999995 112.295 -172.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -41.89 -39.35 1.8 Allowed 'General case' 0 C--N 1.38 1.909 0 CA-C-N 114.035 -1.438 . . . . 0.56999999999999995 113.032 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.48 131.56 48.56 Favored 'General case' 0 C--N 1.383 2.046 0 N-CA-C 118.955 2.946 . . . . 0.56999999999999995 118.955 167.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.453 HG23 ' CE2' ' A' ' 248' ' ' PHE . 21.9 t -73.55 70.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.9 0 CA-C-N 112.256 -2.247 . . . . 0.56999999999999995 111.435 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.459 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -179.55 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-N 113.233 -1.803 . . . . 0.56999999999999995 109.424 -178.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.469 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 3.4 t80 -52.77 140.25 39.63 Favored Pre-proline 0 C--N 1.363 1.193 0 O-C-N 120.014 -1.679 . . . . 0.56999999999999995 109.868 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.469 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 54.0 Cg_exo -54.77 -19.41 18.82 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.8 1.667 . . . . 0.56999999999999995 114.9 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -48.41 107.57 0.13 Allowed 'General case' 0 C--N 1.371 1.515 0 CA-C-O 123.665 1.698 . . . . 0.56999999999999995 110.677 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -81.86 134.11 35.38 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 105.869 -1.9 . . . . 0.56999999999999995 105.869 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.726 ' HD2' ' H33' ' A' ' 269' ' ' HSI . 2.7 tmtt? 174.96 113.49 0.02 OUTLIER 'General case' 0 C--N 1.383 2.048 0 N-CA-C 106.744 -1.576 . . . . 0.56999999999999995 106.744 175.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.59 123.26 9.55 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 113.238 -1.801 . . . . 0.56999999999999995 110.701 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.727 HG11 ' C33' ' A' ' 269' ' ' HSI . 7.7 p -151.35 113.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.779 0 CA-C-N 113.806 -1.543 . . . . 0.56999999999999995 108.103 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.39 150.05 12.2 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 113.211 -1.813 . . . . 0.91000000000000003 107.086 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 248' ' ' PHE . 1.1 mp -75.86 -23.57 16.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 124.227 1.965 . . . . 0.56999999999999995 110.02 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -84.15 -7.52 59.34 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.481 -1.387 . . . . 0.56999999999999995 112.714 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 39.7 p -122.39 3.51 9.71 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-O 123.679 1.704 . . . . 0.56999999999999995 111.578 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -83.97 -156.73 0.23 Allowed 'General case' 0 C--N 1.368 1.4 0 CA-C-N 113.259 -1.791 . . . . 0.56999999999999995 110.376 178.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.4 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER 178.28 163.37 0.69 Allowed 'General case' 0 C--N 1.385 2.124 0 N-CA-C 105.637 -1.986 . . . . 1.2 105.637 168.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -117.56 141.98 47.73 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.732 2.682 . . . . 0.56999999999999995 108.262 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.3 t -64.5 134.02 53.6 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 119.846 -1.784 . . . . 0.56999999999999995 112.645 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.91 -49.91 64.08 Favored 'General case' 0 C--N 1.39 2.361 0 CA-C-N 114.072 -1.422 . . . . 0.56999999999999995 108.663 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -35.96 73.97 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 115.357 -0.838 . . . . 0.91000000000000003 110.845 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -63.94 -55.13 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.91000000000000003 110.885 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.7 pt -66.37 -35.31 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.56999999999999995 111.149 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.404 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 35.5 mtp180 -70.72 -35.52 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 1.2 110.784 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.02 -51.2 55.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.722 . . . . 0.56999999999999995 112.465 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 2.4 pt -61.17 -45.61 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.56999999999999995 111.119 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.21 -28.69 63.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.56999999999999995 110.907 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 31.3 t -77.58 -36.24 52.19 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 119.096 -1.042 . . . . 0.56999999999999995 109.796 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.382 2.007 0 CA-C-O 124.069 1.89 . . . . 0.56999999999999995 110.819 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.545 ' O ' ' HG3' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -99.52 130.82 45.8 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.222 -1.808 . . . . 0.56999999999999995 112.661 177.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.387 3.403 0 CA-C-O 114.622 -3.321 . . . . 0.91000000000000003 120.438 -173.081 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.727 ' C33' HG11 ' A' ' 243' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 CA-C-O 118.97 -0.906 . . . . 0.56999999999999995 111.027 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -56.45 -22.82 44.2 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 121.208 1.272 . . . . 0.56999999999999995 114.439 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 130.14 74.83 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 0 CA-C-N 114.525 -1.216 . . . . 0.56999999999999995 109.481 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -179.14 152.27 0.54 Allowed 'General case' 0 C--N 1.371 1.54 0 N-CA-C 107.399 -1.334 . . . . 0.56999999999999995 107.399 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.36 157.46 31.77 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 125.034 2.349 . . . . 1.2 111.193 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.91 -54.32 1.31 Allowed 'General case' 0 C--N 1.379 1.868 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 107.822 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.388 2.247 0 CA-C-O 124.172 1.939 . . . . 0.56999999999999995 108.471 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.6 103.81 10.06 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-N 112.054 -2.339 . . . . 0.56999999999999995 110.929 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 mm -102.11 146.91 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.112 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -105.93 156.51 18.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.473 . . . . 0.56999999999999995 111.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 20.3 t80 -138.64 160.1 40.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.929 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.528 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -145.68 121.85 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.509 . . . . 1.2 110.847 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.484 HG12 ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -93.51 132.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 111.125 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -59.48 -86.76 0.01 OUTLIER 'General case' 0 C--N 1.375 1.696 0 CA-C-N 114.739 -1.119 . . . . 0.56999999999999995 110.206 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t30 169.4 60.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.28 0 N-CA-C 104.15 -2.537 . . . . 0.56999999999999995 104.15 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -67.07 178.37 1.45 Allowed 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.065 -1.88 . . . . 0.56999999999999995 111.544 166.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 162.45 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.32 2.648 . . . . 0.56999999999999995 108.134 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.71 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-O 124.365 1.735 . . . . 0.56999999999999995 110.079 -165.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.99 3.31 12.54 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 114.309 -1.314 . . . . 0.91000000000000003 113.986 173.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.1 mmt -142.75 119.45 11.13 Favored 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.007 -1.479 . . . . 0.56999999999999995 107.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.32 139.09 31.04 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 122.617 1.199 . . . . 0.56999999999999995 108.58 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -46.66 74.22 Favored 'General case' 0 C--N 1.388 2.261 0 CA-C-O 123.871 1.796 . . . . 1.2 109.261 -166.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.24 -35.17 64.65 Favored 'General case' 0 C--N 1.364 1.208 0 CA-C-N 111.376 -2.647 . . . . 0.91000000000000003 110.979 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.61 -41.92 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.91000000000000003 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.416 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 2.3 t -65.54 -39.57 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 111.112 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.63 -42.1 87.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.838 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -49.02 75.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.949 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.62 -49.1 67.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.052 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.42 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.5 mm -62.22 -46.03 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.094 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -56.28 -43.64 79.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 1.2 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -38.13 89.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.878 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.57 -45.29 87.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.078 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 220' ' ' ILE . 14.9 m-85 -62.97 -34.4 77.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.916 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -40.0 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 110.934 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -34.24 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.56999999999999995 111.125 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.15 -33.62 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 110.929 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.7 m -78.94 -49.01 13.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.808 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.438 ' ND2' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -59.97 -14.84 17.86 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-O 120.969 0.414 . . . . 0.56999999999999995 111.072 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG11 ' CD1' ' A' ' 255' ' ' ILE . 19.6 m -112.51 -13.61 11.24 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 CA-C-O 117.89 -1.053 . . . . 0.56999999999999995 111.016 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.7 142.39 17.93 Favored Pre-proline 0 C--N 1.383 2.038 0 O-C-N 124.859 1.349 . . . . 0.56999999999999995 112.555 -175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -78.52 67.75 8.25 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.201 1.934 . . . . 0.56999999999999995 112.66 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.71 90.58 0.63 Allowed 'General case' 0 C--N 1.372 1.576 0 N-CA-C 104.516 -2.401 . . . . 0.56999999999999995 104.516 -167.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 160.53 25.73 Favored 'General case' 0 C--N 1.381 1.977 0 CA-C-N 114.432 -1.258 . . . . 0.56999999999999995 113.035 170.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -136.32 141.22 43.77 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-N 113.723 -1.58 . . . . 0.56999999999999995 106.747 -172.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -157.02 139.76 15.11 Favored 'General case' 0 C--N 1.366 1.315 0 CA-C-O 124.454 2.073 . . . . 0.56999999999999995 108.161 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.26 145.8 27.37 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 114.199 -1.364 . . . . 0.56999999999999995 109.733 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -111.27 159.48 11.23 Favored 'Isoleucine or valine' 0 C--N 1.367 1.333 0 CA-C-O 123.979 1.847 . . . . 0.56999999999999995 108.032 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -90.1 100.26 13.12 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.21 -1.814 . . . . 0.56999999999999995 107.038 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 67.67 -178.75 0.21 Allowed 'General case' 0 C--N 1.371 1.512 0 CA-C-O 122.189 0.995 . . . . 0.56999999999999995 109.44 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.09 71.35 Favored Glycine 0 C--N 1.371 2.487 0 C-N-CA 119.728 -1.225 . . . . 0.56999999999999995 113.435 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.63 113.89 0.06 Allowed 'General case' 0 C--N 1.374 1.671 0 CA-C-O 122.586 1.184 . . . . 0.56999999999999995 109.735 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -91.31 159.49 15.99 Favored 'General case' 0 C--N 1.37 1.478 0 C-N-CA 117.612 -1.635 . . . . 0.56999999999999995 109.659 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -47.13 68.61 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-N 112.28 -2.236 . . . . 0.91000000000000003 106.061 -171.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.3 mt -103.49 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.388 2.241 0 O-C-N 127.117 2.761 . . . . 0.56999999999999995 111.159 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.41 124.4 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.921 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.9 t -108.75 123.04 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.074 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 124.94 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.156 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' C ' ' HB2' ' A' ' 199' ' ' GLU . 5.4 m-85 -89.46 116.85 27.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.864 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.8 29.7 Favored 'General case' 0 C--N 1.378 1.81 0 CA-C-O 122.89 1.328 . . . . 0.56999999999999995 108.593 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.93 177.11 5.05 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 114.501 -1.227 . . . . 1.2 110.892 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.93 144.19 23.51 Favored Glycine 0 C--N 1.376 2.76 0 CA-C-N 113.213 -1.812 . . . . 0.56999999999999995 111.466 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 82.54 50.83 0.02 OUTLIER 'General case' 0 C--N 1.382 1.993 0 CA-C-O 123.136 1.446 . . . . 0.56999999999999995 112.307 -175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -123.98 168.27 13.05 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 109.69 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -66.28 171.45 28.46 Favored Glycine 0 C--N 1.379 2.929 0 N-CA-C 110.177 -1.169 . . . . 0.56999999999999995 110.177 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.308 0.0 OUTLIER 75.77 0.33 3.34 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-O 122.195 0.998 . . . . 0.91000000000000003 113.153 -177.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -177.22 -173.29 0.44 Allowed 'General case' 0 C--N 1.366 1.297 0 N-CA-C 105.755 -1.943 . . . . 0.56999999999999995 105.755 -163.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.01 -135.31 0.29 Allowed 'General case' 0 CA--C 1.568 1.653 0 CA-C-N 113.716 -1.584 . . . . 0.56999999999999995 108.896 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.68 101.11 0.76 Allowed 'General case' 0 C--N 1.375 1.707 0 C-N-CA 125.646 1.578 . . . . 0.56999999999999995 107.185 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.402 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -91.93 -164.51 1.19 Allowed 'General case' 0 C--N 1.369 1.44 0 CA-C-N 112.857 -1.974 . . . . 0.56999999999999995 108.715 173.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.56 142.13 35.18 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 105.061 -2.2 . . . . 0.91000000000000003 105.061 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.88 157.28 22.93 Favored Glycine 0 C--N 1.368 2.36 0 N-CA-C 107.645 -2.182 . . . . 0.56999999999999995 107.645 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.07 28.21 6.74 Favored 'General case' 0 C--N 1.369 1.425 0 N-CA-C 113.605 0.965 . . . . 0.56999999999999995 113.605 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.62 -163.99 14.9 Favored Glycine 0 C--N 1.364 2.101 0 N-CA-C 108.056 -2.017 . . . . 0.56999999999999995 108.056 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.48 -104.03 3.12 Favored Glycine 0 C--N 1.365 2.188 0 CA-C-N 114.758 -0.721 . . . . 0.56999999999999995 111.42 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.568 HG13 H401 ' A' ' 269' ' ' HSI . 0.5 OUTLIER -81.46 167.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.38 1.898 0 C-N-CA 123.526 0.73 . . . . 0.56999999999999995 109.142 178.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' CE2' ' A' ' 240' ' ' TYR . 5.6 tp -101.13 -42.63 6.29 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 122.087 0.946 . . . . 0.56999999999999995 110.743 173.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.89 -179.99 2.19 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 120.56 -1.337 . . . . 0.56999999999999995 111.102 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.402 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 2.3 p80 -163.87 136.1 4.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.883 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -154.42 163.14 40.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.56999999999999995 111.136 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -121.32 176.59 5.56 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-O 123.191 1.472 . . . . 0.56999999999999995 108.478 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.68 53.09 0.2 Allowed Glycine 0 C--N 1.376 2.763 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 112.219 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.83 -49.84 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 CA-C-O 123.695 1.456 . . . . 0.56999999999999995 110.764 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -155.91 -61.58 0.01 OUTLIER Glycine 0 C--N 1.381 3.053 0 N-CA-C 109.844 -1.303 . . . . 0.56999999999999995 109.844 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m -152.06 -179.73 7.75 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.33 -104.57 1.6 Allowed Glycine 0 C--N 1.379 2.961 0 N-CA-C 105.888 -2.885 . . . . 0.56999999999999995 105.888 171.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.2 tp -55.38 -42.77 68.73 Favored 'Isoleucine or valine' 0 C--N 1.375 1.715 0 CA-C-O 122.818 1.294 . . . . 0.56999999999999995 109.067 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.51 134.69 38.72 Favored Glycine 0 C--N 1.379 2.941 0 C-N-CA 118.37 -1.872 . . . . 0.56999999999999995 108.498 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.6 -29.16 12.36 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 124.287 0.946 . . . . 0.56999999999999995 113.29 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 123.46 26.4 Favored 'General case' 0 C--N 1.371 1.522 0 O-C-N 120.91 -1.347 . . . . 0.91000000000000003 110.885 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.23 146.39 49.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.131 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -123.81 134.47 53.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 110.81 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.3 OUTLIER -108.97 150.01 28.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.883 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 91.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.91000000000000003 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 3.7 tp10 -67.56 -44.56 77.96 Favored 'General case' 0 C--N 1.369 1.414 0 O-C-N 125.714 1.884 . . . . 0.91000000000000003 108.068 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -30.84 43.91 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-O 122.526 1.155 . . . . 0.91000000000000003 111.299 -167.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.52 172.02 0.17 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-O 125.278 2.466 . . . . 0.91000000000000003 114.906 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -120.61 83.36 2.05 Favored 'General case' 0 C--N 1.384 2.07 0 CA-C-N 113.241 -1.8 . . . . 0.56999999999999995 108.463 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -74.4 152.53 39.49 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 113.695 -1.593 . . . . 0.56999999999999995 107.498 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 126.84 35.15 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-O 124.734 2.207 . . . . 0.56999999999999995 105.488 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.8 p -106.42 123.06 47.49 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 105.344 -2.095 . . . . 0.56999999999999995 105.344 -175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 70.6 34.83 2.02 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.318 1.533 . . . . 0.56999999999999995 109.621 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -139.11 -82.06 0.29 Allowed 'General case' 0 C--N 1.375 1.703 0 N-CA-C 107.752 -1.203 . . . . 0.56999999999999995 107.752 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.73 -163.33 33.69 Favored Glycine 0 C--N 1.365 2.148 0 N-CA-C 107.851 -2.1 . . . . 0.56999999999999995 107.851 -171.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.3 -142.85 47.75 Favored Glycine 0 C--N 1.373 2.588 0 C-N-CA 119.295 -1.431 . . . . 0.56999999999999995 110.724 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 p -74.62 115.45 14.19 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-O 124.684 2.183 . . . . 0.56999999999999995 113.723 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.55 147.67 26.49 Favored 'General case' 0 C--N 1.373 1.618 0 CA-C-N 112.748 -2.024 . . . . 0.56999999999999995 110.183 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -34.34 70.44 Favored 'General case' 0 C--N 1.381 1.966 0 N-CA-C 105.339 -2.097 . . . . 0.56999999999999995 105.339 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.499 ' CD1' HG12 ' A' ' 245' ' ' ILE . 3.3 t80 -53.73 -49.95 67.03 Favored 'General case' 0 C--N 1.375 1.686 0 CA-C-N 114.993 -1.003 . . . . 0.56999999999999995 110.9 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -48.28 73.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.946 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -38.2 77.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.128 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -61.55 -46.31 90.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 111.158 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.6 t -65.36 -40.01 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.089 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.12 -50.0 57.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.891 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.9 -42.12 93.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.91000000000000003 110.849 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.475 HD12 ' CE1' ' A' ' 138' ' ' PHE . 2.4 mm -68.44 -43.92 83.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.11 -33.86 76.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.438 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -39.4 89.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.779 0.323 . . . . 0.56999999999999995 110.849 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 m -71.05 -51.56 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.833 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.407 ' CD2' HG23 ' A' ' 220' ' ' ILE . 3.7 pp -69.35 -55.73 9.55 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 116.002 1.853 . . . . 0.56999999999999995 116.002 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -71.73 -148.44 0.67 Allowed Glycine 0 C--N 1.364 2.096 0 N-CA-C 107.51 -2.236 . . . . 0.56999999999999995 107.51 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.63 -21.26 4.5 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 113.19 -1.505 . . . . 0.56999999999999995 108.835 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 148.19 -172.28 28.48 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 123.172 1.429 . . . . 0.56999999999999995 112.847 -161.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 236' ' ' MET . 2.2 m170 -73.97 -162.21 0.13 Allowed 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.074 -2.063 . . . . 0.56999999999999995 109.364 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.1 p -122.15 -10.94 8.5 Favored 'General case' 0 C--N 1.374 1.639 0 C-N-CA 120.313 -0.555 . . . . 0.56999999999999995 109.869 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 85.71 -4.58 0.83 Allowed 'General case' 0 C--N 1.377 1.771 0 N-CA-C 113.834 1.05 . . . . 0.56999999999999995 113.834 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -130.03 152.0 79.26 Favored Pre-proline 0 C--N 1.375 1.708 0 N-CA-C 106.572 -1.64 . . . . 0.91000000000000003 106.572 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -63.72 -21.19 69.78 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.289 1.993 . . . . 0.56999999999999995 114.167 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 14.01 0.26 Allowed 'General case' 0 C--N 1.369 1.448 0 N-CA-C 117.33 2.345 . . . . 0.56999999999999995 117.33 168.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -94.8 132.68 39.32 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 123.074 1.416 . . . . 0.56999999999999995 108.103 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -5.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.372 1.547 0 CA-C-O 124.156 1.931 . . . . 0.56999999999999995 110.857 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.55 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 74.8 mtp -121.77 26.42 8.69 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 114.046 -1.434 . . . . 0.56999999999999995 108.726 -176.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.414 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 0.3 OUTLIER -64.8 149.49 96.04 Favored Pre-proline 0 C--N 1.371 1.505 0 C-N-CA 117.696 -1.602 . . . . 0.56999999999999995 110.231 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 39.6 Cg_endo -78.64 -15.05 13.88 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.278 1.319 . . . . 0.56999999999999995 112.711 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 130.18 45.73 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-O 122.813 1.292 . . . . 0.56999999999999995 109.411 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.508 ' CE2' HD11 ' A' ' 181' ' ' LEU . 6.3 t80 -89.53 106.75 18.66 Favored 'General case' 0 C--N 1.364 1.215 0 N-CA-C 105.822 -1.918 . . . . 0.56999999999999995 105.822 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -154.94 115.83 3.95 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 105.106 -2.183 . . . . 0.56999999999999995 105.106 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -68.6 113.71 6.35 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 110.081 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 p -95.75 -21.42 5.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 CA-C-N 114.142 -1.39 . . . . 0.56999999999999995 112.299 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.312 0.0 OUTLIER 82.32 -11.98 0.96 Allowed 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.033 0.833 . . . . 0.91000000000000003 111.282 -176.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.499 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.6 mt 87.54 14.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.795 0 C-N-CA 124.858 1.263 . . . . 0.56999999999999995 110.766 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.61 -30.47 46.55 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-O 125.595 2.617 . . . . 0.56999999999999995 106.273 -166.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.5 p -119.31 -10.09 9.79 Favored 'General case' 0 C--N 1.386 2.185 0 CA-C-N 112.072 -2.331 . . . . 0.56999999999999995 112.613 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -48.01 103.64 0.05 OUTLIER 'General case' 0 C--N 1.374 1.668 0 CA-C-O 123.162 1.458 . . . . 0.56999999999999995 107.461 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.423 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -138.4 146.71 42.54 Favored 'General case' 0 C--N 1.363 1.188 0 N-CA-C 104.816 -2.291 . . . . 1.2 104.816 -172.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.423 ' O ' ' NE ' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -115.8 132.02 56.76 Favored 'General case' 0 C--N 1.368 1.373 0 CA-C-N 111.704 -2.498 . . . . 0.56999999999999995 106.482 -172.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.7 t -79.51 146.05 32.88 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 119.804 -1.81 . . . . 0.56999999999999995 109.325 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.82 90.18 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 114.704 -1.134 . . . . 0.56999999999999995 109.264 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.58 -39.35 90.86 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.462 -0.79 . . . . 0.91000000000000003 110.852 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -55.0 24.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.91000000000000003 110.871 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.494 ' CD1' HG11 ' A' ' 144' ' ' VAL . 11.8 pt -65.99 -34.84 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 111.166 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.7 mtt-85 -70.05 -31.45 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.927 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.53 56.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.56999999999999995 112.445 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.43 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.94 -44.28 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.56999999999999995 111.149 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.43 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.08 -19.96 61.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.913 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t -73.88 -19.55 60.68 Favored 'General case' 0 C--N 1.391 2.406 0 CA-C-O 126.135 2.874 . . . . 0.56999999999999995 107.782 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -54.97 15.52 Favored 'General case' 0 C--N 1.395 2.57 0 O-C-N 118.49 -2.632 . . . . 0.56999999999999995 108.397 -170.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.13 20.49 14.45 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 112.172 -2.286 . . . . 0.56999999999999995 115.622 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.278 2.864 0 N-CA-C 117.931 1.932 . . . . 0.91000000000000003 117.931 -177.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.568 H401 HG13 ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 110.808 -0.917 . . . . 0.56999999999999995 110.808 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.79 115.01 4.16 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.159 1.906 . . . . 0.56999999999999995 110.05 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 144.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.373 1.598 0 CA-C-N 113.671 -1.604 . . . . 0.56999999999999995 108.296 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -160.23 152.21 20.26 Favored 'General case' 0 C--N 1.384 2.099 0 CA-C-N 113.663 -1.608 . . . . 0.56999999999999995 107.509 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 -132.83 153.58 51.16 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-O 123.835 1.779 . . . . 1.2 107.691 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -48.79 1.73 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-N 112.653 -2.067 . . . . 0.56999999999999995 109.89 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -85.11 -37.47 20.21 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-O 124.226 1.965 . . . . 0.56999999999999995 107.838 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -81.39 122.46 27.52 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.066 -1.425 . . . . 0.56999999999999995 110.882 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.94 138.67 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.163 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 p -131.1 157.27 43.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.139 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.601 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -137.41 159.38 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.874 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -135.08 129.4 33.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.467 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -99.08 124.72 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.145 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . 15.7 t-20 -41.81 -59.41 1.69 Allowed 'General case' 0 C--N 1.384 2.108 0 C-N-CA 117.498 -1.681 . . . . 0.56999999999999995 110.122 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 164.36 35.49 0.0 OUTLIER 'General case' 0 C--N 1.387 2.201 0 O-C-N 126.023 2.077 . . . . 0.56999999999999995 109.521 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 1.7 m-30 80.05 -173.37 0.05 Allowed 'General case' 0 C--N 1.385 2.151 0 N-CA-C 105.36 -2.089 . . . . 0.56999999999999995 105.36 170.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.69 160.72 65.04 Favored Pre-proline 0 C--N 1.369 1.45 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 108.835 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.66 -49.99 1.42 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.315 1.343 . . . . 0.56999999999999995 112.166 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.22 -65.71 0.98 Allowed 'General case' 0 C--N 1.388 2.244 0 N-CA-C 104.726 -2.324 . . . . 0.91000000000000003 104.726 -163.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.0 ttm -59.62 140.9 56.0 Favored 'General case' 0 C--N 1.38 1.912 0 CA-C-O 126.464 3.031 . . . . 0.56999999999999995 110.071 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.496 ' ND2' HH21 ' A' ' 127' ' ' ARG . 0.4 OUTLIER -72.73 139.29 47.08 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 112.698 -2.046 . . . . 0.56999999999999995 109.773 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.496 HH21 ' ND2' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -69.63 -52.13 28.71 Favored 'General case' 0 C--N 1.374 1.658 0 N-CA-C 105.414 -2.069 . . . . 1.2 105.414 -168.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.32 -34.57 57.98 Favored 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.001 -2.363 . . . . 0.91000000000000003 110.877 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.76 -44.01 71.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.91000000000000003 110.931 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.93 -41.5 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.166 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.82 -40.6 92.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.91000000000000003 110.858 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -37.98 81.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.945 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.18 71.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.091 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.3 pt -61.4 -41.47 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.135 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -43.58 97.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 213' ' ' PHE . 2.0 tppt? -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.881 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.8 98.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.092 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 18.7 m-85 -63.7 -36.53 84.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.861 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.2 tp60 -67.71 -39.83 84.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.903 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.441 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 2.3 t -68.72 -34.05 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 111.196 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -84.5 -33.38 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.919 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -73.82 -47.67 36.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.849 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -62.34 -12.05 18.88 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 118.836 -1.145 . . . . 0.56999999999999995 112.877 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.71 0.1 9.71 Favored 'Isoleucine or valine' 0 C--N 1.379 1.882 0 CA-C-N 113.844 -1.525 . . . . 0.56999999999999995 112.675 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.427 HG23 ' CE1' ' A' ' 262' ' ' TYR . 2.1 m -150.53 140.43 13.88 Favored Pre-proline 0 C--N 1.376 1.745 0 CA-C-O 124.234 1.969 . . . . 0.56999999999999995 110.559 -172.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.419 ' HD2' ' CG2' ' A' ' 145' ' ' THR . 45.5 Cg_endo -79.6 63.16 8.7 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.092 1.861 . . . . 0.56999999999999995 114.048 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.39 120.62 9.53 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 105.824 -1.917 . . . . 0.56999999999999995 105.824 -169.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 158.28 34.79 Favored 'General case' 0 C--N 1.382 1.982 0 CA-C-N 113.278 -1.783 . . . . 0.56999999999999995 113.416 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -129.31 136.31 49.87 Favored 'General case' 0 C--N 1.388 2.276 0 CA-C-N 112.68 -2.055 . . . . 0.56999999999999995 109.818 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.98 111.83 3.52 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 124.808 2.242 . . . . 0.56999999999999995 109.163 -175.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tttm -89.34 146.66 24.55 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 114.108 -1.405 . . . . 0.56999999999999995 111.938 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.64 163.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 109.498 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 9.04 13.4 Favored 'General case' 0 C--N 1.382 2.004 0 CA-C-N 113.06 -1.882 . . . . 0.56999999999999995 111.552 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.8 m -145.0 125.97 14.48 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.97 -130.17 10.15 Favored Glycine 0 C--N 1.376 2.785 0 N-CA-C 109.389 -1.484 . . . . 0.56999999999999995 109.389 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.5 ttp -150.66 146.95 26.81 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.986 1.375 . . . . 0.56999999999999995 107.303 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.35 177.06 6.97 Favored 'General case' 0 C--N 1.373 1.59 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 109.695 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -65.23 -68.18 0.38 Allowed 'General case' 0 C--N 1.378 1.846 0 N-CA-C 104.69 -2.337 . . . . 0.91000000000000003 104.69 -168.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.0 mp -92.87 110.26 22.8 Favored 'Isoleucine or valine' 0 C--N 1.378 1.805 0 O-C-N 124.649 1.218 . . . . 0.56999999999999995 111.098 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 121.81 46.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.48 116.95 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.56999999999999995 111.136 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.5 m -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.152 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.13 125.71 33.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.887 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.5 169.88 17.1 Favored 'General case' 0 C--N 1.369 1.445 0 C-N-CA 117.898 -1.521 . . . . 0.56999999999999995 107.675 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 168.29 9.42 Favored 'General case' 0 C--N 1.367 1.343 0 CA-C-N 114.2 -1.363 . . . . 1.2 108.608 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -44.6 132.81 7.35 Favored Glycine 0 C--N 1.377 2.856 0 O-C-N 124.933 1.396 . . . . 0.56999999999999995 111.82 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.99 105.39 0.06 Allowed 'General case' 0 C--N 1.401 2.822 0 CA-C-O 124.668 2.175 . . . . 0.56999999999999995 112.385 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -173.74 26.08 0.01 OUTLIER 'General case' 0 C--N 1.387 2.206 0 CA-C-O 123.401 1.572 . . . . 0.56999999999999995 111.995 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.8 176.66 51.34 Favored Glycine 0 C--N 1.378 2.887 0 C-N-CA 118.79 -1.671 . . . . 0.56999999999999995 109.606 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.284 0.0 OUTLIER 56.71 17.82 3.37 Favored 'General case' 0 C--N 1.394 2.525 0 CA-C-N 113.39 -1.405 . . . . 0.91000000000000003 114.032 174.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 164.35 133.4 0.01 OUTLIER 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.112 1.911 . . . . 0.56999999999999995 108.161 -160.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -89.18 75.79 7.79 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 112.875 -1.966 . . . . 0.56999999999999995 109.248 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 78.2 132.44 0.05 Allowed 'General case' 0 C--N 1.387 2.225 0 CA-C-O 123.328 1.537 . . . . 0.56999999999999995 109.873 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -117.19 -165.79 1.11 Allowed 'General case' 0 C--N 1.386 2.185 0 CA-C-N 113.146 -1.843 . . . . 0.56999999999999995 111.353 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.27 159.8 16.35 Favored 'General case' 0 C--N 1.38 1.913 0 CA-C-N 114.45 -1.25 . . . . 0.91000000000000003 109.849 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -136.52 62.28 0.6 Allowed Glycine 0 C--N 1.378 2.895 0 CA-C-O 123.869 1.816 . . . . 0.56999999999999995 110.095 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -166.66 -35.53 0.03 OUTLIER 'General case' 0 C--N 1.376 1.736 0 CA-C-N 113.23 -1.485 . . . . 0.56999999999999995 112.713 169.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.48 -63.68 0.04 OUTLIER Glycine 0 C--N 1.37 2.457 0 C-N-CA 119.567 -1.301 . . . . 0.56999999999999995 113.003 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 180' ' ' ILE . . . -35.88 112.39 0.12 Allowed Glycine 0 C--N 1.375 2.729 0 N-CA-C 109.241 -1.544 . . . . 0.56999999999999995 109.241 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.591 ' HA ' H401 ' A' ' 269' ' ' HSI . 0.5 OUTLIER 88.91 52.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.889 0 O-C-N 119.217 -2.343 . . . . 0.56999999999999995 108.559 175.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.462 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 2.5 tp -43.11 -30.91 0.49 Allowed 'General case' 0 C--N 1.375 1.697 0 CA-C-O 123.797 1.76 . . . . 0.56999999999999995 112.083 -174.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -179.49 179.78 0.58 Allowed 'General case' 0 C--N 1.368 1.41 0 CA-C-N 113.229 -1.805 . . . . 0.56999999999999995 111.123 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.592 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -142.56 164.67 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.837 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.79 140.87 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -89.93 152.49 21.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 117.816 -1.554 . . . . 0.56999999999999995 109.449 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -92.54 -42.17 4.59 Favored Glycine 0 C--N 1.373 2.595 0 CA-C-N 114.417 -1.265 . . . . 0.56999999999999995 113.623 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 50.7 Cg_exo -63.53 -143.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.401 3.32 0 CA-C-O 125.953 2.397 . . . . 0.56999999999999995 111.676 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -151.47 -148.31 4.78 Favored Glycine 0 C--N 1.376 2.755 0 C-N-CA 117.493 -2.289 . . . . 0.56999999999999995 109.781 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m 77.76 52.17 0.04 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-N 112.629 -1.785 . . . . 0.56999999999999995 107.512 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.54 -72.73 2.75 Favored Glycine 0 C--N 1.376 2.761 0 N-CA-C 106.919 -2.473 . . . . 0.56999999999999995 106.919 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.12 -48.2 63.48 Favored 'Isoleucine or valine' 0 C--N 1.374 1.649 0 CA-C-O 125.85 2.738 . . . . 0.56999999999999995 105.515 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.29 153.92 53.03 Favored Glycine 0 C--N 1.378 2.91 0 C-N-CA 116.282 -2.866 . . . . 0.56999999999999995 108.351 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.23 22.46 Favored Glycine 0 C--N 1.372 2.549 0 CA-C-O 124.178 1.988 . . . . 0.56999999999999995 113.305 -173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.07 146.38 53.54 Favored 'General case' 0 C--N 1.374 1.636 0 O-C-N 120.287 -1.714 . . . . 0.91000000000000003 110.833 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 183' ' ' HIS . . . -144.04 137.36 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.56999999999999995 111.098 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 1.1 m170 -128.39 150.17 50.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.791 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.3 OUTLIER -123.11 150.19 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.48 112.62 14.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.799 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -43.5 88.54 Favored 'General case' 0 C--N 1.383 2.053 0 CA-C-O 117.436 -1.268 . . . . 0.91000000000000003 108.966 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.74 -32.85 0.65 Allowed 'General case' 0 C--N 1.38 1.9 0 O-C-N 125.646 1.841 . . . . 0.91000000000000003 108.959 -173.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.96 176.1 0.44 Allowed 'General case' 0 C--N 1.384 2.072 0 CA-C-O 126.535 3.064 . . . . 0.91000000000000003 109.216 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.91 80.5 1.33 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-N 112.615 -2.084 . . . . 0.56999999999999995 109.016 -175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.462 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 79.6 m95 -76.13 109.14 9.54 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 106.977 -1.49 . . . . 0.56999999999999995 106.977 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.57 121.88 31.75 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-O 125.149 2.404 . . . . 0.56999999999999995 109.869 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.2 p -96.99 151.27 19.87 Favored 'General case' 0 C--N 1.368 1.395 0 N-CA-C 106.198 -1.778 . . . . 0.56999999999999995 106.198 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.65 -48.55 0.23 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 114.316 -1.311 . . . . 0.56999999999999995 109.915 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.3 m -168.78 137.98 2.21 Favored 'General case' 0 C--N 1.384 2.092 0 N-CA-C 108.05 -1.093 . . . . 0.56999999999999995 108.05 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 148.2 -36.92 1.09 Allowed Glycine 0 C--N 1.382 3.122 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 111.671 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 148.82 -84.16 0.17 Allowed Glycine 0 C--N 1.386 3.344 0 CA-C-O 123.801 1.778 . . . . 0.56999999999999995 111.686 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.0 p -78.7 135.94 37.3 Favored 'General case' 0 C--N 1.383 2.025 0 CA-C-N 113.079 -1.56 . . . . 0.56999999999999995 110.964 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.71 141.39 52.14 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 113.949 -1.478 . . . . 0.56999999999999995 108.011 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.15 -26.74 63.13 Favored 'General case' 0 C--N 1.387 2.225 0 CA-C-O 125.086 2.374 . . . . 0.56999999999999995 108.576 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 3.5 t80 -57.6 -50.15 74.08 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-N 113.862 -1.517 . . . . 0.56999999999999995 110.855 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.424 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.2 OUTLIER -61.61 -51.22 69.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.933 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -44.41 97.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.423 ' HA ' ' OE2' ' A' ' 219' ' ' GLU . . . -57.08 -41.36 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.079 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.42 -39.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 111.096 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.458 ' CD2' ' CE ' ' A' ' 236' ' ' MET . 3.7 t-160 -70.08 -50.51 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.802 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 216' ' ' ALA . 0.7 OUTLIER -64.08 -42.02 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.91000000000000003 110.902 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.01 -34.22 62.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 111.113 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.19 -33.48 73.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.699 -0.762 . . . . 0.56999999999999995 112.444 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.59 -44.02 95.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 110.842 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.24 -49.96 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 13.48 5.02 Favored 'General case' 0 C--N 1.392 2.441 0 CA-C-O 123.595 1.664 . . . . 0.56999999999999995 115.324 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -153.12 176.93 31.02 Favored Glycine 0 C--N 1.363 2.04 0 CA-C-O 126.635 3.353 . . . . 0.56999999999999995 108.167 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -158.93 0.23 Allowed 'General case' 0 C--N 1.367 1.337 0 CA-C-O 125.873 2.749 . . . . 0.56999999999999995 109.278 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.78 -143.18 0.11 Allowed Glycine 0 C--N 1.387 3.411 0 CA-C-O 125.524 2.736 . . . . 0.56999999999999995 112.311 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 236' ' ' MET . 34.0 m170 -83.83 -175.29 5.74 Favored 'General case' 0 C--N 1.379 1.861 0 O-C-N 120.444 -1.621 . . . . 0.56999999999999995 114.609 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.11 -84.46 0.4 Allowed 'General case' 0 C--N 1.389 2.308 0 N-CA-C 106.448 -1.686 . . . . 0.56999999999999995 106.448 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 m 155.81 -30.25 0.0 OUTLIER 'General case' 0 C--N 1.389 2.29 0 O-C-N 125.842 1.964 . . . . 0.56999999999999995 113.168 -167.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -110.2 152.07 42.95 Favored Pre-proline 0 C--N 1.388 2.282 0 N-CA-C 108.291 -1.003 . . . . 0.91000000000000003 108.291 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -60.7 -47.83 12.48 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.687 2.258 . . . . 0.56999999999999995 111.92 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.42 22.79 Favored 'General case' 0 C--N 1.381 1.948 0 CA-C-N 113.252 -1.794 . . . . 0.56999999999999995 115.284 176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.46 120.11 16.57 Favored 'General case' 0 C--N 1.375 1.674 0 CA-C-O 125.158 2.408 . . . . 0.56999999999999995 113.0 173.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 236' ' ' MET . 68.2 t -73.93 86.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.867 0 CA-C-N 111.446 -2.615 . . . . 0.56999999999999995 108.612 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 218' ' ' HIS . 0.0 OUTLIER 162.06 -34.28 0.0 OUTLIER 'General case' 0 C--N 1.377 1.802 0 O-C-N 125.37 1.669 . . . . 0.56999999999999995 109.273 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 4.4 t80 -49.97 146.96 7.33 Favored Pre-proline 0 C--N 1.372 1.579 0 CA-C-O 122.971 1.367 . . . . 0.56999999999999995 110.223 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 74.0 Cg_exo -56.53 -36.99 98.27 Favored 'Trans proline' 0 C--N 1.393 2.904 0 C-N-CA 122.219 1.946 . . . . 0.56999999999999995 112.406 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -45.39 111.79 0.38 Allowed 'General case' 0 C--N 1.376 1.741 0 CA-C-O 123.633 1.683 . . . . 0.56999999999999995 110.642 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -83.92 94.62 8.29 Favored 'General case' 0 C--N 1.38 1.914 0 CA-C-O 124.385 2.041 . . . . 0.56999999999999995 106.431 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.677 ' HB3' ' H35' ' A' ' 269' ' ' HSI . 1.2 tmtt? -110.84 119.41 39.01 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 108.124 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -55.6 120.91 7.96 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-O 126.105 2.859 . . . . 0.56999999999999995 110.991 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.79 115.23 5.88 Favored 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 105.86 -1.904 . . . . 0.56999999999999995 105.86 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -77.3 33.46 0.16 Allowed 'General case' 0 C--N 1.364 1.239 0 N-CA-C 114.885 1.439 . . . . 0.91000000000000003 114.885 170.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.472 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.5 mt 82.94 -2.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.382 1.987 0 CA-C-O 124.145 1.926 . . . . 0.56999999999999995 108.713 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -88.5 -35.48 16.96 Favored 'General case' 0 C--N 1.38 1.904 0 N-CA-C 103.016 -2.957 . . . . 0.56999999999999995 103.016 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.464 ' O ' 'CL1 ' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -113.27 3.47 15.97 Favored 'General case' 0 C--N 1.387 2.229 0 CA-C-N 113.47 -1.695 . . . . 0.56999999999999995 109.778 -173.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.72 12.06 3.43 Favored 'General case' 0 C--N 1.386 2.195 0 O-C-N 125.754 1.909 . . . . 0.56999999999999995 109.86 -171.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 154.07 12.02 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 124.724 2.202 . . . . 1.2 107.778 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.07 126.97 52.08 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 103.676 -2.713 . . . . 0.56999999999999995 103.676 -167.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.03 140.53 48.79 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-O 124.883 2.278 . . . . 0.56999999999999995 116.323 169.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.47 86.83 Favored 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.689 -1.596 . . . . 0.56999999999999995 110.184 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.22 -33.12 74.69 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.994 -1.003 . . . . 0.91000000000000003 110.863 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -55.23 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.91000000000000003 110.901 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.144 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -70.17 -32.95 71.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.92 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.7 -48.0 58.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.56999999999999995 112.495 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.467 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.3 pt -62.42 -45.8 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.56999999999999995 111.1 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.467 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.1 pt20 -72.53 -19.11 61.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 110.954 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -15.13 63.23 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 122.575 1.178 . . . . 0.56999999999999995 110.687 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.05 -52.58 6.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-O 123.618 1.675 . . . . 0.56999999999999995 111.986 176.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.427 ' CE1' HG23 ' A' ' 145' ' ' THR . 0.1 OUTLIER -103.82 90.26 3.58 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-N 113.866 -1.515 . . . . 0.56999999999999995 111.311 -173.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.386 3.31 0 N-CA-C 121.243 3.257 . . . . 0.91000000000000003 121.243 -171.501 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.677 ' H35' ' HB3' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.17 0 N-CA-C 111.338 -0.705 . . . . 0.56999999999999995 111.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.52 143.39 42.53 Favored 'Trans proline' 0 C--N 1.376 1.992 0 O-C-N 123.291 1.153 . . . . 0.56999999999999995 110.997 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.77 120.38 55.78 Favored 'Isoleucine or valine' 0 C--N 1.382 1.98 0 CA-C-N 113.466 -1.697 . . . . 0.56999999999999995 108.295 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -130.87 -9.36 3.92 Favored 'General case' 0 C--N 1.384 2.072 0 CA-C-N 112.883 -1.962 . . . . 0.56999999999999995 111.127 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.89 172.19 7.41 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 114.817 -1.083 . . . . 1.2 110.942 175.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 60.14 176.94 0.09 Allowed 'General case' 0 C--N 1.399 2.746 0 CA-C-N 113.407 -1.724 . . . . 0.56999999999999995 110.471 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.27 -84.99 0.03 OUTLIER 'General case' 0 C--N 1.387 2.224 0 CA-C-N 114.23 -1.35 . . . . 0.56999999999999995 110.323 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -117.49 107.08 13.87 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.44 1.713 . . . . 0.56999999999999995 110.933 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -103.0 147.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.149 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -109.79 134.96 51.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.145 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.507 ' CD2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -143.87 155.61 44.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.892 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -142.43 139.4 31.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.851 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.08 142.97 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.118 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 163' ' ' PHE . 22.9 t30 -54.07 -63.87 1.01 Allowed 'General case' 0 C--N 1.366 1.29 0 N-CA-C 108.433 -0.951 . . . . 0.56999999999999995 108.433 -171.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.45 -172.01 3.2 Favored 'General case' 0 C--N 1.38 1.916 0 N-CA-C 107.398 -1.334 . . . . 0.56999999999999995 107.398 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -176.96 82.57 0.02 OUTLIER 'General case' 0 C--N 1.39 2.327 0 CA-C-O 124.419 2.057 . . . . 0.56999999999999995 113.653 -172.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 125' ' ' MET . 0.5 OUTLIER -171.71 -56.28 0.0 OUTLIER Pre-proline 0 C--N 1.372 1.574 0 O-C-N 119.894 -1.753 . . . . 0.56999999999999995 110.167 -174.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -69.9 -55.31 0.18 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 N-CA-C 107.932 -1.603 . . . . 0.56999999999999995 107.932 -171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -129.46 -12.07 4.47 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 114.221 -1.354 . . . . 0.91000000000000003 110.921 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -114.19 128.08 56.2 Favored 'General case' 0 C--N 1.38 1.907 0 CA-C-O 124.638 2.161 . . . . 0.56999999999999995 106.798 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.02 144.56 25.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.446 -2.659 . . . . 0.56999999999999995 110.256 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -53.49 8.27 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 106.409 -1.701 . . . . 1.2 106.409 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.54 -37.69 88.42 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-N 114.222 -1.354 . . . . 0.91000000000000003 110.934 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -70.2 -44.06 69.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.91000000000000003 110.896 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.22 -46.28 77.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.095 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -56.82 -44.16 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.839 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -39.6 90.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.37 -49.07 70.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.56999999999999995 111.141 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.4 pt -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.172 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -49.32 77.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -35.66 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.88 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.41 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.133 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 149' ' ' PHE . 1.8 m-85 -67.25 -33.67 75.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.835 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.474 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.6 pt20 -68.44 -40.72 81.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.912 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.471 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 5.2 p -70.53 -34.35 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.168 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.418 ' CD1' HD22 ' A' ' 224' ' ' LEU . 4.4 m95 -83.25 -33.72 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.6 m -78.26 -50.55 11.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.898 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -56.59 -13.88 2.75 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 113.278 0.844 . . . . 0.56999999999999995 113.278 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.429 HG13 ' ND2' ' A' ' 143' ' ' ASN . 18.2 m -114.52 9.11 7.7 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 CA-C-N 114.541 -1.209 . . . . 0.56999999999999995 111.451 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.2 p -149.23 147.17 22.78 Favored Pre-proline 0 C--N 1.373 1.594 0 CA-C-O 124.599 2.142 . . . . 0.56999999999999995 108.484 -173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.85 22.07 1.0 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 121.544 1.496 . . . . 0.56999999999999995 113.056 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.91 101.03 6.15 Favored 'General case' 0 C--N 1.378 1.829 0 N-CA-C 105.619 -1.993 . . . . 0.56999999999999995 105.619 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.27 159.59 30.98 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-O 126.77 3.176 . . . . 0.56999999999999995 116.263 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . 45.6 m-85 -132.19 162.64 30.42 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.533 -2.122 . . . . 0.56999999999999995 107.396 -177.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.3 m -157.67 123.33 4.62 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 125.859 2.742 . . . . 0.56999999999999995 108.394 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -95.97 141.48 29.34 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 110.972 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.93 159.55 41.85 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-O 124.276 1.988 . . . . 0.56999999999999995 108.986 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.4 -15.01 14.56 Favored 'General case' 0 C--N 1.384 2.097 0 CA-C-N 113.117 -1.856 . . . . 0.56999999999999995 107.807 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 89.3 m -60.22 -59.8 4.83 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 123.343 1.544 . . . . 0.56999999999999995 107.373 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.93 146.16 4.9 Favored Glycine 0 C--N 1.38 2.997 0 N-CA-C 110.539 -1.024 . . . . 0.56999999999999995 110.539 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.6 ttp 78.79 88.59 0.06 Allowed 'General case' 0 C--N 1.399 2.758 0 CA-C-O 124.465 2.078 . . . . 0.56999999999999995 110.075 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -133.9 172.16 13.18 Favored 'General case' 0 C--N 1.373 1.622 0 CA-C-N 113.158 -1.837 . . . . 0.56999999999999995 109.718 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 115' ' ' THR . 33.1 m-20 -61.15 -59.4 5.39 Favored 'General case' 0 C--N 1.37 1.469 0 N-CA-C 105.836 -1.913 . . . . 0.91000000000000003 105.836 -173.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.82 109.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.388 2.282 0 O-C-N 124.326 1.016 . . . . 0.56999999999999995 111.118 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.8 128.59 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 17.4 t -105.48 118.26 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.087 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.438 ' HB ' ' CD2' ' A' ' 196' ' ' HIS . 6.8 t -131.48 132.16 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.085 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 119' ' ' ASN . 4.2 m-85 -90.61 121.32 32.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.836 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.15 166.57 24.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 107.599 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 167.62 9.76 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 114.19 -1.368 . . . . 1.2 109.888 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -39.45 121.49 1.42 Allowed Glycine 0 C--N 1.395 3.825 0 O-C-N 125.297 1.623 . . . . 0.56999999999999995 111.018 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 87.71 80.9 0.01 OUTLIER 'General case' 0 C--N 1.397 2.653 0 CA-C-O 125.214 2.435 . . . . 0.56999999999999995 109.882 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -140.29 -54.48 0.52 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 113.13 -1.85 . . . . 0.56999999999999995 110.494 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 173.04 -173.15 45.54 Favored Glycine 0 C--N 1.377 2.806 0 N-CA-C 109.091 -1.604 . . . . 0.56999999999999995 109.091 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 78.25 -71.68 0.1 Allowed 'General case' 0 C--N 1.4 2.776 0 CA-C-N 112.642 -1.779 . . . . 0.91000000000000003 107.691 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.5 -166.54 1.33 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 124.647 2.165 . . . . 0.56999999999999995 108.023 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 21.9 m170 -77.99 65.09 3.33 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 114.194 -1.366 . . . . 0.56999999999999995 109.67 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 172' ' ' HIS . . . 78.85 -166.98 0.04 OUTLIER 'General case' 0 C--N 1.387 2.212 0 CA-C-N 114.168 -1.378 . . . . 0.56999999999999995 111.768 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.436 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -124.11 -161.5 1.0 Allowed 'General case' 0 C--N 1.39 2.361 0 CA-C-N 113.01 -1.904 . . . . 0.56999999999999995 111.804 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.61 -54.38 4.3 Favored 'General case' 0 C--N 1.388 2.269 0 CA-C-N 114.676 -1.147 . . . . 0.91000000000000003 111.934 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.03 105.64 0.05 OUTLIER Glycine 0 C--N 1.396 3.87 0 C-N-CA 118.591 -1.766 . . . . 0.56999999999999995 117.317 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.66 90.4 0.09 Allowed 'General case' 0 C--N 1.381 1.967 0 CA-C-O 125.28 2.467 . . . . 0.56999999999999995 112.43 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.29 -144.73 26.09 Favored Glycine 0 C--N 1.381 3.079 0 O-C-N 119.529 -1.982 . . . . 0.56999999999999995 113.453 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.72 -118.96 8.6 Favored Glycine 0 C--N 1.395 3.817 0 N-CA-C 108.39 -1.884 . . . . 0.56999999999999995 108.39 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.418 HG22 H442 ' A' ' 269' ' ' HSI . 0.6 OUTLIER -76.57 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.706 0 N-CA-C 105.94 -1.874 . . . . 0.56999999999999995 105.94 -175.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.432 ' CD2' ' CE1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -38.23 -33.94 0.11 Allowed 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.881 -175.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -178.41 179.95 0.73 Allowed 'General case' 0 C--N 1.383 2.057 0 O-C-N 125.727 1.892 . . . . 0.56999999999999995 111.081 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.456 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -151.03 151.01 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.865 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -142.81 140.36 31.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.063 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.1 OUTLIER -87.64 124.24 33.33 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 118.323 -1.351 . . . . 0.56999999999999995 108.715 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -124.48 50.19 0.87 Allowed Glycine 0 C--N 1.371 2.476 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 113.579 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 33.9 Cg_endo -76.49 -52.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 121.217 1.278 . . . . 0.56999999999999995 109.765 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.17 47.36 0.71 Allowed Glycine 0 C--N 1.392 3.642 0 CA-C-O 123.759 1.755 . . . . 0.56999999999999995 111.869 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -155.02 -147.79 0.22 Allowed 'General case' 0 C--N 1.384 2.065 0 O-C-N 121.074 -1.251 . . . . 0.56999999999999995 108.732 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -55.85 -79.19 0.1 OUTLIER Glycine 0 C--N 1.388 3.466 0 CA-C-O 126.105 3.058 . . . . 0.56999999999999995 112.531 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -11.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.387 2.232 0 CA-C-O 124.823 2.249 . . . . 0.56999999999999995 110.362 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.06 126.51 22.71 Favored Glycine 0 C--N 1.37 2.446 0 O-C-N 118.292 -2.755 . . . . 0.56999999999999995 111.829 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 108.93 -50.14 0.8 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 113.527 -1.336 . . . . 0.56999999999999995 111.985 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -34.92 102.7 0.02 OUTLIER 'General case' 0 C--N 1.379 1.877 0 O-C-N 124.649 0.852 . . . . 0.91000000000000003 110.901 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -116.52 150.32 38.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.068 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.438 ' CD2' ' HB ' ' A' ' 162' ' ' VAL . 19.5 m170 -135.03 139.16 44.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 110.854 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.4 OUTLIER -111.09 150.11 29.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 110.903 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.31 110.82 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.788 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.91 -20.66 52.47 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-O 126.423 3.011 . . . . 0.91000000000000003 108.555 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -12.38 60.27 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 118.3 -2.75 . . . . 0.91000000000000003 110.712 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.05 -179.63 7.47 Favored 'General case' 0 C--N 1.398 2.678 0 N-CA-C 102.651 -3.092 . . . . 0.91000000000000003 102.651 -168.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.98 82.05 1.59 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.346 -1.752 . . . . 0.56999999999999995 110.624 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.464 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 60.5 m95 -72.51 102.93 3.35 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 123.788 1.756 . . . . 0.56999999999999995 108.754 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.35 130.82 35.44 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 113.762 -1.563 . . . . 0.56999999999999995 110.953 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.7 p -119.02 101.24 7.88 Favored 'General case' 0 C--N 1.385 2.135 0 CA-C-N 113.034 -1.894 . . . . 0.56999999999999995 107.752 -175.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 77.6 36.73 0.26 Allowed 'General case' 0 C--N 1.403 2.9 0 CA-C-O 126.039 2.828 . . . . 0.56999999999999995 104.863 168.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 t -138.07 -92.22 0.21 Allowed 'General case' 0 C--N 1.391 2.406 0 CA-C-N 112.716 -2.038 . . . . 0.56999999999999995 109.053 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.58 156.39 24.0 Favored Glycine 0 C--N 1.38 3.022 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 110.541 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.24 -136.44 13.01 Favored Glycine 0 C--N 1.369 2.412 0 CA-C-O 124.126 1.959 . . . . 0.56999999999999995 111.242 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.9 m -69.08 117.54 10.86 Favored 'General case' 0 C--N 1.384 2.078 0 CA-C-O 123.317 1.532 . . . . 0.56999999999999995 112.517 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.92 153.91 19.74 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.311 1.529 . . . . 0.56999999999999995 111.603 176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.72 -31.45 64.98 Favored 'General case' 0 C--N 1.389 2.324 0 CA-C-N 113.347 -1.752 . . . . 0.56999999999999995 106.653 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . 0.477 ' O ' ' CG2' ' A' ' 217' ' ' VAL . 1.6 t80 -59.04 -50.46 73.99 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.086 -1.634 . . . . 0.56999999999999995 110.859 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.725 ' CD1' ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -58.19 -51.83 68.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.906 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -33.96 75.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.178 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 219' ' ' GLU . . . -68.83 -39.48 79.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.56999999999999995 111.114 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 213' ' ' PHE . 41.4 t -68.1 -38.46 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 111.154 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -70.06 -50.85 37.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.56999999999999995 110.837 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -56.6 -45.19 81.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.91000000000000003 110.913 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 217' ' ' VAL . 5.5 pt -72.73 -39.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 111.075 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.03 -33.88 64.92 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.474 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.86 -44.02 94.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.56999999999999995 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -50.24 55.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.828 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.418 HD22 ' CD1' ' A' ' 141' ' ' TRP . 3.4 pp -75.82 0.6 17.51 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.954 2.576 . . . . 0.56999999999999995 117.954 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -145.73 -158.79 7.86 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 -173.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.28 -156.73 0.76 Allowed 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 107.678 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -55.93 -167.21 0.06 OUTLIER Glycine 0 C--N 1.397 3.951 0 CA-C-O 125.717 2.843 . . . . 0.56999999999999995 112.486 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.5 m80 -100.28 -150.31 0.38 Allowed 'General case' 0 C--N 1.37 1.484 0 O-C-N 120.387 -1.654 . . . . 0.56999999999999995 110.225 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.1 p -122.39 -24.24 5.05 Favored 'General case' 0 C--N 1.387 2.219 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 110.493 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 83.06 16.43 0.31 Allowed 'General case' 0 C--N 1.398 2.704 0 CA-C-O 123.2 1.476 . . . . 0.56999999999999995 113.21 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -134.29 150.28 73.59 Favored Pre-proline 0 C--N 1.386 2.18 0 N-CA-C 104.818 -2.29 . . . . 0.91000000000000003 104.818 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -56.6 -20.58 34.81 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.091 2.527 . . . . 0.56999999999999995 114.036 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -40.29 85.09 Favored 'General case' 0 C--N 1.385 2.142 0 CA-C-N 113.329 -1.76 . . . . 0.56999999999999995 115.628 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -51.79 128.33 23.43 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 123.86 1.79 . . . . 0.56999999999999995 110.716 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -75.52 2.48 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.126 0 CA-C-O 125.38 2.514 . . . . 0.56999999999999995 111.53 -177.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.496 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 5.7 ptm -142.31 8.19 1.79 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 120.422 -1.424 . . . . 0.56999999999999995 110.188 -175.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.746 ' HE1' ' C26' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -42.79 143.96 1.11 Allowed Pre-proline 0 C--N 1.37 1.459 0 CA-C-O 124.097 1.903 . . . . 0.56999999999999995 112.844 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.413 ' O ' ' H14' ' A' ' 269' ' ' HSI . 71.9 Cg_exo -51.92 -50.31 14.41 Favored 'Trans proline' 0 C--N 1.371 1.728 0 O-C-N 119.481 -0.852 . . . . 0.56999999999999995 112.351 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.501 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -52.46 126.46 19.45 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-O 123.318 1.532 . . . . 0.56999999999999995 109.669 -175.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.531 ' CE1' HD23 ' A' ' 214' ' ' LEU . 78.4 t80 -99.28 166.57 11.15 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 119.959 -1.713 . . . . 0.56999999999999995 107.833 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 169.36 121.45 0.01 OUTLIER 'General case' 0 C--N 1.39 2.352 0 N-CA-C 106.058 -1.83 . . . . 0.56999999999999995 106.058 173.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.85 121.6 6.19 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.882 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.38 113.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.741 -1.572 . . . . 0.56999999999999995 107.702 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -44.65 146.0 0.81 Allowed 'General case' 0 C--N 1.383 2.044 0 CA-C-O 125.737 2.684 . . . . 0.91000000000000003 107.719 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.464 ' CG1' ' CD1' ' A' ' 213' ' ' PHE . 3.9 mp -62.03 -22.87 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-N 113.319 -1.764 . . . . 0.56999999999999995 112.603 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.66 -21.93 66.63 Favored 'General case' 0 C--N 1.372 1.585 0 CA-C-O 123.034 1.397 . . . . 0.56999999999999995 111.397 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.6 p -108.36 1.11 21.58 Favored 'General case' 0 C--N 1.385 2.134 0 N-CA-C 114.904 1.446 . . . . 0.56999999999999995 114.904 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 235' ' ' VAL . 51.3 t80 -74.47 83.84 1.99 Allowed 'General case' 0 C--N 1.376 1.725 0 CA-C-O 124.973 2.32 . . . . 0.56999999999999995 109.292 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.448 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 1.6 tmt_? -99.32 154.79 17.91 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-O 123.813 1.768 . . . . 1.2 108.913 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -121.84 136.1 54.92 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 106.246 -173.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 42.5 m -67.67 137.65 55.73 Favored 'General case' 0 C--N 1.376 1.719 0 CA-C-N 113.305 -1.771 . . . . 0.56999999999999995 111.627 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.08 -46.36 81.45 Favored 'General case' 0 C--N 1.384 2.099 0 N-CA-C 108.055 -1.091 . . . . 0.56999999999999995 108.055 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.71 -36.81 79.76 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 115.41 -0.814 . . . . 0.91000000000000003 110.845 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.46 -55.22 25.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.91000000000000003 110.846 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.3 pt -66.09 -36.38 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.116 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.419 ' HA ' ' CG ' ' A' ' 259' ' ' GLN . 4.3 mtt-85 -70.32 -33.33 71.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.828 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.86 76.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.56999999999999995 112.48 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.497 ' CG1' ' N ' ' A' ' 259' ' ' GLN . 1.2 pt -64.81 -45.05 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.685 0.279 . . . . 0.56999999999999995 111.052 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.497 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.14 -23.5 61.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.981 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 t -71.03 -32.55 69.33 Favored 'General case' 0 C--N 1.366 1.302 0 CA-C-O 122.403 1.096 . . . . 0.56999999999999995 109.785 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.42 -66.19 0.44 Allowed 'General case' 0 C--N 1.387 2.208 0 CA-C-O 123.416 1.579 . . . . 0.56999999999999995 109.608 -175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.4 116.56 32.15 Favored 'General case' 0 C--N 1.377 1.801 0 CA-C-N 113.718 -1.583 . . . . 0.56999999999999995 111.761 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.383 3.193 0 CA-C-O 114.817 -3.213 . . . . 0.91000000000000003 118.048 -171.573 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' HSI . . . . . 0.746 ' C26' ' HE1' ' A' ' 237' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 mtt-85 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 123.146 1.451 . . . . 1.2 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 52.57 0.48 Allowed 'General case' 0 C--N 1.379 1.87 0 CA-C-O 123.553 1.644 . . . . 0.57 108.179 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -168.96 -55.39 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.219 -1.355 . . . . 0.57 109.321 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -98.62 112.13 24.28 Favored 'General case' 0 C--N 1.371 1.515 0 O-C-N 124.006 0.816 . . . . 0.57 110.934 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 158' ' ' ASP . 1.2 mm -111.72 151.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.57 111.062 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -106.0 159.77 15.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.57 111.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.477 ' OH ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -148.59 150.51 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.57 110.92 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -142.8 132.91 24.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 1.2 110.889 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.97 140.46 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.57 111.147 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 121' ' ' TYR . 4.3 t30 -66.87 -160.88 0.02 OUTLIER 'General case' 0 C--N 1.379 1.883 0 CA-C-O 124.362 2.03 . . . . 0.57 109.718 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.32 39.38 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 O-C-N 118.572 -2.58 . . . . 0.57 111.069 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.505 ' C ' HG23 ' A' ' 122' ' ' THR . 9.2 m-85 59.33 16.8 5.32 Favored 'General case' 0 C--N 1.386 2.161 0 O-C-N 124.362 1.039 . . . . 0.57 110.083 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.631 HG22 ' CZ ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER 65.98 158.18 0.13 Allowed Pre-proline 0 C--N 1.367 1.331 0 O-C-N 128.217 3.448 . . . . 0.57 109.793 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.44 -43.65 0.35 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 O-C-N 118.265 -1.492 . . . . 0.57 112.145 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -63.71 1.18 Allowed 'General case' 0 C--N 1.371 1.509 0 C-N-CA 125.209 1.404 . . . . 0.91 113.471 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.414 ' HE2' ' CD2' ' A' ' 203' ' ' TRP . 4.1 ttm -42.64 132.44 3.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 128.035 3.779 . . . . 0.57 110.336 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.759 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.6 m120 -78.06 143.4 37.46 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.038 -2.289 . . . . 0.57 107.97 -172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -46.59 47.06 Favored 'General case' 0 C--N 1.38 1.903 0 N-CA-C 107.03 -1.47 . . . . 1.2 107.03 -164.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -54.75 -34.78 62.99 Favored 'General case' 0 C--N 1.396 2.602 0 CA-C-N 111.428 -2.624 . . . . 0.91 110.927 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 205' ' ' THR . 1.4 m-20 -70.11 -43.71 70.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.91 110.933 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -63.62 -39.07 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.174 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.13 87.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.91 110.89 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -67.32 -49.05 65.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.57 110.929 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.12 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.57 111.101 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.44 -31.94 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.57 111.17 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -67.93 -46.78 70.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CD ' ' OE1' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.56 -46.05 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.926 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.89 80.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.57 111.061 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 -44.11 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.57 110.902 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.433 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 2.0 pt20 -63.75 -37.05 85.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.57 110.91 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -69.47 -34.01 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.57 111.13 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 145' ' ' THR . 49.6 m95 -82.97 -34.3 26.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.57 110.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -49.36 13.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.875 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.631 ' OD1' HG13 ' A' ' 144' ' ' VAL . 6.0 p-10 -59.51 -12.71 6.83 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-O 121.429 0.633 . . . . 0.57 112.352 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 258' ' ' ILE . 23.8 m -115.63 16.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 C-N-CA 124.027 0.931 . . . . 0.57 109.531 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 141' ' ' TRP . 75.2 p -146.01 150.69 43.04 Favored Pre-proline 0 C--N 1.367 1.362 0 CA-C-O 124.642 2.163 . . . . 0.57 107.474 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -80.38 -11.01 13.31 Favored 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-O 123.027 1.178 . . . . 0.57 111.072 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.75 113.19 26.62 Favored 'General case' 0 C--N 1.371 1.529 0 N-CA-C 103.85 -2.648 . . . . 0.57 103.85 -172.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.52 158.4 36.32 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-O 125.213 2.435 . . . . 0.57 117.177 166.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.638 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 9.6 m-85 -131.15 158.8 39.49 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.573 -1.649 . . . . 0.57 107.439 -174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 125.57 5.96 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-O 124.29 1.995 . . . . 0.57 106.956 -171.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 150.08 20.95 Favored 'General case' 0 C--N 1.367 1.363 0 CA-C-O 123.335 1.54 . . . . 0.57 109.736 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 pt -144.15 -178.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.552 0 CA-C-O 123.618 1.675 . . . . 0.57 108.919 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 154' ' ' THR . 26.3 t30 -155.09 54.59 0.64 Allowed 'General case' 0 C--N 1.379 1.89 0 CA-C-N 113.917 -1.492 . . . . 0.57 107.949 -175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -161.4 -69.27 0.06 Allowed 'General case' 0 C--N 1.377 1.781 0 C-N-CA 119.955 -0.698 . . . . 0.57 109.813 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -86.05 173.64 46.88 Favored Glycine 0 C--N 1.372 2.569 0 CA-C-O 124.161 1.978 . . . . 0.57 110.38 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.2 ttt -63.66 154.4 33.07 Favored 'General case' 0 C--N 1.377 1.782 0 CA-C-N 112.331 -1.935 . . . . 0.57 107.81 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . . . -137.59 170.92 15.25 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 113.721 -1.582 . . . . 0.57 109.636 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 114' ' ' ILE . 3.0 m-20 -83.67 -67.8 0.76 Allowed 'General case' 0 C--N 1.379 1.877 0 N-CA-C 102.255 -3.239 . . . . 0.91 102.255 -168.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 223' ' ' SER . 56.9 mt -92.51 109.9 22.17 Favored 'Isoleucine or valine' 0 C--N 1.402 2.871 0 O-C-N 124.544 1.153 . . . . 0.57 111.087 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -105.45 132.11 52.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.918 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 197' ' ' PHE . 72.5 t -109.84 117.02 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.57 111.143 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.61 146.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.57 111.137 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.631 ' CZ ' HG22 ' A' ' 122' ' ' THR . 57.1 m-85 -103.74 118.48 36.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.57 110.833 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.25 167.59 23.12 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-O 124.109 1.909 . . . . 0.57 109.69 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 149.29 24.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.426 -2.046 . . . . 1.2 108.524 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.78 121.05 1.83 Allowed Glycine 0 C--N 1.375 2.738 0 CA-C-N 113.349 -1.751 . . . . 0.57 110.861 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -178.21 -57.8 0.01 OUTLIER 'General case' 0 C--N 1.379 1.878 0 CA-C-O 123.028 1.394 . . . . 0.57 108.396 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--N 1.389 2.286 0 CA-C-O 123.266 1.507 . . . . 0.57 109.732 -174.015 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.948 0 CA-C-O 122.616 1.198 . . . . 0.57 111.44 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -57.44 -97.52 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 123.986 1.85 . . . . 0.57 112.894 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.48 178.36 4.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 125.25 2.452 . . . . 0.91 110.324 173.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -150.87 35.53 0.92 Allowed Glycine 0 C--N 1.372 2.561 0 CA-C-N 112.221 -2.263 . . . . 0.57 112.258 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 14.55 0.14 Allowed 'General case' 0 C--N 1.376 1.76 0 CA-C-O 122.012 0.911 . . . . 0.57 112.541 -175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.56 -143.46 10.2 Favored Glycine 0 C--N 1.364 2.097 0 CA-C-O 122.515 1.064 . . . . 0.57 110.801 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.93 -130.99 47.61 Favored Glycine 0 C--N 1.36 1.881 0 O-C-N 119.994 -1.886 . . . . 0.57 111.194 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 174' ' ' PHE . 1.0 OUTLIER -54.41 163.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.517 0 CA-C-N 113.065 -1.568 . . . . 0.57 108.866 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 210' ' ' THR . 11.2 mt -111.4 -40.29 4.43 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 115.527 1.677 . . . . 0.57 115.527 169.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -175.03 179.92 1.49 Allowed 'General case' 0 C--N 1.363 1.177 0 O-C-N 121.278 -0.889 . . . . 0.57 111.111 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.467 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 0.2 OUTLIER -156.34 159.9 39.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.852 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.57 153.06 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.57 111.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -93.85 -177.82 4.47 Favored 'General case' 0 C--N 1.373 1.588 0 CA-C-O 123.052 1.406 . . . . 0.57 109.758 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.58 -158.96 15.92 Favored Glycine 0 C--N 1.378 2.866 0 CA-C-N 114.372 -1.286 . . . . 0.57 112.075 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.39 -139.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.443 2.762 . . . . 0.57 112.169 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.19 -132.4 10.94 Favored Glycine 0 C--N 1.371 2.513 0 O-C-N 119.307 -2.12 . . . . 0.57 108.968 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.66 157.13 31.25 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.817 -1.549 . . . . 0.57 106.817 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.71 3.8 Favored Glycine 0 C--N 1.381 3.053 1 N-CA-C 102.479 -4.249 . . . . 0.57 102.479 165.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -36.35 67.95 Favored 'Isoleucine or valine' 0 C--N 1.377 1.785 0 CA-C-O 124.534 2.111 . . . . 0.57 109.97 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.15 132.48 28.24 Favored Glycine 0 C--N 1.38 2.996 0 N-CA-C 104.389 -3.484 . . . . 0.57 104.389 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.46 -6.61 57.68 Favored Glycine 0 C--N 1.366 2.2 0 CA-C-O 124.085 1.936 . . . . 0.57 110.268 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.53 ' CG ' ' HB2' ' A' ' 160' ' ' LEU . 1.3 m-20 -88.24 166.67 14.18 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.073 -1.839 . . . . 0.91 110.897 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -135.54 161.12 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.57 111.066 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -129.24 125.77 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.57 110.919 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.0 m-85 -105.41 133.0 50.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.57 110.883 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -61.83 86.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.886 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.01 -33.05 70.0 Favored 'General case' 0 C--N 1.398 2.674 0 C-N-CA 115.823 -2.351 . . . . 0.91 105.576 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.98 -47.72 8.62 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 123.821 0.848 . . . . 0.91 108.774 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -54.02 174.37 0.06 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-O 127.562 3.553 . . . . 0.91 111.978 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.467 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 0.1 OUTLIER -102.21 110.63 22.64 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 112.365 -2.198 . . . . 0.57 109.898 177.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.7 m95 -93.09 148.56 21.9 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 107.588 -1.264 . . . . 0.57 107.588 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.621 HG21 ' O ' ' A' ' 208' ' ' GLY . 56.1 p -127.14 125.94 42.05 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-O 124.763 2.22 . . . . 0.57 110.007 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CB ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -98.06 133.74 42.11 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.452 -1.685 . . . . 0.57 106.452 -176.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 80.69 -43.76 0.22 Allowed 'General case' 0 C--N 1.374 1.646 0 CA-C-N 114.571 -1.195 . . . . 0.57 109.591 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.54 153.98 0.37 Allowed 'General case' 0 C--N 1.369 1.43 0 N-CA-C 107.996 -1.112 . . . . 0.57 107.996 -173.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 204' ' ' THR . . . 125.93 6.25 6.0 Favored Glycine 0 C--N 1.376 2.784 0 CA-C-N 114.556 -1.202 . . . . 0.57 114.089 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 144.31 -119.75 1.33 Allowed Glycine 0 C--N 1.378 2.869 0 CA-C-O 123.752 1.751 . . . . 0.57 112.36 -168.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 181' ' ' LEU . 6.6 p -94.25 133.0 38.25 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-N 113.951 -1.124 . . . . 0.57 109.331 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.627 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -98.2 150.39 21.55 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.878 1.799 . . . . 0.57 111.713 177.39 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.633 HD13 ' O ' ' A' ' 212' ' ' LEU . 3.2 tm? -75.54 -29.65 59.49 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 106.087 -1.82 . . . . 0.57 106.087 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 213' ' ' PHE . 7.8 t80 -57.45 -50.25 73.63 Favored 'General case' 0 C--N 1.373 1.623 0 CA-C-N 115.305 -0.861 . . . . 0.57 110.909 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -55.55 -51.15 68.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.57 110.952 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -67.32 -35.5 79.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.57 111.132 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 212' ' ' LEU . . . -62.59 -44.21 96.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.57 111.114 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 213' ' ' PHE . 95.4 t -65.23 -48.02 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.57 111.171 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 236' ' ' MET . 6.4 t-160 -64.63 -50.21 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.57 110.815 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 197' ' ' PHE . 17.3 mm-40 -57.92 -42.22 84.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.91 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.552 ' CG2' HD21 ' A' ' 224' ' ' LEU . 1.0 OUTLIER -66.56 -46.81 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.57 111.182 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.32 -33.53 61.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.57 112.501 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -64.71 -38.89 92.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.57 110.833 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.407 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 0.5 OUTLIER -71.99 -53.23 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.57 110.831 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.0 pp -93.94 -56.8 2.74 Favored 'General case' 0 C--N 1.381 1.958 0 N-CA-C 117.783 2.512 . . . . 0.57 117.783 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -45.08 149.89 1.1 Allowed Glycine 0 C--N 1.373 2.611 1 CA-C-O 128.049 4.139 . . . . 0.57 110.486 177.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.16 -153.51 0.05 Allowed 'General case' 0 C--N 1.365 1.247 0 CA-C-N 109.975 -3.113 . . . . 0.57 107.153 -171.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.0 -175.62 0.5 Allowed Glycine 0 C--N 1.379 2.923 0 CA-C-O 127.213 3.674 . . . . 0.57 113.001 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -100.56 -174.25 2.6 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 118.997 -2.472 . . . . 0.57 111.343 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.1 p -103.63 -34.67 8.55 Favored 'General case' 0 C--N 1.38 1.932 0 CA-C-N 113.835 -1.53 . . . . 0.57 108.748 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.78 22.37 0.39 Allowed 'General case' 0 C--N 1.385 2.121 0 N-CA-C 114.152 1.168 . . . . 0.57 114.152 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.74 131.99 11.05 Favored Pre-proline 0 C--N 1.378 1.838 0 N-CA-C 102.828 -3.027 . . . . 0.91 102.828 -164.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.479 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 47.5 Cg_exo -61.73 74.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 124.9 3.733 . . . . 0.57 114.913 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.38 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 CA-C-N 113.634 -1.621 . . . . 0.57 111.349 -171.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.61 133.53 34.84 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-O 123.549 1.642 . . . . 0.57 106.655 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 248' ' ' PHE . 11.5 p -70.48 68.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.318 0 CA-C-N 113.028 -1.896 . . . . 0.57 112.166 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER -175.64 -35.76 0.01 OUTLIER 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.635 -1.291 . . . . 0.57 109.931 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.16 145.46 0.32 Allowed Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 124.948 2.309 . . . . 0.57 111.575 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -57.93 -47.66 19.73 Favored 'Trans proline' 0 C--N 1.374 1.869 0 O-C-N 119.21 -0.995 . . . . 0.57 111.499 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 14.1 m -49.35 124.66 9.58 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-O 124.328 2.013 . . . . 0.57 109.921 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.551 ' OH ' HG22 ' A' ' 210' ' ' THR . 57.2 t80 -94.15 140.19 30.06 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-O 123.297 1.523 . . . . 0.57 107.997 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -155.56 109.39 2.82 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 105.635 -1.987 . . . . 0.57 105.635 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -54.03 123.71 13.4 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-O 124.144 1.926 . . . . 0.57 109.628 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 243' ' ' VAL . 9.6 p -154.65 111.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 114.158 -1.383 . . . . 0.57 107.349 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.21 142.44 51.77 Favored 'General case' 0 C--N 1.365 1.248 0 N-CA-C 103.219 -2.882 . . . . 0.91 103.219 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.471 HG12 ' CG ' ' A' ' 213' ' ' PHE . 1.1 mp -46.05 -23.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.309 0 CA-C-N 111.248 -2.706 . . . . 0.57 112.769 174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -51.72 -37.47 51.13 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.051 -0.977 . . . . 0.57 109.767 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.9 p -103.88 -0.64 28.84 Favored 'General case' 0 C--N 1.386 2.171 0 N-CA-C 116.48 2.03 . . . . 0.57 116.48 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.719 ' HE1' HG21 ' A' ' 235' ' ' VAL . 34.3 t80 -63.17 93.66 0.07 Allowed 'General case' 0 C--N 1.365 1.252 0 CA-C-O 127.039 3.304 . . . . 0.57 107.491 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.403 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.95 152.57 42.33 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 112.745 -2.025 . . . . 1.2 106.371 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.63 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.15 131.31 53.89 Favored 'General case' 0 C--N 1.372 1.577 0 CA-C-O 125.634 2.635 . . . . 0.57 104.987 -170.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.77 136.71 58.0 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.599 -1.938 . . . . 0.57 111.68 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -60.28 -45.23 94.06 Favored 'General case' 0 C--N 1.383 2.05 0 N-CA-C 106.245 -1.761 . . . . 0.57 106.245 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -41.03 85.16 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.215 -0.928 . . . . 0.91 110.858 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -63.93 -55.34 23.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.91 110.892 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.8 pt -66.21 -34.9 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.108 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.489 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 22.0 mtp180 -70.44 -30.38 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.872 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.15 -39.78 57.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.798 -0.715 . . . . 0.57 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -70.19 -41.41 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.57 111.175 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -34.45 68.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.57 110.829 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.382 2.012 0 CA-C-O 122.23 1.014 . . . . 0.57 109.489 -176.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.87 -0.789 . . . . 1.2 108.87 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 -50.94 0.01 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 122.316 1.055 . . . . 0.57 110.4 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -69.68 -32.24 70.74 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 114.117 -1.401 . . . . 0.57 108.482 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -109.17 109.47 20.44 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 120.129 -1.607 . . . . 0.57 110.935 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.69 139.88 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.139 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 4.4 p -112.94 159.76 18.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.57 111.118 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -149.08 153.37 37.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.57 110.955 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -142.1 122.02 13.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.939 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.472 HG21 ' HD1' ' A' ' 121' ' ' TYR . 12.8 mm -87.65 117.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.57 111.14 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ILE . 1.5 t-20 -37.52 -57.72 0.92 Allowed 'General case' 0 C--N 1.37 1.473 0 C-N-CA 120.019 -0.672 . . . . 0.57 111.382 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 24.9 t-20 -155.87 -61.14 0.11 Allowed 'General case' 0 C--N 1.378 1.812 0 CA-C-N 113.725 -1.58 . . . . 0.57 107.995 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.472 ' HD1' HG21 ' A' ' 118' ' ' ILE . 1.2 m-30 152.99 30.76 0.0 OUTLIER 'General case' 0 C--N 1.379 1.88 0 O-C-N 126.17 2.169 . . . . 0.57 112.731 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.651 HG23 ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 68.87 141.54 0.08 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 CA-C-O 124.38 2.038 . . . . 0.57 107.924 172.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 199' ' ' GLU . 39.7 Cg_endo -70.47 -41.58 3.28 Favored 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 118.432 -1.404 . . . . 0.57 112.319 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -110.74 -51.76 2.84 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 114.844 -1.071 . . . . 0.91 111.074 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.644 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -43.96 143.87 1.02 Allowed 'General case' 0 C--N 1.377 1.802 0 CA-C-O 124.953 2.311 . . . . 0.57 108.926 -174.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.0 m-20 -73.47 139.01 45.48 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.977 -1.92 . . . . 0.57 109.358 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.412 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -67.59 -50.07 60.08 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 107.758 -1.201 . . . . 1.2 107.758 -170.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.96 -36.36 65.26 Favored 'General case' 0 C--N 1.38 1.894 0 CA-C-N 113.271 -1.786 . . . . 0.91 110.891 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 126' ' ' ASN . 97.4 m-20 -70.82 -37.83 73.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.91 110.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 126' ' ' ASN . 4.9 t -65.18 -49.2 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.57 111.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 16.8 m-20 -69.93 -40.62 75.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.91 110.817 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -66.02 -42.22 89.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.57 110.891 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 212' ' ' LEU . . . -63.62 -49.01 75.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.57 111.136 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 15.8 pt -64.9 -31.94 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.57 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -66.89 -46.8 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.88 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -46.04 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.57 110.913 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.98 83.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.57 111.049 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.97 -44.89 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.57 110.893 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.4 pt20 -64.97 -35.27 80.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.57 110.918 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.862 HG13 HD21 ' A' ' 250' ' ' LEU . 1.2 t -69.53 -34.2 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.57 111.085 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 7.5 m95 -83.03 -34.2 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.57 110.911 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -48.24 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.57 110.853 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.679 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.4 p-10 -61.0 -12.61 12.07 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.854 0.835 . . . . 0.57 111.612 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 140' ' ' VAL . 19.6 m -115.42 -10.06 12.21 Favored 'Isoleucine or valine' 0 C--N 1.375 1.687 0 CA-C-N 114.835 -1.075 . . . . 0.57 111.533 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 224' ' ' LEU . 0.5 OUTLIER -139.99 148.73 56.09 Favored Pre-proline 0 C--N 1.36 1.058 0 CA-C-O 125.092 2.377 . . . . 0.57 110.021 -177.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -70.7 -39.67 4.5 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 118.24 -1.505 . . . . 0.57 111.857 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 224' ' ' LEU . 3.7 mt -50.63 111.41 0.54 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 122.734 1.254 . . . . 0.57 107.923 -174.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -76.37 159.24 30.68 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 114.473 -1.239 . . . . 0.57 111.176 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 6.1 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 113.25 -1.795 . . . . 0.57 108.756 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 m -159.85 110.96 1.96 Allowed 'General case' 0 C--N 1.386 2.183 0 CA-C-O 124.923 2.297 . . . . 0.57 109.022 -172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.55 133.83 37.75 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 113.915 -1.493 . . . . 0.57 109.645 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.641 HD12 ' H ' ' A' ' 155' ' ' GLY . 2.3 pt -111.03 172.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.364 1.231 0 CA-C-O 124.545 2.117 . . . . 0.57 110.135 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -63.77 1.24 Allowed 'General case' 0 C--N 1.383 2.038 0 CA-C-N 113.31 -1.768 . . . . 0.57 110.023 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 154' ' ' THR . 13.9 t -142.62 52.58 1.42 Allowed 'General case' 0 C--N 1.376 1.733 0 CA-C-O 124.926 2.298 . . . . 0.57 110.154 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.641 ' H ' HD12 ' A' ' 152' ' ' ILE . . . -127.9 21.94 5.5 Favored Glycine 0 C--N 1.364 2.106 0 C-N-CA 118.492 -1.813 . . . . 0.57 112.515 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.454 ' C ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER 67.12 95.05 0.06 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.961 2.315 . . . . 0.57 110.264 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 117' ' ' ARG . . . -96.36 174.68 6.75 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 117.89 -1.524 . . . . 0.57 112.49 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.16 -50.75 13.74 Favored 'General case' 0 C--N 1.375 1.694 0 N-CA-C 105.197 -2.149 . . . . 0.91 105.197 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.646 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.8 pp -114.11 116.18 51.83 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 CA-C-N 115.158 -0.928 . . . . 0.57 111.141 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 117' ' ' ARG . 4.3 mp -92.87 132.15 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.57 110.877 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.849 HG13 ' CE1' ' A' ' 197' ' ' PHE . 30.6 t -101.96 117.0 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.57 111.1 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.02 146.01 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.57 111.132 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CE1' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -106.18 119.99 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.57 110.89 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.28 168.6 18.58 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 123.795 1.76 . . . . 0.57 109.696 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -107.3 167.72 9.72 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.701 -1.25 . . . . 1.2 110.595 177.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -40.17 143.05 0.58 Allowed Glycine 0 C--N 1.38 3.027 0 CA-C-O 123.22 1.455 . . . . 0.57 112.303 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 72.19 43.65 0.5 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-O 124.708 2.194 . . . . 0.57 109.218 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 165' ' ' ARG . 31.2 p-80 . . . . . 0 C--N 1.373 1.607 0 CA-C-O 123.663 1.697 . . . . 0.57 108.385 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.756 0 CA-C-O 122.026 0.917 . . . . 0.57 109.593 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.529 ' HE1' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -116.73 -161.6 0.81 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 114.221 -1.354 . . . . 0.57 111.697 175.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.635 ' HB3' HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -99.38 -68.68 0.79 Allowed 'General case' 0 C--N 1.378 1.827 0 N-CA-C 108.758 -0.83 . . . . 0.91 108.758 178.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.401 ' N ' ' OD2' ' A' ' 175' ' ' ASP . . . 54.69 165.16 0.02 OUTLIER Glycine 0 C--N 1.392 3.666 0 CA-C-O 125.095 2.497 . . . . 0.57 116.813 -167.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.49 7.77 5.11 Favored 'General case' 0 C--N 1.379 1.88 0 O-C-N 120.507 -1.584 . . . . 0.57 113.48 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.18 -140.73 11.98 Favored Glycine 0 C--N 1.363 2.072 0 N-CA-C 110.045 -1.222 . . . . 0.57 110.045 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.02 -104.17 0.11 Allowed Glycine 0 C--N 1.362 2.026 0 CA-C-O 123.566 1.648 . . . . 0.57 112.52 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 175' ' ' ASP . 9.7 mt -62.58 169.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.494 0 CA-C-O 123.333 1.54 . . . . 0.57 112.506 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 215' ' ' THR . 23.5 tp -128.92 -40.31 1.53 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 118.211 -2.805 . . . . 0.57 110.499 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 215' ' ' THR . . . -176.5 179.94 1.11 Allowed 'General case' 0 C--N 1.379 1.854 0 CA-C-N 114.918 -1.037 . . . . 0.57 111.081 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.438 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -155.04 145.86 22.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.57 110.846 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.01 151.24 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.082 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.13 -179.99 7.13 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.968 1.842 . . . . 0.57 111.131 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.99 -162.89 24.0 Favored Glycine 0 C--N 1.38 2.985 0 CA-C-O 124.142 1.968 . . . . 0.57 111.703 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.24 79.15 1.79 Allowed 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.099 1.866 . . . . 0.57 112.074 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -128.31 160.76 22.1 Favored Glycine 0 C--N 1.367 2.281 0 CA-C-O 123.182 1.434 . . . . 0.57 110.074 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -74.94 -177.61 3.4 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.428 -1.386 . . . . 0.57 109.237 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.13 -117.22 5.9 Favored Glycine 0 C--N 1.383 3.186 0 N-CA-C 109.834 -1.306 . . . . 0.57 109.834 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 192' ' ' GLY . 6.3 tp -59.44 -46.81 92.44 Favored 'Isoleucine or valine' 0 C--N 1.383 2.051 0 CA-C-N 112.547 -1.826 . . . . 0.57 110.44 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -42.7 133.89 4.61 Favored Glycine 0 C--N 1.369 2.415 0 CA-C-O 124.486 2.159 . . . . 0.57 109.671 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.8 -48.82 1.21 Allowed Glycine 0 C--N 1.37 2.465 0 CA-C-N 113.051 -1.574 . . . . 0.57 113.129 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.29 160.06 0.17 Allowed 'General case' 0 C--N 1.376 1.724 0 CA-C-O 120.798 0.333 . . . . 0.91 110.901 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -143.98 146.46 32.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.57 111.101 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -121.62 126.25 48.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.57 110.875 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.849 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.5 m-85 -108.22 150.08 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.57 110.89 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 90.41 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.91 110.803 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.453 ' OE1' HG22 ' A' ' 122' ' ' THR . 3.8 tp10 -74.65 -5.52 43.52 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 124.216 1.96 . . . . 0.91 110.475 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -32.97 35.16 Favored 'General case' 0 C--N 1.369 1.416 0 CA-C-O 123.003 1.382 . . . . 0.91 108.902 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.58 176.06 2.58 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-O 123.439 1.59 . . . . 0.91 111.99 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.76 104.02 16.01 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-N 112.576 -2.102 . . . . 0.57 112.589 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.421 ' CE3' ' HG3' ' A' ' 125' ' ' MET . 18.2 m95 -76.7 128.52 34.83 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 114.273 -1.33 . . . . 0.57 108.525 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.0 p -122.86 104.88 9.56 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-O 125.093 2.378 . . . . 0.57 109.309 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.401 HG21 ' HB3' ' A' ' 129' ' ' ASP . 0.6 OUTLIER -115.46 130.83 57.01 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.065 1.412 . . . . 0.57 108.658 -177.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 24.85 3.45 Favored 'General case' 0 C--N 1.389 2.318 0 CA-C-O 123.601 1.667 . . . . 0.57 111.402 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.16 -71.41 0.5 Allowed 'General case' 0 C--N 1.38 1.896 0 CA-C-N 114.241 -1.345 . . . . 0.57 108.479 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.94 90.96 0.08 OUTLIER Glycine 0 C--N 1.389 3.487 0 C-N-CA 118.478 -1.82 . . . . 0.57 113.09 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.5 -141.71 7.61 Favored Glycine 0 C--N 1.378 2.879 0 C-N-CA 119.55 -1.309 . . . . 0.57 110.132 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 181' ' ' LEU . 72.7 p -67.42 128.66 37.25 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-O 124.128 1.918 . . . . 0.57 112.146 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.556 ' O ' HD21 ' A' ' 181' ' ' LEU . 12.6 p30 -135.34 145.46 47.45 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 113.917 -1.492 . . . . 0.57 109.607 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 133' ' ' ALA . 1.4 pt? -65.0 -25.37 67.83 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-O 123.911 1.815 . . . . 0.57 108.933 -174.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.992 ' O ' HG23 ' A' ' 217' ' ' VAL . 48.7 t80 -54.18 -42.65 69.92 Favored 'General case' 0 C--N 1.372 1.568 0 CA-C-N 113.734 -1.575 . . . . 0.57 110.879 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -57.11 -51.11 70.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.926 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -69.55 -33.78 73.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.57 111.139 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -65.92 -46.33 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.57 111.113 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 213' ' ' PHE . 6.0 t -65.43 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.57 111.14 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -71.33 -50.04 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.57 110.844 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.31 -42.07 98.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.91 110.876 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 216' ' ' ALA . 34.5 mt -65.04 -37.94 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.57 111.119 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.501 ' HA3' ' CZ2' ' A' ' 141' ' ' TRP . . . -68.3 -33.99 79.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 0.57 112.49 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.448 ' CG ' ' CE ' ' A' ' 236' ' ' MET . 2.9 m-70 -67.39 -40.67 85.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.57 110.871 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m -70.54 -41.22 72.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.57 110.882 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 145' ' ' THR . 0.7 OUTLIER -40.76 -36.97 0.69 Allowed 'General case' 0 C--N 1.358 0.97 0 CA-C-O 124.475 2.083 . . . . 0.57 111.753 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.4 -38.92 1.13 Allowed Glycine 0 C--N 1.369 2.386 0 N-CA-C 108.392 -1.883 . . . . 0.57 108.392 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.551 HD11 HG22 ' A' ' 258' ' ' ILE . 1.3 pt? -100.09 150.95 21.95 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-O 123.062 1.41 . . . . 0.57 111.602 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.22 -118.92 0.27 Allowed Glycine 0 C--N 1.374 2.668 0 CA-C-O 125.063 2.479 . . . . 0.57 111.881 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -110.55 -155.01 0.55 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 120.825 -1.397 . . . . 0.57 109.053 -178.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.681 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.6 p -115.56 -8.06 12.16 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 114.614 -1.175 . . . . 0.57 111.149 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 82.54 -5.41 1.36 Allowed 'General case' 0 C--N 1.381 1.962 0 N-CA-C 113.527 0.936 . . . . 0.57 113.527 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.56 158.84 74.23 Favored Pre-proline 0 C--N 1.372 1.577 0 N-CA-C 107.346 -1.353 . . . . 0.91 107.346 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -55.02 -29.92 67.26 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.952 2.435 . . . . 0.57 112.99 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 229' ' ' SER . 0.2 OUTLIER -47.35 -25.51 1.02 Allowed 'General case' 0 C--N 1.382 2.021 0 CA-C-N 114.662 -1.154 . . . . 0.57 113.589 177.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -91.13 124.62 35.49 Favored 'General case' 0 C--N 1.378 1.814 0 CA-C-O 124.656 2.169 . . . . 0.57 110.77 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -70.41 -8.36 10.65 Favored 'Isoleucine or valine' 0 C--N 1.377 1.768 0 CA-C-N 113.016 -1.902 . . . . 0.57 111.838 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.501 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 1.3 ttt -99.4 17.92 19.02 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.227 -0.897 . . . . 0.57 110.689 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 9.8 t80 -55.3 141.54 61.56 Favored Pre-proline 0 C--N 1.367 1.344 0 CA-C-O 123.12 1.438 . . . . 0.57 108.693 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 51.6 Cg_exo -51.76 -52.94 7.89 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.98 1.787 . . . . 0.57 113.714 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.95 142.24 56.62 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 125.288 1.618 . . . . 0.57 109.929 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 7.9 t80 -94.71 153.21 17.9 Favored 'General case' 0 C--N 1.385 2.126 0 CA-C-N 113.583 -1.644 . . . . 0.57 109.63 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 4.2 tmtt? 177.31 104.17 0.02 OUTLIER 'General case' 0 C--N 1.389 2.292 0 CA-C-O 123.238 1.494 . . . . 0.57 107.461 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.25 120.02 4.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 125.105 2.384 . . . . 0.57 109.927 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.95 9.51 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-N 113.25 -1.795 . . . . 0.57 110.407 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.594 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER 84.88 -16.31 0.5 Allowed 'General case' 0 C--N 1.367 1.342 0 O-C-N 125.631 1.832 . . . . 0.91 111.683 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.5 mt 74.87 -48.71 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.121 0 N-CA-C 114.605 1.335 . . . . 0.57 114.605 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -45.22 -27.06 0.57 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 114.376 1.25 . . . . 0.57 114.376 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.594 HG23 ' OD1' ' A' ' 244' ' ' ASP . 1.3 p -106.28 -0.68 24.2 Favored 'General case' 0 C--N 1.376 1.721 0 CA-C-N 115.373 -0.83 . . . . 0.57 110.959 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 235' ' ' VAL . 12.5 t80 -58.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.372 1.559 0 CA-C-O 124.46 2.076 . . . . 0.57 109.054 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.454 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -109.74 152.0 26.21 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-N 113.351 -1.75 . . . . 1.2 107.22 -176.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.862 HD21 HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -121.83 134.66 54.89 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-O 124.549 2.118 . . . . 0.57 106.246 -173.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -67.01 136.79 55.84 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 120.551 -1.343 . . . . 0.57 110.441 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.4 94.94 Favored 'General case' 0 C--N 1.381 1.977 0 N-CA-C 107.218 -1.401 . . . . 0.57 107.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.43 -37.51 87.78 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 119.62 -1.925 . . . . 0.91 110.849 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 m-20 -63.83 -55.35 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.91 110.886 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.484 ' CG2' HG11 ' A' ' 144' ' ' VAL . 11.7 pt -66.23 -35.51 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.094 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.432 ' N ' HG13 ' A' ' 255' ' ' ILE . 48.7 mtm180 -70.33 -34.32 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.2 110.843 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.63 -49.56 59.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.57 112.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.15 -45.23 99.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.57 111.089 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.493 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -71.45 -28.06 63.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.57 110.878 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.362 1.111 0 CA-C-O 121.909 0.862 . . . . 0.57 110.883 -178.896 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 122.867 1.318 . . . . 1.2 107.962 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.58 -44.13 0.09 Allowed 'General case' 0 C--N 1.372 1.549 0 CA-C-N 113.301 -1.772 . . . . 0.57 110.185 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' HA ' HD23 ' A' ' 147' ' ' LEU . 2.4 p-80 -89.43 -21.65 22.92 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 113.001 -1.909 . . . . 0.57 111.644 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.479 ' HE1' ' HG ' ' A' ' 150' ' ' SER . 0.7 OUTLIER -113.04 107.95 16.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 115.784 -0.644 . . . . 0.57 110.92 -178.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 155.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.57 111.138 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 150.55 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.137 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -150.04 160.08 43.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.925 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -141.14 129.18 21.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.849 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -94.5 129.52 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.57 111.162 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 121' ' ' TYR . 54.6 t30 -54.36 178.78 0.02 OUTLIER 'General case' 0 C--N 1.369 1.447 0 CA-C-O 124.701 2.191 . . . . 0.57 109.121 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.51 45.09 0.84 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.026 -1.672 . . . . 0.57 109.926 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 7.0 m-85 53.85 -168.15 0.07 Allowed 'General case' 0 C--N 1.386 2.152 0 CA-C-N 113.344 -1.753 . . . . 0.57 107.432 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.63 165.34 17.62 Favored Pre-proline 0 C--N 1.378 1.837 0 CA-C-N 113.668 -1.606 . . . . 0.57 107.487 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 -55.62 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 120.904 1.069 . . . . 0.57 113.467 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.78 -52.71 63.09 Favored 'General case' 0 C--N 1.375 1.701 0 CA-C-N 114.042 -1.436 . . . . 0.91 111.985 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.538 ' CE ' ' CD1' ' A' ' 203' ' ' TRP . 2.6 ttm -77.03 126.85 31.66 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 124.565 2.126 . . . . 0.57 110.844 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.2 m-80 -72.05 131.36 42.78 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-N 112.78 -2.009 . . . . 0.57 109.009 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.62 -49.95 64.59 Favored 'General case' 0 C--N 1.366 1.313 0 N-CA-C 107.737 -1.208 . . . . 1.2 107.737 -169.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -55.52 -35.38 65.57 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-N 112.221 -2.263 . . . . 0.91 110.841 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.44 -43.35 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.91 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -61.04 -49.93 82.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.57 111.092 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -59.22 -44.14 92.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.91 110.803 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.72 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.57 110.938 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.1 -49.06 73.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.062 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.642 HD11 HD11 ' A' ' 212' ' ' LEU . 2.4 mm -65.28 -40.41 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.57 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.35 -46.13 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.2 110.852 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -42.7 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.57 110.921 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -58.45 -44.93 89.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.57 111.11 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 149' ' ' PHE . 11.8 m-85 -64.15 -36.35 83.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.57 110.86 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.12 -40.05 86.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.57 110.95 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -69.5 -34.1 60.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.106 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 224' ' ' LEU . 43.8 m95 -82.92 -34.03 26.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.57 110.939 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 m -79.3 -50.57 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.57 110.883 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.656 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.4 p-10 -56.77 -14.04 3.04 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.34 0.867 . . . . 0.57 113.34 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 140' ' ' VAL . 17.9 m -113.73 -7.33 12.04 Favored 'Isoleucine or valine' 0 C--N 1.377 1.788 0 CA-C-N 113.678 -1.601 . . . . 0.57 112.628 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.801 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.58 143.18 16.18 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-O 125.068 2.366 . . . . 0.57 109.291 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.801 ' HD2' HG22 ' A' ' 145' ' ' THR . 55.7 Cg_endo -82.12 49.9 3.28 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.017 1.811 . . . . 0.57 111.362 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 112' ' ' HIS . 1.8 mt -134.02 73.79 1.52 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 106.551 -1.648 . . . . 0.57 106.551 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.75 161.9 22.57 Favored 'General case' 0 C--N 1.369 1.456 0 CA-C-O 125.468 2.556 . . . . 0.57 117.499 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -135.15 159.94 39.95 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.486 -2.143 . . . . 0.57 106.237 -172.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.479 ' HG ' ' HE1' ' A' ' 113' ' ' TYR . 1.2 m -140.78 111.16 6.74 Favored 'General case' 0 C--N 1.379 1.885 0 CA-C-O 124.154 1.931 . . . . 0.57 106.523 -171.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 27.5 tttt -82.19 145.97 29.78 Favored 'General case' 0 C--N 1.369 1.446 0 CA-C-N 112.833 -1.985 . . . . 0.57 111.934 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.0 pt -128.68 162.14 36.2 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 CA-C-N 112.928 -1.942 . . . . 0.57 109.48 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -139.8 39.76 2.0 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-N 113.442 -1.708 . . . . 0.57 110.684 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.62 -70.81 0.54 Allowed 'General case' 0 C--N 1.378 1.83 0 CA-C-N 112.864 -1.971 . . . . 0.57 108.479 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -99.41 -130.44 6.95 Favored Glycine 0 C--N 1.382 3.108 0 N-CA-C 108.802 -1.719 . . . . 0.57 108.802 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -122.79 134.67 54.42 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 111.885 -2.158 . . . . 0.57 109.083 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -99.48 179.0 4.7 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 112.831 -1.986 . . . . 0.57 111.527 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.24 -65.34 0.74 Allowed 'General case' 0 C--N 1.387 2.217 0 N-CA-C 103.924 -2.621 . . . . 0.91 103.924 -166.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.728 HG22 ' CA ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -98.84 109.84 24.96 Favored 'Isoleucine or valine' 0 C--N 1.37 1.486 0 CA-C-N 114.834 -1.075 . . . . 0.57 111.112 178.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -104.0 130.97 51.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.927 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.3 t -102.09 117.02 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.57 111.094 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.1 146.02 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.105 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -99.15 116.74 32.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.57 110.857 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.08 170.04 16.51 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 124.967 2.318 . . . . 0.57 110.923 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 168.26 9.25 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 113.753 -1.567 . . . . 1.2 111.646 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 174' ' ' PHE . . . -43.41 128.12 5.75 Favored Glycine 0 C--N 1.385 3.27 0 O-C-N 126.299 2.25 . . . . 0.57 112.569 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -179.89 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.384 2.076 0 CA-C-N 111.7 -2.25 . . . . 0.57 110.853 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.378 1.83 0 CA-C-N 113.656 -1.611 . . . . 0.57 108.578 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.268 0 CA-C-O 122.11 0.957 . . . . 0.57 112.124 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.598 ' CE1' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -133.53 -159.88 1.0 Allowed 'General case' 0 C--N 1.368 1.408 0 CA-C-O 122.771 1.272 . . . . 0.57 110.273 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.34 175.31 6.79 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.28 -1.782 . . . . 0.91 110.946 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.03 34.59 1.65 Allowed Glycine 0 C--N 1.389 3.516 0 CA-C-N 111.927 -2.397 . . . . 0.57 111.697 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.45 -40.99 0.05 OUTLIER 'General case' 0 C--N 1.376 1.749 0 CA-C-N 112.79 -1.705 . . . . 0.57 112.077 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -166.65 -122.56 0.61 Allowed Glycine 0 C--N 1.38 2.978 0 C-N-CA 117.846 -2.121 . . . . 0.57 110.399 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.48 -122.52 26.88 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 117.316 -1.825 . . . . 0.57 113.418 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.598 HG21 ' CE1' ' A' ' 174' ' ' PHE . 0.3 OUTLIER -45.75 170.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 O-C-N 127.434 2.491 . . . . 0.57 114.077 172.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.693 HD13 ' OH ' ' A' ' 240' ' ' TYR . 6.6 tp -123.77 -66.71 0.98 Allowed 'General case' 0 C--N 1.374 1.634 0 CA-C-O 123.151 1.453 . . . . 0.57 113.864 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 197' ' ' PHE . . . -178.15 179.88 0.78 Allowed 'General case' 0 C--N 1.358 0.963 0 CA-C-N 112.719 -2.037 . . . . 0.57 111.054 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.503 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.8 p80 -158.23 177.12 11.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.57 110.854 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -157.97 143.75 17.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.57 111.151 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.508 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 4.9 m-30 -84.69 173.41 10.75 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 118.578 -1.249 . . . . 0.57 108.9 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.07 -156.17 4.33 Favored Glycine 0 C--N 1.382 3.085 0 C-N-CA 118.356 -1.878 . . . . 0.57 110.563 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.66 -87.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.063 1.175 . . . . 0.57 110.643 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.28 -143.52 2.42 Favored Glycine 0 C--N 1.387 3.388 0 CA-C-O 123.958 1.866 . . . . 0.57 110.233 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.88 163.99 38.06 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 111.164 -2.518 . . . . 0.57 108.705 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.82 -108.26 2.51 Favored Glycine 0 C--N 1.386 3.308 0 N-CA-C 108.072 -2.011 . . . . 0.57 108.072 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.64 -37.32 69.05 Favored 'Isoleucine or valine' 0 C--N 1.386 2.158 0 CA-C-O 125.513 2.578 . . . . 0.57 109.292 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.11 138.5 49.5 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 108.922 -1.671 . . . . 0.57 108.922 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.728 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 96.77 -15.78 62.09 Favored Glycine 0 C--N 1.37 2.468 0 CA-C-O 124.701 2.279 . . . . 0.57 109.044 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -73.72 144.22 45.82 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.531 -1.334 . . . . 0.91 110.864 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -125.76 152.62 45.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.57 111.114 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -134.04 132.45 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.874 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -121.04 147.26 45.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.57 110.907 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' OD2' HG23 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.97 83.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.91 110.881 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.4 -46.81 78.58 Favored 'General case' 0 C--N 1.375 1.682 0 N-CA-C 105.327 -2.101 . . . . 0.91 105.327 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -44.3 -43.43 7.42 Favored 'General case' 0 C--N 1.372 1.544 0 O-C-N 126.092 2.12 . . . . 0.91 109.706 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -49.23 173.92 0.02 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 125.53 2.586 . . . . 0.91 113.971 172.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.446 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 16.2 m-85 -113.28 95.08 5.19 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.388 -2.187 . . . . 0.57 112.412 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.575 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 35.5 m95 -75.63 132.39 40.58 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.218 -1.81 . . . . 0.57 106.95 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.3 p -110.86 103.26 11.75 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 124.908 2.289 . . . . 0.57 109.038 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 69.5 p -104.13 106.88 17.54 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 114.096 -1.411 . . . . 0.57 110.122 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 171.46 -59.46 0.01 OUTLIER 'General case' 0 C--N 1.383 2.047 0 CA-C-N 113.222 -1.808 . . . . 0.57 107.333 177.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.42 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 0.5 OUTLIER 158.18 58.88 0.0 OUTLIER 'General case' 0 C--N 1.391 2.372 0 O-C-N 127.772 3.17 . . . . 0.57 110.992 -171.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.3 -88.1 0.3 Allowed Glycine 0 C--N 1.382 3.129 0 C-N-CA 117.082 -2.485 . . . . 0.57 113.442 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.97 -108.23 3.19 Favored Glycine 0 C--N 1.383 3.14 0 CA-C-O 126.984 3.547 . . . . 0.57 112.787 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.565 HG22 ' OH ' ' A' ' 240' ' ' TYR . 1.4 p -66.63 119.33 11.56 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 111.744 -2.228 . . . . 0.57 111.512 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.17 143.34 43.37 Favored 'General case' 0 C--N 1.373 1.614 0 CA-C-N 113.758 -1.565 . . . . 0.57 109.702 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -73.43 -25.12 60.38 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-N 112.728 -2.033 . . . . 0.57 107.276 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.897 ' O ' HG23 ' A' ' 217' ' ' VAL . 12.4 t80 -58.47 -49.16 78.33 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 113.926 -1.488 . . . . 0.57 110.823 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -54.97 -50.96 67.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.57 110.976 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -67.22 -37.65 83.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.57 111.121 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.93 91.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.57 111.093 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 213' ' ' PHE . 7.8 t -65.14 -40.17 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.57 111.111 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -72.08 -37.55 69.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.57 110.892 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -42.07 97.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.91 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.655 HD12 ' HB1' ' A' ' 137' ' ' ALA . 64.6 mt -70.0 -38.98 76.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.57 111.134 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.18 93.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.57 112.481 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.1 OUTLIER -63.97 -43.17 96.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.57 110.844 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -38.07 72.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.886 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -47.11 -42.93 19.99 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 118.452 -1.299 . . . . 0.57 111.007 -172.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 127.25 33.46 0.62 Allowed Glycine 0 C--N 1.385 3.265 0 CA-C-N 112.33 -2.213 . . . . 0.57 109.449 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -102.34 177.35 4.9 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-O 123.523 1.63 . . . . 0.57 109.355 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -136.08 23.39 3.35 Favored Glycine 0 C--N 1.381 3.082 0 CA-C-N 112.679 -2.055 . . . . 0.57 110.526 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 6.6 m170 62.68 177.07 0.14 Allowed 'General case' 0 C--N 1.395 2.546 0 CA-C-N 113.056 -1.572 . . . . 0.57 110.041 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.5 p -103.85 -23.59 13.37 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 113.206 -1.815 . . . . 0.57 111.17 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 81.39 21.39 0.35 Allowed 'General case' 0 C--N 1.385 2.134 0 O-C-N 125.683 1.864 . . . . 0.57 112.627 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.9 143.68 45.39 Favored Pre-proline 0 C--N 1.392 2.419 0 N-CA-C 103.216 -2.883 . . . . 0.91 103.216 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.82 66.49 6.71 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.444 2.763 . . . . 0.57 111.005 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 -35.44 0.01 OUTLIER 'General case' 0 C--N 1.362 1.142 0 CA-C-N 113.537 -1.665 . . . . 0.57 112.699 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -70.05 114.63 8.4 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 113.724 -1.58 . . . . 0.57 112.141 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 235' ' ' VAL . 5.1 t -53.2 88.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 CA-C-N 112.907 -1.951 . . . . 0.57 112.17 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.436 ' CB ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 159.13 -29.33 0.0 OUTLIER 'General case' 0 C--N 1.367 1.347 0 CA-C-N 115.033 -0.985 . . . . 0.57 111.747 -174.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 9.2 p90 -45.61 143.99 2.75 Favored Pre-proline 0 C--N 1.372 1.55 0 CA-C-N 113.915 -1.493 . . . . 0.57 110.65 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -59.54 -38.08 84.94 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 120.54 0.826 . . . . 0.57 111.911 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.464 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.4 m -40.49 113.51 0.37 Allowed 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.596 1.665 . . . . 0.57 111.383 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.693 ' OH ' HD13 ' A' ' 181' ' ' LEU . 2.6 t80 -76.66 133.83 39.46 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 112.603 -2.09 . . . . 0.57 105.909 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -175.53 98.24 0.07 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 124.267 1.984 . . . . 0.57 108.815 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -61.12 127.88 33.68 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 124.1 1.905 . . . . 0.57 110.973 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -9.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.365 1.282 0 CA-C-N 113.022 -1.899 . . . . 0.57 112.267 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER 75.85 -3.64 2.53 Favored 'General case' 0 C--N 1.384 2.088 0 O-C-N 126.605 2.441 . . . . 0.91 110.865 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 213' ' ' PHE . 2.4 mt 83.0 5.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.696 0 CA-C-N 114.525 -1.216 . . . . 0.57 113.105 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 0.4 OUTLIER -81.3 -36.6 29.61 Favored 'General case' 0 C--N 1.385 2.126 0 N-CA-C 102.713 -3.069 . . . . 0.57 102.713 -165.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.7 p -116.92 -4.68 11.52 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 113.164 -1.835 . . . . 0.57 114.023 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 217' ' ' VAL . 30.9 t80 -56.02 91.48 0.01 OUTLIER 'General case' 0 C--N 1.373 1.594 0 CA-C-O 124.312 2.006 . . . . 0.57 109.485 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.45 151.7 51.82 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 112.434 -2.167 . . . . 1.2 106.675 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 250' ' ' LEU . 0.6 OUTLIER -124.17 127.59 47.98 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 125.082 2.372 . . . . 0.57 104.936 -171.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 147.22 46.87 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 113.666 -1.606 . . . . 0.57 111.896 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.37 93.07 Favored 'General case' 0 C--N 1.388 2.239 0 CA-C-N 113.218 -1.81 . . . . 0.57 108.7 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -37.28 85.35 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-N 115.516 -0.765 . . . . 0.91 110.862 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 258' ' ' ILE . 3.6 t0 -64.22 -55.02 24.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.91 110.846 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 12.9 pt -66.1 -34.78 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.57 111.125 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 31.3 mtp180 -70.08 -30.12 67.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.841 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.74 -41.51 49.78 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 0.57 112.471 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 254' ' ' ASP . 0.6 OUTLIER -68.09 -42.66 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.57 111.089 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.691 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -71.97 -27.26 62.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.97 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.366 1.293 0 CA-C-O 124.121 1.915 . . . . 0.57 108.784 -176.119 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.845 0 CA-C-O 121.541 0.686 . . . . 1.2 109.172 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.05 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.373 1.63 0 CA-C-O 123.044 1.402 . . . . 0.57 110.437 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.733 ' HA ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 -68.1 -17.3 64.33 Favored 'General case' 0 C--N 1.375 1.687 0 CA-C-N 113.929 -1.487 . . . . 0.57 110.438 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.98 106.65 14.67 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.456 -1.247 . . . . 0.57 110.938 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.44 155.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.57 111.119 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.1 p -134.53 159.96 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.57 111.143 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.668 ' CE2' ' CE2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -140.26 160.08 40.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.935 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -139.11 121.96 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 1.2 110.873 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -78.13 117.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.57 111.14 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -36.97 -60.18 0.65 Allowed 'General case' 0 C--N 1.351 0.649 0 CA-C-N 116.116 -0.493 . . . . 0.57 109.972 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 157.16 33.67 0.0 OUTLIER 'General case' 0 C--N 1.37 1.478 0 O-C-N 125.938 2.024 . . . . 0.57 111.204 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 2.4 m-30 73.54 -170.96 0.12 Allowed 'General case' 0 C--N 1.374 1.641 0 CA-C-N 114.65 -1.159 . . . . 0.57 108.13 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.5 149.79 58.52 Favored Pre-proline 0 C--N 1.364 1.204 0 CA-C-O 122.34 1.066 . . . . 0.57 109.068 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.58 -55.03 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.463 1.442 . . . . 0.57 112.764 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -63.25 -48.72 77.01 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.3 1.048 . . . . 0.91 112.573 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 212' ' ' LEU . 3.6 ttm -83.15 142.11 31.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.484 2.087 . . . . 0.57 111.471 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.85 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.1 m-80 -70.68 135.89 48.65 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 120.324 -1.485 . . . . 0.57 109.869 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.504 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.96 -51.21 57.97 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.087 -0.708 . . . . 1.2 109.087 -173.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -34.89 61.7 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-N 113.615 -1.63 . . . . 0.91 110.917 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.02 -44.04 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.91 110.893 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -62.33 -38.75 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.182 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.61 -43.17 81.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.91 110.866 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -47.7 76.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.57 110.905 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.97 -48.24 78.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.57 111.033 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.5 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.2 mm -61.85 -35.81 70.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.57 111.146 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -64.56 -48.05 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 1.2 110.854 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HB3' ' CD1' ' A' ' 213' ' ' PHE . 0.0 OUTLIER -62.88 -38.59 91.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.57 110.872 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.07 94.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.57 111.064 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.668 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 15.3 m-85 -64.21 -34.12 77.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.906 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -67.74 -41.13 83.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.859 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.706 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -69.7 -34.0 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.57 111.105 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.458 ' CZ2' ' HA3' ' A' ' 221' ' ' GLY . 7.3 m95 -82.95 -34.04 26.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.57 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.47 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 49.1 m -79.27 -48.87 13.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.57 110.852 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.677 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.5 p-10 -59.83 -12.99 8.62 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.838 0.828 . . . . 0.57 111.965 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.793 HG11 HG21 ' A' ' 255' ' ' ILE . 20.6 m -115.32 3.29 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.751 -1.113 . . . . 0.57 112.127 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.91 148.86 40.56 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 124.105 1.907 . . . . 0.57 110.418 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.18 -32.22 6.95 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 120.862 1.041 . . . . 0.57 112.509 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.733 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.3 mt -56.27 109.63 0.63 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 122.771 1.272 . . . . 0.57 109.531 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 157.39 33.5 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.494 -1.23 . . . . 0.57 111.77 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.697 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 10.8 m-85 -127.57 149.05 50.33 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-N 113.671 -1.604 . . . . 0.57 109.19 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.39 121.19 6.02 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-O 123.605 1.669 . . . . 0.57 109.792 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 21.0 tttp -92.52 145.89 24.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 120.674 -1.266 . . . . 0.57 110.834 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.3 pt -128.53 129.02 68.69 Favored 'Isoleucine or valine' 0 C--N 1.372 1.544 0 CA-C-O 123.325 1.536 . . . . 0.57 109.546 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -73.95 -55.46 6.13 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.147 0.975 . . . . 0.57 110.773 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.99 113.18 25.36 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 114.575 -1.193 . . . . 0.57 110.781 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.27 164.5 19.23 Favored Glycine 0 C--N 1.37 2.466 0 CA-C-N 114.894 -1.048 . . . . 0.57 112.123 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.9 ttt -88.28 131.75 34.66 Favored 'General case' 0 C--N 1.371 1.523 0 CA-C-O 122.192 0.996 . . . . 0.57 111.085 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.53 175.02 6.37 Favored 'General case' 0 C--N 1.366 1.298 0 CA-C-N 114.423 -1.262 . . . . 0.57 110.856 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.44 -46.47 89.94 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 106.432 -1.692 . . . . 0.91 106.432 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 193' ' ' GLY . 1.8 mt -113.88 109.93 30.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 114.733 -1.121 . . . . 0.57 111.166 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 162' ' ' VAL . 0.2 OUTLIER -98.79 120.99 40.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.975 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.758 HG12 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -102.34 116.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.57 111.171 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.538 HG11 HD21 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -133.93 146.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.101 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.566 ' CD2' ' CD1' ' A' ' 197' ' ' PHE . 0.5 OUTLIER -98.68 122.76 42.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.57 110.887 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.795 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -144.97 168.45 20.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.242 1.02 . . . . 0.57 109.929 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 166.25 10.91 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.547 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -30.62 105.37 0.01 OUTLIER Glycine 0 C--N 1.375 2.71 0 O-C-N 124.288 0.993 . . . . 0.57 113.246 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 80.56 93.55 0.05 OUTLIER 'General case' 0 C--N 1.391 2.402 0 CA-C-O 124.741 2.21 . . . . 0.57 113.338 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.795 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 1.2 p-80 . . . . . 0 C--N 1.371 1.506 0 CA-C-N 113.729 -1.578 . . . . 0.57 110.693 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 124.484 2.088 . . . . 0.57 109.644 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.448 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -99.78 -160.36 0.8 Allowed 'General case' 0 C--N 1.362 1.145 0 CA-C-N 114.145 -1.388 . . . . 0.57 112.027 177.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.503 ' CB ' ' CG1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -113.13 139.36 48.8 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-N 115.23 -0.895 . . . . 0.91 110.85 176.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -100.16 92.47 1.11 Allowed Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.426 -1.261 . . . . 0.57 112.798 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER 69.95 50.07 0.48 Allowed 'General case' 0 C--N 1.377 1.779 0 CA-C-O 122.596 1.189 . . . . 0.57 112.132 175.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 176.13 19.99 Favored Glycine 0 C--N 1.357 1.695 0 N-CA-C 108.217 -1.953 . . . . 0.57 108.217 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 240' ' ' TYR . . . -44.46 -33.57 3.2 Favored Glycine 0 C--N 1.379 2.952 0 CA-C-O 122.198 0.888 . . . . 0.57 112.252 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 180' ' ' ILE . 3.1 mm -45.24 168.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 O-C-N 121.556 -0.967 . . . . 0.57 111.722 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -148.17 -39.09 0.18 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.86 0.838 . . . . 0.57 110.102 177.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -176.63 179.94 1.07 Allowed 'General case' 0 C--N 1.363 1.176 0 CA-C-N 115.32 -0.855 . . . . 0.57 111.042 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.426 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -153.35 141.86 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.57 110.889 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.14 152.42 33.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.57 111.142 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.725 -0.67 . . . . 0.57 109.551 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 -151.56 7.98 Favored Glycine 0 C--N 1.367 2.255 0 CA-C-N 114.996 -1.002 . . . . 0.57 110.905 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.33 88.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.707 2.272 . . . . 0.57 112.958 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.25 118.11 1.32 Allowed Glycine 0 C--N 1.37 2.436 0 N-CA-C 109.501 -1.44 . . . . 0.57 109.501 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -61.93 104.79 0.49 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.303 1.049 . . . . 0.57 109.73 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.12 -101.59 1.01 Allowed Glycine 0 C--N 1.377 2.815 0 CA-C-N 114.965 -1.016 . . . . 0.57 112.491 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.15 -37.61 77.82 Favored 'Isoleucine or valine' 0 C--N 1.375 1.691 0 CA-C-O 122.84 1.305 . . . . 0.57 109.36 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.58 126.15 15.67 Favored Glycine 0 C--N 1.369 2.378 0 CA-C-O 122.696 1.165 . . . . 0.57 110.579 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 106.95 -49.82 0.84 Allowed Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.844 -0.678 . . . . 0.57 111.483 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 194' ' ' ASP . 1.0 OUTLIER -45.45 107.61 0.1 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 120.86 0.362 . . . . 0.91 110.88 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -104.31 142.17 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.063 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.536 ' ND1' HG22 ' A' ' 162' ' ' VAL . 17.1 m-70 -134.87 135.83 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.57 110.827 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.758 ' CE2' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -105.22 150.21 25.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.923 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.5 p30 -83.37 93.07 7.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.91 110.865 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.96 80.07 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.991 -0.744 . . . . 0.91 108.991 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -36.22 -45.07 0.43 Allowed 'General case' 0 C--N 1.363 1.194 0 CA-C-O 122.464 1.126 . . . . 0.91 110.053 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 177' ' ' LYS . 8.5 pt-20 -56.54 -176.19 0.01 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-O 125.218 2.437 . . . . 0.91 113.225 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -112.28 89.95 3.21 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.115 -1.616 . . . . 0.57 111.185 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.65 ' HH2' HG21 ' A' ' 215' ' ' THR . 49.1 m95 -71.93 142.84 49.45 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 114.195 -1.366 . . . . 0.57 109.164 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -125.73 126.56 44.81 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-O 123.047 1.403 . . . . 0.57 109.727 -177.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.8 p -103.89 111.58 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.387 -1.279 . . . . 0.57 108.29 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 83.46 65.36 0.02 OUTLIER 'General case' 0 C--N 1.386 2.191 0 CA-C-N 114.386 -1.279 . . . . 0.57 108.867 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.62 124.37 0.03 OUTLIER 'General case' 0 C--N 1.383 2.052 0 CA-C-O 124.532 2.11 . . . . 0.57 108.869 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 204' ' ' THR . . . 149.61 -12.4 1.01 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 120.537 -1.352 . . . . 0.57 112.611 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.83 -115.08 0.64 Allowed Glycine 0 C--N 1.375 2.734 0 CA-C-O 122.955 1.309 . . . . 0.57 110.919 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.739 HG22 ' OH ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -99.18 119.58 38.1 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-O 123.549 1.642 . . . . 0.57 108.059 -175.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.525 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.2 p30 -91.07 142.13 28.09 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-N 114.252 -1.34 . . . . 0.57 110.39 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -63.32 -27.72 69.52 Favored 'General case' 0 C--N 1.375 1.714 0 CA-C-O 124.596 2.141 . . . . 0.57 107.695 -175.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 217' ' ' VAL . 32.8 t80 -59.67 -50.0 75.56 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.346 -1.297 . . . . 0.57 110.886 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -62.13 -41.97 98.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.57 110.917 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.65 HG21 ' HH2' ' A' ' 203' ' ' TRP . 94.3 m -65.11 -45.01 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.57 111.157 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -63.13 -36.66 84.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.57 111.085 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 213' ' ' PHE . 59.7 t -65.87 -41.0 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.57 111.118 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -72.05 -51.08 23.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.57 110.861 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -62.13 -39.96 94.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.91 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.582 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.7 mm -70.18 -47.21 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.57 111.142 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.75 -34.26 64.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.57 112.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -67.82 -36.07 79.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.57 110.814 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -49.33 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.57 110.888 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.4 pp -97.66 -58.62 1.95 Allowed 'General case' 0 C--N 1.353 0.751 0 N-CA-C 113.96 1.096 . . . . 0.57 113.96 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.807 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -43.69 159.28 0.1 Allowed Glycine 0 C--N 1.365 2.145 0 CA-C-O 125.211 2.562 . . . . 0.57 110.936 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -81.12 -67.68 0.76 Allowed 'General case' 0 C--N 1.364 1.226 0 CA-C-N 113.195 -1.502 . . . . 0.57 108.735 -174.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.18 39.0 Favored Glycine 0 C--N 1.368 2.358 0 CA-C-O 123.298 1.499 . . . . 0.57 110.595 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.63 ' CD2' ' N ' ' A' ' 228' ' ' HIS . 3.8 m170 -91.11 165.38 13.53 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-N 113.891 -1.154 . . . . 0.57 110.218 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -84.04 -8.63 59.07 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 114.438 -1.255 . . . . 0.57 110.682 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.84 1.14 2.48 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 122.886 1.327 . . . . 0.57 111.97 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 145.44 57.07 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 114.542 -1.208 . . . . 0.91 109.115 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.45 -44.97 37.59 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 121.717 1.611 . . . . 0.57 112.072 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -32.49 0.19 Allowed 'General case' 0 C--N 1.371 1.525 0 CA-C-N 115.297 -0.865 . . . . 0.57 113.237 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.19 136.73 48.22 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 124.383 2.039 . . . . 0.57 114.81 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -73.76 -23.45 19.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 124.043 1.878 . . . . 0.57 111.102 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.431 ' O ' ' CG ' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -84.08 8.88 14.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.464 -1.698 . . . . 0.57 111.183 -178.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 5.3 t80 -51.81 142.56 24.37 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-O 123.211 1.481 . . . . 0.57 110.601 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 47.4 Cg_endo -78.56 -45.46 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.389 1.393 . . . . 0.57 112.256 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.3 m -57.99 138.01 56.29 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.524 1.154 . . . . 0.57 110.27 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.739 ' OH ' HG22 ' A' ' 210' ' ' THR . 2.5 t80 -75.42 154.14 37.28 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-N 114.052 -1.431 . . . . 0.57 108.652 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 46.2 tttt 178.63 106.34 0.03 OUTLIER 'General case' 0 C--N 1.378 1.838 0 CA-C-O 122.462 1.125 . . . . 0.57 108.796 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -55.19 121.22 8.34 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 124.08 1.895 . . . . 0.57 110.153 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.9 m -125.86 -14.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-N 114.195 -1.366 . . . . 0.57 110.804 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 1.4 p30 60.21 18.23 7.68 Favored 'General case' 0 C--N 1.369 1.453 0 O-C-N 124.31 1.006 . . . . 0.91 111.98 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.544 HG12 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mt 79.05 -10.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.672 0 CA-C-N 114.91 -1.041 . . . . 0.57 113.423 -175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -41.35 99.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.773 -1.566 . . . . 0.57 106.773 -171.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -15.43 14.4 Favored 'General case' 0 C--N 1.373 1.627 0 N-CA-C 114.572 1.323 . . . . 0.57 114.572 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.535 ' CE1' ' CG2' ' A' ' 235' ' ' VAL . 17.2 t80 -53.48 87.29 0.0 OUTLIER 'General case' 0 C--N 1.366 1.323 0 CA-C-O 123.566 1.651 . . . . 0.57 110.563 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.434 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.49 149.2 45.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.452 -1.249 . . . . 1.2 109.172 -178.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -113.38 131.9 55.81 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-O 123.75 1.738 . . . . 0.57 108.664 -176.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.68 134.39 52.16 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 120.413 -1.429 . . . . 0.57 110.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.64 -42.24 83.03 Favored 'General case' 0 C--N 1.373 1.605 0 CA-C-N 115.009 -0.996 . . . . 0.57 109.507 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -41.29 97.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.954 -0.567 . . . . 0.91 110.79 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.6 -55.27 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.91 110.898 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.793 HG21 HG11 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -66.24 -38.35 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.57 111.173 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.642 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.9 mtt180 -68.51 -29.91 68.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.869 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -69.62 -47.92 46.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.57 112.476 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 144' ' ' VAL . 1.1 pt -63.58 -43.18 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 0.57 111.117 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.47 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.07 -34.64 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.57 110.906 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.351 0.644 0 CA-C-O 122.18 0.99 . . . . 0.57 110.915 -178.722 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 122.718 1.247 . . . . 1.2 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -156.04 55.73 0.59 Allowed 'General case' 0 C--N 1.391 2.38 0 CA-C-O 123.927 1.822 . . . . 0.57 108.671 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -166.8 -43.51 0.02 OUTLIER 'General case' 0 C--N 1.381 1.96 0 CA-C-N 113.895 -1.502 . . . . 0.57 109.719 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.506 ' C ' HD13 ' A' ' 114' ' ' ILE . 1.3 t80 -113.68 105.52 13.4 Favored 'General case' 0 C--N 1.367 1.338 0 CA-C-N 115.049 -0.978 . . . . 0.57 110.905 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.711 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -99.13 155.0 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.15 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.506 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 20.7 p -116.68 135.22 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.57 111.091 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -128.43 139.01 52.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.57 110.961 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -122.87 121.98 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.2 110.923 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -82.58 133.15 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.57 111.121 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.755 ' HB2' HG13 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -49.32 -63.0 1.23 Allowed 'General case' 0 C--N 1.372 1.575 0 N-CA-C 107.908 -1.145 . . . . 0.57 107.908 -173.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 161.04 32.45 0.0 OUTLIER 'General case' 0 C--N 1.391 2.397 0 CA-C-N 113.6 -1.637 . . . . 0.57 110.608 -169.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.7 m-85 63.28 -151.1 0.33 Allowed 'General case' 0 C--N 1.386 2.189 0 N-CA-C 106.926 -1.509 . . . . 0.57 106.926 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.608 HG21 ' OE1' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -176.23 166.7 1.61 Allowed Pre-proline 0 C--N 1.38 1.894 0 CA-C-O 123.313 1.53 . . . . 0.57 109.616 -175.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.601 ' HD2' HG22 ' A' ' 122' ' ' THR . 31.5 Cg_endo -70.59 -42.38 2.59 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 120.865 1.043 . . . . 0.57 112.049 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.43 -34.95 35.7 Favored 'General case' 0 C--N 1.38 1.893 0 CA-C-N 114.591 -1.186 . . . . 0.91 112.779 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.3 ttm -93.14 111.86 23.63 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-O 125.67 2.652 . . . . 0.57 109.068 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.26 141.74 54.31 Favored 'General case' 0 C--N 1.384 2.074 0 CA-C-N 113.272 -1.786 . . . . 0.57 109.118 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.14 -51.41 58.1 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.446 -1.316 . . . . 1.2 107.446 -170.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -54.41 -34.76 61.95 Favored 'General case' 0 C--N 1.39 2.345 0 CA-C-N 113.06 -1.882 . . . . 0.91 110.948 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.35 -44.01 69.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.91 110.892 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -61.46 -43.09 96.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.57 111.122 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -66.45 -44.1 83.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.91 110.872 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -49.09 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.57 110.885 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.67 84.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.122 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.1 mm -67.44 -32.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.57 111.126 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -65.51 -48.1 73.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.2 110.88 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.28 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.57 111.136 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.533 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 6.7 m-85 -67.01 -33.87 76.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.57 110.912 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -68.6 -42.08 78.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.57 110.928 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -69.43 -34.17 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.57 111.172 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.725 ' O ' HG22 ' A' ' 145' ' ' THR . 3.7 m95 -83.02 -34.16 26.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.57 110.912 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.9 m -78.78 -50.46 11.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.883 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.662 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.7 p-10 -57.4 -13.51 3.57 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 113.255 0.835 . . . . 0.57 113.255 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 140' ' ' VAL . 21.6 m -114.99 -11.11 12.14 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-N 114.517 -1.22 . . . . 0.57 111.375 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -135.81 149.03 67.62 Favored Pre-proline 0 C--N 1.371 1.541 0 CA-C-O 125.517 2.58 . . . . 0.57 109.057 -177.176 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.37 44.44 1.63 Allowed 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.611 2.208 . . . . 0.57 112.25 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 145' ' ' THR . 0.6 OUTLIER -140.75 89.28 2.25 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 105.649 -1.982 . . . . 0.57 105.649 -173.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -69.43 157.72 36.54 Favored 'General case' 0 C--N 1.38 1.921 0 CA-C-O 125.12 2.391 . . . . 0.57 114.538 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CG ' ' CE1' ' A' ' 138' ' ' PHE . 72.7 m-85 -126.28 155.52 41.79 Favored 'General case' 0 C--N 1.387 2.222 0 CA-C-N 112.879 -1.964 . . . . 0.57 108.903 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 124.62 7.31 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-O 125.302 2.477 . . . . 0.57 107.101 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.505 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 33.2 tttt -82.82 145.38 29.52 Favored 'General case' 0 C--N 1.379 1.861 0 CA-C-N 113.626 -1.624 . . . . 0.57 111.005 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.81 HD12 HG22 ' A' ' 154' ' ' THR . 8.4 pt -135.78 172.37 15.76 Favored 'Isoleucine or valine' 0 C--N 1.38 1.911 0 CA-C-O 123.641 1.686 . . . . 0.57 109.321 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -125.95 29.26 5.93 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-O 123.819 1.771 . . . . 0.57 110.597 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.81 HG22 HD12 ' A' ' 152' ' ' ILE . 1.1 t -80.79 -170.46 2.67 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-N 114.217 -1.356 . . . . 0.57 111.025 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 154' ' ' THR . . . -49.44 -55.24 13.6 Favored Glycine 0 C--N 1.391 3.62 0 CA-C-N 113.812 -1.54 . . . . 0.57 110.929 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.89 138.9 9.6 Favored 'General case' 0 C--N 1.379 1.86 0 N-CA-C 107.663 -1.236 . . . . 0.57 107.663 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -104.07 172.46 6.79 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-N 113.79 -1.55 . . . . 0.57 110.874 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -49.99 -65.45 0.56 Allowed 'General case' 0 C--N 1.38 1.924 0 CA-C-N 113.614 -1.63 . . . . 0.91 106.919 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 193' ' ' GLY . 6.9 mt -97.97 110.06 24.88 Favored 'Isoleucine or valine' 0 C--N 1.371 1.527 0 O-C-N 121.802 -0.561 . . . . 0.57 111.13 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.752 HD23 ' HB3' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -95.34 120.99 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.57 110.887 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.732 HG12 ' CE1' ' A' ' 197' ' ' PHE . 0.1 OUTLIER -104.45 118.12 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.115 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -133.12 146.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.57 111.149 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.68 120.65 42.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.57 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.9 167.26 26.19 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 123.242 1.496 . . . . 0.57 108.214 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 169.26 8.57 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 115.06 -0.973 . . . . 1.2 109.926 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -41.79 133.68 3.72 Favored Glycine 0 C--N 1.387 3.381 0 CA-C-N 114.13 -1.396 . . . . 0.57 109.623 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 85.32 45.14 0.02 OUTLIER 'General case' 0 C--N 1.4 2.792 0 CA-C-O 124.191 1.948 . . . . 0.57 111.203 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 C--N 1.379 1.877 0 CA-C-N 113.512 -1.676 . . . . 0.57 110.978 -179.662 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 123.433 1.587 . . . . 0.57 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.84 -173.08 2.47 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.95 -1.932 . . . . 0.57 110.36 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.24 -178.66 3.51 Favored 'General case' 0 C--N 1.377 1.789 0 CA-C-N 113.044 -1.889 . . . . 0.91 112.862 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.73 150.22 21.06 Favored Glycine 0 C--N 1.385 3.285 0 CA-C-N 113.47 -1.696 . . . . 0.57 109.029 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.24 8.33 5.26 Favored 'General case' 0 C--N 1.376 1.748 0 CA-C-O 122.721 1.248 . . . . 0.57 111.617 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 159.22 -104.53 0.25 Allowed Glycine 0 C--N 1.378 2.9 0 CA-C-O 122.869 1.261 . . . . 0.57 110.185 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.31 -126.15 35.92 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-O 123.635 1.686 . . . . 0.57 110.388 176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 181' ' ' LEU . 2.3 pp -79.03 -173.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.876 0 CA-C-N 113.745 -1.227 . . . . 0.57 109.557 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.801 HD22 ' CE1' ' A' ' 240' ' ' TYR . 9.4 tp -109.83 -37.1 5.73 Favored 'General case' 0 C--N 1.377 1.765 0 N-CA-C 115.763 1.764 . . . . 0.57 115.763 170.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 215' ' ' THR . . . -178.78 179.84 0.68 Allowed 'General case' 0 C--N 1.384 2.083 0 CA-C-N 113.787 -1.551 . . . . 0.57 111.117 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -161.59 136.04 7.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.57 110.848 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -135.02 144.21 47.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.57 111.108 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -79.56 175.88 10.21 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-O 123.244 1.497 . . . . 0.57 109.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.84 -173.39 40.63 Favored Glycine 0 C--N 1.383 3.172 0 CA-C-O 123.158 1.421 . . . . 0.57 111.312 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.52 71.83 3.79 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.56 2.173 . . . . 0.57 111.506 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.13 -123.03 1.0 Allowed Glycine 0 C--N 1.382 3.087 0 CA-C-O 123.931 1.85 . . . . 0.57 110.184 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.0 m -125.41 -62.89 1.18 Allowed 'General case' 0 C--N 1.392 2.417 0 CA-C-O 123.386 1.565 . . . . 0.57 108.205 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.06 -71.3 0.7 Allowed Glycine 0 C--N 1.394 3.802 0 N-CA-C 108.861 -1.696 . . . . 0.57 108.861 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.76 56.15 Favored 'Isoleucine or valine' 0 C--N 1.384 2.1 0 CA-C-O 125.815 2.721 . . . . 0.57 108.885 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.3 134.94 29.12 Favored Glycine 0 C--N 1.393 3.746 0 N-CA-C 106.562 -2.615 . . . . 0.57 106.562 -172.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 102.37 -19.8 47.02 Favored Glycine 0 C--N 1.368 2.308 0 N-CA-C 110.172 -1.171 . . . . 0.57 110.172 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 160' ' ' LEU . 1.1 m-20 -73.96 124.86 26.99 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.993 -1.298 . . . . 0.91 110.922 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -107.3 142.09 37.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.57 111.083 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -124.69 129.39 50.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.57 110.925 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.732 ' CE1' HG12 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -108.62 150.18 27.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.57 110.919 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -79.5 91.25 5.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.91 110.887 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 122' ' ' THR . 9.9 tp10 -64.74 -47.51 77.96 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-N 114.977 -1.01 . . . . 0.91 108.815 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.51 -44.9 0.06 Allowed 'General case' 0 C--N 1.374 1.633 0 CA-C-O 122.566 1.174 . . . . 0.91 111.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 203' ' ' TRP . 1.4 mp0 -62.58 -178.14 0.18 Allowed 'General case' 0 C--N 1.382 1.999 0 CA-C-O 127.219 3.39 . . . . 0.91 106.948 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.24 78.0 1.18 Allowed 'General case' 0 C--N 1.379 1.848 0 O-C-N 118.664 -2.522 . . . . 0.57 108.241 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.72 ' CH2' HD12 ' A' ' 181' ' ' LEU . 21.4 m95 -74.0 143.16 45.7 Favored 'General case' 0 C--N 1.376 1.744 0 CA-C-N 113.827 -1.533 . . . . 0.57 109.154 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 60.6 p -114.2 123.35 49.36 Favored 'General case' 0 C--N 1.377 1.8 0 CA-C-O 124.349 2.023 . . . . 0.57 108.905 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.1 p -96.11 111.68 23.64 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-O 123.929 1.823 . . . . 0.57 108.497 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 77.34 48.96 0.05 Allowed 'General case' 0 C--N 1.388 2.276 0 CA-C-O 124.57 2.129 . . . . 0.57 110.626 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 t -129.09 -91.78 0.47 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 114.242 -1.345 . . . . 0.57 109.651 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 244' ' ' ASP . . . -177.91 -45.07 0.07 OUTLIER Glycine 0 C--N 1.387 3.381 0 C-N-CA 119.356 -1.402 . . . . 0.57 111.985 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.51 -133.65 0.03 OUTLIER Glycine 0 C--N 1.393 3.743 0 CA-C-O 126.708 3.393 . . . . 0.57 109.598 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.589 HG22 ' OH ' ' A' ' 240' ' ' TYR . 41.5 p -67.71 130.63 43.59 Favored 'General case' 0 C--N 1.37 1.473 0 O-C-N 119.582 -2.128 . . . . 0.57 110.945 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.834 ' CB ' HD11 ' A' ' 245' ' ' ILE . 17.2 p30 -134.09 149.52 51.11 Favored 'General case' 0 C--N 1.38 1.923 0 CA-C-N 113.338 -1.755 . . . . 0.57 108.476 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.0 pt? -71.08 -23.92 62.22 Favored 'General case' 0 C--N 1.375 1.702 0 CA-C-O 124.836 2.255 . . . . 0.57 111.111 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -54.51 -39.29 67.45 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.506 -1.679 . . . . 0.57 110.855 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -55.0 -51.13 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.57 110.895 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.581 HG23 HD23 ' A' ' 181' ' ' LEU . 11.7 p -66.53 -40.41 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.131 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.79 96.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.57 111.09 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.69 HG11 ' HZ ' ' A' ' 248' ' ' PHE . 24.6 t -65.31 -40.83 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.57 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.417 ' HA ' ' SD ' ' A' ' 236' ' ' MET . 66.3 t60 -69.29 -44.97 70.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.57 110.858 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 220' ' ' ILE . 2.5 pt-20 -59.64 -41.49 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.91 110.936 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.483 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 49.8 mt -66.48 -40.86 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.181 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.54 -33.7 87.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.57 112.441 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -43.35 96.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.847 0.356 . . . . 0.57 110.889 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -37.36 73.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.863 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 ' CE3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -45.47 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.367 1.343 0 CA-C-O 124.434 2.064 . . . . 0.57 114.26 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -158.11 -88.74 0.07 OUTLIER Glycine 0 C--N 1.377 2.828 0 C-N-CA 118.654 -1.736 . . . . 0.57 110.837 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.391 2.412 0 O-C-N 125.66 1.447 . . . . 0.57 110.581 -173.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 99.07 98.28 2.14 Favored Glycine 0 C--N 1.385 3.303 0 C-N-CA 118.894 -1.622 . . . . 0.57 110.281 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 172.75 0.16 Allowed 'General case' 0 C--N 1.395 2.556 0 CA-C-O 124.3 2.0 . . . . 0.57 108.188 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -131.61 -6.42 3.67 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 117.294 -1.762 . . . . 0.57 110.408 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.1 t 83.28 -12.25 0.87 Allowed 'General case' 0 C--N 1.391 2.397 0 CA-C-N 115.299 -0.864 . . . . 0.57 112.049 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.68 148.17 45.49 Favored Pre-proline 0 C--N 1.385 2.129 0 N-CA-C 106.135 -1.802 . . . . 0.91 106.135 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.33 -16.64 35.72 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.031 2.487 . . . . 0.57 112.273 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 1.89 2.49 Favored 'General case' 0 C--N 1.38 1.91 0 N-CA-C 116.305 1.965 . . . . 0.57 116.305 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -111.5 143.1 42.89 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-O 124.877 2.275 . . . . 0.57 108.687 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.646 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -72.91 -11.83 15.17 Favored 'Isoleucine or valine' 0 C--N 1.382 1.985 0 CA-C-N 112.322 -2.217 . . . . 0.57 111.842 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 218' ' ' HIS . 0.3 OUTLIER -108.29 26.67 10.16 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-N 114.437 -1.256 . . . . 0.57 110.349 -178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.588 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 17.0 t80 -54.64 142.62 52.07 Favored Pre-proline 0 C--N 1.371 1.506 0 CA-C-O 122.292 1.044 . . . . 0.57 108.914 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.588 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 76.6 Cg_exo -54.92 -49.34 17.0 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.022 1.814 . . . . 0.57 112.762 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 m -62.9 136.03 57.63 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 123.303 1.525 . . . . 0.57 110.459 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.801 ' CE1' HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -94.21 82.96 4.17 Favored 'General case' 0 C--N 1.382 2.001 0 CA-C-O 124.521 2.105 . . . . 0.57 108.555 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 243' ' ' VAL . 1.4 tmtt? -111.69 100.14 8.72 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-O 123.711 1.72 . . . . 0.57 108.89 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -53.05 118.68 3.92 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-O 125.666 2.651 . . . . 0.57 110.629 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -96.12 11.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 CA-C-N 112.499 -2.137 . . . . 0.57 111.406 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.421 ' HB2' ' HA2' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 86.68 -16.01 0.42 Allowed 'General case' 0 C--N 1.377 1.768 0 O-C-N 125.247 1.592 . . . . 0.91 111.918 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 211' ' ' ASN . 3.6 mt 75.64 -49.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.389 2.284 0 N-CA-C 114.296 1.221 . . . . 0.57 114.296 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -46.26 -28.86 1.4 Allowed 'General case' 0 C--N 1.368 1.383 0 N-CA-C 113.395 0.887 . . . . 0.57 113.395 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 p -108.19 9.47 28.13 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-O 122.592 1.187 . . . . 0.57 111.295 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.69 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 9.9 t80 -68.01 86.54 0.25 Allowed 'General case' 0 C--N 1.377 1.775 0 CA-C-O 125.023 2.344 . . . . 0.57 108.97 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.443 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -108.63 153.51 23.3 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-O 124.748 2.213 . . . . 1.2 107.204 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.687 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.4 131.82 54.07 Favored 'General case' 0 C--N 1.381 1.938 0 CA-C-O 125.874 2.75 . . . . 0.57 105.867 -172.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 45.2 t -66.45 138.28 57.43 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.359 -2.088 . . . . 0.57 110.26 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.92 -43.21 86.13 Favored 'General case' 0 C--N 1.393 2.49 0 CA-C-N 113.612 -1.631 . . . . 0.57 108.614 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.289 -0.882 . . . . 0.91 110.87 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.7 OUTLIER -64.06 -55.08 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.91 110.86 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 256' ' ' ARG . 22.7 pt -66.08 -35.23 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.57 111.166 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.692 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -70.35 -35.44 73.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 1.2 110.852 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.51 -49.58 64.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.57 112.469 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.32 -45.65 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.57 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.485 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.11 -24.04 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.57 110.92 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--N 1.367 1.354 0 CA-C-O 123.388 1.566 . . . . 0.57 111.03 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 107.717 -1.216 . . . . 1.2 107.717 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.42 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.383 2.03 0 CA-C-N 113.692 -1.595 . . . . 0.57 111.402 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.797 ' HA ' HD22 ' A' ' 147' ' ' LEU . 5.8 p-80 -53.04 -35.91 59.99 Favored 'General case' 0 C--N 1.382 2.008 0 CA-C-N 112.91 -1.95 . . . . 0.57 109.954 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -111.11 111.59 22.79 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.493 -1.38 . . . . 0.57 110.891 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -111.24 144.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.57 111.085 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.767 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -105.94 158.47 16.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.57 111.149 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.928 ' CE2' HD13 ' A' ' 159' ' ' ILE . 15.7 m-85 -140.6 159.59 41.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.57 110.886 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.754 HH11 ' N ' ' A' ' 156' ' ' MET . 12.3 ttm180 -150.0 129.62 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 1.2 110.854 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.751 HD11 ' CD1' ' A' ' 134' ' ' ILE . 1.1 mm -99.09 128.92 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.57 111.08 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.61 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.373 1.624 0 CA-C-O 123.325 1.536 . . . . 0.57 112.682 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -179.18 24.63 0.0 OUTLIER 'General case' 0 C--N 1.378 1.822 0 CA-C-N 113.595 -1.639 . . . . 0.57 107.767 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.3 m-85 82.87 -152.56 0.01 OUTLIER 'General case' 0 C--N 1.392 2.415 0 N-CA-C 105.504 -2.036 . . . . 0.57 105.504 170.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.2 167.56 14.1 Favored Pre-proline 0 C--N 1.382 2.01 0 N-CA-C 108.542 -0.91 . . . . 0.57 108.542 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -57.04 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 121.303 1.335 . . . . 0.57 114.305 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.32 -59.05 3.1 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.837 -1.529 . . . . 0.91 112.986 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.466 ' HG2' ' CG2' ' A' ' 205' ' ' THR . 2.4 mtm -63.39 137.17 58.07 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 123.903 1.811 . . . . 0.57 108.902 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -89.49 143.86 26.48 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 106.095 -1.817 . . . . 0.57 106.095 -171.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.03 -49.67 42.47 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.728 -1.582 . . . . 1.2 106.728 -167.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.74 -34.79 62.98 Favored 'General case' 0 C--N 1.392 2.425 0 CA-C-N 112.238 -2.255 . . . . 0.91 110.884 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -44.03 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.91 110.877 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -65.03 -49.32 80.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.57 111.15 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -56.79 -44.07 81.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.91 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -38.03 89.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.88 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -65.92 -40.64 91.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.086 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.751 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -66.97 -42.56 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.57 111.178 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -62.05 -44.83 95.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 1.2 110.841 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.27 96.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.57 110.91 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.654 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -60.87 -44.69 96.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.57 111.117 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 134' ' ' ILE . 14.4 m-85 -62.53 -33.68 75.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.57 110.901 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.455 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -68.28 -39.36 82.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.884 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.6 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -72.3 -33.87 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.57 111.189 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.608 ' O ' HG23 ' A' ' 145' ' ' THR . 9.8 m95 -83.16 -34.06 26.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.57 110.923 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.2 m -77.99 -49.13 14.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.57 110.852 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.616 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.9 p-10 -59.99 -13.06 9.58 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 122.049 0.928 . . . . 0.57 112.349 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.616 HG13 ' OD1' ' A' ' 143' ' ' ASN . 17.6 m -112.87 9.45 8.12 Favored 'Isoleucine or valine' 0 C--N 1.382 2.009 0 CA-C-N 114.326 -1.306 . . . . 0.57 112.757 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.3 p -149.32 151.62 34.15 Favored Pre-proline 0 C--N 1.378 1.812 0 CA-C-O 126.201 2.905 . . . . 0.57 110.677 -171.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.57 -29.29 2.38 Favored 'Trans proline' 0 C--N 1.365 1.432 0 O-C-N 117.31 -1.995 . . . . 0.57 110.923 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 112' ' ' HIS . 3.6 mt -73.3 111.98 8.94 Favored 'General case' 0 C--N 1.376 1.76 0 N-CA-C 106.543 -1.651 . . . . 0.57 106.543 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -69.48 157.75 36.52 Favored 'General case' 0 C--N 1.381 1.963 0 CA-C-O 124.369 2.033 . . . . 0.57 116.279 170.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 17.0 m-85 -130.4 154.25 47.9 Favored 'General case' 0 C--N 1.387 2.213 0 CA-C-N 112.675 -2.057 . . . . 0.57 109.141 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 m -156.15 109.13 2.65 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-O 125.442 2.544 . . . . 0.57 108.83 -171.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.53 149.53 23.56 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.323 -1.762 . . . . 0.57 112.394 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -160.17 -172.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.385 2.109 0 CA-C-N 113.833 -1.53 . . . . 0.57 110.334 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -163.36 98.17 0.91 Allowed 'General case' 0 C--N 1.38 1.905 0 N-CA-C 108.555 -0.905 . . . . 0.57 108.555 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 155' ' ' GLY . 17.6 m -147.03 -81.59 0.14 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 115.288 -0.869 . . . . 0.57 109.92 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.634 ' H ' ' NH1' ' A' ' 117' ' ' ARG . . . -136.39 51.07 0.82 Allowed Glycine 0 C--N 1.384 3.228 0 N-CA-C 107.404 -2.278 . . . . 0.57 107.404 -169.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.754 ' N ' HH11 ' A' ' 117' ' ' ARG . 5.0 ttm 72.19 135.98 0.04 OUTLIER 'General case' 0 C--N 1.404 2.977 0 O-C-N 126.362 1.86 . . . . 0.57 108.274 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.22 163.67 27.23 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.27 -1.752 . . . . 0.57 106.27 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 158' ' ' ASP 0.288 0.0 OUTLIER -18.7 -73.62 0.01 OUTLIER 'General case' 0 C--N 1.377 1.803 0 CA-C-N 112.875 -1.966 . . . . 0.91 113.996 165.587 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.928 HD13 ' CE2' ' A' ' 116' ' ' TYR . 2.5 mp -96.15 109.8 23.43 Favored 'Isoleucine or valine' 0 C--N 1.383 2.063 0 O-C-N 126.9 2.625 . . . . 0.57 111.215 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 122.49 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.57 110.879 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.637 HG23 HD13 ' A' ' 118' ' ' ILE . 1.4 m -110.44 121.44 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.08 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.646 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.13 139.97 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.087 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -90.19 118.84 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.946 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.46 169.18 20.07 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 118.861 -1.135 . . . . 0.57 109.162 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 167.3 9.88 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 115.245 -0.889 . . . . 1.2 110.398 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -40.11 129.02 2.78 Favored Glycine 0 C--N 1.393 3.726 0 O-C-N 125.201 1.563 . . . . 0.57 111.699 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.69 104.04 0.06 Allowed 'General case' 0 C--N 1.406 3.041 0 CA-C-O 124.893 2.283 . . . . 0.57 112.271 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 . . . . . 0 C--N 1.386 2.187 0 CA-C-N 113.823 -1.535 . . . . 0.57 110.405 -177.117 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 125.549 2.595 . . . . 0.57 109.023 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -64.93 178.06 0.88 Allowed 'General case' 0 C--N 1.377 1.784 0 CA-C-N 111.945 -2.389 . . . . 0.57 112.051 177.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 180' ' ' ILE . 2.5 p-10 -58.37 -160.27 0.0 OUTLIER 'General case' 0 C--N 1.386 2.19 0 CA-C-O 124.519 2.104 . . . . 0.91 114.479 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -172.63 101.39 0.16 Allowed Glycine 0 C--N 1.391 3.602 0 C-N-CA 117.261 -2.4 . . . . 0.57 109.205 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.63 96.64 0.07 Allowed 'General case' 0 C--N 1.39 2.345 0 CA-C-O 123.472 1.605 . . . . 0.57 113.056 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.27 -152.37 25.45 Favored Glycine 0 C--N 1.381 3.065 0 C-N-CA 119.02 -1.562 . . . . 0.57 110.596 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.83 -132.91 40.66 Favored Glycine 0 C--N 1.376 2.784 0 N-CA-C 111.788 -0.525 . . . . 0.57 111.788 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -46.97 168.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.061 0 O-C-N 125.806 1.533 . . . . 0.57 113.196 175.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 215' ' ' THR . 1.6 tp -121.94 -92.26 0.54 Allowed 'General case' 0 C--N 1.359 1.008 0 CA-C-O 126.781 3.181 . . . . 0.57 112.907 172.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.478 ' HB2' ' CG2' ' A' ' 215' ' ' THR . . . -106.22 179.73 4.18 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 112.524 -2.126 . . . . 0.57 111.1 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 54.4 p-80 -163.12 135.84 5.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.856 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -132.7 166.74 21.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.57 111.072 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -71.71 0.6 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 117.491 -1.684 . . . . 0.57 108.083 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.23 0.55 Allowed Glycine 0 C--N 1.386 3.331 0 C-N-CA 120.696 -0.764 . . . . 0.57 112.579 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -53.16 -47.29 28.3 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 121.757 1.638 . . . . 0.57 110.755 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.99 -169.74 23.22 Favored Glycine 0 C--N 1.378 2.883 0 C-N-CA 118.958 -1.592 . . . . 0.57 113.857 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 78.0 83.09 0.07 Allowed 'General case' 0 C--N 1.392 2.436 0 CA-C-O 124.137 1.922 . . . . 0.57 107.649 173.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.63 -103.65 1.99 Allowed Glycine 0 C--N 1.394 3.781 0 N-CA-C 105.155 -3.178 . . . . 0.57 105.155 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 192' ' ' GLY . 1.2 tp -61.88 -47.18 94.44 Favored 'Isoleucine or valine' 0 C--N 1.387 2.208 0 CA-C-O 127.102 3.334 . . . . 0.57 110.691 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -63.83 158.64 40.51 Favored Glycine 0 N--CA 1.404 -3.469 0 O-C-N 117.019 -3.551 . . . . 0.57 108.827 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.29 -8.11 19.88 Favored Glycine 0 C--N 1.375 2.743 0 CA-C-N 113.782 -1.209 . . . . 0.57 113.853 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.45 108.36 18.98 Favored 'General case' 0 C--N 1.378 1.842 0 CA-C-N 114.464 -0.868 . . . . 0.91 110.835 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -106.18 151.0 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.57 111.137 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.646 ' CD2' HG22 ' A' ' 162' ' ' VAL . 6.7 m170 -135.28 151.21 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.57 110.834 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -114.37 139.7 49.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.57 110.844 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.525 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.3 p-10 -66.92 82.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.91 110.836 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.15 69.78 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 106.629 -1.619 . . . . 0.91 106.629 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -48.37 19.04 Favored 'General case' 0 C--N 1.389 2.297 0 O-C-N 125.835 1.96 . . . . 0.91 107.548 -163.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.89 171.71 0.02 OUTLIER 'General case' 0 C--N 1.392 2.417 0 CA-C-O 127.167 3.365 . . . . 0.91 116.356 172.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -97.06 100.51 12.01 Favored 'General case' 0 C--N 1.378 1.82 0 O-C-N 119.19 -2.194 . . . . 0.57 111.117 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.473 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 47.9 m95 -78.54 152.89 31.69 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.869 -1.514 . . . . 0.57 109.089 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.7 105.6 9.44 Favored 'General case' 0 C--N 1.378 1.805 0 CA-C-O 124.523 2.106 . . . . 0.57 110.599 -175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 125' ' ' MET . 4.3 p -96.93 107.29 19.78 Favored 'General case' 0 C--N 1.365 1.25 0 CA-C-N 114.492 -1.231 . . . . 0.57 110.064 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 53.7 46.92 24.92 Favored 'General case' 0 C--N 1.393 2.476 0 CA-C-O 125.371 2.51 . . . . 0.57 110.846 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 t -134.26 -74.97 0.47 Allowed 'General case' 0 C--N 1.387 2.221 0 CA-C-N 112.5 -2.137 . . . . 0.57 107.793 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.55 64.01 0.05 OUTLIER Glycine 0 C--N 1.394 3.782 0 C-N-CA 118.24 -1.933 . . . . 0.57 111.214 -171.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.64 -142.01 6.14 Favored Glycine 0 C--N 1.387 3.372 0 CA-C-O 123.483 1.602 . . . . 0.57 111.132 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 56.2 m -68.24 118.02 10.81 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.841 -1.18 . . . . 0.57 110.456 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.52 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.4 p30 -92.49 145.47 24.43 Favored 'General case' 0 C--N 1.378 1.826 0 O-C-N 126.117 2.136 . . . . 0.57 112.519 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.684 HD13 ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -73.49 -32.14 64.13 Favored 'General case' 0 C--N 1.391 2.395 0 CA-C-O 124.424 2.059 . . . . 0.57 107.508 -174.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.902 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.3 t80 -49.57 -50.12 43.69 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-N 113.104 -1.862 . . . . 0.57 110.891 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.447 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -57.18 -42.68 81.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.57 110.933 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . 1.035 HG23 HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.62 -45.04 80.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.095 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.71 -47.77 79.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.57 111.063 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 213' ' ' PHE . 2.8 t -59.96 -41.48 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.57 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.76 -36.59 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.832 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -43.23 86.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.91 110.807 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.2 mm -64.02 -45.28 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.57 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.94 87.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.819 -0.705 . . . . 0.57 112.441 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -42.61 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.57 110.821 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 t -71.07 -55.63 7.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.872 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 220' ' ' ILE . 0.2 OUTLIER -78.07 -164.31 0.52 Allowed 'General case' 0 C--N 1.382 1.984 0 N-CA-C 116.305 1.965 . . . . 0.57 116.305 171.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 224' ' ' LEU . . . 68.75 -146.03 44.5 Favored Glycine 0 C--N 1.38 2.998 0 N-CA-C 104.487 -3.445 . . . . 0.57 104.487 169.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 258' ' ' ILE . 0.0 OUTLIER -124.1 -82.18 0.64 Allowed 'General case' 0 C--N 1.38 1.916 0 CA-C-N 111.738 -2.231 . . . . 0.57 110.481 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.91 -157.27 7.29 Favored Glycine 0 C--N 1.379 2.929 0 CA-C-O 123.871 1.817 . . . . 0.57 108.843 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.7 m-70 -103.2 -171.34 1.93 Allowed 'General case' 0 C--N 1.376 1.738 0 CA-C-N 113.777 -1.212 . . . . 0.57 111.934 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.791 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -116.32 -31.26 5.68 Favored 'General case' 0 C--N 1.386 2.166 0 CA-C-N 113.93 -1.487 . . . . 0.57 108.985 -176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 m 82.11 23.11 0.23 Allowed 'General case' 0 C--N 1.401 2.828 0 CA-C-O 123.095 1.426 . . . . 0.57 114.556 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -127.99 151.13 75.38 Favored Pre-proline 0 N--CA 1.418 -2.067 0 CA-C-N 113.105 -1.861 . . . . 0.91 108.345 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.615 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 71.0 Cg_exo -58.23 -28.07 82.91 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.168 1.912 . . . . 0.57 115.289 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.422 ' HE3' ' H ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -70.35 -33.74 71.82 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 111.295 -2.684 . . . . 0.57 117.884 173.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -55.3 131.23 45.09 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 113.778 -1.555 . . . . 0.57 109.483 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.453 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -76.32 -3.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 CA-C-O 125.927 2.775 . . . . 0.57 112.366 -176.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 11.2 mtp -122.82 -10.77 8.23 Favored 'General case' 0 C--N 1.374 1.668 0 CA-C-N 112.847 -1.978 . . . . 0.57 112.153 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -38.66 141.82 0.55 Allowed Pre-proline 0 C--N 1.373 1.605 0 CA-C-O 125.496 2.57 . . . . 0.57 113.638 174.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.94 -50.04 12.65 Favored 'Trans proline' 0 C--N 1.37 1.667 0 O-C-N 118.831 -1.194 . . . . 0.57 111.122 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 39.5 m -44.23 118.71 1.58 Allowed 'General case' 0 C--N 1.366 1.288 0 CA-C-O 123.404 1.573 . . . . 0.57 110.507 -172.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.519 ' CE2' HD13 ' A' ' 181' ' ' LEU . 25.1 t80 -92.92 157.56 16.28 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.555 -1.657 . . . . 0.57 108.326 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.96 126.14 0.02 OUTLIER 'General case' 0 C--N 1.392 2.434 0 N-CA-C 105.448 -2.056 . . . . 0.57 105.448 169.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.67 120.45 7.3 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 125.491 2.567 . . . . 0.57 109.497 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 1.4 p -128.27 -16.05 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 CA-C-N 112.538 -2.119 . . . . 0.57 110.973 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 244' ' ' ASP 0.289 0.0 OUTLIER 84.51 178.22 0.05 OUTLIER 'General case' 0 C--N 1.371 1.54 0 O-C-N 126.872 2.607 . . . . 0.91 111.782 -174.289 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.859 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.8 mp -93.81 -35.64 6.57 Favored 'Isoleucine or valine' 0 C--N 1.382 1.983 0 N-CA-C 118.322 2.712 . . . . 0.57 118.322 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.77 -14.52 0.05 OUTLIER 'General case' 0 C--N 1.377 1.784 0 N-CA-C 117.224 2.305 . . . . 0.57 117.224 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.413 ' HB ' ' CG2' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -124.59 -21.53 4.83 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 114.112 -1.404 . . . . 0.57 110.504 -175.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.453 ' CZ ' HG22 ' A' ' 235' ' ' VAL . 67.3 t80 -61.29 88.67 0.02 OUTLIER 'General case' 0 C--N 1.378 1.845 0 CA-C-O 125.566 2.603 . . . . 0.57 108.488 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.07 154.07 29.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 112.816 -1.993 . . . . 1.2 107.609 -178.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.631 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -124.42 127.84 48.13 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 125.745 2.688 . . . . 0.57 105.393 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 143.27 58.06 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.214 -2.179 . . . . 0.57 111.916 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -61.0 -45.29 95.42 Favored 'General case' 0 C--N 1.392 2.43 0 CA-C-N 113.842 -1.526 . . . . 0.57 107.996 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.71 -38.51 81.83 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 115.644 -0.707 . . . . 0.91 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 59.3 t0 -64.17 -55.09 24.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.91 110.842 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.06 -34.82 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.164 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.449 ' N ' HG13 ' A' ' 255' ' ' ILE . 10.2 mtt180 -70.15 -32.35 70.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.882 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.81 62.41 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.655 -0.783 . . . . 0.57 112.499 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.66 ' HA ' HD21 ' A' ' 226' ' ' LEU . 1.0 OUTLIER -64.8 -44.59 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.57 111.176 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.474 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.17 -19.18 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.57 110.914 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.366 1.326 0 CA-C-O 122.122 0.963 . . . . 0.57 108.667 -175.604 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 . . . . . 0 N--CA 1.435 -1.195 0 CA-C-O 122.303 1.049 . . . . 1.2 109.278 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.83 155.44 14.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.364 -0.976 . . . . 0.57 108.364 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.533 ' H ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 81.96 -41.72 0.14 Allowed 'General case' 0 C--N 1.377 1.777 0 CA-C-O 122.187 0.994 . . . . 0.57 110.622 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -114.4 131.47 56.56 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.579 -1.191 . . . . 0.57 110.868 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 148' ' ' LYS . 1.1 mm -127.45 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.57 111.12 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.56 HG22 HG12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -106.0 157.81 17.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.57 111.098 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE1' HD12 ' A' ' 118' ' ' ILE . 16.7 t80 -145.29 160.02 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.57 110.914 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.598 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 3.9 tpt85 -146.49 121.97 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.841 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.68 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -95.53 125.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.57 111.122 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -61.83 -179.37 0.19 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.616 1.674 . . . . 0.57 111.268 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.09 51.37 0.98 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.505 -1.372 . . . . 0.57 110.824 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 5.2 m-85 44.19 -150.15 0.05 Allowed 'General case' 0 C--N 1.366 1.323 0 CA-C-N 115.239 -0.891 . . . . 0.57 109.045 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.592 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -165.84 168.24 8.07 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-O 122.286 1.041 . . . . 0.57 110.454 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 122' ' ' THR . 32.5 Cg_endo -68.06 -36.23 17.85 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 121.444 1.429 . . . . 0.57 112.963 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -84.84 -45.42 12.32 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.987 1.375 . . . . 0.91 113.134 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.498 ' CE ' ' CE2' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -77.92 110.09 12.52 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 123.68 1.705 . . . . 0.57 109.482 -176.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -71.27 135.89 47.67 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.947 -1.479 . . . . 0.57 109.192 -176.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -61.61 -50.83 70.98 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 108.448 -0.945 . . . . 1.2 108.448 -170.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.56 -34.86 69.63 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 113.083 -1.871 . . . . 0.91 110.896 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -39.71 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.91 110.826 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -64.97 -49.74 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.57 111.153 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -41.61 91.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.91 110.896 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -42.3 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.57 110.863 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.736 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.5 -48.88 68.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.57 111.092 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.575 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -64.35 -31.95 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.57 111.122 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.95 -46.71 70.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 1.2 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -62.82 -37.2 85.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.57 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.52 ' CB ' HG23 ' A' ' 217' ' ' VAL . . . -68.06 -38.5 82.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.57 111.065 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' HG22 ' A' ' 134' ' ' ILE . 5.5 m-85 -67.06 -33.83 76.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.57 110.919 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -70.21 -44.65 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.57 110.871 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 250' ' ' LEU . 7.7 p -68.54 -33.6 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.57 111.16 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.46 -34.31 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.57 110.854 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 138' ' ' PHE . 29.3 m -72.22 -49.45 35.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.57 110.863 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -60.66 -11.97 8.92 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-O 121.881 0.848 . . . . 0.57 112.706 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 145' ' ' THR . 16.9 m -111.98 -5.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.367 1.358 0 CA-C-N 114.792 -1.094 . . . . 0.57 112.69 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.94 HG21 HD13 ' A' ' 224' ' ' LEU . 21.0 p -140.63 146.38 44.43 Favored Pre-proline 0 C--N 1.365 1.261 0 CA-C-O 124.594 2.14 . . . . 0.57 111.115 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -77.19 -25.54 8.48 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 121.218 1.278 . . . . 0.57 111.77 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -77.68 96.09 4.77 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 122.668 1.223 . . . . 0.57 109.518 -176.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -77.04 160.75 28.86 Favored 'General case' 0 C--N 1.363 1.184 0 CA-C-N 115.168 -0.924 . . . . 0.57 112.198 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.487 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -133.05 140.77 47.88 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 107.702 -1.222 . . . . 0.57 107.702 -173.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.0 m -155.67 135.56 12.78 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 123.553 1.644 . . . . 0.57 109.387 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -74.97 144.17 43.3 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 114.513 -1.222 . . . . 0.57 109.213 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 115' ' ' THR . 6.2 pt -125.14 -179.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.364 1.213 0 CA-C-O 121.947 0.879 . . . . 0.57 109.887 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -134.41 63.87 1.61 Allowed 'General case' 0 C--N 1.37 1.483 0 CA-C-O 122.93 1.348 . . . . 0.57 111.299 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.76 95.83 1.57 Allowed 'General case' 0 C--N 1.373 1.624 0 CA-C-N 114.553 -1.203 . . . . 0.57 110.357 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 45.66 -137.63 7.04 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 122.418 1.01 . . . . 0.57 111.681 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 151.53 46.96 Favored 'General case' 0 C--N 1.366 1.307 0 CA-C-O 123.145 1.45 . . . . 0.57 110.74 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 117' ' ' ARG . . . -133.68 163.64 28.99 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 114.497 -1.229 . . . . 0.57 109.814 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.462 ' H ' ' HB ' ' A' ' 115' ' ' THR . 53.6 m-20 -46.06 -52.0 12.75 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 108.245 -1.02 . . . . 0.91 108.245 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 193' ' ' GLY . 41.6 mt -116.43 110.47 31.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 O-C-N 123.816 0.697 . . . . 0.57 111.093 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 122.02 46.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.57 110.977 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.19 120.21 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.57 111.098 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.8 t -131.23 124.94 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.57 111.084 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 197' ' ' PHE . 2.4 m-85 -86.78 120.48 28.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.57 110.852 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.13 169.0 18.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.886 1.327 . . . . 0.57 110.626 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 163.44 13.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.749 -1.219 . . . . 1.2 108.945 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -33.03 130.89 0.3 Allowed Glycine 0 C--N 1.37 2.429 0 O-C-N 124.009 0.818 . . . . 0.57 112.718 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 84.28 40.28 0.03 OUTLIER 'General case' 0 C--N 1.39 2.361 0 CA-C-O 124.763 2.221 . . . . 0.57 112.383 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--N 1.364 1.237 0 CA-C-N 114.249 -1.342 . . . . 0.57 109.087 -178.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.142 0.496 . . . . 0.57 110.72 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.441 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -147.6 -167.82 2.89 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 122.018 0.914 . . . . 0.57 110.07 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.419 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.4 OUTLIER -72.61 -177.74 2.38 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 124.477 1.111 . . . . 0.91 112.252 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.27 49.13 0.21 Allowed Glycine 0 C--N 1.381 3.049 0 CA-C-O 123.411 1.562 . . . . 0.57 113.192 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -171.72 -36.48 0.02 OUTLIER 'General case' 0 C--N 1.384 2.069 0 CA-C-O 123.425 1.583 . . . . 0.57 112.819 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.474 ' N ' ' HD2' ' A' ' 177' ' ' LYS . . . 169.41 -103.62 0.2 Allowed Glycine 0 C--N 1.375 2.7 0 CA-C-O 122.955 1.308 . . . . 0.57 110.457 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.541 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 36.04 -92.19 0.01 OUTLIER Glycine 0 C--N 1.367 2.267 0 O-C-N 120.309 -1.7 . . . . 0.57 114.49 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.57 ' N ' HD13 ' A' ' 180' ' ' ILE . 1.9 mm -51.23 170.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.064 0 CA-C-O 121.297 0.57 . . . . 0.57 111.593 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.697 HD11 ' CB ' ' A' ' 210' ' ' THR . 3.6 tp -136.09 -41.33 0.66 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.945 0.879 . . . . 0.57 112.55 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -176.72 179.87 1.06 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.359 -0.837 . . . . 0.57 111.094 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -156.03 137.91 14.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.928 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.87 140.01 40.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.57 111.101 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.446 ' CB ' HG23 ' A' ' 191' ' ' ILE . 1.9 m-85 -91.93 176.59 6.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.523 1.154 . . . . 0.57 110.964 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.37 55.07 0.1 Allowed Glycine 0 C--N 1.366 2.21 0 CA-C-N 115.501 -0.772 . . . . 0.57 112.797 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HD2' ' CA ' ' A' ' 192' ' ' GLY . 47.0 Cg_endo -74.42 -42.98 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 120.907 1.071 . . . . 0.57 112.008 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.41 87.32 0.17 Allowed Glycine 0 C--N 1.379 2.93 0 C-N-CA 120.137 -1.03 . . . . 0.57 111.569 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 79.75 97.02 0.06 Allowed 'General case' 0 C--N 1.386 2.155 0 CA-C-O 123.59 1.662 . . . . 0.57 110.073 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.65 -118.56 1.27 Allowed Glycine 0 C--N 1.381 3.047 0 N-CA-C 109.61 -1.396 . . . . 0.57 109.61 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -72.11 -11.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 CA-C-O 124.689 2.185 . . . . 0.57 110.36 -178.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 187' ' ' PRO . . . -66.91 124.62 23.89 Favored Glycine 0 C--N 1.372 2.552 0 O-C-N 120.077 -1.639 . . . . 0.57 109.758 -174.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 115.09 -33.12 5.45 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-O 121.737 0.631 . . . . 0.57 112.521 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -72.91 129.37 37.99 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 122.162 -0.61 . . . . 0.91 110.828 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.694 ' HB2' ' HB2' ' A' ' 219' ' ' GLU . . . -121.51 160.05 25.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.481 . . . . 0.57 111.089 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.549 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 9.4 m-70 -133.74 140.07 46.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.829 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.66 139.42 38.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.57 110.887 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.55 78.89 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.91 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -29.61 11.36 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 118.529 -0.748 . . . . 0.91 112.515 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -39.15 -55.94 1.55 Allowed 'General case' 0 C--N 1.352 0.713 0 CA-C-O 124.907 2.289 . . . . 0.91 109.189 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 201' ' ' GLU . 1.6 pm0 -75.09 176.38 7.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-O 125.474 2.559 . . . . 0.91 112.379 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.11 90.82 3.44 Favored 'General case' 0 C--N 1.369 1.431 0 O-C-N 119.282 -2.136 . . . . 0.57 109.638 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -88.63 147.63 24.45 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 114.063 -1.426 . . . . 0.57 111.708 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 99.6 m -123.05 121.57 36.37 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-O 124.387 2.041 . . . . 0.57 112.429 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.35 133.47 34.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 120.865 -1.147 . . . . 0.57 110.588 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' A' ' 207' ' ' SER . 2.2 t-80 78.89 62.79 0.03 OUTLIER 'General case' 0 C--N 1.38 1.909 0 CA-C-O 122.726 1.251 . . . . 0.57 110.219 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.7 m 85.09 92.85 0.03 OUTLIER 'General case' 0 C--N 1.381 1.945 0 CA-C-O 123.703 1.716 . . . . 0.57 109.057 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.42 110.21 0.5 Allowed Glycine 0 C--N 1.375 2.721 0 O-C-N 120.997 -1.064 . . . . 0.57 111.772 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 43.57 -113.26 0.68 Allowed Glycine 0 C--N 1.375 2.73 0 CA-C-O 123.756 1.753 . . . . 0.57 111.689 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.697 ' CB ' HD11 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -93.31 126.21 38.31 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 113.599 -1.3 . . . . 0.57 112.243 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.827 ' HB2' HD11 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -95.71 151.04 19.72 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.186 -1.37 . . . . 0.57 111.885 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -72.75 -38.51 67.35 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 123.518 1.628 . . . . 0.57 107.873 -175.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 213' ' ' PHE . 1.9 t80 -51.79 -46.8 64.33 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 114.242 -1.344 . . . . 0.57 110.867 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -54.76 -51.18 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.57 110.923 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.659 HG23 HD23 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -64.18 -45.37 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.57 111.115 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -59.14 -39.91 83.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.57 111.074 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 248' ' ' PHE . 1.1 t -65.25 -39.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.57 111.118 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -66.31 -49.03 68.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.57 110.827 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . 3.4 pt-20 -57.9 -42.26 84.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.91 110.904 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.715 HG22 ' CD2' ' A' ' 224' ' ' LEU . 11.7 mt -67.0 -46.17 85.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.57 111.16 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.94 -33.67 64.19 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.57 112.476 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.411 ' CE1' ' O ' ' A' ' 227' ' ' GLY . 1.5 m-70 -64.31 -40.65 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.57 110.872 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.6 t -71.23 -51.04 26.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.57 110.815 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.94 HD13 HG21 ' A' ' 145' ' ' THR . 3.3 pp -72.4 -64.89 0.86 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.868 1.062 . . . . 0.57 113.868 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.82 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -73.13 169.98 52.5 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-O 124.871 2.373 . . . . 0.57 111.493 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -66.21 -154.73 0.01 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-O 123.727 1.727 . . . . 0.57 108.796 -177.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 222' ' ' HIS . . . -53.47 -99.47 0.01 OUTLIER Glycine 0 C--N 1.38 2.982 0 CA-C-O 123.849 1.805 . . . . 0.57 111.921 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -112.67 -93.82 0.46 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 119.684 -2.068 . . . . 0.57 112.216 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 16.1 p -162.75 -43.85 0.04 OUTLIER 'General case' 0 C--N 1.372 1.563 0 CA-C-N 115.219 -0.9 . . . . 0.57 110.666 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 83.84 28.99 0.08 Allowed 'General case' 0 C--N 1.399 2.726 0 CA-C-N 114.189 -1.368 . . . . 0.57 114.501 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.3 128.68 2.4 Favored Pre-proline 0 C--N 1.383 2.056 0 CA-C-N 114.459 -1.246 . . . . 0.91 108.545 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.42 64.41 7.26 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.909 2.406 . . . . 0.57 112.12 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.7 -31.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 121.086 -1.009 . . . . 0.57 113.276 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -69.82 120.07 15.01 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-O 123.521 1.629 . . . . 0.57 110.41 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 235' ' ' VAL . 40.0 t -58.4 88.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.71 -1.132 . . . . 0.57 112.849 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 158.37 -20.74 0.0 OUTLIER 'General case' 0 C--N 1.367 1.361 0 CA-C-O 122.292 1.044 . . . . 0.57 112.488 -176.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 4.0 p90 -50.02 153.03 2.48 Favored Pre-proline 0 N--CA 1.43 -1.459 0 CA-C-O 123.088 1.423 . . . . 0.57 111.322 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.67 -47.87 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.331 1.354 . . . . 0.57 110.591 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 m -39.6 121.25 1.2 Allowed 'General case' 0 C--N 1.353 0.719 0 CA-C-O 122.725 1.25 . . . . 0.57 110.926 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.697 ' HE2' HD13 ' A' ' 181' ' ' LEU . 36.2 t80 -68.18 162.52 24.7 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.355 -1.293 . . . . 0.57 108.113 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 14.4 tttt 167.4 124.22 0.01 OUTLIER 'General case' 0 C--N 1.373 1.618 0 CA-C-O 123.064 1.411 . . . . 0.57 108.112 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -74.77 120.11 19.87 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-O 122.898 1.332 . . . . 0.57 111.325 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 243' ' ' VAL . 8.5 p -138.18 115.6 12.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.239 0 CA-C-N 115.166 -0.925 . . . . 0.57 108.891 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -41.47 142.36 0.61 Allowed 'General case' 0 C--N 1.366 1.31 0 CA-C-O 124.052 1.882 . . . . 0.91 109.53 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 211' ' ' ASN . 15.4 mt -65.96 -22.29 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 123.065 1.412 . . . . 0.57 112.209 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -17.04 61.98 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.126 0.965 . . . . 0.57 111.387 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.7 p -112.18 8.25 19.81 Favored 'General case' 0 C--N 1.371 1.519 0 CA-C-O 122.654 1.216 . . . . 0.57 113.376 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.559 ' CE1' HG11 ' A' ' 217' ' ' VAL . 45.0 t80 -77.16 88.49 3.63 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-O 124.193 1.949 . . . . 0.57 108.577 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.522 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -112.42 153.56 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 O-C-N 120.678 -1.263 . . . . 1.2 110.32 177.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.77 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -119.98 129.36 54.25 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 124.331 2.015 . . . . 0.57 107.934 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 143.91 55.51 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 119.659 -1.901 . . . . 0.57 112.25 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.68 89.61 Favored 'General case' 0 C--N 1.382 1.98 0 CA-C-N 114.663 -1.153 . . . . 0.57 109.428 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.17 -40.71 94.92 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.796 -0.638 . . . . 0.91 110.882 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.406 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 26.8 t70 -64.29 -54.92 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.91 110.849 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.1 -34.79 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.57 111.081 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.451 ' N ' HG13 ' A' ' 255' ' ' ILE . 37.3 mtp180 -62.84 -43.47 98.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.934 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.57 -57.52 12.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.57 112.547 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.473 HG13 ' N ' ' A' ' 259' ' ' GLN . 28.4 pt -46.62 -44.2 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.57 111.224 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 258' ' ' ILE . 2.6 pt20 -72.02 -26.75 62.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.57 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.428 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 32.1 t . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 122.594 1.187 . . . . 0.57 110.441 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 123.112 1.434 . . . . 1.2 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.49 ' O ' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -153.17 -44.83 0.1 Allowed 'General case' 0 C--N 1.374 1.659 0 CA-C-N 113.081 -1.872 . . . . 0.57 111.037 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -78.25 -30.86 48.89 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 113.468 -1.696 . . . . 0.57 109.983 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.625 ' C ' HD13 ' A' ' 114' ' ' ILE . 39.6 t80 -112.02 109.12 18.7 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 114.26 -1.336 . . . . 0.57 110.903 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.625 HD13 ' C ' ' A' ' 113' ' ' TYR . 1.9 mm -102.22 155.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.57 111.13 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -114.36 149.5 36.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.57 111.106 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.1 t80 -145.86 156.57 43.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.57 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -154.54 132.17 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.936 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.74 146.32 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.57 111.137 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.667 ' OD1' HG22 ' A' ' 162' ' ' VAL . 55.5 t30 -53.4 -60.44 3.3 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 117.651 -1.619 . . . . 0.57 107.454 -167.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 159.21 31.08 0.0 OUTLIER 'General case' 0 C--N 1.383 2.024 0 O-C-N 126.474 2.359 . . . . 0.57 109.567 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HB3' ' CG ' ' A' ' 127' ' ' ARG . 0.4 OUTLIER 77.18 92.16 0.07 Allowed 'General case' 0 C--N 1.409 3.162 0 N-CA-C 105.461 -2.052 . . . . 0.57 105.461 164.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -49.43 163.82 0.35 Allowed Pre-proline 0 C--N 1.383 2.041 0 CA-C-N 111.993 -2.367 . . . . 0.57 108.548 -168.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.23 -47.92 11.1 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 115.692 -0.503 . . . . 0.57 112.537 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.661 ' H ' HG23 ' A' ' 122' ' ' THR . 0.2 OUTLIER -82.46 -63.72 1.32 Allowed 'General case' 0 C--N 1.386 2.153 0 N-CA-C 104.32 -2.474 . . . . 0.91 104.32 -163.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.819 ' SD ' HG22 ' A' ' 130' ' ' VAL . 5.0 ttm -53.37 154.48 3.35 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-O 125.141 2.4 . . . . 0.57 108.219 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -87.54 137.74 32.07 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 112.79 -2.005 . . . . 0.57 110.125 -177.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.03 -49.43 70.19 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 115.116 -0.947 . . . . 1.2 108.579 -170.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.07 -35.24 64.33 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 126.838 2.586 . . . . 0.91 110.98 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -70.7 -42.26 70.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.91 110.883 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.819 HG22 ' SD ' ' A' ' 125' ' ' MET . 2.5 t -63.13 -47.68 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.1 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.462 ' HA ' HD11 ' A' ' 134' ' ' ILE . 7.7 t70 -60.12 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.91 110.872 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.37 -41.44 97.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.57 110.927 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.679 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -63.23 -49.08 75.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.57 111.125 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 131' ' ' ASP . 18.1 pt -64.76 -39.22 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.144 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -58.85 -49.11 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.813 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.79 -34.87 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.888 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -64.62 -45.15 88.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.57 111.12 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m-85 -63.52 -36.85 85.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.57 110.91 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.38 -39.19 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.57 110.935 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.811 ' CG1' HD11 ' A' ' 250' ' ' LEU . 28.9 t -69.51 -34.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.57 111.152 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CG ' HD11 ' A' ' 224' ' ' LEU . 4.8 m95 -82.93 -34.13 26.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.57 110.977 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.7 m -78.66 -48.11 15.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.905 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.678 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.0 p-10 -61.02 -12.72 12.52 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 121.892 0.853 . . . . 0.57 111.844 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 255' ' ' ILE . 18.9 m -114.48 11.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.378 1.842 0 CA-C-N 113.892 -1.504 . . . . 0.57 112.898 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.594 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -150.67 150.45 28.35 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-O 125.381 2.515 . . . . 0.57 110.264 -173.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.81 -24.54 4.06 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 O-C-N 118.133 -1.562 . . . . 0.57 113.054 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -75.94 111.48 11.35 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-O 124.534 2.112 . . . . 0.57 107.487 -176.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 156.8 38.79 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-O 125.194 2.426 . . . . 0.57 114.687 172.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.658 ' HE2' HD12 ' A' ' 159' ' ' ILE . 1.1 m-85 -128.04 160.01 33.27 Favored 'General case' 0 C--N 1.376 1.723 0 CA-C-N 112.526 -2.125 . . . . 0.57 109.441 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.0 m -157.92 114.71 2.9 Favored 'General case' 0 C--N 1.389 2.29 0 CA-C-O 124.855 2.264 . . . . 0.57 109.344 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -95.3 129.17 42.53 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.106 -1.861 . . . . 0.57 110.69 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 154' ' ' THR . 2.8 pt -105.89 137.07 37.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.406 0 CA-C-O 124.681 2.182 . . . . 0.57 111.361 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -46.29 71.27 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.122 -1.854 . . . . 0.57 110.533 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 152' ' ' ILE . 29.0 p -121.41 171.92 8.43 Favored 'General case' 0 C--N 1.379 1.875 0 CA-C-N 113.361 -1.745 . . . . 0.57 110.143 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.08 -119.91 6.68 Favored Glycine 0 C--N 1.382 3.11 0 N-CA-C 109.514 -1.434 . . . . 0.57 109.514 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 ttt -165.46 108.72 0.82 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-O 123.389 1.566 . . . . 0.57 109.759 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.765 ' O ' HD13 ' A' ' 160' ' ' LEU . . . -106.03 143.58 33.96 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 112.722 -2.035 . . . . 0.57 110.462 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -44.98 -51.22 10.08 Favored 'General case' 0 C--N 1.374 1.665 0 CA-C-N 116.001 -0.545 . . . . 0.91 110.356 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.658 HD12 ' HE2' ' A' ' 149' ' ' PHE . 18.6 mt -90.17 109.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.386 2.169 0 O-C-N 128.124 3.39 . . . . 0.57 111.116 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -106.97 132.06 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.957 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.408 HG21 ' OE2' ' A' ' 219' ' ' GLU . 2.1 t -120.6 118.14 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.57 111.126 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.667 HG22 ' OD1' ' A' ' 119' ' ' ASN . 69.5 t -133.08 146.02 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.57 111.166 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -92.07 121.66 33.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.57 110.834 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.01 168.8 18.86 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-O 123.445 1.593 . . . . 0.57 109.829 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 200' ' ' ASP . 0.2 OUTLIER -115.73 169.78 8.95 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 114.974 -1.012 . . . . 1.2 110.531 177.155 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.35 139.18 2.46 Favored Glycine 0 C--N 1.383 3.152 0 O-C-N 126.202 2.189 . . . . 0.57 111.517 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.68 57.69 0.84 Allowed 'General case' 0 C--N 1.4 2.777 0 CA-C-O 125.475 2.56 . . . . 0.57 110.585 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 . . . . . 0 C--N 1.375 1.681 0 CA-C-N 112.39 -2.187 . . . . 0.57 110.34 -179.363 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.375 0 CA-C-O 121.85 0.833 . . . . 0.57 111.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 180' ' ' ILE . 9.7 m-85 -92.94 179.58 5.41 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-N 111.823 -2.444 . . . . 0.57 111.184 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.422 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -86.7 -175.82 5.56 Favored 'General case' 0 C--N 1.382 2.014 0 CA-C-N 113.724 -1.58 . . . . 0.91 113.009 173.003 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . -147.96 142.68 10.32 Favored Glycine 0 C--N 1.39 3.563 0 O-C-N 126.337 2.273 . . . . 0.57 110.482 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.72 25.02 2.61 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 113.025 -1.587 . . . . 0.57 113.086 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.78 -132.65 4.34 Favored Glycine 0 C--N 1.372 2.564 0 CA-C-O 116.679 -2.178 . . . . 0.57 112.69 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.96 -109.67 1.58 Allowed Glycine 0 C--N 1.38 3.008 0 O-C-N 125.409 1.3 . . . . 0.57 111.405 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 174' ' ' PHE . 9.3 mt -73.77 166.5 2.65 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 N-CA-C 115.332 1.604 . . . . 0.57 115.332 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG23 ' A' ' 215' ' ' THR . 1.1 tp -118.54 -41.4 2.82 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 119.962 -1.711 . . . . 0.57 110.129 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB2' ' HD1' ' A' ' 197' ' ' PHE . . . -175.95 179.9 1.26 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.893 -1.503 . . . . 0.57 111.089 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 1.2 p80 -165.78 135.85 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.57 110.849 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -139.43 162.51 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.57 111.08 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.7 -171.0 1.74 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.337 -0.945 . . . . 0.57 111.05 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -145.66 -76.2 0.03 OUTLIER Glycine 0 C--N 1.377 2.843 0 C-N-CA 119.385 -1.388 . . . . 0.57 110.551 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.47 75.73 4.91 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.019 1.812 . . . . 0.57 111.465 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -148.11 13.97 1.29 Allowed Glycine 0 C--N 1.367 2.288 0 C-N-CA 118.574 -1.774 . . . . 0.57 111.926 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 57.28 -93.19 0.04 OUTLIER 'General case' 0 C--N 1.388 2.278 0 O-C-N 125.549 1.382 . . . . 0.57 110.424 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -62.56 -71.56 0.8 Allowed Glycine 0 C--N 1.389 3.477 0 CA-C-N 114.69 -1.141 . . . . 0.57 112.33 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -31.65 53.79 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 CA-C-O 124.686 2.184 . . . . 0.57 108.915 -176.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.76 140.66 43.66 Favored Glycine 0 C--N 1.376 2.787 0 N-CA-C 107.783 -2.127 . . . . 0.57 107.783 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.42 -38.84 2.97 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-N 113.869 -1.165 . . . . 0.57 113.883 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -48.32 150.97 1.13 Allowed 'General case' 0 C--N 1.392 2.416 0 CA-C-N 113.417 -1.391 . . . . 0.91 110.907 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -144.09 145.86 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.57 111.077 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -121.68 134.48 54.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.57 110.826 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.546 ' HD1' ' HB2' ' A' ' 182' ' ' ALA . 29.0 m-85 -103.94 144.28 31.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.57 110.892 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 75.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.91 110.808 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -56.65 18.1 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 108.211 -1.033 . . . . 0.91 108.211 -175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -40.4 -45.55 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.903 1.377 . . . . 0.91 110.692 -176.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.29 172.64 0.13 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 126.669 3.128 . . . . 0.91 113.178 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.71 102.63 10.67 Favored 'General case' 0 C--N 1.376 1.756 0 CA-C-N 111.975 -2.375 . . . . 0.57 114.119 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -92.28 150.36 20.91 Favored 'General case' 0 C--N 1.361 1.1 0 CA-C-N 112.946 -1.934 . . . . 0.57 108.675 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.47 122.09 42.79 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 123.751 1.739 . . . . 0.57 109.032 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -89.41 131.87 35.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.835 -1.075 . . . . 0.57 112.169 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 78.81 -148.33 0.02 OUTLIER 'General case' 0 C--N 1.395 2.572 0 O-C-N 125.362 1.664 . . . . 0.57 110.492 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.466 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 1.6 t -60.72 93.27 0.03 OUTLIER 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.612 2.148 . . . . 0.57 109.281 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -174.38 -34.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.29 0 CA-C-N 112.359 -2.2 . . . . 0.57 113.407 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 242' ' ' TYR . . . 141.73 -112.97 0.79 Allowed Glycine 0 C--N 1.387 3.41 0 CA-C-O 123.378 1.543 . . . . 0.57 111.81 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 242' ' ' TYR . 26.5 p -82.11 117.68 22.47 Favored 'General case' 0 C--N 1.369 1.427 0 CA-C-N 114.27 -0.965 . . . . 0.57 110.23 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.75 176.87 4.92 Favored 'General case' 0 C--N 1.374 1.655 0 O-C-N 126.72 2.512 . . . . 0.57 110.75 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.5 tm? -70.55 -33.81 71.53 Favored 'General case' 0 C--N 1.382 2.006 0 CA-C-N 113.803 -1.544 . . . . 0.57 107.629 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.991 ' O ' HG23 ' A' ' 217' ' ' VAL . 27.5 t80 -57.53 -50.13 74.08 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.376 -1.453 . . . . 0.57 110.871 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -59.38 -51.41 70.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.57 110.847 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.857 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.78 -32.66 72.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.57 111.098 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 220' ' ' ILE . . . -68.35 -46.12 70.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.57 111.058 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 213' ' ' PHE . 20.1 t -63.33 -39.28 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.57 111.142 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.95 -46.27 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.57 110.879 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 220' ' ' ILE . 3.0 pt-20 -60.91 -44.52 97.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.91 110.837 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.821 HD11 ' HB1' ' A' ' 137' ' ' ALA . 10.1 pt -71.67 -32.82 46.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.235 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -65.17 -34.93 90.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.57 112.453 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.84 -42.07 97.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.57 110.908 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.9 m -70.95 -36.81 72.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.57 110.897 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.718 HD12 ' HA2' ' A' ' 221' ' ' GLY . 29.6 mt -40.64 -60.49 1.13 Allowed 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 123.443 1.592 . . . . 0.57 112.296 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.48 -30.38 0.17 Allowed Glycine 0 C--N 1.392 3.654 0 C-N-CA 118.403 -1.856 . . . . 0.57 112.404 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.769 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -82.81 160.24 22.28 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-N 112.396 -1.902 . . . . 0.57 112.558 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.441 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -83.56 -151.93 12.36 Favored Glycine 0 C--N 1.382 3.088 0 CA-C-O 123.96 1.867 . . . . 0.57 110.61 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -65.28 -97.81 0.0 OUTLIER 'General case' 0 C--N 1.38 1.911 0 CA-C-N 113.162 -1.519 . . . . 0.57 113.484 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 97.0 p -174.3 -32.99 0.01 OUTLIER 'General case' 0 C--N 1.373 1.604 0 C-N-CA 118.498 -1.281 . . . . 0.57 108.916 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.25 5.2 0.85 Allowed 'General case' 0 C--N 1.401 2.826 0 O-C-N 125.862 1.976 . . . . 0.57 114.663 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -135.65 140.51 34.08 Favored Pre-proline 0 C--N 1.382 2.009 0 N-CA-C 104.608 -2.367 . . . . 0.91 104.608 -169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.83 17.64 1.6 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 C-N-CA 123.568 2.845 . . . . 0.57 113.534 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 -0.29 5.52 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 114.109 -1.405 . . . . 0.57 113.729 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -99.3 124.14 44.16 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.709 1.719 . . . . 0.57 112.639 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.1 t -60.55 87.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.233 0 CA-C-N 113.927 -1.488 . . . . 0.57 113.381 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.441 ' HE2' ' O ' ' A' ' 227' ' ' GLY . 3.3 mmm 159.62 -23.94 0.0 OUTLIER 'General case' 0 C--N 1.368 1.411 0 O-C-N 125.045 1.466 . . . . 0.57 111.77 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 5.3 p90 -51.86 153.87 4.09 Favored Pre-proline 0 C--N 1.369 1.432 0 CA-C-O 123.755 1.74 . . . . 0.57 111.999 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.99 -25.22 7.67 Favored 'Trans proline' 0 C--N 1.368 1.596 0 CA-C-O 117.773 -1.011 . . . . 0.57 112.304 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.2 m -41.06 113.67 0.41 Allowed 'General case' 0 C--N 1.368 1.391 0 CA-C-O 124.016 1.865 . . . . 0.57 110.337 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 181' ' ' LEU . 4.7 t80 -80.47 106.25 12.34 Favored 'General case' 0 C--N 1.369 1.453 0 N-CA-C 106.241 -1.763 . . . . 0.57 106.241 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -154.73 107.56 2.8 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 124.772 2.225 . . . . 0.57 107.095 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 210' ' ' THR . 50.1 p90 -61.62 118.03 6.55 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 126.09 2.852 . . . . 0.57 111.633 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 245' ' ' ILE . 2.5 p -101.97 -19.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.05 -1.886 . . . . 0.57 112.627 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 72.87 4.59 5.01 Favored 'General case' 0 C--N 1.365 1.277 0 O-C-N 126.303 2.252 . . . . 0.91 113.531 -179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.0 mt 79.59 7.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.376 1.737 0 CA-C-N 113.647 -1.615 . . . . 0.57 115.054 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -70.13 -35.16 73.88 Favored 'General case' 0 C--N 1.39 2.354 0 N-CA-C 105.107 -2.182 . . . . 0.57 105.107 -165.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.47 -22.79 8.57 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-N 112.394 -2.185 . . . . 0.57 113.087 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 235' ' ' VAL . 13.2 t80 -40.94 99.85 0.02 OUTLIER 'General case' 0 C--N 1.382 1.994 0 O-C-N 125.729 1.893 . . . . 0.57 110.326 -175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -164.64 147.28 8.63 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 112.189 -2.278 . . . . 1.2 106.946 -171.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.811 HD11 ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.99 127.71 55.84 Favored 'General case' 0 C--N 1.372 1.563 0 CA-C-O 124.657 2.17 . . . . 0.57 107.511 -173.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.69 158.8 35.5 Favored 'General case' 0 C--N 1.362 1.116 0 O-C-N 120.445 -1.409 . . . . 0.57 112.014 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.64 ' HA ' HD11 ' A' ' 255' ' ' ILE . . . -56.32 -43.64 79.18 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.289 -1.323 . . . . 0.57 109.491 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -41.56 95.11 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.021 0.528 . . . . 0.91 110.846 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 258' ' ' ILE . 16.2 t0 -63.82 -55.1 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.91 110.869 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.91 HG21 HG11 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -65.94 -35.93 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.134 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.64 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 18.1 mtp85 -70.19 -32.3 70.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.88 -44.83 77.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 0.57 112.495 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.769 ' HB ' HD12 ' A' ' 226' ' ' LEU . 1.1 pt -66.16 -44.7 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.57 111.118 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.483 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -70.77 -20.7 62.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.57 110.891 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--N 1.36 1.052 0 CA-C-O 123.063 1.411 . . . . 0.57 111.35 -178.15 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.051 0 CA-C-O 124.674 2.178 . . . . 1.2 109.034 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.28 -48.75 0.03 OUTLIER 'General case' 0 C--N 1.389 2.284 0 CA-C-N 113.564 -1.653 . . . . 0.57 110.838 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.63 -40.03 95.86 Favored 'General case' 0 C--N 1.389 2.291 0 CA-C-N 113.505 -1.68 . . . . 0.57 108.35 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.84 103.58 11.57 Favored 'General case' 0 C--N 1.384 2.104 0 O-C-N 125.324 1.64 . . . . 0.57 110.88 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.03 154.84 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.158 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -106.03 142.98 34.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.106 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 159' ' ' ILE . 8.3 t80 -140.57 160.07 40.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.57 110.916 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.52 121.84 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.2 110.824 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.705 HG21 ' CE2' ' A' ' 121' ' ' TYR . 1.2 mm -99.4 138.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.57 111.146 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -62.57 173.59 1.22 Allowed 'General case' 0 C--N 1.363 1.187 0 CA-C-O 124.324 2.011 . . . . 0.57 108.944 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.67 73.31 6.38 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 125.166 2.412 . . . . 0.57 109.971 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.705 ' CE2' HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -72.17 -177.53 2.13 Favored 'General case' 0 C--N 1.374 1.648 0 CA-C-N 112.357 -2.201 . . . . 0.57 110.467 173.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.465 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER 160.56 -53.4 0.0 OUTLIER Pre-proline 0 C--N 1.38 1.912 0 C-N-CA 125.337 1.455 . . . . 0.57 107.809 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 122' ' ' THR . 19.0 Cg_endo -75.36 -72.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.406 3.581 0 N-CA-C 108.022 -1.569 . . . . 0.57 108.022 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.86 -7.68 57.02 Favored 'General case' 0 C--N 1.398 2.677 0 CA-C-N 113.131 -1.85 . . . . 0.91 106.578 -171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 122' ' ' THR . 6.4 mtm -154.42 136.04 14.33 Favored 'General case' 0 C--N 1.386 2.191 0 CA-C-N 116.001 -0.545 . . . . 0.57 109.638 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.2 m-20 -90.98 141.63 28.63 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-O 123.182 1.468 . . . . 0.57 109.328 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.426 ' HA ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -64.47 -50.11 68.76 Favored 'General case' 0 C--N 1.384 2.076 0 CA-C-N 114.324 -1.307 . . . . 1.2 109.109 -170.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.25 -35.28 69.54 Favored 'General case' 0 C--N 1.374 1.666 0 CA-C-N 111.992 -2.367 . . . . 0.91 110.874 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 205' ' ' THR . 3.6 m-20 -70.33 -43.78 69.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.91 110.862 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 126' ' ' ASN . 19.1 t -68.69 -39.74 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.57 111.179 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.35 -44.11 97.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.91 110.873 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -40.94 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.824 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.98 -49.19 66.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.57 111.139 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 130' ' ' VAL . 25.2 pt -62.4 -36.9 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.57 111.167 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -63.72 -43.74 95.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.853 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.84 -46.06 89.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.57 110.933 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.09 83.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.57 111.082 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 3.7 m-85 -62.95 -44.06 97.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.821 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.2 pt20 -63.45 -36.21 82.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.57 110.971 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 136' ' ' LYS . 16.0 t -69.64 -34.2 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.57 111.123 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 224' ' ' LEU . 34.1 m95 -83.05 -34.06 26.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.923 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 m -78.99 -51.08 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.57 110.916 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.653 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.4 p-10 -56.2 -13.96 2.45 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 114.103 1.149 . . . . 0.57 114.103 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.653 HG13 ' OD1' ' A' ' 143' ' ' ASN . 20.2 m -113.34 -8.77 12.18 Favored 'Isoleucine or valine' 0 C--N 1.389 2.29 0 CA-C-N 113.876 -1.511 . . . . 0.57 112.298 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.47 141.93 15.16 Favored Pre-proline 0 C--N 1.383 2.055 0 CA-C-O 125.379 2.514 . . . . 0.57 110.14 -172.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 145' ' ' THR . 57.0 Cg_endo -79.7 71.21 7.16 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.138 1.892 . . . . 0.57 114.593 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -169.35 83.52 0.13 Allowed 'General case' 0 C--N 1.39 2.328 0 N-CA-C 106.698 -1.593 . . . . 0.57 106.698 -168.419 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -72.37 162.16 29.84 Favored 'General case' 0 C--N 1.383 2.048 0 CA-C-O 125.739 2.685 . . . . 0.57 115.672 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' ' O ' ' A' ' 147' ' ' LEU . 2.9 m-85 -136.63 158.9 43.37 Favored 'General case' 0 C--N 1.39 2.354 0 CA-C-N 113.004 -1.907 . . . . 0.57 106.09 -172.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -157.48 121.61 4.24 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.879 2.276 . . . . 0.57 108.301 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 133.4 37.17 Favored 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.65 -1.613 . . . . 0.57 110.513 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 157' ' ' ALA . 6.2 pt -107.18 171.95 2.01 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-O 124.214 1.959 . . . . 0.57 110.921 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -141.72 51.65 1.53 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 113.482 -1.69 . . . . 0.57 110.566 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 p -117.66 -62.59 1.54 Allowed 'General case' 0 C--N 1.384 2.096 0 CA-C-N 113.479 -1.691 . . . . 0.57 109.887 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.68 -152.87 5.73 Favored Glycine 0 C--N 1.381 3.028 0 N-CA-C 108.796 -1.722 . . . . 0.57 108.796 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.4 ttp -72.11 110.49 6.62 Favored 'General case' 0 C--N 1.386 2.176 0 CA-C-O 123.705 1.716 . . . . 0.57 108.246 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -98.19 177.83 5.27 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.058 -1.883 . . . . 0.57 111.186 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.96 -59.38 4.91 Favored 'General case' 0 C--N 1.397 2.645 0 CA-C-N 112.456 -2.156 . . . . 0.91 105.233 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 116' ' ' TYR . 6.3 mt -95.79 111.47 26.22 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 C-N-CA 122.942 0.497 . . . . 0.57 111.14 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 126.59 51.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.57 110.942 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.57 111.083 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.556 HG13 ' ND2' ' A' ' 119' ' ' ASN . 3.9 t -133.15 128.94 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.57 111.134 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -85.0 122.77 29.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.57 110.884 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -146.53 170.14 17.5 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 118.812 -1.155 . . . . 0.57 108.636 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.91 167.8 9.72 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.69 -1.595 . . . . 1.2 108.842 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -38.1 118.91 0.72 Allowed Glycine 0 C--N 1.389 3.497 0 CA-C-N 114.135 -1.393 . . . . 0.57 111.956 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 81.37 63.44 0.02 OUTLIER 'General case' 0 C--N 1.417 3.524 0 CA-C-O 125.469 2.557 . . . . 0.57 114.117 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.688 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 22.7 p-80 . . . . . 0 C--N 1.386 2.19 0 CA-C-N 113.12 -1.855 . . . . 0.57 111.966 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 123.876 1.798 . . . . 0.57 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.549 ' CE2' HG22 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -83.05 -158.98 0.31 Allowed 'General case' 0 C--N 1.388 2.255 0 CA-C-N 112.961 -1.927 . . . . 0.57 113.753 173.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.16 173.39 6.32 Favored 'General case' 0 C--N 1.388 2.251 0 CA-C-N 114.627 -1.169 . . . . 0.91 111.686 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.51 114.69 0.89 Allowed Glycine 1 C--N 1.4 4.109 0 CA-C-N 111.566 -2.561 . . . . 0.57 113.89 166.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER 70.85 82.8 0.15 Allowed 'General case' 0 C--N 1.406 3.037 0 CA-C-O 124.757 2.218 . . . . 0.57 113.533 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.51 -155.7 22.05 Favored Glycine 0 C--N 1.376 2.786 0 CA-C-N 114.259 -1.337 . . . . 0.57 110.67 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -35.71 149.17 0.03 OUTLIER Glycine 1 C--N 1.403 4.276 0 CA-C-N 113.384 -1.408 . . . . 0.57 110.098 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.549 HG22 ' CE2' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 89.28 65.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.399 2.731 0 N-CA-C 108.483 -0.932 . . . . 0.57 108.483 175.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.548 HD12 ' OE1' ' A' ' 201' ' ' GLU . 4.3 mp -71.22 -37.45 72.05 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-O 123.448 1.594 . . . . 0.57 111.78 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 197' ' ' PHE . . . -174.33 179.84 1.74 Allowed 'General case' 0 C--N 1.364 1.199 0 CA-C-N 113.986 -1.461 . . . . 0.57 111.09 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -164.23 142.46 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.57 110.874 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.94 167.52 23.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.57 111.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 191' ' ' ILE . 2.3 m-85 -77.02 -87.1 0.05 OUTLIER 'General case' 0 C--N 1.372 1.562 0 C-N-CA 117.749 -1.58 . . . . 0.57 108.699 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 193' ' ' GLY . . . 120.12 -61.22 0.51 Allowed Glycine 0 C--N 1.397 3.956 0 C-N-CA 119.848 -1.168 . . . . 0.57 112.836 -175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.91 56.13 5.22 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.142 2.561 . . . . 0.57 111.774 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' HA3' ' A' ' 192' ' ' GLY . . . 47.66 -154.79 1.22 Allowed Glycine 0 C--N 1.39 3.536 0 CA-C-O 123.579 1.655 . . . . 0.57 111.265 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.76 57.61 0.01 OUTLIER 'General case' 0 C--N 1.387 2.228 0 CA-C-O 123.965 1.841 . . . . 0.57 106.524 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.79 -88.92 0.37 Allowed Glycine 0 C--N 1.398 3.996 0 O-C-N 120.692 -1.255 . . . . 0.57 110.008 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.468 HG21 ' CZ ' ' A' ' 185' ' ' PHE . 1.7 tp -62.2 0.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.165 0 CA-C-O 124.964 2.316 . . . . 0.57 113.854 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 188' ' ' GLY . . . -73.37 117.21 5.77 Favored Glycine 0 C--N 1.393 3.737 0 C-N-CA 117.384 -2.341 . . . . 0.57 107.283 -169.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 186' ' ' GLY . . . 109.35 -44.73 1.44 Allowed Glycine 0 C--N 1.373 2.584 0 O-C-N 124.871 0.983 . . . . 0.57 114.123 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.68 113.4 0.89 Allowed 'General case' 0 C--N 1.385 2.123 0 CA-C-N 115.358 -0.421 . . . . 0.91 110.841 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -111.68 156.82 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.57 111.111 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -130.17 131.9 45.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.859 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 215' ' ' THR . 2.4 m-85 -104.04 148.51 26.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.57 110.944 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.0 p-10 -89.97 102.46 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.91 110.853 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -36.55 64.42 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 116.912 -1.518 . . . . 0.91 109.3 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -45.5 -40.96 9.09 Favored 'General case' 0 C--N 1.376 1.761 0 O-C-N 125.366 1.666 . . . . 0.91 107.507 -163.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.548 ' OE1' HD12 ' A' ' 181' ' ' LEU . 12.4 mt-10 -56.48 -173.28 0.01 OUTLIER 'General case' 0 C--N 1.391 2.378 0 CA-C-O 128.143 3.83 . . . . 0.91 114.439 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.4 77.44 1.57 Allowed 'General case' 0 C--N 1.379 1.865 0 O-C-N 118.091 -2.88 . . . . 0.57 108.941 -172.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.493 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 52.1 m95 -72.82 115.45 12.13 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-O 122.64 1.21 . . . . 0.57 108.317 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.3 p -123.89 128.02 48.86 Favored 'General case' 0 C--N 1.384 2.094 0 CA-C-O 123.965 1.841 . . . . 0.57 109.425 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' ASP . 5.1 p -116.2 105.94 13.14 Favored 'General case' 0 C--N 1.369 1.424 0 CA-C-O 122.939 1.352 . . . . 0.57 108.724 -176.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 172.5 -51.94 0.01 OUTLIER 'General case' 0 C--N 1.395 2.568 0 CA-C-N 112.877 -1.965 . . . . 0.57 107.099 175.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 158.66 50.72 0.0 OUTLIER 'General case' 0 C--N 1.412 3.316 0 O-C-N 126.315 2.259 . . . . 0.57 110.172 -171.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.16 -108.46 2.69 Favored Glycine 0 C--N 1.393 3.74 0 C-N-CA 118.16 -1.972 . . . . 0.57 113.681 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.97 -91.49 2.21 Favored Glycine 0 C--N 1.397 3.957 0 CA-C-O 124.857 2.365 . . . . 0.57 112.792 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 p -73.89 117.5 15.75 Favored 'General case' 0 C--N 1.384 2.088 0 CA-C-O 123.847 1.784 . . . . 0.57 111.454 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -111.15 150.26 29.72 Favored 'General case' 0 C--N 1.388 2.279 0 CA-C-N 112.307 -2.224 . . . . 0.57 110.13 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.6 tm? -73.45 -32.7 64.51 Favored 'General case' 0 C--N 1.394 2.505 0 CA-C-O 124.412 2.053 . . . . 0.57 108.858 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.707 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.7 t80 -52.28 -50.08 62.84 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 112.678 -2.056 . . . . 0.57 110.848 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -62.29 -43.61 98.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.57 110.924 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.608 HG21 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -61.27 -49.36 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.57 111.19 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.2 73.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.107 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.761 HG11 ' HE1' ' A' ' 248' ' ' PHE . 53.3 t -64.48 -48.18 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.143 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -71.57 -43.21 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.57 110.867 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -57.91 -42.14 84.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.91 110.877 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.46 HG21 ' CD1' ' A' ' 141' ' ' TRP . 57.7 mt -69.61 -39.78 78.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.57 111.187 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.471 ' C ' ' HE3' ' A' ' 236' ' ' MET . . . -61.46 -33.78 85.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.57 112.465 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.603 ' N ' ' HE3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -63.85 -44.28 93.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.353 . . . . 0.57 110.813 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' LEU . 71.1 m -71.27 -44.5 65.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.57 110.864 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -36.38 -47.79 0.62 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 119.771 -0.772 . . . . 0.57 112.557 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.13 -106.47 0.22 Allowed Glycine 1 C--N 1.398 4.026 0 O-C-N 126.699 2.499 . . . . 0.57 112.061 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.01 172.78 0.01 OUTLIER 'General case' 0 C--N 1.395 2.559 0 CA-C-O 125.726 2.679 . . . . 0.57 112.554 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.35 -120.91 0.02 OUTLIER Glycine 0 C--N 1.392 3.665 0 CA-C-O 126.133 3.074 . . . . 0.57 110.677 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -123.96 -76.19 0.59 Allowed 'General case' 0 C--N 1.391 2.382 0 CA-C-N 112.258 -1.971 . . . . 0.57 108.375 -174.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -177.36 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.754 -1.567 . . . . 0.57 108.373 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.06 23.48 0.31 Allowed 'General case' 0 C--N 1.422 3.727 0 N-CA-C 118.925 2.935 . . . . 0.57 118.925 -171.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -137.65 143.29 39.96 Favored Pre-proline 0 C--N 1.398 2.703 0 C-N-CA 116.348 -2.141 . . . . 0.91 106.086 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 71.7 Cg_exo -54.97 -41.11 81.94 Favored 'Trans proline' 0 C--N 1.375 1.93 0 CA-C-O 124.724 1.885 . . . . 0.57 114.09 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -41.91 86.18 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-N 111.61 -2.541 . . . . 0.57 113.492 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -50.82 125.21 12.79 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-O 125.317 2.484 . . . . 0.57 111.82 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 235' ' ' VAL . 0.4 OUTLIER -76.03 -1.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.386 2.154 0 CA-C-N 112.473 -2.149 . . . . 0.57 112.504 -177.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.603 ' HE3' ' N ' ' A' ' 222' ' ' HIS . 0.8 OUTLIER -124.62 -5.49 7.58 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-N 114.056 -1.429 . . . . 0.57 109.03 -177.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.771 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -40.57 148.2 0.36 Allowed Pre-proline 0 C--N 1.376 1.753 0 CA-C-O 125.22 2.438 . . . . 0.57 113.951 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.57 -48.85 19.68 Favored 'Trans proline' 0 C--N 1.381 2.289 0 O-C-N 118.824 -1.198 . . . . 0.57 113.7 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.486 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -51.74 135.13 29.82 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-O 125.012 2.339 . . . . 0.57 110.959 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.66 142.57 34.09 Favored 'General case' 0 C--N 1.386 2.154 0 CA-C-O 123.106 1.431 . . . . 0.57 107.362 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -158.28 114.56 2.77 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-O 124.515 2.102 . . . . 0.57 108.453 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -55.25 118.57 4.5 Favored 'General case' 0 C--N 1.368 1.398 0 CA-C-O 126.433 3.016 . . . . 0.57 108.861 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 243' ' ' VAL . 2.6 p -125.41 -13.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 CA-C-N 112.498 -2.137 . . . . 0.57 111.062 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.266 0.7 OUTLIER 70.53 4.36 4.92 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-O 123.153 1.454 . . . . 0.91 112.811 176.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 213' ' ' PHE . 2.0 mt 77.88 4.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.394 2.533 0 CA-C-N 113.347 -1.751 . . . . 0.57 114.315 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.11 -33.17 69.89 Favored 'General case' 0 C--N 1.379 1.85 0 N-CA-C 104.593 -2.373 . . . . 0.57 104.593 -163.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -112.7 -16.65 12.74 Favored 'General case' 0 C--N 1.39 2.365 0 CA-C-N 112.739 -2.028 . . . . 0.57 113.107 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.761 ' HE1' HG11 ' A' ' 217' ' ' VAL . 19.2 t80 -38.86 99.46 0.02 OUTLIER 'General case' 0 C--N 1.388 2.28 0 CA-C-O 126.034 2.826 . . . . 0.57 109.319 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -133.09 149.12 52.16 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-N 112.18 -2.282 . . . . 1.2 105.374 -175.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.617 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.09 130.38 56.11 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 126.7 3.143 . . . . 0.57 107.325 -173.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.87 145.43 42.75 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 117.99 -2.944 . . . . 0.57 110.606 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.05 86.43 Favored 'General case' 0 C--N 1.4 2.797 0 CA-C-N 113.676 -1.602 . . . . 0.57 110.416 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -35.74 81.1 Favored 'General case' 0 C--N 1.367 1.342 0 CA-C-N 114.874 -1.057 . . . . 0.91 110.802 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 t70 -63.36 -55.29 25.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.91 110.854 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.0 pt -66.04 -36.56 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.57 111.168 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 34.7 mtt180 -70.3 -34.1 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 1.2 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.29 -47.52 79.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.57 112.511 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.35 -45.46 95.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.57 111.163 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.685 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.3 -21.03 61.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.57 110.933 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.369 1.435 0 CA-C-O 125.154 2.407 . . . . 0.57 110.22 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 123.712 1.72 . . . . 1.2 109.368 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.53 -49.84 0.02 OUTLIER 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.851 -1.522 . . . . 0.57 110.646 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.21 -8.55 27.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 112.98 -1.918 . . . . 0.57 111.091 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -114.56 112.76 23.45 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.169 -0.923 . . . . 0.57 110.872 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.11 138.19 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.57 111.119 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.855 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -109.26 135.27 50.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.57 111.109 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -129.81 150.9 50.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.888 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -143.52 129.88 19.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.2 110.903 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.51 HD12 ' HZ ' ' A' ' 163' ' ' PHE . 2.0 mm -99.03 130.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.57 111.169 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' ND2' HD13 ' A' ' 160' ' ' LEU . 24.6 m-20 -118.89 131.67 56.07 Favored 'General case' 0 C--N 1.368 1.385 0 N-CA-C 107.636 -1.246 . . . . 0.57 107.636 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.3 t30 50.41 81.13 0.07 Allowed 'General case' 0 C--N 1.391 2.401 0 O-C-N 126.527 2.392 . . . . 0.57 109.587 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 163' ' ' PHE . 22.6 m-85 -37.73 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.391 2.395 0 O-C-N 126.721 2.513 . . . . 0.57 109.514 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.55 HG23 ' HD2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 175.0 135.14 0.16 Allowed Pre-proline 0 C--N 1.371 1.522 0 C-N-CA 118.285 -1.366 . . . . 0.57 108.355 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 122' ' ' THR . 36.6 Cg_endo -78.17 -52.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-O 122.341 0.892 . . . . 0.57 110.938 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -77.22 -33.29 56.19 Favored 'General case' 0 C--N 1.388 2.256 0 CA-C-N 113.937 -1.483 . . . . 0.91 114.486 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.524 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -94.38 134.24 37.09 Favored 'General case' 0 C--N 1.374 1.663 0 CA-C-O 125.747 2.689 . . . . 0.57 106.002 -173.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.53 139.7 53.83 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-N 113.44 -1.709 . . . . 0.57 110.555 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -48.63 37.6 Favored 'General case' 0 C--N 1.378 1.821 0 N-CA-C 106.918 -1.512 . . . . 1.2 106.918 -169.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -35.26 62.33 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.788 -2.005 . . . . 0.91 110.89 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.04 -43.15 71.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.91 110.869 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.4 t -63.42 -37.94 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.57 111.082 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.411 ' OD1' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -68.51 -40.36 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.91 110.847 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' CE ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -65.29 -41.8 93.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.57 110.877 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.842 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.23 -49.12 73.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.57 111.111 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.411 HD11 ' OD1' ' A' ' 131' ' ' ASP . 22.7 pt -62.55 -40.16 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.57 111.178 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -60.59 -43.39 97.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 1.2 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -62.92 -43.4 98.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.873 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 140' ' ' VAL . . . -61.59 -39.65 91.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.57 111.117 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.488 ' CE1' ' CE2' ' A' ' 116' ' ' TYR . 17.3 m-85 -67.17 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.57 110.917 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -67.66 -40.49 84.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.57 110.909 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.0 p -71.46 -33.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.57 111.16 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.746 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 5.1 m95 -82.59 -34.04 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.925 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 m -79.21 -49.18 12.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.57 110.817 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.636 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.1 p-10 -59.36 -13.3 7.79 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-O 121.804 0.811 . . . . 0.57 112.564 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 140' ' ' VAL . 19.8 m -113.91 12.77 8.19 Favored 'Isoleucine or valine' 0 C--N 1.382 2.022 0 CA-C-N 114.145 -1.388 . . . . 0.57 112.028 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 141' ' ' TRP . 29.5 p -148.03 146.75 24.46 Favored Pre-proline 0 N--CA 1.428 -1.544 0 CA-C-O 124.132 1.92 . . . . 0.57 109.197 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.86 8.74 3.59 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.285 1.323 . . . . 0.57 114.449 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.566 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -112.51 110.76 21.13 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.358 -1.292 . . . . 0.57 109.117 -177.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.92 158.56 35.24 Favored 'General case' 0 C--N 1.382 1.999 0 CA-C-O 123.672 1.701 . . . . 0.57 114.778 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.566 ' HE1' HD12 ' A' ' 147' ' ' LEU . 15.6 m-30 -126.5 151.37 47.92 Favored 'General case' 0 C--N 1.389 2.314 0 CA-C-N 112.788 -2.005 . . . . 0.57 108.675 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.99 110.99 2.66 Favored 'General case' 0 C--N 1.39 2.364 0 CA-C-O 124.653 2.168 . . . . 0.57 108.302 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -95.2 133.41 39.08 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 113.776 -1.556 . . . . 0.57 110.254 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 155' ' ' GLY . 5.9 pt -117.14 173.78 4.08 Favored 'Isoleucine or valine' 0 C--N 1.372 1.562 0 CA-C-O 124.175 1.941 . . . . 0.57 109.957 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -127.2 -2.03 6.37 Favored 'General case' 0 C--N 1.384 2.067 0 CA-C-N 113.175 -1.83 . . . . 0.57 112.687 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 m -136.72 89.4 2.45 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 114.583 -1.189 . . . . 0.57 108.067 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 152' ' ' ILE . . . 124.29 99.69 1.32 Allowed Glycine 0 C--N 1.386 3.36 0 C-N-CA 118.956 -1.592 . . . . 0.57 110.513 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.4 ttp -42.95 118.35 1.25 Allowed 'General case' 0 C--N 1.377 1.804 0 CA-C-O 122.56 1.172 . . . . 0.57 111.3 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.855 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -95.34 169.79 9.82 Favored 'General case' 0 C--N 1.381 1.957 0 CA-C-N 113.025 -1.898 . . . . 0.57 109.517 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -54.45 23.29 Favored 'General case' 0 C--N 1.386 2.179 0 CA-C-N 113.501 -1.681 . . . . 0.91 110.586 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 116' ' ' TYR . 3.5 mt -90.64 109.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.385 2.143 0 O-C-N 127.846 3.216 . . . . 0.57 111.127 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -107.98 129.45 55.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.57 110.856 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.413 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -115.98 116.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.57 111.08 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -133.47 124.88 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.57 111.109 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -93.7 121.42 35.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.57 110.876 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -145.33 168.01 21.5 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 123.701 1.715 . . . . 0.57 108.51 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.71 160.28 16.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.592 -1.262 . . . . 1.2 107.592 -177.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 167' ' ' ALA . . . -39.28 93.87 0.01 OUTLIER Glycine 0 C--N 1.385 3.26 0 O-C-N 125.894 1.997 . . . . 0.57 117.401 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . 154.31 45.57 0.0 OUTLIER 'General case' 0 C--N 1.405 2.982 0 CA-C-O 125.734 2.683 . . . . 0.57 112.898 -165.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 . . . . . 0 C--N 1.38 1.899 0 CA-C-N 113.416 -1.72 . . . . 0.57 109.874 178.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.211 -1.033 . . . . 0.57 108.211 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.532 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.5 OUTLIER -50.64 168.54 0.05 OUTLIER 'General case' 0 C--N 1.388 2.277 0 O-C-N 126.7 2.5 . . . . 0.57 107.152 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -44.57 163.21 0.02 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 117.904 -1.518 . . . . 0.91 112.969 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 200' ' ' ASP . . . -149.53 48.25 0.6 Allowed Glycine 0 C--N 1.388 3.458 0 C-N-CA 117.287 -2.387 . . . . 0.57 111.815 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -168.66 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.389 2.323 0 C-N-CA 118.868 -1.133 . . . . 0.57 111.336 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -165.3 -61.65 0.02 OUTLIER Glycine 0 C--N 1.392 3.663 0 CA-C-O 125.014 2.452 . . . . 0.57 112.852 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -42.84 147.16 0.75 Allowed Glycine 0 C--N 1.376 2.802 0 O-C-N 118.963 -2.493 . . . . 0.57 110.24 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.532 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 1.6 mt 84.75 49.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-O 122.462 1.125 . . . . 0.57 108.951 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 214' ' ' LEU . 9.9 tp -42.94 -41.72 3.46 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.876 2.274 . . . . 0.57 111.345 -172.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 179.84 -174.31 0.25 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 112.415 -2.175 . . . . 0.57 111.047 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -143.95 158.59 43.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.57 110.879 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 222' ' ' HIS . . . -151.02 155.19 38.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 0.57 111.087 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.407 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 5.4 m-85 -117.44 -179.52 3.75 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 105.249 -2.13 . . . . 0.57 105.249 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' O ' ' CA ' ' A' ' 192' ' ' GLY . . . -122.15 -160.11 10.85 Favored Glycine 0 C--N 1.382 3.101 0 C-N-CA 119.795 -1.193 . . . . 0.57 111.493 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.44 -65.94 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.831 1.687 . . . . 0.57 112.508 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.44 -104.87 0.07 OUTLIER Glycine 0 C--N 1.395 3.858 0 O-C-N 125.605 1.816 . . . . 0.57 110.537 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.72 129.3 0.04 OUTLIER 'General case' 0 C--N 1.393 2.478 0 CA-C-N 112.794 -1.703 . . . . 0.57 108.886 175.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -95.86 1.64 Allowed Glycine 0 C--N 1.388 3.445 0 CA-C-O 122.773 1.207 . . . . 0.57 110.697 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.3 tp -66.85 -11.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.394 2.541 0 CA-C-O 126.845 3.212 . . . . 0.57 110.745 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 186' ' ' GLY . . . -66.71 134.34 32.53 Favored Glycine 0 C--N 1.377 2.827 0 N-CA-C 107.12 -2.392 . . . . 0.57 107.12 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.407 ' H ' ' CB ' ' A' ' 185' ' ' PHE . . . 96.49 -4.68 64.35 Favored Glycine 0 C--N 1.375 2.704 0 N-CA-C 110.169 -1.172 . . . . 0.57 110.169 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.78 141.25 39.35 Favored 'General case' 0 C--N 1.378 1.841 0 CA-C-N 114.221 -0.99 . . . . 0.91 110.872 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.03 132.63 22.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.57 111.098 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 1.1 m-70 -126.52 143.2 51.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.57 110.89 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.527 ' CD2' ' CD1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.55 148.38 26.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.685 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.8 p-10 -81.12 87.89 6.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.91 110.854 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -74.26 5.49 4.45 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.566 1.174 . . . . 0.91 111.615 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 4.1 t0 -78.77 -35.13 44.98 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-O 123.328 1.537 . . . . 0.91 109.92 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -73.76 176.87 5.9 Favored 'General case' 0 C--N 1.382 1.998 0 CA-C-O 124.289 1.995 . . . . 0.91 108.965 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.53 111.11 23.09 Favored 'General case' 0 C--N 1.391 2.398 0 CA-C-N 112.642 -2.072 . . . . 0.57 112.992 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 36.4 m95 -92.62 148.0 22.42 Favored 'General case' 0 C--N 1.382 2.017 0 CA-C-N 113.144 -1.844 . . . . 0.57 108.495 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 14.4 m -121.28 104.21 9.55 Favored 'General case' 0 C--N 1.384 2.069 0 CA-C-N 114.143 -1.39 . . . . 0.57 107.806 -174.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -103.02 106.91 17.53 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 115.499 -0.773 . . . . 0.57 109.864 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 205' ' ' THR . 1.7 t-80 169.1 -70.71 0.0 OUTLIER 'General case' 0 C--N 1.392 2.429 0 N-CA-C 106.944 -1.502 . . . . 0.57 106.944 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.413 ' C ' ' OD2' ' A' ' 244' ' ' ASP . 4.7 p 150.75 63.19 0.0 OUTLIER 'General case' 0 C--N 1.399 2.731 0 CA-C-O 127.412 3.482 . . . . 0.57 110.325 -166.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.18 29.58 0.11 Allowed Glycine 0 C--N 1.394 3.803 0 C-N-CA 116.964 -2.541 . . . . 0.57 113.136 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.6 -162.32 35.81 Favored Glycine 0 C--N 1.383 3.144 0 CA-C-O 124.234 2.019 . . . . 0.57 110.873 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.443 ' N ' ' HB2' ' A' ' 242' ' ' TYR . 0.9 OUTLIER -77.08 122.26 24.71 Favored 'General case' 0 C--N 1.372 1.58 0 CA-C-O 123.478 1.608 . . . . 0.57 107.761 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 245' ' ' ILE . 17.8 p-10 -121.01 -167.77 1.55 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-N 112.84 -1.982 . . . . 0.57 111.039 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 133' ' ' ALA . 1.5 tm? -70.2 -33.54 71.83 Favored 'General case' 0 C--N 1.392 2.436 0 CA-C-N 112.901 -1.954 . . . . 0.57 109.541 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.734 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 9.8 t80 -51.75 -50.15 61.21 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 114.456 -1.247 . . . . 0.57 110.909 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -62.86 -51.02 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.57 110.948 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 219' ' ' GLU . 12.4 m -58.95 -35.65 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.17 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.565 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -67.2 -41.53 85.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.57 111.097 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 248' ' ' PHE . 93.7 t -64.15 -46.46 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.57 111.094 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -72.36 -49.91 30.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.57 110.762 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 215' ' ' THR . 8.2 mm-40 -57.66 -42.5 83.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.91 110.927 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 216' ' ' ALA . 60.7 mt -70.32 -43.32 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.57 111.121 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.814 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -56.82 -33.93 64.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.57 112.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -63.75 -41.09 98.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.749 0.309 . . . . 0.57 110.823 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -71.26 -44.36 65.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.867 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.814 HD12 ' HA2' ' A' ' 221' ' ' GLY . 84.3 mt -42.89 -62.54 0.99 Allowed 'General case' 0 C--N 1.365 1.248 0 CA-C-O 123.829 1.776 . . . . 0.57 112.148 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 226' ' ' LEU . . . 169.6 134.65 1.77 Allowed Glycine 0 C--N 1.374 2.694 0 N-CA-C 107.774 -2.131 . . . . 0.57 107.774 175.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 225' ' ' GLY . 0.2 OUTLIER 78.85 -170.54 0.05 OUTLIER 'General case' 0 C--N 1.393 2.494 0 CA-C-O 124.329 2.014 . . . . 0.57 109.524 176.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.21 -154.63 10.66 Favored Glycine 0 C--N 1.386 3.318 0 CA-C-O 125.728 2.849 . . . . 0.57 112.86 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -93.95 -178.97 4.82 Favored 'General case' 0 C--N 1.376 1.722 0 CA-C-N 111.217 -2.491 . . . . 0.57 110.717 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 3.2 p -72.24 -31.59 65.96 Favored 'General case' 0 C--N 1.387 2.236 0 CA-C-N 113.647 -1.615 . . . . 0.57 109.187 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 82.8 23.59 0.17 Allowed 'General case' 0 C--N 1.399 2.734 0 N-CA-C 114.932 1.456 . . . . 0.57 114.932 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.41 151.01 35.69 Favored Pre-proline 0 C--N 1.383 2.027 0 N-CA-C 105.361 -2.089 . . . . 0.91 105.361 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.34 75.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 124.826 3.684 . . . . 0.57 113.871 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 178.42 -33.56 0.01 OUTLIER 'General case' 0 C--N 1.374 1.644 0 CA-C-N 113.814 -1.539 . . . . 0.57 112.722 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -60.12 149.05 33.86 Favored 'General case' 0 C--N 1.382 2.02 0 CA-C-N 113.619 -1.628 . . . . 0.57 107.854 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 250' ' ' LEU . 0.7 OUTLIER -69.28 -0.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.099 0 CA-C-N 113.052 -1.885 . . . . 0.57 112.959 -177.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.442 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -160.1 28.53 0.17 Allowed 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 113.137 -1.847 . . . . 0.57 109.885 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.592 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -48.64 147.41 4.33 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 123.866 1.793 . . . . 0.57 113.023 176.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.429 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 72.5 Cg_exo -55.49 -50.15 13.72 Favored 'Trans proline' 0 C--N 1.373 1.824 0 O-C-N 118.875 -1.171 . . . . 0.57 112.44 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.459 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.3 OUTLIER -50.18 125.4 12.27 Favored 'General case' 0 C--N 1.368 1.382 0 CA-C-O 123.989 1.852 . . . . 0.57 110.553 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -81.34 144.96 31.11 Favored 'General case' 0 C--N 1.369 1.435 0 O-C-N 119.894 -1.754 . . . . 0.57 108.232 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 242' ' ' TYR . 0.8 OUTLIER -175.29 121.3 0.2 Allowed 'General case' 0 C--N 1.388 2.27 0 CA-C-O 124.187 1.946 . . . . 0.57 107.556 173.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 210' ' ' THR . 25.9 p90 -68.86 132.85 47.42 Favored 'General case' 0 C--N 1.368 1.393 0 CA-C-O 125.761 2.696 . . . . 0.57 109.704 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 245' ' ' ILE . 3.0 p -117.75 -16.88 7.82 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 O-C-N 119.759 -1.838 . . . . 0.57 113.353 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 246' ' ' ASN . 0.0 OUTLIER 79.18 -8.15 1.66 Allowed 'General case' 0 C--N 1.376 1.736 0 O-C-N 125.077 1.486 . . . . 0.91 114.393 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.641 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.8 mt 81.68 18.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.381 1.978 0 CA-C-N 114.028 -1.442 . . . . 0.57 112.524 -174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 1.6 t-20 -84.22 -28.57 27.18 Favored 'General case' 0 C--N 1.391 2.381 0 C-N-CA 114.057 -3.057 . . . . 0.57 103.11 -165.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.0 p -119.04 -6.84 10.45 Favored 'General case' 0 C--N 1.389 2.311 0 CA-C-N 112.603 -2.089 . . . . 0.57 112.237 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.666 ' HE1' HG11 ' A' ' 217' ' ' VAL . 39.5 t80 -38.09 97.33 0.01 OUTLIER 'General case' 0 C--N 1.384 2.068 0 CA-C-O 125.059 2.362 . . . . 0.57 110.588 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -134.58 151.72 51.28 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.665 -2.061 . . . . 1.2 105.46 -174.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.642 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.43 128.94 55.09 Favored 'General case' 0 C--N 1.376 1.76 0 CA-C-O 126.142 2.877 . . . . 0.57 108.337 -172.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.6 t -73.23 136.24 44.62 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.363 -2.711 . . . . 0.57 109.947 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -55.44 -44.78 76.63 Favored 'General case' 0 C--N 1.388 2.244 0 CA-C-N 113.996 -1.456 . . . . 0.57 109.094 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.07 -41.25 92.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.257 0.623 . . . . 0.91 110.917 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 20.9 t0 -64.03 -55.12 24.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.91 110.838 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.5 pt -66.12 -35.28 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.57 111.089 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.755 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.4 mtp85 -70.42 -34.08 72.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.2 110.86 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.18 -46.94 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.57 112.446 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.746 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 1.1 pt -64.48 -44.78 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.57 111.172 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.492 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.19 -21.0 61.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.57 110.952 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--N 1.363 1.168 0 CA-C-O 122.227 1.013 . . . . 0.57 109.533 -178.091 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 . . . . . 0 C--O 1.237 0.417 0 N-CA-C 106.949 -1.5 . . . . 1.2 106.949 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.29 121.22 0.04 OUTLIER 'General case' 0 C--N 1.4 2.794 0 CA-C-N 114.106 -1.407 . . . . 0.57 111.456 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 77.47 -59.57 0.46 Allowed 'General case' 0 C--N 1.391 2.4 0 CA-C-N 114.585 -1.189 . . . . 0.57 112.325 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.14 125.34 53.68 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-N 114.64 -1.163 . . . . 0.57 110.875 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -119.85 154.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.106 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.9 p -119.96 160.07 23.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.57 111.103 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 3.0 t80 -147.07 152.88 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.57 110.933 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.566 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.97 122.0 14.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.852 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -98.97 126.32 52.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.57 111.097 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -59.59 -174.36 0.02 OUTLIER 'General case' 0 C--N 1.366 1.307 0 CA-C-O 124.873 2.273 . . . . 0.57 108.963 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -76.36 48.58 0.54 Allowed 'General case' 0 C--N 1.369 1.427 0 O-C-N 120.216 -1.552 . . . . 0.57 111.676 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 4.6 m-85 48.4 -148.24 0.22 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 122.467 1.127 . . . . 0.57 108.221 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -166.8 167.13 8.19 Favored Pre-proline 0 C--N 1.38 1.892 0 CA-C-N 113.703 -1.59 . . . . 0.57 108.839 -178.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 122' ' ' THR . 33.0 Cg_endo -72.39 -47.07 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 CA-C-O 122.673 1.03 . . . . 0.57 112.906 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 4.5 p-10 -71.92 -38.71 69.84 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 113.658 -1.61 . . . . 0.91 114.249 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.42 ' SD ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -89.43 110.67 21.47 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-O 125.427 2.537 . . . . 0.57 109.751 -178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -71.88 143.53 49.35 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 112.399 -2.182 . . . . 0.57 108.558 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.66 -49.33 59.94 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 114.18 -1.373 . . . . 1.2 107.529 -168.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.83 -34.74 63.19 Favored 'General case' 0 C--N 1.394 2.523 0 CA-C-N 112.586 -2.097 . . . . 0.91 110.903 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.25 -43.44 70.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.91 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -63.39 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.57 111.149 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.19 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.91 110.906 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.97 -49.0 79.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.57 110.937 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -60.6 -47.22 87.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.57 111.065 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 1.1 mm -66.77 -31.91 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.57 111.116 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -66.2 -47.85 72.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.849 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -40.35 97.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.57 110.898 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.88 94.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.57 111.082 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 220' ' ' ILE . 1.0 OUTLIER -67.19 -33.77 76.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.57 110.914 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -68.55 -42.12 78.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.57 110.909 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.7 p -69.69 -34.25 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.57 111.112 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.553 ' O ' HG23 ' A' ' 145' ' ' THR . 13.0 m95 -82.94 -34.04 26.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.57 110.898 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.1 m -79.2 -49.58 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.57 110.901 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.65 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.4 p-10 -58.68 -13.02 4.85 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 121.837 0.827 . . . . 0.57 113.104 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.65 HG13 ' OD1' ' A' ' 143' ' ' ASN . 21.4 m -114.01 12.03 8.11 Favored 'Isoleucine or valine' 0 C--N 1.391 2.375 0 CA-C-N 114.118 -1.401 . . . . 0.57 111.943 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 141' ' ' TRP . 24.2 p -150.76 145.04 17.85 Favored Pre-proline 0 C--N 1.381 1.953 0 CA-C-O 125.405 2.526 . . . . 0.57 108.619 -172.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.22 -24.27 9.6 Favored 'Trans proline' 0 C--N 1.37 1.679 0 O-C-N 118.344 -1.451 . . . . 0.57 111.891 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -82.35 102.87 11.52 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 114.077 -1.42 . . . . 0.57 111.176 178.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.11 162.45 28.97 Favored 'General case' 0 C--N 1.382 1.991 0 CA-C-O 124.108 1.909 . . . . 0.57 114.099 171.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -135.6 160.7 37.67 Favored 'General case' 0 C--N 1.392 2.433 0 CA-C-N 112.466 -2.152 . . . . 0.57 107.007 -172.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 m -160.3 122.34 3.22 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 125.177 2.418 . . . . 0.57 107.353 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -92.65 135.93 33.66 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.493 -1.685 . . . . 0.57 110.364 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.35 177.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.755 0 CA-C-O 124.254 1.978 . . . . 0.57 110.195 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -104.18 -38.76 6.77 Favored 'General case' 0 C--N 1.386 2.161 0 CA-C-N 112.581 -2.1 . . . . 0.57 112.401 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.4 p -130.25 133.27 46.39 Favored 'General case' 0 C--N 1.379 1.852 0 CA-C-O 122.409 1.099 . . . . 0.57 108.929 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.09 169.59 15.54 Favored Glycine 0 C--N 1.386 3.334 0 CA-C-O 123.864 1.813 . . . . 0.57 112.389 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.1 ttt -80.72 139.15 36.27 Favored 'General case' 0 C--N 1.389 2.292 0 CA-C-N 112.114 -2.043 . . . . 0.57 109.551 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -131.71 173.23 11.35 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-N 112.446 -2.161 . . . . 0.57 111.144 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.9 -59.33 2.53 Favored 'General case' 0 C--N 1.385 2.12 0 N-CA-C 103.501 -2.778 . . . . 0.91 103.501 -168.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 223' ' ' SER . 5.6 mt -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 C--N 1.389 2.288 0 O-C-N 125.064 1.478 . . . . 0.57 111.15 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -99.21 128.44 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.884 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 197' ' ' PHE . 1.0 OUTLIER -114.59 119.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.57 111.086 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.72 125.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.57 111.087 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.421 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.4 OUTLIER -98.51 122.76 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.86 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 199' ' ' GLU . . . -142.66 167.94 20.9 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-O 123.258 1.504 . . . . 0.57 107.12 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -112.48 135.63 52.95 Favored 'General case' 0 C--N 1.369 1.437 0 CA-C-N 114.097 -1.411 . . . . 1.2 109.775 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.13 -133.86 28.27 Favored Glycine 0 C--N 1.397 3.919 0 CA-C-O 124.913 2.396 . . . . 0.57 109.562 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.39 135.18 39.69 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 111.496 -2.352 . . . . 0.57 113.799 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 . . . . . 0 C--N 1.398 2.683 0 CA-C-N 113.533 -1.667 . . . . 0.57 107.096 -171.922 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 122.931 1.348 . . . . 0.57 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -98.97 -157.08 0.58 Allowed 'General case' 0 C--N 1.384 2.074 0 CA-C-N 112.776 -2.011 . . . . 0.57 111.253 175.459 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.46 -77.52 0.1 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.475 -1.693 . . . . 0.91 112.267 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.45 16.43 Favored Glycine 0 C--N 1.385 3.266 0 C-N-CA 120.882 -0.675 . . . . 0.57 113.757 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 160.38 40.88 0.0 OUTLIER 'General case' 0 C--N 1.399 2.759 0 CA-C-O 124.183 1.944 . . . . 0.57 112.341 -170.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.02 -156.79 15.42 Favored Glycine 0 C--N 1.37 2.446 0 N-CA-C 107.009 -2.436 . . . . 0.57 107.009 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.45 -39.84 2.54 Favored Glycine 0 C--N 1.367 2.265 0 O-C-N 120.268 -1.725 . . . . 0.57 113.989 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -152.56 167.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.86 0 N-CA-C 105.294 -2.113 . . . . 0.57 105.294 -172.731 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' A' ' 210' ' ' THR . 66.9 mt -118.77 -80.6 0.62 Allowed 'General case' 0 C--N 1.374 1.673 0 O-C-N 126.684 2.49 . . . . 0.57 114.77 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -107.65 179.5 4.22 Favored 'General case' 0 C--N 1.377 1.765 0 CA-C-N 115.356 -0.838 . . . . 0.57 111.112 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER -169.24 135.9 1.72 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.57 110.904 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -160.05 161.97 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.57 111.151 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -171.22 2.85 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.029 1.395 . . . . 0.57 110.846 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.91 -159.11 35.16 Favored Glycine 0 C--N 1.385 3.275 0 CA-C-N 114.001 -1.454 . . . . 0.57 112.838 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.42 74.28 3.74 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 122.818 2.345 . . . . 0.57 110.068 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.76 -134.86 6.95 Favored Glycine 0 C--N 1.376 2.798 0 CA-C-O 124.067 1.926 . . . . 0.57 110.155 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.26 -80.08 0.6 Allowed 'General case' 0 C--N 1.396 2.604 0 CA-C-N 112.909 -1.645 . . . . 0.57 108.938 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.99 -54.76 2.11 Favored Glycine 1 C--N 1.398 4.006 0 N-CA-C 108.252 -1.939 . . . . 0.57 108.252 -174.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -44.37 99.47 Favored 'Isoleucine or valine' 0 C--N 1.396 2.625 0 CA-C-N 113.38 -1.41 . . . . 0.57 107.615 -173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.52 136.44 43.89 Favored Glycine 0 C--N 1.395 3.835 0 N-CA-C 106.89 -2.484 . . . . 0.57 106.89 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.62 -41.54 2.11 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-N 113.33 -1.435 . . . . 0.57 113.531 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.83 97.16 0.1 Allowed 'General case' 0 C--N 1.39 2.343 0 CA-C-N 115.096 -0.552 . . . . 0.91 110.921 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -102.95 148.29 25.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.57 111.08 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -129.37 151.27 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.57 110.895 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.59 150.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.57 110.897 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.577 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 2.8 p30 -79.39 83.19 5.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.91 110.833 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 203' ' ' TRP . 11.7 tp10 -57.1 -32.52 66.39 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 117.72 -1.133 . . . . 0.91 110.349 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -41.98 -51.41 4.44 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 125.768 1.918 . . . . 0.91 110.429 -173.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -173.87 0.01 OUTLIER 'General case' 0 C--N 1.392 2.434 0 CA-C-O 127.766 3.65 . . . . 0.91 113.045 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 122.59 46.71 Favored 'General case' 0 C--N 1.382 2.019 0 O-C-N 119.125 -2.234 . . . . 0.57 113.078 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.568 ' CZ2' ' HA ' ' A' ' 199' ' ' GLU . 26.1 m0 -96.39 123.85 40.18 Favored 'General case' 0 C--N 1.391 2.383 0 N-CA-C 105.262 -2.125 . . . . 0.57 105.262 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 102.61 11.44 Favored 'General case' 0 C--N 1.374 1.649 0 CA-C-O 126.235 2.921 . . . . 0.57 112.136 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.8 p -102.09 120.59 40.68 Favored 'General case' 0 C--N 1.376 1.739 0 O-C-N 119.564 -1.96 . . . . 0.57 108.904 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 65.86 66.63 0.5 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-O 123.958 1.837 . . . . 0.57 109.673 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.98 -72.14 0.01 OUTLIER 'General case' 0 C--N 1.397 2.661 0 CA-C-O 123.522 1.629 . . . . 0.57 109.334 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.81 -145.92 5.2 Favored Glycine 0 C--N 1.385 3.263 0 N-CA-C 108.262 -1.935 . . . . 0.57 108.262 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 47.06 -146.56 3.75 Favored Glycine 0 C--N 1.383 3.18 0 CA-C-O 127.134 3.63 . . . . 0.57 110.095 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.55 ' CB ' HD21 ' A' ' 181' ' ' LEU . 8.3 p -77.77 124.34 27.84 Favored 'General case' 0 C--N 1.368 1.378 0 O-C-N 119.983 -1.892 . . . . 0.57 112.331 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 214' ' ' LEU . 0.7 OUTLIER -116.86 155.97 28.12 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-N 114.815 -1.084 . . . . 0.57 109.435 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -65.87 -32.93 74.73 Favored 'General case' 0 C--N 1.393 2.491 0 CA-C-O 124.22 1.962 . . . . 0.57 107.641 -173.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.83 ' CD2' HG23 ' A' ' 245' ' ' ILE . 27.5 t80 -57.55 -50.0 74.53 Favored 'General case' 0 C--N 1.376 1.72 0 CA-C-N 113.16 -1.836 . . . . 0.57 110.898 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.617 HD23 ' OD1' ' A' ' 211' ' ' ASN . 1.0 OUTLIER -55.03 -51.12 67.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.937 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -63.83 -44.95 91.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.151 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.93 -42.87 80.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.57 111.085 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.579 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 0.9 OUTLIER -65.17 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.096 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.26 -49.97 62.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.57 110.823 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -59.35 -42.11 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.91 110.885 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.3 mm -67.68 -47.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.57 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.79 -33.75 63.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.57 112.466 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.41 -38.74 88.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.57 110.9 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 159' ' ' ILE . 11.0 t -71.22 -53.53 14.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.836 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.2 pp -72.23 -60.77 2.06 Favored 'General case' 0 C--N 1.375 1.68 0 N-CA-C 118.992 2.96 . . . . 0.57 118.992 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.811 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -70.42 -175.09 17.1 Favored Glycine 0 C--N 1.375 2.741 0 CA-C-O 126.157 3.087 . . . . 0.57 110.114 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.602 HD12 ' H ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -89.01 -146.33 0.16 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-N 109.628 -3.286 . . . . 0.57 106.432 -172.02 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.01 -107.57 0.01 OUTLIER Glycine 0 C--N 1.394 3.794 0 CA-C-O 125.769 2.871 . . . . 0.57 111.665 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.445 ' CE1' ' HG3' ' A' ' 238' ' ' PRO . 21.4 m170 -113.83 -96.43 0.45 Allowed 'General case' 0 C--N 1.382 1.994 0 O-C-N 119.633 -2.098 . . . . 0.57 110.34 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.03 -42.58 0.01 OUTLIER 'General case' 0 C--N 1.391 2.413 0 N-CA-C 107.893 -1.151 . . . . 0.57 107.893 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 81.87 24.11 0.23 Allowed 'General case' 0 C--N 1.415 3.454 0 N-CA-C 116.676 2.102 . . . . 0.57 116.676 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 4.5 t0 -157.94 138.2 8.95 Favored Pre-proline 0 C--N 1.386 2.156 0 N-CA-C 106.539 -1.652 . . . . 0.91 106.539 -171.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 67.8 Cg_exo -57.29 -57.68 1.18 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.445 2.763 . . . . 0.57 114.529 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.99 -37.75 4.25 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 112.976 -1.92 . . . . 0.57 113.396 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -65.63 117.56 8.27 Favored 'General case' 0 C--N 1.393 2.493 0 CA-C-O 124.445 2.069 . . . . 0.57 115.762 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 235' ' ' VAL . 10.3 t -72.19 47.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.033 0 CA-C-O 124.693 2.187 . . . . 0.57 115.449 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.8 mmm -144.76 -31.94 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 CA-C-N 113.575 -1.648 . . . . 0.57 110.227 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.0 OUTLIER -39.11 144.37 0.44 Allowed Pre-proline 0 C--N 1.38 1.928 0 CA-C-O 126.283 2.944 . . . . 0.57 114.371 173.586 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.445 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 54.0 Cg_exo -58.87 -48.14 15.66 Favored 'Trans proline' 0 C--N 1.383 2.371 0 O-C-N 118.294 -1.477 . . . . 0.57 111.806 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 98.9 m -46.3 122.54 4.07 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 124.842 2.258 . . . . 0.57 110.003 -173.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.503 ' CZ ' HG22 ' A' ' 210' ' ' THR . 0.0 OUTLIER -98.03 117.69 32.96 Favored 'General case' 0 C--N 1.386 2.164 0 CA-C-N 112.81 -1.995 . . . . 0.57 106.602 -178.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -138.5 108.03 6.19 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 113.281 -1.781 . . . . 0.57 106.63 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.5 120.89 5.03 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-O 124.455 2.074 . . . . 0.57 110.796 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.24 18.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 CA-C-N 112.868 -1.969 . . . . 0.57 110.718 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.3 t0 64.03 115.95 0.02 OUTLIER 'General case' 0 C--N 1.385 2.147 0 CA-C-O 126.937 3.256 . . . . 0.91 106.651 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.83 HG23 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mp -51.97 -19.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.46 0 O-C-N 119.048 -2.283 . . . . 0.57 115.4 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -31.46 64.56 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.003 -1.453 . . . . 0.57 111.23 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -5.62 15.42 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 123.121 0.568 . . . . 0.57 110.914 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.579 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 22.9 t80 -65.01 93.85 0.12 Allowed 'General case' 0 C--N 1.385 2.119 0 CA-C-O 125.678 2.656 . . . . 0.57 105.332 -170.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.542 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -114.41 154.14 28.64 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 112.414 -2.176 . . . . 1.2 105.79 -177.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.89 132.62 53.77 Favored 'General case' 0 C--N 1.385 2.15 0 CA-C-O 125.559 2.6 . . . . 0.57 105.768 -170.552 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 25.8 m -69.32 141.79 54.19 Favored 'General case' 0 C--N 1.365 1.249 0 O-C-N 120.229 -1.544 . . . . 0.57 109.124 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -59.93 -42.45 93.98 Favored 'General case' 0 C--N 1.396 2.609 0 CA-C-N 113.337 -1.756 . . . . 0.57 107.412 -174.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -41.52 89.07 Favored 'General case' 0 C--N 1.365 1.243 0 CA-C-N 115.501 -0.772 . . . . 0.91 110.834 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 258' ' ' ILE . 23.2 t0 -64.4 -54.8 27.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.91 110.857 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.6 pt -66.08 -34.54 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.57 111.196 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.661 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 7.4 mtp180 -67.55 -31.12 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.2 110.796 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.41 19.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.57 112.457 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 224' ' ' LEU . 1.2 pt -59.59 -36.15 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.731 0.301 . . . . 0.57 111.077 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 260' ' ' SER . 18.5 pt20 -70.13 -44.61 68.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.896 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 1.5 t . . . . . 0 C--N 1.374 1.673 0 CA-C-O 121.933 0.873 . . . . 0.57 110.891 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 122.986 1.374 . . . . 1.2 108.943 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -65.83 0.03 OUTLIER 'General case' 0 C--N 1.382 2.018 0 CA-C-N 113.886 -1.507 . . . . 0.57 111.07 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.754 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -77.31 -11.61 59.85 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 125.542 2.591 . . . . 0.57 110.268 -179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -110.07 105.48 14.61 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.144 -1.598 . . . . 0.57 110.946 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -110.01 135.32 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.57 111.108 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.42 159.03 18.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.181 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.912 ' OH ' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -150.14 158.07 43.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.57 110.883 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -156.07 126.5 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.2 110.921 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.912 HD12 ' OH ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -77.98 136.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.114 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -53.23 -53.92 43.65 Favored 'General case' 0 C--N 1.376 1.744 0 N-CA-C 107.805 -1.183 . . . . 0.57 107.805 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 161.98 35.44 0.0 OUTLIER 'General case' 0 C--N 1.382 1.996 0 O-C-N 126.599 2.437 . . . . 0.57 110.049 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 4.8 m-30 72.52 -172.22 0.15 Allowed 'General case' 0 C--N 1.383 2.025 0 N-CA-C 107.41 -1.33 . . . . 0.57 107.41 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -139.74 161.51 55.98 Favored Pre-proline 0 C--N 1.373 1.614 0 CA-C-N 114.141 -1.39 . . . . 0.57 108.619 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -50.51 1.41 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.757 1.638 . . . . 0.57 112.584 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' H ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -80.16 -66.87 0.82 Allowed 'General case' 0 C--N 1.379 1.882 0 N-CA-C 104.768 -2.308 . . . . 0.91 104.768 -165.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.7 ttm -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-O 125.694 2.664 . . . . 0.57 110.19 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.728 ' O ' HG23 ' A' ' 130' ' ' VAL . 69.2 m-20 -75.95 139.69 41.7 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.396 -2.184 . . . . 0.57 107.714 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.47 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.47 -47.46 67.03 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 107.736 -1.209 . . . . 1.2 107.736 -168.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -34.67 63.27 Favored 'General case' 0 C--N 1.387 2.226 0 O-C-N 126.482 2.364 . . . . 0.91 110.898 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -44.04 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.91 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.31 -44.55 98.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.57 111.092 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.84 -44.09 97.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.91 110.869 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.61 -44.06 87.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.57 110.894 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.1 -43.97 87.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.57 111.13 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.527 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -65.15 -42.89 95.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.57 111.112 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -49.05 78.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.868 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -36.55 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.91 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -63.26 -42.06 99.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.57 111.132 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 134' ' ' ILE . 20.4 m-85 -65.93 -37.09 85.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.57 110.86 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -67.16 -38.11 84.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.882 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 144' ' ' VAL . 8.3 t -71.12 -34.07 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.57 111.122 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CG ' HD11 ' A' ' 224' ' ' LEU . 1.3 m95 -83.25 -34.09 25.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.57 110.913 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m -77.55 -49.39 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.876 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.59 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.1 p-10 -59.76 -12.56 7.45 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-O 122.174 0.988 . . . . 0.57 112.737 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 140' ' ' VAL . 25.0 m -115.98 1.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.379 1.854 0 CA-C-N 114.014 -1.448 . . . . 0.57 111.42 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.8 150.28 45.92 Favored Pre-proline 0 C--N 1.368 1.412 0 CA-C-O 125.615 2.626 . . . . 0.57 110.203 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.38 -34.03 6.36 Favored 'Trans proline' 0 C--N 1.361 1.224 0 O-C-N 118.114 -1.572 . . . . 0.57 110.69 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.1 mt -58.7 114.34 2.46 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-O 123.672 1.701 . . . . 0.57 108.73 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 158.36 32.05 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 113.742 -1.572 . . . . 0.57 112.507 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 224' ' ' LEU . 12.6 m-85 -130.07 139.61 50.94 Favored 'General case' 0 C--N 1.388 2.272 0 CA-C-N 112.368 -2.196 . . . . 0.57 108.711 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.4 m -145.53 125.02 13.14 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.763 2.22 . . . . 0.57 108.367 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 116' ' ' TYR . 15.9 tttt -89.45 146.58 24.54 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-N 114.077 -1.42 . . . . 0.57 112.731 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' HA ' ' A' ' 157' ' ' ALA . 8.2 pt -139.11 155.97 27.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.852 0 CA-C-O 123.41 1.576 . . . . 0.57 109.738 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 -6.23 1.48 Allowed 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.808 -1.542 . . . . 0.57 109.951 -174.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.5 p -76.79 -62.82 1.51 Allowed 'General case' 0 C--N 1.372 1.569 0 CA-C-N 114.184 -1.371 . . . . 0.57 110.539 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.56 -174.69 17.47 Favored Glycine 0 C--N 1.374 2.648 0 CA-C-O 123.253 1.474 . . . . 0.57 110.861 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 ttt -57.62 124.97 20.89 Favored 'General case' 0 C--N 1.382 1.997 0 CA-C-N 113.014 -1.593 . . . . 0.57 108.411 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 152' ' ' ILE . . . -97.04 173.56 7.21 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.147 -1.842 . . . . 0.57 110.582 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.43 -83.39 0.03 OUTLIER 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.989 -1.914 . . . . 0.91 107.674 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.94 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.9 pp -94.69 114.57 31.54 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-N 114.665 -1.152 . . . . 0.57 111.108 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 157' ' ' ALA . 4.5 mp -96.38 132.06 42.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.57 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 197' ' ' PHE . 21.6 t -102.02 116.9 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.57 111.148 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.33 145.13 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.57 111.101 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -102.77 117.77 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.57 110.89 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.36 170.12 18.0 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 124.341 2.019 . . . . 0.57 109.646 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.6 134.02 52.43 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.909 -1.744 . . . . 1.2 108.156 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 42.32 -106.02 0.07 OUTLIER Glycine 0 C--N 1.379 2.957 0 O-C-N 126.135 2.147 . . . . 0.57 113.009 171.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.478 ' H ' ' CB ' ' A' ' 173' ' ' ALA . . . 57.04 -140.03 0.86 Allowed 'General case' 0 C--N 1.384 2.097 0 O-C-N 127.111 2.301 . . . . 0.57 107.518 170.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.383 2.059 0 O-C-N 124.957 1.411 . . . . 0.57 111.36 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.478 ' CB ' ' H ' ' A' ' 167' ' ' ALA . . . . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 124.157 1.932 . . . . 0.57 115.185 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.756 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -85.89 -131.1 0.05 OUTLIER 'General case' 0 C--N 1.376 1.745 0 CA-C-N 113.224 -1.807 . . . . 0.57 108.633 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.578 ' H ' HD13 ' A' ' 180' ' ' ILE . 6.9 t70 54.0 -157.42 0.19 Allowed 'General case' 0 C--N 1.39 2.343 0 N-CA-C 105.647 -1.982 . . . . 0.91 105.647 170.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 127.72 9.18 4.02 Favored Glycine 0 C--N 1.368 2.344 0 N-CA-C 109.067 -1.613 . . . . 0.57 109.067 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.13 -57.14 0.01 OUTLIER 'General case' 0 C--N 1.393 2.492 0 CA-C-O 122.764 1.269 . . . . 0.57 111.031 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -156.95 -38.25 0.02 OUTLIER Glycine 0 C--N 1.382 3.102 0 CA-C-N 114.126 -1.397 . . . . 0.57 111.497 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.618 ' C ' HD12 ' A' ' 180' ' ' ILE . . . -41.6 142.06 1.19 Allowed Glycine 0 C--N 1.38 3.027 0 O-C-N 120.0 -1.883 . . . . 0.57 109.379 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 174' ' ' PHE . 1.3 mp 74.04 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.62 0 O-C-N 124.153 0.561 . . . . 0.57 112.449 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 215' ' ' THR . 2.7 tp -124.29 -57.81 1.56 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 122.966 1.365 . . . . 0.57 111.882 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 215' ' ' THR . . . -177.43 179.53 0.94 Allowed 'General case' 0 C--N 1.364 1.229 0 CA-C-N 114.584 -1.189 . . . . 0.57 111.042 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.518 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.7 p80 -152.94 168.24 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.874 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.89 142.71 22.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.57 111.057 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.453 ' CB ' ' HA2' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -52.02 129.71 27.93 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 117.745 -1.582 . . . . 0.57 110.143 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 187' ' ' PRO . . . -74.26 -58.19 4.4 Favored Glycine 0 C--N 1.381 3.046 0 CA-C-N 112.859 -1.973 . . . . 0.57 111.785 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 186' ' ' GLY . 30.7 Cg_endo -67.96 -83.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 121.495 1.463 . . . . 0.57 111.342 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.463 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . 167.32 -142.52 7.61 Favored Glycine 0 C--N 1.375 2.711 0 N-CA-C 108.984 -1.646 . . . . 0.57 108.984 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 83.59 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.382 1.987 0 O-C-N 125.611 1.418 . . . . 0.57 109.382 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -44.87 -65.08 1.91 Allowed Glycine 0 C--N 1.388 3.426 0 CA-C-O 125.678 2.821 . . . . 0.57 112.549 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 191' ' ' ILE . 1.5 mp -71.97 -15.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.382 1.982 0 CA-C-N 111.306 -2.447 . . . . 0.57 109.03 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -44.98 148.35 1.39 Allowed Glycine 0 C--N 1.362 1.972 0 O-C-N 120.693 -1.254 . . . . 0.57 113.676 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.94 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 76.38 -44.47 1.94 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 117.428 1.731 . . . . 0.57 117.428 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -37.48 147.15 0.04 OUTLIER 'General case' 0 C--N 1.387 2.205 0 O-C-N 124.894 0.997 . . . . 0.91 110.853 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -143.42 152.0 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.57 111.113 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.538 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.33 126.41 37.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.57 110.828 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.664 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -109.97 134.93 51.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.57 110.923 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.43 ' HB2' ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -60.83 85.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.86 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -72.98 -49.24 30.27 Favored 'General case' 0 C--N 1.382 1.999 0 N-CA-C 104.209 -2.515 . . . . 0.91 104.209 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.84 -45.75 0.1 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 123.938 0.895 . . . . 0.91 112.151 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -53.19 174.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 126.631 3.11 . . . . 0.91 109.77 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 2.1 t80 -97.1 107.52 20.07 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 112.74 -2.027 . . . . 0.57 114.275 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 40.9 m95 -91.25 151.42 20.92 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 113.63 -1.623 . . . . 0.57 108.493 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.0 p -126.22 104.4 8.2 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-O 123.601 1.667 . . . . 0.57 109.92 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.56 137.29 37.43 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-N 113.271 -1.786 . . . . 0.57 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 207' ' ' SER . 1.3 t60 76.78 42.56 0.15 Allowed 'General case' 0 C--N 1.385 2.144 0 CA-C-N 113.796 -1.547 . . . . 0.57 110.834 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.1 p 81.69 123.17 0.04 OUTLIER 'General case' 0 C--N 1.382 1.989 0 CA-C-O 124.55 2.119 . . . . 0.57 108.849 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.37 -13.91 0.15 Allowed Glycine 0 C--N 1.382 3.135 0 C-N-CA 118.514 -1.803 . . . . 0.57 111.752 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 153.88 -119.13 0.92 Allowed Glycine 0 C--N 1.389 3.509 0 CA-C-O 123.723 1.735 . . . . 0.57 112.994 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.7 p -80.02 117.53 20.94 Favored 'General case' 0 C--N 1.377 1.795 0 CA-C-O 123.142 1.448 . . . . 0.57 111.625 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -91.59 152.14 20.41 Favored 'General case' 0 C--N 1.369 1.417 0 CA-C-N 112.738 -2.028 . . . . 0.57 111.648 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -75.04 -31.23 61.27 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 113.184 -1.825 . . . . 0.57 107.338 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.3 t80 -58.22 -46.61 85.57 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-N 113.819 -1.537 . . . . 0.57 110.889 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -55.68 -51.84 65.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.898 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.01 -49.05 69.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.57 111.162 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.32 73.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.174 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 213' ' ' PHE . 92.5 t -65.18 -39.49 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.57 111.081 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 236' ' ' MET . 7.2 t-160 -70.29 -42.3 72.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.866 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 219' ' ' GLU . 1.2 mm-40 -61.1 -43.78 98.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.91 110.869 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 137' ' ' ALA . 12.5 pt -71.09 -42.94 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.57 111.114 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.96 -33.76 64.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.57 112.523 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.53 -42.02 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.57 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.482 ' CB ' HG21 ' A' ' 159' ' ' ILE . 17.7 t -71.01 -36.01 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.57 110.888 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.647 ' CD2' HD12 ' A' ' 114' ' ' ILE . 26.8 mt -43.74 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.367 1.344 0 CA-C-O 124.25 1.976 . . . . 0.57 114.318 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.64 -161.83 35.56 Favored Glycine 0 C--N 1.369 2.408 0 N-CA-C 107.93 -2.068 . . . . 0.57 107.93 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 227' ' ' GLY . 0.5 OUTLIER 50.65 -164.07 0.05 OUTLIER 'General case' 0 C--N 1.389 2.293 0 CA-C-N 112.633 -1.783 . . . . 0.57 111.131 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.533 ' H ' HD22 ' A' ' 226' ' ' LEU . . . -111.34 -162.61 17.51 Favored Glycine 0 C--N 1.373 2.624 0 CA-C-O 125.61 2.783 . . . . 0.57 112.682 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.48 -167.06 1.74 Allowed 'General case' 0 C--N 1.39 2.328 0 CA-C-N 110.578 -2.811 . . . . 0.57 112.032 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -94.24 -20.1 20.13 Favored 'General case' 0 C--N 1.385 2.125 0 CA-C-N 113.421 -1.718 . . . . 0.57 109.944 -175.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 86.48 5.38 0.39 Allowed 'General case' 0 C--N 1.387 2.22 0 O-C-N 125.558 1.786 . . . . 0.57 114.853 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -149.12 143.86 17.43 Favored Pre-proline 0 C--N 1.38 1.908 0 O-C-N 125.193 1.558 . . . . 0.91 109.377 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 239' ' ' THR . 87.6 Cg_exo -59.11 -47.18 18.56 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.589 2.192 . . . . 0.57 112.295 -172.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -41.89 -39.35 1.8 Allowed 'General case' 0 C--N 1.38 1.909 0 CA-C-N 114.035 -1.438 . . . . 0.57 113.032 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 229' ' ' SER . . . -63.48 131.56 48.56 Favored 'General case' 0 C--N 1.383 2.046 0 N-CA-C 118.955 2.946 . . . . 0.57 118.955 167.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 248' ' ' PHE . 21.9 t -73.55 70.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.9 0 CA-C-N 112.256 -2.247 . . . . 0.57 111.435 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.459 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -179.55 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-N 113.233 -1.803 . . . . 0.57 109.424 -178.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 3.4 t80 -52.77 140.25 39.63 Favored Pre-proline 0 C--N 1.363 1.193 0 O-C-N 120.014 -1.679 . . . . 0.57 109.868 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 54.0 Cg_exo -54.77 -19.41 18.82 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.8 1.667 . . . . 0.57 114.9 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 232' ' ' PRO . 1.0 OUTLIER -48.41 107.57 0.13 Allowed 'General case' 0 C--N 1.371 1.515 0 CA-C-O 123.665 1.698 . . . . 0.57 110.677 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -81.86 134.11 35.38 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 105.869 -1.9 . . . . 0.57 105.869 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? 174.96 113.49 0.02 OUTLIER 'General case' 0 C--N 1.383 2.048 0 N-CA-C 106.744 -1.576 . . . . 0.57 106.744 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.59 123.26 9.55 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 113.238 -1.801 . . . . 0.57 110.701 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 243' ' ' VAL . 7.7 p -151.35 113.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.779 0 CA-C-N 113.806 -1.543 . . . . 0.57 108.103 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.39 150.05 12.2 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 113.211 -1.813 . . . . 0.91 107.086 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.1 mp -75.86 -23.57 16.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 124.227 1.965 . . . . 0.57 110.02 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -84.15 -7.52 59.34 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.481 -1.387 . . . . 0.57 112.714 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 39.7 p -122.39 3.51 9.71 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-O 123.679 1.704 . . . . 0.57 111.578 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -83.97 -156.73 0.23 Allowed 'General case' 0 C--N 1.368 1.4 0 CA-C-N 113.259 -1.791 . . . . 0.57 110.376 178.462 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER 178.28 163.37 0.69 Allowed 'General case' 0 C--N 1.385 2.124 0 N-CA-C 105.637 -1.986 . . . . 1.2 105.637 168.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -117.56 141.98 47.73 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.732 2.682 . . . . 0.57 108.262 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.3 t -64.5 134.02 53.6 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 119.846 -1.784 . . . . 0.57 112.645 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.91 -49.91 64.08 Favored 'General case' 0 C--N 1.39 2.361 0 CA-C-N 114.072 -1.422 . . . . 0.57 108.663 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -35.96 73.97 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 115.357 -0.838 . . . . 0.91 110.845 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 258' ' ' ILE . 30.6 t0 -63.94 -55.13 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.91 110.885 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.7 pt -66.37 -35.31 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.57 111.149 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 35.5 mtp180 -70.72 -35.52 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 1.2 110.784 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.02 -51.2 55.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.722 . . . . 0.57 112.465 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.713 HD11 HG23 ' A' ' 144' ' ' VAL . 2.4 pt -61.17 -45.61 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.57 111.119 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.21 -28.69 63.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.57 110.907 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 31.3 t . . . . . 0 C--N 1.365 1.251 0 C-N-CA 119.096 -1.042 . . . . 0.57 109.796 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.349 0 CA-C-O 125.034 2.349 . . . . 1.2 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -127.91 -54.32 1.31 Allowed 'General case' 0 C--N 1.379 1.868 0 O-C-N 120.411 -1.431 . . . . 0.57 107.822 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.388 2.247 0 CA-C-O 124.172 1.939 . . . . 0.57 108.471 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.6 103.81 10.06 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-N 112.054 -2.339 . . . . 0.57 110.929 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 149' ' ' PHE . 1.3 mm -102.11 146.91 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.57 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.572 ' HB ' ' H ' ' A' ' 158' ' ' ASP . 1.3 m -105.93 156.51 18.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.473 . . . . 0.57 111.125 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.753 ' CE1' HD12 ' A' ' 118' ' ' ILE . 20.3 t80 -138.64 160.1 40.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.929 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.528 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -145.68 121.85 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.509 . . . . 1.2 110.847 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -93.51 132.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.57 111.125 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -59.48 -86.76 0.01 OUTLIER 'General case' 0 C--N 1.375 1.696 0 CA-C-N 114.739 -1.119 . . . . 0.57 110.206 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t30 169.4 60.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.28 0 N-CA-C 104.15 -2.537 . . . . 0.57 104.15 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.723 ' CD2' HG21 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -67.07 178.37 1.45 Allowed 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.065 -1.88 . . . . 0.57 111.544 166.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 162.45 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.32 2.648 . . . . 0.57 108.134 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.71 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-O 124.365 1.735 . . . . 0.57 110.079 -165.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.99 3.31 12.54 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 114.309 -1.314 . . . . 0.91 113.986 173.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.1 mmt -142.75 119.45 11.13 Favored 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.007 -1.479 . . . . 0.57 107.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 t-20 -93.32 139.09 31.04 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 122.617 1.199 . . . . 0.57 108.58 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -46.66 74.22 Favored 'General case' 0 C--N 1.388 2.261 0 CA-C-O 123.871 1.796 . . . . 1.2 109.261 -166.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.24 -35.17 64.65 Favored 'General case' 0 C--N 1.364 1.208 0 CA-C-N 111.376 -2.647 . . . . 0.91 110.979 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.61 -41.92 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.91 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -65.54 -39.57 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.57 111.112 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.63 -42.1 87.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.91 110.838 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -49.02 75.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.57 110.949 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.62 -49.1 67.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.57 111.052 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.521 HG13 HG12 ' A' ' 130' ' ' VAL . 1.5 mm -62.22 -46.03 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.57 111.094 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -56.28 -43.64 79.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 1.2 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -38.13 89.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.57 110.878 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -64.57 -45.29 87.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 0.57 111.078 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 220' ' ' ILE . 14.9 m-85 -62.97 -34.4 77.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.57 110.916 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -68.11 -40.0 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.57 110.934 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.48 -34.24 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.57 111.125 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.419 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 14.5 m95 -83.15 -33.62 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.57 110.929 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.7 m -78.94 -49.01 13.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.808 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.649 ' OD1' HG13 ' A' ' 144' ' ' VAL . 6.4 p-10 -59.97 -14.84 17.86 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-O 120.969 0.414 . . . . 0.57 111.072 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.649 HG13 ' OD1' ' A' ' 143' ' ' ASN . 19.6 m -112.51 -13.61 11.24 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 CA-C-O 117.89 -1.053 . . . . 0.57 111.016 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.625 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -145.7 142.39 17.93 Favored Pre-proline 0 C--N 1.383 2.038 0 O-C-N 124.859 1.349 . . . . 0.57 112.555 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD2' HG22 ' A' ' 145' ' ' THR . 47.3 Cg_endo -78.52 67.75 8.25 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.201 1.934 . . . . 0.57 112.66 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -163.71 90.58 0.63 Allowed 'General case' 0 C--N 1.372 1.576 0 N-CA-C 104.516 -2.401 . . . . 0.57 104.516 -167.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 160.53 25.73 Favored 'General case' 0 C--N 1.381 1.977 0 CA-C-N 114.432 -1.258 . . . . 0.57 113.035 170.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 25.0 m-85 -136.32 141.22 43.77 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-N 113.723 -1.58 . . . . 0.57 106.747 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -157.02 139.76 15.11 Favored 'General case' 0 C--N 1.366 1.315 0 CA-C-O 124.454 2.073 . . . . 0.57 108.161 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.26 145.8 27.37 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 114.199 -1.364 . . . . 0.57 109.733 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 157' ' ' ALA . 16.8 pt -111.27 159.48 11.23 Favored 'Isoleucine or valine' 0 C--N 1.367 1.333 0 CA-C-O 123.979 1.847 . . . . 0.57 108.032 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -90.1 100.26 13.12 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.21 -1.814 . . . . 0.57 107.038 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 67.67 -178.75 0.21 Allowed 'General case' 0 C--N 1.371 1.512 0 CA-C-O 122.189 0.995 . . . . 0.57 109.44 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.09 71.35 Favored Glycine 0 C--N 1.371 2.487 0 C-N-CA 119.728 -1.225 . . . . 0.57 113.435 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.63 113.89 0.06 Allowed 'General case' 0 C--N 1.374 1.671 0 CA-C-O 122.586 1.184 . . . . 0.57 109.735 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 152' ' ' ILE . . . -91.31 159.49 15.99 Favored 'General case' 0 C--N 1.37 1.478 0 C-N-CA 117.612 -1.635 . . . . 0.57 109.659 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.572 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -53.03 -47.13 68.61 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-N 112.28 -2.236 . . . . 0.91 106.061 -171.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.3 mt -103.49 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.388 2.241 0 O-C-N 127.117 2.761 . . . . 0.57 111.159 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.41 124.4 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.921 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 197' ' ' PHE . 24.9 t -108.75 123.04 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.074 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 124.94 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.57 111.156 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.44 ' C ' ' HB2' ' A' ' 199' ' ' GLU . 5.4 m-85 -89.46 116.85 27.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.864 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.8 29.7 Favored 'General case' 0 C--N 1.378 1.81 0 CA-C-O 122.89 1.328 . . . . 0.57 108.593 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -100.93 177.11 5.05 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 114.501 -1.227 . . . . 1.2 110.892 174.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -52.93 144.19 23.51 Favored Glycine 0 C--N 1.376 2.76 0 CA-C-N 113.213 -1.812 . . . . 0.57 111.466 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.54 50.83 0.02 OUTLIER 'General case' 0 C--N 1.382 1.993 0 CA-C-O 123.136 1.446 . . . . 0.57 112.307 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 . . . . . 0 C--N 1.377 1.778 0 CA-C-N 114.943 -1.026 . . . . 0.57 109.69 -179.475 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 107.185 -1.413 . . . . 0.57 107.185 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -91.93 -164.51 1.19 Allowed 'General case' 0 C--N 1.369 1.44 0 CA-C-N 112.857 -1.974 . . . . 0.57 108.715 173.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.56 142.13 35.18 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 105.061 -2.2 . . . . 0.91 105.061 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.88 157.28 22.93 Favored Glycine 0 C--N 1.368 2.36 0 N-CA-C 107.645 -2.182 . . . . 0.57 107.645 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.07 28.21 6.74 Favored 'General case' 0 C--N 1.369 1.425 0 N-CA-C 113.605 0.965 . . . . 0.57 113.605 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.62 -163.99 14.9 Favored Glycine 0 C--N 1.364 2.101 0 N-CA-C 108.056 -2.017 . . . . 0.57 108.056 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.48 -104.03 3.12 Favored Glycine 0 C--N 1.365 2.188 0 CA-C-N 114.758 -0.721 . . . . 0.57 111.42 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.46 167.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.38 1.898 0 C-N-CA 123.526 0.73 . . . . 0.57 109.142 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 240' ' ' TYR . 5.6 tp -101.13 -42.63 6.29 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 122.087 0.946 . . . . 0.57 110.743 173.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.89 -179.99 2.19 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 120.56 -1.337 . . . . 0.57 111.102 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -163.87 136.1 4.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.57 110.883 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.694 ' HB2' ' CB ' ' A' ' 195' ' ' ALA . . . -154.42 163.14 40.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.57 111.136 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -121.32 176.59 5.56 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-O 123.191 1.472 . . . . 0.57 108.478 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.68 53.09 0.2 Allowed Glycine 0 C--N 1.376 2.763 0 CA-C-N 113.827 -1.533 . . . . 0.57 112.219 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.83 -49.84 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 CA-C-O 123.695 1.456 . . . . 0.57 110.764 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -155.91 -61.58 0.01 OUTLIER Glycine 0 C--N 1.381 3.053 0 N-CA-C 109.844 -1.303 . . . . 0.57 109.844 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m -152.06 -179.73 7.75 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 107.859 -1.163 . . . . 0.57 107.859 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.33 -104.57 1.6 Allowed Glycine 0 C--N 1.379 2.961 0 N-CA-C 105.888 -2.885 . . . . 0.57 105.888 171.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.2 tp -55.38 -42.77 68.73 Favored 'Isoleucine or valine' 0 C--N 1.375 1.715 0 CA-C-O 122.818 1.294 . . . . 0.57 109.067 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.51 134.69 38.72 Favored Glycine 0 C--N 1.379 2.941 0 C-N-CA 118.37 -1.872 . . . . 0.57 108.498 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.6 -29.16 12.36 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 124.287 0.946 . . . . 0.57 113.29 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 123.46 26.4 Favored 'General case' 0 C--N 1.371 1.522 0 O-C-N 120.91 -1.347 . . . . 0.91 110.885 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.694 ' CB ' ' HB2' ' A' ' 184' ' ' ALA . . . -125.23 146.39 49.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.57 111.131 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -123.81 134.47 53.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.57 110.81 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.713 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -108.97 150.01 28.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.883 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 91.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.91 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.44 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 3.7 tp10 -67.56 -44.56 77.96 Favored 'General case' 0 C--N 1.369 1.414 0 O-C-N 125.714 1.884 . . . . 0.91 108.068 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -30.84 43.91 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-O 122.526 1.155 . . . . 0.91 111.299 -167.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.52 172.02 0.17 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-O 125.278 2.466 . . . . 0.91 114.906 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -120.61 83.36 2.05 Favored 'General case' 0 C--N 1.384 2.07 0 CA-C-N 113.241 -1.8 . . . . 0.57 108.463 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -74.4 152.53 39.49 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 113.695 -1.593 . . . . 0.57 107.498 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 126.84 35.15 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-O 124.734 2.207 . . . . 0.57 105.488 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.8 p -106.42 123.06 47.49 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 105.344 -2.095 . . . . 0.57 105.344 -175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 70.6 34.83 2.02 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.318 1.533 . . . . 0.57 109.621 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -139.11 -82.06 0.29 Allowed 'General case' 0 C--N 1.375 1.703 0 N-CA-C 107.752 -1.203 . . . . 0.57 107.752 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.73 -163.33 33.69 Favored Glycine 0 C--N 1.365 2.148 0 N-CA-C 107.851 -2.1 . . . . 0.57 107.851 -171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.3 -142.85 47.75 Favored Glycine 0 C--N 1.373 2.588 0 C-N-CA 119.295 -1.431 . . . . 0.57 110.724 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 p -74.62 115.45 14.19 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-O 124.684 2.183 . . . . 0.57 113.723 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.495 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.7 p30 -102.55 147.67 26.49 Favored 'General case' 0 C--N 1.373 1.618 0 CA-C-N 112.748 -2.024 . . . . 0.57 110.183 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.526 HD13 ' C ' ' A' ' 212' ' ' LEU . 0.1 OUTLIER -71.34 -34.34 70.44 Favored 'General case' 0 C--N 1.381 1.966 0 N-CA-C 105.339 -2.097 . . . . 0.57 105.339 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.921 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -53.73 -49.95 67.03 Favored 'General case' 0 C--N 1.375 1.686 0 CA-C-N 114.993 -1.003 . . . . 0.57 110.9 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -54.94 -48.28 73.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.946 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -38.2 77.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.57 111.128 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -61.55 -46.31 90.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.57 111.158 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 213' ' ' PHE . 3.6 t -65.36 -40.01 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.57 111.089 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.12 -50.0 57.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.57 110.891 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.9 -42.12 93.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.91 110.849 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.721 HG22 HD23 ' A' ' 224' ' ' LEU . 2.4 mm -68.44 -43.92 83.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.11 -33.86 76.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.57 112.438 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -39.4 89.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.779 0.323 . . . . 0.57 110.849 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 m -71.05 -51.56 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.57 110.833 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.721 HD23 HG22 ' A' ' 220' ' ' ILE . 3.7 pp -69.35 -55.73 9.55 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 116.002 1.853 . . . . 0.57 116.002 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.641 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -71.73 -148.44 0.67 Allowed Glycine 0 C--N 1.364 2.096 0 N-CA-C 107.51 -2.236 . . . . 0.57 107.51 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER -125.63 -21.26 4.5 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 113.19 -1.505 . . . . 0.57 108.835 -172.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.521 ' N ' HD22 ' A' ' 226' ' ' LEU . . . 148.19 -172.28 28.48 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 123.172 1.429 . . . . 0.57 112.847 -161.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 236' ' ' MET . 2.2 m170 -73.97 -162.21 0.13 Allowed 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.074 -2.063 . . . . 0.57 109.364 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 2.1 p -122.15 -10.94 8.5 Favored 'General case' 0 C--N 1.374 1.639 0 C-N-CA 120.313 -0.555 . . . . 0.57 109.869 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 85.71 -4.58 0.83 Allowed 'General case' 0 C--N 1.377 1.771 0 N-CA-C 113.834 1.05 . . . . 0.57 113.834 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -130.03 152.0 79.26 Favored Pre-proline 0 C--N 1.375 1.708 0 N-CA-C 106.572 -1.64 . . . . 0.91 106.572 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -63.72 -21.19 69.78 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.289 1.993 . . . . 0.57 114.167 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 14.01 0.26 Allowed 'General case' 0 C--N 1.369 1.448 0 N-CA-C 117.33 2.345 . . . . 0.57 117.33 168.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.447 ' HB2' ' OG ' ' A' ' 229' ' ' SER . . . -94.8 132.68 39.32 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 123.074 1.416 . . . . 0.57 108.103 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 248' ' ' PHE . 0.3 OUTLIER -76.61 -5.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.372 1.547 0 CA-C-O 124.156 1.931 . . . . 0.57 110.857 -176.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.55 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 74.8 mtp -121.77 26.42 8.69 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 114.046 -1.434 . . . . 0.57 108.726 -176.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.417 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 0.3 OUTLIER -64.8 149.49 96.04 Favored Pre-proline 0 C--N 1.371 1.505 0 C-N-CA 117.696 -1.602 . . . . 0.57 110.231 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 39.6 Cg_endo -78.64 -15.05 13.88 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.278 1.319 . . . . 0.57 112.711 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 130.18 45.73 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-O 122.813 1.292 . . . . 0.57 109.411 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.481 ' CE2' HD13 ' A' ' 181' ' ' LEU . 6.3 t80 -89.53 106.75 18.66 Favored 'General case' 0 C--N 1.364 1.215 0 N-CA-C 105.822 -1.918 . . . . 0.57 105.822 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -154.94 115.83 3.95 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 105.106 -2.183 . . . . 0.57 105.106 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -68.6 113.71 6.35 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-O 125.093 2.378 . . . . 0.57 110.081 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 p -95.75 -21.42 5.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 CA-C-N 114.142 -1.39 . . . . 0.57 112.299 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.418 ' C ' HG13 ' A' ' 245' ' ' ILE 0.312 0.0 OUTLIER 82.32 -11.98 0.96 Allowed 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.033 0.833 . . . . 0.91 111.282 -176.674 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.577 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.6 mt 87.54 14.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.795 0 C-N-CA 124.858 1.263 . . . . 0.57 110.766 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.61 -30.47 46.55 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-O 125.595 2.617 . . . . 0.57 106.273 -166.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.5 p -119.31 -10.09 9.79 Favored 'General case' 0 C--N 1.386 2.185 0 CA-C-N 112.072 -2.331 . . . . 0.57 112.613 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.624 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 49.9 t80 -48.01 103.64 0.05 OUTLIER 'General case' 0 C--N 1.374 1.668 0 CA-C-O 123.162 1.458 . . . . 0.57 107.461 -172.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -138.4 146.71 42.54 Favored 'General case' 0 C--N 1.363 1.188 0 N-CA-C 104.816 -2.291 . . . . 1.2 104.816 -172.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.554 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.8 132.02 56.76 Favored 'General case' 0 C--N 1.368 1.373 0 CA-C-N 111.704 -2.498 . . . . 0.57 106.482 -172.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.7 t -79.51 146.05 32.88 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 119.804 -1.81 . . . . 0.57 109.325 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.82 90.18 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 114.704 -1.134 . . . . 0.57 109.264 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.58 -39.35 90.86 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.462 -0.79 . . . . 0.91 110.852 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -64.22 -55.0 24.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.91 110.871 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 256' ' ' ARG . 11.8 pt -65.99 -34.84 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.57 111.166 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 255' ' ' ILE . 6.7 mtt-85 -70.05 -31.45 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.927 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.53 56.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.57 112.445 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.0 OUTLIER -64.94 -44.28 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.57 111.149 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.6 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.08 -19.96 61.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.57 110.913 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.391 2.406 0 CA-C-O 126.135 2.874 . . . . 0.57 107.782 -174.707 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 123.835 1.779 . . . . 1.2 107.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -48.79 1.73 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-N 112.653 -2.067 . . . . 0.57 109.89 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -85.11 -37.47 20.21 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-O 124.226 1.965 . . . . 0.57 107.838 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -81.39 122.46 27.52 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.066 -1.425 . . . . 0.57 110.882 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.94 138.67 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.57 111.163 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.465 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 70.6 p -131.1 157.27 43.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.57 111.139 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.657 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -137.41 159.38 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.57 110.874 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -135.08 129.4 33.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD13 HG23 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -99.08 124.72 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.57 111.145 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . 15.7 t-20 -41.81 -59.41 1.69 Allowed 'General case' 0 C--N 1.384 2.108 0 C-N-CA 117.498 -1.681 . . . . 0.57 110.122 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 164.36 35.49 0.0 OUTLIER 'General case' 0 C--N 1.387 2.201 0 O-C-N 126.023 2.077 . . . . 0.57 109.521 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 1.7 m-30 80.05 -173.37 0.05 Allowed 'General case' 0 C--N 1.385 2.151 0 N-CA-C 105.36 -2.089 . . . . 0.57 105.36 170.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -130.69 160.72 65.04 Favored Pre-proline 0 C--N 1.369 1.45 0 CA-C-N 114.038 -1.437 . . . . 0.57 108.835 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.66 -49.99 1.42 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.315 1.343 . . . . 0.57 112.166 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.564 ' H ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -82.22 -65.71 0.98 Allowed 'General case' 0 C--N 1.388 2.244 0 N-CA-C 104.726 -2.324 . . . . 0.91 104.726 -163.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.596 ' SD ' HG22 ' A' ' 130' ' ' VAL . 2.0 ttm -59.62 140.9 56.0 Favored 'General case' 0 C--N 1.38 1.912 0 CA-C-O 126.464 3.031 . . . . 0.57 110.071 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.8 OUTLIER -72.73 139.29 47.08 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 112.698 -2.046 . . . . 0.57 109.773 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -69.63 -52.13 28.71 Favored 'General case' 0 C--N 1.374 1.658 0 N-CA-C 105.414 -2.069 . . . . 1.2 105.414 -168.101 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.32 -34.57 57.98 Favored 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.001 -2.363 . . . . 0.91 110.877 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.881 ' HB3' HG21 ' A' ' 205' ' ' THR . 11.9 m-20 -69.76 -44.01 71.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.91 110.931 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.93 -41.5 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.166 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 134' ' ' ILE . 3.5 m-20 -65.82 -40.6 92.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.91 110.858 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -37.98 81.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.57 110.945 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.593 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.88 -49.18 71.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.57 111.091 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 131' ' ' ASP . 12.3 pt -61.4 -41.47 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.57 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -43.58 97.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 140' ' ' VAL . 2.0 tppt? -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.57 110.881 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.8 98.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.57 111.092 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 18.7 m-85 -63.7 -36.53 84.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.57 110.861 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.71 -39.83 84.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.57 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 136' ' ' LYS . 2.3 t -68.72 -34.05 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.57 111.196 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -84.5 -33.38 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.57 110.919 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -73.82 -47.67 36.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.849 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -62.34 -12.05 18.88 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 118.836 -1.145 . . . . 0.57 112.877 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.71 0.1 9.71 Favored 'Isoleucine or valine' 0 C--N 1.379 1.882 0 CA-C-N 113.844 -1.525 . . . . 0.57 112.675 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.663 HG22 ' HD2' ' A' ' 146' ' ' PRO . 2.1 m -150.53 140.43 13.88 Favored Pre-proline 0 C--N 1.376 1.745 0 CA-C-O 124.234 1.969 . . . . 0.57 110.559 -172.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.687 ' O ' HD23 ' A' ' 147' ' ' LEU . 45.5 Cg_endo -79.6 63.16 8.7 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.092 1.861 . . . . 0.57 114.048 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -146.39 120.62 9.53 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 105.824 -1.917 . . . . 0.57 105.824 -169.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 158.28 34.79 Favored 'General case' 0 C--N 1.382 1.982 0 CA-C-N 113.278 -1.783 . . . . 0.57 113.416 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HZ ' HD22 ' A' ' 224' ' ' LEU . 0.8 OUTLIER -129.31 136.31 49.87 Favored 'General case' 0 C--N 1.388 2.276 0 CA-C-N 112.68 -2.055 . . . . 0.57 109.818 -177.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.98 111.83 3.52 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 124.808 2.242 . . . . 0.57 109.163 -175.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tttm -89.34 146.66 24.55 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 114.108 -1.405 . . . . 0.57 111.938 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 154' ' ' THR . 4.9 pt -130.64 163.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 113.44 -1.709 . . . . 0.57 109.498 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 9.04 13.4 Favored 'General case' 0 C--N 1.382 2.004 0 CA-C-N 113.06 -1.882 . . . . 0.57 111.552 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.489 ' O ' HD12 ' A' ' 152' ' ' ILE . 6.8 m -145.0 125.97 14.48 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 106.888 -1.523 . . . . 0.57 106.888 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.97 -130.17 10.15 Favored Glycine 0 C--N 1.376 2.785 0 N-CA-C 109.389 -1.484 . . . . 0.57 109.389 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.5 ttp -150.66 146.95 26.81 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.986 1.375 . . . . 0.57 107.303 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.465 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -127.35 177.06 6.97 Favored 'General case' 0 C--N 1.373 1.59 0 CA-C-N 112.864 -1.971 . . . . 0.57 109.695 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -65.23 -68.18 0.38 Allowed 'General case' 0 C--N 1.378 1.846 0 N-CA-C 104.69 -2.337 . . . . 0.91 104.69 -168.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.0 mp -92.87 110.26 22.8 Favored 'Isoleucine or valine' 0 C--N 1.378 1.805 0 O-C-N 124.649 1.218 . . . . 0.57 111.098 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 121.81 46.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 118' ' ' ILE . 2.5 m -102.48 116.95 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.57 111.136 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.415 HG22 ' ND1' ' A' ' 196' ' ' HIS . 1.5 m -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.57 111.152 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.13 125.71 33.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.887 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 168' ' ' HIS . . . -144.5 169.88 17.1 Favored 'General case' 0 C--N 1.369 1.445 0 C-N-CA 117.898 -1.521 . . . . 0.57 107.675 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 168.29 9.42 Favored 'General case' 0 C--N 1.367 1.343 0 CA-C-N 114.2 -1.363 . . . . 1.2 108.608 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -44.6 132.81 7.35 Favored Glycine 0 C--N 1.377 2.856 0 O-C-N 124.933 1.396 . . . . 0.57 111.82 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.99 105.39 0.06 Allowed 'General case' 0 C--N 1.401 2.822 0 CA-C-O 124.668 2.175 . . . . 0.57 112.385 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 164' ' ' ALA . 3.5 p-80 . . . . . 0 C--N 1.387 2.206 0 CA-C-O 123.401 1.572 . . . . 0.57 111.995 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 CA-C-O 123.328 1.537 . . . . 0.57 109.873 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.647 ' CZ ' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -117.19 -165.79 1.11 Allowed 'General case' 0 C--N 1.386 2.185 0 CA-C-N 113.146 -1.843 . . . . 0.57 111.353 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.27 159.8 16.35 Favored 'General case' 0 C--N 1.38 1.913 0 CA-C-N 114.45 -1.25 . . . . 0.91 109.849 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -136.52 62.28 0.6 Allowed Glycine 0 C--N 1.378 2.895 0 CA-C-O 123.869 1.816 . . . . 0.57 110.095 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -166.66 -35.53 0.03 OUTLIER 'General case' 0 C--N 1.376 1.736 0 CA-C-N 113.23 -1.485 . . . . 0.57 112.713 169.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.48 -63.68 0.04 OUTLIER Glycine 0 C--N 1.37 2.457 0 C-N-CA 119.567 -1.301 . . . . 0.57 113.003 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 180' ' ' ILE . . . -35.88 112.39 0.12 Allowed Glycine 0 C--N 1.375 2.729 0 N-CA-C 109.241 -1.544 . . . . 0.57 109.241 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.647 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 88.91 52.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.889 0 O-C-N 119.217 -2.343 . . . . 0.57 108.559 175.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.479 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 2.5 tp -43.11 -30.91 0.49 Allowed 'General case' 0 C--N 1.375 1.697 0 CA-C-O 123.797 1.76 . . . . 0.57 112.083 -174.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -179.49 179.78 0.58 Allowed 'General case' 0 C--N 1.368 1.41 0 CA-C-N 113.229 -1.805 . . . . 0.57 111.123 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.589 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -142.56 164.67 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.837 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.79 140.87 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.57 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -89.93 152.49 21.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 117.816 -1.554 . . . . 0.57 109.449 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -92.54 -42.17 4.59 Favored Glycine 0 C--N 1.373 2.595 0 CA-C-N 114.417 -1.265 . . . . 0.57 113.623 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 50.7 Cg_exo -63.53 -143.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.401 3.32 0 CA-C-O 125.953 2.397 . . . . 0.57 111.676 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -151.47 -148.31 4.78 Favored Glycine 0 C--N 1.376 2.755 0 C-N-CA 117.493 -2.289 . . . . 0.57 109.781 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.2 m 77.76 52.17 0.04 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-N 112.629 -1.785 . . . . 0.57 107.512 171.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.54 -72.73 2.75 Favored Glycine 0 C--N 1.376 2.761 0 N-CA-C 106.919 -2.473 . . . . 0.57 106.919 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 189' ' ' SER . 1.9 mp -70.12 -48.2 63.48 Favored 'Isoleucine or valine' 0 C--N 1.374 1.649 0 CA-C-O 125.85 2.738 . . . . 0.57 105.515 -171.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.29 153.92 53.03 Favored Glycine 0 C--N 1.378 2.91 0 C-N-CA 116.282 -2.866 . . . . 0.57 108.351 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 80.96 -15.23 22.46 Favored Glycine 0 C--N 1.372 2.549 0 CA-C-O 124.178 1.988 . . . . 0.57 113.305 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.07 146.38 53.54 Favored 'General case' 0 C--N 1.374 1.636 0 O-C-N 120.287 -1.714 . . . . 0.91 110.833 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -144.04 137.36 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.57 111.098 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 1.8 m-70 -128.39 150.17 50.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.791 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -123.11 150.19 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.57 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.48 112.62 14.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.91 110.799 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -43.5 88.54 Favored 'General case' 0 C--N 1.383 2.053 0 CA-C-O 117.436 -1.268 . . . . 0.91 108.966 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.74 -32.85 0.65 Allowed 'General case' 0 C--N 1.38 1.9 0 O-C-N 125.646 1.841 . . . . 0.91 108.959 -173.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.96 176.1 0.44 Allowed 'General case' 0 C--N 1.384 2.072 0 CA-C-O 126.535 3.064 . . . . 0.91 109.216 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.91 80.5 1.33 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-N 112.615 -2.084 . . . . 0.57 109.016 -175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 79.6 m95 -76.13 109.14 9.54 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 106.977 -1.49 . . . . 0.57 106.977 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.57 121.88 31.75 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-O 125.149 2.404 . . . . 0.57 109.869 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.881 HG21 ' HB3' ' A' ' 129' ' ' ASP . 11.2 p -96.99 151.27 19.87 Favored 'General case' 0 C--N 1.368 1.395 0 N-CA-C 106.198 -1.778 . . . . 0.57 106.198 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.65 -48.55 0.23 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 114.316 -1.311 . . . . 0.57 109.915 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.3 m -168.78 137.98 2.21 Favored 'General case' 0 C--N 1.384 2.092 0 N-CA-C 108.05 -1.093 . . . . 0.57 108.05 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 148.2 -36.92 1.09 Allowed Glycine 0 C--N 1.382 3.122 0 CA-C-N 114.358 -1.292 . . . . 0.57 111.671 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 148.82 -84.16 0.17 Allowed Glycine 0 C--N 1.386 3.344 0 CA-C-O 123.801 1.778 . . . . 0.57 111.686 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.0 p -78.7 135.94 37.3 Favored 'General case' 0 C--N 1.383 2.025 0 CA-C-N 113.079 -1.56 . . . . 0.57 110.964 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.71 141.39 52.14 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 113.949 -1.478 . . . . 0.57 108.011 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.743 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.4 tm? -71.15 -26.74 63.13 Favored 'General case' 0 C--N 1.387 2.225 0 CA-C-O 125.086 2.374 . . . . 0.57 108.576 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.545 ' CD1' HG12 ' A' ' 245' ' ' ILE . 3.5 t80 -57.6 -50.15 74.08 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-N 113.862 -1.517 . . . . 0.57 110.855 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -51.22 69.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.933 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -44.41 97.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HA ' ' OE2' ' A' ' 219' ' ' GLU . . . -57.08 -41.36 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.079 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.42 -39.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.57 111.096 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -70.08 -50.51 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.57 110.802 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 216' ' ' ALA . 0.7 OUTLIER -64.08 -42.02 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.902 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.713 HG22 HD23 ' A' ' 224' ' ' LEU . 69.8 mt -69.01 -34.22 62.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.57 111.113 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 225' ' ' GLY . . . -69.19 -33.48 73.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.699 -0.762 . . . . 0.57 112.444 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.59 -44.02 95.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.57 110.842 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.24 -49.96 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.57 110.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 220' ' ' ILE . 0.5 OUTLIER -84.04 13.48 5.02 Favored 'General case' 0 C--N 1.392 2.441 0 CA-C-O 123.595 1.664 . . . . 0.57 115.324 177.283 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 221' ' ' GLY . . . -153.12 176.93 31.02 Favored Glycine 0 C--N 1.363 2.04 0 CA-C-O 126.635 3.353 . . . . 0.57 108.167 -168.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -158.93 0.23 Allowed 'General case' 0 C--N 1.367 1.337 0 CA-C-O 125.873 2.749 . . . . 0.57 109.278 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.78 -143.18 0.11 Allowed Glycine 0 C--N 1.387 3.411 0 CA-C-O 125.524 2.736 . . . . 0.57 112.311 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 236' ' ' MET . 34.0 m170 -83.83 -175.29 5.74 Favored 'General case' 0 C--N 1.379 1.861 0 O-C-N 120.444 -1.621 . . . . 0.57 114.609 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.528 ' CB ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -99.11 -84.46 0.4 Allowed 'General case' 0 C--N 1.389 2.308 0 N-CA-C 106.448 -1.686 . . . . 0.57 106.448 179.314 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 m 155.81 -30.25 0.0 OUTLIER 'General case' 0 C--N 1.389 2.29 0 O-C-N 125.842 1.964 . . . . 0.57 113.168 -167.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.596 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 3.3 t70 -110.2 152.07 42.95 Favored Pre-proline 0 C--N 1.388 2.282 0 N-CA-C 108.291 -1.003 . . . . 0.91 108.291 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -60.7 -47.83 12.48 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.687 2.258 . . . . 0.57 111.92 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.42 22.79 Favored 'General case' 0 C--N 1.381 1.948 0 CA-C-N 113.252 -1.794 . . . . 0.57 115.284 176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -71.46 120.11 16.57 Favored 'General case' 0 C--N 1.375 1.674 0 CA-C-O 125.158 2.408 . . . . 0.57 113.0 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 236' ' ' MET . 68.2 t -73.93 86.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.867 0 CA-C-N 111.446 -2.615 . . . . 0.57 108.612 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.458 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER 162.06 -34.28 0.0 OUTLIER 'General case' 0 C--N 1.377 1.802 0 O-C-N 125.37 1.669 . . . . 0.57 109.273 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 4.4 t80 -49.97 146.96 7.33 Favored Pre-proline 0 C--N 1.372 1.579 0 CA-C-O 122.971 1.367 . . . . 0.57 110.223 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 74.0 Cg_exo -56.53 -36.99 98.27 Favored 'Trans proline' 0 C--N 1.393 2.904 0 C-N-CA 122.219 1.946 . . . . 0.57 112.406 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -45.39 111.79 0.38 Allowed 'General case' 0 C--N 1.376 1.741 0 CA-C-O 123.633 1.683 . . . . 0.57 110.642 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -83.92 94.62 8.29 Favored 'General case' 0 C--N 1.38 1.914 0 CA-C-O 124.385 2.041 . . . . 0.57 106.431 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -110.84 119.41 39.01 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 113.122 -1.854 . . . . 0.57 108.124 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -55.6 120.91 7.96 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-O 126.105 2.859 . . . . 0.57 110.991 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 248' ' ' PHE . 5.4 p -140.79 115.23 5.88 Favored 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 105.86 -1.904 . . . . 0.57 105.86 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -77.3 33.46 0.16 Allowed 'General case' 0 C--N 1.364 1.239 0 N-CA-C 114.885 1.439 . . . . 0.91 114.885 170.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.545 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.5 mt 82.94 -2.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.382 1.987 0 CA-C-O 124.145 1.926 . . . . 0.57 108.713 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -88.5 -35.48 16.96 Favored 'General case' 0 C--N 1.38 1.904 0 N-CA-C 103.016 -2.957 . . . . 0.57 103.016 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.27 3.47 15.97 Favored 'General case' 0 C--N 1.387 2.229 0 CA-C-N 113.47 -1.695 . . . . 0.57 109.778 -173.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.485 ' N ' HG21 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -80.72 12.06 3.43 Favored 'General case' 0 C--N 1.386 2.195 0 O-C-N 125.754 1.909 . . . . 0.57 109.86 -171.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 154.07 12.02 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 124.724 2.202 . . . . 1.2 107.778 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.585 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -120.07 126.97 52.08 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 103.676 -2.713 . . . . 0.57 103.676 -167.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.03 140.53 48.79 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-O 124.883 2.278 . . . . 0.57 116.323 169.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.47 86.83 Favored 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.689 -1.596 . . . . 0.57 110.184 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.22 -33.12 74.69 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.994 -1.003 . . . . 0.91 110.863 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -63.95 -55.23 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.91 110.901 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.5 pt -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.57 111.144 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.418 ' N ' HG13 ' A' ' 255' ' ' ILE . 75.8 mtt-85 -70.17 -32.95 71.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.92 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.7 -48.0 58.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.57 112.495 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.3 pt -62.42 -45.8 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.57 111.1 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.467 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.1 pt20 -72.53 -19.11 61.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.57 110.954 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.377 1.775 0 CA-C-O 122.575 1.178 . . . . 0.57 110.687 -176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.013 0 CA-C-O 122.341 1.067 . . . . 1.2 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 60.14 176.94 0.09 Allowed 'General case' 0 C--N 1.399 2.746 0 CA-C-N 113.407 -1.724 . . . . 0.57 110.471 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.27 -84.99 0.03 OUTLIER 'General case' 0 C--N 1.387 2.224 0 CA-C-N 114.23 -1.35 . . . . 0.57 110.323 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 150' ' ' SER . 31.0 t80 -117.49 107.08 13.87 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.44 1.713 . . . . 0.57 110.933 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 ' OD2' ' A' ' 158' ' ' ASP . 0.7 OUTLIER -103.0 147.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.57 111.149 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.688 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -109.79 134.96 51.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.145 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -143.87 155.61 44.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.57 110.892 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -142.43 139.4 31.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.851 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.08 142.97 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.118 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 163' ' ' PHE . 22.9 t30 -54.07 -63.87 1.01 Allowed 'General case' 0 C--N 1.366 1.29 0 N-CA-C 108.433 -0.951 . . . . 0.57 108.433 -171.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.45 -172.01 3.2 Favored 'General case' 0 C--N 1.38 1.916 0 N-CA-C 107.398 -1.334 . . . . 0.57 107.398 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' HG22 ' A' ' 122' ' ' THR . 3.3 p90 -176.96 82.57 0.02 OUTLIER 'General case' 0 C--N 1.39 2.327 0 CA-C-O 124.419 2.057 . . . . 0.57 113.653 -172.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.53 HG23 ' CD ' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -171.71 -56.28 0.0 OUTLIER Pre-proline 0 C--N 1.372 1.574 0 O-C-N 119.894 -1.753 . . . . 0.57 110.167 -174.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.53 ' CD ' HG23 ' A' ' 122' ' ' THR . 12.0 Cg_endo -69.9 -55.31 0.18 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 N-CA-C 107.932 -1.603 . . . . 0.57 107.932 -171.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -129.46 -12.07 4.47 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 114.221 -1.354 . . . . 0.91 110.921 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -114.19 128.08 56.2 Favored 'General case' 0 C--N 1.38 1.907 0 CA-C-O 124.638 2.161 . . . . 0.57 106.798 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.819 ' H ' HG21 ' A' ' 205' ' ' THR . 0.5 OUTLIER -90.02 144.56 25.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.446 -2.659 . . . . 0.57 110.256 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -53.49 8.27 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 106.409 -1.701 . . . . 1.2 106.409 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.54 -37.69 88.42 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-N 114.222 -1.354 . . . . 0.91 110.934 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 205' ' ' THR . 19.4 t70 -70.2 -44.06 69.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.91 110.896 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.75 HG22 ' HG ' ' A' ' 212' ' ' LEU . 21.0 t -69.22 -46.28 77.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.095 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -56.82 -44.16 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.91 110.839 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -39.6 90.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.57 110.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.733 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -65.37 -49.07 70.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.57 111.141 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 135' ' ' ARG . 48.4 pt -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.57 111.172 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.458 ' N ' HG13 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -61.06 -49.32 77.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.853 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -35.66 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.57 110.88 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.913 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -65.98 -41.41 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.133 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 149' ' ' PHE . 1.8 m-85 -67.25 -33.67 75.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.57 110.835 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.6 pt20 -68.44 -40.72 81.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.57 110.912 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -70.53 -34.35 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.168 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.801 ' CD2' HD11 ' A' ' 224' ' ' LEU . 4.4 m95 -83.25 -33.72 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.57 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.6 m -78.26 -50.55 11.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.57 110.898 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.606 ' OD1' HG13 ' A' ' 144' ' ' VAL . 2.5 p-10 -56.59 -13.88 2.75 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 113.278 0.844 . . . . 0.57 113.278 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.606 HG13 ' OD1' ' A' ' 143' ' ' ASN . 18.2 m -114.52 9.11 7.7 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 CA-C-N 114.541 -1.209 . . . . 0.57 111.451 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.2 p -149.23 147.17 22.78 Favored Pre-proline 0 C--N 1.373 1.594 0 CA-C-O 124.599 2.142 . . . . 0.57 108.484 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.85 22.07 1.0 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 121.544 1.496 . . . . 0.57 113.056 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.91 101.03 6.15 Favored 'General case' 0 C--N 1.378 1.829 0 N-CA-C 105.619 -1.993 . . . . 0.57 105.619 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.27 159.59 30.98 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-O 126.77 3.176 . . . . 0.57 116.263 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . 45.6 m-85 -132.19 162.64 30.42 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.533 -2.122 . . . . 0.57 107.396 -177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 113' ' ' TYR . 54.3 m -157.67 123.33 4.62 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 125.859 2.742 . . . . 0.57 108.394 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -95.97 141.48 29.34 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-N 113.344 -1.753 . . . . 0.57 110.972 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 155' ' ' GLY . 4.4 pt -129.93 159.55 41.85 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-O 124.276 1.988 . . . . 0.57 108.986 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.4 -15.01 14.56 Favored 'General case' 0 C--N 1.384 2.097 0 CA-C-N 113.117 -1.856 . . . . 0.57 107.807 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 89.3 m -60.22 -59.8 4.83 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 123.343 1.544 . . . . 0.57 107.373 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.511 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 138.93 146.16 4.9 Favored Glycine 0 C--N 1.38 2.997 0 N-CA-C 110.539 -1.024 . . . . 0.57 110.539 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.6 ttp 78.79 88.59 0.06 Allowed 'General case' 0 C--N 1.399 2.758 0 CA-C-O 124.465 2.078 . . . . 0.57 110.075 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -133.9 172.16 13.18 Favored 'General case' 0 C--N 1.373 1.622 0 CA-C-N 113.158 -1.837 . . . . 0.57 109.718 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 115' ' ' THR . 33.1 m-20 -61.15 -59.4 5.39 Favored 'General case' 0 C--N 1.37 1.469 0 N-CA-C 105.836 -1.913 . . . . 0.91 105.836 -173.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.82 109.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.388 2.282 0 O-C-N 124.326 1.016 . . . . 0.57 111.118 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -100.8 128.59 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.57 110.933 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 197' ' ' PHE . 17.4 t -105.48 118.26 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.57 111.087 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.48 132.16 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.57 111.085 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 119' ' ' ASN . 4.2 m-85 -90.61 121.32 32.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.836 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.15 166.57 24.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 123.044 1.402 . . . . 0.57 107.599 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 167.62 9.76 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 114.19 -1.368 . . . . 1.2 109.888 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -39.45 121.49 1.42 Allowed Glycine 0 C--N 1.395 3.825 0 O-C-N 125.297 1.623 . . . . 0.57 111.018 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 87.71 80.9 0.01 OUTLIER 'General case' 0 C--N 1.397 2.653 0 CA-C-O 125.214 2.435 . . . . 0.57 109.882 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--N 1.39 2.351 0 CA-C-N 113.13 -1.85 . . . . 0.57 110.494 -179.446 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 122.609 1.195 . . . . 0.57 111.768 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.434 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -124.11 -161.5 1.0 Allowed 'General case' 0 C--N 1.39 2.361 0 CA-C-N 113.01 -1.904 . . . . 0.57 111.804 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.448 ' CB ' ' H ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -87.61 -54.38 4.3 Favored 'General case' 0 C--N 1.388 2.269 0 CA-C-N 114.676 -1.147 . . . . 0.91 111.934 174.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.03 105.64 0.05 OUTLIER Glycine 0 C--N 1.396 3.87 0 C-N-CA 118.591 -1.766 . . . . 0.57 117.317 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.66 90.4 0.09 Allowed 'General case' 0 C--N 1.381 1.967 0 CA-C-O 125.28 2.467 . . . . 0.57 112.43 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.29 -144.73 26.09 Favored Glycine 0 C--N 1.381 3.079 0 O-C-N 119.529 -1.982 . . . . 0.57 113.453 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.425 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 52.72 -118.96 8.6 Favored Glycine 0 C--N 1.395 3.817 0 N-CA-C 108.39 -1.884 . . . . 0.57 108.39 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.448 ' H ' ' CB ' ' A' ' 175' ' ' ASP . 0.6 OUTLIER -76.57 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.706 0 N-CA-C 105.94 -1.874 . . . . 0.57 105.94 -175.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.899 HD22 ' CE1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -38.23 -33.94 0.11 Allowed 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.417 1.087 . . . . 0.57 109.881 -175.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -178.41 179.95 0.73 Allowed 'General case' 0 C--N 1.383 2.057 0 O-C-N 125.727 1.892 . . . . 0.57 111.081 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.456 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -151.03 151.01 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.57 110.865 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 195' ' ' ALA . . . -142.81 140.36 31.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.57 111.063 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.1 OUTLIER -87.64 124.24 33.33 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 118.323 -1.351 . . . . 0.57 108.715 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -124.48 50.19 0.87 Allowed Glycine 0 C--N 1.371 2.476 0 O-C-N 120.756 -1.215 . . . . 0.57 113.579 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 33.9 Cg_endo -76.49 -52.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 121.217 1.278 . . . . 0.57 109.765 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.17 47.36 0.71 Allowed Glycine 0 C--N 1.392 3.642 0 CA-C-O 123.759 1.755 . . . . 0.57 111.869 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -155.02 -147.79 0.22 Allowed 'General case' 0 C--N 1.384 2.065 0 O-C-N 121.074 -1.251 . . . . 0.57 108.732 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -55.85 -79.19 0.1 OUTLIER Glycine 0 C--N 1.388 3.466 0 CA-C-O 126.105 3.058 . . . . 0.57 112.531 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -11.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.387 2.232 0 CA-C-O 124.823 2.249 . . . . 0.57 110.362 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.06 126.51 22.71 Favored Glycine 0 C--N 1.37 2.446 0 O-C-N 118.292 -2.755 . . . . 0.57 111.829 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 108.93 -50.14 0.8 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 113.527 -1.336 . . . . 0.57 111.985 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -34.92 102.7 0.02 OUTLIER 'General case' 0 C--N 1.379 1.877 0 O-C-N 124.649 0.852 . . . . 0.91 110.901 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 184' ' ' ALA . . . -116.52 150.32 38.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.068 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -135.03 139.16 44.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.57 110.854 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -111.09 150.11 29.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.57 110.903 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 1.5 m-20 -58.31 110.82 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.467 . . . . 0.91 110.788 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 4.2 tp10 -77.91 -20.66 52.47 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-O 126.423 3.011 . . . . 0.91 108.555 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -12.38 60.27 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 118.3 -2.75 . . . . 0.91 110.712 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -82.05 -179.63 7.47 Favored 'General case' 0 C--N 1.398 2.678 0 N-CA-C 102.651 -3.092 . . . . 0.91 102.651 -168.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.98 82.05 1.59 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.346 -1.752 . . . . 0.57 110.624 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 60.5 m95 -72.51 102.93 3.35 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 123.788 1.756 . . . . 0.57 108.754 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.629 HG21 ' O ' ' A' ' 208' ' ' GLY . 0.1 OUTLIER -80.35 130.82 35.44 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 113.762 -1.563 . . . . 0.57 110.953 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.819 HG21 ' H ' ' A' ' 126' ' ' ASN . 7.7 p -119.02 101.24 7.88 Favored 'General case' 0 C--N 1.385 2.135 0 CA-C-N 113.034 -1.894 . . . . 0.57 107.752 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 77.6 36.73 0.26 Allowed 'General case' 0 C--N 1.403 2.9 0 CA-C-O 126.039 2.828 . . . . 0.57 104.863 168.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 t -138.07 -92.22 0.21 Allowed 'General case' 0 C--N 1.391 2.406 0 CA-C-N 112.716 -2.038 . . . . 0.57 109.053 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.629 ' O ' HG21 ' A' ' 204' ' ' THR . . . -173.58 156.39 24.0 Favored Glycine 0 C--N 1.38 3.022 0 CA-C-N 114.943 -1.026 . . . . 0.57 110.541 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.24 -136.44 13.01 Favored Glycine 0 C--N 1.369 2.412 0 CA-C-O 124.126 1.959 . . . . 0.57 111.242 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.9 m -69.08 117.54 10.86 Favored 'General case' 0 C--N 1.384 2.078 0 CA-C-O 123.317 1.532 . . . . 0.57 112.517 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -102.92 153.91 19.74 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.311 1.529 . . . . 0.57 111.603 176.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.75 ' HG ' HG22 ' A' ' 130' ' ' VAL . 2.1 tm? -72.72 -31.45 64.98 Favored 'General case' 0 C--N 1.389 2.324 0 CA-C-N 113.347 -1.752 . . . . 0.57 106.653 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.6 t80 -59.04 -50.46 73.99 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.086 -1.634 . . . . 0.57 110.859 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.719 HD21 ' CE1' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -58.19 -51.83 68.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.57 110.906 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.53 -33.96 75.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.178 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 219' ' ' GLU . . . -68.83 -39.48 79.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.57 111.114 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 213' ' ' PHE . 41.4 t -68.1 -38.46 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.57 111.154 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -70.06 -50.85 37.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.57 110.837 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' HG23 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -56.6 -45.19 81.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.91 110.913 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.913 HD11 ' HB1' ' A' ' 137' ' ' ALA . 5.5 pt -72.73 -39.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.57 111.075 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.03 -33.88 64.92 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.57 112.474 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.86 -44.02 94.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.57 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -50.24 55.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.828 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.801 HD11 ' CD2' ' A' ' 141' ' ' TRP . 3.4 pp -75.82 0.6 17.51 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.954 2.576 . . . . 0.57 117.954 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -145.73 -158.79 7.86 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 108.072 -2.011 . . . . 0.57 108.072 -173.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.28 -156.73 0.76 Allowed 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.051 -1.574 . . . . 0.57 107.678 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -55.93 -167.21 0.06 OUTLIER Glycine 0 C--N 1.397 3.951 0 CA-C-O 125.717 2.843 . . . . 0.57 112.486 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.5 m80 -100.28 -150.31 0.38 Allowed 'General case' 0 C--N 1.37 1.484 0 O-C-N 120.387 -1.654 . . . . 0.57 110.225 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.803 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 9.1 p -122.39 -24.24 5.05 Favored 'General case' 0 C--N 1.387 2.219 0 CA-C-N 114.521 -1.218 . . . . 0.57 110.493 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 83.06 16.43 0.31 Allowed 'General case' 0 C--N 1.398 2.704 0 CA-C-O 123.2 1.476 . . . . 0.57 113.21 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -134.29 150.28 73.59 Favored Pre-proline 0 C--N 1.386 2.18 0 N-CA-C 104.818 -2.29 . . . . 0.91 104.818 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 72.5 Cg_exo -56.6 -20.58 34.81 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.091 2.527 . . . . 0.57 114.036 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -40.29 85.09 Favored 'General case' 0 C--N 1.385 2.142 0 CA-C-N 113.329 -1.76 . . . . 0.57 115.628 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -51.79 128.33 23.43 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 123.86 1.79 . . . . 0.57 110.716 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 249' ' ' ARG . 0.4 OUTLIER -75.52 2.48 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.126 0 CA-C-O 125.38 2.514 . . . . 0.57 111.53 -177.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.496 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 5.7 ptm -142.31 8.19 1.79 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 120.422 -1.424 . . . . 0.57 110.188 -175.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.862 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -42.79 143.96 1.11 Allowed Pre-proline 0 C--N 1.37 1.459 0 CA-C-O 124.097 1.903 . . . . 0.57 112.844 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.92 -50.31 14.41 Favored 'Trans proline' 0 C--N 1.371 1.728 0 O-C-N 119.481 -0.852 . . . . 0.57 112.351 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.505 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -52.46 126.46 19.45 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-O 123.318 1.532 . . . . 0.57 109.669 -175.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.899 ' CE1' HD22 ' A' ' 181' ' ' LEU . 78.4 t80 -99.28 166.57 11.15 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 119.959 -1.713 . . . . 0.57 107.833 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 169.36 121.45 0.01 OUTLIER 'General case' 0 C--N 1.39 2.352 0 N-CA-C 106.058 -1.83 . . . . 0.57 106.058 173.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.85 121.6 6.19 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.842 2.258 . . . . 0.57 110.882 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 243' ' ' VAL . 7.1 p -147.38 113.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.741 -1.572 . . . . 0.57 107.702 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -44.65 146.0 0.81 Allowed 'General case' 0 C--N 1.383 2.044 0 CA-C-O 125.737 2.684 . . . . 0.91 107.719 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 213' ' ' PHE . 3.9 mp -62.03 -22.87 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-N 113.319 -1.764 . . . . 0.57 112.603 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.66 -21.93 66.63 Favored 'General case' 0 C--N 1.372 1.585 0 CA-C-O 123.034 1.397 . . . . 0.57 111.397 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.6 p -108.36 1.11 21.58 Favored 'General case' 0 C--N 1.385 2.134 0 N-CA-C 114.904 1.446 . . . . 0.57 114.904 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CE1' HG11 ' A' ' 217' ' ' VAL . 51.3 t80 -74.47 83.84 1.99 Allowed 'General case' 0 C--N 1.376 1.725 0 CA-C-O 124.973 2.32 . . . . 0.57 109.292 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 235' ' ' VAL . 1.6 tmt_? -99.32 154.79 17.91 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-O 123.813 1.768 . . . . 1.2 108.913 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.725 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -121.84 136.1 54.92 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 125.194 2.426 . . . . 0.57 106.246 -173.301 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 42.5 m -67.67 137.65 55.73 Favored 'General case' 0 C--N 1.376 1.719 0 CA-C-N 113.305 -1.771 . . . . 0.57 111.627 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.08 -46.36 81.45 Favored 'General case' 0 C--N 1.384 2.099 0 N-CA-C 108.055 -1.091 . . . . 0.57 108.055 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.71 -36.81 79.76 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 115.41 -0.814 . . . . 0.91 110.845 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 258' ' ' ILE . 40.8 t0 -63.46 -55.22 25.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.91 110.846 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 21.3 pt -66.09 -36.38 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.57 111.116 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 4.3 mtt-85 -70.32 -33.33 71.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.828 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.86 76.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.57 112.48 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.81 -45.05 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.685 0.279 . . . . 0.57 111.052 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.497 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.14 -23.5 61.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.57 110.981 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.366 1.302 0 CA-C-O 122.403 1.096 . . . . 0.57 109.785 -178.064 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 CA-C-O 119.319 -0.711 . . . . 0.57 111.612 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.82 108.39 2.64 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.316 2.677 . . . . 0.57 108.983 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.41 122.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.545 0 CA-C-N 114.755 -1.111 . . . . 0.57 109.057 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -166.59 72.88 0.14 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 124.397 2.046 . . . . 0.57 109.121 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 mtt-85 -115.48 156.67 25.25 Favored 'General case' 0 C--N 1.375 1.679 0 CA-C-O 123.146 1.451 . . . . 1.2 109.468 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 52.57 0.48 Allowed 'General case' 0 C--N 1.379 1.87 0 CA-C-O 123.553 1.644 . . . . 0.57 108.179 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -168.96 -55.39 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.219 -1.355 . . . . 0.57 109.321 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -98.62 112.13 24.28 Favored 'General case' 0 C--N 1.371 1.515 0 O-C-N 124.006 0.816 . . . . 0.57 110.934 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 158' ' ' ASP . 1.2 mm -111.72 151.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.57 111.062 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -106.0 159.77 15.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.57 111.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.477 ' OH ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -148.59 150.51 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.57 110.92 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -142.8 132.91 24.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 1.2 110.889 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.97 140.46 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.57 111.147 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 121' ' ' TYR . 4.3 t30 -66.87 -160.88 0.02 OUTLIER 'General case' 0 C--N 1.379 1.883 0 CA-C-O 124.362 2.03 . . . . 0.57 109.718 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.32 39.38 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 O-C-N 118.572 -2.58 . . . . 0.57 111.069 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.505 ' C ' HG23 ' A' ' 122' ' ' THR . 9.2 m-85 59.33 16.8 5.32 Favored 'General case' 0 C--N 1.386 2.161 0 O-C-N 124.362 1.039 . . . . 0.57 110.083 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.631 HG22 ' CZ ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER 65.98 158.18 0.13 Allowed Pre-proline 0 C--N 1.367 1.331 0 O-C-N 128.217 3.448 . . . . 0.57 109.793 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.44 -43.65 0.35 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 O-C-N 118.265 -1.492 . . . . 0.57 112.145 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -63.71 1.18 Allowed 'General case' 0 C--N 1.371 1.509 0 C-N-CA 125.209 1.404 . . . . 0.91 113.471 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.414 ' HE2' ' CD2' ' A' ' 203' ' ' TRP . 4.1 ttm -42.64 132.44 3.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 128.035 3.779 . . . . 0.57 110.336 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.759 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.6 m120 -78.06 143.4 37.46 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.038 -2.289 . . . . 0.57 107.97 -172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -46.59 47.06 Favored 'General case' 0 C--N 1.38 1.903 0 N-CA-C 107.03 -1.47 . . . . 1.2 107.03 -164.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -54.75 -34.78 62.99 Favored 'General case' 0 C--N 1.396 2.602 0 CA-C-N 111.428 -2.624 . . . . 0.91 110.927 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 205' ' ' THR . 1.4 m-20 -70.11 -43.71 70.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.91 110.933 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -63.62 -39.07 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.174 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.13 87.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.91 110.89 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -67.32 -49.05 65.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.57 110.929 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.12 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.57 111.101 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.44 -31.94 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.57 111.17 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -67.93 -46.78 70.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CD ' ' OE1' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.56 -46.05 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.926 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.89 80.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.57 111.061 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 -44.11 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.57 110.902 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.433 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 2.0 pt20 -63.75 -37.05 85.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.57 110.91 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -69.47 -34.01 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.57 111.13 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 145' ' ' THR . 49.6 m95 -82.97 -34.3 26.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.57 110.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -49.36 13.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.875 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.631 ' OD1' HG13 ' A' ' 144' ' ' VAL . 6.0 p-10 -59.51 -12.71 6.83 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-O 121.429 0.633 . . . . 0.57 112.352 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.77 HG23 HD11 ' A' ' 258' ' ' ILE . 23.8 m -115.63 16.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 C-N-CA 124.027 0.931 . . . . 0.57 109.531 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 141' ' ' TRP . 75.2 p -146.01 150.69 43.04 Favored Pre-proline 0 C--N 1.367 1.362 0 CA-C-O 124.642 2.163 . . . . 0.57 107.474 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -80.38 -11.01 13.31 Favored 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-O 123.027 1.178 . . . . 0.57 111.072 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.75 113.19 26.62 Favored 'General case' 0 C--N 1.371 1.529 0 N-CA-C 103.85 -2.648 . . . . 0.57 103.85 -172.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.52 158.4 36.32 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-O 125.213 2.435 . . . . 0.57 117.177 166.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.638 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 9.6 m-85 -131.15 158.8 39.49 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.573 -1.649 . . . . 0.57 107.439 -174.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 125.57 5.96 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-O 124.29 1.995 . . . . 0.57 106.956 -171.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 150.08 20.95 Favored 'General case' 0 C--N 1.367 1.363 0 CA-C-O 123.335 1.54 . . . . 0.57 109.736 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 pt -144.15 -178.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.552 0 CA-C-O 123.618 1.675 . . . . 0.57 108.919 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 154' ' ' THR . 26.3 t30 -155.09 54.59 0.64 Allowed 'General case' 0 C--N 1.379 1.89 0 CA-C-N 113.917 -1.492 . . . . 0.57 107.949 -175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -161.4 -69.27 0.06 Allowed 'General case' 0 C--N 1.377 1.781 0 C-N-CA 119.955 -0.698 . . . . 0.57 109.813 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -86.05 173.64 46.88 Favored Glycine 0 C--N 1.372 2.569 0 CA-C-O 124.161 1.978 . . . . 0.57 110.38 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.2 ttt -63.66 154.4 33.07 Favored 'General case' 0 C--N 1.377 1.782 0 CA-C-N 112.331 -1.935 . . . . 0.57 107.81 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . . . -137.59 170.92 15.25 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 113.721 -1.582 . . . . 0.57 109.636 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 114' ' ' ILE . 3.0 m-20 -83.67 -67.8 0.76 Allowed 'General case' 0 C--N 1.379 1.877 0 N-CA-C 102.255 -3.239 . . . . 0.91 102.255 -168.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 223' ' ' SER . 56.9 mt -92.51 109.9 22.17 Favored 'Isoleucine or valine' 0 C--N 1.402 2.871 0 O-C-N 124.544 1.153 . . . . 0.57 111.087 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -105.45 132.11 52.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.918 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 197' ' ' PHE . 72.5 t -109.84 117.02 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.57 111.143 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.61 146.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.57 111.137 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.631 ' CZ ' HG22 ' A' ' 122' ' ' THR . 57.1 m-85 -103.74 118.48 36.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.57 110.833 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.25 167.59 23.12 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-O 124.109 1.909 . . . . 0.57 109.69 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 149.29 24.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.426 -2.046 . . . . 1.2 108.524 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.78 121.05 1.83 Allowed Glycine 0 C--N 1.375 2.738 0 CA-C-N 113.349 -1.751 . . . . 0.57 110.861 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -178.21 -57.8 0.01 OUTLIER 'General case' 0 C--N 1.379 1.878 0 CA-C-O 123.028 1.394 . . . . 0.57 108.396 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -68.61 -15.56 63.57 Favored 'General case' 0 C--N 1.389 2.286 0 CA-C-O 123.266 1.507 . . . . 0.57 109.732 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 177.32 -127.79 1.24 Allowed Glycine 0 C--N 1.377 2.83 0 N-CA-C 108.286 -1.925 . . . . 0.57 108.286 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.519 ' HB3' ' CD2' ' A' ' 174' ' ' PHE . 3.2 m-20 67.84 26.44 7.62 Favored 'General case' 0 C--N 1.382 2.012 0 N-CA-C 105.825 -1.917 . . . . 0.91 105.825 170.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 76.58 54.51 0.04 OUTLIER 'General case' 0 C--N 1.379 1.872 0 CA-C-N 114.67 -1.15 . . . . 0.57 108.205 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 64.07 42.37 5.74 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 119.19 -1.004 . . . . 0.57 111.814 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.94 95.63 0.03 OUTLIER 'General case' 0 C--N 1.368 1.395 0 CA-C-O 122.616 1.198 . . . . 0.57 111.44 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -57.44 -97.52 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 123.986 1.85 . . . . 0.57 112.894 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.48 178.36 4.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 125.25 2.452 . . . . 0.91 110.324 173.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -150.87 35.53 0.92 Allowed Glycine 0 C--N 1.372 2.561 0 CA-C-N 112.221 -2.263 . . . . 0.57 112.258 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 14.55 0.14 Allowed 'General case' 0 C--N 1.376 1.76 0 CA-C-O 122.012 0.911 . . . . 0.57 112.541 -175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.56 -143.46 10.2 Favored Glycine 0 C--N 1.364 2.097 0 CA-C-O 122.515 1.064 . . . . 0.57 110.801 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.93 -130.99 47.61 Favored Glycine 0 C--N 1.36 1.881 0 O-C-N 119.994 -1.886 . . . . 0.57 111.194 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 174' ' ' PHE . 1.0 OUTLIER -54.41 163.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.517 0 CA-C-N 113.065 -1.568 . . . . 0.57 108.866 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 210' ' ' THR . 11.2 mt -111.4 -40.29 4.43 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 115.527 1.677 . . . . 0.57 115.527 169.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -175.03 179.92 1.49 Allowed 'General case' 0 C--N 1.363 1.177 0 O-C-N 121.278 -0.889 . . . . 0.57 111.111 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.467 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 0.3 OUTLIER -156.34 159.9 39.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.852 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.57 153.06 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.57 111.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -93.85 -177.82 4.47 Favored 'General case' 0 C--N 1.373 1.588 0 CA-C-O 123.052 1.406 . . . . 0.57 109.758 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.58 -158.96 15.92 Favored Glycine 0 C--N 1.378 2.866 0 CA-C-N 114.372 -1.286 . . . . 0.57 112.075 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.39 -139.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.443 2.762 . . . . 0.57 112.169 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.19 -132.4 10.94 Favored Glycine 0 C--N 1.371 2.513 0 O-C-N 119.307 -2.12 . . . . 0.57 108.968 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.66 157.13 31.25 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.817 -1.549 . . . . 0.57 106.817 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.71 3.8 Favored Glycine 0 C--N 1.381 3.053 1 N-CA-C 102.479 -4.249 . . . . 0.57 102.479 165.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -36.35 67.95 Favored 'Isoleucine or valine' 0 C--N 1.377 1.785 0 CA-C-O 124.534 2.111 . . . . 0.57 109.97 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.15 132.48 28.24 Favored Glycine 0 C--N 1.38 2.996 0 N-CA-C 104.389 -3.484 . . . . 0.57 104.389 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.46 -6.61 57.68 Favored Glycine 0 C--N 1.366 2.2 0 CA-C-O 124.085 1.936 . . . . 0.57 110.268 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.53 ' CG ' ' HB2' ' A' ' 160' ' ' LEU . 1.3 m-20 -88.24 166.67 14.18 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.073 -1.839 . . . . 0.91 110.897 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -135.54 161.12 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.57 111.066 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.499 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -129.24 125.77 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.57 110.919 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.0 m-85 -105.41 133.0 50.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.57 110.883 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -61.83 86.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.886 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.01 -33.05 70.0 Favored 'General case' 0 C--N 1.398 2.674 0 C-N-CA 115.823 -2.351 . . . . 0.91 105.576 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.98 -47.72 8.62 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 123.821 0.848 . . . . 0.91 108.774 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -54.02 174.37 0.06 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-O 127.562 3.553 . . . . 0.91 111.978 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.467 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 0.1 OUTLIER -102.21 110.63 22.64 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 112.365 -2.198 . . . . 0.57 109.898 177.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.7 m95 -93.09 148.56 21.9 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 107.588 -1.264 . . . . 0.57 107.588 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.621 HG21 ' O ' ' A' ' 208' ' ' GLY . 56.1 p -127.14 125.94 42.05 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-O 124.763 2.22 . . . . 0.57 110.007 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CB ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -98.06 133.74 42.11 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.452 -1.685 . . . . 0.57 106.452 -176.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 80.69 -43.76 0.22 Allowed 'General case' 0 C--N 1.374 1.646 0 CA-C-N 114.571 -1.195 . . . . 0.57 109.591 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.54 153.98 0.37 Allowed 'General case' 0 C--N 1.369 1.43 0 N-CA-C 107.996 -1.112 . . . . 0.57 107.996 -173.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 204' ' ' THR . . . 125.93 6.25 6.0 Favored Glycine 0 C--N 1.376 2.784 0 CA-C-N 114.556 -1.202 . . . . 0.57 114.089 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 144.31 -119.75 1.33 Allowed Glycine 0 C--N 1.378 2.869 0 CA-C-O 123.752 1.751 . . . . 0.57 112.36 -168.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 181' ' ' LEU . 6.6 p -94.25 133.0 38.25 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-N 113.951 -1.124 . . . . 0.57 109.331 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.627 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -98.2 150.39 21.55 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.878 1.799 . . . . 0.57 111.713 177.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.633 HD13 ' O ' ' A' ' 212' ' ' LEU . 3.2 tm? -75.54 -29.65 59.49 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 106.087 -1.82 . . . . 0.57 106.087 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 213' ' ' PHE . 7.8 t80 -57.45 -50.25 73.63 Favored 'General case' 0 C--N 1.373 1.623 0 CA-C-N 115.305 -0.861 . . . . 0.57 110.909 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.508 HD11 ' C25' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -55.55 -51.15 68.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.57 110.952 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -67.32 -35.5 79.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.57 111.132 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 212' ' ' LEU . . . -62.59 -44.21 96.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.57 111.114 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 213' ' ' PHE . 95.4 t -65.23 -48.02 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.57 111.171 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 236' ' ' MET . 6.4 t-160 -64.63 -50.21 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.57 110.815 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 197' ' ' PHE . 17.3 mm-40 -57.92 -42.22 84.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.91 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.552 ' CG2' HD21 ' A' ' 224' ' ' LEU . 1.0 OUTLIER -66.56 -46.81 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.57 111.182 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.32 -33.53 61.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.57 112.501 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -64.71 -38.89 92.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.57 110.833 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.407 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 0.5 OUTLIER -71.99 -53.23 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.57 110.831 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.0 pp -93.94 -56.8 2.74 Favored 'General case' 0 C--N 1.381 1.958 0 N-CA-C 117.783 2.512 . . . . 0.57 117.783 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -45.08 149.89 1.1 Allowed Glycine 0 C--N 1.373 2.611 1 CA-C-O 128.049 4.139 . . . . 0.57 110.486 177.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -77.16 -153.51 0.05 Allowed 'General case' 0 C--N 1.365 1.247 0 CA-C-N 109.975 -3.113 . . . . 0.57 107.153 -171.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.0 -175.62 0.5 Allowed Glycine 0 C--N 1.379 2.923 0 CA-C-O 127.213 3.674 . . . . 0.57 113.001 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -100.56 -174.25 2.6 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 118.997 -2.472 . . . . 0.57 111.343 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.1 p -103.63 -34.67 8.55 Favored 'General case' 0 C--N 1.38 1.932 0 CA-C-N 113.835 -1.53 . . . . 0.57 108.748 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.78 22.37 0.39 Allowed 'General case' 0 C--N 1.385 2.121 0 N-CA-C 114.152 1.168 . . . . 0.57 114.152 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.74 131.99 11.05 Favored Pre-proline 0 C--N 1.378 1.838 0 N-CA-C 102.828 -3.027 . . . . 0.91 102.828 -164.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.479 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 47.5 Cg_exo -61.73 74.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 124.9 3.733 . . . . 0.57 114.913 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.38 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 CA-C-N 113.634 -1.621 . . . . 0.57 111.349 -171.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.61 133.53 34.84 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-O 123.549 1.642 . . . . 0.57 106.655 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 248' ' ' PHE . 11.5 p -70.48 68.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.318 0 CA-C-N 113.028 -1.896 . . . . 0.57 112.166 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER -175.64 -35.76 0.01 OUTLIER 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.635 -1.291 . . . . 0.57 109.931 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.16 145.46 0.32 Allowed Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 124.948 2.309 . . . . 0.57 111.575 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.555 ' HB3' H522 ' A' ' 269' ' ' HSI . 89.2 Cg_exo -57.93 -47.66 19.73 Favored 'Trans proline' 0 C--N 1.374 1.869 0 O-C-N 119.21 -0.995 . . . . 0.57 111.499 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 14.1 m -49.35 124.66 9.58 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-O 124.328 2.013 . . . . 0.57 109.921 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.551 ' OH ' HG22 ' A' ' 210' ' ' THR . 57.2 t80 -94.15 140.19 30.06 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-O 123.297 1.523 . . . . 0.57 107.997 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.498 ' HD2' ' H33' ' A' ' 269' ' ' HSI . 4.9 tmtt? -155.56 109.39 2.82 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 105.635 -1.987 . . . . 0.57 105.635 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -54.03 123.71 13.4 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-O 124.144 1.926 . . . . 0.57 109.628 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.479 HG11 ' C32' ' A' ' 269' ' ' HSI . 9.6 p -154.65 111.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 114.158 -1.383 . . . . 0.57 107.349 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.21 142.44 51.77 Favored 'General case' 0 C--N 1.365 1.248 0 N-CA-C 103.219 -2.882 . . . . 0.91 103.219 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.471 HG12 ' CG ' ' A' ' 213' ' ' PHE . 1.1 mp -46.05 -23.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.309 0 CA-C-N 111.248 -2.706 . . . . 0.57 112.769 174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -51.72 -37.47 51.13 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.051 -0.977 . . . . 0.57 109.767 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.9 p -103.88 -0.64 28.84 Favored 'General case' 0 C--N 1.386 2.171 0 N-CA-C 116.48 2.03 . . . . 0.57 116.48 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.719 ' HE1' HG21 ' A' ' 235' ' ' VAL . 34.3 t80 -63.17 93.66 0.07 Allowed 'General case' 0 C--N 1.365 1.252 0 CA-C-O 127.039 3.304 . . . . 0.57 107.491 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.403 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.95 152.57 42.33 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 112.745 -2.025 . . . . 1.2 106.371 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.63 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.15 131.31 53.89 Favored 'General case' 0 C--N 1.372 1.577 0 CA-C-O 125.634 2.635 . . . . 0.57 104.987 -170.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.77 136.71 58.0 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.599 -1.938 . . . . 0.57 111.68 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -60.28 -45.23 94.06 Favored 'General case' 0 C--N 1.383 2.05 0 N-CA-C 106.245 -1.761 . . . . 0.57 106.245 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -41.03 85.16 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.215 -0.928 . . . . 0.91 110.858 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -63.93 -55.34 23.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.91 110.892 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.8 pt -66.21 -34.9 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.108 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.489 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 22.0 mtp180 -70.44 -30.38 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.872 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.15 -39.78 57.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.798 -0.715 . . . . 0.57 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -70.19 -41.41 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.57 111.175 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -34.45 68.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.57 110.829 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t -76.77 -24.0 52.93 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-O 122.23 1.014 . . . . 0.57 109.489 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -60.92 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.897 1.808 . . . . 0.57 109.945 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.32 18.52 8.21 Favored 'General case' 0 C--N 1.369 1.447 0 CA-C-N 113.979 -1.464 . . . . 0.57 114.824 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 2.296 0 N-CA-C 117.764 1.866 . . . . 0.91 117.764 174.831 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.555 H522 ' HB3' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 111.093 -0.803 . . . . 0.57 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.89 93.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.589 2.193 . . . . 0.57 112.945 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.56 132.98 56.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 CA-C-N 113.935 -1.484 . . . . 0.57 108.565 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -162.95 59.18 0.2 Allowed 'General case' 0 C--N 1.383 2.043 0 CA-C-O 125.671 2.653 . . . . 0.57 108.663 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.59 146.52 26.59 Favored 'General case' 0 C--N 1.374 1.635 0 O-C-N 119.944 -1.722 . . . . 1.2 108.87 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 -50.94 0.01 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 122.316 1.055 . . . . 0.57 110.4 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -69.68 -32.24 70.74 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 114.117 -1.401 . . . . 0.57 108.482 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -109.17 109.47 20.44 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 120.129 -1.607 . . . . 0.57 110.935 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.69 139.88 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.139 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 4.4 p -112.94 159.76 18.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.57 111.118 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -149.08 153.37 37.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.57 110.955 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -142.1 122.02 13.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.939 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.472 HG21 ' HD1' ' A' ' 121' ' ' TYR . 12.8 mm -87.65 117.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.57 111.14 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ILE . 1.5 t-20 -37.52 -57.72 0.92 Allowed 'General case' 0 C--N 1.37 1.473 0 C-N-CA 120.019 -0.672 . . . . 0.57 111.382 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 24.9 t-20 -155.87 -61.14 0.11 Allowed 'General case' 0 C--N 1.378 1.812 0 CA-C-N 113.725 -1.58 . . . . 0.57 107.995 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.472 ' HD1' HG21 ' A' ' 118' ' ' ILE . 1.2 m-30 152.99 30.76 0.0 OUTLIER 'General case' 0 C--N 1.379 1.88 0 O-C-N 126.17 2.169 . . . . 0.57 112.731 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.651 HG23 ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 68.87 141.54 0.08 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 CA-C-O 124.38 2.038 . . . . 0.57 107.924 172.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 199' ' ' GLU . 39.7 Cg_endo -70.47 -41.58 3.28 Favored 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 118.432 -1.404 . . . . 0.57 112.319 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -110.74 -51.76 2.84 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 114.844 -1.071 . . . . 0.91 111.074 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.644 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -43.96 143.87 1.02 Allowed 'General case' 0 C--N 1.377 1.802 0 CA-C-O 124.953 2.311 . . . . 0.57 108.926 -174.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.0 m-20 -73.47 139.01 45.48 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.977 -1.92 . . . . 0.57 109.358 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.412 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -67.59 -50.07 60.08 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 107.758 -1.201 . . . . 1.2 107.758 -170.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.96 -36.36 65.26 Favored 'General case' 0 C--N 1.38 1.894 0 CA-C-N 113.271 -1.786 . . . . 0.91 110.891 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 126' ' ' ASN . 97.4 m-20 -70.82 -37.83 73.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.91 110.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 126' ' ' ASN . 4.9 t -65.18 -49.2 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.57 111.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 16.8 m-20 -69.93 -40.62 75.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.91 110.817 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -66.02 -42.22 89.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.57 110.891 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 212' ' ' LEU . . . -63.62 -49.01 75.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.57 111.136 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 15.8 pt -64.9 -31.94 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.57 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -66.89 -46.8 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.88 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -46.04 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.57 110.913 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.98 83.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.57 111.049 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.97 -44.89 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.57 110.893 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.4 pt20 -64.97 -35.27 80.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.57 110.918 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.862 HG13 HD21 ' A' ' 250' ' ' LEU . 1.2 t -69.53 -34.2 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.57 111.085 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 7.5 m95 -83.03 -34.2 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.57 110.911 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -48.24 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.57 110.853 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.679 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.4 p-10 -61.0 -12.61 12.07 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.854 0.835 . . . . 0.57 111.612 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 140' ' ' VAL . 19.6 m -115.42 -10.06 12.21 Favored 'Isoleucine or valine' 0 C--N 1.375 1.687 0 CA-C-N 114.835 -1.075 . . . . 0.57 111.533 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 224' ' ' LEU . 0.5 OUTLIER -139.99 148.73 56.09 Favored Pre-proline 0 C--N 1.36 1.058 0 CA-C-O 125.092 2.377 . . . . 0.57 110.021 -177.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -70.7 -39.67 4.5 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 118.24 -1.505 . . . . 0.57 111.857 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 224' ' ' LEU . 3.7 mt -50.63 111.41 0.54 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 122.734 1.254 . . . . 0.57 107.923 -174.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -76.37 159.24 30.68 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 114.473 -1.239 . . . . 0.57 111.176 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 6.1 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 113.25 -1.795 . . . . 0.57 108.756 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 m -159.85 110.96 1.96 Allowed 'General case' 0 C--N 1.386 2.183 0 CA-C-O 124.923 2.297 . . . . 0.57 109.022 -172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.55 133.83 37.75 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 113.915 -1.493 . . . . 0.57 109.645 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.641 HD12 ' H ' ' A' ' 155' ' ' GLY . 2.3 pt -111.03 172.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.364 1.231 0 CA-C-O 124.545 2.117 . . . . 0.57 110.135 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -63.77 1.24 Allowed 'General case' 0 C--N 1.383 2.038 0 CA-C-N 113.31 -1.768 . . . . 0.57 110.023 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 154' ' ' THR . 13.9 t -142.62 52.58 1.42 Allowed 'General case' 0 C--N 1.376 1.733 0 CA-C-O 124.926 2.298 . . . . 0.57 110.154 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.641 ' H ' HD12 ' A' ' 152' ' ' ILE . . . -127.9 21.94 5.5 Favored Glycine 0 C--N 1.364 2.106 0 C-N-CA 118.492 -1.813 . . . . 0.57 112.515 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.454 ' C ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER 67.12 95.05 0.06 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.961 2.315 . . . . 0.57 110.264 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 117' ' ' ARG . . . -96.36 174.68 6.75 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 117.89 -1.524 . . . . 0.57 112.49 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.16 -50.75 13.74 Favored 'General case' 0 C--N 1.375 1.694 0 N-CA-C 105.197 -2.149 . . . . 0.91 105.197 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.646 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.8 pp -114.11 116.18 51.83 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 CA-C-N 115.158 -0.928 . . . . 0.57 111.141 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 117' ' ' ARG . 4.3 mp -92.87 132.15 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.57 110.877 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.849 HG13 ' CE1' ' A' ' 197' ' ' PHE . 30.6 t -101.96 117.0 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.57 111.1 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.02 146.01 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.57 111.132 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CE1' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -106.18 119.99 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.57 110.89 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.28 168.6 18.58 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 123.795 1.76 . . . . 0.57 109.696 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -107.3 167.72 9.72 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.701 -1.25 . . . . 1.2 110.595 177.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -40.17 143.05 0.58 Allowed Glycine 0 C--N 1.38 3.027 0 CA-C-O 123.22 1.455 . . . . 0.57 112.303 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 72.19 43.65 0.5 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-O 124.708 2.194 . . . . 0.57 109.218 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 165' ' ' ARG . 31.2 p-80 -99.27 -54.3 3.0 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 123.663 1.697 . . . . 0.57 108.385 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.2 -169.99 42.92 Favored Glycine 0 C--N 1.372 2.548 0 N-CA-C 109.156 -1.578 . . . . 0.57 109.156 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.63 18.57 8.56 Favored 'General case' 0 C--N 1.391 2.41 0 CA-C-N 112.8 -1.7 . . . . 0.91 109.182 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 159.9 -32.88 0.0 OUTLIER 'General case' 0 C--N 1.372 1.563 0 O-C-N 125.063 1.477 . . . . 0.57 111.377 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.1 t60 82.85 34.48 0.06 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 123.62 1.676 . . . . 0.57 111.565 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 167.54 121.13 0.01 OUTLIER 'General case' 0 C--N 1.385 2.129 0 O-C-N 120.894 -1.129 . . . . 0.57 109.593 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.529 ' HE1' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -116.73 -161.6 0.81 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 114.221 -1.354 . . . . 0.57 111.697 175.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.635 ' HB3' HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -99.38 -68.68 0.79 Allowed 'General case' 0 C--N 1.378 1.827 0 N-CA-C 108.758 -0.83 . . . . 0.91 108.758 178.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.401 ' N ' ' OD2' ' A' ' 175' ' ' ASP . . . 54.69 165.16 0.02 OUTLIER Glycine 0 C--N 1.392 3.666 0 CA-C-O 125.095 2.497 . . . . 0.57 116.813 -167.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.49 7.77 5.11 Favored 'General case' 0 C--N 1.379 1.88 0 O-C-N 120.507 -1.584 . . . . 0.57 113.48 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.18 -140.73 11.98 Favored Glycine 0 C--N 1.363 2.072 0 N-CA-C 110.045 -1.222 . . . . 0.57 110.045 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.02 -104.17 0.11 Allowed Glycine 0 C--N 1.362 2.026 0 CA-C-O 123.566 1.648 . . . . 0.57 112.52 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 175' ' ' ASP . 9.7 mt -62.58 169.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.494 0 CA-C-O 123.333 1.54 . . . . 0.57 112.506 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 215' ' ' THR . 23.5 tp -128.92 -40.31 1.53 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 118.211 -2.805 . . . . 0.57 110.499 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 215' ' ' THR . . . -176.5 179.94 1.11 Allowed 'General case' 0 C--N 1.379 1.854 0 CA-C-N 114.918 -1.037 . . . . 0.57 111.081 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.438 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -155.04 145.86 22.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.57 110.846 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.01 151.24 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.082 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.13 -179.99 7.13 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.968 1.842 . . . . 0.57 111.131 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.99 -162.89 24.0 Favored Glycine 0 C--N 1.38 2.985 0 CA-C-O 124.142 1.968 . . . . 0.57 111.703 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.24 79.15 1.79 Allowed 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.099 1.866 . . . . 0.57 112.074 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -128.31 160.76 22.1 Favored Glycine 0 C--N 1.367 2.281 0 CA-C-O 123.182 1.434 . . . . 0.57 110.074 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -74.94 -177.61 3.4 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.428 -1.386 . . . . 0.57 109.237 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.13 -117.22 5.9 Favored Glycine 0 C--N 1.383 3.186 0 N-CA-C 109.834 -1.306 . . . . 0.57 109.834 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 192' ' ' GLY . 6.3 tp -59.44 -46.81 92.44 Favored 'Isoleucine or valine' 0 C--N 1.383 2.051 0 CA-C-N 112.547 -1.826 . . . . 0.57 110.44 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -42.7 133.89 4.61 Favored Glycine 0 C--N 1.369 2.415 0 CA-C-O 124.486 2.159 . . . . 0.57 109.671 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.8 -48.82 1.21 Allowed Glycine 0 C--N 1.37 2.465 0 CA-C-N 113.051 -1.574 . . . . 0.57 113.129 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.29 160.06 0.17 Allowed 'General case' 0 C--N 1.376 1.724 0 CA-C-O 120.798 0.333 . . . . 0.91 110.901 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -143.98 146.46 32.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.57 111.101 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -121.62 126.25 48.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.57 110.875 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.849 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.5 m-85 -108.22 150.08 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.57 110.89 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 90.41 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.91 110.803 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.453 ' OE1' HG22 ' A' ' 122' ' ' THR . 3.8 tp10 -74.65 -5.52 43.52 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 124.216 1.96 . . . . 0.91 110.475 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -32.97 35.16 Favored 'General case' 0 C--N 1.369 1.416 0 CA-C-O 123.003 1.382 . . . . 0.91 108.902 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.58 176.06 2.58 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-O 123.439 1.59 . . . . 0.91 111.99 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.76 104.02 16.01 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-N 112.576 -2.102 . . . . 0.57 112.589 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.421 ' CE3' ' HG3' ' A' ' 125' ' ' MET . 18.2 m95 -76.7 128.52 34.83 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 114.273 -1.33 . . . . 0.57 108.525 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.0 p -122.86 104.88 9.56 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-O 125.093 2.378 . . . . 0.57 109.309 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.401 HG21 ' HB3' ' A' ' 129' ' ' ASP . 0.6 OUTLIER -115.46 130.83 57.01 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.065 1.412 . . . . 0.57 108.658 -177.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 24.85 3.45 Favored 'General case' 0 C--N 1.389 2.318 0 CA-C-O 123.601 1.667 . . . . 0.57 111.402 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.16 -71.41 0.5 Allowed 'General case' 0 C--N 1.38 1.896 0 CA-C-N 114.241 -1.345 . . . . 0.57 108.479 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.94 90.96 0.08 OUTLIER Glycine 0 C--N 1.389 3.487 0 C-N-CA 118.478 -1.82 . . . . 0.57 113.09 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.5 -141.71 7.61 Favored Glycine 0 C--N 1.378 2.879 0 C-N-CA 119.55 -1.309 . . . . 0.57 110.132 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 181' ' ' LEU . 72.7 p -67.42 128.66 37.25 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-O 124.128 1.918 . . . . 0.57 112.146 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.556 ' O ' HD21 ' A' ' 181' ' ' LEU . 12.6 p30 -135.34 145.46 47.45 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 113.917 -1.492 . . . . 0.57 109.607 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 133' ' ' ALA . 1.4 pt? -65.0 -25.37 67.83 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-O 123.911 1.815 . . . . 0.57 108.933 -174.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.992 ' O ' HG23 ' A' ' 217' ' ' VAL . 48.7 t80 -54.18 -42.65 69.92 Favored 'General case' 0 C--N 1.372 1.568 0 CA-C-N 113.734 -1.575 . . . . 0.57 110.879 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -57.11 -51.11 70.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.926 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -69.55 -33.78 73.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.57 111.139 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -65.92 -46.33 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.57 111.113 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 213' ' ' PHE . 6.0 t -65.43 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.57 111.14 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 236' ' ' MET . 6.2 t-160 -71.33 -50.04 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.57 110.844 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.31 -42.07 98.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.91 110.876 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 216' ' ' ALA . 34.5 mt -65.04 -37.94 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.57 111.119 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.501 ' HA3' ' CZ2' ' A' ' 141' ' ' TRP . . . -68.3 -33.99 79.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 0.57 112.49 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.448 ' CG ' ' CE ' ' A' ' 236' ' ' MET . 2.9 m-70 -67.39 -40.67 85.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.57 110.871 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m -70.54 -41.22 72.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.57 110.882 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 145' ' ' THR . 0.7 OUTLIER -40.76 -36.97 0.69 Allowed 'General case' 0 C--N 1.358 0.97 0 CA-C-O 124.475 2.083 . . . . 0.57 111.753 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.4 -38.92 1.13 Allowed Glycine 0 C--N 1.369 2.386 0 N-CA-C 108.392 -1.883 . . . . 0.57 108.392 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.551 HD11 HG22 ' A' ' 258' ' ' ILE . 1.3 pt? -100.09 150.95 21.95 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-O 123.062 1.41 . . . . 0.57 111.602 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.22 -118.92 0.27 Allowed Glycine 0 C--N 1.374 2.668 0 CA-C-O 125.063 2.479 . . . . 0.57 111.881 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -110.55 -155.01 0.55 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 120.825 -1.397 . . . . 0.57 109.053 -178.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.681 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.6 p -115.56 -8.06 12.16 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 114.614 -1.175 . . . . 0.57 111.149 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 82.54 -5.41 1.36 Allowed 'General case' 0 C--N 1.381 1.962 0 N-CA-C 113.527 0.936 . . . . 0.57 113.527 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.56 158.84 74.23 Favored Pre-proline 0 C--N 1.372 1.577 0 N-CA-C 107.346 -1.353 . . . . 0.91 107.346 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -55.02 -29.92 67.26 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.952 2.435 . . . . 0.57 112.99 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 229' ' ' SER . 0.2 OUTLIER -47.35 -25.51 1.02 Allowed 'General case' 0 C--N 1.382 2.021 0 CA-C-N 114.662 -1.154 . . . . 0.57 113.589 177.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -91.13 124.62 35.49 Favored 'General case' 0 C--N 1.378 1.814 0 CA-C-O 124.656 2.169 . . . . 0.57 110.77 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -70.41 -8.36 10.65 Favored 'Isoleucine or valine' 0 C--N 1.377 1.768 0 CA-C-N 113.016 -1.902 . . . . 0.57 111.838 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.501 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 1.3 ttt -99.4 17.92 19.02 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.227 -0.897 . . . . 0.57 110.689 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 9.8 t80 -55.3 141.54 61.56 Favored Pre-proline 0 C--N 1.367 1.344 0 CA-C-O 123.12 1.438 . . . . 0.57 108.693 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 51.6 Cg_exo -51.76 -52.94 7.89 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.98 1.787 . . . . 0.57 113.714 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.95 142.24 56.62 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 125.288 1.618 . . . . 0.57 109.929 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.568 ' HA ' ' C25' ' A' ' 269' ' ' HSI . 7.9 t80 -94.71 153.21 17.9 Favored 'General case' 0 C--N 1.385 2.126 0 CA-C-N 113.583 -1.644 . . . . 0.57 109.63 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 4.2 tmtt? 177.31 104.17 0.02 OUTLIER 'General case' 0 C--N 1.389 2.292 0 CA-C-O 123.238 1.494 . . . . 0.57 107.461 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.25 120.02 4.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 125.105 2.384 . . . . 0.57 109.927 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.95 9.51 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-N 113.25 -1.795 . . . . 0.57 110.407 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.594 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER 84.88 -16.31 0.5 Allowed 'General case' 0 C--N 1.367 1.342 0 O-C-N 125.631 1.832 . . . . 0.91 111.683 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.5 mt 74.87 -48.71 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.121 0 N-CA-C 114.605 1.335 . . . . 0.57 114.605 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -45.22 -27.06 0.57 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 114.376 1.25 . . . . 0.57 114.376 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.594 HG23 ' OD1' ' A' ' 244' ' ' ASP . 1.3 p -106.28 -0.68 24.2 Favored 'General case' 0 C--N 1.376 1.721 0 CA-C-N 115.373 -0.83 . . . . 0.57 110.959 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 235' ' ' VAL . 12.5 t80 -58.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.372 1.559 0 CA-C-O 124.46 2.076 . . . . 0.57 109.054 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.454 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -109.74 152.0 26.21 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-N 113.351 -1.75 . . . . 1.2 107.22 -176.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.862 HD21 HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -121.83 134.66 54.89 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-O 124.549 2.118 . . . . 0.57 106.246 -173.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -67.01 136.79 55.84 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 120.551 -1.343 . . . . 0.57 110.441 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.4 94.94 Favored 'General case' 0 C--N 1.381 1.977 0 N-CA-C 107.218 -1.401 . . . . 0.57 107.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.43 -37.51 87.78 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 119.62 -1.925 . . . . 0.91 110.849 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 m-20 -63.83 -55.35 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.91 110.886 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.484 ' CG2' HG11 ' A' ' 144' ' ' VAL . 11.7 pt -66.23 -35.51 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.094 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.432 ' N ' HG13 ' A' ' 255' ' ' ILE . 48.7 mtm180 -70.33 -34.32 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.2 110.843 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.63 -49.56 59.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.57 112.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.15 -45.23 99.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.57 111.089 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.493 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -71.45 -28.06 63.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.57 110.878 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.7 t -75.25 -21.11 58.81 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-O 121.909 0.862 . . . . 0.57 110.883 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -81.71 0.04 OUTLIER 'General case' 0 C--N 1.375 1.675 0 CA-C-O 123.531 1.634 . . . . 0.57 109.903 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 58.8 1.67 Allowed 'General case' 0 C--N 1.37 1.462 0 CA-C-N 114.818 -1.083 . . . . 0.57 110.589 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.366 2.229 0 CA-C-O 115.843 -2.643 . . . . 0.91 115.151 176.522 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.568 ' C25' ' HA ' ' A' ' 240' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.455 0 CA-C-O 118.655 -1.08 . . . . 0.57 111.305 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.21 131.71 47.93 Favored 'Trans proline' 0 C--N 1.367 1.539 0 O-C-N 125.673 2.407 . . . . 0.57 110.89 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 108' ' ' VAL . 16.0 m -131.34 117.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-N 112.268 -2.242 . . . . 0.57 109.2 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -153.82 105.38 2.77 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 113.166 -1.834 . . . . 0.57 108.986 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.01 151.69 18.24 Favored 'General case' 0 C--N 1.381 1.935 0 CA-C-N 112.835 -1.984 . . . . 1.2 107.962 -172.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.58 -44.13 0.09 Allowed 'General case' 0 C--N 1.372 1.549 0 CA-C-N 113.301 -1.772 . . . . 0.57 110.185 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' HA ' HD23 ' A' ' 147' ' ' LEU . 2.4 p-80 -89.43 -21.65 22.92 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 113.001 -1.909 . . . . 0.57 111.644 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.479 ' HE1' ' HG ' ' A' ' 150' ' ' SER . 0.7 OUTLIER -113.04 107.95 16.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 115.784 -0.644 . . . . 0.57 110.92 -178.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 155.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.57 111.138 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 150.55 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.137 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -150.04 160.08 43.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.925 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -141.14 129.18 21.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.849 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -94.5 129.52 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.57 111.162 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 121' ' ' TYR . 54.6 t30 -54.36 178.78 0.02 OUTLIER 'General case' 0 C--N 1.369 1.447 0 CA-C-O 124.701 2.191 . . . . 0.57 109.121 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.51 45.09 0.84 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.026 -1.672 . . . . 0.57 109.926 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 7.0 m-85 53.85 -168.15 0.07 Allowed 'General case' 0 C--N 1.386 2.152 0 CA-C-N 113.344 -1.753 . . . . 0.57 107.432 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.63 165.34 17.62 Favored Pre-proline 0 C--N 1.378 1.837 0 CA-C-N 113.668 -1.606 . . . . 0.57 107.487 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 -55.62 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 120.904 1.069 . . . . 0.57 113.467 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.78 -52.71 63.09 Favored 'General case' 0 C--N 1.375 1.701 0 CA-C-N 114.042 -1.436 . . . . 0.91 111.985 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.538 ' CE ' ' CD1' ' A' ' 203' ' ' TRP . 2.6 ttm -77.03 126.85 31.66 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 124.565 2.126 . . . . 0.57 110.844 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.2 m-80 -72.05 131.36 42.78 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-N 112.78 -2.009 . . . . 0.57 109.009 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.62 -49.95 64.59 Favored 'General case' 0 C--N 1.366 1.313 0 N-CA-C 107.737 -1.208 . . . . 1.2 107.737 -169.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -55.52 -35.38 65.57 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-N 112.221 -2.263 . . . . 0.91 110.841 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.44 -43.35 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.91 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -61.04 -49.93 82.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.57 111.092 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -59.22 -44.14 92.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.91 110.803 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.72 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.57 110.938 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.1 -49.06 73.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.062 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.642 HD11 HD11 ' A' ' 212' ' ' LEU . 2.4 mm -65.28 -40.41 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.57 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.35 -46.13 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.2 110.852 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -42.7 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.57 110.921 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -58.45 -44.93 89.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.57 111.11 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 149' ' ' PHE . 11.8 m-85 -64.15 -36.35 83.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.57 110.86 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.12 -40.05 86.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.57 110.95 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -69.5 -34.1 60.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.106 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 224' ' ' LEU . 43.8 m95 -82.92 -34.03 26.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.57 110.939 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 m -79.3 -50.57 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.57 110.883 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.656 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.4 p-10 -56.77 -14.04 3.04 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.34 0.867 . . . . 0.57 113.34 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 140' ' ' VAL . 17.9 m -113.73 -7.33 12.04 Favored 'Isoleucine or valine' 0 C--N 1.377 1.788 0 CA-C-N 113.678 -1.601 . . . . 0.57 112.628 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.801 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.58 143.18 16.18 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-O 125.068 2.366 . . . . 0.57 109.291 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.801 ' HD2' HG22 ' A' ' 145' ' ' THR . 55.7 Cg_endo -82.12 49.9 3.28 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.017 1.811 . . . . 0.57 111.362 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 112' ' ' HIS . 1.8 mt -134.02 73.79 1.52 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 106.551 -1.648 . . . . 0.57 106.551 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.75 161.9 22.57 Favored 'General case' 0 C--N 1.369 1.456 0 CA-C-O 125.468 2.556 . . . . 0.57 117.499 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -135.15 159.94 39.95 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.486 -2.143 . . . . 0.57 106.237 -172.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.479 ' HG ' ' HE1' ' A' ' 113' ' ' TYR . 1.2 m -140.78 111.16 6.74 Favored 'General case' 0 C--N 1.379 1.885 0 CA-C-O 124.154 1.931 . . . . 0.57 106.523 -171.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 27.5 tttt -82.19 145.97 29.78 Favored 'General case' 0 C--N 1.369 1.446 0 CA-C-N 112.833 -1.985 . . . . 0.57 111.934 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.0 pt -128.68 162.14 36.2 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 CA-C-N 112.928 -1.942 . . . . 0.57 109.48 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -139.8 39.76 2.0 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-N 113.442 -1.708 . . . . 0.57 110.684 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.62 -70.81 0.54 Allowed 'General case' 0 C--N 1.378 1.83 0 CA-C-N 112.864 -1.971 . . . . 0.57 108.479 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -99.41 -130.44 6.95 Favored Glycine 0 C--N 1.382 3.108 0 N-CA-C 108.802 -1.719 . . . . 0.57 108.802 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -122.79 134.67 54.42 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 111.885 -2.158 . . . . 0.57 109.083 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -99.48 179.0 4.7 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 112.831 -1.986 . . . . 0.57 111.527 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.24 -65.34 0.74 Allowed 'General case' 0 C--N 1.387 2.217 0 N-CA-C 103.924 -2.621 . . . . 0.91 103.924 -166.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.728 HG22 ' CA ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -98.84 109.84 24.96 Favored 'Isoleucine or valine' 0 C--N 1.37 1.486 0 CA-C-N 114.834 -1.075 . . . . 0.57 111.112 178.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -104.0 130.97 51.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.927 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.3 t -102.09 117.02 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.57 111.094 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.1 146.02 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.105 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -99.15 116.74 32.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.57 110.857 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.08 170.04 16.51 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 124.967 2.318 . . . . 0.57 110.923 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 168.26 9.25 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 113.753 -1.567 . . . . 1.2 111.646 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 174' ' ' PHE . . . -43.41 128.12 5.75 Favored Glycine 0 C--N 1.385 3.27 0 O-C-N 126.299 2.25 . . . . 0.57 112.569 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -179.89 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.384 2.076 0 CA-C-N 111.7 -2.25 . . . . 0.57 110.853 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.34 142.98 48.65 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.656 -1.611 . . . . 0.57 108.578 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 37.59 -138.28 0.6 Allowed Glycine 0 C--N 1.377 2.854 0 O-C-N 125.629 1.83 . . . . 0.57 112.637 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 11.8 m-20 64.74 38.47 6.86 Favored 'General case' 0 C--N 1.401 2.808 0 CA-C-O 125.632 2.634 . . . . 0.91 106.276 169.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 63.99 -97.43 0.06 Allowed 'General case' 0 C--N 1.381 1.977 0 CA-C-N 113.431 -1.713 . . . . 0.57 110.747 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.641 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 59.3 t-80 -115.58 63.97 0.69 Allowed 'General case' 0 C--N 1.379 1.886 0 CA-C-N 114.357 -1.292 . . . . 0.57 110.846 174.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 73.97 -159.29 0.08 Allowed 'General case' 0 C--N 1.376 1.746 0 C-N-CA 117.969 -1.492 . . . . 0.57 112.124 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.598 ' CE1' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -133.53 -159.88 1.0 Allowed 'General case' 0 C--N 1.368 1.408 0 CA-C-O 122.771 1.272 . . . . 0.57 110.273 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.34 175.31 6.79 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.28 -1.782 . . . . 0.91 110.946 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.03 34.59 1.65 Allowed Glycine 0 C--N 1.389 3.516 0 CA-C-N 111.927 -2.397 . . . . 0.57 111.697 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.45 -40.99 0.05 OUTLIER 'General case' 0 C--N 1.376 1.749 0 CA-C-N 112.79 -1.705 . . . . 0.57 112.077 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -166.65 -122.56 0.61 Allowed Glycine 0 C--N 1.38 2.978 0 C-N-CA 117.846 -2.121 . . . . 0.57 110.399 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.48 -122.52 26.88 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 117.316 -1.825 . . . . 0.57 113.418 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.598 HG21 ' CE1' ' A' ' 174' ' ' PHE . 0.3 OUTLIER -45.75 170.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 O-C-N 127.434 2.491 . . . . 0.57 114.077 172.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.693 HD13 ' OH ' ' A' ' 240' ' ' TYR . 6.6 tp -123.77 -66.71 0.98 Allowed 'General case' 0 C--N 1.374 1.634 0 CA-C-O 123.151 1.453 . . . . 0.57 113.864 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 197' ' ' PHE . . . -178.15 179.88 0.78 Allowed 'General case' 0 C--N 1.358 0.963 0 CA-C-N 112.719 -2.037 . . . . 0.57 111.054 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.503 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.8 p80 -158.23 177.12 11.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.57 110.854 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -157.97 143.75 17.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.57 111.151 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.508 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 4.9 m-30 -84.69 173.41 10.75 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 118.578 -1.249 . . . . 0.57 108.9 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.07 -156.17 4.33 Favored Glycine 0 C--N 1.382 3.085 0 C-N-CA 118.356 -1.878 . . . . 0.57 110.563 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.66 -87.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.063 1.175 . . . . 0.57 110.643 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.28 -143.52 2.42 Favored Glycine 0 C--N 1.387 3.388 0 CA-C-O 123.958 1.866 . . . . 0.57 110.233 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.88 163.99 38.06 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 111.164 -2.518 . . . . 0.57 108.705 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.82 -108.26 2.51 Favored Glycine 0 C--N 1.386 3.308 0 N-CA-C 108.072 -2.011 . . . . 0.57 108.072 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.64 -37.32 69.05 Favored 'Isoleucine or valine' 0 C--N 1.386 2.158 0 CA-C-O 125.513 2.578 . . . . 0.57 109.292 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.11 138.5 49.5 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 108.922 -1.671 . . . . 0.57 108.922 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.728 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 96.77 -15.78 62.09 Favored Glycine 0 C--N 1.37 2.468 0 CA-C-O 124.701 2.279 . . . . 0.57 109.044 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -73.72 144.22 45.82 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.531 -1.334 . . . . 0.91 110.864 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -125.76 152.62 45.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.57 111.114 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -134.04 132.45 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.874 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -121.04 147.26 45.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.57 110.907 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' OD2' HG23 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.97 83.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.91 110.881 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.4 -46.81 78.58 Favored 'General case' 0 C--N 1.375 1.682 0 N-CA-C 105.327 -2.101 . . . . 0.91 105.327 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -44.3 -43.43 7.42 Favored 'General case' 0 C--N 1.372 1.544 0 O-C-N 126.092 2.12 . . . . 0.91 109.706 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -49.23 173.92 0.02 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 125.53 2.586 . . . . 0.91 113.971 172.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.446 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 16.2 m-85 -113.28 95.08 5.19 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.388 -2.187 . . . . 0.57 112.412 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.575 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 35.5 m95 -75.63 132.39 40.58 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.218 -1.81 . . . . 0.57 106.95 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.3 p -110.86 103.26 11.75 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 124.908 2.289 . . . . 0.57 109.038 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 69.5 p -104.13 106.88 17.54 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 114.096 -1.411 . . . . 0.57 110.122 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 171.46 -59.46 0.01 OUTLIER 'General case' 0 C--N 1.383 2.047 0 CA-C-N 113.222 -1.808 . . . . 0.57 107.333 177.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.42 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 0.5 OUTLIER 158.18 58.88 0.0 OUTLIER 'General case' 0 C--N 1.391 2.372 0 O-C-N 127.772 3.17 . . . . 0.57 110.992 -171.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.3 -88.1 0.3 Allowed Glycine 0 C--N 1.382 3.129 0 C-N-CA 117.082 -2.485 . . . . 0.57 113.442 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.97 -108.23 3.19 Favored Glycine 0 C--N 1.383 3.14 0 CA-C-O 126.984 3.547 . . . . 0.57 112.787 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.565 HG22 ' OH ' ' A' ' 240' ' ' TYR . 1.4 p -66.63 119.33 11.56 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 111.744 -2.228 . . . . 0.57 111.512 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.17 143.34 43.37 Favored 'General case' 0 C--N 1.373 1.614 0 CA-C-N 113.758 -1.565 . . . . 0.57 109.702 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -73.43 -25.12 60.38 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-N 112.728 -2.033 . . . . 0.57 107.276 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.897 ' O ' HG23 ' A' ' 217' ' ' VAL . 12.4 t80 -58.47 -49.16 78.33 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 113.926 -1.488 . . . . 0.57 110.823 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -54.97 -50.96 67.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.57 110.976 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -67.22 -37.65 83.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.57 111.121 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.93 91.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.57 111.093 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 213' ' ' PHE . 7.8 t -65.14 -40.17 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.57 111.111 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -72.08 -37.55 69.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.57 110.892 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -42.07 97.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.91 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.655 HD12 ' HB1' ' A' ' 137' ' ' ALA . 64.6 mt -70.0 -38.98 76.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.57 111.134 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.18 93.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.57 112.481 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.4 OUTLIER -63.97 -43.17 96.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.57 110.844 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -38.07 72.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.886 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -47.11 -42.93 19.99 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 118.452 -1.299 . . . . 0.57 111.007 -172.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 127.25 33.46 0.62 Allowed Glycine 0 C--N 1.385 3.265 0 CA-C-N 112.33 -2.213 . . . . 0.57 109.449 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.643 HD23 ' OH ' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -102.34 177.35 4.9 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-O 123.523 1.63 . . . . 0.57 109.355 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -136.08 23.39 3.35 Favored Glycine 0 C--N 1.381 3.082 0 CA-C-N 112.679 -2.055 . . . . 0.57 110.526 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.2 OUTLIER 62.68 177.07 0.14 Allowed 'General case' 0 C--N 1.395 2.546 0 CA-C-N 113.056 -1.572 . . . . 0.57 110.041 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.5 p -103.85 -23.59 13.37 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 113.206 -1.815 . . . . 0.57 111.17 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 81.39 21.39 0.35 Allowed 'General case' 0 C--N 1.385 2.134 0 O-C-N 125.683 1.864 . . . . 0.57 112.627 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.9 143.68 45.39 Favored Pre-proline 0 C--N 1.392 2.419 0 N-CA-C 103.216 -2.883 . . . . 0.91 103.216 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.82 66.49 6.71 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.444 2.763 . . . . 0.57 111.005 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 -35.44 0.01 OUTLIER 'General case' 0 C--N 1.362 1.142 0 CA-C-N 113.537 -1.665 . . . . 0.57 112.699 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -70.05 114.63 8.4 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 113.724 -1.58 . . . . 0.57 112.141 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 235' ' ' VAL . 5.1 t -53.2 88.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 CA-C-N 112.907 -1.951 . . . . 0.57 112.17 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER 159.13 -29.33 0.0 OUTLIER 'General case' 0 C--N 1.367 1.347 0 CA-C-N 115.033 -0.985 . . . . 0.57 111.747 -174.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 9.2 p90 -45.61 143.99 2.75 Favored Pre-proline 0 C--N 1.372 1.55 0 CA-C-N 113.915 -1.493 . . . . 0.57 110.65 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.416 ' O ' ' H14' ' A' ' 269' ' ' HSI . 55.9 Cg_exo -59.54 -38.08 84.94 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 120.54 0.826 . . . . 0.57 111.911 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.464 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.4 m -40.49 113.51 0.37 Allowed 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.596 1.665 . . . . 0.57 111.383 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.693 ' OH ' HD13 ' A' ' 181' ' ' LEU . 2.6 t80 -76.66 133.83 39.46 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 112.603 -2.09 . . . . 0.57 105.909 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.723 ' HD3' ' H33' ' A' ' 269' ' ' HSI . 1.2 tmtt? -175.53 98.24 0.07 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 124.267 1.984 . . . . 0.57 108.815 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -61.12 127.88 33.68 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 124.1 1.905 . . . . 0.57 110.973 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -9.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.365 1.282 0 CA-C-N 113.022 -1.899 . . . . 0.57 112.267 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER 75.85 -3.64 2.53 Favored 'General case' 0 C--N 1.384 2.088 0 O-C-N 126.605 2.441 . . . . 0.91 110.865 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 213' ' ' PHE . 2.4 mt 83.0 5.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.696 0 CA-C-N 114.525 -1.216 . . . . 0.57 113.105 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 0.4 OUTLIER -81.3 -36.6 29.61 Favored 'General case' 0 C--N 1.385 2.126 0 N-CA-C 102.713 -3.069 . . . . 0.57 102.713 -165.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.7 p -116.92 -4.68 11.52 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 113.164 -1.835 . . . . 0.57 114.023 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 217' ' ' VAL . 30.9 t80 -56.02 91.48 0.01 OUTLIER 'General case' 0 C--N 1.373 1.594 0 CA-C-O 124.312 2.006 . . . . 0.57 109.485 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.45 151.7 51.82 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 112.434 -2.167 . . . . 1.2 106.675 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 250' ' ' LEU . 0.6 OUTLIER -124.17 127.59 47.98 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 125.082 2.372 . . . . 0.57 104.936 -171.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 147.22 46.87 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 113.666 -1.606 . . . . 0.57 111.896 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.37 93.07 Favored 'General case' 0 C--N 1.388 2.239 0 CA-C-N 113.218 -1.81 . . . . 0.57 108.7 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -37.28 85.35 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-N 115.516 -0.765 . . . . 0.91 110.862 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 258' ' ' ILE . 3.6 t0 -64.22 -55.02 24.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.91 110.846 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 12.9 pt -66.1 -34.78 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.57 111.125 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 31.3 mtp180 -70.08 -30.12 67.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.841 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.74 -41.51 49.78 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 0.57 112.471 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 254' ' ' ASP . 0.6 OUTLIER -68.09 -42.66 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.57 111.089 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.691 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -71.97 -27.26 62.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.97 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 t -66.71 -32.85 74.43 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 124.121 1.915 . . . . 0.57 108.784 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt -48.3 -67.32 0.28 Allowed 'General case' 0 C--N 1.384 2.088 0 CA-C-O 124.045 1.879 . . . . 0.57 110.686 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.643 ' OH ' HD23 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -105.07 74.44 1.11 Allowed 'General case' 0 C--N 1.367 1.335 0 CA-C-N 113.164 -1.835 . . . . 0.57 112.9 178.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 3.471 0 CA-C-O 114.973 -3.126 . . . . 0.91 117.919 -172.696 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.723 ' H33' ' HD3' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.605 0 CA-C-O 121.367 0.426 . . . . 0.57 112.063 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 96.03 0.9 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.734 1.623 . . . . 0.57 112.187 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 p -117.19 134.65 60.09 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 CA-C-O 122.743 1.259 . . . . 0.57 110.143 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.11 162.67 13.42 Favored 'General case' 0 C--N 1.366 1.296 0 CA-C-O 123.244 1.497 . . . . 0.57 111.387 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.08 143.94 12.69 Favored 'General case' 0 C--N 1.369 1.447 0 CA-C-N 114.726 -1.125 . . . . 1.2 109.172 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.05 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.373 1.63 0 CA-C-O 123.044 1.402 . . . . 0.57 110.437 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.733 ' HA ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 -68.1 -17.3 64.33 Favored 'General case' 0 C--N 1.375 1.687 0 CA-C-N 113.929 -1.487 . . . . 0.57 110.438 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.98 106.65 14.67 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.456 -1.247 . . . . 0.57 110.938 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.44 155.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.57 111.119 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.1 p -134.53 159.96 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.57 111.143 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.668 ' CE2' ' CE2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -140.26 160.08 40.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.935 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -139.11 121.96 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 1.2 110.873 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -78.13 117.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.57 111.14 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -36.97 -60.18 0.65 Allowed 'General case' 0 C--N 1.351 0.649 0 CA-C-N 116.116 -0.493 . . . . 0.57 109.972 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 157.16 33.67 0.0 OUTLIER 'General case' 0 C--N 1.37 1.478 0 O-C-N 125.938 2.024 . . . . 0.57 111.204 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 2.4 m-30 73.54 -170.96 0.12 Allowed 'General case' 0 C--N 1.374 1.641 0 CA-C-N 114.65 -1.159 . . . . 0.57 108.13 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.5 149.79 58.52 Favored Pre-proline 0 C--N 1.364 1.204 0 CA-C-O 122.34 1.066 . . . . 0.57 109.068 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.58 -55.03 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.463 1.442 . . . . 0.57 112.764 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -63.25 -48.72 77.01 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.3 1.048 . . . . 0.91 112.573 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 212' ' ' LEU . 3.6 ttm -83.15 142.11 31.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.484 2.087 . . . . 0.57 111.471 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.85 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.1 m-80 -70.68 135.89 48.65 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 120.324 -1.485 . . . . 0.57 109.869 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.504 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.96 -51.21 57.97 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.087 -0.708 . . . . 1.2 109.087 -173.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -34.89 61.7 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-N 113.615 -1.63 . . . . 0.91 110.917 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.02 -44.04 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.91 110.893 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -62.33 -38.75 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.182 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.61 -43.17 81.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.91 110.866 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -47.7 76.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.57 110.905 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.97 -48.24 78.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.57 111.033 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.5 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.2 mm -61.85 -35.81 70.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.57 111.146 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -64.56 -48.05 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 1.2 110.854 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HB3' ' CD1' ' A' ' 213' ' ' PHE . 0.0 OUTLIER -62.88 -38.59 91.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.57 110.872 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.07 94.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.57 111.064 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.668 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 15.3 m-85 -64.21 -34.12 77.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.906 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -67.74 -41.13 83.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.859 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.706 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -69.7 -34.0 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.57 111.105 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.458 ' CZ2' ' HA3' ' A' ' 221' ' ' GLY . 7.3 m95 -82.95 -34.04 26.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.57 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.47 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 49.1 m -79.27 -48.87 13.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.57 110.852 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.677 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.5 p-10 -59.83 -12.99 8.62 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.838 0.828 . . . . 0.57 111.965 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.793 HG11 HG21 ' A' ' 255' ' ' ILE . 20.6 m -115.32 3.29 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.751 -1.113 . . . . 0.57 112.127 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.91 148.86 40.56 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 124.105 1.907 . . . . 0.57 110.418 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.18 -32.22 6.95 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 120.862 1.041 . . . . 0.57 112.509 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.733 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.3 mt -56.27 109.63 0.63 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 122.771 1.272 . . . . 0.57 109.531 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 157.39 33.5 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.494 -1.23 . . . . 0.57 111.77 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.697 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 10.8 m-85 -127.57 149.05 50.33 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-N 113.671 -1.604 . . . . 0.57 109.19 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.39 121.19 6.02 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-O 123.605 1.669 . . . . 0.57 109.792 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 21.0 tttp -92.52 145.89 24.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 120.674 -1.266 . . . . 0.57 110.834 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.3 pt -128.53 129.02 68.69 Favored 'Isoleucine or valine' 0 C--N 1.372 1.544 0 CA-C-O 123.325 1.536 . . . . 0.57 109.546 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -73.95 -55.46 6.13 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.147 0.975 . . . . 0.57 110.773 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.99 113.18 25.36 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 114.575 -1.193 . . . . 0.57 110.781 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.27 164.5 19.23 Favored Glycine 0 C--N 1.37 2.466 0 CA-C-N 114.894 -1.048 . . . . 0.57 112.123 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.9 ttt -88.28 131.75 34.66 Favored 'General case' 0 C--N 1.371 1.523 0 CA-C-O 122.192 0.996 . . . . 0.57 111.085 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.53 175.02 6.37 Favored 'General case' 0 C--N 1.366 1.298 0 CA-C-N 114.423 -1.262 . . . . 0.57 110.856 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.44 -46.47 89.94 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 106.432 -1.692 . . . . 0.91 106.432 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 193' ' ' GLY . 1.8 mt -113.88 109.93 30.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 114.733 -1.121 . . . . 0.57 111.166 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 162' ' ' VAL . 0.2 OUTLIER -98.79 120.99 40.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.975 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.758 HG12 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -102.34 116.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.57 111.171 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.736 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.93 146.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.101 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.566 ' CD2' ' CD1' ' A' ' 197' ' ' PHE . 0.5 OUTLIER -98.68 122.76 42.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.57 110.887 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.795 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -144.97 168.45 20.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.242 1.02 . . . . 0.57 109.929 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 166.25 10.91 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.547 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -30.62 105.37 0.01 OUTLIER Glycine 0 C--N 1.375 2.71 0 O-C-N 124.288 0.993 . . . . 0.57 113.246 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 80.56 93.55 0.05 OUTLIER 'General case' 0 C--N 1.391 2.402 0 CA-C-O 124.741 2.21 . . . . 0.57 113.338 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.795 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 1.2 p-80 -126.51 -95.08 0.45 Allowed 'General case' 0 C--N 1.371 1.506 0 CA-C-N 113.729 -1.578 . . . . 0.57 110.693 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.31 -76.34 1.22 Allowed Glycine 0 C--N 1.375 2.716 0 N-CA-C 111.485 -0.646 . . . . 0.57 111.485 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.07 -41.21 1.2 Allowed 'General case' 0 C--N 1.361 1.072 0 CA-C-N 114.874 -0.663 . . . . 0.91 110.558 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.7 t80 81.53 68.73 0.02 OUTLIER 'General case' 0 C--N 1.385 2.136 0 CA-C-O 124.878 2.275 . . . . 0.57 105.545 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -142.34 11.5 1.93 Allowed 'General case' 0 C--N 1.37 1.462 0 CA-C-N 113.596 -1.638 . . . . 0.57 110.862 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.8 113.37 0.02 OUTLIER 'General case' 0 C--N 1.383 2.023 0 CA-C-O 124.484 2.088 . . . . 0.57 109.644 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.448 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -99.78 -160.36 0.8 Allowed 'General case' 0 C--N 1.362 1.145 0 CA-C-N 114.145 -1.388 . . . . 0.57 112.027 177.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.503 ' CB ' ' CG1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -113.13 139.36 48.8 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-N 115.23 -0.895 . . . . 0.91 110.85 176.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -100.16 92.47 1.11 Allowed Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.426 -1.261 . . . . 0.57 112.798 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER 69.95 50.07 0.48 Allowed 'General case' 0 C--N 1.377 1.779 0 CA-C-O 122.596 1.189 . . . . 0.57 112.132 175.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 176.13 19.99 Favored Glycine 0 C--N 1.357 1.695 0 N-CA-C 108.217 -1.953 . . . . 0.57 108.217 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 240' ' ' TYR . . . -44.46 -33.57 3.2 Favored Glycine 0 C--N 1.379 2.952 0 CA-C-O 122.198 0.888 . . . . 0.57 112.252 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 180' ' ' ILE . 3.1 mm -45.24 168.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 O-C-N 121.556 -0.967 . . . . 0.57 111.722 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -148.17 -39.09 0.18 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.86 0.838 . . . . 0.57 110.102 177.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.46 ' O ' H402 ' A' ' 269' ' ' HSI . . . -176.63 179.94 1.07 Allowed 'General case' 0 C--N 1.363 1.176 0 CA-C-N 115.32 -0.855 . . . . 0.57 111.042 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.426 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -153.35 141.86 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.57 110.889 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.14 152.42 33.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.57 111.142 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.725 -0.67 . . . . 0.57 109.551 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 -151.56 7.98 Favored Glycine 0 C--N 1.367 2.255 0 CA-C-N 114.996 -1.002 . . . . 0.57 110.905 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.33 88.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.707 2.272 . . . . 0.57 112.958 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.25 118.11 1.32 Allowed Glycine 0 C--N 1.37 2.436 0 N-CA-C 109.501 -1.44 . . . . 0.57 109.501 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -61.93 104.79 0.49 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.303 1.049 . . . . 0.57 109.73 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.12 -101.59 1.01 Allowed Glycine 0 C--N 1.377 2.815 0 CA-C-N 114.965 -1.016 . . . . 0.57 112.491 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.15 -37.61 77.82 Favored 'Isoleucine or valine' 0 C--N 1.375 1.691 0 CA-C-O 122.84 1.305 . . . . 0.57 109.36 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.58 126.15 15.67 Favored Glycine 0 C--N 1.369 2.378 0 CA-C-O 122.696 1.165 . . . . 0.57 110.579 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 106.95 -49.82 0.84 Allowed Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.844 -0.678 . . . . 0.57 111.483 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 194' ' ' ASP . 1.0 OUTLIER -45.45 107.61 0.1 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 120.86 0.362 . . . . 0.91 110.88 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -104.31 142.17 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.063 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.736 ' CD2' HG22 ' A' ' 162' ' ' VAL . 16.3 m170 -134.87 135.83 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.57 110.827 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.758 ' CE2' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -105.22 150.21 25.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.923 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.5 p30 -83.37 93.07 7.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.91 110.865 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.96 80.07 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.991 -0.744 . . . . 0.91 108.991 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -36.22 -45.07 0.43 Allowed 'General case' 0 C--N 1.363 1.194 0 CA-C-O 122.464 1.126 . . . . 0.91 110.053 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 177' ' ' LYS . 8.5 pt-20 -56.54 -176.19 0.01 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-O 125.218 2.437 . . . . 0.91 113.225 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -112.28 89.95 3.21 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.115 -1.616 . . . . 0.57 111.185 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.65 ' HH2' HG21 ' A' ' 215' ' ' THR . 49.1 m95 -71.93 142.84 49.45 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 114.195 -1.366 . . . . 0.57 109.164 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -125.73 126.56 44.81 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-O 123.047 1.403 . . . . 0.57 109.727 -177.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.8 p -103.89 111.58 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.387 -1.279 . . . . 0.57 108.29 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 83.46 65.36 0.02 OUTLIER 'General case' 0 C--N 1.386 2.191 0 CA-C-N 114.386 -1.279 . . . . 0.57 108.867 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.62 124.37 0.03 OUTLIER 'General case' 0 C--N 1.383 2.052 0 CA-C-O 124.532 2.11 . . . . 0.57 108.869 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 204' ' ' THR . . . 149.61 -12.4 1.01 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 120.537 -1.352 . . . . 0.57 112.611 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.83 -115.08 0.64 Allowed Glycine 0 C--N 1.375 2.734 0 CA-C-O 122.955 1.309 . . . . 0.57 110.919 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.739 HG22 ' OH ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -99.18 119.58 38.1 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-O 123.549 1.642 . . . . 0.57 108.059 -175.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.525 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.2 p30 -91.07 142.13 28.09 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-N 114.252 -1.34 . . . . 0.57 110.39 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -63.32 -27.72 69.52 Favored 'General case' 0 C--N 1.375 1.714 0 CA-C-O 124.596 2.141 . . . . 0.57 107.695 -175.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 217' ' ' VAL . 32.8 t80 -59.67 -50.0 75.56 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.346 -1.297 . . . . 0.57 110.886 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -62.13 -41.97 98.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.57 110.917 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.65 HG21 ' HH2' ' A' ' 203' ' ' TRP . 94.3 m -65.11 -45.01 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.57 111.157 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -63.13 -36.66 84.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.57 111.085 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 213' ' ' PHE . 59.7 t -65.87 -41.0 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.57 111.118 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -72.05 -51.08 23.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.57 110.861 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -62.13 -39.96 94.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.91 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.582 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.7 mm -70.18 -47.21 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.57 111.142 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.75 -34.26 64.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.57 112.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 1.1 m-70 -67.82 -36.07 79.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.57 110.814 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -49.33 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.57 110.888 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.4 pp -97.66 -58.62 1.95 Allowed 'General case' 0 C--N 1.353 0.751 0 N-CA-C 113.96 1.096 . . . . 0.57 113.96 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.807 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -43.69 159.28 0.1 Allowed Glycine 0 C--N 1.365 2.145 0 CA-C-O 125.211 2.562 . . . . 0.57 110.936 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -81.12 -67.68 0.76 Allowed 'General case' 0 C--N 1.364 1.226 0 CA-C-N 113.195 -1.502 . . . . 0.57 108.735 -174.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.18 39.0 Favored Glycine 0 C--N 1.368 2.358 0 CA-C-O 123.298 1.499 . . . . 0.57 110.595 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 1.1 m-70 -91.11 165.38 13.53 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-N 113.891 -1.154 . . . . 0.57 110.218 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -84.04 -8.63 59.07 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 114.438 -1.255 . . . . 0.57 110.682 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.84 1.14 2.48 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 122.886 1.327 . . . . 0.57 111.97 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 145.44 57.07 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 114.542 -1.208 . . . . 0.91 109.115 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.45 -44.97 37.59 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 121.717 1.611 . . . . 0.57 112.072 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -32.49 0.19 Allowed 'General case' 0 C--N 1.371 1.525 0 CA-C-N 115.297 -0.865 . . . . 0.57 113.237 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.19 136.73 48.22 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 124.383 2.039 . . . . 0.57 114.81 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -73.76 -23.45 19.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 124.043 1.878 . . . . 0.57 111.102 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.492 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -84.08 8.88 14.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.464 -1.698 . . . . 0.57 111.183 -178.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 5.3 t80 -51.81 142.56 24.37 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-O 123.211 1.481 . . . . 0.57 110.601 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 47.4 Cg_endo -78.56 -45.46 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.389 1.393 . . . . 0.57 112.256 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.3 m -57.99 138.01 56.29 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.524 1.154 . . . . 0.57 110.27 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.739 ' OH ' HG22 ' A' ' 210' ' ' THR . 2.5 t80 -75.42 154.14 37.28 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-N 114.052 -1.431 . . . . 0.57 108.652 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 46.2 tttt 178.63 106.34 0.03 OUTLIER 'General case' 0 C--N 1.378 1.838 0 CA-C-O 122.462 1.125 . . . . 0.57 108.796 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -55.19 121.22 8.34 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 124.08 1.895 . . . . 0.57 110.153 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.9 m -125.86 -14.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-N 114.195 -1.366 . . . . 0.57 110.804 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 1.4 p30 60.21 18.23 7.68 Favored 'General case' 0 C--N 1.369 1.453 0 O-C-N 124.31 1.006 . . . . 0.91 111.98 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.544 HG12 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mt 79.05 -10.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.672 0 CA-C-N 114.91 -1.041 . . . . 0.57 113.423 -175.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -41.35 99.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.773 -1.566 . . . . 0.57 106.773 -171.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -15.43 14.4 Favored 'General case' 0 C--N 1.373 1.627 0 N-CA-C 114.572 1.323 . . . . 0.57 114.572 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.535 ' CE1' ' CG2' ' A' ' 235' ' ' VAL . 17.2 t80 -53.48 87.29 0.0 OUTLIER 'General case' 0 C--N 1.366 1.323 0 CA-C-O 123.566 1.651 . . . . 0.57 110.563 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.434 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.49 149.2 45.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.452 -1.249 . . . . 1.2 109.172 -178.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -113.38 131.9 55.81 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-O 123.75 1.738 . . . . 0.57 108.664 -176.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.68 134.39 52.16 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 120.413 -1.429 . . . . 0.57 110.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.64 -42.24 83.03 Favored 'General case' 0 C--N 1.373 1.605 0 CA-C-N 115.009 -0.996 . . . . 0.57 109.507 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -41.29 97.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.954 -0.567 . . . . 0.91 110.79 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.6 -55.27 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.91 110.898 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.793 HG21 HG11 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -66.24 -38.35 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.57 111.173 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.642 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.9 mtt180 -68.51 -29.91 68.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.869 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -69.62 -47.92 46.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.57 112.476 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 144' ' ' VAL . 1.1 pt -63.58 -43.18 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 0.57 111.117 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.47 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.07 -34.64 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.57 110.906 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.5 t -74.44 -15.68 60.9 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 122.18 0.99 . . . . 0.57 110.915 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 261' ' ' LEU . 10.5 mt -71.24 -87.38 0.02 OUTLIER 'General case' 0 C--N 1.37 1.494 0 CA-C-O 123.676 1.703 . . . . 0.57 110.903 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.02 0.79 49.3 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-N 114.607 -1.178 . . . . 0.57 112.776 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 2.131 0 N-CA-C 117.778 1.871 . . . . 0.91 117.778 173.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.46 H402 ' O ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.708 0 N-CA-C 111.737 -0.545 . . . . 0.57 111.737 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.44 158.05 1.88 Allowed 'Trans proline' 0 C--N 1.391 2.773 0 O-C-N 123.681 1.359 . . . . 0.57 112.122 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.74 132.99 68.46 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.57 108.673 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -177.52 118.87 0.1 Allowed 'General case' 0 C--N 1.38 1.904 0 CA-C-O 123.364 1.554 . . . . 0.57 108.392 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -134.81 158.03 45.25 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-N 114.107 -1.406 . . . . 1.2 109.579 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -156.04 55.73 0.59 Allowed 'General case' 0 C--N 1.391 2.38 0 CA-C-O 123.927 1.822 . . . . 0.57 108.671 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -166.8 -43.51 0.02 OUTLIER 'General case' 0 C--N 1.381 1.96 0 CA-C-N 113.895 -1.502 . . . . 0.57 109.719 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' C ' HD13 ' A' ' 114' ' ' ILE . 1.3 t80 -113.68 105.52 13.4 Favored 'General case' 0 C--N 1.367 1.338 0 CA-C-N 115.049 -0.978 . . . . 0.57 110.905 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.711 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -99.13 155.0 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.15 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.506 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 20.7 p -116.68 135.22 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.57 111.091 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -128.43 139.01 52.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.57 110.961 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -122.87 121.98 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.2 110.923 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -82.58 133.15 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.57 111.121 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.755 ' HB2' HG13 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -49.32 -63.0 1.23 Allowed 'General case' 0 C--N 1.372 1.575 0 N-CA-C 107.908 -1.145 . . . . 0.57 107.908 -173.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 161.04 32.45 0.0 OUTLIER 'General case' 0 C--N 1.391 2.397 0 CA-C-N 113.6 -1.637 . . . . 0.57 110.608 -169.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.7 m-85 63.28 -151.1 0.33 Allowed 'General case' 0 C--N 1.386 2.189 0 N-CA-C 106.926 -1.509 . . . . 0.57 106.926 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.608 HG21 ' OE1' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -176.23 166.7 1.61 Allowed Pre-proline 0 C--N 1.38 1.894 0 CA-C-O 123.313 1.53 . . . . 0.57 109.616 -175.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.601 ' HD2' HG22 ' A' ' 122' ' ' THR . 31.5 Cg_endo -70.59 -42.38 2.59 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 120.865 1.043 . . . . 0.57 112.049 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.43 -34.95 35.7 Favored 'General case' 0 C--N 1.38 1.893 0 CA-C-N 114.591 -1.186 . . . . 0.91 112.779 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.3 ttm -93.14 111.86 23.63 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-O 125.67 2.652 . . . . 0.57 109.068 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.26 141.74 54.31 Favored 'General case' 0 C--N 1.384 2.074 0 CA-C-N 113.272 -1.786 . . . . 0.57 109.118 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.14 -51.41 58.1 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.446 -1.316 . . . . 1.2 107.446 -170.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -54.41 -34.76 61.95 Favored 'General case' 0 C--N 1.39 2.345 0 CA-C-N 113.06 -1.882 . . . . 0.91 110.948 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.35 -44.01 69.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.91 110.892 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -61.46 -43.09 96.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.57 111.122 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -66.45 -44.1 83.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.91 110.872 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -49.09 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.57 110.885 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.67 84.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.122 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.1 mm -67.44 -32.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.57 111.126 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -65.51 -48.1 73.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.2 110.88 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.28 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.57 111.136 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.533 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 6.7 m-85 -67.01 -33.87 76.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.57 110.912 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -68.6 -42.08 78.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.57 110.928 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -69.43 -34.17 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.57 111.172 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.725 ' O ' HG22 ' A' ' 145' ' ' THR . 3.7 m95 -83.02 -34.16 26.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.57 110.912 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.9 m -78.78 -50.46 11.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.883 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.662 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.7 p-10 -57.4 -13.51 3.57 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 113.255 0.835 . . . . 0.57 113.255 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 140' ' ' VAL . 21.6 m -114.99 -11.11 12.14 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-N 114.517 -1.22 . . . . 0.57 111.375 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -135.81 149.03 67.62 Favored Pre-proline 0 C--N 1.371 1.541 0 CA-C-O 125.517 2.58 . . . . 0.57 109.057 -177.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.37 44.44 1.63 Allowed 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.611 2.208 . . . . 0.57 112.25 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 145' ' ' THR . 0.6 OUTLIER -140.75 89.28 2.25 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 105.649 -1.982 . . . . 0.57 105.649 -173.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -69.43 157.72 36.54 Favored 'General case' 0 C--N 1.38 1.921 0 CA-C-O 125.12 2.391 . . . . 0.57 114.538 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CG ' ' CE1' ' A' ' 138' ' ' PHE . 72.7 m-85 -126.28 155.52 41.79 Favored 'General case' 0 C--N 1.387 2.222 0 CA-C-N 112.879 -1.964 . . . . 0.57 108.903 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 124.62 7.31 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-O 125.302 2.477 . . . . 0.57 107.101 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.505 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 33.2 tttt -82.82 145.38 29.52 Favored 'General case' 0 C--N 1.379 1.861 0 CA-C-N 113.626 -1.624 . . . . 0.57 111.005 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.81 HD12 HG22 ' A' ' 154' ' ' THR . 8.4 pt -135.78 172.37 15.76 Favored 'Isoleucine or valine' 0 C--N 1.38 1.911 0 CA-C-O 123.641 1.686 . . . . 0.57 109.321 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -125.95 29.26 5.93 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-O 123.819 1.771 . . . . 0.57 110.597 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.81 HG22 HD12 ' A' ' 152' ' ' ILE . 1.1 t -80.79 -170.46 2.67 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-N 114.217 -1.356 . . . . 0.57 111.025 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 154' ' ' THR . . . -49.44 -55.24 13.6 Favored Glycine 0 C--N 1.391 3.62 0 CA-C-N 113.812 -1.54 . . . . 0.57 110.929 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.89 138.9 9.6 Favored 'General case' 0 C--N 1.379 1.86 0 N-CA-C 107.663 -1.236 . . . . 0.57 107.663 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -104.07 172.46 6.79 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-N 113.79 -1.55 . . . . 0.57 110.874 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -49.99 -65.45 0.56 Allowed 'General case' 0 C--N 1.38 1.924 0 CA-C-N 113.614 -1.63 . . . . 0.91 106.919 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 193' ' ' GLY . 6.9 mt -97.97 110.06 24.88 Favored 'Isoleucine or valine' 0 C--N 1.371 1.527 0 O-C-N 121.802 -0.561 . . . . 0.57 111.13 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.752 HD23 ' HB3' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -95.34 120.99 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.57 110.887 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.732 HG12 ' CE1' ' A' ' 197' ' ' PHE . 0.1 OUTLIER -104.45 118.12 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.115 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -133.12 146.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.57 111.149 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.68 120.65 42.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.57 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.9 167.26 26.19 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 123.242 1.496 . . . . 0.57 108.214 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 169.26 8.57 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 115.06 -0.973 . . . . 1.2 109.926 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -41.79 133.68 3.72 Favored Glycine 0 C--N 1.387 3.381 0 CA-C-N 114.13 -1.396 . . . . 0.57 109.623 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 85.32 45.14 0.02 OUTLIER 'General case' 0 C--N 1.4 2.792 0 CA-C-O 124.191 1.948 . . . . 0.57 111.203 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -104.41 -57.2 2.07 Favored 'General case' 0 C--N 1.379 1.877 0 CA-C-N 113.512 -1.676 . . . . 0.57 110.978 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.82 -165.7 32.7 Favored Glycine 0 C--N 1.376 2.788 0 N-CA-C 108.925 -1.67 . . . . 0.57 108.925 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.92 93.89 0.06 Allowed 'General case' 0 C--N 1.4 2.767 0 CA-C-O 123.906 1.812 . . . . 0.91 107.701 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 69.19 -97.11 0.03 OUTLIER 'General case' 0 C--N 1.376 1.734 0 CA-C-N 114.095 -1.411 . . . . 0.57 110.138 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -122.46 -132.7 0.28 Allowed 'General case' 0 C--N 1.383 2.047 0 CA-C-O 124.252 1.977 . . . . 0.57 109.482 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.82 179.2 4.34 Favored 'General case' 0 C--N 1.381 1.971 0 CA-C-O 123.433 1.587 . . . . 0.57 110.211 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.544 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 1.4 m-85 -119.84 -173.08 2.47 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.95 -1.932 . . . . 0.57 110.36 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.24 -178.66 3.51 Favored 'General case' 0 C--N 1.377 1.789 0 CA-C-N 113.044 -1.889 . . . . 0.91 112.862 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.73 150.22 21.06 Favored Glycine 0 C--N 1.385 3.285 0 CA-C-N 113.47 -1.696 . . . . 0.57 109.029 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.24 8.33 5.26 Favored 'General case' 0 C--N 1.376 1.748 0 CA-C-O 122.721 1.248 . . . . 0.57 111.617 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 159.22 -104.53 0.25 Allowed Glycine 0 C--N 1.378 2.9 0 CA-C-O 122.869 1.261 . . . . 0.57 110.185 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.31 -126.15 35.92 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-O 123.635 1.686 . . . . 0.57 110.388 176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 181' ' ' LEU . 2.3 pp -79.03 -173.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.876 0 CA-C-N 113.745 -1.227 . . . . 0.57 109.557 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.801 HD22 ' CE1' ' A' ' 240' ' ' TYR . 9.4 tp -109.83 -37.1 5.73 Favored 'General case' 0 C--N 1.377 1.765 0 N-CA-C 115.763 1.764 . . . . 0.57 115.763 170.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 215' ' ' THR . . . -178.78 179.84 0.68 Allowed 'General case' 0 C--N 1.384 2.083 0 CA-C-N 113.787 -1.551 . . . . 0.57 111.117 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 4.9 p80 -161.59 136.04 7.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.57 110.848 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -135.02 144.21 47.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.57 111.108 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -79.56 175.88 10.21 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-O 123.244 1.497 . . . . 0.57 109.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.84 -173.39 40.63 Favored Glycine 0 C--N 1.383 3.172 0 CA-C-O 123.158 1.421 . . . . 0.57 111.312 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.52 71.83 3.79 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.56 2.173 . . . . 0.57 111.506 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.13 -123.03 1.0 Allowed Glycine 0 C--N 1.382 3.087 0 CA-C-O 123.931 1.85 . . . . 0.57 110.184 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.0 m -125.41 -62.89 1.18 Allowed 'General case' 0 C--N 1.392 2.417 0 CA-C-O 123.386 1.565 . . . . 0.57 108.205 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.06 -71.3 0.7 Allowed Glycine 0 C--N 1.394 3.802 0 N-CA-C 108.861 -1.696 . . . . 0.57 108.861 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.76 56.15 Favored 'Isoleucine or valine' 0 C--N 1.384 2.1 0 CA-C-O 125.815 2.721 . . . . 0.57 108.885 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.3 134.94 29.12 Favored Glycine 0 C--N 1.393 3.746 0 N-CA-C 106.562 -2.615 . . . . 0.57 106.562 -172.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 102.37 -19.8 47.02 Favored Glycine 0 C--N 1.368 2.308 0 N-CA-C 110.172 -1.171 . . . . 0.57 110.172 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 160' ' ' LEU . 1.1 m-20 -73.96 124.86 26.99 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.993 -1.298 . . . . 0.91 110.922 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -107.3 142.09 37.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.57 111.083 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -124.69 129.39 50.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.57 110.925 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.732 ' CE1' HG12 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -108.62 150.18 27.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.57 110.919 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -79.5 91.25 5.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.91 110.887 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 122' ' ' THR . 9.9 tp10 -64.74 -47.51 77.96 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-N 114.977 -1.01 . . . . 0.91 108.815 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.51 -44.9 0.06 Allowed 'General case' 0 C--N 1.374 1.633 0 CA-C-O 122.566 1.174 . . . . 0.91 111.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 203' ' ' TRP . 1.4 mp0 -62.58 -178.14 0.18 Allowed 'General case' 0 C--N 1.382 1.999 0 CA-C-O 127.219 3.39 . . . . 0.91 106.948 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.24 78.0 1.18 Allowed 'General case' 0 C--N 1.379 1.848 0 O-C-N 118.664 -2.522 . . . . 0.57 108.241 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.72 ' CH2' HD12 ' A' ' 181' ' ' LEU . 21.4 m95 -74.0 143.16 45.7 Favored 'General case' 0 C--N 1.376 1.744 0 CA-C-N 113.827 -1.533 . . . . 0.57 109.154 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 60.6 p -114.2 123.35 49.36 Favored 'General case' 0 C--N 1.377 1.8 0 CA-C-O 124.349 2.023 . . . . 0.57 108.905 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.1 p -96.11 111.68 23.64 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-O 123.929 1.823 . . . . 0.57 108.497 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 77.34 48.96 0.05 Allowed 'General case' 0 C--N 1.388 2.276 0 CA-C-O 124.57 2.129 . . . . 0.57 110.626 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 t -129.09 -91.78 0.47 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 114.242 -1.345 . . . . 0.57 109.651 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 244' ' ' ASP . . . -177.91 -45.07 0.07 OUTLIER Glycine 0 C--N 1.387 3.381 0 C-N-CA 119.356 -1.402 . . . . 0.57 111.985 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.51 -133.65 0.03 OUTLIER Glycine 0 C--N 1.393 3.743 0 CA-C-O 126.708 3.393 . . . . 0.57 109.598 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.589 HG22 ' OH ' ' A' ' 240' ' ' TYR . 41.5 p -67.71 130.63 43.59 Favored 'General case' 0 C--N 1.37 1.473 0 O-C-N 119.582 -2.128 . . . . 0.57 110.945 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.834 ' CB ' HD11 ' A' ' 245' ' ' ILE . 17.2 p30 -134.09 149.52 51.11 Favored 'General case' 0 C--N 1.38 1.923 0 CA-C-N 113.338 -1.755 . . . . 0.57 108.476 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 212' ' ' LEU . 2.0 pt? -71.08 -23.92 62.22 Favored 'General case' 0 C--N 1.375 1.702 0 CA-C-O 124.836 2.255 . . . . 0.57 111.111 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -54.51 -39.29 67.45 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.506 -1.679 . . . . 0.57 110.855 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 214' ' ' LEU . 0.3 OUTLIER -55.0 -51.13 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.57 110.895 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.581 HG23 HD23 ' A' ' 181' ' ' LEU . 11.7 p -66.53 -40.41 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.131 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.79 96.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.57 111.09 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.69 HG11 ' HZ ' ' A' ' 248' ' ' PHE . 24.6 t -65.31 -40.83 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.57 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.417 ' HA ' ' SD ' ' A' ' 236' ' ' MET . 24.8 t-80 -69.29 -44.97 70.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.57 110.858 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 220' ' ' ILE . 2.5 pt-20 -59.64 -41.49 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.91 110.936 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.483 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 49.8 mt -66.48 -40.86 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.181 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.54 -33.7 87.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.57 112.441 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -43.35 96.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.847 0.356 . . . . 0.57 110.889 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -37.36 73.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.863 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 ' CE3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -45.47 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.367 1.343 0 CA-C-O 124.434 2.064 . . . . 0.57 114.26 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -158.11 -88.74 0.07 OUTLIER Glycine 0 C--N 1.377 2.828 0 C-N-CA 118.654 -1.736 . . . . 0.57 110.837 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.391 2.412 0 O-C-N 125.66 1.447 . . . . 0.57 110.581 -173.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 99.07 98.28 2.14 Favored Glycine 0 C--N 1.385 3.303 0 C-N-CA 118.894 -1.622 . . . . 0.57 110.281 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' CD2' ' HE3' ' A' ' 236' ' ' MET . 0.0 OUTLIER 63.28 172.75 0.16 Allowed 'General case' 0 C--N 1.395 2.556 0 CA-C-O 124.3 2.0 . . . . 0.57 108.188 171.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -131.61 -6.42 3.67 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 117.294 -1.762 . . . . 0.57 110.408 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.1 t 83.28 -12.25 0.87 Allowed 'General case' 0 C--N 1.391 2.397 0 CA-C-N 115.299 -0.864 . . . . 0.57 112.049 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.68 148.17 45.49 Favored Pre-proline 0 C--N 1.385 2.129 0 N-CA-C 106.135 -1.802 . . . . 0.91 106.135 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.33 -16.64 35.72 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.031 2.487 . . . . 0.57 112.273 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 1.89 2.49 Favored 'General case' 0 C--N 1.38 1.91 0 N-CA-C 116.305 1.965 . . . . 0.57 116.305 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -111.5 143.1 42.89 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-O 124.877 2.275 . . . . 0.57 108.687 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.877 ' O ' ' H28' ' A' ' 269' ' ' HSI . 0.5 OUTLIER -72.91 -11.83 15.17 Favored 'Isoleucine or valine' 0 C--N 1.382 1.985 0 CA-C-N 112.322 -2.217 . . . . 0.57 111.842 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.492 ' HE3' ' CD2' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -108.29 26.67 10.16 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-N 114.437 -1.256 . . . . 0.57 110.349 -178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.588 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 17.0 t80 -54.64 142.62 52.07 Favored Pre-proline 0 C--N 1.371 1.506 0 CA-C-O 122.292 1.044 . . . . 0.57 108.914 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.588 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 76.6 Cg_exo -54.92 -49.34 17.0 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.022 1.814 . . . . 0.57 112.762 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 m -62.9 136.03 57.63 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 123.303 1.525 . . . . 0.57 110.459 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.801 ' CE1' HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -94.21 82.96 4.17 Favored 'General case' 0 C--N 1.382 2.001 0 CA-C-O 124.521 2.105 . . . . 0.57 108.555 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 243' ' ' VAL . 1.4 tmtt? -111.69 100.14 8.72 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-O 123.711 1.72 . . . . 0.57 108.89 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -53.05 118.68 3.92 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-O 125.666 2.651 . . . . 0.57 110.629 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -96.12 11.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 CA-C-N 112.499 -2.137 . . . . 0.57 111.406 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.421 ' HB2' ' HA2' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 86.68 -16.01 0.42 Allowed 'General case' 0 C--N 1.377 1.768 0 O-C-N 125.247 1.592 . . . . 0.91 111.918 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 211' ' ' ASN . 3.6 mt 75.64 -49.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.389 2.284 0 N-CA-C 114.296 1.221 . . . . 0.57 114.296 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -46.26 -28.86 1.4 Allowed 'General case' 0 C--N 1.368 1.383 0 N-CA-C 113.395 0.887 . . . . 0.57 113.395 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 p -108.19 9.47 28.13 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-O 122.592 1.187 . . . . 0.57 111.295 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.69 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 9.9 t80 -68.01 86.54 0.25 Allowed 'General case' 0 C--N 1.377 1.775 0 CA-C-O 125.023 2.344 . . . . 0.57 108.97 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.443 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -108.63 153.51 23.3 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-O 124.748 2.213 . . . . 1.2 107.204 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.687 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.4 131.82 54.07 Favored 'General case' 0 C--N 1.381 1.938 0 CA-C-O 125.874 2.75 . . . . 0.57 105.867 -172.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 45.2 t -66.45 138.28 57.43 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.359 -2.088 . . . . 0.57 110.26 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.92 -43.21 86.13 Favored 'General case' 0 C--N 1.393 2.49 0 CA-C-N 113.612 -1.631 . . . . 0.57 108.614 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.289 -0.882 . . . . 0.91 110.87 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.7 OUTLIER -64.06 -55.08 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.91 110.86 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 256' ' ' ARG . 22.7 pt -66.08 -35.23 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.57 111.166 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.692 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -70.35 -35.44 73.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 1.2 110.852 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 261' ' ' LEU . . . -64.51 -49.58 64.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.57 112.469 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.32 -45.65 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.57 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.485 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.11 -24.04 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.57 110.92 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.7 t -76.03 -16.84 59.88 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 123.388 1.566 . . . . 0.57 111.03 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 257' ' ' GLY . 0.3 OUTLIER -81.65 -93.98 0.05 Allowed 'General case' 0 C--N 1.386 2.179 0 CA-C-O 123.965 1.84 . . . . 0.57 112.444 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.47 14.51 8.03 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 114.315 -1.311 . . . . 0.57 113.531 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.375 2.73 0 N-CA-C 118.382 2.113 . . . . 0.91 118.382 172.365 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.877 ' H28' ' O ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 3.865 0 CA-C-O 119.247 -0.751 . . . . 0.57 111.935 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.5 103.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 122.171 1.914 . . . . 0.57 112.5 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 t -111.44 134.95 52.16 Favored 'Isoleucine or valine' 0 C--N 1.374 1.661 0 CA-C-N 112.909 -1.95 . . . . 0.57 109.125 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -122.01 -89.8 0.59 Allowed 'General case' 0 C--N 1.387 2.203 0 CA-C-N 112.918 -1.946 . . . . 0.57 109.429 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.47 156.63 36.9 Favored 'General case' 0 C--N 1.378 1.824 0 N-CA-C 107.717 -1.216 . . . . 1.2 107.717 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.42 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.383 2.03 0 CA-C-N 113.692 -1.595 . . . . 0.57 111.402 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.797 ' HA ' HD22 ' A' ' 147' ' ' LEU . 5.8 p-80 -53.04 -35.91 59.99 Favored 'General case' 0 C--N 1.382 2.008 0 CA-C-N 112.91 -1.95 . . . . 0.57 109.954 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -111.11 111.59 22.79 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.493 -1.38 . . . . 0.57 110.891 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -111.24 144.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.57 111.085 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.767 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -105.94 158.47 16.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.57 111.149 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.928 ' CE2' HD13 ' A' ' 159' ' ' ILE . 15.7 m-85 -140.6 159.59 41.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.57 110.886 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.754 HH11 ' N ' ' A' ' 156' ' ' MET . 12.3 ttm180 -150.0 129.62 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 1.2 110.854 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.751 HD11 ' CD1' ' A' ' 134' ' ' ILE . 1.1 mm -99.09 128.92 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.57 111.08 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.61 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.373 1.624 0 CA-C-O 123.325 1.536 . . . . 0.57 112.682 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -179.18 24.63 0.0 OUTLIER 'General case' 0 C--N 1.378 1.822 0 CA-C-N 113.595 -1.639 . . . . 0.57 107.767 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.3 m-85 82.87 -152.56 0.01 OUTLIER 'General case' 0 C--N 1.392 2.415 0 N-CA-C 105.504 -2.036 . . . . 0.57 105.504 170.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.2 167.56 14.1 Favored Pre-proline 0 C--N 1.382 2.01 0 N-CA-C 108.542 -0.91 . . . . 0.57 108.542 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -57.04 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 121.303 1.335 . . . . 0.57 114.305 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.32 -59.05 3.1 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.837 -1.529 . . . . 0.91 112.986 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.466 ' HG2' ' CG2' ' A' ' 205' ' ' THR . 2.4 mtm -63.39 137.17 58.07 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 123.903 1.811 . . . . 0.57 108.902 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -89.49 143.86 26.48 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 106.095 -1.817 . . . . 0.57 106.095 -171.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.03 -49.67 42.47 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.728 -1.582 . . . . 1.2 106.728 -167.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.74 -34.79 62.98 Favored 'General case' 0 C--N 1.392 2.425 0 CA-C-N 112.238 -2.255 . . . . 0.91 110.884 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -44.03 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.91 110.877 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -65.03 -49.32 80.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.57 111.15 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -56.79 -44.07 81.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.91 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -38.03 89.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.88 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -65.92 -40.64 91.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.086 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.751 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -66.97 -42.56 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.57 111.178 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -62.05 -44.83 95.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 1.2 110.841 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.27 96.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.57 110.91 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.654 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -60.87 -44.69 96.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.57 111.117 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 134' ' ' ILE . 14.4 m-85 -62.53 -33.68 75.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.57 110.901 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.455 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -68.28 -39.36 82.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.884 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.6 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -72.3 -33.87 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.57 111.189 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.608 ' O ' HG23 ' A' ' 145' ' ' THR . 9.8 m95 -83.16 -34.06 26.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.57 110.923 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.2 m -77.99 -49.13 14.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.57 110.852 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.616 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.9 p-10 -59.99 -13.06 9.58 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 122.049 0.928 . . . . 0.57 112.349 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.616 HG13 ' OD1' ' A' ' 143' ' ' ASN . 17.6 m -112.87 9.45 8.12 Favored 'Isoleucine or valine' 0 C--N 1.382 2.009 0 CA-C-N 114.326 -1.306 . . . . 0.57 112.757 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.3 p -149.32 151.62 34.15 Favored Pre-proline 0 C--N 1.378 1.812 0 CA-C-O 126.201 2.905 . . . . 0.57 110.677 -171.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.57 -29.29 2.38 Favored 'Trans proline' 0 C--N 1.365 1.432 0 O-C-N 117.31 -1.995 . . . . 0.57 110.923 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 112' ' ' HIS . 3.6 mt -73.3 111.98 8.94 Favored 'General case' 0 C--N 1.376 1.76 0 N-CA-C 106.543 -1.651 . . . . 0.57 106.543 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -69.48 157.75 36.52 Favored 'General case' 0 C--N 1.381 1.963 0 CA-C-O 124.369 2.033 . . . . 0.57 116.279 170.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 17.0 m-85 -130.4 154.25 47.9 Favored 'General case' 0 C--N 1.387 2.213 0 CA-C-N 112.675 -2.057 . . . . 0.57 109.141 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 m -156.15 109.13 2.65 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-O 125.442 2.544 . . . . 0.57 108.83 -171.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.53 149.53 23.56 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.323 -1.762 . . . . 0.57 112.394 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -160.17 -172.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.385 2.109 0 CA-C-N 113.833 -1.53 . . . . 0.57 110.334 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -163.36 98.17 0.91 Allowed 'General case' 0 C--N 1.38 1.905 0 N-CA-C 108.555 -0.905 . . . . 0.57 108.555 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 155' ' ' GLY . 17.6 m -147.03 -81.59 0.14 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 115.288 -0.869 . . . . 0.57 109.92 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.634 ' H ' ' NH1' ' A' ' 117' ' ' ARG . . . -136.39 51.07 0.82 Allowed Glycine 0 C--N 1.384 3.228 0 N-CA-C 107.404 -2.278 . . . . 0.57 107.404 -169.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.754 ' N ' HH11 ' A' ' 117' ' ' ARG . 5.0 ttm 72.19 135.98 0.04 OUTLIER 'General case' 0 C--N 1.404 2.977 0 O-C-N 126.362 1.86 . . . . 0.57 108.274 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.22 163.67 27.23 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.27 -1.752 . . . . 0.57 106.27 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 158' ' ' ASP 0.288 0.0 OUTLIER -18.7 -73.62 0.01 OUTLIER 'General case' 0 C--N 1.377 1.803 0 CA-C-N 112.875 -1.966 . . . . 0.91 113.996 165.587 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.928 HD13 ' CE2' ' A' ' 116' ' ' TYR . 2.5 mp -96.15 109.8 23.43 Favored 'Isoleucine or valine' 0 C--N 1.383 2.063 0 O-C-N 126.9 2.625 . . . . 0.57 111.215 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 122.49 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.57 110.879 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.637 HG23 HD13 ' A' ' 118' ' ' ILE . 1.4 m -110.44 121.44 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.08 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.646 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.13 139.97 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.087 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -90.19 118.84 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.946 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.46 169.18 20.07 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 118.861 -1.135 . . . . 0.57 109.162 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 167.3 9.88 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 115.245 -0.889 . . . . 1.2 110.398 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -40.11 129.02 2.78 Favored Glycine 0 C--N 1.393 3.726 0 O-C-N 125.201 1.563 . . . . 0.57 111.699 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.69 104.04 0.06 Allowed 'General case' 0 C--N 1.406 3.041 0 CA-C-O 124.893 2.283 . . . . 0.57 112.271 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -171.18 -59.37 0.02 OUTLIER 'General case' 0 C--N 1.386 2.187 0 CA-C-N 113.823 -1.535 . . . . 0.57 110.405 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -155.82 -125.12 0.9 Allowed Glycine 0 C--N 1.381 3.032 0 CA-C-N 115.048 -0.978 . . . . 0.57 110.799 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 41.1 p-10 -33.78 147.68 0.02 OUTLIER 'General case' 0 C--N 1.388 2.245 0 O-C-N 127.331 2.43 . . . . 0.91 113.532 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.492 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.5 t80 78.15 -151.19 0.02 OUTLIER 'General case' 0 C--N 1.394 2.534 0 CA-C-N 113.12 -1.855 . . . . 0.57 111.986 -172.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -167.51 97.27 0.48 Allowed 'General case' 0 C--N 1.382 2.006 0 N-CA-C 108.254 -1.017 . . . . 0.57 108.254 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.74 77.94 0.31 Allowed 'General case' 0 C--N 1.398 2.681 0 CA-C-O 125.549 2.595 . . . . 0.57 109.023 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -64.93 178.06 0.88 Allowed 'General case' 0 C--N 1.377 1.784 0 CA-C-N 111.945 -2.389 . . . . 0.57 112.051 177.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 180' ' ' ILE . 2.5 p-10 -58.37 -160.27 0.0 OUTLIER 'General case' 0 C--N 1.386 2.19 0 CA-C-O 124.519 2.104 . . . . 0.91 114.479 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -172.63 101.39 0.16 Allowed Glycine 0 C--N 1.391 3.602 0 C-N-CA 117.261 -2.4 . . . . 0.57 109.205 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.63 96.64 0.07 Allowed 'General case' 0 C--N 1.39 2.345 0 CA-C-O 123.472 1.605 . . . . 0.57 113.056 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.27 -152.37 25.45 Favored Glycine 0 C--N 1.381 3.065 0 C-N-CA 119.02 -1.562 . . . . 0.57 110.596 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.83 -132.91 40.66 Favored Glycine 0 C--N 1.376 2.784 0 N-CA-C 111.788 -0.525 . . . . 0.57 111.788 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -46.97 168.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.061 0 O-C-N 125.806 1.533 . . . . 0.57 113.196 175.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 215' ' ' THR . 1.6 tp -121.94 -92.26 0.54 Allowed 'General case' 0 C--N 1.359 1.008 0 CA-C-O 126.781 3.181 . . . . 0.57 112.907 172.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.478 ' HB2' ' CG2' ' A' ' 215' ' ' THR . . . -106.22 179.73 4.18 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 112.524 -2.126 . . . . 0.57 111.1 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 54.4 p-80 -163.12 135.84 5.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.856 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -132.7 166.74 21.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.57 111.072 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -71.71 0.6 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 117.491 -1.684 . . . . 0.57 108.083 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.23 0.55 Allowed Glycine 0 C--N 1.386 3.331 0 C-N-CA 120.696 -0.764 . . . . 0.57 112.579 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -53.16 -47.29 28.3 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 121.757 1.638 . . . . 0.57 110.755 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.99 -169.74 23.22 Favored Glycine 0 C--N 1.378 2.883 0 C-N-CA 118.958 -1.592 . . . . 0.57 113.857 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 78.0 83.09 0.07 Allowed 'General case' 0 C--N 1.392 2.436 0 CA-C-O 124.137 1.922 . . . . 0.57 107.649 173.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.63 -103.65 1.99 Allowed Glycine 0 C--N 1.394 3.781 0 N-CA-C 105.155 -3.178 . . . . 0.57 105.155 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 192' ' ' GLY . 1.2 tp -61.88 -47.18 94.44 Favored 'Isoleucine or valine' 0 C--N 1.387 2.208 0 CA-C-O 127.102 3.334 . . . . 0.57 110.691 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -63.83 158.64 40.51 Favored Glycine 0 N--CA 1.404 -3.469 0 O-C-N 117.019 -3.551 . . . . 0.57 108.827 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.29 -8.11 19.88 Favored Glycine 0 C--N 1.375 2.743 0 CA-C-N 113.782 -1.209 . . . . 0.57 113.853 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.45 108.36 18.98 Favored 'General case' 0 C--N 1.378 1.842 0 CA-C-N 114.464 -0.868 . . . . 0.91 110.835 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -106.18 151.0 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.57 111.137 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.646 ' CD2' HG22 ' A' ' 162' ' ' VAL . 6.7 m170 -135.28 151.21 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.57 110.834 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -114.37 139.7 49.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.57 110.844 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.525 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.3 p-10 -66.92 82.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.91 110.836 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.15 69.78 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 106.629 -1.619 . . . . 0.91 106.629 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -48.37 19.04 Favored 'General case' 0 C--N 1.389 2.297 0 O-C-N 125.835 1.96 . . . . 0.91 107.548 -163.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.89 171.71 0.02 OUTLIER 'General case' 0 C--N 1.392 2.417 0 CA-C-O 127.167 3.365 . . . . 0.91 116.356 172.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -97.06 100.51 12.01 Favored 'General case' 0 C--N 1.378 1.82 0 O-C-N 119.19 -2.194 . . . . 0.57 111.117 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.473 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 47.9 m95 -78.54 152.89 31.69 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.869 -1.514 . . . . 0.57 109.089 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.7 105.6 9.44 Favored 'General case' 0 C--N 1.378 1.805 0 CA-C-O 124.523 2.106 . . . . 0.57 110.599 -175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 125' ' ' MET . 4.3 p -96.93 107.29 19.78 Favored 'General case' 0 C--N 1.365 1.25 0 CA-C-N 114.492 -1.231 . . . . 0.57 110.064 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 53.7 46.92 24.92 Favored 'General case' 0 C--N 1.393 2.476 0 CA-C-O 125.371 2.51 . . . . 0.57 110.846 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 t -134.26 -74.97 0.47 Allowed 'General case' 0 C--N 1.387 2.221 0 CA-C-N 112.5 -2.137 . . . . 0.57 107.793 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.55 64.01 0.05 OUTLIER Glycine 0 C--N 1.394 3.782 0 C-N-CA 118.24 -1.933 . . . . 0.57 111.214 -171.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.64 -142.01 6.14 Favored Glycine 0 C--N 1.387 3.372 0 CA-C-O 123.483 1.602 . . . . 0.57 111.132 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 56.2 m -68.24 118.02 10.81 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.841 -1.18 . . . . 0.57 110.456 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.52 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.4 p30 -92.49 145.47 24.43 Favored 'General case' 0 C--N 1.378 1.826 0 O-C-N 126.117 2.136 . . . . 0.57 112.519 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.684 HD13 ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -73.49 -32.14 64.13 Favored 'General case' 0 C--N 1.391 2.395 0 CA-C-O 124.424 2.059 . . . . 0.57 107.508 -174.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.902 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.3 t80 -49.57 -50.12 43.69 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-N 113.104 -1.862 . . . . 0.57 110.891 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.447 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -57.18 -42.68 81.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.57 110.933 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . 1.035 HG23 HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.62 -45.04 80.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.095 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.71 -47.77 79.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.57 111.063 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 213' ' ' PHE . 2.8 t -59.96 -41.48 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.57 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.515 ' HD1' ' C19' ' A' ' 269' ' ' HSI . 2.8 t-160 -62.76 -36.59 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.832 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -43.23 86.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.91 110.807 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.2 mm -64.02 -45.28 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.57 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.94 87.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.819 -0.705 . . . . 0.57 112.441 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.425 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -64.01 -42.61 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.57 110.821 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 t -71.07 -55.63 7.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.872 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 220' ' ' ILE . 0.2 OUTLIER -78.07 -164.31 0.52 Allowed 'General case' 0 C--N 1.382 1.984 0 N-CA-C 116.305 1.965 . . . . 0.57 116.305 171.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 224' ' ' LEU . . . 68.75 -146.03 44.5 Favored Glycine 0 C--N 1.38 2.998 0 N-CA-C 104.487 -3.445 . . . . 0.57 104.487 169.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 258' ' ' ILE . 0.0 OUTLIER -124.1 -82.18 0.64 Allowed 'General case' 0 C--N 1.38 1.916 0 CA-C-N 111.738 -2.231 . . . . 0.57 110.481 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.91 -157.27 7.29 Favored Glycine 0 C--N 1.379 2.929 0 CA-C-O 123.871 1.817 . . . . 0.57 108.843 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.7 m-70 -103.2 -171.34 1.93 Allowed 'General case' 0 C--N 1.376 1.738 0 CA-C-N 113.777 -1.212 . . . . 0.57 111.934 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.791 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -116.32 -31.26 5.68 Favored 'General case' 0 C--N 1.386 2.166 0 CA-C-N 113.93 -1.487 . . . . 0.57 108.985 -176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 m 82.11 23.11 0.23 Allowed 'General case' 0 C--N 1.401 2.828 0 CA-C-O 123.095 1.426 . . . . 0.57 114.556 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -127.99 151.13 75.38 Favored Pre-proline 0 N--CA 1.418 -2.067 0 CA-C-N 113.105 -1.861 . . . . 0.91 108.345 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.615 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 71.0 Cg_exo -58.23 -28.07 82.91 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.168 1.912 . . . . 0.57 115.289 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.422 ' HE3' ' H ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -70.35 -33.74 71.82 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 111.295 -2.684 . . . . 0.57 117.884 173.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -55.3 131.23 45.09 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 113.778 -1.555 . . . . 0.57 109.483 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.453 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -76.32 -3.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 CA-C-O 125.927 2.775 . . . . 0.57 112.366 -176.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 11.2 mtp -122.82 -10.77 8.23 Favored 'General case' 0 C--N 1.374 1.668 0 CA-C-N 112.847 -1.978 . . . . 0.57 112.153 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -38.66 141.82 0.55 Allowed Pre-proline 0 C--N 1.373 1.605 0 CA-C-O 125.496 2.57 . . . . 0.57 113.638 174.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.477 ' CA ' H441 ' A' ' 269' ' ' HSI . 75.2 Cg_exo -56.94 -50.04 12.65 Favored 'Trans proline' 0 C--N 1.37 1.667 0 O-C-N 118.831 -1.194 . . . . 0.57 111.122 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 39.5 m -44.23 118.71 1.58 Allowed 'General case' 0 C--N 1.366 1.288 0 CA-C-O 123.404 1.573 . . . . 0.57 110.507 -172.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.519 ' CE2' HD13 ' A' ' 181' ' ' LEU . 25.1 t80 -92.92 157.56 16.28 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.555 -1.657 . . . . 0.57 108.326 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.96 126.14 0.02 OUTLIER 'General case' 0 C--N 1.392 2.434 0 N-CA-C 105.448 -2.056 . . . . 0.57 105.448 169.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.67 120.45 7.3 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 125.491 2.567 . . . . 0.57 109.497 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 1.029 HG11 ' C33' ' A' ' 269' ' ' HSI . 1.4 p -128.27 -16.05 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 CA-C-N 112.538 -2.119 . . . . 0.57 110.973 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 244' ' ' ASP 0.289 0.0 OUTLIER 84.51 178.22 0.05 OUTLIER 'General case' 0 C--N 1.371 1.54 0 O-C-N 126.872 2.607 . . . . 0.91 111.782 -174.289 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.859 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.8 mp -93.81 -35.64 6.57 Favored 'Isoleucine or valine' 0 C--N 1.382 1.983 0 N-CA-C 118.322 2.712 . . . . 0.57 118.322 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.77 -14.52 0.05 OUTLIER 'General case' 0 C--N 1.377 1.784 0 N-CA-C 117.224 2.305 . . . . 0.57 117.224 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.413 ' HB ' ' CG2' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -124.59 -21.53 4.83 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 114.112 -1.404 . . . . 0.57 110.504 -175.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.453 ' CZ ' HG22 ' A' ' 235' ' ' VAL . 67.3 t80 -61.29 88.67 0.02 OUTLIER 'General case' 0 C--N 1.378 1.845 0 CA-C-O 125.566 2.603 . . . . 0.57 108.488 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.07 154.07 29.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 112.816 -1.993 . . . . 1.2 107.609 -178.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.631 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -124.42 127.84 48.13 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 125.745 2.688 . . . . 0.57 105.393 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 143.27 58.06 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.214 -2.179 . . . . 0.57 111.916 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -61.0 -45.29 95.42 Favored 'General case' 0 C--N 1.392 2.43 0 CA-C-N 113.842 -1.526 . . . . 0.57 107.996 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.71 -38.51 81.83 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 115.644 -0.707 . . . . 0.91 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 59.3 t0 -64.17 -55.09 24.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.91 110.842 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.06 -34.82 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.164 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.449 ' N ' HG13 ' A' ' 255' ' ' ILE . 10.2 mtt180 -70.15 -32.35 70.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.882 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.81 62.41 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.655 -0.783 . . . . 0.57 112.499 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.66 ' HA ' HD21 ' A' ' 226' ' ' LEU . 1.0 OUTLIER -64.8 -44.59 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.57 111.176 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.474 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.17 -19.18 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.57 110.914 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.5 t -67.14 -31.7 72.32 Favored 'General case' 0 C--N 1.366 1.326 0 CA-C-O 122.122 0.963 . . . . 0.57 108.667 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -69.85 0.1 Allowed 'General case' 0 C--N 1.388 2.239 0 CA-C-O 124.859 2.266 . . . . 0.57 111.226 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.621 ' CE1' HD11 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -96.23 142.25 28.61 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 112.729 -2.032 . . . . 0.57 111.903 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.576 3.865 0 N-CA-C 120.24 2.856 . . . . 0.91 120.24 -168.687 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 1.029 ' C33' HG11 ' A' ' 243' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.325 -0.708 . . . . 0.57 111.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.48 179.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 O-C-N 125.101 2.106 . . . . 0.57 111.619 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.62 126.4 71.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.113 0 CA-C-O 123.242 1.496 . . . . 0.57 111.053 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.5 -170.05 3.42 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 114.68 -1.146 . . . . 0.57 108.428 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 -129.45 162.32 28.37 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 122.303 1.049 . . . . 1.2 109.278 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.83 155.44 14.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.364 -0.976 . . . . 0.57 108.364 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.533 ' H ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 81.96 -41.72 0.14 Allowed 'General case' 0 C--N 1.377 1.777 0 CA-C-O 122.187 0.994 . . . . 0.57 110.622 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -114.4 131.47 56.56 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.579 -1.191 . . . . 0.57 110.868 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 148' ' ' LYS . 1.1 mm -127.45 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.57 111.12 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.56 HG22 HG12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -106.0 157.81 17.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.57 111.098 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE1' HD12 ' A' ' 118' ' ' ILE . 16.7 t80 -145.29 160.02 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.57 110.914 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.598 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 3.9 tpt85 -146.49 121.97 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.841 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.68 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -95.53 125.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.57 111.122 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -61.83 -179.37 0.19 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.616 1.674 . . . . 0.57 111.268 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.09 51.37 0.98 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.505 -1.372 . . . . 0.57 110.824 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 5.2 m-85 44.19 -150.15 0.05 Allowed 'General case' 0 C--N 1.366 1.323 0 CA-C-N 115.239 -0.891 . . . . 0.57 109.045 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.592 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -165.84 168.24 8.07 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-O 122.286 1.041 . . . . 0.57 110.454 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 122' ' ' THR . 32.5 Cg_endo -68.06 -36.23 17.85 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 121.444 1.429 . . . . 0.57 112.963 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -84.84 -45.42 12.32 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.987 1.375 . . . . 0.91 113.134 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.498 ' CE ' ' CE2' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -77.92 110.09 12.52 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 123.68 1.705 . . . . 0.57 109.482 -176.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -71.27 135.89 47.67 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.947 -1.479 . . . . 0.57 109.192 -176.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -61.61 -50.83 70.98 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 108.448 -0.945 . . . . 1.2 108.448 -170.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.56 -34.86 69.63 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 113.083 -1.871 . . . . 0.91 110.896 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -39.71 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.91 110.826 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -64.97 -49.74 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.57 111.153 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -41.61 91.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.91 110.896 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -42.3 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.57 110.863 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.736 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.5 -48.88 68.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.57 111.092 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.575 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -64.35 -31.95 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.57 111.122 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.95 -46.71 70.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 1.2 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -62.82 -37.2 85.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.57 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.52 ' CB ' HG23 ' A' ' 217' ' ' VAL . . . -68.06 -38.5 82.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.57 111.065 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' HG22 ' A' ' 134' ' ' ILE . 5.5 m-85 -67.06 -33.83 76.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.57 110.919 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -70.21 -44.65 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.57 110.871 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 250' ' ' LEU . 7.7 p -68.54 -33.6 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.57 111.16 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.46 -34.31 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.57 110.854 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 138' ' ' PHE . 29.3 m -72.22 -49.45 35.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.57 110.863 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -60.66 -11.97 8.92 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-O 121.881 0.848 . . . . 0.57 112.706 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 145' ' ' THR . 16.9 m -111.98 -5.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.367 1.358 0 CA-C-N 114.792 -1.094 . . . . 0.57 112.69 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.94 HG21 HD13 ' A' ' 224' ' ' LEU . 21.0 p -140.63 146.38 44.43 Favored Pre-proline 0 C--N 1.365 1.261 0 CA-C-O 124.594 2.14 . . . . 0.57 111.115 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -77.19 -25.54 8.48 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 121.218 1.278 . . . . 0.57 111.77 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -77.68 96.09 4.77 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 122.668 1.223 . . . . 0.57 109.518 -176.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -77.04 160.75 28.86 Favored 'General case' 0 C--N 1.363 1.184 0 CA-C-N 115.168 -0.924 . . . . 0.57 112.198 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.487 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -133.05 140.77 47.88 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 107.702 -1.222 . . . . 0.57 107.702 -173.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.0 m -155.67 135.56 12.78 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 123.553 1.644 . . . . 0.57 109.387 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -74.97 144.17 43.3 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 114.513 -1.222 . . . . 0.57 109.213 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 115' ' ' THR . 6.2 pt -125.14 -179.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.364 1.213 0 CA-C-O 121.947 0.879 . . . . 0.57 109.887 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -134.41 63.87 1.61 Allowed 'General case' 0 C--N 1.37 1.483 0 CA-C-O 122.93 1.348 . . . . 0.57 111.299 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.76 95.83 1.57 Allowed 'General case' 0 C--N 1.373 1.624 0 CA-C-N 114.553 -1.203 . . . . 0.57 110.357 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 45.66 -137.63 7.04 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 122.418 1.01 . . . . 0.57 111.681 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 151.53 46.96 Favored 'General case' 0 C--N 1.366 1.307 0 CA-C-O 123.145 1.45 . . . . 0.57 110.74 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 117' ' ' ARG . . . -133.68 163.64 28.99 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 114.497 -1.229 . . . . 0.57 109.814 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.462 ' H ' ' HB ' ' A' ' 115' ' ' THR . 53.6 m-20 -46.06 -52.0 12.75 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 108.245 -1.02 . . . . 0.91 108.245 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 193' ' ' GLY . 41.6 mt -116.43 110.47 31.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 O-C-N 123.816 0.697 . . . . 0.57 111.093 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 122.02 46.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.57 110.977 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.19 120.21 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.57 111.098 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.8 t -131.23 124.94 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.57 111.084 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 197' ' ' PHE . 2.4 m-85 -86.78 120.48 28.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.57 110.852 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.13 169.0 18.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.886 1.327 . . . . 0.57 110.626 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 163.44 13.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.749 -1.219 . . . . 1.2 108.945 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -33.03 130.89 0.3 Allowed Glycine 0 C--N 1.37 2.429 0 O-C-N 124.009 0.818 . . . . 0.57 112.718 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 84.28 40.28 0.03 OUTLIER 'General case' 0 C--N 1.39 2.361 0 CA-C-O 124.763 2.221 . . . . 0.57 112.383 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -107.0 155.6 19.63 Favored 'General case' 0 C--N 1.364 1.237 0 CA-C-N 114.249 -1.342 . . . . 0.57 109.087 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.79 168.77 1.32 Allowed Glycine 0 C--N 1.378 2.865 0 N-CA-C 110.104 -1.198 . . . . 0.57 110.104 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.77 8.03 5.66 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-O 122.402 1.096 . . . . 0.91 113.367 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.41 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -165.76 -77.65 0.03 OUTLIER 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.085 -0.961 . . . . 0.57 111.152 -171.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER 83.2 43.78 0.02 OUTLIER 'General case' 0 C--N 1.373 1.608 0 CA-C-O 123.034 1.397 . . . . 0.57 110.239 175.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 159.88 114.17 0.0 OUTLIER 'General case' 0 C--N 1.382 2.012 0 CA-C-N 114.999 -1.001 . . . . 0.57 110.72 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.441 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -147.6 -167.82 2.89 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 122.018 0.914 . . . . 0.57 110.07 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.419 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.4 OUTLIER -72.61 -177.74 2.38 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 124.477 1.111 . . . . 0.91 112.252 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.27 49.13 0.21 Allowed Glycine 0 C--N 1.381 3.049 0 CA-C-O 123.411 1.562 . . . . 0.57 113.192 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -171.72 -36.48 0.02 OUTLIER 'General case' 0 C--N 1.384 2.069 0 CA-C-O 123.425 1.583 . . . . 0.57 112.819 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.474 ' N ' ' HD2' ' A' ' 177' ' ' LYS . . . 169.41 -103.62 0.2 Allowed Glycine 0 C--N 1.375 2.7 0 CA-C-O 122.955 1.308 . . . . 0.57 110.457 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.541 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 36.04 -92.19 0.01 OUTLIER Glycine 0 C--N 1.367 2.267 0 O-C-N 120.309 -1.7 . . . . 0.57 114.49 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.57 ' N ' HD13 ' A' ' 180' ' ' ILE . 1.9 mm -51.23 170.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.064 0 CA-C-O 121.297 0.57 . . . . 0.57 111.593 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD11 ' CB ' ' A' ' 210' ' ' THR . 3.6 tp -136.09 -41.33 0.66 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.945 0.879 . . . . 0.57 112.55 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -176.72 179.87 1.06 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.359 -0.837 . . . . 0.57 111.094 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -156.03 137.91 14.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.928 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.87 140.01 40.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.57 111.101 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.446 ' CB ' HG23 ' A' ' 191' ' ' ILE . 1.9 m-85 -91.93 176.59 6.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.523 1.154 . . . . 0.57 110.964 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.37 55.07 0.1 Allowed Glycine 0 C--N 1.366 2.21 0 CA-C-N 115.501 -0.772 . . . . 0.57 112.797 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HD2' ' CA ' ' A' ' 192' ' ' GLY . 47.0 Cg_endo -74.42 -42.98 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 120.907 1.071 . . . . 0.57 112.008 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.41 87.32 0.17 Allowed Glycine 0 C--N 1.379 2.93 0 C-N-CA 120.137 -1.03 . . . . 0.57 111.569 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 79.75 97.02 0.06 Allowed 'General case' 0 C--N 1.386 2.155 0 CA-C-O 123.59 1.662 . . . . 0.57 110.073 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.65 -118.56 1.27 Allowed Glycine 0 C--N 1.381 3.047 0 N-CA-C 109.61 -1.396 . . . . 0.57 109.61 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -72.11 -11.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 CA-C-O 124.689 2.185 . . . . 0.57 110.36 -178.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 187' ' ' PRO . . . -66.91 124.62 23.89 Favored Glycine 0 C--N 1.372 2.552 0 O-C-N 120.077 -1.639 . . . . 0.57 109.758 -174.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 115.09 -33.12 5.45 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-O 121.737 0.631 . . . . 0.57 112.521 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -72.91 129.37 37.99 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 122.162 -0.61 . . . . 0.91 110.828 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.694 ' HB2' ' HB2' ' A' ' 219' ' ' GLU . . . -121.51 160.05 25.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.481 . . . . 0.57 111.089 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.549 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 46.0 m170 -133.74 140.07 46.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.829 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.66 139.42 38.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.57 110.887 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.55 78.89 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.91 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -29.61 11.36 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 118.529 -0.748 . . . . 0.91 112.515 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -39.15 -55.94 1.55 Allowed 'General case' 0 C--N 1.352 0.713 0 CA-C-O 124.907 2.289 . . . . 0.91 109.189 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 201' ' ' GLU . 1.6 pm0 -75.09 176.38 7.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-O 125.474 2.559 . . . . 0.91 112.379 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.11 90.82 3.44 Favored 'General case' 0 C--N 1.369 1.431 0 O-C-N 119.282 -2.136 . . . . 0.57 109.638 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -88.63 147.63 24.45 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 114.063 -1.426 . . . . 0.57 111.708 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 99.6 m -123.05 121.57 36.37 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-O 124.387 2.041 . . . . 0.57 112.429 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.35 133.47 34.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 120.865 -1.147 . . . . 0.57 110.588 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' A' ' 207' ' ' SER . 2.2 t-80 78.89 62.79 0.03 OUTLIER 'General case' 0 C--N 1.38 1.909 0 CA-C-O 122.726 1.251 . . . . 0.57 110.219 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.7 m 85.09 92.85 0.03 OUTLIER 'General case' 0 C--N 1.381 1.945 0 CA-C-O 123.703 1.716 . . . . 0.57 109.057 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.42 110.21 0.5 Allowed Glycine 0 C--N 1.375 2.721 0 O-C-N 120.997 -1.064 . . . . 0.57 111.772 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 43.57 -113.26 0.68 Allowed Glycine 0 C--N 1.375 2.73 0 CA-C-O 123.756 1.753 . . . . 0.57 111.689 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.697 ' CB ' HD11 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -93.31 126.21 38.31 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 113.599 -1.3 . . . . 0.57 112.243 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.827 ' HB2' HD11 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -95.71 151.04 19.72 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.186 -1.37 . . . . 0.57 111.885 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -72.75 -38.51 67.35 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 123.518 1.628 . . . . 0.57 107.873 -175.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 213' ' ' PHE . 1.9 t80 -51.79 -46.8 64.33 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 114.242 -1.344 . . . . 0.57 110.867 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.517 HD11 ' C25' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -54.76 -51.18 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.57 110.923 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.659 HG23 HD23 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -64.18 -45.37 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.57 111.115 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -59.14 -39.91 83.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.57 111.074 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 248' ' ' PHE . 1.1 t -65.25 -39.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.57 111.118 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.466 ' HD1' ' C19' ' A' ' 269' ' ' HSI . 3.5 t-160 -66.31 -49.03 68.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.57 110.827 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . 3.4 pt-20 -57.9 -42.26 84.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.91 110.904 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.715 HG22 ' CD2' ' A' ' 224' ' ' LEU . 11.7 mt -67.0 -46.17 85.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.57 111.16 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.94 -33.67 64.19 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.57 112.476 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.411 ' CE1' ' O ' ' A' ' 227' ' ' GLY . 1.5 m-70 -64.31 -40.65 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.57 110.872 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.6 t -71.23 -51.04 26.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.57 110.815 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.94 HD13 HG21 ' A' ' 145' ' ' THR . 3.3 pp -72.4 -64.89 0.86 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.868 1.062 . . . . 0.57 113.868 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.82 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -73.13 169.98 52.5 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-O 124.871 2.373 . . . . 0.57 111.493 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.781 HD21 HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER -66.21 -154.73 0.01 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-O 123.727 1.727 . . . . 0.57 108.796 -177.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 222' ' ' HIS . . . -53.47 -99.47 0.01 OUTLIER Glycine 0 C--N 1.38 2.982 0 CA-C-O 123.849 1.805 . . . . 0.57 111.921 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -112.67 -93.82 0.46 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 119.684 -2.068 . . . . 0.57 112.216 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 16.1 p -162.75 -43.85 0.04 OUTLIER 'General case' 0 C--N 1.372 1.563 0 CA-C-N 115.219 -0.9 . . . . 0.57 110.666 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 83.84 28.99 0.08 Allowed 'General case' 0 C--N 1.399 2.726 0 CA-C-N 114.189 -1.368 . . . . 0.57 114.501 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.3 128.68 2.4 Favored Pre-proline 0 C--N 1.383 2.056 0 CA-C-N 114.459 -1.246 . . . . 0.91 108.545 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.42 64.41 7.26 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.909 2.406 . . . . 0.57 112.12 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.7 -31.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 121.086 -1.009 . . . . 0.57 113.276 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -69.82 120.07 15.01 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-O 123.521 1.629 . . . . 0.57 110.41 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 235' ' ' VAL . 40.0 t -58.4 88.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.71 -1.132 . . . . 0.57 112.849 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 158.37 -20.74 0.0 OUTLIER 'General case' 0 C--N 1.367 1.361 0 CA-C-O 122.292 1.044 . . . . 0.57 112.488 -176.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 4.0 p90 -50.02 153.03 2.48 Favored Pre-proline 0 N--CA 1.43 -1.459 0 CA-C-O 123.088 1.423 . . . . 0.57 111.322 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.67 -47.87 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.331 1.354 . . . . 0.57 110.591 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 m -39.6 121.25 1.2 Allowed 'General case' 0 C--N 1.353 0.719 0 CA-C-O 122.725 1.25 . . . . 0.57 110.926 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.697 ' HE2' HD13 ' A' ' 181' ' ' LEU . 36.2 t80 -68.18 162.52 24.7 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.355 -1.293 . . . . 0.57 108.113 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 14.4 tttt 167.4 124.22 0.01 OUTLIER 'General case' 0 C--N 1.373 1.618 0 CA-C-O 123.064 1.411 . . . . 0.57 108.112 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -74.77 120.11 19.87 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-O 122.898 1.332 . . . . 0.57 111.325 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 243' ' ' VAL . 8.5 p -138.18 115.6 12.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.239 0 CA-C-N 115.166 -0.925 . . . . 0.57 108.891 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -41.47 142.36 0.61 Allowed 'General case' 0 C--N 1.366 1.31 0 CA-C-O 124.052 1.882 . . . . 0.91 109.53 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 211' ' ' ASN . 15.4 mt -65.96 -22.29 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 123.065 1.412 . . . . 0.57 112.209 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -17.04 61.98 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.126 0.965 . . . . 0.57 111.387 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.7 p -112.18 8.25 19.81 Favored 'General case' 0 C--N 1.371 1.519 0 CA-C-O 122.654 1.216 . . . . 0.57 113.376 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.559 ' CE1' HG11 ' A' ' 217' ' ' VAL . 45.0 t80 -77.16 88.49 3.63 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-O 124.193 1.949 . . . . 0.57 108.577 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.522 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -112.42 153.56 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 O-C-N 120.678 -1.263 . . . . 1.2 110.32 177.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.77 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -119.98 129.36 54.25 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 124.331 2.015 . . . . 0.57 107.934 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 143.91 55.51 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 119.659 -1.901 . . . . 0.57 112.25 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.68 89.61 Favored 'General case' 0 C--N 1.382 1.98 0 CA-C-N 114.663 -1.153 . . . . 0.57 109.428 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.17 -40.71 94.92 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.796 -0.638 . . . . 0.91 110.882 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.406 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 26.8 t70 -64.29 -54.92 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.91 110.849 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.1 -34.79 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.57 111.081 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.451 ' N ' HG13 ' A' ' 255' ' ' ILE . 37.3 mtp180 -62.84 -43.47 98.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.934 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.57 -57.52 12.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.57 112.547 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.473 HG13 ' N ' ' A' ' 259' ' ' GLN . 28.4 pt -46.62 -44.2 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.57 111.224 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 258' ' ' ILE . 2.6 pt20 -72.02 -26.75 62.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.57 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.428 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 32.1 t -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.594 1.187 . . . . 0.57 110.441 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.781 HD11 HD21 ' A' ' 226' ' ' LEU . 2.3 mp -50.95 -56.87 10.27 Favored 'General case' 0 C--N 1.377 1.802 0 CA-C-O 123.101 1.429 . . . . 0.57 110.92 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.424 ' CZ ' ' O ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -92.52 -73.68 0.54 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-N 114.367 -1.288 . . . . 0.57 113.054 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.268 2.225 0 CA-C-O 117.09 -1.95 . . . . 0.91 115.094 173.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.596 ' H30' HG22 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.573 0 CA-C-O 119.256 -0.747 . . . . 0.57 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.5 -30.58 28.12 Favored 'Trans proline' 0 C--N 1.377 2.049 0 O-C-N 124.336 1.703 . . . . 0.57 113.377 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 109' ' ' TRP . 3.7 t -111.46 124.09 67.9 Favored 'Isoleucine or valine' 0 C--N 1.382 1.981 0 CA-C-N 113.951 -1.477 . . . . 0.57 108.847 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.483 ' CD1' HG12 ' A' ' 108' ' ' VAL . 11.3 m0 70.67 -158.9 0.14 Allowed 'General case' 0 C--N 1.386 2.175 0 CA-C-N 112.623 -2.08 . . . . 0.57 106.925 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.86 149.15 31.75 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-O 123.112 1.434 . . . . 1.2 109.382 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.49 ' O ' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -153.17 -44.83 0.1 Allowed 'General case' 0 C--N 1.374 1.659 0 CA-C-N 113.081 -1.872 . . . . 0.57 111.037 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -78.25 -30.86 48.89 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 113.468 -1.696 . . . . 0.57 109.983 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.625 ' C ' HD13 ' A' ' 114' ' ' ILE . 39.6 t80 -112.02 109.12 18.7 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 114.26 -1.336 . . . . 0.57 110.903 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.625 HD13 ' C ' ' A' ' 113' ' ' TYR . 1.9 mm -102.22 155.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.57 111.13 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -114.36 149.5 36.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.57 111.106 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.1 t80 -145.86 156.57 43.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.57 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -154.54 132.17 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.936 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.74 146.32 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.57 111.137 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.667 ' OD1' HG22 ' A' ' 162' ' ' VAL . 55.5 t30 -53.4 -60.44 3.3 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 117.651 -1.619 . . . . 0.57 107.454 -167.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 159.21 31.08 0.0 OUTLIER 'General case' 0 C--N 1.383 2.024 0 O-C-N 126.474 2.359 . . . . 0.57 109.567 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HB3' ' CG ' ' A' ' 127' ' ' ARG . 0.4 OUTLIER 77.18 92.16 0.07 Allowed 'General case' 0 C--N 1.409 3.162 0 N-CA-C 105.461 -2.052 . . . . 0.57 105.461 164.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -49.43 163.82 0.35 Allowed Pre-proline 0 C--N 1.383 2.041 0 CA-C-N 111.993 -2.367 . . . . 0.57 108.548 -168.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.23 -47.92 11.1 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 115.692 -0.503 . . . . 0.57 112.537 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.661 ' H ' HG23 ' A' ' 122' ' ' THR . 0.2 OUTLIER -82.46 -63.72 1.32 Allowed 'General case' 0 C--N 1.386 2.153 0 N-CA-C 104.32 -2.474 . . . . 0.91 104.32 -163.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.819 ' SD ' HG22 ' A' ' 130' ' ' VAL . 5.0 ttm -53.37 154.48 3.35 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-O 125.141 2.4 . . . . 0.57 108.219 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -87.54 137.74 32.07 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 112.79 -2.005 . . . . 0.57 110.125 -177.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.03 -49.43 70.19 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 115.116 -0.947 . . . . 1.2 108.579 -170.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.07 -35.24 64.33 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 126.838 2.586 . . . . 0.91 110.98 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -70.7 -42.26 70.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.91 110.883 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.819 HG22 ' SD ' ' A' ' 125' ' ' MET . 2.5 t -63.13 -47.68 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.1 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.462 ' HA ' HD11 ' A' ' 134' ' ' ILE . 7.7 t70 -60.12 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.91 110.872 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.37 -41.44 97.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.57 110.927 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.679 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -63.23 -49.08 75.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.57 111.125 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 131' ' ' ASP . 18.1 pt -64.76 -39.22 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.144 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -58.85 -49.11 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.813 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.79 -34.87 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.888 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -64.62 -45.15 88.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.57 111.12 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m-85 -63.52 -36.85 85.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.57 110.91 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.38 -39.19 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.57 110.935 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.811 ' CG1' HD11 ' A' ' 250' ' ' LEU . 28.9 t -69.51 -34.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.57 111.152 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CG ' HD11 ' A' ' 224' ' ' LEU . 4.8 m95 -82.93 -34.13 26.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.57 110.977 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.7 m -78.66 -48.11 15.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.905 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.678 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.0 p-10 -61.02 -12.72 12.52 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 121.892 0.853 . . . . 0.57 111.844 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 255' ' ' ILE . 18.9 m -114.48 11.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.378 1.842 0 CA-C-N 113.892 -1.504 . . . . 0.57 112.898 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.594 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -150.67 150.45 28.35 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-O 125.381 2.515 . . . . 0.57 110.264 -173.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.413 ' HG3' ' HA2' ' A' ' 263' ' ' GLY . 42.3 Cg_endo -81.81 -24.54 4.06 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 O-C-N 118.133 -1.562 . . . . 0.57 113.054 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -75.94 111.48 11.35 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-O 124.534 2.112 . . . . 0.57 107.487 -176.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 156.8 38.79 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-O 125.194 2.426 . . . . 0.57 114.687 172.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.658 ' HE2' HD12 ' A' ' 159' ' ' ILE . 1.1 m-85 -128.04 160.01 33.27 Favored 'General case' 0 C--N 1.376 1.723 0 CA-C-N 112.526 -2.125 . . . . 0.57 109.441 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.0 m -157.92 114.71 2.9 Favored 'General case' 0 C--N 1.389 2.29 0 CA-C-O 124.855 2.264 . . . . 0.57 109.344 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -95.3 129.17 42.53 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.106 -1.861 . . . . 0.57 110.69 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 154' ' ' THR . 2.8 pt -105.89 137.07 37.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.406 0 CA-C-O 124.681 2.182 . . . . 0.57 111.361 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -46.29 71.27 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.122 -1.854 . . . . 0.57 110.533 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 152' ' ' ILE . 29.0 p -121.41 171.92 8.43 Favored 'General case' 0 C--N 1.379 1.875 0 CA-C-N 113.361 -1.745 . . . . 0.57 110.143 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.08 -119.91 6.68 Favored Glycine 0 C--N 1.382 3.11 0 N-CA-C 109.514 -1.434 . . . . 0.57 109.514 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 ttt -165.46 108.72 0.82 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-O 123.389 1.566 . . . . 0.57 109.759 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.765 ' O ' HD13 ' A' ' 160' ' ' LEU . . . -106.03 143.58 33.96 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 112.722 -2.035 . . . . 0.57 110.462 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -44.98 -51.22 10.08 Favored 'General case' 0 C--N 1.374 1.665 0 CA-C-N 116.001 -0.545 . . . . 0.91 110.356 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.658 HD12 ' HE2' ' A' ' 149' ' ' PHE . 18.6 mt -90.17 109.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.386 2.169 0 O-C-N 128.124 3.39 . . . . 0.57 111.116 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -106.97 132.06 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.957 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.408 HG21 ' OE2' ' A' ' 219' ' ' GLU . 2.1 t -120.6 118.14 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.57 111.126 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.667 HG22 ' OD1' ' A' ' 119' ' ' ASN . 69.5 t -133.08 146.02 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.57 111.166 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -92.07 121.66 33.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.57 110.834 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.01 168.8 18.86 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-O 123.445 1.593 . . . . 0.57 109.829 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 200' ' ' ASP . 0.2 OUTLIER -115.73 169.78 8.95 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 114.974 -1.012 . . . . 1.2 110.531 177.155 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.35 139.18 2.46 Favored Glycine 0 C--N 1.383 3.152 0 O-C-N 126.202 2.189 . . . . 0.57 111.517 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.68 57.69 0.84 Allowed 'General case' 0 C--N 1.4 2.777 0 CA-C-O 125.475 2.56 . . . . 0.57 110.585 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -108.5 -50.31 3.05 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 112.39 -2.187 . . . . 0.57 110.34 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -171.77 -121.54 0.6 Allowed Glycine 0 C--N 1.377 2.823 0 CA-C-N 114.395 -1.275 . . . . 0.57 111.857 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 41.7 p-10 -36.22 147.38 0.03 OUTLIER 'General case' 0 C--N 1.387 2.221 0 O-C-N 127.138 2.317 . . . . 0.91 112.494 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.3 OUTLIER 75.72 -155.11 0.04 OUTLIER 'General case' 0 C--N 1.391 2.392 0 CA-C-N 112.501 -2.136 . . . . 0.57 112.181 -172.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -112.57 -133.74 0.34 Allowed 'General case' 0 C--N 1.38 1.913 0 CA-C-O 123.452 1.596 . . . . 0.57 107.463 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.51 128.31 54.0 Favored 'General case' 0 C--N 1.38 1.92 0 CA-C-N 114.959 -1.019 . . . . 0.57 111.129 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 180' ' ' ILE . 9.7 m-85 -92.94 179.58 5.41 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-N 111.823 -2.444 . . . . 0.57 111.184 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.422 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -86.7 -175.82 5.56 Favored 'General case' 0 C--N 1.382 2.014 0 CA-C-N 113.724 -1.58 . . . . 0.91 113.009 173.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . -147.96 142.68 10.32 Favored Glycine 0 C--N 1.39 3.563 0 O-C-N 126.337 2.273 . . . . 0.57 110.482 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.72 25.02 2.61 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 113.025 -1.587 . . . . 0.57 113.086 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.78 -132.65 4.34 Favored Glycine 0 C--N 1.372 2.564 0 CA-C-O 116.679 -2.178 . . . . 0.57 112.69 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.96 -109.67 1.58 Allowed Glycine 0 C--N 1.38 3.008 0 O-C-N 125.409 1.3 . . . . 0.57 111.405 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 174' ' ' PHE . 9.3 mt -73.77 166.5 2.65 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 N-CA-C 115.332 1.604 . . . . 0.57 115.332 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG23 ' A' ' 215' ' ' THR . 1.1 tp -118.54 -41.4 2.82 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 119.962 -1.711 . . . . 0.57 110.129 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB2' ' HD1' ' A' ' 197' ' ' PHE . . . -175.95 179.9 1.26 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.893 -1.503 . . . . 0.57 111.089 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 1.2 p80 -165.78 135.85 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.57 110.849 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -139.43 162.51 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.57 111.08 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.7 -171.0 1.74 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.337 -0.945 . . . . 0.57 111.05 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -145.66 -76.2 0.03 OUTLIER Glycine 0 C--N 1.377 2.843 0 C-N-CA 119.385 -1.388 . . . . 0.57 110.551 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.47 75.73 4.91 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.019 1.812 . . . . 0.57 111.465 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -148.11 13.97 1.29 Allowed Glycine 0 C--N 1.367 2.288 0 C-N-CA 118.574 -1.774 . . . . 0.57 111.926 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 57.28 -93.19 0.04 OUTLIER 'General case' 0 C--N 1.388 2.278 0 O-C-N 125.549 1.382 . . . . 0.57 110.424 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -62.56 -71.56 0.8 Allowed Glycine 0 C--N 1.389 3.477 0 CA-C-N 114.69 -1.141 . . . . 0.57 112.33 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -31.65 53.79 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 CA-C-O 124.686 2.184 . . . . 0.57 108.915 -176.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.76 140.66 43.66 Favored Glycine 0 C--N 1.376 2.787 0 N-CA-C 107.783 -2.127 . . . . 0.57 107.783 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.42 -38.84 2.97 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-N 113.869 -1.165 . . . . 0.57 113.883 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -48.32 150.97 1.13 Allowed 'General case' 0 C--N 1.392 2.416 0 CA-C-N 113.417 -1.391 . . . . 0.91 110.907 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -144.09 145.86 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.57 111.077 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -121.68 134.48 54.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.57 110.826 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.546 ' HD1' ' HB2' ' A' ' 182' ' ' ALA . 29.0 m-85 -103.94 144.28 31.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.57 110.892 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 75.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.91 110.808 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -56.65 18.1 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 108.211 -1.033 . . . . 0.91 108.211 -175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -40.4 -45.55 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.903 1.377 . . . . 0.91 110.692 -176.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.29 172.64 0.13 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 126.669 3.128 . . . . 0.91 113.178 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.71 102.63 10.67 Favored 'General case' 0 C--N 1.376 1.756 0 CA-C-N 111.975 -2.375 . . . . 0.57 114.119 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -92.28 150.36 20.91 Favored 'General case' 0 C--N 1.361 1.1 0 CA-C-N 112.946 -1.934 . . . . 0.57 108.675 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.47 122.09 42.79 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 123.751 1.739 . . . . 0.57 109.032 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -89.41 131.87 35.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.835 -1.075 . . . . 0.57 112.169 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 78.81 -148.33 0.02 OUTLIER 'General case' 0 C--N 1.395 2.572 0 O-C-N 125.362 1.664 . . . . 0.57 110.492 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.466 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 1.6 t -60.72 93.27 0.03 OUTLIER 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.612 2.148 . . . . 0.57 109.281 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -174.38 -34.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.29 0 CA-C-N 112.359 -2.2 . . . . 0.57 113.407 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 242' ' ' TYR . . . 141.73 -112.97 0.79 Allowed Glycine 0 C--N 1.387 3.41 0 CA-C-O 123.378 1.543 . . . . 0.57 111.81 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 242' ' ' TYR . 26.5 p -82.11 117.68 22.47 Favored 'General case' 0 C--N 1.369 1.427 0 CA-C-N 114.27 -0.965 . . . . 0.57 110.23 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.75 176.87 4.92 Favored 'General case' 0 C--N 1.374 1.655 0 O-C-N 126.72 2.512 . . . . 0.57 110.75 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.5 tm? -70.55 -33.81 71.53 Favored 'General case' 0 C--N 1.382 2.006 0 CA-C-N 113.803 -1.544 . . . . 0.57 107.629 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.991 ' O ' HG23 ' A' ' 217' ' ' VAL . 27.5 t80 -57.53 -50.13 74.08 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.376 -1.453 . . . . 0.57 110.871 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -59.38 -51.41 70.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.57 110.847 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.857 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.78 -32.66 72.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.57 111.098 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 220' ' ' ILE . . . -68.35 -46.12 70.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.57 111.058 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 213' ' ' PHE . 20.1 t -63.33 -39.28 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.57 111.142 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.95 -46.27 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.57 110.879 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 220' ' ' ILE . 3.0 pt-20 -60.91 -44.52 97.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.91 110.837 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.821 HD11 ' HB1' ' A' ' 137' ' ' ALA . 10.1 pt -71.67 -32.82 46.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.235 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -65.17 -34.93 90.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.57 112.453 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.84 -42.07 97.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.57 110.908 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.9 m -70.95 -36.81 72.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.57 110.897 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.718 HD12 ' HA2' ' A' ' 221' ' ' GLY . 29.6 mt -40.64 -60.49 1.13 Allowed 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 123.443 1.592 . . . . 0.57 112.296 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.48 -30.38 0.17 Allowed Glycine 0 C--N 1.392 3.654 0 C-N-CA 118.403 -1.856 . . . . 0.57 112.404 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.769 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -82.81 160.24 22.28 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-N 112.396 -1.902 . . . . 0.57 112.558 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.56 -151.93 12.36 Favored Glycine 0 C--N 1.382 3.088 0 CA-C-O 123.96 1.867 . . . . 0.57 110.61 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -65.28 -97.81 0.0 OUTLIER 'General case' 0 C--N 1.38 1.911 0 CA-C-N 113.162 -1.519 . . . . 0.57 113.484 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 97.0 p -174.3 -32.99 0.01 OUTLIER 'General case' 0 C--N 1.373 1.604 0 C-N-CA 118.498 -1.281 . . . . 0.57 108.916 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.25 5.2 0.85 Allowed 'General case' 0 C--N 1.401 2.826 0 O-C-N 125.862 1.976 . . . . 0.57 114.663 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -135.65 140.51 34.08 Favored Pre-proline 0 C--N 1.382 2.009 0 N-CA-C 104.608 -2.367 . . . . 0.91 104.608 -169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.83 17.64 1.6 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 C-N-CA 123.568 2.845 . . . . 0.57 113.534 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 -0.29 5.52 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 114.109 -1.405 . . . . 0.57 113.729 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -99.3 124.14 44.16 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.709 1.719 . . . . 0.57 112.639 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.1 t -60.55 87.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.233 0 CA-C-N 113.927 -1.488 . . . . 0.57 113.381 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 3.3 mmm 159.62 -23.94 0.0 OUTLIER 'General case' 0 C--N 1.368 1.411 0 O-C-N 125.045 1.466 . . . . 0.57 111.77 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 5.3 p90 -51.86 153.87 4.09 Favored Pre-proline 0 C--N 1.369 1.432 0 CA-C-O 123.755 1.74 . . . . 0.57 111.999 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.99 -25.22 7.67 Favored 'Trans proline' 0 C--N 1.368 1.596 0 CA-C-O 117.773 -1.011 . . . . 0.57 112.304 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.2 m -41.06 113.67 0.41 Allowed 'General case' 0 C--N 1.368 1.391 0 CA-C-O 124.016 1.865 . . . . 0.57 110.337 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 181' ' ' LEU . 4.7 t80 -80.47 106.25 12.34 Favored 'General case' 0 C--N 1.369 1.453 0 N-CA-C 106.241 -1.763 . . . . 0.57 106.241 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -154.73 107.56 2.8 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 124.772 2.225 . . . . 0.57 107.095 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 210' ' ' THR . 50.1 p90 -61.62 118.03 6.55 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 126.09 2.852 . . . . 0.57 111.633 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 245' ' ' ILE . 2.5 p -101.97 -19.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.05 -1.886 . . . . 0.57 112.627 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 72.87 4.59 5.01 Favored 'General case' 0 C--N 1.365 1.277 0 O-C-N 126.303 2.252 . . . . 0.91 113.531 -179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.0 mt 79.59 7.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.376 1.737 0 CA-C-N 113.647 -1.615 . . . . 0.57 115.054 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -70.13 -35.16 73.88 Favored 'General case' 0 C--N 1.39 2.354 0 N-CA-C 105.107 -2.182 . . . . 0.57 105.107 -165.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.47 -22.79 8.57 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-N 112.394 -2.185 . . . . 0.57 113.087 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 235' ' ' VAL . 13.2 t80 -40.94 99.85 0.02 OUTLIER 'General case' 0 C--N 1.382 1.994 0 O-C-N 125.729 1.893 . . . . 0.57 110.326 -175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -164.64 147.28 8.63 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 112.189 -2.278 . . . . 1.2 106.946 -171.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.811 HD11 ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.99 127.71 55.84 Favored 'General case' 0 C--N 1.372 1.563 0 CA-C-O 124.657 2.17 . . . . 0.57 107.511 -173.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.69 158.8 35.5 Favored 'General case' 0 C--N 1.362 1.116 0 O-C-N 120.445 -1.409 . . . . 0.57 112.014 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.64 ' HA ' HD11 ' A' ' 255' ' ' ILE . . . -56.32 -43.64 79.18 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.289 -1.323 . . . . 0.57 109.491 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -41.56 95.11 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.021 0.528 . . . . 0.91 110.846 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 258' ' ' ILE . 16.2 t0 -63.82 -55.1 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.91 110.869 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.91 HG21 HG11 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -65.94 -35.93 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.134 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.64 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 18.1 mtp85 -70.19 -32.3 70.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.88 -44.83 77.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 0.57 112.495 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.769 ' HB ' HD12 ' A' ' 226' ' ' LEU . 1.1 pt -66.16 -44.7 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.57 111.118 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.543 ' HA ' ' CE1' ' A' ' 262' ' ' TYR . 1.0 OUTLIER -70.77 -20.7 62.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.57 110.891 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.3 t -64.27 -15.07 59.43 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.063 1.411 . . . . 0.57 111.35 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.75 -85.99 0.07 Allowed 'General case' 0 C--N 1.385 2.117 0 CA-C-O 123.653 1.692 . . . . 0.57 115.348 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.543 ' CE1' ' HA ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.31 -178.14 0.34 Allowed 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.932 -1.94 . . . . 0.57 112.85 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.413 ' HA2' ' HG3' ' A' ' 146' ' ' PRO . . . . . . . . 0 C--N 1.38 2.976 0 CA-C-O 114.202 -3.555 . . . . 0.91 114.722 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.676 ' H30' ' HA ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.059 0 N-CA-C 111.626 -0.59 . . . . 0.57 111.626 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.41 -86.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.36 1.374 . . . . 0.57 111.087 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.72 117.27 26.22 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 N-CA-C 106.245 -1.761 . . . . 0.57 106.245 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -142.6 148.78 38.05 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-N 112.636 -2.074 . . . . 0.57 108.673 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.52 158.16 45.09 Favored 'General case' 0 C--N 1.385 2.122 0 CA-C-O 124.674 2.178 . . . . 1.2 109.034 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.28 -48.75 0.03 OUTLIER 'General case' 0 C--N 1.389 2.284 0 CA-C-N 113.564 -1.653 . . . . 0.57 110.838 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.63 -40.03 95.86 Favored 'General case' 0 C--N 1.389 2.291 0 CA-C-N 113.505 -1.68 . . . . 0.57 108.35 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.84 103.58 11.57 Favored 'General case' 0 C--N 1.384 2.104 0 O-C-N 125.324 1.64 . . . . 0.57 110.88 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.03 154.84 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.158 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -106.03 142.98 34.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.106 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 159' ' ' ILE . 8.3 t80 -140.57 160.07 40.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.57 110.916 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.52 121.84 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.2 110.824 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.705 HG21 ' CE2' ' A' ' 121' ' ' TYR . 1.2 mm -99.4 138.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.57 111.146 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -62.57 173.59 1.22 Allowed 'General case' 0 C--N 1.363 1.187 0 CA-C-O 124.324 2.011 . . . . 0.57 108.944 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.67 73.31 6.38 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 125.166 2.412 . . . . 0.57 109.971 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.705 ' CE2' HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -72.17 -177.53 2.13 Favored 'General case' 0 C--N 1.374 1.648 0 CA-C-N 112.357 -2.201 . . . . 0.57 110.467 173.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.465 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER 160.56 -53.4 0.0 OUTLIER Pre-proline 0 C--N 1.38 1.912 0 C-N-CA 125.337 1.455 . . . . 0.57 107.809 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 122' ' ' THR . 19.0 Cg_endo -75.36 -72.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.406 3.581 0 N-CA-C 108.022 -1.569 . . . . 0.57 108.022 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.86 -7.68 57.02 Favored 'General case' 0 C--N 1.398 2.677 0 CA-C-N 113.131 -1.85 . . . . 0.91 106.578 -171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 122' ' ' THR . 6.4 mtm -154.42 136.04 14.33 Favored 'General case' 0 C--N 1.386 2.191 0 CA-C-N 116.001 -0.545 . . . . 0.57 109.638 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.2 m-20 -90.98 141.63 28.63 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-O 123.182 1.468 . . . . 0.57 109.328 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.426 ' HA ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -64.47 -50.11 68.76 Favored 'General case' 0 C--N 1.384 2.076 0 CA-C-N 114.324 -1.307 . . . . 1.2 109.109 -170.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.25 -35.28 69.54 Favored 'General case' 0 C--N 1.374 1.666 0 CA-C-N 111.992 -2.367 . . . . 0.91 110.874 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 205' ' ' THR . 3.6 m-20 -70.33 -43.78 69.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.91 110.862 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 126' ' ' ASN . 19.1 t -68.69 -39.74 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.57 111.179 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.35 -44.11 97.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.91 110.873 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -40.94 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.824 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.98 -49.19 66.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.57 111.139 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 130' ' ' VAL . 25.2 pt -62.4 -36.9 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.57 111.167 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -63.72 -43.74 95.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.853 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.84 -46.06 89.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.57 110.933 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.09 83.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.57 111.082 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 3.7 m-85 -62.95 -44.06 97.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.821 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.2 pt20 -63.45 -36.21 82.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.57 110.971 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 136' ' ' LYS . 16.0 t -69.64 -34.2 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.57 111.123 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 224' ' ' LEU . 34.1 m95 -83.05 -34.06 26.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.923 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 m -78.99 -51.08 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.57 110.916 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.653 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.4 p-10 -56.2 -13.96 2.45 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 114.103 1.149 . . . . 0.57 114.103 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.653 HG13 ' OD1' ' A' ' 143' ' ' ASN . 20.2 m -113.34 -8.77 12.18 Favored 'Isoleucine or valine' 0 C--N 1.389 2.29 0 CA-C-N 113.876 -1.511 . . . . 0.57 112.298 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.47 141.93 15.16 Favored Pre-proline 0 C--N 1.383 2.055 0 CA-C-O 125.379 2.514 . . . . 0.57 110.14 -172.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 145' ' ' THR . 57.0 Cg_endo -79.7 71.21 7.16 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.138 1.892 . . . . 0.57 114.593 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -169.35 83.52 0.13 Allowed 'General case' 0 C--N 1.39 2.328 0 N-CA-C 106.698 -1.593 . . . . 0.57 106.698 -168.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -72.37 162.16 29.84 Favored 'General case' 0 C--N 1.383 2.048 0 CA-C-O 125.739 2.685 . . . . 0.57 115.672 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' ' O ' ' A' ' 147' ' ' LEU . 2.9 m-85 -136.63 158.9 43.37 Favored 'General case' 0 C--N 1.39 2.354 0 CA-C-N 113.004 -1.907 . . . . 0.57 106.09 -172.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -157.48 121.61 4.24 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.879 2.276 . . . . 0.57 108.301 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 133.4 37.17 Favored 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.65 -1.613 . . . . 0.57 110.513 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 157' ' ' ALA . 6.2 pt -107.18 171.95 2.01 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-O 124.214 1.959 . . . . 0.57 110.921 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -141.72 51.65 1.53 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 113.482 -1.69 . . . . 0.57 110.566 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 p -117.66 -62.59 1.54 Allowed 'General case' 0 C--N 1.384 2.096 0 CA-C-N 113.479 -1.691 . . . . 0.57 109.887 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.68 -152.87 5.73 Favored Glycine 0 C--N 1.381 3.028 0 N-CA-C 108.796 -1.722 . . . . 0.57 108.796 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.4 ttp -72.11 110.49 6.62 Favored 'General case' 0 C--N 1.386 2.176 0 CA-C-O 123.705 1.716 . . . . 0.57 108.246 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -98.19 177.83 5.27 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.058 -1.883 . . . . 0.57 111.186 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.96 -59.38 4.91 Favored 'General case' 0 C--N 1.397 2.645 0 CA-C-N 112.456 -2.156 . . . . 0.91 105.233 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 116' ' ' TYR . 6.3 mt -95.79 111.47 26.22 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 C-N-CA 122.942 0.497 . . . . 0.57 111.14 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 126.59 51.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.57 110.942 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.57 111.083 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.556 HG13 ' ND2' ' A' ' 119' ' ' ASN . 3.9 t -133.15 128.94 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.57 111.134 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -85.0 122.77 29.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.57 110.884 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -146.53 170.14 17.5 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 118.812 -1.155 . . . . 0.57 108.636 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.91 167.8 9.72 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.69 -1.595 . . . . 1.2 108.842 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -38.1 118.91 0.72 Allowed Glycine 0 C--N 1.389 3.497 0 CA-C-N 114.135 -1.393 . . . . 0.57 111.956 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 81.37 63.44 0.02 OUTLIER 'General case' 0 C--N 1.417 3.524 0 CA-C-O 125.469 2.557 . . . . 0.57 114.117 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.688 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 22.7 p-80 -105.38 -61.45 1.48 Allowed 'General case' 0 C--N 1.386 2.19 0 CA-C-N 113.12 -1.855 . . . . 0.57 111.966 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.06 -115.85 0.85 Allowed Glycine 0 C--N 1.389 3.486 0 C-N-CA 119.188 -1.482 . . . . 0.57 110.077 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -37.62 -34.73 0.11 Allowed 'General case' 0 C--N 1.388 2.24 0 N-CA-C 115.904 1.816 . . . . 0.91 115.904 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.72 87.94 2.62 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-O 124.884 2.278 . . . . 0.57 113.364 171.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 69.6 m80 -80.68 49.39 1.18 Allowed 'General case' 0 C--N 1.377 1.783 0 CA-C-N 113.871 -1.513 . . . . 0.57 110.502 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 160.03 69.2 0.0 OUTLIER 'General case' 0 C--N 1.395 2.579 0 CA-C-O 123.876 1.798 . . . . 0.57 110.263 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.549 ' CE2' HG22 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -83.05 -158.98 0.31 Allowed 'General case' 0 C--N 1.388 2.255 0 CA-C-N 112.961 -1.927 . . . . 0.57 113.753 173.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.16 173.39 6.32 Favored 'General case' 0 C--N 1.388 2.251 0 CA-C-N 114.627 -1.169 . . . . 0.91 111.686 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.51 114.69 0.89 Allowed Glycine 1 C--N 1.4 4.109 0 CA-C-N 111.566 -2.561 . . . . 0.57 113.89 166.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER 70.85 82.8 0.15 Allowed 'General case' 0 C--N 1.406 3.037 0 CA-C-O 124.757 2.218 . . . . 0.57 113.533 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.51 -155.7 22.05 Favored Glycine 0 C--N 1.376 2.786 0 CA-C-N 114.259 -1.337 . . . . 0.57 110.67 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -35.71 149.17 0.03 OUTLIER Glycine 1 C--N 1.403 4.276 0 CA-C-N 113.384 -1.408 . . . . 0.57 110.098 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.549 HG22 ' CE2' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 89.28 65.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.399 2.731 0 N-CA-C 108.483 -0.932 . . . . 0.57 108.483 175.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.548 HD12 ' OE1' ' A' ' 201' ' ' GLU . 4.3 mp -71.22 -37.45 72.05 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-O 123.448 1.594 . . . . 0.57 111.78 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 197' ' ' PHE . . . -174.33 179.84 1.74 Allowed 'General case' 0 C--N 1.364 1.199 0 CA-C-N 113.986 -1.461 . . . . 0.57 111.09 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -164.23 142.46 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.57 110.874 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.94 167.52 23.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.57 111.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 191' ' ' ILE . 2.3 m-85 -77.02 -87.1 0.05 OUTLIER 'General case' 0 C--N 1.372 1.562 0 C-N-CA 117.749 -1.58 . . . . 0.57 108.699 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 193' ' ' GLY . . . 120.12 -61.22 0.51 Allowed Glycine 0 C--N 1.397 3.956 0 C-N-CA 119.848 -1.168 . . . . 0.57 112.836 -175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.91 56.13 5.22 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.142 2.561 . . . . 0.57 111.774 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' HA3' ' A' ' 192' ' ' GLY . . . 47.66 -154.79 1.22 Allowed Glycine 0 C--N 1.39 3.536 0 CA-C-O 123.579 1.655 . . . . 0.57 111.265 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.76 57.61 0.01 OUTLIER 'General case' 0 C--N 1.387 2.228 0 CA-C-O 123.965 1.841 . . . . 0.57 106.524 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.79 -88.92 0.37 Allowed Glycine 0 C--N 1.398 3.996 0 O-C-N 120.692 -1.255 . . . . 0.57 110.008 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.468 HG21 ' CZ ' ' A' ' 185' ' ' PHE . 1.7 tp -62.2 0.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.165 0 CA-C-O 124.964 2.316 . . . . 0.57 113.854 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 188' ' ' GLY . . . -73.37 117.21 5.77 Favored Glycine 0 C--N 1.393 3.737 0 C-N-CA 117.384 -2.341 . . . . 0.57 107.283 -169.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 186' ' ' GLY . . . 109.35 -44.73 1.44 Allowed Glycine 0 C--N 1.373 2.584 0 O-C-N 124.871 0.983 . . . . 0.57 114.123 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.68 113.4 0.89 Allowed 'General case' 0 C--N 1.385 2.123 0 CA-C-N 115.358 -0.421 . . . . 0.91 110.841 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -111.68 156.82 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.57 111.111 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -130.17 131.9 45.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.859 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 215' ' ' THR . 2.4 m-85 -104.04 148.51 26.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.57 110.944 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.564 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.0 p-10 -89.97 102.46 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.91 110.853 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -36.55 64.42 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 116.912 -1.518 . . . . 0.91 109.3 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -45.5 -40.96 9.09 Favored 'General case' 0 C--N 1.376 1.761 0 O-C-N 125.366 1.666 . . . . 0.91 107.507 -163.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.548 ' OE1' HD12 ' A' ' 181' ' ' LEU . 12.4 mt-10 -56.48 -173.28 0.01 OUTLIER 'General case' 0 C--N 1.391 2.378 0 CA-C-O 128.143 3.83 . . . . 0.91 114.439 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.4 77.44 1.57 Allowed 'General case' 0 C--N 1.379 1.865 0 O-C-N 118.091 -2.88 . . . . 0.57 108.941 -172.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.493 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 52.1 m95 -72.82 115.45 12.13 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-O 122.64 1.21 . . . . 0.57 108.317 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.3 p -123.89 128.02 48.86 Favored 'General case' 0 C--N 1.384 2.094 0 CA-C-O 123.965 1.841 . . . . 0.57 109.425 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' ASP . 5.1 p -116.2 105.94 13.14 Favored 'General case' 0 C--N 1.369 1.424 0 CA-C-O 122.939 1.352 . . . . 0.57 108.724 -176.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 172.5 -51.94 0.01 OUTLIER 'General case' 0 C--N 1.395 2.568 0 CA-C-N 112.877 -1.965 . . . . 0.57 107.099 175.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 158.66 50.72 0.0 OUTLIER 'General case' 0 C--N 1.412 3.316 0 O-C-N 126.315 2.259 . . . . 0.57 110.172 -171.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.16 -108.46 2.69 Favored Glycine 0 C--N 1.393 3.74 0 C-N-CA 118.16 -1.972 . . . . 0.57 113.681 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.97 -91.49 2.21 Favored Glycine 0 C--N 1.397 3.957 0 CA-C-O 124.857 2.365 . . . . 0.57 112.792 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 p -73.89 117.5 15.75 Favored 'General case' 0 C--N 1.384 2.088 0 CA-C-O 123.847 1.784 . . . . 0.57 111.454 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -111.15 150.26 29.72 Favored 'General case' 0 C--N 1.388 2.279 0 CA-C-N 112.307 -2.224 . . . . 0.57 110.13 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.6 tm? -73.45 -32.7 64.51 Favored 'General case' 0 C--N 1.394 2.505 0 CA-C-O 124.412 2.053 . . . . 0.57 108.858 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.707 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.7 t80 -52.28 -50.08 62.84 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 112.678 -2.056 . . . . 0.57 110.848 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.5 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -62.29 -43.61 98.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.57 110.924 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.608 HG21 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -61.27 -49.36 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.57 111.19 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.2 73.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.107 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.761 HG11 ' HE1' ' A' ' 248' ' ' PHE . 53.3 t -64.48 -48.18 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.143 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -71.57 -43.21 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.57 110.867 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -57.91 -42.14 84.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.91 110.877 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.46 HG21 ' CD1' ' A' ' 141' ' ' TRP . 57.7 mt -69.61 -39.78 78.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.57 111.187 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.453 ' C ' ' HE3' ' A' ' 236' ' ' MET . . . -61.46 -33.78 85.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.57 112.465 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.59 ' N ' ' HE3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -63.85 -44.28 93.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.353 . . . . 0.57 110.813 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' LEU . 71.1 m -71.27 -44.5 65.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.57 110.864 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -36.38 -47.79 0.62 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 119.771 -0.772 . . . . 0.57 112.557 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.13 -106.47 0.22 Allowed Glycine 1 C--N 1.398 4.026 0 O-C-N 126.699 2.499 . . . . 0.57 112.061 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.408 HD13 ' CD1' ' A' ' 261' ' ' LEU . 0.8 OUTLIER -48.01 172.78 0.01 OUTLIER 'General case' 0 C--N 1.395 2.559 0 CA-C-O 125.726 2.679 . . . . 0.57 112.554 173.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.35 -120.91 0.02 OUTLIER Glycine 0 C--N 1.392 3.665 0 CA-C-O 126.133 3.074 . . . . 0.57 110.677 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -123.96 -76.19 0.59 Allowed 'General case' 0 C--N 1.391 2.382 0 CA-C-N 112.258 -1.971 . . . . 0.57 108.375 -174.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -177.36 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.754 -1.567 . . . . 0.57 108.373 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.06 23.48 0.31 Allowed 'General case' 0 C--N 1.422 3.727 0 N-CA-C 118.925 2.935 . . . . 0.57 118.925 -171.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -137.65 143.29 39.96 Favored Pre-proline 0 C--N 1.398 2.703 0 C-N-CA 116.348 -2.141 . . . . 0.91 106.086 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 71.7 Cg_exo -54.97 -41.11 81.94 Favored 'Trans proline' 0 C--N 1.375 1.93 0 CA-C-O 124.724 1.885 . . . . 0.57 114.09 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -41.91 86.18 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-N 111.61 -2.541 . . . . 0.57 113.492 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -50.82 125.21 12.79 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-O 125.317 2.484 . . . . 0.57 111.82 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.788 HG22 ' H30' ' A' ' 269' ' ' HSI . 0.4 OUTLIER -76.03 -1.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.386 2.154 0 CA-C-N 112.473 -2.149 . . . . 0.57 112.504 -177.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.59 ' HE3' ' N ' ' A' ' 222' ' ' HIS . 0.8 OUTLIER -124.62 -5.49 7.58 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-N 114.056 -1.429 . . . . 0.57 109.03 -177.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.771 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -40.57 148.2 0.36 Allowed Pre-proline 0 C--N 1.376 1.753 0 CA-C-O 125.22 2.438 . . . . 0.57 113.951 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.432 ' O ' ' H14' ' A' ' 269' ' ' HSI . 76.2 Cg_exo -53.57 -48.85 19.68 Favored 'Trans proline' 0 C--N 1.381 2.289 0 O-C-N 118.824 -1.198 . . . . 0.57 113.7 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.486 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -51.74 135.13 29.82 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-O 125.012 2.339 . . . . 0.57 110.959 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.66 142.57 34.09 Favored 'General case' 0 C--N 1.386 2.154 0 CA-C-O 123.106 1.431 . . . . 0.57 107.362 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -158.28 114.56 2.77 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-O 124.515 2.102 . . . . 0.57 108.453 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -55.25 118.57 4.5 Favored 'General case' 0 C--N 1.368 1.398 0 CA-C-O 126.433 3.016 . . . . 0.57 108.861 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 243' ' ' VAL . 2.6 p -125.41 -13.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 CA-C-N 112.498 -2.137 . . . . 0.57 111.062 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.266 0.7 OUTLIER 70.53 4.36 4.92 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-O 123.153 1.454 . . . . 0.91 112.811 176.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 213' ' ' PHE . 2.0 mt 77.88 4.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.394 2.533 0 CA-C-N 113.347 -1.751 . . . . 0.57 114.315 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.11 -33.17 69.89 Favored 'General case' 0 C--N 1.379 1.85 0 N-CA-C 104.593 -2.373 . . . . 0.57 104.593 -163.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -112.7 -16.65 12.74 Favored 'General case' 0 C--N 1.39 2.365 0 CA-C-N 112.739 -2.028 . . . . 0.57 113.107 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.761 ' HE1' HG11 ' A' ' 217' ' ' VAL . 19.2 t80 -38.86 99.46 0.02 OUTLIER 'General case' 0 C--N 1.388 2.28 0 CA-C-O 126.034 2.826 . . . . 0.57 109.319 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -133.09 149.12 52.16 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-N 112.18 -2.282 . . . . 1.2 105.374 -175.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.617 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.09 130.38 56.11 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 126.7 3.143 . . . . 0.57 107.325 -173.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.87 145.43 42.75 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 117.99 -2.944 . . . . 0.57 110.606 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.05 86.43 Favored 'General case' 0 C--N 1.4 2.797 0 CA-C-N 113.676 -1.602 . . . . 0.57 110.416 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -35.74 81.1 Favored 'General case' 0 C--N 1.367 1.342 0 CA-C-N 114.874 -1.057 . . . . 0.91 110.802 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 t70 -63.36 -55.29 25.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.91 110.854 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.0 pt -66.04 -36.56 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.57 111.168 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 34.7 mtt180 -70.3 -34.1 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 1.2 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.29 -47.52 79.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.57 112.511 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.35 -45.46 95.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.57 111.163 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.685 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.3 -21.03 61.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.57 110.933 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.44 -28.33 66.03 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-O 125.154 2.407 . . . . 0.57 110.22 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.408 ' CD1' HD13 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -60.38 -64.79 0.83 Allowed 'General case' 0 C--N 1.4 2.798 0 CA-C-O 124.55 2.119 . . . . 0.57 109.63 -175.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.56 80.53 3.13 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 113.372 -1.74 . . . . 0.57 113.279 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.39 3.577 0 N-CA-C 120.488 2.955 . . . . 0.91 120.488 -170.593 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.788 ' H30' HG22 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.254 0 CA-C-O 119.597 -0.557 . . . . 0.57 113.181 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.07 168.92 1.06 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 O-C-N 124.58 1.832 . . . . 0.57 111.043 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.11 144.86 29.96 Favored 'Isoleucine or valine' 0 C--N 1.373 1.625 0 CA-C-N 112.992 -1.913 . . . . 0.57 109.866 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.45 102.59 0.42 Allowed 'General case' 0 C--N 1.389 2.31 0 CA-C-O 124.095 1.902 . . . . 0.57 109.625 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.47 151.1 50.46 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-O 123.712 1.72 . . . . 1.2 109.368 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.53 -49.84 0.02 OUTLIER 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.851 -1.522 . . . . 0.57 110.646 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.21 -8.55 27.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 112.98 -1.918 . . . . 0.57 111.091 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -114.56 112.76 23.45 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.169 -0.923 . . . . 0.57 110.872 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.11 138.19 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.57 111.119 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.855 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -109.26 135.27 50.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.57 111.109 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -129.81 150.9 50.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.888 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -143.52 129.88 19.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.2 110.903 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.51 HD12 ' HZ ' ' A' ' 163' ' ' PHE . 2.0 mm -99.03 130.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.57 111.169 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' ND2' HD13 ' A' ' 160' ' ' LEU . 24.6 m-20 -118.89 131.67 56.07 Favored 'General case' 0 C--N 1.368 1.385 0 N-CA-C 107.636 -1.246 . . . . 0.57 107.636 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.3 t30 50.41 81.13 0.07 Allowed 'General case' 0 C--N 1.391 2.401 0 O-C-N 126.527 2.392 . . . . 0.57 109.587 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 163' ' ' PHE . 22.6 m-85 -37.73 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.391 2.395 0 O-C-N 126.721 2.513 . . . . 0.57 109.514 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.55 HG23 ' HD2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 175.0 135.14 0.16 Allowed Pre-proline 0 C--N 1.371 1.522 0 C-N-CA 118.285 -1.366 . . . . 0.57 108.355 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 122' ' ' THR . 36.6 Cg_endo -78.17 -52.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-O 122.341 0.892 . . . . 0.57 110.938 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -77.22 -33.29 56.19 Favored 'General case' 0 C--N 1.388 2.256 0 CA-C-N 113.937 -1.483 . . . . 0.91 114.486 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.524 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -94.38 134.24 37.09 Favored 'General case' 0 C--N 1.374 1.663 0 CA-C-O 125.747 2.689 . . . . 0.57 106.002 -173.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.53 139.7 53.83 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-N 113.44 -1.709 . . . . 0.57 110.555 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -48.63 37.6 Favored 'General case' 0 C--N 1.378 1.821 0 N-CA-C 106.918 -1.512 . . . . 1.2 106.918 -169.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -35.26 62.33 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.788 -2.005 . . . . 0.91 110.89 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.04 -43.15 71.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.91 110.869 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.4 t -63.42 -37.94 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.57 111.082 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.411 ' OD1' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -68.51 -40.36 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.91 110.847 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' CE ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -65.29 -41.8 93.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.57 110.877 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.842 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.23 -49.12 73.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.57 111.111 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.411 HD11 ' OD1' ' A' ' 131' ' ' ASP . 22.7 pt -62.55 -40.16 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.57 111.178 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -60.59 -43.39 97.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 1.2 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -62.92 -43.4 98.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.873 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 140' ' ' VAL . . . -61.59 -39.65 91.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.57 111.117 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.488 ' CE1' ' CE2' ' A' ' 116' ' ' TYR . 17.3 m-85 -67.17 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.57 110.917 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -67.66 -40.49 84.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.57 110.909 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.0 p -71.46 -33.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.57 111.16 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.746 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 5.1 m95 -82.59 -34.04 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.925 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 m -79.21 -49.18 12.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.57 110.817 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.636 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.1 p-10 -59.36 -13.3 7.79 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-O 121.804 0.811 . . . . 0.57 112.564 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 140' ' ' VAL . 19.8 m -113.91 12.77 8.19 Favored 'Isoleucine or valine' 0 C--N 1.382 2.022 0 CA-C-N 114.145 -1.388 . . . . 0.57 112.028 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 141' ' ' TRP . 29.5 p -148.03 146.75 24.46 Favored Pre-proline 0 N--CA 1.428 -1.544 0 CA-C-O 124.132 1.92 . . . . 0.57 109.197 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.86 8.74 3.59 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.285 1.323 . . . . 0.57 114.449 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.566 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -112.51 110.76 21.13 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.358 -1.292 . . . . 0.57 109.117 -177.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.92 158.56 35.24 Favored 'General case' 0 C--N 1.382 1.999 0 CA-C-O 123.672 1.701 . . . . 0.57 114.778 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.566 ' HE1' HD12 ' A' ' 147' ' ' LEU . 15.6 m-30 -126.5 151.37 47.92 Favored 'General case' 0 C--N 1.389 2.314 0 CA-C-N 112.788 -2.005 . . . . 0.57 108.675 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.99 110.99 2.66 Favored 'General case' 0 C--N 1.39 2.364 0 CA-C-O 124.653 2.168 . . . . 0.57 108.302 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -95.2 133.41 39.08 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 113.776 -1.556 . . . . 0.57 110.254 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 155' ' ' GLY . 5.9 pt -117.14 173.78 4.08 Favored 'Isoleucine or valine' 0 C--N 1.372 1.562 0 CA-C-O 124.175 1.941 . . . . 0.57 109.957 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -127.2 -2.03 6.37 Favored 'General case' 0 C--N 1.384 2.067 0 CA-C-N 113.175 -1.83 . . . . 0.57 112.687 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 m -136.72 89.4 2.45 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 114.583 -1.189 . . . . 0.57 108.067 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 152' ' ' ILE . . . 124.29 99.69 1.32 Allowed Glycine 0 C--N 1.386 3.36 0 C-N-CA 118.956 -1.592 . . . . 0.57 110.513 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.4 ttp -42.95 118.35 1.25 Allowed 'General case' 0 C--N 1.377 1.804 0 CA-C-O 122.56 1.172 . . . . 0.57 111.3 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.855 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -95.34 169.79 9.82 Favored 'General case' 0 C--N 1.381 1.957 0 CA-C-N 113.025 -1.898 . . . . 0.57 109.517 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -54.45 23.29 Favored 'General case' 0 C--N 1.386 2.179 0 CA-C-N 113.501 -1.681 . . . . 0.91 110.586 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 116' ' ' TYR . 3.5 mt -90.64 109.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.385 2.143 0 O-C-N 127.846 3.216 . . . . 0.57 111.127 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -107.98 129.45 55.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.57 110.856 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.413 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -115.98 116.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.57 111.08 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -133.47 124.88 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.57 111.109 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -93.7 121.42 35.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.57 110.876 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -145.33 168.01 21.5 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 123.701 1.715 . . . . 0.57 108.51 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.71 160.28 16.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.592 -1.262 . . . . 1.2 107.592 -177.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 167' ' ' ALA . . . -39.28 93.87 0.01 OUTLIER Glycine 0 C--N 1.385 3.26 0 O-C-N 125.894 1.997 . . . . 0.57 117.401 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . 154.31 45.57 0.0 OUTLIER 'General case' 0 C--N 1.405 2.982 0 CA-C-O 125.734 2.683 . . . . 0.57 112.898 -165.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -159.85 -155.78 0.47 Allowed 'General case' 0 C--N 1.38 1.899 0 CA-C-N 113.416 -1.72 . . . . 0.57 109.874 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.91 -175.37 2.07 Favored Glycine 0 C--N 1.39 3.577 0 CA-C-O 122.499 1.055 . . . . 0.57 113.504 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER 59.83 77.47 0.31 Allowed 'General case' 0 C--N 1.416 3.457 0 CA-C-O 124.688 2.185 . . . . 0.91 107.399 167.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 78.94 -154.27 0.02 OUTLIER 'General case' 0 C--N 1.381 1.937 0 CA-C-N 112.388 -2.187 . . . . 0.57 111.791 -174.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -115.4 -127.17 0.29 Allowed 'General case' 0 C--N 1.386 2.163 0 CA-C-O 122.694 1.235 . . . . 0.57 109.052 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.92 85.43 0.22 Allowed 'General case' 0 C--N 1.387 2.219 0 N-CA-C 108.211 -1.033 . . . . 0.57 108.211 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.532 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.5 OUTLIER -50.64 168.54 0.05 OUTLIER 'General case' 0 C--N 1.388 2.277 0 O-C-N 126.7 2.5 . . . . 0.57 107.152 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -44.57 163.21 0.02 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 117.904 -1.518 . . . . 0.91 112.969 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 200' ' ' ASP . . . -149.53 48.25 0.6 Allowed Glycine 0 C--N 1.388 3.458 0 C-N-CA 117.287 -2.387 . . . . 0.57 111.815 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -168.66 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.389 2.323 0 C-N-CA 118.868 -1.133 . . . . 0.57 111.336 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -165.3 -61.65 0.02 OUTLIER Glycine 0 C--N 1.392 3.663 0 CA-C-O 125.014 2.452 . . . . 0.57 112.852 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -42.84 147.16 0.75 Allowed Glycine 0 C--N 1.376 2.802 0 O-C-N 118.963 -2.493 . . . . 0.57 110.24 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.532 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 1.6 mt 84.75 49.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-O 122.462 1.125 . . . . 0.57 108.951 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 214' ' ' LEU . 9.9 tp -42.94 -41.72 3.46 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.876 2.274 . . . . 0.57 111.345 -172.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 179.84 -174.31 0.25 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 112.415 -2.175 . . . . 0.57 111.047 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -143.95 158.59 43.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.57 110.879 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 222' ' ' HIS . . . -151.02 155.19 38.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 0.57 111.087 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.407 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 5.4 m-85 -117.44 -179.52 3.75 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 105.249 -2.13 . . . . 0.57 105.249 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' O ' ' CA ' ' A' ' 192' ' ' GLY . . . -122.15 -160.11 10.85 Favored Glycine 0 C--N 1.382 3.101 0 C-N-CA 119.795 -1.193 . . . . 0.57 111.493 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.44 -65.94 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.831 1.687 . . . . 0.57 112.508 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.44 -104.87 0.07 OUTLIER Glycine 0 C--N 1.395 3.858 0 O-C-N 125.605 1.816 . . . . 0.57 110.537 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.72 129.3 0.04 OUTLIER 'General case' 0 C--N 1.393 2.478 0 CA-C-N 112.794 -1.703 . . . . 0.57 108.886 175.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -95.86 1.64 Allowed Glycine 0 C--N 1.388 3.445 0 CA-C-O 122.773 1.207 . . . . 0.57 110.697 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.3 tp -66.85 -11.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.394 2.541 0 CA-C-O 126.845 3.212 . . . . 0.57 110.745 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 186' ' ' GLY . . . -66.71 134.34 32.53 Favored Glycine 0 C--N 1.377 2.827 0 N-CA-C 107.12 -2.392 . . . . 0.57 107.12 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.407 ' H ' ' CB ' ' A' ' 185' ' ' PHE . . . 96.49 -4.68 64.35 Favored Glycine 0 C--N 1.375 2.704 0 N-CA-C 110.169 -1.172 . . . . 0.57 110.169 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.78 141.25 39.35 Favored 'General case' 0 C--N 1.378 1.841 0 CA-C-N 114.221 -0.99 . . . . 0.91 110.872 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.03 132.63 22.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.57 111.098 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -126.52 143.2 51.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.57 110.89 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.527 ' CD2' ' CD1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.55 148.38 26.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.685 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 3.8 p-10 -81.12 87.89 6.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.91 110.854 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -74.26 5.49 4.45 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.566 1.174 . . . . 0.91 111.615 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 4.1 t0 -78.77 -35.13 44.98 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-O 123.328 1.537 . . . . 0.91 109.92 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -73.76 176.87 5.9 Favored 'General case' 0 C--N 1.382 1.998 0 CA-C-O 124.289 1.995 . . . . 0.91 108.965 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.53 111.11 23.09 Favored 'General case' 0 C--N 1.391 2.398 0 CA-C-N 112.642 -2.072 . . . . 0.57 112.992 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 36.4 m95 -92.62 148.0 22.42 Favored 'General case' 0 C--N 1.382 2.017 0 CA-C-N 113.144 -1.844 . . . . 0.57 108.495 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 14.4 m -121.28 104.21 9.55 Favored 'General case' 0 C--N 1.384 2.069 0 CA-C-N 114.143 -1.39 . . . . 0.57 107.806 -174.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -103.02 106.91 17.53 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 115.499 -0.773 . . . . 0.57 109.864 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 205' ' ' THR . 1.7 t-80 169.1 -70.71 0.0 OUTLIER 'General case' 0 C--N 1.392 2.429 0 N-CA-C 106.944 -1.502 . . . . 0.57 106.944 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.413 ' C ' ' OD2' ' A' ' 244' ' ' ASP . 4.7 p 150.75 63.19 0.0 OUTLIER 'General case' 0 C--N 1.399 2.731 0 CA-C-O 127.412 3.482 . . . . 0.57 110.325 -166.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.18 29.58 0.11 Allowed Glycine 0 C--N 1.394 3.803 0 C-N-CA 116.964 -2.541 . . . . 0.57 113.136 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.6 -162.32 35.81 Favored Glycine 0 C--N 1.383 3.144 0 CA-C-O 124.234 2.019 . . . . 0.57 110.873 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.443 ' N ' ' HB2' ' A' ' 242' ' ' TYR . 0.9 OUTLIER -77.08 122.26 24.71 Favored 'General case' 0 C--N 1.372 1.58 0 CA-C-O 123.478 1.608 . . . . 0.57 107.761 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 245' ' ' ILE . 17.8 p-10 -121.01 -167.77 1.55 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-N 112.84 -1.982 . . . . 0.57 111.039 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 133' ' ' ALA . 1.5 tm? -70.2 -33.54 71.83 Favored 'General case' 0 C--N 1.392 2.436 0 CA-C-N 112.901 -1.954 . . . . 0.57 109.541 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.734 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 9.8 t80 -51.75 -50.15 61.21 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 114.456 -1.247 . . . . 0.57 110.909 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -62.86 -51.02 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.57 110.948 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 219' ' ' GLU . 12.4 m -58.95 -35.65 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.17 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.565 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -67.2 -41.53 85.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.57 111.097 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 248' ' ' PHE . 93.7 t -64.15 -46.46 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.57 111.094 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -72.36 -49.91 30.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.57 110.762 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 215' ' ' THR . 8.2 mm-40 -57.66 -42.5 83.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.91 110.927 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 216' ' ' ALA . 60.7 mt -70.32 -43.32 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.57 111.121 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.814 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -56.82 -33.93 64.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.57 112.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -63.75 -41.09 98.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.749 0.309 . . . . 0.57 110.823 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -71.26 -44.36 65.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.867 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.814 HD12 ' HA2' ' A' ' 221' ' ' GLY . 84.3 mt -42.89 -62.54 0.99 Allowed 'General case' 0 C--N 1.365 1.248 0 CA-C-O 123.829 1.776 . . . . 0.57 112.148 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 226' ' ' LEU . . . 169.6 134.65 1.77 Allowed Glycine 0 C--N 1.374 2.694 0 N-CA-C 107.774 -2.131 . . . . 0.57 107.774 175.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.865 HD21 HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER 78.85 -170.54 0.05 OUTLIER 'General case' 0 C--N 1.393 2.494 0 CA-C-O 124.329 2.014 . . . . 0.57 109.524 176.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.21 -154.63 10.66 Favored Glycine 0 C--N 1.386 3.318 0 CA-C-O 125.728 2.849 . . . . 0.57 112.86 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -93.95 -178.97 4.82 Favored 'General case' 0 C--N 1.376 1.722 0 CA-C-N 111.217 -2.491 . . . . 0.57 110.717 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 3.2 p -72.24 -31.59 65.96 Favored 'General case' 0 C--N 1.387 2.236 0 CA-C-N 113.647 -1.615 . . . . 0.57 109.187 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 82.8 23.59 0.17 Allowed 'General case' 0 C--N 1.399 2.734 0 N-CA-C 114.932 1.456 . . . . 0.57 114.932 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.41 151.01 35.69 Favored Pre-proline 0 C--N 1.383 2.027 0 N-CA-C 105.361 -2.089 . . . . 0.91 105.361 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.34 75.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 124.826 3.684 . . . . 0.57 113.871 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 178.42 -33.56 0.01 OUTLIER 'General case' 0 C--N 1.374 1.644 0 CA-C-N 113.814 -1.539 . . . . 0.57 112.722 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -60.12 149.05 33.86 Favored 'General case' 0 C--N 1.382 2.02 0 CA-C-N 113.619 -1.628 . . . . 0.57 107.854 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 250' ' ' LEU . 0.7 OUTLIER -69.28 -0.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.099 0 CA-C-N 113.052 -1.885 . . . . 0.57 112.959 -177.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.442 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -160.1 28.53 0.17 Allowed 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 113.137 -1.847 . . . . 0.57 109.885 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.745 ' HE1' ' C26' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -48.64 147.41 4.33 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 123.866 1.793 . . . . 0.57 113.023 176.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' H14' ' A' ' 269' ' ' HSI . 72.5 Cg_exo -55.49 -50.15 13.72 Favored 'Trans proline' 0 C--N 1.373 1.824 0 O-C-N 118.875 -1.171 . . . . 0.57 112.44 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.588 ' O ' ' H16' ' A' ' 269' ' ' HSI . 0.3 OUTLIER -50.18 125.4 12.27 Favored 'General case' 0 C--N 1.368 1.382 0 CA-C-O 123.989 1.852 . . . . 0.57 110.553 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -81.34 144.96 31.11 Favored 'General case' 0 C--N 1.369 1.435 0 O-C-N 119.894 -1.754 . . . . 0.57 108.232 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 242' ' ' TYR . 0.8 OUTLIER -175.29 121.3 0.2 Allowed 'General case' 0 C--N 1.388 2.27 0 CA-C-O 124.187 1.946 . . . . 0.57 107.556 173.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 210' ' ' THR . 25.9 p90 -68.86 132.85 47.42 Favored 'General case' 0 C--N 1.368 1.393 0 CA-C-O 125.761 2.696 . . . . 0.57 109.704 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 245' ' ' ILE . 3.0 p -117.75 -16.88 7.82 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 O-C-N 119.759 -1.838 . . . . 0.57 113.353 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 246' ' ' ASN . 0.0 OUTLIER 79.18 -8.15 1.66 Allowed 'General case' 0 C--N 1.376 1.736 0 O-C-N 125.077 1.486 . . . . 0.91 114.393 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.641 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.8 mt 81.68 18.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.381 1.978 0 CA-C-N 114.028 -1.442 . . . . 0.57 112.524 -174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 1.6 t-20 -84.22 -28.57 27.18 Favored 'General case' 0 C--N 1.391 2.381 0 C-N-CA 114.057 -3.057 . . . . 0.57 103.11 -165.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.0 p -119.04 -6.84 10.45 Favored 'General case' 0 C--N 1.389 2.311 0 CA-C-N 112.603 -2.089 . . . . 0.57 112.237 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.666 ' HE1' HG11 ' A' ' 217' ' ' VAL . 39.5 t80 -38.09 97.33 0.01 OUTLIER 'General case' 0 C--N 1.384 2.068 0 CA-C-O 125.059 2.362 . . . . 0.57 110.588 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -134.58 151.72 51.28 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.665 -2.061 . . . . 1.2 105.46 -174.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.642 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.43 128.94 55.09 Favored 'General case' 0 C--N 1.376 1.76 0 CA-C-O 126.142 2.877 . . . . 0.57 108.337 -172.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.6 t -73.23 136.24 44.62 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.363 -2.711 . . . . 0.57 109.947 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -55.44 -44.78 76.63 Favored 'General case' 0 C--N 1.388 2.244 0 CA-C-N 113.996 -1.456 . . . . 0.57 109.094 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.07 -41.25 92.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.257 0.623 . . . . 0.91 110.917 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 20.9 t0 -64.03 -55.12 24.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.91 110.838 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.5 pt -66.12 -35.28 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.57 111.089 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.755 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.4 mtp85 -70.42 -34.08 72.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.2 110.86 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.18 -46.94 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.57 112.446 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.746 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 1.1 pt -64.48 -44.78 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.57 111.172 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.492 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.19 -21.0 61.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.57 110.952 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.1 t -74.07 -34.8 64.15 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 122.227 1.013 . . . . 0.57 109.533 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.865 HD11 HD21 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -49.37 -63.84 0.98 Allowed 'General case' 0 C--N 1.388 2.251 0 CA-C-O 124.325 2.012 . . . . 0.57 110.273 -173.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 79.15 2.93 Favored 'General case' 0 C--N 1.377 1.794 0 CA-C-N 113.114 -1.857 . . . . 0.57 112.617 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.374 2.69 0 CA-C-O 115.267 -2.963 . . . . 0.91 115.79 -175.235 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.745 ' C26' ' HE1' ' A' ' 237' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 CA-C-O 119.073 -0.848 . . . . 0.57 111.278 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.91 162.06 2.0 Favored 'Trans proline' 0 C--N 1.382 2.319 0 O-C-N 125.589 2.363 . . . . 0.57 111.919 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.53 118.98 59.76 Favored 'Isoleucine or valine' 0 C--N 1.385 2.119 0 CA-C-N 112.975 -1.92 . . . . 0.57 107.326 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -76.23 121.78 23.42 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.872 -1.967 . . . . 0.57 109.453 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -145.33 170.32 16.54 Favored 'General case' 0 C--N 1.39 2.329 0 CA-C-N 113.776 -1.556 . . . . 1.2 106.949 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.29 121.22 0.04 OUTLIER 'General case' 0 C--N 1.4 2.794 0 CA-C-N 114.106 -1.407 . . . . 0.57 111.456 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 77.47 -59.57 0.46 Allowed 'General case' 0 C--N 1.391 2.4 0 CA-C-N 114.585 -1.189 . . . . 0.57 112.325 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.14 125.34 53.68 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-N 114.64 -1.163 . . . . 0.57 110.875 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -119.85 154.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.106 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.9 p -119.96 160.07 23.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.57 111.103 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 3.0 t80 -147.07 152.88 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.57 110.933 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.566 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.97 122.0 14.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.852 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -98.97 126.32 52.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.57 111.097 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -59.59 -174.36 0.02 OUTLIER 'General case' 0 C--N 1.366 1.307 0 CA-C-O 124.873 2.273 . . . . 0.57 108.963 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -76.36 48.58 0.54 Allowed 'General case' 0 C--N 1.369 1.427 0 O-C-N 120.216 -1.552 . . . . 0.57 111.676 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 4.6 m-85 48.4 -148.24 0.22 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 122.467 1.127 . . . . 0.57 108.221 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -166.8 167.13 8.19 Favored Pre-proline 0 C--N 1.38 1.892 0 CA-C-N 113.703 -1.59 . . . . 0.57 108.839 -178.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 122' ' ' THR . 33.0 Cg_endo -72.39 -47.07 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 CA-C-O 122.673 1.03 . . . . 0.57 112.906 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 4.5 p-10 -71.92 -38.71 69.84 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 113.658 -1.61 . . . . 0.91 114.249 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.42 ' SD ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -89.43 110.67 21.47 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-O 125.427 2.537 . . . . 0.57 109.751 -178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -71.88 143.53 49.35 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 112.399 -2.182 . . . . 0.57 108.558 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.66 -49.33 59.94 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 114.18 -1.373 . . . . 1.2 107.529 -168.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.83 -34.74 63.19 Favored 'General case' 0 C--N 1.394 2.523 0 CA-C-N 112.586 -2.097 . . . . 0.91 110.903 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.25 -43.44 70.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.91 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -63.39 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.57 111.149 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.19 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.91 110.906 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.97 -49.0 79.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.57 110.937 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -60.6 -47.22 87.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.57 111.065 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 1.1 mm -66.77 -31.91 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.57 111.116 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -66.2 -47.85 72.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.849 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -40.35 97.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.57 110.898 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.88 94.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.57 111.082 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 220' ' ' ILE . 1.0 OUTLIER -67.19 -33.77 76.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.57 110.914 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -68.55 -42.12 78.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.57 110.909 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.7 p -69.69 -34.25 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.57 111.112 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.553 ' O ' HG23 ' A' ' 145' ' ' THR . 13.0 m95 -82.94 -34.04 26.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.57 110.898 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.1 m -79.2 -49.58 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.57 110.901 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.65 ' OD1' HG13 ' A' ' 144' ' ' VAL . 4.4 p-10 -58.68 -13.02 4.85 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 121.837 0.827 . . . . 0.57 113.104 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.65 HG13 ' OD1' ' A' ' 143' ' ' ASN . 21.4 m -114.01 12.03 8.11 Favored 'Isoleucine or valine' 0 C--N 1.391 2.375 0 CA-C-N 114.118 -1.401 . . . . 0.57 111.943 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 141' ' ' TRP . 24.2 p -150.76 145.04 17.85 Favored Pre-proline 0 C--N 1.381 1.953 0 CA-C-O 125.405 2.526 . . . . 0.57 108.619 -172.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.22 -24.27 9.6 Favored 'Trans proline' 0 C--N 1.37 1.679 0 O-C-N 118.344 -1.451 . . . . 0.57 111.891 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -82.35 102.87 11.52 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 114.077 -1.42 . . . . 0.57 111.176 178.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.11 162.45 28.97 Favored 'General case' 0 C--N 1.382 1.991 0 CA-C-O 124.108 1.909 . . . . 0.57 114.099 171.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -135.6 160.7 37.67 Favored 'General case' 0 C--N 1.392 2.433 0 CA-C-N 112.466 -2.152 . . . . 0.57 107.007 -172.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 m -160.3 122.34 3.22 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 125.177 2.418 . . . . 0.57 107.353 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -92.65 135.93 33.66 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.493 -1.685 . . . . 0.57 110.364 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.35 177.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.755 0 CA-C-O 124.254 1.978 . . . . 0.57 110.195 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -104.18 -38.76 6.77 Favored 'General case' 0 C--N 1.386 2.161 0 CA-C-N 112.581 -2.1 . . . . 0.57 112.401 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.4 p -130.25 133.27 46.39 Favored 'General case' 0 C--N 1.379 1.852 0 CA-C-O 122.409 1.099 . . . . 0.57 108.929 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.09 169.59 15.54 Favored Glycine 0 C--N 1.386 3.334 0 CA-C-O 123.864 1.813 . . . . 0.57 112.389 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.1 ttt -80.72 139.15 36.27 Favored 'General case' 0 C--N 1.389 2.292 0 CA-C-N 112.114 -2.043 . . . . 0.57 109.551 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -131.71 173.23 11.35 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-N 112.446 -2.161 . . . . 0.57 111.144 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.9 -59.33 2.53 Favored 'General case' 0 C--N 1.385 2.12 0 N-CA-C 103.501 -2.778 . . . . 0.91 103.501 -168.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 223' ' ' SER . 5.6 mt -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 C--N 1.389 2.288 0 O-C-N 125.064 1.478 . . . . 0.57 111.15 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -99.21 128.44 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.57 110.884 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 197' ' ' PHE . 1.0 OUTLIER -114.59 119.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.57 111.086 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.72 125.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.57 111.087 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.421 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.4 OUTLIER -98.51 122.76 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.86 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 199' ' ' GLU . . . -142.66 167.94 20.9 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-O 123.258 1.504 . . . . 0.57 107.12 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -112.48 135.63 52.95 Favored 'General case' 0 C--N 1.369 1.437 0 CA-C-N 114.097 -1.411 . . . . 1.2 109.775 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.13 -133.86 28.27 Favored Glycine 0 C--N 1.397 3.919 0 CA-C-O 124.913 2.396 . . . . 0.57 109.562 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.39 135.18 39.69 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 111.496 -2.352 . . . . 0.57 113.799 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 179.64 119.8 0.05 Allowed 'General case' 0 C--N 1.398 2.683 0 CA-C-N 113.533 -1.667 . . . . 0.57 107.096 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 40.65 -125.82 2.84 Favored Glycine 0 C--N 1.384 3.228 0 CA-C-O 123.804 1.78 . . . . 0.57 114.288 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -50.52 106.33 0.12 Allowed 'General case' 0 C--N 1.397 2.65 0 CA-C-N 110.772 -2.714 . . . . 0.91 112.853 165.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 83.58 75.63 0.02 OUTLIER 'General case' 0 C--N 1.409 3.185 0 CA-C-O 126.687 3.137 . . . . 0.57 107.786 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 21.9 p-80 -69.93 59.89 0.17 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 112.665 -2.062 . . . . 0.57 113.533 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 162.56 91.14 0.0 OUTLIER 'General case' 0 C--N 1.39 2.359 0 CA-C-O 122.931 1.348 . . . . 0.57 109.094 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -98.97 -157.08 0.58 Allowed 'General case' 0 C--N 1.384 2.074 0 CA-C-N 112.776 -2.011 . . . . 0.57 111.253 175.459 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.46 -77.52 0.1 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.475 -1.693 . . . . 0.91 112.267 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.45 16.43 Favored Glycine 0 C--N 1.385 3.266 0 C-N-CA 120.882 -0.675 . . . . 0.57 113.757 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 160.38 40.88 0.0 OUTLIER 'General case' 0 C--N 1.399 2.759 0 CA-C-O 124.183 1.944 . . . . 0.57 112.341 -170.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.02 -156.79 15.42 Favored Glycine 0 C--N 1.37 2.446 0 N-CA-C 107.009 -2.436 . . . . 0.57 107.009 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.45 -39.84 2.54 Favored Glycine 0 C--N 1.367 2.265 0 O-C-N 120.268 -1.725 . . . . 0.57 113.989 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -152.56 167.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.86 0 N-CA-C 105.294 -2.113 . . . . 0.57 105.294 -172.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' A' ' 210' ' ' THR . 66.9 mt -118.77 -80.6 0.62 Allowed 'General case' 0 C--N 1.374 1.673 0 O-C-N 126.684 2.49 . . . . 0.57 114.77 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -107.65 179.5 4.22 Favored 'General case' 0 C--N 1.377 1.765 0 CA-C-N 115.356 -0.838 . . . . 0.57 111.112 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER -169.24 135.9 1.72 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.57 110.904 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -160.05 161.97 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.57 111.151 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -171.22 2.85 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.029 1.395 . . . . 0.57 110.846 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.91 -159.11 35.16 Favored Glycine 0 C--N 1.385 3.275 0 CA-C-N 114.001 -1.454 . . . . 0.57 112.838 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.42 74.28 3.74 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 122.818 2.345 . . . . 0.57 110.068 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.76 -134.86 6.95 Favored Glycine 0 C--N 1.376 2.798 0 CA-C-O 124.067 1.926 . . . . 0.57 110.155 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.26 -80.08 0.6 Allowed 'General case' 0 C--N 1.396 2.604 0 CA-C-N 112.909 -1.645 . . . . 0.57 108.938 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.99 -54.76 2.11 Favored Glycine 1 C--N 1.398 4.006 0 N-CA-C 108.252 -1.939 . . . . 0.57 108.252 -174.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -44.37 99.47 Favored 'Isoleucine or valine' 0 C--N 1.396 2.625 0 CA-C-N 113.38 -1.41 . . . . 0.57 107.615 -173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.52 136.44 43.89 Favored Glycine 0 C--N 1.395 3.835 0 N-CA-C 106.89 -2.484 . . . . 0.57 106.89 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.62 -41.54 2.11 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-N 113.33 -1.435 . . . . 0.57 113.531 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.83 97.16 0.1 Allowed 'General case' 0 C--N 1.39 2.343 0 CA-C-N 115.096 -0.552 . . . . 0.91 110.921 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -102.95 148.29 25.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.57 111.08 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -129.37 151.27 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.57 110.895 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.59 150.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.57 110.897 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.577 ' CG ' ' O ' ' A' ' 198' ' ' ASP . 2.8 p30 -79.39 83.19 5.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.91 110.833 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 203' ' ' TRP . 11.7 tp10 -57.1 -32.52 66.39 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 117.72 -1.133 . . . . 0.91 110.349 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -41.98 -51.41 4.44 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 125.768 1.918 . . . . 0.91 110.429 -173.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -173.87 0.01 OUTLIER 'General case' 0 C--N 1.392 2.434 0 CA-C-O 127.766 3.65 . . . . 0.91 113.045 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 122.59 46.71 Favored 'General case' 0 C--N 1.382 2.019 0 O-C-N 119.125 -2.234 . . . . 0.57 113.078 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.568 ' CZ2' ' HA ' ' A' ' 199' ' ' GLU . 26.1 m0 -96.39 123.85 40.18 Favored 'General case' 0 C--N 1.391 2.383 0 N-CA-C 105.262 -2.125 . . . . 0.57 105.262 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 102.61 11.44 Favored 'General case' 0 C--N 1.374 1.649 0 CA-C-O 126.235 2.921 . . . . 0.57 112.136 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.8 p -102.09 120.59 40.68 Favored 'General case' 0 C--N 1.376 1.739 0 O-C-N 119.564 -1.96 . . . . 0.57 108.904 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 65.86 66.63 0.5 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-O 123.958 1.837 . . . . 0.57 109.673 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.98 -72.14 0.01 OUTLIER 'General case' 0 C--N 1.397 2.661 0 CA-C-O 123.522 1.629 . . . . 0.57 109.334 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.81 -145.92 5.2 Favored Glycine 0 C--N 1.385 3.263 0 N-CA-C 108.262 -1.935 . . . . 0.57 108.262 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 47.06 -146.56 3.75 Favored Glycine 0 C--N 1.383 3.18 0 CA-C-O 127.134 3.63 . . . . 0.57 110.095 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.55 ' CB ' HD21 ' A' ' 181' ' ' LEU . 8.3 p -77.77 124.34 27.84 Favored 'General case' 0 C--N 1.368 1.378 0 O-C-N 119.983 -1.892 . . . . 0.57 112.331 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 214' ' ' LEU . 0.7 OUTLIER -116.86 155.97 28.12 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-N 114.815 -1.084 . . . . 0.57 109.435 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -65.87 -32.93 74.73 Favored 'General case' 0 C--N 1.393 2.491 0 CA-C-O 124.22 1.962 . . . . 0.57 107.641 -173.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.83 ' CD2' HG23 ' A' ' 245' ' ' ILE . 27.5 t80 -57.55 -50.0 74.53 Favored 'General case' 0 C--N 1.376 1.72 0 CA-C-N 113.16 -1.836 . . . . 0.57 110.898 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.617 HD23 ' OD1' ' A' ' 211' ' ' ASN . 1.0 OUTLIER -55.03 -51.12 67.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.937 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -63.83 -44.95 91.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.57 111.151 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.93 -42.87 80.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.57 111.085 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.579 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 0.9 OUTLIER -65.17 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.096 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.26 -49.97 62.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.57 110.823 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -59.35 -42.11 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.91 110.885 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.3 mm -67.68 -47.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.57 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.79 -33.75 63.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.57 112.466 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.41 -38.74 88.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.57 110.9 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 159' ' ' ILE . 11.0 t -71.22 -53.53 14.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.836 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.2 pp -72.23 -60.77 2.06 Favored 'General case' 0 C--N 1.375 1.68 0 N-CA-C 118.992 2.96 . . . . 0.57 118.992 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.811 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -70.42 -175.09 17.1 Favored Glycine 0 C--N 1.375 2.741 0 CA-C-O 126.157 3.087 . . . . 0.57 110.114 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.715 HD21 ' HG ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -89.01 -146.33 0.16 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-N 109.628 -3.286 . . . . 0.57 106.432 -172.02 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.01 -107.57 0.01 OUTLIER Glycine 0 C--N 1.394 3.794 0 CA-C-O 125.769 2.871 . . . . 0.57 111.665 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.445 ' CE1' ' HG3' ' A' ' 238' ' ' PRO . 21.4 m170 -113.83 -96.43 0.45 Allowed 'General case' 0 C--N 1.382 1.994 0 O-C-N 119.633 -2.098 . . . . 0.57 110.34 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.03 -42.58 0.01 OUTLIER 'General case' 0 C--N 1.391 2.413 0 N-CA-C 107.893 -1.151 . . . . 0.57 107.893 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 81.87 24.11 0.23 Allowed 'General case' 0 C--N 1.415 3.454 0 N-CA-C 116.676 2.102 . . . . 0.57 116.676 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 4.5 t0 -157.94 138.2 8.95 Favored Pre-proline 0 C--N 1.386 2.156 0 N-CA-C 106.539 -1.652 . . . . 0.91 106.539 -171.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 67.8 Cg_exo -57.29 -57.68 1.18 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.445 2.763 . . . . 0.57 114.529 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.99 -37.75 4.25 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 112.976 -1.92 . . . . 0.57 113.396 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -65.63 117.56 8.27 Favored 'General case' 0 C--N 1.393 2.493 0 CA-C-O 124.445 2.069 . . . . 0.57 115.762 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.555 HG13 ' H28' ' A' ' 269' ' ' HSI . 10.3 t -72.19 47.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.033 0 CA-C-O 124.693 2.187 . . . . 0.57 115.449 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.8 mmm -144.76 -31.94 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 CA-C-N 113.575 -1.648 . . . . 0.57 110.227 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.0 OUTLIER -39.11 144.37 0.44 Allowed Pre-proline 0 C--N 1.38 1.928 0 CA-C-O 126.283 2.944 . . . . 0.57 114.371 173.586 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.445 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 54.0 Cg_exo -58.87 -48.14 15.66 Favored 'Trans proline' 0 C--N 1.383 2.371 0 O-C-N 118.294 -1.477 . . . . 0.57 111.806 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 98.9 m -46.3 122.54 4.07 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 124.842 2.258 . . . . 0.57 110.003 -173.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.503 ' CZ ' HG22 ' A' ' 210' ' ' THR . 0.0 OUTLIER -98.03 117.69 32.96 Favored 'General case' 0 C--N 1.386 2.164 0 CA-C-N 112.81 -1.995 . . . . 0.57 106.602 -178.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -138.5 108.03 6.19 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 113.281 -1.781 . . . . 0.57 106.63 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.5 120.89 5.03 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-O 124.455 2.074 . . . . 0.57 110.796 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.24 18.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 CA-C-N 112.868 -1.969 . . . . 0.57 110.718 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.3 t0 64.03 115.95 0.02 OUTLIER 'General case' 0 C--N 1.385 2.147 0 CA-C-O 126.937 3.256 . . . . 0.91 106.651 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.83 HG23 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mp -51.97 -19.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.46 0 O-C-N 119.048 -2.283 . . . . 0.57 115.4 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -31.46 64.56 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.003 -1.453 . . . . 0.57 111.23 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -5.62 15.42 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 123.121 0.568 . . . . 0.57 110.914 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.579 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 22.9 t80 -65.01 93.85 0.12 Allowed 'General case' 0 C--N 1.385 2.119 0 CA-C-O 125.678 2.656 . . . . 0.57 105.332 -170.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.542 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -114.41 154.14 28.64 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 112.414 -2.176 . . . . 1.2 105.79 -177.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.89 132.62 53.77 Favored 'General case' 0 C--N 1.385 2.15 0 CA-C-O 125.559 2.6 . . . . 0.57 105.768 -170.552 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 25.8 m -69.32 141.79 54.19 Favored 'General case' 0 C--N 1.365 1.249 0 O-C-N 120.229 -1.544 . . . . 0.57 109.124 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -59.93 -42.45 93.98 Favored 'General case' 0 C--N 1.396 2.609 0 CA-C-N 113.337 -1.756 . . . . 0.57 107.412 -174.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -41.52 89.07 Favored 'General case' 0 C--N 1.365 1.243 0 CA-C-N 115.501 -0.772 . . . . 0.91 110.834 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 258' ' ' ILE . 23.2 t0 -64.4 -54.8 27.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.91 110.857 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.6 pt -66.08 -34.54 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.57 111.196 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.661 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 7.4 mtp180 -67.55 -31.12 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.2 110.796 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.74 ' O ' HD23 ' A' ' 261' ' ' LEU . . . -73.21 -48.41 19.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.57 112.457 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 224' ' ' LEU . 1.2 pt -59.59 -36.15 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.731 0.301 . . . . 0.57 111.077 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 260' ' ' SER . 18.5 pt20 -70.13 -44.61 68.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.896 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 1.5 t -64.99 -42.56 94.4 Favored 'General case' 0 C--N 1.374 1.673 0 CA-C-O 121.933 0.873 . . . . 0.57 110.891 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 257' ' ' GLY . 0.5 OUTLIER -136.29 126.83 26.94 Favored 'General case' 0 C--N 1.38 1.933 0 CA-C-O 125.48 2.562 . . . . 0.57 107.66 -176.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 147' ' ' LEU . 32.0 m-85 -105.37 9.58 33.7 Favored 'General case' 0 C--N 1.379 1.85 0 CA-C-N 112.716 -2.038 . . . . 0.57 110.778 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 226' ' ' LEU . . . . . . . . 1 C--N 1.4 4.118 0 CA-C-O 114.625 -3.32 . . . . 0.91 119.716 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.555 ' H28' HG13 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' HG13 ' A' ' 108' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.128 0 CA-C-O 118.414 -1.214 . . . . 0.57 111.315 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.11 121.27 9.35 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.249 2.633 . . . . 0.57 111.077 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 106' ' ' GLY . 16.2 m -123.71 132.87 70.65 Favored 'Isoleucine or valine' 0 C--N 1.374 1.667 0 CA-C-N 113.414 -1.721 . . . . 0.57 109.26 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.92 114.66 4.94 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.857 -1.519 . . . . 0.57 107.81 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -118.09 150.36 39.46 Favored 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.851 -1.522 . . . . 1.2 108.943 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -65.83 0.03 OUTLIER 'General case' 0 C--N 1.382 2.018 0 CA-C-N 113.886 -1.507 . . . . 0.57 111.07 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.754 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -77.31 -11.61 59.85 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 125.542 2.591 . . . . 0.57 110.268 -179.174 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -110.07 105.48 14.61 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.144 -1.598 . . . . 0.57 110.946 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -110.01 135.32 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.57 111.108 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.42 159.03 18.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.57 111.181 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.912 ' OH ' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -150.14 158.07 43.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.57 110.883 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -156.07 126.5 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.2 110.921 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.912 HD12 ' OH ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -77.98 136.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.57 111.114 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -53.23 -53.92 43.65 Favored 'General case' 0 C--N 1.376 1.744 0 N-CA-C 107.805 -1.183 . . . . 0.57 107.805 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 161.98 35.44 0.0 OUTLIER 'General case' 0 C--N 1.382 1.996 0 O-C-N 126.599 2.437 . . . . 0.57 110.049 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 4.8 m-30 72.52 -172.22 0.15 Allowed 'General case' 0 C--N 1.383 2.025 0 N-CA-C 107.41 -1.33 . . . . 0.57 107.41 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -139.74 161.51 55.98 Favored Pre-proline 0 C--N 1.373 1.614 0 CA-C-N 114.141 -1.39 . . . . 0.57 108.619 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -50.51 1.41 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.757 1.638 . . . . 0.57 112.584 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' H ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -80.16 -66.87 0.82 Allowed 'General case' 0 C--N 1.379 1.882 0 N-CA-C 104.768 -2.308 . . . . 0.91 104.768 -165.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.7 ttm -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-O 125.694 2.664 . . . . 0.57 110.19 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.728 ' O ' HG23 ' A' ' 130' ' ' VAL . 69.2 m-20 -75.95 139.69 41.7 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.396 -2.184 . . . . 0.57 107.714 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.47 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.47 -47.46 67.03 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 107.736 -1.209 . . . . 1.2 107.736 -168.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -34.67 63.27 Favored 'General case' 0 C--N 1.387 2.226 0 O-C-N 126.482 2.364 . . . . 0.91 110.898 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -44.04 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.91 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.31 -44.55 98.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.57 111.092 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.84 -44.09 97.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.91 110.869 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.61 -44.06 87.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.57 110.894 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.1 -43.97 87.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.57 111.13 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.527 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -65.15 -42.89 95.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.57 111.112 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -49.05 78.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.868 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -36.55 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.91 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -63.26 -42.06 99.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.57 111.132 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 134' ' ' ILE . 20.4 m-85 -65.93 -37.09 85.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.57 110.86 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -67.16 -38.11 84.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.882 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 144' ' ' VAL . 8.3 t -71.12 -34.07 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.57 111.122 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CG ' HD11 ' A' ' 224' ' ' LEU . 1.3 m95 -83.25 -34.09 25.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.57 110.913 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m -77.55 -49.39 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.876 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.59 ' OD1' HG13 ' A' ' 144' ' ' VAL . 3.1 p-10 -59.76 -12.56 7.45 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-O 122.174 0.988 . . . . 0.57 112.737 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 140' ' ' VAL . 25.0 m -115.98 1.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.379 1.854 0 CA-C-N 114.014 -1.448 . . . . 0.57 111.42 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.8 150.28 45.92 Favored Pre-proline 0 C--N 1.368 1.412 0 CA-C-O 125.615 2.626 . . . . 0.57 110.203 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.572 ' HG3' ' O ' ' A' ' 262' ' ' TYR . 33.8 Cg_endo -73.38 -34.03 6.36 Favored 'Trans proline' 0 C--N 1.361 1.224 0 O-C-N 118.114 -1.572 . . . . 0.57 110.69 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.1 mt -58.7 114.34 2.46 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-O 123.672 1.701 . . . . 0.57 108.73 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 158.36 32.05 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 113.742 -1.572 . . . . 0.57 112.507 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 224' ' ' LEU . 12.6 m-85 -130.07 139.61 50.94 Favored 'General case' 0 C--N 1.388 2.272 0 CA-C-N 112.368 -2.196 . . . . 0.57 108.711 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.4 m -145.53 125.02 13.14 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.763 2.22 . . . . 0.57 108.367 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 116' ' ' TYR . 15.9 tttt -89.45 146.58 24.54 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-N 114.077 -1.42 . . . . 0.57 112.731 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' HA ' ' A' ' 157' ' ' ALA . 8.2 pt -139.11 155.97 27.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.852 0 CA-C-O 123.41 1.576 . . . . 0.57 109.738 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 -6.23 1.48 Allowed 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.808 -1.542 . . . . 0.57 109.951 -174.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.5 p -76.79 -62.82 1.51 Allowed 'General case' 0 C--N 1.372 1.569 0 CA-C-N 114.184 -1.371 . . . . 0.57 110.539 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.56 -174.69 17.47 Favored Glycine 0 C--N 1.374 2.648 0 CA-C-O 123.253 1.474 . . . . 0.57 110.861 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 ttt -57.62 124.97 20.89 Favored 'General case' 0 C--N 1.382 1.997 0 CA-C-N 113.014 -1.593 . . . . 0.57 108.411 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 152' ' ' ILE . . . -97.04 173.56 7.21 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.147 -1.842 . . . . 0.57 110.582 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.43 -83.39 0.03 OUTLIER 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.989 -1.914 . . . . 0.91 107.674 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.94 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.9 pp -94.69 114.57 31.54 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-N 114.665 -1.152 . . . . 0.57 111.108 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 157' ' ' ALA . 4.5 mp -96.38 132.06 42.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.57 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 197' ' ' PHE . 21.6 t -102.02 116.9 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.57 111.148 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.33 145.13 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.57 111.101 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -102.77 117.77 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.57 110.89 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.36 170.12 18.0 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 124.341 2.019 . . . . 0.57 109.646 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.6 134.02 52.43 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.909 -1.744 . . . . 1.2 108.156 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 42.32 -106.02 0.07 OUTLIER Glycine 0 C--N 1.379 2.957 0 O-C-N 126.135 2.147 . . . . 0.57 113.009 171.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.478 ' H ' ' CB ' ' A' ' 173' ' ' ALA . . . 57.04 -140.03 0.86 Allowed 'General case' 0 C--N 1.384 2.097 0 O-C-N 127.111 2.301 . . . . 0.57 107.518 170.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.451 ' O ' ' CD2' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -40.31 145.78 0.16 Allowed 'General case' 0 C--N 1.383 2.059 0 O-C-N 124.957 1.411 . . . . 0.57 111.36 177.474 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.9 -145.86 0.68 Allowed Glycine 0 C--N 1.376 2.761 0 C-N-CA 116.874 -2.584 . . . . 0.57 114.256 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.84 23.98 13.95 Favored 'General case' 0 C--N 1.395 2.57 0 CA-C-N 112.59 -1.805 . . . . 0.91 108.341 167.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.0 t80 60.48 76.69 0.35 Allowed 'General case' 0 C--N 1.383 2.031 0 CA-C-N 114.063 -1.426 . . . . 0.57 112.616 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 0.1 OUTLIER 44.84 42.76 6.39 Favored 'General case' 0 C--N 1.384 2.099 0 CA-C-N 114.842 -1.072 . . . . 0.57 112.936 177.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 65.16 101.92 0.04 OUTLIER 'General case' 0 C--N 1.377 1.769 0 CA-C-O 124.157 1.932 . . . . 0.57 115.185 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.756 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -85.89 -131.1 0.05 OUTLIER 'General case' 0 C--N 1.376 1.745 0 CA-C-N 113.224 -1.807 . . . . 0.57 108.633 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.578 ' H ' HD13 ' A' ' 180' ' ' ILE . 6.9 t70 54.0 -157.42 0.19 Allowed 'General case' 0 C--N 1.39 2.343 0 N-CA-C 105.647 -1.982 . . . . 0.91 105.647 170.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 127.72 9.18 4.02 Favored Glycine 0 C--N 1.368 2.344 0 N-CA-C 109.067 -1.613 . . . . 0.57 109.067 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.13 -57.14 0.01 OUTLIER 'General case' 0 C--N 1.393 2.492 0 CA-C-O 122.764 1.269 . . . . 0.57 111.031 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -156.95 -38.25 0.02 OUTLIER Glycine 0 C--N 1.382 3.102 0 CA-C-N 114.126 -1.397 . . . . 0.57 111.497 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.618 ' C ' HD12 ' A' ' 180' ' ' ILE . . . -41.6 142.06 1.19 Allowed Glycine 0 C--N 1.38 3.027 0 O-C-N 120.0 -1.883 . . . . 0.57 109.379 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 174' ' ' PHE . 1.3 mp 74.04 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.62 0 O-C-N 124.153 0.561 . . . . 0.57 112.449 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 215' ' ' THR . 2.7 tp -124.29 -57.81 1.56 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 122.966 1.365 . . . . 0.57 111.882 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 215' ' ' THR . . . -177.43 179.53 0.94 Allowed 'General case' 0 C--N 1.364 1.229 0 CA-C-N 114.584 -1.189 . . . . 0.57 111.042 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.518 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.7 p80 -152.94 168.24 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.57 110.874 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.89 142.71 22.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.57 111.057 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.453 ' CB ' ' HA2' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -52.02 129.71 27.93 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 117.745 -1.582 . . . . 0.57 110.143 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 187' ' ' PRO . . . -74.26 -58.19 4.4 Favored Glycine 0 C--N 1.381 3.046 0 CA-C-N 112.859 -1.973 . . . . 0.57 111.785 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 186' ' ' GLY . 30.7 Cg_endo -67.96 -83.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 121.495 1.463 . . . . 0.57 111.342 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.463 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . 167.32 -142.52 7.61 Favored Glycine 0 C--N 1.375 2.711 0 N-CA-C 108.984 -1.646 . . . . 0.57 108.984 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 83.59 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.382 1.987 0 O-C-N 125.611 1.418 . . . . 0.57 109.382 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -44.87 -65.08 1.91 Allowed Glycine 0 C--N 1.388 3.426 0 CA-C-O 125.678 2.821 . . . . 0.57 112.549 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 191' ' ' ILE . 1.5 mp -71.97 -15.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.382 1.982 0 CA-C-N 111.306 -2.447 . . . . 0.57 109.03 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -44.98 148.35 1.39 Allowed Glycine 0 C--N 1.362 1.972 0 O-C-N 120.693 -1.254 . . . . 0.57 113.676 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.94 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 76.38 -44.47 1.94 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 117.428 1.731 . . . . 0.57 117.428 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -37.48 147.15 0.04 OUTLIER 'General case' 0 C--N 1.387 2.205 0 O-C-N 124.894 0.997 . . . . 0.91 110.853 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -143.42 152.0 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.57 111.113 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.538 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.33 126.41 37.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.57 110.828 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.664 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -109.97 134.93 51.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.57 110.923 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.43 ' HB2' ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -60.83 85.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.86 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -72.98 -49.24 30.27 Favored 'General case' 0 C--N 1.382 1.999 0 N-CA-C 104.209 -2.515 . . . . 0.91 104.209 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.84 -45.75 0.1 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 123.938 0.895 . . . . 0.91 112.151 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -53.19 174.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 126.631 3.11 . . . . 0.91 109.77 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 2.1 t80 -97.1 107.52 20.07 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 112.74 -2.027 . . . . 0.57 114.275 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 40.9 m95 -91.25 151.42 20.92 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 113.63 -1.623 . . . . 0.57 108.493 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.0 p -126.22 104.4 8.2 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-O 123.601 1.667 . . . . 0.57 109.92 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.56 137.29 37.43 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-N 113.271 -1.786 . . . . 0.57 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 207' ' ' SER . 1.3 t60 76.78 42.56 0.15 Allowed 'General case' 0 C--N 1.385 2.144 0 CA-C-N 113.796 -1.547 . . . . 0.57 110.834 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.1 p 81.69 123.17 0.04 OUTLIER 'General case' 0 C--N 1.382 1.989 0 CA-C-O 124.55 2.119 . . . . 0.57 108.849 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.37 -13.91 0.15 Allowed Glycine 0 C--N 1.382 3.135 0 C-N-CA 118.514 -1.803 . . . . 0.57 111.752 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 153.88 -119.13 0.92 Allowed Glycine 0 C--N 1.389 3.509 0 CA-C-O 123.723 1.735 . . . . 0.57 112.994 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.7 p -80.02 117.53 20.94 Favored 'General case' 0 C--N 1.377 1.795 0 CA-C-O 123.142 1.448 . . . . 0.57 111.625 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -91.59 152.14 20.41 Favored 'General case' 0 C--N 1.369 1.417 0 CA-C-N 112.738 -2.028 . . . . 0.57 111.648 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -75.04 -31.23 61.27 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 113.184 -1.825 . . . . 0.57 107.338 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.3 t80 -58.22 -46.61 85.57 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-N 113.819 -1.537 . . . . 0.57 110.889 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.621 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -55.68 -51.84 65.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.898 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.01 -49.05 69.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.57 111.162 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.32 73.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.57 111.174 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 213' ' ' PHE . 92.5 t -65.18 -39.49 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.57 111.081 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 236' ' ' MET . 7.2 t-160 -70.29 -42.3 72.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.57 110.866 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 219' ' ' GLU . 1.2 mm-40 -61.1 -43.78 98.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.91 110.869 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 137' ' ' ALA . 12.5 pt -71.09 -42.94 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.57 111.114 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.96 -33.76 64.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.57 112.523 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.53 -42.02 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.57 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.482 ' CB ' HG21 ' A' ' 159' ' ' ILE . 17.7 t -71.01 -36.01 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.57 110.888 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.647 ' CD2' HD12 ' A' ' 114' ' ' ILE . 26.8 mt -43.74 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.367 1.344 0 CA-C-O 124.25 1.976 . . . . 0.57 114.318 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.64 -161.83 35.56 Favored Glycine 0 C--N 1.369 2.408 0 N-CA-C 107.93 -2.068 . . . . 0.57 107.93 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 261' ' ' LEU . 0.5 OUTLIER 50.65 -164.07 0.05 OUTLIER 'General case' 0 C--N 1.389 2.293 0 CA-C-N 112.633 -1.783 . . . . 0.57 111.131 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.533 ' H ' HD22 ' A' ' 226' ' ' LEU . . . -111.34 -162.61 17.51 Favored Glycine 0 C--N 1.373 2.624 0 CA-C-O 125.61 2.783 . . . . 0.57 112.682 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.48 -167.06 1.74 Allowed 'General case' 0 C--N 1.39 2.328 0 CA-C-N 110.578 -2.811 . . . . 0.57 112.032 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -94.24 -20.1 20.13 Favored 'General case' 0 C--N 1.385 2.125 0 CA-C-N 113.421 -1.718 . . . . 0.57 109.944 -175.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 86.48 5.38 0.39 Allowed 'General case' 0 C--N 1.387 2.22 0 O-C-N 125.558 1.786 . . . . 0.57 114.853 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -149.12 143.86 17.43 Favored Pre-proline 0 C--N 1.38 1.908 0 O-C-N 125.193 1.558 . . . . 0.91 109.377 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 239' ' ' THR . 87.6 Cg_exo -59.11 -47.18 18.56 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.589 2.192 . . . . 0.57 112.295 -172.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -41.89 -39.35 1.8 Allowed 'General case' 0 C--N 1.38 1.909 0 CA-C-N 114.035 -1.438 . . . . 0.57 113.032 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 229' ' ' SER . . . -63.48 131.56 48.56 Favored 'General case' 0 C--N 1.383 2.046 0 N-CA-C 118.955 2.946 . . . . 0.57 118.955 167.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 248' ' ' PHE . 21.9 t -73.55 70.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.9 0 CA-C-N 112.256 -2.247 . . . . 0.57 111.435 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.459 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -179.55 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-N 113.233 -1.803 . . . . 0.57 109.424 -178.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 3.4 t80 -52.77 140.25 39.63 Favored Pre-proline 0 C--N 1.363 1.193 0 O-C-N 120.014 -1.679 . . . . 0.57 109.868 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 54.0 Cg_exo -54.77 -19.41 18.82 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.8 1.667 . . . . 0.57 114.9 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 232' ' ' PRO . 1.0 OUTLIER -48.41 107.57 0.13 Allowed 'General case' 0 C--N 1.371 1.515 0 CA-C-O 123.665 1.698 . . . . 0.57 110.677 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -81.86 134.11 35.38 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 105.869 -1.9 . . . . 0.57 105.869 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.695 ' HD2' ' H33' ' A' ' 269' ' ' HSI . 2.7 tmtt? 174.96 113.49 0.02 OUTLIER 'General case' 0 C--N 1.383 2.048 0 N-CA-C 106.744 -1.576 . . . . 0.57 106.744 175.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.59 123.26 9.55 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 113.238 -1.801 . . . . 0.57 110.701 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.658 HG11 ' C32' ' A' ' 269' ' ' HSI . 7.7 p -151.35 113.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.779 0 CA-C-N 113.806 -1.543 . . . . 0.57 108.103 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.39 150.05 12.2 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 113.211 -1.813 . . . . 0.91 107.086 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.1 mp -75.86 -23.57 16.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 124.227 1.965 . . . . 0.57 110.02 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -84.15 -7.52 59.34 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.481 -1.387 . . . . 0.57 112.714 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 39.7 p -122.39 3.51 9.71 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-O 123.679 1.704 . . . . 0.57 111.578 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -83.97 -156.73 0.23 Allowed 'General case' 0 C--N 1.368 1.4 0 CA-C-N 113.259 -1.791 . . . . 0.57 110.376 178.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER 178.28 163.37 0.69 Allowed 'General case' 0 C--N 1.385 2.124 0 N-CA-C 105.637 -1.986 . . . . 1.2 105.637 168.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -117.56 141.98 47.73 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.732 2.682 . . . . 0.57 108.262 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.3 t -64.5 134.02 53.6 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 119.846 -1.784 . . . . 0.57 112.645 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.91 -49.91 64.08 Favored 'General case' 0 C--N 1.39 2.361 0 CA-C-N 114.072 -1.422 . . . . 0.57 108.663 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -35.96 73.97 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 115.357 -0.838 . . . . 0.91 110.845 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 258' ' ' ILE . 30.6 t0 -63.94 -55.13 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.91 110.885 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.7 pt -66.37 -35.31 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.57 111.149 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 35.5 mtp180 -70.72 -35.52 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 1.2 110.784 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.02 -51.2 55.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.722 . . . . 0.57 112.465 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.713 HD11 HG23 ' A' ' 144' ' ' VAL . 2.4 pt -61.17 -45.61 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.57 111.119 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.21 -28.69 63.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.57 110.907 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 31.3 t -77.58 -36.24 52.19 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 119.096 -1.042 . . . . 0.57 109.796 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -52.57 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.382 2.007 0 CA-C-O 124.069 1.89 . . . . 0.57 110.819 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.572 ' O ' ' HG3' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -99.52 130.82 45.8 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.222 -1.808 . . . . 0.57 112.661 177.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.387 3.403 0 CA-C-O 114.622 -3.321 . . . . 0.91 120.438 -173.081 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.695 ' H33' ' HD2' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 CA-C-O 118.97 -0.906 . . . . 0.57 111.027 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -56.45 -22.82 44.2 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 121.208 1.272 . . . . 0.57 114.439 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 130.14 74.83 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 0 CA-C-N 114.525 -1.216 . . . . 0.57 109.481 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -179.14 152.27 0.54 Allowed 'General case' 0 C--N 1.371 1.54 0 N-CA-C 107.399 -1.334 . . . . 0.57 107.399 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.36 157.46 31.77 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 125.034 2.349 . . . . 1.2 111.193 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -127.91 -54.32 1.31 Allowed 'General case' 0 C--N 1.379 1.868 0 O-C-N 120.411 -1.431 . . . . 0.57 107.822 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.388 2.247 0 CA-C-O 124.172 1.939 . . . . 0.57 108.471 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.6 103.81 10.06 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-N 112.054 -2.339 . . . . 0.57 110.929 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 149' ' ' PHE . 1.3 mm -102.11 146.91 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.57 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.572 ' HB ' ' H ' ' A' ' 158' ' ' ASP . 1.3 m -105.93 156.51 18.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.473 . . . . 0.57 111.125 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.753 ' CE1' HD12 ' A' ' 118' ' ' ILE . 20.3 t80 -138.64 160.1 40.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.929 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.528 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -145.68 121.85 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.509 . . . . 1.2 110.847 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -93.51 132.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.57 111.125 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -59.48 -86.76 0.01 OUTLIER 'General case' 0 C--N 1.375 1.696 0 CA-C-N 114.739 -1.119 . . . . 0.57 110.206 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t30 169.4 60.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.28 0 N-CA-C 104.15 -2.537 . . . . 0.57 104.15 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.723 ' CD2' HG21 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -67.07 178.37 1.45 Allowed 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.065 -1.88 . . . . 0.57 111.544 166.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 162.45 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.32 2.648 . . . . 0.57 108.134 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.71 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-O 124.365 1.735 . . . . 0.57 110.079 -165.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.99 3.31 12.54 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 114.309 -1.314 . . . . 0.91 113.986 173.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.1 mmt -142.75 119.45 11.13 Favored 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.007 -1.479 . . . . 0.57 107.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 t-20 -93.32 139.09 31.04 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 122.617 1.199 . . . . 0.57 108.58 -177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.89 -46.66 74.22 Favored 'General case' 0 C--N 1.388 2.261 0 CA-C-O 123.871 1.796 . . . . 1.2 109.261 -166.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.24 -35.17 64.65 Favored 'General case' 0 C--N 1.364 1.208 0 CA-C-N 111.376 -2.647 . . . . 0.91 110.979 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.61 -41.92 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.91 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -65.54 -39.57 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.57 111.112 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.63 -42.1 87.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.91 110.838 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -49.02 75.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.57 110.949 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.62 -49.1 67.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.57 111.052 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.521 HG13 HG12 ' A' ' 130' ' ' VAL . 1.5 mm -62.22 -46.03 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.57 111.094 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -56.28 -43.64 79.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 1.2 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -38.13 89.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.57 110.878 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -64.57 -45.29 87.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 0.57 111.078 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 220' ' ' ILE . 14.9 m-85 -62.97 -34.4 77.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.57 110.916 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -68.11 -40.0 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.57 110.934 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.48 -34.24 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.57 111.125 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.419 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 14.5 m95 -83.15 -33.62 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.57 110.929 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.7 m -78.94 -49.01 13.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.57 110.808 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.649 ' OD1' HG13 ' A' ' 144' ' ' VAL . 6.4 p-10 -59.97 -14.84 17.86 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-O 120.969 0.414 . . . . 0.57 111.072 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.649 HG13 ' OD1' ' A' ' 143' ' ' ASN . 19.6 m -112.51 -13.61 11.24 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 CA-C-O 117.89 -1.053 . . . . 0.57 111.016 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.625 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -145.7 142.39 17.93 Favored Pre-proline 0 C--N 1.383 2.038 0 O-C-N 124.859 1.349 . . . . 0.57 112.555 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD2' HG22 ' A' ' 145' ' ' THR . 47.3 Cg_endo -78.52 67.75 8.25 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.201 1.934 . . . . 0.57 112.66 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -163.71 90.58 0.63 Allowed 'General case' 0 C--N 1.372 1.576 0 N-CA-C 104.516 -2.401 . . . . 0.57 104.516 -167.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 160.53 25.73 Favored 'General case' 0 C--N 1.381 1.977 0 CA-C-N 114.432 -1.258 . . . . 0.57 113.035 170.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 25.0 m-85 -136.32 141.22 43.77 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-N 113.723 -1.58 . . . . 0.57 106.747 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -157.02 139.76 15.11 Favored 'General case' 0 C--N 1.366 1.315 0 CA-C-O 124.454 2.073 . . . . 0.57 108.161 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.26 145.8 27.37 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 114.199 -1.364 . . . . 0.57 109.733 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 157' ' ' ALA . 16.8 pt -111.27 159.48 11.23 Favored 'Isoleucine or valine' 0 C--N 1.367 1.333 0 CA-C-O 123.979 1.847 . . . . 0.57 108.032 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -90.1 100.26 13.12 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.21 -1.814 . . . . 0.57 107.038 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 67.67 -178.75 0.21 Allowed 'General case' 0 C--N 1.371 1.512 0 CA-C-O 122.189 0.995 . . . . 0.57 109.44 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.09 71.35 Favored Glycine 0 C--N 1.371 2.487 0 C-N-CA 119.728 -1.225 . . . . 0.57 113.435 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.63 113.89 0.06 Allowed 'General case' 0 C--N 1.374 1.671 0 CA-C-O 122.586 1.184 . . . . 0.57 109.735 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 152' ' ' ILE . . . -91.31 159.49 15.99 Favored 'General case' 0 C--N 1.37 1.478 0 C-N-CA 117.612 -1.635 . . . . 0.57 109.659 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.572 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -53.03 -47.13 68.61 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-N 112.28 -2.236 . . . . 0.91 106.061 -171.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.3 mt -103.49 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.388 2.241 0 O-C-N 127.117 2.761 . . . . 0.57 111.159 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.41 124.4 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.57 110.921 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 197' ' ' PHE . 24.9 t -108.75 123.04 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.074 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 124.94 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.57 111.156 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.44 ' C ' ' HB2' ' A' ' 199' ' ' GLU . 5.4 m-85 -89.46 116.85 27.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.57 110.864 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.8 29.7 Favored 'General case' 0 C--N 1.378 1.81 0 CA-C-O 122.89 1.328 . . . . 0.57 108.593 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -100.93 177.11 5.05 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 114.501 -1.227 . . . . 1.2 110.892 174.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -52.93 144.19 23.51 Favored Glycine 0 C--N 1.376 2.76 0 CA-C-N 113.213 -1.812 . . . . 0.57 111.466 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.54 50.83 0.02 OUTLIER 'General case' 0 C--N 1.382 1.993 0 CA-C-O 123.136 1.446 . . . . 0.57 112.307 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -123.98 168.27 13.05 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-N 114.943 -1.026 . . . . 0.57 109.69 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -66.28 171.45 28.46 Favored Glycine 0 C--N 1.379 2.929 0 N-CA-C 110.177 -1.169 . . . . 0.57 110.177 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.308 0.0 OUTLIER 75.77 0.33 3.34 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-O 122.195 0.998 . . . . 0.91 113.153 -177.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -177.22 -173.29 0.44 Allowed 'General case' 0 C--N 1.366 1.297 0 N-CA-C 105.755 -1.943 . . . . 0.57 105.755 -163.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.01 -135.31 0.29 Allowed 'General case' 0 CA--C 1.568 1.653 0 CA-C-N 113.716 -1.584 . . . . 0.57 108.896 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.68 101.11 0.76 Allowed 'General case' 0 C--N 1.375 1.707 0 C-N-CA 125.646 1.578 . . . . 0.57 107.185 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -91.93 -164.51 1.19 Allowed 'General case' 0 C--N 1.369 1.44 0 CA-C-N 112.857 -1.974 . . . . 0.57 108.715 173.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.56 142.13 35.18 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 105.061 -2.2 . . . . 0.91 105.061 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.88 157.28 22.93 Favored Glycine 0 C--N 1.368 2.36 0 N-CA-C 107.645 -2.182 . . . . 0.57 107.645 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.07 28.21 6.74 Favored 'General case' 0 C--N 1.369 1.425 0 N-CA-C 113.605 0.965 . . . . 0.57 113.605 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.62 -163.99 14.9 Favored Glycine 0 C--N 1.364 2.101 0 N-CA-C 108.056 -2.017 . . . . 0.57 108.056 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.48 -104.03 3.12 Favored Glycine 0 C--N 1.365 2.188 0 CA-C-N 114.758 -0.721 . . . . 0.57 111.42 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.694 HG13 H402 ' A' ' 269' ' ' HSI . 0.5 OUTLIER -81.46 167.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.38 1.898 0 C-N-CA 123.526 0.73 . . . . 0.57 109.142 178.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 240' ' ' TYR . 5.6 tp -101.13 -42.63 6.29 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 122.087 0.946 . . . . 0.57 110.743 173.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.89 -179.99 2.19 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 120.56 -1.337 . . . . 0.57 111.102 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.402 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 2.3 p80 -163.87 136.1 4.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.57 110.883 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.694 ' HB2' ' CB ' ' A' ' 195' ' ' ALA . . . -154.42 163.14 40.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.57 111.136 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -121.32 176.59 5.56 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-O 123.191 1.472 . . . . 0.57 108.478 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.68 53.09 0.2 Allowed Glycine 0 C--N 1.376 2.763 0 CA-C-N 113.827 -1.533 . . . . 0.57 112.219 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.83 -49.84 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 CA-C-O 123.695 1.456 . . . . 0.57 110.764 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -155.91 -61.58 0.01 OUTLIER Glycine 0 C--N 1.381 3.053 0 N-CA-C 109.844 -1.303 . . . . 0.57 109.844 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m -152.06 -179.73 7.75 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 107.859 -1.163 . . . . 0.57 107.859 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.33 -104.57 1.6 Allowed Glycine 0 C--N 1.379 2.961 0 N-CA-C 105.888 -2.885 . . . . 0.57 105.888 171.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.2 tp -55.38 -42.77 68.73 Favored 'Isoleucine or valine' 0 C--N 1.375 1.715 0 CA-C-O 122.818 1.294 . . . . 0.57 109.067 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.51 134.69 38.72 Favored Glycine 0 C--N 1.379 2.941 0 C-N-CA 118.37 -1.872 . . . . 0.57 108.498 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.6 -29.16 12.36 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 124.287 0.946 . . . . 0.57 113.29 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 123.46 26.4 Favored 'General case' 0 C--N 1.371 1.522 0 O-C-N 120.91 -1.347 . . . . 0.91 110.885 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.694 ' CB ' ' HB2' ' A' ' 184' ' ' ALA . . . -125.23 146.39 49.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.57 111.131 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -123.81 134.47 53.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.57 110.81 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.713 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -108.97 150.01 28.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.883 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 91.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.91 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.44 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 3.7 tp10 -67.56 -44.56 77.96 Favored 'General case' 0 C--N 1.369 1.414 0 O-C-N 125.714 1.884 . . . . 0.91 108.068 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -30.84 43.91 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-O 122.526 1.155 . . . . 0.91 111.299 -167.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.52 172.02 0.17 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-O 125.278 2.466 . . . . 0.91 114.906 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -120.61 83.36 2.05 Favored 'General case' 0 C--N 1.384 2.07 0 CA-C-N 113.241 -1.8 . . . . 0.57 108.463 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -74.4 152.53 39.49 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 113.695 -1.593 . . . . 0.57 107.498 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 126.84 35.15 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-O 124.734 2.207 . . . . 0.57 105.488 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.8 p -106.42 123.06 47.49 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 105.344 -2.095 . . . . 0.57 105.344 -175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 70.6 34.83 2.02 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.318 1.533 . . . . 0.57 109.621 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -139.11 -82.06 0.29 Allowed 'General case' 0 C--N 1.375 1.703 0 N-CA-C 107.752 -1.203 . . . . 0.57 107.752 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.73 -163.33 33.69 Favored Glycine 0 C--N 1.365 2.148 0 N-CA-C 107.851 -2.1 . . . . 0.57 107.851 -171.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.3 -142.85 47.75 Favored Glycine 0 C--N 1.373 2.588 0 C-N-CA 119.295 -1.431 . . . . 0.57 110.724 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 p -74.62 115.45 14.19 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-O 124.684 2.183 . . . . 0.57 113.723 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.495 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.7 p30 -102.55 147.67 26.49 Favored 'General case' 0 C--N 1.373 1.618 0 CA-C-N 112.748 -2.024 . . . . 0.57 110.183 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.526 HD13 ' C ' ' A' ' 212' ' ' LEU . 0.1 OUTLIER -71.34 -34.34 70.44 Favored 'General case' 0 C--N 1.381 1.966 0 N-CA-C 105.339 -2.097 . . . . 0.57 105.339 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.921 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -53.73 -49.95 67.03 Favored 'General case' 0 C--N 1.375 1.686 0 CA-C-N 114.993 -1.003 . . . . 0.57 110.9 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -54.94 -48.28 73.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.57 110.946 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -38.2 77.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.57 111.128 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -61.55 -46.31 90.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.57 111.158 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 213' ' ' PHE . 3.6 t -65.36 -40.01 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.57 111.089 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.12 -50.0 57.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.57 110.891 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.9 -42.12 93.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.91 110.849 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.721 HG22 HD23 ' A' ' 224' ' ' LEU . 2.4 mm -68.44 -43.92 83.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.11 -33.86 76.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.57 112.438 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -39.4 89.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.779 0.323 . . . . 0.57 110.849 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 m -71.05 -51.56 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.57 110.833 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.721 HD23 HG22 ' A' ' 220' ' ' ILE . 3.7 pp -69.35 -55.73 9.55 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 116.002 1.853 . . . . 0.57 116.002 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.641 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -71.73 -148.44 0.67 Allowed Glycine 0 C--N 1.364 2.096 0 N-CA-C 107.51 -2.236 . . . . 0.57 107.51 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER -125.63 -21.26 4.5 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 113.19 -1.505 . . . . 0.57 108.835 -172.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.521 ' N ' HD22 ' A' ' 226' ' ' LEU . . . 148.19 -172.28 28.48 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 123.172 1.429 . . . . 0.57 112.847 -161.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 236' ' ' MET . 2.2 m170 -73.97 -162.21 0.13 Allowed 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.074 -2.063 . . . . 0.57 109.364 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 2.1 p -122.15 -10.94 8.5 Favored 'General case' 0 C--N 1.374 1.639 0 C-N-CA 120.313 -0.555 . . . . 0.57 109.869 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 85.71 -4.58 0.83 Allowed 'General case' 0 C--N 1.377 1.771 0 N-CA-C 113.834 1.05 . . . . 0.57 113.834 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -130.03 152.0 79.26 Favored Pre-proline 0 C--N 1.375 1.708 0 N-CA-C 106.572 -1.64 . . . . 0.91 106.572 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -63.72 -21.19 69.78 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.289 1.993 . . . . 0.57 114.167 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 14.01 0.26 Allowed 'General case' 0 C--N 1.369 1.448 0 N-CA-C 117.33 2.345 . . . . 0.57 117.33 168.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.447 ' HB2' ' OG ' ' A' ' 229' ' ' SER . . . -94.8 132.68 39.32 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 123.074 1.416 . . . . 0.57 108.103 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 248' ' ' PHE . 0.3 OUTLIER -76.61 -5.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.372 1.547 0 CA-C-O 124.156 1.931 . . . . 0.57 110.857 -176.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.55 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 74.8 mtp -121.77 26.42 8.69 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 114.046 -1.434 . . . . 0.57 108.726 -176.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.417 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 0.3 OUTLIER -64.8 149.49 96.04 Favored Pre-proline 0 C--N 1.371 1.505 0 C-N-CA 117.696 -1.602 . . . . 0.57 110.231 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.465 ' HB2' H603 ' A' ' 269' ' ' HSI . 39.6 Cg_endo -78.64 -15.05 13.88 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.278 1.319 . . . . 0.57 112.711 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 130.18 45.73 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-O 122.813 1.292 . . . . 0.57 109.411 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.481 ' CE2' HD13 ' A' ' 181' ' ' LEU . 6.3 t80 -89.53 106.75 18.66 Favored 'General case' 0 C--N 1.364 1.215 0 N-CA-C 105.822 -1.918 . . . . 0.57 105.822 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -154.94 115.83 3.95 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 105.106 -2.183 . . . . 0.57 105.106 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -68.6 113.71 6.35 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-O 125.093 2.378 . . . . 0.57 110.081 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 p -95.75 -21.42 5.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 CA-C-N 114.142 -1.39 . . . . 0.57 112.299 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' C ' HG13 ' A' ' 245' ' ' ILE 0.312 0.0 OUTLIER 82.32 -11.98 0.96 Allowed 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.033 0.833 . . . . 0.91 111.282 -176.674 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.577 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.6 mt 87.54 14.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.795 0 C-N-CA 124.858 1.263 . . . . 0.57 110.766 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.61 -30.47 46.55 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-O 125.595 2.617 . . . . 0.57 106.273 -166.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.5 p -119.31 -10.09 9.79 Favored 'General case' 0 C--N 1.386 2.185 0 CA-C-N 112.072 -2.331 . . . . 0.57 112.613 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.624 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 49.9 t80 -48.01 103.64 0.05 OUTLIER 'General case' 0 C--N 1.374 1.668 0 CA-C-O 123.162 1.458 . . . . 0.57 107.461 -172.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -138.4 146.71 42.54 Favored 'General case' 0 C--N 1.363 1.188 0 N-CA-C 104.816 -2.291 . . . . 1.2 104.816 -172.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.554 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.8 132.02 56.76 Favored 'General case' 0 C--N 1.368 1.373 0 CA-C-N 111.704 -2.498 . . . . 0.57 106.482 -172.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.7 t -79.51 146.05 32.88 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 119.804 -1.81 . . . . 0.57 109.325 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.82 90.18 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 114.704 -1.134 . . . . 0.57 109.264 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.58 -39.35 90.86 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.462 -0.79 . . . . 0.91 110.852 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -64.22 -55.0 24.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.91 110.871 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 256' ' ' ARG . 11.8 pt -65.99 -34.84 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.57 111.166 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 255' ' ' ILE . 6.7 mtt-85 -70.05 -31.45 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.927 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.53 56.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.57 112.445 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.0 OUTLIER -64.94 -44.28 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.57 111.149 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.6 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.08 -19.96 61.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.57 110.913 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t -73.88 -19.55 60.68 Favored 'General case' 0 C--N 1.391 2.406 0 CA-C-O 126.135 2.874 . . . . 0.57 107.782 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -54.97 15.52 Favored 'General case' 0 C--N 1.395 2.57 0 O-C-N 118.49 -2.632 . . . . 0.57 108.397 -170.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.405 ' CD2' ' HD3' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -100.13 20.49 14.45 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 112.172 -2.286 . . . . 0.57 115.622 175.473 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.278 2.864 0 N-CA-C 117.931 1.932 . . . . 0.91 117.931 -177.953 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.694 H402 HG13 ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 110.808 -0.917 . . . . 0.57 110.808 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.79 115.01 4.16 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.159 1.906 . . . . 0.57 110.05 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 144.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.373 1.598 0 CA-C-N 113.671 -1.604 . . . . 0.57 108.296 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -160.23 152.21 20.26 Favored 'General case' 0 C--N 1.384 2.099 0 CA-C-N 113.663 -1.608 . . . . 0.57 107.509 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 -132.83 153.58 51.16 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-O 123.835 1.779 . . . . 1.2 107.691 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -48.79 1.73 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-N 112.653 -2.067 . . . . 0.57 109.89 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -85.11 -37.47 20.21 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-O 124.226 1.965 . . . . 0.57 107.838 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -81.39 122.46 27.52 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.066 -1.425 . . . . 0.57 110.882 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.94 138.67 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.57 111.163 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.465 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 70.6 p -131.1 157.27 43.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.57 111.139 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.657 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -137.41 159.38 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.57 110.874 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -135.08 129.4 33.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD13 HG23 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -99.08 124.72 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.57 111.145 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . 15.7 t-20 -41.81 -59.41 1.69 Allowed 'General case' 0 C--N 1.384 2.108 0 C-N-CA 117.498 -1.681 . . . . 0.57 110.122 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 164.36 35.49 0.0 OUTLIER 'General case' 0 C--N 1.387 2.201 0 O-C-N 126.023 2.077 . . . . 0.57 109.521 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 1.7 m-30 80.05 -173.37 0.05 Allowed 'General case' 0 C--N 1.385 2.151 0 N-CA-C 105.36 -2.089 . . . . 0.57 105.36 170.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -130.69 160.72 65.04 Favored Pre-proline 0 C--N 1.369 1.45 0 CA-C-N 114.038 -1.437 . . . . 0.57 108.835 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.66 -49.99 1.42 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.315 1.343 . . . . 0.57 112.166 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.564 ' H ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -82.22 -65.71 0.98 Allowed 'General case' 0 C--N 1.388 2.244 0 N-CA-C 104.726 -2.324 . . . . 0.91 104.726 -163.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.596 ' SD ' HG22 ' A' ' 130' ' ' VAL . 2.0 ttm -59.62 140.9 56.0 Favored 'General case' 0 C--N 1.38 1.912 0 CA-C-O 126.464 3.031 . . . . 0.57 110.071 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.8 OUTLIER -72.73 139.29 47.08 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 112.698 -2.046 . . . . 0.57 109.773 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -69.63 -52.13 28.71 Favored 'General case' 0 C--N 1.374 1.658 0 N-CA-C 105.414 -2.069 . . . . 1.2 105.414 -168.101 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.32 -34.57 57.98 Favored 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.001 -2.363 . . . . 0.91 110.877 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.881 ' HB3' HG21 ' A' ' 205' ' ' THR . 11.9 m-20 -69.76 -44.01 71.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.91 110.931 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.93 -41.5 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.57 111.166 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 134' ' ' ILE . 3.5 m-20 -65.82 -40.6 92.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.91 110.858 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -37.98 81.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.57 110.945 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.593 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.88 -49.18 71.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.57 111.091 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 131' ' ' ASP . 12.3 pt -61.4 -41.47 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.57 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -43.58 97.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 140' ' ' VAL . 2.0 tppt? -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.57 110.881 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.8 98.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.57 111.092 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 18.7 m-85 -63.7 -36.53 84.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.57 110.861 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.71 -39.83 84.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.57 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 136' ' ' LYS . 2.3 t -68.72 -34.05 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.57 111.196 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -84.5 -33.38 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.57 110.919 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -73.82 -47.67 36.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.849 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -62.34 -12.05 18.88 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 118.836 -1.145 . . . . 0.57 112.877 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.71 0.1 9.71 Favored 'Isoleucine or valine' 0 C--N 1.379 1.882 0 CA-C-N 113.844 -1.525 . . . . 0.57 112.675 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.663 HG22 ' HD2' ' A' ' 146' ' ' PRO . 2.1 m -150.53 140.43 13.88 Favored Pre-proline 0 C--N 1.376 1.745 0 CA-C-O 124.234 1.969 . . . . 0.57 110.559 -172.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.687 ' O ' HD23 ' A' ' 147' ' ' LEU . 45.5 Cg_endo -79.6 63.16 8.7 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.092 1.861 . . . . 0.57 114.048 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -146.39 120.62 9.53 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 105.824 -1.917 . . . . 0.57 105.824 -169.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 158.28 34.79 Favored 'General case' 0 C--N 1.382 1.982 0 CA-C-N 113.278 -1.783 . . . . 0.57 113.416 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HZ ' HD22 ' A' ' 224' ' ' LEU . 0.8 OUTLIER -129.31 136.31 49.87 Favored 'General case' 0 C--N 1.388 2.276 0 CA-C-N 112.68 -2.055 . . . . 0.57 109.818 -177.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.98 111.83 3.52 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 124.808 2.242 . . . . 0.57 109.163 -175.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tttm -89.34 146.66 24.55 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 114.108 -1.405 . . . . 0.57 111.938 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 154' ' ' THR . 4.9 pt -130.64 163.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 113.44 -1.709 . . . . 0.57 109.498 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 9.04 13.4 Favored 'General case' 0 C--N 1.382 2.004 0 CA-C-N 113.06 -1.882 . . . . 0.57 111.552 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.489 ' O ' HD12 ' A' ' 152' ' ' ILE . 6.8 m -145.0 125.97 14.48 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 106.888 -1.523 . . . . 0.57 106.888 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.97 -130.17 10.15 Favored Glycine 0 C--N 1.376 2.785 0 N-CA-C 109.389 -1.484 . . . . 0.57 109.389 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.5 ttp -150.66 146.95 26.81 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.986 1.375 . . . . 0.57 107.303 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.465 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -127.35 177.06 6.97 Favored 'General case' 0 C--N 1.373 1.59 0 CA-C-N 112.864 -1.971 . . . . 0.57 109.695 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -65.23 -68.18 0.38 Allowed 'General case' 0 C--N 1.378 1.846 0 N-CA-C 104.69 -2.337 . . . . 0.91 104.69 -168.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.0 mp -92.87 110.26 22.8 Favored 'Isoleucine or valine' 0 C--N 1.378 1.805 0 O-C-N 124.649 1.218 . . . . 0.57 111.098 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 121.81 46.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.57 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 118' ' ' ILE . 2.5 m -102.48 116.95 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.57 111.136 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.615 HG22 ' CD2' ' A' ' 196' ' ' HIS . 1.5 m -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.57 111.152 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.13 125.71 33.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.887 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 168' ' ' HIS . . . -144.5 169.88 17.1 Favored 'General case' 0 C--N 1.369 1.445 0 C-N-CA 117.898 -1.521 . . . . 0.57 107.675 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 168.29 9.42 Favored 'General case' 0 C--N 1.367 1.343 0 CA-C-N 114.2 -1.363 . . . . 1.2 108.608 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -44.6 132.81 7.35 Favored Glycine 0 C--N 1.377 2.856 0 O-C-N 124.933 1.396 . . . . 0.57 111.82 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.99 105.39 0.06 Allowed 'General case' 0 C--N 1.401 2.822 0 CA-C-O 124.668 2.175 . . . . 0.57 112.385 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 164' ' ' ALA . 3.5 p-80 -173.74 26.08 0.01 OUTLIER 'General case' 0 C--N 1.387 2.206 0 CA-C-O 123.401 1.572 . . . . 0.57 111.995 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.8 176.66 51.34 Favored Glycine 0 C--N 1.378 2.887 0 C-N-CA 118.79 -1.671 . . . . 0.57 109.606 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.284 0.0 OUTLIER 56.71 17.82 3.37 Favored 'General case' 0 C--N 1.394 2.525 0 CA-C-N 113.39 -1.405 . . . . 0.91 114.032 174.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 164.35 133.4 0.01 OUTLIER 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.112 1.911 . . . . 0.57 108.161 -160.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.521 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 74.1 t60 -89.18 75.79 7.79 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 112.875 -1.966 . . . . 0.57 109.248 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 78.2 132.44 0.05 Allowed 'General case' 0 C--N 1.387 2.225 0 CA-C-O 123.328 1.537 . . . . 0.57 109.873 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.647 ' CZ ' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -117.19 -165.79 1.11 Allowed 'General case' 0 C--N 1.386 2.185 0 CA-C-N 113.146 -1.843 . . . . 0.57 111.353 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.27 159.8 16.35 Favored 'General case' 0 C--N 1.38 1.913 0 CA-C-N 114.45 -1.25 . . . . 0.91 109.849 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -136.52 62.28 0.6 Allowed Glycine 0 C--N 1.378 2.895 0 CA-C-O 123.869 1.816 . . . . 0.57 110.095 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -166.66 -35.53 0.03 OUTLIER 'General case' 0 C--N 1.376 1.736 0 CA-C-N 113.23 -1.485 . . . . 0.57 112.713 169.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.48 -63.68 0.04 OUTLIER Glycine 0 C--N 1.37 2.457 0 C-N-CA 119.567 -1.301 . . . . 0.57 113.003 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 180' ' ' ILE . . . -35.88 112.39 0.12 Allowed Glycine 0 C--N 1.375 2.729 0 N-CA-C 109.241 -1.544 . . . . 0.57 109.241 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.647 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 88.91 52.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.889 0 O-C-N 119.217 -2.343 . . . . 0.57 108.559 175.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.479 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 2.5 tp -43.11 -30.91 0.49 Allowed 'General case' 0 C--N 1.375 1.697 0 CA-C-O 123.797 1.76 . . . . 0.57 112.083 -174.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -179.49 179.78 0.58 Allowed 'General case' 0 C--N 1.368 1.41 0 CA-C-N 113.229 -1.805 . . . . 0.57 111.123 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.589 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -142.56 164.67 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.57 110.837 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.79 140.87 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.57 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -89.93 152.49 21.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 117.816 -1.554 . . . . 0.57 109.449 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -92.54 -42.17 4.59 Favored Glycine 0 C--N 1.373 2.595 0 CA-C-N 114.417 -1.265 . . . . 0.57 113.623 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 50.7 Cg_exo -63.53 -143.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.401 3.32 0 CA-C-O 125.953 2.397 . . . . 0.57 111.676 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -151.47 -148.31 4.78 Favored Glycine 0 C--N 1.376 2.755 0 C-N-CA 117.493 -2.289 . . . . 0.57 109.781 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.2 m 77.76 52.17 0.04 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-N 112.629 -1.785 . . . . 0.57 107.512 171.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.54 -72.73 2.75 Favored Glycine 0 C--N 1.376 2.761 0 N-CA-C 106.919 -2.473 . . . . 0.57 106.919 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 189' ' ' SER . 1.9 mp -70.12 -48.2 63.48 Favored 'Isoleucine or valine' 0 C--N 1.374 1.649 0 CA-C-O 125.85 2.738 . . . . 0.57 105.515 -171.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.29 153.92 53.03 Favored Glycine 0 C--N 1.378 2.91 0 C-N-CA 116.282 -2.866 . . . . 0.57 108.351 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 80.96 -15.23 22.46 Favored Glycine 0 C--N 1.372 2.549 0 CA-C-O 124.178 1.988 . . . . 0.57 113.305 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.07 146.38 53.54 Favored 'General case' 0 C--N 1.374 1.636 0 O-C-N 120.287 -1.714 . . . . 0.91 110.833 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -144.04 137.36 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.57 111.098 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.615 ' CD2' HG22 ' A' ' 162' ' ' VAL . 1.1 m170 -128.39 150.17 50.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.57 110.791 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -123.11 150.19 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.57 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.48 112.62 14.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.91 110.799 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -43.5 88.54 Favored 'General case' 0 C--N 1.383 2.053 0 CA-C-O 117.436 -1.268 . . . . 0.91 108.966 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.74 -32.85 0.65 Allowed 'General case' 0 C--N 1.38 1.9 0 O-C-N 125.646 1.841 . . . . 0.91 108.959 -173.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.96 176.1 0.44 Allowed 'General case' 0 C--N 1.384 2.072 0 CA-C-O 126.535 3.064 . . . . 0.91 109.216 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.91 80.5 1.33 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-N 112.615 -2.084 . . . . 0.57 109.016 -175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 79.6 m95 -76.13 109.14 9.54 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 106.977 -1.49 . . . . 0.57 106.977 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.57 121.88 31.75 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-O 125.149 2.404 . . . . 0.57 109.869 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.881 HG21 ' HB3' ' A' ' 129' ' ' ASP . 11.2 p -96.99 151.27 19.87 Favored 'General case' 0 C--N 1.368 1.395 0 N-CA-C 106.198 -1.778 . . . . 0.57 106.198 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.65 -48.55 0.23 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 114.316 -1.311 . . . . 0.57 109.915 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.3 m -168.78 137.98 2.21 Favored 'General case' 0 C--N 1.384 2.092 0 N-CA-C 108.05 -1.093 . . . . 0.57 108.05 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 148.2 -36.92 1.09 Allowed Glycine 0 C--N 1.382 3.122 0 CA-C-N 114.358 -1.292 . . . . 0.57 111.671 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 148.82 -84.16 0.17 Allowed Glycine 0 C--N 1.386 3.344 0 CA-C-O 123.801 1.778 . . . . 0.57 111.686 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.0 p -78.7 135.94 37.3 Favored 'General case' 0 C--N 1.383 2.025 0 CA-C-N 113.079 -1.56 . . . . 0.57 110.964 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.71 141.39 52.14 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 113.949 -1.478 . . . . 0.57 108.011 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.743 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.4 tm? -71.15 -26.74 63.13 Favored 'General case' 0 C--N 1.387 2.225 0 CA-C-O 125.086 2.374 . . . . 0.57 108.576 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.545 ' CD1' HG12 ' A' ' 245' ' ' ILE . 3.5 t80 -57.6 -50.15 74.08 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-N 113.862 -1.517 . . . . 0.57 110.855 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.649 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.2 OUTLIER -61.61 -51.22 69.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.933 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -44.41 97.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.57 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HA ' ' OE2' ' A' ' 219' ' ' GLU . . . -57.08 -41.36 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.57 111.079 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.42 -39.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.57 111.096 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.458 ' CD2' ' CE ' ' A' ' 236' ' ' MET . 3.7 t-160 -70.08 -50.51 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.57 110.802 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 216' ' ' ALA . 0.7 OUTLIER -64.08 -42.02 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.902 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.713 HG22 HD23 ' A' ' 224' ' ' LEU . 69.8 mt -69.01 -34.22 62.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.57 111.113 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 225' ' ' GLY . . . -69.19 -33.48 73.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.699 -0.762 . . . . 0.57 112.444 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.59 -44.02 95.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.57 110.842 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.24 -49.96 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.57 110.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 220' ' ' ILE . 0.5 OUTLIER -84.04 13.48 5.02 Favored 'General case' 0 C--N 1.392 2.441 0 CA-C-O 123.595 1.664 . . . . 0.57 115.324 177.283 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.449 ' HA2' ' OH ' ' A' ' 262' ' ' TYR . . . -153.12 176.93 31.02 Favored Glycine 0 C--N 1.363 2.04 0 CA-C-O 126.635 3.353 . . . . 0.57 108.167 -168.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -158.93 0.23 Allowed 'General case' 0 C--N 1.367 1.337 0 CA-C-O 125.873 2.749 . . . . 0.57 109.278 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.78 -143.18 0.11 Allowed Glycine 0 C--N 1.387 3.411 0 CA-C-O 125.524 2.736 . . . . 0.57 112.311 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 236' ' ' MET . 34.0 m170 -83.83 -175.29 5.74 Favored 'General case' 0 C--N 1.379 1.861 0 O-C-N 120.444 -1.621 . . . . 0.57 114.609 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.528 ' CB ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -99.11 -84.46 0.4 Allowed 'General case' 0 C--N 1.389 2.308 0 N-CA-C 106.448 -1.686 . . . . 0.57 106.448 179.314 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 m 155.81 -30.25 0.0 OUTLIER 'General case' 0 C--N 1.389 2.29 0 O-C-N 125.842 1.964 . . . . 0.57 113.168 -167.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.596 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 3.3 t70 -110.2 152.07 42.95 Favored Pre-proline 0 C--N 1.388 2.282 0 N-CA-C 108.291 -1.003 . . . . 0.91 108.291 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -60.7 -47.83 12.48 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.687 2.258 . . . . 0.57 111.92 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.42 22.79 Favored 'General case' 0 C--N 1.381 1.948 0 CA-C-N 113.252 -1.794 . . . . 0.57 115.284 176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -71.46 120.11 16.57 Favored 'General case' 0 C--N 1.375 1.674 0 CA-C-O 125.158 2.408 . . . . 0.57 113.0 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 236' ' ' MET . 68.2 t -73.93 86.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.867 0 CA-C-N 111.446 -2.615 . . . . 0.57 108.612 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 218' ' ' HIS . 0.0 OUTLIER 162.06 -34.28 0.0 OUTLIER 'General case' 0 C--N 1.377 1.802 0 O-C-N 125.37 1.669 . . . . 0.57 109.273 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 4.4 t80 -49.97 146.96 7.33 Favored Pre-proline 0 C--N 1.372 1.579 0 CA-C-O 122.971 1.367 . . . . 0.57 110.223 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 74.0 Cg_exo -56.53 -36.99 98.27 Favored 'Trans proline' 0 C--N 1.393 2.904 0 C-N-CA 122.219 1.946 . . . . 0.57 112.406 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -45.39 111.79 0.38 Allowed 'General case' 0 C--N 1.376 1.741 0 CA-C-O 123.633 1.683 . . . . 0.57 110.642 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -83.92 94.62 8.29 Favored 'General case' 0 C--N 1.38 1.914 0 CA-C-O 124.385 2.041 . . . . 0.57 106.431 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.704 ' HB3' ' H35' ' A' ' 269' ' ' HSI . 1.2 tmtt? -110.84 119.41 39.01 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 113.122 -1.854 . . . . 0.57 108.124 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -55.6 120.91 7.96 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-O 126.105 2.859 . . . . 0.57 110.991 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 248' ' ' PHE . 5.4 p -140.79 115.23 5.88 Favored 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 105.86 -1.904 . . . . 0.57 105.86 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -77.3 33.46 0.16 Allowed 'General case' 0 C--N 1.364 1.239 0 N-CA-C 114.885 1.439 . . . . 0.91 114.885 170.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.545 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.5 mt 82.94 -2.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.382 1.987 0 CA-C-O 124.145 1.926 . . . . 0.57 108.713 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -88.5 -35.48 16.96 Favored 'General case' 0 C--N 1.38 1.904 0 N-CA-C 103.016 -2.957 . . . . 0.57 103.016 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.464 ' O ' 'CL1 ' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -113.27 3.47 15.97 Favored 'General case' 0 C--N 1.387 2.229 0 CA-C-N 113.47 -1.695 . . . . 0.57 109.778 -173.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.485 ' N ' HG21 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -80.72 12.06 3.43 Favored 'General case' 0 C--N 1.386 2.195 0 O-C-N 125.754 1.909 . . . . 0.57 109.86 -171.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 154.07 12.02 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 124.724 2.202 . . . . 1.2 107.778 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.585 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -120.07 126.97 52.08 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 103.676 -2.713 . . . . 0.57 103.676 -167.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.03 140.53 48.79 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-O 124.883 2.278 . . . . 0.57 116.323 169.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.47 86.83 Favored 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.689 -1.596 . . . . 0.57 110.184 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.22 -33.12 74.69 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.994 -1.003 . . . . 0.91 110.863 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -63.95 -55.23 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.91 110.901 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.5 pt -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.57 111.144 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.418 ' N ' HG13 ' A' ' 255' ' ' ILE . 75.8 mtt-85 -70.17 -32.95 71.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.92 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.7 -48.0 58.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.57 112.495 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.3 pt -62.42 -45.8 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.57 111.1 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.467 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.1 pt20 -72.53 -19.11 61.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.57 110.954 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -15.13 63.23 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 122.575 1.178 . . . . 0.57 110.687 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.536 HD23 ' CE2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -84.05 -52.58 6.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-O 123.618 1.675 . . . . 0.57 111.986 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.536 ' CE2' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -103.82 90.26 3.58 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-N 113.866 -1.515 . . . . 0.57 111.311 -173.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.386 3.31 0 N-CA-C 121.243 3.257 . . . . 0.91 121.243 -171.501 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 0.704 ' H35' ' HB3' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.17 0 N-CA-C 111.338 -0.705 . . . . 0.57 111.338 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.52 143.39 42.53 Favored 'Trans proline' 0 C--N 1.376 1.992 0 O-C-N 123.291 1.153 . . . . 0.57 110.997 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.77 120.38 55.78 Favored 'Isoleucine or valine' 0 C--N 1.382 1.98 0 CA-C-N 113.466 -1.697 . . . . 0.57 108.295 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -130.87 -9.36 3.92 Favored 'General case' 0 C--N 1.384 2.072 0 CA-C-N 112.883 -1.962 . . . . 0.57 111.127 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.89 172.19 7.41 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 114.817 -1.083 . . . . 1.2 110.942 175.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 60.14 176.94 0.09 Allowed 'General case' 0 C--N 1.399 2.746 0 CA-C-N 113.407 -1.724 . . . . 0.57 110.471 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.27 -84.99 0.03 OUTLIER 'General case' 0 C--N 1.387 2.224 0 CA-C-N 114.23 -1.35 . . . . 0.57 110.323 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 150' ' ' SER . 31.0 t80 -117.49 107.08 13.87 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.44 1.713 . . . . 0.57 110.933 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 ' OD2' ' A' ' 158' ' ' ASP . 0.7 OUTLIER -103.0 147.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.57 111.149 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.688 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -109.79 134.96 51.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.145 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -143.87 155.61 44.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.57 110.892 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -142.43 139.4 31.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.851 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.08 142.97 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.118 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 163' ' ' PHE . 22.9 t30 -54.07 -63.87 1.01 Allowed 'General case' 0 C--N 1.366 1.29 0 N-CA-C 108.433 -0.951 . . . . 0.57 108.433 -171.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.45 -172.01 3.2 Favored 'General case' 0 C--N 1.38 1.916 0 N-CA-C 107.398 -1.334 . . . . 0.57 107.398 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' HG22 ' A' ' 122' ' ' THR . 3.3 p90 -176.96 82.57 0.02 OUTLIER 'General case' 0 C--N 1.39 2.327 0 CA-C-O 124.419 2.057 . . . . 0.57 113.653 -172.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.53 HG23 ' CD ' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -171.71 -56.28 0.0 OUTLIER Pre-proline 0 C--N 1.372 1.574 0 O-C-N 119.894 -1.753 . . . . 0.57 110.167 -174.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.53 ' CD ' HG23 ' A' ' 122' ' ' THR . 12.0 Cg_endo -69.9 -55.31 0.18 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 N-CA-C 107.932 -1.603 . . . . 0.57 107.932 -171.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -129.46 -12.07 4.47 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 114.221 -1.354 . . . . 0.91 110.921 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -114.19 128.08 56.2 Favored 'General case' 0 C--N 1.38 1.907 0 CA-C-O 124.638 2.161 . . . . 0.57 106.798 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.819 ' H ' HG21 ' A' ' 205' ' ' THR . 0.5 OUTLIER -90.02 144.56 25.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.446 -2.659 . . . . 0.57 110.256 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -53.49 8.27 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 106.409 -1.701 . . . . 1.2 106.409 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.54 -37.69 88.42 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-N 114.222 -1.354 . . . . 0.91 110.934 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 205' ' ' THR . 19.4 t70 -70.2 -44.06 69.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.91 110.896 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.75 HG22 ' HG ' ' A' ' 212' ' ' LEU . 21.0 t -69.22 -46.28 77.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.095 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -56.82 -44.16 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.91 110.839 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -39.6 90.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.57 110.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.733 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -65.37 -49.07 70.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.57 111.141 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 135' ' ' ARG . 48.4 pt -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.57 111.172 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.458 ' N ' HG13 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -61.06 -49.32 77.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.853 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -35.66 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.57 110.88 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.913 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -65.98 -41.41 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.57 111.133 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 149' ' ' PHE . 1.8 m-85 -67.25 -33.67 75.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.57 110.835 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.6 pt20 -68.44 -40.72 81.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.57 110.912 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -70.53 -34.35 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.57 111.168 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.801 ' CD2' HD11 ' A' ' 224' ' ' LEU . 4.4 m95 -83.25 -33.72 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.57 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.6 m -78.26 -50.55 11.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.57 110.898 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.606 ' OD1' HG13 ' A' ' 144' ' ' VAL . 2.5 p-10 -56.59 -13.88 2.75 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 113.278 0.844 . . . . 0.57 113.278 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.606 HG13 ' OD1' ' A' ' 143' ' ' ASN . 18.2 m -114.52 9.11 7.7 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 CA-C-N 114.541 -1.209 . . . . 0.57 111.451 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.2 p -149.23 147.17 22.78 Favored Pre-proline 0 C--N 1.373 1.594 0 CA-C-O 124.599 2.142 . . . . 0.57 108.484 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.85 22.07 1.0 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 121.544 1.496 . . . . 0.57 113.056 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.813 HD11 ' CE1' ' A' ' 262' ' ' TYR . 0.4 OUTLIER -127.91 101.03 6.15 Favored 'General case' 0 C--N 1.378 1.829 0 N-CA-C 105.619 -1.993 . . . . 0.57 105.619 -173.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.27 159.59 30.98 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-O 126.77 3.176 . . . . 0.57 116.263 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . 45.6 m-85 -132.19 162.64 30.42 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.533 -2.122 . . . . 0.57 107.396 -177.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 113' ' ' TYR . 54.3 m -157.67 123.33 4.62 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 125.859 2.742 . . . . 0.57 108.394 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -95.97 141.48 29.34 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-N 113.344 -1.753 . . . . 0.57 110.972 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 155' ' ' GLY . 4.4 pt -129.93 159.55 41.85 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-O 124.276 1.988 . . . . 0.57 108.986 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.4 -15.01 14.56 Favored 'General case' 0 C--N 1.384 2.097 0 CA-C-N 113.117 -1.856 . . . . 0.57 107.807 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 89.3 m -60.22 -59.8 4.83 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 123.343 1.544 . . . . 0.57 107.373 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.511 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 138.93 146.16 4.9 Favored Glycine 0 C--N 1.38 2.997 0 N-CA-C 110.539 -1.024 . . . . 0.57 110.539 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.6 ttp 78.79 88.59 0.06 Allowed 'General case' 0 C--N 1.399 2.758 0 CA-C-O 124.465 2.078 . . . . 0.57 110.075 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -133.9 172.16 13.18 Favored 'General case' 0 C--N 1.373 1.622 0 CA-C-N 113.158 -1.837 . . . . 0.57 109.718 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 115' ' ' THR . 33.1 m-20 -61.15 -59.4 5.39 Favored 'General case' 0 C--N 1.37 1.469 0 N-CA-C 105.836 -1.913 . . . . 0.91 105.836 -173.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.82 109.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.388 2.282 0 O-C-N 124.326 1.016 . . . . 0.57 111.118 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -100.8 128.59 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.57 110.933 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 197' ' ' PHE . 17.4 t -105.48 118.26 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.57 111.087 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 196' ' ' HIS . 6.8 t -131.48 132.16 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.57 111.085 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 119' ' ' ASN . 4.2 m-85 -90.61 121.32 32.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.57 110.836 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.15 166.57 24.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 123.044 1.402 . . . . 0.57 107.599 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 167.62 9.76 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 114.19 -1.368 . . . . 1.2 109.888 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -39.45 121.49 1.42 Allowed Glycine 0 C--N 1.395 3.825 0 O-C-N 125.297 1.623 . . . . 0.57 111.018 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 87.71 80.9 0.01 OUTLIER 'General case' 0 C--N 1.397 2.653 0 CA-C-O 125.214 2.435 . . . . 0.57 109.882 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -140.29 -54.48 0.52 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 113.13 -1.85 . . . . 0.57 110.494 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 173.04 -173.15 45.54 Favored Glycine 0 C--N 1.377 2.806 0 N-CA-C 109.091 -1.604 . . . . 0.57 109.091 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 78.25 -71.68 0.1 Allowed 'General case' 0 C--N 1.4 2.776 0 CA-C-N 112.642 -1.779 . . . . 0.91 107.691 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.5 -166.54 1.33 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 124.647 2.165 . . . . 0.57 108.023 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.636 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 21.9 m170 -77.99 65.09 3.33 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 114.194 -1.366 . . . . 0.57 109.67 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 78.85 -166.98 0.04 OUTLIER 'General case' 0 C--N 1.387 2.212 0 CA-C-N 114.168 -1.378 . . . . 0.57 111.768 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.434 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -124.11 -161.5 1.0 Allowed 'General case' 0 C--N 1.39 2.361 0 CA-C-N 113.01 -1.904 . . . . 0.57 111.804 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.448 ' CB ' ' H ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -87.61 -54.38 4.3 Favored 'General case' 0 C--N 1.388 2.269 0 CA-C-N 114.676 -1.147 . . . . 0.91 111.934 174.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.03 105.64 0.05 OUTLIER Glycine 0 C--N 1.396 3.87 0 C-N-CA 118.591 -1.766 . . . . 0.57 117.317 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.66 90.4 0.09 Allowed 'General case' 0 C--N 1.381 1.967 0 CA-C-O 125.28 2.467 . . . . 0.57 112.43 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.29 -144.73 26.09 Favored Glycine 0 C--N 1.381 3.079 0 O-C-N 119.529 -1.982 . . . . 0.57 113.453 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.425 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 52.72 -118.96 8.6 Favored Glycine 0 C--N 1.395 3.817 0 N-CA-C 108.39 -1.884 . . . . 0.57 108.39 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.448 ' H ' ' CB ' ' A' ' 175' ' ' ASP . 0.6 OUTLIER -76.57 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.706 0 N-CA-C 105.94 -1.874 . . . . 0.57 105.94 -175.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.899 HD22 ' CE1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -38.23 -33.94 0.11 Allowed 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.417 1.087 . . . . 0.57 109.881 -175.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -178.41 179.95 0.73 Allowed 'General case' 0 C--N 1.383 2.057 0 O-C-N 125.727 1.892 . . . . 0.57 111.081 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.456 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -151.03 151.01 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.57 110.865 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 195' ' ' ALA . . . -142.81 140.36 31.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.57 111.063 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.1 OUTLIER -87.64 124.24 33.33 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 118.323 -1.351 . . . . 0.57 108.715 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -124.48 50.19 0.87 Allowed Glycine 0 C--N 1.371 2.476 0 O-C-N 120.756 -1.215 . . . . 0.57 113.579 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 33.9 Cg_endo -76.49 -52.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 121.217 1.278 . . . . 0.57 109.765 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.17 47.36 0.71 Allowed Glycine 0 C--N 1.392 3.642 0 CA-C-O 123.759 1.755 . . . . 0.57 111.869 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -155.02 -147.79 0.22 Allowed 'General case' 0 C--N 1.384 2.065 0 O-C-N 121.074 -1.251 . . . . 0.57 108.732 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -55.85 -79.19 0.1 OUTLIER Glycine 0 C--N 1.388 3.466 0 CA-C-O 126.105 3.058 . . . . 0.57 112.531 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -11.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.387 2.232 0 CA-C-O 124.823 2.249 . . . . 0.57 110.362 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.06 126.51 22.71 Favored Glycine 0 C--N 1.37 2.446 0 O-C-N 118.292 -2.755 . . . . 0.57 111.829 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 108.93 -50.14 0.8 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 113.527 -1.336 . . . . 0.57 111.985 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -34.92 102.7 0.02 OUTLIER 'General case' 0 C--N 1.379 1.877 0 O-C-N 124.649 0.852 . . . . 0.91 110.901 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 184' ' ' ALA . . . -116.52 150.32 38.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.57 111.068 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.469 ' CD2' ' HB ' ' A' ' 162' ' ' VAL . 19.5 m170 -135.03 139.16 44.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.57 110.854 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -111.09 150.11 29.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.57 110.903 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 1.5 m-20 -58.31 110.82 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.467 . . . . 0.91 110.788 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 4.2 tp10 -77.91 -20.66 52.47 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-O 126.423 3.011 . . . . 0.91 108.555 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -12.38 60.27 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 118.3 -2.75 . . . . 0.91 110.712 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -82.05 -179.63 7.47 Favored 'General case' 0 C--N 1.398 2.678 0 N-CA-C 102.651 -3.092 . . . . 0.91 102.651 -168.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.98 82.05 1.59 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.346 -1.752 . . . . 0.57 110.624 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 60.5 m95 -72.51 102.93 3.35 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 123.788 1.756 . . . . 0.57 108.754 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.629 HG21 ' O ' ' A' ' 208' ' ' GLY . 0.1 OUTLIER -80.35 130.82 35.44 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 113.762 -1.563 . . . . 0.57 110.953 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.819 HG21 ' H ' ' A' ' 126' ' ' ASN . 7.7 p -119.02 101.24 7.88 Favored 'General case' 0 C--N 1.385 2.135 0 CA-C-N 113.034 -1.894 . . . . 0.57 107.752 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 77.6 36.73 0.26 Allowed 'General case' 0 C--N 1.403 2.9 0 CA-C-O 126.039 2.828 . . . . 0.57 104.863 168.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 t -138.07 -92.22 0.21 Allowed 'General case' 0 C--N 1.391 2.406 0 CA-C-N 112.716 -2.038 . . . . 0.57 109.053 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.629 ' O ' HG21 ' A' ' 204' ' ' THR . . . -173.58 156.39 24.0 Favored Glycine 0 C--N 1.38 3.022 0 CA-C-N 114.943 -1.026 . . . . 0.57 110.541 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.24 -136.44 13.01 Favored Glycine 0 C--N 1.369 2.412 0 CA-C-O 124.126 1.959 . . . . 0.57 111.242 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.9 m -69.08 117.54 10.86 Favored 'General case' 0 C--N 1.384 2.078 0 CA-C-O 123.317 1.532 . . . . 0.57 112.517 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -102.92 153.91 19.74 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.311 1.529 . . . . 0.57 111.603 176.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.75 ' HG ' HG22 ' A' ' 130' ' ' VAL . 2.1 tm? -72.72 -31.45 64.98 Favored 'General case' 0 C--N 1.389 2.324 0 CA-C-N 113.347 -1.752 . . . . 0.57 106.653 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.6 t80 -59.04 -50.46 73.99 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.086 -1.634 . . . . 0.57 110.859 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 1.049 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -58.19 -51.83 68.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.57 110.906 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.53 -33.96 75.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.57 111.178 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 219' ' ' GLU . . . -68.83 -39.48 79.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.57 111.114 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 213' ' ' PHE . 41.4 t -68.1 -38.46 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.57 111.154 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -70.06 -50.85 37.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.57 110.837 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' HG23 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -56.6 -45.19 81.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.91 110.913 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.913 HD11 ' HB1' ' A' ' 137' ' ' ALA . 5.5 pt -72.73 -39.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.57 111.075 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.03 -33.88 64.92 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.57 112.474 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.86 -44.02 94.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.57 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -50.24 55.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.57 110.828 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.801 HD11 ' CD2' ' A' ' 141' ' ' TRP . 3.4 pp -75.82 0.6 17.51 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.954 2.576 . . . . 0.57 117.954 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -145.73 -158.79 7.86 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 108.072 -2.011 . . . . 0.57 108.072 -173.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.28 -156.73 0.76 Allowed 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.051 -1.574 . . . . 0.57 107.678 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -55.93 -167.21 0.06 OUTLIER Glycine 0 C--N 1.397 3.951 0 CA-C-O 125.717 2.843 . . . . 0.57 112.486 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.5 m80 -100.28 -150.31 0.38 Allowed 'General case' 0 C--N 1.37 1.484 0 O-C-N 120.387 -1.654 . . . . 0.57 110.225 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.803 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 9.1 p -122.39 -24.24 5.05 Favored 'General case' 0 C--N 1.387 2.219 0 CA-C-N 114.521 -1.218 . . . . 0.57 110.493 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 83.06 16.43 0.31 Allowed 'General case' 0 C--N 1.398 2.704 0 CA-C-O 123.2 1.476 . . . . 0.57 113.21 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -134.29 150.28 73.59 Favored Pre-proline 0 C--N 1.386 2.18 0 N-CA-C 104.818 -2.29 . . . . 0.91 104.818 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 72.5 Cg_exo -56.6 -20.58 34.81 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.091 2.527 . . . . 0.57 114.036 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -40.29 85.09 Favored 'General case' 0 C--N 1.385 2.142 0 CA-C-N 113.329 -1.76 . . . . 0.57 115.628 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -51.79 128.33 23.43 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 123.86 1.79 . . . . 0.57 110.716 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 249' ' ' ARG . 0.4 OUTLIER -75.52 2.48 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.126 0 CA-C-O 125.38 2.514 . . . . 0.57 111.53 -177.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.496 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 5.7 ptm -142.31 8.19 1.79 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 120.422 -1.424 . . . . 0.57 110.188 -175.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.862 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -42.79 143.96 1.11 Allowed Pre-proline 0 C--N 1.37 1.459 0 CA-C-O 124.097 1.903 . . . . 0.57 112.844 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.403 ' O ' ' H14' ' A' ' 269' ' ' HSI . 71.9 Cg_exo -51.92 -50.31 14.41 Favored 'Trans proline' 0 C--N 1.371 1.728 0 O-C-N 119.481 -0.852 . . . . 0.57 112.351 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.505 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -52.46 126.46 19.45 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-O 123.318 1.532 . . . . 0.57 109.669 -175.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.899 ' CE1' HD22 ' A' ' 181' ' ' LEU . 78.4 t80 -99.28 166.57 11.15 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 119.959 -1.713 . . . . 0.57 107.833 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 169.36 121.45 0.01 OUTLIER 'General case' 0 C--N 1.39 2.352 0 N-CA-C 106.058 -1.83 . . . . 0.57 106.058 173.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.85 121.6 6.19 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.842 2.258 . . . . 0.57 110.882 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 243' ' ' VAL . 7.1 p -147.38 113.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.741 -1.572 . . . . 0.57 107.702 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -44.65 146.0 0.81 Allowed 'General case' 0 C--N 1.383 2.044 0 CA-C-O 125.737 2.684 . . . . 0.91 107.719 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 213' ' ' PHE . 3.9 mp -62.03 -22.87 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-N 113.319 -1.764 . . . . 0.57 112.603 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.66 -21.93 66.63 Favored 'General case' 0 C--N 1.372 1.585 0 CA-C-O 123.034 1.397 . . . . 0.57 111.397 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.6 p -108.36 1.11 21.58 Favored 'General case' 0 C--N 1.385 2.134 0 N-CA-C 114.904 1.446 . . . . 0.57 114.904 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CE1' HG11 ' A' ' 217' ' ' VAL . 51.3 t80 -74.47 83.84 1.99 Allowed 'General case' 0 C--N 1.376 1.725 0 CA-C-O 124.973 2.32 . . . . 0.57 109.292 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 235' ' ' VAL . 1.6 tmt_? -99.32 154.79 17.91 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-O 123.813 1.768 . . . . 1.2 108.913 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.725 ' N ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -121.84 136.1 54.92 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 125.194 2.426 . . . . 0.57 106.246 -173.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 42.5 m -67.67 137.65 55.73 Favored 'General case' 0 C--N 1.376 1.719 0 CA-C-N 113.305 -1.771 . . . . 0.57 111.627 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.08 -46.36 81.45 Favored 'General case' 0 C--N 1.384 2.099 0 N-CA-C 108.055 -1.091 . . . . 0.57 108.055 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.71 -36.81 79.76 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 115.41 -0.814 . . . . 0.91 110.845 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 258' ' ' ILE . 40.8 t0 -63.46 -55.22 25.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.91 110.846 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 21.3 pt -66.09 -36.38 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.57 111.116 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 4.3 mtt-85 -70.32 -33.33 71.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.828 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.86 76.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.57 112.48 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.81 -45.05 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.685 0.279 . . . . 0.57 111.052 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.497 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.14 -23.5 61.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.57 110.981 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 t -71.03 -32.55 69.33 Favored 'General case' 0 C--N 1.366 1.302 0 CA-C-O 122.403 1.096 . . . . 0.57 109.785 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.42 -66.19 0.44 Allowed 'General case' 0 C--N 1.387 2.208 0 CA-C-O 123.416 1.579 . . . . 0.57 109.608 -175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.813 ' CE1' HD11 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -107.4 116.56 32.15 Favored 'General case' 0 C--N 1.377 1.801 0 CA-C-N 113.718 -1.583 . . . . 0.57 111.761 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.383 3.193 0 CA-C-O 114.817 -3.213 . . . . 0.91 118.048 -171.573 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 269' ' ' HSI . . . . . 1.049 ' H19' HD11 ' A' ' 214' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 mtt-85 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 123.146 1.451 . . . . 1.2 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 52.57 0.48 Allowed 'General case' 0 C--N 1.379 1.87 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 108.179 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -168.96 -55.39 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.219 -1.355 . . . . 0.56999999999999995 109.321 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -98.62 112.13 24.28 Favored 'General case' 0 C--N 1.371 1.515 0 O-C-N 124.006 0.816 . . . . 0.56999999999999995 110.934 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 158' ' ' ASP . 1.2 mm -111.72 151.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.062 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -106.0 159.77 15.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.56999999999999995 111.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.477 ' OH ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -148.59 150.51 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.92 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -142.8 132.91 24.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 1.2 110.889 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.97 140.46 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.147 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.538 ' ND2' HG22 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -66.87 -160.88 0.02 OUTLIER 'General case' 0 C--N 1.379 1.883 0 CA-C-O 124.362 2.03 . . . . 0.56999999999999995 109.718 -174.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.32 39.38 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 111.069 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.505 ' C ' HG23 ' A' ' 122' ' ' THR . 9.2 m-85 59.33 16.8 5.32 Favored 'General case' 0 C--N 1.386 2.161 0 O-C-N 124.362 1.039 . . . . 0.56999999999999995 110.083 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.631 HG22 ' CZ ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER 65.98 158.18 0.13 Allowed Pre-proline 0 C--N 1.367 1.331 0 O-C-N 128.217 3.448 . . . . 0.56999999999999995 109.793 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.44 -43.65 0.35 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 O-C-N 118.265 -1.492 . . . . 0.56999999999999995 112.145 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -63.71 1.18 Allowed 'General case' 0 C--N 1.371 1.509 0 C-N-CA 125.209 1.404 . . . . 0.91000000000000003 113.471 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.414 ' HE2' ' CD2' ' A' ' 203' ' ' TRP . 4.1 ttm -42.64 132.44 3.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 128.035 3.779 . . . . 0.56999999999999995 110.336 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.759 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.6 m120 -78.06 143.4 37.46 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.038 -2.289 . . . . 0.56999999999999995 107.97 -172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -46.59 47.06 Favored 'General case' 0 C--N 1.38 1.903 0 N-CA-C 107.03 -1.47 . . . . 1.2 107.03 -164.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -54.75 -34.78 62.99 Favored 'General case' 0 C--N 1.396 2.602 0 CA-C-N 111.428 -2.624 . . . . 0.91000000000000003 110.927 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 205' ' ' THR . 1.4 m-20 -70.11 -43.71 70.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.933 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -63.62 -39.07 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.174 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.13 87.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.91000000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -67.32 -49.05 65.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 110.929 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.12 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 111.101 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.44 -31.94 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.17 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -67.93 -46.78 70.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CD ' ' OE1' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.56 -46.05 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.926 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.89 80.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 111.061 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 -44.11 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.56999999999999995 110.902 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.433 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 2.0 pt20 -63.75 -37.05 85.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.91 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -69.47 -34.01 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.13 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 145' ' ' THR . 49.6 m95 -82.97 -34.3 26.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 110.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -49.36 13.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.875 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.781 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -59.51 -12.71 6.83 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-O 121.429 0.633 . . . . 0.56999999999999995 112.352 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.781 HG13 ' ND2' ' A' ' 143' ' ' ASN . 23.8 m -115.63 16.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 C-N-CA 124.027 0.931 . . . . 0.56999999999999995 109.531 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 141' ' ' TRP . 75.2 p -146.01 150.69 43.04 Favored Pre-proline 0 C--N 1.367 1.362 0 CA-C-O 124.642 2.163 . . . . 0.56999999999999995 107.474 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -80.38 -11.01 13.31 Favored 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-O 123.027 1.178 . . . . 0.56999999999999995 111.072 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.75 113.19 26.62 Favored 'General case' 0 C--N 1.371 1.529 0 N-CA-C 103.85 -2.648 . . . . 0.56999999999999995 103.85 -172.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.52 158.4 36.32 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-O 125.213 2.435 . . . . 0.56999999999999995 117.177 166.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.638 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 9.6 m-85 -131.15 158.8 39.49 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.573 -1.649 . . . . 0.56999999999999995 107.439 -174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 125.57 5.96 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-O 124.29 1.995 . . . . 0.56999999999999995 106.956 -171.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 150.08 20.95 Favored 'General case' 0 C--N 1.367 1.363 0 CA-C-O 123.335 1.54 . . . . 0.56999999999999995 109.736 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 pt -144.15 -178.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.552 0 CA-C-O 123.618 1.675 . . . . 0.56999999999999995 108.919 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 154' ' ' THR . 26.3 t30 -155.09 54.59 0.64 Allowed 'General case' 0 C--N 1.379 1.89 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 107.949 -175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -161.4 -69.27 0.06 Allowed 'General case' 0 C--N 1.377 1.781 0 C-N-CA 119.955 -0.698 . . . . 0.56999999999999995 109.813 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -86.05 173.64 46.88 Favored Glycine 0 C--N 1.372 2.569 0 CA-C-O 124.161 1.978 . . . . 0.56999999999999995 110.38 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.2 ttt -63.66 154.4 33.07 Favored 'General case' 0 C--N 1.377 1.782 0 CA-C-N 112.331 -1.935 . . . . 0.56999999999999995 107.81 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . . . -137.59 170.92 15.25 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 113.721 -1.582 . . . . 0.56999999999999995 109.636 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 114' ' ' ILE . 3.0 m-20 -83.67 -67.8 0.76 Allowed 'General case' 0 C--N 1.379 1.877 0 N-CA-C 102.255 -3.239 . . . . 0.91000000000000003 102.255 -168.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 223' ' ' SER . 56.9 mt -92.51 109.9 22.17 Favored 'Isoleucine or valine' 0 C--N 1.402 2.871 0 O-C-N 124.544 1.153 . . . . 0.56999999999999995 111.087 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -105.45 132.11 52.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.918 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 197' ' ' PHE . 72.5 t -109.84 117.02 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 111.143 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.538 HG22 ' ND2' ' A' ' 119' ' ' ASN . 60.8 t -124.61 146.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.137 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.631 ' CZ ' HG22 ' A' ' 122' ' ' THR . 57.1 m-85 -103.74 118.48 36.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.833 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.25 167.59 23.12 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-O 124.109 1.909 . . . . 0.56999999999999995 109.69 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 149.29 24.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.426 -2.046 . . . . 1.2 108.524 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.78 121.05 1.83 Allowed Glycine 0 C--N 1.375 2.738 0 CA-C-N 113.349 -1.751 . . . . 0.56999999999999995 110.861 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -178.21 -57.8 0.01 OUTLIER 'General case' 0 C--N 1.379 1.878 0 CA-C-O 123.028 1.394 . . . . 0.56999999999999995 108.396 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--N 1.389 2.286 0 CA-C-O 123.266 1.507 . . . . 0.56999999999999995 109.732 -174.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.948 0 CA-C-O 122.616 1.198 . . . . 0.56999999999999995 111.44 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -57.44 -97.52 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 123.986 1.85 . . . . 0.56999999999999995 112.894 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.48 178.36 4.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 125.25 2.452 . . . . 0.91000000000000003 110.324 173.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -150.87 35.53 0.92 Allowed Glycine 0 C--N 1.372 2.561 0 CA-C-N 112.221 -2.263 . . . . 0.56999999999999995 112.258 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 14.55 0.14 Allowed 'General case' 0 C--N 1.376 1.76 0 CA-C-O 122.012 0.911 . . . . 0.56999999999999995 112.541 -175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.56 -143.46 10.2 Favored Glycine 0 C--N 1.364 2.097 0 CA-C-O 122.515 1.064 . . . . 0.56999999999999995 110.801 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.93 -130.99 47.61 Favored Glycine 0 C--N 1.36 1.881 0 O-C-N 119.994 -1.886 . . . . 0.56999999999999995 111.194 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 174' ' ' PHE . 1.0 OUTLIER -54.41 163.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.517 0 CA-C-N 113.065 -1.568 . . . . 0.56999999999999995 108.866 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 210' ' ' THR . 11.2 mt -111.4 -40.29 4.43 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 115.527 1.677 . . . . 0.56999999999999995 115.527 169.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -175.03 179.92 1.49 Allowed 'General case' 0 C--N 1.363 1.177 0 O-C-N 121.278 -0.889 . . . . 0.56999999999999995 111.111 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.467 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 0.3 OUTLIER -156.34 159.9 39.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.852 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.57 153.06 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.56999999999999995 111.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -93.85 -177.82 4.47 Favored 'General case' 0 C--N 1.373 1.588 0 CA-C-O 123.052 1.406 . . . . 0.56999999999999995 109.758 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.58 -158.96 15.92 Favored Glycine 0 C--N 1.378 2.866 0 CA-C-N 114.372 -1.286 . . . . 0.56999999999999995 112.075 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.39 -139.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.443 2.762 . . . . 0.56999999999999995 112.169 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.19 -132.4 10.94 Favored Glycine 0 C--N 1.371 2.513 0 O-C-N 119.307 -2.12 . . . . 0.56999999999999995 108.968 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.66 157.13 31.25 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.817 -1.549 . . . . 0.56999999999999995 106.817 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.71 3.8 Favored Glycine 0 C--N 1.381 3.053 1 N-CA-C 102.479 -4.249 . . . . 0.56999999999999995 102.479 165.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -36.35 67.95 Favored 'Isoleucine or valine' 0 C--N 1.377 1.785 0 CA-C-O 124.534 2.111 . . . . 0.56999999999999995 109.97 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.15 132.48 28.24 Favored Glycine 0 C--N 1.38 2.996 0 N-CA-C 104.389 -3.484 . . . . 0.56999999999999995 104.389 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.46 -6.61 57.68 Favored Glycine 0 C--N 1.366 2.2 0 CA-C-O 124.085 1.936 . . . . 0.56999999999999995 110.268 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.53 ' CG ' ' HB2' ' A' ' 160' ' ' LEU . 1.3 m-20 -88.24 166.67 14.18 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.073 -1.839 . . . . 0.91000000000000003 110.897 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -135.54 161.12 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.066 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -129.24 125.77 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.919 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.0 m-85 -105.41 133.0 50.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.56999999999999995 110.883 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -61.83 86.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.886 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.01 -33.05 70.0 Favored 'General case' 0 C--N 1.398 2.674 0 C-N-CA 115.823 -2.351 . . . . 0.91000000000000003 105.576 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.98 -47.72 8.62 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 123.821 0.848 . . . . 0.91000000000000003 108.774 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -54.02 174.37 0.06 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-O 127.562 3.553 . . . . 0.91000000000000003 111.978 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.467 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 0.1 OUTLIER -102.21 110.63 22.64 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 112.365 -2.198 . . . . 0.56999999999999995 109.898 177.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.7 m95 -93.09 148.56 21.9 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 107.588 -1.264 . . . . 0.56999999999999995 107.588 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.621 HG21 ' O ' ' A' ' 208' ' ' GLY . 56.1 p -127.14 125.94 42.05 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 110.007 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CB ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -98.06 133.74 42.11 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.452 -1.685 . . . . 0.56999999999999995 106.452 -176.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 80.69 -43.76 0.22 Allowed 'General case' 0 C--N 1.374 1.646 0 CA-C-N 114.571 -1.195 . . . . 0.56999999999999995 109.591 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.54 153.98 0.37 Allowed 'General case' 0 C--N 1.369 1.43 0 N-CA-C 107.996 -1.112 . . . . 0.56999999999999995 107.996 -173.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 204' ' ' THR . . . 125.93 6.25 6.0 Favored Glycine 0 C--N 1.376 2.784 0 CA-C-N 114.556 -1.202 . . . . 0.56999999999999995 114.089 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 144.31 -119.75 1.33 Allowed Glycine 0 C--N 1.378 2.869 0 CA-C-O 123.752 1.751 . . . . 0.56999999999999995 112.36 -168.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 181' ' ' LEU . 6.6 p -94.25 133.0 38.25 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-N 113.951 -1.124 . . . . 0.56999999999999995 109.331 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.627 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -98.2 150.39 21.55 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.878 1.799 . . . . 0.56999999999999995 111.713 177.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.633 HD13 ' O ' ' A' ' 212' ' ' LEU . 3.2 tm? -75.54 -29.65 59.49 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 106.087 -1.82 . . . . 0.56999999999999995 106.087 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 7.8 t80 -57.45 -50.25 73.63 Favored 'General case' 0 C--N 1.373 1.623 0 CA-C-N 115.305 -0.861 . . . . 0.56999999999999995 110.909 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -55.55 -51.15 68.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.56999999999999995 110.952 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -67.32 -35.5 79.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.56999999999999995 111.132 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 212' ' ' LEU . . . -62.59 -44.21 96.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 111.114 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 213' ' ' PHE . 95.4 t -65.23 -48.02 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.171 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 236' ' ' MET . 6.4 t-160 -64.63 -50.21 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.815 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 197' ' ' PHE . 17.3 mm-40 -57.92 -42.22 84.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.91000000000000003 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.552 ' CG2' HD21 ' A' ' 224' ' ' LEU . 1.0 OUTLIER -66.56 -46.81 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.182 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.32 -33.53 61.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.56999999999999995 112.501 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -64.71 -38.89 92.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.56999999999999995 110.833 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.407 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 0.5 OUTLIER -71.99 -53.23 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.831 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.0 pp -93.94 -56.8 2.74 Favored 'General case' 0 C--N 1.381 1.958 0 N-CA-C 117.783 2.512 . . . . 0.56999999999999995 117.783 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -45.08 149.89 1.1 Allowed Glycine 0 C--N 1.373 2.611 1 CA-C-O 128.049 4.139 . . . . 0.56999999999999995 110.486 177.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.16 -153.51 0.05 Allowed 'General case' 0 C--N 1.365 1.247 0 CA-C-N 109.975 -3.113 . . . . 0.56999999999999995 107.153 -171.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.0 -175.62 0.5 Allowed Glycine 0 C--N 1.379 2.923 0 CA-C-O 127.213 3.674 . . . . 0.56999999999999995 113.001 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -100.56 -174.25 2.6 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 118.997 -2.472 . . . . 0.56999999999999995 111.343 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.1 p -103.63 -34.67 8.55 Favored 'General case' 0 C--N 1.38 1.932 0 CA-C-N 113.835 -1.53 . . . . 0.56999999999999995 108.748 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.78 22.37 0.39 Allowed 'General case' 0 C--N 1.385 2.121 0 N-CA-C 114.152 1.168 . . . . 0.56999999999999995 114.152 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.74 131.99 11.05 Favored Pre-proline 0 C--N 1.378 1.838 0 N-CA-C 102.828 -3.027 . . . . 0.91000000000000003 102.828 -164.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.479 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 47.5 Cg_exo -61.73 74.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 124.9 3.733 . . . . 0.56999999999999995 114.913 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.38 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 CA-C-N 113.634 -1.621 . . . . 0.56999999999999995 111.349 -171.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.61 133.53 34.84 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 106.655 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 248' ' ' PHE . 11.5 p -70.48 68.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.318 0 CA-C-N 113.028 -1.896 . . . . 0.56999999999999995 112.166 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER -175.64 -35.76 0.01 OUTLIER 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.635 -1.291 . . . . 0.56999999999999995 109.931 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.16 145.46 0.32 Allowed Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 124.948 2.309 . . . . 0.56999999999999995 111.575 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -57.93 -47.66 19.73 Favored 'Trans proline' 0 C--N 1.374 1.869 0 O-C-N 119.21 -0.995 . . . . 0.56999999999999995 111.499 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 14.1 m -49.35 124.66 9.58 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-O 124.328 2.013 . . . . 0.56999999999999995 109.921 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.551 ' OH ' HG22 ' A' ' 210' ' ' THR . 57.2 t80 -94.15 140.19 30.06 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-O 123.297 1.523 . . . . 0.56999999999999995 107.997 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -155.56 109.39 2.82 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 105.635 -1.987 . . . . 0.56999999999999995 105.635 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -54.03 123.71 13.4 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-O 124.144 1.926 . . . . 0.56999999999999995 109.628 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.6 p -154.65 111.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 114.158 -1.383 . . . . 0.56999999999999995 107.349 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.21 142.44 51.77 Favored 'General case' 0 C--N 1.365 1.248 0 N-CA-C 103.219 -2.882 . . . . 0.91000000000000003 103.219 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.471 HG12 ' CG ' ' A' ' 213' ' ' PHE . 1.1 mp -46.05 -23.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.309 0 CA-C-N 111.248 -2.706 . . . . 0.56999999999999995 112.769 174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -51.72 -37.47 51.13 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.051 -0.977 . . . . 0.56999999999999995 109.767 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.9 p -103.88 -0.64 28.84 Favored 'General case' 0 C--N 1.386 2.171 0 N-CA-C 116.48 2.03 . . . . 0.56999999999999995 116.48 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.719 ' HE1' HG21 ' A' ' 235' ' ' VAL . 34.3 t80 -63.17 93.66 0.07 Allowed 'General case' 0 C--N 1.365 1.252 0 CA-C-O 127.039 3.304 . . . . 0.56999999999999995 107.491 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.403 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.95 152.57 42.33 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 112.745 -2.025 . . . . 1.2 106.371 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.15 131.31 53.89 Favored 'General case' 0 C--N 1.372 1.577 0 CA-C-O 125.634 2.635 . . . . 0.56999999999999995 104.987 -170.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.77 136.71 58.0 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.599 -1.938 . . . . 0.56999999999999995 111.68 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -60.28 -45.23 94.06 Favored 'General case' 0 C--N 1.383 2.05 0 N-CA-C 106.245 -1.761 . . . . 0.56999999999999995 106.245 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -41.03 85.16 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.215 -0.928 . . . . 0.91000000000000003 110.858 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -63.93 -55.34 23.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.91000000000000003 110.892 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.8 pt -66.21 -34.9 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.108 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.489 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 22.0 mtp180 -70.44 -30.38 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.872 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.15 -39.78 57.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.798 -0.715 . . . . 0.56999999999999995 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -70.19 -41.41 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.175 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -34.45 68.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.382 2.012 0 CA-C-O 122.23 1.014 . . . . 0.56999999999999995 109.489 -176.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.87 -0.789 . . . . 1.2 108.87 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 -50.94 0.01 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 122.316 1.055 . . . . 0.56999999999999995 110.4 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -69.68 -32.24 70.74 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 114.117 -1.401 . . . . 0.56999999999999995 108.482 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -109.17 109.47 20.44 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 120.129 -1.607 . . . . 0.56999999999999995 110.935 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.69 139.88 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.139 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 4.4 p -112.94 159.76 18.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.56999999999999995 111.118 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -149.08 153.37 37.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.955 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -142.1 122.02 13.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.939 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.472 HG21 ' HD1' ' A' ' 121' ' ' TYR . 12.8 mm -87.65 117.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 111.14 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ILE . 1.5 t-20 -37.52 -57.72 0.92 Allowed 'General case' 0 C--N 1.37 1.473 0 C-N-CA 120.019 -0.672 . . . . 0.56999999999999995 111.382 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 24.9 t-20 -155.87 -61.14 0.11 Allowed 'General case' 0 C--N 1.378 1.812 0 CA-C-N 113.725 -1.58 . . . . 0.56999999999999995 107.995 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.472 ' HD1' HG21 ' A' ' 118' ' ' ILE . 1.2 m-30 152.99 30.76 0.0 OUTLIER 'General case' 0 C--N 1.379 1.88 0 O-C-N 126.17 2.169 . . . . 0.56999999999999995 112.731 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.651 HG23 ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 68.87 141.54 0.08 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 CA-C-O 124.38 2.038 . . . . 0.56999999999999995 107.924 172.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 199' ' ' GLU . 39.7 Cg_endo -70.47 -41.58 3.28 Favored 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 118.432 -1.404 . . . . 0.56999999999999995 112.319 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -110.74 -51.76 2.84 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 111.074 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.644 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -43.96 143.87 1.02 Allowed 'General case' 0 C--N 1.377 1.802 0 CA-C-O 124.953 2.311 . . . . 0.56999999999999995 108.926 -174.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.0 m-20 -73.47 139.01 45.48 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.977 -1.92 . . . . 0.56999999999999995 109.358 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.412 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -67.59 -50.07 60.08 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 107.758 -1.201 . . . . 1.2 107.758 -170.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.96 -36.36 65.26 Favored 'General case' 0 C--N 1.38 1.894 0 CA-C-N 113.271 -1.786 . . . . 0.91000000000000003 110.891 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 126' ' ' ASN . 97.4 m-20 -70.82 -37.83 73.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 126' ' ' ASN . 4.9 t -65.18 -49.2 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 111.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 16.8 m-20 -69.93 -40.62 75.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.817 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -66.02 -42.22 89.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.891 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 212' ' ' LEU . . . -63.62 -49.01 75.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 111.136 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 15.8 pt -64.9 -31.94 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -66.89 -46.8 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.88 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -46.04 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.56999999999999995 110.913 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.98 83.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.049 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.97 -44.89 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.56999999999999995 110.893 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.471 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.4 pt20 -64.97 -35.27 80.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.918 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.862 HG13 HD21 ' A' ' 250' ' ' LEU . 1.2 t -69.53 -34.2 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.085 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 7.5 m95 -83.03 -34.2 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.56999999999999995 110.911 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -48.24 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.56999999999999995 110.853 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.829 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -61.0 -12.61 12.07 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.854 0.835 . . . . 0.56999999999999995 111.612 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.829 HG13 ' ND2' ' A' ' 143' ' ' ASN . 19.6 m -115.42 -10.06 12.21 Favored 'Isoleucine or valine' 0 C--N 1.375 1.687 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.533 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 224' ' ' LEU . 0.5 OUTLIER -139.99 148.73 56.09 Favored Pre-proline 0 C--N 1.36 1.058 0 CA-C-O 125.092 2.377 . . . . 0.56999999999999995 110.021 -177.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -70.7 -39.67 4.5 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 118.24 -1.505 . . . . 0.56999999999999995 111.857 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 224' ' ' LEU . 3.7 mt -50.63 111.41 0.54 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 122.734 1.254 . . . . 0.56999999999999995 107.923 -174.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -76.37 159.24 30.68 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 114.473 -1.239 . . . . 0.56999999999999995 111.176 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 6.1 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 108.756 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 m -159.85 110.96 1.96 Allowed 'General case' 0 C--N 1.386 2.183 0 CA-C-O 124.923 2.297 . . . . 0.56999999999999995 109.022 -172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.55 133.83 37.75 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 109.645 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.641 HD12 ' H ' ' A' ' 155' ' ' GLY . 2.3 pt -111.03 172.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.364 1.231 0 CA-C-O 124.545 2.117 . . . . 0.56999999999999995 110.135 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -63.77 1.24 Allowed 'General case' 0 C--N 1.383 2.038 0 CA-C-N 113.31 -1.768 . . . . 0.56999999999999995 110.023 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 154' ' ' THR . 13.9 t -142.62 52.58 1.42 Allowed 'General case' 0 C--N 1.376 1.733 0 CA-C-O 124.926 2.298 . . . . 0.56999999999999995 110.154 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.641 ' H ' HD12 ' A' ' 152' ' ' ILE . . . -127.9 21.94 5.5 Favored Glycine 0 C--N 1.364 2.106 0 C-N-CA 118.492 -1.813 . . . . 0.56999999999999995 112.515 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.454 ' C ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER 67.12 95.05 0.06 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.961 2.315 . . . . 0.56999999999999995 110.264 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 117' ' ' ARG . . . -96.36 174.68 6.75 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 117.89 -1.524 . . . . 0.56999999999999995 112.49 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.16 -50.75 13.74 Favored 'General case' 0 C--N 1.375 1.694 0 N-CA-C 105.197 -2.149 . . . . 0.91000000000000003 105.197 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.646 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.8 pp -114.11 116.18 51.83 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 CA-C-N 115.158 -0.928 . . . . 0.56999999999999995 111.141 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 117' ' ' ARG . 4.3 mp -92.87 132.15 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.56999999999999995 110.877 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.849 HG13 ' CE1' ' A' ' 197' ' ' PHE . 30.6 t -101.96 117.0 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 111.1 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.02 146.01 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.132 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CE1' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -106.18 119.99 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.89 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.28 168.6 18.58 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 123.795 1.76 . . . . 0.56999999999999995 109.696 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -107.3 167.72 9.72 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.701 -1.25 . . . . 1.2 110.595 177.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -40.17 143.05 0.58 Allowed Glycine 0 C--N 1.38 3.027 0 CA-C-O 123.22 1.455 . . . . 0.56999999999999995 112.303 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 72.19 43.65 0.5 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-O 124.708 2.194 . . . . 0.56999999999999995 109.218 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 165' ' ' ARG . 31.2 p-80 . . . . . 0 C--N 1.373 1.607 0 CA-C-O 123.663 1.697 . . . . 0.56999999999999995 108.385 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.756 0 CA-C-O 122.026 0.917 . . . . 0.56999999999999995 109.593 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.529 ' HE1' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -116.73 -161.6 0.81 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 114.221 -1.354 . . . . 0.56999999999999995 111.697 175.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.635 ' HB3' HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -99.38 -68.68 0.79 Allowed 'General case' 0 C--N 1.378 1.827 0 N-CA-C 108.758 -0.83 . . . . 0.91000000000000003 108.758 178.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.401 ' N ' ' OD2' ' A' ' 175' ' ' ASP . . . 54.69 165.16 0.02 OUTLIER Glycine 0 C--N 1.392 3.666 0 CA-C-O 125.095 2.497 . . . . 0.56999999999999995 116.813 -167.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.49 7.77 5.11 Favored 'General case' 0 C--N 1.379 1.88 0 O-C-N 120.507 -1.584 . . . . 0.56999999999999995 113.48 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.18 -140.73 11.98 Favored Glycine 0 C--N 1.363 2.072 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.02 -104.17 0.11 Allowed Glycine 0 C--N 1.362 2.026 0 CA-C-O 123.566 1.648 . . . . 0.56999999999999995 112.52 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 175' ' ' ASP . 9.7 mt -62.58 169.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.494 0 CA-C-O 123.333 1.54 . . . . 0.56999999999999995 112.506 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 215' ' ' THR . 23.5 tp -128.92 -40.31 1.53 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 118.211 -2.805 . . . . 0.56999999999999995 110.499 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 215' ' ' THR . . . -176.5 179.94 1.11 Allowed 'General case' 0 C--N 1.379 1.854 0 CA-C-N 114.918 -1.037 . . . . 0.56999999999999995 111.081 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.438 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -155.04 145.86 22.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 110.846 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.01 151.24 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.082 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.13 -179.99 7.13 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.968 1.842 . . . . 0.56999999999999995 111.131 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.99 -162.89 24.0 Favored Glycine 0 C--N 1.38 2.985 0 CA-C-O 124.142 1.968 . . . . 0.56999999999999995 111.703 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.24 79.15 1.79 Allowed 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.099 1.866 . . . . 0.56999999999999995 112.074 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -128.31 160.76 22.1 Favored Glycine 0 C--N 1.367 2.281 0 CA-C-O 123.182 1.434 . . . . 0.56999999999999995 110.074 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -74.94 -177.61 3.4 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.428 -1.386 . . . . 0.56999999999999995 109.237 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.13 -117.22 5.9 Favored Glycine 0 C--N 1.383 3.186 0 N-CA-C 109.834 -1.306 . . . . 0.56999999999999995 109.834 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 192' ' ' GLY . 6.3 tp -59.44 -46.81 92.44 Favored 'Isoleucine or valine' 0 C--N 1.383 2.051 0 CA-C-N 112.547 -1.826 . . . . 0.56999999999999995 110.44 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -42.7 133.89 4.61 Favored Glycine 0 C--N 1.369 2.415 0 CA-C-O 124.486 2.159 . . . . 0.56999999999999995 109.671 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.8 -48.82 1.21 Allowed Glycine 0 C--N 1.37 2.465 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 113.129 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.29 160.06 0.17 Allowed 'General case' 0 C--N 1.376 1.724 0 CA-C-O 120.798 0.333 . . . . 0.91000000000000003 110.901 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -143.98 146.46 32.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.101 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -121.62 126.25 48.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 110.875 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.849 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.5 m-85 -108.22 150.08 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.89 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 90.41 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.91000000000000003 110.803 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.453 ' OE1' HG22 ' A' ' 122' ' ' THR . 3.8 tp10 -74.65 -5.52 43.52 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 124.216 1.96 . . . . 0.91000000000000003 110.475 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -32.97 35.16 Favored 'General case' 0 C--N 1.369 1.416 0 CA-C-O 123.003 1.382 . . . . 0.91000000000000003 108.902 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.58 176.06 2.58 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-O 123.439 1.59 . . . . 0.91000000000000003 111.99 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.76 104.02 16.01 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-N 112.576 -2.102 . . . . 0.56999999999999995 112.589 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.421 ' CE3' ' HG3' ' A' ' 125' ' ' MET . 18.2 m95 -76.7 128.52 34.83 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 114.273 -1.33 . . . . 0.56999999999999995 108.525 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.0 p -122.86 104.88 9.56 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 109.309 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.401 HG21 ' HB3' ' A' ' 129' ' ' ASP . 0.6 OUTLIER -115.46 130.83 57.01 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 108.658 -177.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 24.85 3.45 Favored 'General case' 0 C--N 1.389 2.318 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 111.402 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.16 -71.41 0.5 Allowed 'General case' 0 C--N 1.38 1.896 0 CA-C-N 114.241 -1.345 . . . . 0.56999999999999995 108.479 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.94 90.96 0.08 OUTLIER Glycine 0 C--N 1.389 3.487 0 C-N-CA 118.478 -1.82 . . . . 0.56999999999999995 113.09 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.5 -141.71 7.61 Favored Glycine 0 C--N 1.378 2.879 0 C-N-CA 119.55 -1.309 . . . . 0.56999999999999995 110.132 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 181' ' ' LEU . 72.7 p -67.42 128.66 37.25 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-O 124.128 1.918 . . . . 0.56999999999999995 112.146 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.556 ' O ' HD21 ' A' ' 181' ' ' LEU . 12.6 p30 -135.34 145.46 47.45 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 109.607 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 133' ' ' ALA . 1.4 pt? -65.0 -25.37 67.83 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-O 123.911 1.815 . . . . 0.56999999999999995 108.933 -174.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.992 ' O ' HG23 ' A' ' 217' ' ' VAL . 48.7 t80 -54.18 -42.65 69.92 Favored 'General case' 0 C--N 1.372 1.568 0 CA-C-N 113.734 -1.575 . . . . 0.56999999999999995 110.879 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -57.11 -51.11 70.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.926 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -69.55 -33.78 73.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 111.139 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -65.92 -46.33 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.113 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 213' ' ' PHE . 6.0 t -65.43 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.14 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 236' ' ' MET . 6.2 t-160 -71.33 -50.04 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 110.844 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.31 -42.07 98.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.91000000000000003 110.876 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 216' ' ' ALA . 34.5 mt -65.04 -37.94 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.56999999999999995 111.119 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.501 ' HA3' ' CZ2' ' A' ' 141' ' ' TRP . . . -68.3 -33.99 79.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 0.56999999999999995 112.49 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.448 ' CG ' ' CE ' ' A' ' 236' ' ' MET . 2.9 m-70 -67.39 -40.67 85.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.56999999999999995 110.871 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m -70.54 -41.22 72.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.882 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 145' ' ' THR . 0.7 OUTLIER -40.76 -36.97 0.69 Allowed 'General case' 0 C--N 1.358 0.97 0 CA-C-O 124.475 2.083 . . . . 0.56999999999999995 111.753 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.4 -38.92 1.13 Allowed Glycine 0 C--N 1.369 2.386 0 N-CA-C 108.392 -1.883 . . . . 0.56999999999999995 108.392 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.551 HD11 HG22 ' A' ' 258' ' ' ILE . 1.3 pt? -100.09 150.95 21.95 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-O 123.062 1.41 . . . . 0.56999999999999995 111.602 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.22 -118.92 0.27 Allowed Glycine 0 C--N 1.374 2.668 0 CA-C-O 125.063 2.479 . . . . 0.56999999999999995 111.881 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -110.55 -155.01 0.55 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 109.053 -178.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.681 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.6 p -115.56 -8.06 12.16 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 114.614 -1.175 . . . . 0.56999999999999995 111.149 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 82.54 -5.41 1.36 Allowed 'General case' 0 C--N 1.381 1.962 0 N-CA-C 113.527 0.936 . . . . 0.56999999999999995 113.527 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.56 158.84 74.23 Favored Pre-proline 0 C--N 1.372 1.577 0 N-CA-C 107.346 -1.353 . . . . 0.91000000000000003 107.346 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -55.02 -29.92 67.26 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.952 2.435 . . . . 0.56999999999999995 112.99 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 229' ' ' SER . 0.2 OUTLIER -47.35 -25.51 1.02 Allowed 'General case' 0 C--N 1.382 2.021 0 CA-C-N 114.662 -1.154 . . . . 0.56999999999999995 113.589 177.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -91.13 124.62 35.49 Favored 'General case' 0 C--N 1.378 1.814 0 CA-C-O 124.656 2.169 . . . . 0.56999999999999995 110.77 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -70.41 -8.36 10.65 Favored 'Isoleucine or valine' 0 C--N 1.377 1.768 0 CA-C-N 113.016 -1.902 . . . . 0.56999999999999995 111.838 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.501 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 1.3 ttt -99.4 17.92 19.02 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.227 -0.897 . . . . 0.56999999999999995 110.689 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 9.8 t80 -55.3 141.54 61.56 Favored Pre-proline 0 C--N 1.367 1.344 0 CA-C-O 123.12 1.438 . . . . 0.56999999999999995 108.693 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 51.6 Cg_exo -51.76 -52.94 7.89 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.98 1.787 . . . . 0.56999999999999995 113.714 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.95 142.24 56.62 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 125.288 1.618 . . . . 0.56999999999999995 109.929 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 241' ' ' LYS . 7.9 t80 -94.71 153.21 17.9 Favored 'General case' 0 C--N 1.385 2.126 0 CA-C-N 113.583 -1.644 . . . . 0.56999999999999995 109.63 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 4.2 tmtt? 177.31 104.17 0.02 OUTLIER 'General case' 0 C--N 1.389 2.292 0 CA-C-O 123.238 1.494 . . . . 0.56999999999999995 107.461 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.25 120.02 4.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 125.105 2.384 . . . . 0.56999999999999995 109.927 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.95 9.51 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 110.407 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.594 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER 84.88 -16.31 0.5 Allowed 'General case' 0 C--N 1.367 1.342 0 O-C-N 125.631 1.832 . . . . 0.91000000000000003 111.683 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.5 mt 74.87 -48.71 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.121 0 N-CA-C 114.605 1.335 . . . . 0.56999999999999995 114.605 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -45.22 -27.06 0.57 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 114.376 1.25 . . . . 0.56999999999999995 114.376 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.594 HG23 ' OD1' ' A' ' 244' ' ' ASP . 1.3 p -106.28 -0.68 24.2 Favored 'General case' 0 C--N 1.376 1.721 0 CA-C-N 115.373 -0.83 . . . . 0.56999999999999995 110.959 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 235' ' ' VAL . 12.5 t80 -58.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.372 1.559 0 CA-C-O 124.46 2.076 . . . . 0.56999999999999995 109.054 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.454 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -109.74 152.0 26.21 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-N 113.351 -1.75 . . . . 1.2 107.22 -176.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.862 HD21 HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -121.83 134.66 54.89 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-O 124.549 2.118 . . . . 0.56999999999999995 106.246 -173.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -67.01 136.79 55.84 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 120.551 -1.343 . . . . 0.56999999999999995 110.441 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.4 94.94 Favored 'General case' 0 C--N 1.381 1.977 0 N-CA-C 107.218 -1.401 . . . . 0.56999999999999995 107.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.43 -37.51 87.78 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 119.62 -1.925 . . . . 0.91000000000000003 110.849 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 m-20 -63.83 -55.35 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.886 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.484 ' CG2' HG11 ' A' ' 144' ' ' VAL . 11.7 pt -66.23 -35.51 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.094 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.432 ' N ' HG13 ' A' ' 255' ' ' ILE . 48.7 mtm180 -70.33 -34.32 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.2 110.843 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.63 -49.56 59.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.15 -45.23 99.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.56999999999999995 111.089 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.493 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -71.45 -28.06 63.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 110.878 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.362 1.111 0 CA-C-O 121.909 0.862 . . . . 0.56999999999999995 110.883 -178.896 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.861 0 CA-C-O 122.867 1.318 . . . . 1.2 107.962 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.58 -44.13 0.09 Allowed 'General case' 0 C--N 1.372 1.549 0 CA-C-N 113.301 -1.772 . . . . 0.56999999999999995 110.185 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' HA ' HD23 ' A' ' 147' ' ' LEU . 2.4 p-80 -89.43 -21.65 22.92 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 113.001 -1.909 . . . . 0.56999999999999995 111.644 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.479 ' HE1' ' HG ' ' A' ' 150' ' ' SER . 0.7 OUTLIER -113.04 107.95 16.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 115.784 -0.644 . . . . 0.56999999999999995 110.92 -178.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 155.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.138 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 150.55 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.137 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -150.04 160.08 43.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -141.14 129.18 21.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.849 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -94.5 129.52 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.162 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 121' ' ' TYR . 54.6 t30 -54.36 178.78 0.02 OUTLIER 'General case' 0 C--N 1.369 1.447 0 CA-C-O 124.701 2.191 . . . . 0.56999999999999995 109.121 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.51 45.09 0.84 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.026 -1.672 . . . . 0.56999999999999995 109.926 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 7.0 m-85 53.85 -168.15 0.07 Allowed 'General case' 0 C--N 1.386 2.152 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 107.432 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.63 165.34 17.62 Favored Pre-proline 0 C--N 1.378 1.837 0 CA-C-N 113.668 -1.606 . . . . 0.56999999999999995 107.487 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 -55.62 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 120.904 1.069 . . . . 0.56999999999999995 113.467 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.78 -52.71 63.09 Favored 'General case' 0 C--N 1.375 1.701 0 CA-C-N 114.042 -1.436 . . . . 0.91000000000000003 111.985 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.538 ' CE ' ' CD1' ' A' ' 203' ' ' TRP . 2.6 ttm -77.03 126.85 31.66 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 124.565 2.126 . . . . 0.56999999999999995 110.844 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.2 m-80 -72.05 131.36 42.78 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-N 112.78 -2.009 . . . . 0.56999999999999995 109.009 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.62 -49.95 64.59 Favored 'General case' 0 C--N 1.366 1.313 0 N-CA-C 107.737 -1.208 . . . . 1.2 107.737 -169.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -55.52 -35.38 65.57 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-N 112.221 -2.263 . . . . 0.91000000000000003 110.841 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.44 -43.35 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.91000000000000003 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -61.04 -49.93 82.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -59.22 -44.14 92.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.91000000000000003 110.803 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.72 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.938 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.1 -49.06 73.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.062 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.642 HD11 HD11 ' A' ' 212' ' ' LEU . 2.4 mm -65.28 -40.41 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.35 -46.13 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.2 110.852 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -42.7 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 110.921 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -58.45 -44.93 89.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.11 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 149' ' ' PHE . 11.8 m-85 -64.15 -36.35 83.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 110.86 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.6 tt0 -67.12 -40.05 86.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.95 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -69.5 -34.1 60.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.106 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 224' ' ' LEU . 43.8 m95 -82.92 -34.03 26.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.56999999999999995 110.939 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 m -79.3 -50.57 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.883 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -56.77 -14.04 3.04 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.34 0.867 . . . . 0.56999999999999995 113.34 178.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.824 HG13 ' ND2' ' A' ' 143' ' ' ASN . 17.9 m -113.73 -7.33 12.04 Favored 'Isoleucine or valine' 0 C--N 1.377 1.788 0 CA-C-N 113.678 -1.601 . . . . 0.56999999999999995 112.628 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.801 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.58 143.18 16.18 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-O 125.068 2.366 . . . . 0.56999999999999995 109.291 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.801 ' HD2' HG22 ' A' ' 145' ' ' THR . 55.7 Cg_endo -82.12 49.9 3.28 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.017 1.811 . . . . 0.56999999999999995 111.362 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 112' ' ' HIS . 1.8 mt -134.02 73.79 1.52 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 106.551 -1.648 . . . . 0.56999999999999995 106.551 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.75 161.9 22.57 Favored 'General case' 0 C--N 1.369 1.456 0 CA-C-O 125.468 2.556 . . . . 0.56999999999999995 117.499 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -135.15 159.94 39.95 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.486 -2.143 . . . . 0.56999999999999995 106.237 -172.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.479 ' HG ' ' HE1' ' A' ' 113' ' ' TYR . 1.2 m -140.78 111.16 6.74 Favored 'General case' 0 C--N 1.379 1.885 0 CA-C-O 124.154 1.931 . . . . 0.56999999999999995 106.523 -171.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 27.5 tttt -82.19 145.97 29.78 Favored 'General case' 0 C--N 1.369 1.446 0 CA-C-N 112.833 -1.985 . . . . 0.56999999999999995 111.934 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.0 pt -128.68 162.14 36.2 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 CA-C-N 112.928 -1.942 . . . . 0.56999999999999995 109.48 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -139.8 39.76 2.0 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-N 113.442 -1.708 . . . . 0.56999999999999995 110.684 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.62 -70.81 0.54 Allowed 'General case' 0 C--N 1.378 1.83 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 108.479 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -99.41 -130.44 6.95 Favored Glycine 0 C--N 1.382 3.108 0 N-CA-C 108.802 -1.719 . . . . 0.56999999999999995 108.802 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -122.79 134.67 54.42 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 111.885 -2.158 . . . . 0.56999999999999995 109.083 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -99.48 179.0 4.7 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 112.831 -1.986 . . . . 0.56999999999999995 111.527 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.24 -65.34 0.74 Allowed 'General case' 0 C--N 1.387 2.217 0 N-CA-C 103.924 -2.621 . . . . 0.91000000000000003 103.924 -166.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.728 HG22 ' CA ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -98.84 109.84 24.96 Favored 'Isoleucine or valine' 0 C--N 1.37 1.486 0 CA-C-N 114.834 -1.075 . . . . 0.56999999999999995 111.112 178.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -104.0 130.97 51.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.927 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.3 t -102.09 117.02 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.094 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.1 146.02 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.105 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -99.15 116.74 32.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.857 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.08 170.04 16.51 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 124.967 2.318 . . . . 0.56999999999999995 110.923 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 168.26 9.25 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 113.753 -1.567 . . . . 1.2 111.646 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 174' ' ' PHE . . . -43.41 128.12 5.75 Favored Glycine 0 C--N 1.385 3.27 0 O-C-N 126.299 2.25 . . . . 0.56999999999999995 112.569 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -179.89 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.384 2.076 0 CA-C-N 111.7 -2.25 . . . . 0.56999999999999995 110.853 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.378 1.83 0 CA-C-N 113.656 -1.611 . . . . 0.56999999999999995 108.578 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.268 0 CA-C-O 122.11 0.957 . . . . 0.56999999999999995 112.124 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.598 ' CE1' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -133.53 -159.88 1.0 Allowed 'General case' 0 C--N 1.368 1.408 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 110.273 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.34 175.31 6.79 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.28 -1.782 . . . . 0.91000000000000003 110.946 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.03 34.59 1.65 Allowed Glycine 0 C--N 1.389 3.516 0 CA-C-N 111.927 -2.397 . . . . 0.56999999999999995 111.697 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.45 -40.99 0.05 OUTLIER 'General case' 0 C--N 1.376 1.749 0 CA-C-N 112.79 -1.705 . . . . 0.56999999999999995 112.077 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -166.65 -122.56 0.61 Allowed Glycine 0 C--N 1.38 2.978 0 C-N-CA 117.846 -2.121 . . . . 0.56999999999999995 110.399 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.48 -122.52 26.88 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 117.316 -1.825 . . . . 0.56999999999999995 113.418 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.598 HG21 ' CE1' ' A' ' 174' ' ' PHE . 0.3 OUTLIER -45.75 170.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 O-C-N 127.434 2.491 . . . . 0.56999999999999995 114.077 172.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.693 HD13 ' OH ' ' A' ' 240' ' ' TYR . 6.6 tp -123.77 -66.71 0.98 Allowed 'General case' 0 C--N 1.374 1.634 0 CA-C-O 123.151 1.453 . . . . 0.56999999999999995 113.864 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 197' ' ' PHE . . . -178.15 179.88 0.78 Allowed 'General case' 0 C--N 1.358 0.963 0 CA-C-N 112.719 -2.037 . . . . 0.56999999999999995 111.054 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.503 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.8 p80 -158.23 177.12 11.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.854 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -157.97 143.75 17.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.56999999999999995 111.151 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.508 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 4.9 m-30 -84.69 173.41 10.75 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 118.578 -1.249 . . . . 0.56999999999999995 108.9 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.07 -156.17 4.33 Favored Glycine 0 C--N 1.382 3.085 0 C-N-CA 118.356 -1.878 . . . . 0.56999999999999995 110.563 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.66 -87.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.063 1.175 . . . . 0.56999999999999995 110.643 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.28 -143.52 2.42 Favored Glycine 0 C--N 1.387 3.388 0 CA-C-O 123.958 1.866 . . . . 0.56999999999999995 110.233 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.88 163.99 38.06 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 111.164 -2.518 . . . . 0.56999999999999995 108.705 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.82 -108.26 2.51 Favored Glycine 0 C--N 1.386 3.308 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.64 -37.32 69.05 Favored 'Isoleucine or valine' 0 C--N 1.386 2.158 0 CA-C-O 125.513 2.578 . . . . 0.56999999999999995 109.292 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.11 138.5 49.5 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 108.922 -1.671 . . . . 0.56999999999999995 108.922 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.728 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 96.77 -15.78 62.09 Favored Glycine 0 C--N 1.37 2.468 0 CA-C-O 124.701 2.279 . . . . 0.56999999999999995 109.044 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -73.72 144.22 45.82 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.531 -1.334 . . . . 0.91000000000000003 110.864 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -125.76 152.62 45.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.114 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -134.04 132.45 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.874 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -121.04 147.26 45.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.907 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' OD2' HG23 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.97 83.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.91000000000000003 110.881 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.4 -46.81 78.58 Favored 'General case' 0 C--N 1.375 1.682 0 N-CA-C 105.327 -2.101 . . . . 0.91000000000000003 105.327 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -44.3 -43.43 7.42 Favored 'General case' 0 C--N 1.372 1.544 0 O-C-N 126.092 2.12 . . . . 0.91000000000000003 109.706 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -49.23 173.92 0.02 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 125.53 2.586 . . . . 0.91000000000000003 113.971 172.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.446 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 16.2 m-85 -113.28 95.08 5.19 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.388 -2.187 . . . . 0.56999999999999995 112.412 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.575 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 35.5 m95 -75.63 132.39 40.58 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 106.95 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.3 p -110.86 103.26 11.75 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 124.908 2.289 . . . . 0.56999999999999995 109.038 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 69.5 p -104.13 106.88 17.54 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 114.096 -1.411 . . . . 0.56999999999999995 110.122 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 171.46 -59.46 0.01 OUTLIER 'General case' 0 C--N 1.383 2.047 0 CA-C-N 113.222 -1.808 . . . . 0.56999999999999995 107.333 177.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.42 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 0.5 OUTLIER 158.18 58.88 0.0 OUTLIER 'General case' 0 C--N 1.391 2.372 0 O-C-N 127.772 3.17 . . . . 0.56999999999999995 110.992 -171.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.3 -88.1 0.3 Allowed Glycine 0 C--N 1.382 3.129 0 C-N-CA 117.082 -2.485 . . . . 0.56999999999999995 113.442 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.97 -108.23 3.19 Favored Glycine 0 C--N 1.383 3.14 0 CA-C-O 126.984 3.547 . . . . 0.56999999999999995 112.787 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.565 HG22 ' OH ' ' A' ' 240' ' ' TYR . 1.4 p -66.63 119.33 11.56 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 111.744 -2.228 . . . . 0.56999999999999995 111.512 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.17 143.34 43.37 Favored 'General case' 0 C--N 1.373 1.614 0 CA-C-N 113.758 -1.565 . . . . 0.56999999999999995 109.702 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -73.43 -25.12 60.38 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-N 112.728 -2.033 . . . . 0.56999999999999995 107.276 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.897 ' O ' HG23 ' A' ' 217' ' ' VAL . 12.4 t80 -58.47 -49.16 78.33 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 113.926 -1.488 . . . . 0.56999999999999995 110.823 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -54.97 -50.96 67.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.56999999999999995 110.976 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -67.22 -37.65 83.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.93 91.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.093 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 213' ' ' PHE . 7.8 t -65.14 -40.17 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.111 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -72.08 -37.55 69.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 110.892 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -42.07 97.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.655 HD12 ' HB1' ' A' ' 137' ' ' ALA . 64.6 mt -70.0 -38.98 76.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 111.134 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.18 93.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.56999999999999995 112.481 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.4 OUTLIER -63.97 -43.17 96.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.56999999999999995 110.844 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -38.07 72.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.886 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -47.11 -42.93 19.99 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 118.452 -1.299 . . . . 0.56999999999999995 111.007 -172.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 127.25 33.46 0.62 Allowed Glycine 0 C--N 1.385 3.265 0 CA-C-N 112.33 -2.213 . . . . 0.56999999999999995 109.449 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 226' ' ' LEU . 0.2 OUTLIER -102.34 177.35 4.9 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-O 123.523 1.63 . . . . 0.56999999999999995 109.355 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -136.08 23.39 3.35 Favored Glycine 0 C--N 1.381 3.082 0 CA-C-N 112.679 -2.055 . . . . 0.56999999999999995 110.526 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.2 OUTLIER 62.68 177.07 0.14 Allowed 'General case' 0 C--N 1.395 2.546 0 CA-C-N 113.056 -1.572 . . . . 0.56999999999999995 110.041 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.5 p -103.85 -23.59 13.37 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 113.206 -1.815 . . . . 0.56999999999999995 111.17 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 81.39 21.39 0.35 Allowed 'General case' 0 C--N 1.385 2.134 0 O-C-N 125.683 1.864 . . . . 0.56999999999999995 112.627 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.9 143.68 45.39 Favored Pre-proline 0 C--N 1.392 2.419 0 N-CA-C 103.216 -2.883 . . . . 0.91000000000000003 103.216 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.82 66.49 6.71 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.444 2.763 . . . . 0.56999999999999995 111.005 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 -35.44 0.01 OUTLIER 'General case' 0 C--N 1.362 1.142 0 CA-C-N 113.537 -1.665 . . . . 0.56999999999999995 112.699 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -70.05 114.63 8.4 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 113.724 -1.58 . . . . 0.56999999999999995 112.141 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 235' ' ' VAL . 5.1 t -53.2 88.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 CA-C-N 112.907 -1.951 . . . . 0.56999999999999995 112.17 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER 159.13 -29.33 0.0 OUTLIER 'General case' 0 C--N 1.367 1.347 0 CA-C-N 115.033 -0.985 . . . . 0.56999999999999995 111.747 -174.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 9.2 p90 -45.61 143.99 2.75 Favored Pre-proline 0 C--N 1.372 1.55 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 110.65 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -59.54 -38.08 84.94 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 120.54 0.826 . . . . 0.56999999999999995 111.911 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.464 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.4 m -40.49 113.51 0.37 Allowed 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.596 1.665 . . . . 0.56999999999999995 111.383 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.693 ' OH ' HD13 ' A' ' 181' ' ' LEU . 2.6 t80 -76.66 133.83 39.46 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 112.603 -2.09 . . . . 0.56999999999999995 105.909 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -175.53 98.24 0.07 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 124.267 1.984 . . . . 0.56999999999999995 108.815 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -61.12 127.88 33.68 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 124.1 1.905 . . . . 0.56999999999999995 110.973 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -9.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.365 1.282 0 CA-C-N 113.022 -1.899 . . . . 0.56999999999999995 112.267 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER 75.85 -3.64 2.53 Favored 'General case' 0 C--N 1.384 2.088 0 O-C-N 126.605 2.441 . . . . 0.91000000000000003 110.865 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 213' ' ' PHE . 2.4 mt 83.0 5.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.696 0 CA-C-N 114.525 -1.216 . . . . 0.56999999999999995 113.105 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 0.7 OUTLIER -81.3 -36.6 29.61 Favored 'General case' 0 C--N 1.385 2.126 0 N-CA-C 102.713 -3.069 . . . . 0.56999999999999995 102.713 -165.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.7 p -116.92 -4.68 11.52 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 113.164 -1.835 . . . . 0.56999999999999995 114.023 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 217' ' ' VAL . 30.9 t80 -56.02 91.48 0.01 OUTLIER 'General case' 0 C--N 1.373 1.594 0 CA-C-O 124.312 2.006 . . . . 0.56999999999999995 109.485 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.45 151.7 51.82 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 112.434 -2.167 . . . . 1.2 106.675 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 250' ' ' LEU . 0.6 OUTLIER -124.17 127.59 47.98 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 125.082 2.372 . . . . 0.56999999999999995 104.936 -171.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 147.22 46.87 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 113.666 -1.606 . . . . 0.56999999999999995 111.896 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.37 93.07 Favored 'General case' 0 C--N 1.388 2.239 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 108.7 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -37.28 85.35 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-N 115.516 -0.765 . . . . 0.91000000000000003 110.862 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 258' ' ' ILE . 3.6 t0 -64.22 -55.02 24.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.91000000000000003 110.846 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 12.9 pt -66.1 -34.78 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 111.125 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 31.3 mtp180 -70.08 -30.12 67.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.841 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.74 -41.51 49.78 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 0.56999999999999995 112.471 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 254' ' ' ASP . 0.6 OUTLIER -68.09 -42.66 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.56999999999999995 111.089 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.691 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -71.97 -27.26 62.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.97 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.366 1.293 0 CA-C-O 124.121 1.915 . . . . 0.56999999999999995 108.784 -176.119 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.845 0 CA-C-O 121.541 0.686 . . . . 1.2 109.172 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.05 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.373 1.63 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 110.437 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.733 ' HA ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 -68.1 -17.3 64.33 Favored 'General case' 0 C--N 1.375 1.687 0 CA-C-N 113.929 -1.487 . . . . 0.56999999999999995 110.438 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.98 106.65 14.67 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.938 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.44 155.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.119 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.1 p -134.53 159.96 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.56999999999999995 111.143 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.668 ' CE2' ' CE2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -140.26 160.08 40.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.935 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -139.11 121.96 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 1.2 110.873 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.504 ' HA ' HD13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -78.13 117.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.14 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -36.97 -60.18 0.65 Allowed 'General case' 0 C--N 1.351 0.649 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 109.972 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 157.16 33.67 0.0 OUTLIER 'General case' 0 C--N 1.37 1.478 0 O-C-N 125.938 2.024 . . . . 0.56999999999999995 111.204 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 2.4 m-30 73.54 -170.96 0.12 Allowed 'General case' 0 C--N 1.374 1.641 0 CA-C-N 114.65 -1.159 . . . . 0.56999999999999995 108.13 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.5 149.79 58.52 Favored Pre-proline 0 C--N 1.364 1.204 0 CA-C-O 122.34 1.066 . . . . 0.56999999999999995 109.068 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.58 -55.03 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.463 1.442 . . . . 0.56999999999999995 112.764 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -63.25 -48.72 77.01 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.3 1.048 . . . . 0.91000000000000003 112.573 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 212' ' ' LEU . 3.6 ttm -83.15 142.11 31.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.484 2.087 . . . . 0.56999999999999995 111.471 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.85 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.1 m-80 -70.68 135.89 48.65 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 120.324 -1.485 . . . . 0.56999999999999995 109.869 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.504 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.96 -51.21 57.97 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.087 -0.708 . . . . 1.2 109.087 -173.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -34.89 61.7 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-N 113.615 -1.63 . . . . 0.91000000000000003 110.917 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.02 -44.04 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.91000000000000003 110.893 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -62.33 -38.75 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.182 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.61 -43.17 81.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.866 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -47.7 76.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.905 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.97 -48.24 78.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 111.033 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.5 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.2 mm -61.85 -35.81 70.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.56999999999999995 111.146 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -64.56 -48.05 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 1.2 110.854 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HB3' ' CD1' ' A' ' 213' ' ' PHE . 0.0 OUTLIER -62.88 -38.59 91.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 110.872 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.07 94.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.56999999999999995 111.064 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.668 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 15.3 m-85 -64.21 -34.12 77.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.906 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.8 tt0 -67.74 -41.13 83.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.706 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -69.7 -34.0 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.56999999999999995 111.105 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.458 ' CZ2' ' HA3' ' A' ' 221' ' ' GLY . 7.3 m95 -82.95 -34.04 26.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.47 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 49.1 m -79.27 -48.87 13.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 110.852 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.842 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.83 -12.99 8.62 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.838 0.828 . . . . 0.56999999999999995 111.965 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.842 HG13 ' ND2' ' A' ' 143' ' ' ASN . 20.6 m -115.32 3.29 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.751 -1.113 . . . . 0.56999999999999995 112.127 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.91 148.86 40.56 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 124.105 1.907 . . . . 0.56999999999999995 110.418 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.18 -32.22 6.95 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 120.862 1.041 . . . . 0.56999999999999995 112.509 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.733 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.3 mt -56.27 109.63 0.63 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 109.531 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 157.39 33.5 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.494 -1.23 . . . . 0.56999999999999995 111.77 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.697 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 10.8 m-85 -127.57 149.05 50.33 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-N 113.671 -1.604 . . . . 0.56999999999999995 109.19 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.39 121.19 6.02 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-O 123.605 1.669 . . . . 0.56999999999999995 109.792 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 21.0 tttp -92.52 145.89 24.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 120.674 -1.266 . . . . 0.56999999999999995 110.834 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.3 pt -128.53 129.02 68.69 Favored 'Isoleucine or valine' 0 C--N 1.372 1.544 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -73.95 -55.46 6.13 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.147 0.975 . . . . 0.56999999999999995 110.773 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.99 113.18 25.36 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 114.575 -1.193 . . . . 0.56999999999999995 110.781 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.27 164.5 19.23 Favored Glycine 0 C--N 1.37 2.466 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.123 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.9 ttt -88.28 131.75 34.66 Favored 'General case' 0 C--N 1.371 1.523 0 CA-C-O 122.192 0.996 . . . . 0.56999999999999995 111.085 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.53 175.02 6.37 Favored 'General case' 0 C--N 1.366 1.298 0 CA-C-N 114.423 -1.262 . . . . 0.56999999999999995 110.856 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.44 -46.47 89.94 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 106.432 -1.692 . . . . 0.91000000000000003 106.432 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 193' ' ' GLY . 1.8 mt -113.88 109.93 30.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 114.733 -1.121 . . . . 0.56999999999999995 111.166 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 162' ' ' VAL . 0.2 OUTLIER -98.79 120.99 40.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.975 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.758 HG12 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -102.34 116.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.171 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.736 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.93 146.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.101 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.566 ' CD2' ' CD1' ' A' ' 197' ' ' PHE . 0.5 OUTLIER -98.68 122.76 42.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.56999999999999995 110.887 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.795 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -144.97 168.45 20.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.242 1.02 . . . . 0.56999999999999995 109.929 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 166.25 10.91 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.547 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -30.62 105.37 0.01 OUTLIER Glycine 0 C--N 1.375 2.71 0 O-C-N 124.288 0.993 . . . . 0.56999999999999995 113.246 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 80.56 93.55 0.05 OUTLIER 'General case' 0 C--N 1.391 2.402 0 CA-C-O 124.741 2.21 . . . . 0.56999999999999995 113.338 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.795 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 1.2 p-80 . . . . . 0 C--N 1.371 1.506 0 CA-C-N 113.729 -1.578 . . . . 0.56999999999999995 110.693 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 124.484 2.088 . . . . 0.56999999999999995 109.644 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.448 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -99.78 -160.36 0.8 Allowed 'General case' 0 C--N 1.362 1.145 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.027 177.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.503 ' CB ' ' CG1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -113.13 139.36 48.8 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-N 115.23 -0.895 . . . . 0.91000000000000003 110.85 176.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -100.16 92.47 1.11 Allowed Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 112.798 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER 69.95 50.07 0.48 Allowed 'General case' 0 C--N 1.377 1.779 0 CA-C-O 122.596 1.189 . . . . 0.56999999999999995 112.132 175.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 176.13 19.99 Favored Glycine 0 C--N 1.357 1.695 0 N-CA-C 108.217 -1.953 . . . . 0.56999999999999995 108.217 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 240' ' ' TYR . . . -44.46 -33.57 3.2 Favored Glycine 0 C--N 1.379 2.952 0 CA-C-O 122.198 0.888 . . . . 0.56999999999999995 112.252 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 180' ' ' ILE . 3.1 mm -45.24 168.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 O-C-N 121.556 -0.967 . . . . 0.56999999999999995 111.722 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -148.17 -39.09 0.18 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.86 0.838 . . . . 0.56999999999999995 110.102 177.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -176.63 179.94 1.07 Allowed 'General case' 0 C--N 1.363 1.176 0 CA-C-N 115.32 -0.855 . . . . 0.56999999999999995 111.042 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.426 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -153.35 141.86 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.889 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.14 152.42 33.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.142 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.725 -0.67 . . . . 0.56999999999999995 109.551 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 -151.56 7.98 Favored Glycine 0 C--N 1.367 2.255 0 CA-C-N 114.996 -1.002 . . . . 0.56999999999999995 110.905 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.33 88.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.958 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.25 118.11 1.32 Allowed Glycine 0 C--N 1.37 2.436 0 N-CA-C 109.501 -1.44 . . . . 0.56999999999999995 109.501 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -61.93 104.79 0.49 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.303 1.049 . . . . 0.56999999999999995 109.73 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.12 -101.59 1.01 Allowed Glycine 0 C--N 1.377 2.815 0 CA-C-N 114.965 -1.016 . . . . 0.56999999999999995 112.491 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.15 -37.61 77.82 Favored 'Isoleucine or valine' 0 C--N 1.375 1.691 0 CA-C-O 122.84 1.305 . . . . 0.56999999999999995 109.36 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.58 126.15 15.67 Favored Glycine 0 C--N 1.369 2.378 0 CA-C-O 122.696 1.165 . . . . 0.56999999999999995 110.579 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 106.95 -49.82 0.84 Allowed Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.844 -0.678 . . . . 0.56999999999999995 111.483 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 1.0 OUTLIER -45.45 107.61 0.1 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 120.86 0.362 . . . . 0.91000000000000003 110.88 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -104.31 142.17 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.063 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.736 ' CD2' HG22 ' A' ' 162' ' ' VAL . 16.3 m170 -134.87 135.83 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.827 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.758 ' CE2' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -105.22 150.21 25.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.923 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.448 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.5 p30 -83.37 93.07 7.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.91000000000000003 110.865 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.96 80.07 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.991 -0.744 . . . . 0.91000000000000003 108.991 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -36.22 -45.07 0.43 Allowed 'General case' 0 C--N 1.363 1.194 0 CA-C-O 122.464 1.126 . . . . 0.91000000000000003 110.053 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 177' ' ' LYS . 8.5 pt-20 -56.54 -176.19 0.01 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-O 125.218 2.437 . . . . 0.91000000000000003 113.225 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -112.28 89.95 3.21 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.115 -1.616 . . . . 0.56999999999999995 111.185 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.65 ' HH2' HG21 ' A' ' 215' ' ' THR . 49.1 m95 -71.93 142.84 49.45 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 109.164 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -125.73 126.56 44.81 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-O 123.047 1.403 . . . . 0.56999999999999995 109.727 -177.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.8 p -103.89 111.58 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.387 -1.279 . . . . 0.56999999999999995 108.29 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 83.46 65.36 0.02 OUTLIER 'General case' 0 C--N 1.386 2.191 0 CA-C-N 114.386 -1.279 . . . . 0.56999999999999995 108.867 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.62 124.37 0.03 OUTLIER 'General case' 0 C--N 1.383 2.052 0 CA-C-O 124.532 2.11 . . . . 0.56999999999999995 108.869 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 204' ' ' THR . . . 149.61 -12.4 1.01 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 120.537 -1.352 . . . . 0.56999999999999995 112.611 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.83 -115.08 0.64 Allowed Glycine 0 C--N 1.375 2.734 0 CA-C-O 122.955 1.309 . . . . 0.56999999999999995 110.919 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.739 HG22 ' OH ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -99.18 119.58 38.1 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 108.059 -175.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.525 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.2 p30 -91.07 142.13 28.09 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-N 114.252 -1.34 . . . . 0.56999999999999995 110.39 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -63.32 -27.72 69.52 Favored 'General case' 0 C--N 1.375 1.714 0 CA-C-O 124.596 2.141 . . . . 0.56999999999999995 107.695 -175.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 217' ' ' VAL . 32.8 t80 -59.67 -50.0 75.56 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.346 -1.297 . . . . 0.56999999999999995 110.886 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -62.13 -41.97 98.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.917 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.65 HG21 ' HH2' ' A' ' 203' ' ' TRP . 94.3 m -65.11 -45.01 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 111.157 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -63.13 -36.66 84.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 111.085 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 213' ' ' PHE . 59.7 t -65.87 -41.0 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.118 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -72.05 -51.08 23.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 110.861 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -62.13 -39.96 94.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.91000000000000003 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.582 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.7 mm -70.18 -47.21 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.56999999999999995 111.142 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.75 -34.26 64.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 1.1 m-70 -67.82 -36.07 79.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.56999999999999995 110.814 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -49.33 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.888 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.4 pp -97.66 -58.62 1.95 Allowed 'General case' 0 C--N 1.353 0.751 0 N-CA-C 113.96 1.096 . . . . 0.56999999999999995 113.96 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.807 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -43.69 159.28 0.1 Allowed Glycine 0 C--N 1.365 2.145 0 CA-C-O 125.211 2.562 . . . . 0.56999999999999995 110.936 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -81.12 -67.68 0.76 Allowed 'General case' 0 C--N 1.364 1.226 0 CA-C-N 113.195 -1.502 . . . . 0.56999999999999995 108.735 -174.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.18 39.0 Favored Glycine 0 C--N 1.368 2.358 0 CA-C-O 123.298 1.499 . . . . 0.56999999999999995 110.595 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 1.1 m-70 -91.11 165.38 13.53 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-N 113.891 -1.154 . . . . 0.56999999999999995 110.218 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -84.04 -8.63 59.07 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 114.438 -1.255 . . . . 0.56999999999999995 110.682 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.84 1.14 2.48 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 111.97 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 145.44 57.07 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 114.542 -1.208 . . . . 0.91000000000000003 109.115 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.45 -44.97 37.59 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 121.717 1.611 . . . . 0.56999999999999995 112.072 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -32.49 0.19 Allowed 'General case' 0 C--N 1.371 1.525 0 CA-C-N 115.297 -0.865 . . . . 0.56999999999999995 113.237 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.19 136.73 48.22 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 124.383 2.039 . . . . 0.56999999999999995 114.81 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -73.76 -23.45 19.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 124.043 1.878 . . . . 0.56999999999999995 111.102 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.492 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -84.08 8.88 14.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.464 -1.698 . . . . 0.56999999999999995 111.183 -178.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 5.3 t80 -51.81 142.56 24.37 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-O 123.211 1.481 . . . . 0.56999999999999995 110.601 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 47.4 Cg_endo -78.56 -45.46 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.389 1.393 . . . . 0.56999999999999995 112.256 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.3 m -57.99 138.01 56.29 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.524 1.154 . . . . 0.56999999999999995 110.27 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.739 ' OH ' HG22 ' A' ' 210' ' ' THR . 2.5 t80 -75.42 154.14 37.28 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-N 114.052 -1.431 . . . . 0.56999999999999995 108.652 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 46.2 tttt 178.63 106.34 0.03 OUTLIER 'General case' 0 C--N 1.378 1.838 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.796 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -55.19 121.22 8.34 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 124.08 1.895 . . . . 0.56999999999999995 110.153 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.9 m -125.86 -14.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 110.804 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 1.4 p30 60.21 18.23 7.68 Favored 'General case' 0 C--N 1.369 1.453 0 O-C-N 124.31 1.006 . . . . 0.91000000000000003 111.98 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.544 HG12 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mt 79.05 -10.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.672 0 CA-C-N 114.91 -1.041 . . . . 0.56999999999999995 113.423 -175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -41.35 99.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.773 -1.566 . . . . 0.56999999999999995 106.773 -171.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -15.43 14.4 Favored 'General case' 0 C--N 1.373 1.627 0 N-CA-C 114.572 1.323 . . . . 0.56999999999999995 114.572 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.535 ' CE1' ' CG2' ' A' ' 235' ' ' VAL . 17.2 t80 -53.48 87.29 0.0 OUTLIER 'General case' 0 C--N 1.366 1.323 0 CA-C-O 123.566 1.651 . . . . 0.56999999999999995 110.563 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.434 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.49 149.2 45.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.452 -1.249 . . . . 1.2 109.172 -178.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -113.38 131.9 55.81 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-O 123.75 1.738 . . . . 0.56999999999999995 108.664 -176.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.68 134.39 52.16 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 120.413 -1.429 . . . . 0.56999999999999995 110.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.64 -42.24 83.03 Favored 'General case' 0 C--N 1.373 1.605 0 CA-C-N 115.009 -0.996 . . . . 0.56999999999999995 109.507 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -41.29 97.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.954 -0.567 . . . . 0.91000000000000003 110.79 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.6 -55.27 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.91000000000000003 110.898 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.793 HG21 HG11 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -66.24 -38.35 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.173 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.642 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.9 mtt180 -68.51 -29.91 68.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.869 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -69.62 -47.92 46.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.56999999999999995 112.476 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 144' ' ' VAL . 1.1 pt -63.58 -43.18 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 0.56999999999999995 111.117 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.47 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.07 -34.64 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 110.906 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.351 0.644 0 CA-C-O 122.18 0.99 . . . . 0.56999999999999995 110.915 -178.722 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 122.718 1.247 . . . . 1.2 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -156.04 55.73 0.59 Allowed 'General case' 0 C--N 1.391 2.38 0 CA-C-O 123.927 1.822 . . . . 0.56999999999999995 108.671 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -166.8 -43.51 0.02 OUTLIER 'General case' 0 C--N 1.381 1.96 0 CA-C-N 113.895 -1.502 . . . . 0.56999999999999995 109.719 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.506 ' C ' HD13 ' A' ' 114' ' ' ILE . 1.3 t80 -113.68 105.52 13.4 Favored 'General case' 0 C--N 1.367 1.338 0 CA-C-N 115.049 -0.978 . . . . 0.56999999999999995 110.905 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -99.13 155.0 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.15 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.506 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 20.7 p -116.68 135.22 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.091 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -128.43 139.01 52.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.961 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -122.87 121.98 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.2 110.923 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -82.58 133.15 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.121 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.755 ' HB2' HG13 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -49.32 -63.0 1.23 Allowed 'General case' 0 C--N 1.372 1.575 0 N-CA-C 107.908 -1.145 . . . . 0.56999999999999995 107.908 -173.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 161.04 32.45 0.0 OUTLIER 'General case' 0 C--N 1.391 2.397 0 CA-C-N 113.6 -1.637 . . . . 0.56999999999999995 110.608 -169.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.7 m-85 63.28 -151.1 0.33 Allowed 'General case' 0 C--N 1.386 2.189 0 N-CA-C 106.926 -1.509 . . . . 0.56999999999999995 106.926 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.608 HG21 ' OE1' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -176.23 166.7 1.61 Allowed Pre-proline 0 C--N 1.38 1.894 0 CA-C-O 123.313 1.53 . . . . 0.56999999999999995 109.616 -175.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.601 ' HD2' HG22 ' A' ' 122' ' ' THR . 31.5 Cg_endo -70.59 -42.38 2.59 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 120.865 1.043 . . . . 0.56999999999999995 112.049 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.43 -34.95 35.7 Favored 'General case' 0 C--N 1.38 1.893 0 CA-C-N 114.591 -1.186 . . . . 0.91000000000000003 112.779 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.3 ttm -93.14 111.86 23.63 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-O 125.67 2.652 . . . . 0.56999999999999995 109.068 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.26 141.74 54.31 Favored 'General case' 0 C--N 1.384 2.074 0 CA-C-N 113.272 -1.786 . . . . 0.56999999999999995 109.118 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.14 -51.41 58.1 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.446 -1.316 . . . . 1.2 107.446 -170.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -54.41 -34.76 61.95 Favored 'General case' 0 C--N 1.39 2.345 0 CA-C-N 113.06 -1.882 . . . . 0.91000000000000003 110.948 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.35 -44.01 69.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.91000000000000003 110.892 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -61.46 -43.09 96.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 111.122 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -66.45 -44.1 83.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.872 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -49.09 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.885 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.67 84.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.122 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.1 mm -67.44 -32.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.126 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -65.51 -48.1 73.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.2 110.88 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.28 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.56999999999999995 111.136 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.533 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 6.7 m-85 -67.01 -33.87 76.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.56999999999999995 110.912 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.464 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.2 tt0 -68.6 -42.08 78.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.928 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -69.43 -34.17 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.56999999999999995 111.172 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.725 ' O ' HG22 ' A' ' 145' ' ' THR . 3.7 m95 -83.02 -34.16 26.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.912 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.9 m -78.78 -50.46 11.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.883 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.821 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -57.4 -13.51 3.57 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 113.255 0.835 . . . . 0.56999999999999995 113.255 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.821 HG13 ' ND2' ' A' ' 143' ' ' ASN . 21.6 m -114.99 -11.11 12.14 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-N 114.517 -1.22 . . . . 0.56999999999999995 111.375 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -135.81 149.03 67.62 Favored Pre-proline 0 C--N 1.371 1.541 0 CA-C-O 125.517 2.58 . . . . 0.56999999999999995 109.057 -177.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.37 44.44 1.63 Allowed 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.611 2.208 . . . . 0.56999999999999995 112.25 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 145' ' ' THR . 0.6 OUTLIER -140.75 89.28 2.25 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 105.649 -1.982 . . . . 0.56999999999999995 105.649 -173.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -69.43 157.72 36.54 Favored 'General case' 0 C--N 1.38 1.921 0 CA-C-O 125.12 2.391 . . . . 0.56999999999999995 114.538 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CG ' ' CE1' ' A' ' 138' ' ' PHE . 72.7 m-85 -126.28 155.52 41.79 Favored 'General case' 0 C--N 1.387 2.222 0 CA-C-N 112.879 -1.964 . . . . 0.56999999999999995 108.903 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 124.62 7.31 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-O 125.302 2.477 . . . . 0.56999999999999995 107.101 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.505 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 33.2 tttt -82.82 145.38 29.52 Favored 'General case' 0 C--N 1.379 1.861 0 CA-C-N 113.626 -1.624 . . . . 0.56999999999999995 111.005 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.81 HD12 HG22 ' A' ' 154' ' ' THR . 8.4 pt -135.78 172.37 15.76 Favored 'Isoleucine or valine' 0 C--N 1.38 1.911 0 CA-C-O 123.641 1.686 . . . . 0.56999999999999995 109.321 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -125.95 29.26 5.93 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-O 123.819 1.771 . . . . 0.56999999999999995 110.597 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.81 HG22 HD12 ' A' ' 152' ' ' ILE . 1.1 t -80.79 -170.46 2.67 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-N 114.217 -1.356 . . . . 0.56999999999999995 111.025 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 154' ' ' THR . . . -49.44 -55.24 13.6 Favored Glycine 0 C--N 1.391 3.62 0 CA-C-N 113.812 -1.54 . . . . 0.56999999999999995 110.929 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.89 138.9 9.6 Favored 'General case' 0 C--N 1.379 1.86 0 N-CA-C 107.663 -1.236 . . . . 0.56999999999999995 107.663 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -104.07 172.46 6.79 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.874 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -49.99 -65.45 0.56 Allowed 'General case' 0 C--N 1.38 1.924 0 CA-C-N 113.614 -1.63 . . . . 0.91000000000000003 106.919 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 193' ' ' GLY . 6.9 mt -97.97 110.06 24.88 Favored 'Isoleucine or valine' 0 C--N 1.371 1.527 0 O-C-N 121.802 -0.561 . . . . 0.56999999999999995 111.13 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.752 HD23 ' HB3' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -95.34 120.99 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 110.887 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.732 HG12 ' CE1' ' A' ' 197' ' ' PHE . 0.1 OUTLIER -104.45 118.12 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.115 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -133.12 146.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.56999999999999995 111.149 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.68 120.65 42.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.9 167.26 26.19 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 123.242 1.496 . . . . 0.56999999999999995 108.214 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 169.26 8.57 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 115.06 -0.973 . . . . 1.2 109.926 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -41.79 133.68 3.72 Favored Glycine 0 C--N 1.387 3.381 0 CA-C-N 114.13 -1.396 . . . . 0.56999999999999995 109.623 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 85.32 45.14 0.02 OUTLIER 'General case' 0 C--N 1.4 2.792 0 CA-C-O 124.191 1.948 . . . . 0.56999999999999995 111.203 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 C--N 1.379 1.877 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 110.978 -179.662 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 123.433 1.587 . . . . 0.56999999999999995 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.544 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 1.4 m-85 -119.84 -173.08 2.47 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.95 -1.932 . . . . 0.56999999999999995 110.36 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.24 -178.66 3.51 Favored 'General case' 0 C--N 1.377 1.789 0 CA-C-N 113.044 -1.889 . . . . 0.91000000000000003 112.862 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.73 150.22 21.06 Favored Glycine 0 C--N 1.385 3.285 0 CA-C-N 113.47 -1.696 . . . . 0.56999999999999995 109.029 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.24 8.33 5.26 Favored 'General case' 0 C--N 1.376 1.748 0 CA-C-O 122.721 1.248 . . . . 0.56999999999999995 111.617 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 159.22 -104.53 0.25 Allowed Glycine 0 C--N 1.378 2.9 0 CA-C-O 122.869 1.261 . . . . 0.56999999999999995 110.185 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.31 -126.15 35.92 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-O 123.635 1.686 . . . . 0.56999999999999995 110.388 176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 181' ' ' LEU . 2.3 pp -79.03 -173.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.876 0 CA-C-N 113.745 -1.227 . . . . 0.56999999999999995 109.557 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.801 HD22 ' CE1' ' A' ' 240' ' ' TYR . 9.4 tp -109.83 -37.1 5.73 Favored 'General case' 0 C--N 1.377 1.765 0 N-CA-C 115.763 1.764 . . . . 0.56999999999999995 115.763 170.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 215' ' ' THR . . . -178.78 179.84 0.68 Allowed 'General case' 0 C--N 1.384 2.083 0 CA-C-N 113.787 -1.551 . . . . 0.56999999999999995 111.117 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 4.9 p80 -161.59 136.04 7.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.848 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -135.02 144.21 47.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.56999999999999995 111.108 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -79.56 175.88 10.21 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-O 123.244 1.497 . . . . 0.56999999999999995 109.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.84 -173.39 40.63 Favored Glycine 0 C--N 1.383 3.172 0 CA-C-O 123.158 1.421 . . . . 0.56999999999999995 111.312 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.52 71.83 3.79 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.56 2.173 . . . . 0.56999999999999995 111.506 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.13 -123.03 1.0 Allowed Glycine 0 C--N 1.382 3.087 0 CA-C-O 123.931 1.85 . . . . 0.56999999999999995 110.184 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.0 m -125.41 -62.89 1.18 Allowed 'General case' 0 C--N 1.392 2.417 0 CA-C-O 123.386 1.565 . . . . 0.56999999999999995 108.205 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.06 -71.3 0.7 Allowed Glycine 0 C--N 1.394 3.802 0 N-CA-C 108.861 -1.696 . . . . 0.56999999999999995 108.861 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.76 56.15 Favored 'Isoleucine or valine' 0 C--N 1.384 2.1 0 CA-C-O 125.815 2.721 . . . . 0.56999999999999995 108.885 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.3 134.94 29.12 Favored Glycine 0 C--N 1.393 3.746 0 N-CA-C 106.562 -2.615 . . . . 0.56999999999999995 106.562 -172.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 102.37 -19.8 47.02 Favored Glycine 0 C--N 1.368 2.308 0 N-CA-C 110.172 -1.171 . . . . 0.56999999999999995 110.172 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 160' ' ' LEU . 1.1 m-20 -73.96 124.86 26.99 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.993 -1.298 . . . . 0.91000000000000003 110.922 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -107.3 142.09 37.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.56999999999999995 111.083 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -124.69 129.39 50.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.925 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.732 ' CE1' HG12 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -108.62 150.18 27.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 110.919 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -79.5 91.25 5.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.91000000000000003 110.887 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 122' ' ' THR . 9.9 tp10 -64.74 -47.51 77.96 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-N 114.977 -1.01 . . . . 0.91000000000000003 108.815 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.51 -44.9 0.06 Allowed 'General case' 0 C--N 1.374 1.633 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 203' ' ' TRP . 1.4 mp0 -62.58 -178.14 0.18 Allowed 'General case' 0 C--N 1.382 1.999 0 CA-C-O 127.219 3.39 . . . . 0.91000000000000003 106.948 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.24 78.0 1.18 Allowed 'General case' 0 C--N 1.379 1.848 0 O-C-N 118.664 -2.522 . . . . 0.56999999999999995 108.241 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.72 ' CH2' HD12 ' A' ' 181' ' ' LEU . 21.4 m95 -74.0 143.16 45.7 Favored 'General case' 0 C--N 1.376 1.744 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 109.154 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 60.6 p -114.2 123.35 49.36 Favored 'General case' 0 C--N 1.377 1.8 0 CA-C-O 124.349 2.023 . . . . 0.56999999999999995 108.905 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.1 p -96.11 111.68 23.64 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-O 123.929 1.823 . . . . 0.56999999999999995 108.497 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 77.34 48.96 0.05 Allowed 'General case' 0 C--N 1.388 2.276 0 CA-C-O 124.57 2.129 . . . . 0.56999999999999995 110.626 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 t -129.09 -91.78 0.47 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 114.242 -1.345 . . . . 0.56999999999999995 109.651 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 244' ' ' ASP . . . -177.91 -45.07 0.07 OUTLIER Glycine 0 C--N 1.387 3.381 0 C-N-CA 119.356 -1.402 . . . . 0.56999999999999995 111.985 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.51 -133.65 0.03 OUTLIER Glycine 0 C--N 1.393 3.743 0 CA-C-O 126.708 3.393 . . . . 0.56999999999999995 109.598 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.589 HG22 ' OH ' ' A' ' 240' ' ' TYR . 41.5 p -67.71 130.63 43.59 Favored 'General case' 0 C--N 1.37 1.473 0 O-C-N 119.582 -2.128 . . . . 0.56999999999999995 110.945 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.834 ' CB ' HD11 ' A' ' 245' ' ' ILE . 17.2 p30 -134.09 149.52 51.11 Favored 'General case' 0 C--N 1.38 1.923 0 CA-C-N 113.338 -1.755 . . . . 0.56999999999999995 108.476 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.0 pt? -71.08 -23.92 62.22 Favored 'General case' 0 C--N 1.375 1.702 0 CA-C-O 124.836 2.255 . . . . 0.56999999999999995 111.111 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -54.51 -39.29 67.45 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.506 -1.679 . . . . 0.56999999999999995 110.855 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -55.0 -51.13 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.895 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.581 HG23 HD23 ' A' ' 181' ' ' LEU . 11.7 p -66.53 -40.41 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.131 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.79 96.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.09 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.69 HG11 ' HZ ' ' A' ' 248' ' ' PHE . 24.6 t -65.31 -40.83 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.417 ' HA ' ' SD ' ' A' ' 236' ' ' MET . 24.8 t-80 -69.29 -44.97 70.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.858 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 220' ' ' ILE . 2.5 pt-20 -59.64 -41.49 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.936 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.483 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 49.8 mt -66.48 -40.86 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.181 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.54 -33.7 87.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.56999999999999995 112.441 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -43.35 96.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.847 0.356 . . . . 0.56999999999999995 110.889 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -37.36 73.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.863 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 ' CE3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -45.47 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.367 1.343 0 CA-C-O 124.434 2.064 . . . . 0.56999999999999995 114.26 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -158.11 -88.74 0.07 OUTLIER Glycine 0 C--N 1.377 2.828 0 C-N-CA 118.654 -1.736 . . . . 0.56999999999999995 110.837 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.391 2.412 0 O-C-N 125.66 1.447 . . . . 0.56999999999999995 110.581 -173.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 99.07 98.28 2.14 Favored Glycine 0 C--N 1.385 3.303 0 C-N-CA 118.894 -1.622 . . . . 0.56999999999999995 110.281 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 172.75 0.16 Allowed 'General case' 0 C--N 1.395 2.556 0 CA-C-O 124.3 2.0 . . . . 0.56999999999999995 108.188 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -131.61 -6.42 3.67 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 117.294 -1.762 . . . . 0.56999999999999995 110.408 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.1 t 83.28 -12.25 0.87 Allowed 'General case' 0 C--N 1.391 2.397 0 CA-C-N 115.299 -0.864 . . . . 0.56999999999999995 112.049 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.68 148.17 45.49 Favored Pre-proline 0 C--N 1.385 2.129 0 N-CA-C 106.135 -1.802 . . . . 0.91000000000000003 106.135 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.33 -16.64 35.72 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.031 2.487 . . . . 0.56999999999999995 112.273 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 1.89 2.49 Favored 'General case' 0 C--N 1.38 1.91 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -111.5 143.1 42.89 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-O 124.877 2.275 . . . . 0.56999999999999995 108.687 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.646 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -72.91 -11.83 15.17 Favored 'Isoleucine or valine' 0 C--N 1.382 1.985 0 CA-C-N 112.322 -2.217 . . . . 0.56999999999999995 111.842 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 218' ' ' HIS . 0.3 OUTLIER -108.29 26.67 10.16 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-N 114.437 -1.256 . . . . 0.56999999999999995 110.349 -178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.588 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 17.0 t80 -54.64 142.62 52.07 Favored Pre-proline 0 C--N 1.371 1.506 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 108.914 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.588 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 76.6 Cg_exo -54.92 -49.34 17.0 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.022 1.814 . . . . 0.56999999999999995 112.762 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 m -62.9 136.03 57.63 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 123.303 1.525 . . . . 0.56999999999999995 110.459 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.801 ' CE1' HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -94.21 82.96 4.17 Favored 'General case' 0 C--N 1.382 2.001 0 CA-C-O 124.521 2.105 . . . . 0.56999999999999995 108.555 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 243' ' ' VAL . 1.4 tmtt? -111.69 100.14 8.72 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-O 123.711 1.72 . . . . 0.56999999999999995 108.89 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -53.05 118.68 3.92 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-O 125.666 2.651 . . . . 0.56999999999999995 110.629 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -96.12 11.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 CA-C-N 112.499 -2.137 . . . . 0.56999999999999995 111.406 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.421 ' HB2' ' HA2' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 86.68 -16.01 0.42 Allowed 'General case' 0 C--N 1.377 1.768 0 O-C-N 125.247 1.592 . . . . 0.91000000000000003 111.918 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 211' ' ' ASN . 3.6 mt 75.64 -49.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.389 2.284 0 N-CA-C 114.296 1.221 . . . . 0.56999999999999995 114.296 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -46.26 -28.86 1.4 Allowed 'General case' 0 C--N 1.368 1.383 0 N-CA-C 113.395 0.887 . . . . 0.56999999999999995 113.395 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 p -108.19 9.47 28.13 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-O 122.592 1.187 . . . . 0.56999999999999995 111.295 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.69 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 9.9 t80 -68.01 86.54 0.25 Allowed 'General case' 0 C--N 1.377 1.775 0 CA-C-O 125.023 2.344 . . . . 0.56999999999999995 108.97 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.443 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -108.63 153.51 23.3 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-O 124.748 2.213 . . . . 1.2 107.204 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.687 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.4 131.82 54.07 Favored 'General case' 0 C--N 1.381 1.938 0 CA-C-O 125.874 2.75 . . . . 0.56999999999999995 105.867 -172.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 45.2 t -66.45 138.28 57.43 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.359 -2.088 . . . . 0.56999999999999995 110.26 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.92 -43.21 86.13 Favored 'General case' 0 C--N 1.393 2.49 0 CA-C-N 113.612 -1.631 . . . . 0.56999999999999995 108.614 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.289 -0.882 . . . . 0.91000000000000003 110.87 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.7 OUTLIER -64.06 -55.08 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.91000000000000003 110.86 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 256' ' ' ARG . 22.7 pt -66.08 -35.23 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.166 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.692 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -70.35 -35.44 73.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 1.2 110.852 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.51 -49.58 64.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.56999999999999995 112.469 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.32 -45.65 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.56999999999999995 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.485 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.11 -24.04 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.56999999999999995 110.92 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--N 1.367 1.354 0 CA-C-O 123.388 1.566 . . . . 0.56999999999999995 111.03 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 107.717 -1.216 . . . . 1.2 107.717 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.42 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.383 2.03 0 CA-C-N 113.692 -1.595 . . . . 0.56999999999999995 111.402 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.797 ' HA ' HD22 ' A' ' 147' ' ' LEU . 5.8 p-80 -53.04 -35.91 59.99 Favored 'General case' 0 C--N 1.382 2.008 0 CA-C-N 112.91 -1.95 . . . . 0.56999999999999995 109.954 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -111.11 111.59 22.79 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.493 -1.38 . . . . 0.56999999999999995 110.891 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -111.24 144.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.085 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.767 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -105.94 158.47 16.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.56999999999999995 111.149 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.928 ' CE2' HD13 ' A' ' 159' ' ' ILE . 15.7 m-85 -140.6 159.59 41.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.886 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.754 HH11 ' N ' ' A' ' 156' ' ' MET . 12.3 ttm180 -150.0 129.62 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 1.2 110.854 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.751 HD11 ' CD1' ' A' ' 134' ' ' ILE . 1.1 mm -99.09 128.92 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 111.08 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.61 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.373 1.624 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 112.682 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -179.18 24.63 0.0 OUTLIER 'General case' 0 C--N 1.378 1.822 0 CA-C-N 113.595 -1.639 . . . . 0.56999999999999995 107.767 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.3 m-85 82.87 -152.56 0.01 OUTLIER 'General case' 0 C--N 1.392 2.415 0 N-CA-C 105.504 -2.036 . . . . 0.56999999999999995 105.504 170.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.2 167.56 14.1 Favored Pre-proline 0 C--N 1.382 2.01 0 N-CA-C 108.542 -0.91 . . . . 0.56999999999999995 108.542 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -57.04 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 121.303 1.335 . . . . 0.56999999999999995 114.305 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.32 -59.05 3.1 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.837 -1.529 . . . . 0.91000000000000003 112.986 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.466 ' HG2' ' CG2' ' A' ' 205' ' ' THR . 2.4 mtm -63.39 137.17 58.07 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 123.903 1.811 . . . . 0.56999999999999995 108.902 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -89.49 143.86 26.48 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 106.095 -1.817 . . . . 0.56999999999999995 106.095 -171.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.03 -49.67 42.47 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.728 -1.582 . . . . 1.2 106.728 -167.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.74 -34.79 62.98 Favored 'General case' 0 C--N 1.392 2.425 0 CA-C-N 112.238 -2.255 . . . . 0.91000000000000003 110.884 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -44.03 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.91000000000000003 110.877 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -65.03 -49.32 80.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.15 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -56.79 -44.07 81.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.91000000000000003 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -38.03 89.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.88 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -65.92 -40.64 91.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.086 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.751 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -66.97 -42.56 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.56999999999999995 111.178 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -62.05 -44.83 95.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 1.2 110.841 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.27 96.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.91 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.654 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -60.87 -44.69 96.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.117 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 134' ' ' ILE . 14.4 m-85 -62.53 -33.68 75.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.901 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.455 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -68.28 -39.36 82.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.884 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.6 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -72.3 -33.87 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.189 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.608 ' O ' HG23 ' A' ' 145' ' ' THR . 9.8 m95 -83.16 -34.06 26.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.923 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.2 m -77.99 -49.13 14.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.56999999999999995 110.852 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.782 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.99 -13.06 9.58 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 122.049 0.928 . . . . 0.56999999999999995 112.349 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.782 HG13 ' ND2' ' A' ' 143' ' ' ASN . 17.6 m -112.87 9.45 8.12 Favored 'Isoleucine or valine' 0 C--N 1.382 2.009 0 CA-C-N 114.326 -1.306 . . . . 0.56999999999999995 112.757 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.3 p -149.32 151.62 34.15 Favored Pre-proline 0 C--N 1.378 1.812 0 CA-C-O 126.201 2.905 . . . . 0.56999999999999995 110.677 -171.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.57 -29.29 2.38 Favored 'Trans proline' 0 C--N 1.365 1.432 0 O-C-N 117.31 -1.995 . . . . 0.56999999999999995 110.923 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 112' ' ' HIS . 3.6 mt -73.3 111.98 8.94 Favored 'General case' 0 C--N 1.376 1.76 0 N-CA-C 106.543 -1.651 . . . . 0.56999999999999995 106.543 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -69.48 157.75 36.52 Favored 'General case' 0 C--N 1.381 1.963 0 CA-C-O 124.369 2.033 . . . . 0.56999999999999995 116.279 170.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 17.0 m-85 -130.4 154.25 47.9 Favored 'General case' 0 C--N 1.387 2.213 0 CA-C-N 112.675 -2.057 . . . . 0.56999999999999995 109.141 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 m -156.15 109.13 2.65 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-O 125.442 2.544 . . . . 0.56999999999999995 108.83 -171.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.53 149.53 23.56 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.323 -1.762 . . . . 0.56999999999999995 112.394 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -160.17 -172.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.385 2.109 0 CA-C-N 113.833 -1.53 . . . . 0.56999999999999995 110.334 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -163.36 98.17 0.91 Allowed 'General case' 0 C--N 1.38 1.905 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 155' ' ' GLY . 17.6 m -147.03 -81.59 0.14 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 115.288 -0.869 . . . . 0.56999999999999995 109.92 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.634 ' H ' ' NH1' ' A' ' 117' ' ' ARG . . . -136.39 51.07 0.82 Allowed Glycine 0 C--N 1.384 3.228 0 N-CA-C 107.404 -2.278 . . . . 0.56999999999999995 107.404 -169.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.754 ' N ' HH11 ' A' ' 117' ' ' ARG . 5.0 ttm 72.19 135.98 0.04 OUTLIER 'General case' 0 C--N 1.404 2.977 0 O-C-N 126.362 1.86 . . . . 0.56999999999999995 108.274 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.22 163.67 27.23 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.27 -1.752 . . . . 0.56999999999999995 106.27 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 158' ' ' ASP 0.288 0.0 OUTLIER -18.7 -73.62 0.01 OUTLIER 'General case' 0 C--N 1.377 1.803 0 CA-C-N 112.875 -1.966 . . . . 0.91000000000000003 113.996 165.587 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.928 HD13 ' CE2' ' A' ' 116' ' ' TYR . 2.5 mp -96.15 109.8 23.43 Favored 'Isoleucine or valine' 0 C--N 1.383 2.063 0 O-C-N 126.9 2.625 . . . . 0.56999999999999995 111.215 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 122.49 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.879 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.637 HG23 HD13 ' A' ' 118' ' ' ILE . 1.4 m -110.44 121.44 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.08 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.646 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.13 139.97 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.087 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -90.19 118.84 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.946 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.46 169.18 20.07 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 118.861 -1.135 . . . . 0.56999999999999995 109.162 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 167.3 9.88 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 115.245 -0.889 . . . . 1.2 110.398 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -40.11 129.02 2.78 Favored Glycine 0 C--N 1.393 3.726 0 O-C-N 125.201 1.563 . . . . 0.56999999999999995 111.699 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.69 104.04 0.06 Allowed 'General case' 0 C--N 1.406 3.041 0 CA-C-O 124.893 2.283 . . . . 0.56999999999999995 112.271 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 . . . . . 0 C--N 1.386 2.187 0 CA-C-N 113.823 -1.535 . . . . 0.56999999999999995 110.405 -177.117 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 125.549 2.595 . . . . 0.56999999999999995 109.023 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -64.93 178.06 0.88 Allowed 'General case' 0 C--N 1.377 1.784 0 CA-C-N 111.945 -2.389 . . . . 0.56999999999999995 112.051 177.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 180' ' ' ILE . 2.5 p-10 -58.37 -160.27 0.0 OUTLIER 'General case' 0 C--N 1.386 2.19 0 CA-C-O 124.519 2.104 . . . . 0.91000000000000003 114.479 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -172.63 101.39 0.16 Allowed Glycine 0 C--N 1.391 3.602 0 C-N-CA 117.261 -2.4 . . . . 0.56999999999999995 109.205 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.63 96.64 0.07 Allowed 'General case' 0 C--N 1.39 2.345 0 CA-C-O 123.472 1.605 . . . . 0.56999999999999995 113.056 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.27 -152.37 25.45 Favored Glycine 0 C--N 1.381 3.065 0 C-N-CA 119.02 -1.562 . . . . 0.56999999999999995 110.596 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.83 -132.91 40.66 Favored Glycine 0 C--N 1.376 2.784 0 N-CA-C 111.788 -0.525 . . . . 0.56999999999999995 111.788 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -46.97 168.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.061 0 O-C-N 125.806 1.533 . . . . 0.56999999999999995 113.196 175.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 215' ' ' THR . 1.6 tp -121.94 -92.26 0.54 Allowed 'General case' 0 C--N 1.359 1.008 0 CA-C-O 126.781 3.181 . . . . 0.56999999999999995 112.907 172.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.478 ' HB2' ' CG2' ' A' ' 215' ' ' THR . . . -106.22 179.73 4.18 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 112.524 -2.126 . . . . 0.56999999999999995 111.1 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 54.4 p-80 -163.12 135.84 5.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.856 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -132.7 166.74 21.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.072 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -71.71 0.6 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 117.491 -1.684 . . . . 0.56999999999999995 108.083 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.23 0.55 Allowed Glycine 0 C--N 1.386 3.331 0 C-N-CA 120.696 -0.764 . . . . 0.56999999999999995 112.579 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -53.16 -47.29 28.3 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 110.755 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.99 -169.74 23.22 Favored Glycine 0 C--N 1.378 2.883 0 C-N-CA 118.958 -1.592 . . . . 0.56999999999999995 113.857 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 78.0 83.09 0.07 Allowed 'General case' 0 C--N 1.392 2.436 0 CA-C-O 124.137 1.922 . . . . 0.56999999999999995 107.649 173.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.63 -103.65 1.99 Allowed Glycine 0 C--N 1.394 3.781 0 N-CA-C 105.155 -3.178 . . . . 0.56999999999999995 105.155 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 192' ' ' GLY . 1.2 tp -61.88 -47.18 94.44 Favored 'Isoleucine or valine' 0 C--N 1.387 2.208 0 CA-C-O 127.102 3.334 . . . . 0.56999999999999995 110.691 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -63.83 158.64 40.51 Favored Glycine 0 N--CA 1.404 -3.469 0 O-C-N 117.019 -3.551 . . . . 0.56999999999999995 108.827 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.29 -8.11 19.88 Favored Glycine 0 C--N 1.375 2.743 0 CA-C-N 113.782 -1.209 . . . . 0.56999999999999995 113.853 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.45 108.36 18.98 Favored 'General case' 0 C--N 1.378 1.842 0 CA-C-N 114.464 -0.868 . . . . 0.91000000000000003 110.835 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -106.18 151.0 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.137 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.646 ' CD2' HG22 ' A' ' 162' ' ' VAL . 6.7 m170 -135.28 151.21 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.56999999999999995 110.834 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -114.37 139.7 49.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.844 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.3 p-10 -66.92 82.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.836 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.15 69.78 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 106.629 -1.619 . . . . 0.91000000000000003 106.629 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -48.37 19.04 Favored 'General case' 0 C--N 1.389 2.297 0 O-C-N 125.835 1.96 . . . . 0.91000000000000003 107.548 -163.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.89 171.71 0.02 OUTLIER 'General case' 0 C--N 1.392 2.417 0 CA-C-O 127.167 3.365 . . . . 0.91000000000000003 116.356 172.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -97.06 100.51 12.01 Favored 'General case' 0 C--N 1.378 1.82 0 O-C-N 119.19 -2.194 . . . . 0.56999999999999995 111.117 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.473 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 47.9 m95 -78.54 152.89 31.69 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.869 -1.514 . . . . 0.56999999999999995 109.089 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.7 105.6 9.44 Favored 'General case' 0 C--N 1.378 1.805 0 CA-C-O 124.523 2.106 . . . . 0.56999999999999995 110.599 -175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 125' ' ' MET . 4.3 p -96.93 107.29 19.78 Favored 'General case' 0 C--N 1.365 1.25 0 CA-C-N 114.492 -1.231 . . . . 0.56999999999999995 110.064 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 53.7 46.92 24.92 Favored 'General case' 0 C--N 1.393 2.476 0 CA-C-O 125.371 2.51 . . . . 0.56999999999999995 110.846 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 t -134.26 -74.97 0.47 Allowed 'General case' 0 C--N 1.387 2.221 0 CA-C-N 112.5 -2.137 . . . . 0.56999999999999995 107.793 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.55 64.01 0.05 OUTLIER Glycine 0 C--N 1.394 3.782 0 C-N-CA 118.24 -1.933 . . . . 0.56999999999999995 111.214 -171.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.64 -142.01 6.14 Favored Glycine 0 C--N 1.387 3.372 0 CA-C-O 123.483 1.602 . . . . 0.56999999999999995 111.132 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 56.2 m -68.24 118.02 10.81 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.841 -1.18 . . . . 0.56999999999999995 110.456 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.52 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.4 p30 -92.49 145.47 24.43 Favored 'General case' 0 C--N 1.378 1.826 0 O-C-N 126.117 2.136 . . . . 0.56999999999999995 112.519 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.684 ' C ' HD13 ' A' ' 212' ' ' LEU . 0.4 OUTLIER -73.49 -32.14 64.13 Favored 'General case' 0 C--N 1.391 2.395 0 CA-C-O 124.424 2.059 . . . . 0.56999999999999995 107.508 -174.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.902 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.3 t80 -49.57 -50.12 43.69 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-N 113.104 -1.862 . . . . 0.56999999999999995 110.891 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.447 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -57.18 -42.68 81.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.933 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 1.035 HG23 HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.62 -45.04 80.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.095 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.71 -47.77 79.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.56999999999999995 111.063 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 213' ' ' PHE . 2.8 t -59.96 -41.48 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.76 -36.59 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.832 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -43.23 86.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.91000000000000003 110.807 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.2 mm -64.02 -45.28 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.94 87.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.819 -0.705 . . . . 0.56999999999999995 112.441 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.425 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -64.01 -42.61 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.56999999999999995 110.821 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 t -71.07 -55.63 7.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.872 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 220' ' ' ILE . 0.2 OUTLIER -78.07 -164.31 0.52 Allowed 'General case' 0 C--N 1.382 1.984 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 171.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 224' ' ' LEU . . . 68.75 -146.03 44.5 Favored Glycine 0 C--N 1.38 2.998 0 N-CA-C 104.487 -3.445 . . . . 0.56999999999999995 104.487 169.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 258' ' ' ILE . 0.0 OUTLIER -124.1 -82.18 0.64 Allowed 'General case' 0 C--N 1.38 1.916 0 CA-C-N 111.738 -2.231 . . . . 0.56999999999999995 110.481 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.91 -157.27 7.29 Favored Glycine 0 C--N 1.379 2.929 0 CA-C-O 123.871 1.817 . . . . 0.56999999999999995 108.843 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.7 m-70 -103.2 -171.34 1.93 Allowed 'General case' 0 C--N 1.376 1.738 0 CA-C-N 113.777 -1.212 . . . . 0.56999999999999995 111.934 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.791 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -116.32 -31.26 5.68 Favored 'General case' 0 C--N 1.386 2.166 0 CA-C-N 113.93 -1.487 . . . . 0.56999999999999995 108.985 -176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 m 82.11 23.11 0.23 Allowed 'General case' 0 C--N 1.401 2.828 0 CA-C-O 123.095 1.426 . . . . 0.56999999999999995 114.556 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -127.99 151.13 75.38 Favored Pre-proline 0 N--CA 1.418 -2.067 0 CA-C-N 113.105 -1.861 . . . . 0.91000000000000003 108.345 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.615 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 71.0 Cg_exo -58.23 -28.07 82.91 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.168 1.912 . . . . 0.56999999999999995 115.289 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.422 ' HE3' ' H ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -70.35 -33.74 71.82 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 111.295 -2.684 . . . . 0.56999999999999995 117.884 173.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -55.3 131.23 45.09 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 113.778 -1.555 . . . . 0.56999999999999995 109.483 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.453 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -76.32 -3.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 CA-C-O 125.927 2.775 . . . . 0.56999999999999995 112.366 -176.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 11.2 mtp -122.82 -10.77 8.23 Favored 'General case' 0 C--N 1.374 1.668 0 CA-C-N 112.847 -1.978 . . . . 0.56999999999999995 112.153 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -38.66 141.82 0.55 Allowed Pre-proline 0 C--N 1.373 1.605 0 CA-C-O 125.496 2.57 . . . . 0.56999999999999995 113.638 174.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.94 -50.04 12.65 Favored 'Trans proline' 0 C--N 1.37 1.667 0 O-C-N 118.831 -1.194 . . . . 0.56999999999999995 111.122 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 39.5 m -44.23 118.71 1.58 Allowed 'General case' 0 C--N 1.366 1.288 0 CA-C-O 123.404 1.573 . . . . 0.56999999999999995 110.507 -172.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.519 ' CE2' HD13 ' A' ' 181' ' ' LEU . 25.1 t80 -92.92 157.56 16.28 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.555 -1.657 . . . . 0.56999999999999995 108.326 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.96 126.14 0.02 OUTLIER 'General case' 0 C--N 1.392 2.434 0 N-CA-C 105.448 -2.056 . . . . 0.56999999999999995 105.448 169.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.67 120.45 7.3 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 125.491 2.567 . . . . 0.56999999999999995 109.497 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 1.4 p -128.27 -16.05 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 CA-C-N 112.538 -2.119 . . . . 0.56999999999999995 110.973 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 244' ' ' ASP 0.289 0.0 OUTLIER 84.51 178.22 0.05 OUTLIER 'General case' 0 C--N 1.371 1.54 0 O-C-N 126.872 2.607 . . . . 0.91000000000000003 111.782 -174.289 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.859 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.8 mp -93.81 -35.64 6.57 Favored 'Isoleucine or valine' 0 C--N 1.382 1.983 0 N-CA-C 118.322 2.712 . . . . 0.56999999999999995 118.322 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.77 -14.52 0.05 OUTLIER 'General case' 0 C--N 1.377 1.784 0 N-CA-C 117.224 2.305 . . . . 0.56999999999999995 117.224 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.413 ' HB ' ' CG2' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -124.59 -21.53 4.83 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.504 -175.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.453 ' CZ ' HG22 ' A' ' 235' ' ' VAL . 67.3 t80 -61.29 88.67 0.02 OUTLIER 'General case' 0 C--N 1.378 1.845 0 CA-C-O 125.566 2.603 . . . . 0.56999999999999995 108.488 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.07 154.07 29.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 112.816 -1.993 . . . . 1.2 107.609 -178.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.631 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -124.42 127.84 48.13 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 125.745 2.688 . . . . 0.56999999999999995 105.393 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 143.27 58.06 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.214 -2.179 . . . . 0.56999999999999995 111.916 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -61.0 -45.29 95.42 Favored 'General case' 0 C--N 1.392 2.43 0 CA-C-N 113.842 -1.526 . . . . 0.56999999999999995 107.996 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.71 -38.51 81.83 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 115.644 -0.707 . . . . 0.91000000000000003 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 59.3 t0 -64.17 -55.09 24.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.91000000000000003 110.842 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.06 -34.82 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.164 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.449 ' N ' HG13 ' A' ' 255' ' ' ILE . 10.2 mtt180 -70.15 -32.35 70.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.882 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.81 62.41 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.655 -0.783 . . . . 0.56999999999999995 112.499 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.66 ' HA ' HD21 ' A' ' 226' ' ' LEU . 1.0 OUTLIER -64.8 -44.59 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.176 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.474 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.17 -19.18 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.914 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 C--N 1.366 1.326 0 CA-C-O 122.122 0.963 . . . . 0.56999999999999995 108.667 -175.604 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 . . . . . 0 N--CA 1.435 -1.195 0 CA-C-O 122.303 1.049 . . . . 1.2 109.278 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.83 155.44 14.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.533 ' H ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 81.96 -41.72 0.14 Allowed 'General case' 0 C--N 1.377 1.777 0 CA-C-O 122.187 0.994 . . . . 0.56999999999999995 110.622 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -114.4 131.47 56.56 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.579 -1.191 . . . . 0.56999999999999995 110.868 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 148' ' ' LYS . 1.1 mm -127.45 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.12 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.56 HG22 HG12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -106.0 157.81 17.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.098 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE1' HD12 ' A' ' 118' ' ' ILE . 16.7 t80 -145.29 160.02 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.914 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.598 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 3.9 tpt85 -146.49 121.97 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.841 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.68 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -95.53 125.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.122 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -61.83 -179.37 0.19 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.616 1.674 . . . . 0.56999999999999995 111.268 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.09 51.37 0.98 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 110.824 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 5.2 m-85 44.19 -150.15 0.05 Allowed 'General case' 0 C--N 1.366 1.323 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 109.045 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.592 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -165.84 168.24 8.07 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-O 122.286 1.041 . . . . 0.56999999999999995 110.454 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 122' ' ' THR . 32.5 Cg_endo -68.06 -36.23 17.85 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 121.444 1.429 . . . . 0.56999999999999995 112.963 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -84.84 -45.42 12.32 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.987 1.375 . . . . 0.91000000000000003 113.134 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.498 ' CE ' ' CE2' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -77.92 110.09 12.52 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 123.68 1.705 . . . . 0.56999999999999995 109.482 -176.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -71.27 135.89 47.67 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.947 -1.479 . . . . 0.56999999999999995 109.192 -176.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -61.61 -50.83 70.98 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 108.448 -0.945 . . . . 1.2 108.448 -170.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.56 -34.86 69.63 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 113.083 -1.871 . . . . 0.91000000000000003 110.896 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -39.71 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.91000000000000003 110.826 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -64.97 -49.74 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 111.153 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -41.61 91.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 110.896 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -42.3 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 110.863 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.736 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.5 -48.88 68.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.56999999999999995 111.092 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.575 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -64.35 -31.95 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.122 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.95 -46.71 70.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 1.2 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -62.82 -37.2 85.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.52 ' CB ' HG23 ' A' ' 217' ' ' VAL . . . -68.06 -38.5 82.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.065 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' HG22 ' A' ' 134' ' ' ILE . 5.5 m-85 -67.06 -33.83 76.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.919 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.426 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.3 tp60 -70.21 -44.65 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.871 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 250' ' ' LEU . 7.7 p -68.54 -33.6 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.56999999999999995 111.16 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.46 -34.31 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.854 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 138' ' ' PHE . 29.3 m -72.22 -49.45 35.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 110.863 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -60.66 -11.97 8.92 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-O 121.881 0.848 . . . . 0.56999999999999995 112.706 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 145' ' ' THR . 16.9 m -111.98 -5.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.367 1.358 0 CA-C-N 114.792 -1.094 . . . . 0.56999999999999995 112.69 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.94 HG21 HD13 ' A' ' 224' ' ' LEU . 21.0 p -140.63 146.38 44.43 Favored Pre-proline 0 C--N 1.365 1.261 0 CA-C-O 124.594 2.14 . . . . 0.56999999999999995 111.115 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -77.19 -25.54 8.48 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 121.218 1.278 . . . . 0.56999999999999995 111.77 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -77.68 96.09 4.77 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 122.668 1.223 . . . . 0.56999999999999995 109.518 -176.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -77.04 160.75 28.86 Favored 'General case' 0 C--N 1.363 1.184 0 CA-C-N 115.168 -0.924 . . . . 0.56999999999999995 112.198 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.487 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -133.05 140.77 47.88 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 107.702 -1.222 . . . . 0.56999999999999995 107.702 -173.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.0 m -155.67 135.56 12.78 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 109.387 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -74.97 144.17 43.3 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 114.513 -1.222 . . . . 0.56999999999999995 109.213 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 115' ' ' THR . 6.2 pt -125.14 -179.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.364 1.213 0 CA-C-O 121.947 0.879 . . . . 0.56999999999999995 109.887 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -134.41 63.87 1.61 Allowed 'General case' 0 C--N 1.37 1.483 0 CA-C-O 122.93 1.348 . . . . 0.56999999999999995 111.299 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.76 95.83 1.57 Allowed 'General case' 0 C--N 1.373 1.624 0 CA-C-N 114.553 -1.203 . . . . 0.56999999999999995 110.357 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 45.66 -137.63 7.04 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 122.418 1.01 . . . . 0.56999999999999995 111.681 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 151.53 46.96 Favored 'General case' 0 C--N 1.366 1.307 0 CA-C-O 123.145 1.45 . . . . 0.56999999999999995 110.74 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 117' ' ' ARG . . . -133.68 163.64 28.99 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 114.497 -1.229 . . . . 0.56999999999999995 109.814 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.462 ' H ' ' HB ' ' A' ' 115' ' ' THR . 53.6 m-20 -46.06 -52.0 12.75 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 108.245 -1.02 . . . . 0.91000000000000003 108.245 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 193' ' ' GLY . 41.6 mt -116.43 110.47 31.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 O-C-N 123.816 0.697 . . . . 0.56999999999999995 111.093 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 122.02 46.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.977 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.19 120.21 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 111.098 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.8 t -131.23 124.94 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 111.084 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 197' ' ' PHE . 2.4 m-85 -86.78 120.48 28.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.852 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.13 169.0 18.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 110.626 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 163.44 13.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.749 -1.219 . . . . 1.2 108.945 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -33.03 130.89 0.3 Allowed Glycine 0 C--N 1.37 2.429 0 O-C-N 124.009 0.818 . . . . 0.56999999999999995 112.718 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 84.28 40.28 0.03 OUTLIER 'General case' 0 C--N 1.39 2.361 0 CA-C-O 124.763 2.221 . . . . 0.56999999999999995 112.383 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--N 1.364 1.237 0 CA-C-N 114.249 -1.342 . . . . 0.56999999999999995 109.087 -178.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 121.142 0.496 . . . . 0.56999999999999995 110.72 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.441 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -147.6 -167.82 2.89 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 122.018 0.914 . . . . 0.56999999999999995 110.07 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.419 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.4 OUTLIER -72.61 -177.74 2.38 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 124.477 1.111 . . . . 0.91000000000000003 112.252 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.27 49.13 0.21 Allowed Glycine 0 C--N 1.381 3.049 0 CA-C-O 123.411 1.562 . . . . 0.56999999999999995 113.192 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -171.72 -36.48 0.02 OUTLIER 'General case' 0 C--N 1.384 2.069 0 CA-C-O 123.425 1.583 . . . . 0.56999999999999995 112.819 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.474 ' N ' ' HD2' ' A' ' 177' ' ' LYS . . . 169.41 -103.62 0.2 Allowed Glycine 0 C--N 1.375 2.7 0 CA-C-O 122.955 1.308 . . . . 0.56999999999999995 110.457 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.541 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 36.04 -92.19 0.01 OUTLIER Glycine 0 C--N 1.367 2.267 0 O-C-N 120.309 -1.7 . . . . 0.56999999999999995 114.49 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.57 ' N ' HD13 ' A' ' 180' ' ' ILE . 1.9 mm -51.23 170.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.064 0 CA-C-O 121.297 0.57 . . . . 0.56999999999999995 111.593 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.697 HD13 ' HE2' ' A' ' 240' ' ' TYR . 3.6 tp -136.09 -41.33 0.66 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.945 0.879 . . . . 0.56999999999999995 112.55 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -176.72 179.87 1.06 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.359 -0.837 . . . . 0.56999999999999995 111.094 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -156.03 137.91 14.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.928 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.87 140.01 40.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.101 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.446 ' CB ' HG23 ' A' ' 191' ' ' ILE . 1.9 m-85 -91.93 176.59 6.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.523 1.154 . . . . 0.56999999999999995 110.964 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.37 55.07 0.1 Allowed Glycine 0 C--N 1.366 2.21 0 CA-C-N 115.501 -0.772 . . . . 0.56999999999999995 112.797 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HD2' ' CA ' ' A' ' 192' ' ' GLY . 47.0 Cg_endo -74.42 -42.98 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 120.907 1.071 . . . . 0.56999999999999995 112.008 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.41 87.32 0.17 Allowed Glycine 0 C--N 1.379 2.93 0 C-N-CA 120.137 -1.03 . . . . 0.56999999999999995 111.569 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 79.75 97.02 0.06 Allowed 'General case' 0 C--N 1.386 2.155 0 CA-C-O 123.59 1.662 . . . . 0.56999999999999995 110.073 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.65 -118.56 1.27 Allowed Glycine 0 C--N 1.381 3.047 0 N-CA-C 109.61 -1.396 . . . . 0.56999999999999995 109.61 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -72.11 -11.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 CA-C-O 124.689 2.185 . . . . 0.56999999999999995 110.36 -178.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 187' ' ' PRO . . . -66.91 124.62 23.89 Favored Glycine 0 C--N 1.372 2.552 0 O-C-N 120.077 -1.639 . . . . 0.56999999999999995 109.758 -174.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 115.09 -33.12 5.45 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-O 121.737 0.631 . . . . 0.56999999999999995 112.521 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -72.91 129.37 37.99 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 122.162 -0.61 . . . . 0.91000000000000003 110.828 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.694 ' HB2' ' HB2' ' A' ' 219' ' ' GLU . . . -121.51 160.05 25.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.481 . . . . 0.56999999999999995 111.089 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.549 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 46.0 m170 -133.74 140.07 46.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.66 139.42 38.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 110.887 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.55 78.89 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -29.61 11.36 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 118.529 -0.748 . . . . 0.91000000000000003 112.515 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -39.15 -55.94 1.55 Allowed 'General case' 0 C--N 1.352 0.713 0 CA-C-O 124.907 2.289 . . . . 0.91000000000000003 109.189 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 201' ' ' GLU . 1.6 pm0 -75.09 176.38 7.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-O 125.474 2.559 . . . . 0.91000000000000003 112.379 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.11 90.82 3.44 Favored 'General case' 0 C--N 1.369 1.431 0 O-C-N 119.282 -2.136 . . . . 0.56999999999999995 109.638 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -88.63 147.63 24.45 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 114.063 -1.426 . . . . 0.56999999999999995 111.708 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 99.6 m -123.05 121.57 36.37 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-O 124.387 2.041 . . . . 0.56999999999999995 112.429 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.35 133.47 34.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 120.865 -1.147 . . . . 0.56999999999999995 110.588 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' A' ' 207' ' ' SER . 2.2 t-80 78.89 62.79 0.03 OUTLIER 'General case' 0 C--N 1.38 1.909 0 CA-C-O 122.726 1.251 . . . . 0.56999999999999995 110.219 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.7 m 85.09 92.85 0.03 OUTLIER 'General case' 0 C--N 1.381 1.945 0 CA-C-O 123.703 1.716 . . . . 0.56999999999999995 109.057 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.42 110.21 0.5 Allowed Glycine 0 C--N 1.375 2.721 0 O-C-N 120.997 -1.064 . . . . 0.56999999999999995 111.772 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 43.57 -113.26 0.68 Allowed Glycine 0 C--N 1.375 2.73 0 CA-C-O 123.756 1.753 . . . . 0.56999999999999995 111.689 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.697 ' CB ' HD11 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -93.31 126.21 38.31 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 113.599 -1.3 . . . . 0.56999999999999995 112.243 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.827 ' HB2' HD11 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -95.71 151.04 19.72 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.186 -1.37 . . . . 0.56999999999999995 111.885 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -72.75 -38.51 67.35 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 123.518 1.628 . . . . 0.56999999999999995 107.873 -175.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 1.9 t80 -51.79 -46.8 64.33 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 114.242 -1.344 . . . . 0.56999999999999995 110.867 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -54.76 -51.18 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.56999999999999995 110.923 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.659 HG23 HD23 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -64.18 -45.37 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.115 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -59.14 -39.91 83.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 111.074 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 248' ' ' PHE . 1.1 t -65.25 -39.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.118 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -66.31 -49.03 68.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.827 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . 3.4 pt-20 -57.9 -42.26 84.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.91000000000000003 110.904 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.715 HG22 ' CD2' ' A' ' 224' ' ' LEU . 11.7 mt -67.0 -46.17 85.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.56999999999999995 111.16 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.94 -33.67 64.19 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.476 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.411 ' CE1' ' O ' ' A' ' 227' ' ' GLY . 1.5 m-70 -64.31 -40.65 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.56999999999999995 110.872 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.6 t -71.23 -51.04 26.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.815 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.94 HD13 HG21 ' A' ' 145' ' ' THR . 3.3 pp -72.4 -64.89 0.86 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.868 1.062 . . . . 0.56999999999999995 113.868 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.82 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -73.13 169.98 52.5 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-O 124.871 2.373 . . . . 0.56999999999999995 111.493 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.612 ' H ' HD12 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -66.21 -154.73 0.01 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-O 123.727 1.727 . . . . 0.56999999999999995 108.796 -177.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 222' ' ' HIS . . . -53.47 -99.47 0.01 OUTLIER Glycine 0 C--N 1.38 2.982 0 CA-C-O 123.849 1.805 . . . . 0.56999999999999995 111.921 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -112.67 -93.82 0.46 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 119.684 -2.068 . . . . 0.56999999999999995 112.216 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 16.1 p -162.75 -43.85 0.04 OUTLIER 'General case' 0 C--N 1.372 1.563 0 CA-C-N 115.219 -0.9 . . . . 0.56999999999999995 110.666 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 83.84 28.99 0.08 Allowed 'General case' 0 C--N 1.399 2.726 0 CA-C-N 114.189 -1.368 . . . . 0.56999999999999995 114.501 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.3 128.68 2.4 Favored Pre-proline 0 C--N 1.383 2.056 0 CA-C-N 114.459 -1.246 . . . . 0.91000000000000003 108.545 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.42 64.41 7.26 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.909 2.406 . . . . 0.56999999999999995 112.12 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.7 -31.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 121.086 -1.009 . . . . 0.56999999999999995 113.276 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -69.82 120.07 15.01 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-O 123.521 1.629 . . . . 0.56999999999999995 110.41 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 235' ' ' VAL . 40.0 t -58.4 88.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.71 -1.132 . . . . 0.56999999999999995 112.849 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 158.37 -20.74 0.0 OUTLIER 'General case' 0 C--N 1.367 1.361 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 112.488 -176.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 4.0 p90 -50.02 153.03 2.48 Favored Pre-proline 0 N--CA 1.43 -1.459 0 CA-C-O 123.088 1.423 . . . . 0.56999999999999995 111.322 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.67 -47.87 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.331 1.354 . . . . 0.56999999999999995 110.591 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 m -39.6 121.25 1.2 Allowed 'General case' 0 C--N 1.353 0.719 0 CA-C-O 122.725 1.25 . . . . 0.56999999999999995 110.926 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.697 ' HE2' HD13 ' A' ' 181' ' ' LEU . 36.2 t80 -68.18 162.52 24.7 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.355 -1.293 . . . . 0.56999999999999995 108.113 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 14.4 tttt 167.4 124.22 0.01 OUTLIER 'General case' 0 C--N 1.373 1.618 0 CA-C-O 123.064 1.411 . . . . 0.56999999999999995 108.112 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -74.77 120.11 19.87 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-O 122.898 1.332 . . . . 0.56999999999999995 111.325 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.5 p -138.18 115.6 12.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.239 0 CA-C-N 115.166 -0.925 . . . . 0.56999999999999995 108.891 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -41.47 142.36 0.61 Allowed 'General case' 0 C--N 1.366 1.31 0 CA-C-O 124.052 1.882 . . . . 0.91000000000000003 109.53 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 211' ' ' ASN . 15.4 mt -65.96 -22.29 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 112.209 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -17.04 61.98 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.126 0.965 . . . . 0.56999999999999995 111.387 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.7 p -112.18 8.25 19.81 Favored 'General case' 0 C--N 1.371 1.519 0 CA-C-O 122.654 1.216 . . . . 0.56999999999999995 113.376 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.559 ' CE1' HG11 ' A' ' 217' ' ' VAL . 45.0 t80 -77.16 88.49 3.63 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-O 124.193 1.949 . . . . 0.56999999999999995 108.577 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.522 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -112.42 153.56 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 O-C-N 120.678 -1.263 . . . . 1.2 110.32 177.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.77 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -119.98 129.36 54.25 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 124.331 2.015 . . . . 0.56999999999999995 107.934 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 143.91 55.51 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 119.659 -1.901 . . . . 0.56999999999999995 112.25 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.68 89.61 Favored 'General case' 0 C--N 1.382 1.98 0 CA-C-N 114.663 -1.153 . . . . 0.56999999999999995 109.428 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.17 -40.71 94.92 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.796 -0.638 . . . . 0.91000000000000003 110.882 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.406 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 26.8 t70 -64.29 -54.92 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.91000000000000003 110.849 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.1 -34.79 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.081 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.451 ' N ' HG13 ' A' ' 255' ' ' ILE . 37.3 mtp180 -62.84 -43.47 98.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.934 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.57 -57.52 12.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.547 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.473 HG13 ' N ' ' A' ' 259' ' ' GLN . 28.4 pt -46.62 -44.2 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.56999999999999995 111.224 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 258' ' ' ILE . 2.6 pt20 -72.02 -26.75 62.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.428 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 32.1 t . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 122.594 1.187 . . . . 0.56999999999999995 110.441 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 123.112 1.434 . . . . 1.2 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.49 ' O ' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -153.17 -44.83 0.1 Allowed 'General case' 0 C--N 1.374 1.659 0 CA-C-N 113.081 -1.872 . . . . 0.56999999999999995 111.037 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -78.25 -30.86 48.89 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 113.468 -1.696 . . . . 0.56999999999999995 109.983 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.625 ' C ' HD13 ' A' ' 114' ' ' ILE . 39.6 t80 -112.02 109.12 18.7 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 114.26 -1.336 . . . . 0.56999999999999995 110.903 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.625 HD13 ' C ' ' A' ' 113' ' ' TYR . 1.9 mm -102.22 155.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 111.13 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -114.36 149.5 36.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 111.106 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.1 t80 -145.86 156.57 43.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -154.54 132.17 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.936 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.74 146.32 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.137 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.667 ' OD1' HG22 ' A' ' 162' ' ' VAL . 55.5 t30 -53.4 -60.44 3.3 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 117.651 -1.619 . . . . 0.56999999999999995 107.454 -167.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 159.21 31.08 0.0 OUTLIER 'General case' 0 C--N 1.383 2.024 0 O-C-N 126.474 2.359 . . . . 0.56999999999999995 109.567 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HB3' ' CG ' ' A' ' 127' ' ' ARG . 0.4 OUTLIER 77.18 92.16 0.07 Allowed 'General case' 0 C--N 1.409 3.162 0 N-CA-C 105.461 -2.052 . . . . 0.56999999999999995 105.461 164.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -49.43 163.82 0.35 Allowed Pre-proline 0 C--N 1.383 2.041 0 CA-C-N 111.993 -2.367 . . . . 0.56999999999999995 108.548 -168.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.23 -47.92 11.1 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 115.692 -0.503 . . . . 0.56999999999999995 112.537 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.661 ' H ' HG23 ' A' ' 122' ' ' THR . 0.2 OUTLIER -82.46 -63.72 1.32 Allowed 'General case' 0 C--N 1.386 2.153 0 N-CA-C 104.32 -2.474 . . . . 0.91000000000000003 104.32 -163.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.819 ' SD ' HG22 ' A' ' 130' ' ' VAL . 5.0 ttm -53.37 154.48 3.35 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-O 125.141 2.4 . . . . 0.56999999999999995 108.219 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -87.54 137.74 32.07 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 112.79 -2.005 . . . . 0.56999999999999995 110.125 -177.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.03 -49.43 70.19 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 115.116 -0.947 . . . . 1.2 108.579 -170.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.07 -35.24 64.33 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 126.838 2.586 . . . . 0.91000000000000003 110.98 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -70.7 -42.26 70.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.91000000000000003 110.883 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.819 HG22 ' SD ' ' A' ' 125' ' ' MET . 2.5 t -63.13 -47.68 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.1 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.462 ' HA ' HD11 ' A' ' 134' ' ' ILE . 7.7 t70 -60.12 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.91000000000000003 110.872 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.37 -41.44 97.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.927 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.679 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -63.23 -49.08 75.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.56999999999999995 111.125 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 131' ' ' ASP . 18.1 pt -64.76 -39.22 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.144 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -58.85 -49.11 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.813 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.79 -34.87 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.888 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -64.62 -45.15 88.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.12 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m-85 -63.52 -36.85 85.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.91 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.446 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 8.2 tt0 -66.38 -39.19 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.56999999999999995 110.935 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.811 ' CG1' HD11 ' A' ' 250' ' ' LEU . 28.9 t -69.51 -34.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.152 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CG ' HD11 ' A' ' 224' ' ' LEU . 4.8 m95 -82.93 -34.13 26.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.977 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.7 m -78.66 -48.11 15.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.905 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -61.02 -12.72 12.52 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 121.892 0.853 . . . . 0.56999999999999995 111.844 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 255' ' ' ILE . 18.9 m -114.48 11.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.378 1.842 0 CA-C-N 113.892 -1.504 . . . . 0.56999999999999995 112.898 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.594 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -150.67 150.45 28.35 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-O 125.381 2.515 . . . . 0.56999999999999995 110.264 -173.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.81 -24.54 4.06 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 O-C-N 118.133 -1.562 . . . . 0.56999999999999995 113.054 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -75.94 111.48 11.35 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-O 124.534 2.112 . . . . 0.56999999999999995 107.487 -176.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 156.8 38.79 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 114.687 172.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.658 ' HE2' HD12 ' A' ' 159' ' ' ILE . 1.1 m-85 -128.04 160.01 33.27 Favored 'General case' 0 C--N 1.376 1.723 0 CA-C-N 112.526 -2.125 . . . . 0.56999999999999995 109.441 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.0 m -157.92 114.71 2.9 Favored 'General case' 0 C--N 1.389 2.29 0 CA-C-O 124.855 2.264 . . . . 0.56999999999999995 109.344 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -95.3 129.17 42.53 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.106 -1.861 . . . . 0.56999999999999995 110.69 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 154' ' ' THR . 2.8 pt -105.89 137.07 37.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.406 0 CA-C-O 124.681 2.182 . . . . 0.56999999999999995 111.361 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -46.29 71.27 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 110.533 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 152' ' ' ILE . 29.0 p -121.41 171.92 8.43 Favored 'General case' 0 C--N 1.379 1.875 0 CA-C-N 113.361 -1.745 . . . . 0.56999999999999995 110.143 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.08 -119.91 6.68 Favored Glycine 0 C--N 1.382 3.11 0 N-CA-C 109.514 -1.434 . . . . 0.56999999999999995 109.514 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 ttt -165.46 108.72 0.82 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-O 123.389 1.566 . . . . 0.56999999999999995 109.759 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.765 ' O ' HD13 ' A' ' 160' ' ' LEU . . . -106.03 143.58 33.96 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 112.722 -2.035 . . . . 0.56999999999999995 110.462 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -44.98 -51.22 10.08 Favored 'General case' 0 C--N 1.374 1.665 0 CA-C-N 116.001 -0.545 . . . . 0.91000000000000003 110.356 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.658 HD12 ' HE2' ' A' ' 149' ' ' PHE . 18.6 mt -90.17 109.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.386 2.169 0 O-C-N 128.124 3.39 . . . . 0.56999999999999995 111.116 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -106.97 132.06 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.957 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.408 HG21 ' OE2' ' A' ' 219' ' ' GLU . 2.1 t -120.6 118.14 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.126 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.667 HG22 ' OD1' ' A' ' 119' ' ' ASN . 69.5 t -133.08 146.02 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 111.166 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -92.07 121.66 33.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.834 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.01 168.8 18.86 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-O 123.445 1.593 . . . . 0.56999999999999995 109.829 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 200' ' ' ASP . 0.2 OUTLIER -115.73 169.78 8.95 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 114.974 -1.012 . . . . 1.2 110.531 177.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.35 139.18 2.46 Favored Glycine 0 C--N 1.383 3.152 0 O-C-N 126.202 2.189 . . . . 0.56999999999999995 111.517 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.68 57.69 0.84 Allowed 'General case' 0 C--N 1.4 2.777 0 CA-C-O 125.475 2.56 . . . . 0.56999999999999995 110.585 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 . . . . . 0 C--N 1.375 1.681 0 CA-C-N 112.39 -2.187 . . . . 0.56999999999999995 110.34 -179.363 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.375 0 CA-C-O 121.85 0.833 . . . . 0.56999999999999995 111.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 180' ' ' ILE . 9.7 m-85 -92.94 179.58 5.41 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-N 111.823 -2.444 . . . . 0.56999999999999995 111.184 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.422 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -86.7 -175.82 5.56 Favored 'General case' 0 C--N 1.382 2.014 0 CA-C-N 113.724 -1.58 . . . . 0.91000000000000003 113.009 173.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . -147.96 142.68 10.32 Favored Glycine 0 C--N 1.39 3.563 0 O-C-N 126.337 2.273 . . . . 0.56999999999999995 110.482 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.72 25.02 2.61 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 113.025 -1.587 . . . . 0.56999999999999995 113.086 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.78 -132.65 4.34 Favored Glycine 0 C--N 1.372 2.564 0 CA-C-O 116.679 -2.178 . . . . 0.56999999999999995 112.69 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.96 -109.67 1.58 Allowed Glycine 0 C--N 1.38 3.008 0 O-C-N 125.409 1.3 . . . . 0.56999999999999995 111.405 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 174' ' ' PHE . 9.3 mt -73.77 166.5 2.65 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 N-CA-C 115.332 1.604 . . . . 0.56999999999999995 115.332 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG23 ' A' ' 215' ' ' THR . 1.1 tp -118.54 -41.4 2.82 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 119.962 -1.711 . . . . 0.56999999999999995 110.129 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB2' ' HD1' ' A' ' 197' ' ' PHE . . . -175.95 179.9 1.26 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.893 -1.503 . . . . 0.56999999999999995 111.089 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 1.2 p80 -165.78 135.85 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 110.849 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -139.43 162.51 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.08 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.7 -171.0 1.74 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.337 -0.945 . . . . 0.56999999999999995 111.05 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -145.66 -76.2 0.03 OUTLIER Glycine 0 C--N 1.377 2.843 0 C-N-CA 119.385 -1.388 . . . . 0.56999999999999995 110.551 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.47 75.73 4.91 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.019 1.812 . . . . 0.56999999999999995 111.465 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -148.11 13.97 1.29 Allowed Glycine 0 C--N 1.367 2.288 0 C-N-CA 118.574 -1.774 . . . . 0.56999999999999995 111.926 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 57.28 -93.19 0.04 OUTLIER 'General case' 0 C--N 1.388 2.278 0 O-C-N 125.549 1.382 . . . . 0.56999999999999995 110.424 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -62.56 -71.56 0.8 Allowed Glycine 0 C--N 1.389 3.477 0 CA-C-N 114.69 -1.141 . . . . 0.56999999999999995 112.33 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -31.65 53.79 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 CA-C-O 124.686 2.184 . . . . 0.56999999999999995 108.915 -176.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.76 140.66 43.66 Favored Glycine 0 C--N 1.376 2.787 0 N-CA-C 107.783 -2.127 . . . . 0.56999999999999995 107.783 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.42 -38.84 2.97 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-N 113.869 -1.165 . . . . 0.56999999999999995 113.883 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -48.32 150.97 1.13 Allowed 'General case' 0 C--N 1.392 2.416 0 CA-C-N 113.417 -1.391 . . . . 0.91000000000000003 110.907 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -144.09 145.86 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 111.077 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -121.68 134.48 54.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.56999999999999995 110.826 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.546 ' HD1' ' HB2' ' A' ' 182' ' ' ALA . 29.0 m-85 -103.94 144.28 31.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.892 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 75.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.808 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -56.65 18.1 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 108.211 -1.033 . . . . 0.91000000000000003 108.211 -175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -40.4 -45.55 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.903 1.377 . . . . 0.91000000000000003 110.692 -176.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.29 172.64 0.13 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 126.669 3.128 . . . . 0.91000000000000003 113.178 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.71 102.63 10.67 Favored 'General case' 0 C--N 1.376 1.756 0 CA-C-N 111.975 -2.375 . . . . 0.56999999999999995 114.119 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -92.28 150.36 20.91 Favored 'General case' 0 C--N 1.361 1.1 0 CA-C-N 112.946 -1.934 . . . . 0.56999999999999995 108.675 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.47 122.09 42.79 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 123.751 1.739 . . . . 0.56999999999999995 109.032 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -89.41 131.87 35.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 112.169 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 78.81 -148.33 0.02 OUTLIER 'General case' 0 C--N 1.395 2.572 0 O-C-N 125.362 1.664 . . . . 0.56999999999999995 110.492 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.466 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 1.6 t -60.72 93.27 0.03 OUTLIER 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.612 2.148 . . . . 0.56999999999999995 109.281 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -174.38 -34.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.29 0 CA-C-N 112.359 -2.2 . . . . 0.56999999999999995 113.407 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 242' ' ' TYR . . . 141.73 -112.97 0.79 Allowed Glycine 0 C--N 1.387 3.41 0 CA-C-O 123.378 1.543 . . . . 0.56999999999999995 111.81 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 242' ' ' TYR . 26.5 p -82.11 117.68 22.47 Favored 'General case' 0 C--N 1.369 1.427 0 CA-C-N 114.27 -0.965 . . . . 0.56999999999999995 110.23 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.75 176.87 4.92 Favored 'General case' 0 C--N 1.374 1.655 0 O-C-N 126.72 2.512 . . . . 0.56999999999999995 110.75 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.5 tm? -70.55 -33.81 71.53 Favored 'General case' 0 C--N 1.382 2.006 0 CA-C-N 113.803 -1.544 . . . . 0.56999999999999995 107.629 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.991 ' O ' HG23 ' A' ' 217' ' ' VAL . 27.5 t80 -57.53 -50.13 74.08 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.376 -1.453 . . . . 0.56999999999999995 110.871 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -59.38 -51.41 70.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.847 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.857 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.78 -32.66 72.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 111.098 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 220' ' ' ILE . . . -68.35 -46.12 70.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.56999999999999995 111.058 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 213' ' ' PHE . 20.1 t -63.33 -39.28 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.142 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.95 -46.27 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.879 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 220' ' ' ILE . 3.0 pt-20 -60.91 -44.52 97.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.91000000000000003 110.837 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.821 HD11 ' HB1' ' A' ' 137' ' ' ALA . 10.1 pt -71.67 -32.82 46.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.235 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -65.17 -34.93 90.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.56999999999999995 112.453 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.84 -42.07 97.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.56999999999999995 110.908 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.9 m -70.95 -36.81 72.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.897 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.718 HD12 ' HA2' ' A' ' 221' ' ' GLY . 29.6 mt -40.64 -60.49 1.13 Allowed 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 123.443 1.592 . . . . 0.56999999999999995 112.296 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.48 -30.38 0.17 Allowed Glycine 0 C--N 1.392 3.654 0 C-N-CA 118.403 -1.856 . . . . 0.56999999999999995 112.404 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.769 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -82.81 160.24 22.28 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-N 112.396 -1.902 . . . . 0.56999999999999995 112.558 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.441 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -83.56 -151.93 12.36 Favored Glycine 0 C--N 1.382 3.088 0 CA-C-O 123.96 1.867 . . . . 0.56999999999999995 110.61 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -65.28 -97.81 0.0 OUTLIER 'General case' 0 C--N 1.38 1.911 0 CA-C-N 113.162 -1.519 . . . . 0.56999999999999995 113.484 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 97.0 p -174.3 -32.99 0.01 OUTLIER 'General case' 0 C--N 1.373 1.604 0 C-N-CA 118.498 -1.281 . . . . 0.56999999999999995 108.916 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.25 5.2 0.85 Allowed 'General case' 0 C--N 1.401 2.826 0 O-C-N 125.862 1.976 . . . . 0.56999999999999995 114.663 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -135.65 140.51 34.08 Favored Pre-proline 0 C--N 1.382 2.009 0 N-CA-C 104.608 -2.367 . . . . 0.91000000000000003 104.608 -169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.83 17.64 1.6 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 C-N-CA 123.568 2.845 . . . . 0.56999999999999995 113.534 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 -0.29 5.52 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 114.109 -1.405 . . . . 0.56999999999999995 113.729 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -99.3 124.14 44.16 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.709 1.719 . . . . 0.56999999999999995 112.639 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.1 t -60.55 87.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.233 0 CA-C-N 113.927 -1.488 . . . . 0.56999999999999995 113.381 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.441 ' HE2' ' O ' ' A' ' 227' ' ' GLY . 3.3 mmm 159.62 -23.94 0.0 OUTLIER 'General case' 0 C--N 1.368 1.411 0 O-C-N 125.045 1.466 . . . . 0.56999999999999995 111.77 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 5.3 p90 -51.86 153.87 4.09 Favored Pre-proline 0 C--N 1.369 1.432 0 CA-C-O 123.755 1.74 . . . . 0.56999999999999995 111.999 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.99 -25.22 7.67 Favored 'Trans proline' 0 C--N 1.368 1.596 0 CA-C-O 117.773 -1.011 . . . . 0.56999999999999995 112.304 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.2 m -41.06 113.67 0.41 Allowed 'General case' 0 C--N 1.368 1.391 0 CA-C-O 124.016 1.865 . . . . 0.56999999999999995 110.337 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 181' ' ' LEU . 4.7 t80 -80.47 106.25 12.34 Favored 'General case' 0 C--N 1.369 1.453 0 N-CA-C 106.241 -1.763 . . . . 0.56999999999999995 106.241 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -154.73 107.56 2.8 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 124.772 2.225 . . . . 0.56999999999999995 107.095 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 210' ' ' THR . 50.1 p90 -61.62 118.03 6.55 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 126.09 2.852 . . . . 0.56999999999999995 111.633 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 245' ' ' ILE . 2.5 p -101.97 -19.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.05 -1.886 . . . . 0.56999999999999995 112.627 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 72.87 4.59 5.01 Favored 'General case' 0 C--N 1.365 1.277 0 O-C-N 126.303 2.252 . . . . 0.91000000000000003 113.531 -179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.0 mt 79.59 7.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.376 1.737 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 115.054 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -35.16 73.88 Favored 'General case' 0 C--N 1.39 2.354 0 N-CA-C 105.107 -2.182 . . . . 0.56999999999999995 105.107 -165.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.47 -22.79 8.57 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-N 112.394 -2.185 . . . . 0.56999999999999995 113.087 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 235' ' ' VAL . 13.2 t80 -40.94 99.85 0.02 OUTLIER 'General case' 0 C--N 1.382 1.994 0 O-C-N 125.729 1.893 . . . . 0.56999999999999995 110.326 -175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -164.64 147.28 8.63 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 112.189 -2.278 . . . . 1.2 106.946 -171.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.811 HD11 ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.99 127.71 55.84 Favored 'General case' 0 C--N 1.372 1.563 0 CA-C-O 124.657 2.17 . . . . 0.56999999999999995 107.511 -173.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.69 158.8 35.5 Favored 'General case' 0 C--N 1.362 1.116 0 O-C-N 120.445 -1.409 . . . . 0.56999999999999995 112.014 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -56.32 -43.64 79.18 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.289 -1.323 . . . . 0.56999999999999995 109.491 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -41.56 95.11 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.021 0.528 . . . . 0.91000000000000003 110.846 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 258' ' ' ILE . 16.2 t0 -63.82 -55.1 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.91000000000000003 110.869 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.91 HG21 HG11 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -65.94 -35.93 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.134 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.64 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 18.1 mtp85 -70.19 -32.3 70.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.88 -44.83 77.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 0.56999999999999995 112.495 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.769 ' HB ' HD12 ' A' ' 226' ' ' LEU . 1.1 pt -66.16 -44.7 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.56999999999999995 111.118 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.483 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -70.77 -20.7 62.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 110.891 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--N 1.36 1.052 0 CA-C-O 123.063 1.411 . . . . 0.56999999999999995 111.35 -178.15 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.051 0 CA-C-O 124.674 2.178 . . . . 1.2 109.034 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.28 -48.75 0.03 OUTLIER 'General case' 0 C--N 1.389 2.284 0 CA-C-N 113.564 -1.653 . . . . 0.56999999999999995 110.838 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.63 -40.03 95.86 Favored 'General case' 0 C--N 1.389 2.291 0 CA-C-N 113.505 -1.68 . . . . 0.56999999999999995 108.35 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.84 103.58 11.57 Favored 'General case' 0 C--N 1.384 2.104 0 O-C-N 125.324 1.64 . . . . 0.56999999999999995 110.88 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.03 154.84 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.158 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -106.03 142.98 34.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.106 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 159' ' ' ILE . 8.3 t80 -140.57 160.07 40.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 110.916 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.52 121.84 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.2 110.824 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.705 HG21 ' CE2' ' A' ' 121' ' ' TYR . 1.2 mm -99.4 138.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 111.146 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -62.57 173.59 1.22 Allowed 'General case' 0 C--N 1.363 1.187 0 CA-C-O 124.324 2.011 . . . . 0.56999999999999995 108.944 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.67 73.31 6.38 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 125.166 2.412 . . . . 0.56999999999999995 109.971 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.705 ' CE2' HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -72.17 -177.53 2.13 Favored 'General case' 0 C--N 1.374 1.648 0 CA-C-N 112.357 -2.201 . . . . 0.56999999999999995 110.467 173.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.465 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER 160.56 -53.4 0.0 OUTLIER Pre-proline 0 C--N 1.38 1.912 0 C-N-CA 125.337 1.455 . . . . 0.56999999999999995 107.809 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 122' ' ' THR . 19.0 Cg_endo -75.36 -72.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.406 3.581 0 N-CA-C 108.022 -1.569 . . . . 0.56999999999999995 108.022 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.86 -7.68 57.02 Favored 'General case' 0 C--N 1.398 2.677 0 CA-C-N 113.131 -1.85 . . . . 0.91000000000000003 106.578 -171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 122' ' ' THR . 6.4 mtm -154.42 136.04 14.33 Favored 'General case' 0 C--N 1.386 2.191 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 109.638 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.2 m-20 -90.98 141.63 28.63 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-O 123.182 1.468 . . . . 0.56999999999999995 109.328 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.426 ' HA ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -64.47 -50.11 68.76 Favored 'General case' 0 C--N 1.384 2.076 0 CA-C-N 114.324 -1.307 . . . . 1.2 109.109 -170.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.25 -35.28 69.54 Favored 'General case' 0 C--N 1.374 1.666 0 CA-C-N 111.992 -2.367 . . . . 0.91000000000000003 110.874 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 205' ' ' THR . 3.6 m-20 -70.33 -43.78 69.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.91000000000000003 110.862 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 126' ' ' ASN . 19.1 t -68.69 -39.74 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.179 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.35 -44.11 97.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.91000000000000003 110.873 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -40.94 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.824 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.98 -49.19 66.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 111.139 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 130' ' ' VAL . 25.2 pt -62.4 -36.9 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 111.167 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -63.72 -43.74 95.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.853 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.84 -46.06 89.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 110.933 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.09 83.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.56999999999999995 111.082 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 3.7 m-85 -62.95 -44.06 97.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.821 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.461 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.2 pt20 -63.45 -36.21 82.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.971 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 136' ' ' LYS . 16.0 t -69.64 -34.2 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.123 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 224' ' ' LEU . 34.1 m95 -83.05 -34.06 26.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.923 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 m -78.99 -51.08 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.916 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.8 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -56.2 -13.96 2.45 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 114.103 1.149 . . . . 0.56999999999999995 114.103 178.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.8 HG13 ' ND2' ' A' ' 143' ' ' ASN . 20.2 m -113.34 -8.77 12.18 Favored 'Isoleucine or valine' 0 C--N 1.389 2.29 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 112.298 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.47 141.93 15.16 Favored Pre-proline 0 C--N 1.383 2.055 0 CA-C-O 125.379 2.514 . . . . 0.56999999999999995 110.14 -172.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 145' ' ' THR . 57.0 Cg_endo -79.7 71.21 7.16 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.138 1.892 . . . . 0.56999999999999995 114.593 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -169.35 83.52 0.13 Allowed 'General case' 0 C--N 1.39 2.328 0 N-CA-C 106.698 -1.593 . . . . 0.56999999999999995 106.698 -168.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -72.37 162.16 29.84 Favored 'General case' 0 C--N 1.383 2.048 0 CA-C-O 125.739 2.685 . . . . 0.56999999999999995 115.672 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' ' O ' ' A' ' 147' ' ' LEU . 2.9 m-85 -136.63 158.9 43.37 Favored 'General case' 0 C--N 1.39 2.354 0 CA-C-N 113.004 -1.907 . . . . 0.56999999999999995 106.09 -172.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -157.48 121.61 4.24 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.879 2.276 . . . . 0.56999999999999995 108.301 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 133.4 37.17 Favored 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.65 -1.613 . . . . 0.56999999999999995 110.513 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 157' ' ' ALA . 6.2 pt -107.18 171.95 2.01 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-O 124.214 1.959 . . . . 0.56999999999999995 110.921 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -141.72 51.65 1.53 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 113.482 -1.69 . . . . 0.56999999999999995 110.566 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 p -117.66 -62.59 1.54 Allowed 'General case' 0 C--N 1.384 2.096 0 CA-C-N 113.479 -1.691 . . . . 0.56999999999999995 109.887 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.68 -152.87 5.73 Favored Glycine 0 C--N 1.381 3.028 0 N-CA-C 108.796 -1.722 . . . . 0.56999999999999995 108.796 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.4 ttp -72.11 110.49 6.62 Favored 'General case' 0 C--N 1.386 2.176 0 CA-C-O 123.705 1.716 . . . . 0.56999999999999995 108.246 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -98.19 177.83 5.27 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.058 -1.883 . . . . 0.56999999999999995 111.186 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.96 -59.38 4.91 Favored 'General case' 0 C--N 1.397 2.645 0 CA-C-N 112.456 -2.156 . . . . 0.91000000000000003 105.233 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 116' ' ' TYR . 6.3 mt -95.79 111.47 26.22 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 C-N-CA 122.942 0.497 . . . . 0.56999999999999995 111.14 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 126.59 51.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.942 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.083 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.556 HG13 ' ND2' ' A' ' 119' ' ' ASN . 3.9 t -133.15 128.94 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 111.134 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -85.0 122.77 29.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.884 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -146.53 170.14 17.5 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 118.812 -1.155 . . . . 0.56999999999999995 108.636 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.91 167.8 9.72 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.69 -1.595 . . . . 1.2 108.842 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -38.1 118.91 0.72 Allowed Glycine 0 C--N 1.389 3.497 0 CA-C-N 114.135 -1.393 . . . . 0.56999999999999995 111.956 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 81.37 63.44 0.02 OUTLIER 'General case' 0 C--N 1.417 3.524 0 CA-C-O 125.469 2.557 . . . . 0.56999999999999995 114.117 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.688 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 22.7 p-80 . . . . . 0 C--N 1.386 2.19 0 CA-C-N 113.12 -1.855 . . . . 0.56999999999999995 111.966 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 123.876 1.798 . . . . 0.56999999999999995 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.549 ' CE2' HG22 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -83.05 -158.98 0.31 Allowed 'General case' 0 C--N 1.388 2.255 0 CA-C-N 112.961 -1.927 . . . . 0.56999999999999995 113.753 173.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.16 173.39 6.32 Favored 'General case' 0 C--N 1.388 2.251 0 CA-C-N 114.627 -1.169 . . . . 0.91000000000000003 111.686 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.51 114.69 0.89 Allowed Glycine 1 C--N 1.4 4.109 0 CA-C-N 111.566 -2.561 . . . . 0.56999999999999995 113.89 166.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER 70.85 82.8 0.15 Allowed 'General case' 0 C--N 1.406 3.037 0 CA-C-O 124.757 2.218 . . . . 0.56999999999999995 113.533 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.51 -155.7 22.05 Favored Glycine 0 C--N 1.376 2.786 0 CA-C-N 114.259 -1.337 . . . . 0.56999999999999995 110.67 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -35.71 149.17 0.03 OUTLIER Glycine 1 C--N 1.403 4.276 0 CA-C-N 113.384 -1.408 . . . . 0.56999999999999995 110.098 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.549 HG22 ' CE2' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 89.28 65.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.399 2.731 0 N-CA-C 108.483 -0.932 . . . . 0.56999999999999995 108.483 175.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.548 HD12 ' OE1' ' A' ' 201' ' ' GLU . 4.3 mp -71.22 -37.45 72.05 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-O 123.448 1.594 . . . . 0.56999999999999995 111.78 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 197' ' ' PHE . . . -174.33 179.84 1.74 Allowed 'General case' 0 C--N 1.364 1.199 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 111.09 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -164.23 142.46 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.874 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.94 167.52 23.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 111.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 191' ' ' ILE . 2.3 m-85 -77.02 -87.1 0.05 OUTLIER 'General case' 0 C--N 1.372 1.562 0 C-N-CA 117.749 -1.58 . . . . 0.56999999999999995 108.699 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 193' ' ' GLY . . . 120.12 -61.22 0.51 Allowed Glycine 0 C--N 1.397 3.956 0 C-N-CA 119.848 -1.168 . . . . 0.56999999999999995 112.836 -175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.91 56.13 5.22 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.142 2.561 . . . . 0.56999999999999995 111.774 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' HA3' ' A' ' 192' ' ' GLY . . . 47.66 -154.79 1.22 Allowed Glycine 0 C--N 1.39 3.536 0 CA-C-O 123.579 1.655 . . . . 0.56999999999999995 111.265 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.76 57.61 0.01 OUTLIER 'General case' 0 C--N 1.387 2.228 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 106.524 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.79 -88.92 0.37 Allowed Glycine 0 C--N 1.398 3.996 0 O-C-N 120.692 -1.255 . . . . 0.56999999999999995 110.008 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.468 HG21 ' CZ ' ' A' ' 185' ' ' PHE . 1.7 tp -62.2 0.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.165 0 CA-C-O 124.964 2.316 . . . . 0.56999999999999995 113.854 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 188' ' ' GLY . . . -73.37 117.21 5.77 Favored Glycine 0 C--N 1.393 3.737 0 C-N-CA 117.384 -2.341 . . . . 0.56999999999999995 107.283 -169.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 186' ' ' GLY . . . 109.35 -44.73 1.44 Allowed Glycine 0 C--N 1.373 2.584 0 O-C-N 124.871 0.983 . . . . 0.56999999999999995 114.123 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.68 113.4 0.89 Allowed 'General case' 0 C--N 1.385 2.123 0 CA-C-N 115.358 -0.421 . . . . 0.91000000000000003 110.841 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -111.68 156.82 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 111.111 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -130.17 131.9 45.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.859 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 215' ' ' THR . 2.4 m-85 -104.04 148.51 26.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 110.944 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.0 p-10 -89.97 102.46 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.91000000000000003 110.853 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -36.55 64.42 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 116.912 -1.518 . . . . 0.91000000000000003 109.3 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -45.5 -40.96 9.09 Favored 'General case' 0 C--N 1.376 1.761 0 O-C-N 125.366 1.666 . . . . 0.91000000000000003 107.507 -163.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.548 ' OE1' HD12 ' A' ' 181' ' ' LEU . 12.4 mt-10 -56.48 -173.28 0.01 OUTLIER 'General case' 0 C--N 1.391 2.378 0 CA-C-O 128.143 3.83 . . . . 0.91000000000000003 114.439 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.4 77.44 1.57 Allowed 'General case' 0 C--N 1.379 1.865 0 O-C-N 118.091 -2.88 . . . . 0.56999999999999995 108.941 -172.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.493 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 52.1 m95 -72.82 115.45 12.13 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-O 122.64 1.21 . . . . 0.56999999999999995 108.317 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.3 p -123.89 128.02 48.86 Favored 'General case' 0 C--N 1.384 2.094 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 109.425 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' ASP . 5.1 p -116.2 105.94 13.14 Favored 'General case' 0 C--N 1.369 1.424 0 CA-C-O 122.939 1.352 . . . . 0.56999999999999995 108.724 -176.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 172.5 -51.94 0.01 OUTLIER 'General case' 0 C--N 1.395 2.568 0 CA-C-N 112.877 -1.965 . . . . 0.56999999999999995 107.099 175.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 158.66 50.72 0.0 OUTLIER 'General case' 0 C--N 1.412 3.316 0 O-C-N 126.315 2.259 . . . . 0.56999999999999995 110.172 -171.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.16 -108.46 2.69 Favored Glycine 0 C--N 1.393 3.74 0 C-N-CA 118.16 -1.972 . . . . 0.56999999999999995 113.681 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.97 -91.49 2.21 Favored Glycine 0 C--N 1.397 3.957 0 CA-C-O 124.857 2.365 . . . . 0.56999999999999995 112.792 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 p -73.89 117.5 15.75 Favored 'General case' 0 C--N 1.384 2.088 0 CA-C-O 123.847 1.784 . . . . 0.56999999999999995 111.454 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -111.15 150.26 29.72 Favored 'General case' 0 C--N 1.388 2.279 0 CA-C-N 112.307 -2.224 . . . . 0.56999999999999995 110.13 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.6 tm? -73.45 -32.7 64.51 Favored 'General case' 0 C--N 1.394 2.505 0 CA-C-O 124.412 2.053 . . . . 0.56999999999999995 108.858 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.707 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.7 t80 -52.28 -50.08 62.84 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 112.678 -2.056 . . . . 0.56999999999999995 110.848 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 214' ' ' LEU . 0.1 OUTLIER -62.29 -43.61 98.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.924 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.608 HG21 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -61.27 -49.36 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.56999999999999995 111.19 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.2 73.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.107 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.761 HG11 ' HE1' ' A' ' 248' ' ' PHE . 53.3 t -64.48 -48.18 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.143 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -71.57 -43.21 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.867 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -57.91 -42.14 84.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.91000000000000003 110.877 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.46 HG21 ' CD1' ' A' ' 141' ' ' TRP . 57.7 mt -69.61 -39.78 78.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.56999999999999995 111.187 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.471 ' C ' ' HE3' ' A' ' 236' ' ' MET . . . -61.46 -33.78 85.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.465 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.603 ' N ' ' HE3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -63.85 -44.28 93.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.353 . . . . 0.56999999999999995 110.813 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' LEU . 71.1 m -71.27 -44.5 65.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 110.864 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -36.38 -47.79 0.62 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 119.771 -0.772 . . . . 0.56999999999999995 112.557 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.13 -106.47 0.22 Allowed Glycine 1 C--N 1.398 4.026 0 O-C-N 126.699 2.499 . . . . 0.56999999999999995 112.061 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.01 172.78 0.01 OUTLIER 'General case' 0 C--N 1.395 2.559 0 CA-C-O 125.726 2.679 . . . . 0.56999999999999995 112.554 173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.35 -120.91 0.02 OUTLIER Glycine 0 C--N 1.392 3.665 0 CA-C-O 126.133 3.074 . . . . 0.56999999999999995 110.677 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -123.96 -76.19 0.59 Allowed 'General case' 0 C--N 1.391 2.382 0 CA-C-N 112.258 -1.971 . . . . 0.56999999999999995 108.375 -174.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -177.36 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.754 -1.567 . . . . 0.56999999999999995 108.373 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.06 23.48 0.31 Allowed 'General case' 0 C--N 1.422 3.727 0 N-CA-C 118.925 2.935 . . . . 0.56999999999999995 118.925 -171.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -137.65 143.29 39.96 Favored Pre-proline 0 C--N 1.398 2.703 0 C-N-CA 116.348 -2.141 . . . . 0.91000000000000003 106.086 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 71.7 Cg_exo -54.97 -41.11 81.94 Favored 'Trans proline' 0 C--N 1.375 1.93 0 CA-C-O 124.724 1.885 . . . . 0.56999999999999995 114.09 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -41.91 86.18 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-N 111.61 -2.541 . . . . 0.56999999999999995 113.492 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -50.82 125.21 12.79 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-O 125.317 2.484 . . . . 0.56999999999999995 111.82 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 235' ' ' VAL . 0.4 OUTLIER -76.03 -1.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.386 2.154 0 CA-C-N 112.473 -2.149 . . . . 0.56999999999999995 112.504 -177.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.603 ' HE3' ' N ' ' A' ' 222' ' ' HIS . 0.8 OUTLIER -124.62 -5.49 7.58 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-N 114.056 -1.429 . . . . 0.56999999999999995 109.03 -177.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.771 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -40.57 148.2 0.36 Allowed Pre-proline 0 C--N 1.376 1.753 0 CA-C-O 125.22 2.438 . . . . 0.56999999999999995 113.951 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.57 -48.85 19.68 Favored 'Trans proline' 0 C--N 1.381 2.289 0 O-C-N 118.824 -1.198 . . . . 0.56999999999999995 113.7 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.486 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -51.74 135.13 29.82 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-O 125.012 2.339 . . . . 0.56999999999999995 110.959 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.66 142.57 34.09 Favored 'General case' 0 C--N 1.386 2.154 0 CA-C-O 123.106 1.431 . . . . 0.56999999999999995 107.362 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -158.28 114.56 2.77 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-O 124.515 2.102 . . . . 0.56999999999999995 108.453 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -55.25 118.57 4.5 Favored 'General case' 0 C--N 1.368 1.398 0 CA-C-O 126.433 3.016 . . . . 0.56999999999999995 108.861 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 243' ' ' VAL . 2.6 p -125.41 -13.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 CA-C-N 112.498 -2.137 . . . . 0.56999999999999995 111.062 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.266 0.7 OUTLIER 70.53 4.36 4.92 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-O 123.153 1.454 . . . . 0.91000000000000003 112.811 176.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 213' ' ' PHE . 2.0 mt 77.88 4.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.394 2.533 0 CA-C-N 113.347 -1.751 . . . . 0.56999999999999995 114.315 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.11 -33.17 69.89 Favored 'General case' 0 C--N 1.379 1.85 0 N-CA-C 104.593 -2.373 . . . . 0.56999999999999995 104.593 -163.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -112.7 -16.65 12.74 Favored 'General case' 0 C--N 1.39 2.365 0 CA-C-N 112.739 -2.028 . . . . 0.56999999999999995 113.107 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.761 ' HE1' HG11 ' A' ' 217' ' ' VAL . 19.2 t80 -38.86 99.46 0.02 OUTLIER 'General case' 0 C--N 1.388 2.28 0 CA-C-O 126.034 2.826 . . . . 0.56999999999999995 109.319 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -133.09 149.12 52.16 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-N 112.18 -2.282 . . . . 1.2 105.374 -175.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.09 130.38 56.11 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 126.7 3.143 . . . . 0.56999999999999995 107.325 -173.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.87 145.43 42.75 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 117.99 -2.944 . . . . 0.56999999999999995 110.606 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.05 86.43 Favored 'General case' 0 C--N 1.4 2.797 0 CA-C-N 113.676 -1.602 . . . . 0.56999999999999995 110.416 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -35.74 81.1 Favored 'General case' 0 C--N 1.367 1.342 0 CA-C-N 114.874 -1.057 . . . . 0.91000000000000003 110.802 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 t70 -63.36 -55.29 25.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.91000000000000003 110.854 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.0 pt -66.04 -36.56 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.168 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 34.7 mtt180 -70.3 -34.1 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 1.2 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.29 -47.52 79.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.56999999999999995 112.511 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.35 -45.46 95.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.56999999999999995 111.163 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.685 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.3 -21.03 61.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.933 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.369 1.435 0 CA-C-O 125.154 2.407 . . . . 0.56999999999999995 110.22 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 123.712 1.72 . . . . 1.2 109.368 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.53 -49.84 0.02 OUTLIER 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.851 -1.522 . . . . 0.56999999999999995 110.646 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -98.21 -8.55 27.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 112.98 -1.918 . . . . 0.56999999999999995 111.091 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -114.56 112.76 23.45 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.169 -0.923 . . . . 0.56999999999999995 110.872 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.11 138.19 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.119 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.855 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -109.26 135.27 50.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.56999999999999995 111.109 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -129.81 150.9 50.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.888 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -143.52 129.88 19.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.2 110.903 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.51 HD12 ' HZ ' ' A' ' 163' ' ' PHE . 2.0 mm -99.03 130.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.169 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' ND2' HD13 ' A' ' 160' ' ' LEU . 24.6 m-20 -118.89 131.67 56.07 Favored 'General case' 0 C--N 1.368 1.385 0 N-CA-C 107.636 -1.246 . . . . 0.56999999999999995 107.636 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.3 t30 50.41 81.13 0.07 Allowed 'General case' 0 C--N 1.391 2.401 0 O-C-N 126.527 2.392 . . . . 0.56999999999999995 109.587 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 163' ' ' PHE . 22.6 m-85 -37.73 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.391 2.395 0 O-C-N 126.721 2.513 . . . . 0.56999999999999995 109.514 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.55 HG23 ' HD2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 175.0 135.14 0.16 Allowed Pre-proline 0 C--N 1.371 1.522 0 C-N-CA 118.285 -1.366 . . . . 0.56999999999999995 108.355 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 122' ' ' THR . 36.6 Cg_endo -78.17 -52.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-O 122.341 0.892 . . . . 0.56999999999999995 110.938 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -77.22 -33.29 56.19 Favored 'General case' 0 C--N 1.388 2.256 0 CA-C-N 113.937 -1.483 . . . . 0.91000000000000003 114.486 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.524 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -94.38 134.24 37.09 Favored 'General case' 0 C--N 1.374 1.663 0 CA-C-O 125.747 2.689 . . . . 0.56999999999999995 106.002 -173.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.53 139.7 53.83 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 110.555 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -48.63 37.6 Favored 'General case' 0 C--N 1.378 1.821 0 N-CA-C 106.918 -1.512 . . . . 1.2 106.918 -169.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -35.26 62.33 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.788 -2.005 . . . . 0.91000000000000003 110.89 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.04 -43.15 71.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.91000000000000003 110.869 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.4 t -63.42 -37.94 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.56999999999999995 111.082 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.411 ' OD1' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -68.51 -40.36 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.91000000000000003 110.847 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' CE ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -65.29 -41.8 93.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.56999999999999995 110.877 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.842 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.23 -49.12 73.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 111.111 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.411 HD11 ' OD1' ' A' ' 131' ' ' ASP . 22.7 pt -62.55 -40.16 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.178 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -60.59 -43.39 97.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 1.2 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -62.92 -43.4 98.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.873 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 140' ' ' VAL . . . -61.59 -39.65 91.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.117 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.488 ' CE1' ' CE2' ' A' ' 116' ' ' TYR . 17.3 m-85 -67.17 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.917 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -67.66 -40.49 84.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.56999999999999995 110.909 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.0 p -71.46 -33.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.16 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.746 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 5.1 m95 -82.59 -34.04 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 m -79.21 -49.18 12.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.56999999999999995 110.817 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.794 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.36 -13.3 7.79 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-O 121.804 0.811 . . . . 0.56999999999999995 112.564 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.794 HG13 ' ND2' ' A' ' 143' ' ' ASN . 19.8 m -113.91 12.77 8.19 Favored 'Isoleucine or valine' 0 C--N 1.382 2.022 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.028 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 141' ' ' TRP . 29.5 p -148.03 146.75 24.46 Favored Pre-proline 0 N--CA 1.428 -1.544 0 CA-C-O 124.132 1.92 . . . . 0.56999999999999995 109.197 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.86 8.74 3.59 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.285 1.323 . . . . 0.56999999999999995 114.449 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.566 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -112.51 110.76 21.13 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 109.117 -177.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.92 158.56 35.24 Favored 'General case' 0 C--N 1.382 1.999 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 114.778 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.566 ' HE1' HD12 ' A' ' 147' ' ' LEU . 15.6 m-30 -126.5 151.37 47.92 Favored 'General case' 0 C--N 1.389 2.314 0 CA-C-N 112.788 -2.005 . . . . 0.56999999999999995 108.675 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.99 110.99 2.66 Favored 'General case' 0 C--N 1.39 2.364 0 CA-C-O 124.653 2.168 . . . . 0.56999999999999995 108.302 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -95.2 133.41 39.08 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 113.776 -1.556 . . . . 0.56999999999999995 110.254 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 155' ' ' GLY . 5.9 pt -117.14 173.78 4.08 Favored 'Isoleucine or valine' 0 C--N 1.372 1.562 0 CA-C-O 124.175 1.941 . . . . 0.56999999999999995 109.957 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -127.2 -2.03 6.37 Favored 'General case' 0 C--N 1.384 2.067 0 CA-C-N 113.175 -1.83 . . . . 0.56999999999999995 112.687 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 m -136.72 89.4 2.45 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 114.583 -1.189 . . . . 0.56999999999999995 108.067 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 152' ' ' ILE . . . 124.29 99.69 1.32 Allowed Glycine 0 C--N 1.386 3.36 0 C-N-CA 118.956 -1.592 . . . . 0.56999999999999995 110.513 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.4 ttp -42.95 118.35 1.25 Allowed 'General case' 0 C--N 1.377 1.804 0 CA-C-O 122.56 1.172 . . . . 0.56999999999999995 111.3 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.855 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -95.34 169.79 9.82 Favored 'General case' 0 C--N 1.381 1.957 0 CA-C-N 113.025 -1.898 . . . . 0.56999999999999995 109.517 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -54.45 23.29 Favored 'General case' 0 C--N 1.386 2.179 0 CA-C-N 113.501 -1.681 . . . . 0.91000000000000003 110.586 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 116' ' ' TYR . 3.5 mt -90.64 109.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.385 2.143 0 O-C-N 127.846 3.216 . . . . 0.56999999999999995 111.127 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -107.98 129.45 55.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.856 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.413 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -115.98 116.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.56999999999999995 111.08 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -133.47 124.88 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.109 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -93.7 121.42 35.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.876 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -145.33 168.01 21.5 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 123.701 1.715 . . . . 0.56999999999999995 108.51 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.71 160.28 16.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.592 -1.262 . . . . 1.2 107.592 -177.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 167' ' ' ALA . . . -39.28 93.87 0.01 OUTLIER Glycine 0 C--N 1.385 3.26 0 O-C-N 125.894 1.997 . . . . 0.56999999999999995 117.401 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . 154.31 45.57 0.0 OUTLIER 'General case' 0 C--N 1.405 2.982 0 CA-C-O 125.734 2.683 . . . . 0.56999999999999995 112.898 -165.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 . . . . . 0 C--N 1.38 1.899 0 CA-C-N 113.416 -1.72 . . . . 0.56999999999999995 109.874 178.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.211 -1.033 . . . . 0.56999999999999995 108.211 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.532 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.5 OUTLIER -50.64 168.54 0.05 OUTLIER 'General case' 0 C--N 1.388 2.277 0 O-C-N 126.7 2.5 . . . . 0.56999999999999995 107.152 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -44.57 163.21 0.02 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 117.904 -1.518 . . . . 0.91000000000000003 112.969 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 200' ' ' ASP . . . -149.53 48.25 0.6 Allowed Glycine 0 C--N 1.388 3.458 0 C-N-CA 117.287 -2.387 . . . . 0.56999999999999995 111.815 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -168.66 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.389 2.323 0 C-N-CA 118.868 -1.133 . . . . 0.56999999999999995 111.336 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -165.3 -61.65 0.02 OUTLIER Glycine 0 C--N 1.392 3.663 0 CA-C-O 125.014 2.452 . . . . 0.56999999999999995 112.852 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -42.84 147.16 0.75 Allowed Glycine 0 C--N 1.376 2.802 0 O-C-N 118.963 -2.493 . . . . 0.56999999999999995 110.24 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.532 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 1.6 mt 84.75 49.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.951 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 214' ' ' LEU . 9.9 tp -42.94 -41.72 3.46 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.876 2.274 . . . . 0.56999999999999995 111.345 -172.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 179.84 -174.31 0.25 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 112.415 -2.175 . . . . 0.56999999999999995 111.047 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -143.95 158.59 43.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.879 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 222' ' ' HIS . . . -151.02 155.19 38.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 0.56999999999999995 111.087 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.407 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 5.4 m-85 -117.44 -179.52 3.75 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 105.249 -2.13 . . . . 0.56999999999999995 105.249 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' O ' ' CA ' ' A' ' 192' ' ' GLY . . . -122.15 -160.11 10.85 Favored Glycine 0 C--N 1.382 3.101 0 C-N-CA 119.795 -1.193 . . . . 0.56999999999999995 111.493 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.44 -65.94 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.831 1.687 . . . . 0.56999999999999995 112.508 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.44 -104.87 0.07 OUTLIER Glycine 0 C--N 1.395 3.858 0 O-C-N 125.605 1.816 . . . . 0.56999999999999995 110.537 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.72 129.3 0.04 OUTLIER 'General case' 0 C--N 1.393 2.478 0 CA-C-N 112.794 -1.703 . . . . 0.56999999999999995 108.886 175.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -95.86 1.64 Allowed Glycine 0 C--N 1.388 3.445 0 CA-C-O 122.773 1.207 . . . . 0.56999999999999995 110.697 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.3 tp -66.85 -11.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.394 2.541 0 CA-C-O 126.845 3.212 . . . . 0.56999999999999995 110.745 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 186' ' ' GLY . . . -66.71 134.34 32.53 Favored Glycine 0 C--N 1.377 2.827 0 N-CA-C 107.12 -2.392 . . . . 0.56999999999999995 107.12 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.407 ' H ' ' CB ' ' A' ' 185' ' ' PHE . . . 96.49 -4.68 64.35 Favored Glycine 0 C--N 1.375 2.704 0 N-CA-C 110.169 -1.172 . . . . 0.56999999999999995 110.169 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.78 141.25 39.35 Favored 'General case' 0 C--N 1.378 1.841 0 CA-C-N 114.221 -0.99 . . . . 0.91000000000000003 110.872 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.03 132.63 22.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.098 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -126.52 143.2 51.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.89 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.527 ' CD2' ' CD1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.55 148.38 26.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.685 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.8 p-10 -81.12 87.89 6.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.91000000000000003 110.854 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -74.26 5.49 4.45 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.615 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 4.1 t0 -78.77 -35.13 44.98 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-O 123.328 1.537 . . . . 0.91000000000000003 109.92 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -73.76 176.87 5.9 Favored 'General case' 0 C--N 1.382 1.998 0 CA-C-O 124.289 1.995 . . . . 0.91000000000000003 108.965 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.53 111.11 23.09 Favored 'General case' 0 C--N 1.391 2.398 0 CA-C-N 112.642 -2.072 . . . . 0.56999999999999995 112.992 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 36.4 m95 -92.62 148.0 22.42 Favored 'General case' 0 C--N 1.382 2.017 0 CA-C-N 113.144 -1.844 . . . . 0.56999999999999995 108.495 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 14.4 m -121.28 104.21 9.55 Favored 'General case' 0 C--N 1.384 2.069 0 CA-C-N 114.143 -1.39 . . . . 0.56999999999999995 107.806 -174.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -103.02 106.91 17.53 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 115.499 -0.773 . . . . 0.56999999999999995 109.864 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 205' ' ' THR . 2.0 t60 169.1 -70.71 0.0 OUTLIER 'General case' 0 C--N 1.392 2.429 0 N-CA-C 106.944 -1.502 . . . . 0.56999999999999995 106.944 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.413 ' C ' ' OD2' ' A' ' 244' ' ' ASP . 4.7 p 150.75 63.19 0.0 OUTLIER 'General case' 0 C--N 1.399 2.731 0 CA-C-O 127.412 3.482 . . . . 0.56999999999999995 110.325 -166.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.18 29.58 0.11 Allowed Glycine 0 C--N 1.394 3.803 0 C-N-CA 116.964 -2.541 . . . . 0.56999999999999995 113.136 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.6 -162.32 35.81 Favored Glycine 0 C--N 1.383 3.144 0 CA-C-O 124.234 2.019 . . . . 0.56999999999999995 110.873 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.443 ' N ' ' HB2' ' A' ' 242' ' ' TYR . 0.9 OUTLIER -77.08 122.26 24.71 Favored 'General case' 0 C--N 1.372 1.58 0 CA-C-O 123.478 1.608 . . . . 0.56999999999999995 107.761 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 245' ' ' ILE . 17.8 p-10 -121.01 -167.77 1.55 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-N 112.84 -1.982 . . . . 0.56999999999999995 111.039 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 133' ' ' ALA . 1.5 tm? -70.2 -33.54 71.83 Favored 'General case' 0 C--N 1.392 2.436 0 CA-C-N 112.901 -1.954 . . . . 0.56999999999999995 109.541 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.734 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 9.8 t80 -51.75 -50.15 61.21 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.909 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -62.86 -51.02 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 110.948 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 219' ' ' GLU . 12.4 m -58.95 -35.65 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.17 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.565 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -67.2 -41.53 85.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.097 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 248' ' ' PHE . 93.7 t -64.15 -46.46 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.094 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -72.36 -49.91 30.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.762 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 215' ' ' THR . 8.2 mm-40 -57.66 -42.5 83.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.91000000000000003 110.927 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 216' ' ' ALA . 60.7 mt -70.32 -43.32 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.814 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -56.82 -33.93 64.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.56999999999999995 112.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -63.75 -41.09 98.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.749 0.309 . . . . 0.56999999999999995 110.823 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -71.26 -44.36 65.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.867 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.814 HD12 ' HA2' ' A' ' 221' ' ' GLY . 84.3 mt -42.89 -62.54 0.99 Allowed 'General case' 0 C--N 1.365 1.248 0 CA-C-O 123.829 1.776 . . . . 0.56999999999999995 112.148 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 226' ' ' LEU . . . 169.6 134.65 1.77 Allowed Glycine 0 C--N 1.374 2.694 0 N-CA-C 107.774 -2.131 . . . . 0.56999999999999995 107.774 175.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 225' ' ' GLY . 0.2 OUTLIER 78.85 -170.54 0.05 OUTLIER 'General case' 0 C--N 1.393 2.494 0 CA-C-O 124.329 2.014 . . . . 0.56999999999999995 109.524 176.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.21 -154.63 10.66 Favored Glycine 0 C--N 1.386 3.318 0 CA-C-O 125.728 2.849 . . . . 0.56999999999999995 112.86 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -93.95 -178.97 4.82 Favored 'General case' 0 C--N 1.376 1.722 0 CA-C-N 111.217 -2.491 . . . . 0.56999999999999995 110.717 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 3.2 p -72.24 -31.59 65.96 Favored 'General case' 0 C--N 1.387 2.236 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 109.187 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 82.8 23.59 0.17 Allowed 'General case' 0 C--N 1.399 2.734 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.41 151.01 35.69 Favored Pre-proline 0 C--N 1.383 2.027 0 N-CA-C 105.361 -2.089 . . . . 0.91000000000000003 105.361 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.34 75.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 124.826 3.684 . . . . 0.56999999999999995 113.871 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 178.42 -33.56 0.01 OUTLIER 'General case' 0 C--N 1.374 1.644 0 CA-C-N 113.814 -1.539 . . . . 0.56999999999999995 112.722 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -60.12 149.05 33.86 Favored 'General case' 0 C--N 1.382 2.02 0 CA-C-N 113.619 -1.628 . . . . 0.56999999999999995 107.854 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 250' ' ' LEU . 0.7 OUTLIER -69.28 -0.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.099 0 CA-C-N 113.052 -1.885 . . . . 0.56999999999999995 112.959 -177.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.442 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -160.1 28.53 0.17 Allowed 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 113.137 -1.847 . . . . 0.56999999999999995 109.885 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.592 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -48.64 147.41 4.33 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 123.866 1.793 . . . . 0.56999999999999995 113.023 176.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.429 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 72.5 Cg_exo -55.49 -50.15 13.72 Favored 'Trans proline' 0 C--N 1.373 1.824 0 O-C-N 118.875 -1.171 . . . . 0.56999999999999995 112.44 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.459 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.3 OUTLIER -50.18 125.4 12.27 Favored 'General case' 0 C--N 1.368 1.382 0 CA-C-O 123.989 1.852 . . . . 0.56999999999999995 110.553 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -81.34 144.96 31.11 Favored 'General case' 0 C--N 1.369 1.435 0 O-C-N 119.894 -1.754 . . . . 0.56999999999999995 108.232 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 242' ' ' TYR . 0.8 OUTLIER -175.29 121.3 0.2 Allowed 'General case' 0 C--N 1.388 2.27 0 CA-C-O 124.187 1.946 . . . . 0.56999999999999995 107.556 173.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 210' ' ' THR . 25.9 p90 -68.86 132.85 47.42 Favored 'General case' 0 C--N 1.368 1.393 0 CA-C-O 125.761 2.696 . . . . 0.56999999999999995 109.704 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 245' ' ' ILE . 3.0 p -117.75 -16.88 7.82 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 O-C-N 119.759 -1.838 . . . . 0.56999999999999995 113.353 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 246' ' ' ASN . 0.0 OUTLIER 79.18 -8.15 1.66 Allowed 'General case' 0 C--N 1.376 1.736 0 O-C-N 125.077 1.486 . . . . 0.91000000000000003 114.393 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.641 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.8 mt 81.68 18.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.381 1.978 0 CA-C-N 114.028 -1.442 . . . . 0.56999999999999995 112.524 -174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 1.6 t-20 -84.22 -28.57 27.18 Favored 'General case' 0 C--N 1.391 2.381 0 C-N-CA 114.057 -3.057 . . . . 0.56999999999999995 103.11 -165.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.0 p -119.04 -6.84 10.45 Favored 'General case' 0 C--N 1.389 2.311 0 CA-C-N 112.603 -2.089 . . . . 0.56999999999999995 112.237 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.666 ' HE1' HG11 ' A' ' 217' ' ' VAL . 39.5 t80 -38.09 97.33 0.01 OUTLIER 'General case' 0 C--N 1.384 2.068 0 CA-C-O 125.059 2.362 . . . . 0.56999999999999995 110.588 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -134.58 151.72 51.28 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.665 -2.061 . . . . 1.2 105.46 -174.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.43 128.94 55.09 Favored 'General case' 0 C--N 1.376 1.76 0 CA-C-O 126.142 2.877 . . . . 0.56999999999999995 108.337 -172.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.6 t -73.23 136.24 44.62 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.363 -2.711 . . . . 0.56999999999999995 109.947 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -55.44 -44.78 76.63 Favored 'General case' 0 C--N 1.388 2.244 0 CA-C-N 113.996 -1.456 . . . . 0.56999999999999995 109.094 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.07 -41.25 92.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.257 0.623 . . . . 0.91000000000000003 110.917 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 20.9 t0 -64.03 -55.12 24.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.838 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.5 pt -66.12 -35.28 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.089 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.755 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.4 mtp85 -70.42 -34.08 72.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.2 110.86 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.18 -46.94 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.56999999999999995 112.446 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.746 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 1.1 pt -64.48 -44.78 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.56999999999999995 111.172 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.492 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.19 -21.0 61.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.952 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 C--N 1.363 1.168 0 CA-C-O 122.227 1.013 . . . . 0.56999999999999995 109.533 -178.091 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 . . . . . 0 C--O 1.237 0.417 0 N-CA-C 106.949 -1.5 . . . . 1.2 106.949 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.29 121.22 0.04 OUTLIER 'General case' 0 C--N 1.4 2.794 0 CA-C-N 114.106 -1.407 . . . . 0.56999999999999995 111.456 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 77.47 -59.57 0.46 Allowed 'General case' 0 C--N 1.391 2.4 0 CA-C-N 114.585 -1.189 . . . . 0.56999999999999995 112.325 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.14 125.34 53.68 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-N 114.64 -1.163 . . . . 0.56999999999999995 110.875 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -119.85 154.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.106 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.9 p -119.96 160.07 23.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.56999999999999995 111.103 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 3.0 t80 -147.07 152.88 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.933 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.566 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.97 122.0 14.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.852 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -98.97 126.32 52.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.097 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -174.36 0.02 OUTLIER 'General case' 0 C--N 1.366 1.307 0 CA-C-O 124.873 2.273 . . . . 0.56999999999999995 108.963 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -76.36 48.58 0.54 Allowed 'General case' 0 C--N 1.369 1.427 0 O-C-N 120.216 -1.552 . . . . 0.56999999999999995 111.676 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 4.6 m-85 48.4 -148.24 0.22 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 122.467 1.127 . . . . 0.56999999999999995 108.221 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -166.8 167.13 8.19 Favored Pre-proline 0 C--N 1.38 1.892 0 CA-C-N 113.703 -1.59 . . . . 0.56999999999999995 108.839 -178.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 122' ' ' THR . 33.0 Cg_endo -72.39 -47.07 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 CA-C-O 122.673 1.03 . . . . 0.56999999999999995 112.906 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 4.5 p-10 -71.92 -38.71 69.84 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 113.658 -1.61 . . . . 0.91000000000000003 114.249 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.42 ' SD ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -89.43 110.67 21.47 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-O 125.427 2.537 . . . . 0.56999999999999995 109.751 -178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -71.88 143.53 49.35 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 112.399 -2.182 . . . . 0.56999999999999995 108.558 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.66 -49.33 59.94 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 114.18 -1.373 . . . . 1.2 107.529 -168.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.83 -34.74 63.19 Favored 'General case' 0 C--N 1.394 2.523 0 CA-C-N 112.586 -2.097 . . . . 0.91000000000000003 110.903 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.25 -43.44 70.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.91000000000000003 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -63.39 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.56999999999999995 111.149 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.19 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.91000000000000003 110.906 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.97 -49.0 79.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.937 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -60.6 -47.22 87.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.065 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 1.1 mm -66.77 -31.91 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.116 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -66.2 -47.85 72.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.849 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -40.35 97.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.898 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.88 94.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.082 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 220' ' ' ILE . 1.0 OUTLIER -67.19 -33.77 76.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.914 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.453 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -68.55 -42.12 78.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.56999999999999995 110.909 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.7 p -69.69 -34.25 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.112 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.553 ' O ' HG23 ' A' ' 145' ' ' THR . 13.0 m95 -82.94 -34.04 26.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 110.898 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.1 m -79.2 -49.58 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.901 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.809 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.68 -13.02 4.85 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 121.837 0.827 . . . . 0.56999999999999995 113.104 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.809 HG13 ' ND2' ' A' ' 143' ' ' ASN . 21.4 m -114.01 12.03 8.11 Favored 'Isoleucine or valine' 0 C--N 1.391 2.375 0 CA-C-N 114.118 -1.401 . . . . 0.56999999999999995 111.943 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 141' ' ' TRP . 24.2 p -150.76 145.04 17.85 Favored Pre-proline 0 C--N 1.381 1.953 0 CA-C-O 125.405 2.526 . . . . 0.56999999999999995 108.619 -172.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.22 -24.27 9.6 Favored 'Trans proline' 0 C--N 1.37 1.679 0 O-C-N 118.344 -1.451 . . . . 0.56999999999999995 111.891 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -82.35 102.87 11.52 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 111.176 178.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.11 162.45 28.97 Favored 'General case' 0 C--N 1.382 1.991 0 CA-C-O 124.108 1.909 . . . . 0.56999999999999995 114.099 171.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -135.6 160.7 37.67 Favored 'General case' 0 C--N 1.392 2.433 0 CA-C-N 112.466 -2.152 . . . . 0.56999999999999995 107.007 -172.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 m -160.3 122.34 3.22 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 125.177 2.418 . . . . 0.56999999999999995 107.353 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -92.65 135.93 33.66 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.493 -1.685 . . . . 0.56999999999999995 110.364 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.35 177.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.755 0 CA-C-O 124.254 1.978 . . . . 0.56999999999999995 110.195 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -104.18 -38.76 6.77 Favored 'General case' 0 C--N 1.386 2.161 0 CA-C-N 112.581 -2.1 . . . . 0.56999999999999995 112.401 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.4 p -130.25 133.27 46.39 Favored 'General case' 0 C--N 1.379 1.852 0 CA-C-O 122.409 1.099 . . . . 0.56999999999999995 108.929 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.09 169.59 15.54 Favored Glycine 0 C--N 1.386 3.334 0 CA-C-O 123.864 1.813 . . . . 0.56999999999999995 112.389 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.1 ttt -80.72 139.15 36.27 Favored 'General case' 0 C--N 1.389 2.292 0 CA-C-N 112.114 -2.043 . . . . 0.56999999999999995 109.551 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -131.71 173.23 11.35 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-N 112.446 -2.161 . . . . 0.56999999999999995 111.144 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.9 -59.33 2.53 Favored 'General case' 0 C--N 1.385 2.12 0 N-CA-C 103.501 -2.778 . . . . 0.91000000000000003 103.501 -168.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 223' ' ' SER . 5.6 mt -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 C--N 1.389 2.288 0 O-C-N 125.064 1.478 . . . . 0.56999999999999995 111.15 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -99.21 128.44 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.884 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 197' ' ' PHE . 1.0 OUTLIER -114.59 119.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.086 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.72 125.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.087 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.421 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.4 OUTLIER -98.51 122.76 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.86 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 199' ' ' GLU . . . -142.66 167.94 20.9 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-O 123.258 1.504 . . . . 0.56999999999999995 107.12 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CD ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -112.48 135.63 52.95 Favored 'General case' 0 C--N 1.369 1.437 0 CA-C-N 114.097 -1.411 . . . . 1.2 109.775 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.13 -133.86 28.27 Favored Glycine 0 C--N 1.397 3.919 0 CA-C-O 124.913 2.396 . . . . 0.56999999999999995 109.562 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.39 135.18 39.69 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 111.496 -2.352 . . . . 0.56999999999999995 113.799 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 . . . . . 0 C--N 1.398 2.683 0 CA-C-N 113.533 -1.667 . . . . 0.56999999999999995 107.096 -171.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 122.931 1.348 . . . . 0.56999999999999995 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -98.97 -157.08 0.58 Allowed 'General case' 0 C--N 1.384 2.074 0 CA-C-N 112.776 -2.011 . . . . 0.56999999999999995 111.253 175.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.46 -77.52 0.1 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.475 -1.693 . . . . 0.91000000000000003 112.267 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.45 16.43 Favored Glycine 0 C--N 1.385 3.266 0 C-N-CA 120.882 -0.675 . . . . 0.56999999999999995 113.757 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 160.38 40.88 0.0 OUTLIER 'General case' 0 C--N 1.399 2.759 0 CA-C-O 124.183 1.944 . . . . 0.56999999999999995 112.341 -170.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.02 -156.79 15.42 Favored Glycine 0 C--N 1.37 2.446 0 N-CA-C 107.009 -2.436 . . . . 0.56999999999999995 107.009 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.45 -39.84 2.54 Favored Glycine 0 C--N 1.367 2.265 0 O-C-N 120.268 -1.725 . . . . 0.56999999999999995 113.989 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -152.56 167.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.86 0 N-CA-C 105.294 -2.113 . . . . 0.56999999999999995 105.294 -172.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' A' ' 210' ' ' THR . 66.9 mt -118.77 -80.6 0.62 Allowed 'General case' 0 C--N 1.374 1.673 0 O-C-N 126.684 2.49 . . . . 0.56999999999999995 114.77 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -107.65 179.5 4.22 Favored 'General case' 0 C--N 1.377 1.765 0 CA-C-N 115.356 -0.838 . . . . 0.56999999999999995 111.112 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER -169.24 135.9 1.72 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.904 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -160.05 161.97 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.151 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -171.22 2.85 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.029 1.395 . . . . 0.56999999999999995 110.846 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.91 -159.11 35.16 Favored Glycine 0 C--N 1.385 3.275 0 CA-C-N 114.001 -1.454 . . . . 0.56999999999999995 112.838 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.42 74.28 3.74 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 110.068 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.76 -134.86 6.95 Favored Glycine 0 C--N 1.376 2.798 0 CA-C-O 124.067 1.926 . . . . 0.56999999999999995 110.155 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.26 -80.08 0.6 Allowed 'General case' 0 C--N 1.396 2.604 0 CA-C-N 112.909 -1.645 . . . . 0.56999999999999995 108.938 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.99 -54.76 2.11 Favored Glycine 1 C--N 1.398 4.006 0 N-CA-C 108.252 -1.939 . . . . 0.56999999999999995 108.252 -174.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -44.37 99.47 Favored 'Isoleucine or valine' 0 C--N 1.396 2.625 0 CA-C-N 113.38 -1.41 . . . . 0.56999999999999995 107.615 -173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.52 136.44 43.89 Favored Glycine 0 C--N 1.395 3.835 0 N-CA-C 106.89 -2.484 . . . . 0.56999999999999995 106.89 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.62 -41.54 2.11 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-N 113.33 -1.435 . . . . 0.56999999999999995 113.531 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.83 97.16 0.1 Allowed 'General case' 0 C--N 1.39 2.343 0 CA-C-N 115.096 -0.552 . . . . 0.91000000000000003 110.921 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -102.95 148.29 25.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.08 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -129.37 151.27 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.895 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.59 150.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.897 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.577 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 2.8 p30 -79.39 83.19 5.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.91000000000000003 110.833 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 203' ' ' TRP . 11.7 tp10 -57.1 -32.52 66.39 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 117.72 -1.133 . . . . 0.91000000000000003 110.349 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -41.98 -51.41 4.44 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 125.768 1.918 . . . . 0.91000000000000003 110.429 -173.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -173.87 0.01 OUTLIER 'General case' 0 C--N 1.392 2.434 0 CA-C-O 127.766 3.65 . . . . 0.91000000000000003 113.045 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 122.59 46.71 Favored 'General case' 0 C--N 1.382 2.019 0 O-C-N 119.125 -2.234 . . . . 0.56999999999999995 113.078 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.568 ' CZ2' ' HA ' ' A' ' 199' ' ' GLU . 26.1 m0 -96.39 123.85 40.18 Favored 'General case' 0 C--N 1.391 2.383 0 N-CA-C 105.262 -2.125 . . . . 0.56999999999999995 105.262 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 102.61 11.44 Favored 'General case' 0 C--N 1.374 1.649 0 CA-C-O 126.235 2.921 . . . . 0.56999999999999995 112.136 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.8 p -102.09 120.59 40.68 Favored 'General case' 0 C--N 1.376 1.739 0 O-C-N 119.564 -1.96 . . . . 0.56999999999999995 108.904 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 65.86 66.63 0.5 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-O 123.958 1.837 . . . . 0.56999999999999995 109.673 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.98 -72.14 0.01 OUTLIER 'General case' 0 C--N 1.397 2.661 0 CA-C-O 123.522 1.629 . . . . 0.56999999999999995 109.334 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.81 -145.92 5.2 Favored Glycine 0 C--N 1.385 3.263 0 N-CA-C 108.262 -1.935 . . . . 0.56999999999999995 108.262 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 47.06 -146.56 3.75 Favored Glycine 0 C--N 1.383 3.18 0 CA-C-O 127.134 3.63 . . . . 0.56999999999999995 110.095 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.55 ' CB ' HD21 ' A' ' 181' ' ' LEU . 8.3 p -77.77 124.34 27.84 Favored 'General case' 0 C--N 1.368 1.378 0 O-C-N 119.983 -1.892 . . . . 0.56999999999999995 112.331 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 214' ' ' LEU . 0.7 OUTLIER -116.86 155.97 28.12 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-N 114.815 -1.084 . . . . 0.56999999999999995 109.435 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -65.87 -32.93 74.73 Favored 'General case' 0 C--N 1.393 2.491 0 CA-C-O 124.22 1.962 . . . . 0.56999999999999995 107.641 -173.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.83 ' CD2' HG23 ' A' ' 245' ' ' ILE . 27.5 t80 -57.55 -50.0 74.53 Favored 'General case' 0 C--N 1.376 1.72 0 CA-C-N 113.16 -1.836 . . . . 0.56999999999999995 110.898 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.617 HD23 ' OD1' ' A' ' 211' ' ' ASN . 1.0 OUTLIER -55.03 -51.12 67.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.937 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -63.83 -44.95 91.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.151 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.93 -42.87 80.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 111.085 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.579 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 0.9 OUTLIER -65.17 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.096 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.26 -49.97 62.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 110.823 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -59.35 -42.11 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.91000000000000003 110.885 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.3 mm -67.68 -47.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.56999999999999995 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.79 -33.75 63.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.466 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.41 -38.74 88.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.56999999999999995 110.9 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 159' ' ' ILE . 11.0 t -71.22 -53.53 14.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.836 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.2 pp -72.23 -60.77 2.06 Favored 'General case' 0 C--N 1.375 1.68 0 N-CA-C 118.992 2.96 . . . . 0.56999999999999995 118.992 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.811 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -70.42 -175.09 17.1 Favored Glycine 0 C--N 1.375 2.741 0 CA-C-O 126.157 3.087 . . . . 0.56999999999999995 110.114 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.602 ' H ' HD12 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -89.01 -146.33 0.16 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-N 109.628 -3.286 . . . . 0.56999999999999995 106.432 -172.02 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.01 -107.57 0.01 OUTLIER Glycine 0 C--N 1.394 3.794 0 CA-C-O 125.769 2.871 . . . . 0.56999999999999995 111.665 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.445 ' CE1' ' HG3' ' A' ' 238' ' ' PRO . 21.4 m170 -113.83 -96.43 0.45 Allowed 'General case' 0 C--N 1.382 1.994 0 O-C-N 119.633 -2.098 . . . . 0.56999999999999995 110.34 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.03 -42.58 0.01 OUTLIER 'General case' 0 C--N 1.391 2.413 0 N-CA-C 107.893 -1.151 . . . . 0.56999999999999995 107.893 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 81.87 24.11 0.23 Allowed 'General case' 0 C--N 1.415 3.454 0 N-CA-C 116.676 2.102 . . . . 0.56999999999999995 116.676 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 4.5 t0 -157.94 138.2 8.95 Favored Pre-proline 0 C--N 1.386 2.156 0 N-CA-C 106.539 -1.652 . . . . 0.91000000000000003 106.539 -171.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 67.8 Cg_exo -57.29 -57.68 1.18 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.445 2.763 . . . . 0.56999999999999995 114.529 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.99 -37.75 4.25 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 112.976 -1.92 . . . . 0.56999999999999995 113.396 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -65.63 117.56 8.27 Favored 'General case' 0 C--N 1.393 2.493 0 CA-C-O 124.445 2.069 . . . . 0.56999999999999995 115.762 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 235' ' ' VAL . 10.3 t -72.19 47.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.033 0 CA-C-O 124.693 2.187 . . . . 0.56999999999999995 115.449 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.8 mmm -144.76 -31.94 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 CA-C-N 113.575 -1.648 . . . . 0.56999999999999995 110.227 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.0 OUTLIER -39.11 144.37 0.44 Allowed Pre-proline 0 C--N 1.38 1.928 0 CA-C-O 126.283 2.944 . . . . 0.56999999999999995 114.371 173.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.445 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 54.0 Cg_exo -58.87 -48.14 15.66 Favored 'Trans proline' 0 C--N 1.383 2.371 0 O-C-N 118.294 -1.477 . . . . 0.56999999999999995 111.806 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 98.9 m -46.3 122.54 4.07 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.003 -173.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.503 ' CZ ' HG22 ' A' ' 210' ' ' THR . 0.0 OUTLIER -98.03 117.69 32.96 Favored 'General case' 0 C--N 1.386 2.164 0 CA-C-N 112.81 -1.995 . . . . 0.56999999999999995 106.602 -178.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -138.5 108.03 6.19 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 113.281 -1.781 . . . . 0.56999999999999995 106.63 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.5 120.89 5.03 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-O 124.455 2.074 . . . . 0.56999999999999995 110.796 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.24 18.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 CA-C-N 112.868 -1.969 . . . . 0.56999999999999995 110.718 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.3 t0 64.03 115.95 0.02 OUTLIER 'General case' 0 C--N 1.385 2.147 0 CA-C-O 126.937 3.256 . . . . 0.91000000000000003 106.651 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.83 HG23 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mp -51.97 -19.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.46 0 O-C-N 119.048 -2.283 . . . . 0.56999999999999995 115.4 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -31.46 64.56 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.003 -1.453 . . . . 0.56999999999999995 111.23 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -5.62 15.42 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 123.121 0.568 . . . . 0.56999999999999995 110.914 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.579 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 22.9 t80 -65.01 93.85 0.12 Allowed 'General case' 0 C--N 1.385 2.119 0 CA-C-O 125.678 2.656 . . . . 0.56999999999999995 105.332 -170.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.542 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -114.41 154.14 28.64 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 112.414 -2.176 . . . . 1.2 105.79 -177.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.89 132.62 53.77 Favored 'General case' 0 C--N 1.385 2.15 0 CA-C-O 125.559 2.6 . . . . 0.56999999999999995 105.768 -170.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 25.8 m -69.32 141.79 54.19 Favored 'General case' 0 C--N 1.365 1.249 0 O-C-N 120.229 -1.544 . . . . 0.56999999999999995 109.124 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -59.93 -42.45 93.98 Favored 'General case' 0 C--N 1.396 2.609 0 CA-C-N 113.337 -1.756 . . . . 0.56999999999999995 107.412 -174.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -41.52 89.07 Favored 'General case' 0 C--N 1.365 1.243 0 CA-C-N 115.501 -0.772 . . . . 0.91000000000000003 110.834 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 258' ' ' ILE . 23.2 t0 -64.4 -54.8 27.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.91000000000000003 110.857 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.6 pt -66.08 -34.54 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 111.196 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.661 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 7.4 mtp180 -67.55 -31.12 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.2 110.796 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.21 -48.41 19.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.56999999999999995 112.457 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 224' ' ' LEU . 1.2 pt -59.59 -36.15 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.731 0.301 . . . . 0.56999999999999995 111.077 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 260' ' ' SER . 6.3 pt20 -70.13 -44.61 68.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.896 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 1.5 t . . . . . 0 C--N 1.374 1.673 0 CA-C-O 121.933 0.873 . . . . 0.56999999999999995 110.891 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 122.986 1.374 . . . . 1.2 108.943 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -65.83 0.03 OUTLIER 'General case' 0 C--N 1.382 2.018 0 CA-C-N 113.886 -1.507 . . . . 0.56999999999999995 111.07 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.754 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -77.31 -11.61 59.85 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 125.542 2.591 . . . . 0.56999999999999995 110.268 -179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -110.07 105.48 14.61 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.144 -1.598 . . . . 0.56999999999999995 110.946 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -110.01 135.32 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.108 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.42 159.03 18.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.181 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.912 ' OH ' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -150.14 158.07 43.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.56999999999999995 110.883 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -156.07 126.5 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.2 110.921 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.912 HD12 ' OH ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -77.98 136.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.114 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -53.23 -53.92 43.65 Favored 'General case' 0 C--N 1.376 1.744 0 N-CA-C 107.805 -1.183 . . . . 0.56999999999999995 107.805 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 161.98 35.44 0.0 OUTLIER 'General case' 0 C--N 1.382 1.996 0 O-C-N 126.599 2.437 . . . . 0.56999999999999995 110.049 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 4.8 m-30 72.52 -172.22 0.15 Allowed 'General case' 0 C--N 1.383 2.025 0 N-CA-C 107.41 -1.33 . . . . 0.56999999999999995 107.41 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -139.74 161.51 55.98 Favored Pre-proline 0 C--N 1.373 1.614 0 CA-C-N 114.141 -1.39 . . . . 0.56999999999999995 108.619 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -50.51 1.41 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 112.584 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' H ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -80.16 -66.87 0.82 Allowed 'General case' 0 C--N 1.379 1.882 0 N-CA-C 104.768 -2.308 . . . . 0.91000000000000003 104.768 -165.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.7 ttm -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-O 125.694 2.664 . . . . 0.56999999999999995 110.19 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.728 ' O ' HG23 ' A' ' 130' ' ' VAL . 69.2 m-20 -75.95 139.69 41.7 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.396 -2.184 . . . . 0.56999999999999995 107.714 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.47 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.47 -47.46 67.03 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 107.736 -1.209 . . . . 1.2 107.736 -168.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -34.67 63.27 Favored 'General case' 0 C--N 1.387 2.226 0 O-C-N 126.482 2.364 . . . . 0.91000000000000003 110.898 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -44.04 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.91000000000000003 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.31 -44.55 98.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.84 -44.09 97.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.91000000000000003 110.869 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.61 -44.06 87.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 110.894 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.1 -43.97 87.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.56999999999999995 111.13 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.527 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -65.15 -42.89 95.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.56999999999999995 111.112 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -49.05 78.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.868 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -36.55 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.91 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -63.26 -42.06 99.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 111.132 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 134' ' ' ILE . 20.4 m-85 -65.93 -37.09 85.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 110.86 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.4 tt0 -67.16 -38.11 84.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.882 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 144' ' ' VAL . 8.3 t -71.12 -34.07 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.122 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CG ' HD11 ' A' ' 224' ' ' LEU . 1.3 m95 -83.25 -34.09 25.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.913 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m -77.55 -49.39 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.876 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.747 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.76 -12.56 7.45 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-O 122.174 0.988 . . . . 0.56999999999999995 112.737 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.747 HG13 ' ND2' ' A' ' 143' ' ' ASN . 25.0 m -115.98 1.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.379 1.854 0 CA-C-N 114.014 -1.448 . . . . 0.56999999999999995 111.42 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.8 150.28 45.92 Favored Pre-proline 0 C--N 1.368 1.412 0 CA-C-O 125.615 2.626 . . . . 0.56999999999999995 110.203 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.38 -34.03 6.36 Favored 'Trans proline' 0 C--N 1.361 1.224 0 O-C-N 118.114 -1.572 . . . . 0.56999999999999995 110.69 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.1 mt -58.7 114.34 2.46 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 108.73 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 158.36 32.05 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 113.742 -1.572 . . . . 0.56999999999999995 112.507 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 224' ' ' LEU . 12.6 m-85 -130.07 139.61 50.94 Favored 'General case' 0 C--N 1.388 2.272 0 CA-C-N 112.368 -2.196 . . . . 0.56999999999999995 108.711 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.4 m -145.53 125.02 13.14 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 108.367 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 116' ' ' TYR . 15.9 tttt -89.45 146.58 24.54 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 112.731 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' HA ' ' A' ' 157' ' ' ALA . 8.2 pt -139.11 155.97 27.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.852 0 CA-C-O 123.41 1.576 . . . . 0.56999999999999995 109.738 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 -6.23 1.48 Allowed 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.808 -1.542 . . . . 0.56999999999999995 109.951 -174.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.5 p -76.79 -62.82 1.51 Allowed 'General case' 0 C--N 1.372 1.569 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.539 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.56 -174.69 17.47 Favored Glycine 0 C--N 1.374 2.648 0 CA-C-O 123.253 1.474 . . . . 0.56999999999999995 110.861 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 ttt -57.62 124.97 20.89 Favored 'General case' 0 C--N 1.382 1.997 0 CA-C-N 113.014 -1.593 . . . . 0.56999999999999995 108.411 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 152' ' ' ILE . . . -97.04 173.56 7.21 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.147 -1.842 . . . . 0.56999999999999995 110.582 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.43 -83.39 0.03 OUTLIER 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.989 -1.914 . . . . 0.91000000000000003 107.674 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.94 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.9 pp -94.69 114.57 31.54 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-N 114.665 -1.152 . . . . 0.56999999999999995 111.108 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 157' ' ' ALA . 4.5 mp -96.38 132.06 42.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 197' ' ' PHE . 21.6 t -102.02 116.9 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.148 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.33 145.13 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.101 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -102.77 117.77 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.89 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.36 170.12 18.0 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 124.341 2.019 . . . . 0.56999999999999995 109.646 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.6 134.02 52.43 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.909 -1.744 . . . . 1.2 108.156 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 42.32 -106.02 0.07 OUTLIER Glycine 0 C--N 1.379 2.957 0 O-C-N 126.135 2.147 . . . . 0.56999999999999995 113.009 171.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.478 ' H ' ' CB ' ' A' ' 173' ' ' ALA . . . 57.04 -140.03 0.86 Allowed 'General case' 0 C--N 1.384 2.097 0 O-C-N 127.111 2.301 . . . . 0.56999999999999995 107.518 170.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 168' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.383 2.059 0 O-C-N 124.957 1.411 . . . . 0.56999999999999995 111.36 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.478 ' CB ' ' H ' ' A' ' 167' ' ' ALA . . . . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 124.157 1.932 . . . . 0.56999999999999995 115.185 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.756 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -85.89 -131.1 0.05 OUTLIER 'General case' 0 C--N 1.376 1.745 0 CA-C-N 113.224 -1.807 . . . . 0.56999999999999995 108.633 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.578 ' H ' HD13 ' A' ' 180' ' ' ILE . 6.9 t70 54.0 -157.42 0.19 Allowed 'General case' 0 C--N 1.39 2.343 0 N-CA-C 105.647 -1.982 . . . . 0.91000000000000003 105.647 170.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 127.72 9.18 4.02 Favored Glycine 0 C--N 1.368 2.344 0 N-CA-C 109.067 -1.613 . . . . 0.56999999999999995 109.067 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.13 -57.14 0.01 OUTLIER 'General case' 0 C--N 1.393 2.492 0 CA-C-O 122.764 1.269 . . . . 0.56999999999999995 111.031 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -156.95 -38.25 0.02 OUTLIER Glycine 0 C--N 1.382 3.102 0 CA-C-N 114.126 -1.397 . . . . 0.56999999999999995 111.497 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.618 ' C ' HD12 ' A' ' 180' ' ' ILE . . . -41.6 142.06 1.19 Allowed Glycine 0 C--N 1.38 3.027 0 O-C-N 120.0 -1.883 . . . . 0.56999999999999995 109.379 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 174' ' ' PHE . 1.3 mp 74.04 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.62 0 O-C-N 124.153 0.561 . . . . 0.56999999999999995 112.449 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 215' ' ' THR . 2.7 tp -124.29 -57.81 1.56 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 122.966 1.365 . . . . 0.56999999999999995 111.882 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 215' ' ' THR . . . -177.43 179.53 0.94 Allowed 'General case' 0 C--N 1.364 1.229 0 CA-C-N 114.584 -1.189 . . . . 0.56999999999999995 111.042 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.518 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.7 p80 -152.94 168.24 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.874 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.89 142.71 22.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.057 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.453 ' CB ' ' HA2' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -52.02 129.71 27.93 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 117.745 -1.582 . . . . 0.56999999999999995 110.143 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 187' ' ' PRO . . . -74.26 -58.19 4.4 Favored Glycine 0 C--N 1.381 3.046 0 CA-C-N 112.859 -1.973 . . . . 0.56999999999999995 111.785 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 186' ' ' GLY . 30.7 Cg_endo -67.96 -83.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 121.495 1.463 . . . . 0.56999999999999995 111.342 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.463 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . 167.32 -142.52 7.61 Favored Glycine 0 C--N 1.375 2.711 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 83.59 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.382 1.987 0 O-C-N 125.611 1.418 . . . . 0.56999999999999995 109.382 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -44.87 -65.08 1.91 Allowed Glycine 0 C--N 1.388 3.426 0 CA-C-O 125.678 2.821 . . . . 0.56999999999999995 112.549 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 191' ' ' ILE . 1.5 mp -71.97 -15.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.382 1.982 0 CA-C-N 111.306 -2.447 . . . . 0.56999999999999995 109.03 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -44.98 148.35 1.39 Allowed Glycine 0 C--N 1.362 1.972 0 O-C-N 120.693 -1.254 . . . . 0.56999999999999995 113.676 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.94 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 76.38 -44.47 1.94 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 117.428 1.731 . . . . 0.56999999999999995 117.428 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -37.48 147.15 0.04 OUTLIER 'General case' 0 C--N 1.387 2.205 0 O-C-N 124.894 0.997 . . . . 0.91000000000000003 110.853 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -143.42 152.0 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.113 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.33 126.41 37.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 110.828 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.664 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -109.97 134.93 51.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 110.923 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.43 ' HB2' ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -60.83 85.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.86 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -72.98 -49.24 30.27 Favored 'General case' 0 C--N 1.382 1.999 0 N-CA-C 104.209 -2.515 . . . . 0.91000000000000003 104.209 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.84 -45.75 0.1 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 123.938 0.895 . . . . 0.91000000000000003 112.151 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -53.19 174.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 126.631 3.11 . . . . 0.91000000000000003 109.77 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 2.1 t80 -97.1 107.52 20.07 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 112.74 -2.027 . . . . 0.56999999999999995 114.275 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 40.9 m95 -91.25 151.42 20.92 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 108.493 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.0 p -126.22 104.4 8.2 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 109.92 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.56 137.29 37.43 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-N 113.271 -1.786 . . . . 0.56999999999999995 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 207' ' ' SER . 1.3 t60 76.78 42.56 0.15 Allowed 'General case' 0 C--N 1.385 2.144 0 CA-C-N 113.796 -1.547 . . . . 0.56999999999999995 110.834 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.1 p 81.69 123.17 0.04 OUTLIER 'General case' 0 C--N 1.382 1.989 0 CA-C-O 124.55 2.119 . . . . 0.56999999999999995 108.849 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.37 -13.91 0.15 Allowed Glycine 0 C--N 1.382 3.135 0 C-N-CA 118.514 -1.803 . . . . 0.56999999999999995 111.752 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 153.88 -119.13 0.92 Allowed Glycine 0 C--N 1.389 3.509 0 CA-C-O 123.723 1.735 . . . . 0.56999999999999995 112.994 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.7 p -80.02 117.53 20.94 Favored 'General case' 0 C--N 1.377 1.795 0 CA-C-O 123.142 1.448 . . . . 0.56999999999999995 111.625 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -91.59 152.14 20.41 Favored 'General case' 0 C--N 1.369 1.417 0 CA-C-N 112.738 -2.028 . . . . 0.56999999999999995 111.648 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -75.04 -31.23 61.27 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 113.184 -1.825 . . . . 0.56999999999999995 107.338 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.3 t80 -58.22 -46.61 85.57 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-N 113.819 -1.537 . . . . 0.56999999999999995 110.889 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -55.68 -51.84 65.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.898 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.01 -49.05 69.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.162 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.32 73.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.174 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 213' ' ' PHE . 92.5 t -65.18 -39.49 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 111.081 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 236' ' ' MET . 7.2 t-160 -70.29 -42.3 72.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.866 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 219' ' ' GLU . 1.2 mm-40 -61.1 -43.78 98.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.91000000000000003 110.869 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 137' ' ' ALA . 12.5 pt -71.09 -42.94 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 111.114 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.96 -33.76 64.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.56999999999999995 112.523 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.53 -42.02 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.482 ' CB ' HG21 ' A' ' 159' ' ' ILE . 17.7 t -71.01 -36.01 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.888 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.647 ' CD2' HD12 ' A' ' 114' ' ' ILE . 26.8 mt -43.74 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.367 1.344 0 CA-C-O 124.25 1.976 . . . . 0.56999999999999995 114.318 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.64 -161.83 35.56 Favored Glycine 0 C--N 1.369 2.408 0 N-CA-C 107.93 -2.068 . . . . 0.56999999999999995 107.93 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 227' ' ' GLY . 0.5 OUTLIER 50.65 -164.07 0.05 OUTLIER 'General case' 0 C--N 1.389 2.293 0 CA-C-N 112.633 -1.783 . . . . 0.56999999999999995 111.131 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.533 ' H ' HD22 ' A' ' 226' ' ' LEU . . . -111.34 -162.61 17.51 Favored Glycine 0 C--N 1.373 2.624 0 CA-C-O 125.61 2.783 . . . . 0.56999999999999995 112.682 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.48 -167.06 1.74 Allowed 'General case' 0 C--N 1.39 2.328 0 CA-C-N 110.578 -2.811 . . . . 0.56999999999999995 112.032 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -94.24 -20.1 20.13 Favored 'General case' 0 C--N 1.385 2.125 0 CA-C-N 113.421 -1.718 . . . . 0.56999999999999995 109.944 -175.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 86.48 5.38 0.39 Allowed 'General case' 0 C--N 1.387 2.22 0 O-C-N 125.558 1.786 . . . . 0.56999999999999995 114.853 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -149.12 143.86 17.43 Favored Pre-proline 0 C--N 1.38 1.908 0 O-C-N 125.193 1.558 . . . . 0.91000000000000003 109.377 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 239' ' ' THR . 87.6 Cg_exo -59.11 -47.18 18.56 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.589 2.192 . . . . 0.56999999999999995 112.295 -172.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -41.89 -39.35 1.8 Allowed 'General case' 0 C--N 1.38 1.909 0 CA-C-N 114.035 -1.438 . . . . 0.56999999999999995 113.032 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 229' ' ' SER . . . -63.48 131.56 48.56 Favored 'General case' 0 C--N 1.383 2.046 0 N-CA-C 118.955 2.946 . . . . 0.56999999999999995 118.955 167.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 248' ' ' PHE . 21.9 t -73.55 70.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.9 0 CA-C-N 112.256 -2.247 . . . . 0.56999999999999995 111.435 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.459 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -179.55 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-N 113.233 -1.803 . . . . 0.56999999999999995 109.424 -178.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 3.4 t80 -52.77 140.25 39.63 Favored Pre-proline 0 C--N 1.363 1.193 0 O-C-N 120.014 -1.679 . . . . 0.56999999999999995 109.868 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 54.0 Cg_exo -54.77 -19.41 18.82 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.8 1.667 . . . . 0.56999999999999995 114.9 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 232' ' ' PRO . 1.0 OUTLIER -48.41 107.57 0.13 Allowed 'General case' 0 C--N 1.371 1.515 0 CA-C-O 123.665 1.698 . . . . 0.56999999999999995 110.677 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -81.86 134.11 35.38 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 105.869 -1.9 . . . . 0.56999999999999995 105.869 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? 174.96 113.49 0.02 OUTLIER 'General case' 0 C--N 1.383 2.048 0 N-CA-C 106.744 -1.576 . . . . 0.56999999999999995 106.744 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.59 123.26 9.55 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 113.238 -1.801 . . . . 0.56999999999999995 110.701 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 243' ' ' VAL . 7.7 p -151.35 113.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.779 0 CA-C-N 113.806 -1.543 . . . . 0.56999999999999995 108.103 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.39 150.05 12.2 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 113.211 -1.813 . . . . 0.91000000000000003 107.086 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.1 mp -75.86 -23.57 16.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 124.227 1.965 . . . . 0.56999999999999995 110.02 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -84.15 -7.52 59.34 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.481 -1.387 . . . . 0.56999999999999995 112.714 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 39.7 p -122.39 3.51 9.71 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-O 123.679 1.704 . . . . 0.56999999999999995 111.578 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -83.97 -156.73 0.23 Allowed 'General case' 0 C--N 1.368 1.4 0 CA-C-N 113.259 -1.791 . . . . 0.56999999999999995 110.376 178.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER 178.28 163.37 0.69 Allowed 'General case' 0 C--N 1.385 2.124 0 N-CA-C 105.637 -1.986 . . . . 1.2 105.637 168.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -117.56 141.98 47.73 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.732 2.682 . . . . 0.56999999999999995 108.262 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.3 t -64.5 134.02 53.6 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 119.846 -1.784 . . . . 0.56999999999999995 112.645 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.91 -49.91 64.08 Favored 'General case' 0 C--N 1.39 2.361 0 CA-C-N 114.072 -1.422 . . . . 0.56999999999999995 108.663 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -35.96 73.97 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 115.357 -0.838 . . . . 0.91000000000000003 110.845 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 258' ' ' ILE . 30.6 t0 -63.94 -55.13 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.91000000000000003 110.885 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.7 pt -66.37 -35.31 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.56999999999999995 111.149 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 35.5 mtp180 -70.72 -35.52 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 1.2 110.784 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.02 -51.2 55.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.722 . . . . 0.56999999999999995 112.465 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.713 HD11 HG23 ' A' ' 144' ' ' VAL . 2.4 pt -61.17 -45.61 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.56999999999999995 111.119 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.21 -28.69 63.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.56999999999999995 110.907 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 31.3 t . . . . . 0 C--N 1.365 1.251 0 C-N-CA 119.096 -1.042 . . . . 0.56999999999999995 109.796 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.349 0 CA-C-O 125.034 2.349 . . . . 1.2 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -127.91 -54.32 1.31 Allowed 'General case' 0 C--N 1.379 1.868 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 107.822 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.388 2.247 0 CA-C-O 124.172 1.939 . . . . 0.56999999999999995 108.471 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.6 103.81 10.06 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-N 112.054 -2.339 . . . . 0.56999999999999995 110.929 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 149' ' ' PHE . 1.3 mm -102.11 146.91 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.572 ' HB ' ' H ' ' A' ' 158' ' ' ASP . 1.3 m -105.93 156.51 18.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.473 . . . . 0.56999999999999995 111.125 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.753 ' CE1' HD12 ' A' ' 118' ' ' ILE . 20.3 t80 -138.64 160.1 40.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.929 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.528 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -145.68 121.85 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.509 . . . . 1.2 110.847 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -93.51 132.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 111.125 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -59.48 -86.76 0.01 OUTLIER 'General case' 0 C--N 1.375 1.696 0 CA-C-N 114.739 -1.119 . . . . 0.56999999999999995 110.206 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t30 169.4 60.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.28 0 N-CA-C 104.15 -2.537 . . . . 0.56999999999999995 104.15 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.723 ' CD2' HG21 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -67.07 178.37 1.45 Allowed 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.065 -1.88 . . . . 0.56999999999999995 111.544 166.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 162.45 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.32 2.648 . . . . 0.56999999999999995 108.134 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.71 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-O 124.365 1.735 . . . . 0.56999999999999995 110.079 -165.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.99 3.31 12.54 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 114.309 -1.314 . . . . 0.91000000000000003 113.986 173.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.1 mmt -142.75 119.45 11.13 Favored 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.007 -1.479 . . . . 0.56999999999999995 107.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -93.32 139.09 31.04 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 122.617 1.199 . . . . 0.56999999999999995 108.58 -177.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.46 ' N ' HD22 ' A' ' 126' ' ' ASN . 0.0 OUTLIER -66.89 -46.66 74.22 Favored 'General case' 0 C--N 1.388 2.261 0 CA-C-O 123.871 1.796 . . . . 1.2 109.261 -166.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.24 -35.17 64.65 Favored 'General case' 0 C--N 1.364 1.208 0 CA-C-N 111.376 -2.647 . . . . 0.91000000000000003 110.979 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.61 -41.92 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.91000000000000003 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -65.54 -39.57 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 111.112 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.63 -42.1 87.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.838 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -49.02 75.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.949 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.62 -49.1 67.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.052 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.521 HG13 HG12 ' A' ' 130' ' ' VAL . 1.5 mm -62.22 -46.03 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.094 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -56.28 -43.64 79.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 1.2 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -38.13 89.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.878 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -64.57 -45.29 87.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.078 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 220' ' ' ILE . 14.9 m-85 -62.97 -34.4 77.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.916 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -68.11 -40.0 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 110.934 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.48 -34.24 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.56999999999999995 111.125 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.419 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 14.5 m95 -83.15 -33.62 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 110.929 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.7 m -78.94 -49.01 13.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.808 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.813 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -59.97 -14.84 17.86 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-O 120.969 0.414 . . . . 0.56999999999999995 111.072 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.813 HG13 ' ND2' ' A' ' 143' ' ' ASN . 19.6 m -112.51 -13.61 11.24 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 CA-C-O 117.89 -1.053 . . . . 0.56999999999999995 111.016 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.625 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -145.7 142.39 17.93 Favored Pre-proline 0 C--N 1.383 2.038 0 O-C-N 124.859 1.349 . . . . 0.56999999999999995 112.555 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD2' HG22 ' A' ' 145' ' ' THR . 47.3 Cg_endo -78.52 67.75 8.25 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.201 1.934 . . . . 0.56999999999999995 112.66 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -163.71 90.58 0.63 Allowed 'General case' 0 C--N 1.372 1.576 0 N-CA-C 104.516 -2.401 . . . . 0.56999999999999995 104.516 -167.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 160.53 25.73 Favored 'General case' 0 C--N 1.381 1.977 0 CA-C-N 114.432 -1.258 . . . . 0.56999999999999995 113.035 170.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 25.0 m-85 -136.32 141.22 43.77 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-N 113.723 -1.58 . . . . 0.56999999999999995 106.747 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -157.02 139.76 15.11 Favored 'General case' 0 C--N 1.366 1.315 0 CA-C-O 124.454 2.073 . . . . 0.56999999999999995 108.161 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.26 145.8 27.37 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 114.199 -1.364 . . . . 0.56999999999999995 109.733 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 157' ' ' ALA . 16.8 pt -111.27 159.48 11.23 Favored 'Isoleucine or valine' 0 C--N 1.367 1.333 0 CA-C-O 123.979 1.847 . . . . 0.56999999999999995 108.032 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -90.1 100.26 13.12 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.21 -1.814 . . . . 0.56999999999999995 107.038 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 67.67 -178.75 0.21 Allowed 'General case' 0 C--N 1.371 1.512 0 CA-C-O 122.189 0.995 . . . . 0.56999999999999995 109.44 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.09 71.35 Favored Glycine 0 C--N 1.371 2.487 0 C-N-CA 119.728 -1.225 . . . . 0.56999999999999995 113.435 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.63 113.89 0.06 Allowed 'General case' 0 C--N 1.374 1.671 0 CA-C-O 122.586 1.184 . . . . 0.56999999999999995 109.735 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 152' ' ' ILE . . . -91.31 159.49 15.99 Favored 'General case' 0 C--N 1.37 1.478 0 C-N-CA 117.612 -1.635 . . . . 0.56999999999999995 109.659 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.572 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -53.03 -47.13 68.61 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-N 112.28 -2.236 . . . . 0.91000000000000003 106.061 -171.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.3 mt -103.49 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.388 2.241 0 O-C-N 127.117 2.761 . . . . 0.56999999999999995 111.159 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.41 124.4 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.921 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 197' ' ' PHE . 24.9 t -108.75 123.04 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.074 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 124.94 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.156 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.44 ' C ' ' HB2' ' A' ' 199' ' ' GLU . 5.4 m-85 -89.46 116.85 27.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.864 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.8 29.7 Favored 'General case' 0 C--N 1.378 1.81 0 CA-C-O 122.89 1.328 . . . . 0.56999999999999995 108.593 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -100.93 177.11 5.05 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 114.501 -1.227 . . . . 1.2 110.892 174.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -52.93 144.19 23.51 Favored Glycine 0 C--N 1.376 2.76 0 CA-C-N 113.213 -1.812 . . . . 0.56999999999999995 111.466 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.54 50.83 0.02 OUTLIER 'General case' 0 C--N 1.382 1.993 0 CA-C-O 123.136 1.446 . . . . 0.56999999999999995 112.307 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 . . . . . 0 C--N 1.377 1.778 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 109.69 -179.475 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 107.185 -1.413 . . . . 0.56999999999999995 107.185 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -91.93 -164.51 1.19 Allowed 'General case' 0 C--N 1.369 1.44 0 CA-C-N 112.857 -1.974 . . . . 0.56999999999999995 108.715 173.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.56 142.13 35.18 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 105.061 -2.2 . . . . 0.91000000000000003 105.061 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.88 157.28 22.93 Favored Glycine 0 C--N 1.368 2.36 0 N-CA-C 107.645 -2.182 . . . . 0.56999999999999995 107.645 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.07 28.21 6.74 Favored 'General case' 0 C--N 1.369 1.425 0 N-CA-C 113.605 0.965 . . . . 0.56999999999999995 113.605 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.62 -163.99 14.9 Favored Glycine 0 C--N 1.364 2.101 0 N-CA-C 108.056 -2.017 . . . . 0.56999999999999995 108.056 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.48 -104.03 3.12 Favored Glycine 0 C--N 1.365 2.188 0 CA-C-N 114.758 -0.721 . . . . 0.56999999999999995 111.42 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.46 167.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.38 1.898 0 C-N-CA 123.526 0.73 . . . . 0.56999999999999995 109.142 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 240' ' ' TYR . 5.6 tp -101.13 -42.63 6.29 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 122.087 0.946 . . . . 0.56999999999999995 110.743 173.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.89 -179.99 2.19 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 120.56 -1.337 . . . . 0.56999999999999995 111.102 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.402 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 2.3 p80 -163.87 136.1 4.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.883 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.694 ' HB2' ' CB ' ' A' ' 195' ' ' ALA . . . -154.42 163.14 40.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.56999999999999995 111.136 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -121.32 176.59 5.56 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-O 123.191 1.472 . . . . 0.56999999999999995 108.478 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.68 53.09 0.2 Allowed Glycine 0 C--N 1.376 2.763 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 112.219 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.83 -49.84 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 CA-C-O 123.695 1.456 . . . . 0.56999999999999995 110.764 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -155.91 -61.58 0.01 OUTLIER Glycine 0 C--N 1.381 3.053 0 N-CA-C 109.844 -1.303 . . . . 0.56999999999999995 109.844 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m -152.06 -179.73 7.75 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.33 -104.57 1.6 Allowed Glycine 0 C--N 1.379 2.961 0 N-CA-C 105.888 -2.885 . . . . 0.56999999999999995 105.888 171.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.2 tp -55.38 -42.77 68.73 Favored 'Isoleucine or valine' 0 C--N 1.375 1.715 0 CA-C-O 122.818 1.294 . . . . 0.56999999999999995 109.067 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.51 134.69 38.72 Favored Glycine 0 C--N 1.379 2.941 0 C-N-CA 118.37 -1.872 . . . . 0.56999999999999995 108.498 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.6 -29.16 12.36 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 124.287 0.946 . . . . 0.56999999999999995 113.29 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 123.46 26.4 Favored 'General case' 0 C--N 1.371 1.522 0 O-C-N 120.91 -1.347 . . . . 0.91000000000000003 110.885 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.694 ' CB ' ' HB2' ' A' ' 184' ' ' ALA . . . -125.23 146.39 49.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.131 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -123.81 134.47 53.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 110.81 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.713 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -108.97 150.01 28.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.883 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 91.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.91000000000000003 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.44 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 3.7 tp10 -67.56 -44.56 77.96 Favored 'General case' 0 C--N 1.369 1.414 0 O-C-N 125.714 1.884 . . . . 0.91000000000000003 108.068 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -30.84 43.91 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-O 122.526 1.155 . . . . 0.91000000000000003 111.299 -167.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.52 172.02 0.17 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-O 125.278 2.466 . . . . 0.91000000000000003 114.906 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -120.61 83.36 2.05 Favored 'General case' 0 C--N 1.384 2.07 0 CA-C-N 113.241 -1.8 . . . . 0.56999999999999995 108.463 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -74.4 152.53 39.49 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 113.695 -1.593 . . . . 0.56999999999999995 107.498 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 126.84 35.15 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-O 124.734 2.207 . . . . 0.56999999999999995 105.488 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.8 p -106.42 123.06 47.49 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 105.344 -2.095 . . . . 0.56999999999999995 105.344 -175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 70.6 34.83 2.02 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.318 1.533 . . . . 0.56999999999999995 109.621 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -139.11 -82.06 0.29 Allowed 'General case' 0 C--N 1.375 1.703 0 N-CA-C 107.752 -1.203 . . . . 0.56999999999999995 107.752 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.73 -163.33 33.69 Favored Glycine 0 C--N 1.365 2.148 0 N-CA-C 107.851 -2.1 . . . . 0.56999999999999995 107.851 -171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.3 -142.85 47.75 Favored Glycine 0 C--N 1.373 2.588 0 C-N-CA 119.295 -1.431 . . . . 0.56999999999999995 110.724 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 p -74.62 115.45 14.19 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-O 124.684 2.183 . . . . 0.56999999999999995 113.723 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.495 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.7 p30 -102.55 147.67 26.49 Favored 'General case' 0 C--N 1.373 1.618 0 CA-C-N 112.748 -2.024 . . . . 0.56999999999999995 110.183 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.526 ' C ' HD13 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -71.34 -34.34 70.44 Favored 'General case' 0 C--N 1.381 1.966 0 N-CA-C 105.339 -2.097 . . . . 0.56999999999999995 105.339 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.921 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -53.73 -49.95 67.03 Favored 'General case' 0 C--N 1.375 1.686 0 CA-C-N 114.993 -1.003 . . . . 0.56999999999999995 110.9 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -54.94 -48.28 73.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.946 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -38.2 77.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.128 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -61.55 -46.31 90.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 111.158 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 213' ' ' PHE . 3.6 t -65.36 -40.01 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.089 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.12 -50.0 57.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.891 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.9 -42.12 93.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.91000000000000003 110.849 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.721 HG22 HD23 ' A' ' 224' ' ' LEU . 2.4 mm -68.44 -43.92 83.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.11 -33.86 76.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.438 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -39.4 89.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.779 0.323 . . . . 0.56999999999999995 110.849 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 m -71.05 -51.56 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.833 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.721 HD23 HG22 ' A' ' 220' ' ' ILE . 3.7 pp -69.35 -55.73 9.55 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 116.002 1.853 . . . . 0.56999999999999995 116.002 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.641 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -71.73 -148.44 0.67 Allowed Glycine 0 C--N 1.364 2.096 0 N-CA-C 107.51 -2.236 . . . . 0.56999999999999995 107.51 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER -125.63 -21.26 4.5 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 113.19 -1.505 . . . . 0.56999999999999995 108.835 -172.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.521 ' N ' HD22 ' A' ' 226' ' ' LEU . . . 148.19 -172.28 28.48 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 123.172 1.429 . . . . 0.56999999999999995 112.847 -161.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 236' ' ' MET . 2.2 m170 -73.97 -162.21 0.13 Allowed 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.074 -2.063 . . . . 0.56999999999999995 109.364 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 2.1 p -122.15 -10.94 8.5 Favored 'General case' 0 C--N 1.374 1.639 0 C-N-CA 120.313 -0.555 . . . . 0.56999999999999995 109.869 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 85.71 -4.58 0.83 Allowed 'General case' 0 C--N 1.377 1.771 0 N-CA-C 113.834 1.05 . . . . 0.56999999999999995 113.834 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -130.03 152.0 79.26 Favored Pre-proline 0 C--N 1.375 1.708 0 N-CA-C 106.572 -1.64 . . . . 0.91000000000000003 106.572 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -63.72 -21.19 69.78 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.289 1.993 . . . . 0.56999999999999995 114.167 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 14.01 0.26 Allowed 'General case' 0 C--N 1.369 1.448 0 N-CA-C 117.33 2.345 . . . . 0.56999999999999995 117.33 168.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.447 ' HB2' ' OG ' ' A' ' 229' ' ' SER . . . -94.8 132.68 39.32 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 123.074 1.416 . . . . 0.56999999999999995 108.103 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 248' ' ' PHE . 0.3 OUTLIER -76.61 -5.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.372 1.547 0 CA-C-O 124.156 1.931 . . . . 0.56999999999999995 110.857 -176.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.55 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 74.8 mtp -121.77 26.42 8.69 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 114.046 -1.434 . . . . 0.56999999999999995 108.726 -176.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.417 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 0.3 OUTLIER -64.8 149.49 96.04 Favored Pre-proline 0 C--N 1.371 1.505 0 C-N-CA 117.696 -1.602 . . . . 0.56999999999999995 110.231 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 39.6 Cg_endo -78.64 -15.05 13.88 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.278 1.319 . . . . 0.56999999999999995 112.711 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 130.18 45.73 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-O 122.813 1.292 . . . . 0.56999999999999995 109.411 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.481 ' CE2' HD13 ' A' ' 181' ' ' LEU . 6.3 t80 -89.53 106.75 18.66 Favored 'General case' 0 C--N 1.364 1.215 0 N-CA-C 105.822 -1.918 . . . . 0.56999999999999995 105.822 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -154.94 115.83 3.95 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 105.106 -2.183 . . . . 0.56999999999999995 105.106 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -68.6 113.71 6.35 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 110.081 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 p -95.75 -21.42 5.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 CA-C-N 114.142 -1.39 . . . . 0.56999999999999995 112.299 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . 0.418 ' C ' HG13 ' A' ' 245' ' ' ILE 0.312 0.0 OUTLIER 82.32 -11.98 0.96 Allowed 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.033 0.833 . . . . 0.91000000000000003 111.282 -176.674 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.577 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.6 mt 87.54 14.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.795 0 C-N-CA 124.858 1.263 . . . . 0.56999999999999995 110.766 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.61 -30.47 46.55 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-O 125.595 2.617 . . . . 0.56999999999999995 106.273 -166.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.5 p -119.31 -10.09 9.79 Favored 'General case' 0 C--N 1.386 2.185 0 CA-C-N 112.072 -2.331 . . . . 0.56999999999999995 112.613 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.624 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 49.9 t80 -48.01 103.64 0.05 OUTLIER 'General case' 0 C--N 1.374 1.668 0 CA-C-O 123.162 1.458 . . . . 0.56999999999999995 107.461 -172.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -138.4 146.71 42.54 Favored 'General case' 0 C--N 1.363 1.188 0 N-CA-C 104.816 -2.291 . . . . 1.2 104.816 -172.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.554 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.8 132.02 56.76 Favored 'General case' 0 C--N 1.368 1.373 0 CA-C-N 111.704 -2.498 . . . . 0.56999999999999995 106.482 -172.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.7 t -79.51 146.05 32.88 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 119.804 -1.81 . . . . 0.56999999999999995 109.325 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.82 90.18 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 114.704 -1.134 . . . . 0.56999999999999995 109.264 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.58 -39.35 90.86 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.462 -0.79 . . . . 0.91000000000000003 110.852 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -64.22 -55.0 24.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.91000000000000003 110.871 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 256' ' ' ARG . 11.8 pt -65.99 -34.84 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 111.166 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 255' ' ' ILE . 6.7 mtt-85 -70.05 -31.45 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.927 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.53 56.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.56999999999999995 112.445 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.0 OUTLIER -64.94 -44.28 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.56999999999999995 111.149 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.6 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.08 -19.96 61.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.913 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.391 2.406 0 CA-C-O 126.135 2.874 . . . . 0.56999999999999995 107.782 -174.707 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 123.835 1.779 . . . . 1.2 107.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -48.79 1.73 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-N 112.653 -2.067 . . . . 0.56999999999999995 109.89 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -85.11 -37.47 20.21 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-O 124.226 1.965 . . . . 0.56999999999999995 107.838 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -81.39 122.46 27.52 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.066 -1.425 . . . . 0.56999999999999995 110.882 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.94 138.67 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.163 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.465 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 70.6 p -131.1 157.27 43.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.139 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.657 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -137.41 159.38 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.874 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -135.08 129.4 33.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD13 HG23 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -99.08 124.72 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.145 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . 15.7 t-20 -41.81 -59.41 1.69 Allowed 'General case' 0 C--N 1.384 2.108 0 C-N-CA 117.498 -1.681 . . . . 0.56999999999999995 110.122 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 164.36 35.49 0.0 OUTLIER 'General case' 0 C--N 1.387 2.201 0 O-C-N 126.023 2.077 . . . . 0.56999999999999995 109.521 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 1.7 m-30 80.05 -173.37 0.05 Allowed 'General case' 0 C--N 1.385 2.151 0 N-CA-C 105.36 -2.089 . . . . 0.56999999999999995 105.36 170.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -130.69 160.72 65.04 Favored Pre-proline 0 C--N 1.369 1.45 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 108.835 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.66 -49.99 1.42 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.315 1.343 . . . . 0.56999999999999995 112.166 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.564 ' H ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -82.22 -65.71 0.98 Allowed 'General case' 0 C--N 1.388 2.244 0 N-CA-C 104.726 -2.324 . . . . 0.91000000000000003 104.726 -163.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.596 ' SD ' HG22 ' A' ' 130' ' ' VAL . 2.0 ttm -59.62 140.9 56.0 Favored 'General case' 0 C--N 1.38 1.912 0 CA-C-O 126.464 3.031 . . . . 0.56999999999999995 110.071 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -72.73 139.29 47.08 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 112.698 -2.046 . . . . 0.56999999999999995 109.773 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -69.63 -52.13 28.71 Favored 'General case' 0 C--N 1.374 1.658 0 N-CA-C 105.414 -2.069 . . . . 1.2 105.414 -168.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.32 -34.57 57.98 Favored 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.001 -2.363 . . . . 0.91000000000000003 110.877 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.881 ' HB3' HG21 ' A' ' 205' ' ' THR . 11.9 m-20 -69.76 -44.01 71.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.91000000000000003 110.931 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.93 -41.5 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.166 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 134' ' ' ILE . 3.5 m-20 -65.82 -40.6 92.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.91000000000000003 110.858 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -37.98 81.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.945 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.593 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.88 -49.18 71.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.091 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 131' ' ' ASP . 12.3 pt -61.4 -41.47 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -43.58 97.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 140' ' ' VAL . 2.0 tppt? -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.881 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.8 98.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.092 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 18.7 m-85 -63.7 -36.53 84.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.861 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.2 tp60 -67.71 -39.83 84.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.903 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 136' ' ' LYS . 2.3 t -68.72 -34.05 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 111.196 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -84.5 -33.38 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.919 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -73.82 -47.67 36.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.849 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.46 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -62.34 -12.05 18.88 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 118.836 -1.145 . . . . 0.56999999999999995 112.877 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG13 ' ND2' ' A' ' 143' ' ' ASN . 8.4 m -108.71 0.1 9.71 Favored 'Isoleucine or valine' 0 C--N 1.379 1.882 0 CA-C-N 113.844 -1.525 . . . . 0.56999999999999995 112.675 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.663 HG22 ' HD2' ' A' ' 146' ' ' PRO . 2.1 m -150.53 140.43 13.88 Favored Pre-proline 0 C--N 1.376 1.745 0 CA-C-O 124.234 1.969 . . . . 0.56999999999999995 110.559 -172.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.687 ' O ' HD23 ' A' ' 147' ' ' LEU . 45.5 Cg_endo -79.6 63.16 8.7 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.092 1.861 . . . . 0.56999999999999995 114.048 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -146.39 120.62 9.53 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 105.824 -1.917 . . . . 0.56999999999999995 105.824 -169.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 158.28 34.79 Favored 'General case' 0 C--N 1.382 1.982 0 CA-C-N 113.278 -1.783 . . . . 0.56999999999999995 113.416 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HZ ' HD22 ' A' ' 224' ' ' LEU . 0.8 OUTLIER -129.31 136.31 49.87 Favored 'General case' 0 C--N 1.388 2.276 0 CA-C-N 112.68 -2.055 . . . . 0.56999999999999995 109.818 -177.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.98 111.83 3.52 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 124.808 2.242 . . . . 0.56999999999999995 109.163 -175.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tttm -89.34 146.66 24.55 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 114.108 -1.405 . . . . 0.56999999999999995 111.938 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 154' ' ' THR . 4.9 pt -130.64 163.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 109.498 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 9.04 13.4 Favored 'General case' 0 C--N 1.382 2.004 0 CA-C-N 113.06 -1.882 . . . . 0.56999999999999995 111.552 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.489 ' O ' HD12 ' A' ' 152' ' ' ILE . 6.8 m -145.0 125.97 14.48 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.97 -130.17 10.15 Favored Glycine 0 C--N 1.376 2.785 0 N-CA-C 109.389 -1.484 . . . . 0.56999999999999995 109.389 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.5 ttp -150.66 146.95 26.81 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.986 1.375 . . . . 0.56999999999999995 107.303 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.465 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -127.35 177.06 6.97 Favored 'General case' 0 C--N 1.373 1.59 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 109.695 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -65.23 -68.18 0.38 Allowed 'General case' 0 C--N 1.378 1.846 0 N-CA-C 104.69 -2.337 . . . . 0.91000000000000003 104.69 -168.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.0 mp -92.87 110.26 22.8 Favored 'Isoleucine or valine' 0 C--N 1.378 1.805 0 O-C-N 124.649 1.218 . . . . 0.56999999999999995 111.098 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 121.81 46.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 118' ' ' ILE . 2.5 m -102.48 116.95 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.56999999999999995 111.136 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.615 HG22 ' CD2' ' A' ' 196' ' ' HIS . 1.5 m -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.152 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.13 125.71 33.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.887 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 168' ' ' HIS . . . -144.5 169.88 17.1 Favored 'General case' 0 C--N 1.369 1.445 0 C-N-CA 117.898 -1.521 . . . . 0.56999999999999995 107.675 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 168.29 9.42 Favored 'General case' 0 C--N 1.367 1.343 0 CA-C-N 114.2 -1.363 . . . . 1.2 108.608 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -44.6 132.81 7.35 Favored Glycine 0 C--N 1.377 2.856 0 O-C-N 124.933 1.396 . . . . 0.56999999999999995 111.82 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.99 105.39 0.06 Allowed 'General case' 0 C--N 1.401 2.822 0 CA-C-O 124.668 2.175 . . . . 0.56999999999999995 112.385 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 164' ' ' ALA . 3.5 p-80 . . . . . 0 C--N 1.387 2.206 0 CA-C-O 123.401 1.572 . . . . 0.56999999999999995 111.995 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 CA-C-O 123.328 1.537 . . . . 0.56999999999999995 109.873 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.647 ' CZ ' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -117.19 -165.79 1.11 Allowed 'General case' 0 C--N 1.386 2.185 0 CA-C-N 113.146 -1.843 . . . . 0.56999999999999995 111.353 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.27 159.8 16.35 Favored 'General case' 0 C--N 1.38 1.913 0 CA-C-N 114.45 -1.25 . . . . 0.91000000000000003 109.849 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -136.52 62.28 0.6 Allowed Glycine 0 C--N 1.378 2.895 0 CA-C-O 123.869 1.816 . . . . 0.56999999999999995 110.095 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -166.66 -35.53 0.03 OUTLIER 'General case' 0 C--N 1.376 1.736 0 CA-C-N 113.23 -1.485 . . . . 0.56999999999999995 112.713 169.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.48 -63.68 0.04 OUTLIER Glycine 0 C--N 1.37 2.457 0 C-N-CA 119.567 -1.301 . . . . 0.56999999999999995 113.003 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 180' ' ' ILE . . . -35.88 112.39 0.12 Allowed Glycine 0 C--N 1.375 2.729 0 N-CA-C 109.241 -1.544 . . . . 0.56999999999999995 109.241 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.647 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 88.91 52.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.889 0 O-C-N 119.217 -2.343 . . . . 0.56999999999999995 108.559 175.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.479 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 2.5 tp -43.11 -30.91 0.49 Allowed 'General case' 0 C--N 1.375 1.697 0 CA-C-O 123.797 1.76 . . . . 0.56999999999999995 112.083 -174.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -179.49 179.78 0.58 Allowed 'General case' 0 C--N 1.368 1.41 0 CA-C-N 113.229 -1.805 . . . . 0.56999999999999995 111.123 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.589 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -142.56 164.67 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.837 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.79 140.87 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -89.93 152.49 21.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 117.816 -1.554 . . . . 0.56999999999999995 109.449 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -92.54 -42.17 4.59 Favored Glycine 0 C--N 1.373 2.595 0 CA-C-N 114.417 -1.265 . . . . 0.56999999999999995 113.623 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 50.7 Cg_exo -63.53 -143.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.401 3.32 0 CA-C-O 125.953 2.397 . . . . 0.56999999999999995 111.676 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -151.47 -148.31 4.78 Favored Glycine 0 C--N 1.376 2.755 0 C-N-CA 117.493 -2.289 . . . . 0.56999999999999995 109.781 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.2 m 77.76 52.17 0.04 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-N 112.629 -1.785 . . . . 0.56999999999999995 107.512 171.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.54 -72.73 2.75 Favored Glycine 0 C--N 1.376 2.761 0 N-CA-C 106.919 -2.473 . . . . 0.56999999999999995 106.919 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 189' ' ' SER . 1.9 mp -70.12 -48.2 63.48 Favored 'Isoleucine or valine' 0 C--N 1.374 1.649 0 CA-C-O 125.85 2.738 . . . . 0.56999999999999995 105.515 -171.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.29 153.92 53.03 Favored Glycine 0 C--N 1.378 2.91 0 C-N-CA 116.282 -2.866 . . . . 0.56999999999999995 108.351 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 80.96 -15.23 22.46 Favored Glycine 0 C--N 1.372 2.549 0 CA-C-O 124.178 1.988 . . . . 0.56999999999999995 113.305 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.07 146.38 53.54 Favored 'General case' 0 C--N 1.374 1.636 0 O-C-N 120.287 -1.714 . . . . 0.91000000000000003 110.833 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -144.04 137.36 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.56999999999999995 111.098 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.615 ' CD2' HG22 ' A' ' 162' ' ' VAL . 1.1 m170 -128.39 150.17 50.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.791 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -123.11 150.19 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.48 112.62 14.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.799 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -43.5 88.54 Favored 'General case' 0 C--N 1.383 2.053 0 CA-C-O 117.436 -1.268 . . . . 0.91000000000000003 108.966 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.74 -32.85 0.65 Allowed 'General case' 0 C--N 1.38 1.9 0 O-C-N 125.646 1.841 . . . . 0.91000000000000003 108.959 -173.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.96 176.1 0.44 Allowed 'General case' 0 C--N 1.384 2.072 0 CA-C-O 126.535 3.064 . . . . 0.91000000000000003 109.216 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.91 80.5 1.33 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-N 112.615 -2.084 . . . . 0.56999999999999995 109.016 -175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 79.6 m95 -76.13 109.14 9.54 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 106.977 -1.49 . . . . 0.56999999999999995 106.977 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.57 121.88 31.75 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-O 125.149 2.404 . . . . 0.56999999999999995 109.869 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.881 HG21 ' HB3' ' A' ' 129' ' ' ASP . 11.2 p -96.99 151.27 19.87 Favored 'General case' 0 C--N 1.368 1.395 0 N-CA-C 106.198 -1.778 . . . . 0.56999999999999995 106.198 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.65 -48.55 0.23 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 114.316 -1.311 . . . . 0.56999999999999995 109.915 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.3 m -168.78 137.98 2.21 Favored 'General case' 0 C--N 1.384 2.092 0 N-CA-C 108.05 -1.093 . . . . 0.56999999999999995 108.05 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 148.2 -36.92 1.09 Allowed Glycine 0 C--N 1.382 3.122 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 111.671 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 148.82 -84.16 0.17 Allowed Glycine 0 C--N 1.386 3.344 0 CA-C-O 123.801 1.778 . . . . 0.56999999999999995 111.686 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.0 p -78.7 135.94 37.3 Favored 'General case' 0 C--N 1.383 2.025 0 CA-C-N 113.079 -1.56 . . . . 0.56999999999999995 110.964 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.71 141.39 52.14 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 113.949 -1.478 . . . . 0.56999999999999995 108.011 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.743 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.4 tm? -71.15 -26.74 63.13 Favored 'General case' 0 C--N 1.387 2.225 0 CA-C-O 125.086 2.374 . . . . 0.56999999999999995 108.576 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.545 ' CD1' HG12 ' A' ' 245' ' ' ILE . 3.5 t80 -57.6 -50.15 74.08 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-N 113.862 -1.517 . . . . 0.56999999999999995 110.855 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -51.22 69.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.933 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -44.41 97.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HA ' ' OE2' ' A' ' 219' ' ' GLU . . . -57.08 -41.36 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.079 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.42 -39.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 111.096 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.458 ' CD2' ' CE ' ' A' ' 236' ' ' MET . 3.7 t-160 -70.08 -50.51 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.802 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 216' ' ' ALA . 0.7 OUTLIER -64.08 -42.02 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.91000000000000003 110.902 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.713 HG22 HD23 ' A' ' 224' ' ' LEU . 69.8 mt -69.01 -34.22 62.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 111.113 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 225' ' ' GLY . . . -69.19 -33.48 73.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.699 -0.762 . . . . 0.56999999999999995 112.444 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.59 -44.02 95.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 110.842 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.24 -49.96 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 220' ' ' ILE . 0.5 OUTLIER -84.04 13.48 5.02 Favored 'General case' 0 C--N 1.392 2.441 0 CA-C-O 123.595 1.664 . . . . 0.56999999999999995 115.324 177.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 221' ' ' GLY . . . -153.12 176.93 31.02 Favored Glycine 0 C--N 1.363 2.04 0 CA-C-O 126.635 3.353 . . . . 0.56999999999999995 108.167 -168.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -158.93 0.23 Allowed 'General case' 0 C--N 1.367 1.337 0 CA-C-O 125.873 2.749 . . . . 0.56999999999999995 109.278 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.78 -143.18 0.11 Allowed Glycine 0 C--N 1.387 3.411 0 CA-C-O 125.524 2.736 . . . . 0.56999999999999995 112.311 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 236' ' ' MET . 34.0 m170 -83.83 -175.29 5.74 Favored 'General case' 0 C--N 1.379 1.861 0 O-C-N 120.444 -1.621 . . . . 0.56999999999999995 114.609 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.528 ' CB ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -99.11 -84.46 0.4 Allowed 'General case' 0 C--N 1.389 2.308 0 N-CA-C 106.448 -1.686 . . . . 0.56999999999999995 106.448 179.314 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 m 155.81 -30.25 0.0 OUTLIER 'General case' 0 C--N 1.389 2.29 0 O-C-N 125.842 1.964 . . . . 0.56999999999999995 113.168 -167.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.596 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 3.3 t70 -110.2 152.07 42.95 Favored Pre-proline 0 C--N 1.388 2.282 0 N-CA-C 108.291 -1.003 . . . . 0.91000000000000003 108.291 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -60.7 -47.83 12.48 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.687 2.258 . . . . 0.56999999999999995 111.92 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.42 22.79 Favored 'General case' 0 C--N 1.381 1.948 0 CA-C-N 113.252 -1.794 . . . . 0.56999999999999995 115.284 176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -71.46 120.11 16.57 Favored 'General case' 0 C--N 1.375 1.674 0 CA-C-O 125.158 2.408 . . . . 0.56999999999999995 113.0 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 236' ' ' MET . 68.2 t -73.93 86.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.867 0 CA-C-N 111.446 -2.615 . . . . 0.56999999999999995 108.612 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 218' ' ' HIS . 0.0 OUTLIER 162.06 -34.28 0.0 OUTLIER 'General case' 0 C--N 1.377 1.802 0 O-C-N 125.37 1.669 . . . . 0.56999999999999995 109.273 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 4.4 t80 -49.97 146.96 7.33 Favored Pre-proline 0 C--N 1.372 1.579 0 CA-C-O 122.971 1.367 . . . . 0.56999999999999995 110.223 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 74.0 Cg_exo -56.53 -36.99 98.27 Favored 'Trans proline' 0 C--N 1.393 2.904 0 C-N-CA 122.219 1.946 . . . . 0.56999999999999995 112.406 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -45.39 111.79 0.38 Allowed 'General case' 0 C--N 1.376 1.741 0 CA-C-O 123.633 1.683 . . . . 0.56999999999999995 110.642 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -83.92 94.62 8.29 Favored 'General case' 0 C--N 1.38 1.914 0 CA-C-O 124.385 2.041 . . . . 0.56999999999999995 106.431 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -110.84 119.41 39.01 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 108.124 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -55.6 120.91 7.96 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-O 126.105 2.859 . . . . 0.56999999999999995 110.991 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 248' ' ' PHE . 5.4 p -140.79 115.23 5.88 Favored 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 105.86 -1.904 . . . . 0.56999999999999995 105.86 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -77.3 33.46 0.16 Allowed 'General case' 0 C--N 1.364 1.239 0 N-CA-C 114.885 1.439 . . . . 0.91000000000000003 114.885 170.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.545 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.5 mt 82.94 -2.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.382 1.987 0 CA-C-O 124.145 1.926 . . . . 0.56999999999999995 108.713 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -88.5 -35.48 16.96 Favored 'General case' 0 C--N 1.38 1.904 0 N-CA-C 103.016 -2.957 . . . . 0.56999999999999995 103.016 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.27 3.47 15.97 Favored 'General case' 0 C--N 1.387 2.229 0 CA-C-N 113.47 -1.695 . . . . 0.56999999999999995 109.778 -173.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.485 ' N ' HG21 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -80.72 12.06 3.43 Favored 'General case' 0 C--N 1.386 2.195 0 O-C-N 125.754 1.909 . . . . 0.56999999999999995 109.86 -171.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 154.07 12.02 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 124.724 2.202 . . . . 1.2 107.778 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -120.07 126.97 52.08 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 103.676 -2.713 . . . . 0.56999999999999995 103.676 -167.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.03 140.53 48.79 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-O 124.883 2.278 . . . . 0.56999999999999995 116.323 169.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.47 86.83 Favored 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.689 -1.596 . . . . 0.56999999999999995 110.184 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.22 -33.12 74.69 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.994 -1.003 . . . . 0.91000000000000003 110.863 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -63.95 -55.23 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.91000000000000003 110.901 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.5 pt -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.144 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.418 ' N ' HG13 ' A' ' 255' ' ' ILE . 75.8 mtt-85 -70.17 -32.95 71.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.92 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.7 -48.0 58.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.56999999999999995 112.495 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.3 pt -62.42 -45.8 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.56999999999999995 111.1 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.467 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.1 pt20 -72.53 -19.11 61.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 110.954 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.377 1.775 0 CA-C-O 122.575 1.178 . . . . 0.56999999999999995 110.687 -176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.013 0 CA-C-O 122.341 1.067 . . . . 1.2 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 60.14 176.94 0.09 Allowed 'General case' 0 C--N 1.399 2.746 0 CA-C-N 113.407 -1.724 . . . . 0.56999999999999995 110.471 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.27 -84.99 0.03 OUTLIER 'General case' 0 C--N 1.387 2.224 0 CA-C-N 114.23 -1.35 . . . . 0.56999999999999995 110.323 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 150' ' ' SER . 31.0 t80 -117.49 107.08 13.87 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.44 1.713 . . . . 0.56999999999999995 110.933 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 ' OD2' ' A' ' 158' ' ' ASP . 0.7 OUTLIER -103.0 147.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.149 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.688 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -109.79 134.96 51.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.145 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -143.87 155.61 44.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.892 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -142.43 139.4 31.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.851 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.08 142.97 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.118 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 163' ' ' PHE . 22.9 t30 -54.07 -63.87 1.01 Allowed 'General case' 0 C--N 1.366 1.29 0 N-CA-C 108.433 -0.951 . . . . 0.56999999999999995 108.433 -171.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.45 -172.01 3.2 Favored 'General case' 0 C--N 1.38 1.916 0 N-CA-C 107.398 -1.334 . . . . 0.56999999999999995 107.398 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' HG22 ' A' ' 122' ' ' THR . 3.3 p90 -176.96 82.57 0.02 OUTLIER 'General case' 0 C--N 1.39 2.327 0 CA-C-O 124.419 2.057 . . . . 0.56999999999999995 113.653 -172.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.53 HG23 ' CD ' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -171.71 -56.28 0.0 OUTLIER Pre-proline 0 C--N 1.372 1.574 0 O-C-N 119.894 -1.753 . . . . 0.56999999999999995 110.167 -174.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.53 ' CD ' HG23 ' A' ' 122' ' ' THR . 12.0 Cg_endo -69.9 -55.31 0.18 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 N-CA-C 107.932 -1.603 . . . . 0.56999999999999995 107.932 -171.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -129.46 -12.07 4.47 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 114.221 -1.354 . . . . 0.91000000000000003 110.921 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -114.19 128.08 56.2 Favored 'General case' 0 C--N 1.38 1.907 0 CA-C-O 124.638 2.161 . . . . 0.56999999999999995 106.798 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.819 ' H ' HG21 ' A' ' 205' ' ' THR . 0.5 OUTLIER -90.02 144.56 25.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.446 -2.659 . . . . 0.56999999999999995 110.256 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -53.49 8.27 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 106.409 -1.701 . . . . 1.2 106.409 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.54 -37.69 88.42 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-N 114.222 -1.354 . . . . 0.91000000000000003 110.934 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 205' ' ' THR . 19.4 t70 -70.2 -44.06 69.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.91000000000000003 110.896 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.75 HG22 ' HG ' ' A' ' 212' ' ' LEU . 21.0 t -69.22 -46.28 77.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.095 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -56.82 -44.16 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.839 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -39.6 90.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.733 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -65.37 -49.07 70.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.56999999999999995 111.141 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 135' ' ' ARG . 48.4 pt -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.172 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.458 ' N ' HG13 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -61.06 -49.32 77.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.853 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -35.66 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.88 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.913 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -65.98 -41.41 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.133 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 149' ' ' PHE . 1.8 m-85 -67.25 -33.67 75.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.835 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.6 pt20 -68.44 -40.72 81.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.912 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -70.53 -34.35 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.168 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.801 ' CD2' HD11 ' A' ' 224' ' ' LEU . 4.4 m95 -83.25 -33.72 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.6 m -78.26 -50.55 11.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.898 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.756 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -56.59 -13.88 2.75 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 113.278 0.844 . . . . 0.56999999999999995 113.278 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.756 HG13 ' ND2' ' A' ' 143' ' ' ASN . 18.2 m -114.52 9.11 7.7 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 CA-C-N 114.541 -1.209 . . . . 0.56999999999999995 111.451 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.2 p -149.23 147.17 22.78 Favored Pre-proline 0 C--N 1.373 1.594 0 CA-C-O 124.599 2.142 . . . . 0.56999999999999995 108.484 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.85 22.07 1.0 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 121.544 1.496 . . . . 0.56999999999999995 113.056 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.91 101.03 6.15 Favored 'General case' 0 C--N 1.378 1.829 0 N-CA-C 105.619 -1.993 . . . . 0.56999999999999995 105.619 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.27 159.59 30.98 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-O 126.77 3.176 . . . . 0.56999999999999995 116.263 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . 45.6 m-85 -132.19 162.64 30.42 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.533 -2.122 . . . . 0.56999999999999995 107.396 -177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 113' ' ' TYR . 54.3 m -157.67 123.33 4.62 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 125.859 2.742 . . . . 0.56999999999999995 108.394 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -95.97 141.48 29.34 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 110.972 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 155' ' ' GLY . 4.4 pt -129.93 159.55 41.85 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-O 124.276 1.988 . . . . 0.56999999999999995 108.986 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.4 -15.01 14.56 Favored 'General case' 0 C--N 1.384 2.097 0 CA-C-N 113.117 -1.856 . . . . 0.56999999999999995 107.807 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 89.3 m -60.22 -59.8 4.83 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 123.343 1.544 . . . . 0.56999999999999995 107.373 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.511 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 138.93 146.16 4.9 Favored Glycine 0 C--N 1.38 2.997 0 N-CA-C 110.539 -1.024 . . . . 0.56999999999999995 110.539 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.6 ttp 78.79 88.59 0.06 Allowed 'General case' 0 C--N 1.399 2.758 0 CA-C-O 124.465 2.078 . . . . 0.56999999999999995 110.075 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -133.9 172.16 13.18 Favored 'General case' 0 C--N 1.373 1.622 0 CA-C-N 113.158 -1.837 . . . . 0.56999999999999995 109.718 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 115' ' ' THR . 33.1 m-20 -61.15 -59.4 5.39 Favored 'General case' 0 C--N 1.37 1.469 0 N-CA-C 105.836 -1.913 . . . . 0.91000000000000003 105.836 -173.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.82 109.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.388 2.282 0 O-C-N 124.326 1.016 . . . . 0.56999999999999995 111.118 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -100.8 128.59 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.933 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 197' ' ' PHE . 17.4 t -105.48 118.26 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.087 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 196' ' ' HIS . 6.8 t -131.48 132.16 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.085 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 119' ' ' ASN . 4.2 m-85 -90.61 121.32 32.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.836 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.15 166.57 24.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 107.599 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 167.62 9.76 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 114.19 -1.368 . . . . 1.2 109.888 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -39.45 121.49 1.42 Allowed Glycine 0 C--N 1.395 3.825 0 O-C-N 125.297 1.623 . . . . 0.56999999999999995 111.018 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 87.71 80.9 0.01 OUTLIER 'General case' 0 C--N 1.397 2.653 0 CA-C-O 125.214 2.435 . . . . 0.56999999999999995 109.882 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 C--N 1.39 2.351 0 CA-C-N 113.13 -1.85 . . . . 0.56999999999999995 110.494 -179.446 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 122.609 1.195 . . . . 0.56999999999999995 111.768 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.434 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -124.11 -161.5 1.0 Allowed 'General case' 0 C--N 1.39 2.361 0 CA-C-N 113.01 -1.904 . . . . 0.56999999999999995 111.804 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.448 ' CB ' ' H ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -87.61 -54.38 4.3 Favored 'General case' 0 C--N 1.388 2.269 0 CA-C-N 114.676 -1.147 . . . . 0.91000000000000003 111.934 174.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.03 105.64 0.05 OUTLIER Glycine 0 C--N 1.396 3.87 0 C-N-CA 118.591 -1.766 . . . . 0.56999999999999995 117.317 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.66 90.4 0.09 Allowed 'General case' 0 C--N 1.381 1.967 0 CA-C-O 125.28 2.467 . . . . 0.56999999999999995 112.43 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.29 -144.73 26.09 Favored Glycine 0 C--N 1.381 3.079 0 O-C-N 119.529 -1.982 . . . . 0.56999999999999995 113.453 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.425 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 52.72 -118.96 8.6 Favored Glycine 0 C--N 1.395 3.817 0 N-CA-C 108.39 -1.884 . . . . 0.56999999999999995 108.39 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.448 ' H ' ' CB ' ' A' ' 175' ' ' ASP . 0.6 OUTLIER -76.57 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.706 0 N-CA-C 105.94 -1.874 . . . . 0.56999999999999995 105.94 -175.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.899 HD22 ' CE1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -38.23 -33.94 0.11 Allowed 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.881 -175.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -178.41 179.95 0.73 Allowed 'General case' 0 C--N 1.383 2.057 0 O-C-N 125.727 1.892 . . . . 0.56999999999999995 111.081 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.456 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -151.03 151.01 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.865 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 195' ' ' ALA . . . -142.81 140.36 31.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.063 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.1 OUTLIER -87.64 124.24 33.33 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 118.323 -1.351 . . . . 0.56999999999999995 108.715 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -124.48 50.19 0.87 Allowed Glycine 0 C--N 1.371 2.476 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 113.579 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 33.9 Cg_endo -76.49 -52.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 121.217 1.278 . . . . 0.56999999999999995 109.765 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.17 47.36 0.71 Allowed Glycine 0 C--N 1.392 3.642 0 CA-C-O 123.759 1.755 . . . . 0.56999999999999995 111.869 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -155.02 -147.79 0.22 Allowed 'General case' 0 C--N 1.384 2.065 0 O-C-N 121.074 -1.251 . . . . 0.56999999999999995 108.732 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -55.85 -79.19 0.1 OUTLIER Glycine 0 C--N 1.388 3.466 0 CA-C-O 126.105 3.058 . . . . 0.56999999999999995 112.531 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -11.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.387 2.232 0 CA-C-O 124.823 2.249 . . . . 0.56999999999999995 110.362 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.06 126.51 22.71 Favored Glycine 0 C--N 1.37 2.446 0 O-C-N 118.292 -2.755 . . . . 0.56999999999999995 111.829 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 108.93 -50.14 0.8 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 113.527 -1.336 . . . . 0.56999999999999995 111.985 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -34.92 102.7 0.02 OUTLIER 'General case' 0 C--N 1.379 1.877 0 O-C-N 124.649 0.852 . . . . 0.91000000000000003 110.901 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 184' ' ' ALA . . . -116.52 150.32 38.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.068 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.469 ' CD2' ' HB ' ' A' ' 162' ' ' VAL . 19.5 m170 -135.03 139.16 44.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 110.854 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -111.09 150.11 29.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 110.903 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 1.5 m-20 -58.31 110.82 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.788 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 4.2 tp10 -77.91 -20.66 52.47 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-O 126.423 3.011 . . . . 0.91000000000000003 108.555 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -12.38 60.27 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 118.3 -2.75 . . . . 0.91000000000000003 110.712 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -82.05 -179.63 7.47 Favored 'General case' 0 C--N 1.398 2.678 0 N-CA-C 102.651 -3.092 . . . . 0.91000000000000003 102.651 -168.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.98 82.05 1.59 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.346 -1.752 . . . . 0.56999999999999995 110.624 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 60.5 m95 -72.51 102.93 3.35 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 123.788 1.756 . . . . 0.56999999999999995 108.754 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.629 HG21 ' O ' ' A' ' 208' ' ' GLY . 0.1 OUTLIER -80.35 130.82 35.44 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 113.762 -1.563 . . . . 0.56999999999999995 110.953 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.819 HG21 ' H ' ' A' ' 126' ' ' ASN . 7.7 p -119.02 101.24 7.88 Favored 'General case' 0 C--N 1.385 2.135 0 CA-C-N 113.034 -1.894 . . . . 0.56999999999999995 107.752 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 77.6 36.73 0.26 Allowed 'General case' 0 C--N 1.403 2.9 0 CA-C-O 126.039 2.828 . . . . 0.56999999999999995 104.863 168.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 t -138.07 -92.22 0.21 Allowed 'General case' 0 C--N 1.391 2.406 0 CA-C-N 112.716 -2.038 . . . . 0.56999999999999995 109.053 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.629 ' O ' HG21 ' A' ' 204' ' ' THR . . . -173.58 156.39 24.0 Favored Glycine 0 C--N 1.38 3.022 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 110.541 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.24 -136.44 13.01 Favored Glycine 0 C--N 1.369 2.412 0 CA-C-O 124.126 1.959 . . . . 0.56999999999999995 111.242 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.9 m -69.08 117.54 10.86 Favored 'General case' 0 C--N 1.384 2.078 0 CA-C-O 123.317 1.532 . . . . 0.56999999999999995 112.517 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -102.92 153.91 19.74 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.311 1.529 . . . . 0.56999999999999995 111.603 176.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.75 ' HG ' HG22 ' A' ' 130' ' ' VAL . 2.1 tm? -72.72 -31.45 64.98 Favored 'General case' 0 C--N 1.389 2.324 0 CA-C-N 113.347 -1.752 . . . . 0.56999999999999995 106.653 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.6 t80 -59.04 -50.46 73.99 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.086 -1.634 . . . . 0.56999999999999995 110.859 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.719 HD21 ' CE1' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -58.19 -51.83 68.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.906 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.53 -33.96 75.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.178 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 219' ' ' GLU . . . -68.83 -39.48 79.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.56999999999999995 111.114 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 213' ' ' PHE . 41.4 t -68.1 -38.46 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 111.154 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -70.06 -50.85 37.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.56999999999999995 110.837 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' HG23 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -56.6 -45.19 81.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.91000000000000003 110.913 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.913 HD11 ' HB1' ' A' ' 137' ' ' ALA . 5.5 pt -72.73 -39.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 111.075 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.03 -33.88 64.92 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.474 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.86 -44.02 94.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.56999999999999995 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -50.24 55.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.828 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.801 HD11 ' CD2' ' A' ' 141' ' ' TRP . 3.4 pp -75.82 0.6 17.51 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.954 2.576 . . . . 0.56999999999999995 117.954 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -145.73 -158.79 7.86 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 -173.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.28 -156.73 0.76 Allowed 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 107.678 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -55.93 -167.21 0.06 OUTLIER Glycine 0 C--N 1.397 3.951 0 CA-C-O 125.717 2.843 . . . . 0.56999999999999995 112.486 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.5 m80 -100.28 -150.31 0.38 Allowed 'General case' 0 C--N 1.37 1.484 0 O-C-N 120.387 -1.654 . . . . 0.56999999999999995 110.225 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.803 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 9.1 p -122.39 -24.24 5.05 Favored 'General case' 0 C--N 1.387 2.219 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 110.493 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 83.06 16.43 0.31 Allowed 'General case' 0 C--N 1.398 2.704 0 CA-C-O 123.2 1.476 . . . . 0.56999999999999995 113.21 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -134.29 150.28 73.59 Favored Pre-proline 0 C--N 1.386 2.18 0 N-CA-C 104.818 -2.29 . . . . 0.91000000000000003 104.818 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 72.5 Cg_exo -56.6 -20.58 34.81 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.091 2.527 . . . . 0.56999999999999995 114.036 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -40.29 85.09 Favored 'General case' 0 C--N 1.385 2.142 0 CA-C-N 113.329 -1.76 . . . . 0.56999999999999995 115.628 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -51.79 128.33 23.43 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 123.86 1.79 . . . . 0.56999999999999995 110.716 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 249' ' ' ARG . 0.4 OUTLIER -75.52 2.48 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.126 0 CA-C-O 125.38 2.514 . . . . 0.56999999999999995 111.53 -177.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.496 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 5.7 ptm -142.31 8.19 1.79 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 120.422 -1.424 . . . . 0.56999999999999995 110.188 -175.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.862 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -42.79 143.96 1.11 Allowed Pre-proline 0 C--N 1.37 1.459 0 CA-C-O 124.097 1.903 . . . . 0.56999999999999995 112.844 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.92 -50.31 14.41 Favored 'Trans proline' 0 C--N 1.371 1.728 0 O-C-N 119.481 -0.852 . . . . 0.56999999999999995 112.351 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.505 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -52.46 126.46 19.45 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-O 123.318 1.532 . . . . 0.56999999999999995 109.669 -175.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.899 ' CE1' HD22 ' A' ' 181' ' ' LEU . 78.4 t80 -99.28 166.57 11.15 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 119.959 -1.713 . . . . 0.56999999999999995 107.833 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 169.36 121.45 0.01 OUTLIER 'General case' 0 C--N 1.39 2.352 0 N-CA-C 106.058 -1.83 . . . . 0.56999999999999995 106.058 173.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.85 121.6 6.19 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.882 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 243' ' ' VAL . 7.1 p -147.38 113.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.741 -1.572 . . . . 0.56999999999999995 107.702 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -44.65 146.0 0.81 Allowed 'General case' 0 C--N 1.383 2.044 0 CA-C-O 125.737 2.684 . . . . 0.91000000000000003 107.719 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 213' ' ' PHE . 3.9 mp -62.03 -22.87 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-N 113.319 -1.764 . . . . 0.56999999999999995 112.603 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.66 -21.93 66.63 Favored 'General case' 0 C--N 1.372 1.585 0 CA-C-O 123.034 1.397 . . . . 0.56999999999999995 111.397 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.6 p -108.36 1.11 21.58 Favored 'General case' 0 C--N 1.385 2.134 0 N-CA-C 114.904 1.446 . . . . 0.56999999999999995 114.904 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CE1' HG11 ' A' ' 217' ' ' VAL . 51.3 t80 -74.47 83.84 1.99 Allowed 'General case' 0 C--N 1.376 1.725 0 CA-C-O 124.973 2.32 . . . . 0.56999999999999995 109.292 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 235' ' ' VAL . 1.6 tmt_? -99.32 154.79 17.91 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-O 123.813 1.768 . . . . 1.2 108.913 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.725 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -121.84 136.1 54.92 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 106.246 -173.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 42.5 m -67.67 137.65 55.73 Favored 'General case' 0 C--N 1.376 1.719 0 CA-C-N 113.305 -1.771 . . . . 0.56999999999999995 111.627 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.08 -46.36 81.45 Favored 'General case' 0 C--N 1.384 2.099 0 N-CA-C 108.055 -1.091 . . . . 0.56999999999999995 108.055 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.71 -36.81 79.76 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 115.41 -0.814 . . . . 0.91000000000000003 110.845 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 258' ' ' ILE . 40.8 t0 -63.46 -55.22 25.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.91000000000000003 110.846 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 21.3 pt -66.09 -36.38 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.116 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 4.3 mtt-85 -70.32 -33.33 71.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.828 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.86 76.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.56999999999999995 112.48 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.81 -45.05 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.685 0.279 . . . . 0.56999999999999995 111.052 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.497 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.14 -23.5 61.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.981 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.366 1.302 0 CA-C-O 122.403 1.096 . . . . 0.56999999999999995 109.785 -178.064 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 CA-C-O 119.319 -0.711 . . . . 0.56999999999999995 111.612 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.82 108.39 2.64 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.316 2.677 . . . . 0.56999999999999995 108.983 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.41 122.8 66.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.545 0 CA-C-N 114.755 -1.111 . . . . 0.56999999999999995 109.057 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -166.59 72.88 0.14 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 124.397 2.046 . . . . 0.56999999999999995 109.121 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 mtt-85 -115.48 156.67 25.25 Favored 'General case' 0 C--N 1.375 1.679 0 CA-C-O 123.146 1.451 . . . . 1.2 109.468 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 52.57 0.48 Allowed 'General case' 0 C--N 1.379 1.87 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 108.179 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -168.96 -55.39 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.219 -1.355 . . . . 0.56999999999999995 109.321 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -98.62 112.13 24.28 Favored 'General case' 0 C--N 1.371 1.515 0 O-C-N 124.006 0.816 . . . . 0.56999999999999995 110.934 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 158' ' ' ASP . 1.2 mm -111.72 151.01 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.062 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -106.0 159.77 15.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.56999999999999995 111.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.477 ' OH ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -148.59 150.51 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.92 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -142.8 132.91 24.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 1.2 110.889 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.97 140.46 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.147 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.538 ' ND2' HG22 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -66.87 -160.88 0.02 OUTLIER 'General case' 0 C--N 1.379 1.883 0 CA-C-O 124.362 2.03 . . . . 0.56999999999999995 109.718 -174.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -73.32 39.38 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 O-C-N 118.572 -2.58 . . . . 0.56999999999999995 111.069 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.505 ' C ' HG23 ' A' ' 122' ' ' THR . 9.2 m-85 59.33 16.8 5.32 Favored 'General case' 0 C--N 1.386 2.161 0 O-C-N 124.362 1.039 . . . . 0.56999999999999995 110.083 170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.631 HG22 ' CZ ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER 65.98 158.18 0.13 Allowed Pre-proline 0 C--N 1.367 1.331 0 O-C-N 128.217 3.448 . . . . 0.56999999999999995 109.793 178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.44 -43.65 0.35 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 O-C-N 118.265 -1.492 . . . . 0.56999999999999995 112.145 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.16 -63.71 1.18 Allowed 'General case' 0 C--N 1.371 1.509 0 C-N-CA 125.209 1.404 . . . . 0.91000000000000003 113.471 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.414 ' HE2' ' CD2' ' A' ' 203' ' ' TRP . 4.1 ttm -42.64 132.44 3.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 128.035 3.779 . . . . 0.56999999999999995 110.336 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.759 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.6 m120 -78.06 143.4 37.46 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.038 -2.289 . . . . 0.56999999999999995 107.97 -172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -46.59 47.06 Favored 'General case' 0 C--N 1.38 1.903 0 N-CA-C 107.03 -1.47 . . . . 1.2 107.03 -164.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -54.75 -34.78 62.99 Favored 'General case' 0 C--N 1.396 2.602 0 CA-C-N 111.428 -2.624 . . . . 0.91000000000000003 110.927 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 205' ' ' THR . 1.4 m-20 -70.11 -43.71 70.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.91000000000000003 110.933 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -63.62 -39.07 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.174 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.13 87.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.91000000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -67.32 -49.05 65.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 110.929 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.12 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 111.101 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.44 -31.94 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.17 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -67.93 -46.78 70.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CD ' ' OE1' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.56 -46.05 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.926 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.89 80.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 111.061 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 -44.11 95.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.56999999999999995 110.902 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.433 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 2.0 pt20 -63.75 -37.05 85.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.91 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -69.47 -34.01 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.13 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 145' ' ' THR . 49.6 m95 -82.97 -34.3 26.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 110.948 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -49.36 13.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.875 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.781 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -59.51 -12.71 6.83 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-O 121.429 0.633 . . . . 0.56999999999999995 112.352 -179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.781 HG13 ' ND2' ' A' ' 143' ' ' ASN . 23.8 m -115.63 16.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.377 1.774 0 C-N-CA 124.027 0.931 . . . . 0.56999999999999995 109.531 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 141' ' ' TRP . 75.2 p -146.01 150.69 43.04 Favored Pre-proline 0 C--N 1.367 1.362 0 CA-C-O 124.642 2.163 . . . . 0.56999999999999995 107.474 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -80.38 -11.01 13.31 Favored 'Trans proline' 0 C--N 1.368 1.576 0 CA-C-O 123.027 1.178 . . . . 0.56999999999999995 111.072 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.75 113.19 26.62 Favored 'General case' 0 C--N 1.371 1.529 0 N-CA-C 103.85 -2.648 . . . . 0.56999999999999995 103.85 -172.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.52 158.4 36.32 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-O 125.213 2.435 . . . . 0.56999999999999995 117.177 166.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.638 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 9.6 m-85 -131.15 158.8 39.49 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.573 -1.649 . . . . 0.56999999999999995 107.439 -174.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 125.57 5.96 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-O 124.29 1.995 . . . . 0.56999999999999995 106.956 -171.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 150.08 20.95 Favored 'General case' 0 C--N 1.367 1.363 0 CA-C-O 123.335 1.54 . . . . 0.56999999999999995 109.736 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 pt -144.15 -178.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.552 0 CA-C-O 123.618 1.675 . . . . 0.56999999999999995 108.919 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.458 ' O ' HG23 ' A' ' 154' ' ' THR . 26.3 t30 -155.09 54.59 0.64 Allowed 'General case' 0 C--N 1.379 1.89 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 107.949 -175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER -161.4 -69.27 0.06 Allowed 'General case' 0 C--N 1.377 1.781 0 C-N-CA 119.955 -0.698 . . . . 0.56999999999999995 109.813 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -86.05 173.64 46.88 Favored Glycine 0 C--N 1.372 2.569 0 CA-C-O 124.161 1.978 . . . . 0.56999999999999995 110.38 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.2 ttt -63.66 154.4 33.07 Favored 'General case' 0 C--N 1.377 1.782 0 CA-C-N 112.331 -1.935 . . . . 0.56999999999999995 107.81 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . . . -137.59 170.92 15.25 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 113.721 -1.582 . . . . 0.56999999999999995 109.636 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 114' ' ' ILE . 3.0 m-20 -83.67 -67.8 0.76 Allowed 'General case' 0 C--N 1.379 1.877 0 N-CA-C 102.255 -3.239 . . . . 0.91000000000000003 102.255 -168.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' CD1' ' HB3' ' A' ' 223' ' ' SER . 56.9 mt -92.51 109.9 22.17 Favored 'Isoleucine or valine' 0 C--N 1.402 2.871 0 O-C-N 124.544 1.153 . . . . 0.56999999999999995 111.087 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -105.45 132.11 52.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.918 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 197' ' ' PHE . 72.5 t -109.84 117.02 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 111.143 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.538 HG22 ' ND2' ' A' ' 119' ' ' ASN . 60.8 t -124.61 146.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.137 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.631 ' CZ ' HG22 ' A' ' 122' ' ' THR . 57.1 m-85 -103.74 118.48 36.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.833 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -146.25 167.59 23.12 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-O 124.109 1.909 . . . . 0.56999999999999995 109.69 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 149.29 24.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.426 -2.046 . . . . 1.2 108.524 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -40.78 121.05 1.83 Allowed Glycine 0 C--N 1.375 2.738 0 CA-C-N 113.349 -1.751 . . . . 0.56999999999999995 110.861 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -178.21 -57.8 0.01 OUTLIER 'General case' 0 C--N 1.379 1.878 0 CA-C-O 123.028 1.394 . . . . 0.56999999999999995 108.396 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -68.61 -15.56 63.57 Favored 'General case' 0 C--N 1.389 2.286 0 CA-C-O 123.266 1.507 . . . . 0.56999999999999995 109.732 -174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 177.32 -127.79 1.24 Allowed Glycine 0 C--N 1.377 2.83 0 N-CA-C 108.286 -1.925 . . . . 0.56999999999999995 108.286 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.519 ' HB3' ' CD2' ' A' ' 174' ' ' PHE . 3.2 m-20 67.84 26.44 7.62 Favored 'General case' 0 C--N 1.382 2.012 0 N-CA-C 105.825 -1.917 . . . . 0.91000000000000003 105.825 170.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 76.58 54.51 0.04 OUTLIER 'General case' 0 C--N 1.379 1.872 0 CA-C-N 114.67 -1.15 . . . . 0.56999999999999995 108.205 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 64.07 42.37 5.74 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 119.19 -1.004 . . . . 0.56999999999999995 111.814 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.94 95.63 0.03 OUTLIER 'General case' 0 C--N 1.368 1.395 0 CA-C-O 122.616 1.198 . . . . 0.56999999999999995 111.44 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -57.44 -97.52 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 123.986 1.85 . . . . 0.56999999999999995 112.894 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.48 178.36 4.7 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 125.25 2.452 . . . . 0.91000000000000003 110.324 173.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -150.87 35.53 0.92 Allowed Glycine 0 C--N 1.372 2.561 0 CA-C-N 112.221 -2.263 . . . . 0.56999999999999995 112.258 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.86 14.55 0.14 Allowed 'General case' 0 C--N 1.376 1.76 0 CA-C-O 122.012 0.911 . . . . 0.56999999999999995 112.541 -175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 153.56 -143.46 10.2 Favored Glycine 0 C--N 1.364 2.097 0 CA-C-O 122.515 1.064 . . . . 0.56999999999999995 110.801 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.93 -130.99 47.61 Favored Glycine 0 C--N 1.36 1.881 0 O-C-N 119.994 -1.886 . . . . 0.56999999999999995 111.194 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 174' ' ' PHE . 1.0 OUTLIER -54.41 163.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.517 0 CA-C-N 113.065 -1.568 . . . . 0.56999999999999995 108.866 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 210' ' ' THR . 11.2 mt -111.4 -40.29 4.43 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 115.527 1.677 . . . . 0.56999999999999995 115.527 169.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -175.03 179.92 1.49 Allowed 'General case' 0 C--N 1.363 1.177 0 O-C-N 121.278 -0.889 . . . . 0.56999999999999995 111.111 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.467 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 0.3 OUTLIER -156.34 159.9 39.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.852 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.57 153.06 50.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.56999999999999995 111.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -93.85 -177.82 4.47 Favored 'General case' 0 C--N 1.373 1.588 0 CA-C-O 123.052 1.406 . . . . 0.56999999999999995 109.758 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.58 -158.96 15.92 Favored Glycine 0 C--N 1.378 2.866 0 CA-C-N 114.372 -1.286 . . . . 0.56999999999999995 112.075 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.39 -139.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.443 2.762 . . . . 0.56999999999999995 112.169 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.19 -132.4 10.94 Favored Glycine 0 C--N 1.371 2.513 0 O-C-N 119.307 -2.12 . . . . 0.56999999999999995 108.968 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.66 157.13 31.25 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.817 -1.549 . . . . 0.56999999999999995 106.817 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.71 3.8 Favored Glycine 0 C--N 1.381 3.053 1 N-CA-C 102.479 -4.249 . . . . 0.56999999999999995 102.479 165.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -36.35 67.95 Favored 'Isoleucine or valine' 0 C--N 1.377 1.785 0 CA-C-O 124.534 2.111 . . . . 0.56999999999999995 109.97 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.15 132.48 28.24 Favored Glycine 0 C--N 1.38 2.996 0 N-CA-C 104.389 -3.484 . . . . 0.56999999999999995 104.389 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.46 -6.61 57.68 Favored Glycine 0 C--N 1.366 2.2 0 CA-C-O 124.085 1.936 . . . . 0.56999999999999995 110.268 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.53 ' CG ' ' HB2' ' A' ' 160' ' ' LEU . 1.3 m-20 -88.24 166.67 14.18 Favored 'General case' 0 C--N 1.37 1.47 0 O-C-N 120.073 -1.839 . . . . 0.91000000000000003 110.897 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -135.54 161.12 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.066 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -129.24 125.77 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.919 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.0 m-85 -105.41 133.0 50.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.56999999999999995 110.883 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.41 ' OD2' ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -61.83 86.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.886 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.01 -33.05 70.0 Favored 'General case' 0 C--N 1.398 2.674 0 C-N-CA 115.823 -2.351 . . . . 0.91000000000000003 105.576 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.98 -47.72 8.62 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 123.821 0.848 . . . . 0.91000000000000003 108.774 -173.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -54.02 174.37 0.06 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-O 127.562 3.553 . . . . 0.91000000000000003 111.978 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.467 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 0.1 OUTLIER -102.21 110.63 22.64 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 112.365 -2.198 . . . . 0.56999999999999995 109.898 177.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.7 m95 -93.09 148.56 21.9 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 107.588 -1.264 . . . . 0.56999999999999995 107.588 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.621 HG21 ' O ' ' A' ' 208' ' ' GLY . 56.1 p -127.14 125.94 42.05 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 110.007 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CB ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -98.06 133.74 42.11 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.452 -1.685 . . . . 0.56999999999999995 106.452 -176.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 80.69 -43.76 0.22 Allowed 'General case' 0 C--N 1.374 1.646 0 CA-C-N 114.571 -1.195 . . . . 0.56999999999999995 109.591 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.54 153.98 0.37 Allowed 'General case' 0 C--N 1.369 1.43 0 N-CA-C 107.996 -1.112 . . . . 0.56999999999999995 107.996 -173.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.621 ' O ' HG21 ' A' ' 204' ' ' THR . . . 125.93 6.25 6.0 Favored Glycine 0 C--N 1.376 2.784 0 CA-C-N 114.556 -1.202 . . . . 0.56999999999999995 114.089 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 144.31 -119.75 1.33 Allowed Glycine 0 C--N 1.378 2.869 0 CA-C-O 123.752 1.751 . . . . 0.56999999999999995 112.36 -168.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 181' ' ' LEU . 6.6 p -94.25 133.0 38.25 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-N 113.951 -1.124 . . . . 0.56999999999999995 109.331 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.627 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -98.2 150.39 21.55 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.878 1.799 . . . . 0.56999999999999995 111.713 177.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.633 HD13 ' O ' ' A' ' 212' ' ' LEU . 3.2 tm? -75.54 -29.65 59.49 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 106.087 -1.82 . . . . 0.56999999999999995 106.087 -172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 7.8 t80 -57.45 -50.25 73.63 Favored 'General case' 0 C--N 1.373 1.623 0 CA-C-N 115.305 -0.861 . . . . 0.56999999999999995 110.909 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.508 HD11 ' C25' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -55.55 -51.15 68.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.56999999999999995 110.952 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.432 ' OG1' HD13 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -67.32 -35.5 79.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.56999999999999995 111.132 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 212' ' ' LEU . . . -62.59 -44.21 96.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 111.114 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 213' ' ' PHE . 95.4 t -65.23 -48.02 85.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.171 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 236' ' ' MET . 6.4 t-160 -64.63 -50.21 68.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.815 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 197' ' ' PHE . 17.3 mm-40 -57.92 -42.22 84.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.91000000000000003 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.552 ' CG2' HD21 ' A' ' 224' ' ' LEU . 1.0 OUTLIER -66.56 -46.81 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.182 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.32 -33.53 61.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.56999999999999995 112.501 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -64.71 -38.89 92.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.56999999999999995 110.833 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.407 ' HB3' ' CD1' ' A' ' 159' ' ' ILE . 0.5 OUTLIER -71.99 -53.23 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.831 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.0 pp -93.94 -56.8 2.74 Favored 'General case' 0 C--N 1.381 1.958 0 N-CA-C 117.783 2.512 . . . . 0.56999999999999995 117.783 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -45.08 149.89 1.1 Allowed Glycine 0 C--N 1.373 2.611 1 CA-C-O 128.049 4.139 . . . . 0.56999999999999995 110.486 177.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -77.16 -153.51 0.05 Allowed 'General case' 0 C--N 1.365 1.247 0 CA-C-N 109.975 -3.113 . . . . 0.56999999999999995 107.153 -171.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -58.0 -175.62 0.5 Allowed Glycine 0 C--N 1.379 2.923 0 CA-C-O 127.213 3.674 . . . . 0.56999999999999995 113.001 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -100.56 -174.25 2.6 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 118.997 -2.472 . . . . 0.56999999999999995 111.343 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.1 p -103.63 -34.67 8.55 Favored 'General case' 0 C--N 1.38 1.932 0 CA-C-N 113.835 -1.53 . . . . 0.56999999999999995 108.748 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.78 22.37 0.39 Allowed 'General case' 0 C--N 1.385 2.121 0 N-CA-C 114.152 1.168 . . . . 0.56999999999999995 114.152 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.74 131.99 11.05 Favored Pre-proline 0 C--N 1.378 1.838 0 N-CA-C 102.828 -3.027 . . . . 0.91000000000000003 102.828 -164.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.479 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 47.5 Cg_exo -61.73 74.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 124.9 3.733 . . . . 0.56999999999999995 114.913 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.38 -37.27 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 CA-C-N 113.634 -1.621 . . . . 0.56999999999999995 111.349 -171.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.61 133.53 34.84 Favored 'General case' 0 C--N 1.379 1.858 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 106.655 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.719 HG21 ' HE1' ' A' ' 248' ' ' PHE . 11.5 p -70.48 68.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.318 0 CA-C-N 113.028 -1.896 . . . . 0.56999999999999995 112.166 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER -175.64 -35.76 0.01 OUTLIER 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.635 -1.291 . . . . 0.56999999999999995 109.931 -176.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.1 OUTLIER -38.16 145.46 0.32 Allowed Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 124.948 2.309 . . . . 0.56999999999999995 111.575 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.555 ' HB3' H522 ' A' ' 269' ' ' HSI . 89.2 Cg_exo -57.93 -47.66 19.73 Favored 'Trans proline' 0 C--N 1.374 1.869 0 O-C-N 119.21 -0.995 . . . . 0.56999999999999995 111.499 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 14.1 m -49.35 124.66 9.58 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-O 124.328 2.013 . . . . 0.56999999999999995 109.921 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.551 ' OH ' HG22 ' A' ' 210' ' ' THR . 57.2 t80 -94.15 140.19 30.06 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-O 123.297 1.523 . . . . 0.56999999999999995 107.997 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.498 ' HD2' ' H33' ' A' ' 269' ' ' HSI . 4.9 tmtt? -155.56 109.39 2.82 Favored 'General case' 0 C--N 1.376 1.74 0 N-CA-C 105.635 -1.987 . . . . 0.56999999999999995 105.635 177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -54.03 123.71 13.4 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-O 124.144 1.926 . . . . 0.56999999999999995 109.628 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.479 HG11 ' C32' ' A' ' 269' ' ' HSI . 9.6 p -154.65 111.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 114.158 -1.383 . . . . 0.56999999999999995 107.349 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.21 142.44 51.77 Favored 'General case' 0 C--N 1.365 1.248 0 N-CA-C 103.219 -2.882 . . . . 0.91000000000000003 103.219 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.471 HG12 ' CG ' ' A' ' 213' ' ' PHE . 1.1 mp -46.05 -23.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.309 0 CA-C-N 111.248 -2.706 . . . . 0.56999999999999995 112.769 174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -51.72 -37.47 51.13 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.051 -0.977 . . . . 0.56999999999999995 109.767 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.9 p -103.88 -0.64 28.84 Favored 'General case' 0 C--N 1.386 2.171 0 N-CA-C 116.48 2.03 . . . . 0.56999999999999995 116.48 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.719 ' HE1' HG21 ' A' ' 235' ' ' VAL . 34.3 t80 -63.17 93.66 0.07 Allowed 'General case' 0 C--N 1.365 1.252 0 CA-C-O 127.039 3.304 . . . . 0.56999999999999995 107.491 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.403 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.95 152.57 42.33 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 112.745 -2.025 . . . . 1.2 106.371 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.15 131.31 53.89 Favored 'General case' 0 C--N 1.372 1.577 0 CA-C-O 125.634 2.635 . . . . 0.56999999999999995 104.987 -170.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.77 136.71 58.0 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.599 -1.938 . . . . 0.56999999999999995 111.68 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -60.28 -45.23 94.06 Favored 'General case' 0 C--N 1.383 2.05 0 N-CA-C 106.245 -1.761 . . . . 0.56999999999999995 106.245 -175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -41.03 85.16 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 121.215 -0.928 . . . . 0.91000000000000003 110.858 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -63.93 -55.34 23.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.91000000000000003 110.892 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.8 pt -66.21 -34.9 73.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.108 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.489 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 22.0 mtp180 -70.44 -30.38 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.872 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.15 -39.78 57.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.798 -0.715 . . . . 0.56999999999999995 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.77 HD11 HG23 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -70.19 -41.41 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.56999999999999995 111.175 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -34.45 68.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 16.5 t -76.77 -24.0 52.93 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-O 122.23 1.014 . . . . 0.56999999999999995 109.489 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -60.92 -81.76 0.02 OUTLIER 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.897 1.808 . . . . 0.56999999999999995 109.945 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.32 18.52 8.21 Favored 'General case' 0 C--N 1.369 1.447 0 CA-C-N 113.979 -1.464 . . . . 0.56999999999999995 114.824 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 2.296 0 N-CA-C 117.764 1.866 . . . . 0.91000000000000003 117.764 174.831 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.555 H522 ' HB3' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 111.093 -0.803 . . . . 0.56999999999999995 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.89 93.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.589 2.193 . . . . 0.56999999999999995 112.945 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.56 132.98 56.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 CA-C-N 113.935 -1.484 . . . . 0.56999999999999995 108.565 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -162.95 59.18 0.2 Allowed 'General case' 0 C--N 1.383 2.043 0 CA-C-O 125.671 2.653 . . . . 0.56999999999999995 108.663 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.59 146.52 26.59 Favored 'General case' 0 C--N 1.374 1.635 0 O-C-N 119.944 -1.722 . . . . 1.2 108.87 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.81 -50.94 0.01 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 122.316 1.055 . . . . 0.56999999999999995 110.4 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -69.68 -32.24 70.74 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 114.117 -1.401 . . . . 0.56999999999999995 108.482 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -109.17 109.47 20.44 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 120.129 -1.607 . . . . 0.56999999999999995 110.935 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.69 139.88 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.139 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.534 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 4.4 p -112.94 159.76 18.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.56999999999999995 111.118 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -149.08 153.37 37.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.955 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -142.1 122.02 13.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.2 110.939 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.472 HG21 ' HD1' ' A' ' 121' ' ' TYR . 12.8 mm -87.65 117.16 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 111.14 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 118' ' ' ILE . 1.5 t-20 -37.52 -57.72 0.92 Allowed 'General case' 0 C--N 1.37 1.473 0 C-N-CA 120.019 -0.672 . . . . 0.56999999999999995 111.382 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 24.9 t-20 -155.87 -61.14 0.11 Allowed 'General case' 0 C--N 1.378 1.812 0 CA-C-N 113.725 -1.58 . . . . 0.56999999999999995 107.995 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.472 ' HD1' HG21 ' A' ' 118' ' ' ILE . 1.2 m-30 152.99 30.76 0.0 OUTLIER 'General case' 0 C--N 1.379 1.88 0 O-C-N 126.17 2.169 . . . . 0.56999999999999995 112.731 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.651 HG23 ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 68.87 141.54 0.08 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 CA-C-O 124.38 2.038 . . . . 0.56999999999999995 107.924 172.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 199' ' ' GLU . 39.7 Cg_endo -70.47 -41.58 3.28 Favored 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 118.432 -1.404 . . . . 0.56999999999999995 112.319 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -110.74 -51.76 2.84 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 111.074 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.644 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.1 OUTLIER -43.96 143.87 1.02 Allowed 'General case' 0 C--N 1.377 1.802 0 CA-C-O 124.953 2.311 . . . . 0.56999999999999995 108.926 -174.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 130' ' ' VAL . 62.0 m-20 -73.47 139.01 45.48 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.977 -1.92 . . . . 0.56999999999999995 109.358 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.412 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -67.59 -50.07 60.08 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 107.758 -1.201 . . . . 1.2 107.758 -170.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -54.96 -36.36 65.26 Favored 'General case' 0 C--N 1.38 1.894 0 CA-C-N 113.271 -1.786 . . . . 0.91000000000000003 110.891 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 126' ' ' ASN . 97.4 m-20 -70.82 -37.83 73.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.851 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 126' ' ' ASN . 4.9 t -65.18 -49.2 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 111.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 16.8 m-20 -69.93 -40.62 75.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.817 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -66.02 -42.22 89.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.891 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 212' ' ' LEU . . . -63.62 -49.01 75.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 111.136 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 131' ' ' ASP . 15.8 pt -64.9 -31.94 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.15 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -66.89 -46.8 73.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.88 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.95 -46.04 89.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.56999999999999995 110.913 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.98 83.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.049 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.97 -44.89 94.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.56999999999999995 110.893 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.471 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.4 pt20 -64.97 -35.27 80.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.918 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.862 HG13 HD21 ' A' ' 250' ' ' LEU . 1.2 t -69.53 -34.2 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.085 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CD1' ' CG2' ' A' ' 220' ' ' ILE . 7.5 m95 -83.03 -34.2 26.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.56999999999999995 110.911 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.71 -48.24 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.56999999999999995 110.853 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.829 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -61.0 -12.61 12.07 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.854 0.835 . . . . 0.56999999999999995 111.612 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.829 HG13 ' ND2' ' A' ' 143' ' ' ASN . 19.6 m -115.42 -10.06 12.21 Favored 'Isoleucine or valine' 0 C--N 1.375 1.687 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 111.533 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.766 HG21 HD13 ' A' ' 224' ' ' LEU . 0.5 OUTLIER -139.99 148.73 56.09 Favored Pre-proline 0 C--N 1.36 1.058 0 CA-C-O 125.092 2.377 . . . . 0.56999999999999995 110.021 -177.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -70.7 -39.67 4.5 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 118.24 -1.505 . . . . 0.56999999999999995 111.857 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 224' ' ' LEU . 3.7 mt -50.63 111.41 0.54 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 122.734 1.254 . . . . 0.56999999999999995 107.923 -174.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -76.37 159.24 30.68 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 114.473 -1.239 . . . . 0.56999999999999995 111.176 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 116' ' ' TYR . 6.1 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 108.756 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 m -159.85 110.96 1.96 Allowed 'General case' 0 C--N 1.386 2.183 0 CA-C-O 124.923 2.297 . . . . 0.56999999999999995 109.022 -172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.55 133.83 37.75 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 109.645 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.641 HD12 ' H ' ' A' ' 155' ' ' GLY . 2.3 pt -111.03 172.66 2.59 Favored 'Isoleucine or valine' 0 C--N 1.364 1.231 0 CA-C-O 124.545 2.117 . . . . 0.56999999999999995 110.135 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -63.77 1.24 Allowed 'General case' 0 C--N 1.383 2.038 0 CA-C-N 113.31 -1.768 . . . . 0.56999999999999995 110.023 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 154' ' ' THR . 13.9 t -142.62 52.58 1.42 Allowed 'General case' 0 C--N 1.376 1.733 0 CA-C-O 124.926 2.298 . . . . 0.56999999999999995 110.154 -175.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.641 ' H ' HD12 ' A' ' 152' ' ' ILE . . . -127.9 21.94 5.5 Favored Glycine 0 C--N 1.364 2.106 0 C-N-CA 118.492 -1.813 . . . . 0.56999999999999995 112.515 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.454 ' C ' HD11 ' A' ' 152' ' ' ILE . 0.0 OUTLIER 67.12 95.05 0.06 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.961 2.315 . . . . 0.56999999999999995 110.264 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 117' ' ' ARG . . . -96.36 174.68 6.75 Favored 'General case' 0 C--N 1.369 1.443 0 C-N-CA 117.89 -1.524 . . . . 0.56999999999999995 112.49 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -76.16 -50.75 13.74 Favored 'General case' 0 C--N 1.375 1.694 0 N-CA-C 105.197 -2.149 . . . . 0.91000000000000003 105.197 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.646 ' O ' HD12 ' A' ' 159' ' ' ILE . 1.8 pp -114.11 116.18 51.83 Favored 'Isoleucine or valine' 0 C--N 1.384 2.09 0 CA-C-N 115.158 -0.928 . . . . 0.56999999999999995 111.141 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 117' ' ' ARG . 4.3 mp -92.87 132.15 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.56999999999999995 110.877 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.849 HG13 ' CE1' ' A' ' 197' ' ' PHE . 30.6 t -101.96 117.0 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 111.1 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.02 146.01 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.132 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CE1' HG23 ' A' ' 122' ' ' THR . 0.3 OUTLIER -106.18 119.99 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.89 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -134.28 168.6 18.58 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 123.795 1.76 . . . . 0.56999999999999995 109.696 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 168' ' ' HIS . 0.0 OUTLIER -107.3 167.72 9.72 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 120.701 -1.25 . . . . 1.2 110.595 177.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -40.17 143.05 0.58 Allowed Glycine 0 C--N 1.38 3.027 0 CA-C-O 123.22 1.455 . . . . 0.56999999999999995 112.303 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 72.19 43.65 0.5 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-O 124.708 2.194 . . . . 0.56999999999999995 109.218 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 165' ' ' ARG . 31.2 p-80 -99.27 -54.3 3.0 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 123.663 1.697 . . . . 0.56999999999999995 108.385 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.2 -169.99 42.92 Favored Glycine 0 C--N 1.372 2.548 0 N-CA-C 109.156 -1.578 . . . . 0.56999999999999995 109.156 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.63 18.57 8.56 Favored 'General case' 0 C--N 1.391 2.41 0 CA-C-N 112.8 -1.7 . . . . 0.91000000000000003 109.182 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 159.9 -32.88 0.0 OUTLIER 'General case' 0 C--N 1.372 1.563 0 O-C-N 125.063 1.477 . . . . 0.56999999999999995 111.377 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.1 t60 82.85 34.48 0.06 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 123.62 1.676 . . . . 0.56999999999999995 111.565 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 167.54 121.13 0.01 OUTLIER 'General case' 0 C--N 1.385 2.129 0 O-C-N 120.894 -1.129 . . . . 0.56999999999999995 109.593 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.529 ' HE1' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -116.73 -161.6 0.81 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 114.221 -1.354 . . . . 0.56999999999999995 111.697 175.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.635 ' HB3' HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -99.38 -68.68 0.79 Allowed 'General case' 0 C--N 1.378 1.827 0 N-CA-C 108.758 -0.83 . . . . 0.91000000000000003 108.758 178.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.401 ' N ' ' OD2' ' A' ' 175' ' ' ASP . . . 54.69 165.16 0.02 OUTLIER Glycine 0 C--N 1.392 3.666 0 CA-C-O 125.095 2.497 . . . . 0.56999999999999995 116.813 -167.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.49 7.77 5.11 Favored 'General case' 0 C--N 1.379 1.88 0 O-C-N 120.507 -1.584 . . . . 0.56999999999999995 113.48 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.18 -140.73 11.98 Favored Glycine 0 C--N 1.363 2.072 0 N-CA-C 110.045 -1.222 . . . . 0.56999999999999995 110.045 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.02 -104.17 0.11 Allowed Glycine 0 C--N 1.362 2.026 0 CA-C-O 123.566 1.648 . . . . 0.56999999999999995 112.52 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 175' ' ' ASP . 9.7 mt -62.58 169.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.494 0 CA-C-O 123.333 1.54 . . . . 0.56999999999999995 112.506 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 215' ' ' THR . 23.5 tp -128.92 -40.31 1.53 Allowed 'General case' 0 C--O 1.242 0.658 0 O-C-N 118.211 -2.805 . . . . 0.56999999999999995 110.499 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.803 ' HB3' HG21 ' A' ' 215' ' ' THR . . . -176.5 179.94 1.11 Allowed 'General case' 0 C--N 1.379 1.854 0 CA-C-N 114.918 -1.037 . . . . 0.56999999999999995 111.081 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.438 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.4 OUTLIER -155.04 145.86 22.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 110.846 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.01 151.24 37.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.082 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -85.13 -179.99 7.13 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.968 1.842 . . . . 0.56999999999999995 111.131 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.99 -162.89 24.0 Favored Glycine 0 C--N 1.38 2.985 0 CA-C-O 124.142 1.968 . . . . 0.56999999999999995 111.703 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.24 79.15 1.79 Allowed 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.099 1.866 . . . . 0.56999999999999995 112.074 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -128.31 160.76 22.1 Favored Glycine 0 C--N 1.367 2.281 0 CA-C-O 123.182 1.434 . . . . 0.56999999999999995 110.074 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -74.94 -177.61 3.4 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.428 -1.386 . . . . 0.56999999999999995 109.237 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.13 -117.22 5.9 Favored Glycine 0 C--N 1.383 3.186 0 N-CA-C 109.834 -1.306 . . . . 0.56999999999999995 109.834 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 192' ' ' GLY . 6.3 tp -59.44 -46.81 92.44 Favored 'Isoleucine or valine' 0 C--N 1.383 2.051 0 CA-C-N 112.547 -1.826 . . . . 0.56999999999999995 110.44 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -42.7 133.89 4.61 Favored Glycine 0 C--N 1.369 2.415 0 CA-C-O 124.486 2.159 . . . . 0.56999999999999995 109.671 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.8 -48.82 1.21 Allowed Glycine 0 C--N 1.37 2.465 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 113.129 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.29 160.06 0.17 Allowed 'General case' 0 C--N 1.376 1.724 0 CA-C-O 120.798 0.333 . . . . 0.91000000000000003 110.901 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -143.98 146.46 32.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 111.101 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -121.62 126.25 48.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 110.875 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.849 ' CE1' HG13 ' A' ' 161' ' ' VAL . 2.5 m-85 -108.22 150.08 27.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.89 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 90.41 2.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.91000000000000003 110.803 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.453 ' OE1' HG22 ' A' ' 122' ' ' THR . 3.8 tp10 -74.65 -5.52 43.52 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 124.216 1.96 . . . . 0.91000000000000003 110.475 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.8 -32.97 35.16 Favored 'General case' 0 C--N 1.369 1.416 0 CA-C-O 123.003 1.382 . . . . 0.91000000000000003 108.902 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.58 176.06 2.58 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-O 123.439 1.59 . . . . 0.91000000000000003 111.99 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.76 104.02 16.01 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-N 112.576 -2.102 . . . . 0.56999999999999995 112.589 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.421 ' CE3' ' HG3' ' A' ' 125' ' ' MET . 18.2 m95 -76.7 128.52 34.83 Favored 'General case' 0 C--N 1.367 1.369 0 CA-C-N 114.273 -1.33 . . . . 0.56999999999999995 108.525 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.0 p -122.86 104.88 9.56 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 109.309 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.401 HG21 ' HB3' ' A' ' 129' ' ' ASP . 0.6 OUTLIER -115.46 130.83 57.01 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 108.658 -177.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.59 24.85 3.45 Favored 'General case' 0 C--N 1.389 2.318 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 111.402 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.16 -71.41 0.5 Allowed 'General case' 0 C--N 1.38 1.896 0 CA-C-N 114.241 -1.345 . . . . 0.56999999999999995 108.479 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 154.94 90.96 0.08 OUTLIER Glycine 0 C--N 1.389 3.487 0 C-N-CA 118.478 -1.82 . . . . 0.56999999999999995 113.09 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.5 -141.71 7.61 Favored Glycine 0 C--N 1.378 2.879 0 C-N-CA 119.55 -1.309 . . . . 0.56999999999999995 110.132 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.446 ' HB ' HD13 ' A' ' 181' ' ' LEU . 72.7 p -67.42 128.66 37.25 Favored 'General case' 0 C--N 1.369 1.441 0 CA-C-O 124.128 1.918 . . . . 0.56999999999999995 112.146 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.556 ' O ' HD21 ' A' ' 181' ' ' LEU . 12.6 p30 -135.34 145.46 47.45 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 113.917 -1.492 . . . . 0.56999999999999995 109.607 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 133' ' ' ALA . 1.4 pt? -65.0 -25.37 67.83 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-O 123.911 1.815 . . . . 0.56999999999999995 108.933 -174.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.992 ' O ' HG23 ' A' ' 217' ' ' VAL . 48.7 t80 -54.18 -42.65 69.92 Favored 'General case' 0 C--N 1.372 1.568 0 CA-C-N 113.734 -1.575 . . . . 0.56999999999999995 110.879 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -57.11 -51.11 70.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.926 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.803 HG21 ' HB3' ' A' ' 182' ' ' ALA . 0.4 OUTLIER -69.55 -33.78 73.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 111.139 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.634 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -65.92 -46.33 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.113 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 213' ' ' PHE . 6.0 t -65.43 -39.97 86.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 111.14 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 236' ' ' MET . 6.2 t-160 -71.33 -50.04 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.56999999999999995 110.844 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.31 -42.07 98.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.91000000000000003 110.876 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 216' ' ' ALA . 34.5 mt -65.04 -37.94 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.56999999999999995 111.119 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.501 ' HA3' ' CZ2' ' A' ' 141' ' ' TRP . . . -68.3 -33.99 79.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 0.56999999999999995 112.49 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.448 ' CG ' ' CE ' ' A' ' 236' ' ' MET . 2.9 m-70 -67.39 -40.67 85.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.56999999999999995 110.871 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.0 m -70.54 -41.22 72.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.882 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 145' ' ' THR . 0.7 OUTLIER -40.76 -36.97 0.69 Allowed 'General case' 0 C--N 1.358 0.97 0 CA-C-O 124.475 2.083 . . . . 0.56999999999999995 111.753 -177.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.4 -38.92 1.13 Allowed Glycine 0 C--N 1.369 2.386 0 N-CA-C 108.392 -1.883 . . . . 0.56999999999999995 108.392 170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.551 HD11 HG22 ' A' ' 258' ' ' ILE . 1.3 pt? -100.09 150.95 21.95 Favored 'General case' 0 C--N 1.37 1.496 0 CA-C-O 123.062 1.41 . . . . 0.56999999999999995 111.602 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.22 -118.92 0.27 Allowed Glycine 0 C--N 1.374 2.668 0 CA-C-O 125.063 2.479 . . . . 0.56999999999999995 111.881 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -110.55 -155.01 0.55 Allowed 'General case' 0 C--N 1.367 1.359 0 O-C-N 120.825 -1.397 . . . . 0.56999999999999995 109.053 -178.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.681 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.6 p -115.56 -8.06 12.16 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 114.614 -1.175 . . . . 0.56999999999999995 111.149 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 82.54 -5.41 1.36 Allowed 'General case' 0 C--N 1.381 1.962 0 N-CA-C 113.527 0.936 . . . . 0.56999999999999995 113.527 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.56 158.84 74.23 Favored Pre-proline 0 C--N 1.372 1.577 0 N-CA-C 107.346 -1.353 . . . . 0.91000000000000003 107.346 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -55.02 -29.92 67.26 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.952 2.435 . . . . 0.56999999999999995 112.99 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 229' ' ' SER . 0.2 OUTLIER -47.35 -25.51 1.02 Allowed 'General case' 0 C--N 1.382 2.021 0 CA-C-N 114.662 -1.154 . . . . 0.56999999999999995 113.589 177.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -91.13 124.62 35.49 Favored 'General case' 0 C--N 1.378 1.814 0 CA-C-O 124.656 2.169 . . . . 0.56999999999999995 110.77 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.66 HG21 ' CE1' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -70.41 -8.36 10.65 Favored 'Isoleucine or valine' 0 C--N 1.377 1.768 0 CA-C-N 113.016 -1.902 . . . . 0.56999999999999995 111.838 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.501 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 1.3 ttt -99.4 17.92 19.02 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.227 -0.897 . . . . 0.56999999999999995 110.689 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 9.8 t80 -55.3 141.54 61.56 Favored Pre-proline 0 C--N 1.367 1.344 0 CA-C-O 123.12 1.438 . . . . 0.56999999999999995 108.693 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 51.6 Cg_exo -51.76 -52.94 7.89 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.98 1.787 . . . . 0.56999999999999995 113.714 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.95 142.24 56.62 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 125.288 1.618 . . . . 0.56999999999999995 109.929 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.568 ' HA ' ' C25' ' A' ' 269' ' ' HSI . 7.9 t80 -94.71 153.21 17.9 Favored 'General case' 0 C--N 1.385 2.126 0 CA-C-N 113.583 -1.644 . . . . 0.56999999999999995 109.63 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 4.2 tmtt? 177.31 104.17 0.02 OUTLIER 'General case' 0 C--N 1.389 2.292 0 CA-C-O 123.238 1.494 . . . . 0.56999999999999995 107.461 171.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.25 120.02 4.17 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-O 125.105 2.384 . . . . 0.56999999999999995 109.927 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.95 9.51 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.386 0 CA-C-N 113.25 -1.795 . . . . 0.56999999999999995 110.407 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.594 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER 84.88 -16.31 0.5 Allowed 'General case' 0 C--N 1.367 1.342 0 O-C-N 125.631 1.832 . . . . 0.91000000000000003 111.683 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 3.5 mt 74.87 -48.71 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.121 0 N-CA-C 114.605 1.335 . . . . 0.56999999999999995 114.605 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -45.22 -27.06 0.57 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 114.376 1.25 . . . . 0.56999999999999995 114.376 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.594 HG23 ' OD1' ' A' ' 244' ' ' ASP . 1.3 p -106.28 -0.68 24.2 Favored 'General case' 0 C--N 1.376 1.721 0 CA-C-N 115.373 -0.83 . . . . 0.56999999999999995 110.959 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.66 ' CE1' HG21 ' A' ' 235' ' ' VAL . 12.5 t80 -58.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.372 1.559 0 CA-C-O 124.46 2.076 . . . . 0.56999999999999995 109.054 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.454 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -109.74 152.0 26.21 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-N 113.351 -1.75 . . . . 1.2 107.22 -176.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.862 HD21 HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -121.83 134.66 54.89 Favored 'General case' 0 C--N 1.377 1.766 0 CA-C-O 124.549 2.118 . . . . 0.56999999999999995 106.246 -173.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -67.01 136.79 55.84 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 120.551 -1.343 . . . . 0.56999999999999995 110.441 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.4 94.94 Favored 'General case' 0 C--N 1.381 1.977 0 N-CA-C 107.218 -1.401 . . . . 0.56999999999999995 107.218 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -64.43 -37.51 87.78 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 119.62 -1.925 . . . . 0.91000000000000003 110.849 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 m-20 -63.83 -55.35 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.886 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.484 ' CG2' HG11 ' A' ' 144' ' ' VAL . 11.7 pt -66.23 -35.51 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.094 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.432 ' N ' HG13 ' A' ' 255' ' ' ILE . 48.7 mtm180 -70.33 -34.32 72.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.2 110.843 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.63 -49.56 59.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.15 -45.23 99.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.56999999999999995 111.089 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.493 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -71.45 -28.06 63.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 110.878 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.7 t -75.25 -21.11 58.81 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-O 121.909 0.862 . . . . 0.56999999999999995 110.883 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -81.71 0.04 OUTLIER 'General case' 0 C--N 1.375 1.675 0 CA-C-O 123.531 1.634 . . . . 0.56999999999999995 109.903 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 58.8 1.67 Allowed 'General case' 0 C--N 1.37 1.462 0 CA-C-N 114.818 -1.083 . . . . 0.56999999999999995 110.589 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.366 2.229 0 CA-C-O 115.843 -2.643 . . . . 0.91000000000000003 115.151 176.522 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.568 ' C25' ' HA ' ' A' ' 240' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 3.455 0 CA-C-O 118.655 -1.08 . . . . 0.56999999999999995 111.305 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.21 131.71 47.93 Favored 'Trans proline' 0 C--N 1.367 1.539 0 O-C-N 125.673 2.407 . . . . 0.56999999999999995 110.89 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 108' ' ' VAL . 16.0 m -131.34 117.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-N 112.268 -2.242 . . . . 0.56999999999999995 109.2 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -153.82 105.38 2.77 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 113.166 -1.834 . . . . 0.56999999999999995 108.986 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.01 151.69 18.24 Favored 'General case' 0 C--N 1.381 1.935 0 CA-C-N 112.835 -1.984 . . . . 1.2 107.962 -172.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.58 -44.13 0.09 Allowed 'General case' 0 C--N 1.372 1.549 0 CA-C-N 113.301 -1.772 . . . . 0.56999999999999995 110.185 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' HA ' HD23 ' A' ' 147' ' ' LEU . 2.4 p-80 -89.43 -21.65 22.92 Favored 'General case' 0 C--N 1.372 1.567 0 CA-C-N 113.001 -1.909 . . . . 0.56999999999999995 111.644 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.479 ' HE1' ' HG ' ' A' ' 150' ' ' SER . 0.7 OUTLIER -113.04 107.95 16.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 115.784 -0.644 . . . . 0.56999999999999995 110.92 -178.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 155.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.138 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.54 150.55 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.137 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -150.04 160.08 43.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -141.14 129.18 21.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.2 110.849 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -94.5 129.52 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.162 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 121' ' ' TYR . 54.6 t30 -54.36 178.78 0.02 OUTLIER 'General case' 0 C--N 1.369 1.447 0 CA-C-O 124.701 2.191 . . . . 0.56999999999999995 109.121 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -81.51 45.09 0.84 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 120.026 -1.672 . . . . 0.56999999999999995 109.926 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 7.0 m-85 53.85 -168.15 0.07 Allowed 'General case' 0 C--N 1.386 2.152 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 107.432 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.63 165.34 17.62 Favored Pre-proline 0 C--N 1.378 1.837 0 CA-C-N 113.668 -1.606 . . . . 0.56999999999999995 107.487 -174.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 -55.62 0.16 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 120.904 1.069 . . . . 0.56999999999999995 113.467 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.78 -52.71 63.09 Favored 'General case' 0 C--N 1.375 1.701 0 CA-C-N 114.042 -1.436 . . . . 0.91000000000000003 111.985 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.538 ' CE ' ' CD1' ' A' ' 203' ' ' TRP . 2.6 ttm -77.03 126.85 31.66 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 124.565 2.126 . . . . 0.56999999999999995 110.844 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.853 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.2 m-80 -72.05 131.36 42.78 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-N 112.78 -2.009 . . . . 0.56999999999999995 109.009 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.62 -49.95 64.59 Favored 'General case' 0 C--N 1.366 1.313 0 N-CA-C 107.737 -1.208 . . . . 1.2 107.737 -169.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -55.52 -35.38 65.57 Favored 'General case' 0 C--N 1.385 2.143 0 CA-C-N 112.221 -2.263 . . . . 0.91000000000000003 110.841 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.44 -43.35 70.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.91000000000000003 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -61.04 -49.93 82.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -59.22 -44.14 92.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.91000000000000003 110.803 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -63.72 -37.98 89.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.938 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.1 -49.06 73.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.062 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.642 HD11 HD11 ' A' ' 212' ' ' LEU . 2.4 mm -65.28 -40.41 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.35 -46.13 86.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.2 110.852 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -42.7 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 110.921 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 220' ' ' ILE . . . -58.45 -44.93 89.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.11 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 149' ' ' PHE . 11.8 m-85 -64.15 -36.35 83.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 110.86 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.458 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.6 tt0 -67.12 -40.05 86.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.56999999999999995 110.95 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -69.5 -34.1 60.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.106 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.559 ' HB3' HD11 ' A' ' 224' ' ' LEU . 43.8 m95 -82.92 -34.03 26.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.56999999999999995 110.939 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.7 m -79.3 -50.57 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.883 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -56.77 -14.04 3.04 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.34 0.867 . . . . 0.56999999999999995 113.34 178.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.824 HG13 ' ND2' ' A' ' 143' ' ' ASN . 17.9 m -113.73 -7.33 12.04 Favored 'Isoleucine or valine' 0 C--N 1.377 1.788 0 CA-C-N 113.678 -1.601 . . . . 0.56999999999999995 112.628 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.801 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.58 143.18 16.18 Favored Pre-proline 0 N--CA 1.429 -1.52 0 CA-C-O 125.068 2.366 . . . . 0.56999999999999995 109.291 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.801 ' HD2' HG22 ' A' ' 145' ' ' THR . 55.7 Cg_endo -82.12 49.9 3.28 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.017 1.811 . . . . 0.56999999999999995 111.362 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 112' ' ' HIS . 1.8 mt -134.02 73.79 1.52 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 106.551 -1.648 . . . . 0.56999999999999995 106.551 -174.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -66.75 161.9 22.57 Favored 'General case' 0 C--N 1.369 1.456 0 CA-C-O 125.468 2.556 . . . . 0.56999999999999995 117.499 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -135.15 159.94 39.95 Favored 'General case' 0 C--N 1.377 1.764 0 CA-C-N 112.486 -2.143 . . . . 0.56999999999999995 106.237 -172.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.479 ' HG ' ' HE1' ' A' ' 113' ' ' TYR . 1.2 m -140.78 111.16 6.74 Favored 'General case' 0 C--N 1.379 1.885 0 CA-C-O 124.154 1.931 . . . . 0.56999999999999995 106.523 -171.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.514 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 27.5 tttt -82.19 145.97 29.78 Favored 'General case' 0 C--N 1.369 1.446 0 CA-C-N 112.833 -1.985 . . . . 0.56999999999999995 111.934 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.0 pt -128.68 162.14 36.2 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 CA-C-N 112.928 -1.942 . . . . 0.56999999999999995 109.48 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -139.8 39.76 2.0 Allowed 'General case' 0 C--N 1.373 1.625 0 CA-C-N 113.442 -1.708 . . . . 0.56999999999999995 110.684 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.62 -70.81 0.54 Allowed 'General case' 0 C--N 1.378 1.83 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 108.479 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -99.41 -130.44 6.95 Favored Glycine 0 C--N 1.382 3.108 0 N-CA-C 108.802 -1.719 . . . . 0.56999999999999995 108.802 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -122.79 134.67 54.42 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 111.885 -2.158 . . . . 0.56999999999999995 109.083 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -99.48 179.0 4.7 Favored 'General case' 0 C--N 1.371 1.512 0 CA-C-N 112.831 -1.986 . . . . 0.56999999999999995 111.527 176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -70.24 -65.34 0.74 Allowed 'General case' 0 C--N 1.387 2.217 0 N-CA-C 103.924 -2.621 . . . . 0.91000000000000003 103.924 -166.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.728 HG22 ' CA ' ' A' ' 193' ' ' GLY . 1.0 OUTLIER -98.84 109.84 24.96 Favored 'Isoleucine or valine' 0 C--N 1.37 1.486 0 CA-C-N 114.834 -1.075 . . . . 0.56999999999999995 111.112 178.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -104.0 130.97 51.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.927 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.884 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.3 t -102.09 117.02 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.094 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.1 146.02 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.105 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -99.15 116.74 32.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.857 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -135.08 170.04 16.51 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 124.967 2.318 . . . . 0.56999999999999995 110.923 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 168.26 9.25 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 113.753 -1.567 . . . . 1.2 111.646 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 174' ' ' PHE . . . -43.41 128.12 5.75 Favored Glycine 0 C--N 1.385 3.27 0 O-C-N 126.299 2.25 . . . . 0.56999999999999995 112.569 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -179.89 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.384 2.076 0 CA-C-N 111.7 -2.25 . . . . 0.56999999999999995 110.853 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.34 142.98 48.65 Favored 'General case' 0 C--N 1.378 1.83 0 CA-C-N 113.656 -1.611 . . . . 0.56999999999999995 108.578 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 37.59 -138.28 0.6 Allowed Glycine 0 C--N 1.377 2.854 0 O-C-N 125.629 1.83 . . . . 0.56999999999999995 112.637 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' A' ' 174' ' ' PHE . 11.8 m-20 64.74 38.47 6.86 Favored 'General case' 0 C--N 1.401 2.808 0 CA-C-O 125.632 2.634 . . . . 0.91000000000000003 106.276 169.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 63.99 -97.43 0.06 Allowed 'General case' 0 C--N 1.381 1.977 0 CA-C-N 113.431 -1.713 . . . . 0.56999999999999995 110.747 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.641 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 51.9 t60 -115.58 63.97 0.69 Allowed 'General case' 0 C--N 1.379 1.886 0 CA-C-N 114.357 -1.292 . . . . 0.56999999999999995 110.846 174.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 73.97 -159.29 0.08 Allowed 'General case' 0 C--N 1.376 1.746 0 C-N-CA 117.969 -1.492 . . . . 0.56999999999999995 112.124 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.598 ' CE1' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -133.53 -159.88 1.0 Allowed 'General case' 0 C--N 1.368 1.408 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 110.273 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.34 175.31 6.79 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.28 -1.782 . . . . 0.91000000000000003 110.946 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.03 34.59 1.65 Allowed Glycine 0 C--N 1.389 3.516 0 CA-C-N 111.927 -2.397 . . . . 0.56999999999999995 111.697 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.45 -40.99 0.05 OUTLIER 'General case' 0 C--N 1.376 1.749 0 CA-C-N 112.79 -1.705 . . . . 0.56999999999999995 112.077 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -166.65 -122.56 0.61 Allowed Glycine 0 C--N 1.38 2.978 0 C-N-CA 117.846 -2.121 . . . . 0.56999999999999995 110.399 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.48 -122.52 26.88 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-O 117.316 -1.825 . . . . 0.56999999999999995 113.418 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.598 HG21 ' CE1' ' A' ' 174' ' ' PHE . 0.3 OUTLIER -45.75 170.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 O-C-N 127.434 2.491 . . . . 0.56999999999999995 114.077 172.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.693 HD13 ' OH ' ' A' ' 240' ' ' TYR . 6.6 tp -123.77 -66.71 0.98 Allowed 'General case' 0 C--N 1.374 1.634 0 CA-C-O 123.151 1.453 . . . . 0.56999999999999995 113.864 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 197' ' ' PHE . . . -178.15 179.88 0.78 Allowed 'General case' 0 C--N 1.358 0.963 0 CA-C-N 112.719 -2.037 . . . . 0.56999999999999995 111.054 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.503 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.8 p80 -158.23 177.12 11.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.854 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -157.97 143.75 17.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.56999999999999995 111.151 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.508 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 4.9 m-30 -84.69 173.41 10.75 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 118.578 -1.249 . . . . 0.56999999999999995 108.9 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -74.07 -156.17 4.33 Favored Glycine 0 C--N 1.382 3.085 0 C-N-CA 118.356 -1.878 . . . . 0.56999999999999995 110.563 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.66 -87.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.063 1.175 . . . . 0.56999999999999995 110.643 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.28 -143.52 2.42 Favored Glycine 0 C--N 1.387 3.388 0 CA-C-O 123.958 1.866 . . . . 0.56999999999999995 110.233 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -151.88 163.99 38.06 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 111.164 -2.518 . . . . 0.56999999999999995 108.705 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.82 -108.26 2.51 Favored Glycine 0 C--N 1.386 3.308 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.64 -37.32 69.05 Favored 'Isoleucine or valine' 0 C--N 1.386 2.158 0 CA-C-O 125.513 2.578 . . . . 0.56999999999999995 109.292 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.11 138.5 49.5 Favored Glycine 0 C--N 1.373 2.589 0 N-CA-C 108.922 -1.671 . . . . 0.56999999999999995 108.922 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.728 ' CA ' HG22 ' A' ' 159' ' ' ILE . . . 96.77 -15.78 62.09 Favored Glycine 0 C--N 1.37 2.468 0 CA-C-O 124.701 2.279 . . . . 0.56999999999999995 109.044 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -73.72 144.22 45.82 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.531 -1.334 . . . . 0.91000000000000003 110.864 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -125.76 152.62 45.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.114 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -134.04 132.45 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.874 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.884 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -121.04 147.26 45.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 110.907 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' OD2' HG23 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.97 83.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.91000000000000003 110.881 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.4 -46.81 78.58 Favored 'General case' 0 C--N 1.375 1.682 0 N-CA-C 105.327 -2.101 . . . . 0.91000000000000003 105.327 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -44.3 -43.43 7.42 Favored 'General case' 0 C--N 1.372 1.544 0 O-C-N 126.092 2.12 . . . . 0.91000000000000003 109.706 -170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -49.23 173.92 0.02 OUTLIER 'General case' 0 C--N 1.38 1.917 0 CA-C-O 125.53 2.586 . . . . 0.91000000000000003 113.971 172.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.446 ' N ' ' HG3' ' A' ' 201' ' ' GLU . 16.2 m-85 -113.28 95.08 5.19 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.388 -2.187 . . . . 0.56999999999999995 112.412 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.575 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 35.5 m95 -75.63 132.39 40.58 Favored 'General case' 0 C--N 1.366 1.294 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 106.95 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.3 p -110.86 103.26 11.75 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 124.908 2.289 . . . . 0.56999999999999995 109.038 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 69.5 p -104.13 106.88 17.54 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 114.096 -1.411 . . . . 0.56999999999999995 110.122 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 171.46 -59.46 0.01 OUTLIER 'General case' 0 C--N 1.383 2.047 0 CA-C-N 113.222 -1.808 . . . . 0.56999999999999995 107.333 177.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.42 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 0.5 OUTLIER 158.18 58.88 0.0 OUTLIER 'General case' 0 C--N 1.391 2.372 0 O-C-N 127.772 3.17 . . . . 0.56999999999999995 110.992 -171.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.3 -88.1 0.3 Allowed Glycine 0 C--N 1.382 3.129 0 C-N-CA 117.082 -2.485 . . . . 0.56999999999999995 113.442 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -108.97 -108.23 3.19 Favored Glycine 0 C--N 1.383 3.14 0 CA-C-O 126.984 3.547 . . . . 0.56999999999999995 112.787 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.565 HG22 ' OH ' ' A' ' 240' ' ' TYR . 1.4 p -66.63 119.33 11.56 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 111.744 -2.228 . . . . 0.56999999999999995 111.512 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.17 143.34 43.37 Favored 'General case' 0 C--N 1.373 1.614 0 CA-C-N 113.758 -1.565 . . . . 0.56999999999999995 109.702 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.2 tm? -73.43 -25.12 60.38 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-N 112.728 -2.033 . . . . 0.56999999999999995 107.276 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.897 ' O ' HG23 ' A' ' 217' ' ' VAL . 12.4 t80 -58.47 -49.16 78.33 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 113.926 -1.488 . . . . 0.56999999999999995 110.823 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -54.97 -50.96 67.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.56999999999999995 110.976 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -67.22 -37.65 83.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.93 91.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.093 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 213' ' ' PHE . 7.8 t -65.14 -40.17 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.111 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -72.08 -37.55 69.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 110.892 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -42.07 97.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.91000000000000003 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.655 HD12 ' HB1' ' A' ' 137' ' ' ALA . 64.6 mt -70.0 -38.98 76.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 111.134 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.18 93.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.56999999999999995 112.481 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.4 OUTLIER -63.97 -43.17 96.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.56999999999999995 110.844 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -38.07 72.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.886 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -47.11 -42.93 19.99 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 118.452 -1.299 . . . . 0.56999999999999995 111.007 -172.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 127.25 33.46 0.62 Allowed Glycine 0 C--N 1.385 3.265 0 CA-C-N 112.33 -2.213 . . . . 0.56999999999999995 109.449 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.643 HD23 ' OH ' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -102.34 177.35 4.9 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-O 123.523 1.63 . . . . 0.56999999999999995 109.355 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -136.08 23.39 3.35 Favored Glycine 0 C--N 1.381 3.082 0 CA-C-N 112.679 -2.055 . . . . 0.56999999999999995 110.526 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.526 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.2 OUTLIER 62.68 177.07 0.14 Allowed 'General case' 0 C--N 1.395 2.546 0 CA-C-N 113.056 -1.572 . . . . 0.56999999999999995 110.041 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.5 p -103.85 -23.59 13.37 Favored 'General case' 0 C--N 1.377 1.784 0 CA-C-N 113.206 -1.815 . . . . 0.56999999999999995 111.17 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 81.39 21.39 0.35 Allowed 'General case' 0 C--N 1.385 2.134 0 O-C-N 125.683 1.864 . . . . 0.56999999999999995 112.627 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -135.9 143.68 45.39 Favored Pre-proline 0 C--N 1.392 2.419 0 N-CA-C 103.216 -2.883 . . . . 0.91000000000000003 103.216 -168.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.82 66.49 6.71 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.444 2.763 . . . . 0.56999999999999995 111.005 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 -35.44 0.01 OUTLIER 'General case' 0 C--N 1.362 1.142 0 CA-C-N 113.537 -1.665 . . . . 0.56999999999999995 112.699 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.422 ' O ' ' CD2' ' A' ' 237' ' ' PHE . . . -70.05 114.63 8.4 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 113.724 -1.58 . . . . 0.56999999999999995 112.141 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 235' ' ' VAL . 5.1 t -53.2 88.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 CA-C-N 112.907 -1.951 . . . . 0.56999999999999995 112.17 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER 159.13 -29.33 0.0 OUTLIER 'General case' 0 C--N 1.367 1.347 0 CA-C-N 115.033 -0.985 . . . . 0.56999999999999995 111.747 -174.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 9.2 p90 -45.61 143.99 2.75 Favored Pre-proline 0 C--N 1.372 1.55 0 CA-C-N 113.915 -1.493 . . . . 0.56999999999999995 110.65 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.416 ' O ' ' H14' ' A' ' 269' ' ' HSI . 55.9 Cg_exo -59.54 -38.08 84.94 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 120.54 0.826 . . . . 0.56999999999999995 111.911 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.464 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.4 m -40.49 113.51 0.37 Allowed 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.596 1.665 . . . . 0.56999999999999995 111.383 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.693 ' OH ' HD13 ' A' ' 181' ' ' LEU . 2.6 t80 -76.66 133.83 39.46 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 112.603 -2.09 . . . . 0.56999999999999995 105.909 -175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.723 ' HD3' ' H33' ' A' ' 269' ' ' HSI . 1.2 tmtt? -175.53 98.24 0.07 Allowed 'General case' 0 C--N 1.383 2.028 0 CA-C-O 124.267 1.984 . . . . 0.56999999999999995 108.815 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -61.12 127.88 33.68 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 124.1 1.905 . . . . 0.56999999999999995 110.973 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -9.48 9.57 Favored 'Isoleucine or valine' 0 C--N 1.365 1.282 0 CA-C-N 113.022 -1.899 . . . . 0.56999999999999995 112.267 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER 75.85 -3.64 2.53 Favored 'General case' 0 C--N 1.384 2.088 0 O-C-N 126.605 2.441 . . . . 0.91000000000000003 110.865 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 213' ' ' PHE . 2.4 mt 83.0 5.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.696 0 CA-C-N 114.525 -1.216 . . . . 0.56999999999999995 113.105 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 0.7 OUTLIER -81.3 -36.6 29.61 Favored 'General case' 0 C--N 1.385 2.126 0 N-CA-C 102.713 -3.069 . . . . 0.56999999999999995 102.713 -165.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.7 p -116.92 -4.68 11.52 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 113.164 -1.835 . . . . 0.56999999999999995 114.023 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 217' ' ' VAL . 30.9 t80 -56.02 91.48 0.01 OUTLIER 'General case' 0 C--N 1.373 1.594 0 CA-C-O 124.312 2.006 . . . . 0.56999999999999995 109.485 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.45 151.7 51.82 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 112.434 -2.167 . . . . 1.2 106.675 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 250' ' ' LEU . 0.6 OUTLIER -124.17 127.59 47.98 Favored 'General case' 0 C--N 1.379 1.884 0 CA-C-O 125.082 2.372 . . . . 0.56999999999999995 104.936 -171.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 147.22 46.87 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 113.666 -1.606 . . . . 0.56999999999999995 111.896 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.37 93.07 Favored 'General case' 0 C--N 1.388 2.239 0 CA-C-N 113.218 -1.81 . . . . 0.56999999999999995 108.7 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -37.28 85.35 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-N 115.516 -0.765 . . . . 0.91000000000000003 110.862 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.722 ' O ' HG23 ' A' ' 258' ' ' ILE . 3.6 t0 -64.22 -55.02 24.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.91000000000000003 110.846 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 12.9 pt -66.1 -34.78 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 111.125 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 31.3 mtp180 -70.08 -30.12 67.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.841 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -72.74 -41.51 49.78 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 0.56999999999999995 112.471 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 254' ' ' ASP . 0.6 OUTLIER -68.09 -42.66 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.56999999999999995 111.089 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.691 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -71.97 -27.26 62.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.97 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 t -66.71 -32.85 74.43 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 124.121 1.915 . . . . 0.56999999999999995 108.784 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt -48.3 -67.32 0.28 Allowed 'General case' 0 C--N 1.384 2.088 0 CA-C-O 124.045 1.879 . . . . 0.56999999999999995 110.686 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.643 ' OH ' HD23 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -105.07 74.44 1.11 Allowed 'General case' 0 C--N 1.367 1.335 0 CA-C-N 113.164 -1.835 . . . . 0.56999999999999995 112.9 178.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.57 3.471 0 CA-C-O 114.973 -3.126 . . . . 0.91000000000000003 117.919 -172.696 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.723 ' H33' ' HD3' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.605 0 CA-C-O 121.367 0.426 . . . . 0.56999999999999995 112.063 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 96.03 0.9 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.734 1.623 . . . . 0.56999999999999995 112.187 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 p -117.19 134.65 60.09 Favored 'Isoleucine or valine' 0 C--N 1.362 1.121 0 CA-C-O 122.743 1.259 . . . . 0.56999999999999995 110.143 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.11 162.67 13.42 Favored 'General case' 0 C--N 1.366 1.296 0 CA-C-O 123.244 1.497 . . . . 0.56999999999999995 111.387 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.08 143.94 12.69 Favored 'General case' 0 C--N 1.369 1.447 0 CA-C-N 114.726 -1.125 . . . . 1.2 109.172 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.05 -42.53 0.01 OUTLIER 'General case' 0 C--N 1.373 1.63 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 110.437 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.733 ' HA ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 -68.1 -17.3 64.33 Favored 'General case' 0 C--N 1.375 1.687 0 CA-C-N 113.929 -1.487 . . . . 0.56999999999999995 110.438 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.98 106.65 14.67 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.938 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.44 155.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.119 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.1 p -134.53 159.96 39.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.56999999999999995 111.143 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.668 ' CE2' ' CE2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -140.26 160.08 40.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.935 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -139.11 121.96 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.075 -0.511 . . . . 1.2 110.873 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.504 ' HA ' HD13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -78.13 117.97 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 111.14 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -36.97 -60.18 0.65 Allowed 'General case' 0 C--N 1.351 0.649 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 109.972 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 157.16 33.67 0.0 OUTLIER 'General case' 0 C--N 1.37 1.478 0 O-C-N 125.938 2.024 . . . . 0.56999999999999995 111.204 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 2.4 m-30 73.54 -170.96 0.12 Allowed 'General case' 0 C--N 1.374 1.641 0 CA-C-N 114.65 -1.159 . . . . 0.56999999999999995 108.13 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.5 149.79 58.52 Favored Pre-proline 0 C--N 1.364 1.204 0 CA-C-O 122.34 1.066 . . . . 0.56999999999999995 109.068 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.58 -55.03 0.13 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 121.463 1.442 . . . . 0.56999999999999995 112.764 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -63.25 -48.72 77.01 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-O 122.3 1.048 . . . . 0.91000000000000003 112.573 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 212' ' ' LEU . 3.6 ttm -83.15 142.11 31.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.484 2.087 . . . . 0.56999999999999995 111.471 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.85 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.1 m-80 -70.68 135.89 48.65 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 120.324 -1.485 . . . . 0.56999999999999995 109.869 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.504 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.96 -51.21 57.97 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.087 -0.708 . . . . 1.2 109.087 -173.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.22 -34.89 61.7 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-N 113.615 -1.63 . . . . 0.91000000000000003 110.917 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -70.02 -44.04 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.91000000000000003 110.893 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -62.33 -38.75 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.182 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.61 -43.17 81.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.866 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -47.7 76.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.905 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -56.97 -48.24 78.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 111.033 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.5 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.2 mm -61.85 -35.81 70.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 0.56999999999999995 111.146 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -64.56 -48.05 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 1.2 110.854 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HB3' ' CD1' ' A' ' 213' ' ' PHE . 0.0 OUTLIER -62.88 -38.59 91.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 110.872 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.07 94.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.56999999999999995 111.064 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.668 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 15.3 m-85 -64.21 -34.12 77.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.906 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.8 tt0 -67.74 -41.13 83.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.706 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -69.7 -34.0 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.56999999999999995 111.105 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.458 ' CZ2' ' HA3' ' A' ' 221' ' ' GLY . 7.3 m95 -82.95 -34.04 26.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.47 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 49.1 m -79.27 -48.87 13.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 110.852 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.842 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.83 -12.99 8.62 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.838 0.828 . . . . 0.56999999999999995 111.965 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.842 HG13 ' ND2' ' A' ' 143' ' ' ASN . 20.6 m -115.32 3.29 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.751 -1.113 . . . . 0.56999999999999995 112.127 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.91 148.86 40.56 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 124.105 1.907 . . . . 0.56999999999999995 110.418 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.18 -32.22 6.95 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 120.862 1.041 . . . . 0.56999999999999995 112.509 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.733 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.3 mt -56.27 109.63 0.63 Allowed 'General case' 0 C--N 1.358 0.965 0 CA-C-O 122.771 1.272 . . . . 0.56999999999999995 109.531 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 157.39 33.5 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.494 -1.23 . . . . 0.56999999999999995 111.77 177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.697 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 10.8 m-85 -127.57 149.05 50.33 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-N 113.671 -1.604 . . . . 0.56999999999999995 109.19 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.39 121.19 6.02 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-O 123.605 1.669 . . . . 0.56999999999999995 109.792 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.635 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 21.0 tttp -92.52 145.89 24.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 120.674 -1.266 . . . . 0.56999999999999995 110.834 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 5.3 pt -128.53 129.02 68.69 Favored 'Isoleucine or valine' 0 C--N 1.372 1.544 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 109.546 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -73.95 -55.46 6.13 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.147 0.975 . . . . 0.56999999999999995 110.773 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.99 113.18 25.36 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 114.575 -1.193 . . . . 0.56999999999999995 110.781 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 110.27 164.5 19.23 Favored Glycine 0 C--N 1.37 2.466 0 CA-C-N 114.894 -1.048 . . . . 0.56999999999999995 112.123 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.9 ttt -88.28 131.75 34.66 Favored 'General case' 0 C--N 1.371 1.523 0 CA-C-O 122.192 0.996 . . . . 0.56999999999999995 111.085 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.53 175.02 6.37 Favored 'General case' 0 C--N 1.366 1.298 0 CA-C-N 114.423 -1.262 . . . . 0.56999999999999995 110.856 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.44 -46.47 89.94 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 106.432 -1.692 . . . . 0.91000000000000003 106.432 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 193' ' ' GLY . 1.8 mt -113.88 109.93 30.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 114.733 -1.121 . . . . 0.56999999999999995 111.166 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 162' ' ' VAL . 0.2 OUTLIER -98.79 120.99 40.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.975 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.758 HG12 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -102.34 116.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.171 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.736 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.93 146.16 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.101 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.566 ' CD2' ' CD1' ' A' ' 197' ' ' PHE . 0.5 OUTLIER -98.68 122.76 42.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.56999999999999995 110.887 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.795 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -144.97 168.45 20.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.242 1.02 . . . . 0.56999999999999995 109.929 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.48 166.25 10.91 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.547 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -30.62 105.37 0.01 OUTLIER Glycine 0 C--N 1.375 2.71 0 O-C-N 124.288 0.993 . . . . 0.56999999999999995 113.246 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 80.56 93.55 0.05 OUTLIER 'General case' 0 C--N 1.391 2.402 0 CA-C-O 124.741 2.21 . . . . 0.56999999999999995 113.338 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.795 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 1.2 p-80 -126.51 -95.08 0.45 Allowed 'General case' 0 C--N 1.371 1.506 0 CA-C-N 113.729 -1.578 . . . . 0.56999999999999995 110.693 -177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -100.31 -76.34 1.22 Allowed Glycine 0 C--N 1.375 2.716 0 N-CA-C 111.485 -0.646 . . . . 0.56999999999999995 111.485 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.07 -41.21 1.2 Allowed 'General case' 0 C--N 1.361 1.072 0 CA-C-N 114.874 -0.663 . . . . 0.91000000000000003 110.558 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 10.7 t80 81.53 68.73 0.02 OUTLIER 'General case' 0 C--N 1.385 2.136 0 CA-C-O 124.878 2.275 . . . . 0.56999999999999995 105.545 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -142.34 11.5 1.93 Allowed 'General case' 0 C--N 1.37 1.462 0 CA-C-N 113.596 -1.638 . . . . 0.56999999999999995 110.862 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.8 113.37 0.02 OUTLIER 'General case' 0 C--N 1.383 2.023 0 CA-C-O 124.484 2.088 . . . . 0.56999999999999995 109.644 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.448 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -99.78 -160.36 0.8 Allowed 'General case' 0 C--N 1.362 1.145 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.027 177.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.503 ' CB ' ' CG1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -113.13 139.36 48.8 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-N 115.23 -0.895 . . . . 0.91000000000000003 110.85 176.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -100.16 92.47 1.11 Allowed Glycine 0 N--CA 1.421 -2.306 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 112.798 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER 69.95 50.07 0.48 Allowed 'General case' 0 C--N 1.377 1.779 0 CA-C-O 122.596 1.189 . . . . 0.56999999999999995 112.132 175.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -134.17 176.13 19.99 Favored Glycine 0 C--N 1.357 1.695 0 N-CA-C 108.217 -1.953 . . . . 0.56999999999999995 108.217 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CD2' ' A' ' 240' ' ' TYR . . . -44.46 -33.57 3.2 Favored Glycine 0 C--N 1.379 2.952 0 CA-C-O 122.198 0.888 . . . . 0.56999999999999995 112.252 -176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 180' ' ' ILE . 3.1 mm -45.24 168.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 O-C-N 121.556 -0.967 . . . . 0.56999999999999995 111.722 177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.539 ' CD2' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -148.17 -39.09 0.18 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.86 0.838 . . . . 0.56999999999999995 110.102 177.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.46 ' O ' H402 ' A' ' 269' ' ' HSI . . . -176.63 179.94 1.07 Allowed 'General case' 0 C--N 1.363 1.176 0 CA-C-N 115.32 -0.855 . . . . 0.56999999999999995 111.042 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.426 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -153.35 141.86 20.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.889 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.14 152.42 33.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.142 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 115.725 -0.67 . . . . 0.56999999999999995 109.551 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 -151.56 7.98 Favored Glycine 0 C--N 1.367 2.255 0 CA-C-N 114.996 -1.002 . . . . 0.56999999999999995 110.905 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.33 88.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.707 2.272 . . . . 0.56999999999999995 112.958 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.25 118.11 1.32 Allowed Glycine 0 C--N 1.37 2.436 0 N-CA-C 109.501 -1.44 . . . . 0.56999999999999995 109.501 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -61.93 104.79 0.49 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.303 1.049 . . . . 0.56999999999999995 109.73 -177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 116.12 -101.59 1.01 Allowed Glycine 0 C--N 1.377 2.815 0 CA-C-N 114.965 -1.016 . . . . 0.56999999999999995 112.491 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.15 -37.61 77.82 Favored 'Isoleucine or valine' 0 C--N 1.375 1.691 0 CA-C-O 122.84 1.305 . . . . 0.56999999999999995 109.36 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -48.58 126.15 15.67 Favored Glycine 0 C--N 1.369 2.378 0 CA-C-O 122.696 1.165 . . . . 0.56999999999999995 110.579 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 106.95 -49.82 0.84 Allowed Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.844 -0.678 . . . . 0.56999999999999995 111.483 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 1.0 OUTLIER -45.45 107.61 0.1 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-O 120.86 0.362 . . . . 0.91000000000000003 110.88 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -104.31 142.17 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.063 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.736 ' CD2' HG22 ' A' ' 162' ' ' VAL . 16.3 m170 -134.87 135.83 41.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.827 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.758 ' CE2' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -105.22 150.21 25.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.923 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.448 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.5 p30 -83.37 93.07 7.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.91000000000000003 110.865 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -35.96 80.07 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.991 -0.744 . . . . 0.91000000000000003 108.991 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -36.22 -45.07 0.43 Allowed 'General case' 0 C--N 1.363 1.194 0 CA-C-O 122.464 1.126 . . . . 0.91000000000000003 110.053 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 177' ' ' LYS . 8.5 pt-20 -56.54 -176.19 0.01 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-O 125.218 2.437 . . . . 0.91000000000000003 113.225 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -112.28 89.95 3.21 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 120.115 -1.616 . . . . 0.56999999999999995 111.185 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.65 ' HH2' HG21 ' A' ' 215' ' ' THR . 49.1 m95 -71.93 142.84 49.45 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 109.164 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -125.73 126.56 44.81 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-O 123.047 1.403 . . . . 0.56999999999999995 109.727 -177.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 17.8 p -103.89 111.58 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.387 -1.279 . . . . 0.56999999999999995 108.29 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 83.46 65.36 0.02 OUTLIER 'General case' 0 C--N 1.386 2.191 0 CA-C-N 114.386 -1.279 . . . . 0.56999999999999995 108.867 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.62 124.37 0.03 OUTLIER 'General case' 0 C--N 1.383 2.052 0 CA-C-O 124.532 2.11 . . . . 0.56999999999999995 108.869 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 204' ' ' THR . . . 149.61 -12.4 1.01 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 120.537 -1.352 . . . . 0.56999999999999995 112.611 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 160.83 -115.08 0.64 Allowed Glycine 0 C--N 1.375 2.734 0 CA-C-O 122.955 1.309 . . . . 0.56999999999999995 110.919 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.739 HG22 ' OH ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -99.18 119.58 38.1 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-O 123.549 1.642 . . . . 0.56999999999999995 108.059 -175.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.525 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.2 p30 -91.07 142.13 28.09 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-N 114.252 -1.34 . . . . 0.56999999999999995 110.39 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.752 ' HG ' HG13 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -63.32 -27.72 69.52 Favored 'General case' 0 C--N 1.375 1.714 0 CA-C-O 124.596 2.141 . . . . 0.56999999999999995 107.695 -175.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.888 ' O ' HG23 ' A' ' 217' ' ' VAL . 32.8 t80 -59.67 -50.0 75.56 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.346 -1.297 . . . . 0.56999999999999995 110.886 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -62.13 -41.97 98.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.56999999999999995 110.917 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.65 HG21 ' HH2' ' A' ' 203' ' ' TRP . 94.3 m -65.11 -45.01 86.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 111.157 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.48 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -63.13 -36.66 84.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 111.085 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 213' ' ' PHE . 59.7 t -65.87 -41.0 89.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.118 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -72.05 -51.08 23.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 110.861 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 216' ' ' ALA . 0.8 OUTLIER -62.13 -39.96 94.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.91000000000000003 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.582 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.7 mm -70.18 -47.21 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.56999999999999995 111.142 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.75 -34.26 64.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 1.1 m-70 -67.82 -36.07 79.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 0.56999999999999995 110.814 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -49.33 41.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.888 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.4 pp -97.66 -58.62 1.95 Allowed 'General case' 0 C--N 1.353 0.751 0 N-CA-C 113.96 1.096 . . . . 0.56999999999999995 113.96 178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.807 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -43.69 159.28 0.1 Allowed Glycine 0 C--N 1.365 2.145 0 CA-C-O 125.211 2.562 . . . . 0.56999999999999995 110.936 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 258' ' ' ILE . 0.1 OUTLIER -81.12 -67.68 0.76 Allowed 'General case' 0 C--N 1.364 1.226 0 CA-C-N 113.195 -1.502 . . . . 0.56999999999999995 108.735 -174.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.89 179.18 39.0 Favored Glycine 0 C--N 1.368 2.358 0 CA-C-O 123.298 1.499 . . . . 0.56999999999999995 110.595 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.502 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 1.1 m-70 -91.11 165.38 13.53 Favored 'General case' 0 C--N 1.366 1.319 0 CA-C-N 113.891 -1.154 . . . . 0.56999999999999995 110.218 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 p -84.04 -8.63 59.07 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 114.438 -1.255 . . . . 0.56999999999999995 110.682 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.84 1.14 2.48 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 111.97 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 145.44 57.07 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 114.542 -1.208 . . . . 0.91000000000000003 109.115 -174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.45 -44.97 37.59 Favored 'Trans proline' 0 C--N 1.373 1.821 0 C-N-CA 121.717 1.611 . . . . 0.56999999999999995 112.072 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.38 -32.49 0.19 Allowed 'General case' 0 C--N 1.371 1.525 0 CA-C-N 115.297 -0.865 . . . . 0.56999999999999995 113.237 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.19 136.73 48.22 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 124.383 2.039 . . . . 0.56999999999999995 114.81 172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 248' ' ' PHE . 0.5 OUTLIER -73.76 -23.45 19.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 124.043 1.878 . . . . 0.56999999999999995 111.102 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.492 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -84.08 8.88 14.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.464 -1.698 . . . . 0.56999999999999995 111.183 -178.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.584 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 5.3 t80 -51.81 142.56 24.37 Favored Pre-proline 0 N--CA 1.434 -1.236 0 CA-C-O 123.211 1.481 . . . . 0.56999999999999995 110.601 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 47.4 Cg_endo -78.56 -45.46 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.389 1.393 . . . . 0.56999999999999995 112.256 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.3 m -57.99 138.01 56.29 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.524 1.154 . . . . 0.56999999999999995 110.27 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.739 ' OH ' HG22 ' A' ' 210' ' ' THR . 2.5 t80 -75.42 154.14 37.28 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-N 114.052 -1.431 . . . . 0.56999999999999995 108.652 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 46.2 tttt 178.63 106.34 0.03 OUTLIER 'General case' 0 C--N 1.378 1.838 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.796 173.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -55.19 121.22 8.34 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 124.08 1.895 . . . . 0.56999999999999995 110.153 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.9 m -125.86 -14.77 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-N 114.195 -1.366 . . . . 0.56999999999999995 110.804 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' O ' ' CB ' ' A' ' 245' ' ' ILE . 1.4 p30 60.21 18.23 7.68 Favored 'General case' 0 C--N 1.369 1.453 0 O-C-N 124.31 1.006 . . . . 0.91000000000000003 111.98 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.544 HG12 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mt 79.05 -10.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.672 0 CA-C-N 114.91 -1.041 . . . . 0.56999999999999995 113.423 -175.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -41.35 99.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 106.773 -1.566 . . . . 0.56999999999999995 106.773 -171.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -15.43 14.4 Favored 'General case' 0 C--N 1.373 1.627 0 N-CA-C 114.572 1.323 . . . . 0.56999999999999995 114.572 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.535 ' CE1' ' CG2' ' A' ' 235' ' ' VAL . 17.2 t80 -53.48 87.29 0.0 OUTLIER 'General case' 0 C--N 1.366 1.323 0 CA-C-O 123.566 1.651 . . . . 0.56999999999999995 110.563 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.434 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.49 149.2 45.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.452 -1.249 . . . . 1.2 109.172 -178.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -113.38 131.9 55.81 Favored 'General case' 0 C--N 1.363 1.16 0 CA-C-O 123.75 1.738 . . . . 0.56999999999999995 108.664 -176.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.68 134.39 52.16 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 120.413 -1.429 . . . . 0.56999999999999995 110.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.64 -42.24 83.03 Favored 'General case' 0 C--N 1.373 1.605 0 CA-C-N 115.009 -0.996 . . . . 0.56999999999999995 109.507 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -41.29 97.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.954 -0.567 . . . . 0.91000000000000003 110.79 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.6 -55.27 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.91000000000000003 110.898 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.793 HG21 HG11 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -66.24 -38.35 81.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.173 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.642 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.9 mtt180 -68.51 -29.91 68.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.869 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -69.62 -47.92 46.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.56999999999999995 112.476 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.719 HD11 HG23 ' A' ' 144' ' ' VAL . 1.1 pt -63.58 -43.18 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.736 0.303 . . . . 0.56999999999999995 111.117 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.47 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.07 -34.64 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 110.906 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 40.5 t -74.44 -15.68 60.9 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 122.18 0.99 . . . . 0.56999999999999995 110.915 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 261' ' ' LEU . 10.5 mt -71.24 -87.38 0.02 OUTLIER 'General case' 0 C--N 1.37 1.494 0 CA-C-O 123.676 1.703 . . . . 0.56999999999999995 110.903 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.02 0.79 49.3 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-N 114.607 -1.178 . . . . 0.56999999999999995 112.776 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 2.131 0 N-CA-C 117.778 1.871 . . . . 0.91000000000000003 117.778 173.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.46 ' H30' ' HA ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.708 0 N-CA-C 111.737 -0.545 . . . . 0.56999999999999995 111.737 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.44 158.05 1.88 Allowed 'Trans proline' 0 C--N 1.391 2.773 0 O-C-N 123.681 1.359 . . . . 0.56999999999999995 112.122 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.74 132.99 68.46 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.56999999999999995 108.673 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -177.52 118.87 0.1 Allowed 'General case' 0 C--N 1.38 1.904 0 CA-C-O 123.364 1.554 . . . . 0.56999999999999995 108.392 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -134.81 158.03 45.25 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-N 114.107 -1.406 . . . . 1.2 109.579 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -156.04 55.73 0.59 Allowed 'General case' 0 C--N 1.391 2.38 0 CA-C-O 123.927 1.822 . . . . 0.56999999999999995 108.671 -175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -166.8 -43.51 0.02 OUTLIER 'General case' 0 C--N 1.381 1.96 0 CA-C-N 113.895 -1.502 . . . . 0.56999999999999995 109.719 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' C ' HD13 ' A' ' 114' ' ' ILE . 1.3 t80 -113.68 105.52 13.4 Favored 'General case' 0 C--N 1.367 1.338 0 CA-C-N 115.049 -0.978 . . . . 0.56999999999999995 110.905 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -99.13 155.0 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.15 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.506 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 20.7 p -116.68 135.22 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.091 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' C ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -128.43 139.01 52.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 110.961 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -122.87 121.98 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.2 110.923 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 0.2 OUTLIER -82.58 133.15 29.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.121 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.755 ' HB2' HG13 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -49.32 -63.0 1.23 Allowed 'General case' 0 C--N 1.372 1.575 0 N-CA-C 107.908 -1.145 . . . . 0.56999999999999995 107.908 -173.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 161.04 32.45 0.0 OUTLIER 'General case' 0 C--N 1.391 2.397 0 CA-C-N 113.6 -1.637 . . . . 0.56999999999999995 110.608 -169.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.7 m-85 63.28 -151.1 0.33 Allowed 'General case' 0 C--N 1.386 2.189 0 N-CA-C 106.926 -1.509 . . . . 0.56999999999999995 106.926 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.608 HG21 ' OE1' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -176.23 166.7 1.61 Allowed Pre-proline 0 C--N 1.38 1.894 0 CA-C-O 123.313 1.53 . . . . 0.56999999999999995 109.616 -175.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.601 ' HD2' HG22 ' A' ' 122' ' ' THR . 31.5 Cg_endo -70.59 -42.38 2.59 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 120.865 1.043 . . . . 0.56999999999999995 112.049 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -80.43 -34.95 35.7 Favored 'General case' 0 C--N 1.38 1.893 0 CA-C-N 114.591 -1.186 . . . . 0.91000000000000003 112.779 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.3 ttm -93.14 111.86 23.63 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-O 125.67 2.652 . . . . 0.56999999999999995 109.068 -177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.26 141.74 54.31 Favored 'General case' 0 C--N 1.384 2.074 0 CA-C-N 113.272 -1.786 . . . . 0.56999999999999995 109.118 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -66.14 -51.41 58.1 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.446 -1.316 . . . . 1.2 107.446 -170.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -54.41 -34.76 61.95 Favored 'General case' 0 C--N 1.39 2.345 0 CA-C-N 113.06 -1.882 . . . . 0.91000000000000003 110.948 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.35 -44.01 69.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.91000000000000003 110.892 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -61.46 -43.09 96.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 111.122 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -66.45 -44.1 83.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.872 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -49.09 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.885 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.91 -46.67 84.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.122 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 138' ' ' PHE . 1.1 mm -67.44 -32.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.126 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -65.51 -48.1 73.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.2 110.88 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -43.17 99.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.876 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.28 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.56999999999999995 111.136 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.533 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 6.7 m-85 -67.01 -33.87 76.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.56999999999999995 110.912 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.464 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.2 tt0 -68.6 -42.08 78.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.928 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -69.43 -34.17 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.56999999999999995 111.172 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.725 ' O ' HG22 ' A' ' 145' ' ' THR . 3.7 m95 -83.02 -34.16 26.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.912 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.9 m -78.78 -50.46 11.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.883 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.821 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -57.4 -13.51 3.57 Favored 'General case' 0 C--N 1.364 1.234 0 N-CA-C 113.255 0.835 . . . . 0.56999999999999995 113.255 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.821 HG13 ' ND2' ' A' ' 143' ' ' ASN . 21.6 m -114.99 -11.11 12.14 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-N 114.517 -1.22 . . . . 0.56999999999999995 111.375 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -135.81 149.03 67.62 Favored Pre-proline 0 C--N 1.371 1.541 0 CA-C-O 125.517 2.58 . . . . 0.56999999999999995 109.057 -177.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.37 44.44 1.63 Allowed 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.611 2.208 . . . . 0.56999999999999995 112.25 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 145' ' ' THR . 0.6 OUTLIER -140.75 89.28 2.25 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 105.649 -1.982 . . . . 0.56999999999999995 105.649 -173.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -69.43 157.72 36.54 Favored 'General case' 0 C--N 1.38 1.921 0 CA-C-O 125.12 2.391 . . . . 0.56999999999999995 114.538 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CG ' ' CE1' ' A' ' 138' ' ' PHE . 72.7 m-85 -126.28 155.52 41.79 Favored 'General case' 0 C--N 1.387 2.222 0 CA-C-N 112.879 -1.964 . . . . 0.56999999999999995 108.903 -178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.68 124.62 7.31 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-O 125.302 2.477 . . . . 0.56999999999999995 107.101 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.505 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 33.2 tttt -82.82 145.38 29.52 Favored 'General case' 0 C--N 1.379 1.861 0 CA-C-N 113.626 -1.624 . . . . 0.56999999999999995 111.005 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.81 HD12 HG22 ' A' ' 154' ' ' THR . 8.4 pt -135.78 172.37 15.76 Favored 'Isoleucine or valine' 0 C--N 1.38 1.911 0 CA-C-O 123.641 1.686 . . . . 0.56999999999999995 109.321 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -125.95 29.26 5.93 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-O 123.819 1.771 . . . . 0.56999999999999995 110.597 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.81 HG22 HD12 ' A' ' 152' ' ' ILE . 1.1 t -80.79 -170.46 2.67 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-N 114.217 -1.356 . . . . 0.56999999999999995 111.025 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 154' ' ' THR . . . -49.44 -55.24 13.6 Favored Glycine 0 C--N 1.391 3.62 0 CA-C-N 113.812 -1.54 . . . . 0.56999999999999995 110.929 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.89 138.9 9.6 Favored 'General case' 0 C--N 1.379 1.86 0 N-CA-C 107.663 -1.236 . . . . 0.56999999999999995 107.663 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -104.07 172.46 6.79 Favored 'General case' 0 C--N 1.376 1.735 0 CA-C-N 113.79 -1.55 . . . . 0.56999999999999995 110.874 175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -49.99 -65.45 0.56 Allowed 'General case' 0 C--N 1.38 1.924 0 CA-C-N 113.614 -1.63 . . . . 0.91000000000000003 106.919 -173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 193' ' ' GLY . 6.9 mt -97.97 110.06 24.88 Favored 'Isoleucine or valine' 0 C--N 1.371 1.527 0 O-C-N 121.802 -0.561 . . . . 0.56999999999999995 111.13 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.752 HD23 ' HB3' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -95.34 120.99 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 110.887 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.732 HG12 ' CE1' ' A' ' 197' ' ' PHE . 0.1 OUTLIER -104.45 118.12 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.115 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -133.12 146.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.56999999999999995 111.149 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.68 120.65 42.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.9 167.26 26.19 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 123.242 1.496 . . . . 0.56999999999999995 108.214 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 169.26 8.57 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 115.06 -0.973 . . . . 1.2 109.926 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -41.79 133.68 3.72 Favored Glycine 0 C--N 1.387 3.381 0 CA-C-N 114.13 -1.396 . . . . 0.56999999999999995 109.623 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 85.32 45.14 0.02 OUTLIER 'General case' 0 C--N 1.4 2.792 0 CA-C-O 124.191 1.948 . . . . 0.56999999999999995 111.203 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -104.41 -57.2 2.07 Favored 'General case' 0 C--N 1.379 1.877 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 110.978 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.82 -165.7 32.7 Favored Glycine 0 C--N 1.376 2.788 0 N-CA-C 108.925 -1.67 . . . . 0.56999999999999995 108.925 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.92 93.89 0.06 Allowed 'General case' 0 C--N 1.4 2.767 0 CA-C-O 123.906 1.812 . . . . 0.91000000000000003 107.701 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 69.19 -97.11 0.03 OUTLIER 'General case' 0 C--N 1.376 1.734 0 CA-C-N 114.095 -1.411 . . . . 0.56999999999999995 110.138 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -122.46 -132.7 0.28 Allowed 'General case' 0 C--N 1.383 2.047 0 CA-C-O 124.252 1.977 . . . . 0.56999999999999995 109.482 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.82 179.2 4.34 Favored 'General case' 0 C--N 1.381 1.971 0 CA-C-O 123.433 1.587 . . . . 0.56999999999999995 110.211 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.544 ' CZ ' ' CD2' ' A' ' 183' ' ' HIS . 1.4 m-85 -119.84 -173.08 2.47 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.95 -1.932 . . . . 0.56999999999999995 110.36 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -74.24 -178.66 3.51 Favored 'General case' 0 C--N 1.377 1.789 0 CA-C-N 113.044 -1.889 . . . . 0.91000000000000003 112.862 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.73 150.22 21.06 Favored Glycine 0 C--N 1.385 3.285 0 CA-C-N 113.47 -1.696 . . . . 0.56999999999999995 109.029 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.24 8.33 5.26 Favored 'General case' 0 C--N 1.376 1.748 0 CA-C-O 122.721 1.248 . . . . 0.56999999999999995 111.617 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 159.22 -104.53 0.25 Allowed Glycine 0 C--N 1.378 2.9 0 CA-C-O 122.869 1.261 . . . . 0.56999999999999995 110.185 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.31 -126.15 35.92 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-O 123.635 1.686 . . . . 0.56999999999999995 110.388 176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 181' ' ' LEU . 2.3 pp -79.03 -173.45 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.876 0 CA-C-N 113.745 -1.227 . . . . 0.56999999999999995 109.557 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.801 HD22 ' CE1' ' A' ' 240' ' ' TYR . 9.4 tp -109.83 -37.1 5.73 Favored 'General case' 0 C--N 1.377 1.765 0 N-CA-C 115.763 1.764 . . . . 0.56999999999999995 115.763 170.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 215' ' ' THR . . . -178.78 179.84 0.68 Allowed 'General case' 0 C--N 1.384 2.083 0 CA-C-N 113.787 -1.551 . . . . 0.56999999999999995 111.117 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 4.9 p80 -161.59 136.04 7.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.848 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -135.02 144.21 47.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.56999999999999995 111.108 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -79.56 175.88 10.21 Favored 'General case' 0 C--N 1.365 1.24 0 CA-C-O 123.244 1.497 . . . . 0.56999999999999995 109.992 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.84 -173.39 40.63 Favored Glycine 0 C--N 1.383 3.172 0 CA-C-O 123.158 1.421 . . . . 0.56999999999999995 111.312 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.52 71.83 3.79 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.56 2.173 . . . . 0.56999999999999995 111.506 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -84.13 -123.03 1.0 Allowed Glycine 0 C--N 1.382 3.087 0 CA-C-O 123.931 1.85 . . . . 0.56999999999999995 110.184 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.0 m -125.41 -62.89 1.18 Allowed 'General case' 0 C--N 1.392 2.417 0 CA-C-O 123.386 1.565 . . . . 0.56999999999999995 108.205 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.06 -71.3 0.7 Allowed Glycine 0 C--N 1.394 3.802 0 N-CA-C 108.861 -1.696 . . . . 0.56999999999999995 108.861 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -32.76 56.15 Favored 'Isoleucine or valine' 0 C--N 1.384 2.1 0 CA-C-O 125.815 2.721 . . . . 0.56999999999999995 108.885 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.3 134.94 29.12 Favored Glycine 0 C--N 1.393 3.746 0 N-CA-C 106.562 -2.615 . . . . 0.56999999999999995 106.562 -172.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 102.37 -19.8 47.02 Favored Glycine 0 C--N 1.368 2.308 0 N-CA-C 110.172 -1.171 . . . . 0.56999999999999995 110.172 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 160' ' ' LEU . 1.1 m-20 -73.96 124.86 26.99 Favored 'General case' 0 C--N 1.363 1.154 0 O-C-N 120.993 -1.298 . . . . 0.91000000000000003 110.922 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -107.3 142.09 37.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.56999999999999995 111.083 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -124.69 129.39 50.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.925 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.732 ' CE1' HG12 ' A' ' 161' ' ' VAL . 0.6 OUTLIER -108.62 150.18 27.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 110.919 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -79.5 91.25 5.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.91000000000000003 110.887 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.608 ' OE1' HG21 ' A' ' 122' ' ' THR . 9.9 tp10 -64.74 -47.51 77.96 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-N 114.977 -1.01 . . . . 0.91000000000000003 108.815 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.51 -44.9 0.06 Allowed 'General case' 0 C--N 1.374 1.633 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.837 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 203' ' ' TRP . 1.4 mp0 -62.58 -178.14 0.18 Allowed 'General case' 0 C--N 1.382 1.999 0 CA-C-O 127.219 3.39 . . . . 0.91000000000000003 106.948 -172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.24 78.0 1.18 Allowed 'General case' 0 C--N 1.379 1.848 0 O-C-N 118.664 -2.522 . . . . 0.56999999999999995 108.241 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.72 ' CH2' HD12 ' A' ' 181' ' ' LEU . 21.4 m95 -74.0 143.16 45.7 Favored 'General case' 0 C--N 1.376 1.744 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 109.154 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 60.6 p -114.2 123.35 49.36 Favored 'General case' 0 C--N 1.377 1.8 0 CA-C-O 124.349 2.023 . . . . 0.56999999999999995 108.905 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 35.1 p -96.11 111.68 23.64 Favored 'General case' 0 C--N 1.374 1.653 0 CA-C-O 123.929 1.823 . . . . 0.56999999999999995 108.497 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 77.34 48.96 0.05 Allowed 'General case' 0 C--N 1.388 2.276 0 CA-C-O 124.57 2.129 . . . . 0.56999999999999995 110.626 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 t -129.09 -91.78 0.47 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 114.242 -1.345 . . . . 0.56999999999999995 109.651 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 244' ' ' ASP . . . -177.91 -45.07 0.07 OUTLIER Glycine 0 C--N 1.387 3.381 0 C-N-CA 119.356 -1.402 . . . . 0.56999999999999995 111.985 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.51 -133.65 0.03 OUTLIER Glycine 0 C--N 1.393 3.743 0 CA-C-O 126.708 3.393 . . . . 0.56999999999999995 109.598 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.589 HG22 ' OH ' ' A' ' 240' ' ' TYR . 41.5 p -67.71 130.63 43.59 Favored 'General case' 0 C--N 1.37 1.473 0 O-C-N 119.582 -2.128 . . . . 0.56999999999999995 110.945 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.834 ' CB ' HD11 ' A' ' 245' ' ' ILE . 17.2 p30 -134.09 149.52 51.11 Favored 'General case' 0 C--N 1.38 1.923 0 CA-C-N 113.338 -1.755 . . . . 0.56999999999999995 108.476 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 212' ' ' LEU . 2.0 pt? -71.08 -23.92 62.22 Favored 'General case' 0 C--N 1.375 1.702 0 CA-C-O 124.836 2.255 . . . . 0.56999999999999995 111.111 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.68 ' CE1' HG21 ' A' ' 217' ' ' VAL . 23.8 t80 -54.51 -39.29 67.45 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.506 -1.679 . . . . 0.56999999999999995 110.855 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -55.0 -51.13 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.56999999999999995 110.895 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.581 HG23 HD23 ' A' ' 181' ' ' LEU . 11.7 p -66.53 -40.41 89.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.131 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.79 96.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 111.09 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.69 HG11 ' HZ ' ' A' ' 248' ' ' PHE . 24.6 t -65.31 -40.83 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.56999999999999995 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.417 ' HA ' ' SD ' ' A' ' 236' ' ' MET . 24.8 t-80 -69.29 -44.97 70.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.858 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' HG2' ' N ' ' A' ' 220' ' ' ILE . 2.5 pt-20 -59.64 -41.49 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.936 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.483 ' CG2' ' CD1' ' A' ' 141' ' ' TRP . 49.8 mt -66.48 -40.86 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.181 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.54 -33.7 87.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.56999999999999995 112.441 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -43.35 96.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.847 0.356 . . . . 0.56999999999999995 110.889 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -37.36 73.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.863 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.5 HD12 ' CE3' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -45.47 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.367 1.343 0 CA-C-O 124.434 2.064 . . . . 0.56999999999999995 114.26 -177.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -158.11 -88.74 0.07 OUTLIER Glycine 0 C--N 1.377 2.828 0 C-N-CA 118.654 -1.736 . . . . 0.56999999999999995 110.837 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.38 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.391 2.412 0 O-C-N 125.66 1.447 . . . . 0.56999999999999995 110.581 -173.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 99.07 98.28 2.14 Favored Glycine 0 C--N 1.385 3.303 0 C-N-CA 118.894 -1.622 . . . . 0.56999999999999995 110.281 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.492 ' CD2' ' HE3' ' A' ' 236' ' ' MET . 0.0 OUTLIER 63.28 172.75 0.16 Allowed 'General case' 0 C--N 1.395 2.556 0 CA-C-O 124.3 2.0 . . . . 0.56999999999999995 108.188 171.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -131.61 -6.42 3.67 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 117.294 -1.762 . . . . 0.56999999999999995 110.408 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.1 t 83.28 -12.25 0.87 Allowed 'General case' 0 C--N 1.391 2.397 0 CA-C-N 115.299 -0.864 . . . . 0.56999999999999995 112.049 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.68 148.17 45.49 Favored Pre-proline 0 C--N 1.385 2.129 0 N-CA-C 106.135 -1.802 . . . . 0.91000000000000003 106.135 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -59.33 -16.64 35.72 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 123.031 2.487 . . . . 0.56999999999999995 112.273 -174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 1.89 2.49 Favored 'General case' 0 C--N 1.38 1.91 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 229' ' ' SER . . . -111.5 143.1 42.89 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-O 124.877 2.275 . . . . 0.56999999999999995 108.687 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.877 ' O ' ' H28' ' A' ' 269' ' ' HSI . 0.5 OUTLIER -72.91 -11.83 15.17 Favored 'Isoleucine or valine' 0 C--N 1.382 1.985 0 CA-C-N 112.322 -2.217 . . . . 0.56999999999999995 111.842 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.492 ' HE3' ' CD2' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -108.29 26.67 10.16 Favored 'General case' 0 C--N 1.371 1.532 0 CA-C-N 114.437 -1.256 . . . . 0.56999999999999995 110.349 -178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.588 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 17.0 t80 -54.64 142.62 52.07 Favored Pre-proline 0 C--N 1.371 1.506 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 108.914 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.588 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 76.6 Cg_exo -54.92 -49.34 17.0 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.022 1.814 . . . . 0.56999999999999995 112.762 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 m -62.9 136.03 57.63 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 123.303 1.525 . . . . 0.56999999999999995 110.459 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.801 ' CE1' HD22 ' A' ' 181' ' ' LEU . 0.7 OUTLIER -94.21 82.96 4.17 Favored 'General case' 0 C--N 1.382 2.001 0 CA-C-O 124.521 2.105 . . . . 0.56999999999999995 108.555 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 243' ' ' VAL . 1.4 tmtt? -111.69 100.14 8.72 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-O 123.711 1.72 . . . . 0.56999999999999995 108.89 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -53.05 118.68 3.92 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-O 125.666 2.651 . . . . 0.56999999999999995 110.629 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -96.12 11.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 CA-C-N 112.499 -2.137 . . . . 0.56999999999999995 111.406 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.421 ' HB2' ' HA2' ' A' ' 208' ' ' GLY . 0.0 OUTLIER 86.68 -16.01 0.42 Allowed 'General case' 0 C--N 1.377 1.768 0 O-C-N 125.247 1.592 . . . . 0.91000000000000003 111.918 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 211' ' ' ASN . 3.6 mt 75.64 -49.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.389 2.284 0 N-CA-C 114.296 1.221 . . . . 0.56999999999999995 114.296 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -46.26 -28.86 1.4 Allowed 'General case' 0 C--N 1.368 1.383 0 N-CA-C 113.395 0.887 . . . . 0.56999999999999995 113.395 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 p -108.19 9.47 28.13 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-O 122.592 1.187 . . . . 0.56999999999999995 111.295 -176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.69 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 9.9 t80 -68.01 86.54 0.25 Allowed 'General case' 0 C--N 1.377 1.775 0 CA-C-O 125.023 2.344 . . . . 0.56999999999999995 108.97 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.443 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -108.63 153.51 23.3 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-O 124.748 2.213 . . . . 1.2 107.204 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.687 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -122.4 131.82 54.07 Favored 'General case' 0 C--N 1.381 1.938 0 CA-C-O 125.874 2.75 . . . . 0.56999999999999995 105.867 -172.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 45.2 t -66.45 138.28 57.43 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.359 -2.088 . . . . 0.56999999999999995 110.26 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -57.92 -43.21 86.13 Favored 'General case' 0 C--N 1.393 2.49 0 CA-C-N 113.612 -1.631 . . . . 0.56999999999999995 108.614 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -41.09 93.72 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.289 -0.882 . . . . 0.91000000000000003 110.87 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.7 OUTLIER -64.06 -55.08 24.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.465 . . . . 0.91000000000000003 110.86 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 256' ' ' ARG . 22.7 pt -66.08 -35.23 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.166 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.692 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 0.2 OUTLIER -70.35 -35.44 73.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 1.2 110.852 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 261' ' ' LEU . . . -64.51 -49.58 64.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.56999999999999995 112.469 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 144' ' ' VAL . 1.3 pt -62.32 -45.65 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.774 0.321 . . . . 0.56999999999999995 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.485 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.11 -24.04 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.56999999999999995 110.92 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.7 t -76.03 -16.84 59.88 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-O 123.388 1.566 . . . . 0.56999999999999995 111.03 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 257' ' ' GLY . 0.3 OUTLIER -81.65 -93.98 0.05 Allowed 'General case' 0 C--N 1.386 2.179 0 CA-C-O 123.965 1.84 . . . . 0.56999999999999995 112.444 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -87.47 14.51 8.03 Favored 'General case' 0 C--N 1.382 2.009 0 CA-C-N 114.315 -1.311 . . . . 0.56999999999999995 113.531 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.375 2.73 0 N-CA-C 118.382 2.113 . . . . 0.91000000000000003 118.382 172.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.877 ' H28' ' O ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 3.865 0 CA-C-O 119.247 -0.751 . . . . 0.56999999999999995 111.935 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.5 103.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 122.171 1.914 . . . . 0.56999999999999995 112.5 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 t -111.44 134.95 52.16 Favored 'Isoleucine or valine' 0 C--N 1.374 1.661 0 CA-C-N 112.909 -1.95 . . . . 0.56999999999999995 109.125 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -122.01 -89.8 0.59 Allowed 'General case' 0 C--N 1.387 2.203 0 CA-C-N 112.918 -1.946 . . . . 0.56999999999999995 109.429 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.47 156.63 36.9 Favored 'General case' 0 C--N 1.378 1.824 0 N-CA-C 107.717 -1.216 . . . . 1.2 107.717 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.42 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.383 2.03 0 CA-C-N 113.692 -1.595 . . . . 0.56999999999999995 111.402 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.797 ' HA ' HD22 ' A' ' 147' ' ' LEU . 5.8 p-80 -53.04 -35.91 59.99 Favored 'General case' 0 C--N 1.382 2.008 0 CA-C-N 112.91 -1.95 . . . . 0.56999999999999995 109.954 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -111.11 111.59 22.79 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.493 -1.38 . . . . 0.56999999999999995 110.891 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -111.24 144.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.085 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.767 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -105.94 158.47 16.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.56999999999999995 111.149 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.928 ' CE2' HD13 ' A' ' 159' ' ' ILE . 15.7 m-85 -140.6 159.59 41.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.56999999999999995 110.886 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.754 HH11 ' N ' ' A' ' 156' ' ' MET . 12.3 ttm180 -150.0 129.62 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 1.2 110.854 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.751 HD11 ' CD1' ' A' ' 134' ' ' ILE . 1.1 mm -99.09 128.92 50.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 111.08 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.61 -76.26 0.03 OUTLIER 'General case' 0 C--N 1.373 1.624 0 CA-C-O 123.325 1.536 . . . . 0.56999999999999995 112.682 -174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -179.18 24.63 0.0 OUTLIER 'General case' 0 C--N 1.378 1.822 0 CA-C-N 113.595 -1.639 . . . . 0.56999999999999995 107.767 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 1.3 m-85 82.87 -152.56 0.01 OUTLIER 'General case' 0 C--N 1.392 2.415 0 N-CA-C 105.504 -2.036 . . . . 0.56999999999999995 105.504 170.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.2 167.56 14.1 Favored Pre-proline 0 C--N 1.382 2.01 0 N-CA-C 108.542 -0.91 . . . . 0.56999999999999995 108.542 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -57.04 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 121.303 1.335 . . . . 0.56999999999999995 114.305 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.32 -59.05 3.1 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.837 -1.529 . . . . 0.91000000000000003 112.986 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.466 ' HG2' ' CG2' ' A' ' 205' ' ' THR . 2.4 mtm -63.39 137.17 58.07 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-O 123.903 1.811 . . . . 0.56999999999999995 108.902 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -89.49 143.86 26.48 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 106.095 -1.817 . . . . 0.56999999999999995 106.095 -171.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -71.03 -49.67 42.47 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.728 -1.582 . . . . 1.2 106.728 -167.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.74 -34.79 62.98 Favored 'General case' 0 C--N 1.392 2.425 0 CA-C-N 112.238 -2.255 . . . . 0.91000000000000003 110.884 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -44.03 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.91000000000000003 110.877 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -65.03 -49.32 80.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.15 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -56.79 -44.07 81.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.91000000000000003 110.873 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -38.03 89.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.88 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' ' HA ' ' A' ' 213' ' ' PHE . . . -65.92 -40.64 91.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.086 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.751 ' CD1' HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -66.97 -42.56 88.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.56999999999999995 111.178 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -62.05 -44.83 95.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 1.2 110.841 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -44.27 96.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.91 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.654 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -60.87 -44.69 96.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.117 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 134' ' ' ILE . 14.4 m-85 -62.53 -33.68 75.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.901 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.455 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -68.28 -39.36 82.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.884 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.6 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -72.3 -33.87 47.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.189 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.608 ' O ' HG23 ' A' ' 145' ' ' THR . 9.8 m95 -83.16 -34.06 26.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.923 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 68.2 m -77.99 -49.13 14.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.56999999999999995 110.852 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.782 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.99 -13.06 9.58 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 122.049 0.928 . . . . 0.56999999999999995 112.349 -178.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.782 HG13 ' ND2' ' A' ' 143' ' ' ASN . 17.6 m -112.87 9.45 8.12 Favored 'Isoleucine or valine' 0 C--N 1.382 2.009 0 CA-C-N 114.326 -1.306 . . . . 0.56999999999999995 112.757 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.3 p -149.32 151.62 34.15 Favored Pre-proline 0 C--N 1.378 1.812 0 CA-C-O 126.201 2.905 . . . . 0.56999999999999995 110.677 -171.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.57 -29.29 2.38 Favored 'Trans proline' 0 C--N 1.365 1.432 0 O-C-N 117.31 -1.995 . . . . 0.56999999999999995 110.923 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 112' ' ' HIS . 3.6 mt -73.3 111.98 8.94 Favored 'General case' 0 C--N 1.376 1.76 0 N-CA-C 106.543 -1.651 . . . . 0.56999999999999995 106.543 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -69.48 157.75 36.52 Favored 'General case' 0 C--N 1.381 1.963 0 CA-C-O 124.369 2.033 . . . . 0.56999999999999995 116.279 170.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 17.0 m-85 -130.4 154.25 47.9 Favored 'General case' 0 C--N 1.387 2.213 0 CA-C-N 112.675 -2.057 . . . . 0.56999999999999995 109.141 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 m -156.15 109.13 2.65 Favored 'General case' 0 C--N 1.39 2.334 0 CA-C-O 125.442 2.544 . . . . 0.56999999999999995 108.83 -171.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.53 149.53 23.56 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 113.323 -1.762 . . . . 0.56999999999999995 112.394 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 115' ' ' THR . 0.6 OUTLIER -160.17 -172.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.385 2.109 0 CA-C-N 113.833 -1.53 . . . . 0.56999999999999995 110.334 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -163.36 98.17 0.91 Allowed 'General case' 0 C--N 1.38 1.905 0 N-CA-C 108.555 -0.905 . . . . 0.56999999999999995 108.555 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 155' ' ' GLY . 17.6 m -147.03 -81.59 0.14 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 115.288 -0.869 . . . . 0.56999999999999995 109.92 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.634 ' H ' ' NH1' ' A' ' 117' ' ' ARG . . . -136.39 51.07 0.82 Allowed Glycine 0 C--N 1.384 3.228 0 N-CA-C 107.404 -2.278 . . . . 0.56999999999999995 107.404 -169.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.754 ' N ' HH11 ' A' ' 117' ' ' ARG . 5.0 ttm 72.19 135.98 0.04 OUTLIER 'General case' 0 C--N 1.404 2.977 0 O-C-N 126.362 1.86 . . . . 0.56999999999999995 108.274 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -131.22 163.67 27.23 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.27 -1.752 . . . . 0.56999999999999995 106.27 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 158' ' ' ASP 0.288 0.0 OUTLIER -18.7 -73.62 0.01 OUTLIER 'General case' 0 C--N 1.377 1.803 0 CA-C-N 112.875 -1.966 . . . . 0.91000000000000003 113.996 165.587 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.928 HD13 ' CE2' ' A' ' 116' ' ' TYR . 2.5 mp -96.15 109.8 23.43 Favored 'Isoleucine or valine' 0 C--N 1.383 2.063 0 O-C-N 126.9 2.625 . . . . 0.56999999999999995 111.215 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.33 122.49 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.879 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.637 HG23 HD13 ' A' ' 118' ' ' ILE . 1.4 m -110.44 121.44 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.08 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.646 HG22 ' CD2' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -133.13 139.97 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.087 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -90.19 118.84 30.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.946 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.46 169.18 20.07 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 118.861 -1.135 . . . . 0.56999999999999995 109.162 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 167.3 9.88 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 115.245 -0.889 . . . . 1.2 110.398 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -40.11 129.02 2.78 Favored Glycine 0 C--N 1.393 3.726 0 O-C-N 125.201 1.563 . . . . 0.56999999999999995 111.699 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.69 104.04 0.06 Allowed 'General case' 0 C--N 1.406 3.041 0 CA-C-O 124.893 2.283 . . . . 0.56999999999999995 112.271 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -171.18 -59.37 0.02 OUTLIER 'General case' 0 C--N 1.386 2.187 0 CA-C-N 113.823 -1.535 . . . . 0.56999999999999995 110.405 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -155.82 -125.12 0.9 Allowed Glycine 0 C--N 1.381 3.032 0 CA-C-N 115.048 -0.978 . . . . 0.56999999999999995 110.799 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 41.1 p-10 -33.78 147.68 0.02 OUTLIER 'General case' 0 C--N 1.388 2.245 0 O-C-N 127.331 2.43 . . . . 0.91000000000000003 113.532 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.492 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.5 t80 78.15 -151.19 0.02 OUTLIER 'General case' 0 C--N 1.394 2.534 0 CA-C-N 113.12 -1.855 . . . . 0.56999999999999995 111.986 -172.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -167.51 97.27 0.48 Allowed 'General case' 0 C--N 1.382 2.006 0 N-CA-C 108.254 -1.017 . . . . 0.56999999999999995 108.254 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.74 77.94 0.31 Allowed 'General case' 0 C--N 1.398 2.681 0 CA-C-O 125.549 2.595 . . . . 0.56999999999999995 109.023 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.509 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -64.93 178.06 0.88 Allowed 'General case' 0 C--N 1.377 1.784 0 CA-C-N 111.945 -2.389 . . . . 0.56999999999999995 112.051 177.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 180' ' ' ILE . 2.5 p-10 -58.37 -160.27 0.0 OUTLIER 'General case' 0 C--N 1.386 2.19 0 CA-C-O 124.519 2.104 . . . . 0.91000000000000003 114.479 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -172.63 101.39 0.16 Allowed Glycine 0 C--N 1.391 3.602 0 C-N-CA 117.261 -2.4 . . . . 0.56999999999999995 109.205 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.63 96.64 0.07 Allowed 'General case' 0 C--N 1.39 2.345 0 CA-C-O 123.472 1.605 . . . . 0.56999999999999995 113.056 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.27 -152.37 25.45 Favored Glycine 0 C--N 1.381 3.065 0 C-N-CA 119.02 -1.562 . . . . 0.56999999999999995 110.596 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 52.83 -132.91 40.66 Favored Glycine 0 C--N 1.376 2.784 0 N-CA-C 111.788 -0.525 . . . . 0.56999999999999995 111.788 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -46.97 168.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.061 0 O-C-N 125.806 1.533 . . . . 0.56999999999999995 113.196 175.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 215' ' ' THR . 1.6 tp -121.94 -92.26 0.54 Allowed 'General case' 0 C--N 1.359 1.008 0 CA-C-O 126.781 3.181 . . . . 0.56999999999999995 112.907 172.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.478 ' HB2' ' CG2' ' A' ' 215' ' ' THR . . . -106.22 179.73 4.18 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 112.524 -2.126 . . . . 0.56999999999999995 111.1 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 54.4 p-80 -163.12 135.84 5.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.856 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -132.7 166.74 21.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.56999999999999995 111.072 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -71.71 0.6 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 117.491 -1.684 . . . . 0.56999999999999995 108.083 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.23 0.55 Allowed Glycine 0 C--N 1.386 3.331 0 C-N-CA 120.696 -0.764 . . . . 0.56999999999999995 112.579 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -53.16 -47.29 28.3 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 110.755 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 98.99 -169.74 23.22 Favored Glycine 0 C--N 1.378 2.883 0 C-N-CA 118.958 -1.592 . . . . 0.56999999999999995 113.857 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 78.0 83.09 0.07 Allowed 'General case' 0 C--N 1.392 2.436 0 CA-C-O 124.137 1.922 . . . . 0.56999999999999995 107.649 173.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.63 -103.65 1.99 Allowed Glycine 0 C--N 1.394 3.781 0 N-CA-C 105.155 -3.178 . . . . 0.56999999999999995 105.155 171.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 192' ' ' GLY . 1.2 tp -61.88 -47.18 94.44 Favored 'Isoleucine or valine' 0 C--N 1.387 2.208 0 CA-C-O 127.102 3.334 . . . . 0.56999999999999995 110.691 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' HG23 ' A' ' 191' ' ' ILE . . . -63.83 158.64 40.51 Favored Glycine 0 N--CA 1.404 -3.469 0 O-C-N 117.019 -3.551 . . . . 0.56999999999999995 108.827 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.29 -8.11 19.88 Favored Glycine 0 C--N 1.375 2.743 0 CA-C-N 113.782 -1.209 . . . . 0.56999999999999995 113.853 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -87.45 108.36 18.98 Favored 'General case' 0 C--N 1.378 1.842 0 CA-C-N 114.464 -0.868 . . . . 0.91000000000000003 110.835 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -106.18 151.0 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.137 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.646 ' CD2' HG22 ' A' ' 162' ' ' VAL . 6.7 m170 -135.28 151.21 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.56999999999999995 110.834 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 197' ' ' PHE . 0.2 OUTLIER -114.37 139.7 49.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.844 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.525 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.3 p-10 -66.92 82.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.836 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -35.15 69.78 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 106.629 -1.619 . . . . 0.91000000000000003 106.629 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -48.37 19.04 Favored 'General case' 0 C--N 1.389 2.297 0 O-C-N 125.835 1.96 . . . . 0.91000000000000003 107.548 -163.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.89 171.71 0.02 OUTLIER 'General case' 0 C--N 1.392 2.417 0 CA-C-O 127.167 3.365 . . . . 0.91000000000000003 116.356 172.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -97.06 100.51 12.01 Favored 'General case' 0 C--N 1.378 1.82 0 O-C-N 119.19 -2.194 . . . . 0.56999999999999995 111.117 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.473 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 47.9 m95 -78.54 152.89 31.69 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.869 -1.514 . . . . 0.56999999999999995 109.089 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.7 105.6 9.44 Favored 'General case' 0 C--N 1.378 1.805 0 CA-C-O 124.523 2.106 . . . . 0.56999999999999995 110.599 -175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 125' ' ' MET . 4.3 p -96.93 107.29 19.78 Favored 'General case' 0 C--N 1.365 1.25 0 CA-C-N 114.492 -1.231 . . . . 0.56999999999999995 110.064 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 53.7 46.92 24.92 Favored 'General case' 0 C--N 1.393 2.476 0 CA-C-O 125.371 2.51 . . . . 0.56999999999999995 110.846 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.5 t -134.26 -74.97 0.47 Allowed 'General case' 0 C--N 1.387 2.221 0 CA-C-N 112.5 -2.137 . . . . 0.56999999999999995 107.793 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.55 64.01 0.05 OUTLIER Glycine 0 C--N 1.394 3.782 0 C-N-CA 118.24 -1.933 . . . . 0.56999999999999995 111.214 -171.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.64 -142.01 6.14 Favored Glycine 0 C--N 1.387 3.372 0 CA-C-O 123.483 1.602 . . . . 0.56999999999999995 111.132 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 56.2 m -68.24 118.02 10.81 Favored 'General case' 0 C--N 1.378 1.806 0 CA-C-N 113.841 -1.18 . . . . 0.56999999999999995 110.456 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.52 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.4 p30 -92.49 145.47 24.43 Favored 'General case' 0 C--N 1.378 1.826 0 O-C-N 126.117 2.136 . . . . 0.56999999999999995 112.519 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.684 ' C ' HD13 ' A' ' 212' ' ' LEU . 0.4 OUTLIER -73.49 -32.14 64.13 Favored 'General case' 0 C--N 1.391 2.395 0 CA-C-O 124.424 2.059 . . . . 0.56999999999999995 107.508 -174.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.902 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.3 t80 -49.57 -50.12 43.69 Favored 'General case' 0 C--N 1.363 1.167 0 CA-C-N 113.104 -1.862 . . . . 0.56999999999999995 110.891 -177.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.447 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -57.18 -42.68 81.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.56999999999999995 110.933 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 1.035 HG23 HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.62 -45.04 80.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.095 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.71 -47.77 79.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.56999999999999995 111.063 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 213' ' ' PHE . 2.8 t -59.96 -41.48 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.515 ' HD1' ' C19' ' A' ' 269' ' ' HSI . 2.8 t-160 -62.76 -36.59 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.832 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -43.23 86.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.91000000000000003 110.807 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.807 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.2 mm -64.02 -45.28 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.79 -33.94 87.31 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.819 -0.705 . . . . 0.56999999999999995 112.441 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.425 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.3 OUTLIER -64.01 -42.61 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.56999999999999995 110.821 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 t -71.07 -55.63 7.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.872 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 220' ' ' ILE . 0.2 OUTLIER -78.07 -164.31 0.52 Allowed 'General case' 0 C--N 1.382 1.984 0 N-CA-C 116.305 1.965 . . . . 0.56999999999999995 116.305 171.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 224' ' ' LEU . . . 68.75 -146.03 44.5 Favored Glycine 0 C--N 1.38 2.998 0 N-CA-C 104.487 -3.445 . . . . 0.56999999999999995 104.487 169.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 258' ' ' ILE . 0.0 OUTLIER -124.1 -82.18 0.64 Allowed 'General case' 0 C--N 1.38 1.916 0 CA-C-N 111.738 -2.231 . . . . 0.56999999999999995 110.481 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.91 -157.27 7.29 Favored Glycine 0 C--N 1.379 2.929 0 CA-C-O 123.871 1.817 . . . . 0.56999999999999995 108.843 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.7 m-70 -103.2 -171.34 1.93 Allowed 'General case' 0 C--N 1.376 1.738 0 CA-C-N 113.777 -1.212 . . . . 0.56999999999999995 111.934 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.791 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 1.5 p -116.32 -31.26 5.68 Favored 'General case' 0 C--N 1.386 2.166 0 CA-C-N 113.93 -1.487 . . . . 0.56999999999999995 108.985 -176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.4 m 82.11 23.11 0.23 Allowed 'General case' 0 C--N 1.401 2.828 0 CA-C-O 123.095 1.426 . . . . 0.56999999999999995 114.556 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -127.99 151.13 75.38 Favored Pre-proline 0 N--CA 1.418 -2.067 0 CA-C-N 113.105 -1.861 . . . . 0.91000000000000003 108.345 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.615 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 71.0 Cg_exo -58.23 -28.07 82.91 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.168 1.912 . . . . 0.56999999999999995 115.289 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.422 ' HE3' ' H ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -70.35 -33.74 71.82 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 111.295 -2.684 . . . . 0.56999999999999995 117.884 173.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -55.3 131.23 45.09 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 113.778 -1.555 . . . . 0.56999999999999995 109.483 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.453 HG22 ' CZ ' ' A' ' 248' ' ' PHE . 0.4 OUTLIER -76.32 -3.04 4.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 CA-C-O 125.927 2.775 . . . . 0.56999999999999995 112.366 -176.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.479 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 11.2 mtp -122.82 -10.77 8.23 Favored 'General case' 0 C--N 1.374 1.668 0 CA-C-N 112.847 -1.978 . . . . 0.56999999999999995 112.153 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -38.66 141.82 0.55 Allowed Pre-proline 0 C--N 1.373 1.605 0 CA-C-O 125.496 2.57 . . . . 0.56999999999999995 113.638 174.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.477 ' CA ' H441 ' A' ' 269' ' ' HSI . 75.2 Cg_exo -56.94 -50.04 12.65 Favored 'Trans proline' 0 C--N 1.37 1.667 0 O-C-N 118.831 -1.194 . . . . 0.56999999999999995 111.122 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 39.5 m -44.23 118.71 1.58 Allowed 'General case' 0 C--N 1.366 1.288 0 CA-C-O 123.404 1.573 . . . . 0.56999999999999995 110.507 -172.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.519 ' CE2' HD13 ' A' ' 181' ' ' LEU . 25.1 t80 -92.92 157.56 16.28 Favored 'General case' 0 C--N 1.375 1.682 0 CA-C-N 113.555 -1.657 . . . . 0.56999999999999995 108.326 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.96 126.14 0.02 OUTLIER 'General case' 0 C--N 1.392 2.434 0 N-CA-C 105.448 -2.056 . . . . 0.56999999999999995 105.448 169.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.67 120.45 7.3 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 125.491 2.567 . . . . 0.56999999999999995 109.497 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 1.029 HG11 ' C33' ' A' ' 269' ' ' HSI . 1.4 p -128.27 -16.05 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 CA-C-N 112.538 -2.119 . . . . 0.56999999999999995 110.973 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 244' ' ' ASP 0.289 0.0 OUTLIER 84.51 178.22 0.05 OUTLIER 'General case' 0 C--N 1.371 1.54 0 O-C-N 126.872 2.607 . . . . 0.91000000000000003 111.782 -174.289 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.859 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.8 mp -93.81 -35.64 6.57 Favored 'Isoleucine or valine' 0 C--N 1.382 1.983 0 N-CA-C 118.322 2.712 . . . . 0.56999999999999995 118.322 168.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.77 -14.52 0.05 OUTLIER 'General case' 0 C--N 1.377 1.784 0 N-CA-C 117.224 2.305 . . . . 0.56999999999999995 117.224 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.413 ' HB ' ' CG2' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -124.59 -21.53 4.83 Favored 'General case' 0 C--N 1.378 1.809 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.504 -175.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.453 ' CZ ' HG22 ' A' ' 235' ' ' VAL . 67.3 t80 -61.29 88.67 0.02 OUTLIER 'General case' 0 C--N 1.378 1.845 0 CA-C-O 125.566 2.603 . . . . 0.56999999999999995 108.488 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.07 154.07 29.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-N 112.816 -1.993 . . . . 1.2 107.609 -178.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.631 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -124.42 127.84 48.13 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-O 125.745 2.688 . . . . 0.56999999999999995 105.393 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 143.27 58.06 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.214 -2.179 . . . . 0.56999999999999995 111.916 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -61.0 -45.29 95.42 Favored 'General case' 0 C--N 1.392 2.43 0 CA-C-N 113.842 -1.526 . . . . 0.56999999999999995 107.996 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.71 -38.51 81.83 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 115.644 -0.707 . . . . 0.91000000000000003 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 59.3 t0 -64.17 -55.09 24.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.91000000000000003 110.842 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.06 -34.82 72.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.164 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.449 ' N ' HG13 ' A' ' 255' ' ' ILE . 10.2 mtt180 -70.15 -32.35 70.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 1.2 110.882 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.81 62.41 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.655 -0.783 . . . . 0.56999999999999995 112.499 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.66 ' HA ' HD21 ' A' ' 226' ' ' LEU . 1.0 OUTLIER -64.8 -44.59 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.176 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.474 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.17 -19.18 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.914 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 20.5 t -67.14 -31.7 72.32 Favored 'General case' 0 C--N 1.366 1.326 0 CA-C-O 122.122 0.963 . . . . 0.56999999999999995 108.667 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -69.85 0.1 Allowed 'General case' 0 C--N 1.388 2.239 0 CA-C-O 124.859 2.266 . . . . 0.56999999999999995 111.226 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.621 ' CE1' HD11 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -96.23 142.25 28.61 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 112.729 -2.032 . . . . 0.56999999999999995 111.903 177.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.576 3.865 0 N-CA-C 120.24 2.856 . . . . 0.91000000000000003 120.24 -168.687 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 1.029 ' C33' HG11 ' A' ' 243' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.325 -0.708 . . . . 0.56999999999999995 111.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.48 179.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 O-C-N 125.101 2.106 . . . . 0.56999999999999995 111.619 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.62 126.4 71.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.113 0 CA-C-O 123.242 1.496 . . . . 0.56999999999999995 111.053 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.5 -170.05 3.42 Favored 'General case' 0 C--N 1.363 1.178 0 CA-C-N 114.68 -1.146 . . . . 0.56999999999999995 108.428 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 -129.45 162.32 28.37 Favored 'General case' 0 C--N 1.372 1.573 0 CA-C-O 122.303 1.049 . . . . 1.2 109.278 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.83 155.44 14.32 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.364 -0.976 . . . . 0.56999999999999995 108.364 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.533 ' H ' HD22 ' A' ' 147' ' ' LEU . 6.1 m-70 81.96 -41.72 0.14 Allowed 'General case' 0 C--N 1.377 1.777 0 CA-C-O 122.187 0.994 . . . . 0.56999999999999995 110.622 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -114.4 131.47 56.56 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 114.579 -1.191 . . . . 0.56999999999999995 110.868 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 148' ' ' LYS . 1.1 mm -127.45 145.45 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.12 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.56 HG22 HG12 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -106.0 157.81 17.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 111.098 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.68 ' CE1' HD12 ' A' ' 118' ' ' ILE . 16.7 t80 -145.29 160.02 42.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.914 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.598 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 3.9 tpt85 -146.49 121.97 10.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.841 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.68 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -95.53 125.4 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.56999999999999995 111.122 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -61.83 -179.37 0.19 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.616 1.674 . . . . 0.56999999999999995 111.268 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.09 51.37 0.98 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.505 -1.372 . . . . 0.56999999999999995 110.824 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 5.2 m-85 44.19 -150.15 0.05 Allowed 'General case' 0 C--N 1.366 1.323 0 CA-C-N 115.239 -0.891 . . . . 0.56999999999999995 109.045 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.592 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -165.84 168.24 8.07 Favored Pre-proline 0 N--CA 1.427 -1.592 0 CA-C-O 122.286 1.041 . . . . 0.56999999999999995 110.454 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 122' ' ' THR . 32.5 Cg_endo -68.06 -36.23 17.85 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 121.444 1.429 . . . . 0.56999999999999995 112.963 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -84.84 -45.42 12.32 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.987 1.375 . . . . 0.91000000000000003 113.134 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.498 ' CE ' ' CE2' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -77.92 110.09 12.52 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 123.68 1.705 . . . . 0.56999999999999995 109.482 -176.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.855 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -71.27 135.89 47.67 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 113.947 -1.479 . . . . 0.56999999999999995 109.192 -176.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -61.61 -50.83 70.98 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 108.448 -0.945 . . . . 1.2 108.448 -170.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -57.56 -34.86 69.63 Favored 'General case' 0 C--N 1.371 1.514 0 CA-C-N 113.083 -1.871 . . . . 0.91000000000000003 110.896 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -39.71 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.91000000000000003 110.826 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.7 t -64.97 -49.74 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 111.153 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -41.61 91.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.91000000000000003 110.896 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.12 -42.3 80.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 110.863 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.736 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.5 -48.88 68.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.56999999999999995 111.092 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.575 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -64.35 -31.95 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.122 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.95 -46.71 70.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 1.2 110.887 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -62.82 -37.2 85.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.52 ' CB ' HG23 ' A' ' 217' ' ' VAL . . . -68.06 -38.5 82.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.065 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' CE2' HG22 ' A' ' 134' ' ' ILE . 5.5 m-85 -67.06 -33.83 76.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 110.919 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.426 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 7.3 tp60 -70.21 -44.65 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.871 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 250' ' ' LEU . 7.7 p -68.54 -33.6 60.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.56999999999999995 111.16 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.46 -34.31 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.854 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 138' ' ' PHE . 29.3 m -72.22 -49.45 35.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 110.863 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -60.66 -11.97 8.92 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-O 121.881 0.848 . . . . 0.56999999999999995 112.706 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.77 HG23 HG23 ' A' ' 145' ' ' THR . 16.9 m -111.98 -5.29 11.35 Favored 'Isoleucine or valine' 0 C--N 1.367 1.358 0 CA-C-N 114.792 -1.094 . . . . 0.56999999999999995 112.69 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.94 HG21 HD13 ' A' ' 224' ' ' LEU . 21.0 p -140.63 146.38 44.43 Favored Pre-proline 0 C--N 1.365 1.261 0 CA-C-O 124.594 2.14 . . . . 0.56999999999999995 111.115 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -77.19 -25.54 8.48 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 121.218 1.278 . . . . 0.56999999999999995 111.77 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -77.68 96.09 4.77 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 122.668 1.223 . . . . 0.56999999999999995 109.518 -176.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -77.04 160.75 28.86 Favored 'General case' 0 C--N 1.363 1.184 0 CA-C-N 115.168 -0.924 . . . . 0.56999999999999995 112.198 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.487 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -133.05 140.77 47.88 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 107.702 -1.222 . . . . 0.56999999999999995 107.702 -173.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.0 m -155.67 135.56 12.78 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 123.553 1.644 . . . . 0.56999999999999995 109.387 -174.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -74.97 144.17 43.3 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-N 114.513 -1.222 . . . . 0.56999999999999995 109.213 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 115' ' ' THR . 6.2 pt -125.14 -179.63 2.52 Favored 'Isoleucine or valine' 0 C--N 1.364 1.213 0 CA-C-O 121.947 0.879 . . . . 0.56999999999999995 109.887 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -134.41 63.87 1.61 Allowed 'General case' 0 C--N 1.37 1.483 0 CA-C-O 122.93 1.348 . . . . 0.56999999999999995 111.299 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.76 95.83 1.57 Allowed 'General case' 0 C--N 1.373 1.624 0 CA-C-N 114.553 -1.203 . . . . 0.56999999999999995 110.357 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 45.66 -137.63 7.04 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 122.418 1.01 . . . . 0.56999999999999995 111.681 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.98 151.53 46.96 Favored 'General case' 0 C--N 1.366 1.307 0 CA-C-O 123.145 1.45 . . . . 0.56999999999999995 110.74 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 117' ' ' ARG . . . -133.68 163.64 28.99 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 114.497 -1.229 . . . . 0.56999999999999995 109.814 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.462 ' H ' ' HB ' ' A' ' 115' ' ' THR . 53.6 m-20 -46.06 -52.0 12.75 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 108.245 -1.02 . . . . 0.91000000000000003 108.245 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.926 HG23 ' O ' ' A' ' 193' ' ' GLY . 41.6 mt -116.43 110.47 31.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 O-C-N 123.816 0.697 . . . . 0.56999999999999995 111.093 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 122.02 46.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.56999999999999995 110.977 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.19 120.21 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 111.098 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.8 t -131.23 124.94 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 111.084 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 197' ' ' PHE . 2.4 m-85 -86.78 120.48 28.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.852 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.13 169.0 18.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.886 1.327 . . . . 0.56999999999999995 110.626 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 163.44 13.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 120.749 -1.219 . . . . 1.2 108.945 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -33.03 130.89 0.3 Allowed Glycine 0 C--N 1.37 2.429 0 O-C-N 124.009 0.818 . . . . 0.56999999999999995 112.718 175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 84.28 40.28 0.03 OUTLIER 'General case' 0 C--N 1.39 2.361 0 CA-C-O 124.763 2.221 . . . . 0.56999999999999995 112.383 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -107.0 155.6 19.63 Favored 'General case' 0 C--N 1.364 1.237 0 CA-C-N 114.249 -1.342 . . . . 0.56999999999999995 109.087 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -53.79 168.77 1.32 Allowed Glycine 0 C--N 1.378 2.865 0 N-CA-C 110.104 -1.198 . . . . 0.56999999999999995 110.104 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.77 8.03 5.66 Favored 'General case' 0 C--N 1.373 1.613 0 CA-C-O 122.402 1.096 . . . . 0.91000000000000003 113.367 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.41 ' O ' ' CB ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -165.76 -77.65 0.03 OUTLIER 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.085 -0.961 . . . . 0.56999999999999995 111.152 -171.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER 83.2 43.78 0.02 OUTLIER 'General case' 0 C--N 1.373 1.608 0 CA-C-O 123.034 1.397 . . . . 0.56999999999999995 110.239 175.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 159.88 114.17 0.0 OUTLIER 'General case' 0 C--N 1.382 2.012 0 CA-C-N 114.999 -1.001 . . . . 0.56999999999999995 110.72 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.441 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -147.6 -167.82 2.89 Favored 'General case' 0 C--N 1.361 1.096 0 CA-C-O 122.018 0.914 . . . . 0.56999999999999995 110.07 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.419 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.4 OUTLIER -72.61 -177.74 2.38 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 124.477 1.111 . . . . 0.91000000000000003 112.252 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.27 49.13 0.21 Allowed Glycine 0 C--N 1.381 3.049 0 CA-C-O 123.411 1.562 . . . . 0.56999999999999995 113.192 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -171.72 -36.48 0.02 OUTLIER 'General case' 0 C--N 1.384 2.069 0 CA-C-O 123.425 1.583 . . . . 0.56999999999999995 112.819 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.474 ' N ' ' HD2' ' A' ' 177' ' ' LYS . . . 169.41 -103.62 0.2 Allowed Glycine 0 C--N 1.375 2.7 0 CA-C-O 122.955 1.308 . . . . 0.56999999999999995 110.457 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.541 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 36.04 -92.19 0.01 OUTLIER Glycine 0 C--N 1.367 2.267 0 O-C-N 120.309 -1.7 . . . . 0.56999999999999995 114.49 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.57 ' N ' HD13 ' A' ' 180' ' ' ILE . 1.9 mm -51.23 170.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.064 0 CA-C-O 121.297 0.57 . . . . 0.56999999999999995 111.593 176.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD13 ' HE2' ' A' ' 240' ' ' TYR . 3.6 tp -136.09 -41.33 0.66 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.945 0.879 . . . . 0.56999999999999995 112.55 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -176.72 179.87 1.06 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.359 -0.837 . . . . 0.56999999999999995 111.094 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.6 OUTLIER -156.03 137.91 14.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.928 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -137.87 140.01 40.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.56999999999999995 111.101 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.446 ' CB ' HG23 ' A' ' 191' ' ' ILE . 1.9 m-85 -91.93 176.59 6.46 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.523 1.154 . . . . 0.56999999999999995 110.964 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.37 55.07 0.1 Allowed Glycine 0 C--N 1.366 2.21 0 CA-C-N 115.501 -0.772 . . . . 0.56999999999999995 112.797 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.441 ' HD2' ' CA ' ' A' ' 192' ' ' GLY . 47.0 Cg_endo -74.42 -42.98 0.54 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 120.907 1.071 . . . . 0.56999999999999995 112.008 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 138.41 87.32 0.17 Allowed Glycine 0 C--N 1.379 2.93 0 C-N-CA 120.137 -1.03 . . . . 0.56999999999999995 111.569 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.6 t 79.75 97.02 0.06 Allowed 'General case' 0 C--N 1.386 2.155 0 CA-C-O 123.59 1.662 . . . . 0.56999999999999995 110.073 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.65 -118.56 1.27 Allowed Glycine 0 C--N 1.381 3.047 0 N-CA-C 109.61 -1.396 . . . . 0.56999999999999995 109.61 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.446 HG23 ' CB ' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -72.11 -11.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 CA-C-O 124.689 2.185 . . . . 0.56999999999999995 110.36 -178.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.441 ' CA ' ' HD2' ' A' ' 187' ' ' PRO . . . -66.91 124.62 23.89 Favored Glycine 0 C--N 1.372 2.552 0 O-C-N 120.077 -1.639 . . . . 0.56999999999999995 109.758 -174.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 159' ' ' ILE . . . 115.09 -33.12 5.45 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-O 121.737 0.631 . . . . 0.56999999999999995 112.521 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -72.91 129.37 37.99 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 122.162 -0.61 . . . . 0.91000000000000003 110.828 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.694 ' HB2' ' HB2' ' A' ' 219' ' ' GLU . . . -121.51 160.05 25.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.481 . . . . 0.56999999999999995 111.089 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.549 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 46.0 m170 -133.74 140.07 46.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.829 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.66 139.42 38.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 110.887 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.55 78.89 7.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.91000000000000003 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 -29.61 11.36 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 118.529 -0.748 . . . . 0.91000000000000003 112.515 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -39.15 -55.94 1.55 Allowed 'General case' 0 C--N 1.352 0.713 0 CA-C-O 124.907 2.289 . . . . 0.91000000000000003 109.189 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 201' ' ' GLU . 1.6 pm0 -75.09 176.38 7.32 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-O 125.474 2.559 . . . . 0.91000000000000003 112.379 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.11 90.82 3.44 Favored 'General case' 0 C--N 1.369 1.431 0 O-C-N 119.282 -2.136 . . . . 0.56999999999999995 109.638 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -88.63 147.63 24.45 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 114.063 -1.426 . . . . 0.56999999999999995 111.708 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 99.6 m -123.05 121.57 36.37 Favored 'General case' 0 C--N 1.363 1.183 0 CA-C-O 124.387 2.041 . . . . 0.56999999999999995 112.429 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.35 133.47 34.96 Favored 'General case' 0 N--CA 1.436 -1.141 0 O-C-N 120.865 -1.147 . . . . 0.56999999999999995 110.588 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.451 ' O ' ' CB ' ' A' ' 207' ' ' SER . 2.2 t-80 78.89 62.79 0.03 OUTLIER 'General case' 0 C--N 1.38 1.909 0 CA-C-O 122.726 1.251 . . . . 0.56999999999999995 110.219 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.7 m 85.09 92.85 0.03 OUTLIER 'General case' 0 C--N 1.381 1.945 0 CA-C-O 123.703 1.716 . . . . 0.56999999999999995 109.057 175.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.42 110.21 0.5 Allowed Glycine 0 C--N 1.375 2.721 0 O-C-N 120.997 -1.064 . . . . 0.56999999999999995 111.772 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 43.57 -113.26 0.68 Allowed Glycine 0 C--N 1.375 2.73 0 CA-C-O 123.756 1.753 . . . . 0.56999999999999995 111.689 177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.697 ' CB ' HD11 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -93.31 126.21 38.31 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 113.599 -1.3 . . . . 0.56999999999999995 112.243 175.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.827 ' HB2' HD11 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -95.71 151.04 19.72 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.186 -1.37 . . . . 0.56999999999999995 111.885 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -72.75 -38.51 67.35 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 123.518 1.628 . . . . 0.56999999999999995 107.873 -175.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 213' ' ' PHE . 1.9 t80 -51.79 -46.8 64.33 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 114.242 -1.344 . . . . 0.56999999999999995 110.867 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.517 HD11 ' C25' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -54.76 -51.18 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.56999999999999995 110.923 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.659 HG23 HD23 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -64.18 -45.37 88.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.115 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -59.14 -39.91 83.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 111.074 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 248' ' ' PHE . 1.1 t -65.25 -39.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.56999999999999995 111.118 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.466 ' HD1' ' C19' ' A' ' 269' ' ' HSI . 3.5 t-160 -66.31 -49.03 68.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.827 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . 3.4 pt-20 -57.9 -42.26 84.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.91000000000000003 110.904 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.715 HG22 ' CD2' ' A' ' 224' ' ' LEU . 11.7 mt -67.0 -46.17 85.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.56999999999999995 111.16 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.94 -33.67 64.19 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.476 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.411 ' CE1' ' O ' ' A' ' 227' ' ' GLY . 1.5 m-70 -64.31 -40.65 96.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.56999999999999995 110.872 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 17.6 t -71.23 -51.04 26.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.815 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.94 HD13 HG21 ' A' ' 145' ' ' THR . 3.3 pp -72.4 -64.89 0.86 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.868 1.062 . . . . 0.56999999999999995 113.868 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.82 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -73.13 169.98 52.5 Favored Glycine 0 N--CA 1.418 -2.501 0 CA-C-O 124.871 2.373 . . . . 0.56999999999999995 111.493 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.781 HD21 HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER -66.21 -154.73 0.01 OUTLIER 'General case' 0 C--N 1.371 1.532 0 CA-C-O 123.727 1.727 . . . . 0.56999999999999995 108.796 -177.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 222' ' ' HIS . . . -53.47 -99.47 0.01 OUTLIER Glycine 0 C--N 1.38 2.982 0 CA-C-O 123.849 1.805 . . . . 0.56999999999999995 111.921 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -112.67 -93.82 0.46 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 119.684 -2.068 . . . . 0.56999999999999995 112.216 176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 16.1 p -162.75 -43.85 0.04 OUTLIER 'General case' 0 C--N 1.372 1.563 0 CA-C-N 115.219 -0.9 . . . . 0.56999999999999995 110.666 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 83.84 28.99 0.08 Allowed 'General case' 0 C--N 1.399 2.726 0 CA-C-N 114.189 -1.368 . . . . 0.56999999999999995 114.501 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.3 128.68 2.4 Favored Pre-proline 0 C--N 1.383 2.056 0 CA-C-N 114.459 -1.246 . . . . 0.91000000000000003 108.545 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.42 64.41 7.26 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.909 2.406 . . . . 0.56999999999999995 112.12 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.7 -31.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 121.086 -1.009 . . . . 0.56999999999999995 113.276 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -69.82 120.07 15.01 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-O 123.521 1.629 . . . . 0.56999999999999995 110.41 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.621 ' O ' HG12 ' A' ' 235' ' ' VAL . 40.0 t -58.4 88.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.71 -1.132 . . . . 0.56999999999999995 112.849 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.456 ' CG ' ' O ' ' A' ' 235' ' ' VAL . 0.0 OUTLIER 158.37 -20.74 0.0 OUTLIER 'General case' 0 C--N 1.367 1.361 0 CA-C-O 122.292 1.044 . . . . 0.56999999999999995 112.488 -176.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 234' ' ' ALA . 4.0 p90 -50.02 153.03 2.48 Favored Pre-proline 0 N--CA 1.43 -1.459 0 CA-C-O 123.088 1.423 . . . . 0.56999999999999995 111.322 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.67 -47.87 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 121.331 1.354 . . . . 0.56999999999999995 110.591 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.7 m -39.6 121.25 1.2 Allowed 'General case' 0 C--N 1.353 0.719 0 CA-C-O 122.725 1.25 . . . . 0.56999999999999995 110.926 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.697 ' HE2' HD13 ' A' ' 181' ' ' LEU . 36.2 t80 -68.18 162.52 24.7 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.355 -1.293 . . . . 0.56999999999999995 108.113 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 14.4 tttt 167.4 124.22 0.01 OUTLIER 'General case' 0 C--N 1.373 1.618 0 CA-C-O 123.064 1.411 . . . . 0.56999999999999995 108.112 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -74.77 120.11 19.87 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-O 122.898 1.332 . . . . 0.56999999999999995 111.325 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 243' ' ' VAL . 8.5 p -138.18 115.6 12.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.239 0 CA-C-N 115.166 -0.925 . . . . 0.56999999999999995 108.891 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -41.47 142.36 0.61 Allowed 'General case' 0 C--N 1.366 1.31 0 CA-C-O 124.052 1.882 . . . . 0.91000000000000003 109.53 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.827 HD11 ' HB2' ' A' ' 211' ' ' ASN . 15.4 mt -65.96 -22.29 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 123.065 1.412 . . . . 0.56999999999999995 112.209 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -17.04 61.98 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.126 0.965 . . . . 0.56999999999999995 111.387 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.7 p -112.18 8.25 19.81 Favored 'General case' 0 C--N 1.371 1.519 0 CA-C-O 122.654 1.216 . . . . 0.56999999999999995 113.376 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.559 ' CE1' HG11 ' A' ' 217' ' ' VAL . 45.0 t80 -77.16 88.49 3.63 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-O 124.193 1.949 . . . . 0.56999999999999995 108.577 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.522 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -112.42 153.56 27.16 Favored 'General case' 0 N--CA 1.422 -1.833 0 O-C-N 120.678 -1.263 . . . . 1.2 110.32 177.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.77 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -119.98 129.36 54.25 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 124.331 2.015 . . . . 0.56999999999999995 107.934 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 143.91 55.51 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 119.659 -1.901 . . . . 0.56999999999999995 112.25 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.68 89.61 Favored 'General case' 0 C--N 1.382 1.98 0 CA-C-N 114.663 -1.153 . . . . 0.56999999999999995 109.428 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -61.17 -40.71 94.92 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.796 -0.638 . . . . 0.91000000000000003 110.882 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.406 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 26.8 t70 -64.29 -54.92 25.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.91000000000000003 110.849 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.1 pt -66.1 -34.79 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.081 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.451 ' N ' HG13 ' A' ' 255' ' ' ILE . 37.3 mtp180 -62.84 -43.47 98.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.934 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.57 -57.52 12.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.547 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.473 HG13 ' N ' ' A' ' 259' ' ' GLN . 28.4 pt -46.62 -44.2 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.56999999999999995 111.224 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.473 ' N ' HG13 ' A' ' 258' ' ' ILE . 2.6 pt20 -72.02 -26.75 62.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.428 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 32.1 t -63.9 -40.0 95.48 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.594 1.187 . . . . 0.56999999999999995 110.441 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.781 HD11 HD21 ' A' ' 226' ' ' LEU . 2.3 mp -50.95 -56.87 10.27 Favored 'General case' 0 C--N 1.377 1.802 0 CA-C-O 123.101 1.429 . . . . 0.56999999999999995 110.92 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.424 ' CZ ' ' O ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -92.52 -73.68 0.54 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-N 114.367 -1.288 . . . . 0.56999999999999995 113.054 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.268 2.225 0 CA-C-O 117.09 -1.95 . . . . 0.91000000000000003 115.094 173.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.596 ' H30' HG22 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.573 0 CA-C-O 119.256 -0.747 . . . . 0.56999999999999995 111.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.5 -30.58 28.12 Favored 'Trans proline' 0 C--N 1.377 2.049 0 O-C-N 124.336 1.703 . . . . 0.56999999999999995 113.377 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 109' ' ' TRP . 3.7 t -111.46 124.09 67.9 Favored 'Isoleucine or valine' 0 C--N 1.382 1.981 0 CA-C-N 113.951 -1.477 . . . . 0.56999999999999995 108.847 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.483 ' CD1' HG12 ' A' ' 108' ' ' VAL . 11.3 m0 70.67 -158.9 0.14 Allowed 'General case' 0 C--N 1.386 2.175 0 CA-C-N 112.623 -2.08 . . . . 0.56999999999999995 106.925 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.86 149.15 31.75 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-O 123.112 1.434 . . . . 1.2 109.382 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.49 ' O ' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -153.17 -44.83 0.1 Allowed 'General case' 0 C--N 1.374 1.659 0 CA-C-N 113.081 -1.872 . . . . 0.56999999999999995 111.037 178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -78.25 -30.86 48.89 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 113.468 -1.696 . . . . 0.56999999999999995 109.983 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.625 ' C ' HD13 ' A' ' 114' ' ' ILE . 39.6 t80 -112.02 109.12 18.7 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 114.26 -1.336 . . . . 0.56999999999999995 110.903 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.625 HD13 ' C ' ' A' ' 113' ' ' TYR . 1.9 mm -102.22 155.04 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 111.13 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -114.36 149.5 36.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.56999999999999995 111.106 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 8.1 t80 -145.86 156.57 43.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.99 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.587 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -154.54 132.17 11.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.936 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -95.74 146.32 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.137 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.667 ' OD1' HG22 ' A' ' 162' ' ' VAL . 55.5 t30 -53.4 -60.44 3.3 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 117.651 -1.619 . . . . 0.56999999999999995 107.454 -167.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 159.21 31.08 0.0 OUTLIER 'General case' 0 C--N 1.383 2.024 0 O-C-N 126.474 2.359 . . . . 0.56999999999999995 109.567 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.438 ' HB3' ' CG ' ' A' ' 127' ' ' ARG . 0.4 OUTLIER 77.18 92.16 0.07 Allowed 'General case' 0 C--N 1.409 3.162 0 N-CA-C 105.461 -2.052 . . . . 0.56999999999999995 105.461 164.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -49.43 163.82 0.35 Allowed Pre-proline 0 C--N 1.383 2.041 0 CA-C-N 111.993 -2.367 . . . . 0.56999999999999995 108.548 -168.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.23 -47.92 11.1 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 115.692 -0.503 . . . . 0.56999999999999995 112.537 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.661 ' H ' HG23 ' A' ' 122' ' ' THR . 0.2 OUTLIER -82.46 -63.72 1.32 Allowed 'General case' 0 C--N 1.386 2.153 0 N-CA-C 104.32 -2.474 . . . . 0.91000000000000003 104.32 -163.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.819 ' SD ' HG22 ' A' ' 130' ' ' VAL . 5.0 ttm -53.37 154.48 3.35 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-O 125.141 2.4 . . . . 0.56999999999999995 108.219 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.803 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -87.54 137.74 32.07 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 112.79 -2.005 . . . . 0.56999999999999995 110.125 -177.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' CG ' ' HB3' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -65.03 -49.43 70.19 Favored 'General case' 0 C--N 1.369 1.433 0 CA-C-N 115.116 -0.947 . . . . 1.2 108.579 -170.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.07 -35.24 64.33 Favored 'General case' 0 C--N 1.383 2.04 0 O-C-N 126.838 2.586 . . . . 0.91000000000000003 110.98 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -70.7 -42.26 70.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.91000000000000003 110.883 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.819 HG22 ' SD ' ' A' ' 125' ' ' MET . 2.5 t -63.13 -47.68 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.1 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.462 ' HA ' HD11 ' A' ' 134' ' ' ILE . 7.7 t70 -60.12 -44.05 95.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.91000000000000003 110.872 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.37 -41.44 97.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.927 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.679 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -63.23 -49.08 75.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.56999999999999995 111.125 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 131' ' ' ASP . 18.1 pt -64.76 -39.22 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.144 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -58.85 -49.11 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.813 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.79 -34.87 78.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.888 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -64.62 -45.15 88.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.12 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' CE1' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m-85 -63.52 -36.85 85.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.56999999999999995 110.91 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 8.2 tt0 -66.38 -39.19 88.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.496 . . . . 0.56999999999999995 110.935 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.811 ' CG1' HD11 ' A' ' 250' ' ' LEU . 28.9 t -69.51 -34.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.152 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.672 ' CG ' HD11 ' A' ' 224' ' ' LEU . 4.8 m95 -82.93 -34.13 26.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.977 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.7 m -78.66 -48.11 15.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.905 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.824 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -61.02 -12.72 12.52 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 121.892 0.853 . . . . 0.56999999999999995 111.844 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.91 HG11 HG21 ' A' ' 255' ' ' ILE . 18.9 m -114.48 11.43 7.95 Favored 'Isoleucine or valine' 0 C--N 1.378 1.842 0 CA-C-N 113.892 -1.504 . . . . 0.56999999999999995 112.898 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.594 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -150.67 150.45 28.35 Favored Pre-proline 0 N--CA 1.424 -1.755 0 CA-C-O 125.381 2.515 . . . . 0.56999999999999995 110.264 -173.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.413 ' HG3' ' HA2' ' A' ' 263' ' ' GLY . 42.3 Cg_endo -81.81 -24.54 4.06 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 O-C-N 118.133 -1.562 . . . . 0.56999999999999995 113.054 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' HB ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -75.94 111.48 11.35 Favored 'General case' 0 C--N 1.371 1.51 0 CA-C-O 124.534 2.112 . . . . 0.56999999999999995 107.487 -176.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 156.8 38.79 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 114.687 172.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.658 ' HE2' HD12 ' A' ' 159' ' ' ILE . 1.1 m-85 -128.04 160.01 33.27 Favored 'General case' 0 C--N 1.376 1.723 0 CA-C-N 112.526 -2.125 . . . . 0.56999999999999995 109.441 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.0 m -157.92 114.71 2.9 Favored 'General case' 0 C--N 1.389 2.29 0 CA-C-O 124.855 2.264 . . . . 0.56999999999999995 109.344 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -95.3 129.17 42.53 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.106 -1.861 . . . . 0.56999999999999995 110.69 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 154' ' ' THR . 2.8 pt -105.89 137.07 37.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.406 0 CA-C-O 124.681 2.182 . . . . 0.56999999999999995 111.361 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -46.29 71.27 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 110.533 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 152' ' ' ILE . 29.0 p -121.41 171.92 8.43 Favored 'General case' 0 C--N 1.379 1.875 0 CA-C-N 113.361 -1.745 . . . . 0.56999999999999995 110.143 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 100.08 -119.91 6.68 Favored Glycine 0 C--N 1.382 3.11 0 N-CA-C 109.514 -1.434 . . . . 0.56999999999999995 109.514 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 ttt -165.46 108.72 0.82 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-O 123.389 1.566 . . . . 0.56999999999999995 109.759 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.765 ' O ' HD13 ' A' ' 160' ' ' LEU . . . -106.03 143.58 33.96 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 112.722 -2.035 . . . . 0.56999999999999995 110.462 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.484 ' OD2' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -44.98 -51.22 10.08 Favored 'General case' 0 C--N 1.374 1.665 0 CA-C-N 116.001 -0.545 . . . . 0.91000000000000003 110.356 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.658 HD12 ' HE2' ' A' ' 149' ' ' PHE . 18.6 mt -90.17 109.81 21.16 Favored 'Isoleucine or valine' 0 C--N 1.386 2.169 0 O-C-N 128.124 3.39 . . . . 0.56999999999999995 111.116 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -106.97 132.06 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.957 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.408 HG21 ' OE2' ' A' ' 219' ' ' GLU . 2.1 t -120.6 118.14 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.56999999999999995 111.126 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.667 HG22 ' OD1' ' A' ' 119' ' ' ASN . 69.5 t -133.08 146.02 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.56999999999999995 111.166 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CE2' ' HB3' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -92.07 121.66 33.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.834 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.01 168.8 18.86 Favored 'General case' 0 C--N 1.365 1.247 0 CA-C-O 123.445 1.593 . . . . 0.56999999999999995 109.829 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.43 ' CB ' ' HB3' ' A' ' 200' ' ' ASP . 0.2 OUTLIER -115.73 169.78 8.95 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 114.974 -1.012 . . . . 1.2 110.531 177.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.35 139.18 2.46 Favored Glycine 0 C--N 1.383 3.152 0 O-C-N 126.202 2.189 . . . . 0.56999999999999995 111.517 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 65.68 57.69 0.84 Allowed 'General case' 0 C--N 1.4 2.777 0 CA-C-O 125.475 2.56 . . . . 0.56999999999999995 110.585 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -108.5 -50.31 3.05 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 112.39 -2.187 . . . . 0.56999999999999995 110.34 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -171.77 -121.54 0.6 Allowed Glycine 0 C--N 1.377 2.823 0 CA-C-N 114.395 -1.275 . . . . 0.56999999999999995 111.857 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.477 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 41.7 p-10 -36.22 147.38 0.03 OUTLIER 'General case' 0 C--N 1.387 2.221 0 O-C-N 127.138 2.317 . . . . 0.91000000000000003 112.494 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.3 OUTLIER 75.72 -155.11 0.04 OUTLIER 'General case' 0 C--N 1.391 2.392 0 CA-C-N 112.501 -2.136 . . . . 0.56999999999999995 112.181 -172.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -112.57 -133.74 0.34 Allowed 'General case' 0 C--N 1.38 1.913 0 CA-C-O 123.452 1.596 . . . . 0.56999999999999995 107.463 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -106.51 128.31 54.0 Favored 'General case' 0 C--N 1.38 1.92 0 CA-C-N 114.959 -1.019 . . . . 0.56999999999999995 111.129 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 180' ' ' ILE . 9.7 m-85 -92.94 179.58 5.41 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-N 111.823 -2.444 . . . . 0.56999999999999995 111.184 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.422 ' CG ' ' N ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -86.7 -175.82 5.56 Favored 'General case' 0 C--N 1.382 2.014 0 CA-C-N 113.724 -1.58 . . . . 0.91000000000000003 113.009 173.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 175' ' ' ASP . . . -147.96 142.68 10.32 Favored Glycine 0 C--N 1.39 3.563 0 O-C-N 126.337 2.273 . . . . 0.56999999999999995 110.482 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.72 25.02 2.61 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 113.025 -1.587 . . . . 0.56999999999999995 113.086 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.78 -132.65 4.34 Favored Glycine 0 C--N 1.372 2.564 0 CA-C-O 116.679 -2.178 . . . . 0.56999999999999995 112.69 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 240' ' ' TYR . . . 55.96 -109.67 1.58 Allowed Glycine 0 C--N 1.38 3.008 0 O-C-N 125.409 1.3 . . . . 0.56999999999999995 111.405 168.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.578 HG21 ' CE2' ' A' ' 174' ' ' PHE . 9.3 mt -73.77 166.5 2.65 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 N-CA-C 115.332 1.604 . . . . 0.56999999999999995 115.332 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG23 ' A' ' 215' ' ' THR . 1.1 tp -118.54 -41.4 2.82 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 119.962 -1.711 . . . . 0.56999999999999995 110.129 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.546 ' HB2' ' HD1' ' A' ' 197' ' ' PHE . . . -175.95 179.9 1.26 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.893 -1.503 . . . . 0.56999999999999995 111.089 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 1.2 p80 -165.78 135.85 3.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 110.849 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -139.43 162.51 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.08 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -110.7 -171.0 1.74 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.337 -0.945 . . . . 0.56999999999999995 111.05 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -145.66 -76.2 0.03 OUTLIER Glycine 0 C--N 1.377 2.843 0 C-N-CA 119.385 -1.388 . . . . 0.56999999999999995 110.551 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.47 75.73 4.91 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.019 1.812 . . . . 0.56999999999999995 111.465 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -148.11 13.97 1.29 Allowed Glycine 0 C--N 1.367 2.288 0 C-N-CA 118.574 -1.774 . . . . 0.56999999999999995 111.926 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 57.28 -93.19 0.04 OUTLIER 'General case' 0 C--N 1.388 2.278 0 O-C-N 125.549 1.382 . . . . 0.56999999999999995 110.424 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -62.56 -71.56 0.8 Allowed Glycine 0 C--N 1.389 3.477 0 CA-C-N 114.69 -1.141 . . . . 0.56999999999999995 112.33 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -31.65 53.79 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 CA-C-O 124.686 2.184 . . . . 0.56999999999999995 108.915 -176.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -56.76 140.66 43.66 Favored Glycine 0 C--N 1.376 2.787 0 N-CA-C 107.783 -2.127 . . . . 0.56999999999999995 107.783 -171.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.42 -38.84 2.97 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-N 113.869 -1.165 . . . . 0.56999999999999995 113.883 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -48.32 150.97 1.13 Allowed 'General case' 0 C--N 1.392 2.416 0 CA-C-N 113.417 -1.391 . . . . 0.91000000000000003 110.907 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -144.09 145.86 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 111.077 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -121.68 134.48 54.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.56999999999999995 110.826 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.546 ' HD1' ' HB2' ' A' ' 182' ' ' ALA . 29.0 m-85 -103.94 144.28 31.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.892 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 75.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 110.808 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -56.65 18.1 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 108.211 -1.033 . . . . 0.91000000000000003 108.211 -175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -40.4 -45.55 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 124.903 1.377 . . . . 0.91000000000000003 110.692 -176.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.29 172.64 0.13 Allowed 'General case' 0 C--N 1.383 2.056 0 CA-C-O 126.669 3.128 . . . . 0.91000000000000003 113.178 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.71 102.63 10.67 Favored 'General case' 0 C--N 1.376 1.756 0 CA-C-N 111.975 -2.375 . . . . 0.56999999999999995 114.119 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.518 ' CH2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -92.28 150.36 20.91 Favored 'General case' 0 C--N 1.361 1.1 0 CA-C-N 112.946 -1.934 . . . . 0.56999999999999995 108.675 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.47 122.09 42.79 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 123.751 1.739 . . . . 0.56999999999999995 109.032 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 p -89.41 131.87 35.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.835 -1.075 . . . . 0.56999999999999995 112.169 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 78.81 -148.33 0.02 OUTLIER 'General case' 0 C--N 1.395 2.572 0 O-C-N 125.362 1.664 . . . . 0.56999999999999995 110.492 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.466 ' HA ' ' OD2' ' A' ' 244' ' ' ASP . 1.6 t -60.72 93.27 0.03 OUTLIER 'General case' 0 C--N 1.386 2.18 0 CA-C-O 124.612 2.148 . . . . 0.56999999999999995 109.281 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -174.38 -34.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.29 0 CA-C-N 112.359 -2.2 . . . . 0.56999999999999995 113.407 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 242' ' ' TYR . . . 141.73 -112.97 0.79 Allowed Glycine 0 C--N 1.387 3.41 0 CA-C-O 123.378 1.543 . . . . 0.56999999999999995 111.81 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.682 HG23 ' HB3' ' A' ' 242' ' ' TYR . 26.5 p -82.11 117.68 22.47 Favored 'General case' 0 C--N 1.369 1.427 0 CA-C-N 114.27 -0.965 . . . . 0.56999999999999995 110.23 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.75 176.87 4.92 Favored 'General case' 0 C--N 1.374 1.655 0 O-C-N 126.72 2.512 . . . . 0.56999999999999995 110.75 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.5 tm? -70.55 -33.81 71.53 Favored 'General case' 0 C--N 1.382 2.006 0 CA-C-N 113.803 -1.544 . . . . 0.56999999999999995 107.629 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.991 ' O ' HG23 ' A' ' 217' ' ' VAL . 27.5 t80 -57.53 -50.13 74.08 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.376 -1.453 . . . . 0.56999999999999995 110.871 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.491 ' HG ' ' N ' ' A' ' 215' ' ' THR . 0.1 OUTLIER -59.38 -51.41 70.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.56999999999999995 110.847 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.857 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.78 -32.66 72.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 111.098 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 220' ' ' ILE . . . -68.35 -46.12 70.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.56999999999999995 111.058 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 213' ' ' PHE . 20.1 t -63.33 -39.28 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.142 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.95 -46.27 68.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.879 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 220' ' ' ILE . 3.0 pt-20 -60.91 -44.52 97.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.91000000000000003 110.837 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.821 HD11 ' HB1' ' A' ' 137' ' ' ALA . 10.1 pt -71.67 -32.82 46.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.235 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.718 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -65.17 -34.93 90.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.56999999999999995 112.453 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.84 -42.07 97.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.56999999999999995 110.908 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.9 m -70.95 -36.81 72.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.56999999999999995 110.897 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.718 HD12 ' HA2' ' A' ' 221' ' ' GLY . 29.6 mt -40.64 -60.49 1.13 Allowed 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 123.443 1.592 . . . . 0.56999999999999995 112.296 -175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 168.48 -30.38 0.17 Allowed Glycine 0 C--N 1.392 3.654 0 C-N-CA 118.403 -1.856 . . . . 0.56999999999999995 112.404 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.769 HD12 ' HB ' ' A' ' 258' ' ' ILE . 1.0 OUTLIER -82.81 160.24 22.28 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-N 112.396 -1.902 . . . . 0.56999999999999995 112.558 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -83.56 -151.93 12.36 Favored Glycine 0 C--N 1.382 3.088 0 CA-C-O 123.96 1.867 . . . . 0.56999999999999995 110.61 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -65.28 -97.81 0.0 OUTLIER 'General case' 0 C--N 1.38 1.911 0 CA-C-N 113.162 -1.519 . . . . 0.56999999999999995 113.484 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 234' ' ' ALA . 97.0 p -174.3 -32.99 0.01 OUTLIER 'General case' 0 C--N 1.373 1.604 0 C-N-CA 118.498 -1.281 . . . . 0.56999999999999995 108.916 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.25 5.2 0.85 Allowed 'General case' 0 C--N 1.401 2.826 0 O-C-N 125.862 1.976 . . . . 0.56999999999999995 114.663 -176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -135.65 140.51 34.08 Favored Pre-proline 0 C--N 1.382 2.009 0 N-CA-C 104.608 -2.367 . . . . 0.91000000000000003 104.608 -169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -82.83 17.64 1.6 Allowed 'Trans proline' 0 C--N 1.363 1.34 0 C-N-CA 123.568 2.845 . . . . 0.56999999999999995 113.534 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 -0.29 5.52 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 114.109 -1.405 . . . . 0.56999999999999995 113.729 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' A' ' 229' ' ' SER . . . -99.3 124.14 44.16 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.709 1.719 . . . . 0.56999999999999995 112.639 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 235' ' ' VAL . 11.1 t -60.55 87.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.233 0 CA-C-N 113.927 -1.488 . . . . 0.56999999999999995 113.381 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 3.3 mmm 159.62 -23.94 0.0 OUTLIER 'General case' 0 C--N 1.368 1.411 0 O-C-N 125.045 1.466 . . . . 0.56999999999999995 111.77 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 239' ' ' THR . 5.3 p90 -51.86 153.87 4.09 Favored Pre-proline 0 C--N 1.369 1.432 0 CA-C-O 123.755 1.74 . . . . 0.56999999999999995 111.999 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -77.99 -25.22 7.67 Favored 'Trans proline' 0 C--N 1.368 1.596 0 CA-C-O 117.773 -1.011 . . . . 0.56999999999999995 112.304 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 237' ' ' PHE . 1.2 m -41.06 113.67 0.41 Allowed 'General case' 0 C--N 1.368 1.391 0 CA-C-O 124.016 1.865 . . . . 0.56999999999999995 110.337 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.649 ' CE2' HD13 ' A' ' 181' ' ' LEU . 4.7 t80 -80.47 106.25 12.34 Favored 'General case' 0 C--N 1.369 1.453 0 N-CA-C 106.241 -1.763 . . . . 0.56999999999999995 106.241 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -154.73 107.56 2.8 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 124.772 2.225 . . . . 0.56999999999999995 107.095 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 210' ' ' THR . 50.1 p90 -61.62 118.03 6.55 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 126.09 2.852 . . . . 0.56999999999999995 111.633 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 245' ' ' ILE . 2.5 p -101.97 -19.64 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.05 -1.886 . . . . 0.56999999999999995 112.627 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' A' ' 207' ' ' SER . 0.0 OUTLIER 72.87 4.59 5.01 Favored 'General case' 0 C--N 1.365 1.277 0 O-C-N 126.303 2.252 . . . . 0.91000000000000003 113.531 -179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.0 mt 79.59 7.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.376 1.737 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 115.054 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -35.16 73.88 Favored 'General case' 0 C--N 1.39 2.354 0 N-CA-C 105.107 -2.182 . . . . 0.56999999999999995 105.107 -165.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.47 -22.79 8.57 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-N 112.394 -2.185 . . . . 0.56999999999999995 113.087 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 235' ' ' VAL . 13.2 t80 -40.94 99.85 0.02 OUTLIER 'General case' 0 C--N 1.382 1.994 0 O-C-N 125.729 1.893 . . . . 0.56999999999999995 110.326 -175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.406 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -164.64 147.28 8.63 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 112.189 -2.278 . . . . 1.2 106.946 -171.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.811 HD11 ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -114.99 127.71 55.84 Favored 'General case' 0 C--N 1.372 1.563 0 CA-C-O 124.657 2.17 . . . . 0.56999999999999995 107.511 -173.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.69 158.8 35.5 Favored 'General case' 0 C--N 1.362 1.116 0 O-C-N 120.445 -1.409 . . . . 0.56999999999999995 112.014 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -56.32 -43.64 79.18 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.289 -1.323 . . . . 0.56999999999999995 109.491 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -41.56 95.11 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.021 0.528 . . . . 0.91000000000000003 110.846 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 258' ' ' ILE . 16.2 t0 -63.82 -55.1 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.91000000000000003 110.869 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.91 HG21 HG11 ' A' ' 144' ' ' VAL . 0.5 OUTLIER -65.94 -35.93 76.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.134 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.64 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 18.1 mtp85 -70.19 -32.3 70.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.88 -44.83 77.81 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.697 -0.763 . . . . 0.56999999999999995 112.495 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.769 ' HB ' HD12 ' A' ' 226' ' ' LEU . 1.1 pt -66.16 -44.7 91.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 0.56999999999999995 111.118 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.543 ' HA ' ' CE1' ' A' ' 262' ' ' TYR . 1.0 OUTLIER -70.77 -20.7 62.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.56999999999999995 110.891 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.3 t -64.27 -15.07 59.43 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 123.063 1.411 . . . . 0.56999999999999995 111.35 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.75 -85.99 0.07 Allowed 'General case' 0 C--N 1.385 2.117 0 CA-C-O 123.653 1.692 . . . . 0.56999999999999995 115.348 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.543 ' CE1' ' HA ' ' A' ' 259' ' ' GLN . 1.0 OUTLIER -64.31 -178.14 0.34 Allowed 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.932 -1.94 . . . . 0.56999999999999995 112.85 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.413 ' HA2' ' HG3' ' A' ' 146' ' ' PRO . . . . . . . . 0 C--N 1.38 2.976 0 CA-C-O 114.202 -3.555 . . . . 0.91000000000000003 114.722 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.676 ' H30' ' HA ' ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.059 0 N-CA-C 111.626 -0.59 . . . . 0.56999999999999995 111.626 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.41 -86.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.36 1.374 . . . . 0.56999999999999995 111.087 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.72 117.27 26.22 Favored 'Isoleucine or valine' 0 C--N 1.388 2.255 0 N-CA-C 106.245 -1.761 . . . . 0.56999999999999995 106.245 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -142.6 148.78 38.05 Favored 'General case' 0 C--N 1.378 1.808 0 CA-C-N 112.636 -2.074 . . . . 0.56999999999999995 108.673 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.52 158.16 45.09 Favored 'General case' 0 C--N 1.385 2.122 0 CA-C-O 124.674 2.178 . . . . 1.2 109.034 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.28 -48.75 0.03 OUTLIER 'General case' 0 C--N 1.389 2.284 0 CA-C-N 113.564 -1.653 . . . . 0.56999999999999995 110.838 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -63.63 -40.03 95.86 Favored 'General case' 0 C--N 1.389 2.291 0 CA-C-N 113.505 -1.68 . . . . 0.56999999999999995 108.35 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.84 103.58 11.57 Favored 'General case' 0 C--N 1.384 2.104 0 O-C-N 125.324 1.64 . . . . 0.56999999999999995 110.88 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.03 154.84 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.158 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -106.03 142.98 34.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.106 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.549 ' CE2' HG21 ' A' ' 159' ' ' ILE . 8.3 t80 -140.57 160.07 40.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.56999999999999995 110.916 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -156.52 121.84 4.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.2 110.824 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.705 HG21 ' CE2' ' A' ' 121' ' ' TYR . 1.2 mm -99.4 138.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 111.146 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.556 ' ND2' HG13 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -62.57 173.59 1.22 Allowed 'General case' 0 C--N 1.363 1.187 0 CA-C-O 124.324 2.011 . . . . 0.56999999999999995 108.944 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.67 73.31 6.38 Favored 'General case' 0 C--N 1.383 2.041 0 CA-C-O 125.166 2.412 . . . . 0.56999999999999995 109.971 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.705 ' CE2' HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -72.17 -177.53 2.13 Favored 'General case' 0 C--N 1.374 1.648 0 CA-C-N 112.357 -2.201 . . . . 0.56999999999999995 110.467 173.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.465 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 1.0 OUTLIER 160.56 -53.4 0.0 OUTLIER Pre-proline 0 C--N 1.38 1.912 0 C-N-CA 125.337 1.455 . . . . 0.56999999999999995 107.809 175.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 122' ' ' THR . 19.0 Cg_endo -75.36 -72.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.406 3.581 0 N-CA-C 108.022 -1.569 . . . . 0.56999999999999995 108.022 -167.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.86 -7.68 57.02 Favored 'General case' 0 C--N 1.398 2.677 0 CA-C-N 113.131 -1.85 . . . . 0.91000000000000003 106.578 -171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 122' ' ' THR . 6.4 mtm -154.42 136.04 14.33 Favored 'General case' 0 C--N 1.386 2.191 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 109.638 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.2 m-20 -90.98 141.63 28.63 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-O 123.182 1.468 . . . . 0.56999999999999995 109.328 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.426 ' HA ' ' CE1' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -64.47 -50.11 68.76 Favored 'General case' 0 C--N 1.384 2.076 0 CA-C-N 114.324 -1.307 . . . . 1.2 109.109 -170.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.25 -35.28 69.54 Favored 'General case' 0 C--N 1.374 1.666 0 CA-C-N 111.992 -2.367 . . . . 0.91000000000000003 110.874 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 205' ' ' THR . 3.6 m-20 -70.33 -43.78 69.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.91000000000000003 110.862 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 126' ' ' ASN . 19.1 t -68.69 -39.74 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.179 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.35 -44.11 97.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.91000000000000003 110.873 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -40.94 86.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.824 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.98 -49.19 66.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 111.139 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 130' ' ' VAL . 25.2 pt -62.4 -36.9 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 111.167 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -63.72 -43.74 95.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.853 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -62.84 -46.06 89.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.56999999999999995 110.933 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.09 83.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.56999999999999995 111.082 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE1' ' CG ' ' A' ' 149' ' ' PHE . 3.7 m-85 -62.95 -44.06 97.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.821 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.461 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.2 pt20 -63.45 -36.21 82.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.971 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 136' ' ' LYS . 16.0 t -69.64 -34.2 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.123 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 224' ' ' LEU . 34.1 m95 -83.05 -34.06 26.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.923 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.9 m -78.99 -51.08 10.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 110.916 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.8 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -56.2 -13.96 2.45 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 114.103 1.149 . . . . 0.56999999999999995 114.103 178.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.8 HG13 ' ND2' ' A' ' 143' ' ' ASN . 20.2 m -113.34 -8.77 12.18 Favored 'Isoleucine or valine' 0 C--N 1.389 2.29 0 CA-C-N 113.876 -1.511 . . . . 0.56999999999999995 112.298 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.741 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -150.47 141.93 15.16 Favored Pre-proline 0 C--N 1.383 2.055 0 CA-C-O 125.379 2.514 . . . . 0.56999999999999995 110.14 -172.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.741 ' HD2' HG22 ' A' ' 145' ' ' THR . 57.0 Cg_endo -79.7 71.21 7.16 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.138 1.892 . . . . 0.56999999999999995 114.593 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -169.35 83.52 0.13 Allowed 'General case' 0 C--N 1.39 2.328 0 N-CA-C 106.698 -1.593 . . . . 0.56999999999999995 106.698 -168.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -72.37 162.16 29.84 Favored 'General case' 0 C--N 1.383 2.048 0 CA-C-O 125.739 2.685 . . . . 0.56999999999999995 115.672 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' ' O ' ' A' ' 147' ' ' LEU . 2.9 m-85 -136.63 158.9 43.37 Favored 'General case' 0 C--N 1.39 2.354 0 CA-C-N 113.004 -1.907 . . . . 0.56999999999999995 106.09 -172.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.8 m -157.48 121.61 4.24 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.879 2.276 . . . . 0.56999999999999995 108.301 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 133.4 37.17 Favored 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.65 -1.613 . . . . 0.56999999999999995 110.513 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' A' ' 157' ' ' ALA . 6.2 pt -107.18 171.95 2.01 Favored 'Isoleucine or valine' 0 C--N 1.377 1.791 0 CA-C-O 124.214 1.959 . . . . 0.56999999999999995 110.921 174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -141.72 51.65 1.53 Allowed 'General case' 0 C--N 1.384 2.085 0 CA-C-N 113.482 -1.69 . . . . 0.56999999999999995 110.566 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 p -117.66 -62.59 1.54 Allowed 'General case' 0 C--N 1.384 2.096 0 CA-C-N 113.479 -1.691 . . . . 0.56999999999999995 109.887 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.68 -152.87 5.73 Favored Glycine 0 C--N 1.381 3.028 0 N-CA-C 108.796 -1.722 . . . . 0.56999999999999995 108.796 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.4 ttp -72.11 110.49 6.62 Favored 'General case' 0 C--N 1.386 2.176 0 CA-C-O 123.705 1.716 . . . . 0.56999999999999995 108.246 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.463 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -98.19 177.83 5.27 Favored 'General case' 0 C--N 1.382 2.016 0 CA-C-N 113.058 -1.883 . . . . 0.56999999999999995 111.186 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -62.96 -59.38 4.91 Favored 'General case' 0 C--N 1.397 2.645 0 CA-C-N 112.456 -2.156 . . . . 0.91000000000000003 105.233 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.549 HG21 ' CE2' ' A' ' 116' ' ' TYR . 6.3 mt -95.79 111.47 26.22 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 C-N-CA 122.942 0.497 . . . . 0.56999999999999995 111.14 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 126.59 51.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.56999999999999995 110.942 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.91 131.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.083 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.556 HG13 ' ND2' ' A' ' 119' ' ' ASN . 3.9 t -133.15 128.94 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 111.134 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -85.0 122.77 29.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.56999999999999995 110.884 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -146.53 170.14 17.5 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 118.812 -1.155 . . . . 0.56999999999999995 108.636 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.91 167.8 9.72 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.69 -1.595 . . . . 1.2 108.842 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -38.1 118.91 0.72 Allowed Glycine 0 C--N 1.389 3.497 0 CA-C-N 114.135 -1.393 . . . . 0.56999999999999995 111.956 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 81.37 63.44 0.02 OUTLIER 'General case' 0 C--N 1.417 3.524 0 CA-C-O 125.469 2.557 . . . . 0.56999999999999995 114.117 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.688 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 22.7 p-80 -105.38 -61.45 1.48 Allowed 'General case' 0 C--N 1.386 2.19 0 CA-C-N 113.12 -1.855 . . . . 0.56999999999999995 111.966 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.06 -115.85 0.85 Allowed Glycine 0 C--N 1.389 3.486 0 C-N-CA 119.188 -1.482 . . . . 0.56999999999999995 110.077 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -37.62 -34.73 0.11 Allowed 'General case' 0 C--N 1.388 2.24 0 N-CA-C 115.904 1.816 . . . . 0.91000000000000003 115.904 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.72 87.94 2.62 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-O 124.884 2.278 . . . . 0.56999999999999995 113.364 171.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 69.6 m80 -80.68 49.39 1.18 Allowed 'General case' 0 C--N 1.377 1.783 0 CA-C-N 113.871 -1.513 . . . . 0.56999999999999995 110.502 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 160.03 69.2 0.0 OUTLIER 'General case' 0 C--N 1.395 2.579 0 CA-C-O 123.876 1.798 . . . . 0.56999999999999995 110.263 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.549 ' CE2' HG22 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -83.05 -158.98 0.31 Allowed 'General case' 0 C--N 1.388 2.255 0 CA-C-N 112.961 -1.927 . . . . 0.56999999999999995 113.753 173.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.16 173.39 6.32 Favored 'General case' 0 C--N 1.388 2.251 0 CA-C-N 114.627 -1.169 . . . . 0.91000000000000003 111.686 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.51 114.69 0.89 Allowed Glycine 1 C--N 1.4 4.109 0 CA-C-N 111.566 -2.561 . . . . 0.56999999999999995 113.89 166.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 200' ' ' ASP . 0.0 OUTLIER 70.85 82.8 0.15 Allowed 'General case' 0 C--N 1.406 3.037 0 CA-C-O 124.757 2.218 . . . . 0.56999999999999995 113.533 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.51 -155.7 22.05 Favored Glycine 0 C--N 1.376 2.786 0 CA-C-N 114.259 -1.337 . . . . 0.56999999999999995 110.67 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -35.71 149.17 0.03 OUTLIER Glycine 1 C--N 1.403 4.276 0 CA-C-N 113.384 -1.408 . . . . 0.56999999999999995 110.098 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.549 HG22 ' CE2' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 89.28 65.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.399 2.731 0 N-CA-C 108.483 -0.932 . . . . 0.56999999999999995 108.483 175.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.548 HD12 ' OE1' ' A' ' 201' ' ' GLU . 4.3 mp -71.22 -37.45 72.05 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-O 123.448 1.594 . . . . 0.56999999999999995 111.78 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 197' ' ' PHE . . . -174.33 179.84 1.74 Allowed 'General case' 0 C--N 1.364 1.199 0 CA-C-N 113.986 -1.461 . . . . 0.56999999999999995 111.09 -177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -164.23 142.46 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 110.874 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -146.94 167.52 23.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.56999999999999995 111.111 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 191' ' ' ILE . 2.3 m-85 -77.02 -87.1 0.05 OUTLIER 'General case' 0 C--N 1.372 1.562 0 C-N-CA 117.749 -1.58 . . . . 0.56999999999999995 108.699 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 193' ' ' GLY . . . 120.12 -61.22 0.51 Allowed Glycine 0 C--N 1.397 3.956 0 C-N-CA 119.848 -1.168 . . . . 0.56999999999999995 112.836 -175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.91 56.13 5.22 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.142 2.561 . . . . 0.56999999999999995 111.774 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' HA3' ' A' ' 192' ' ' GLY . . . 47.66 -154.79 1.22 Allowed Glycine 0 C--N 1.39 3.536 0 CA-C-O 123.579 1.655 . . . . 0.56999999999999995 111.265 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 83.76 57.61 0.01 OUTLIER 'General case' 0 C--N 1.387 2.228 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 106.524 170.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.79 -88.92 0.37 Allowed Glycine 0 C--N 1.398 3.996 0 O-C-N 120.692 -1.255 . . . . 0.56999999999999995 110.008 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.468 HG21 ' CZ ' ' A' ' 185' ' ' PHE . 1.7 tp -62.2 0.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.386 2.165 0 CA-C-O 124.964 2.316 . . . . 0.56999999999999995 113.854 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 188' ' ' GLY . . . -73.37 117.21 5.77 Favored Glycine 0 C--N 1.393 3.737 0 C-N-CA 117.384 -2.341 . . . . 0.56999999999999995 107.283 -169.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' H ' ' H ' ' A' ' 186' ' ' GLY . . . 109.35 -44.73 1.44 Allowed Glycine 0 C--N 1.373 2.584 0 O-C-N 124.871 0.983 . . . . 0.56999999999999995 114.123 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.68 113.4 0.89 Allowed 'General case' 0 C--N 1.385 2.123 0 CA-C-N 115.358 -0.421 . . . . 0.91000000000000003 110.841 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.993 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -111.68 156.82 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 111.111 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -130.17 131.9 45.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.859 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 215' ' ' THR . 2.4 m-85 -104.04 148.51 26.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 110.944 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.0 p-10 -89.97 102.46 15.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.91000000000000003 110.853 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -36.55 64.42 Favored 'General case' 0 C--N 1.369 1.452 0 CA-C-O 116.912 -1.518 . . . . 0.91000000000000003 109.3 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -45.5 -40.96 9.09 Favored 'General case' 0 C--N 1.376 1.761 0 O-C-N 125.366 1.666 . . . . 0.91000000000000003 107.507 -163.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.548 ' OE1' HD12 ' A' ' 181' ' ' LEU . 12.4 mt-10 -56.48 -173.28 0.01 OUTLIER 'General case' 0 C--N 1.391 2.378 0 CA-C-O 128.143 3.83 . . . . 0.91000000000000003 114.439 170.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.4 77.44 1.57 Allowed 'General case' 0 C--N 1.379 1.865 0 O-C-N 118.091 -2.88 . . . . 0.56999999999999995 108.941 -172.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.493 ' CH2' ' HG ' ' A' ' 181' ' ' LEU . 52.1 m95 -72.82 115.45 12.13 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-O 122.64 1.21 . . . . 0.56999999999999995 108.317 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.3 p -123.89 128.02 48.86 Favored 'General case' 0 C--N 1.384 2.094 0 CA-C-O 123.965 1.841 . . . . 0.56999999999999995 109.425 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' ASP . 5.1 p -116.2 105.94 13.14 Favored 'General case' 0 C--N 1.369 1.424 0 CA-C-O 122.939 1.352 . . . . 0.56999999999999995 108.724 -176.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 205' ' ' THR . 0.0 OUTLIER 172.5 -51.94 0.01 OUTLIER 'General case' 0 C--N 1.395 2.568 0 CA-C-N 112.877 -1.965 . . . . 0.56999999999999995 107.099 175.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 158.66 50.72 0.0 OUTLIER 'General case' 0 C--N 1.412 3.316 0 O-C-N 126.315 2.259 . . . . 0.56999999999999995 110.172 -171.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.16 -108.46 2.69 Favored Glycine 0 C--N 1.393 3.74 0 C-N-CA 118.16 -1.972 . . . . 0.56999999999999995 113.681 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -103.97 -91.49 2.21 Favored Glycine 0 C--N 1.397 3.957 0 CA-C-O 124.857 2.365 . . . . 0.56999999999999995 112.792 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.9 p -73.89 117.5 15.75 Favored 'General case' 0 C--N 1.384 2.088 0 CA-C-O 123.847 1.784 . . . . 0.56999999999999995 111.454 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -111.15 150.26 29.72 Favored 'General case' 0 C--N 1.388 2.279 0 CA-C-N 112.307 -2.224 . . . . 0.56999999999999995 110.13 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.6 tm? -73.45 -32.7 64.51 Favored 'General case' 0 C--N 1.394 2.505 0 CA-C-O 124.412 2.053 . . . . 0.56999999999999995 108.858 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.707 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.7 t80 -52.28 -50.08 62.84 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 112.678 -2.056 . . . . 0.56999999999999995 110.848 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.5 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -62.29 -43.61 98.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.924 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.608 HG21 ' CE2' ' A' ' 197' ' ' PHE . 0.0 OUTLIER -61.27 -49.36 77.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 0.56999999999999995 111.19 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.2 73.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.107 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.761 HG11 ' HE1' ' A' ' 248' ' ' PHE . 53.3 t -64.48 -48.18 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.143 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -71.57 -43.21 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.867 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -57.91 -42.14 84.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.91000000000000003 110.877 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.46 HG21 ' CD1' ' A' ' 141' ' ' TRP . 57.7 mt -69.61 -39.78 78.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.56999999999999995 111.187 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.453 ' C ' ' HE3' ' A' ' 236' ' ' MET . . . -61.46 -33.78 85.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.56999999999999995 112.465 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.59 ' N ' ' HE3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -63.85 -44.28 93.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.353 . . . . 0.56999999999999995 110.813 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 224' ' ' LEU . 71.1 m -71.27 -44.5 65.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.56999999999999995 110.864 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -36.38 -47.79 0.62 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 119.771 -0.772 . . . . 0.56999999999999995 112.557 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.13 -106.47 0.22 Allowed Glycine 1 C--N 1.398 4.026 0 O-C-N 126.699 2.499 . . . . 0.56999999999999995 112.061 169.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.408 HD13 ' CD1' ' A' ' 261' ' ' LEU . 0.8 OUTLIER -48.01 172.78 0.01 OUTLIER 'General case' 0 C--N 1.395 2.559 0 CA-C-O 125.726 2.679 . . . . 0.56999999999999995 112.554 173.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.35 -120.91 0.02 OUTLIER Glycine 0 C--N 1.392 3.665 0 CA-C-O 126.133 3.074 . . . . 0.56999999999999995 110.677 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -123.96 -76.19 0.59 Allowed 'General case' 0 C--N 1.391 2.382 0 CA-C-N 112.258 -1.971 . . . . 0.56999999999999995 108.375 -174.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -177.36 -36.67 0.01 OUTLIER 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.754 -1.567 . . . . 0.56999999999999995 108.373 -178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.06 23.48 0.31 Allowed 'General case' 0 C--N 1.422 3.727 0 N-CA-C 118.925 2.935 . . . . 0.56999999999999995 118.925 -171.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -137.65 143.29 39.96 Favored Pre-proline 0 C--N 1.398 2.703 0 C-N-CA 116.348 -2.141 . . . . 0.91000000000000003 106.086 -168.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 237' ' ' PHE . 71.7 Cg_exo -54.97 -41.11 81.94 Favored 'Trans proline' 0 C--N 1.375 1.93 0 CA-C-O 124.724 1.885 . . . . 0.56999999999999995 114.09 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -41.91 86.18 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-N 111.61 -2.541 . . . . 0.56999999999999995 113.492 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -50.82 125.21 12.79 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-O 125.317 2.484 . . . . 0.56999999999999995 111.82 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.788 HG22 ' H30' ' A' ' 269' ' ' HSI . 0.4 OUTLIER -76.03 -1.04 3.14 Favored 'Isoleucine or valine' 0 C--N 1.386 2.154 0 CA-C-N 112.473 -2.149 . . . . 0.56999999999999995 112.504 -177.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.59 ' HE3' ' N ' ' A' ' 222' ' ' HIS . 0.8 OUTLIER -124.62 -5.49 7.58 Favored 'General case' 0 C--N 1.371 1.526 0 CA-C-N 114.056 -1.429 . . . . 0.56999999999999995 109.03 -177.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.771 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -40.57 148.2 0.36 Allowed Pre-proline 0 C--N 1.376 1.753 0 CA-C-O 125.22 2.438 . . . . 0.56999999999999995 113.951 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.432 ' O ' ' H14' ' A' ' 269' ' ' HSI . 76.2 Cg_exo -53.57 -48.85 19.68 Favored 'Trans proline' 0 C--N 1.381 2.289 0 O-C-N 118.824 -1.198 . . . . 0.56999999999999995 113.7 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.486 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -51.74 135.13 29.82 Favored 'General case' 0 C--O 1.2 -1.511 0 CA-C-O 125.012 2.339 . . . . 0.56999999999999995 110.959 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.66 142.57 34.09 Favored 'General case' 0 C--N 1.386 2.154 0 CA-C-O 123.106 1.431 . . . . 0.56999999999999995 107.362 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -158.28 114.56 2.77 Favored 'General case' 0 C--N 1.387 2.207 0 CA-C-O 124.515 2.102 . . . . 0.56999999999999995 108.453 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -55.25 118.57 4.5 Favored 'General case' 0 C--N 1.368 1.398 0 CA-C-O 126.433 3.016 . . . . 0.56999999999999995 108.861 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 243' ' ' VAL . 2.6 p -125.41 -13.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.634 0 CA-C-N 112.498 -2.137 . . . . 0.56999999999999995 111.062 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . 0.266 0.7 OUTLIER 70.53 4.36 4.92 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-O 123.153 1.454 . . . . 0.91000000000000003 112.811 176.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 213' ' ' PHE . 2.0 mt 77.88 4.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.394 2.533 0 CA-C-N 113.347 -1.751 . . . . 0.56999999999999995 114.315 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -71.11 -33.17 69.89 Favored 'General case' 0 C--N 1.379 1.85 0 N-CA-C 104.593 -2.373 . . . . 0.56999999999999995 104.593 -163.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 243' ' ' VAL . 0.6 OUTLIER -112.7 -16.65 12.74 Favored 'General case' 0 C--N 1.39 2.365 0 CA-C-N 112.739 -2.028 . . . . 0.56999999999999995 113.107 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.761 ' HE1' HG11 ' A' ' 217' ' ' VAL . 19.2 t80 -38.86 99.46 0.02 OUTLIER 'General case' 0 C--N 1.388 2.28 0 CA-C-O 126.034 2.826 . . . . 0.56999999999999995 109.319 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -133.09 149.12 52.16 Favored 'General case' 0 C--N 1.38 1.93 0 CA-C-N 112.18 -2.282 . . . . 1.2 105.374 -175.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.09 130.38 56.11 Favored 'General case' 0 C--N 1.375 1.685 0 CA-C-O 126.7 3.143 . . . . 0.56999999999999995 107.325 -173.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.87 145.43 42.75 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 117.99 -2.944 . . . . 0.56999999999999995 110.606 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.05 86.43 Favored 'General case' 0 C--N 1.4 2.797 0 CA-C-N 113.676 -1.602 . . . . 0.56999999999999995 110.416 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 -35.74 81.1 Favored 'General case' 0 C--N 1.367 1.342 0 CA-C-N 114.874 -1.057 . . . . 0.91000000000000003 110.802 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.7 t70 -63.36 -55.29 25.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.91000000000000003 110.854 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.0 pt -66.04 -36.56 77.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.168 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 34.7 mtt180 -70.3 -34.1 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 1.2 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -65.29 -47.52 79.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.56999999999999995 112.511 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.35 -45.46 95.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.56999999999999995 111.163 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.685 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.3 -21.03 61.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.56999999999999995 110.933 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.44 -28.33 66.03 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-O 125.154 2.407 . . . . 0.56999999999999995 110.22 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.408 ' CD1' HD13 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -60.38 -64.79 0.83 Allowed 'General case' 0 C--N 1.4 2.798 0 CA-C-O 124.55 2.119 . . . . 0.56999999999999995 109.63 -175.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.56 80.53 3.13 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 113.372 -1.74 . . . . 0.56999999999999995 113.279 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.39 3.577 0 N-CA-C 120.488 2.955 . . . . 0.91000000000000003 120.488 -170.593 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.788 ' H30' HG22 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.254 0 CA-C-O 119.597 -0.557 . . . . 0.56999999999999995 113.181 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.07 168.92 1.06 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 O-C-N 124.58 1.832 . . . . 0.56999999999999995 111.043 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -122.11 144.86 29.96 Favored 'Isoleucine or valine' 0 C--N 1.373 1.625 0 CA-C-N 112.992 -1.913 . . . . 0.56999999999999995 109.866 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -168.45 102.59 0.42 Allowed 'General case' 0 C--N 1.389 2.31 0 CA-C-O 124.095 1.902 . . . . 0.56999999999999995 109.625 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.47 151.1 50.46 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-O 123.712 1.72 . . . . 1.2 109.368 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.53 -49.84 0.02 OUTLIER 'General case' 0 C--N 1.377 1.799 0 CA-C-N 113.851 -1.522 . . . . 0.56999999999999995 110.646 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -98.21 -8.55 27.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 112.98 -1.918 . . . . 0.56999999999999995 111.091 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -114.56 112.76 23.45 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 115.169 -0.923 . . . . 0.56999999999999995 110.872 -178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.11 138.19 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.56999999999999995 111.119 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.855 ' HB ' ' HB1' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -109.26 135.27 50.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.56999999999999995 111.109 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.584 ' CE2' HD12 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -129.81 150.9 50.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.888 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.9 ttt85 -143.52 129.88 19.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.509 . . . . 1.2 110.903 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.51 HD12 ' HZ ' ' A' ' 163' ' ' PHE . 2.0 mm -99.03 130.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.169 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' ND2' HD13 ' A' ' 160' ' ' LEU . 24.6 m-20 -118.89 131.67 56.07 Favored 'General case' 0 C--N 1.368 1.385 0 N-CA-C 107.636 -1.246 . . . . 0.56999999999999995 107.636 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.3 t30 50.41 81.13 0.07 Allowed 'General case' 0 C--N 1.391 2.401 0 O-C-N 126.527 2.392 . . . . 0.56999999999999995 109.587 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.454 ' O ' ' CD2' ' A' ' 163' ' ' PHE . 22.6 m-85 -37.73 -81.04 0.01 OUTLIER 'General case' 0 C--N 1.391 2.395 0 O-C-N 126.721 2.513 . . . . 0.56999999999999995 109.514 -173.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.55 HG23 ' HD2' ' A' ' 163' ' ' PHE . 0.0 OUTLIER 175.0 135.14 0.16 Allowed Pre-proline 0 C--N 1.371 1.522 0 C-N-CA 118.285 -1.366 . . . . 0.56999999999999995 108.355 -176.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 122' ' ' THR . 36.6 Cg_endo -78.17 -52.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-O 122.341 0.892 . . . . 0.56999999999999995 110.938 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 p-10 -77.22 -33.29 56.19 Favored 'General case' 0 C--N 1.388 2.256 0 CA-C-N 113.937 -1.483 . . . . 0.91000000000000003 114.486 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.524 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -94.38 134.24 37.09 Favored 'General case' 0 C--N 1.374 1.663 0 CA-C-O 125.747 2.689 . . . . 0.56999999999999995 106.002 -173.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.824 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -69.53 139.7 53.83 Favored 'General case' 0 C--N 1.37 1.457 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 110.555 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -48.63 37.6 Favored 'General case' 0 C--N 1.378 1.821 0 N-CA-C 106.918 -1.512 . . . . 1.2 106.918 -169.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -35.26 62.33 Favored 'General case' 0 C--N 1.387 2.201 0 CA-C-N 112.788 -2.005 . . . . 0.91000000000000003 110.89 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.04 -43.15 71.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.91000000000000003 110.869 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.4 t -63.42 -37.94 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.56999999999999995 111.082 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.411 ' OD1' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -68.51 -40.36 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.91000000000000003 110.847 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' O ' ' CE ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -65.29 -41.8 93.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.56999999999999995 110.877 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.842 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.23 -49.12 73.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 111.111 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.411 HD11 ' OD1' ' A' ' 131' ' ' ASP . 22.7 pt -62.55 -40.16 87.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.178 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -60.59 -43.39 97.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 1.2 110.836 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -62.92 -43.4 98.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.873 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 140' ' ' VAL . . . -61.59 -39.65 91.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.117 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.488 ' CE1' ' CE2' ' A' ' 116' ' ' TYR . 17.3 m-85 -67.17 -33.87 76.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.917 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -67.66 -40.49 84.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.56999999999999995 110.909 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.0 p -71.46 -33.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 111.16 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.746 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 5.1 m95 -82.59 -34.04 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.925 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 m -79.21 -49.18 12.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.56999999999999995 110.817 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.794 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.36 -13.3 7.79 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-O 121.804 0.811 . . . . 0.56999999999999995 112.564 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.794 HG13 ' ND2' ' A' ' 143' ' ' ASN . 19.8 m -113.91 12.77 8.19 Favored 'Isoleucine or valine' 0 C--N 1.382 2.022 0 CA-C-N 114.145 -1.388 . . . . 0.56999999999999995 112.028 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 141' ' ' TRP . 29.5 p -148.03 146.75 24.46 Favored Pre-proline 0 N--CA 1.428 -1.544 0 CA-C-O 124.132 1.92 . . . . 0.56999999999999995 109.197 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.86 8.74 3.59 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 121.285 1.323 . . . . 0.56999999999999995 114.449 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.566 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -112.51 110.76 21.13 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 109.117 -177.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.92 158.56 35.24 Favored 'General case' 0 C--N 1.382 1.999 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 114.778 172.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.566 ' HE1' HD12 ' A' ' 147' ' ' LEU . 15.6 m-30 -126.5 151.37 47.92 Favored 'General case' 0 C--N 1.389 2.314 0 CA-C-N 112.788 -2.005 . . . . 0.56999999999999995 108.675 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.99 110.99 2.66 Favored 'General case' 0 C--N 1.39 2.364 0 CA-C-O 124.653 2.168 . . . . 0.56999999999999995 108.302 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -95.2 133.41 39.08 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 113.776 -1.556 . . . . 0.56999999999999995 110.254 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 155' ' ' GLY . 5.9 pt -117.14 173.78 4.08 Favored 'Isoleucine or valine' 0 C--N 1.372 1.562 0 CA-C-O 124.175 1.941 . . . . 0.56999999999999995 109.957 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -127.2 -2.03 6.37 Favored 'General case' 0 C--N 1.384 2.067 0 CA-C-N 113.175 -1.83 . . . . 0.56999999999999995 112.687 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 m -136.72 89.4 2.45 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 114.583 -1.189 . . . . 0.56999999999999995 108.067 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.486 ' O ' HD11 ' A' ' 152' ' ' ILE . . . 124.29 99.69 1.32 Allowed Glycine 0 C--N 1.386 3.36 0 C-N-CA 118.956 -1.592 . . . . 0.56999999999999995 110.513 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.4 ttp -42.95 118.35 1.25 Allowed 'General case' 0 C--N 1.377 1.804 0 CA-C-O 122.56 1.172 . . . . 0.56999999999999995 111.3 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.855 ' HB1' ' HB ' ' A' ' 115' ' ' THR . . . -95.34 169.79 9.82 Favored 'General case' 0 C--N 1.381 1.957 0 CA-C-N 113.025 -1.898 . . . . 0.56999999999999995 109.517 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.75 -54.45 23.29 Favored 'General case' 0 C--N 1.386 2.179 0 CA-C-N 113.501 -1.681 . . . . 0.91000000000000003 110.586 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 116' ' ' TYR . 3.5 mt -90.64 109.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.385 2.143 0 O-C-N 127.846 3.216 . . . . 0.56999999999999995 111.127 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -107.98 129.45 55.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.856 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.413 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -115.98 116.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 0.56999999999999995 111.08 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -133.47 124.88 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.109 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -93.7 121.42 35.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 110.876 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -145.33 168.01 21.5 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 123.701 1.715 . . . . 0.56999999999999995 108.51 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.71 160.28 16.44 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.592 -1.262 . . . . 1.2 107.592 -177.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 167' ' ' ALA . . . -39.28 93.87 0.01 OUTLIER Glycine 0 C--N 1.385 3.26 0 O-C-N 125.894 1.997 . . . . 0.56999999999999995 117.401 177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . 154.31 45.57 0.0 OUTLIER 'General case' 0 C--N 1.405 2.982 0 CA-C-O 125.734 2.683 . . . . 0.56999999999999995 112.898 -165.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -159.85 -155.78 0.47 Allowed 'General case' 0 C--N 1.38 1.899 0 CA-C-N 113.416 -1.72 . . . . 0.56999999999999995 109.874 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.91 -175.37 2.07 Favored Glycine 0 C--N 1.39 3.577 0 CA-C-O 122.499 1.055 . . . . 0.56999999999999995 113.504 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER 59.83 77.47 0.31 Allowed 'General case' 0 C--N 1.416 3.457 0 CA-C-O 124.688 2.185 . . . . 0.91000000000000003 107.399 167.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 78.94 -154.27 0.02 OUTLIER 'General case' 0 C--N 1.381 1.937 0 CA-C-N 112.388 -2.187 . . . . 0.56999999999999995 111.791 -174.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -115.4 -127.17 0.29 Allowed 'General case' 0 C--N 1.386 2.163 0 CA-C-O 122.694 1.235 . . . . 0.56999999999999995 109.052 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.92 85.43 0.22 Allowed 'General case' 0 C--N 1.387 2.219 0 N-CA-C 108.211 -1.033 . . . . 0.56999999999999995 108.211 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.532 ' CZ ' ' CG2' ' A' ' 180' ' ' ILE . 0.5 OUTLIER -50.64 168.54 0.05 OUTLIER 'General case' 0 C--N 1.388 2.277 0 O-C-N 126.7 2.5 . . . . 0.56999999999999995 107.152 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -44.57 163.21 0.02 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 117.904 -1.518 . . . . 0.91000000000000003 112.969 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 200' ' ' ASP . . . -149.53 48.25 0.6 Allowed Glycine 0 C--N 1.388 3.458 0 C-N-CA 117.287 -2.387 . . . . 0.56999999999999995 111.815 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -168.66 -50.11 0.02 OUTLIER 'General case' 0 C--N 1.389 2.323 0 C-N-CA 118.868 -1.133 . . . . 0.56999999999999995 111.336 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -165.3 -61.65 0.02 OUTLIER Glycine 0 C--N 1.392 3.663 0 CA-C-O 125.014 2.452 . . . . 0.56999999999999995 112.852 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 178' ' ' GLY . . . -42.84 147.16 0.75 Allowed Glycine 0 C--N 1.376 2.802 0 O-C-N 118.963 -2.493 . . . . 0.56999999999999995 110.24 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.532 ' CG2' ' CZ ' ' A' ' 174' ' ' PHE . 1.6 mt 84.75 49.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-O 122.462 1.125 . . . . 0.56999999999999995 108.951 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 214' ' ' LEU . 9.9 tp -42.94 -41.72 3.46 Favored 'General case' 0 C--N 1.381 1.96 0 CA-C-O 124.876 2.274 . . . . 0.56999999999999995 111.345 -172.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 181' ' ' LEU . . . 179.84 -174.31 0.25 Allowed 'General case' 0 C--N 1.366 1.284 0 CA-C-N 112.415 -2.175 . . . . 0.56999999999999995 111.047 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -143.95 158.59 43.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 110.879 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 222' ' ' HIS . . . -151.02 155.19 38.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.452 . . . . 0.56999999999999995 111.087 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.407 ' CB ' ' H ' ' A' ' 193' ' ' GLY . 5.4 m-85 -117.44 -179.52 3.75 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 105.249 -2.13 . . . . 0.56999999999999995 105.249 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' O ' ' CA ' ' A' ' 192' ' ' GLY . . . -122.15 -160.11 10.85 Favored Glycine 0 C--N 1.382 3.101 0 C-N-CA 119.795 -1.193 . . . . 0.56999999999999995 111.493 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.44 -65.94 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 121.831 1.687 . . . . 0.56999999999999995 112.508 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 44.44 -104.87 0.07 OUTLIER Glycine 0 C--N 1.395 3.858 0 O-C-N 125.605 1.816 . . . . 0.56999999999999995 110.537 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.72 129.3 0.04 OUTLIER 'General case' 0 C--N 1.393 2.478 0 CA-C-N 112.794 -1.703 . . . . 0.56999999999999995 108.886 175.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 80.78 -95.86 1.64 Allowed Glycine 0 C--N 1.388 3.445 0 CA-C-O 122.773 1.207 . . . . 0.56999999999999995 110.697 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.3 tp -66.85 -11.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.394 2.541 0 CA-C-O 126.845 3.212 . . . . 0.56999999999999995 110.745 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 186' ' ' GLY . . . -66.71 134.34 32.53 Favored Glycine 0 C--N 1.377 2.827 0 N-CA-C 107.12 -2.392 . . . . 0.56999999999999995 107.12 -175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.407 ' H ' ' CB ' ' A' ' 185' ' ' PHE . . . 96.49 -4.68 64.35 Favored Glycine 0 C--N 1.375 2.704 0 N-CA-C 110.169 -1.172 . . . . 0.56999999999999995 110.169 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.78 141.25 39.35 Favored 'General case' 0 C--N 1.378 1.841 0 CA-C-N 114.221 -0.99 . . . . 0.91000000000000003 110.872 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.03 132.63 22.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.56999999999999995 111.098 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 183' ' ' HIS . 0.3 OUTLIER -126.52 143.2 51.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.89 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.527 ' CD2' ' CD1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -103.55 148.38 26.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.883 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.685 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 3.8 p-10 -81.12 87.89 6.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.91000000000000003 110.854 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -74.26 5.49 4.45 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 122.566 1.174 . . . . 0.91000000000000003 111.615 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 4.1 t0 -78.77 -35.13 44.98 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-O 123.328 1.537 . . . . 0.91000000000000003 109.92 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -73.76 176.87 5.9 Favored 'General case' 0 C--N 1.382 1.998 0 CA-C-O 124.289 1.995 . . . . 0.91000000000000003 108.965 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -95.53 111.11 23.09 Favored 'General case' 0 C--N 1.391 2.398 0 CA-C-N 112.642 -2.072 . . . . 0.56999999999999995 112.992 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 36.4 m95 -92.62 148.0 22.42 Favored 'General case' 0 C--N 1.382 2.017 0 CA-C-N 113.144 -1.844 . . . . 0.56999999999999995 108.495 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 211' ' ' ASN . 14.4 m -121.28 104.21 9.55 Favored 'General case' 0 C--N 1.384 2.069 0 CA-C-N 114.143 -1.39 . . . . 0.56999999999999995 107.806 -174.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 206' ' ' HIS . 0.6 OUTLIER -103.02 106.91 17.53 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 115.499 -0.773 . . . . 0.56999999999999995 109.864 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 205' ' ' THR . 2.0 t60 169.1 -70.71 0.0 OUTLIER 'General case' 0 C--N 1.392 2.429 0 N-CA-C 106.944 -1.502 . . . . 0.56999999999999995 106.944 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.413 ' C ' ' OD2' ' A' ' 244' ' ' ASP . 4.7 p 150.75 63.19 0.0 OUTLIER 'General case' 0 C--N 1.399 2.731 0 CA-C-O 127.412 3.482 . . . . 0.56999999999999995 110.325 -166.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.18 29.58 0.11 Allowed Glycine 0 C--N 1.394 3.803 0 C-N-CA 116.964 -2.541 . . . . 0.56999999999999995 113.136 171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.6 -162.32 35.81 Favored Glycine 0 C--N 1.383 3.144 0 CA-C-O 124.234 2.019 . . . . 0.56999999999999995 110.873 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.443 ' N ' ' HB2' ' A' ' 242' ' ' TYR . 0.9 OUTLIER -77.08 122.26 24.71 Favored 'General case' 0 C--N 1.372 1.58 0 CA-C-O 123.478 1.608 . . . . 0.56999999999999995 107.761 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 245' ' ' ILE . 17.8 p-10 -121.01 -167.77 1.55 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-N 112.84 -1.982 . . . . 0.56999999999999995 111.039 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 133' ' ' ALA . 1.5 tm? -70.2 -33.54 71.83 Favored 'General case' 0 C--N 1.392 2.436 0 CA-C-N 112.901 -1.954 . . . . 0.56999999999999995 109.541 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.734 ' HA ' ' HB1' ' A' ' 133' ' ' ALA . 9.8 t80 -51.75 -50.15 61.21 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 114.456 -1.247 . . . . 0.56999999999999995 110.909 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -62.86 -51.02 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.56999999999999995 110.948 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.58 HG22 ' HG3' ' A' ' 219' ' ' GLU . 12.4 m -58.95 -35.65 73.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.17 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.565 ' O ' HD12 ' A' ' 220' ' ' ILE . . . -67.2 -41.53 85.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.097 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 248' ' ' PHE . 93.7 t -64.15 -46.46 93.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.094 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -72.36 -49.91 30.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.762 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 215' ' ' THR . 8.2 mm-40 -57.66 -42.5 83.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.91000000000000003 110.927 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 216' ' ' ALA . 60.7 mt -70.32 -43.32 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 111.121 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.814 ' HA2' HD12 ' A' ' 224' ' ' LEU . . . -56.82 -33.93 64.23 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.56999999999999995 112.502 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -63.75 -41.09 98.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.749 0.309 . . . . 0.56999999999999995 110.823 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.464 ' CB ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -71.26 -44.36 65.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.867 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.814 HD12 ' HA2' ' A' ' 221' ' ' GLY . 84.3 mt -42.89 -62.54 0.99 Allowed 'General case' 0 C--N 1.365 1.248 0 CA-C-O 123.829 1.776 . . . . 0.56999999999999995 112.148 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 226' ' ' LEU . . . 169.6 134.65 1.77 Allowed Glycine 0 C--N 1.374 2.694 0 N-CA-C 107.774 -2.131 . . . . 0.56999999999999995 107.774 175.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.865 HD21 HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER 78.85 -170.54 0.05 OUTLIER 'General case' 0 C--N 1.393 2.494 0 CA-C-O 124.329 2.014 . . . . 0.56999999999999995 109.524 176.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.21 -154.63 10.66 Favored Glycine 0 C--N 1.386 3.318 0 CA-C-O 125.728 2.849 . . . . 0.56999999999999995 112.86 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.0 OUTLIER -93.95 -178.97 4.82 Favored 'General case' 0 C--N 1.376 1.722 0 CA-C-N 111.217 -2.491 . . . . 0.56999999999999995 110.717 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 3.2 p -72.24 -31.59 65.96 Favored 'General case' 0 C--N 1.387 2.236 0 CA-C-N 113.647 -1.615 . . . . 0.56999999999999995 109.187 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 82.8 23.59 0.17 Allowed 'General case' 0 C--N 1.399 2.734 0 N-CA-C 114.932 1.456 . . . . 0.56999999999999995 114.932 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.41 151.01 35.69 Favored Pre-proline 0 C--N 1.383 2.027 0 N-CA-C 105.361 -2.089 . . . . 0.91000000000000003 105.361 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.34 75.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 124.826 3.684 . . . . 0.56999999999999995 113.871 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 178.42 -33.56 0.01 OUTLIER 'General case' 0 C--N 1.374 1.644 0 CA-C-N 113.814 -1.539 . . . . 0.56999999999999995 112.722 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.592 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -60.12 149.05 33.86 Favored 'General case' 0 C--N 1.382 2.02 0 CA-C-N 113.619 -1.628 . . . . 0.56999999999999995 107.854 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 250' ' ' LEU . 0.7 OUTLIER -69.28 -0.93 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.099 0 CA-C-N 113.052 -1.885 . . . . 0.56999999999999995 112.959 -177.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.442 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -160.1 28.53 0.17 Allowed 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 113.137 -1.847 . . . . 0.56999999999999995 109.885 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.745 ' HE1' ' C26' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -48.64 147.41 4.33 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 123.866 1.793 . . . . 0.56999999999999995 113.023 176.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.576 ' O ' ' H14' ' A' ' 269' ' ' HSI . 72.5 Cg_exo -55.49 -50.15 13.72 Favored 'Trans proline' 0 C--N 1.373 1.824 0 O-C-N 118.875 -1.171 . . . . 0.56999999999999995 112.44 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.588 ' O ' ' H16' ' A' ' 269' ' ' HSI . 0.3 OUTLIER -50.18 125.4 12.27 Favored 'General case' 0 C--N 1.368 1.382 0 CA-C-O 123.989 1.852 . . . . 0.56999999999999995 110.553 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -81.34 144.96 31.11 Favored 'General case' 0 C--N 1.369 1.435 0 O-C-N 119.894 -1.754 . . . . 0.56999999999999995 108.232 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 242' ' ' TYR . 0.8 OUTLIER -175.29 121.3 0.2 Allowed 'General case' 0 C--N 1.388 2.27 0 CA-C-O 124.187 1.946 . . . . 0.56999999999999995 107.556 173.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.443 ' HB2' ' N ' ' A' ' 210' ' ' THR . 25.9 p90 -68.86 132.85 47.42 Favored 'General case' 0 C--N 1.368 1.393 0 CA-C-O 125.761 2.696 . . . . 0.56999999999999995 109.704 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 245' ' ' ILE . 3.0 p -117.75 -16.88 7.82 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 O-C-N 119.759 -1.838 . . . . 0.56999999999999995 113.353 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 246' ' ' ASN . 0.0 OUTLIER 79.18 -8.15 1.66 Allowed 'General case' 0 C--N 1.376 1.736 0 O-C-N 125.077 1.486 . . . . 0.91000000000000003 114.393 -176.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.641 ' H ' HG13 ' A' ' 243' ' ' VAL . 2.8 mt 81.68 18.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.381 1.978 0 CA-C-N 114.028 -1.442 . . . . 0.56999999999999995 112.524 -174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' OD1' ' A' ' 244' ' ' ASP . 1.6 t-20 -84.22 -28.57 27.18 Favored 'General case' 0 C--N 1.391 2.381 0 C-N-CA 114.057 -3.057 . . . . 0.56999999999999995 103.11 -165.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.0 p -119.04 -6.84 10.45 Favored 'General case' 0 C--N 1.389 2.311 0 CA-C-N 112.603 -2.089 . . . . 0.56999999999999995 112.237 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.666 ' HE1' HG11 ' A' ' 217' ' ' VAL . 39.5 t80 -38.09 97.33 0.01 OUTLIER 'General case' 0 C--N 1.384 2.068 0 CA-C-O 125.059 2.362 . . . . 0.56999999999999995 110.588 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -134.58 151.72 51.28 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.665 -2.061 . . . . 1.2 105.46 -174.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -118.43 128.94 55.09 Favored 'General case' 0 C--N 1.376 1.76 0 CA-C-O 126.142 2.877 . . . . 0.56999999999999995 108.337 -172.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.6 t -73.23 136.24 44.62 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.363 -2.711 . . . . 0.56999999999999995 109.947 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -55.44 -44.78 76.63 Favored 'General case' 0 C--N 1.388 2.244 0 CA-C-N 113.996 -1.456 . . . . 0.56999999999999995 109.094 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.07 -41.25 92.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.257 0.623 . . . . 0.91000000000000003 110.917 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 258' ' ' ILE . 20.9 t0 -64.03 -55.12 24.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.91000000000000003 110.838 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.5 pt -66.12 -35.28 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.089 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.755 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 3.4 mtp85 -70.42 -34.08 72.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 1.2 110.86 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.18 -46.94 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.56999999999999995 112.446 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.746 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 1.1 pt -64.48 -44.78 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 0.56999999999999995 111.172 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.492 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.19 -21.0 61.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.56999999999999995 110.952 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.1 t -74.07 -34.8 64.15 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 122.227 1.013 . . . . 0.56999999999999995 109.533 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.865 HD11 HD21 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -49.37 -63.84 0.98 Allowed 'General case' 0 C--N 1.388 2.251 0 CA-C-O 124.325 2.012 . . . . 0.56999999999999995 110.273 -173.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.78 79.15 2.93 Favored 'General case' 0 C--N 1.377 1.794 0 CA-C-N 113.114 -1.857 . . . . 0.56999999999999995 112.617 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.374 2.69 0 CA-C-O 115.267 -2.963 . . . . 0.91000000000000003 115.79 -175.235 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.745 ' C26' ' HE1' ' A' ' 237' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 CA-C-O 119.073 -0.848 . . . . 0.56999999999999995 111.278 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.91 162.06 2.0 Favored 'Trans proline' 0 C--N 1.382 2.319 0 O-C-N 125.589 2.363 . . . . 0.56999999999999995 111.919 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.53 118.98 59.76 Favored 'Isoleucine or valine' 0 C--N 1.385 2.119 0 CA-C-N 112.975 -1.92 . . . . 0.56999999999999995 107.326 -176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -76.23 121.78 23.42 Favored 'General case' 0 C--N 1.377 1.767 0 CA-C-N 112.872 -1.967 . . . . 0.56999999999999995 109.453 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -145.33 170.32 16.54 Favored 'General case' 0 C--N 1.39 2.329 0 CA-C-N 113.776 -1.556 . . . . 1.2 106.949 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.29 121.22 0.04 OUTLIER 'General case' 0 C--N 1.4 2.794 0 CA-C-N 114.106 -1.407 . . . . 0.56999999999999995 111.456 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 77.47 -59.57 0.46 Allowed 'General case' 0 C--N 1.391 2.4 0 CA-C-N 114.585 -1.189 . . . . 0.56999999999999995 112.325 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.14 125.34 53.68 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-N 114.64 -1.163 . . . . 0.56999999999999995 110.875 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 147' ' ' LEU . 0.8 OUTLIER -119.85 154.88 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 111.106 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.9 p -119.96 160.07 23.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.56999999999999995 111.103 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 117' ' ' ARG . 3.0 t80 -147.07 152.88 39.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 110.933 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.566 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -140.97 122.0 14.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.2 110.852 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -98.97 126.32 52.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.097 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -174.36 0.02 OUTLIER 'General case' 0 C--N 1.366 1.307 0 CA-C-O 124.873 2.273 . . . . 0.56999999999999995 108.963 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -76.36 48.58 0.54 Allowed 'General case' 0 C--N 1.369 1.427 0 O-C-N 120.216 -1.552 . . . . 0.56999999999999995 111.676 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 127' ' ' ARG . 4.6 m-85 48.4 -148.24 0.22 Allowed 'General case' 0 C--N 1.385 2.136 0 CA-C-O 122.467 1.127 . . . . 0.56999999999999995 108.221 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.551 HG22 ' HD2' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -166.8 167.13 8.19 Favored Pre-proline 0 C--N 1.38 1.892 0 CA-C-N 113.703 -1.59 . . . . 0.56999999999999995 108.839 -178.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 122' ' ' THR . 33.0 Cg_endo -72.39 -47.07 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 CA-C-O 122.673 1.03 . . . . 0.56999999999999995 112.906 -178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 124' ' ' ASP . 4.5 p-10 -71.92 -38.71 69.84 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 113.658 -1.61 . . . . 0.91000000000000003 114.249 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.42 ' SD ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -89.43 110.67 21.47 Favored 'General case' 0 C--N 1.372 1.575 0 CA-C-O 125.427 2.537 . . . . 0.56999999999999995 109.751 -178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.5 OUTLIER -71.88 143.53 49.35 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 112.399 -2.182 . . . . 0.56999999999999995 108.558 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.66 -49.33 59.94 Favored 'General case' 0 C--N 1.382 1.992 0 CA-C-N 114.18 -1.373 . . . . 1.2 107.529 -168.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -54.83 -34.74 63.19 Favored 'General case' 0 C--N 1.394 2.523 0 CA-C-N 112.586 -2.097 . . . . 0.91000000000000003 110.903 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -70.25 -43.44 70.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.91000000000000003 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.2 t -63.39 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.56999999999999995 111.149 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.19 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.91000000000000003 110.906 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -60.97 -49.0 79.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.937 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.66 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -60.6 -47.22 87.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.065 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 1.1 mm -66.77 -31.91 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.56999999999999995 111.116 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -66.2 -47.85 72.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.2 110.849 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.03 -40.35 97.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 110.898 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.88 94.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 111.082 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 220' ' ' ILE . 1.0 OUTLIER -67.19 -33.77 76.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.914 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.453 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.4 OUTLIER -68.55 -42.12 78.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.56999999999999995 110.909 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.7 p -69.69 -34.25 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.112 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.553 ' O ' HG23 ' A' ' 145' ' ' THR . 13.0 m95 -82.94 -34.04 26.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 110.898 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.1 m -79.2 -49.58 12.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.901 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.809 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.68 -13.02 4.85 Favored 'General case' 0 C--N 1.371 1.521 0 CA-C-O 121.837 0.827 . . . . 0.56999999999999995 113.104 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.809 HG13 ' ND2' ' A' ' 143' ' ' ASN . 21.4 m -114.01 12.03 8.11 Favored 'Isoleucine or valine' 0 C--N 1.391 2.375 0 CA-C-N 114.118 -1.401 . . . . 0.56999999999999995 111.943 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 141' ' ' TRP . 24.2 p -150.76 145.04 17.85 Favored Pre-proline 0 C--N 1.381 1.953 0 CA-C-O 125.405 2.526 . . . . 0.56999999999999995 108.619 -172.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.22 -24.27 9.6 Favored 'Trans proline' 0 C--N 1.37 1.679 0 O-C-N 118.344 -1.451 . . . . 0.56999999999999995 111.891 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -82.35 102.87 11.52 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 111.176 178.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.11 162.45 28.97 Favored 'General case' 0 C--N 1.382 1.991 0 CA-C-O 124.108 1.909 . . . . 0.56999999999999995 114.099 171.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 138' ' ' PHE . 0.9 OUTLIER -135.6 160.7 37.67 Favored 'General case' 0 C--N 1.392 2.433 0 CA-C-N 112.466 -2.152 . . . . 0.56999999999999995 107.007 -172.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 m -160.3 122.34 3.22 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 125.177 2.418 . . . . 0.56999999999999995 107.353 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -92.65 135.93 33.66 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.493 -1.685 . . . . 0.56999999999999995 110.364 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -114.35 177.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.376 1.755 0 CA-C-O 124.254 1.978 . . . . 0.56999999999999995 110.195 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -104.18 -38.76 6.77 Favored 'General case' 0 C--N 1.386 2.161 0 CA-C-N 112.581 -2.1 . . . . 0.56999999999999995 112.401 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.4 p -130.25 133.27 46.39 Favored 'General case' 0 C--N 1.379 1.852 0 CA-C-O 122.409 1.099 . . . . 0.56999999999999995 108.929 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 116.09 169.59 15.54 Favored Glycine 0 C--N 1.386 3.334 0 CA-C-O 123.864 1.813 . . . . 0.56999999999999995 112.389 -175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.1 ttt -80.72 139.15 36.27 Favored 'General case' 0 C--N 1.389 2.292 0 CA-C-N 112.114 -2.043 . . . . 0.56999999999999995 109.551 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HB1' ' N ' ' A' ' 116' ' ' TYR . . . -131.71 173.23 11.35 Favored 'General case' 0 C--N 1.384 2.077 0 CA-C-N 112.446 -2.161 . . . . 0.56999999999999995 111.144 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -82.9 -59.33 2.53 Favored 'General case' 0 C--N 1.385 2.12 0 N-CA-C 103.501 -2.778 . . . . 0.91000000000000003 103.501 -168.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 223' ' ' SER . 5.6 mt -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 C--N 1.389 2.288 0 O-C-N 125.064 1.478 . . . . 0.56999999999999995 111.15 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -99.21 128.44 45.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.884 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 197' ' ' PHE . 1.0 OUTLIER -114.59 119.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.56999999999999995 111.086 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.1 t -132.72 125.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.087 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.421 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.4 OUTLIER -98.51 122.76 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.86 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 199' ' ' GLU . . . -142.66 167.94 20.9 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-O 123.258 1.504 . . . . 0.56999999999999995 107.12 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CD ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -112.48 135.63 52.95 Favored 'General case' 0 C--N 1.369 1.437 0 CA-C-N 114.097 -1.411 . . . . 1.2 109.775 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 50.13 -133.86 28.27 Favored Glycine 0 C--N 1.397 3.919 0 CA-C-O 124.913 2.396 . . . . 0.56999999999999995 109.562 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.39 135.18 39.69 Favored 'General case' 0 C--N 1.385 2.115 0 CA-C-N 111.496 -2.352 . . . . 0.56999999999999995 113.799 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 179.64 119.8 0.05 Allowed 'General case' 0 C--N 1.398 2.683 0 CA-C-N 113.533 -1.667 . . . . 0.56999999999999995 107.096 -171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 40.65 -125.82 2.84 Favored Glycine 0 C--N 1.384 3.228 0 CA-C-O 123.804 1.78 . . . . 0.56999999999999995 114.288 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -50.52 106.33 0.12 Allowed 'General case' 0 C--N 1.397 2.65 0 CA-C-N 110.772 -2.714 . . . . 0.91000000000000003 112.853 165.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 83.58 75.63 0.02 OUTLIER 'General case' 0 C--N 1.409 3.185 0 CA-C-O 126.687 3.137 . . . . 0.56999999999999995 107.786 173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.539 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 21.9 p-80 -69.93 59.89 0.17 Allowed 'General case' 0 C--N 1.382 1.997 0 CA-C-N 112.665 -2.062 . . . . 0.56999999999999995 113.533 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 172' ' ' HIS . . . 162.56 91.14 0.0 OUTLIER 'General case' 0 C--N 1.39 2.359 0 CA-C-O 122.931 1.348 . . . . 0.56999999999999995 109.094 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -98.97 -157.08 0.58 Allowed 'General case' 0 C--N 1.384 2.074 0 CA-C-N 112.776 -2.011 . . . . 0.56999999999999995 111.253 175.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -72.46 -77.52 0.1 Allowed 'General case' 0 C--N 1.378 1.846 0 CA-C-N 113.475 -1.693 . . . . 0.91000000000000003 112.267 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.45 16.43 Favored Glycine 0 C--N 1.385 3.266 0 C-N-CA 120.882 -0.675 . . . . 0.56999999999999995 113.757 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 160.38 40.88 0.0 OUTLIER 'General case' 0 C--N 1.399 2.759 0 CA-C-O 124.183 1.944 . . . . 0.56999999999999995 112.341 -170.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.02 -156.79 15.42 Favored Glycine 0 C--N 1.37 2.446 0 N-CA-C 107.009 -2.436 . . . . 0.56999999999999995 107.009 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.45 -39.84 2.54 Favored Glycine 0 C--N 1.367 2.265 0 O-C-N 120.268 -1.725 . . . . 0.56999999999999995 113.989 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 174' ' ' PHE . 0.9 OUTLIER -152.56 167.9 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.86 0 N-CA-C 105.294 -2.113 . . . . 0.56999999999999995 105.294 -172.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' A' ' 210' ' ' THR . 66.9 mt -118.77 -80.6 0.62 Allowed 'General case' 0 C--N 1.374 1.673 0 O-C-N 126.684 2.49 . . . . 0.56999999999999995 114.77 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -107.65 179.5 4.22 Favored 'General case' 0 C--N 1.377 1.765 0 CA-C-N 115.356 -0.838 . . . . 0.56999999999999995 111.112 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.422 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER -169.24 135.9 1.72 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.904 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -160.05 161.97 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.151 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.11 -171.22 2.85 Favored 'General case' 0 C--N 1.369 1.426 0 CA-C-O 123.029 1.395 . . . . 0.56999999999999995 110.846 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.91 -159.11 35.16 Favored Glycine 0 C--N 1.385 3.275 0 CA-C-N 114.001 -1.454 . . . . 0.56999999999999995 112.838 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.42 74.28 3.74 Favored 'Trans proline' 0 C--N 1.394 2.961 0 C-N-CA 122.818 2.345 . . . . 0.56999999999999995 110.068 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -92.76 -134.86 6.95 Favored Glycine 0 C--N 1.376 2.798 0 CA-C-O 124.067 1.926 . . . . 0.56999999999999995 110.155 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.26 -80.08 0.6 Allowed 'General case' 0 C--N 1.396 2.604 0 CA-C-N 112.909 -1.645 . . . . 0.56999999999999995 108.938 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.99 -54.76 2.11 Favored Glycine 1 C--N 1.398 4.006 0 N-CA-C 108.252 -1.939 . . . . 0.56999999999999995 108.252 -174.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -44.37 99.47 Favored 'Isoleucine or valine' 0 C--N 1.396 2.625 0 CA-C-N 113.38 -1.41 . . . . 0.56999999999999995 107.615 -173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.52 136.44 43.89 Favored Glycine 0 C--N 1.395 3.835 0 N-CA-C 106.89 -2.484 . . . . 0.56999999999999995 106.89 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.62 -41.54 2.11 Favored Glycine 0 C--N 1.375 2.739 0 CA-C-N 113.33 -1.435 . . . . 0.56999999999999995 113.531 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.83 97.16 0.1 Allowed 'General case' 0 C--N 1.39 2.343 0 CA-C-N 115.096 -0.552 . . . . 0.91000000000000003 110.921 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 184' ' ' ALA . . . -102.95 148.29 25.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.56999999999999995 111.08 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -129.37 151.27 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.895 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -123.59 150.1 44.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.56999999999999995 110.897 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.577 ' O ' ' CG ' ' A' ' 198' ' ' ASP . 2.8 p30 -79.39 83.19 5.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.216 -0.447 . . . . 0.91000000000000003 110.833 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 203' ' ' TRP . 11.7 tp10 -57.1 -32.52 66.39 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 117.72 -1.133 . . . . 0.91000000000000003 110.349 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -41.98 -51.41 4.44 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 125.768 1.918 . . . . 0.91000000000000003 110.429 -173.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.25 -173.87 0.01 OUTLIER 'General case' 0 C--N 1.392 2.434 0 CA-C-O 127.766 3.65 . . . . 0.91000000000000003 113.045 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.9 122.59 46.71 Favored 'General case' 0 C--N 1.382 2.019 0 O-C-N 119.125 -2.234 . . . . 0.56999999999999995 113.078 173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.568 ' CZ2' ' HA ' ' A' ' 199' ' ' GLU . 26.1 m0 -96.39 123.85 40.18 Favored 'General case' 0 C--N 1.391 2.383 0 N-CA-C 105.262 -2.125 . . . . 0.56999999999999995 105.262 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.46 102.61 11.44 Favored 'General case' 0 C--N 1.374 1.649 0 CA-C-O 126.235 2.921 . . . . 0.56999999999999995 112.136 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.8 p -102.09 120.59 40.68 Favored 'General case' 0 C--N 1.376 1.739 0 O-C-N 119.564 -1.96 . . . . 0.56999999999999995 108.904 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 65.86 66.63 0.5 Allowed 'General case' 0 C--N 1.394 2.537 0 CA-C-O 123.958 1.837 . . . . 0.56999999999999995 109.673 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.98 -72.14 0.01 OUTLIER 'General case' 0 C--N 1.397 2.661 0 CA-C-O 123.522 1.629 . . . . 0.56999999999999995 109.334 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -172.81 -145.92 5.2 Favored Glycine 0 C--N 1.385 3.263 0 N-CA-C 108.262 -1.935 . . . . 0.56999999999999995 108.262 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 47.06 -146.56 3.75 Favored Glycine 0 C--N 1.383 3.18 0 CA-C-O 127.134 3.63 . . . . 0.56999999999999995 110.095 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.55 ' CB ' HD21 ' A' ' 181' ' ' LEU . 8.3 p -77.77 124.34 27.84 Favored 'General case' 0 C--N 1.368 1.378 0 O-C-N 119.983 -1.892 . . . . 0.56999999999999995 112.331 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 214' ' ' LEU . 0.7 OUTLIER -116.86 155.97 28.12 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-N 114.815 -1.084 . . . . 0.56999999999999995 109.435 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.66 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -65.87 -32.93 74.73 Favored 'General case' 0 C--N 1.393 2.491 0 CA-C-O 124.22 1.962 . . . . 0.56999999999999995 107.641 -173.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.83 ' CD2' HG23 ' A' ' 245' ' ' ILE . 27.5 t80 -57.55 -50.0 74.53 Favored 'General case' 0 C--N 1.376 1.72 0 CA-C-N 113.16 -1.836 . . . . 0.56999999999999995 110.898 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.617 HD23 ' OD1' ' A' ' 211' ' ' ASN . 1.0 OUTLIER -55.03 -51.12 67.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.56999999999999995 110.937 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -63.83 -44.95 91.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 111.151 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 220' ' ' ILE . . . -56.93 -42.87 80.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 111.085 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.579 HG21 ' CZ ' ' A' ' 248' ' ' PHE . 0.9 OUTLIER -65.17 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.096 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.26 -49.97 62.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.56999999999999995 110.823 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.464 ' OE2' ' HB3' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -59.35 -42.11 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.91000000000000003 110.885 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.682 HD12 ' CE1' ' A' ' 138' ' ' PHE . 3.3 mm -67.68 -47.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.56999999999999995 111.133 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 225' ' ' GLY . . . -56.79 -33.75 63.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 0.56999999999999995 112.466 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.41 -38.74 88.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.56999999999999995 110.9 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 159' ' ' ILE . 11.0 t -71.22 -53.53 14.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.836 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 225' ' ' GLY . 3.2 pp -72.23 -60.77 2.06 Favored 'General case' 0 C--N 1.375 1.68 0 N-CA-C 118.992 2.96 . . . . 0.56999999999999995 118.992 173.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.811 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -70.42 -175.09 17.1 Favored Glycine 0 C--N 1.375 2.741 0 CA-C-O 126.157 3.087 . . . . 0.56999999999999995 110.114 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.715 HD21 ' HG ' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -89.01 -146.33 0.16 Allowed 'General case' 0 C--N 1.386 2.18 0 CA-C-N 109.628 -3.286 . . . . 0.56999999999999995 106.432 -172.02 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.01 -107.57 0.01 OUTLIER Glycine 0 C--N 1.394 3.794 0 CA-C-O 125.769 2.871 . . . . 0.56999999999999995 111.665 -177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.445 ' CE1' ' HG3' ' A' ' 238' ' ' PRO . 21.4 m170 -113.83 -96.43 0.45 Allowed 'General case' 0 C--N 1.382 1.994 0 O-C-N 119.633 -2.098 . . . . 0.56999999999999995 110.34 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.03 -42.58 0.01 OUTLIER 'General case' 0 C--N 1.391 2.413 0 N-CA-C 107.893 -1.151 . . . . 0.56999999999999995 107.893 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 81.87 24.11 0.23 Allowed 'General case' 0 C--N 1.415 3.454 0 N-CA-C 116.676 2.102 . . . . 0.56999999999999995 116.676 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 4.5 t0 -157.94 138.2 8.95 Favored Pre-proline 0 C--N 1.386 2.156 0 N-CA-C 106.539 -1.652 . . . . 0.91000000000000003 106.539 -171.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.542 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 67.8 Cg_exo -57.29 -57.68 1.18 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.445 2.763 . . . . 0.56999999999999995 114.529 -175.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.99 -37.75 4.25 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 112.976 -1.92 . . . . 0.56999999999999995 113.396 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -65.63 117.56 8.27 Favored 'General case' 0 C--N 1.393 2.493 0 CA-C-O 124.445 2.069 . . . . 0.56999999999999995 115.762 167.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.555 HG13 ' H28' ' A' ' 269' ' ' HSI . 10.3 t -72.19 47.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.383 2.033 0 CA-C-O 124.693 2.187 . . . . 0.56999999999999995 115.449 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.8 mmm -144.76 -31.94 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 CA-C-N 113.575 -1.648 . . . . 0.56999999999999995 110.227 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 239' ' ' THR . 0.0 OUTLIER -39.11 144.37 0.44 Allowed Pre-proline 0 C--N 1.38 1.928 0 CA-C-O 126.283 2.944 . . . . 0.56999999999999995 114.371 173.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.445 ' HG3' ' CE1' ' A' ' 228' ' ' HIS . 54.0 Cg_exo -58.87 -48.14 15.66 Favored 'Trans proline' 0 C--N 1.383 2.371 0 O-C-N 118.294 -1.477 . . . . 0.56999999999999995 111.806 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 98.9 m -46.3 122.54 4.07 Favored 'General case' 0 C--N 1.378 1.84 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.003 -173.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.503 ' CZ ' HG22 ' A' ' 210' ' ' THR . 0.0 OUTLIER -98.03 117.69 32.96 Favored 'General case' 0 C--N 1.386 2.164 0 CA-C-N 112.81 -1.995 . . . . 0.56999999999999995 106.602 -178.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 46.7 tttt -138.5 108.03 6.19 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-N 113.281 -1.781 . . . . 0.56999999999999995 106.63 174.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.5 120.89 5.03 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-O 124.455 2.074 . . . . 0.56999999999999995 110.796 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.24 18.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 CA-C-N 112.868 -1.969 . . . . 0.56999999999999995 110.718 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.3 t0 64.03 115.95 0.02 OUTLIER 'General case' 0 C--N 1.385 2.147 0 CA-C-O 126.937 3.256 . . . . 0.91000000000000003 106.651 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.83 HG23 ' CD2' ' A' ' 213' ' ' PHE . 2.6 mp -51.97 -19.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.46 0 O-C-N 119.048 -2.283 . . . . 0.56999999999999995 115.4 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.97 -31.46 64.56 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 114.003 -1.453 . . . . 0.56999999999999995 111.23 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.95 -5.62 15.42 Favored 'General case' 0 C--N 1.38 1.895 0 C-N-CA 123.121 0.568 . . . . 0.56999999999999995 110.914 -174.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.579 ' CZ ' HG21 ' A' ' 217' ' ' VAL . 22.9 t80 -65.01 93.85 0.12 Allowed 'General case' 0 C--N 1.385 2.119 0 CA-C-O 125.678 2.656 . . . . 0.56999999999999995 105.332 -170.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.542 ' C ' HD13 ' A' ' 250' ' ' LEU . 0.0 OUTLIER -114.41 154.14 28.64 Favored 'General case' 0 C--N 1.375 1.677 0 CA-C-N 112.414 -2.176 . . . . 1.2 105.79 -177.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -123.89 132.62 53.77 Favored 'General case' 0 C--N 1.385 2.15 0 CA-C-O 125.559 2.6 . . . . 0.56999999999999995 105.768 -170.552 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 25.8 m -69.32 141.79 54.19 Favored 'General case' 0 C--N 1.365 1.249 0 O-C-N 120.229 -1.544 . . . . 0.56999999999999995 109.124 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 256' ' ' ARG . . . -59.93 -42.45 93.98 Favored 'General case' 0 C--N 1.396 2.609 0 CA-C-N 113.337 -1.756 . . . . 0.56999999999999995 107.412 -174.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.27 -41.52 89.07 Favored 'General case' 0 C--N 1.365 1.243 0 CA-C-N 115.501 -0.772 . . . . 0.91000000000000003 110.834 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 258' ' ' ILE . 23.2 t0 -64.4 -54.8 27.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.91000000000000003 110.857 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.43 HG13 ' N ' ' A' ' 256' ' ' ARG . 26.6 pt -66.08 -34.54 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.56999999999999995 111.196 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.661 ' HD2' ' HB1' ' A' ' 252' ' ' ALA . 7.4 mtp180 -67.55 -31.12 70.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.2 110.796 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.74 ' O ' HD23 ' A' ' 261' ' ' LEU . . . -73.21 -48.41 19.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.788 -0.72 . . . . 0.56999999999999995 112.457 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 224' ' ' LEU . 1.2 pt -59.59 -36.15 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.731 0.301 . . . . 0.56999999999999995 111.077 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 260' ' ' SER . 6.3 pt20 -70.13 -44.61 68.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 110.896 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 259' ' ' GLN . 1.5 t -64.99 -42.56 94.4 Favored 'General case' 0 C--N 1.374 1.673 0 CA-C-O 121.933 0.873 . . . . 0.56999999999999995 110.891 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 257' ' ' GLY . 0.5 OUTLIER -136.29 126.83 26.94 Favored 'General case' 0 C--N 1.38 1.933 0 CA-C-O 125.48 2.562 . . . . 0.56999999999999995 107.66 -176.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 147' ' ' LEU . 32.0 m-85 -105.37 9.58 33.7 Favored 'General case' 0 C--N 1.379 1.85 0 CA-C-N 112.716 -2.038 . . . . 0.56999999999999995 110.778 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 226' ' ' LEU . . . . . . . . 1 C--N 1.4 4.118 0 CA-C-O 114.625 -3.32 . . . . 0.91000000000000003 119.716 171.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.555 ' H28' HG13 ' A' ' 235' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' HG13 ' A' ' 108' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.128 0 CA-C-O 118.414 -1.214 . . . . 0.56999999999999995 111.315 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.11 121.27 9.35 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.249 2.633 . . . . 0.56999999999999995 111.077 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 106' ' ' GLY . 16.2 m -123.71 132.87 70.65 Favored 'Isoleucine or valine' 0 C--N 1.374 1.667 0 CA-C-N 113.414 -1.721 . . . . 0.56999999999999995 109.26 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.92 114.66 4.94 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 113.857 -1.519 . . . . 0.56999999999999995 107.81 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -118.09 150.36 39.46 Favored 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.851 -1.522 . . . . 1.2 108.943 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.48 -65.83 0.03 OUTLIER 'General case' 0 C--N 1.382 2.018 0 CA-C-N 113.886 -1.507 . . . . 0.56999999999999995 111.07 178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.754 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -77.31 -11.61 59.85 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 125.542 2.591 . . . . 0.56999999999999995 110.268 -179.174 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -110.07 105.48 14.61 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.144 -1.598 . . . . 0.56999999999999995 110.946 -176.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -110.01 135.32 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.108 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.42 159.03 18.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.56999999999999995 111.181 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.912 ' OH ' HD12 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -150.14 158.07 43.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.56999999999999995 110.883 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -156.07 126.5 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.2 110.921 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.912 HD12 ' OH ' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -77.98 136.22 24.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.56999999999999995 111.114 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -53.23 -53.92 43.65 Favored 'General case' 0 C--N 1.376 1.744 0 N-CA-C 107.805 -1.183 . . . . 0.56999999999999995 107.805 -172.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 161.98 35.44 0.0 OUTLIER 'General case' 0 C--N 1.382 1.996 0 O-C-N 126.599 2.437 . . . . 0.56999999999999995 110.049 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 4.8 m-30 72.52 -172.22 0.15 Allowed 'General case' 0 C--N 1.383 2.025 0 N-CA-C 107.41 -1.33 . . . . 0.56999999999999995 107.41 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -139.74 161.51 55.98 Favored Pre-proline 0 C--N 1.373 1.614 0 CA-C-N 114.141 -1.39 . . . . 0.56999999999999995 108.619 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -50.51 1.41 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.757 1.638 . . . . 0.56999999999999995 112.584 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' H ' HG23 ' A' ' 122' ' ' THR . 0.5 OUTLIER -80.16 -66.87 0.82 Allowed 'General case' 0 C--N 1.379 1.882 0 N-CA-C 104.768 -2.308 . . . . 0.91000000000000003 104.768 -165.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.7 ttm -59.54 139.11 57.43 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-O 125.694 2.664 . . . . 0.56999999999999995 110.19 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.728 ' O ' HG23 ' A' ' 130' ' ' VAL . 69.2 m-20 -75.95 139.69 41.7 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-N 112.396 -2.184 . . . . 0.56999999999999995 107.714 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.47 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -68.47 -47.46 67.03 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 107.736 -1.209 . . . . 1.2 107.736 -168.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.88 -34.67 63.27 Favored 'General case' 0 C--N 1.387 2.226 0 O-C-N 126.482 2.364 . . . . 0.91000000000000003 110.898 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.05 -44.04 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.91000000000000003 110.909 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.31 -44.55 98.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.56999999999999995 111.092 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.84 -44.09 97.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.91000000000000003 110.869 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -65.61 -44.06 87.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.56999999999999995 110.894 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.603 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.1 -43.97 87.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.56999999999999995 111.13 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.527 HG22 ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -65.15 -42.89 95.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.56999999999999995 111.112 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -49.05 78.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.868 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -36.55 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.91 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -63.26 -42.06 99.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.56999999999999995 111.132 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 134' ' ' ILE . 20.4 m-85 -65.93 -37.09 85.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 110.86 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 6.4 tt0 -67.16 -38.11 84.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.882 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 144' ' ' VAL . 8.3 t -71.12 -34.07 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 111.122 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CG ' HD11 ' A' ' 224' ' ' LEU . 1.3 m95 -83.25 -34.09 25.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.56999999999999995 110.913 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 4.5 m -77.55 -49.39 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.876 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.747 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -59.76 -12.56 7.45 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-O 122.174 0.988 . . . . 0.56999999999999995 112.737 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.747 HG13 ' ND2' ' A' ' 143' ' ' ASN . 25.0 m -115.98 1.39 8.19 Favored 'Isoleucine or valine' 0 C--N 1.379 1.854 0 CA-C-N 114.014 -1.448 . . . . 0.56999999999999995 111.42 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.8 150.28 45.92 Favored Pre-proline 0 C--N 1.368 1.412 0 CA-C-O 125.615 2.626 . . . . 0.56999999999999995 110.203 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.572 ' HG3' ' O ' ' A' ' 262' ' ' TYR . 33.8 Cg_endo -73.38 -34.03 6.36 Favored 'Trans proline' 0 C--N 1.361 1.224 0 O-C-N 118.114 -1.572 . . . . 0.56999999999999995 110.69 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 112' ' ' HIS . 1.1 mt -58.7 114.34 2.46 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-O 123.672 1.701 . . . . 0.56999999999999995 108.73 -175.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 158.36 32.05 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 113.742 -1.572 . . . . 0.56999999999999995 112.507 175.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 224' ' ' LEU . 12.6 m-85 -130.07 139.61 50.94 Favored 'General case' 0 C--N 1.388 2.272 0 CA-C-N 112.368 -2.196 . . . . 0.56999999999999995 108.711 -175.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.4 m -145.53 125.02 13.14 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.763 2.22 . . . . 0.56999999999999995 108.367 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 116' ' ' TYR . 15.9 tttt -89.45 146.58 24.54 Favored 'General case' 0 C--N 1.37 1.463 0 CA-C-N 114.077 -1.42 . . . . 0.56999999999999995 112.731 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.781 HD11 ' HA ' ' A' ' 157' ' ' ALA . 8.2 pt -139.11 155.97 27.17 Favored 'Isoleucine or valine' 0 C--N 1.379 1.852 0 CA-C-O 123.41 1.576 . . . . 0.56999999999999995 109.738 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 -6.23 1.48 Allowed 'General case' 0 C--N 1.374 1.657 0 CA-C-N 113.808 -1.542 . . . . 0.56999999999999995 109.951 -174.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.5 p -76.79 -62.82 1.51 Allowed 'General case' 0 C--N 1.372 1.569 0 CA-C-N 114.184 -1.371 . . . . 0.56999999999999995 110.539 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -116.56 -174.69 17.47 Favored Glycine 0 C--N 1.374 2.648 0 CA-C-O 123.253 1.474 . . . . 0.56999999999999995 110.861 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.0 ttt -57.62 124.97 20.89 Favored 'General case' 0 C--N 1.382 1.997 0 CA-C-N 113.014 -1.593 . . . . 0.56999999999999995 108.411 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 152' ' ' ILE . . . -97.04 173.56 7.21 Favored 'General case' 0 C--N 1.377 1.763 0 CA-C-N 113.147 -1.842 . . . . 0.56999999999999995 110.582 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.43 -83.39 0.03 OUTLIER 'General case' 0 C--N 1.381 1.95 0 CA-C-N 112.989 -1.914 . . . . 0.91000000000000003 107.674 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.94 HG22 ' HA3' ' A' ' 193' ' ' GLY . 1.9 pp -94.69 114.57 31.54 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-N 114.665 -1.152 . . . . 0.56999999999999995 111.108 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 157' ' ' ALA . 4.5 mp -96.38 132.06 42.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.56999999999999995 110.92 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 197' ' ' PHE . 21.6 t -102.02 116.9 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.148 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.33 145.13 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 111.101 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.625 ' HZ ' HG11 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -102.77 117.77 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.89 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.36 170.12 18.0 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-O 124.341 2.019 . . . . 0.56999999999999995 109.646 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.517 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -109.6 134.02 52.43 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 119.909 -1.744 . . . . 1.2 108.156 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.467 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 42.32 -106.02 0.07 OUTLIER Glycine 0 C--N 1.379 2.957 0 O-C-N 126.135 2.147 . . . . 0.56999999999999995 113.009 171.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.478 ' H ' ' CB ' ' A' ' 173' ' ' ALA . . . 57.04 -140.03 0.86 Allowed 'General case' 0 C--N 1.384 2.097 0 O-C-N 127.111 2.301 . . . . 0.56999999999999995 107.518 170.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 168' ' ' HIS . 0.1 OUTLIER -40.31 145.78 0.16 Allowed 'General case' 0 C--N 1.383 2.059 0 O-C-N 124.957 1.411 . . . . 0.56999999999999995 111.36 177.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 41.9 -145.86 0.68 Allowed Glycine 0 C--N 1.376 2.761 0 C-N-CA 116.874 -2.584 . . . . 0.56999999999999995 114.256 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.84 23.98 13.95 Favored 'General case' 0 C--N 1.395 2.57 0 CA-C-N 112.59 -1.805 . . . . 0.91000000000000003 108.341 167.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.0 t80 60.48 76.69 0.35 Allowed 'General case' 0 C--N 1.383 2.031 0 CA-C-N 114.063 -1.426 . . . . 0.56999999999999995 112.616 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 0.1 OUTLIER 44.84 42.76 6.39 Favored 'General case' 0 C--N 1.384 2.099 0 CA-C-N 114.842 -1.072 . . . . 0.56999999999999995 112.936 177.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 65.16 101.92 0.04 OUTLIER 'General case' 0 C--N 1.377 1.769 0 CA-C-O 124.157 1.932 . . . . 0.56999999999999995 115.185 -173.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.756 ' CE2' HG21 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -85.89 -131.1 0.05 OUTLIER 'General case' 0 C--N 1.376 1.745 0 CA-C-N 113.224 -1.807 . . . . 0.56999999999999995 108.633 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.578 ' H ' HD13 ' A' ' 180' ' ' ILE . 6.9 t70 54.0 -157.42 0.19 Allowed 'General case' 0 C--N 1.39 2.343 0 N-CA-C 105.647 -1.982 . . . . 0.91000000000000003 105.647 170.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 127.72 9.18 4.02 Favored Glycine 0 C--N 1.368 2.344 0 N-CA-C 109.067 -1.613 . . . . 0.56999999999999995 109.067 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.13 -57.14 0.01 OUTLIER 'General case' 0 C--N 1.393 2.492 0 CA-C-O 122.764 1.269 . . . . 0.56999999999999995 111.031 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 179' ' ' GLY . . . -156.95 -38.25 0.02 OUTLIER Glycine 0 C--N 1.382 3.102 0 CA-C-N 114.126 -1.397 . . . . 0.56999999999999995 111.497 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.618 ' C ' HD12 ' A' ' 180' ' ' ILE . . . -41.6 142.06 1.19 Allowed Glycine 0 C--N 1.38 3.027 0 O-C-N 120.0 -1.883 . . . . 0.56999999999999995 109.379 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 174' ' ' PHE . 1.3 mp 74.04 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.62 0 O-C-N 124.153 0.561 . . . . 0.56999999999999995 112.449 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 215' ' ' THR . 2.7 tp -124.29 -57.81 1.56 Allowed 'General case' 0 C--N 1.365 1.276 0 CA-C-O 122.966 1.365 . . . . 0.56999999999999995 111.882 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.572 ' HB3' HG22 ' A' ' 215' ' ' THR . . . -177.43 179.53 0.94 Allowed 'General case' 0 C--N 1.364 1.229 0 CA-C-N 114.584 -1.189 . . . . 0.56999999999999995 111.042 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.518 ' O ' ' HB1' ' A' ' 195' ' ' ALA . 2.7 p80 -152.94 168.24 26.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.56999999999999995 110.874 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 195' ' ' ALA . . . -151.89 142.71 22.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.56999999999999995 111.057 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.453 ' CB ' ' HA2' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -52.02 129.71 27.93 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 117.745 -1.582 . . . . 0.56999999999999995 110.143 -177.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 187' ' ' PRO . . . -74.26 -58.19 4.4 Favored Glycine 0 C--N 1.381 3.046 0 CA-C-N 112.859 -1.973 . . . . 0.56999999999999995 111.785 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 186' ' ' GLY . 30.7 Cg_endo -67.96 -83.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 121.495 1.463 . . . . 0.56999999999999995 111.342 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.463 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . 167.32 -142.52 7.61 Favored Glycine 0 C--N 1.375 2.711 0 N-CA-C 108.984 -1.646 . . . . 0.56999999999999995 108.984 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 83.59 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.382 1.987 0 O-C-N 125.611 1.418 . . . . 0.56999999999999995 109.382 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -44.87 -65.08 1.91 Allowed Glycine 0 C--N 1.388 3.426 0 CA-C-O 125.678 2.821 . . . . 0.56999999999999995 112.549 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 191' ' ' ILE . 1.5 mp -71.97 -15.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.382 1.982 0 CA-C-N 111.306 -2.447 . . . . 0.56999999999999995 109.03 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.463 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -44.98 148.35 1.39 Allowed Glycine 0 C--N 1.362 1.972 0 O-C-N 120.693 -1.254 . . . . 0.56999999999999995 113.676 177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.94 ' HA3' HG22 ' A' ' 159' ' ' ILE . . . 76.38 -44.47 1.94 Allowed Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 117.428 1.731 . . . . 0.56999999999999995 117.428 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -37.48 147.15 0.04 OUTLIER 'General case' 0 C--N 1.387 2.205 0 O-C-N 124.894 0.997 . . . . 0.91000000000000003 110.853 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -143.42 152.0 41.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.56999999999999995 111.113 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.538 ' C ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.33 126.41 37.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 110.828 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.664 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.7 OUTLIER -109.97 134.93 51.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.56999999999999995 110.923 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.43 ' HB2' ' CG ' ' A' ' 175' ' ' ASP . 0.1 OUTLIER -60.83 85.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.91000000000000003 110.86 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -72.98 -49.24 30.27 Favored 'General case' 0 C--N 1.382 1.999 0 N-CA-C 104.209 -2.515 . . . . 0.91000000000000003 104.209 -169.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.84 -45.75 0.1 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 123.938 0.895 . . . . 0.91000000000000003 112.151 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -53.19 174.15 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.007 0 CA-C-O 126.631 3.11 . . . . 0.91000000000000003 109.77 -178.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 201' ' ' GLU . 2.1 t80 -97.1 107.52 20.07 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 112.74 -2.027 . . . . 0.56999999999999995 114.275 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 40.9 m95 -91.25 151.42 20.92 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 108.493 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.0 p -126.22 104.4 8.2 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-O 123.601 1.667 . . . . 0.56999999999999995 109.92 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.56 137.29 37.43 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-N 113.271 -1.786 . . . . 0.56999999999999995 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.404 ' O ' ' CB ' ' A' ' 207' ' ' SER . 1.3 t60 76.78 42.56 0.15 Allowed 'General case' 0 C--N 1.385 2.144 0 CA-C-N 113.796 -1.547 . . . . 0.56999999999999995 110.834 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 206' ' ' HIS . 1.1 p 81.69 123.17 0.04 OUTLIER 'General case' 0 C--N 1.382 1.989 0 CA-C-O 124.55 2.119 . . . . 0.56999999999999995 108.849 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.37 -13.91 0.15 Allowed Glycine 0 C--N 1.382 3.135 0 C-N-CA 118.514 -1.803 . . . . 0.56999999999999995 111.752 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 153.88 -119.13 0.92 Allowed Glycine 0 C--N 1.389 3.509 0 CA-C-O 123.723 1.735 . . . . 0.56999999999999995 112.994 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.7 p -80.02 117.53 20.94 Favored 'General case' 0 C--N 1.377 1.795 0 CA-C-O 123.142 1.448 . . . . 0.56999999999999995 111.625 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -91.59 152.14 20.41 Favored 'General case' 0 C--N 1.369 1.417 0 CA-C-N 112.738 -2.028 . . . . 0.56999999999999995 111.648 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.603 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -75.04 -31.23 61.27 Favored 'General case' 0 C--N 1.385 2.113 0 CA-C-N 113.184 -1.825 . . . . 0.56999999999999995 107.338 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.879 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.3 t80 -58.22 -46.61 85.57 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-N 113.819 -1.537 . . . . 0.56999999999999995 110.889 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.621 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -55.68 -51.84 65.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.898 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.641 HG23 ' HB3' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -66.01 -49.05 69.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.56999999999999995 111.162 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.83 -39.32 73.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.56999999999999995 111.174 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 213' ' ' PHE . 92.5 t -65.18 -39.49 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.56999999999999995 111.081 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.459 ' CE1' ' O ' ' A' ' 236' ' ' MET . 7.2 t-160 -70.29 -42.3 72.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.56999999999999995 110.866 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 219' ' ' GLU . 1.2 mm-40 -61.1 -43.78 98.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.91000000000000003 110.869 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 137' ' ' ALA . 12.5 pt -71.09 -42.94 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 111.114 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.96 -33.76 64.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.744 -0.741 . . . . 0.56999999999999995 112.523 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -63.53 -42.02 98.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.482 ' CB ' HG21 ' A' ' 159' ' ' ILE . 17.7 t -71.01 -36.01 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.888 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.647 ' CD2' HD12 ' A' ' 114' ' ' ILE . 26.8 mt -43.74 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.367 1.344 0 CA-C-O 124.25 1.976 . . . . 0.56999999999999995 114.318 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.64 -161.83 35.56 Favored Glycine 0 C--N 1.369 2.408 0 N-CA-C 107.93 -2.068 . . . . 0.56999999999999995 107.93 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.553 HD11 HD12 ' A' ' 261' ' ' LEU . 0.5 OUTLIER 50.65 -164.07 0.05 OUTLIER 'General case' 0 C--N 1.389 2.293 0 CA-C-N 112.633 -1.783 . . . . 0.56999999999999995 111.131 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.533 ' H ' HD22 ' A' ' 226' ' ' LEU . . . -111.34 -162.61 17.51 Favored Glycine 0 C--N 1.373 2.624 0 CA-C-O 125.61 2.783 . . . . 0.56999999999999995 112.682 171.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.48 -167.06 1.74 Allowed 'General case' 0 C--N 1.39 2.328 0 CA-C-N 110.578 -2.811 . . . . 0.56999999999999995 112.032 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 234' ' ' ALA . 0.9 OUTLIER -94.24 -20.1 20.13 Favored 'General case' 0 C--N 1.385 2.125 0 CA-C-N 113.421 -1.718 . . . . 0.56999999999999995 109.944 -175.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 86.48 5.38 0.39 Allowed 'General case' 0 C--N 1.387 2.22 0 O-C-N 125.558 1.786 . . . . 0.56999999999999995 114.853 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -149.12 143.86 17.43 Favored Pre-proline 0 C--N 1.38 1.908 0 O-C-N 125.193 1.558 . . . . 0.91000000000000003 109.377 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 239' ' ' THR . 87.6 Cg_exo -59.11 -47.18 18.56 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.589 2.192 . . . . 0.56999999999999995 112.295 -172.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -41.89 -39.35 1.8 Allowed 'General case' 0 C--N 1.38 1.909 0 CA-C-N 114.035 -1.438 . . . . 0.56999999999999995 113.032 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 229' ' ' SER . . . -63.48 131.56 48.56 Favored 'General case' 0 C--N 1.383 2.046 0 N-CA-C 118.955 2.946 . . . . 0.56999999999999995 118.955 167.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.586 HG21 ' CE2' ' A' ' 248' ' ' PHE . 21.9 t -73.55 70.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.9 0 CA-C-N 112.256 -2.247 . . . . 0.56999999999999995 111.435 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.459 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -179.55 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.367 1.346 0 CA-C-N 113.233 -1.803 . . . . 0.56999999999999995 109.424 -178.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 3.4 t80 -52.77 140.25 39.63 Favored Pre-proline 0 C--N 1.363 1.193 0 O-C-N 120.014 -1.679 . . . . 0.56999999999999995 109.868 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 54.0 Cg_exo -54.77 -19.41 18.82 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.8 1.667 . . . . 0.56999999999999995 114.9 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 232' ' ' PRO . 1.0 OUTLIER -48.41 107.57 0.13 Allowed 'General case' 0 C--N 1.371 1.515 0 CA-C-O 123.665 1.698 . . . . 0.56999999999999995 110.677 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -81.86 134.11 35.38 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 105.869 -1.9 . . . . 0.56999999999999995 105.869 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.695 ' HD2' ' H33' ' A' ' 269' ' ' HSI . 2.7 tmtt? 174.96 113.49 0.02 OUTLIER 'General case' 0 C--N 1.383 2.048 0 N-CA-C 106.744 -1.576 . . . . 0.56999999999999995 106.744 175.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.59 123.26 9.55 Favored 'General case' 0 C--N 1.372 1.55 0 CA-C-N 113.238 -1.801 . . . . 0.56999999999999995 110.701 176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.658 HG11 ' C32' ' A' ' 269' ' ' HSI . 7.7 p -151.35 113.85 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.779 0 CA-C-N 113.806 -1.543 . . . . 0.56999999999999995 108.103 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.39 150.05 12.2 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 113.211 -1.813 . . . . 0.91000000000000003 107.086 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 213' ' ' PHE . 1.1 mp -75.86 -23.57 16.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 124.227 1.965 . . . . 0.56999999999999995 110.02 -175.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -84.15 -7.52 59.34 Favored 'General case' 0 C--N 1.366 1.306 0 O-C-N 120.481 -1.387 . . . . 0.56999999999999995 112.714 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 39.7 p -122.39 3.51 9.71 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-O 123.679 1.704 . . . . 0.56999999999999995 111.578 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.586 ' CE2' HG21 ' A' ' 235' ' ' VAL . 0.0 OUTLIER -83.97 -156.73 0.23 Allowed 'General case' 0 C--N 1.368 1.4 0 CA-C-N 113.259 -1.791 . . . . 0.56999999999999995 110.376 178.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER 178.28 163.37 0.69 Allowed 'General case' 0 C--N 1.385 2.124 0 N-CA-C 105.637 -1.986 . . . . 1.2 105.637 168.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -117.56 141.98 47.73 Favored 'General case' 0 C--N 1.37 1.46 0 CA-C-O 125.732 2.682 . . . . 0.56999999999999995 108.262 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 14.3 t -64.5 134.02 53.6 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 119.846 -1.784 . . . . 0.56999999999999995 112.645 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -66.91 -49.91 64.08 Favored 'General case' 0 C--N 1.39 2.361 0 CA-C-N 114.072 -1.422 . . . . 0.56999999999999995 108.663 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -35.96 73.97 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 115.357 -0.838 . . . . 0.91000000000000003 110.845 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 258' ' ' ILE . 30.6 t0 -63.94 -55.13 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.91000000000000003 110.885 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 256' ' ' ARG . 24.7 pt -66.37 -35.31 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.56999999999999995 111.149 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.452 ' N ' HG13 ' A' ' 255' ' ' ILE . 35.5 mtp180 -70.72 -35.52 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 1.2 110.784 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.02 -51.2 55.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.785 -0.722 . . . . 0.56999999999999995 112.465 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.713 HD11 HG23 ' A' ' 144' ' ' VAL . 2.4 pt -61.17 -45.61 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.777 0.322 . . . . 0.56999999999999995 111.119 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.9 OUTLIER -72.21 -28.69 63.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.56999999999999995 110.907 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 31.3 t -77.58 -36.24 52.19 Favored 'General case' 0 C--N 1.365 1.251 0 C-N-CA 119.096 -1.042 . . . . 0.56999999999999995 109.796 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.553 HD12 HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -52.57 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.382 2.007 0 CA-C-O 124.069 1.89 . . . . 0.56999999999999995 110.819 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.572 ' O ' ' HG3' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -99.52 130.82 45.8 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.222 -1.808 . . . . 0.56999999999999995 112.661 177.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.387 3.403 0 CA-C-O 114.622 -3.321 . . . . 0.91000000000000003 120.438 -173.081 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.695 ' H33' ' HD2' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.717 0 CA-C-O 118.97 -0.906 . . . . 0.56999999999999995 111.027 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -56.45 -22.82 44.2 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 121.208 1.272 . . . . 0.56999999999999995 114.439 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.94 130.14 74.83 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 0 CA-C-N 114.525 -1.216 . . . . 0.56999999999999995 109.481 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -179.14 152.27 0.54 Allowed 'General case' 0 C--N 1.371 1.54 0 N-CA-C 107.399 -1.334 . . . . 0.56999999999999995 107.399 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.36 157.46 31.77 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-O 125.034 2.349 . . . . 1.2 111.193 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -127.91 -54.32 1.31 Allowed 'General case' 0 C--N 1.379 1.868 0 O-C-N 120.411 -1.431 . . . . 0.56999999999999995 107.822 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.388 2.247 0 CA-C-O 124.172 1.939 . . . . 0.56999999999999995 108.471 -167.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -118.6 103.81 10.06 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-N 112.054 -2.339 . . . . 0.56999999999999995 110.929 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 149' ' ' PHE . 1.3 mm -102.11 146.91 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.572 ' HB ' ' H ' ' A' ' 158' ' ' ASP . 1.3 m -105.93 156.51 18.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.473 . . . . 0.56999999999999995 111.125 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.753 ' CE1' HD12 ' A' ' 118' ' ' ILE . 20.3 t80 -138.64 160.1 40.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.929 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.528 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.0 OUTLIER -145.68 121.85 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.509 . . . . 1.2 110.847 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.753 HD12 ' CE1' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -93.51 132.65 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.56999999999999995 111.125 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -59.48 -86.76 0.01 OUTLIER 'General case' 0 C--N 1.375 1.696 0 CA-C-N 114.739 -1.119 . . . . 0.56999999999999995 110.206 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.1 t30 169.4 60.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.28 0 N-CA-C 104.15 -2.537 . . . . 0.56999999999999995 104.15 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.723 ' CD2' HG21 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -67.07 178.37 1.45 Allowed 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.065 -1.88 . . . . 0.56999999999999995 111.544 166.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 162.45 -52.67 0.0 OUTLIER Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.32 2.648 . . . . 0.56999999999999995 108.134 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.71 -83.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.051 0 CA-C-O 124.365 1.735 . . . . 0.56999999999999995 110.079 -165.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.99 3.31 12.54 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 114.309 -1.314 . . . . 0.91000000000000003 113.986 173.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.1 mmt -142.75 119.45 11.13 Favored 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.007 -1.479 . . . . 0.56999999999999995 107.007 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.763 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -93.32 139.09 31.04 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 122.617 1.199 . . . . 0.56999999999999995 108.58 -177.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.46 ' N ' HD22 ' A' ' 126' ' ' ASN . 0.0 OUTLIER -66.89 -46.66 74.22 Favored 'General case' 0 C--N 1.388 2.261 0 CA-C-O 123.871 1.796 . . . . 1.2 109.261 -166.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -55.24 -35.17 64.65 Favored 'General case' 0 C--N 1.364 1.208 0 CA-C-N 111.376 -2.647 . . . . 0.91000000000000003 110.979 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.61 -41.92 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 0.91000000000000003 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.3 t -65.54 -39.57 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.56999999999999995 111.112 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.63 -42.1 87.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.838 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -49.02 75.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.949 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.404 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -66.62 -49.1 67.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.08 -0.509 . . . . 0.56999999999999995 111.052 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.521 HG13 HG12 ' A' ' 130' ' ' VAL . 1.5 mm -62.22 -46.03 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.56999999999999995 111.094 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -56.28 -43.64 79.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 1.2 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -38.13 89.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.56999999999999995 110.878 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 217' ' ' VAL . . . -64.57 -45.29 87.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.078 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 220' ' ' ILE . 14.9 m-85 -62.97 -34.4 77.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.56999999999999995 110.916 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 0.7 OUTLIER -68.11 -40.0 82.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 110.934 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -70.48 -34.24 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.56999999999999995 111.125 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.419 ' CZ3' HD13 ' A' ' 258' ' ' ILE . 14.5 m95 -83.15 -33.62 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.56999999999999995 110.929 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.7 m -78.94 -49.01 13.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.56999999999999995 110.808 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.813 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -59.97 -14.84 17.86 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-O 120.969 0.414 . . . . 0.56999999999999995 111.072 -178.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.813 HG13 ' ND2' ' A' ' 143' ' ' ASN . 19.6 m -112.51 -13.61 11.24 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 CA-C-O 117.89 -1.053 . . . . 0.56999999999999995 111.016 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.625 HG22 ' HD2' ' A' ' 146' ' ' PRO . 0.2 OUTLIER -145.7 142.39 17.93 Favored Pre-proline 0 C--N 1.383 2.038 0 O-C-N 124.859 1.349 . . . . 0.56999999999999995 112.555 -175.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD2' HG22 ' A' ' 145' ' ' THR . 47.3 Cg_endo -78.52 67.75 8.25 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.201 1.934 . . . . 0.56999999999999995 112.66 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -163.71 90.58 0.63 Allowed 'General case' 0 C--N 1.372 1.576 0 N-CA-C 104.516 -2.401 . . . . 0.56999999999999995 104.516 -167.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.09 160.53 25.73 Favored 'General case' 0 C--N 1.381 1.977 0 CA-C-N 114.432 -1.258 . . . . 0.56999999999999995 113.035 170.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' CZ ' HD22 ' A' ' 224' ' ' LEU . 25.0 m-85 -136.32 141.22 43.77 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-N 113.723 -1.58 . . . . 0.56999999999999995 106.747 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.0 m -157.02 139.76 15.11 Favored 'General case' 0 C--N 1.366 1.315 0 CA-C-O 124.454 2.073 . . . . 0.56999999999999995 108.161 -170.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.26 145.8 27.37 Favored 'General case' 0 C--N 1.371 1.503 0 CA-C-N 114.199 -1.364 . . . . 0.56999999999999995 109.733 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 157' ' ' ALA . 16.8 pt -111.27 159.48 11.23 Favored 'Isoleucine or valine' 0 C--N 1.367 1.333 0 CA-C-O 123.979 1.847 . . . . 0.56999999999999995 108.032 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -90.1 100.26 13.12 Favored 'General case' 0 C--N 1.369 1.455 0 CA-C-N 113.21 -1.814 . . . . 0.56999999999999995 107.038 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 67.67 -178.75 0.21 Allowed 'General case' 0 C--N 1.371 1.512 0 CA-C-O 122.189 0.995 . . . . 0.56999999999999995 109.44 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.09 71.35 Favored Glycine 0 C--N 1.371 2.487 0 C-N-CA 119.728 -1.225 . . . . 0.56999999999999995 113.435 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.63 113.89 0.06 Allowed 'General case' 0 C--N 1.374 1.671 0 CA-C-O 122.586 1.184 . . . . 0.56999999999999995 109.735 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 152' ' ' ILE . . . -91.31 159.49 15.99 Favored 'General case' 0 C--N 1.37 1.478 0 C-N-CA 117.612 -1.635 . . . . 0.56999999999999995 109.659 176.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.572 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -53.03 -47.13 68.61 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-N 112.28 -2.236 . . . . 0.91000000000000003 106.061 -171.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.3 mt -103.49 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.388 2.241 0 O-C-N 127.117 2.761 . . . . 0.56999999999999995 111.159 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.41 124.4 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.56999999999999995 110.921 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.713 HG13 ' CE1' ' A' ' 197' ' ' PHE . 24.9 t -108.75 123.04 64.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.074 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.99 124.94 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.56999999999999995 111.156 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.44 ' C ' ' HB2' ' A' ' 199' ' ' GLU . 5.4 m-85 -89.46 116.85 27.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 110.864 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.8 29.7 Favored 'General case' 0 C--N 1.378 1.81 0 CA-C-O 122.89 1.328 . . . . 0.56999999999999995 108.593 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -100.93 177.11 5.05 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 114.501 -1.227 . . . . 1.2 110.892 174.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -52.93 144.19 23.51 Favored Glycine 0 C--N 1.376 2.76 0 CA-C-N 113.213 -1.812 . . . . 0.56999999999999995 111.466 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 82.54 50.83 0.02 OUTLIER 'General case' 0 C--N 1.382 1.993 0 CA-C-O 123.136 1.446 . . . . 0.56999999999999995 112.307 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -123.98 168.27 13.05 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 109.69 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -66.28 171.45 28.46 Favored Glycine 0 C--N 1.379 2.929 0 N-CA-C 110.177 -1.169 . . . . 0.56999999999999995 110.177 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.308 0.0 OUTLIER 75.77 0.33 3.34 Favored 'General case' 0 C--N 1.374 1.657 0 CA-C-O 122.195 0.998 . . . . 0.91000000000000003 113.153 -177.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -177.22 -173.29 0.44 Allowed 'General case' 0 C--N 1.366 1.297 0 N-CA-C 105.755 -1.943 . . . . 0.56999999999999995 105.755 -163.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.01 -135.31 0.29 Allowed 'General case' 0 CA--C 1.568 1.653 0 CA-C-N 113.716 -1.584 . . . . 0.56999999999999995 108.896 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.68 101.11 0.76 Allowed 'General case' 0 C--N 1.375 1.707 0 C-N-CA 125.646 1.578 . . . . 0.56999999999999995 107.185 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -91.93 -164.51 1.19 Allowed 'General case' 0 C--N 1.369 1.44 0 CA-C-N 112.857 -1.974 . . . . 0.56999999999999995 108.715 173.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -104.56 142.13 35.18 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 105.061 -2.2 . . . . 0.91000000000000003 105.061 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.88 157.28 22.93 Favored Glycine 0 C--N 1.368 2.36 0 N-CA-C 107.645 -2.182 . . . . 0.56999999999999995 107.645 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.07 28.21 6.74 Favored 'General case' 0 C--N 1.369 1.425 0 N-CA-C 113.605 0.965 . . . . 0.56999999999999995 113.605 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 121.62 -163.99 14.9 Favored Glycine 0 C--N 1.364 2.101 0 N-CA-C 108.056 -2.017 . . . . 0.56999999999999995 108.056 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.48 -104.03 3.12 Favored Glycine 0 C--N 1.365 2.188 0 CA-C-N 114.758 -0.721 . . . . 0.56999999999999995 111.42 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.694 HG13 H402 ' A' ' 269' ' ' HSI . 0.5 OUTLIER -81.46 167.68 2.03 Favored 'Isoleucine or valine' 0 C--N 1.38 1.898 0 C-N-CA 123.526 0.73 . . . . 0.56999999999999995 109.142 178.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 240' ' ' TYR . 5.6 tp -101.13 -42.63 6.29 Favored 'General case' 0 C--N 1.369 1.45 0 CA-C-O 122.087 0.946 . . . . 0.56999999999999995 110.743 173.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.89 -179.99 2.19 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 120.56 -1.337 . . . . 0.56999999999999995 111.102 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.402 ' CD2' ' CZ ' ' A' ' 174' ' ' PHE . 2.3 p80 -163.87 136.1 4.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.56999999999999995 110.883 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.694 ' HB2' ' CB ' ' A' ' 195' ' ' ALA . . . -154.42 163.14 40.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.56999999999999995 111.136 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -121.32 176.59 5.56 Favored 'General case' 0 C--N 1.365 1.267 0 CA-C-O 123.191 1.472 . . . . 0.56999999999999995 108.478 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -169.68 53.09 0.2 Allowed Glycine 0 C--N 1.376 2.763 0 CA-C-N 113.827 -1.533 . . . . 0.56999999999999995 112.219 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.83 -49.84 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 CA-C-O 123.695 1.456 . . . . 0.56999999999999995 110.764 -175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -155.91 -61.58 0.01 OUTLIER Glycine 0 C--N 1.381 3.053 0 N-CA-C 109.844 -1.303 . . . . 0.56999999999999995 109.844 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.6 m -152.06 -179.73 7.75 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 107.859 -1.163 . . . . 0.56999999999999995 107.859 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.33 -104.57 1.6 Allowed Glycine 0 C--N 1.379 2.961 0 N-CA-C 105.888 -2.885 . . . . 0.56999999999999995 105.888 171.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.2 tp -55.38 -42.77 68.73 Favored 'Isoleucine or valine' 0 C--N 1.375 1.715 0 CA-C-O 122.818 1.294 . . . . 0.56999999999999995 109.067 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -64.51 134.69 38.72 Favored Glycine 0 C--N 1.379 2.941 0 C-N-CA 118.37 -1.872 . . . . 0.56999999999999995 108.498 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 104.6 -29.16 12.36 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 124.287 0.946 . . . . 0.56999999999999995 113.29 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 123.46 26.4 Favored 'General case' 0 C--N 1.371 1.522 0 O-C-N 120.91 -1.347 . . . . 0.91000000000000003 110.885 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.694 ' CB ' ' HB2' ' A' ' 184' ' ' ALA . . . -125.23 146.39 49.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.131 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -123.81 134.47 53.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 110.81 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.713 ' CE1' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -108.97 150.01 28.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.883 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 91.58 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.91000000000000003 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.44 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 3.7 tp10 -67.56 -44.56 77.96 Favored 'General case' 0 C--N 1.369 1.414 0 O-C-N 125.714 1.884 . . . . 0.91000000000000003 108.068 -174.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.56 -30.84 43.91 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-O 122.526 1.155 . . . . 0.91000000000000003 111.299 -167.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.52 172.02 0.17 Allowed 'General case' 0 C--N 1.374 1.66 0 CA-C-O 125.278 2.466 . . . . 0.91000000000000003 114.906 166.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -120.61 83.36 2.05 Favored 'General case' 0 C--N 1.384 2.07 0 CA-C-N 113.241 -1.8 . . . . 0.56999999999999995 108.463 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -74.4 152.53 39.49 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 113.695 -1.593 . . . . 0.56999999999999995 107.498 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 126.84 35.15 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-O 124.734 2.207 . . . . 0.56999999999999995 105.488 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.8 p -106.42 123.06 47.49 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 105.344 -2.095 . . . . 0.56999999999999995 105.344 -175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 70.6 34.83 2.02 Favored 'General case' 0 C--N 1.371 1.525 0 CA-C-O 123.318 1.533 . . . . 0.56999999999999995 109.621 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -139.11 -82.06 0.29 Allowed 'General case' 0 C--N 1.375 1.703 0 N-CA-C 107.752 -1.203 . . . . 0.56999999999999995 107.752 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 174.73 -163.33 33.69 Favored Glycine 0 C--N 1.365 2.148 0 N-CA-C 107.851 -2.1 . . . . 0.56999999999999995 107.851 -171.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.3 -142.85 47.75 Favored Glycine 0 C--N 1.373 2.588 0 C-N-CA 119.295 -1.431 . . . . 0.56999999999999995 110.724 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.8 p -74.62 115.45 14.19 Favored 'General case' 0 C--N 1.368 1.376 0 CA-C-O 124.684 2.183 . . . . 0.56999999999999995 113.723 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.495 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 2.7 p30 -102.55 147.67 26.49 Favored 'General case' 0 C--N 1.373 1.618 0 CA-C-N 112.748 -2.024 . . . . 0.56999999999999995 110.183 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.526 ' C ' HD13 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -71.34 -34.34 70.44 Favored 'General case' 0 C--N 1.381 1.966 0 N-CA-C 105.339 -2.097 . . . . 0.56999999999999995 105.339 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.921 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -53.73 -49.95 67.03 Favored 'General case' 0 C--N 1.375 1.686 0 CA-C-N 114.993 -1.003 . . . . 0.56999999999999995 110.9 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 211' ' ' ASN . 0.1 OUTLIER -54.94 -48.28 73.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 110.946 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.58 -38.2 77.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.56999999999999995 111.128 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 220' ' ' ILE . . . -61.55 -46.31 90.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.56999999999999995 111.158 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 213' ' ' PHE . 3.6 t -65.36 -40.01 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 111.089 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.12 -50.0 57.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.56999999999999995 110.891 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -59.9 -42.12 93.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.91000000000000003 110.849 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.721 HG22 HD23 ' A' ' 224' ' ' LEU . 2.4 mm -68.44 -43.92 83.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.11 -33.86 76.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.56999999999999995 112.438 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -39.4 89.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.779 0.323 . . . . 0.56999999999999995 110.849 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 m -71.05 -51.56 24.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.56999999999999995 110.833 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.721 HD23 HG22 ' A' ' 220' ' ' ILE . 3.7 pp -69.35 -55.73 9.55 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 116.002 1.853 . . . . 0.56999999999999995 116.002 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.641 ' N ' HD12 ' A' ' 224' ' ' LEU . . . -71.73 -148.44 0.67 Allowed Glycine 0 C--N 1.364 2.096 0 N-CA-C 107.51 -2.236 . . . . 0.56999999999999995 107.51 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 227' ' ' GLY . 0.0 OUTLIER -125.63 -21.26 4.5 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 113.19 -1.505 . . . . 0.56999999999999995 108.835 -172.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.521 ' N ' HD22 ' A' ' 226' ' ' LEU . . . 148.19 -172.28 28.48 Favored Glycine 0 C--N 1.376 2.787 0 CA-C-O 123.172 1.429 . . . . 0.56999999999999995 112.847 -161.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 236' ' ' MET . 2.2 m170 -73.97 -162.21 0.13 Allowed 'General case' 0 C--N 1.371 1.538 0 CA-C-N 112.074 -2.063 . . . . 0.56999999999999995 109.364 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 2.1 p -122.15 -10.94 8.5 Favored 'General case' 0 C--N 1.374 1.639 0 C-N-CA 120.313 -0.555 . . . . 0.56999999999999995 109.869 -177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 85.71 -4.58 0.83 Allowed 'General case' 0 C--N 1.377 1.771 0 N-CA-C 113.834 1.05 . . . . 0.56999999999999995 113.834 -175.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -130.03 152.0 79.26 Favored Pre-proline 0 C--N 1.375 1.708 0 N-CA-C 106.572 -1.64 . . . . 0.91000000000000003 106.572 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -63.72 -21.19 69.78 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.289 1.993 . . . . 0.56999999999999995 114.167 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.09 14.01 0.26 Allowed 'General case' 0 C--N 1.369 1.448 0 N-CA-C 117.33 2.345 . . . . 0.56999999999999995 117.33 168.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.447 ' HB2' ' OG ' ' A' ' 229' ' ' SER . . . -94.8 132.68 39.32 Favored 'General case' 0 C--N 1.367 1.332 0 CA-C-O 123.074 1.416 . . . . 0.56999999999999995 108.103 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 248' ' ' PHE . 0.3 OUTLIER -76.61 -5.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.372 1.547 0 CA-C-O 124.156 1.931 . . . . 0.56999999999999995 110.857 -176.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.55 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 74.8 mtp -121.77 26.42 8.69 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 114.046 -1.434 . . . . 0.56999999999999995 108.726 -176.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.417 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 0.3 OUTLIER -64.8 149.49 96.04 Favored Pre-proline 0 C--N 1.371 1.505 0 C-N-CA 117.696 -1.602 . . . . 0.56999999999999995 110.231 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.465 ' HB2' H603 ' A' ' 269' ' ' HSI . 39.6 Cg_endo -78.64 -15.05 13.88 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.278 1.319 . . . . 0.56999999999999995 112.711 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.89 130.18 45.73 Favored 'General case' 0 C--N 1.37 1.48 0 CA-C-O 122.813 1.292 . . . . 0.56999999999999995 109.411 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.481 ' CE2' HD13 ' A' ' 181' ' ' LEU . 6.3 t80 -89.53 106.75 18.66 Favored 'General case' 0 C--N 1.364 1.215 0 N-CA-C 105.822 -1.918 . . . . 0.56999999999999995 105.822 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -154.94 115.83 3.95 Favored 'General case' 0 C--N 1.372 1.556 0 N-CA-C 105.106 -2.183 . . . . 0.56999999999999995 105.106 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -68.6 113.71 6.35 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-O 125.093 2.378 . . . . 0.56999999999999995 110.081 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.4 p -95.75 -21.42 5.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 CA-C-N 114.142 -1.39 . . . . 0.56999999999999995 112.299 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.418 ' C ' HG13 ' A' ' 245' ' ' ILE 0.312 0.0 OUTLIER 82.32 -11.98 0.96 Allowed 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.033 0.833 . . . . 0.91000000000000003 111.282 -176.674 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.577 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.6 mt 87.54 14.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.795 0 C-N-CA 124.858 1.263 . . . . 0.56999999999999995 110.766 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.61 -30.47 46.55 Favored 'General case' 0 C--N 1.388 2.268 0 CA-C-O 125.595 2.617 . . . . 0.56999999999999995 106.273 -166.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 1.5 p -119.31 -10.09 9.79 Favored 'General case' 0 C--N 1.386 2.185 0 CA-C-N 112.072 -2.331 . . . . 0.56999999999999995 112.613 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.624 ' HZ ' HG11 ' A' ' 217' ' ' VAL . 49.9 t80 -48.01 103.64 0.05 OUTLIER 'General case' 0 C--N 1.374 1.668 0 CA-C-O 123.162 1.458 . . . . 0.56999999999999995 107.461 -172.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.427 ' NE ' ' O ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -138.4 146.71 42.54 Favored 'General case' 0 C--N 1.363 1.188 0 N-CA-C 104.816 -2.291 . . . . 1.2 104.816 -172.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.554 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -115.8 132.02 56.76 Favored 'General case' 0 C--N 1.368 1.373 0 CA-C-N 111.704 -2.498 . . . . 0.56999999999999995 106.482 -172.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.7 t -79.51 146.05 32.88 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 119.804 -1.81 . . . . 0.56999999999999995 109.325 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.82 90.18 Favored 'General case' 0 C--N 1.377 1.777 0 CA-C-N 114.704 -1.134 . . . . 0.56999999999999995 109.264 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.58 -39.35 90.86 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.462 -0.79 . . . . 0.91000000000000003 110.852 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.8 OUTLIER -64.22 -55.0 24.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.91000000000000003 110.871 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 256' ' ' ARG . 11.8 pt -65.99 -34.84 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 111.166 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.414 ' N ' HG13 ' A' ' 255' ' ' ILE . 6.7 mtt-85 -70.05 -31.45 69.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 1.2 110.927 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.53 56.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.56999999999999995 112.445 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.0 OUTLIER -64.94 -44.28 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.56999999999999995 111.149 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.6 ' CB ' HG23 ' A' ' 145' ' ' THR . 0.9 OUTLIER -72.08 -19.96 61.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.56999999999999995 110.913 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t -73.88 -19.55 60.68 Favored 'General case' 0 C--N 1.391 2.406 0 CA-C-O 126.135 2.874 . . . . 0.56999999999999995 107.782 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -54.97 15.52 Favored 'General case' 0 C--N 1.395 2.57 0 O-C-N 118.49 -2.632 . . . . 0.56999999999999995 108.397 -170.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.405 ' CD2' ' HD3' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -100.13 20.49 14.45 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 112.172 -2.286 . . . . 0.56999999999999995 115.622 175.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.278 2.864 0 N-CA-C 117.931 1.932 . . . . 0.91000000000000003 117.931 -177.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.694 H402 HG13 ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 110.808 -0.917 . . . . 0.56999999999999995 110.808 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -74.79 115.01 4.16 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.159 1.906 . . . . 0.56999999999999995 110.05 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.15 144.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.373 1.598 0 CA-C-N 113.671 -1.604 . . . . 0.56999999999999995 108.296 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -160.23 152.21 20.26 Favored 'General case' 0 C--N 1.384 2.099 0 CA-C-N 113.663 -1.608 . . . . 0.56999999999999995 107.509 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 -132.83 153.58 51.16 Favored 'General case' 0 C--N 1.373 1.627 0 CA-C-O 123.835 1.779 . . . . 1.2 107.691 -177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -48.79 1.73 Allowed 'General case' 0 C--N 1.383 2.041 0 CA-C-N 112.653 -2.067 . . . . 0.56999999999999995 109.89 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -85.11 -37.47 20.21 Favored 'General case' 0 C--N 1.383 2.038 0 CA-C-O 124.226 1.965 . . . . 0.56999999999999995 107.838 -173.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -81.39 122.46 27.52 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-N 114.066 -1.425 . . . . 0.56999999999999995 110.882 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.94 138.67 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.163 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.465 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 70.6 p -131.1 157.27 43.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 111.139 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.657 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -137.41 159.38 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 110.874 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -135.08 129.4 33.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD13 HG23 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -99.08 124.72 52.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.56999999999999995 111.145 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 118' ' ' ILE . 15.7 t-20 -41.81 -59.41 1.69 Allowed 'General case' 0 C--N 1.384 2.108 0 C-N-CA 117.498 -1.681 . . . . 0.56999999999999995 110.122 -173.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 164.36 35.49 0.0 OUTLIER 'General case' 0 C--N 1.387 2.201 0 O-C-N 126.023 2.077 . . . . 0.56999999999999995 109.521 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 127' ' ' ARG . 1.7 m-30 80.05 -173.37 0.05 Allowed 'General case' 0 C--N 1.385 2.151 0 N-CA-C 105.36 -2.089 . . . . 0.56999999999999995 105.36 170.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -130.69 160.72 65.04 Favored Pre-proline 0 C--N 1.369 1.45 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 108.835 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.66 -49.99 1.42 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.315 1.343 . . . . 0.56999999999999995 112.166 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.564 ' H ' HG23 ' A' ' 122' ' ' THR . 0.4 OUTLIER -82.22 -65.71 0.98 Allowed 'General case' 0 C--N 1.388 2.244 0 N-CA-C 104.726 -2.324 . . . . 0.91000000000000003 104.726 -163.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.596 ' SD ' HG22 ' A' ' 130' ' ' VAL . 2.0 ttm -59.62 140.9 56.0 Favored 'General case' 0 C--N 1.38 1.912 0 CA-C-O 126.464 3.031 . . . . 0.56999999999999995 110.071 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.4 OUTLIER -72.73 139.29 47.08 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 112.698 -2.046 . . . . 0.56999999999999995 109.773 -178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -69.63 -52.13 28.71 Favored 'General case' 0 C--N 1.374 1.658 0 N-CA-C 105.414 -2.069 . . . . 1.2 105.414 -168.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.32 -34.57 57.98 Favored 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.001 -2.363 . . . . 0.91000000000000003 110.877 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.881 ' HB3' HG21 ' A' ' 205' ' ' THR . 11.9 m-20 -69.76 -44.01 71.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.91000000000000003 110.931 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 126' ' ' ASN . 2.5 t -61.93 -41.5 91.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 111.166 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 134' ' ' ILE . 3.5 m-20 -65.82 -40.6 92.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.91000000000000003 110.858 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -37.98 81.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.56999999999999995 110.945 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.593 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -64.88 -49.18 71.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.083 -0.508 . . . . 0.56999999999999995 111.091 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 131' ' ' ASP . 12.3 pt -61.4 -41.47 90.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 111.135 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -43.58 97.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 1.2 110.853 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 140' ' ' VAL . 2.0 tppt? -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.56999999999999995 110.881 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.8 98.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.56999999999999995 111.092 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 116' ' ' TYR . 18.7 m-85 -63.7 -36.53 84.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.861 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.2 tp60 -67.71 -39.83 84.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.56999999999999995 110.903 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 136' ' ' LYS . 2.3 t -68.72 -34.05 62.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 111.196 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -84.5 -33.38 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 110.919 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 m -73.82 -47.67 36.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.849 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.46 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -62.34 -12.05 18.88 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 118.836 -1.145 . . . . 0.56999999999999995 112.877 -178.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG13 ' ND2' ' A' ' 143' ' ' ASN . 8.4 m -108.71 0.1 9.71 Favored 'Isoleucine or valine' 0 C--N 1.379 1.882 0 CA-C-N 113.844 -1.525 . . . . 0.56999999999999995 112.675 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.663 HG22 ' HD2' ' A' ' 146' ' ' PRO . 2.1 m -150.53 140.43 13.88 Favored Pre-proline 0 C--N 1.376 1.745 0 CA-C-O 124.234 1.969 . . . . 0.56999999999999995 110.559 -172.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.687 ' O ' HD23 ' A' ' 147' ' ' LEU . 45.5 Cg_endo -79.6 63.16 8.7 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 122.092 1.861 . . . . 0.56999999999999995 114.048 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 146' ' ' PRO . 0.9 OUTLIER -146.39 120.62 9.53 Favored 'General case' 0 C--N 1.38 1.913 0 N-CA-C 105.824 -1.917 . . . . 0.56999999999999995 105.824 -169.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.86 158.28 34.79 Favored 'General case' 0 C--N 1.382 1.982 0 CA-C-N 113.278 -1.783 . . . . 0.56999999999999995 113.416 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HZ ' HD22 ' A' ' 224' ' ' LEU . 0.8 OUTLIER -129.31 136.31 49.87 Favored 'General case' 0 C--N 1.388 2.276 0 CA-C-N 112.68 -2.055 . . . . 0.56999999999999995 109.818 -177.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.98 111.83 3.52 Favored 'General case' 0 C--N 1.387 2.232 0 CA-C-O 124.808 2.242 . . . . 0.56999999999999995 109.163 -175.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tttm -89.34 146.66 24.55 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 114.108 -1.405 . . . . 0.56999999999999995 111.938 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 154' ' ' THR . 4.9 pt -130.64 163.7 35.69 Favored 'Isoleucine or valine' 0 C--N 1.379 1.871 0 CA-C-N 113.44 -1.709 . . . . 0.56999999999999995 109.498 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.18 9.04 13.4 Favored 'General case' 0 C--N 1.382 2.004 0 CA-C-N 113.06 -1.882 . . . . 0.56999999999999995 111.552 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.489 ' O ' HD12 ' A' ' 152' ' ' ILE . 6.8 m -145.0 125.97 14.48 Favored 'General case' 0 C--N 1.376 1.737 0 N-CA-C 106.888 -1.523 . . . . 0.56999999999999995 106.888 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.97 -130.17 10.15 Favored Glycine 0 C--N 1.376 2.785 0 N-CA-C 109.389 -1.484 . . . . 0.56999999999999995 109.389 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.5 ttp -150.66 146.95 26.81 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.986 1.375 . . . . 0.56999999999999995 107.303 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.465 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -127.35 177.06 6.97 Favored 'General case' 0 C--N 1.373 1.59 0 CA-C-N 112.864 -1.971 . . . . 0.56999999999999995 109.695 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -65.23 -68.18 0.38 Allowed 'General case' 0 C--N 1.378 1.846 0 N-CA-C 104.69 -2.337 . . . . 0.91000000000000003 104.69 -168.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.0 mp -92.87 110.26 22.8 Favored 'Isoleucine or valine' 0 C--N 1.378 1.805 0 O-C-N 124.649 1.218 . . . . 0.56999999999999995 111.098 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 121.81 46.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.56999999999999995 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 118' ' ' ILE . 2.5 m -102.48 116.95 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.56999999999999995 111.136 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.615 HG22 ' CD2' ' A' ' 196' ' ' HIS . 1.5 m -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.56999999999999995 111.152 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -86.13 125.71 33.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.887 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.426 ' HB3' ' CE1' ' A' ' 168' ' ' HIS . . . -144.5 169.88 17.1 Favored 'General case' 0 C--N 1.369 1.445 0 C-N-CA 117.898 -1.521 . . . . 0.56999999999999995 107.675 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 168.29 9.42 Favored 'General case' 0 C--N 1.367 1.343 0 CA-C-N 114.2 -1.363 . . . . 1.2 108.608 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 174' ' ' PHE . . . -44.6 132.81 7.35 Favored Glycine 0 C--N 1.377 2.856 0 O-C-N 124.933 1.396 . . . . 0.56999999999999995 111.82 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.99 105.39 0.06 Allowed 'General case' 0 C--N 1.401 2.822 0 CA-C-O 124.668 2.175 . . . . 0.56999999999999995 112.385 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 164' ' ' ALA . 3.5 p-80 -173.74 26.08 0.01 OUTLIER 'General case' 0 C--N 1.387 2.206 0 CA-C-O 123.401 1.572 . . . . 0.56999999999999995 111.995 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.8 176.66 51.34 Favored Glycine 0 C--N 1.378 2.887 0 C-N-CA 118.79 -1.671 . . . . 0.56999999999999995 109.606 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.284 0.0 OUTLIER 56.71 17.82 3.37 Favored 'General case' 0 C--N 1.394 2.525 0 CA-C-N 113.39 -1.405 . . . . 0.91000000000000003 114.032 174.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 164.35 133.4 0.01 OUTLIER 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.112 1.911 . . . . 0.56999999999999995 108.161 -160.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.521 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 74.1 t60 -89.18 75.79 7.79 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 112.875 -1.966 . . . . 0.56999999999999995 109.248 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 78.2 132.44 0.05 Allowed 'General case' 0 C--N 1.387 2.225 0 CA-C-O 123.328 1.537 . . . . 0.56999999999999995 109.873 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.647 ' CZ ' HG21 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -117.19 -165.79 1.11 Allowed 'General case' 0 C--N 1.386 2.185 0 CA-C-N 113.146 -1.843 . . . . 0.56999999999999995 111.353 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.27 159.8 16.35 Favored 'General case' 0 C--N 1.38 1.913 0 CA-C-N 114.45 -1.25 . . . . 0.91000000000000003 109.849 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -136.52 62.28 0.6 Allowed Glycine 0 C--N 1.378 2.895 0 CA-C-O 123.869 1.816 . . . . 0.56999999999999995 110.095 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -166.66 -35.53 0.03 OUTLIER 'General case' 0 C--N 1.376 1.736 0 CA-C-N 113.23 -1.485 . . . . 0.56999999999999995 112.713 169.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.48 -63.68 0.04 OUTLIER Glycine 0 C--N 1.37 2.457 0 C-N-CA 119.567 -1.301 . . . . 0.56999999999999995 113.003 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 180' ' ' ILE . . . -35.88 112.39 0.12 Allowed Glycine 0 C--N 1.375 2.729 0 N-CA-C 109.241 -1.544 . . . . 0.56999999999999995 109.241 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.647 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 0.5 OUTLIER 88.91 52.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.889 0 O-C-N 119.217 -2.343 . . . . 0.56999999999999995 108.559 175.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.479 ' HG ' ' CH2' ' A' ' 203' ' ' TRP . 2.5 tp -43.11 -30.91 0.49 Allowed 'General case' 0 C--N 1.375 1.697 0 CA-C-O 123.797 1.76 . . . . 0.56999999999999995 112.083 -174.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . . . -179.49 179.78 0.58 Allowed 'General case' 0 C--N 1.368 1.41 0 CA-C-N 113.229 -1.805 . . . . 0.56999999999999995 111.123 178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.589 ' CE1' ' HB2' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -142.56 164.67 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.56999999999999995 110.837 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -152.79 140.87 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 111.037 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -89.93 152.49 21.2 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 117.816 -1.554 . . . . 0.56999999999999995 109.449 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.405 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -92.54 -42.17 4.59 Favored Glycine 0 C--N 1.373 2.595 0 CA-C-N 114.417 -1.265 . . . . 0.56999999999999995 113.623 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 50.7 Cg_exo -63.53 -143.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.401 3.32 0 CA-C-O 125.953 2.397 . . . . 0.56999999999999995 111.676 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -151.47 -148.31 4.78 Favored Glycine 0 C--N 1.376 2.755 0 C-N-CA 117.493 -2.289 . . . . 0.56999999999999995 109.781 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 191' ' ' ILE . 2.2 m 77.76 52.17 0.04 OUTLIER 'General case' 0 C--N 1.382 2.0 0 CA-C-N 112.629 -1.785 . . . . 0.56999999999999995 107.512 171.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.54 -72.73 2.75 Favored Glycine 0 C--N 1.376 2.761 0 N-CA-C 106.919 -2.473 . . . . 0.56999999999999995 106.919 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 189' ' ' SER . 1.9 mp -70.12 -48.2 63.48 Favored 'Isoleucine or valine' 0 C--N 1.374 1.649 0 CA-C-O 125.85 2.738 . . . . 0.56999999999999995 105.515 -171.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.29 153.92 53.03 Favored Glycine 0 C--N 1.378 2.91 0 C-N-CA 116.282 -2.866 . . . . 0.56999999999999995 108.351 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 80.96 -15.23 22.46 Favored Glycine 0 C--N 1.372 2.549 0 CA-C-O 124.178 1.988 . . . . 0.56999999999999995 113.305 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -68.07 146.38 53.54 Favored 'General case' 0 C--N 1.374 1.636 0 O-C-N 120.287 -1.714 . . . . 0.91000000000000003 110.833 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 183' ' ' HIS . . . -144.04 137.36 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.56999999999999995 111.098 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.615 ' CD2' HG22 ' A' ' 162' ' ' VAL . 1.1 m170 -128.39 150.17 50.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 110.791 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 182' ' ' ALA . 0.3 OUTLIER -123.11 150.19 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.881 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.48 112.62 14.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.91000000000000003 110.799 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -43.5 88.54 Favored 'General case' 0 C--N 1.383 2.053 0 CA-C-O 117.436 -1.268 . . . . 0.91000000000000003 108.966 -174.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.74 -32.85 0.65 Allowed 'General case' 0 C--N 1.38 1.9 0 O-C-N 125.646 1.841 . . . . 0.91000000000000003 108.959 -173.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.96 176.1 0.44 Allowed 'General case' 0 C--N 1.384 2.072 0 CA-C-O 126.535 3.064 . . . . 0.91000000000000003 109.216 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.91 80.5 1.33 Allowed 'General case' 0 C--N 1.383 2.025 0 CA-C-N 112.615 -2.084 . . . . 0.56999999999999995 109.016 -175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.484 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 79.6 m95 -76.13 109.14 9.54 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 106.977 -1.49 . . . . 0.56999999999999995 106.977 -175.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.57 121.88 31.75 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-O 125.149 2.404 . . . . 0.56999999999999995 109.869 -175.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.881 HG21 ' HB3' ' A' ' 129' ' ' ASP . 11.2 p -96.99 151.27 19.87 Favored 'General case' 0 C--N 1.368 1.395 0 N-CA-C 106.198 -1.778 . . . . 0.56999999999999995 106.198 -176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.65 -48.55 0.23 Allowed 'General case' 0 C--N 1.378 1.805 0 CA-C-N 114.316 -1.311 . . . . 0.56999999999999995 109.915 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.3 m -168.78 137.98 2.21 Favored 'General case' 0 C--N 1.384 2.092 0 N-CA-C 108.05 -1.093 . . . . 0.56999999999999995 108.05 -174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 148.2 -36.92 1.09 Allowed Glycine 0 C--N 1.382 3.122 0 CA-C-N 114.358 -1.292 . . . . 0.56999999999999995 111.671 176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 148.82 -84.16 0.17 Allowed Glycine 0 C--N 1.386 3.344 0 CA-C-O 123.801 1.778 . . . . 0.56999999999999995 111.686 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.0 p -78.7 135.94 37.3 Favored 'General case' 0 C--N 1.383 2.025 0 CA-C-N 113.079 -1.56 . . . . 0.56999999999999995 110.964 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.71 141.39 52.14 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 113.949 -1.478 . . . . 0.56999999999999995 108.011 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.743 ' HG ' HG13 ' A' ' 130' ' ' VAL . 1.4 tm? -71.15 -26.74 63.13 Favored 'General case' 0 C--N 1.387 2.225 0 CA-C-O 125.086 2.374 . . . . 0.56999999999999995 108.576 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.545 ' CD1' HG12 ' A' ' 245' ' ' ILE . 3.5 t80 -57.6 -50.15 74.08 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-N 113.862 -1.517 . . . . 0.56999999999999995 110.855 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.649 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.2 OUTLIER -61.61 -51.22 69.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.56999999999999995 110.933 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -44.41 97.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.56999999999999995 111.147 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.424 ' HA ' ' OE2' ' A' ' 219' ' ' GLU . . . -57.08 -41.36 78.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 111.079 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.42 -39.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.56999999999999995 111.096 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.458 ' CD2' ' CE ' ' A' ' 236' ' ' MET . 3.7 t-160 -70.08 -50.51 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.56999999999999995 110.802 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 216' ' ' ALA . 0.7 OUTLIER -64.08 -42.02 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.91000000000000003 110.902 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.713 HG22 HD23 ' A' ' 224' ' ' LEU . 69.8 mt -69.01 -34.22 62.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.56999999999999995 111.113 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 225' ' ' GLY . . . -69.19 -33.48 73.78 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.699 -0.762 . . . . 0.56999999999999995 112.444 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.59 -44.02 95.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 110.842 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.24 -49.96 37.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.56999999999999995 110.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.713 HD23 HG22 ' A' ' 220' ' ' ILE . 0.5 OUTLIER -84.04 13.48 5.02 Favored 'General case' 0 C--N 1.392 2.441 0 CA-C-O 123.595 1.664 . . . . 0.56999999999999995 115.324 177.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.449 ' HA2' ' OH ' ' A' ' 262' ' ' TYR . . . -153.12 176.93 31.02 Favored Glycine 0 C--N 1.363 2.04 0 CA-C-O 126.635 3.353 . . . . 0.56999999999999995 108.167 -168.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -158.93 0.23 Allowed 'General case' 0 C--N 1.367 1.337 0 CA-C-O 125.873 2.749 . . . . 0.56999999999999995 109.278 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.78 -143.18 0.11 Allowed Glycine 0 C--N 1.387 3.411 0 CA-C-O 125.524 2.736 . . . . 0.56999999999999995 112.311 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 236' ' ' MET . 34.0 m170 -83.83 -175.29 5.74 Favored 'General case' 0 C--N 1.379 1.861 0 O-C-N 120.444 -1.621 . . . . 0.56999999999999995 114.609 174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.528 ' CB ' ' HB1' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -99.11 -84.46 0.4 Allowed 'General case' 0 C--N 1.389 2.308 0 N-CA-C 106.448 -1.686 . . . . 0.56999999999999995 106.448 179.314 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 m 155.81 -30.25 0.0 OUTLIER 'General case' 0 C--N 1.389 2.29 0 O-C-N 125.842 1.964 . . . . 0.56999999999999995 113.168 -167.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.596 ' O ' ' HB3' ' A' ' 234' ' ' ALA . 3.3 t70 -110.2 152.07 42.95 Favored Pre-proline 0 C--N 1.388 2.282 0 N-CA-C 108.291 -1.003 . . . . 0.91000000000000003 108.291 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -60.7 -47.83 12.48 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.687 2.258 . . . . 0.56999999999999995 111.92 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -14.42 22.79 Favored 'General case' 0 C--N 1.381 1.948 0 CA-C-N 113.252 -1.794 . . . . 0.56999999999999995 115.284 176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 231' ' ' ASP . . . -71.46 120.11 16.57 Favored 'General case' 0 C--N 1.375 1.674 0 CA-C-O 125.158 2.408 . . . . 0.56999999999999995 113.0 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 236' ' ' MET . 68.2 t -73.93 86.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.867 0 CA-C-N 111.446 -2.615 . . . . 0.56999999999999995 108.612 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.458 ' CE ' ' CD2' ' A' ' 218' ' ' HIS . 0.0 OUTLIER 162.06 -34.28 0.0 OUTLIER 'General case' 0 C--N 1.377 1.802 0 O-C-N 125.37 1.669 . . . . 0.56999999999999995 109.273 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 4.4 t80 -49.97 146.96 7.33 Favored Pre-proline 0 C--N 1.372 1.579 0 CA-C-O 122.971 1.367 . . . . 0.56999999999999995 110.223 -175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 74.0 Cg_exo -56.53 -36.99 98.27 Favored 'Trans proline' 0 C--N 1.393 2.904 0 C-N-CA 122.219 1.946 . . . . 0.56999999999999995 112.406 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.4 m -45.39 111.79 0.38 Allowed 'General case' 0 C--N 1.376 1.741 0 CA-C-O 123.633 1.683 . . . . 0.56999999999999995 110.642 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.413 ' CD1' ' C ' ' A' ' 240' ' ' TYR . 0.2 OUTLIER -83.92 94.62 8.29 Favored 'General case' 0 C--N 1.38 1.914 0 CA-C-O 124.385 2.041 . . . . 0.56999999999999995 106.431 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.704 ' HB3' ' H35' ' A' ' 269' ' ' HSI . 1.2 tmtt? -110.84 119.41 39.01 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 113.122 -1.854 . . . . 0.56999999999999995 108.124 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -55.6 120.91 7.96 Favored 'General case' 0 C--N 1.38 1.922 0 CA-C-O 126.105 2.859 . . . . 0.56999999999999995 110.991 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 248' ' ' PHE . 5.4 p -140.79 115.23 5.88 Favored 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 105.86 -1.904 . . . . 0.56999999999999995 105.86 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -77.3 33.46 0.16 Allowed 'General case' 0 C--N 1.364 1.239 0 N-CA-C 114.885 1.439 . . . . 0.91000000000000003 114.885 170.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.545 HG12 ' CD1' ' A' ' 213' ' ' PHE . 2.5 mt 82.94 -2.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.382 1.987 0 CA-C-O 124.145 1.926 . . . . 0.56999999999999995 108.713 173.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -88.5 -35.48 16.96 Favored 'General case' 0 C--N 1.38 1.904 0 N-CA-C 103.016 -2.957 . . . . 0.56999999999999995 103.016 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.464 ' O ' 'CL1 ' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -113.27 3.47 15.97 Favored 'General case' 0 C--N 1.387 2.229 0 CA-C-N 113.47 -1.695 . . . . 0.56999999999999995 109.778 -173.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.485 ' N ' HG21 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -80.72 12.06 3.43 Favored 'General case' 0 C--N 1.386 2.195 0 O-C-N 125.754 1.909 . . . . 0.56999999999999995 109.86 -171.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 154.07 12.02 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 124.724 2.202 . . . . 1.2 107.778 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -120.07 126.97 52.08 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 103.676 -2.713 . . . . 0.56999999999999995 103.676 -167.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.03 140.53 48.79 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-O 124.883 2.278 . . . . 0.56999999999999995 116.323 169.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.47 86.83 Favored 'General case' 0 C--N 1.394 2.531 0 CA-C-N 113.689 -1.596 . . . . 0.56999999999999995 110.184 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.22 -33.12 74.69 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.994 -1.003 . . . . 0.91000000000000003 110.863 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -63.95 -55.23 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.91000000000000003 110.901 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 256' ' ' ARG . 28.5 pt -66.19 -35.14 74.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.56999999999999995 111.144 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.418 ' N ' HG13 ' A' ' 255' ' ' ILE . 75.8 mtt-85 -70.17 -32.95 71.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.2 110.92 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.7 -48.0 58.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.56999999999999995 112.495 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.3 pt -62.42 -45.8 97.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 0.56999999999999995 111.1 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.467 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 1.1 pt20 -72.53 -19.11 61.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.56999999999999995 110.954 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.61 -15.13 63.23 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 122.575 1.178 . . . . 0.56999999999999995 110.687 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.536 HD23 ' CE2' ' A' ' 262' ' ' TYR . 0.3 OUTLIER -84.05 -52.58 6.19 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-O 123.618 1.675 . . . . 0.56999999999999995 111.986 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.536 ' CE2' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER -103.82 90.26 3.58 Favored 'General case' 0 C--N 1.376 1.724 0 CA-C-N 113.866 -1.515 . . . . 0.56999999999999995 111.311 -173.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.386 3.31 0 N-CA-C 121.243 3.257 . . . . 0.91000000000000003 121.243 -171.501 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 0.704 ' H35' ' HB3' ' A' ' 241' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 3.17 0 N-CA-C 111.338 -0.705 . . . . 0.56999999999999995 111.338 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.52 143.39 42.53 Favored 'Trans proline' 0 C--N 1.376 1.992 0 O-C-N 123.291 1.153 . . . . 0.56999999999999995 110.997 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.77 120.38 55.78 Favored 'Isoleucine or valine' 0 C--N 1.382 1.98 0 CA-C-N 113.466 -1.697 . . . . 0.56999999999999995 108.295 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -130.87 -9.36 3.92 Favored 'General case' 0 C--N 1.384 2.072 0 CA-C-N 112.883 -1.962 . . . . 0.56999999999999995 111.127 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.89 172.19 7.41 Favored 'General case' 0 C--N 1.382 2.019 0 CA-C-N 114.817 -1.083 . . . . 1.2 110.942 175.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' CD ' ' N ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER 60.14 176.94 0.09 Allowed 'General case' 0 C--N 1.399 2.746 0 CA-C-N 113.407 -1.724 . . . . 0.56999999999999995 110.471 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.27 -84.99 0.03 OUTLIER 'General case' 0 C--N 1.387 2.224 0 CA-C-N 114.23 -1.35 . . . . 0.56999999999999995 110.323 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 150' ' ' SER . 31.0 t80 -117.49 107.08 13.87 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.44 1.713 . . . . 0.56999999999999995 110.933 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.405 HG23 ' OD2' ' A' ' 158' ' ' ASP . 0.7 OUTLIER -103.0 147.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.56999999999999995 111.149 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.688 ' C ' ' HB1' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -109.79 134.96 51.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.145 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -143.87 155.61 44.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.56999999999999995 110.892 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -142.43 139.4 31.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.851 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.08 142.97 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.118 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 163' ' ' PHE . 22.9 t30 -54.07 -63.87 1.01 Allowed 'General case' 0 C--N 1.366 1.29 0 N-CA-C 108.433 -0.951 . . . . 0.56999999999999995 108.433 -171.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.45 -172.01 3.2 Favored 'General case' 0 C--N 1.38 1.916 0 N-CA-C 107.398 -1.334 . . . . 0.56999999999999995 107.398 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' HG22 ' A' ' 122' ' ' THR . 3.3 p90 -176.96 82.57 0.02 OUTLIER 'General case' 0 C--N 1.39 2.327 0 CA-C-O 124.419 2.057 . . . . 0.56999999999999995 113.653 -172.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.53 HG23 ' CD ' ' A' ' 123' ' ' PRO . 0.5 OUTLIER -171.71 -56.28 0.0 OUTLIER Pre-proline 0 C--N 1.372 1.574 0 O-C-N 119.894 -1.753 . . . . 0.56999999999999995 110.167 -174.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.53 ' CD ' HG23 ' A' ' 122' ' ' THR . 12.0 Cg_endo -69.9 -55.31 0.18 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 N-CA-C 107.932 -1.603 . . . . 0.56999999999999995 107.932 -171.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -129.46 -12.07 4.47 Favored 'General case' 0 C--N 1.379 1.857 0 CA-C-N 114.221 -1.354 . . . . 0.91000000000000003 110.921 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -114.19 128.08 56.2 Favored 'General case' 0 C--N 1.38 1.907 0 CA-C-O 124.638 2.161 . . . . 0.56999999999999995 106.798 -175.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.819 ' H ' HG21 ' A' ' 205' ' ' THR . 0.5 OUTLIER -90.02 144.56 25.8 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.446 -2.659 . . . . 0.56999999999999995 110.256 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -53.49 8.27 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 106.409 -1.701 . . . . 1.2 106.409 -171.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -64.54 -37.69 88.42 Favored 'General case' 0 C--N 1.378 1.818 0 CA-C-N 114.222 -1.354 . . . . 0.91000000000000003 110.934 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 205' ' ' THR . 19.4 t70 -70.2 -44.06 69.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.91000000000000003 110.896 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.75 HG22 ' HG ' ' A' ' 212' ' ' LEU . 21.0 t -69.22 -46.28 77.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.095 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -56.82 -44.16 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.839 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -39.6 90.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.56999999999999995 110.908 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.733 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -65.37 -49.07 70.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.56999999999999995 111.141 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 135' ' ' ARG . 48.4 pt -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.56999999999999995 111.172 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.458 ' N ' HG13 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -61.06 -49.32 77.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.853 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.44 -35.66 81.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.56999999999999995 110.88 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.913 ' HB1' HD11 ' A' ' 220' ' ' ILE . . . -65.98 -41.41 91.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.56999999999999995 111.133 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' CE1' ' CB ' ' A' ' 149' ' ' PHE . 1.8 m-85 -67.25 -33.67 75.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 110.835 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 140' ' ' VAL . 1.6 pt20 -68.44 -40.72 81.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.912 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 144' ' ' VAL . 5.2 p -70.53 -34.35 57.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.56999999999999995 111.168 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.801 ' CD2' HD11 ' A' ' 224' ' ' LEU . 4.4 m95 -83.25 -33.72 25.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.93 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.6 m -78.26 -50.55 11.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.56999999999999995 110.898 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.756 ' ND2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -56.59 -13.88 2.75 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 113.278 0.844 . . . . 0.56999999999999995 113.278 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.756 HG13 ' ND2' ' A' ' 143' ' ' ASN . 18.2 m -114.52 9.11 7.7 Favored 'Isoleucine or valine' 0 C--N 1.379 1.889 0 CA-C-N 114.541 -1.209 . . . . 0.56999999999999995 111.451 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 141' ' ' TRP . 19.2 p -149.23 147.17 22.78 Favored Pre-proline 0 C--N 1.373 1.594 0 CA-C-O 124.599 2.142 . . . . 0.56999999999999995 108.484 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.85 22.07 1.0 Allowed 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 121.544 1.496 . . . . 0.56999999999999995 113.056 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.813 HD11 ' CE1' ' A' ' 262' ' ' TYR . 0.4 OUTLIER -127.91 101.03 6.15 Favored 'General case' 0 C--N 1.378 1.829 0 N-CA-C 105.619 -1.993 . . . . 0.56999999999999995 105.619 -173.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.27 159.59 30.98 Favored 'General case' 0 C--N 1.372 1.557 0 CA-C-O 126.77 3.176 . . . . 0.56999999999999995 116.263 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . 45.6 m-85 -132.19 162.64 30.42 Favored 'General case' 0 C--N 1.382 2.01 0 CA-C-N 112.533 -2.122 . . . . 0.56999999999999995 107.396 -177.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 113' ' ' TYR . 54.3 m -157.67 123.33 4.62 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 125.859 2.742 . . . . 0.56999999999999995 108.394 -172.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -95.97 141.48 29.34 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-N 113.344 -1.753 . . . . 0.56999999999999995 110.972 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 155' ' ' GLY . 4.4 pt -129.93 159.55 41.85 Favored 'Isoleucine or valine' 0 C--N 1.383 2.044 0 CA-C-O 124.276 1.988 . . . . 0.56999999999999995 108.986 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.4 -15.01 14.56 Favored 'General case' 0 C--N 1.384 2.097 0 CA-C-N 113.117 -1.856 . . . . 0.56999999999999995 107.807 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 89.3 m -60.22 -59.8 4.83 Favored 'General case' 0 C--N 1.386 2.165 0 CA-C-O 123.343 1.544 . . . . 0.56999999999999995 107.373 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.511 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 138.93 146.16 4.9 Favored Glycine 0 C--N 1.38 2.997 0 N-CA-C 110.539 -1.024 . . . . 0.56999999999999995 110.539 -177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.6 ttp 78.79 88.59 0.06 Allowed 'General case' 0 C--N 1.399 2.758 0 CA-C-O 124.465 2.078 . . . . 0.56999999999999995 110.075 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.688 ' HB1' ' C ' ' A' ' 115' ' ' THR . . . -133.9 172.16 13.18 Favored 'General case' 0 C--N 1.373 1.622 0 CA-C-N 113.158 -1.837 . . . . 0.56999999999999995 109.718 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 115' ' ' THR . 33.1 m-20 -61.15 -59.4 5.39 Favored 'General case' 0 C--N 1.37 1.469 0 N-CA-C 105.836 -1.913 . . . . 0.91000000000000003 105.836 -173.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.82 109.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.388 2.282 0 O-C-N 124.326 1.016 . . . . 0.56999999999999995 111.118 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -100.8 128.59 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.56999999999999995 110.933 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 197' ' ' PHE . 17.4 t -105.48 118.26 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.56999999999999995 111.087 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 196' ' ' HIS . 6.8 t -131.48 132.16 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.56999999999999995 111.085 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 119' ' ' ASN . 4.2 m-85 -90.61 121.32 32.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.56999999999999995 110.836 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -142.15 166.57 24.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 123.044 1.402 . . . . 0.56999999999999995 107.599 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.97 167.62 9.76 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-N 114.19 -1.368 . . . . 1.2 109.888 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 167' ' ' ALA . . . -39.45 121.49 1.42 Allowed Glycine 0 C--N 1.395 3.825 0 O-C-N 125.297 1.623 . . . . 0.56999999999999995 111.018 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 166' ' ' GLY . . . 87.71 80.9 0.01 OUTLIER 'General case' 0 C--N 1.397 2.653 0 CA-C-O 125.214 2.435 . . . . 0.56999999999999995 109.882 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -140.29 -54.48 0.52 Allowed 'General case' 0 C--N 1.39 2.351 0 CA-C-N 113.13 -1.85 . . . . 0.56999999999999995 110.494 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 173.04 -173.15 45.54 Favored Glycine 0 C--N 1.377 2.806 0 N-CA-C 109.091 -1.604 . . . . 0.56999999999999995 109.091 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 78.25 -71.68 0.1 Allowed 'General case' 0 C--N 1.4 2.776 0 CA-C-N 112.642 -1.779 . . . . 0.91000000000000003 107.691 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.5 -166.54 1.33 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 124.647 2.165 . . . . 0.56999999999999995 108.023 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.636 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 21.9 m170 -77.99 65.09 3.33 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-N 114.194 -1.366 . . . . 0.56999999999999995 109.67 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 172' ' ' HIS . . . 78.85 -166.98 0.04 OUTLIER 'General case' 0 C--N 1.387 2.212 0 CA-C-N 114.168 -1.378 . . . . 0.56999999999999995 111.768 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.434 ' CB ' ' HA2' ' A' ' 166' ' ' GLY . 0.1 OUTLIER -124.11 -161.5 1.0 Allowed 'General case' 0 C--N 1.39 2.361 0 CA-C-N 113.01 -1.904 . . . . 0.56999999999999995 111.804 175.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.448 ' CB ' ' H ' ' A' ' 180' ' ' ILE . 0.0 OUTLIER -87.61 -54.38 4.3 Favored 'General case' 0 C--N 1.388 2.269 0 CA-C-N 114.676 -1.147 . . . . 0.91000000000000003 111.934 174.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.03 105.64 0.05 OUTLIER Glycine 0 C--N 1.396 3.87 0 C-N-CA 118.591 -1.766 . . . . 0.56999999999999995 117.317 -166.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.66 90.4 0.09 Allowed 'General case' 0 C--N 1.381 1.967 0 CA-C-O 125.28 2.467 . . . . 0.56999999999999995 112.43 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.29 -144.73 26.09 Favored Glycine 0 C--N 1.381 3.079 0 O-C-N 119.529 -1.982 . . . . 0.56999999999999995 113.453 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.425 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 52.72 -118.96 8.6 Favored Glycine 0 C--N 1.395 3.817 0 N-CA-C 108.39 -1.884 . . . . 0.56999999999999995 108.39 170.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.448 ' H ' ' CB ' ' A' ' 175' ' ' ASP . 0.6 OUTLIER -76.57 74.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.706 0 N-CA-C 105.94 -1.874 . . . . 0.56999999999999995 105.94 -175.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.899 HD22 ' CE1' ' A' ' 240' ' ' TYR . 0.9 OUTLIER -38.23 -33.94 0.11 Allowed 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.417 1.087 . . . . 0.56999999999999995 109.881 -175.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -178.41 179.95 0.73 Allowed 'General case' 0 C--N 1.383 2.057 0 O-C-N 125.727 1.892 . . . . 0.56999999999999995 111.081 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.456 ' ND1' ' C ' ' A' ' 183' ' ' HIS . 0.1 OUTLIER -151.03 151.01 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.56999999999999995 110.865 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 195' ' ' ALA . . . -142.81 140.36 31.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.56999999999999995 111.063 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 193' ' ' GLY . 0.1 OUTLIER -87.64 124.24 33.33 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 118.323 -1.351 . . . . 0.56999999999999995 108.715 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -124.48 50.19 0.87 Allowed Glycine 0 C--N 1.371 2.476 0 O-C-N 120.756 -1.215 . . . . 0.56999999999999995 113.579 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 33.9 Cg_endo -76.49 -52.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 121.217 1.278 . . . . 0.56999999999999995 109.765 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 112.17 47.36 0.71 Allowed Glycine 0 C--N 1.392 3.642 0 CA-C-O 123.759 1.755 . . . . 0.56999999999999995 111.869 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -155.02 -147.79 0.22 Allowed 'General case' 0 C--N 1.384 2.065 0 O-C-N 121.074 -1.251 . . . . 0.56999999999999995 108.732 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -55.85 -79.19 0.1 OUTLIER Glycine 0 C--N 1.388 3.466 0 CA-C-O 126.105 3.058 . . . . 0.56999999999999995 112.531 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -11.55 6.69 Favored 'Isoleucine or valine' 0 C--N 1.387 2.232 0 CA-C-O 124.823 2.249 . . . . 0.56999999999999995 110.362 178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -50.06 126.51 22.71 Favored Glycine 0 C--N 1.37 2.446 0 O-C-N 118.292 -2.755 . . . . 0.56999999999999995 111.829 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 185' ' ' PHE . . . 108.93 -50.14 0.8 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 113.527 -1.336 . . . . 0.56999999999999995 111.985 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -34.92 102.7 0.02 OUTLIER 'General case' 0 C--N 1.379 1.877 0 O-C-N 124.649 0.852 . . . . 0.91000000000000003 110.901 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 184' ' ' ALA . . . -116.52 150.32 38.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.56999999999999995 111.068 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.469 ' CD2' ' HB ' ' A' ' 162' ' ' VAL . 19.5 m170 -135.03 139.16 44.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.56999999999999995 110.854 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CH2' ' A' ' 203' ' ' TRP . 0.4 OUTLIER -111.09 150.11 29.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.56999999999999995 110.903 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.414 ' HB3' ' CD ' ' A' ' 201' ' ' GLU . 1.5 m-20 -58.31 110.82 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.467 . . . . 0.91000000000000003 110.788 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.405 ' HB2' ' C ' ' A' ' 163' ' ' PHE . 4.2 tp10 -77.91 -20.66 52.47 Favored 'General case' 0 C--N 1.37 1.49 0 CA-C-O 126.423 3.011 . . . . 0.91000000000000003 108.555 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -12.38 60.27 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 118.3 -2.75 . . . . 0.91000000000000003 110.712 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 198' ' ' ASP . 0.0 OUTLIER -82.05 -179.63 7.47 Favored 'General case' 0 C--N 1.398 2.678 0 N-CA-C 102.651 -3.092 . . . . 0.91000000000000003 102.651 -168.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.98 82.05 1.59 Allowed 'General case' 0 C--N 1.386 2.189 0 CA-C-N 113.346 -1.752 . . . . 0.56999999999999995 110.624 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 197' ' ' PHE . 60.5 m95 -72.51 102.93 3.35 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-O 123.788 1.756 . . . . 0.56999999999999995 108.754 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.629 HG21 ' O ' ' A' ' 208' ' ' GLY . 0.1 OUTLIER -80.35 130.82 35.44 Favored 'General case' 0 C--N 1.37 1.478 0 CA-C-N 113.762 -1.563 . . . . 0.56999999999999995 110.953 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.819 HG21 ' H ' ' A' ' 126' ' ' ASN . 7.7 p -119.02 101.24 7.88 Favored 'General case' 0 C--N 1.385 2.135 0 CA-C-N 113.034 -1.894 . . . . 0.56999999999999995 107.752 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 77.6 36.73 0.26 Allowed 'General case' 0 C--N 1.403 2.9 0 CA-C-O 126.039 2.828 . . . . 0.56999999999999995 104.863 168.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.3 t -138.07 -92.22 0.21 Allowed 'General case' 0 C--N 1.391 2.406 0 CA-C-N 112.716 -2.038 . . . . 0.56999999999999995 109.053 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.629 ' O ' HG21 ' A' ' 204' ' ' THR . . . -173.58 156.39 24.0 Favored Glycine 0 C--N 1.38 3.022 0 CA-C-N 114.943 -1.026 . . . . 0.56999999999999995 110.541 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.24 -136.44 13.01 Favored Glycine 0 C--N 1.369 2.412 0 CA-C-O 124.126 1.959 . . . . 0.56999999999999995 111.242 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.9 m -69.08 117.54 10.86 Favored 'General case' 0 C--N 1.384 2.078 0 CA-C-O 123.317 1.532 . . . . 0.56999999999999995 112.517 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.595 ' H ' ' ND2' ' A' ' 211' ' ' ASN . 0.7 OUTLIER -102.92 153.91 19.74 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-O 123.311 1.529 . . . . 0.56999999999999995 111.603 176.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.75 ' HG ' HG22 ' A' ' 130' ' ' VAL . 2.1 tm? -72.72 -31.45 64.98 Favored 'General case' 0 C--N 1.389 2.324 0 CA-C-N 113.347 -1.752 . . . . 0.56999999999999995 106.653 -176.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.965 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.6 t80 -59.04 -50.46 73.99 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 120.086 -1.634 . . . . 0.56999999999999995 110.859 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 1.049 HD11 ' H19' ' A' ' 269' ' ' HSI . 0.1 OUTLIER -58.19 -51.83 68.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 110.906 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.554 HG23 HD23 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -68.53 -33.96 75.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.56999999999999995 111.178 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 219' ' ' GLU . . . -68.83 -39.48 79.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.56999999999999995 111.114 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 213' ' ' PHE . 41.4 t -68.1 -38.46 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.56999999999999995 111.154 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -70.06 -50.85 37.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.56999999999999995 110.837 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.51 ' OE2' HG23 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -56.6 -45.19 81.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.91000000000000003 110.913 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.913 HD11 ' HB1' ' A' ' 137' ' ' ALA . 5.5 pt -72.73 -39.28 59.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 111.075 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.03 -33.88 64.92 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.56999999999999995 112.474 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.86 -44.02 94.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.56999999999999995 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -50.24 55.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.56999999999999995 110.828 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.801 HD11 ' CD2' ' A' ' 141' ' ' TRP . 3.4 pp -75.82 0.6 17.51 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.954 2.576 . . . . 0.56999999999999995 117.954 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -145.73 -158.79 7.86 Favored Glycine 0 C--N 1.358 1.791 0 N-CA-C 108.072 -2.011 . . . . 0.56999999999999995 108.072 -173.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.28 -156.73 0.76 Allowed 'General case' 0 C--N 1.375 1.679 0 CA-C-N 113.051 -1.574 . . . . 0.56999999999999995 107.678 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -55.93 -167.21 0.06 OUTLIER Glycine 0 C--N 1.397 3.951 0 CA-C-O 125.717 2.843 . . . . 0.56999999999999995 112.486 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 236' ' ' MET . 1.5 m80 -100.28 -150.31 0.38 Allowed 'General case' 0 C--N 1.37 1.484 0 O-C-N 120.387 -1.654 . . . . 0.56999999999999995 110.225 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.803 ' OG ' ' HB2' ' A' ' 234' ' ' ALA . 9.1 p -122.39 -24.24 5.05 Favored 'General case' 0 C--N 1.387 2.219 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 110.493 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 83.06 16.43 0.31 Allowed 'General case' 0 C--N 1.398 2.704 0 CA-C-O 123.2 1.476 . . . . 0.56999999999999995 113.21 -177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -134.29 150.28 73.59 Favored Pre-proline 0 C--N 1.386 2.18 0 N-CA-C 104.818 -2.29 . . . . 0.91000000000000003 104.818 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 237' ' ' PHE . 72.5 Cg_exo -56.6 -20.58 34.81 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.091 2.527 . . . . 0.56999999999999995 114.036 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -40.29 85.09 Favored 'General case' 0 C--N 1.385 2.142 0 CA-C-N 113.329 -1.76 . . . . 0.56999999999999995 115.628 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.862 ' HB3' ' HB3' ' A' ' 237' ' ' PHE . . . -51.79 128.33 23.43 Favored 'General case' 0 C--N 1.382 1.986 0 CA-C-O 123.86 1.79 . . . . 0.56999999999999995 110.716 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 249' ' ' ARG . 0.4 OUTLIER -75.52 2.48 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.385 2.126 0 CA-C-O 125.38 2.514 . . . . 0.56999999999999995 111.53 -177.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.496 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 5.7 ptm -142.31 8.19 1.79 Allowed 'General case' 0 N--CA 1.428 -1.544 0 O-C-N 120.422 -1.424 . . . . 0.56999999999999995 110.188 -175.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.862 ' HB3' ' HB3' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -42.79 143.96 1.11 Allowed Pre-proline 0 C--N 1.37 1.459 0 CA-C-O 124.097 1.903 . . . . 0.56999999999999995 112.844 175.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.403 ' O ' ' H14' ' A' ' 269' ' ' HSI . 71.9 Cg_exo -51.92 -50.31 14.41 Favored 'Trans proline' 0 C--N 1.371 1.728 0 O-C-N 119.481 -0.852 . . . . 0.56999999999999995 112.351 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.505 ' HB ' ' CE2' ' A' ' 237' ' ' PHE . 0.2 OUTLIER -52.46 126.46 19.45 Favored 'General case' 0 C--N 1.368 1.411 0 CA-C-O 123.318 1.532 . . . . 0.56999999999999995 109.669 -175.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.899 ' CE1' HD22 ' A' ' 181' ' ' LEU . 78.4 t80 -99.28 166.57 11.15 Favored 'General case' 0 C--N 1.367 1.358 0 O-C-N 119.959 -1.713 . . . . 0.56999999999999995 107.833 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 169.36 121.45 0.01 OUTLIER 'General case' 0 C--N 1.39 2.352 0 N-CA-C 106.058 -1.83 . . . . 0.56999999999999995 106.058 173.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.85 121.6 6.19 Favored 'General case' 0 C--N 1.373 1.607 0 CA-C-O 124.842 2.258 . . . . 0.56999999999999995 110.882 175.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 243' ' ' VAL . 7.1 p -147.38 113.93 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.87 0 CA-C-N 113.741 -1.572 . . . . 0.56999999999999995 107.702 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -44.65 146.0 0.81 Allowed 'General case' 0 C--N 1.383 2.044 0 CA-C-O 125.737 2.684 . . . . 0.91000000000000003 107.719 -177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.897 HG23 ' CE1' ' A' ' 213' ' ' PHE . 3.9 mp -62.03 -22.87 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-N 113.319 -1.764 . . . . 0.56999999999999995 112.603 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.66 -21.93 66.63 Favored 'General case' 0 C--N 1.372 1.585 0 CA-C-O 123.034 1.397 . . . . 0.56999999999999995 111.397 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.6 p -108.36 1.11 21.58 Favored 'General case' 0 C--N 1.385 2.134 0 N-CA-C 114.904 1.446 . . . . 0.56999999999999995 114.904 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CE1' HG11 ' A' ' 217' ' ' VAL . 51.3 t80 -74.47 83.84 1.99 Allowed 'General case' 0 C--N 1.376 1.725 0 CA-C-O 124.973 2.32 . . . . 0.56999999999999995 109.292 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 235' ' ' VAL . 1.6 tmt_? -99.32 154.79 17.91 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-O 123.813 1.768 . . . . 1.2 108.913 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.725 HD13 ' N ' ' A' ' 250' ' ' LEU . 0.0 OUTLIER -121.84 136.1 54.92 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 125.194 2.426 . . . . 0.56999999999999995 106.246 -173.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 42.5 m -67.67 137.65 55.73 Favored 'General case' 0 C--N 1.376 1.719 0 CA-C-N 113.305 -1.771 . . . . 0.56999999999999995 111.627 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -65.08 -46.36 81.45 Favored 'General case' 0 C--N 1.384 2.099 0 N-CA-C 108.055 -1.091 . . . . 0.56999999999999995 108.055 -174.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.71 -36.81 79.76 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 115.41 -0.814 . . . . 0.91000000000000003 110.845 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.644 ' O ' HG23 ' A' ' 258' ' ' ILE . 40.8 t0 -63.46 -55.22 25.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.91000000000000003 110.846 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 256' ' ' ARG . 21.3 pt -66.09 -36.38 77.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.56999999999999995 111.116 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.448 ' N ' HG13 ' A' ' 255' ' ' ILE . 4.3 mtt-85 -70.32 -33.33 71.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.828 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.86 76.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 0.56999999999999995 112.48 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 254' ' ' ASP . 1.2 pt -64.81 -45.05 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.685 0.279 . . . . 0.56999999999999995 111.052 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.497 ' N ' ' CG1' ' A' ' 258' ' ' ILE . 0.8 OUTLIER -72.14 -23.5 61.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.56999999999999995 110.981 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.1 t -71.03 -32.55 69.33 Favored 'General case' 0 C--N 1.366 1.302 0 CA-C-O 122.403 1.096 . . . . 0.56999999999999995 109.785 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.42 -66.19 0.44 Allowed 'General case' 0 C--N 1.387 2.208 0 CA-C-O 123.416 1.579 . . . . 0.56999999999999995 109.608 -175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.813 ' CE1' HD11 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -107.4 116.56 32.15 Favored 'General case' 0 C--N 1.377 1.801 0 CA-C-N 113.718 -1.583 . . . . 0.56999999999999995 111.761 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.383 3.193 0 CA-C-O 114.817 -3.213 . . . . 0.91000000000000003 118.048 -171.573 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' HSI . . . . . 1.049 ' H19' HD11 ' A' ' 214' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_